PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tang, W; Yu, F; Yao, H; Cui, X; Jiao, Y; Lin, L; Chen, J; Yin, D; Song, E; Liu, Q				Tang, W.; Yu, F.; Yao, H.; Cui, X.; Jiao, Y.; Lin, L.; Chen, J.; Yin, D.; Song, E.; Liu, Q.			miR-27a regulates endothelial differentiation of breast cancer stem like cells	ONCOGENE			English	Article						breast cancer; cancer stem cell; microRNA; miR-27a; angiogenesis; endothelial differentiation	TUMOR MICROVASCULATURE; MICROENVIRONMENT; ANGIOGENESIS; VASCULARIZATION; MICRORNAS; TARGETS	Recent studies suggested that cancer stem cells (CSCs) are capable of differentiating into endothelial cells and tumor endothelium may be derived from CSCs. But the mechanism remains unclear. We showed that vascular endothelial growth factor (VEGF) induced the expression of endothelial markers in breast cancer stem like cells (BCSLCs). In addition, the VEGF-treated BCSLCs formed capillary structure in matrigel and released vWF upon histamine treatment. The miR-27a expression was significantly increased in VEGF-treated BCSLCs. Antagonizing miR-27a by miR-27a anti-sense oligos (ASOs) in VEGF-treated BCSLCs led to decreased endothelial markers and function, while increasing miR-27a in BCSLCs resulted in enhanced endothelial properties. VEGF enhanced the transcription of miR-27a by increasing RUNX1 binding to miR-27a promoter. Increased miR-27a paralleled the reduced expression of ZBTB10, a known miR-27a target. Both expression of miR-27a and knockdown of ZBTB10 in BCSLCs promoted in vivo angiogenesis and tumor metastasis. Further, we demonstrated that VEGF-treated BCSLCs secreted more endogenous VEGF compared with undifferentiated BCSLCs. Thus, miR-27a promotes angiogenesis by mediating endothelial differentiation of BCSLCs and it may be a new target for anti-angiogenesis cancer therapy.	[Tang, W.; Yu, F.; Yao, H.; Lin, L.; Chen, J.; Song, E.; Liu, Q.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou 510120, Guangdong, Peoples R China; [Cui, X.; Yin, D.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Key Lab Malignant Tumor Gene Regulat & Target The, Guangzhou 510120, Guangdong, Peoples R China; [Jiao, Y.] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510120, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Liu, Q (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, 107 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.	songerwei02@yahoo.com.cn; victorlq@hotmail.com		Lin, Ling/0000-0001-5603-0688; Liu, Qiang/0000-0002-5451-4862; Yao, Herui/0000-0001-5520-6469	973 Projects from the Ministry of Science and Technology of China [2010CB912800, 2011CB504203]; Natural Science Foundation of China [81072178, 81272894, 81230060, 81261140373, 81071788]; Ministry of Education of China [20120171110075]; Ministry of Health of China [2011ZX09102-010-02]; Guangdong Natural Science Fundation for Distinguished Young Scholar [S20120011199]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD) [81000-3149001]	973 Projects from the Ministry of Science and Technology of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Ministry of Health of China; Guangdong Natural Science Fundation for Distinguished Young Scholar; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD)(Foundation for the Author of National Excellent Doctoral Dissertation of China)	This work was supported by the 973 Projects (2010CB912800, 2011CB504203) from the Ministry of Science and Technology of China, and grants from the Natural Science Foundation of China (81072178, 81272894, 81230060, 81261140373, 81071788), Ministry of Education of China (20120171110075), a grant for Development of Important New Drugs from the Ministry of Health of China (2011ZX09102-010-02), grants from Guangdong Natural Science Fundation for Distinguished Young Scholar (S20120011199) and Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD, 81000-3149001).	Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; Bussolati B, 2009, J CELL MOL MED, V13, P309, DOI 10.1111/j.1582-4934.2008.00338.x; de Castro G, 2006, CRIT REV ONCOL HEMAT, V59, P40, DOI 10.1016/j.critrevonc.2006.02.007; Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302; Fang K, 2012, CURR MOL MED, V12, P536, DOI 10.2174/156652412800620002; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; JAIN RK, 1988, CANCER RES, V48, P2641; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Leonardo TR, 2012, NAT CELL BIOL, V14, P1114, DOI 10.1038/ncb2613; Liu C, 2011, CANCER RES, V71, P5950, DOI 10.1158/0008-5472.CAN-11-1035; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Tang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051702; Wang H, 2005, CELL BIOL INT, V29, P654, DOI 10.1016/j.cellbi.2005.03.019; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Weigand Melanie, 2005, Angiogenesis, V8, P197, DOI 10.1007/s10456-005-9010-0; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	25	75	78	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2629	2638		10.1038/onc.2013.214	http://dx.doi.org/10.1038/onc.2013.214			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23752185				2022-12-25	WOS:000336502700009
J	Yan, S; Serna, S; Reichardt, NC; Paschinger, K; Wilson, IBH				Yan, Shi; Serna, Sonia; Reichardt, Niels-Christian; Paschinger, Katharina; Wilson, Iain B. H.			Array-assisted Characterization of a Fucosyltransferase Required for the Biosynthesis of Complex Core Modifications of Nematode N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOENZYMATIC SYNTHESIS; SUBSTRATE-SPECIFICITY; MOLECULAR-CLONING; IMMUNE-RESPONSES; GLYCOPROTEIN; MICROARRAYS; DISCOVERY; ANTIGEN; ALPHA-1,3-FUCOSYL-TRANSFERASE; IDENTIFICATION	Fucose is a common monosaccharide component of cell surfaces and is involved in many biological recognition events. Therefore, definition and exploitation of the specificity of the enzymes (fucosyltransferases) involved in fucosylation is a recurrent theme in modern glycosciences. Despite various studies, the specificities of many fucosyltransferases are still unknown, so new approaches are required to study these. The model nematode Caenorhabditis elegans expresses a wide range of fucosylated glycans, includingN-linked oligosaccharides with unusual complex core modifications. Up to three fucose residues can be present on the standard N, N'-diacetylchitobiose unit of these N-glycans, but only the fucosyltransferases responsible for transfer of two of these (the core alpha 1,3-fucosyltransferase FUT-1 and the core alpha 1,6-fucosyltransferase FUT-8) were previously characterized. By use of a glycan library in both array and solution formats, we were able to reveal that FUT-6, another C. elegans alpha 1,3-fucosyltransferase, modifies nematode glycan cores, specifically the distal N-acetylglucosamine residue; this result is in accordance with glycomic analysis of fut-6 mutant worms. This core-modifying activity of FUT-6 in vitro and in vivo is in addition to its previously determined ability to synthesize Lewis X epitopes in vitro. A larger scale synthesis of a nematode N-glycan core in vitro using all three fucosyltransferases was performed, and the nature of the glycosidic linkages was determined by NMR. FUT-6 is probably the first eukaryotic glycosyltransferase whose specificity has been redefined with the aid of glycan microarrays and so is a paradigm for the study of other unusual glycosidic linkages in model and parasitic organisms.	[Yan, Shi; Paschinger, Katharina; Wilson, Iain B. H.] Univ Bodenkultur, Dept Chem, A-1190 Vienna, Austria; [Serna, Sonia; Reichardt, Niels-Christian] CICbiomaGUNE, Biofunct Nanomat Unit, San Sebastian 20009, Spain	CIC biomaGUNE	Wilson, IBH (corresponding author), Univ Bodenkultur, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Serna, Sonia/K-5795-2014; Yan, Shi/H-9091-2013; Serna, Sonia/ABF-5345-2020; Wilson, Iain/B-3326-2009; Reichardt, Niels-Christian/K-8950-2017; biomaGUNE, CIC/J-9136-2014	Serna, Sonia/0000-0002-2085-4412; Yan, Shi/0000-0003-4949-9140; Wilson, Iain/0000-0001-8996-1518; Reichardt, Niels-Christian/0000-0002-9092-7023; Paschinger, Katharina/0000-0002-3594-7136; biomaGUNE, CIC/0000-0001-7690-0660	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [P23922, P21946]; Spanish Ministerio de Ciencia e Innovacion Projects [CTQ2008-04444/BQA, CTQ2011-27874]; Government of the Basque Country (Etortek grant); European Commission (Euroglycanarrays Marie Curie ITN) [PITN-GA-2008-215536]; Austrian Science Fund (FWF) [P 21946, P 23922] Funding Source: researchfish	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Spanish Ministerio de Ciencia e Innovacion Projects; Government of the Basque Country (Etortek grant); European Commission (Euroglycanarrays Marie Curie ITN); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grants P23922 (to I. B. H. W.) and P21946 (to K. P.), by Spanish Ministerio de Ciencia e Innovacion Projects CTQ2008-04444/BQA and CTQ2011-27874, by the Government of the Basque Country (Etortek grant), and by the European Commission (Euroglycanarrays Marie Curie ITN, PITN-GA-2008-215536).	Agard NJ, 2009, ACCOUNTS CHEM RES, V42, P788, DOI 10.1021/ar800267j; Aranzamendi C, 2011, EXP PARASITOL, V129, P221, DOI 10.1016/j.exppara.2011.08.015; Ban L, 2008, ANGEW CHEM INT EDIT, V47, P3396, DOI 10.1002/anie.200704998; Ban L, 2012, NAT CHEM BIOL, V8, P769, DOI [10.1038/NCHEMBIO.1022, 10.1038/nchembio.1022]; Blaxter M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001050; Blixt O, 2008, GLYCOCONJUGATE J, V25, P59, DOI 10.1007/s10719-007-9062-z; Blixt O, 2006, METHOD ENZYMOL, V415, P137, DOI 10.1016/S0076-6879(06)15009-0; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; DeBose-Boyd RA, 1998, GLYCOBIOLOGY, V8, P905, DOI 10.1093/glycob/8.9.905; Ellis SE, 2012, PARASITE IMMUNOL, V34, P285, DOI 10.1111/j.1365-3024.2011.01317.x; Fazio F, 2002, J AM CHEM SOC, V124, P14397, DOI 10.1021/ja020887u; HAGOPIAN A, 1968, ARCH BIOCHEM BIOPHYS, V128, P422, DOI 10.1016/0003-9861(68)90048-9; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Haslam SM, 1996, J BIOL CHEM, V271, P30561, DOI 10.1074/jbc.271.48.30561; Haslam SM, 1999, J BIOL CHEM, V274, P20953, DOI 10.1074/jbc.274.30.20953; Haslam SM, 2000, GLYCOBIOLOGY, V10, P223, DOI 10.1093/glycob/10.2.223; Hein WR, 2005, VET PARASITOL, V132, P217, DOI 10.1016/j.vetpar.2005.07.006; Iskratsch T, 2009, ANAL BIOCHEM, V386, P133, DOI 10.1016/j.ab.2008.12.005; Laurent N, 2008, CHEMBIOCHEM, V9, P883, DOI 10.1002/cbic.200700692; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; Morelle W, 2000, GLYCOBIOLOGY, V10, P941, DOI 10.1093/glycob/10.9.941; Nguyen K, 2007, GLYCOBIOLOGY, V17, P586, DOI 10.1093/glycob/cwm023; Nyame AK, 1998, GLYCOBIOLOGY, V8, P615, DOI 10.1093/glycob/8.6.615; Park S, 2013, CHEM SOC REV, V42, P4310, DOI 10.1039/c2cs35401b; Paschinger K, 2004, J BIOL CHEM, V279, P49588, DOI 10.1074/jbc.M408978200; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Rendic D, 2007, BIOCHEM J, V402, P105, DOI 10.1042/BJ20060964; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Sanchez-Ruiz A, 2011, ANGEW CHEM INT EDIT, V50, P1801, DOI 10.1002/anie.201006304; Sardzik R, 2012, J AM CHEM SOC, V134, P4521, DOI 10.1021/ja211861m; Schubert M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002706; Serna S, 2011, J AM CHEM SOC, V133, P16495, DOI 10.1021/ja205392z; Serna S, 2010, CHEM-EUR J, V16, P13163, DOI 10.1002/chem.201001295; Shipp M, 2008, GLYCOCONJUGATE J, V25, P49, DOI 10.1007/s10719-007-9060-1; Soderman P, 2002, EUR J ORG CHEM, V2002, P1614, DOI 10.1002/1099-0690(200205)2002:10<1614::AID-EJOC1614>3.0.CO;2-1; Struwe WB, 2012, GLYCOBIOLOGY, V22, P863, DOI 10.1093/glycob/cws053; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Takeuchi T, 2008, GLYCOBIOLOGY, V18, P882, DOI 10.1093/glycob/cwn077; Tawill S, 2004, INFECT IMMUN, V72, P398, DOI 10.1128/IAI.72.1.398-407.2004; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; Tundup S, 2012, ANN NY ACAD SCI, V1253, pE1, DOI 10.1111/j.1749-6632.2012.06618.x; Voglmeir J, 2010, OMICS, V14, P437, DOI 10.1089/omi.2010.0035; Walti MA, 2008, J MOL BIOL, V379, P146, DOI 10.1016/j.jmb.2008.03.062; WESTON BW, 1992, J BIOL CHEM, V267, P4152; Yan S, 2012, J BIOL CHEM, V287, P28276, DOI 10.1074/jbc.M112.353128	47	26	30	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21015	21028		10.1074/jbc.M113.479147	http://dx.doi.org/10.1074/jbc.M113.479147			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754284	Green Published, hybrid			2022-12-25	WOS:000322014400023
J	Ruiz, MF; Sarno, F; Zorrilla, S; Rivas, G; Sanchez, L				Fernanda Ruiz, Maria; Sarno, Francesca; Zorrilla, Silvia; Rivas, German; Sanchez, Lucas			Biochemical and Functional Analysis of Drosophila-Sciara Chimeric Sex-Lethal Proteins	PLOS ONE			English	Article							DOSAGE COMPENSATION REGULATORS; MSL-2 MESSENGER-RNA; DETERMINING GENE; TRANSLATIONAL REPRESSION; X-CHROMOSOME; SWITCH GENE; SPLICE-SITE; BINDING; MELANOGASTER; EXPRESSION	Background: The Drosophila SXL protein controls sex determination and dosage compensation. It is a sex-specific factor controlling splicing of its own Sxl pre-mRNA (auto-regulation), tra pre-mRNA (sex determination) and msl-2 pre-mRNA plus translation of msl-2 mRNA (dosage compensation). Outside the drosophilids, the same SXL protein has been found in both sexes so that, in the non-drosophilids, SXL does not appear to play the key discriminating role in sex determination and dosage compensation that it plays in Drosophila. Comparison of SXL proteins revealed that its spatial organisation is conserved, with the RNA-binding domains being highly conserved, whereas the N- and C-terminal domains showing significant variation. This manuscript focuses on the evolution of the SXL protein itself and not on regulation of its expression. Methodology: Drosophila-Sciara chimeric SXL proteins were produced. Sciara SXL represents the non-sex-specific function of ancient SXL in the non-drosophilids from which presumably Drosophila SXL evolved. Two questions were addressed. Did the Drosophila SXL protein have affected their functions when their N- and C-terminal domains were replaced by the corresponding ones of Sciara? Did the Sciara SXL protein acquire Drosophila sex-specific functions when the Drosophila Nand C-terminal domains replaced those of Sciara? The chimeric SXL proteins were analysed in vitro to study their binding affinity and cooperative properties, and in vivo to analyse their effect on sex determination and dosage compensation by producing Drosophila flies that were transgenic for the chimeric SXL proteins. Conclusions: The sex-specific properties of extant Drosophila SXL protein depend on its global structure rather than on a specific domain. This implies that the modifications, mainly in the N- and C-terminal domains, that occurred in the SXL protein during its evolution within the drosophilid lineage represent co-evolutionary changes that determine the appropriate folding of SXL to carry out its sex-specific functions.	[Fernanda Ruiz, Maria; Sarno, Francesca; Rivas, German; Sanchez, Lucas] CSIC, Ctr Invest Biol, Madrid, Spain; [Zorrilla, Silvia] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Sanchez, L (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	lsanchez@cib.csic.es	Sarno, Francesca/AAA-8460-2019; Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Ruiz, Maria Fernanda/F-3290-2016; Sánchez, Lucas/K-4238-2015; Zorrilla, Silvia/J-9771-2014	Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Sánchez, Lucas/0000-0002-7725-8961; Ruiz, Maria Fernanda/0000-0002-1649-2105; Zorrilla, Silvia/0000-0002-6309-9058	Spanish Government	Spanish Government(Spanish GovernmentEuropean Commission)	This study was supported by the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; ALBRECHT EB, 1993, GENETICS, V134, P801; BACHILLER D, 1991, GENET RES, V57, P23, DOI 10.1017/S0016672300028998; BACHILLER D, 1986, DEV BIOL, V118, P379, DOI 10.1016/0012-1606(86)90007-2; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; Bopp D, 1996, DEVELOPMENT, V122, P971; BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; Cline TW, 2010, GENETICS, V186, P1321, DOI 10.1534/genetics.110.121202; CLINE TW, 1984, GENETICS, V107, P231; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; DACUNHA PR, 1994, GENETICS, V138, P787; Deng XX, 2011, NAT GENET, V43, P1179, DOI 10.1038/ng.948; Deshpande G, 1999, DEVELOPMENT, V126, P2841; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Gerbi S.A., 1986, Results and Problems in Cell Differentiation, V13, P71; Granadino B, 1997, P NATL ACAD SCI USA, V94, P7343, DOI 10.1073/pnas.94.14.7343; GRANADINO B, 1990, EMBO J, V9, P2597, DOI 10.1002/j.1460-2075.1990.tb07441.x; Granadino B, 1996, MOL GEN GENET, V253, P26, DOI 10.1007/s004380050292; Gupta Vaijayanti, 2006, J Biol, V5, P3, DOI 10.1186/jbiol30; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; HILFIKER A, 1991, ROUX ARCH DEV BIOL, V200, P240, DOI 10.1007/BF00241293; Hilfiker A, 1995, DEVELOPMENT, V121, P4017; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; KANAAR R, 1995, EMBO J, V14, P4530, DOI 10.1002/j.1460-2075.1995.tb00132.x; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagos D, 2005, GENE, V348, P111, DOI 10.1016/j.gene.2004.12.053; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Lucchesi JC, 2009, CURR OPIN GENET DEV, V19, P550, DOI 10.1016/j.gde.2009.10.004; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Meiklejohn CD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001126; Meise M, 1998, DEVELOPMENT, V125, P1487; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; MULLERHOLTKAMP F, 1995, J MOL EVOL, V41, P467, DOI 10.1007/BF00160318; Mullon C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-5; Niimi T, 2006, GENOME, V49, P263, DOI 10.1139/G05-108; Oliver B, 2002, INT REV CYTOL, V219, P1; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; Penalva LOF, 1996, GENETICS, V144, P1653; RASTELLI L, 1995, MECH DEVELOP, V53, P223, DOI 10.1016/0925-4773(95)00438-7; Rastelli L, 1998, MECH DEVELOP, V71, P107, DOI 10.1016/S0925-4773(98)00009-4; Ruiz MF, 2003, GENE EXPR PATTERNS, V3, P341, DOI 10.1016/S1567-133X(03)00031-0; Ruiz MF, 2000, GENETICS, V156, P1853; Saccone G, 1998, DEVELOPMENT, V125, P1495; Sakashita E, 1996, J BIOCHEM, V120, P1028; Salz HK, 1996, GENETICS, V144, P95; Samuels M, 1998, NUCLEIC ACIDS RES, V26, P2625, DOI 10.1093/nar/26.11.2625; SAMUELS ME, 1994, MOL CELL BIOL, V14, P4975, DOI 10.1128/MCB.14.7.4975; SANCHEZ L, 1983, EMBO J, V2, P485, DOI 10.1002/j.1460-2075.1983.tb01451.x; Sanchez L, 2008, INT J DEV BIOL, V52, P1059, DOI 10.1387/ijdb.072439ls; Serna E, 2004, GENETICS, V168, P907, DOI 10.1534/genetics.104.031278; Sievert V, 2000, GENOME, V43, P382, DOI 10.1139/gen-43-2-382; Sievert V, 1997, GENOME, V40, P211, DOI 10.1139/g97-030; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Traut W, 2006, GENOME, V49, P254, DOI 10.1139/G05-107; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Vibranovski MD, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-49; Wang JW, 1997, J BIOL CHEM, V272, P22227, DOI 10.1074/jbc.272.35.22227; WANG JW, 1994, GENE DEV, V8, P2072, DOI 10.1101/gad.8.17.2072; Yanowitz JL, 1999, MOL CELL BIOL, V19, P3018; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x	69	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65171	10.1371/journal.pone.0065171	http://dx.doi.org/10.1371/journal.pone.0065171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762307	Green Published, gold			2022-12-25	WOS:000320440500030
J	Mehta, R; Katta, H; Alimirah, F; Patel, R; Murillo, G; Peng, XJ; Muzzio, M; Mehta, RG				Mehta, Rajeshwari; Katta, Harshadadevi; Alimirah, Fatouma; Patel, Rutulkumar; Murillo, Genoveva; Peng, Xinjian; Muzzio, Miguel; Mehta, Rajendra G.			Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; HEPATOCYTE GROWTH; AKT INHIBITOR; UNPHOSPHORYLATED STAT3; GENE-EXPRESSION; CARCINOMA; ACTIVATION; APOPTOSIS; LINES	Background: Treatment of breast cancer patients with antiestrogens and aromatase inhibitor(s) or Herceptin have shown significant success in steroid receptor positive or Her-2+ breast cancers respectively. However, choice of treatments for breast cancer patients with negative status for estrogen, progesterone receptors and HER2/neu is limited. As a result, search for appropriate therapy regimen for these triple negative breast cancers (TNBC) has become a major focus of investigations for many laboratories. Recently, Deguelin, a natural product isolated from African plant Mundulea sericea (Leguminossae) has shown both antiproliferative actions in various cancers including breast as well as chemoprenventive activity against carcinogen induced experimental cancers. In this report we evaluated efficacy and mechanism of action of Deguelin in triple negative breast cancer cell lines. Methods/Findings: In vitro, Deguelin in a dose and time dependent manner inhibited the growth of MDA-MB-231, MDA-MB-468, BT-549 and BT-20 cells. Deguelin (2 or 4 mg/kg body weight), when injected intraperitoneally, reduced the in vivo tumor growth of MDA-MB-231 cells transplanted subcutaneously in athymic mice. Moreover it was nontoxic as evident from daily observations on mobility, food and water consumption and comparison of bodyweight and other visceral organ weights with those in control animals at the termination of the study. The western blot analyses and immunostaining studies indicated that the deguelin effects may be mediated through EGFR-PAKT/c-Met p-ERK and NF-kappa B by down regulating their downstream targets such as p-STAT3, c-Myc, Survivin. Conclusion/Significance: These results suggest that Deguelin may have a significant therapeutic value for the treatment of TNBC patients.	[Mehta, Rajendra G.] IIT Res Inst, Div Canc Biol, Chicago, IL USA; IIT Res Inst, Div Analyt Chem, Chicago, IL USA	Illinois Institute of Technology; Illinois Institute of Technology	Mehta, RG (corresponding author), IIT Res Inst, Div Canc Biol, Chicago, IL USA.	RMehta@iitri.org		Patel, Rutulkumar/0000-0001-6652-6070	National Institutes of Health (NIH), National Cancer Institute (NCI) [R01-140321]; NATIONAL CANCER INSTITUTE [R01CA140321] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health (NIH), National Cancer Institute (NCI) grant R01-140321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 1998, LANCET, V351, P882, DOI 10.1016/S0140-6736(05)70294-4; Aggarwal BB, 2011, CANCER DISCOV, V1, P469, DOI 10.1158/2159-8290.CD-11-0260; Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Bilici A, 2012, J BUON, V17, P209; Bonine-Summers AR, 2007, CANCER BIOL THER, V6, P561, DOI 10.4161/cbt.6.4.3851; Brouckaert O, 2012, INT J WOMENS HEALTH, V4, P511, DOI 10.2147/IJWH.S18541; Caboni P, 2004, CHEM RES TOXICOL, V17, P1540, DOI 10.1021/tx049867r; Chen Q, 2009, BIOCHIM BIOPHYS ACTA, V1796, P162; Chu Zhao-hui, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P533; CIARDIELLO F, 1991, ANN ONCOL, V2, P169; DAVIDSON NE, 1987, MOL ENDOCRINOL, V1, P216, DOI 10.1210/mend-1-3-216; Dell'Eva R, 2007, CARCINOGENESIS, V28, P404, DOI 10.1093/carcin/bgl162; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Griffiths Carrie L, 2012, J Pharm Pract, V25, P319, DOI 10.1177/0897190012442062; Gumuskaya B, 2010, CANCER GENET CYTOGEN, V203, P222, DOI 10.1016/j.cancergencyto.2010.07.118; Huang WL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-309; Kang HW, 2012, DIGEST DIS SCI, V57, P2873, DOI 10.1007/s10620-012-2237-x; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Martinez-Carpio PA, 1999, CELL SIGNAL, V11, P753, DOI 10.1016/S0898-6568(99)00048-0; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; Mehta Rajendra G, 2002, Curr Oncol Rep, V4, P478, DOI 10.1007/s11912-002-0059-2; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Murillo G, 2003, INT J CANCER, V104, P7, DOI 10.1002/ijc.10901; Murillo G, 2009, CANCER PREV RES, V2, P942, DOI 10.1158/1940-6207.CAPR-08-0232; Nair AS, 2006, J IMMUNOL, V177, P5612, DOI 10.4049/jimmunol.177.8.5612; Nakajima H, 2012, BREAST CANC; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; Sizemore N, 1999, GASTROENTEROLOGY, V117, P567, DOI 10.1016/S0016-5085(99)70449-X; Takabatake D, 2007, INT J CANCER, V120, P181, DOI 10.1002/ijc.22187; Tamm I, 1998, CANCER RES, V58, P5315; Thamilselvan V, 2011, INT J CANCER, V129, P2916, DOI 10.1002/ijc.25949; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Waligorska-Stachura J, 2012, GINEKOL POL, V83, P537; Xu C., 2012, BREAST CANC; Yan Y, 2005, NEOPLASIA, V7, P1053, DOI 10.1593/neo.05532; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuen HF, 2012, BIOSCIENCE REP, V32, P413, DOI 10.1042/BSR20120050; Zhang YW, 2010, CANCER RES, V70, P6880, DOI 10.1158/0008-5472.CAN-10-0898	43	46	49	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65113	10.1371/journal.pone.0065113	http://dx.doi.org/10.1371/journal.pone.0065113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762292	Green Submitted, Green Published, gold			2022-12-25	WOS:000320440500024
J	Betanzos, A; Javier-Reyna, R; Garcia-Rivera, G; Banuelos, C; Gonzalez-Mariscal, L; Schnoor, M; Orozco, E				Betanzos, Abigail; Javier-Reyna, Rosario; Garcia-Rivera, Guillermina; Banuelos, Cecilia; Gonzalez-Mariscal, Lorenza; Schnoor, Michael; Orozco, Esther			The EhCPADH112 Complex of Entamoeba histolytica Interacts with Tight Junction Proteins Occludin and Claudin-1 to Produce Epithelial Damage	PLOS ONE			English	Article							LIVER-ABSCESS FORMATION; CYSTEINE PROTEASE; CELLS; PARASITE; ADHESIN; LECTIN; PHOSPHORYLATION; IDENTIFICATION; PERMEABILITY; EHADH112	Entamoeba histolytica, the protozoan responsible for human amoebiasis, causes between 30,000 and 100,000 deaths per year worldwide. Amoebiasis is characterized by intestinal epithelial damage provoking severe diarrhea. However, the molecular mechanisms by which this protozoan causes epithelial damage are poorly understood. Here, we studied the initial molecular interactions between the E. histolytica EhCPADH112 virulence complex and epithelial MDCK and Caco-2 cells. By confocal microscopy, we discovered that after contact with trophozoites or trophozoite extracts (TE), EhCPADH112 and proteins forming this complex (EhCP112 and EhADH112) co-localize with occludin and claudin-1 at tight junctions (TJ). Immunoprecipitation assays revealed interaction between EhCPADH112 and occludin, claudin-1, ZO-1 and ZO-2. Overlay assays confirmed an interaction of EhCP112 and EhADH112 with occludin and claudin-1, whereas only EhADH112 interacted also with ZO-2. We observed degradation of all mentioned TJ proteins after incubation with TE. Importantly, inhibiting proteolytic activity or blocking the complex with a specific antibody not only prevented TJ protein degradation but also epithelial barrier disruption. Furthermore, we discovered that TE treatment induces autophagy and apoptosis in MDCK cells that could contribute to the observed barrier disruption. Our results suggest a model in which epithelial damage caused by E. histolytica is initiated by the interaction of EhCP112 and EhADH112 with TJ proteins followed by their degradation. Disruption of TJs then induces increased paracellular permeability, thus facilitating the entry of more proteases and other parasite molecules leading eventually to tissue destruction.	[Betanzos, Abigail; Javier-Reyna, Rosario; Garcia-Rivera, Guillermina; Orozco, Esther] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Distrito Fed, Mexico; [Gonzalez-Mariscal, Lorenza] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Physiol Biophys & Neurosci, Distrito Fed, Mexico; [Schnoor, Michael] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Mol Biomed, Distrito Fed, Mexico; [Banuelos, Cecilia] Inst Sci & Technol Fed Dist, Distrito Fed, Mexico; [Orozco, Esther] Autonomous Univ Mexico City, Distrito Fed, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Orozco, E (corresponding author), Natl Polytech Inst, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Distrito Fed, Mexico.	orozco.esther@gmail.com	Schnoor, Michael/H-1863-2016	Schnoor, Michael/0000-0002-0269-5884; Gonzalez-Mariscal, Lorenza/0000-0003-4914-7671; Betanzos, Abigail/0000-0003-1761-0481	European Economic Community [ICA4-CT-2001-10073]; Institute of Science and Technology of the Federal District [64/2012]	European Economic Community; Institute of Science and Technology of the Federal District	This study was supported by the European Economic Community (Phagoamoeba project ICA4-CT-2001-10073) and the Institute of Science and Technology of the Federal District (grant number 64/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonte-Becerril M, 2010, APOPTOSIS, V15, P631, DOI 10.1007/s10495-010-0458-z; ARROYO R, 1987, MOL BIOCHEM PARASIT, V23, P151, DOI 10.1016/0166-6851(87)90150-2; Avila-Flores A, 2001, BIOCHEM J, V360, P295, DOI 10.1042/0264-6021:3600295; Bansal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000551; Banuelos C, 2005, EXP PARASITOL, V110, P292, DOI 10.1016/j.exppara.2005.03.005; Banuelos C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/657942; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Betanzos A, 2004, EXP CELL RES, V292, P51, DOI 10.1016/j.yexcr.2003.08.007; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Garcia-Rivera G, 1999, MOL MICROBIOL, V33, P556, DOI 10.1046/j.1365-2958.1999.01500.x; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Horwitz AF, 1997, SCI AM, V276, P68, DOI 10.1038/scientificamerican0597-68; Hou YZ, 2010, J BIOL CHEM, V285, P35497, DOI 10.1074/jbc.M109.066035; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Joyce M. P., 1988, Amebiasis: human infection by Entamoeba histolytica., P129; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Kim KA, 2013, KOREAN J PARASITOL, V51, P61, DOI 10.3347/kjp.2013.51.1.61; Kissoon-Singh V, 2013, AM J PATHOL, V182, P852, DOI 10.1016/j.ajpath.2012.11.035; Lauwaet T, 2004, INT J PARASITOL, V34, P549, DOI 10.1016/j.ijpara.2003.11.013; Leippe M, 1997, PARASITOL TODAY, V13, P178, DOI 10.1016/S0169-4758(97)01038-7; Lejeune M, 2011, AM J PATHOL, V179, P807, DOI 10.1016/j.ajpath.2011.05.001; LEROY A, 1995, INFECT IMMUN, V63, P4253, DOI 10.1128/IAI.63.11.4253-4260.1995; Leroy A, 2000, ARCH MED RES, V31, pS218, DOI 10.1016/S0188-4409(00)00145-4; Leroy A, 2000, FASEB J, V14, P1139, DOI 10.1096/fasebj.14.9.1139; Leroy Ancy, 1997, Invasion and Metastasis, V17, P138; LI E, 1994, INFECT IMMUN, V62, P5112, DOI 10.1128/IAI.62.11.5112-5119.1994; Lopez-Vancell R, 2000, PARASITOL RES, V86, P226, DOI 10.1007/s004360050035; Martinez-Lopez C, 2004, CELL MICROBIOL, V6, P367, DOI 10.1111/j.1462-5822.2004.00363.x; MARTINEZPALOMO A, 1985, J PROTOZOOL, V32, P166, DOI 10.1111/j.1550-7408.1985.tb03033.x; Mortimer L, 2010, EXP PARASITOL, V126, P366, DOI 10.1016/j.exppara.2010.03.005; Ocadiz R, 2005, CELL MICROBIOL, V7, P221, DOI 10.1111/j.1462-5822.2004.00453.x; OROZCO E, 1983, J EXP MED, V158, P1511, DOI 10.1084/jem.158.5.1511; Perez-Tamayo R., 1986, Amebiasis. (Human Parasitic Diseases Vol. 2.), P45; PETRI WA, 1995, METHOD ENZYMOL, V253, P98; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Rodriguez MA, 2000, MOL BIOCHEM PARASIT, V108, P199, DOI 10.1016/S0166-6851(00)00216-4; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Shen L, 2006, AM J PHYSIOL-GASTR L, V290, pG577, DOI 10.1152/ajpgi.00439.2005; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tapia R, 2009, MOL BIOL CELL, V20, P1102, DOI 10.1091/mbc.E08-03-0277; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Yan L, 2001, INFECT IMMUN, V69, P7911, DOI 10.1128/IAI.69.12.7911-7914.2001	51	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65100	10.1371/journal.pone.0065100	http://dx.doi.org/10.1371/journal.pone.0065100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762290	gold, Green Published, Green Submitted			2022-12-25	WOS:000321094800018
J	Coy, S; Volanakis, A; Shah, S; Vasiljeva, L				Coy, Sarah; Volanakis, Adam; Shah, Sneha; Vasiljeva, Lidia			The Sm Complex Is Required for the Processing of Non-Coding RNAs by the Exosome	PLOS ONE			English	Article							NUCLEOLAR RNP PROTEINS; SMALL NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; TELOMERASE RNA; RIBOSOMAL-RNA; SECONDARY STRUCTURE; STRUCTURAL DOMAIN; IN-VITRO; YEAST; SNRNA	A key question in the field of RNA regulation is how some exosome substrates, such as spliceosomal snRNAs and telomerase RNA, evade degradation and are processed into stable, functional RNA molecules. Typical feature of these non-coding RNAs is presence of the Sm complex at the 3 ' end of the mature RNA molecule. Here, we report that in Saccharomyces cerevisiae presence of intact Sm binding site is required for the exosome-mediated processing of telomerase RNA from a polyadenylated precursor into its mature form and is essential for its function in elongating telomeres. Additionally, we demonstrate that the same pathway is involved in the maturation of snRNAs. Furthermore, the insertion of an Sm binding site into an unstable RNA that is normally completely destroyed by the exosome, leads to its partial stabilization. We also show that telomerase RNA accumulates in Schizosaccharomyces pombe exosome mutants, suggesting a conserved role for the exosome in processing and degradation of telomerase RNA. In summary, our data provide important mechanistic insight into the regulation of exosome dependent RNA processing as well as telomerase RNA biogenesis.	[Coy, Sarah; Volanakis, Adam; Shah, Sneha; Vasiljeva, Lidia] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Vasiljeva, L (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	lidia.vasilieva@bioch.ox.ac.uk	Vasilieva, Lidia/AAU-1473-2020	Shah, Sneha/0000-0002-0691-9566; Volanakis, Adam/0000-0002-9074-4825; Vasiljeva, Lidia/0000-0002-1244-8772; Coy, Sarah/0000-0003-2548-2045	Wellcome Trust [WT088359MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work is funded by the Wellcome Trust Career Development grant (WT088359MA)(http://www.wellcome.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Azzouz N, 2009, RNA, V15, P377, DOI 10.1261/rna.1348209; Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Bernard P, 2010, MOL CELL BIOL, V30, P1145, DOI 10.1128/MCB.01317-09; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bosoy D, 2003, J BIOL CHEM, V278, P3882, DOI 10.1074/jbc.M210645200; Box JA, 2008, J BIOL CHEM, V283, P24224, DOI 10.1074/jbc.M802043200; Box JA, 2008, NATURE, V456, P910, DOI 10.1038/nature07584; BRANLANT C, 1982, EMBO J, V1, P1259, DOI 10.1002/j.1460-2075.1982.tb00022.x; Butler JS, 2010, ADV EXP MED BIOL, V702, P91, DOI 10.1007/978-1-4419-7841-7_8; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chanfreau G, 1997, GENE DEV, V11, P2741, DOI 10.1101/gad.11.20.2741; Chapon C, 1997, RNA, V3, P1337; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; Dez C, 2001, NUCLEIC ACIDS RES, V29, P598, DOI 10.1093/nar/29.3.598; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Flynt AS, 2010, MOL CELL, V38, P900, DOI 10.1016/j.molcel.2010.06.014; Franke J, 2008, J CELL SCI, V121, P3553, DOI 10.1242/jcs.033308; Gallardo F, 2008, EMBO J, V27, P748, DOI 10.1038/emboj.2008.21; Ganot P, 1997, GENE DEV, V11, P941, DOI 10.1101/gad.11.7.941; Graham AC, 2006, MOL BIOL CELL, V17, P1399, DOI 10.1091/mbc.e05-08-0805; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Jamonnak N, 2011, RNA, V17, P2011, DOI 10.1261/rna.2840711; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lendvay TS, 1996, GENETICS, V144, P1399; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; LIAUTARD JP, 1982, J MOL BIOL, V162, P623, DOI 10.1016/0022-2836(82)90392-8; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Malet H, 2010, EMBO REP, V11, P936, DOI 10.1038/embor.2010.164; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Mozdy AD, 2006, RNA, V12, P1721, DOI 10.1261/rna.134706; Noel JF, 2012, NUCL ACIDS RES; PLESSEL G, 1994, MOL CELL BIOL, V14, P4160, DOI 10.1128/MCB.14.6.4160; PORTER G, 1990, MOL CELL BIOL, V10, P2874, DOI 10.1128/MCB.10.6.2874; Prescott J, 1997, GENE DEV, V11, P528, DOI 10.1101/gad.11.4.528; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; Qiu ZCR, 2011, NUCLEIC ACIDS RES, V39, P5633, DOI 10.1093/nar/gkr083; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; RYMOND BC, 1993, P NATL ACAD SCI USA, V90, P848, DOI 10.1073/pnas.90.3.848; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; SERAPHIN B, 1991, NUCLEIC ACIDS RES, V19, P3857, DOI 10.1093/nar/19.14.3857; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; SILICIANO PG, 1987, CELL, V50, P585, DOI 10.1016/0092-8674(87)90031-6; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; STUTZ F, 1993, MOL CELL BIOL, V13, P2126, DOI 10.1128/MCB.13.4.2126; Tang W, 2012, NATURE; Teixeira MT, 2002, EMBO REP, V3, P652, DOI 10.1093/embo-reports/kvf133; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Uguen P, 2004, NUCLEIC ACIDS RES, V32, P2987, DOI 10.1093/nar/gkh619; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Zhang D, 2001, MOL CELL, V7, P319, DOI 10.1016/S1097-2765(01)00180-0	76	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65606	10.1371/journal.pone.0065606	http://dx.doi.org/10.1371/journal.pone.0065606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755256	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000082
J	Hau, AM; Greenwood, JA; Lohr, CV; Serrill, JD; Proteau, PJ; Ganley, IG; McPhail, KL; Ishmael, JE				Hau, Andrew M.; Greenwood, Jeffrey A.; Loehr, Christiane V.; Serrill, Jeffrey D.; Proteau, Philip J.; Ganley, Ian G.; McPhail, Kerry L.; Ishmael, Jane E.			Coibamide A Induces mTOR-Independent Autophagy and Cell Death in Human Glioblastoma Cells	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; MARINE CYANOBACTERIA; RADIATION-THERAPY; NATURAL-PRODUCTS; IN-VITRO; INHIBITORS; RAPAMYCIN; SURVIVAL; APOPTOSIS; CANCER	Coibamide A is an N-methyl-stabilized depsipeptide that was isolated from a marine cyanobacterium as part of an International Cooperative Biodiversity Groups (ICBG) program based in Panama. Previous testing of coibamide A in the NCI in vitro 60 cancer cell line panel revealed a potent anti-proliferative response and "COMPARE-negative" profile indicative of a unique mechanism of action. We report that coibamide A is a more potent and efficacious cytotoxin than was previously appreciated, inducing concentration-and time-dependent cytotoxicity (EC50<100 nM) in human U87-MG and SF-295 glioblastoma cells and mouse embryonic fibroblasts (MEFs). This activity was lost upon linearization of the molecule, highlighting the importance of the cyclized structure for both anti-proliferative and cytotoxic responses. We show that coibamide A induces autophagosome accumulation in human glioblastoma cell types and MEFs via an mTOR-independent mechanism; no change was observed in the phosphorylation state of ULK1 (Ser-757), p70 S6K1 (Thr-389), S6 ribosomal protein (Ser-235/236) and 4EBP-1 (Thr-37/46). Coibamide A also induces morphologically and biochemically distinct forms of cell death according to cell type. SF-295 glioblastoma cells showed caspase-3 activation and evidence of apoptotic cell death in a pattern that was also seen in wild-type and autophagy-deficient (ATG5-null) MEFs. In contrast, cell death in U87-MG glioblastoma cells was characterized by extensive cytoplasmic vacuolization and lacked clear apoptotic features. Cell death was attenuated, but still triggered, in Apaf-1-null MEFs lacking a functional mitochondria-mediated apoptotic pathway. From the study of ATG5-null MEFs we conclude that a conventional autophagy response is not required for coibamide A-induced cell death, but likely occurs in dying cells in response to treatment. Coibamide A represents a natural product scaffold with potential for the study of mTOR-independent signaling and cell death mechanisms in apoptotic-resistant cancer cells.	[Hau, Andrew M.; Serrill, Jeffrey D.; Proteau, Philip J.; McPhail, Kerry L.; Ishmael, Jane E.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Greenwood, Jeffrey A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Loehr, Christiane V.] Oregon State Univ, Dept Biomed Sci, Corvallis, OR 97331 USA; [Ganley, Ian G.] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat Unit, Dundee, Scotland	Oregon State University; Oregon State University; Oregon State University; University of Dundee	McPhail, KL (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	kerry.mcphail@oregonstate.edu; jane.ishmael@oregonstate.edu	Löhr, C. V./AAU-4902-2020	Löhr, C. V./0000-0003-3787-5583; Greenwood, Juliet/0000-0001-6438-964X; McPhail, Kerry/0000-0003-2076-1002; Ganley, Ian/0000-0003-1481-9407	NIH Fogarty International Center ICBG [TW006634-06]; Medical Research Foundation of Oregon; American Foundation for Pharmaceutical Education; OSU College of Pharmacy and Division of Health Sciences; Cell Imaging and Analysis Facilities and Services Core of the OSU Environmental Heath Sciences Center (NIEHS) [P30-ES000210]; MRC [MC_UU_12016/4, MC_UP_A500_1019] Funding Source: UKRI; Medical Research Council [MC_UP_A500_1019, MC_UU_12016/4] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	NIH Fogarty International Center ICBG; Medical Research Foundation of Oregon; American Foundation for Pharmaceutical Education; OSU College of Pharmacy and Division of Health Sciences; Cell Imaging and Analysis Facilities and Services Core of the OSU Environmental Heath Sciences Center (NIEHS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support was provided by: the NIH Fogarty International Center ICBG grant TW006634-06, the Medical Research Foundation of Oregon, the American Foundation for Pharmaceutical Education and the OSU College of Pharmacy and Division of Health Sciences. We are also grateful for services provided by the Cell Imaging and Analysis Facilities and Services Core of the OSU Environmental Heath Sciences Center (NIEHS grant P30-ES000210). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brennan C, 2011, CURR NEUROL NEUROSCI, V11, P291, DOI 10.1007/s11910-011-0198-7; Brown PD, 2008, J CLIN ONCOL, V26, P5603, DOI 10.1200/JCO.2008.18.0612; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Collins A, 2007, TOXICOL LETT, V171, P60, DOI 10.1016/j.toxlet.2007.04.004; Fan QW, 2011, AUTOPHAGY, V7, P536, DOI 10.4161/auto.7.5.14779; Gammoh N, 2012, P NATL ACAD SCI USA, V109, P6561, DOI 10.1073/pnas.1204429109; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gerwick WH, 2001, ALKALOIDS, V57, P75, DOI 10.1016/S0099-9598(01)57003-0; Hammerova J, 2012, BIOL CHEM, V393, P647, DOI 10.1515/hsz-2011-0279; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Korsnes MS, 2012, TOXINS, V4, P568, DOI 10.3390/toxins4070568; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Medina RA, 2008, J AM CHEM SOC, V130, P6324, DOI 10.1021/ja801383f; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munafo DB, 2001, J CELL SCI, V114, P3619; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Prados MD, 2009, J CLIN ONCOL, V27, P579, DOI 10.1200/JCO.2008.18.9639; Reubold TF, 2012, CELL SIGNAL, V24, P1420, DOI 10.1016/j.cellsig.2012.03.007; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Simmons TL, 2009, J NAT PROD, V72, P1011, DOI 10.1021/np9001674; Sini P, 2010, AUTOPHAGY, V6, P553, DOI 10.4161/auto.6.4.11671; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tan LT, 2007, PHYTOCHEMISTRY, V68, P954, DOI 10.1016/j.phytochem.2007.01.012; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tripathi A, 2010, J NAT PROD, V73, P1810, DOI 10.1021/np100442x; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X	45	52	53	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65250	10.1371/journal.pone.0065250	http://dx.doi.org/10.1371/journal.pone.0065250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762328	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000049
J	Xue, G; He, QH; Lu, ZL; Levin, IP; Dong, Q; Bechara, A				Xue, Gui; He, Qinghua; Lu, Zhong-Lin; Levin, Irwin P.; Dong, Qi; Bechara, Antoine			Agency Modulates the Lateral and Medial Prefrontal Cortex Responses in Belief-Based Decision Making	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; SOMATIC MARKER HYPOTHESIS; IOWA GAMBLING TASK; EVENT-RELATED FMRI; HOT HAND; GAMBLERS FALLACY; INDIVIDUAL-DIFFERENCES; PREDICTION ERRORS; FRONTAL-CORTEX; SELF-CONTROL	Many real-life decisions in complex and changing environments are guided by the decision maker's beliefs, such as her perceived control over decision outcomes (i.e., agency), leading to phenomena like the "illusion of control". However, the neural mechanisms underlying the "agency" effect on belief-based decisions are not well understood. Using functional imaging and a card guessing game, we revealed that the agency manipulation (i.e., either asking the subjects (SG) or the computer (CG) to guess the location of the winning card) not only affected the size of subjects' bets, but also their "world model" regarding the outcome dependency. Functional imaging results revealed that the decision-related activation in the lateral and medial prefrontal cortex (PFC) was significantly modulated by agency and previous outcome. Specifically, these PFC regions showed stronger activation when subjects made decisions after losses than after wins under the CG condition, but the pattern was reversed under the SG condition. Furthermore, subjects with high external attribution of negative events were more affected by agency at the behavioral and neural levels. These results suggest that the prefrontal decision-making system can be modulated by abstract beliefs, and are thus vulnerable to factors such as false agency and attribution.	[Xue, Gui; Dong, Qi] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [He, Qinghua; Bechara, Antoine] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [He, Qinghua; Bechara, Antoine] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA; [Lu, Zhong-Lin] Ohio State Univ, Ctr Cognit & Behav Brain Imaging, Columbus, OH 43210 USA; [Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Levin, Irwin P.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	Beijing Normal University; University of Southern California; University of Southern California; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Iowa	Xue, G (corresponding author), Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	guixue@gmail.com	Xue, Gui/A-1762-2009; He, Qinghua/B-2573-2008	Xue, Gui/0000-0001-7891-8151; He, Qinghua/0000-0001-6396-6273; Bechara, Antoine/0000-0001-5127-2549; Lu, Zhong-Lin/0000-0002-7295-727X	National Science Foundation of China [31130025]; Advancing Scholarship in the Humanities and Social Sciences; National Institute on Drug Abuse (NIDA) [R01 DA023051]; National Cancer Institute (NCI) [R01 CA152062]; NATIONAL CANCER INSTITUTE [R01CA152062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023051] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Advancing Scholarship in the Humanities and Social Sciences; National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the following grants from the National Science Foundation of China (31130025), the Advancing Scholarship in the Humanities and Social Sciences, the National Institute on Drug Abuse (NIDA) R01 DA023051 and National Cancer Institute (NCI) R01 CA152062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni E, 2008, ANN NY ACAD SCI, V1124, P145, DOI 10.1196/annals.1440.007; Akitsuki Y, 2003, NEUROIMAGE, V19, P1674, DOI 10.1016/S1053-8119(03)00250-7; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersson J.L.R, 2007, TR07JA2 FMRIB; Ayton P, 2004, MEM COGNITION, V32, P1369, DOI 10.3758/BF03206327; Barriga AQ, 1996, AGGRESSIVE BEHAV, V22, P333; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2005, TRENDS COGN SCI, V9, P159, DOI 10.1016/j.tics.2005.02.002; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Beck A, 1979, COGNITIVE THERAPY DE; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Burns BD, 2004, PSYCHON B REV, V11, P179, DOI 10.3758/BF03206480; Clark L, 2009, NEURON, V61, P481, DOI 10.1016/j.neuron.2008.12.031; Coricelli G, 2009, P NATL ACAD SCI USA, V106, P9163, DOI 10.1073/pnas.0807721106; Coventry KR, 1998, BRIT J PSYCHOL, V89, P629, DOI 10.1111/j.2044-8295.1998.tb02707.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Croson R, 2005, J RISK UNCERTAINTY, V30, P195, DOI 10.1007/s11166-005-1153-2; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Davis D, 2000, J APPL SOC PSYCHOL, V30, P1224, DOI 10.1111/j.1559-1816.2000.tb02518.x; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hecht D, 2010, J NEUROSCI, V30, P4241, DOI 10.1523/JNEUROSCI.2924-09.2010; Huettel SA, 2002, NAT NEUROSCI, V5, P485, DOI 10.1038/nn841; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; KRUEGER N, 1994, DECISION SCI, V25, P385, DOI 10.1111/j.1540-5915.1994.tb01849.x; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; Laplace P S, 1951, PHILOS ESSAY PROBABI; Lee DY, 2007, ANN NY ACAD SCI, V1104, P108, DOI 10.1196/annals.1390.007; Lesieur HR, 1987, AM J PSYCHIAT, P144; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Mumford J., 2007, GUIDE CALCULAT UNPUB; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; PETERSON C, 1988, J ABNORM PSYCHOL, V97, P87, DOI 10.1037/0021-843X.97.1.87; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Shiv B, 2005, PSYCHOL SCI, V16, P435; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Sperduti M, 2011, BRAIN STRUCT FUNCT, V216, P151, DOI 10.1007/s00429-010-0298-1; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Studer B, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00046; Studer B, 2011, COGN AFFECT BEHAV NE, V11, P144, DOI 10.3758/s13415-011-0025-2; Sundali J, 2006, JUDGM DECIS MAK, V1, P1; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Toneatto T, 1997, J Gambl Stud, V13, P253, DOI 10.1023/A:1024983300428; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Walton ME, 2007, NEUROIMAGE, V36, pT142, DOI 10.1016/j.neuroimage.2007.03.029; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Worsley K. J., 2001, FUNCTIONAL MRI INTRO, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]; Xue G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047019; Xue G, 2012, P NATL ACAD SCI USA, V109, P4401, DOI 10.1073/pnas.1111927109; Xue G, 2011, HUM BRAIN MAPP, V32, P271, DOI 10.1002/hbm.21015; Xue G, 2010, NEUROIMAGE, V50, P709, DOI 10.1016/j.neuroimage.2009.12.097; Xue G, 2009, CEREB CORTEX, V19, P1019, DOI 10.1093/cercor/bhn147; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Zhu LS, 2012, P NATL ACAD SCI USA, V109, P1419, DOI 10.1073/pnas.1116783109	77	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65274	10.1371/journal.pone.0065274	http://dx.doi.org/10.1371/journal.pone.0065274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762332	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000051
J	Yang, HJ; Kim, HJ; Yu, J; Lee, E; Jung, YH; Kim, HY; Seo, JH; Kwon, GY; Park, JH; Gwack, J; Youn, SK; Kwon, JW; Jun, BY; Kim, KW; Ahn, K; Lee, SY; Park, JD; Kwon, JW; Kim, BJ; Lee, MS; Do, KH; Jang, SJ; Pyun, BY; Hong, SJ				Yang, Hyeon-Jong; Kim, Hwa-Jung; Yu, Jinho; Lee, Eun; Jung, Young-Ho; Kim, Hyung-Young; Seo, Ju-Hee; Kwon, Geun-Yong; Park, Ji-Hyuk; Gwack, Jin; Youn, Seung-Ki; Kwon, Jun-Wook; Jun, Byung-Yool; Kim, Kyung Won; Ahn, Kangmo; Lee, Soo-Young; Park, June-Dong; Kwon, Ji-Won; Kim, Byoung-Ju; Lee, Moo-Song; Do, Kyung-Hyun; Jang, Se-Jin; Pyun, Bok-Yang; Hong, Soo-Jong			Inhalation Toxicity of Humidifier Disinfectants as a Risk Factor of Children's Interstitial Lung Disease in Korea: A Case-Control Study	PLOS ONE			English	Article							DIDECYLDIMETHYLAMMONIUM CHLORIDE; POLYHEXAMETHYLENE BIGUANIDE; CONSUMER PRODUCTS; CHEMICALS; INJURY; HEALTH; NANOPARTICLES; FIBROSIS; MICE	Background: The occurrence of numerous cases of interstitial lung disease in children (chILD) every spring in Korea starting in 2006 raised suspicion about a causal relationship with the use of humidifier disinfectants (HDs). The aim of this study was to evaluate the association between HD use and the risk of chILD. Methods: This retrospective, 1:3 matched case-control study consisted of 16 cases of chILD that had developed between 2010 and 2011. The three groups of parallel controls (patients with acute lobar pneumonia, asthma, and healthy children) were matched by age, gender, and index date. Indoor/outdoor environmental risk factors, including HD use, were investigated by asking the guardians to complete a questionnaire. Results: The median age of the affected children (43.8% male) was 26 months (18.25-36.25). The chILD group did not differ significantly from the control groups with respect to socio-demographic and clinical variables. Indoor and outdoor environmental factors were not associated with a risk of chILD. However, the previous use of HDs (OR; 2.73. 95% CI; 1.41-5.90, P = 0.00) were independently associated with an increased risk. Conclusions: This study showed that HDs, which are widely used in South Korea in the winter season, independently increased the risk of chILD in spring. Therefore, continuous monitoring and, if needed, changes in policy are essential to prevent and control pediatric diseases caused by toxic chemicals.	[Yang, Hyeon-Jong; Pyun, Bok-Yang] Soonchunhyang Univ, Coll Med, Soonchunhyang Univ Hosp, Dept Pediat,Pediat Allergy & Resp Ctr, Seoul, South Korea; [Kim, Hwa-Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat,Asan Canc Ctr, Seoul, South Korea; [Yu, Jinho; Lee, Eun; Jung, Young-Ho; Kim, Hyung-Young; Hong, Soo-Jong] Univ Ulsan, Coll Med, Childrens Hosp, Dept Pediat,Childhood Asthma Atopy Ctr,Asan Med C, Seoul, South Korea; [Lee, Eun; Jung, Young-Ho; Kim, Hyung-Young; Hong, Soo-Jong] Univ Ulsan, Coll Med, Childrens Hosp, Res Ctr Standardizat Allerg Dis,Asan Med Ctr, Seoul, South Korea; [Seo, Ju-Hee] Korean Canc Ctr Hosp, Dept Pediat, Seoul, South Korea; [Kwon, Geun-Yong; Park, Ji-Hyuk; Gwack, Jin; Youn, Seung-Ki; Jun, Byung-Yool] Korea Ctr Dis Control & Prevent, Div Epidem Intelligence Serv, Osong, South Korea; [Kwon, Jun-Wook; Jun, Byung-Yool] Korea Ctr Dis Control & Prevent, Ctr Infect Dis Surveillance & Response, Osong, South Korea; [Kim, Kyung Won] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Kim, Kyung Won] Yonsei Univ, Coll Med, Inst Allergy, Biomol Secret Res Ctr, Seoul, South Korea; [Ahn, Kangmo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Lee, Soo-Young] Ajou Univ, Sch Med, Dept Pediat, Ajou Univ Hosp, Suwon 441749, South Korea; [Park, June-Dong] Univ Seoul, Coll Med, Seoul Natl Univ, Dept Pediat,Childrens Hosp, Seoul, South Korea; [Kwon, Ji-Won] Univ Seoul, Coll Med, Seoul Natl Univ, Dept Pediat,Bundang Hosp, Seungnam, South Korea; [Kim, Byoung-Ju] Univ Inje, Coll Med, Haeundae Paik Hosp, Dept Pediat, Pusan, South Korea; [Lee, Moo-Song] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Prevent Med,Asan Canc Ctr, Seoul, South Korea; [Do, Kyung-Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Jang, Se-Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University Hospital; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; National Cancer Center - Korea (NCC); Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea CDC Center for Infectious Disease Control; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea CDC Center for Infectious Disease Control; Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Ajou University; Ajou University Hospital; Seoul National University (SNU); Seoul National University Hospital; University of Seoul; Seoul National University (SNU); University of Seoul; Inje University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Pyun, BY (corresponding author), Soonchunhyang Univ, Coll Med, Soonchunhyang Univ Hosp, Dept Pediat,Pediat Allergy & Resp Ctr, Seoul, South Korea.	bypyun@schmc.ac.kr; sjhong@amc.seoul.kr	Yu, Jinho/P-4293-2014; Ahn, Kangmo/F-4609-2014; Hong, Soo-Jong/AAR-1788-2020	Yu, Jinho/0000-0002-1226-8077; Hong, Soo-Jong/0000-0003-1409-2113; Park, June Dong/0000-0001-8113-1384; Kim, Kyung Won/0000-0003-4529-6135; Kim, Byoung-Ju/0000-0003-0271-9417				Allen MJ, 2006, MICROBIOL-SGM, V152, P989, DOI 10.1099/mic.0.28643-0; [Anonymous], 2006, RER EL DEC AL ALK QU; Bonner James C, 2010, Proc Am Thorac Soc, V7, P138, DOI 10.1513/pats.200907-061RM; Chang M. H., 2012, ENV HLTH TOXICOL, V27; Daftary AS, 2011, PEDIATRICS, V127, pE509, DOI 10.1542/peds.2010-1312; Deterding R, 2007, SEMIN RESP CRIT CARE, V28, P333, DOI 10.1055/s-2007-981654; Dishop MK, 2011, PAEDIATR RESPIR REV, V12, P230, DOI 10.1016/j.prrv.2011.01.002; 김병주, 2009, Clinical and Experimental Pediatrics, V52, P324; European Commission on the Environment, REACH; Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006; 전종근, 2008, Clinical and Experimental Pediatrics, V51, P383; Hubbs AF, 1997, TOXICOL APPL PHARM, V143, P37, DOI 10.1006/taap.1996.8053; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P17, DOI 10.1159/000318264; Jeon B.H., 2012, ENV HLTH TOXICOL, V27, DOI DOI 10.5620/EHT.2012.27.E2012002; KCDC (Korea Centers for Disease Control and Prevention), 2011, PUBLIC HLTH WKLY REP, P820; Kim JY, 2012, CARDIOVASC TOXICOL; Korea Centers for Disease Control and Prevention, 2011, PUBLIC HLTH WKLY REP, P831; Landrigan PJ, 2011, HEALTH AFFAIR, V30, P842, DOI 10.1377/hlthaff.2011.0151; Landrigan PJ, 2011, MT SINAI J MED, V78, P1, DOI 10.1002/msj.20236; Lee E, 2012, ALLERGY ASTHMA IMMUN, V4, P240, DOI 10.4168/aair.2012.4.4.240; Lee JH, 2012, ENVIRON SCI TECHNOL, V46, P2498, DOI 10.1021/es300567j; Lucas AD, 2012, B ENVIRON CONTAM TOX, V88, P322, DOI 10.1007/s00128-011-0436-3; Makri A, 2004, J TOXICOL ENV HEAL B, V7, P417, DOI 10.1080/10937400490512465; Muller-Wening D, 2006, DEUT MED WOCHENSCHR, V131, P491, DOI 10.1055/s-2006-932548; Ohnuma A, 2011, INHAL TOXICOL, V23, P476, DOI 10.3109/08958378.2011.584080; Ohnuma A, 2010, EXP TOXICOL PATHOL, V62, P643, DOI 10.1016/j.etp.2009.08.007; Pauluhn J, 2008, INHAL TOXICOL, V20, P1245, DOI [10.1080/08958370802220634, 10.1080/08958370802220634 ]; Solodun Yuriy V, 2011, Interdiscip Toxicol, V4, P198, DOI 10.2478/v10102-011-0030-x; Spivey A, 2007, ENVIRON HEALTH PERSP, V115, pA192, DOI 10.1289/ehp.115-a192; United States Environmental Protection Agency, 2004, RER EL DEC AL ALK QU	30	53	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64430	10.1371/journal.pone.0064430	http://dx.doi.org/10.1371/journal.pone.0064430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755124	Green Submitted, gold, Green Published			2022-12-25	WOS:000320579400015
J	Fraga, A; Ribeiro, L; Lobato, M; Santos, V; Silva, JR; Gomes, H; Moraes, JLD; Menezes, JD; de Oliveira, CJL; Campos, E; da Fonseca, RN				Fraga, Amanda; Ribeiro, Lupis; Lobato, Mariana; Santos, Vitoria; Silva, Jose Roberto; Gomes, Helga; da Cunha Moraes, Jorge Luiz; Menezes, Jackson de Souza; Logullo de Oliveira, Carlos Jorge; Campos, Eldo; da Fonseca, Rodrigo Nunes			Glycogen and Glucose Metabolism Are Essential for Early Embryonic Development of the Red Flour Beetle Tribolium castaneum	PLOS ONE			English	Article							INSECT FLIGHT-MUSCLE; DROSOPHILA-MELANOGASTER; WNT PATHWAY; HEXOKINASE; EVOLUTION; EXPRESSION; XENOPUS; IDENTIFICATION; EMBRYOGENESIS; LOCALIZATION	Control of energy metabolism is an essential process for life. In insects, egg formation (oogenesis) and embryogenesis is dependent on stored molecules deposited by the mother or transcribed later by the zygote. In oviparous insects the egg becomes an isolated system after egg laying with all energy conversion taking place during embryogenesis. Previous studies in a few vector species showed a strong correlation of key morphogenetic events and changes in glucose metabolism. Here, we investigate glycogen and glucose metabolism in the red flour beetle Tribolium castaneum, an insect amenable to functional genomic studies. To examine the role of the key enzymes on glycogen and glucose regulation we cloned and analyzed the function of glycogen synthase kinase 3 (GSK-3) and hexokinase (HexA) genes during T. castaneum embryogenesis. Expression analysis via in situ hybridization shows that both genes are expressed only in the embryonic tissue, suggesting that embryonic and extra-embryonic cells display different metabolic activities. dsRNA adult female injection (parental RNAi) of both genes lead a reduction in egg laying and to embryonic lethality. Morphological analysis via DAPI stainings indicates that early development is impaired in Tc-GSK-3 and Tc-HexA1 RNAi embryos. Importantly, glycogen levels are upregulated after Tc-GSK-3 RNAi and glucose levels are upregulated after Tc-HexA1 RNAi, indicating that both genes control metabolism during embryogenesis and oogenesis, respectively. Altogether our results show that T. castaneum embryogenesis depends on the proper control of glucose and glycogen.	[Fraga, Amanda; Ribeiro, Lupis; Lobato, Mariana; Santos, Vitoria; Silva, Jose Roberto; Gomes, Helga; da Cunha Moraes, Jorge Luiz; Menezes, Jackson de Souza; Campos, Eldo; da Fonseca, Rodrigo Nunes] Univ Fed Rio de Janeiro, Nucleo Pesquisas Ecol & Socioambientais Macae NUP, Lab Integrado Bioquim Hatisaburo Masuda, Rio De Janeiro, Brazil; [Fraga, Amanda; Ribeiro, Lupis; Silva, Jose Roberto; da Cunha Moraes, Jorge Luiz; Menezes, Jackson de Souza; Logullo de Oliveira, Carlos Jorge; Campos, Eldo; da Fonseca, Rodrigo Nunes] Univ Fed Rio de Janeiro, Programa Posgrad Prod Bioativos & Biociencias PPG, Rio De Janeiro, Brazil; [Logullo de Oliveira, Carlos Jorge] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Quim & Funcao Prot & Peptideos, Rio De Janeiro, Brazil; [Logullo de Oliveira, Carlos Jorge] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Unidade Expt Anim, Rio De Janeiro, Brazil; [Silva, Jose Roberto; da Cunha Moraes, Jorge Luiz; Menezes, Jackson de Souza; Logullo de Oliveira, Carlos Jorge; Campos, Eldo; da Fonseca, Rodrigo Nunes] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	da Fonseca, RN (corresponding author), Univ Fed Rio de Janeiro, Nucleo Pesquisas Ecol & Socioambientais Macae NUP, Lab Integrado Bioquim Hatisaburo Masuda, UFRJCampus Macae, Rio De Janeiro, Brazil.	rnfonseca@macae.ufrj.br	da Fonseca, Rodrigo Nunes/S-3964-2018; Logullo de Oliveira, Carlos Jorge/G-3436-2013; Silva, José Roberto/F-2931-2017; Lobato, Mariana/GPX-7165-2022; Fernandes Gomes, Helga/AFV-5696-2022; Nunes-da-Fonseca, Rodrigo/ABI-1404-2022; Moraes, Jorge Luiz/M-4659-2014; Fonseca, Rodrigo/B-2981-2009	da Fonseca, Rodrigo Nunes/0000-0001-9576-2849; Nunes-da-Fonseca, Rodrigo/0000-0001-9576-2849; Fonseca, Rodrigo/0000-0003-3063-7806; Tobias Santos, Vitoria/0000-0001-5958-9700	FAPERJ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Portuguese: Research Support Foundation of the State of Rio de Janeiro; Brazil); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil); INCT-Entomologia Molecular	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Portuguese: Research Support Foundation of the State of Rio de Janeiro; Brazil); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT-Entomologia Molecular	Brazil is funded by FAPERJ, (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Portuguese: Research Support Foundation of the State of Rio de Janeiro; Brazil)) CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)) and INCT-Entomologia Molecular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Baumer D, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-15; BORK P, 1993, PROTEIN SCI, V2, P31; Brown SJ, 2009, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.EM0126; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CAVENER DR, 1980, BIOCHEM GENET, V18, P929, DOI 10.1007/BF00500125; CHILDRES.CC, 1970, J BIOL CHEM, V245, P2927; CHILDRES.CC, 1970, J CELL BIOL, V45, P83, DOI 10.1083/jcb.45.1.83; da Fonseca RN, 2008, DEV CELL, V14, P605, DOI 10.1016/j.devcel.2008.02.011; da Fonseca RN, 2010, DEV BIOL, V345, P80, DOI 10.1016/j.ydbio.2010.05.019; da Fonseca RN, 2009, CURR OPIN GENET DEV, V19, P404, DOI 10.1016/j.gde.2009.04.009; Duvernell DD, 2000, GENETICS, V156, P1191; Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017; EldarFinkelman H, 1996, P NATL ACAD SCI USA, V93, P10228, DOI 10.1073/pnas.93.19.10228; FORD WCL, 1972, BIOCHEM J, V130, P1101, DOI 10.1042/bj1301101; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fritz HL, 1999, HISTOCHEM CELL BIOL, V112, P359, DOI 10.1007/s004180050417; Frommer WB, 2003, SCIENCE, V300, P261, DOI 10.1126/science.1084120; Fu JP, 2012, P NATL ACAD SCI USA, V109, P7782, DOI 10.1073/pnas.1116641109; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Galina A, 2000, PHYTOCHEMISTRY, V53, P29, DOI 10.1016/S0031-9422(99)00456-2; Gonzalez-Alvarez R, 2009, COMP BIOCHEM PHYS B, V152, P189, DOI 10.1016/j.cbpb.2008.11.004; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Handel K, 2000, DEV GENES EVOL, V210, P167, DOI 10.1007/s004270050301; HANSFORD RG, 1970, FEBS LETT, V7, P183, DOI 10.1016/0014-5793(70)80152-1; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heming BS., 2003, INSECT DEV EVOLUTION; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Jayakumar PC, 2007, INSECT MOL BIOL, V16, P3, DOI 10.1111/j.1365-2583.2006.00664.x; Jayakumar PC, 2001, INSECT BIOCHEM MOLEC, V31, P1165, DOI 10.1016/S0965-1748(01)00062-5; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Lee SY, 2012, CANC RES; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lynch J, 2003, CURR BIOL, V13, pR557, DOI 10.1016/S0960-9822(03)00472-X; Lynch JA, 2010, CURR BIOL, V20, P1042, DOI 10.1016/j.cub.2010.04.023; Moraes J, 2007, COMP BIOCHEM PHYS A, V146, P528, DOI 10.1016/j.cbpa.2006.05.009; MURRAY RF, 1967, SCIENCE, V156, P81, DOI 10.1126/science.156.3771.81; Pace NR, 2001, P NATL ACAD SCI USA, V98, P805, DOI 10.1073/pnas.98.3.805; Philip BN, 2011, METHODS MOL BIOL, V772, P471, DOI 10.1007/978-1-61779-228-1_28; Posnien N, 2009, COLD SPRING HARB PRO, V2009; RADDATZ E, 1986, EXP CELL BIOL, V54, P53; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sonanez-Organis JG, 2011, COMP BIOCHEM PHYS B, V158, P242, DOI 10.1016/j.cbpb.2010.12.006; SURHOLT B, 1981, BIOCHEM J, V198, P621, DOI 10.1042/bj1980621; SURHOLT B, 1983, BIOCHEM J, V210, P49, DOI 10.1042/bj2100049; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25; Wang LJ, 2007, NUCLEIC ACIDS RES, V35, pD476, DOI 10.1093/nar/gkl776; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Worthington C.C., 1988, WORTHINGTON ENZYME M; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002	60	40	41	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65125	10.1371/journal.pone.0065125	http://dx.doi.org/10.1371/journal.pone.0065125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750237	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900039
J	Huang, YQ; Wang, J; Zhang, LD; Zuo, KJ				Huang, Yiqun; Wang, Jin; Zhang, Lida; Zuo, Kaijing			A Cotton Annexin Protein AnxGb6 Regulates Fiber Elongation through Its Interaction with Actin 1	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; BINDING PROTEINS; CELL ELONGATION; F-ACTIN; IDENTIFICATION; GROWTH; COMPONENTS; PURIFICATION; CYTOSKELETON	Annexins are assumed to be involved in regulating cotton fiber elongation, but direct evidence remains to be presented. Here we cloned six Annexin genes (AnxGb) abundantly expressed in fiber from sea-island cotton (G. barbadense). qRT-PCR results indicated that all six G. barbadense annexin genes were expressed in elongating cotton fibers, while only the expression of AnxGb6 was cotton fiber-specific. Yeast two hybridization and BiFC analysis revealed that AnxGb6 homodimer interacted with a cotton fiber specific actin GbAct1. Ectopic-expressed AnxGb6 in Arabidopsis enhanced its root elongation without increasing the root cell number. Ectopic AnxGb6 expression resulted in more F-actin accumulation in the basal part of the root cell elongation zone. Analysis of AnxGb6 expression in three cotton genotypes with different fiber length confirmed that AnxGb6 expression was correlated to cotton fiber length, especially fiber elongation rate. Our results demonstrated that AnxGb6 was important for fiber elongation by potentially providing a domain for F-actin organization.	[Huang, Yiqun; Zhang, Lida; Zuo, Kaijing] Shanghai Jiao Tong Univ, Sch Agr & Biol, SJTU Cornell Inst Sustainable Agr & Biotechnol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China; [Wang, Jin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zuo, KJ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, SJTU Cornell Inst Sustainable Agr & Biotechnol, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China.	kjzuo@sjtu.edu.cn			973 project in China [2013CB733903]; NSFC [31071458]; China Transgenic Plant Project [2011AA100605]	973 project in China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); China Transgenic Plant Project	This work was funded by the 973 project in China (2013CB733903), NSFC (31071458) and China Transgenic Plant Project (2011AA100605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlvarezMartinez MT, 1997, BBA-PROTEIN STRUCT M, V1339, P331, DOI 10.1016/S0167-4838(97)00018-6; ANDRAWIS A, 1993, PLANT J, V3, P763, DOI 10.1111/j.1365-313X.1993.00763.x; Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Bassani M, 2004, PLANT MOL BIOL, V56, P367, DOI 10.1007/s11103-004-3474-y; BLACKBOURN HD, 1992, PLANT PHYSIOL, V99, P864, DOI 10.1104/pp.99.3.864; BOUSTEAD CM, 1989, FEBS LETT, V244, P456, DOI 10.1016/0014-5793(89)80582-4; Calvert CM, 1996, PLANT CELL, V8, P333, DOI 10.1105/tpc.8.2.333; Carroll AD, 1998, PLANT CELL, V10, P1267, DOI 10.1105/tpc.10.8.1267; Clark GB, 2001, PLANT PHYSIOL, V126, P1072, DOI 10.1104/pp.126.3.1072; Clark GB, 2012, NEW PHYTOL, V196, P695, DOI 10.1111/j.1469-8137.2012.04308.x; CREUTZ CE, 1978, J BIOL CHEM, V253, P2858; Dai S, 2006, PROTEOMICS, V6, P2504, DOI 10.1002/pmic.200401351; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; DIAZMUNOZ M, 1990, J BIOL CHEM, V265, P15894; Divya K, 2010, PLANT MOL BIOL, V73, P293, DOI 10.1007/s11103-010-9615-6; Dixon DC, 2000, INT J PLANT SCI, V161, P63, DOI 10.1086/314224; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gao P, 2007, PLANT SCI, V173, P61, DOI 10.1016/j.plantsci.2007.04.008; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; HASENFRATZ MP, 1995, PLANT PHYSIOL, V108, P1395, DOI 10.1104/pp.108.4.1395; Hofmann A, 2003, EUR J BIOCHEM, V270, P2557, DOI 10.1046/j.1432-1033.2003.03612.x; Hoshino D, 2004, PLANTA, V219, P867, DOI 10.1007/s00425-004-1285-7; Hu SQ, 2000, PLANT J, V24, P127, DOI 10.1046/j.1365-313x.2000.00852.x; Huang QS, 2008, PLANT CELL REP, V27, P1869, DOI 10.1007/s00299-008-0603-0; Ji SJ, 2002, BIOCHEM BIOPH RES CO, V296, P1245, DOI 10.1016/S0006-291X(02)02069-7; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Konopka-Postupolska D, 2007, PROTOPLASMA, V230, P203, DOI 10.1007/s00709-006-0234-7; Konopka-Postupolska D, 2009, PLANT PHYSIOL, V150, P1394, DOI 10.1104/pp.109.135228; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwon HK, 2005, PLANT CELL PHYSIOL, V46, P843, DOI 10.1093/pcp/pci089; Lafont F, 1998, J CELL BIOL, V142, P1413, DOI 10.1083/jcb.142.6.1413; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Laohavisit A, 2009, PLANT CELL, V21, P479, DOI 10.1105/tpc.108.059550; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Lim EK, 1998, J BIOL CHEM, V273, P34920, DOI 10.1074/jbc.273.52.34920; Liu K, 2012, GENOMICS, V100, P42, DOI 10.1016/j.ygeno.2012.04.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McArthur S, 2009, FASEB J, V23, P4000, DOI 10.1096/fj.09-131391; Mei WQ, 2009, J GENET GENOMICS, V36, P141, DOI 10.1016/S1673-8527(08)60101-0; Miwa N, 2008, FEBS J, V275, P4945, DOI 10.1111/j.1742-4658.2008.06653.x; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Mortimer JC, 2008, J EXP BOT, V59, P533, DOI 10.1093/jxb/erm344; Pang CY, 2010, MOL CELL PROTEOMICS, V9, P2019, DOI 10.1074/mcp.M110.000349; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pei WK, 2012, PLANT SCI, V187, P10, DOI 10.1016/j.plantsci.2012.01.008; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; QUADER H, 1987, PROTOPLASMA, V137, P56, DOI 10.1007/BF01281176; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rohila JS, 2006, PLANT J, V46, P1, DOI 10.1111/j.1365-313X.2006.02671.x; SEAGULL RW, 1990, PROTOPLASMA, V159, P44, DOI 10.1007/BF01326634; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Taliercio EW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-22; Waller F, 2002, PROTOPLASMA, V219, P72, DOI 10.1007/s007090200007; Wang HY, 2009, PLANT BIOTECHNOL J, V7, P13, DOI 10.1111/j.1467-7652.2008.00367.x; Wang JA, 2010, PLANT CELL PHYSIOL, V51, P1276, DOI 10.1093/pcp/pcq086; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang LK, 2010, MOL BIOL REP, V37, P3327, DOI 10.1007/s11033-009-9919-2; Wang YC, 2009, BIOSCIENCE REP, V29, P111, DOI 10.1042/BSR20070052; Wang YS, 2008, NEW PHYTOL, V177, P525, DOI 10.1111/j.1469-8137.2007.02261.x; Whittaker DJ, 1999, PLANT PHYSIOL, V121, P181, DOI 10.1104/pp.121.1.181; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t; Zhou L, 2011, J INTEGR PLANT BIOL, V53, P347, DOI 10.1111/j.1744-7909.2011.01034.x; Zobiack N, 2002, J CELL SCI, V115, P91	72	95	98	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66160	10.1371/journal.pone.0066160	http://dx.doi.org/10.1371/journal.pone.0066160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750279	gold, Green Published, Green Submitted			2022-12-25	WOS:000319961900081
J	Jutfelt, F; de Souza, KB; Vuylsteke, A; Sturve, J				Jutfelt, Fredrik; de Souza, Karine Bresolin; Vuylsteke, Amandine; Sturve, Joachim			Behavioural Disturbances in a Temperate Fish Exposed to Sustained High-CO2 Levels	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CARBON-DIOXIDE; HIGH CO2; SEAWATER; ACCLIMATION; TOLERANCE	As atmospheric CO2 levels rise, the CO2 concentration in ocean surface waters increases through a process commonly referred to as ocean acidification. Recently, surprising behavioural modifications has been detected in the early life stages of tropical coral reef fish exposed to ocean acidification-relevant CO2 concentrations, but it has been unclear if this effect could occur in temperate waters. Here we show several severe behavioural disturbances, including effects on boldness, exploratory behaviour, lateralisation, and learning in a temperate fish, the three-spined stickleback (Gasterosteus aculeatus). The behavioural effects were consistent throughout the exposure period and increased in effect size with exposure time. We observed the effects on adult sticklebacks, a species known to be tolerant to other environmental stressors. Our findings suggest that behavioural abnormalities that stem from CO2 exposure are not restricted to sensitive tropical species or early life stages and may therefore affect fish on a global scale. The severity of disturbances and the possibility of a serious behavioural problem for fish across the globe is cause for concern.	[Jutfelt, Fredrik; de Souza, Karine Bresolin; Vuylsteke, Amandine; Sturve, Joachim] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Jutfelt, F (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	fredrik.jutfelt@bioenv.gu.se	Vuylsteke, Alain/AAF-2108-2020; Jutfelt, Fredrik/B-6988-2014	Jutfelt, Fredrik/0000-0001-9838-3991; Sturve, Joachim/0000-0001-9370-993X	Swedish Research Council Formas through the grant Jutfelt [2009-596]	Swedish Research Council Formas through the grant Jutfelt	This work was funded by the Swedish Research Council Formas through the grant Jutfelt 2009-596. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett RDH, 2011, P ROY SOC B-BIOL SCI, V278, P233, DOI 10.1098/rspb.2010.0923; Brauner CJ, 2009, PATTERNS ACID BASE R, DOI [10.1007/978-3-540-93985-6, DOI 10.1007/978-3-540-93985-6]; Briffa M, 2012, MAR POLLUT BULL, V64, P1519, DOI 10.1016/j.marpolbul.2012.05.032; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; Dadda M, 2006, BEHAV ECOL, V17, P358, DOI 10.1093/beheco/arj040; Dahlbom SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023565; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Domenici P, 2012, BIOL LETTERS, V8, P78, DOI 10.1098/rsbl.2011.0591; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Ferrari MCO, 2012, FUNCT ECOL, V26, P553, DOI 10.1111/j.1365-2435.2011.01951.x; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; Fivelstad S, 1998, AQUACULTURE, V160, P305, DOI 10.1016/S0044-8486(97)00166-X; Foss A, 2003, AQUACULTURE, V220, P607, DOI 10.1016/S0044-8486(02)00613-0; Ishimatsu A, 2008, MAR ECOL PROG SER, V373, P295, DOI 10.3354/meps07823; Lutterschmidt W, 2011, MEASURES THERMAL TOL, DOI [10.1016/B978-0-1237-4553-8.00200-8, DOI 10.1016/B978-0-1237-4553-8.00200-8]; Maneja RH, 2013, MAR BIOL, V160, P1963, DOI 10.1007/s00227-012-2054-y; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Melzner F, 2009, AQUAT TOXICOL, V92, P30, DOI 10.1016/j.aquatox.2008.12.011; Munday PL, 2013, MAR BIOL, V160, P2137, DOI 10.1007/s00227-012-2111-6; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; Nepomnyashchikh V.A., 2006, J ICHTHYOL, V46, pS235, DOI [10.1134/S0032945206110142, DOI 10.1134/S0032945206110142]; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Ostlund-Nilsson S, 2006, BIOL 3 SPINED STICKL; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pottinger TG, 2002, J FISH BIOL, V61, P207, DOI 10.1006/jfbi.2002.2034; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Sangiao-Alvarellos S, 2005, J EXP BIOL, V208, P4291, DOI 10.1242/jeb.01900; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Sloman K., 2005, FISH PHYSL BEHAV PHY, V24; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Toms CN., 2010, INT J COMPPSYCHOL, V23, P1, DOI DOI 10.1002/CPMO.17	33	114	116	2	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65825	10.1371/journal.pone.0065825	http://dx.doi.org/10.1371/journal.pone.0065825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750274	gold, Green Published, Green Submitted			2022-12-25	WOS:000319961900076
J	Karthikeyan, RS; Priya, JL; Leal, SM; Toska, J; Rietsch, A; Prajna, V; Pearlman, E; Lalitha, P				Karthikeyan, Rajapandian SivaGanesa; Priya, Jeganathan Lakshmi; Leal, Sixto M., Jr.; Toska, Jonida; Rietsch, Arne; Prajna, Venkatesh; Pearlman, Eric; Lalitha, Prajna			Host Response and Bacterial Virulence Factor Expression in Pseudomonas aeruginosa and Streptococcus pneumoniae Corneal Ulcers	PLOS ONE			English	Article							III SECRETION SYSTEM; OCULAR INFECTIONS; SOUTH-INDIA; CASPASE-1 ACTIVATION; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; RISK-FACTORS; PNEUMOLYSIN; KERATITIS; INFLAMMASOMES	P. aeruginosa and S. pneumoniae are major bacterial causes of corneal ulcers in industrialized and in developing countries. The current study examined host innate immune responses at the site of infection, and also expression of bacterial virulence factors in clinical isolates from patients in south India. Corneal ulcer material was obtained from 49 patients with confirmed P. aeruginosa and 27 patients with S. pneumoniae, and gene expression of Toll Like Receptors (TLR), cytokines and inflammasome proteins was measured by quantitative PCR. Expression of P. aeruginosa type III secretion exotoxins and S. pneumoniae pneumolysin was detected by western blot analysis. We found that neutrophils comprised >90% cells in corneal ulcers, and that there was elevated expression of TLR2, TLR4, TLR5 and TLR9, the NLRP3 and NLRC4 inflammasomes and the ASC adaptor molecule. IL-1 alpha IL-1b beta and IFN-gamma expression was also elevated; however, there was no significant difference in expression of any of these genes between corneal ulcers from P. aeruginosa and S. pneumoniae infected patients. We also show that 41/49 (84%) of P. aeruginosa clinical isolates expressed ExoS and ExoT, whereas 5/49 (10%) of isolates expressed ExoS, ExoT and ExoU with only 2/49 isolates expressing ExoT and ExoU. In contrast, all 27 S. pneumoniae clinical isolates produced pneumolysin. Taken together, these findings demonstrate that ExoS/T expressing P. aeruginosa and pneumolysin expressing S. pneumoniae predominate in bacterial keratitis. While P. aeruginosa strains expressing both ExoU and ExoS are usually rare, these strains actually outnumbered strains expressing only ExoU in the current study. Further, as neutrophils are the predominant cell type in these corneal ulcers, they are the likely source of cytokines and of the increased TLR and inflammasome expression.	[Karthikeyan, Rajapandian SivaGanesa; Priya, Jeganathan Lakshmi; Prajna, Venkatesh; Lalitha, Prajna] Aravind Eye Hosp, Dr G Venkatasamy Eye Res Inst, Madurai, Tamil Nadu, India; [Leal, Sixto M., Jr.; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Toska, Jonida; Rietsch, Arne] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Lalitha, P (corresponding author), Aravind Eye Hosp, Dr G Venkatasamy Eye Res Inst, Madurai, Tamil Nadu, India.	lalitha@aravind.org		Leal, Sixto/0000-0001-6939-9572; Rietsch, Arne/0000-0002-1556-7064; Namperumalsamy, Venkatesh Prajna/0000-0003-2019-4044; Siva Ganesa Karthikeyan, Rajapandian/0000-0002-7449-2402	Indian Council for Medical Research; NIH [RO1 EY14362, EY22052]; Alcon Research Institute award; NATIONAL EYE INSTITUTE [R01EY022052, R01EY014362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	Indian Council for Medical Research(Indian Council of Medical Research (ICMR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alcon Research Institute award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Indian Council for Medical Research (LP), NIH grants RO1 EY14362 (EP), EY22052 (AR). EP is a recipient of an Alcon Research Institute award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus AA, 2008, INFECT IMMUN, V76, P1992, DOI 10.1128/IAI.01221-07; Angus AA, 2010, INFECT IMMUN, V78, P4500, DOI 10.1128/IAI.00417-10; Bharathi MJ, 2007, OPHTHAL EPIDEMIOL, V14, P61, DOI 10.1080/09286580601001347; Bharathi MJ, 2010, INDIAN J OPHTHALMOL, V58, P497, DOI 10.4103/0301-4738.71678; Bharathi MJ, 2009, INDIAN J MED RES, V130, P749; Borkar DS, 2013, JAMA OPHTHALMOL, V131, P147, DOI 10.1001/jamaophthalmol.2013.778; Cockeran R, 2009, EUR RESPIR J, V34, P1167, DOI 10.1183/09031936.00007109; Cockeran R, 2001, J INFECT DIS, V183, P604, DOI 10.1086/318536; Cole N, 1998, CURR EYE RES, V17, P730, DOI 10.1080/02713689808951250; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Fleiszig SMJ, 1996, INFECT IMMUN, V64, P2288, DOI 10.1128/IAI.64.6.2288-2294.1996; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 1998, MOL MICROBIOL, V27, P807, DOI 10.1046/j.1365-2958.1998.00727.x; JOHNSON MK, 1992, CURR EYE RES, V11, P1221, DOI 10.3109/02713689208999547; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Karthikeyan RS, 2011, J INFECT DIS, V204, P942, DOI 10.1093/infdis/jir426; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mankan AK, 2012, EUR J IMMUNOL, V42, P710, DOI 10.1002/eji.201141921; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Norcross Erin W, 2011, J Bacteriol Parasitol, V2, P108; Parmar P, 2003, CLIN EXP OPHTHALMOL, V31, P44, DOI 10.1046/j.1442-9071.2003.00598.x; Pearlman E, 2013, INT REV IMMUNOL, V32, P4, DOI 10.3109/08830185.2012.749400; Ramesh S, 2010, INDIAN J PATHOL MICR, V53, P281, DOI 10.4103/0377-4929.64336; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Szczotka-Flynn LB, 2010, EYE CONTACT LENS, V36, P116, DOI 10.1097/ICL.0b013e3181d20cae; Tam C, 2007, EXP EYE RES, V85, P799, DOI 10.1016/j.exer.2007.08.015; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; UPADHYAY MP, 1991, AM J OPHTHALMOL, V111, P92, DOI 10.1016/S0002-9394(14)76903-X; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143	39	46	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64867	10.1371/journal.pone.0064867	http://dx.doi.org/10.1371/journal.pone.0064867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750216	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900018
J	Yan, GR; Zhou, HH; Wang, Y; Zhong, Y; Tan, ZL; Wang, YQ; He, QY				Yan, Guang-Rong; Zhou, Hui-Hua; Wang, Yang; Zhong, Yin; Tan, Zi-Lu; Wang, Yuqiang; He, Qing-Yu			Protective Effects of Andrographolide Analogue AL-1 on ROS-Induced RIN-m beta Cell Death by Inducing ROS Generation	PLOS ONE			English	Article							OXYGEN SPECIES ROS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; CARDIOVASCULAR-DISEASE; SUPEROXIDE-DISMUTASE; CANCER CELLS; CYTOTOXICITY; PHOSPHORYLATION; HOMEOSTASIS	Oxidative stress is considered to be a major factor contributing to pathogenesis and progression of many diseases. A novel andrographolide-lipoic acid conjugate (AL-1) could protect pancreatic beta-cells from reactive oxygen species (ROS)-induced oxidative injury. However, its protective mechanism is still unclear. In this work, we used proteomics to identify AL-1-regulated proteins in beta-cells and found that 13 of the 71 proteins regulated by AL-1 were closely associated with antioxidation. These differential proteins were mainly involved in the ERK1/2 and AKT1 signaling pathways. Functional investigation demonstrated that AL-1 exerted its protective effects on H2O2-induced cell death of beta-cells by generating NADPH oxidase-dependent ROS to activate ERK1/2 and AKT1 signaling pathways. As a consequence, the expressions of antioxidant proteins including Trx1, Prx1 and Prx5, and anti-apoptotic proteins including PDCD6IP, prohibitin, galectin-1 and HSP were upregulated. AL-1 probably worked as a "vaccinum" to activate the cellular antioxidant system by inducing the generation of low concentration ROS which then reciprocally protected beta-cells from oxidative damage caused by high-level ROS from H2O2. To the best of our knowledge, this is the first comprehensive proteomic analysis illustrating a novel molecular mechanism for the protective effects of antioxidants on beta-cells from H2O2-induced cell death.	[Yan, Guang-Rong; Zhou, Hui-Hua; Wang, Yang; Zhong, Yin; Tan, Zi-Lu; He, Qing-Yu] Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Guangdong Higher Educ Inst,Key Lab Funct Prot Res, Guangzhou, Guangdong, Peoples R China; [Wang, Yuqiang] Jinan Univ, Coll Pharm, Inst New Drug Res, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Yan, GR (corresponding author), Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Guangdong Higher Educ Inst,Key Lab Funct Prot Res, Guangzhou, Guangdong, Peoples R China.	tgryan@jnu.edu.cn; tqyhe@jnu.edu.cn	He, Qing-Yu/H-7078-2014; Wang, Yang/GQH-2363-2022	He, Qing-Yu/0000-0003-0503-9492; Wang, Yang/0000-0001-6440-0204	National "973'' Projects of China [2011CB910700]; National Natural Science Foundation of China [81071618, 81272285]; Fundamental Research Funds for the Central Universities [21600201, 21610101]; China New Drug Development Project [2009ZX09102-010]	National "973'' Projects of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China New Drug Development Project	This work was partially supported by National "973'' Projects of China (2011CB910700), National Natural Science Foundation of China (81071618, 81272285), the Fundamental Research Funds for the Central Universities (21600201, 21610101), the China New Drug Development Project (2009ZX09102-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birringer M, 2010, FREE RADICAL BIO MED, V49, P1315, DOI 10.1016/j.freeradbiomed.2010.07.024; Chen JX, 2007, AM J PHYSIOL-HEART C, V292, pH1664, DOI 10.1152/ajpheart.01138.2006; Chen Y, 2010, PEDIATR PULM, V45, P1192, DOI 10.1002/ppul.21307; Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x; Drews G, 2010, PFLUG ARCH EUR J PHY, V460, P703, DOI 10.1007/s00424-010-0862-9; Elbling L, 2010, FREE RADICAL BIO MED, V49, P1444, DOI 10.1016/j.freeradbiomed.2010.08.008; Feng Gang, 2010, BMC Res Notes, V3, P10, DOI 10.1186/1756-0500-3-10; FIGTREE GA, 2012, FREE RADIC BIOL MED; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Gao YA, 2010, BRAIN RES, V1358, P239, DOI 10.1016/j.brainres.2010.08.043; GAZDAR AF, 1980, P NATL ACAD SCI-BIOL, V77, P3519, DOI 10.1073/pnas.77.6.3519; Gil-Izquierdo A, 2012, CURR PHARM BIOTECHNO, V13, P624, DOI 10.2174/138920112799857585; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SB, 2009, MOL CELLS, V28, P583, DOI 10.1007/s10059-009-0152-6; Lee WC, 2005, NEUROCHEM RES, V30, P263, DOI 10.1007/s11064-005-2449-y; Lee YM, 2009, NUTR RES PRACT, V3, P156, DOI 10.4162/nrp.2009.3.2.156; Lei YL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005397; Lonn ME, 2012, FREE RADICAL BIO MED, V53, P863, DOI 10.1016/j.freeradbiomed.2012.05.027; Lu YH, 2010, NEUROSCI LETT, V484, P6, DOI 10.1016/j.neulet.2010.07.078; Murakami T, 2005, J BIOL CHEM, V280, P31841, DOI 10.1074/jbc.M503108200; Mustafi SB, 2009, CELL STRESS CHAPERON, V14, P579, DOI 10.1007/s12192-009-0109-x; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Schreibelt G, 2008, FREE RADICAL BIO MED, V45, P256, DOI 10.1016/j.freeradbiomed.2008.03.024; Selvaraju V, 2012, TOXICOL MECH METHOD, V22, P330, DOI 10.3109/15376516.2012.666648; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tian YY, 2006, LIFE SCI, V80, P193, DOI 10.1016/j.lfs.2006.09.010; Wang Y, 2006, PROTEOMICS, V6, P2422, DOI 10.1002/pmic.200500595; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Yan GG, 2006, PROTEOMICS, V6, P1810, DOI 10.1002/pmic.200500156; Yan GR, 2012, PROTEOMICS, V12, P2391, DOI 10.1002/pmic.201100652; Yan GR, 2010, PROTEOMICS, V10, P976, DOI 10.1002/pmic.200900662; Yang HL, 2009, MOL CELL PROTEOMICS, V8, P571, DOI 10.1074/mcp.M800297-MCP200; Yi XW, 2006, DIABETES, V55, P2238, DOI 10.2337/db06-0251; Yu BC, 2003, PLANTA MED, V69, P1075, DOI 10.1055/s-2003-45185; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang ZJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-62; Zhou F, 2009, BRAIN RES, V1272, P62, DOI 10.1016/j.brainres.2009.03.023; Zhu YY, 2013, PROTEOMICS, V13, P169, DOI 10.1002/pmic.201200273	46	22	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e63656	10.1371/journal.pone.0063656	http://dx.doi.org/10.1371/journal.pone.0063656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750203	gold, Green Published			2022-12-25	WOS:000319961900005
J	Zhu, SH; Fang, Z; Hu, SY; Wang, Z; Rao, HY				Zhu, Senhua; Fang, Zhuo; Hu, Siyuan; Wang, Ze; Rao, Hengyi			Resting State Brain Function Analysis Using Concurrent BOLD in ASL Perfusion fMRI	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; DEFAULT-MODE; CINGULATE CORTEX; MRI; CONNECTIVITY; FLUCTUATIONS; NETWORK; SIGNAL; ASSOCIATION	The past decade has seen astounding discoveries about resting-state brain activity patterns in normal brain as well as their alterations in brain diseases. While the vast majority of resting-state studies are based on the blood-oxygen-level-dependent (BOLD) functional MRI (fMRI), arterial spin labeling (ASL) perfusion fMRI can simultaneously capture BOLD and cerebral blood flow (CBF) signals, providing a unique opportunity for assessing resting brain functions with concurrent BOLD (ccBOLD) and CBF signals. Before taking that benefit, it is necessary to validate the utility of ccBOLD signal for resting-state analysis using conventional BOLD (cvBOLD) signal acquired without ASL modulations. To address this technical issue, resting cvBOLD and ASL perfusion MRI were acquired from a large cohort (n = 89) of healthy subjects. Four widely used resting-state brain function analyses were conducted and compared between the two types of BOLD signal, including the posterior cingulate cortex (PCC) seed-based functional connectivity (FC) analysis, independent component analysis (ICA), analysis of amplitude of low frequency fluctuation (ALFF), and analysis of regional homogeneity (ReHo). Consistent default mode network (DMN) as well as other resting-state networks (RSNs) were observed from cvBOLD and ccBOLD using PCC-FC analysis and ICA. ALFF from both modalities were the same for most of brain regions but were different in peripheral regions suffering from the susceptibility gradients induced signal drop. ReHo showed difference in many brain regions, likely reflecting the SNR and resolution differences between the two BOLD modalities. The DMN and auditory networks showed highest CBF values among all RSNs. These results demonstrated the feasibility of ASL perfusion MRI for assessing resting brain functions using its concurrent BOLD in addition to CBF signal, which provides a potentially useful way to maximize the utility of ASL perfusion MRI.	[Zhu, Senhua; Fang, Zhuo; Rao, Hengyi] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Senhua; Fang, Zhuo; Hu, Siyuan; Wang, Ze; Rao, Hengyi] Univ Penn, Dept Neurol, Perelman Sch Med, Ctr Funct Neuroimaging, Philadelphia, PA 19104 USA; [Wang, Ze; Rao, Hengyi] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hu, Siyuan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Sun Yat Sen University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Beijing Normal University	Wang, Z (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Ctr Funct Neuroimaging, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu; hengyi@mail.med.upenn.edu	Rao, Hengyi/AAQ-4919-2020; Rao, Hengyi/A-7064-2009; Rao, Hengyi/K-5152-2019	Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; 	National Institutes of Health (NIH) [R01 HL102119, R21 DA032022, R03 DA027098]; National Nature Science Foundation of China [31070984, 31000507, 91124004]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027098, R21DA032022] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported in part by National Institutes of Health (NIH) Grants R01 HL102119, R21 DA032022, and R03 DA027098, and the National Nature Science Foundation of China Grants 31070984, 31000507, and 91124004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Detre JA, 2007, 15 ISMRM BERL GERM; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; Detre JA, 2009, CURR OPIN NEUROL, V22, P348, DOI 10.1097/WCO.0b013e32832d9505; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Floyd TF, 2001, 9 ISMRM GLASG SCOTL; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hong LE, 2009, ARCH GEN PSYCHIAT, V66, P431, DOI 10.1001/archgenpsychiatry.2009.2; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Liu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048181; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Marchetti I, 2012, NEUROPSYCHOL REV, V22, P229, DOI 10.1007/s11065-012-9199-9; Nandy R, 2007, NEUROIMAGE, V34, P1562, DOI 10.1016/j.neuroimage.2006.10.025; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rao HY, 2007, HUM BRAIN MAPP, V28, P593, DOI 10.1002/hbm.20288; Sanz-Arigita EJ, 2012, HUMAN BRAIN IN PRESS; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Tomasi D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010815; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Wang Z, 2008, NEUROIMAGE, V39, P973, DOI 10.1016/j.neuroimage.2007.09.045; Wang Z, 2012, MAGN RESON IMAGING, V30, P1409, DOI 10.1016/j.mri.2012.05.004; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042730; Wong EC, 2000, MAGNET RESON MED, V44, P511, DOI 10.1002/1522-2594(200010)44:4<511::AID-MRM2>3.0.CO;2-6; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	45	33	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65884	10.1371/journal.pone.0065884	http://dx.doi.org/10.1371/journal.pone.0065884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750275	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900077
J	Balint, Z; Zabini, D; Konya, V; Nagaraj, C; Vegh, AG; Varo, G; Wilhelm, I; Fazakas, C; Krizbai, IA; Heinemann, A; Olschewski, H; Olschewski, A				Balint, Zoltan; Zabini, Diana; Konya, Viktoria; Nagaraj, Chandran; Vegh, Attila G.; Varo, Gyoergy; Wilhelm, Imola; Fazakas, Csilla; Krizbai, Istvan A.; Heinemann, Akos; Olschewski, Horst; Olschewski, Andrea			Double-Stranded RNA Attenuates the Barrier Function of Human Pulmonary Artery Endothelial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; ENDOPLASMIC-RETICULUM STRESS; ATOMIC-FORCE MICROSCOPY; EXTRACELLULAR RNA; CA2+ ENTRY; ATPASE 2B; PERMEABILITY; TLR3; ACTIVATION; CHANNELS	Circulating RNA may result from excessive cell damage or acute viral infection and can interact with vascular endothelial cells. Despite the obvious clinical implications associated with the presence of circulating RNA, its pathological effects on endothelial cells and the governing molecular mechanisms are still not fully elucidated. We analyzed the effects of double stranded RNA on primary human pulmonary artery endothelial cells (hPAECs). The effect of natural and synthetic double-stranded RNA (dsRNA) on hPAECs was investigated using trans-endothelial electric resistance, molecule trafficking, calcium (Ca2+) homeostasis, gene expression and proliferation studies. Furthermore, the morphology and mechanical changes of the cells caused by synthetic dsRNA was followed by in-situ atomic force microscopy, by vascular-endothelial cadherin and F-actin staining. Our results indicated that exposure of hPAECs to synthetic dsRNA led to functional deficits. This was reflected by morphological and mechanical changes and an increase in the permeability of the endothelial monolayer. hPAECs treated with synthetic dsRNA accumulated in the G1 phase of the cell cycle. Additionally, the proliferation rate of the cells in the presence of synthetic dsRNA was significantly decreased. Furthermore, we found that natural and synthetic dsRNA modulated Ca2+ signaling in hPAECs by inhibiting the sarco-endoplasmic Ca2+-ATPase (SERCA) which is involved in the regulation of the intracellular Ca2+ homeostasis and thus cell growth. Even upon synthetic dsRNA stimulation silencing of SERCA3 preserved the endothelial monolayer integrity. Our data identify novel mechanisms by which dsRNA can disrupt endothelial barrier function and these may be relevant in inflammatory processes.	[Balint, Zoltan; Zabini, Diana; Nagaraj, Chandran; Olschewski, Andrea] Med Univ Graz, Dept Anesthesia & Intens Care Med, Graz, Austria; [Balint, Zoltan; Olschewski, Andrea] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [Olschewski, Horst] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria; [Vegh, Attila G.; Varo, Gyoergy; Wilhelm, Imola; Fazakas, Csilla; Krizbai, Istvan A.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Konya, Viktoria; Heinemann, Akos] Med Univ Graz, Inst Expt & Clin Pharmacol, Graz, Austria	Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Hungarian Academy of Sciences; Hungarian Biological Research Center; Medical University of Graz	Olschewski, A (corresponding author), Med Univ Graz, Dept Anesthesia & Intens Care Med, Graz, Austria.	andrea.olschewski@medunigraz.at	Bálint, Zoltán/AAJ-3080-2020; Chandran, Nagaraj/AAP-2007-2020; Végh, Attila Gergely/A-4789-2011; Olschewski, Horst/L-3547-2019	Chandran, Nagaraj/0000-0003-3825-8587; Végh, Attila Gergely/0000-0003-0524-0946; Olschewski, Horst/0000-0002-2834-7466; Balint, Zoltan/0000-0001-8598-2784; Krizbai, Istvan/0000-0002-0764-1527; Heinemann, Akos/0000-0002-8554-2372; Konya, Viktoria/0000-0002-7999-9093; Olschewski, Andrea/0000-0002-8189-3634	Medical University of Graz (PhD Program Molecular Medicine); EU FP6 "PULMOTENSION'' [LSHM-CT-2005-018725]; National Science Fund of Hungary [OTKA K 81180]; Austrian-Hungarian Joint Grant [AT-4/2009]	Medical University of Graz (PhD Program Molecular Medicine); EU FP6 "PULMOTENSION''; National Science Fund of Hungary(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Austrian-Hungarian Joint Grant	This study was funded by the Medical University of Graz (PhD Program Molecular Medicine) to CN, DZ and VK, EU FP6 "PULMOTENSION'' (LSHM-CT-2005-018725) to AO and HO, National Science Fund of Hungary OTKA K 81180 to GV, and Austrian-Hungarian Joint Grant AT-4/2009 to GV and AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeffner F, 2011, AM J PHYSIOL-LUNG C, V301, pL99, DOI 10.1152/ajplung.00398.2010; Ahmmed GU, 2005, PFLUG ARCH EUR J PHY, V451, P131, DOI 10.1007/s00424-005-1461-z; Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Auer-Grumbach M, 2010, NAT GENET, V42, P160, DOI 10.1038/ng.508; Balint Z, 2007, EUR BIOPHYS J BIOPHY, V36, P113, DOI 10.1007/s00249-006-0112-4; Birukova AA, 2009, NANOMED-NANOTECHNOL, V5, P30, DOI 10.1016/j.nano.2008.07.002; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Caspersen C, 2000, J BIOL CHEM, V275, P22363, DOI 10.1074/jbc.M001569200; Cheng GM, 1996, ARCH BIOCHEM BIOPHYS, V329, P65, DOI 10.1006/abbi.1996.0192; Chiang ET, 2006, J CLIN IMMUNOL, V26, P406, DOI 10.1007/s10875-006-9024-4; Cooper PR, 2009, AM J PHYSIOL-LUNG C, V297, pL530, DOI 10.1152/ajplung.00133.2009; Dellis O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-59; Dewi BE, 2008, J GEN VIROL, V89, P642, DOI 10.1099/vir.0.83356-0; Fischer L, 2004, AM J PHYSIOL-GASTR L, V287, pG1200, DOI 10.1152/ajpgi.00212.2004; Fischer S, 2007, BLOOD, V110, P2457, DOI 10.1182/blood-2006-08-040691; Fischer S, 2009, FASEB J, V23, P2100, DOI 10.1096/fj.08-121608; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Harcourt JL, 2000, J INTERF CYTOK RES, V20, P1007, DOI 10.1089/10799900050198453; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Khan I, 2000, MOL CELL BIOCHEM, V203, P11, DOI 10.1023/A:1007093516593; Konya V, 2010, J ALLERGY CLIN IMMUN, V125, P1105, DOI 10.1016/j.jaci.2009.12.002; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Londhe VA, 2005, PEDIATR RES, V58, P919, DOI 10.1203/01.PDR.0000181377.78061.3E; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Malli R, 2007, CELL CALCIUM, V41, P63, DOI 10.1016/j.ceca.2006.05.001; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL574, DOI 10.1152/ajplung.1998.275.3.L574; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; O'Callaghan R, 2011, AM J PHYSIOL-LUNG C, V301, pL353, DOI 10.1152/ajplung.00342.2010; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Shibamiya A, 2009, BLOOD, V113, P714, DOI 10.1182/blood-2008-02-137901; Siflinger-Birnboim A, 2003, AM J PHYSIOL-LUNG C, V284, pL435, DOI 10.1152/ajplung.00106.2002; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Sutliff RL, 1999, CIRC RES, V84, P360, DOI 10.1161/01.RES.84.3.360; Szewczyk MM, 2007, J CELL MOL MED, V11, P129, DOI 10.1111/j.1582-4934.2007.00010.x; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Tsuji Y, 2011, CIRCULATION, V123, P2192, DOI 10.1161/CIRCULATIONAHA.110.016683; Wilhelm I, 2007, PHYS MED BIOL, V52, P6261, DOI 10.1088/0031-9155/52/20/012; Zimmer S, 2011, CIRC RES, V108, P1358, DOI 10.1161/CIRCRESAHA.111.243246	48	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63776	10.1371/journal.pone.0063776	http://dx.doi.org/10.1371/journal.pone.0063776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755110	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000319872300014
J	Hamer, M; Stamatakis, E				Hamer, Mark; Stamatakis, Emmanuel			Screen-Based Sedentary Behavior, Physical Activity, and Muscle Strength in the English Longitudinal Study of Ageing	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; BODY-COMPOSITION; GRIP STRENGTH; HEALTH; TELEVISION; MEN; WOMEN; RISK; ASSOCIATIONS; PERFORMANCE	Background: Sarcopenia is associated with loss of independence and ill-health in the elderly although the causes remain poorly understood. We examined the association between two screen-based leisure time sedentary activities (daily TV viewing time and internet use) and muscle strength. Methods and Results: We studied 6228 men and women (aged 64.9 +/- 9.1 yrs) from wave 4 (2008-09) of the English Longitudinal Study of Ageing, a prospective study of community dwelling older adults. Muscle strength was assessed by a hand grip test and the time required to complete five chair rises. TV viewing and internet usage were inversely associated with one another. Participants viewing TV >= 6hrs/d had lower grip strength (Men, B = -1.20 kg, 95% Cl, -2.26, -0.14; Women, -0.75 kg, 95% Cl, -1.48, -0.03) in comparison to <2hrs/d TV, after adjustment for age, physical activity, smoking, alcohol, chronic disease, disability, depressive symptoms, social status, and body mass index. In contrast, internet use was associated with higher grip strength (Men, B = 2.43 kg, 95% Cl, 1.74, 3.12; Women, 0.76 kg, 95% Cl, 0.32, 1.20). These associations persisted after mutual adjustment for both types of sedentary behaviour. Conclusions: In older adults, the association between sedentary activities and physical function is context specific (TV viewing vs. computer use). Adverse effects of TV viewing might reflect the prolonged sedentary nature of this behavior.	[Hamer, Mark; Stamatakis, Emmanuel] UCL, Populat Hlth Domain Phys Act Res Grp, London, England; [Hamer, Mark; Stamatakis, Emmanuel] UCL, Dept Epidemiol & Publ Hlth, London, England; [Hamer, Mark] North West Univ, Sch Physiol Nutr & Consumer Sci, Potchefstroom, South Africa; [Stamatakis, Emmanuel] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia	University of London; University College London; University of London; University College London; North West University - South Africa; University of Sydney	Hamer, M (corresponding author), UCL, Populat Hlth Domain Phys Act Res Grp, London, England.	m.hamer@ucl.ac.uk	Hamer, Mark/C-1602-2008; Stamatakis, Emmanuel/C-4958-2009; Hamer, Mark/AAJ-6814-2021	Hamer, Mark/0000-0002-8726-7992; Stamatakis, Emmanuel/0000-0001-7323-3225; Hamer, Mark/0000-0002-8726-7992	National Institute on Aging in the United States [2RO1AG7644-01A1, 2RO1AG017644]; British Heart Foundation [RE/10/005/28296]; National Institute for Health Research Career Development Fellowship; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER; National Institute for Health Research [CDF-2010-03-30] Funding Source: researchfish	National Institute on Aging in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); National Institute for Health Research Career Development Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute on Aging in the United States (grants 2RO1AG7644-01A1 and 2RO1AG017644) and a consortium of UK government departments coordinated by the Office for National Statistics. MH is supported by the British Heart Foundation (RE/10/005/28296); ES is supported by a National Institute for Health Research Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Daly RM, 2008, J AM GERIATR SOC, V56, P2252, DOI 10.1111/j.1532-5415.2008.02039.x; Demakakos P, 2010, DIABETOLOGIA, V53, P1877, DOI 10.1007/s00125-010-1785-x; Ekelund U, 2005, AM J CLIN NUTR, V81, P964; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamer M, 2010, AM J PREV MED, V38, P375, DOI 10.1016/j.amepre.2009.12.030; Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kyle UG, 2001, MED SCI SPORT EXER, V33, P576; Lader D, 2006, TIME USE SURVEY 2005; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee JSW, 2007, GERONTOLOGY, V53, P404, DOI 10.1159/000107355; Manini TM, 2009, AM J CLIN NUTR, V90, P1336, DOI 10.3945/ajcn.2009.27659; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Onder G, 2005, J GERONTOL A-BIOL, V60, P74, DOI 10.1093/gerona/60.1.74; Paalanne NP, 2009, MED SCI SPORT EXER, V41, P1997, DOI 10.1249/MSS.0b013e3181a7f3a6; Park H, 2010, EUR J APPL PHYSIOL, V109, P953, DOI 10.1007/s00421-010-1424-8; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Pierce MB, 2009, DIABETIC MED, V26, P679, DOI 10.1111/j.1464-5491.2009.02755.x; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; Stamatakis E, 2012, DIABETOLOGIA, V55, P311, DOI 10.1007/s00125-011-2358-3; Stamatakis E, 2009, J EPIDEMIOL COMMUN H, V63, P734, DOI 10.1136/jech.2008.085902; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Stamatakis E, 2011, J AM COLL CARDIOL, V57, P292, DOI 10.1016/j.jacc.2010.05.065; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004	29	76	80	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66222	10.1371/journal.pone.0066222	http://dx.doi.org/10.1371/journal.pone.0066222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	157CD	23755302	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300105
J	Menzaghi, C; Bacci, S; Salvemini, L; Mendonca, C; Palladino, G; Fontana, A; De Bonis, C; Marucci, A; Goheen, E; Prudente, S; Morini, E; Rizza, S; Kanagaki, A; Fini, G; Mangiacotti, D; Federici, M; De Cosmo, S; Pellegrini, F; Doria, A; Trischitta, V				Menzaghi, Claudia; Bacci, Simonetta; Salvemini, Lucia; Mendonca, Christine; Palladino, Giuseppe; Fontana, Andrea; De Bonis, Concetta; Marucci, Antonella; Goheen, Elizabeth; Prudente, Sabrina; Morini, Eleonora; Rizza, Stefano; Kanagaki, Alyssa; Fini, Grazia; Mangiacotti, Davide; Federici, Massimo; De Cosmo, Salvatore; Pellegrini, Fabio; Doria, Alessandro; Trischitta, Vincenzo			Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; HORMONE RESISTIN; ARTERY-DISEASE; RISK; MARKER; ASSOCIATION; ADIPONECTIN	Background: High serum resistin has been associated with increased risk of cardiovascular disease in the general population, Only sparse and conflicting results, limited to Asian individuals, have been reported, so far, in type 2 diabetes. We studied the role of serum resistin on coronary artery disease, major cardiovascular events and all-cause mortality in type 2 diabetes. Methods: We tested the association of circulating resistin concentrations with coronary artery disease, major cardiovascular events (cardiovascular death, non-fatal myocardial infarction and non-fatal stroke) and all-cause mortality in 2,313 diabetic patients of European ancestry from two cross-sectional and two prospective studies. In addition, the expression of resistin gene (RETN) was measured in blood cells of 68 diabetic patients and correlated with their serum resistin levels. Results: In a model comprising age, sex, smoking habits, BMI, HbA1c, and insulin, antihypertensive and antidyslipidemic therapies, serum resistin was associated with coronary artery disease in both cross-sectional studies: OR (95%CI) per SD increment = 1.35 (1.101.64) and 1.99 (1.552.55). Additionally, serum resistin predicted incident major cardiovascular events (HR per SD increment = 1.31; 1.101.56) and all-cause mortality (HR per SD increment = 1.16; 1.061.26). Adjusting also for fibrinogen levels affected the association with coronary artery disease and incident cardiovascular events, but not that with all cause-mortality. Finally, serum resistin was positively correlated with RETN mRNA expression (rho = 0.343). Conclusions: This is the first study showing that high serum resistin (a likely consequence, at least partly, of increased RETN expression) is a risk factor for cardiovascular disease and all-cause mortality in diabetic patients of European ancestry.	[Menzaghi, Claudia; Salvemini, Lucia; Palladino, Giuseppe; De Bonis, Concetta; Marucci, Antonella; Morini, Eleonora; Fini, Grazia; Mangiacotti, Davide; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy; [Bacci, Simonetta; De Cosmo, Salvatore] IRCCS Casa Sollievo Sofferenza, Unit Endocrinol, San Giovanni Rotondo, Italy; [Mendonca, Christine; Goheen, Elizabeth; Kanagaki, Alyssa; Doria, Alessandro] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Fontana, Andrea; Pellegrini, Fabio] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy; [Prudente, Sabrina; Trischitta, Vincenzo] IRCSS Casa Sollievo Sofferenza, Mendel Lab, Rome, Italy; [Rizza, Stefano; Federici, Massimo] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Pellegrini, Fabio] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Unit Biostat, I-66030 Santa Maria Imbaro, Italy; [Doria, Alessandro] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Harvard University; Joslin Diabetes Center, Inc.; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; University of Rome Tor Vergata; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Harvard University; Harvard Medical School; Sapienza University Rome	Menzaghi, C (corresponding author), IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy.	c.menzaghi@operapadrepio.it; v.trischitta@operapadrepio.it	Trischitta, Vincenzo/K-1487-2016; Bacci, Simonetta/AAB-8598-2022; mangiacotti, davide/AAM-8142-2020; fini, grazia/AAM-3320-2020; marucci, antonella/B-8722-2017; DE BONIS, CONCETTA/AAM-8146-2020; Federici, Massimo/G-9940-2012; Fontana, Andrea/J-8584-2016; Palladino, Giuseppe/GOP-0198-2022; Menzaghi, Claudia/J-7210-2016; Doria, Alessandro/H-9157-2018; De Cosmo, Salvatore/J-7420-2016; Rizza, Stefano/AFI-4801-2022; Prudente, Sabrina/H-2886-2016; Salvemini, Lucia/K-2121-2016	Trischitta, Vincenzo/0000-0003-1174-127X; Bacci, Simonetta/0000-0002-5024-8958; marucci, antonella/0000-0001-8131-8317; Federici, Massimo/0000-0003-4989-5194; Fontana, Andrea/0000-0002-6660-5315; Menzaghi, Claudia/0000-0002-7438-8955; Doria, Alessandro/0000-0002-3830-4304; De Cosmo, Salvatore/0000-0001-8787-8286; Rizza, Stefano/0000-0001-5496-4890; Prudente, Sabrina/0000-0001-9220-8981; Salvemini, Lucia/0000-0001-8776-9477	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; PO Puglia FESR; Italian Ministry of Health [RC2011, RC2012]; European Foundation for the Study of Diabetes/Pfizer; National Institutes of Health [HL073168]; EFSD/Pfizer; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168] Funding Source: NIH RePORTER	Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST; PO Puglia FESR; Italian Ministry of Health(Ministry of Health, Italy); European Foundation for the Study of Diabetes/Pfizer; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EFSD/Pfizer(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by Accordo Programma Quadro in Materia di Ricerca Scientifica nella Regione Puglia-PST 2006 and PO Puglia FESR 2007-2013, Italian Ministry of Health grants RC2011, RC2012, European Foundation for the Study of Diabetes/Pfizer grant (CM) and National Institutes of Health grant HL073168 (AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CM received funding from the EFSD/Pfizer. MF is a PLOS ONE Editorial Board member. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.	Bacci S, 2004, DIABETES CARE, V27, P2015, DOI 10.2337/diacare.27.8.2015; Bacci S, 2011, DIABETES, V60, P1000, DOI 10.2337/db10-1300; Burnett MS, 2005, ATHEROSCLEROSIS, V182, P241, DOI 10.1016/j.atherosclerosis.2005.02.014; Butler J, 2009, ARTERIOSCL THROM VAS, V29, P1144, DOI 10.1161/ATVBAHA.109.186783; Chamnan P, 2009, DIABETOLOGIA, V52, P2001, DOI 10.1007/s00125-009-1454-0; Coleman RL, 2007, DIABETES CARE, V30, P1292, DOI 10.2337/dc06-1358; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2004, HDB STAT, V23; Frankel DS, 2009, J AM COLL CARDIOL, V53, P754, DOI 10.1016/j.jacc.2008.07.073; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Hoefle G, 2007, CLIN CHIM ACTA, V386, P1, DOI 10.1016/j.cca.2007.07.001; Langheim S, 2010, AM J PHYSIOL-HEART C, V298, pH746, DOI 10.1152/ajpheart.00617.2009; Lee SH, 2009, CORONARY ARTERY DIS, V20, P33, DOI 10.1097/MCA.0b013e328318ecb0; Lim S, 2008, ATHEROSCLEROSIS, V196, P398, DOI 10.1016/j.atherosclerosis.2006.11.017; Lubos E, 2007, ATHEROSCLEROSIS, V193, P121, DOI 10.1016/j.atherosclerosis.2006.05.039; Luc G, 2010, INT J OBESITY, V34, P118, DOI 10.1038/ijo.2009.204; Menzaghi C, 2010, DIABETOLOGIA, V53, P226, DOI 10.1007/s00125-009-1589-z; Menzaghi C, 2006, J CLIN ENDOCR METAB, V91, P2792, DOI 10.1210/jc.2005-2715; Ohmori R, 2005, J AM COLL CARDIOL, V46, P379, DOI 10.1016/j.jacc.2005.04.022; On YK, 2007, CIRC J, V71, P868, DOI 10.1253/circj.71.868; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pilz S, 2007, CLIN ENDOCRINOL, V66, P380, DOI 10.1111/j.1365-2265.2007.02743.x; Pischon T, 2005, OBES RES, V13, P1764, DOI 10.1038/oby.2005.215; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Prudente S, 2011, ATHEROSCLEROSIS, V219, P667, DOI 10.1016/j.atherosclerosis.2011.08.019; Qi L, 2011, J AM COLL CARDIOL, V58, P2675, DOI 10.1016/j.jacc.2011.08.054; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Tsukahara T, 2009, DIABETES RES CLIN PR, V84, P179, DOI 10.1016/j.diabres.2008.10.021; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; von Eynatten M, 2005, DIABETES CARE, V28, P754, DOI 10.2337/diacare.28.3.754; Weikert C, 2008, J CLIN ENDOCR METAB, V93, P2647, DOI 10.1210/jc.2007-2735; Weikert C, 2007, CLIN CHEM LAB MED, V45, P899, DOI 10.1515/CCLM.2007.148; Zhang MH, 2011, J CARD FAIL, V17, P24, DOI 10.1016/j.cardfail.2010.08.007	40	62	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64729	10.1371/journal.pone.0064729	http://dx.doi.org/10.1371/journal.pone.0064729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755138	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300025
J	Garcia-Murillas, I; Sharpe, R; Pearson, A; Campbell, J; Natrajan, R; Ashworth, A; Turner, NC				Garcia-Murillas, I.; Sharpe, R.; Pearson, A.; Campbell, J.; Natrajan, R.; Ashworth, A.; Turner, N. C.			An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer	ONCOGENE			English	Article						breast cancer; amplification; GNAS; siRNA	OVARIAN-CANCER; ALPHA-S; CELL-LINES; AMPLIFICATION; TUMORS; GROWTH; PHOSPHORYLATION; SENSITIVITY; ABERRATIONS; ACTIVATION	Poor-prognosis oestrogen receptor-positive breast cancer is characterised by the presence of high-level focal amplifications. We utilised a focused small interfering RNA screen in 14 breast cancer cell lines to define genes that were pathogenic in three genomic regions focally amplified in oestrogen receptor-positive breast cancer, 8p11-12, 11q13 and 20q. Silencing the GNAS locus, that encodes the G protein alpha stimulatory subunit Gas, specifically reduced the growth of 20q amplified breast cancer cell lines. Examination of a publically available small hairpin RNA data set confirmed GNAS silencing to be selective for 20q amplified cancer cell lines. Cell lines with 20q amplification were found to overexpress specifically the extra long Gas splice variant (XL alpha s). Overexpression of XL alpha s induced cAMP levels to a greater extent than Gas, suggesting that amplification of the GNAS locus, and overexpression of the XL alpha s variant in particular, enhanced cAMP signalling. GNAS silencing in amplified cell lines reduced extracellular-signal-regulated kinase 1/2 (ERK1/2) phosphorylation, and conversely overexpression of exogenous XL alpha s in a nonamplified cell line increased MEK-ERK1/2 phosphorylation, identifying one potential downstream consequence of enhanced cAMP signalling. Our data indicate that amplification of the GNAS locus may contribute to the pathogenesis of breast cancer, and highlight a previously unrecognised role for the GNAS XL alpha s variant in cancer.	[Garcia-Murillas, I.; Sharpe, R.; Pearson, A.; Campbell, J.; Natrajan, R.; Ashworth, A.; Turner, N. C.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Turner, N. C.] Royal Marsden Hosp, Breast Unit, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Turner, NC (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	nicholas.turner@icr.ac.uk		Natrajan, Rachael/0000-0002-9987-2946; Turner, Nicholas/0000-0001-8937-0873; garcia-murillas, isaac/0000-0001-8183-7969	Cancer Research UK; Breakthrough Breast Cancer; NIHR Biomedical Research Centre	Cancer Research UK(Cancer Research UK); Breakthrough Breast Cancer; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	We thank Murat Bastepe for supplying cDNA contructs for G alpha s and XL alpha s. This work was supported by grants from Cancer Research UK and Breakthrough Breast Cancer. Dr Nicholas Turner is a CRUK Clinician Scientist. We acknowledge NHS funding to the NIHR Biomedical Research Centre.	Aydin C, 2009, ENDOCRINOLOGY, V150, P3567, DOI 10.1210/en.2009-0318; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Collins C, 1998, P NATL ACAD SCI USA, V95, P8703, DOI 10.1073/pnas.95.15.8703; Consonni SV, 2012, P NATL ACAD SCI USA, V109, P3814, DOI 10.1073/pnas.1117599109; Courjal F, 1997, CANCER RES, V57, P4360; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Freda PU, 2007, PITUITARY, V10, P275, DOI 10.1007/s11102-007-0058-2; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Liu Z, 2011, J BIOL CHEM, V286, P38558, DOI 10.1074/jbc.M111.240150; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Mackay A, 2009, BREAST CANCER RES TR, V118, P481, DOI 10.1007/s10549-008-0296-7; Mariot V, 2011, BONE, V48, P312, DOI 10.1016/j.bone.2010.09.032; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nonet GH, 2001, CANCER RES, V61, P1250; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Press MF, 2011, J CLIN ONCOL, V29, P859, DOI 10.1200/JCO.2009.27.5644; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Sircoulomb F, 2011, EMBO MOL MED, V3, P153, DOI 10.1002/emmm.201100121; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Wadhawan S, 2008, MOL BIOL EVOL, V25, P2745, DOI 10.1093/molbev/msn229; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Zhang L, 2005, CANCER RES, V65, P925	42	23	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2478	2486		10.1038/onc.2013.202	http://dx.doi.org/10.1038/onc.2013.202			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23752180	Green Accepted			2022-12-25	WOS:000336033600007
J	Komori, T; Tanaka, M; Senba, E; Miyajima, A; Morikawa, Y				Komori, Tadasuke; Tanaka, Minoru; Senba, Emiko; Miyajima, Atsushi; Morikawa, Yoshihiro			Lack of Oncostatin M Receptor beta Leads to Adipose Tissue Inflammation and Insulin Resistance by Switching Macrophage Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; Cytokine; Inflammation; Insulin Resistance; Macrophages; Obesity	SYNTHASE ARGINASE BALANCE; DORSAL-ROOT GANGLIA; SKELETAL-MUSCLE; T-CELLS; OBESITY; MICE; EXPRESSION; ACTIVATION; FAT; HYPERINSULINEMIA	Oncostatin M (OSM), a member of the IL-6 family of cytokines, plays important roles in a variety of biological functions, including inflammatory responses. However, the roles of OSM in metabolic diseases are unknown. We herein analyzed the metabolic parameters of OSM receptor subunit-deficient (OSMR-/-) mice under normal diet conditions. At 32 weeks of age, OSMR-/- mice exhibited mature-onset obesity, severer hepatic steatosis, and insulin resistance. Surprisingly, insulin resistance without obesity was observed in OSMR-/- mice at 16 weeks of age, suggesting that insulin resistance precedes obesity in OSMR-/- mice. Both OSM and OSMR were expressed strongly in the adipose tissue and little in some other metabolic organs, including the liver and skeletal muscle. In addition, OSMR is mainly expressed in the adipose tissue macrophages (ATMs) but not in adipocytes. In OSMR-/- mice, the ATMs were polarized to M1 phenotypes with the augmentation of adipose tissue inflammation. Treatment of OSMR-/- mice with an anti-inflammatory agent, sodium salicylate, improved insulin resistance. In addition, the stimulation of a macrophage cell line, RAW264.7, and peritoneal exudate macrophages with OSM resulted in the increased expression of M2 markers, IL-10, arginase-1, and CD206. Furthermore, treatment of C57BL/6J mice with OSM increased insulin sensitivity and polarized the phenotypes of ATMs to M2. Thus, OSM suppresses the development of insulin resistance at least in part through the polarization of the macrophage phenotypes to M2, and OSMR-/- mice provide a unique mouse model of metabolic diseases.	[Komori, Tadasuke; Senba, Emiko; Morikawa, Yoshihiro] Wakayama Med Univ, Dept Anat & Neurobiol, Wakayama 6418509, Japan; [Tanaka, Minoru; Miyajima, Atsushi] Univ Tokyo, Lab Cell Growth & Differentiat, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Wakayama Medical University; University of Tokyo	Morikawa, Y (corresponding author), Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshim@wakayama-med.ac.jp			Wakayama Medical University; Wakayama Medical Award for Young Researchers	Wakayama Medical University; Wakayama Medical Award for Young Researchers	This work was supported in part by a Research Grant on Priority Areas from Wakayama Medical University and the 2012 Wakayama Medical Award for Young Researchers.	Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grzelkowska-Kowalczyk K, 2010, CELL BIOL INT, V34, P117, DOI 10.1042/CBI20090135; Hamilton T.A., 2002, MACROPHAGE, V2, P73; Hirasaka K, 2007, DIABETES, V56, P2511, DOI 10.2337/db06-1768; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Igaz P, 2006, ENDOCRINOLOGY, V147, P1037, DOI 10.1210/en.2005-0729; Ishikawa M, 1998, DIABETES, V47, P788, DOI 10.2337/diabetes.47.5.788; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Komori T, 2005, BRAIN RES, V1049, P34, DOI 10.1016/j.brainres.2005.04.079; Komori T, 2008, J COMP NEUROL, V511, P92, DOI 10.1002/cne.21838; Komori T, 2010, J BIOL CHEM, V285, P37884, DOI 10.1074/jbc.M110.148973; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; MORIKAWA Y, 1993, CELL IMMUNOL, V152, P200, DOI 10.1006/cimm.1993.1279; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Mukouyama YS, 1998, IMMUNITY, V8, P105, DOI 10.1016/S1074-7613(00)80463-X; Munder M, 1998, J IMMUNOL, V160, P5347; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; Odeleye OE, 1997, DIABETES, V46, P1341, DOI 10.2337/diabetes.46.8.1341; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tamura S, 2002, MECH DEVELOP, V115, P127, DOI 10.1016/S0925-4773(02)00081-3; Tamura S, 2002, DEV DYNAM, V225, P327, DOI 10.1002/dvdy.10156; Tanaka M, 1999, BLOOD, V93, P804, DOI 10.1182/blood.V93.3.804.403a16_804_815; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Wallace PM, 1999, J IMMUNOL, V162, P5547; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	51	50	52	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21861	10.1074/jbc.M113.461905	http://dx.doi.org/10.1074/jbc.M113.461905			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760275	hybrid, Green Published			2022-12-25	WOS:000328841900035
J	Cheng, HH; Yi, HS; Kim, Y; Kroh, EM; Chien, JW; Eaton, KD; Goodman, MT; Tait, JF; Tewari, M; Pritchard, CC				Cheng, Heather H.; Yi, Hye Son; Kim, Yeonju; Kroh, Evan M.; Chien, Jason W.; Eaton, Keith D.; Goodman, Marc T.; Tait, Jonathan F.; Tewari, Muneesh; Pritchard, Colin C.			Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels	PLOS ONE			English	Article							PLATELET MICRORNA; LUNG-CANCER; BLOOD; SERUM; THROMBOCYTOSIS; MARKERS; AGENTS; PCR	Circulating, cell-free microRNAs (miRNAs) are promising candidate biomarkers, but optimal conditions for processing blood specimens for miRNA measurement remain to be established. Our previous work showed that the majority of plasma miRNAs are likely blood cell-derived. In the course of profiling lung cancer cases versus healthy controls, we observed a broad increase in circulating miRNA levels in cases compared to controls and that higher miRNA expression correlated with higher platelet and particle counts. We therefore hypothesized that the quantity of residual platelets and microparticles remaining after plasma processing might impact miRNA measurements. To systematically investigate this, we subjected matched plasma from healthy individuals to stepwise processing with differential centrifugation and 0.22 mm filtration and performed miRNA profiling. We found a major effect on circulating miRNAs, with the majority (72%) of detectable miRNAs substantially affected by processing alone. Specifically, 10% of miRNAs showed 4-30x variation, 46% showed 30-1,000x variation, and 15% showed >1,000x variation in expression solely from processing. This was predominantly due to platelet contamination, which persisted despite using standard laboratory protocols. Importantly, we show that platelet contamination in archived samples could largely be eliminated by additional centrifugation, even in frozen samples stored for six years. To minimize confounding effects in microRNA biomarker studies, additional steps to limit platelet contamination for circulating miRNA biomarker studies are necessary. We provide specific practical recommendations to help minimize confounding variation attributable to plasma processing and platelet contamination.	[Cheng, Heather H.; Chien, Jason W.; Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Cheng, Heather H.; Eaton, Keith D.; Tewari, Muneesh] Univ Washington, Dept Med, Seattle, WA USA; [Yi, Hye Son; Tait, Jonathan F.; Pritchard, Colin C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Kim, Yeonju; Tewari, Muneesh] Univ Hawaii, Program Epidemiol, Honolulu, HI 96822 USA; [Kroh, Evan M.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Goodman, Marc T.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA; [Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Hawaii System; Fred Hutchinson Cancer Center; Cedars Sinai Medical Center; Fred Hutchinson Cancer Center	Pritchard, CC (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	cpritch@uw.edu	Kim, Yeonju/D-8948-2013	Kim, Yeonju/0000-0002-2570-750X; Cheng, Heather/0000-0002-1365-0702; Eaton, Keith/0000-0001-5025-2001; Goodman, Marc/0000-0002-4839-3021	NIH [T32CA009515-28, R01CA058598-13, TR01 5R01DK085714]; Canary Foundation; Damon Runyon-Rachleff Innovation Award; NATIONAL CANCER INSTITUTE [R01CA058598, T32CA009515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085714] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canary Foundation; Damon Runyon-Rachleff Innovation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by: NIH T32CA009515-28 (HHC), NIH R01CA058598-13(MG), Canary Foundation (MT), Damon Runyon-Rachleff Innovation Award (MT), NIH TR01 5R01DK085714 (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoe K, 2004, RESPIRATION, V71, P170, DOI 10.1159/000076679; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Dancey JE, 2010, CLIN CANCER RES, V16, P1745, DOI 10.1158/1078-0432.CCR-09-2167; de Boer HC, 2013, EUR HEART J, DOI 10.1093/eurheartj/eht007; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Goodman MT, 2007, CANCER RES, V67, P5987, DOI 10.1158/0008-5472.CAN-07-0313; Hastings ML, 2012, METHODS; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Kim DJ, 2012, J MOL DIAGN, V14, P71, DOI 10.1016/j.jmoldx.2011.09.002; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mostert B, 2011, EXPERT REV MOL DIAGN, V11, P259, DOI [10.1586/ERM.11.11, 10.1586/erm.11.11]; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Pedersen LM, 1996, EUR RESPIR J, V9, P1826; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Simak J, 2006, TRANSFUS MED REV, V20, P1, DOI 10.1016/j.tmrv.2005.08.001; Tomita Masaki, 2008, Interact Cardiovasc Thorac Surg, V7, P613, DOI 10.1510/icvts.2007.174391; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zhao XY, 2012, J IMMUNOL METHODS, V378, P72, DOI 10.1016/j.jim.2012.02.007	28	217	223	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64795	10.1371/journal.pone.0064795	http://dx.doi.org/10.1371/journal.pone.0064795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762257	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800008
J	Holliday, CM; Tsai, HP; Skiljan, RJ; George, ID; Pathan, S				Holliday, Casey M.; Tsai, Henry P.; Skiljan, Rebecca J.; George, Ian D.; Pathan, Sami			A 3D Interactive Model and Atlas of the Jaw Musculature of Alligator mississippiensis	PLOS ONE			English	Article							MORPHOLOGY; EVOLUTION; MICROCT	Modern imaging and dissemination methods enable morphologists to share complex, three-dimensional (3D) data in ways not previously possible. Here we present a 3D interactive model of the jaw musculature of the American Alligator (Alligator mississippiensis). Alligator and crocodylian jaw musculature is notoriously challenging to inspect and interpret because of the derived nature of the feeding apparatus. Using Iodine-contrast enhanced microCT imaging, a segmented model of jaw muscles, trigeminal nerve, brain and skull are presented as a cross-sectional atlas and 3D, interactive pdf of the rendered model. Modern 3D dissemination methods like this 3D Alligator hold great potential for morphologists to share anatomical information to scientists, educators, and the public in an easily downloadable format.	[Holliday, Casey M.; Tsai, Henry P.; Skiljan, Rebecca J.; George, Ian D.; Pathan, Sami] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Holliday, CM (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	hollidayca@missouri.edu		Holliday, Casey/0000-0001-8210-8434	University of Missouri Research Council; University of Missouri School of Medicine Department of Pathology and Anatomical Sciences; MU Life Sciences Fellowships; MU-HHMI C3 Fellowship	University of Missouri Research Council; University of Missouri School of Medicine Department of Pathology and Anatomical Sciences; MU Life Sciences Fellowships; MU-HHMI C3 Fellowship	This study was funded by the University of Missouri Research Council (http://research.missouri.edu/internal/researchcouncil), University of Missouri School of Medicine Department of Pathology and Anatomical Sciences (http://pathology-anatomy.missouri.edu/). HPT and IDG were funded by the MU Life Sciences Fellowships (http://bondlsc.missouri.edu/fellowships). RJS was funded by the MU-HHMI C3 Fellowship (http://hhmi.missouri.edu/). No current external funding sources funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bona P, 2011, J MORPHOL, V272, P780, DOI 10.1002/jmor.10894; BUSBEY AB, 1989, J MORPHOL, V202, P99, DOI 10.1002/jmor.1052020108; Curtis N, 2010, J R SOC INTERFACE, V7, P153, DOI 10.1098/rsif.2009.0139; Dumont ER, 2011, J ANAT, V218, P151, DOI 10.1111/j.1469-7580.2010.01247.x; George ID, 2013, ANAT REC, V296, P670, DOI 10.1002/ar.22666; Handschuh S, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-41; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; Iordansky Nikolai N., 2000, Russian Journal of Herpetology, V7, P41; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Johnston P, 2011, COMPUT TOMOGR, P259, DOI [-10.5772/21982, DOI 10.5772/21982]; Lakjer T., 1926, TRIGEMINUS VERSORGTE; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Ruthensteiner B, 2008, MICROSC RES TECHNIQ, V71, P778, DOI 10.1002/jemt.20618; Schumacher GH, 1973, BIOL REPTILIA, V4, P101; Tsai HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024935	16	69	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e62806	10.1371/journal.pone.0062806	http://dx.doi.org/10.1371/journal.pone.0062806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762228	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800001
J	Zinetti, F; Dapporto, L; Vovlas, A; Chelazzi, G; Bonelli, S; Balletto, E; Ciofi, C				Zinetti, Francesca; Dapporto, Leonardo; Vovlas, Alessio; Chelazzi, Guido; Bonelli, Simona; Balletto, Emilio; Ciofi, Claudio			When the Rule Becomes the Exception. No Evidence of Gene Flow between Two Zerynthia Cryptic Butterflies Suggests the Emergence of a New Model Group	PLOS ONE			English	Article							PARNASSIINAE LEPIDOPTERA; POLYXENA LEPIDOPTERA; MOLECULAR PHYLOGENY; ARISTOLOCHIC ACIDS; PAPILIONIDAE; MITOCHONDRIAL; HYBRIDIZATION; SWALLOWTAIL; PATTERNS; DIFFERENTIATION	There is increasing evidence that most parapatric cryptic/sister taxa are reproductively compatible across their areas of contact. Consequently, the biological species concept, which assumes absence of interbreeding, is becoming a not so effective criterion in evolutionary ecology. Nevertheless, the few parapatric sister taxa showing complete reproductive barriers represent interesting models to study speciation processes and the evolution of reproductive isolation. In this study, we examined contact populations in northwestern Italy of two butterfly species, Zerynthia polyxena and Z. cassandra, characterized by different genitalic morphotypes. We studied levels of divergence among 21 populations distributed from Sicily to France using three genetic markers (the mitochondrial COI and ND1 genes and the nuclear wingless gene) and genitalic geometric morphometrics. Moreover, we performed species distribution modelling to estimate different climatic requirements of Z. polyxena and Z. cassandra. We projected climatic data into glacial maximum scenarios in order to verify if and to which extent glacial cycles could have contributed to speciation processes. Genetic and morphometric analyses identified two main groups. All specimens showed a concordant pattern of diversification, including those individuals sampled in the contact area. Haplotype distribution and climatic models showed that during glacial maxima both species experienced a strong range contraction and presumably remained separated into different microrefugia in southern France, in the Italian Peninsula and on the islands of Elba and Sicily. Long term separation was probably favoured by reduced dispersal ability and high phylopatry, while genitalic diversification probably favoured interbreeding avoidance. Conversely, the aposematic wing pattern remained almost identical. We compared our results with those obtained in other species and concluded that Z. polyxena and Z. cassandra represent a valuable model in the study of speciation.	[Zinetti, Francesca; Chelazzi, Guido; Ciofi, Claudio] Univ Florence, Dipartimento Biol, Florence, Italy; [Dapporto, Leonardo] Ist Comprens Materna Elementare Media Convenevole, Prato, Italy; [Vovlas, Alessio; Bonelli, Simona; Balletto, Emilio] Univ Turin, Dipartimento Sci Vita & Biol Sistemi, Turin, Italy	University of Florence; University of Turin	Dapporto, L (corresponding author), Ist Comprens Materna Elementare Media Convenevole, Prato, Italy.	leonadap@gmail.com	Dapporto, Leonardo/E-5752-2010; Ciofi, Claudio/AAH-9461-2019	Dapporto, Leonardo/0000-0001-7129-4526; BALLETTO, Emilio/0000-0003-1168-2791; Bonelli, Simona/0000-0001-5185-8136; CIOFI, CLAUDIO/0000-0001-8537-8659; Vovlas, Alessio/0000-0003-1682-7101	Italian Ministry of University and Research; Spanish Ministerio de Ciencia e Innovacion [CGL2010-21226/BOS]; "Definizione dello status di conservazione delle falene e della malacofauna terrestre dell'Arcipelago Toscano'' project	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); "Definizione dello status di conservazione delle falene e della malacofauna terrestre dell'Arcipelago Toscano'' project	This study was part of the program "A multitaxa approach to study the impact of climate change on the biodiversity of Italian ecosystems" funded by the Italian Ministry of University and Research, the Spanish Ministerio de Ciencia e Innovacion project CGL2010-21226/BOS and the "Definizione dello status di conservazione delle falene e della malacofauna terrestre dell'Arcipelago Toscano'' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aubert J, 1999, MOL PHYLOGENET EVOL, V12, P156, DOI 10.1006/mpev.1998.0605; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Balletto E., 2007, CHECKLIST DISTRIBUTI, V17, P257; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bollino M., 2012, BUTTERFLIES WORL S20; Bookstein F L, 1997, Med Image Anal, V1, P225; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Celik T, 2012, EUR J ENTOMOL, V109, P217, DOI 10.14411/eje.2012.028; Cianchi R, 2003, MOL ECOL, V12, P1461, DOI 10.1046/j.1365-294X.2003.01813.x; Coyne FM, 2004, SPECIATION; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dapporto L, 2012, DIVERS DISTRIB, V18, P1066, DOI 10.1111/j.1472-4642.2012.00903.x; Dapporto L, 2011, BIOL J LINN SOC, V103, P571, DOI 10.1111/j.1095-8312.2011.01639.x; Dapporto L, 2010, J ZOOL SYST EVOL RES, V48, P229, DOI 10.1111/j.1439-0469.2009.00550.x; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Dasmahapatra KK, 2010, MOL ECOL, V19, P4283, DOI 10.1111/j.1365-294X.2010.04802.x; Descimon Henri, 2009, P219; Dinca V, 2011, MOL ECOL, V20, P3921, DOI 10.1111/j.1365-294X.2011.05223.x; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Elith Jane, 2002, P39; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Friberg M, 2008, BEHAV ECOL SOCIOBIOL, V62, P873, DOI 10.1007/s00265-007-0511-2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Habel JC, 2013, J HERED, V104, P234, DOI 10.1093/jhered/ess092; Habel JC, 2010, BIOL J LINN SOC, V99, P818, DOI 10.1111/j.1095-8312.2010.01394.x; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kim MI, 2009, MOL CELLS, V28, P347, DOI 10.1007/s10059-009-0129-5; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kudrna O., 2011, DISTRIBUTION ATLAS B; Lorkovic Zdravko, 1993, Natura Croatica, V2, P1; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Mallet J, 2011, INSECT CONSERV DIVER, V4, P192, DOI 10.1111/j.1752-4598.2010.00122.x; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Michel F, 2008, ANN SOC ENTOMOL FR, V44, P1; Nazari V, 2007, INSECT SYST EVOL, V38, P121, DOI 10.1163/187631207788783996; Nazari V, 2007, MOL PHYLOGENET EVOL, V42, P131, DOI 10.1016/j.ympev.2006.06.022; Otto-Bliesner BL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029475; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Porter Adam H., 2009, P296; Posada D., 2003, CURRENT PROTOCOLS BI; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rohlf F, 2010, TPSDIG DIGITIZE LAND; Rohlf F., 2012, TPSUTIL FILE UTILITY; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2010, ANNU REV ENTOMOL, V55, P189, DOI 10.1146/annurev.ento.54.110807.090529; ROTHSCHILD M, 1972, INSECT BIOCHEM, V2, P334, DOI 10.1016/0020-1790(72)90038-8; Sanudo-Restrepo CP, 2012, MOL PHYLOGE IN PRESS; Sime KR, 2000, CHEMOECOLOGY, V10, P169, DOI 10.1007/PL00001819; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Wiemers Martin, 2010, Entomologische Zeitschrift, V120, P111; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	60	40	40	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65746	10.1371/journal.pone.0065746	http://dx.doi.org/10.1371/journal.pone.0065746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755277	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000100
J	Zhang, JD; Himes, JH; Guo, Y; Jiang, JX; Yang, L; Lu, QZ; Ruan, HY; Shi, SH				Zhang, Jianduan; Himes, John H.; Guo, Yuan; Jiang, Jingxiong; Yang, Liu; Lu, Qiaozhen; Ruan, Haiyan; Shi, Shuhua			Birth Weight, Growth and Feeding Pattern in Early Infancy Predict Overweight/Obesity Status at Two Years of Age: A Birth Cohort Study of Chinese Infants	PLOS ONE			English	Article							BODY-MASS INDEX; CHILDHOOD OBESITY; PRESCHOOL-CHILDREN; UNITED-STATES; FOLLOW-UP; PREVALENCE; TRENDS; RISK; GAIN; BEHAVIORS	Objectives: To investigate the early determinants of overweight and obesity status at age two years. Methods: A total of 1098 healthy neonates (563 boys and 535 girls) were involved in this community-based prospective study in China. Data on body weight and length were collected at birth, the 3rd and 24th month. A self-administered questionnaire was used to collect data on social demography and feeding patterns of children, etc. Three multivariable logistic regression models were employed to make various comparisons of weight status, i.e., model 1 (obesity vs. non-obesity), model 2 (combined overweight and obesity vs. normal weight, and model 3 (obesity, overweight and normal weight). Results: Prevalences of overweight/obesity (95th > BMI >= 85th p and BMI >= 95th p, referring to WHO BMI standards) at 2 years of age are 15.8%/11.2% for boys and 12.9%/9.0% for girls, respectively. Being born with macrosomia (OR: 1.80-1.88), relatively greater BMI increment in the first 3 months (OR: 1.15-1.16) and bottle emptying by encouragement at age two (OR: 1.30-1.57) were found in all three models to be significant risk factors for higher BMI status at 2 years. Pre-pregnancy maternal BMI (OR: 1.09-1.12), paternal BMI (OR: 1.06), and mixed breastfeeding (OR: 1.54-1.57) or formula feeding (OR: 1.90-1.93) in the first month were identified as significant in models 2 and 3. Child-initiated bottle emptying at age two was observed to increase the risk of obesity by 1.31 times but only in model 1. Conclusion: Fetal and early postnatal growth and feeding pattern appear to have significant impacts on early childhood overweight and obesity status independent of parental BMI. Policy-based and multidisciplinary approaches to promote breastfeeding and enhancement of feeding skills of care takers may be promising intervention strategies.	[Zhang, Jianduan; Guo, Yuan; Shi, Shuhua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Woman & Childs Care & Adolescence Hlth, Wuhan 430074, Hubei, Peoples R China; [Himes, John H.] Univ Minnesota, Sch Publ Hlth, Dept Epidemiol & Community Hlth, Minneapolis, MN USA; [Jiang, Jingxiong] Chinese Ctr Dis Control & Prevent, Natl Ctr Women & Childrens Hlth Care, Dept Child Hlth, Beijing, Peoples R China; [Yang, Liu] Shenyang Municipal Maternal & Child Hlth Care Ctr, Dept Maternal Hlth, Shenyang, Liaoning, Peoples R China; [Lu, Qiaozhen] Haizhu Maternal & Child Hlth Hosp, Dept Child Hlth, Guangzhou, Guangdong, Peoples R China; [Ruan, Haiyan] Panyu Dist Maternal & Child Hlth Hosp, Dept Child Hlth, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; University of Minnesota System; University of Minnesota Twin Cities; Chinese Center for Disease Control & Prevention	Zhang, JD (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Woman & Childs Care & Adolescence Hlth, Wuhan 430074, Hubei, Peoples R China.	jd_zh@mail.hust.edu.cn	Zhang, Jianduan/K-9698-2015	Zhang, Jianduan/0000-0002-7942-8362	National Natural Science Fund (NNSF) of China [30800917]; Special Fund for Basic Scientific Research of Central Colleges [2011TS017]	National Natural Science Fund (NNSF) of China(National Natural Science Foundation of China (NSFC)); Special Fund for Basic Scientific Research of Central Colleges	This work was supported by: 1. National Natural Science Fund (NNSF) of China (Grand No. 30800917). 2. The Special Fund for Basic Scientific Research of Central Colleges (Grant No. 2011TS017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; Breitfelder A, 2009, ECON HUM BIOL, V9, P302; Brophy S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-467; Bruss MB, 2003, J AM DIET ASSOC, V103, P1042, DOI 10.1016/S0002-8223(03)00472-3; Clark HR, 2008, PUBLIC HEALTH NUTR, V11, P1030, DOI 10.1017/S1368980007001401; De Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009155; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dennison BA, 2006, OBESITY, V14, P491, DOI 10.1038/oby.2006.64; Dietz WH, 1998, J NUTR, V128, p411S, DOI 10.1093/jn/128.2.411S; Dietz WH, 2001, ANNU REV PUBL HEALTH, V22, P337, DOI 10.1146/annurev.publhealth.22.1.337; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Eriksson J, 2003, INT J OBESITY, V27, P722, DOI 10.1038/sj.ijo.0802278; Gubbels JS, 2009, J PEDIATR-US, V155, P194, DOI 10.1016/j.jpeds.2009.02.027; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Haisma H, 2003, EUR J CLIN NUTR, V57, P1633, DOI 10.1038/sj.ejcn.1601735; Harrington JW, 2010, CLIN PEDIATR, V49, P638, DOI 10.1177/0009922809359418; Huus K, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-42; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Karaolis-Danckert N, 2007, AM J CLIN NUTR, V86, P1700, DOI 10.1093/ajcn/86.5.1700; Leung GM, 2002, BIRTH-ISS PERINAT C, V29, P162, DOI 10.1046/j.1523-536X.2002.00183.x; Li RW, 2008, PEDIATRICS, V122, pS77, DOI 10.1542/peds.2008-1315j; Li RW, 2005, PEDIATRICS, V115, pE31, DOI 10.1542/peds.2004-0481; Lindberg SM, 2012, MATERN CHILD HLTH J, V16, P1879, DOI 10.1007/s10995-012-1024-9; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; Lu L, 2004, CHILD FAMILY ED, V10, P6; Luo J, 2002, INT J OBESITY, V26, P553, DOI 10.1038/sj.ijo.0801944; Ma YN, 2011, ARCH MED RES, V42, P633, DOI 10.1016/j.arcmed.2011.10.011; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Qiu Liqian, 2008, Asia Pac J Public Health, V20 Suppl, P220; Rosenberg KD, 2008, AM J PUBLIC HEALTH, V98, P290, DOI 10.2105/AJPH.2006.103218; Sanigorski AM, 2007, OBESITY, V15, P1908, DOI 10.1038/oby.2007.226; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Spurgeon David, 2002, BMJ, V324, P1416; Stamatakis E, 2005, ARCH DIS CHILD, V90, P999, DOI 10.1136/adc.2004.068932; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Stockton MB, 2009, J PEDIATR PSYCHOL, V34, P1144, DOI 10.1093/jpepsy/jsp023; van den Hurk K, 2007, ARCH DIS CHILD, V92, P992, DOI 10.1136/adc.2006.115402; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Yan S, 2012, OBES REV, V13, P810, DOI 10.1111/j.1467-789X.2012.01016.x; Zhang JD, 2012, AM J HUM BIOL, V24, P633, DOI 10.1002/ajhb.22284; Zhao Yao, 2006, Zhonghua Yufang Yixue Zazhi, V40, P46	47	36	40	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64542	10.1371/journal.pone.0064542	http://dx.doi.org/10.1371/journal.pone.0064542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755127	Green Submitted, gold, Green Published			2022-12-25	WOS:000320579400018
J	Pfirrmann, T; Lokapally, A; Andreasson, C; Ljungdahl, P; Hollemann, T				Pfirrmann, Thorsten; Lokapally, Ashwin; Andreasson, Claes; Ljungdahl, Per; Hollemann, Thomas			SOMA: A Single Oligonucleotide Mutagenesis and Cloning Approach	PLOS ONE			English	Article							SITE; STRATEGY; DESIGN; PRIMER; SENSOR	Modern biology research requires simple techniques for efficient and restriction site-independent modification of genetic material. Classical cloning and mutagenesis strategies are limited by their dependency on restriction sites and the use of complementary primer pairs. Here, we describe the Single Oligonucleotide Mutagenesis and Cloning Approach (SOMA) that is independent of restriction sites and only requires a single mutagenic oligonucleotide to modify a plasmid. We demonstrate the broad application spectrum of SOMA with three examples. First, we present a novel plasmid that in a standardized and rapid fashion can be used as a template for SOMA to generate GFP-reporters. We successfully use such a reporter to assess the in vivo knock-down quality of morpholinos in Xenopus laevis embryos. In a second example, we show how to use a SOMA-based protocol for restriction-site independent cloning to generate chimeric proteins by domain swapping between the two human hRMD5a and hRMD5b isoforms. Last, we show that SOMA simplifies the generation of randomized single-site mutagenized gene libraries. As an example we random-mutagenize a single codon affecting the catalytic activity of the yeast Ssy5 endoprotease and identify a spectrum of tolerated and non-tolerated substitutions. Thus, SOMA represents a highly efficient alternative to classical cloning and mutagenesis strategies.	[Pfirrmann, Thorsten; Lokapally, Ashwin; Hollemann, Thomas] Univ Halle Wittenberg, Inst Physiol Chem, Dept Mol Med, D-06108 Halle, Germany; [Andreasson, Claes; Ljungdahl, Per] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Martin Luther University Halle Wittenberg; Stockholm University	Pfirrmann, T (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, Dept Mol Med, D-06108 Halle, Germany.	thorsten.pfirrmann@medizin.uni-halle.de	Pfirrmann, Thorsten/AAC-5563-2019; Ljungdahl, Per O/M-5258-2013	Ljungdahl, Per O/0000-0002-6625-3540; Andreasson, Claes/0000-0001-8948-0685; Pfirrmann, Thorsten/0000-0002-9474-9535; Lokapally, Ashwin/0000-0002-1192-9849	Swedish Research Council; Fonds der Chemischen Industrie, Frankfurt	Swedish Research Council(Swedish Research CouncilEuropean Commission); Fonds der Chemischen Industrie, Frankfurt(Fonds der Chemischen Industrie)	This research was supported by funding from the Swedish Research Council and the Fonds der Chemischen Industrie, Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Antikainen NM, 2005, BIOORGAN MED CHEM, V13, P2701, DOI 10.1016/j.bmc.2005.01.059; Benders GA, 2010, NUCLEIC ACIDS RES, V38, P2558, DOI 10.1093/nar/gkq119; Benoit RM, 2006, PROTEIN EXPRES PURIF, V45, P66, DOI 10.1016/j.pep.2005.09.022; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Braman J, 1996, Methods Mol Biol, V57, P31; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Diamond SL, 2007, CURR OPIN CHEM BIOL, V11, P46, DOI 10.1016/j.cbpa.2006.11.021; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Faber J., 1967, NORMAL TABLE XENOPUS; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gurdon J.B., 1977, Methods Cell Biol, V16, P125; Hogrefe HH, 2002, BIOTECHNIQUES, V33, P1158, DOI 10.2144/02335pf01; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Peccoud J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043231; PFIRRMANN T, 2012, HDB PROTEOLYTIC ENZY; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; Pleiss J, 2011, CURR OPIN BIOTECH, V22, P611, DOI 10.1016/j.copbio.2011.03.004; Poulsen P, 2006, EUKARYOT CELL, V5, P601, DOI 10.1128/EC.5.3.601-608.2006; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SHULDINER AR, 1991, ANAL BIOCHEM, V194, P9, DOI 10.1016/0003-2697(91)90144-I; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Zawaira A, 2012, MOL BIOTECHNOL, V51, P67, DOI 10.1007/s12033-011-9448-9; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536; Zuo PJ, 2010, CURR ISSUES MOL BIOL, V12, P11	33	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64870	10.1371/journal.pone.0064870	http://dx.doi.org/10.1371/journal.pone.0064870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750217	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900019
J	Varriale, A; Marabotti, A; Mei, G; Staiano, M; D'Auria, S				Varriale, Antonio; Marabotti, Anna; Mei, Giampiero; Staiano, Maria; D'Auria, Sabato			Correlation Spectroscopy and Molecular Dynamics Simulations to Study the Structural Features of Proteins	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ACID-BINDING PROTEIN; ARCHAEON SULFOLOBUS-SOLFATARICUS; BETA-GLYCOSIDASE; CONFORMATIONAL DYNAMICS; DENATURED PROTEINS; ASCORBATE OXIDASE; TRYPTOPHAN; STABILITY; THERMOSTABILITY	In this work, we used a combination of fluorescence correlation spectroscopy (FCS) and molecular dynamics (MD) simulation methodologies to acquire structural information on pH-induced unfolding of the maltotriose-binding protein from Thermus thermophilus (MalE2). FCS has emerged as a powerful technique for characterizing the dynamics of molecules and it is, in fact, used to study molecular diffusion on timescale of microsecond and longer. Our results showed that keeping temperature constant, the protein diffusion coefficient decreased from 84 +/- 4 mu m(2)/s to 44 +/- 3 mu m(2)/s when pH was changed from 7.0 to 4.0. An even more marked decrease of the MalE2 diffusion coefficient (31 +/- 3 mu m(2)/s) was registered when pH was raised from 7.0 to 10.0. According to the size of MalE2 (a monomeric protein with a molecular weight of 43 kDa) as well as of its globular native shape, the values of 44 mu m(2)/s and 31 mu m(2)/s could be ascribed to deformations of the protein structure, which enhances its propensity to form aggregates at extreme pH values. The obtained fluorescence correlation data, corroborated by circular dichroism, fluorescence emission and light-scattering experiments, are discussed together with the MD simulations results.	[Varriale, Antonio; Staiano, Maria; D'Auria, Sabato] IBP CNR, Lab Mol Sensing, Naples, Italy; [Marabotti, Anna] Univ Salerno, Dept Biol & Chem, Fisciano, SA, Italy; [Marabotti, Anna] ISA CNR, Lab Bioinformat, Avellino, Italy; [Mei, Giampiero] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Rome Tor Vergata	Varriale, A (corresponding author), IBP CNR, Lab Mol Sensing, Naples, Italy.	a.varriale@ibp.cnr.it; s.dauria@ibp.cnr.it	d'auria, sabato/C-3565-2015; Varriale, Antonio/AAL-1439-2020; STAIANO, MARIA/B-9584-2015	d'auria, sabato/0000-0001-9320-494X; STAIANO, MARIA/0000-0003-0223-1825; Marabotti, Anna/0000-0002-9510-5205	CNR Commessa "Diagnostica Avanzata ed Alimentazione''; CNR Italian Bioinformatics Network (CNR-National Research Council)	CNR Commessa "Diagnostica Avanzata ed Alimentazione''; CNR Italian Bioinformatics Network (CNR-National Research Council)	This project was realized in the frame of the CNR Commessa "Diagnostica Avanzata ed Alimentazione'' (AV, MS, SD) and in the frame of CNR Italian Bioinformatics Network (AM) (CNR-National Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bakowies D, 2002, J MOL BIOL, V315, P713, DOI 10.1006/jmbi.2001.5202; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chattopadhyay K, 2005, BIOPHYS J, V88, P1413, DOI 10.1529/biophysj.104.053199; Chattopadhyay K, 2002, P NATL ACAD SCI USA, V99, P14171, DOI 10.1073/pnas.172524899; Cuneo MJ, 2009, J MOL BIOL, V389, P157, DOI 10.1016/j.jmb.2009.04.008; D'Auria S, 1999, BIOPHYS CHEM, V81, P23, DOI 10.1016/S0301-4622(99)00086-1; D'Auria S, 1998, BIOCHIMIE, V80, P949, DOI 10.1016/S0300-9084(00)88892-6; D'Auria S, 2008, J PROTEOME RES, V7, P1151, DOI 10.1021/pr700755z; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; DAuria S, 1997, PROTEINS, V27, P71; Di Venere A, 1998, EUR J BIOCHEM, V257, P337, DOI 10.1046/j.1432-1327.1998.2570337.x; Di Venere A, 2000, J BIOL CHEM, V275, P3915, DOI 10.1074/jbc.275.6.3915; Di Venere A, 2011, FEBS J, V278, P1585, DOI 10.1111/j.1742-4658.2011.08084.x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frieden C, 2002, ADV PROTEIN CHEM, V62, P91; FRIEDEN C, 1995, BIOCHEMISTRY-US, V34, P2724, DOI 10.1021/bi00008a040; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hess ST, 2002, BIOPHYS J, V83, P2300, DOI 10.1016/S0006-3495(02)73990-8; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; JIANG N, 1993, BIOCHEMISTRY-US, V32, P11015, DOI 10.1021/bi00092a010; Kutzner C, 2007, J COMPUT CHEM, V28, P2075, DOI 10.1002/jcc.20703; Lakowicz J R, 1999, PRINCIPLES FLUORESCE, P367, DOI 10.1007/978-1-4757-3061-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Marabotti A, 2008, PROTEINS, V72, P769, DOI 10.1002/prot.21966; Mei G, 2008, BIOCHEMISTRY-US, V47, P9234, DOI 10.1021/bi800638v; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Papaleo E, 2009, J MOL GRAPH MODEL, V27, P889, DOI 10.1016/j.jmgm.2009.01.006; Perrin F, 1936, J PHYS-PARIS, V7, P1, DOI 10.1051/jphysrad:01936007010100; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scire A, 2010, MOL BIOSYST, V6, P687, DOI 10.1039/b922092e; Scire A, 2009, J PROTEOME RES, V8, P4005, DOI 10.1021/pr900346z; Sherman E, 2008, BIOPHYS J, V94, P4819, DOI 10.1529/biophysj.107.120220; Silva Z, 2005, J BACTERIOL, V187, P1210, DOI 10.1128/JB.187.4.1210-1218.2005; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Stepanenko OV, 2008, PROTEINS, V71, P35, DOI 10.1002/prot.21658; TEMPLETON EFG, 1985, MOL IMMUNOL, V22, P45, DOI 10.1016/0161-5890(85)90033-1; van Gunsteren WF, 1996, BIOMOLECULAR SIMULAT, V1042; Varriale A, 2007, ANAL CHEM, V79, P4687, DOI 10.1021/ac070475+; Varriale A, 2009, PROTEIN PEPTIDE LETT, V16, P1425, DOI 10.2174/092986609789839359; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Yeh SR, 2001, BIOCHEMISTRY-US, V40, P4205, DOI 10.1021/bi0155044	52	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64840	10.1371/journal.pone.0064840	http://dx.doi.org/10.1371/journal.pone.0064840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750215	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900017
J	Vodovnik, M; Duncan, SH; Reid, MD; Cantlay, L; Turner, K; Parkhill, J; Lamed, R; Yeoman, CJ; Miller, MEB; White, BA; Bayer, EA; Marinsek-Logar, R; Flint, HJ				Vodovnik, Masa; Duncan, Sylvia H.; Reid, Martin D.; Cantlay, Louise; Turner, Keith; Parkhill, Julian; Lamed, Raphael; Yeoman, Carl J.; Miller, Margret E. Berg; White, Bryan A.; Bayer, Edward A.; Marinsek-Logar, Romana; Flint, Harry J.			Expression of Cellulosome Components and Type IV Pili within the Extracellular Proteome of Ruminococcus flavefaciens 007	PLOS ONE			English	Article							RUBRERYTHRIN-LIKE PROTEIN; CLOSTRIDIUM-THERMOCELLUM; BACTERIAL ADHESION; BINDING PROTEIN; ALBUS; GENES; ACID; RUMINOCOCCUS-FLAVEFACIENS-17; IDENTIFICATION; REDUCTASE	Background: Ruminococcus flavefaciens is an important fibre-degrading bacterium found in the mammalian gut. Cellulolytic strains from the bovine rumen have been shown to produce complex cellulosome structures that are associated with the cell surface. R. flavefaciens 007 is a highly cellulolytic strain whose ability to degrade dewaxed cotton, but not Avicel cellulose, was lost following initial isolation in the variant 007S. The ability was recovered after serial subculture to give the cotton-degrading strain 007C. This has allowed us to investigate the factors required for degradation of this particularly recalcitrant form of cellulose. Methodology/Principal Findings: The major proteins associated with the bacterial cell surface and with the culture supernatant were analyzed for R. flavefaciens 007S and 007C grown with cellobiose, xylan or Avicel cellulose as energy sources. Identification of the proteins was enabled by a draft genome sequence obtained for 007C. Among supernatant proteins a cellulosomal GH48 hydrolase, a rubrerthyrin-like protein and a protein with type IV pili N-terminal domain were the most strongly up-regulated in 007C cultures grown on Avicel compared with cellobiose. Strain 007S also showed substrate-related changes, but supernatant expression of the Pil protein and rubrerythrin in particular were markedly lower in 007S than in 007C during growth on Avicel. Conclusions/Significance: This study provides new information on the extracellular proteome of R. flavefaciens and its regulation in response to different growth substrates. Furthermore it suggests that the cotton cellulose non-degrading strain (007S) has altered regulation of multiple proteins that may be required for breakdown of cotton cellulose. One of these, the type IV pilus was previously shown to play a role in adhesion to cellulose in R. albus, and a related pilin protein was identified here for the first time as a major extracellular protein in R. flavefaciens.	[Vodovnik, Masa; Marinsek-Logar, Romana] Univ Ljubljana, Biotech Fac, Chair Microbiol & Microbial Biotechnol, Ljubljana, Slovenia; [Vodovnik, Masa; Duncan, Sylvia H.; Reid, Martin D.; Cantlay, Louise; Flint, Harry J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Turner, Keith; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Ramat Aviv, Israel; [Yeoman, Carl J.; Miller, Margret E. Berg; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL USA	University of Ljubljana; University of Aberdeen; Wellcome Trust Sanger Institute; Weizmann Institute of Science; Tel Aviv University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Flint, HJ (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	h.flint@abdn.ac.uk	Yeoman, Carl/ABA-1906-2021; Parkhill, Julian/G-4703-2011; Vodovnik, Masa/U-4580-2019	Yeoman, Carl/0000-0002-8775-7879; Parkhill, Julian/0000-0002-7069-5958; Duncan, Sylvia/0000-0002-4903-0978; Berg, Margret/0000-0002-0411-1619; Vodovnik, Masa/0000-0002-1189-2417	SG-RESAS (Scottish Government Rural and Environmental Science and Analysis Service); FEMS; Slovene human resources development and scholarship funds; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel; Israel Science Foundation [966/09, 159/07 291/08]	SG-RESAS (Scottish Government Rural and Environmental Science and Analysis Service); FEMS; Slovene human resources development and scholarship funds; United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	The Rowett Institute receives funding from SG-RESAS (Scottish Government Rural and Environmental Science and Analysis Service). Visit of M.V. was supported by research grants from FEMS and Slovene human resources development and scholarship funds. Parts of this work were funded by grants from the United States-Israel Binational Science Foundation (BSF), Jerusalem, Israel - BSF Energy Research grant to E.A.B. and B.A.W. and Regular BSF Research grants to R.L. and B.A.W. - and by the Israel Science Foundation (grant nos 966/09 and 159/07 291/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Bevillard E, 2004, J BACTERIOL, V186, P136, DOI 10.1128/JB.186.1.136-145.2004; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; Dror TW, 2003, J BACTERIOL, V185, P3042, DOI 10.1128/JB.185.10.3042-3048.2003; Geissmann TA, 1999, J BACTERIOL, V181, P7136, DOI 10.1128/JB.181.22.7136-7139.1999; Gold ND, 2007, J BACTERIOL, V189, P6787, DOI 10.1128/JB.00882-07; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hillmann F, 2006, ARCH MICROBIOL, V185, P270, DOI 10.1007/s00203-006-0091-y; HUNGATE RE, 1982, APPL ENVIRON MICROB, V44, P79, DOI 10.1128/AEM.44.1.79-83.1982; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; Jun HS, 2007, J BACTERIOL, V189, P6806, DOI 10.1128/JB.00560-07; Kawasaki S, 2007, FEBS LETT, V581, P2460, DOI 10.1016/j.febslet.2007.04.050; Kurtz DM, 2006, J INORG BIOCHEM, V100, P679, DOI 10.1016/j.jinorgbio.2005.12.017; LEVER M, 1977, ANAL BIOCHEM, V81, P21, DOI 10.1016/0003-2697(77)90594-2; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Morisaka H, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-37; Morrison M, 2000, FEMS MICROBIOL LETT, V185, P109; Mosoni P, 2001, ARCH MICROBIOL, V176, P52, DOI 10.1007/s002030100292; Pegden RS, 1998, J BACTERIOL, V180, P5921, DOI 10.1128/JB.180.22.5921-5927.1998; Rakotoarivonina H, 2002, MICROBIOL-SGM, V148, P1871, DOI 10.1099/00221287-148-6-1871; Rakotoarivonina H, 2005, MICROBIOL-SGM, V151, P1291, DOI 10.1099/mic.0.27735-0; Rakotoarivonina H, 2009, ARCH MICROBIOL, V191, P379, DOI 10.1007/s00203-009-0463-1; Raman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005271; Rincon MT, 2007, J BACTERIOL, V189, P4774, DOI 10.1128/JB.00143-07; Rincon MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012476; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Rincon MT, 2003, J BACTERIOL, V185, P703, DOI 10.1128/JB.185.3.703-713.2003; Rincon MT, 2001, APPL ENVIRON MICROB, V67, P4426, DOI 10.1128/AEM.67.10.4426-4431.2001; Stevenson DM, 2005, APPL ENVIRON MICROB, V71, P4672, DOI 10.1128/AEM.71.8.4672-4678.2005; STEWART CS, 1990, J APPL BACTERIOL, V68, P349, DOI 10.1111/j.1365-2672.1990.tb02885.x; STEWART CS, 1990, FEMS MICROBIOL LETT, V72, P47, DOI 10.1016/0378-1097(90)90342-N; Sztukowska M, 2002, MOL MICROBIOL, V44, P479, DOI 10.1046/j.1365-2958.2002.02892.x; Varga JJ, 2006, MOL MICROBIOL, V62, P680, DOI 10.1111/j.1365-2958.2006.05414.x; Weinberg MV, 2004, J BACTERIOL, V186, P7888, DOI 10.1128/JB.186.23.7888-7895.2004	37	24	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65333	10.1371/journal.pone.0065333	http://dx.doi.org/10.1371/journal.pone.0065333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750253	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900055
J	Yuan, LX; Zhu, YY; Lin, ZQ; Banuelos, G; Li, W; Yin, XB				Yuan, Linxi; Zhu, Yuanyuan; Lin, Zhi-Qing; Banuelos, Gary; Li, Wei; Yin, Xuebin			A Novel Selenocystine-Accumulating Plant in Selenium-Mine Drainage Area in Enshi, China	PLOS ONE			English	Article							HYPERACCUMULATOR STANLEYA-PINNATA; PRAIRIE DOG HERBIVORY; INDIAN MUSTARD; MOLECULAR-MECHANISMS; ENDEMIC DISEASES; BRASSICA-JUNCEA; PROTECTS PLANTS; HUBEI PROVINCE; ASTRAGALUS; SPECIATION	Plant samples of Cardamine hupingshanesis (Brassicaceae), Ligulariafischeri (Ledeb.) turcz (Steraceae) and their underlying top sediments were collected from selenium (Se) mine drainage areas in Enshi, China. Concentrations of total Se were measured using Hydride Generation-Atomic Fluorescence Spectrometry (HG-AFS) and Se speciation were determined using liquid chromatography/UV irradiation-hydride generation-atomic fluorescence spectrometry (LC-UV-HG-AFS). The results showed that C. hupingshanesis could accumulate Se to 239 +/- 201 mg/kg DW in roots, 316 +/- 184 mg/kg DW in stems, and 380 +/- 323 mg/kg DW in leaves, which identifies it as Se secondary accumulator. Particularly, it could accumulate Se up to 1965 +/- 271 mg/kg DW in leaves, 1787 +/- 167 mg/kg DW in stem and 4414 +/- 3446 mg/kg DW in roots, living near Se mine tailing. Moreover, over 70% of the total Se accumulated in C. hupingshanesis were in the form of selenocystine (SeCys(2)), increasing with increased total Se concentration in plant, in contrast to selenomethionine (SeMet) in non-accumulators (eg. Arabidopsis) and secondary accumulators (eg. Brassica juncea), and selenomethylcysteine (SeMeCys) in hyperaccumulators (eg. Stanleya pinnata). There is no convincing explanation on SeCys(2) accumulation in C. hupingshanesis based on current Se metabolism theory in higher plants, and further study will be needed.	[Yuan, Linxi; Zhu, Yuanyuan; Li, Wei; Yin, Xuebin] Jiangsu Bioengn Res Ctr Selenium, Suzhou, Jiangsu, Peoples R China; [Yuan, Linxi; Yin, Xuebin] Univ Sci & Technol China, Sch Earth & Space Sci, Hefei, Anhui, Peoples R China; [Lin, Zhi-Qing] So Illinois Univ, Environm Sci Program, Edwardsville, IL 62026 USA; [Lin, Zhi-Qing] So Illinois Univ, Dept Biol Sci, Edwardsville, IL 62026 USA; [Banuelos, Gary] USDA ARS, Parlier, CA USA; [Yuan, Linxi; Yin, Xuebin] Univ Sci & Technol China, Suzhou Inst Adv Study, Adv Lab Selenium & Human Hlth, Suzhou, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Southern Illinois University System; Southern Illinois University Edwardsville; Southern Illinois University System; Southern Illinois University Edwardsville; United States Department of Agriculture (USDA); Chinese Academy of Sciences; University of Science & Technology of China, CAS	Yuan, LX (corresponding author), Jiangsu Bioengn Res Ctr Selenium, Suzhou, Jiangsu, Peoples R China.	yuanli@mail.ustc.edu.cn; xbyin@ustc.edu.cn	Yuan, Linxi/Y-9313-2019	Yuan, Linxi/0000-0002-1043-8933	Natural Science Youth Foundation of Jiangsu Province for Youth, China [BK2012202]; Open Fund of State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences [Y052010020]; Open Fund of SOA Key Laboratory for Polar Science, Polar Research Institute of China [KP201106]; National Science Foundation of China [NSFC 40601088]	Natural Science Youth Foundation of Jiangsu Province for Youth, China; Open Fund of State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences(Chinese Academy of Sciences); Open Fund of SOA Key Laboratory for Polar Science, Polar Research Institute of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Youth Foundation of Jiangsu Province for Youth, China (BK2012202) (http://www.jsnsf.gov.cn/Index.aspx), Open Fund of State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences (Y052010020) (http://www.ssa.ac.cn/), Open Fund of SOA Key Laboratory for Polar Science, Polar Research Institute of China (KP201106) (http://www.pric.gov.cn/bmm.asp?bigid = 19), National Science Foundation of China (NSFC 40601088) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford ER, 2010, PLANT SOIL, V337, P33, DOI 10.1007/s11104-010-0482-3; Banuelos G, 2005, ENVIRON SCI TECHNOL, V39, P1771, DOI 10.1021/es049035f; Banuelos G, 2007, ENVIRON SCI TECHNOL, V41, P599, DOI 10.1021/es061152i; Banuelos GS, 1997, J ENVIRON QUAL, V26, P639, DOI 10.2134/jeq1997.00472425002600030008x; Banuelos GS, 2002, INT J PHYTOREMEDIAT, V4, P315, DOI 10.1080/15226510208500090; Beilstein M A, 1991, Biomed Environ Sci, V4, P392; Bierla K, 2008, CURRENT ADVANCES IN SELENIUM RESEARCH AND APPLICATIONS, VOL 1, P107; BROWN TA, 1982, BIOL REV, V57, P59, DOI 10.1111/j.1469-185X.1982.tb00364.x; BROWN TA, 1981, PLANT PHYSIOL, V67, P1051, DOI 10.1104/pp.67.5.1051; DAVIS AM, 1986, AGRON J, V78, P727, DOI 10.2134/agronj1986.00021962007800040033x; DAVIS AM, 1972, AGRON J, V64, P751, DOI 10.2134/agronj1972.00021962006400060013x; de Souza MP, 1998, PLANT PHYSIOL, V117, P1487, DOI 10.1104/pp.117.4.1487; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; Environmental Protection Administration (EPA) USA, 1997, 3114 ARS SEL HYDR GE; Feng CX, 2009, ACTA PETROL SIN, V25, P1253; Fordyce FM, 2000, APPL GEOCHEM, V15, P117, DOI 10.1016/S0883-2927(99)00035-9; Freeman JL, 2007, NEW PHYTOL, V175, P490, DOI 10.1111/j.1469-8137.2007.02119.x; Freeman JL, 2006, CURR BIOL, V16, P2181, DOI 10.1016/j.cub.2006.09.015; Freeman JL, 2006, PLANT PHYSIOL, V142, P124, DOI 10.1104/pp.106.081158; Freeman JL, 2011, ENVIRON SCI TECHNOL, V45, P9703, DOI 10.1021/es201600f; Freeman JL, 2010, PLANT PHYSIOL, V153, P1630, DOI [10.1104/pp.110.156570, 10.1186/1472-6785-10-19]; Freeman JL, 2009, AM J BOT, V96, P1075, DOI 10.3732/ajb.0800287; Galeas ML, 2008, NEW PHYTOL, V177, P715, DOI 10.1111/j.1469-8137.2007.02285.x; Galeas ML, 2007, NEW PHYTOL, V173, P517, DOI 10.1111/j.1469-8137.2006.01943.x; Gao J, 2011, FOOD CHEM, V126, P1088, DOI 10.1016/j.foodchem.2010.11.137; Hanson B, 2004, NEW PHYTOL, V162, P655, DOI 10.1111/j.1469-8137.2004.01067.x; Hanson B, 2003, NEW PHYTOL, V159, P461, DOI 10.1046/j.1469-8137.2003.00786.x; Jitaru P, 2010, ACCREDIT QUAL ASSUR, V15, P343, DOI 10.1007/s00769-010-0637-1; Kahakachchi C, 2004, J CHROMATOGR A, V1054, P303, DOI 10.1016/j.chroma.2004.07.083; LeDuc DL, 2004, PLANT PHYSIOL, V135, P377, DOI 10.1104/pp.103.026989; Li HF, 2008, NEW PHYTOL, V178, P92, DOI 10.1111/j.1469-8137.2007.02343.x; Liang L, 2006, J CHROMATOGR A, V1118, P139, DOI 10.1016/j.chroma.2006.03.113; Mazej D, 2006, TALANTA, V68, P558, DOI 10.1016/j.talanta.2005.04.056; Montes-Bayon M, 2002, J ANAL ATOM SPECTROM, V17, P872, DOI 10.1039/b202608m; Neuhierl B, 1999, J BIOL CHEM, V274, P5407, DOI 10.1074/jbc.274.9.5407; Neuhierl B, 1996, EUR J BIOCHEM, V239, P235, DOI 10.1111/j.1432-1033.1996.0235u.x; Persans MW, 2000, BIOTECHNOL GENET ENG, V17, P389, DOI 10.1080/02648725.2000.10647999; Pickering IJ, 2003, J SYNCHROTRON RADIAT, V10, P289, DOI 10.1107/S0909049503003273; Pilon-Smits EAH, 2010, PLANT CELL MONOGR, V17, P225, DOI [10.1007/978-3-642-10613-2_10, 10.1016/j.bbagen.2018.05.006]; Quinn CF, 2011, J EXP BOT, DOI [10.1093/jxb/errr247, DOI 10.1093/JXB/ERRR247]; Quinn CF, 2008, OECOLOGIA, V155, P267, DOI 10.1007/s00442-007-0907-8; Seppanen MM, 2010, PLANT SOIL, V337, P273, DOI 10.1007/s11104-010-0523-y; Stadlober M, 2001, FOOD CHEM, V73, P357, DOI 10.1016/S0308-8146(01)00115-7; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Tan JA, 2002, SCI TOTAL ENVIRON, V284, P227, DOI 10.1016/S0048-9697(01)00889-0; TAN JN, 1991, WATER AIR SOIL POLL, V57-8, P59, DOI 10.1007/BF00282869; Terry N, 2000, ANNU REV PLANT PHYS, V51, P401, DOI 10.1146/annurev.arplant.51.1.401; VIRUPAKSHA TK, 1965, BIOCHIM BIOPHYS ACTA, V107, P69, DOI 10.1016/0304-4165(65)90389-2; Wangeline AL, 2011, AM J BOT, V98, P1139, DOI 10.3732/ajb.1000369; White PJ, 2004, J EXP BOT, V55, P1927, DOI 10.1093/jxb/erh192; YANG GQ, 1983, AM J CLIN NUTR, V37, P872, DOI 10.1093/ajcn/37.5.872; Yin S.A., 1996, ACTA NUTRIMENTA SINI, V18, P367; Yu RY, 1993, HUBEI GEOLOGY, V7, P50; Zayed A, 1998, PLANTA, V206, P284, DOI 10.1007/s004250050402; Zhu JM, 2008, SCI TOTAL ENVIRON, V392, P252, DOI 10.1016/j.scitotenv.2007.12.019; Zhu JM, 2001, APPL GEOCHEM, V16, P1333, DOI 10.1016/S0883-2927(01)00047-6; Zhu YG, 2009, TRENDS PLANT SCI, V14, P436, DOI 10.1016/j.tplants.2009.06.006	57	74	83	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65615	10.1371/journal.pone.0065615	http://dx.doi.org/10.1371/journal.pone.0065615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750270	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900072
J	Gabasa, M; Royo, D; Molina-Molina, M; Roca-Ferrer, J; Pujols, L; Picado, C; Xaubet, A; Pereda, J				Gabasa, Marta; Royo, Dolores; Molina-Molina, Maria; Roca-Ferrer, Jordi; Pujols, Laura; Picado, Cesar; Xaubet, Antoni; Pereda, Javier			Lung Myofibroblasts Are Characterized by Down-Regulated Cyclooxygenase-2 and Its Main Metabolite, Prostaglandin E2	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; TRANSFORMING GROWTH-FACTOR-BETA-1; INHIBITS FIBROBLAST; ARACHIDONIC-ACID; GROWTH; E-2; TRANSITION; EXPRESSION; TGF-BETA-1; APOPTOSIS	Background: Prostaglandin E2 (PGE(2)), the main metabolite of cyclooxygenase (COX), is a well-known anti-fibrotic agent. Moreover, myofibroblasts expressing alpha-smooth muscle actin (alpha-SMA), fibroblast expansion and epithelial-mesenchymal transition (EMT) are critical to the pathogenesis of idiopathic pulmonary fibrosis (IPF). Our aim was to investigate the expression of COX-2 and PGE(2) in human lung myofibroblasts and establish whether fibroblast-myofibroblast transition (FMT) and EMT are associated with COX-2 and PGE(2) down-regulation. Methods: Fibroblasts obtained from IPF patients (n = 6) and patients undergoing spontaneous pneumothorax (control, n = 6) and alveolar epithelial cell line A549 were incubated with TGF-beta 1 and FMT and EMT markers were evaluated. COX-2 and alpha-SMA expression, PGE(2) secretion and cell proliferation were measured after IL-1 beta and PGE(2) incubation. Results: Myofibroblasts from both control and IPF fibroblast cultures stimulated with IL-1 beta showed no COX-2 expression. IPF fibroblasts showed increased myofibroblast population and reduced COX-2 expression in response to IL-1 beta. TGF-beta 1 increased the number of myofibroblasts in a time-dependent manner. In contrast, TGF-beta 1 induced slight COX-2 expression at 4 h (without increase in myofibroblasts) and 24 h, but not at 72 h. Both IPF and control cultures incubated with TGF-beta 1 for 72 h showed diminished COX-2 induction, PGE(2) secretion and alpha-SMA expression after IL-1 beta addition. The latter decreased proliferation in fibroblasts but not in myofibroblasts. A549 cells incubated with TGF-beta 1 for 72 h showed down-regulated COX-2 expression and low basal PGE(2) secretion in response to IL-1 beta. Immuno-histochemical analysis of IPF lung tissue showed no COX-2 immuno-reactivity in myofibroblast foci. Conclusions: Myofibroblasts are associated with COX-2 down-regulation and reduced PGE(2) production, which could be crucial in IPF development and progression.	[Gabasa, Marta; Royo, Dolores; Roca-Ferrer, Jordi; Pujols, Laura; Pereda, Javier] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Gabasa, Marta; Royo, Dolores; Molina-Molina, Maria; Roca-Ferrer, Jordi; Pujols, Laura; Picado, Cesar; Xaubet, Antoni; Pereda, Javier] Hosp Llobregat, Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBEL, Serv Pneumol,Grp Recerca Pneumol, Barcelona, Spain; [Molina-Molina, Maria] Univ Barcelona, Hosp Clin, Inst Clin Torax, Serv Pneumol & Al Lergia Resp, E-08007 Barcelona, Spain; [Picado, Cesar; Xaubet, Antoni] Univ Valencia, Fac Farm, Dept Fisiol, E-46010 Valencia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Valencia		axaubet@clinic.ub.es	/AFX-9519-2022; Pereda, Javier/N-2424-2014; Pujols, Laura/G-8920-2015; /AAL-7347-2021; Roca-Ferrer, Jordi/AFQ-4652-2022	Pereda, Javier/0000-0002-8690-8938; Pujols, Laura/0000-0003-3708-5098; Roca-Ferrer, Jordi/0000-0002-9527-2273; MOLINA MOLINA, MARIA/0000-0002-1852-1723; Gabasa Ferrandez, Marta/0000-0002-3758-2265	SEPAR Fundacion Respira;  [FIS PI060064]	SEPAR Fundacion Respira; 	This study was supported by FIS PI060064 grant and SEPAR Fundacion Respira. The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; Bonner JC, 2002, AM J PATHOL, V161, P459, DOI 10.1016/S0002-9440(10)64202-2; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Brock TG, 1999, J BIOL CHEM, V274, P11660, DOI 10.1074/jbc.274.17.11660; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Coward WR, 2009, MOL CELL BIOL, V29, P4325, DOI 10.1128/MCB.01776-08; Diaz A, 1998, EXP CELL RES, V241, P222, DOI 10.1006/excr.1998.4050; ELIAS JA, 1985, AM REV RESPIR DIS, V131, P94; Fang HY, 2010, EXP LUNG RES, V36, P323, DOI 10.3109/01902141003628579; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2; Horowitz JC, 2010, AM J RESP CRIT CARE, V182, P2, DOI 10.1164/rccm.201002-0239ED; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; KUHN C, 1991, AM J PATHOL, V138, P1257; Lappi-Blanco E, 2006, AM J CLIN PATHOL, V126, P717, DOI 10.1309/PFGXCLNG2N17PJX9; Ling H, 2010, MOL CARCINOGEN, V49, P271, DOI 10.1002/mc.20597; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Matsumura T, 2009, J BIOL CHEM, V284, P35861, DOI 10.1074/jbc.M109.014639; MCANULTY RJ, 1995, BIOCHEM J, V307, P63, DOI 10.1042/bj3070063; MITCHELL JA, 1994, BRIT J PHARMACOL, V113, P1008, DOI 10.1111/j.1476-5381.1994.tb17093.x; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Roca-Ferrer J, 2011, J ALLERGY CLIN IMMUN, V128, P66, DOI 10.1016/j.jaci.2011.01.065; SALTZMAN LE, 1982, BIOCHEM J, V204, P25, DOI 10.1042/bj2040025; Singh Shailendra R, 2008, Proc Am Thorac Soc, V5, P127, DOI 10.1513/pats.200706-070VS; Uhal BD, 2007, CURR PHARM DESIGN, V13, P1247, DOI 10.2174/138161207780618885; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P35	34	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65445	10.1371/journal.pone.0065445	http://dx.doi.org/10.1371/journal.pone.0065445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755232	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300082
J	Gao, JF; Wang, Z; Yang, Y; Zhang, WJ; Tao, CY; Guan, JA; Rao, NN				Gao, Junfeng; Wang, Zhao; Yang, Yong; Zhang, Wenjia; Tao, Chunyi; Guan, Jinan; Rao, Nini			A Novel Approach for Lie Detection Based on F-Score and Extreme Learning Machine	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; FEATURE-SELECTION; P300; CLASSIFICATION; NETWORKS; ACCURATE; TRUTH; TIME; PCA	A new machine learning method referred to as F-score_ELM was proposed to classify the lying and truth-telling using the electroencephalogram (EEG) signals from 28 guilty and innocent subjects. Thirty-one features were extracted from the probe responses from these subjects. Then, a recently-developed classifier called extreme learning machine (ELM) was combined with F-score, a simple but effective feature selection method, to jointly optimize the number of the hidden nodes of ELM and the feature subset by a grid-searching training procedure. The method was compared to two classification models combining principal component analysis with back-propagation network and support vector machine classifiers. We thoroughly assessed the performance of these classification models including the training and testing time, sensitivity and specificity from the training and testing sets, as well as network size. The experimental results showed that the number of the hidden nodes can be effectively optimized by the proposed method. Also, F-score_ELM obtained the best classification accuracy and required the shortest training and testing time.	[Gao, Junfeng; Zhang, Wenjia; Tao, Chunyi; Guan, Jinan] South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China; [Wang, Zhao] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Yang, Yong] Jiangxi Univ Finance & Econ, Sch Informat Technol, Nanchang, Peoples R China; [Rao, Nini] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China	South Central Minzu University; Case Western Reserve University; Jiangxi University of Finance & Economics; University of Electronic Science & Technology of China	Guan, JA (corresponding author), South Cent Univ Nationalities, Coll Biomed Engn, Wuhan, Peoples R China.	guanja@tom.com; raonini@uestc.edu.cn	Wang, Zhao/E-3515-2015; Guan, Jinan/AHA-4376-2022	Wang, Zhao/0000-0002-3628-5699; Guan, Jinan/0000-0003-1094-733X	National Nature Science Foundation of China [81271659, 61262034, 91120017, 81171411]; Science and Technology Research Project of the Education Department of Jiangxi Province [GJJ13302]; Special Fund for Basic Scientific Research of Central Colleges, South-Central University for Nationalities [CZY12011]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Project of the Education Department of Jiangxi Province; Special Fund for Basic Scientific Research of Central Colleges, South-Central University for Nationalities	The work is supported by National Nature Science Foundation of China (No. 81271659, 61262034, 91120017 and 81171411), by the Science and Technology Research Project of the Education Department of Jiangxi Province (No. GJJ13302) and by the Special Fund for Basic Scientific Research of Central Colleges, South-Central University for Nationalities (No. CZY12011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abootalebi V, 2009, COMPUT METH PROG BIO, V94, P48, DOI 10.1016/j.cmpb.2008.10.001; Acharya UR, 2012, INT J NEURAL SYST, V22, DOI [10.1142/S0129065712500025, 10.1142/S0129065712500116]; Akay MF, 2009, EXPERT SYST APPL, V36, P3240, DOI 10.1016/j.eswa.2008.01.009; Bartlett PL, 1998, IEEE T INFORM THEORY, V44, P525, DOI 10.1109/18.661502; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cao JW, 2012, INFORM SCIENCES, V185, P66, DOI 10.1016/j.ins.2011.09.015; Chawla MPS, 2009, NEURAL COMPUT APPL, V18, P539, DOI 10.1007/s00521-008-0195-1; Chen FL, 2011, EXPERT SYST APPL, V38, P1336, DOI 10.1016/j.eswa.2010.07.014; Chen FL, 2010, EXPERT SYST APPL, V37, P4902, DOI 10.1016/j.eswa.2009.12.025; Choi K, 2011, PATTERN RECOGN, V44, P386, DOI 10.1016/j.patcog.2010.08.009; Dash M, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P115, DOI 10.1109/ICDM.2002.1183893; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; FARWELL LA, 1991, PSYCHOPHYSIOLOGY, V28, P531, DOI 10.1111/j.1469-8986.1991.tb01990.x; Faust O, 2010, INT J NEURAL SYST, V20, P159, DOI 10.1142/S0129065710002334; Feng GR, 2009, IEEE T NEURAL NETWOR, V20, P1352, DOI 10.1109/TNN.2009.2024147; Gao JF, 2012, CLIN EEG NEUROSCI, V43, P54, DOI 10.1177/1550059411428715; Gao JF, 2011, COMPUT METH PROG BIO, V104, P410, DOI 10.1016/j.cmpb.2010.10.002; Han F, 2006, INT J NEURAL SYST, V16, P39, DOI 10.1142/S0129065706000494; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Hsu WY, 2012, INT J NEURAL SYST, V22, P51, DOI 10.1142/S0129065712002979; Hsu WY, 2011, INT J NEURAL SYST, V21, P335, DOI 10.1142/S0129065711002870; Huang CJ, 2008, EXPERT SYST APPL, V34, P2870, DOI 10.1016/j.eswa.2007.05.035; Huang GB, 2008, NEUROCOMPUTING, V71, P3460, DOI 10.1016/j.neucom.2007.10.008; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Huang GB, 2011, INT J MACH LEARN CYB, V2, P107, DOI 10.1007/s13042-011-0019-y; Huynh HT, 2008, INT J NEURAL SYST, V18, P433, DOI 10.1142/S0129065708001695; Ihrke M, 2011, INT J NEURAL SYST, V21, P65, DOI 10.1142/S0129065711002651; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Langleben DD, 2005, HUM BRAIN MAPP, V26, P262, DOI 10.1002/hbm.20191; Lee MC, 2009, EXPERT SYST APPL, V36, P10896, DOI 10.1016/j.eswa.2009.02.038; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Liang NY, 2006, INT J NEURAL SYST, V16, P29, DOI 10.1142/S0129065706000482; Lin C-J, 2003, NIPS 2003 FEATURE SE, P1; Lopez-Gordo MA, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S0129065712500098; Malhi A, 2004, IEEE T INSTRUM MEAS, V53, P1517, DOI 10.1109/TIM.2004.834070; Meijer EH, 2007, INT J PSYCHOPHYSIOL, V66, P231, DOI 10.1016/j.ijpsycho.2007.08.001; Miche Y, 2011, NEUROCOMPUTING, V74, P2413, DOI 10.1016/j.neucom.2010.12.042; Phan KL, 2005, ACAD RADIOL, V12, P164, DOI 10.1016/j.acra.2004.11.023; Polat K, 2009, EXPERT SYST APPL, V36, P10367, DOI 10.1016/j.eswa.2009.01.041; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rong HJ, 2008, NEUROCOMPUTING, V72, P359, DOI 10.1016/j.neucom.2008.01.005; Rosenfeld JP, 2008, PSYCHOPHYSIOLOGY, V45, P906, DOI 10.1111/j.1469-8986.2008.00708.x; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; Rosenfeld JP, 2002, HDB POLYGRAPH TESTIN, P265; Shao SY, 2009, IEEE T BIO-MED ENG, V56, P336, DOI 10.1109/TBME.2008.2005969; Shi LC, 2013, NEUROCOMPUTING, V102, P135, DOI 10.1016/j.neucom.2012.02.041; Vapnik V., 1998, STAT LEARNING THEORY; Yuan Q, 2011, EPILEPSY RES, V96, P29, DOI 10.1016/j.eplepsyres.2011.04.013; Yuedong Song, 2010, Journal of Biomedical Science & Engineering, V3, P556, DOI 10.4236/jbise.2010.36078	53	98	104	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64704	10.1371/journal.pone.0064704	http://dx.doi.org/10.1371/journal.pone.0064704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755136	gold, Green Submitted, Green Published			2022-12-25	WOS:000319872300024
J	Liang, DY; Liu, LM; Ye, CG; Zhao, L; Yu, FP; Gao, DY; Wang, YY; Yang, ZW; Wang, YY				Liang, Dong-yu; Liu, Liang-ming; Ye, Chang-gen; Zhao, Liang; Yu, Fang-ping; Gao, De-yong; Wang, Ying-ying; Yang, Zhi-wen; Wang, Yan-yan			Inhibition of UII/UTR System Relieves Acute Inflammation of Liver through Preventing Activation of NF-kappa B Pathway in ALF Mice	PLOS ONE			English	Article							UROTENSIN-II; D-GALACTOSAMINE; CYTOKINE PRODUCTION; PLASMA UROTENSIN; HEPATIC-FAILURE; EXPRESSION; RECEPTOR; APOPTOSIS; PROTECTS; CLONING	Urotensin II (UII) is implicated in immune inflammatory diseases through its specific high-affinity UT receptor (UTR). Enhanced expression of UII/UTR was recently demonstrated in the liver with acute liver failure (ALF). Here, we analysed the relationship between UII/UTR expression and ALF in lipopolysaccharide (LPS)/D-galactosamine (GalN)-challenged mice. Thereafter, we investigated the effects produced by the inhibition of UII/UTR system using urantide, a special antagonist of UTR, and the potential molecular mechanisms involved in ALF. Urantide was administered to mice treated with LPS/GalN. Expression of UII/UTR, releases of proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and interferon-gamma (IFN-gamma), and activation of nuclear factor kappa B (NF-kappa B) signaling pathway were assessed in the lethal ALF with or without urantide pretreatment. We found that LPS/GalN-challenged mice showed high mortality and marked hepatic inflammatory infiltration and cell apoptosis as well as a significant increase of UII/UTR expression. Urantide pretreatment protected against the injury in liver following downregulation of UII/UTR expression. A close relationship between the acutely flamed hepatic injury and UII/UTR expression was observed. In addition, urantide prevented the increases of proinflammatory cytokines such as TNF-alpha, IL-1 beta and IFN-gamma, and activation of NF-kappa B signaling pathway induced by LPS/GalN in mice. Thus, we conclude that UII/UTR system plays a role in LPS/GalN-induced ALF. Urantide has a protective effect on the acutely inflamed injury of liver in part through preventing releases of proinflammatory cytokines and activation of NF-kappa B pathway.	[Liang, Dong-yu; Liu, Liang-ming; Ye, Chang-gen; Zhao, Liang; Yu, Fang-ping; Gao, De-yong; Wang, Ying-ying; Yang, Zhi-wen; Wang, Yan-yan] Shanghai Jiao Tong Univ, Peoples Hosp 1, Songjiang Hosp, Dept Hepatol, Shanghai 200030, Peoples R China; [Liu, Liang-ming; Ye, Chang-gen; Gao, De-yong] Shanghai Jiao Tong Univ, Peoples Hosp 1, Songjiang Hosp, Dept Infect, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, LM (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 1, Songjiang Hosp, Dept Hepatol, Shanghai 200030, Peoples R China.	liuliangming@hotmail.com	liang, dy/GZA-4770-2022; 叶, 长根/GPW-6602-2022	叶, 长根/0000-0001-5750-7660	National Natural Science Foundation of China [81070357, 30660066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from National Natural Science Foundation of China (No. 81070357, No. 30660066) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balat A, 2012, INT J NEPHROL; Birker-Robaczewska M, 2003, J RECEPT SIG TRANSD, V23, P289, DOI 10.1081/RRS-120026972; Cervantes CF, 2011, J MOL BIOL, V405, P754, DOI 10.1016/j.jmb.2010.10.055; Chai SB, 2010, HEART VESSELS, V25, P138, DOI 10.1007/s00380-009-1178-6; Chen Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044890; Cirillo P, 2008, J THROMB HAEMOST, V6, P726, DOI 10.1111/j.1538-7836.2008.02923.x; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Deng T, 2012, IMMUNOL CEL IN PRESS; Desai N, 2008, CARDIOL REV, V16, P142, DOI 10.1097/CRD.0b013e31815c8048; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dong X, 2012, HEART VESSELS; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; Dyson HJ, 2012, IUBMB LIFE, V64, P499, DOI 10.1002/iub.1044; Fukuda T, 2006, LIFE SCI, V79, P822, DOI 10.1016/j.lfs.2006.03.025; Gruson D, 2010, J CLIN HYPERTENS, V12, P653, DOI 10.1111/j.1751-7176.2010.00336.x; Hadem J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00340; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Johns DG, 2004, N-S ARCH PHARMACOL, V370, P238, DOI 10.1007/s00210-004-0980-z; Kiss RS, 2011, PEPTIDES, V32, P956, DOI 10.1016/j.peptides.2011.02.016; Kuhla A, 2008, APOPTOSIS, V13, P1427, DOI 10.1007/s10495-008-0269-7; Lee WM, 2012, SEMIN RESP CRIT CARE, V33, P36, DOI 10.1055/s-0032-1301733; Leifeld L, 1999, AM J PATHOL, V154, P1711, DOI 10.1016/S0002-9440(10)65427-2; Leifeld L, 2010, DIGEST DIS SCI, V55, P1458, DOI 10.1007/s10620-009-0875-4; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu LM, 2010, EUR J CLIN INVEST, V40, P127, DOI 10.1111/j.1365-2362.2009.02235.x; Mignon A, 1999, AM J RESP CRIT CARE, V159, P1308, DOI 10.1164/ajrccm.159.4.9712012; Nakama T, 2001, HEPATOLOGY, V33, P1441, DOI 10.1053/jhep.2001.24561; Ng LL, 2002, CIRCULATION, V106, P2877, DOI 10.1161/01.CIR.0000044388.19119.02; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W; Ren S, 2013, INT J BIOCHEM CELL B, V45, P335, DOI 10.1016/j.biocel.2012.11.012; Rodrigo R, 2011, HYPERTENS RES, V34, P431, DOI 10.1038/hr.2010.264; Romanelli RG, 2011, DIGEST LIVER DIS, V43, P314, DOI 10.1016/j.dld.2010.08.012; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; Rutherford A, 2012, GASTROENTEROLOGY, V143, P1237, DOI 10.1053/j.gastro.2012.07.113; Segain JP, 2007, J IMMUNOL, V179, P901, DOI 10.4049/jimmunol.179.2.901; Sun DX, 2005, J SURG RES, V129, P114, DOI 10.1016/j.jss.2005.05.028; Trebicka J, 2008, HEPATOLOGY, V47, P1264, DOI 10.1002/hep.22170; van Meurs M, 2012, SHOCK, V37, P392, DOI 10.1097/SHK.0b013e318248225e; Watanabe T, 2009, CURR MED CHEM, V16, P550, DOI 10.2174/092986709787458515; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x; Zhang JY, 2012, CAN J PHYSIOL PHARM, V90, P637, DOI [10.1139/Y2012-048, 10.1139/y2012-048]; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056	44	36	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64895	10.1371/journal.pone.0064895	http://dx.doi.org/10.1371/journal.pone.0064895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755157	gold, Green Submitted, Green Published			2022-12-25	WOS:000319872300036
J	Rehman, H; Krishnasamy, Y; Haque, K; Thurman, RG; Lemasters, JJ; Schnellmann, RG; Zhong, Z				Rehman, Hasibur; Krishnasamy, Yasodha; Haque, Khujista; Thurman, Ronald G.; Lemasters, John J.; Schnellmann, Rick G.; Zhong, Zhi			Green Tea Polyphenols Stimulate Mitochondrial Biogenesis and Improve Renal Function after Chronic Cyclosporin A Treatment in Rats	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR; PROTEIN-KINASE; RADICAL PRODUCTION; ENERGY-METABOLISM; PGC-1-ALPHA; DYSFUNCTION; EXPRESSION; INJURY	Our previous studies showed that an extract from Camellia sinenesis (green tea), which contains several polyphenols, attenuates nephrotoxicity caused by cyclosporine A (CsA). Since polyphenols are stimulators of mitochondrial biogenesis (MB), this study investigated whether stimulation of MB plays a role in green tea polyphenol protection against CsA renal toxicity. Rats were fed a powdered diet containing green tea polyphenolic extract (0.1%) starting 3 days prior to CsA treatment (25 mg/kg, i.g. daily for 3 weeks). CsA alone decreased renal nuclear DNA-encoded oxidative phosphorylation (OXPHOS) protein ATP synthase-beta (AS-beta) by 42%, mitochondrial DNA (mtDNA)-encoded OXPHOS protein NADH dehydrogenase-3 (ND3) by 87% and their associated mRNAs. Mitochondrial DNA copy number was also decreased by 78% by CsA. Immunohistochemical analysis showed decreased cytochrome c oxidase subunit IV (COX-IV), an OXPHOS protein, in tubular cells. Peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1 alpha, the master regulator of MB, and mitochondrial transcription factor-A (Tfam), the transcription factor that regulates mtDNA replication and transcription, were 42% and 90% lower, respectively, in the kidneys of CsA-treated than in untreated rats. These results indicate suppression of MB by chronic CsA treatment. Green tea polyphenols alone and following CsA increased AS-beta, ND3, COX-IV, mtDNA copy number, PGC-1 alpha mRNA and protein, decreased acetylated PGC-1 alpha, and increased Tfam mRNA and protein. In association with suppressed MB, CsA increased serum creatinine, caused loss of brush border and dilatation of proximal tubules, tubular atrophy, vacuolization, apoptosis, calcification, and increased neutrophil gelatinase-associated lipocalin expression, leukocyte infiltration, and renal fibrosis. Green tea polyphenols markedly attenuated CsA-induced renal injury and improved renal function. Together, these results demonstrate that green tea polyphenols attenuate CsA-induced kidney injury, at least in part, through the stimulation of MB.	[Rehman, Hasibur; Krishnasamy, Yasodha; Haque, Khujista; Lemasters, John J.; Schnellmann, Rick G.; Zhong, Zhi] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Lemasters, John J.; Schnellmann, Rick G.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Lemasters, John J.; Schnellmann, Rick G.; Zhong, Zhi] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Thurman, Ronald G.; Zhong, Zhi] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Schnellmann, Rick G.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Zhong, Z (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	zhong@musc.edu	Rehman, Hasibur/K-5224-2019	Rehman, Hasibur/0000-0003-1551-6520	National Institutes of Health [DK70844, DK37034, GM 084147]; South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling [P20 GM103542]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073336, R56DK037034, R01DK037034, R01DK070844, R37DK037034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542, R01GM084147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in part, by Grants DK70844, DK37034, and GM 084147 from the National Institutes of Health and South Carolina COBRE in Oxidants, Redox Balance and Stress Signaling [P20 GM103542]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany I, 2010, AM J PHYSIOL-RENAL, V298, pF1214, DOI 10.1152/ajprenal.00639.2009; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; BARROS EJG, 1987, KIDNEY INT, V32, P19, DOI 10.1038/ki.1987.166; Beeson CC, 2010, ANAL BIOCHEM, V404, P75, DOI 10.1016/j.ab.2010.04.040; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Biswas S, 2012, CURR MED CHEM; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Bolignano D, 2009, KIDNEY BLOOD PRESS R, V32, P91, DOI 10.1159/000209379; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Darvesh AS, 2013, NUTR CANCER, V65, P329, DOI 10.1080/01635581.2013.767367; Devaux F, 2010, FEBS LETT, V584, P4273, DOI 10.1016/j.febslet.2010.09.030; DIEDERICH D, 1994, HYPERTENSION, V23, P957, DOI 10.1161/01.HYP.23.6.957; Duluc L, 2013, INT J BIOCHEM CELL B, V45, P783, DOI 10.1016/j.biocel.2013.01.007; FARTHING MJG, 1981, BIOCHEM PHARMACOL, V30, P3311, DOI 10.1016/0006-2952(81)90604-3; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Frankel EN, 1999, ANTIOXIDANT FOOD SUP, P385, DOI 10.1016/b978-012543590-1/50026-3; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Garnier A, 2005, FASEB J, V19, P43, DOI 10.1096/fj.04-2173com; Goldstein SL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-135; Gundimeda U, 2012, J BIOL CHEM, V287, P34694, DOI 10.1074/jbc.M112.356899; Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210, DOI 10.1016/S0005-2760(96)00122-1; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Halloran PF, 1996, CLIN TRANSPLANT, V10, P118; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; HARA Y, 1994, AM BIOTECHNOL LAB, V12, P48; Herrmann JM, 2012, ADV EXP MED BIOL, V748, P41, DOI 10.1007/978-1-4614-3573-0_3; Hugel HM, 2012, MINI-REV MED CHEM, V12, P380; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; JUNG K, 1985, FEBS LETT, V183, P167, DOI 10.1016/0014-5793(85)80977-7; KADA T, 1985, MUTAT RES, V150, P127, DOI 10.1016/0027-5107(85)90109-5; Kishimoto Y, 2013, EUR J CLIN NUTR, V67, P532, DOI 10.1038/ejcn.2013.29; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee SH, 2001, PHARMACOL RES, V43, P161, DOI 10.1006/phrs.2000.0759; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lim SW, 2005, TRANSPLANTATION, V80, P691, DOI 10.1097/01.tp.0000173594.69089.a0; Lin AMY, 1998, CHINESE J PHYSIOL, V41, P189; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041834; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Marechal X, 2011, CLIN SCI, V121, P405, DOI 10.1042/CS20110069; MARGREITER R, 1983, TRANSPLANTATION, V36, P203, DOI 10.1097/00007890-198308000-00020; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitscher LA, 1997, MED RES REV, V17, P327, DOI 10.1002/(SICI)1098-1128(199707)17:4<327::AID-MED2>3.0.CO;2-Y; Miyagawa C, 1997, BIOSCI BIOTECH BIOCH, V61, P1901, DOI 10.1271/bbb.61.1901; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nieman DC, 2009, MED SCI SPORT EXER, V41, P1467, DOI 10.1249/MSS.0b013e318199491f; Niemann CU, 2002, J PHARMACOL EXP THER, V302, P1123, DOI 10.1124/jpet.102.036848; Nogueira L, 2011, J PHYSIOL-LONDON, V589, P4615, DOI 10.1113/jphysiol.2011.209924; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Rasbach KA, 2007, BIOCHEM BIOPH RES CO, V355, P734, DOI 10.1016/j.bbrc.2007.02.023; Rasbach KA, 2010, J PHARMACOL EXP THER, V332, P632, DOI 10.1124/jpet.109.159947; Recio MC, 2012, CURR MED CHEM, V19, P2088; Rehman H, 2008, J PHARMACOL EXP THER, V327, P699, DOI 10.1124/jpet.108.143578; Reichert AS, 2004, TRENDS GENET, V20, P555, DOI 10.1016/j.tig.2004.08.012; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ryder JW, 2003, J BIOL CHEM, V278, P44298, DOI 10.1074/jbc.M304510200; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Schaeffer PJ, 2004, J BIOL CHEM, V279, P39593, DOI 10.1074/jbc.M403649200; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Serkova N, 2003, TRANSPLANT INT, V16, P748, DOI 10.1007/s00147-003-0631-1; Serkova N, 1996, BBA-MOL CELL RES, V1314, P93, DOI 10.1016/S0167-4889(96)00081-X; Serkova N, 2001, BRIT J PHARMACOL, V133, P875, DOI 10.1038/sj.bjp.0704142; SHEHATA M, 1995, KIDNEY INT, V48, P1487, DOI 10.1038/ki.1995.438; SIBLEY RK, 1983, SURGERY, V94, P225; Taub PR, 2012, CTS-CLIN TRANSL SCI, V5, P43, DOI 10.1111/j.1752-8062.2011.00357.x; Tedesco D, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/230386; TEXTOR SC, 1995, KIDNEY INT, V47, P1426, DOI 10.1038/ki.1995.200; Thurman RG, 1997, TRANSPLANTATION, V63, P1661, DOI 10.1097/00007890-199706150-00021; Vinson JA, 2000, BIOFACTORS, V13, P127, DOI 10.1002/biof.5520130121; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261; Williams D, 2006, ADV CHRONIC KIDNEY D, V13, P47, DOI 10.1053/j.ackd.2005.11.001; Wills LP, 2012, J PHARMACOL EXP THER, V342, P106, DOI 10.1124/jpet.112.191528; Winder WW, 2006, MED SCI SPORT EXER, V38, P1945, DOI 10.1249/01.mss.0000233798.62153.50; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yan J, 2012, J NUTR BIOCHEM, V23, P716, DOI 10.1016/j.jnutbio.2011.03.014; Yoshino M, 1998, ANAL BIOCHEM, V257, P40, DOI 10.1006/abio.1997.2522; Yoshioka N, 1999, CANCER LETT, V136, P79, DOI 10.1016/S0304-3835(98)00313-9; Yun JM, 2010, BRIT J NUTR, V103, P1771, DOI 10.1017/S000711451000005X; Zhong Z, 1999, MOL PHARMACOL, V56, P455, DOI 10.1124/mol.56.3.455; Zhong Z, 2005, GASTROENTEROLOGY, V129, P652, DOI [10.1053/j.gastro.2005.05.060, 10.1016/j.gastro.2005.05.060]; Zhong Z, 2003, AM J PHYSIOL-GASTR L, V285, pG1004, DOI 10.1152/ajpgi.00008.2003; Zhong Z, 2002, AM J PHYSIOL-GASTR L, V283, pG957, DOI 10.1152/ajpgi.00216.2001; Zhong Z, 1998, AM J PHYSIOL-RENAL, V275, pF595, DOI 10.1152/ajprenal.1998.275.4.F595; Zhong Z, 2006, J PHARM PHARMACOL, V58, P1533, DOI 10.1211/jpp.58.11.0015; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	97	34	37	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65029	10.1371/journal.pone.0065029	http://dx.doi.org/10.1371/journal.pone.0065029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755172	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300044
J	Naville, D; Pinteur, C; Vega, N; Menade, Y; Vigier, M; Le Bourdais, A; Labaronne, E; Debard, C; Luquain-Costaz, C; Begeot, M; Vidal, H; Le Magueresse-Battistoni, B				Naville, Danielle; Pinteur, Claudie; Vega, Nathalie; Menade, Yoan; Vigier, Michele; Le Bourdais, Alexandre; Labaronne, Emmanuel; Debard, Cyrille; Luquain-Costaz, Celine; Begeot, Martine; Vidal, Hubert; Le Magueresse-Battistoni, Brigitte			Low-dose food contaminants trigger sex-specific, hepatic metabolic changes in the progeny of obese mice	FASEB JOURNAL			English	Article						BPA; DEHP; persistent organic pollutant; estrogen sulfotransferase; cholesterol biosynthesis	ENDOCRINE-DISRUPTING CHEMICALS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; ESTROGEN SULFOTRANSFERASE; ENVIRONMENTAL CHEMICALS; DEVELOPMENTAL ORIGINS; GENE-EXPRESSION; BISPHENOL-A; RECEPTOR; LIVER; EXPOSURE	Environmental contaminants are suspected to be involved in the epidemic incidence of metabolic disorders, food ingestion being a primarily route of exposure. We hypothesized that life-long consumption of a high-fat diet that contains low doses of pollutants will aggravate metabolic disorders induced by obesity itself. Mice were challenged from preconception throughout life with a high-fat diet containing pollutants commonly present in food (2,3,7,8-tetrachlorodibenzo-p-dioxin, polychlorinated biphenyl 153, diethylhexyl phthalate, and bisphenol A), added at low doses in the tolerable daily intake range. We measured several blood parameters, glucose and insulin tolerance, hepatic lipid accumulation, and gene expression in adult mice. Pollutant-exposed mice exhibited significant sex-dependent metabolic disorders in the absence of toxicity and weight gain. In males, pollutants increased the expression of hepatic genes (from 36 to 88%) encoding proteins related to cholesterol biosynthesis and decreased (40%) hepatic total cholesterol levels. In females, there was a marked deterioration of glucose tolerance, which may be related to the 2-fold induction of estrogen sulfotransferase and reduced expression of estrogen receptor (25%) and estrogen target genes (>34%). Because of the very low doses of pollutants used in the mixture, these findings may have strong implications in terms of understanding the potential role of environmental contaminants in food in the development of metabolic diseases.Naville, D., Pinteur, C., Vega, N., Menade, Y., Vigier, M., Le Bourdais, A., Labaronne, E., Debard, C., Luquain-Costaz, C., Begeot, M., Vidal, H., Le Magueresse-Battistoni, B. Low-dose food contaminants trigger sex-specific, hepatic metabolic changes in the progeny of obese mice.	[Naville, Danielle; Pinteur, Claudie; Vega, Nathalie; Menade, Yoan; Vigier, Michele; Le Bourdais, Alexandre; Labaronne, Emmanuel; Debard, Cyrille; Luquain-Costaz, Celine; Begeot, Martine; Vidal, Hubert; Le Magueresse-Battistoni, Brigitte] INSERM, U1060, Cardiovasc Metab Diabetol & Nutr CarMeN Lab, Oullins, France; [Naville, Danielle; Pinteur, Claudie; Vega, Nathalie; Menade, Yoan; Vigier, Michele; Le Bourdais, Alexandre; Labaronne, Emmanuel; Debard, Cyrille; Luquain-Costaz, Celine; Begeot, Martine; Vidal, Hubert; Le Magueresse-Battistoni, Brigitte] Inst Natl Rech Agron INRA U1362, Oullins, France; [Naville, Danielle; Pinteur, Claudie; Vega, Nathalie; Menade, Yoan; Vigier, Michele; Le Bourdais, Alexandre; Labaronne, Emmanuel; Debard, Cyrille; Luquain-Costaz, Celine; Begeot, Martine; Vidal, Hubert; Le Magueresse-Battistoni, Brigitte] Univ Lyon 1, F-69622 Villeurbanne, France; [Luquain-Costaz, Celine; Vidal, Hubert] Inst Natl Sci Appl INSA Lyon, IMBL, Villeurbanne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon	Le Magueresse-Battistoni, B (corresponding author), INSERM U1060 CarMeN, Fac Med Lyon Sud, 165 Chemin Grand Revoyet, F-69921 Oullins, France.	brigitte.lemagueresse@inserm.fr	Le Magueresse-Battistoni, Brigitte/M-6927-2017; Le Magueresse-Battistoni, Brigitte/AAZ-5601-2021; Naville, Danielle/N-1200-2017; Tuomisto, Jouko/J-7450-2012; Vidal, Hubert/M-6674-2017	Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Le Magueresse-Battistoni, Brigitte/0000-0002-7247-4403; Naville, Danielle/0000-0003-2615-6161; Vidal, Hubert/0000-0002-9467-0317; Labaronne, Emmanuel/0000-0001-6314-7809	Institut Benjamin Delessert; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES; Programme National Environnement-Environnement-Sante-Travail) [EST-2010/2/2007]; European Foundation of the Study of Diabetes (EFSD/Novo Nordisk)	Institut Benjamin Delessert; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES; Programme National Environnement-Environnement-Sante-Travail)(French National Research Agency (ANR)); European Foundation of the Study of Diabetes (EFSD/Novo Nordisk)	The authors thank Michel Beylot for the indirect calorimetry measurement. This work was supported by grants from Institut Benjamin Delessert (2010), Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement et du Travail (ANSES; Programme National Environnement-Environnement-Sante-Travail, EST-2010/2/2007), and the European Foundation of the Study of Diabetes (EFSD/Novo Nordisk, program 2011). The authors declare no conflicts of interest.	Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Anton R, 2005, EFSA J, V3, DOI 10.2903/j.efsa.2005.204/full; Baars AJ, 2004, TOXICOL LETT, V151, P51, DOI 10.1016/j.toxlet.2004.01.028; Barker DJP, 2005, HORM RES, V64, P2, DOI 10.1159/000089311; Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; Barros RPA, 2006, TRENDS MOL MED, V12, P425, DOI 10.1016/j.molmed.2006.07.004; Beylot M, 2012, METABOLISM, V61, P415, DOI 10.1016/j.metabol.2011.07.019; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boutros PC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-419; Carpenter David O., 2008, Reviews on Environmental Health, V23, P59; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Croutch CR, 2005, TOXICOL SCI, V85, P560, DOI 10.1093/toxsci/kfi106; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dorne JLCM, 2010, TOXICOLOGY, V268, P156, DOI 10.1016/j.tox.2009.11.004; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fromenty B, 2013, J HEPATOL, V58, P824, DOI 10.1016/j.jhep.2012.12.018; Gao H, 2008, MOL ENDOCRINOL, V22, P10, DOI 10.1210/me.2007-0121; Gao J, 2012, DIABETES, V61, P1543, DOI 10.2337/db11-1152; Gout J, 2010, MOL CELL ENDOCRINOL, V319, P99, DOI 10.1016/j.mce.2010.01.021; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; He JH, 2011, EXP BIOL MED, V236, P1116, DOI 10.1258/ebm.2011.011128; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Hevir N, 2013, MOL CELL ENDOCRINOL, V367, P74, DOI 10.1016/j.mce.2012.12.019; Ibrahim MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025170; Jacobsen PR, 2012, REPROD TOXICOL, V34, P237, DOI 10.1016/j.reprotox.2012.05.099; Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; LEITER EH, 1994, J CLIN INVEST, V93, P2007, DOI 10.1172/JCI117194; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Martens K, 2008, BBA-MOL CELL BIOL L, V1781, P694, DOI 10.1016/j.bbalip.2008.07.010; Mauvais-Jarvis F, 2012, DIABETES, V61, P1353, DOI 10.2337/db12-0357; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Nadal A, 2013, NAT REV ENDOCRINOL, V9, P9, DOI 10.1038/nrendo.2012.205; Nault R, 2013, TOXICOL APPL PHARM, V267, P184, DOI 10.1016/j.taap.2012.11.028; Naville D, 2011, TOXICOL LETT, V207, P251, DOI 10.1016/j.toxlet.2011.09.019; Pageaux JF, 1996, ARCH BIOCHEM BIOPHYS, V327, P142, DOI 10.1006/abbi.1996.0102; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Schafer KS, 2002, J EPIDEMIOL COMMUN H, V56, P813, DOI 10.1136/jech.56.11.813; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Silins I, 2011, INT J ENV RES PUB HE, V8, P629, DOI 10.3390/ijerph8030629; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; Taxvig C, 2012, MOL CELL ENDOCRINOL, V361, P106, DOI 10.1016/j.mce.2012.03.021; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; van Leeuwen FXR, 2000, CHEMOSPHERE, V40, P1095, DOI 10.1016/S0045-6535(99)00358-6; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148; Wahlang B, 2013, J NUTR BIOCHEM, V24, P1587, DOI 10.1016/j.jnutbio.2013.01.009; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; WHO, 2003, 55 WHO CONC INT CHEM; Xi W, 2012, ENVIRON SCI POLLUT R, V19, P2515, DOI 10.1007/s11356-012-0827-y; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271; Zhou XD, 2012, J NUTR BIOCHEM, V23, P532, DOI 10.1016/j.jnutbio.2011.02.008	58	41	42	0	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3860	3870		10.1096/fj.13-231670	http://dx.doi.org/10.1096/fj.13-231670			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23756648	Green Submitted			2022-12-25	WOS:000328840500043
J	Minassian, NA; Gibbs, A; Shih, AY; Liu, Y; Neff, RA; Sutton, SW; Mirzadegan, T; Connor, J; Fellows, R; Husovsky, M; Nelson, S; Hunter, MJ; Flinspach, M; Wickenden, AD				Minassian, Natali A.; Gibbs, Alan; Shih, Amy Y.; Liu, Yi; Neff, Robert A.; Sutton, Steven W.; Mirzadegan, Tara; Connor, Judith; Fellows, Ross; Husovsky, Matthew; Nelson, Serena; Hunter, Michael J.; Flinspach, Mack; Wickenden, Alan D.			Analysis of the Structural and Molecular Basis of Voltage-sensitive Sodium Channel Inhibition by the Spider Toxin Huwentoxin-IV (mu-TRTX-Hh2a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARANTULA TOXINS; HAINANTOXIN-IV; VENOM PEPTIDES; DOMAIN-II; MUTATIONS; SENSORS; PROTEIN; SCN9A; PAIN; BINDING	Voltage-gated sodium channels (VGSCs) are essential to the normal function of the vertebrate nervous system. Aberrant function of VGSCs underlies a variety of disorders, including epilepsy, arrhythmia, and pain. A large number of animal toxins target these ion channels and may have significant therapeutic potential. Most of these toxins, however, have not been characterized in detail. Here, by combining patch clamp electrophysiology and radioligand binding studies with peptide mutagenesis, NMR structure determination, and molecular modeling, we have revealed key molecular determinants of the interaction between the tarantula toxin huwentoxin-IV and two VGSC isoforms, Nav1.7 and Nav1.2. Nine huwentoxin-IV residues (F6A, P11A, D14A, L22A, S25A, W30A, K32A, Y33A, and I35A) were important for block of Nav1.7 and Nav1.2. Importantly, molecular dynamics simulations and NMR studies indicated that folding was normal for several key mutants, suggesting that these amino acids probably make specific interactions with sodium channel residues. Additionally, we identified several amino acids (F6A, K18A, R26A, and K27A) that are involved in isoform-specific VGSC interactions. Our structural and functional data were used to model the docking of huwentoxin-IV into the domain II voltage sensor of Nav1.7. The model predicts that a hydrophobic patch composed of Trp-30 and Phe-6, along with the basic Lys-32 residue, docks into a groove formed by the Nav1.7 S1-S2 and S3-S4 loops. These results provide new insight into the structural and molecular basis of sodium channel block by huwentoxin-IV and may provide a basis for the rational design of toxin-based peptides with improved VGSC potency and/or selectivity.	[Minassian, Natali A.; Liu, Yi; Neff, Robert A.; Sutton, Steven W.; Wickenden, Alan D.] Janssen Res & Dev LLC, Dept Neurosci Discovery, San Diego, CA 92121 USA; [Connor, Judith; Fellows, Ross; Husovsky, Matthew; Nelson, Serena; Hunter, Michael J.; Flinspach, Mack] Janssen Res & Dev LLC, Dept Biol Res, San Diego, CA 92121 USA; [Gibbs, Alan] Janssen Res & Dev LLC, Dept Biol Struct, San Diego, CA 92121 USA; [Shih, Amy Y.; Mirzadegan, Tara] Janssen Res & Dev LLC, Dept Comp Aided Drug Design, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Wickenden, AD (corresponding author), Janssen Res & Dev LLC, 3210 Merryfield Row, San Diego, CA 92121 USA.	awickend@its.jnj.com	Gibbs, Alan/P-9912-2019	Gibbs, Alan/0000-0002-4305-6755; Neff, Robert/0000-0002-7550-4348				Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Burgoyne NJ, 2006, BIOINFORMATICS, V22, P1335, DOI 10.1093/bioinformatics/btl079; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P533, DOI 10.1016/B978-012164491-8/50009-9; Chagot B, 2004, PROTEIN SCI, V13, P1197, DOI 10.1110/ps.03584304; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Fiorucci S, 2010, BIOPHYS J, V98, P1921, DOI 10.1016/j.bpj.2009.12.4332; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; King GF, 2004, TOXICON, V43, P471, DOI 10.1016/j.toxicon.2004.02.001; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Lee S, 2010, BIOCHEMISTRY-US, V49, P5134, DOI 10.1021/bi100246u; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; LIANG SP, 1993, TOXICON, V31, P969, DOI 10.1016/0041-0101(93)90256-I; Liu Y, 2011, ASSAY DRUG DEV TECHN, V9, P628, DOI 10.1089/adt.2011.0375; Liu Y, 2012, J PEPT SCI, V18, P643, DOI 10.1002/psc.2451; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Mouhat S, 2005, J PEPT SCI, V11, P65, DOI 10.1002/psc.630; Noble D, 2002, P NATL ACAD SCI USA, V99, P5755, DOI 10.1073/pnas.102171699; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roland BL, 1999, ENDOCRINOLOGY, V140, P5736, DOI 10.1210/en.140.12.5736; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Spassov VZ, 2002, J PHYS CHEM B, V106, P8726, DOI 10.1021/jp020674r; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Wood DLA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-375; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yogeeswari P, 2004, CURR DRUG TARGETS, V5, P589, DOI 10.2174/1389450043345227; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742; Zhang JZ, 2011, J BIOL CHEM, V286, P33641, DOI 10.1074/jbc.M111.282509	54	60	63	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22707	22720		10.1074/jbc.M113.461392	http://dx.doi.org/10.1074/jbc.M113.461392			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23760503	Green Published, hybrid			2022-12-25	WOS:000330596300049
J	Ruan, GX; Kazlauskas, A				Ruan, Guo-Xiang; Kazlauskas, Andrius			Lactate Engages Receptor Tyrosine Kinases Axl, Tie2, and Vascular Endothelial Growth Factor Receptor 2 to Activate Phosphoinositide 3-Kinase/Akt and Promote Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT ACTIVATION; EXPRESSION; METABOLISM; HYPOXIA; METASTASES; RESISTANCE; SURVIVAL; PREDICT; TUMORS	Although a high level of lactate is quintessential to both tumors and wound healing, the manner by which lactate impacts endothelial cells to promote angiogenesis and thereby create or restore vascular perfusion to growing tissues has not been fully elucidated. Here we report that lactate activated the PI3K/Akt pathway in primary human endothelial cells. Furthermore, activating this signaling pathway was required for lactate-stimulated organization of endothelial cells into tubes and for sprouting of vessels from mouse aortic explants. Lactate engaged the PI3K/Akt pathway via ligand-mediated activation of the three receptor tyrosine kinases Axl, Tie2, and VEGF receptor 2. Neutralizing the ligands for these receptor tyrosine kinases, pharmacologically inhibiting their kinase activity or suppressing their expression largely eliminated the ability of cells and explants to respond to lactate. Elucidating the mechanism by which lactate communicates with endothelial cells presents a previously unappreciated opportunity to improve our understanding of the angiogenic program and to govern it.	[Ruan, Guo-Xiang; Kazlauskas, Andrius] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Kazlauskas, A (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	andrius_kazlauskas@meei.harvard.edu			National Institutes of Health [EY018344]; Juvenile Diabetes Research Foundation Advanced Postdoctoral Fellowship [102011367]; NATIONAL EYE INSTITUTE [R01EY018344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Advanced Postdoctoral Fellowship(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY018344 (to A. K.). This work was also supported by Juvenile Diabetes Research Foundation Advanced Postdoctoral Fellowship 102011367 (to G. X. R.).	Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Beckert S, 2006, WOUND REPAIR REGEN, V14, P321, DOI 10.1111/j.1743-6109.2006.00127.x; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Constant JS, 2000, WOUND REPAIR REGEN, V8, P353, DOI 10.1046/j.1524-475x.2000.00353.x; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; HUNT TK, 1978, AM J SURG, V135, P328, DOI 10.1016/0002-9610(78)90061-2; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Im E, 2010, MOL CELL BIOL, V30, P2401, DOI 10.1128/MCB.01275-09; JENSEN JA, 1986, LAB INVEST, V54, P574; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Klinghoffer RA, 1996, MOL CELL BIOL, V16, P5905; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kontos CD, 1998, MOL CELL BIOL, V18, P4131, DOI 10.1128/MCB.18.7.4131; Kumar VBS, 2007, J CELL PHYSIOL, V211, P477, DOI 10.1002/jcp.20955; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Martin V, 2008, HISTOL HISTOPATHOL, V23, P773, DOI 10.14670/HH-23.773; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Naumov GN, 2008, APMIS, V116, P569, DOI 10.1111/j.1600-0463.2008.01213.x; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Peters KG, 1998, BRIT J CANCER, V77, P51, DOI 10.1038/bjc.1998.8; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0; Rahimi N, 1999, MOL BIOL CELL, V10, P3401, DOI 10.1091/mbc.10.10.3401; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Ruan GX, 2011, EXP EYE RES, V93, P570, DOI 10.1016/j.exer.2010.06.016; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sjostrand M, 2000, AM J PHYSIOL-ENDOC M, V279, pE1097, DOI 10.1152/ajpendo.2000.279.5.E1097; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stratmann A, 1998, AM J PATHOL, V153, P1459, DOI 10.1016/S0002-9440(10)65733-1; Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Walenta S, 2000, CANCER RES, V60, P916; Walenta S, 1997, AM J PATHOL, V150, P409; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Willam C, 2000, CIRC RES, V87, P370; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567	51	112	115	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21161	21172		10.1074/jbc.M113.474619	http://dx.doi.org/10.1074/jbc.M113.474619			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754286	Green Published, hybrid			2022-12-25	WOS:000322014400036
J	Flajollet, S; Rachez, C; Ploton, M; Schulz, C; Gallais, R; Metivier, R; Pawlak, M; Leray, A; Issulahi, A; Heliot, L; Staels, B; Salbert, G; Lefebvre, P				Flajollet, Sebastien; Rachez, Christophe; Ploton, Maheul; Schulz, Celine; Gallais, Rozenn; Metivier, Raphael; Pawlak, Michal; Leray, Aymeric; Issulahi, Al Amine; Heliot, Laurent; Staels, Bart; Salbert, Gilles; Lefebvre, Philippe			The Elongation Complex Components BRD4 and MLLT3/AF9 Are Transcriptional Coactivators of Nuclear Retinoid Receptors	PLOS ONE			English	Article							BROMODOMAIN PROTEIN BRD4; P-TEFB; ESTROGEN-RECEPTOR; ACTIVATE TRANSCRIPTION; P21-ACTIVATED KINASE; GENE-EXPRESSION; STEM-CELLS; HIV-1 TAT; ACID; INTERACTS	Nuclear all-trans retinoic acid receptors (RARs) initiate early transcriptional events which engage pluripotent cells to differentiate into specific lineages. RAR-controlled transactivation depends mostly on agonist-induced structural transitions in RAR C-terminus (AF-2), thus bridging coactivators or corepressors to chromatin, hence controlling preinitiation complex assembly. However, the contribution of other domains of RAR to its overall transcriptional activity remains poorly defined. A proteomic characterization of nuclear proteins interacting with RAR regions distinct from the AF-2 revealed unsuspected functional properties of the RAR N-terminus. Indeed, mass spectrometry fingerprinting identified the Bromodomain-containing protein 4 (BRD4) and ALL1-fused gene from chromosome 9 (AF9/MLLT3), known to associate with and regulates the activity of Positive Transcription Elongation Factor b (P-TEFb), as novel RAR coactivators. In addition to promoter sequences, RAR binds to genomic, transcribed regions of retinoid-regulated genes, in association with RNA polymerase II and as a function of P-TEFb activity. Knockdown of either AF9 or BRD4 expression affected differentially the neural differentiation of stem cell-like P19 cells. Clusters of retinoid-regulated genes were selectively dependent on BRD4 and/or AF9 expression, which correlated with RAR association to transcribed regions. Thus RAR establishes physical and functional links with components of the elongation complex, enabling the rapid retinoid-induced induction of genes required for neuronal differentiation. Our data thereby extends the previously known RAR interactome from classical transcriptional modulators to components of the elongation machinery, and unravel a functional role of RAR in transcriptional elongation.	[Flajollet, Sebastien; Ploton, Maheul; Pawlak, Michal; Staels, Bart; Lefebvre, Philippe] EGID, FR 3508, Lille, France; [Flajollet, Sebastien; Ploton, Maheul; Pawlak, Michal; Staels, Bart; Lefebvre, Philippe] INSERM, UMR1011, F-59045 Lille, France; [Flajollet, Sebastien; Ploton, Maheul; Pawlak, Michal; Staels, Bart; Lefebvre, Philippe] Univ Lille 2, Lille, France; [Flajollet, Sebastien; Ploton, Maheul; Pawlak, Michal; Staels, Bart; Lefebvre, Philippe] Inst Pasteur, F-59019 Lille, France; [Rachez, Christophe] Inst Pasteur, CNRS, Dept Dev Biol, Unite Regulat Epigenet,URA 2578, Paris, France; [Schulz, Celine; Leray, Aymeric; Issulahi, Al Amine; Heliot, Laurent] Univ Lille 1, CNRS, USR Biophoton Cellulaire Fonct 3078, Interdisciplinary Res Inst, F-59655 Villeneuve Dascq, France; [Gallais, Rozenn; Metivier, Raphael; Salbert, Gilles] Univ Rennes 1, Equipe SPARTE, CNRS, UMR 6026, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Lefebvre, P (corresponding author), EGID, FR 3508, Lille, France.	philippe-claude.lefebvre@inserm.fr	Staels, Bart/N-9497-2016; Pawlak, Michal/ABF-1129-2020; Salbert, Gilles/W-9196-2019; Lefebvre, Philippe/F-2685-2010; Pawlak, Michal/E-2765-2014; Rachez, Christophe/GLR-0102-2022	Staels, Bart/0000-0002-3784-1503; Pawlak, Michal/0000-0001-7679-5493; Salbert, Gilles/0000-0001-6115-4140; Lefebvre, Philippe/0000-0002-9366-5129; PLOTON, Maheul/0000-0002-1569-0070; Rachez, Christophe/0000-0001-8502-4738; Schulz, Celine/0000-0003-3867-1443	La Ligue Nationale contre le Cancer; European Genomic Institute for Diabetes (E.G.I.D.) [ANR-10-LABX-46]; Contrat Plan Etat-Region "Campus Intelligent"; ANR "MULtimodal"	La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); European Genomic Institute for Diabetes (E.G.I.D.); Contrat Plan Etat-Region "Campus Intelligent"; ANR "MULtimodal"(French National Research Agency (ANR))	This work was funded by grants from La Ligue Nationale contre le Cancer (to PL), from European Genomic Institute for Diabetes (E.G.I.D., ANR-10-LABX-46), Contrat Plan Etat-Region "Campus Intelligent" to LH, and ANR "MULtimodal" to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann PM, 2011, CURR MED CHEM, V18, P1405; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Brand Celine, 2002, BMC Pharmacol, V2, P13, DOI 10.1186/1471-2210-2-13; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Briand O, 2012, MOL ENDOCRINOL, V26, P399, DOI 10.1210/me.2011-1317; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; De Falco G, 2000, ONCOGENE, V19, P373, DOI 10.1038/sj.onc.1203305; Depoix C, 2001, J BIOL CHEM, V276, P9452, DOI 10.1074/jbc.M008004200; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Flajollet S, 2006, J BIOL CHEM, V281, P20338, DOI 10.1074/jbc.M603023200; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Iankova I, 2006, MOL ENDOCRINOL, V20, P1494, DOI 10.1210/me.2005-0222; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Lefebvre B, 2002, EMBO REP, V3, P335, DOI 10.1093/embo-reports/kvf066; Lefebvre B, 2006, MOL ENDOCRINOL, V20, P2109, DOI 10.1210/me.2005-0321; Lefebvre B, 2010, J CLIN INVEST, V120, P1454, DOI 10.1172/JCI38606; Lefebvre P, 1998, J BIOL CHEM, V273, P12288, DOI 10.1074/jbc.273.20.12288; Leray A, 2009, MICROSC RES TECHNIQ, V72, P371, DOI 10.1002/jemt.20665; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Martin PJ, 2005, NUCLEIC ACIDS RES, V33, P4311, DOI 10.1093/nar/gki745; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Samarut E, 2012, MOL CELL ENDOCRINOL, V348, P348, DOI 10.1016/j.mce.2011.03.025; SCHOORLEMMER J, 1994, MOL CELL BIOL, V14, P1122, DOI 10.1128/MCB.14.2.1122; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zhou MS, 2009, J VIROL, V83, P1036, DOI 10.1128/JVI.01316-08; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	53	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64880	10.1371/journal.pone.0064880	http://dx.doi.org/10.1371/journal.pone.0064880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762261	Green Published, gold, Green Submitted			2022-12-25	WOS:000320440500008
J	Ding, GY; Zhang, Y; Gao, L; Ma, W; Li, XJ; Liu, J; Liu, QY; Jiang, BF				Ding, Guoyong; Zhang, Ying; Gao, Lu; Ma, Wei; Li, Xiujun; Liu, Jing; Liu, Qiyong; Jiang, Baofa			Quantitative Analysis of Burden of Infectious Diarrhea Associated with Floods in Northwest of Anhui Province, China: A Mixed Method Evaluation	PLOS ONE			English	Article							CASE-CROSSOVER ANALYSES; HEALTH IMPACTS; REFERENT SELECTION; BANGLADESH; EPIDEMICS; ILLNESS; DHAKA; RISK	Background: Persistent and heavy rainfall in the upper and middle Huaihe River of China brought about severe floods during the end of June and July 2007. However, there has been no assessment on the association between the floods and infectious diarrhea. This study aimed to quantify the impact of the floods in 2007 on the burden of disease due to infectious diarrhea in northwest of Anhui Province. Methods: A time-stratified case-crossover analysis was firstly conducted to examine the relationship between daily cases of infectious diarrhea and the 2007 floods in Fuyang and Bozhou of Anhui Province. Odds ratios (ORs) of the flood risk were quantified by conditional logistic regression. The years lived with disability (YLDs) of infectious diarrhea attributable to floods were then estimated based on the WHO framework of the calculating potential impact fraction in the Burden of Disease study. Results: A total of 197 infectious diarrheas were notified during the exposure and control periods in the two study areas. The strongest effect was shown with a 2-day lag in Fuyang and a 5-day lag in Bozhou. Multivariable analysis showed that floods were significantly associated with an increased risk of the number cases of infectious diarrhea (OR = 3.175, 95% CI: 1.126-8.954 in Fuyang; OR = 6.754, 95% CI: 1.954-23.344 in Bozhou). Attributable YLD per 1000 of infectious diarrhea resulting from the floods was 0.0081 in Fuyang and 0.0209 in Bozhou. Conclusions: Our findings confirm that floods have significantly increased the risks of infectious diarrhea in the study areas. In addition, prolonged moderate flood may cause more burdens of infectious diarrheas than severe flood with a shorter duration. More attention should be paid to particular vulnerable groups, including younger children and elderly, in developing public health preparation and intervention programs. Findings have significant implications for developing strategies to prevent and reduce health impact of floods.	[Ding, Guoyong; Gao, Lu; Ma, Wei; Li, Xiujun; Liu, Jing; Jiang, Baofa] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China; [Zhang, Ying] Univ Sydney, Sch Publ Hlth, China Studies Ctr, Sydney, NSW 2006, Australia; [Liu, Qiyong] China CDC, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China	Shandong University; University of Sydney; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Jiang, BF (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China.	bjiang@sdu.edu.cn	Ma, Wei/L-2374-2019; Zhang, Ying/ABE-2275-2021; Ma, Wei/C-4748-2019	Ma, Wei/0000-0002-8092-3280; Zhang, Ying/0000-0001-6214-2440; Ma, Wei/0000-0002-8092-3280	National Basic Research Program of China (973 Program) [2012CB955500-955502]; Australian National Health and Medical Research Council Public Health Training Fellowship [627049]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Australian National Health and Medical Research Council Public Health Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the National Basic Research Program of China (973 Program) (Grant NO. 2012CB955500-955502). Ying Zhang received the Australian National Health and Medical Research Council Public Health Training Fellowship (627049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaya SW, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.2019; Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004; Alderman K, 2012, ENVIRON INT, V47, P37, DOI 10.1016/j.envint.2012.06.003; [Anonymous], YB METEROROLOGICAL D; [Anonymous], 2001, NATL BURDEN DIS STUD; [Anonymous], 2011, ANN DISASTER STAT RE; Borchardt MA, 2003, APPL ENVIRON MICROB, V69, P1172, DOI 10.1128/AEM.69.2.1172-1180.2003; Campbell-Lendrum D., 2007, Climate change: quantifying the health impact at national and local levels; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P369; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Du WW, 2010, PREHOSP DISASTER MED, V25, P265, DOI 10.1017/S1049023X00008141; E JP, 2008, B FLOOD DROUGHT DISA; Fewtrell L, 2008, PUBLIC HEALTH, V122, P446, DOI 10.1016/j.puhe.2007.09.010; Harris AM, 2008, AM J TROP MED HYG, V79, P708, DOI 10.4269/ajtmh.2008.79.708; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Janes H, 2005, STAT MED, V24, P285, DOI 10.1002/sim.1889; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Kunii O, 2002, PUBLIC HEALTH, V116, P68, DOI [10.1016/S0033-3506(02)00506-1, 10.1038/sj.ph.1900828]; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Levy D, 2001, EPIDEMIOLOGY, V12, P186, DOI 10.1097/00001648-200103000-00010; Li XL, 2007, T ROY SOC TROP MED H, V101, P299, DOI 10.1016/j.trstmh.2006.05.011; Milojevic A, 2012, EPIDEMIOLOGY, V23, P107, DOI 10.1097/EDE.0b013e31823ac606; Pruss-Ustun A, 2003, ENV BURDEN DIS SERIE, V1; Reacher M, 2004, COMMUN DIS PUBLIC HL, V7, P717; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Schnitzler J, 2007, J PUBLIC HEALTH MAN, V13, P461; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067; SHEARS P, 1988, LANCET, V2, P517, DOI 10.1016/S0140-6736(88)90173-0; SIDDIQUE AK, 1991, J DIARRHOEAL DIS RES, V9, P310; Su C.-L, 2006, BETABUSTER; Sur D, 2000, INDIAN J MED RES, V112, P178; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4; Wade TJ, 2004, AM J EPIDEMIOL, V159, P398, DOI 10.1093/aje/kwh050; Wang JN, 2008, STAT YB ANHUI PROVIN; Waring S, 2005, INT J HYG ENVIR HEAL, V208, P109, DOI 10.1016/j.ijheh.2005.01.020; *WHO, 2004, CHANG HIST; Zhang Y, 2007, J INFECTION, V55, P194, DOI 10.1016/j.jinf.2006.12.002; Zhao ZL, 2007, ANHUI J PREV MED, V13, P15	38	57	61	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65112	10.1371/journal.pone.0065112	http://dx.doi.org/10.1371/journal.pone.0065112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762291	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000032
J	Knapp, B; Dorffner, G; Schreiner, W				Knapp, Bernhard; Dorffner, Georg; Schreiner, Wolfgang			Early Relaxation Dynamics in the LC 13 T Cell Receptor in Reaction to 172 Altered Peptide Ligands: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							CONFORMATIONAL-CHANGES; ANTIGEN RECOGNITION; BINDING-AFFINITY; STRUCTURAL BASIS; COMPLEX; PROTEIN; TCR; PREDICTION; MODEL; FLEXIBILITY	The interaction between the T cell receptor and the major histocompatibility complex is one of the most important events in adaptive immunology. Although several different models for the activation process of the T cell via the T cell receptor have been proposed, it could not be shown that a structural mechanism, which discriminates between peptides of different immunogenicity levels, exists within the T cell receptor. In this study, we performed systematic molecular dynamics simulations of 172 closely related altered peptide ligands in the same T cell receptor/major histocompatibility complex system. Statistical evaluations yielded significant differences in the initial relaxation process between sets of peptides at four different immunogenicity levels.	[Knapp, Bernhard; Schreiner, Wolfgang] Med Univ Vienna, Sect Biosimulat & Bioinformat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Knapp, Bernhard] Univ Oxford, Dept Stat, Prot Informat Grp, Oxford OX1 3TG, England; [Dorffner, Georg] Med Univ Vienna, Sect Artificial Intelligence, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; University of Oxford; Medical University of Vienna	Knapp, B (corresponding author), Med Univ Vienna, Sect Biosimulat & Bioinformat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria.	bernhard.knapp@meduniwien.ac.at	Dorffner, Georg/AAQ-1455-2020	Dorffner, Georg/0000-0002-3181-2576	Austrian Science Fund [FWF P22258-B12]; Austrian Science Fund (FWF) [P 22258] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I017909/1] Funding Source: researchfish; EPSRC [EP/I017909/1] Funding Source: UKRI	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was supported by the Austrian Science Fund (FWF P22258-B12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Burrows SR, 1997, EUR J IMMUNOL, V27, P178, DOI 10.1002/eji.1830270126; Camacho CJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000231; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; Cuendet MA, 2011, PROTEINS, V79, P3007, DOI 10.1002/prot.23104; De Rosa MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011550; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Frankild S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001831; Gregoire C, 1996, P NATL ACAD SCI USA, V93, P7184, DOI 10.1073/pnas.93.14.7184; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guy CS, 2009, IMMUNOL REV, V232, P7, DOI 10.1111/j.1600-065X.2009.00843.x; Haidar JN, 2009, PROTEINS, V74, P948, DOI 10.1002/prot.22203; Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1; Hemmer B, 1998, J IMMUNOL, V160, P3631; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2002, J IMMUNOL, V169, P5153, DOI 10.4049/jimmunol.169.9.5153; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Knapp B, 2008, PROTEIN SCI, V17, P977, DOI 10.1110/ps.073402508; Knapp B, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-43; Knapp B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011653; Knapp B, 2009, MOL IMMUNOL, V46, P1839, DOI 10.1016/j.molimm.2009.01.009; Knapp B, 2009, J COMPUT AID MOL DES, V23, P301, DOI 10.1007/s10822-009-9259-2; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; Ma ZY, 2010, TRENDS IMMUNOL, V31, P1, DOI 10.1016/j.it.2009.09.008; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Mazur AK, 1998, J PHYS CHEM B, V102, P473, DOI 10.1021/jp972381h; Mishra S, 2009, J BIOMOL STRUCT DYN, V27, P293, DOI 10.1080/07391102.2009.10507317; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Narzi D, 2012, J MOL BIOL, V415, P429, DOI 10.1016/j.jmb.2011.11.021; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; ROGNAN D, 1992, EUR J BIOCHEM, V208, P101, DOI 10.1111/j.1432-1033.1992.tb17163.x; Rognan D, 2000, J COMPUT AID MOL DES, V14, P53, DOI 10.1023/A:1008142830353; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schamel WWA, 2007, P NATL ACAD SCI USA, V104, P16398, DOI 10.1073/pnas.0708462104; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Stavrakoudis A, 2011, CELL BIOCHEM BIOPHYS, V60, P283, DOI 10.1007/s12013-011-9151-2; Tai K, 2001, BIOPHYS J, V81, P715, DOI 10.1016/S0006-3495(01)75736-0; Toh H, 2000, PROTEIN ENG, V13, P423, DOI 10.1093/protein/13.6.423; Tong JC, 2007, BRIEF BIOINFORM, V8, P96, DOI 10.1093/bib/bbl038; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; Tung CW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-446; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; Wan S, 2008, MOL IMMUNOL, V45, P1221, DOI 10.1016/j.molimm.2007.09.022; Wan SZ, 2005, J IMMUNOL, V175, P1715, DOI 10.4049/jimmunol.175.3.1715; Wan SZ, 2004, J COMPUT CHEM, V25, P1803, DOI 10.1002/jcc.20100; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	64	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64464	10.1371/journal.pone.0064464	http://dx.doi.org/10.1371/journal.pone.0064464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762240	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000008
J	Sleiman, D; Barraud, P; Brachet, F; Tisne, C				Sleiman, Dona; Barraud, Pierre; Brachet, Franck; Tisne, Carine			The Interaction between tRNA(3)(Lys) and the Primer Activation Signal Deciphered by NMR Spectroscopy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 REVERSE TRANSCRIPTION; BINDING-SITE COMPLEMENTARY; ACID-CHAPERONE ACTIVITY; TRANSFER-RNA PRIMER; NUCLEOCAPSID PROTEIN; INITIATION COMPLEX; EFFICIENT INITIATION; SECONDARY STRUCTURE; VIRAL-RNA	The initiation of reverse transcription of the human immunodeficiency virus type 1 (HIV-1) requires the opening of the three-dimensional structure of the primer tRNA(3)(Lys) for its annealing to the viral RNA at the primer binding site (PBS). Despite the fact that the result of this rearrangement is thermodynamically more stable, there is a high-energy barrier that requires the chaperoning activity of the viral nucleocapsid protein. In addition to the nucleotide complementarity to the PBS, several regions of tRNA(3)(Lys) have been described as interacting with the viral genomic RNA. Among these sequences, a sequence of the viral genome called PAS for "primer activation signal" was proposed to interact with the T-arm of tRNA(3)(Lys), this interaction stimulating the initiation of reverse transcription. In this report, we investigate the formation of this additional interaction with NMR spectroscopy, using a simple system composed of the primer tRNA(3)(Lys), the 18 nucleotides of the PBS, the PAS (8 nucleotides) encompassed or not in a hairpin structure, and the nucleocapsid protein. Our NMR study provides molecular evidence of the existence of this interaction and highlights the role of the nucleocapsid protein in promoting this additional RNA-RNA annealing. This study presents the first direct observation at a single base-pair resolution of the PAS/anti-PAS association, which has been proposed to be involved in the chronological regulation of the reverse transcription.	[Sleiman, Dona; Barraud, Pierre; Brachet, Franck; Tisne, Carine] Univ Paris 05, Paris Sorbonne Cite, CNRS, Lab Cristallog & RMN Biol, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Tisne, C (corresponding author), Univ Paris 05, Paris Sorbonne Cite, CNRS, Lab Cristallog & RMN Biol, Paris, France.	carine.tisne@parisdescartes.fr	Barraud, Pierre/AAT-9884-2020	Barraud, Pierre/0000-0003-4460-8360; Sleiman, Dona/0000-0002-4005-6514; Tisne, Carine/0000-0001-5534-4650	"Ministere de la Recherche"; French National Agency for Research on AIDS and Viral Hepatitis (ANRS)	"Ministere de la Recherche"(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, FranceSpanish Government); French National Agency for Research on AIDS and Viral Hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	D.S. was the recipient of a studentship from the "Ministere de la Recherche". This work was supported by grants from the French National Agency for Research on AIDS and Viral Hepatitis (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink TEM, 2004, J VIROL, V78, P10706, DOI 10.1128/jvi.78.19.10706-10714.2004; Abbink TEM, 2007, ADV PHARMACOL, V55, P99, DOI 10.1016/S1054-3589(07)55003-9; Abbink TEM, 2008, VIRUS RES, V134, P4, DOI 10.1016/j.virusres.2007.12.009; AIYAR A, 1992, J VIROL, V66, P2464, DOI 10.1128/JVI.66.4.2464-2472.1992; Azoulay J, 2003, J MOL BIOL, V326, P691, DOI 10.1016/S0022-2836(02)01430-4; BARAT C, 1989, EMBO J, V8, P3279, DOI 10.1002/j.1460-2075.1989.tb08488.x; Barraud P, 2007, BIOCHIMIE, V89, P1204, DOI 10.1016/j.biochi.2007.01.016; BAUDIN F, 1993, J MOL BIOL, V229, P382, DOI 10.1006/jmbi.1993.1041; Beerens N, 2002, J VIROL, V76, P2329, DOI 10.1128/JVI.76.5.2329-2339.2002; Beerens N, 2002, RNA, V8, P357, DOI 10.1017/S1355838202028194; Beerens N, 2001, J BIOL CHEM, V276, P31247, DOI 10.1074/jbc.M102441200; Beerens N, 2013, RNA; Beltz H, 2004, J MOL BIOL, V338, P711, DOI 10.1016/j.jmb.2004.03.019; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Cen S, 2000, J VIROL, V74, P10796, DOI 10.1128/JVI.74.22.10796-10800.2000; Cruceanu M, 2006, NUCLEIC ACIDS RES, V34, P593, DOI 10.1093/nar/gkj458; Cruceanu M, 2006, J MOL BIOL, V363, P867, DOI 10.1016/j.jmb.2006.08.070; Darlix J L, 2000, Adv Pharmacol, V48, P345; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Dupuy LC, 2003, J VIROL, V77, P8756, DOI 10.1128/JVI.77.16.8756-8764.2003; Freund F, 2001, NUCLEIC ACIDS RES, V29, P2757, DOI 10.1093/nar/29.13.2757; Goldschmidt V, 2004, J BIOL CHEM, V279, P35923, DOI 10.1074/jbc.M404473200; Goldschmidt V, 2003, NUCLEIC ACIDS RES, V31, P850, DOI 10.1093/nar/gkg187; Hargittai MRS, 2004, J MOL BIOL, V337, P951, DOI 10.1016/j.jmb.2004.01.054; Houzet L, 2008, NUCLEIC ACIDS RES, V36, P2311, DOI 10.1093/nar/gkn069; Isel C, 1998, NUCLEIC ACIDS RES, V26, P1198, DOI 10.1093/nar/26.5.1198; ISEL C, 1993, J BIOL CHEM, V268, P25269; Isel C, 1999, EMBO J, V18, P1038, DOI 10.1093/emboj/18.4.1038; ISEL C, 1995, J MOL BIOL, V247, P236, DOI 10.1006/jmbi.1994.0136; Iwatani Y, 2003, J BIOL CHEM, V278, P14185, DOI 10.1074/jbc.M211618200; Kang SM, 1999, VIROLOGY, V257, P95, DOI 10.1006/viro.1999.9615; Kang SM, 1997, J VIROL, V71, P207, DOI 10.1128/JVI.71.1.207-217.1997; Lee BM, 1998, J MOL BIOL, V279, P633, DOI 10.1006/jmbi.1998.1766; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; LI XG, 1994, J VIROL, V68, P6198, DOI 10.1128/JVI.68.10.6198-6206.1994; Liang C, 1997, J VIROL, V71, P5750, DOI 10.1128/JVI.71.8.5750-5757.1997; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MARQUET R, 1995, BIOCHIMIE, V77, P113, DOI 10.1016/0300-9084(96)88114-4; Miller JT, 2001, J BIOL CHEM, V276, P27721, DOI 10.1074/jbc.M100513200; Ooms M, 2007, NUCLEIC ACIDS RES, V35, P1649, DOI 10.1093/nar/gkm046; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Puglisi EV, 2011, J MOL BIOL, V410, P863, DOI 10.1016/j.jmb.2011.04.024; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Saadatmand J, 2009, VIROLOGY, V391, P334, DOI 10.1016/j.virol.2009.06.036; Sleiman D, 2012, VIRUS RES, V169, P324, DOI 10.1016/j.virusres.2012.06.006; Tisne C, 2000, RNA, V6, P1403, DOI 10.1017/S1355838200000947; Tisne C, 2005, CURR HIV RES, V3, P147, DOI 10.2174/1570162053506919; Tisne C, 2004, J BIOL CHEM, V279, P3588, DOI 10.1074/jbc.M310368200; Tisne C, 2001, J MOL BIOL, V306, P443, DOI 10.1006/jmbi.2000.4391; WAKEFIELD JK, 1995, J VIROL, V69, P6021, DOI 10.1128/JVI.69.10.6021-6029.1995; Wakefield JK, 1996, J VIROL, V70, P966, DOI 10.1128/JVI.70.2.966-975.1996; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Williams MC, 2001, P NATL ACAD SCI USA, V98, P6121, DOI 10.1073/pnas.101033198; Zhang ZJ, 1996, VIROLOGY, V226, P306, DOI 10.1006/viro.1996.0658	58	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64700	10.1371/journal.pone.0064700	http://dx.doi.org/10.1371/journal.pone.0064700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762248	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000016
J	Boesten, DMPHJ; Berger, A; de Cock, P; Dong, H; Hammock, BD; den Hartog, GJM; Bast, A				Boesten, Danielle M. P. H. J.; Berger, Alvin; de Cock, Peter; Dong, Hua; Hammock, Bruce D.; den Hartog, Gertjan J. M.; Bast, Aalt			Multi-Targeted Mechanisms Underlying the Endothelial Protective Effects of the Diabetic-Safe Sweetener Erythritol	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MITOCHONDRIAL SUPEROXIDE-PRODUCTION; HIGH GLUCOSE; OXIDATIVE STRESS; TRANSCRIPTIONAL ACTIVATION; GENECHIP DATA; PROBE LEVEL; RAT AORTA; CELLS; DYSFUNCTION	Diabetes is characterized by hyperglycemia and development of vascular pathology. Endothelial cell dysfunction is a starting point for pathogenesis of vascular complications in diabetes. We previously showed the polyol erythritol to be a hydroxyl radical scavenger preventing endothelial cell dysfunction onset in diabetic rats. To unravel mechanisms, other than scavenging of radicals, by which erythritol mediates this protective effect, we evaluated effects of erythritol in endothelial cells exposed to normal (7 mM) and high glucose (30 mM) or diabetic stressors (e.g. SIN-1) using targeted and transcriptomic approaches. This study demonstrates that erythritol (i.e. under non-diabetic conditions) has minimal effects on endothelial cells. However, under hyperglycemic conditions erythritol protected endothelial cells against cell death induced by diabetic stressors (i.e. high glucose and peroxynitrite). Also a number of harmful effects caused by high glucose, e.g. increased nitric oxide release, are reversed. Additionally, total transcriptome analysis indicated that biological processes which are differentially regulated due to high glucose are corrected by erythritol. We conclude that erythritol protects endothelial cells during high glucose conditions via effects on multiple targets. Overall, these data indicate a therapeutically important endothelial protective effect of erythritol under hyperglycemic conditions.	[Boesten, Danielle M. P. H. J.; den Hartog, Gertjan J. M.; Bast, Aalt] Maastricht Univ, Dept Toxicol, Maastricht, Netherlands; [Berger, Alvin] Cargill, Global Food Res, Wayzata, MN USA; [de Cock, Peter] Cargill RandD Ctr Europe, Vilvoorde, Belgium; [Dong, Hua; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Dong, Hua; Hammock, Bruce D.] Univ Calif Davis, UCD Comprehens Canc Ctr, Davis, CA 95616 USA	Maastricht University; Cargill; Cargill; University of California System; University of California Davis; University of California System; University of California Davis	Boesten, DMPHJ (corresponding author), Maastricht Univ, Dept Toxicol, Maastricht, Netherlands.	danielle.boesten@maastrichtuniversity.nl	Berger, Alvin/AAE-5353-2022; Bast, Aalt/I-7809-2013	Bast, Aalt/0000-0002-5383-2789; de Cock, Peter/0000-0002-7367-7560	Cargill; Alvin Berger and Peter de Cock	Cargill; Alvin Berger and Peter de Cock	This research was financially supported by Cargill (http://www.cargill.com/). The funders were helpful in the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish.; Research was financially supported by Cargill, the employer of Alvin Berger and Peter de Cock. Erythritol was provided by Cargill. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bernt WO, 1996, REGUL TOXICOL PHARM, V24, pS191, DOI 10.1006/rtph.1996.0098; Bhasin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-342; Bolstad B, 2005, BIOINFORMATICS COMPU; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Ceriello A, 2003, DIABETES CARE, V26, P1589, DOI 10.2337/diacare.26.5.1589; Chakrabarti S, 2012, AM J PHYSIOL-CELL PH, V302, pC666, DOI 10.1152/ajpcell.00181.2011; Channon KM, 2002, J PHYSIOL PHARMACOL, V53, P515; Chen JQ, 1999, TOXICOL SCI, V51, P224, DOI 10.1093/toxsci/51.2.224; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; den Hartog GJM, 2010, NUTRITION, V26, P449, DOI 10.1016/j.nut.2009.05.004; den Hartog GJM, 2003, TOXICOL IN VITRO, V17, P165, DOI 10.1016/S0887-2333(03)00007-9; Ding H, 2007, J CELL PHYSIOL, V212, P682, DOI 10.1002/jcp.21063; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FURCHGOTT RF, 1991, BLOOD VESSELS, V28, P52; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grieve DJ, 1998, EUR J PHARMACOL, V348, P181, DOI 10.1016/S0014-2999(98)00142-3; Hedrick CC, 1999, ADV EXP MED BIOL, V469, P455; Hippeli S, 1997, Z NATURFORSCH C, V52, P564; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kageyama S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-73; Koshimura K, 2002, NEUROSCI RES, V43, P31, DOI 10.1016/S0168-0102(02)00016-0; Li JM, 2011, J BIOL CHEM, V286, P4912, DOI 10.1074/jbc.M110.199729; Liu JY, 2010, P NATL ACAD SCI USA, V107, P17017, DOI 10.1073/pnas.1011278107; Lundstrom SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033780; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moran JH, 2001, TOXICOL APPL PHARM, V172, P150, DOI 10.1006/taap.2001.9149; Munro IC, 1998, FOOD CHEM TOXICOL, V36, P1139, DOI 10.1016/S0278-6915(98)00091-X; Nanda N, 2005, J BIOL CHEM, V280, P24680, DOI 10.1074/jbc.M413411200; Natarajan R, 2002, DIABETOLOGIA, V45, P125, DOI 10.1007/s125-002-8253-x; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; NODA K, 1994, EUR J CLIN NUTR, V48, P286; Oguro A, 2009, DRUG METAB PHARMACOK, V24, P438, DOI 10.2133/dmpk.24.438; Pakala R, 1999, ATHEROSCLEROSIS, V147, P25, DOI 10.1016/S0021-9150(99)00144-6; Pandolfi A, 2010, CARDIOVASC RES, V86, P9, DOI 10.1093/cvr/cvq055; Paquay JBG, 1999, BRIT J PHARMACOL, V127, P331, DOI 10.1038/sj.bjp.0702552; Pendurthi UR, 1997, ARTERIOSCL THROM VAS, V17, P940, DOI 10.1161/01.ATV.17.5.940; Pratico D, 2005, ATHEROSCLEROSIS, V181, P215, DOI 10.1016/j.atherosclerosis.2005.03.005; Ramasamy R, 2005, TRENDS CARDIOVAS MED, V15, P237, DOI 10.1016/j.tcm.2005.08.003; Rathel Thomas R., 2003, Biol Proced Online, V5, P136, DOI 10.1251/bpo55; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Seol GH, 2004, AM J PHYSIOL-HEART C, V286, pH329, DOI 10.1152/ajpheart.00503.2003; Simionescu N, 1988, ENDOTHELIAL CELL BIO, P385; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; TANG DG, 1995, J CELL SCI, V108, P2629; *TEAM RDC, 2003, R LANG ENV STAT COMP; Tsuneki H, 2007, EUR J PHARMACOL, V566, P1, DOI 10.1016/j.ejphar.2007.03.006; Ulker S, 2003, HYPERTENSION, V41, P534, DOI 10.1161/01.HYP.0000057421.28533.37; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Wadham C, 2007, DIABETES, V56, P2715, DOI 10.2337/db06-1294; Wattanapitayakul SK, 2001, PHARMACOL THERAPEUT, V89, P187, DOI 10.1016/S0163-7258(00)00114-5; Weseler AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028460; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Yokozawa T, 2002, J AGR FOOD CHEM, V50, P5485, DOI 10.1021/jf020168z; Zou MH, 2002, DIABETES, V51, P198, DOI 10.2337/diabetes.51.1.198	59	11	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65741	10.1371/journal.pone.0065741	http://dx.doi.org/10.1371/journal.pone.0065741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755276	Green Submitted, Green Published, gold			2022-12-25	WOS:000320579400076
J	Bognar, E; Sarszegi, Z; Szabo, A; Debreceni, B; Kalman, N; Tucsek, Z; Sumegi, B; Gallyas, F				Bognar, Eszter; Sarszegi, Zsolt; Szabo, Aliz; Debreceni, Balazs; Kalman, Nikoletta; Tucsek, Zsuzsanna; Sumegi, Balazs; Gallyas, Ferenc, Jr.			Antioxidant and Anti-Inflammatory Effects in RAW264.7 Macrophages of Malvidin, a Major Red Wine Polyphenol	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; EPITHELIAL-CELL LINES; RAW 264.7 MACROPHAGES; TOLL-LIKE RECEPTORS; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; IKK-BETA; CYCLOOXYGENASE-2 EXPRESSION; POLYMERASE-1 INHIBITOR	Background: Red wine polyphenols can prevent cardiovascular and inflammatory diseases. Resveratrol, the most extensively studied constituent, is unlikely to solely account for these beneficial effects because of its rather low abundance and bioavailability. Malvidin is far the most abundant polyphenol in red wine; however, very limited data are available about its effect on inflammatory processes and kinase signaling pathways. Methods & Findings: The present study was carried out by using RAW 264.7 macrophages stimulated by bacterial lipopolysaccharide in the presence and absence of malvidin. From the cells, activation of nuclear factor-kappaB, mitogen-activated protein kinase, protein kinase B/Akt and poly ADP-ribose polymerase, reactive oxygen species production, mitogen-activated protein kinase phosphatase-1 expression and mitochondrial depolarization were determined. We found that malvidin attenuated lipopolysaccharide-induced nuclear factor-kappaB, poly ADP-ribose polymerase and mitogen-activated protein kinase activation, reactive oxygen species production and mitochondrial depolarization, while upregulated the compensatory processes; mitogen-activated protein kinase phosphatase-1 expression and Akt activation. Conclusions: These effects of malvidin may explain the previous findings and at least partially account for the positive effects of moderate red wine consumption on inflammation-mediated chronic maladies such as obesity, diabetes, hypertension and cardiovascular disease.	[Bognar, Eszter; Szabo, Aliz; Debreceni, Balazs; Kalman, Nikoletta; Tucsek, Zsuzsanna; Sumegi, Balazs; Gallyas, Ferenc, Jr.] Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Hungary; [Sarszegi, Zsolt] Univ Pecs, Sch Med, Inst Heart, Pecs, Hungary; [Bognar, Eszter; Sumegi, Balazs; Gallyas, Ferenc, Jr.] Hungarian Acad Sci, Nuclear Mitochondrial Interact Res Grp, Budapest, Hungary; [Szabo, Aliz; Kalman, Nikoletta; Sumegi, Balazs; Gallyas, Ferenc, Jr.] Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs; Hungarian Academy of Sciences	Gallyas, F (corresponding author), Univ Pecs, Sch Med, Dept Biochem & Med Chem, Pecs, Hungary.	ferenc.gallyas@aok.pte.hu	Gallyas, Ferenc/AAY-5343-2020; Gallyas, Ferenc/C-2272-2012; Sarszegi, Zsolt/AAU-9051-2021	Gallyas, Ferenc/0000-0002-1906-4333	 [SROP-4.2.1.B-10/2/KONV-2010-0002];  [SROP-4.2.2/B-10/1-2010-0029];  [OTKA K73738];  [34039/KA-OTKA/11-06]	; ; ; 	This work was supported by Hungarian grants SROP-4.2.1.B-10/2/KONV-2010-0002, SROP-4.2.2/B-10/1-2010-0029, OTKA K73738 and 34039/KA-OTKA/11-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Chen CC, 1999, MOL PHARMACOL, V55, P481; Chun OK, 2008, J NUTR, V138, P753; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Gescher AJ, 2003, CANCER EPIDEM BIOMAR, V12, P953; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Hou DX, 2010, J AGR FOOD CHEM, V58, P12735, DOI 10.1021/jf103605j; Hou DX, 2005, BIOCHEM PHARMACOL, V70, P417, DOI 10.1016/j.bcp.2005.05.003; Joung SM, 2011, J IMMUNOL, V186, P499, DOI 10.4049/jimmunol.0903534; Kim HJ, 2006, TOXICOLOGY, V225, P36, DOI 10.1016/j.tox.2006.04.053; Kim HK, 1999, BIOCHEM PHARMACOL, V58, P759, DOI 10.1016/S0006-2952(99)00160-4; Kroon PA, 2010, CURR MED CHEM, V17, P2442; Lee HS, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-23; Li DY, 2012, CELL PHYSIOL BIOCHEM, V29, P9, DOI 10.1159/000337581; Liu Ling, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P89, DOI 10.2174/187153008784534385; Lorne E, 2010, INTENS CARE MED, V36, P1826, DOI 10.1007/s00134-010-1983-5; Lu Y, 2012, J CELL BIOCHEM, V113, P1022, DOI 10.1002/jcb.23434; Manukyan MC, 2010, SHOCK, V34, P442, DOI 10.1097/SHK.0b013e3181e14ea9; Marko D, 2004, MOL NUTR FOOD RES, V48, P318, DOI 10.1002/mnfr.200400034; Matern U., 1993, POLYPHENOLIC PHENOME, P143; Miyamoto S, 2009, J BIOENERG BIOMEMBR, V41, P169, DOI 10.1007/s10863-009-9205-y; Nikfardjam MSP, 2006, FOOD CHEM, V98, P453, DOI 10.1016/j.foodchem.2005.06.014; Palfi A, 2009, J NUTR BIOCHEM, V20, P418, DOI 10.1016/j.jnutbio.2008.04.009; Poulose SM, 2012, J AGR FOOD CHEM, V60, P1084, DOI 10.1021/jf203989k; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Quintieri AM, 2012, J NUTR BIOC IN PRESS; Racz B, 2010, FREE RADICAL BIO MED, V49, P1978, DOI 10.1016/j.freeradbiomed.2010.09.026; Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Soleas GJ, 1997, J CLIN LAB ANAL, V11, P287, DOI 10.1002/(SICI)1098-2825(1997)11:5<287::AID-JCLA6>3.0.CO;2-4; Sun AY, 2002, FREE RADICAL BIO MED, V32, P314, DOI 10.1016/S0891-5849(01)00803-6; Sun BS, 2009, J AGR FOOD CHEM, V57, P8623, DOI 10.1021/jf901610h; Tang CH, 2007, J CELL PHYSIOL, V211, P45, DOI 10.1002/jcp.20896; Udenigwe CC, 2008, NUTR REV, V66, P445, DOI 10.1111/j.1753-4887.2008.00076.x; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Veres B, 2003, BIOCHEM PHARMACOL, V65, P1373, DOI 10.1016/S0006-2952(03)00077-7; Veres B, 2004, J PHARMACOL EXP THER, V310, P247, DOI 10.1124/jpet.104.065151; Virag L, 2001, FASEB J, V15, P99, DOI 10.1096/fj.00-0299com; Virgili F, 1998, FREE RADICAL BIO MED, V24, P1120, DOI 10.1016/S0891-5849(97)00430-9; Visioli F, 2011, MINI-REV MED CHEM, V11, P1186; Wang J, 2002, J AGR FOOD CHEM, V50, P4183, DOI 10.1021/jf011613d; Wu GS, 2007, CANCER METAST REV, V26, P579, DOI 10.1007/s10555-007-9079-6; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yeh CT, 2005, J AGR FOOD CHEM, V53, P1740, DOI 10.1021/jf048955e; Yi WG, 2005, J AGR FOOD CHEM, V53, P8804, DOI 10.1021/jf0515328; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044956; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	51	105	109	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65355	10.1371/journal.pone.0065355	http://dx.doi.org/10.1371/journal.pone.0065355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755222	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000320579400054
J	McDonald, RI; Girvetz, EH				McDonald, Robert I.; Girvetz, Evan H.			Two Challenges for U. S. Irrigation Due to Climate Change: Increasing Irrigated Area in Wet States and Increasing Irrigation Rates in Dry States	PLOS ONE			English	Article							CHANGE IMPACTS; INTEGRATED ASSESSMENT; WATER AVAILABILITY; FOOD SECURITY; RIVER-BASINS; ELEVATED CO2; AGRICULTURE; DEMAND; CROP; EVAPOTRANSPIRATION	Agricultural irrigation practices will likely be affected by climate change. In this paper, we use a statistical model relating observed water use by U. S. producers to the moisture deficit, and then use this statistical model to project climate changes impact on both the fraction of agricultural land irrigated and the irrigation rate (m(3)ha(-1)). Data on water withdrawals for US states (1985-2005) show that both quantities are highly positively correlated with moisture deficit (precipitation - PET). If current trends hold, climate change would increase agricultural demand for irrigation in 2090 by 4.5-21.9 million ha (B1 scenario demand: 4.5-8.7 million ha, A2 scenario demand: 9.1-21.9 million ha). Much of this new irrigated area would occur in states that currently have a wet climate and a small fraction of their agricultural land currently irrigated, posing a challenge to policymakers in states with less experience with strict regulation of agriculture water use. Moreover, most of this expansion will occur in states where current agricultural production has relatively low market value per hectare, which may make installation of irrigation uneconomical without significant changes in crops or practices by producers. Without significant increases in irrigation efficiency, climate change would also increase the average irrigation rate from 7,963 to 8,400-10,415 m(3)ha(-1) (B1 rate: 8,400-9,145 m(3)ha(-1), A2 rate: 9,380-10,415 m(3)ha(-1)). The irrigation rate will increase the most in states that already have dry climates and large irrigation rates, posing a challenge for water supply systems in these states. Accounting for both the increase in irrigated area and irrigation rate, total withdrawals might increase by 47.7-283.4 billion m(3) (B1 withdrawal: 47.7-106.0 billion m(3), A2 withdrawal: 117.4-283.4 billion m(3)). Increases in irrigation water-use efficiency, particularly by reducing the prevalence of surface irrigation, could eliminate the increase in total irrigation withdrawals in many states.	[McDonald, Robert I.] Nature Conservancy, Cent Sci Program, Arlington, VA USA; [Girvetz, Evan H.] Nature Conservancy, Global Climate Change Program, Seattle, WA USA	Nature Conservancy; Nature Conservancy	McDonald, RI (corresponding author), Nature Conservancy, Cent Sci Program, 1815 N Lynn St, Arlington, VA USA.	rob_mcdonald@tnc.org		McDonald, Robert/0000-0002-7273-6549	Nature Conservancy	Nature Conservancy	The authors are supported by The Nature Conservancy and its members. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2007, HYDROLOG SCI J, V52, P247, DOI 10.1623/hysj.52.2.247; Connor J, 2009, AUST J AGR RESOUR EC, V53, P437, DOI 10.1111/j.1467-8489.2009.00460.x; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Easterling WE, 1996, AGR FOREST METEOROL, V80, P1, DOI 10.1016/0168-1923(95)02315-1; Elbakidze L, 2006, J AM WATER RESOUR AS, V42, P841, DOI 10.1111/j.1752-1688.2006.tb04498.x; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Fischer G, 2007, TECHNOL FORECAST SOC, V74, P1083, DOI 10.1016/j.techfore.2006.05.021; Girvetz EH, 2009, PLOS ONE, V4; Hellegers PJGJ, 2006, INT J WATER RESOUR D, V22, P79, DOI 10.1080/07900620500405643; Hooker MA, 1998, J AM WATER RESOUR AS, V34, P497, DOI 10.1111/j.1752-1688.1998.tb00949.x; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Huang JG, 2007, CRIT REV PLANT SCI, V26, P265, DOI 10.1080/07352680701626978; Hunsaker DJ, 2000, AGR FOREST METEOROL, V104, P85, DOI 10.1016/S0168-1923(00)00157-X; IPCC (Intergovernmental Panel on Climate Change), 2000, SPECIAL REPORT EMISS; Kenny J.F., 2009, ESTIMATED USE WATER; Kingston DG, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040267; Lu JB, 2005, J AM WATER RESOUR AS, V41, P621, DOI 10.1111/j.1752-1688.2005.tb03759.x; Luedeling E, 2011, GLOBAL CHANGE BIOL, V17, P228, DOI 10.1111/j.1365-2486.2010.02227.x; Manderscheid R, 2007, AGRON SUSTAIN DEV, V27, P79, DOI 10.1051/agro:2006035; Medlyn BE, 2001, NEW PHYTOL, V149, P247, DOI 10.1046/j.1469-8137.2001.00028.x; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Moore BD, 1999, PLANT CELL ENVIRON, V22, P567, DOI 10.1046/j.1365-3040.1999.00432.x; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Palmer MA, 2008, FRONT ECOL ENVIRON, V6, P81, DOI 10.1890/060148; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Rosegrant MW, 2009, ANNU REV ENV RESOUR, V34, P205, DOI 10.1146/annurev.environ.030308.090351; Rosenzweig C, 2004, GLOBAL ENVIRON CHANG, V14, P345, DOI 10.1016/j.gloenvcha.2004.09.003; Savenije HHG, 2002, WATER INT, V27, P98, DOI 10.1080/02508060208686982; Schlenker W, 2005, AM ECON REV, V95, P395, DOI 10.1257/0002828053828455; Schlenker W, 2007, CLIMATIC CHANGE, V81, P19, DOI 10.1007/s10584-005-9008-z; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sun G, 2008, J AM WATER RESOUR AS, V44, P1441, DOI 10.1111/j.1752-1688.2008.00250.x; Tardieu H, 2002, IRRIG DRAIN, V51, P97, DOI 10.1002/ird.44; Taylor RG, 2013, NAT CLIM CHANGE, V3, P322, DOI [10.1038/nclimate1744, 10.1038/NCLIMATE1744]; Thomson AM, 2005, CLIMATIC CHANGE, V69, P89, DOI 10.1007/s10584-005-3611-x; Tubiello FN, 2007, P NATL ACAD SCI USA, V104, P19686, DOI 10.1073/pnas.0701728104; Tubiello FN, 2007, TECHNOL FORECAST SOC, V74, P1030, DOI 10.1016/j.techfore.2006.05.027; USDA, 2008, FARM RANCH IRR SURV; USDA, 2009, US CENS AGR 2007; Vorosmarty CJ, 1998, J HYDROL, V207, P147, DOI 10.1016/S0022-1694(98)00109-7; Wullschleger SD, 2002, PLANT CELL ENVIRON, V25, P319, DOI 10.1046/j.1365-3040.2002.00796.x	44	45	45	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65589	10.1371/journal.pone.0065589	http://dx.doi.org/10.1371/journal.pone.0065589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755255	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400069
J	Patke, S; Srinivasan, S; Maheshwari, R; Srivastava, SK; Aguilera, JJ; Colon, W; Kane, RS				Patke, Sanket; Srinivasan, Saipraveen; Maheshwari, Ronak; Srivastava, Sunit K.; Aguilera, J. Javier; Colon, Wilfredo; Kane, Ravi S.			Characterization of the Oligomerization and Aggregation of Human Serum Amyloid A	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ACUTE-PHASE PROTEIN; AMINO-ACID-SEQUENCE; FIBRIL FORMATION; A-PROTEIN; PHYSIOLOGICAL TEMPERATURE; MARGINAL STABILITY; SOLUBLE OLIGOMERS; SAA; DISEASE	The fibrillation of Serum Amyloid A (SAA) - a major acute phase protein - is believed to play a role in the disease Amyloid A (AA) Amyloidosis. To better understand the amyloid formation pathway of SAA, we characterized the oligomerization, misfolding, and aggregation of a disease-associated isoform of human SAA - human SAA1.1 (hSAA1.1) - using techniques ranging from circular dichroism spectroscopy to atomic force microscopy, fluorescence spectroscopy, immunoblot studies, solubility measurements, and seeding experiments. We found that hSAA1.1 formed alpha helix-rich, marginally stable oligomers in vitro on refolding and cross-beta-rich aggregates following incubation at 37 degrees C. Strikingly, while hSAA1.1 was not highly amyloidogenic in vitro, the addition of a single N-terminal methionine residue significantly enhanced the fibrillation propensity of hSAA1.1 and modulated its fibrillation pathway. A deeper understanding of the oligomerization and fibrillation pathway of hSAA1.1 may help elucidate its pathological role.	[Patke, Sanket; Kane, Ravi S.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA; [Patke, Sanket; Srinivasan, Saipraveen; Maheshwari, Ronak; Srivastava, Sunit K.; Aguilera, J. Javier; Colon, Wilfredo; Kane, Ravi S.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12181 USA; [Aguilera, J. Javier; Colon, Wilfredo] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Colon, W (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12181 USA.	colonw@rpi.edu; kaner@rpi.edu	Colon, Wilfredo/A-8343-2012		National Institutes of Health [R01 AG028158]; P.K. Lashmet Chair Fund; NATIONAL INSTITUTE ON AGING [R01AG028158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P.K. Lashmet Chair Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors acknowledge support from National Institutes of Health grant R01 AG028158 to W.C. and from the P.K. Lashmet Chair Fund to R.S.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; BANKA CL, 1995, J LIPID RES, V36, P1058; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Cai H, 2007, J IMMUNOL, V178, P1852, DOI 10.4049/jimmunol.178.3.1852; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Digambaranath JL, 2010, BIOPOLYMERS, V93, P299, DOI 10.1002/bip.21324; ERIKSEN N, 1980, P NATL ACAD SCI-BIOL, V77, P6860, DOI 10.1073/pnas.77.11.6860; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; He RL, 2009, BLOOD, V113, P429, DOI 10.1182/blood-2008-03-139923; Hirakura Y, 2002, AMYLOID, V9, P13, DOI 10.3109/13506120209072440; Hosoai H, 1999, J LIPID RES, V40, P648; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kinkley SM, 2006, AMYLOID, V13, P123, DOI 10.1080/13506120600877201; Kisilevsky R, 2002, PEDIATR PATHOL MOL M, V21, P291, DOI 10.1080/02770930290056523; KISILEVSKY R, 1992, LAB INVEST, V66, P778; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Klunk WE, 1999, ANAL BIOCHEM, V266, P66, DOI 10.1006/abio.1998.2933; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LIEPNIEKS JJ, 1995, BBA-MOL BASIS DIS, V1270, P81, DOI 10.1016/0925-4439(94)00076-3; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; Noborn F, 2012, J BIOL CHEM, V287, P25669, DOI 10.1074/jbc.M112.363895; PARMELEE DC, 1982, BIOCHEMISTRY-US, V21, P3298, DOI 10.1021/bi00257a008; Patel H, 1996, BIOCHEM J, V318, P1041, DOI 10.1042/bj3181041; Patke S, 2012, BIOCHEMISTRY-US, V51, P3092, DOI 10.1021/bi201903s; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rocken C, 2002, VIRCHOWS ARCH, V440, P111, DOI 10.1007/s00428-001-0582-9; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; SLETTEN K, 1976, BIOCHEM BIOPH RES CO, V69, P19, DOI 10.1016/S0006-291X(76)80266-5; Srinivasan R, 2003, J MOL BIOL, V333, P1003, DOI 10.1016/j.jmb.2003.09.001; Srinivasan S, 2013, J BIOL CHEM, V288, P2744, DOI 10.1074/jbc.M112.394155; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; TAPE C, 1988, SCAND J IMMUNOL, V28, P317, DOI 10.1111/j.1365-3083.1988.tb01455.x; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Wang LM, 2007, BIOCHEMISTRY-US, V46, P5562, DOI 10.1021/bi602629y; Wang LM, 2005, AMYLOID, V12, P139, DOI 10.1080/13506120500223084; Wang LM, 2005, PROTEIN SCI, V14, P1811, DOI 10.1110/ps.051387005; Wang LM, 2002, P NATL ACAD SCI USA, V99, P15947, DOI 10.1073/pnas.252508399; Wang Y, 2011, BIOCHEM BIOPH RES CO, V407, P725, DOI 10.1016/j.bbrc.2011.03.090; WESTERMARK GT, 1992, BIOCHEM BIOPH RES CO, V182, P27, DOI 10.1016/S0006-291X(05)80107-X; YAMADA T, 1994, BBA-MOL BASIS DIS, V1226, P323, DOI 10.1016/0925-4439(94)90044-2; Ye ZQ, 2011, BIOCHEMISTRY-US, V50, P9184, DOI 10.1021/bi200856v	48	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64974	10.1371/journal.pone.0064974	http://dx.doi.org/10.1371/journal.pone.0064974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750222	gold, Green Published, Green Submitted			2022-12-25	WOS:000319961900024
J	Rovini, A; Gauthier, G; Berges, R; Kruczynski, A; Braguer, D; Honore, S				Rovini, Amandine; Gauthier, Geraldine; Berges, Raphael; Kruczynski, Anna; Braguer, Diane; Honore, Stephane			Anti-Migratory Effect of Vinflunine in Endothelial and Glioblastoma Cells Is Associated with Changes in EB1 C-Terminal Detyrosinated/Tyrosinated Status	PLOS ONE			English	Article							PLUS-END TRACKING; CAP-GLY DOMAIN; ALPHA-TUBULIN; MICROTUBULE DYNAMICS; POSTTRANSLATIONAL NITROTYROSINATION; BINDING-PROTEINS; NITRIC-OXIDE; SUPPRESSION; INHIBITION; ARREST	We previously showed that vinflunine, a microtubule-targeting drug of the Vinca-alkaloid family exerted its anti-angiogenic/anti-migratory activities through an increase in microtubule dynamics and an inhibition of microtubule targeting to adhesion sites. Such effect was associated with a reduction of EB1 comet length at microtubule (+) ends. In this work we first showed that the pro-angiogenic vascular endothelial growth factor VEGF suppressed microtubule dynamics in living Human Umbilical Vein Endothelial Cells (HUVECs), increased EB1 comet length by 40%, and induced EB1 to bind all along the microtubules, without modifying its expression level. Such microtubule (+) end stabilization occurred close to the plasma membrane in the vicinity of focal adhesion as shown by TIRF microscopy experiments. Vinflunine completely abolished the effect of VEGF on EB1 comets. Interestingly, we found a correlation between the reduction of EB1 comet length by vinflunine and the inhibition of cell migration. By using 2D gel electrophoresis we demonstrated for the first time that EB1 underwent several post-translational modifications in endothelial and tumor cells. Particularly, the C-terminal EEY sequence was poorly detectable in control and VEGF-treated HUVECs suggesting the existence of a non-tyrosinated form of EB1. By using specific antibodies that specifically recognized and discriminated the native tyrosinated form of EB1 and a putative C-terminal detyrosinated form, we showed that a detyrosinated form of EB1 exists in HUVECs and tumor cells. Interestingly, vinflunine decreased the level of the detyrosinated form and increased the native tyrosinated form of EB1. Using 3-L-Nitrotyrosine incorporation experiments, we concluded that the EB1 C-terminal modifications result from a detyrosination/retyrosination cycle as described for tubulin. Altogether, our results show that vinflunine inhibits endothelial cell migration through an alteration of EB1 comet length and EB1 detyrosination/retyrosination cycle.	[Rovini, Amandine; Gauthier, Geraldine; Berges, Raphael; Braguer, Diane; Honore, Stephane] Aix Marseille Univ, INSERM, UMR S 911, Marseille, France; [Gauthier, Geraldine; Braguer, Diane; Honore, Stephane] Hop Enfants La Timone, APHM, Marseille, France; [Kruczynski, Anna] Inst Rech Pierre Fabre, Ctr Rech Oncol Expt, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Honore, S (corresponding author), Aix Marseille Univ, INSERM, UMR S 911, Marseille, France.	stephane.honore@univ-amu.fr	rovini, amandine/W-1703-2019	Rovini, Amandine/0000-0003-0483-9092	INCa; Inserm; DGOS (SIRIC label) INCa-DGOS-Inserm [6038]; ARC foundation (Association pour la Recherche contre le Cancer) fellowship	INCa(Institut National du Cancer (INCA) France); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); DGOS (SIRIC label) INCa-DGOS-Inserm; ARC foundation (Association pour la Recherche contre le Cancer) fellowship	The authors acknowledge the financial support of INCa, Inserm and DGOS (SIRIC label) INCa-DGOS-Inserm 6038. AR received an ARC foundation (Association pour la Recherche contre le Cancer) fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Behrens J, 2012, J BIOL CHEM; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Bisig CG, 2002, EUR J BIOCHEM, V269, P5037, DOI 10.1046/j.1432-1033.2002.03220.x; Bosson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033490; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Calligaris D, 2012, J PROTEOMICS, V75, P3605, DOI 10.1016/j.jprot.2012.04.006; Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Eiserich JP, 1999, P NATL ACAD SCI USA, V96, P6365, DOI 10.1073/pnas.96.11.6365; ERSFELD K, 1993, J CELL BIOL, V120, P725, DOI 10.1083/jcb.120.3.725; Etienne-Manneville S, 2010, CURR OPIN CELL BIOL, V22, P104, DOI 10.1016/j.ceb.2009.11.008; GOTLIEB AI, 1983, J CELL BIOL, V96, P1266, DOI 10.1083/jcb.96.5.1266; Gouveia SM, 2010, INT REV CEL MOL BIO, V285, P1, DOI 10.1016/S1937-6448(10)85001-4; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Honore S, 2004, CANCER RES, V64, P4957, DOI 10.1158/0008-5472.CAN-04-0693; Honore S, 2003, MOL CANCER THER, V2, P1303; Honore S, 2008, MOL CANCER THER, V7, P2080, DOI 10.1158/1535-7163.MCT-08-0156; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kalisz HM, 2000, BBA-PROTEIN STRUCT M, V1481, P131, DOI 10.1016/S0167-4838(00)00110-2; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Mialhe A, 2001, CANCER RES, V61, P5024; Murtagh J, 2006, CANCER RES, V66, P8192, DOI 10.1158/0008-5472.CAN-06-0748; Pagano A, 2012, BIOCHEM PHARMACOL, V84, P432, DOI 10.1016/j.bcp.2012.05.010; Pasquier E, 2005, CANCER RES, V65, P2433, DOI 10.1158/0008-5472.CAN-04-2624; Pasquier E, 2006, DRUG RESIST UPDATE, V9, P74, DOI 10.1016/j.drup.2006.04.003; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Phung AD, 2006, EUR J CELL BIOL, V85, P1241, DOI 10.1016/j.ejcb.2006.05.016; Pourroy B, 2006, CANCER RES, V66, P3256, DOI 10.1158/0008-5472.CAN-05-3885; Pourroy B, 2004, MOL PHARMACOL, V66, P580; Rovini A, 2010, BIOCHEM PHARMACOL, V80, P884, DOI 10.1016/j.bcp.2010.04.018; Sahab ZJ, 2011, CANCER RES, V71, P1219, DOI 10.1158/0008-5472.CAN-10-2294; Schober JM, 2009, CANCER LETT, V284, P30, DOI 10.1016/j.canlet.2009.04.007; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Scolz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051259; Skube SB, 2010, CYTOSKELETON, V67, P1, DOI 10.1002/cm.20409; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; VASILIEV JM, 1970, J EMBRYOL EXP MORPH, V24, P625; Wasylyk C, 2010, INT J CANCER, V127, P2542, DOI 10.1002/ijc.25261; WEHLAND J, 1984, EMBO J, V3, P1295, DOI 10.1002/j.1460-2075.1984.tb01965.x; Wen YD, 2004, KENYON REV, V26, P1; Whipple RA, 2010, CANCER RES, V70, P8127, DOI 10.1158/0008-5472.CAN-09-4613; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107	53	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65694	10.1371/journal.pone.0065694	http://dx.doi.org/10.1371/journal.pone.0065694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750272	Green Published, gold			2022-12-25	WOS:000319961900074
J	Bush, CO; Greenstein, AE; Delaney, WE; Beran, RKF				Bush, Caroline O.; Greenstein, Andrew E.; Delaney, William E.; Beran, Rudolf K. F.			Hepatitis C Viral Entry Inhibitors Prolong Viral Suppression by Replication Inhibitors in Persistently-Infected Huh7 Cultures	PLOS ONE			English	Article							VIRUS ENTRY; IN-VITRO; RESISTANCE; REQUIRES; RECEPTOR; CELLS; CORECEPTOR; BMS-790052; THERAPY; BINDING	Efforts to treat HCV patients are focused on developing antiviral combinations that lead to the eradication of infection. Thus, it is important to identify optimal combinations from the various viral inhibitor classes. Based on viral dynamic models, HCV entry inhibitors are predicted to reduce viral load in a monophasic manner reflecting the slow death rate of infected hepatocytes (t(1/2) = 2-70 days) and the protection of naive, un-infected cells from HCV infection. In contrast, replication inhibitors are predicted to reduce viral load in a biphasic manner. The initial rapid reduction phase is due to the inhibition of virus production and elimination of plasma virus (t(1/2)similar to 3 hours). The second, slower reduction phase results from the elimination of infected hepatocytes. Here we sought to compare the ability of HCV entry and replication inhibitors as well as combinations thereof to reduce HCV infection in persistently-infected Huh7 cells. Treatment with 5xEC(50) of entry inhibitors anti-CD81 Ab or EI-1 resulted in modest (<= 1 log(10) RNA copies/ml), monophasic declines in viral levels during 3 weeks of treatment. In contrast, treatment with 5xEC(50) of the replication inhibitors BILN-2016 or BMS-790052 reduced extracellular virus levels more potently (similar to 2 log(10) RNA copies/ml) over time in a biphasic manner. However, this was followed by a slow rise to steady-state virus levels due to the emergence of resistance mutations. Combining an entry inhibitor with a replication inhibitor did not substantially enhance the rate of virus reduction. However, entry/replication inhibitor and replication/replication inhibitor combinations reduced viral levels further than monotherapies (up to 3 log(10) RNA copies/ml) and prolonged this reduction relative to monotherapies. Our results demonstrated that HCV entry inhibitors combined with replication inhibitors can prolong antiviral suppression, likely due to the delay of viral resistance emergence.	[Bush, Caroline O.; Greenstein, Andrew E.; Delaney, William E.; Beran, Rudolf K. F.] Gilead Sci Inc, Dept Biol, Foster City, CA 94404 USA	Gilead Sciences	Beran, RKF (corresponding author), Gilead Sci Inc, Dept Biol, 353 Lakeside Dr, Foster City, CA 94404 USA.	rudolf.beran@gilead.com		Greenstein, Andrew/0000-0002-1470-1970				Baldick CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001086; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bauhofer O, 2012, GASTROENTEROLOGY, V143, P429, DOI 10.1053/j.gastro.2012.04.018; Beran RKF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030286; Chan KT, 2012, VIROLOGY, V422, P224, DOI 10.1016/j.virol.2011.10.022; Ciesek S, 2011, HEPATOLOGY, V54, P1947, DOI 10.1002/hep.24610; Coburn GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035351; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; de Bruijne J, 2010, ANTIVIR THER, V15, P765, DOI 10.3851/IMP1606; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Dvory-Sobol H, 2012, ANTIMICROB AGENTS CH; Dvory-Sobol H, 2012, ANTIMICROB AGENTS CH, V56, P5289, DOI 10.1128/AAC.00780-12; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fridell RA, 2011, HEPATOLOGY, V54, P1924, DOI 10.1002/hep.24594; Fridell RA, 2011, J VIROL, V85, P7312, DOI 10.1128/JVI.00253-11; Goldwasser J, 2011, J HEPATOL, V55, P963, DOI 10.1016/j.jhep.2011.02.011; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Mittapalli GK, 2012, BIOORG MED CHEM LETT; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Pelosi LA, 2012, ANTIMICROB AGENTS CH; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Pokrovskii MV, 2011, J VIROL, V85, P3978, DOI 10.1128/JVI.01760-10; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schultz B, 2011, CURR PROTOC PHARM; Sulkowski M, 2013, RANDOMIZED DOUBLE BL; Summa V., 2012, ANTIMICROB AGENTS CH; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Zhu HH, 2012, J INFECT DIS, V205, P656, DOI 10.1093/infdis/jir802	38	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65273	10.1371/journal.pone.0065273	http://dx.doi.org/10.1371/journal.pone.0065273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755208	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300067
J	Folpp, H; Lowry, M; Gregson, M; Suthers, IM				Folpp, Heath; Lowry, Michael; Gregson, Marcus; Suthers, Iain M.			Fish Assemblages on Estuarine Artificial Reefs: Natural Rocky-Reef Mimics or Discrete Assemblages?	PLOS ONE			English	Article							UNDERWATER VIDEO STATIONS; NEW-SOUTH-WALES; MARINE PARK; CORAL-REEFS; HABITAT; AUSTRALIA; DENSITY; COMMUNITIES; SYSTEM; COLONIZATION	If the primary goal of artificial reef construction is the creation of additional reef habitat that is comparable to adjacent natural rocky-reef, then performance should be evaluated using simultaneous comparisons with adjacent natural habitats. Using baited remote underwater video (BRUV) fish assemblages on purpose-built estuarine artificial reefs and adjacent natural rocky-reef and sand-flat were assessed 18 months post-deployment in three south-east Australian estuaries. Fish abundance, species richness and diversity were found to be greater on the artificial reefs than on either naturally occurring reef or sand-flat in all estuaries. Comparisons within each estuary identified significant differences in the species composition between the artificial and natural rocky-reefs. The artificial reef assemblage was dominated by sparid species including Acanthopagrus australis and Rhabdosargus sarba. The preference for a range of habitats by theses sparid species is evident by their detection on sand-flat, natural rocky reef and artificial reef habitats. The fish assemblage identified on the artificial reefs remained distinct from the adjacent rocky-reef, comprising a range of species drawn from naturally occurring rocky-reef and sand-flat. In addition, some mid-water schooling species including Trachurus novaezelandiae and Pseudocaranx georgianus were only identified on the artificial reef community; presumably as result of the reef's isolated location in open-water. We concluded that estuarine artificial reef assemblages are likely to differ significantly from adjacent rocky-reef, potentially as a result of physical factors such as reef isolation, coupled with species specific behavioural traits such as the ability of some species to traverse large sand flats in order to locate reef structure, and feeding preferences. Artificial reefs should not be viewed as direct surrogates for natural reef. The assemblages are likely to remain distinct from naturally occurring habitat comprised of species that reside on a range of adjacent natural habitats.	[Folpp, Heath; Gregson, Marcus] NSW Dept Primary Ind, Recreat & Indigenous Fishing Div, Coffs Harbour Jetty, NSW, Australia; [Lowry, Michael] Port Stephens Fisheries Inst, NSW Dept Primary Ind, Wild Fisheries Res Div, Nelson Bay, NSW, Australia; [Folpp, Heath; Suthers, Iain M.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	NSW Department of Primary Industries; NSW Department of Primary Industries; University of New South Wales Sydney	Folpp, H (corresponding author), NSW Dept Primary Ind, Recreat & Indigenous Fishing Div, Coffs Harbour Jetty, NSW, Australia.	heath.folpp@dpi.nsw.gov.au	Suthers, Iain M/C-4559-2008	Suthers, Iain M/0000-0002-9340-7461	NSW Recreational Fishing Trust	NSW Recreational Fishing Trust	The authors would like to thank the NSW Recreational Fishing Trust for funding the construction of the artificial reefs and also funding this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBANI A, 2008, ENV ASSESSMENT BOT B; AMBROSE RF, 1990, MAR BIOL, V107, P41, DOI 10.1007/BF01313240; Anderson M. J., 2005, PERMANOVA FORTRAN CO, P24; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; ANDERSON TW, 1989, B MAR SCI, V44, P681; Ault TR, 1998, ECOL MONOGR, V68, P25, DOI 10.1890/0012-9615(1998)068[0025:SATPFO]2.0.CO;2; Bell J. D., 1994, B MAR SCI, V55, P1344; BELL JD, 1986, J EXP MAR BIOL ECOL, V104, P275; Belmaker J, 2005, MAR ECOL PROG SER, V289, P273, DOI 10.3354/meps289273; BOHNSACK JA, 1989, B MAR SCI, V44, P631; BORTONE SA, 1994, B MAR SCI, V55, P319; BURCHMORE JJ, 1985, B MAR SCI, V37, P70; Burt J, 2009, CORAL REEFS, V28, P663, DOI 10.1007/s00338-009-0500-1; Caddy J. F., 2007, MARINE HABITAT COVER; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 2006, AUSTR SOC FISH BIOL, P101; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; Chapman MG, 2006, J EXP MAR BIOL ECOL, V338, P164, DOI 10.1016/j.jembe.2006.06.018; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; Charbonnel E, 2002, ICES J MAR SCI, V59, pS208, DOI 10.1006/jmsc.2002.1263; Clark S, 1999, AQUAT CONSERV, P9; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Clynick BG, 2008, AUSTRAL ECOL, V33, P140, DOI 10.1111/j.1442-9993.2007.01802.x; Coll J, 1998, HYDROBIOLOGIA, V385, P139, DOI 10.1023/A:1003457810293; Connell SD, 1998, MAR ECOL PROG SER, V169, P251, DOI 10.3354/meps169251; Edwards RA, 2005, MAR FRESHWATER RES, V56, P133, DOI 10.1071/MF04202; Einbinder S, 2006, MAR ENVIRON RES, V61, P110, DOI 10.1016/j.marenvres.2005.07.001; Folpp H, 2011, BRAZ J OCEANOGR, V59, P55, DOI 10.1590/S1679-87592011000500008; Fujita T, 1996, ENVIRON BIOL FISH, V46, P351, DOI 10.1007/BF00005013; Gregg Kurtis L., 1995, North American Journal of Fisheries Management, V15, P316, DOI 10.1577/1548-8675(1995)015<0316:COTMAR>2.3.CO;2; KAILOLA PJ, 1993, AUSTR FISHERIES RESO; Kim CG, 2001, FISHERIES, V26, P15, DOI 10.1577/1548-8446(2001)026<0015:ARIK>2.0.CO;2; Kuiter R. H., 2000, COASTAL FISHES S E A; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; Lowry M, 2012, J EXPT MARINE BIOL E; Lowry M, 2011, BRAZ J OCEANOGR, V59, P119, DOI 10.1590/S1679-87592011000300014; Lowry M, 2011, FISH RES, V110, P10, DOI 10.1016/j.fishres.2011.03.003; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Mckenzie R, 2011, BRAZ J OCEANOGR, V59, P107, DOI 10.1590/S1679-87592011000300013; NLWRA, 2009, NATL LAND WATER RESO; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Perkol-Finkel S, 2004, CORAL REEFS, V23, P195, DOI 10.1007/s00338-004-0384-z; Pickering H, 1997, FISH RES, V31, P39, DOI 10.1016/S0165-7836(97)00019-2; Pizzolon M, 2008, ESTUAR COAST SHELF S, V78, P166, DOI 10.1016/j.ecss.2007.11.014; POLLARD DA, 1985, B MAR SCI, V37, P299; Pondella DJ, 2002, ICES J MAR SCI, V59, pS88, DOI 10.1006/jmsc.2002.1219; Rilov G, 2000, MAR BIOL, V136, P931, DOI 10.1007/s002279900250; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; Rowling K, 2010, STATUS FISHERIES RES, P295; Rowling K, 2010, STATUS FISHERIES RES, P373; Smith L, 1994, B MARINE SCI, P55; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; STEPHENS JS, 1994, B MAR SCI, V55, P1224; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; Vega Fernandez T, 2008, AQUAT BIOL, V1, P239, DOI 10.3354/ab00027; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Zalmon IR, 2002, ICES J MAR SCI, V59, pS83, DOI 10.1006/jmsc.2002.1273	59	50	52	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63505	10.1371/journal.pone.0063505	http://dx.doi.org/10.1371/journal.pone.0063505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755106	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300011
J	Takata, N; Yokota, K; Ohki, S; Mori, M; Taniguchi, T; Kurita, M				Takata, Naoki; Yokota, Kiyonobu; Ohki, Shinya; Mori, Masashi; Taniguchi, Toru; Kurita, Manabu			Evolutionary Relationship and Structural Characterization of the EPF/EPFL Gene Family	PLOS ONE			English	Article							LIGAND-RECEPTOR PAIRS; STOMATAL DENSITY; SECRETORY PEPTIDE; LAND PLANTS; GENERATION; ALIGNMENT	EPF1-EPF2 and EPFL9/Stomagen act antagonistically in regulating leaf stomatal density. The aim of this study was to elucidate the evolutionary functional divergence of EPF/EPFL family genes. Phylogenetic analyses showed that AtEPFL9/Stomagen-like genes are conserved only in vascular plants and are closely related to AtEPF1/EPF2-like genes. Modeling showed that EPF/EPFL peptides share a common 3D structure that is constituted of a scaffold and loop. Molecular dynamics simulation suggested that AtEPF1/EPF2-like peptides form an additional disulfide bond in their loop regions and show greater flexibility in these regions than AtEPFL9/Stomagen-like peptides. This study uncovered the evolutionary relationship and the conformational divergence of proteins encoded by the EPF/EPFL family genes.	[Takata, Naoki; Taniguchi, Toru; Kurita, Manabu] Forestry & Forest Prod Res Inst, Forest Biores Ctr, Hitachi, Ibaraki, Japan; [Yokota, Kiyonobu] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Ohki, Shinya] Japan Adv Inst Sci & Technol, Ctr Nanomat & Technol, Nomi, Japan; [Mori, Masashi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan; [Taniguchi, Toru; Kurita, Manabu] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Hitachi, Ibaraki, Japan	Forestry & Forest Products Research Institute - Japan; Kanazawa University; Japan Advanced Institute of Science & Technology (JAIST); Ishikawa Prefecture University; Forestry & Forest Products Research Institute - Japan	Kurita, M (corresponding author), Forestry & Forest Prod Res Inst, Forest Biores Ctr, Hitachi, Ibaraki, Japan.	mkuri@affrc.go.jp	Takata, Naoki/AAD-9822-2020	Takata, Naoki/0000-0002-8479-8165	JST Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST); JST-SENTAN; Grants-in-Aid for Scientific Research [25850124] Funding Source: KAKEN	JST Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); JST-SENTAN(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was principally supported by the JST Advanced Low Carbon Technology Research and Development Program (ALCA) from the Japan Science and Technology Agency (JST) (to NT, TT and MK). This work was supported in part by JST-SENTAN (to SO and MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Beerling DJ, 2001, NATURE, V410, P352, DOI 10.1038/35066546; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Duche D, 1996, J BIOL CHEM, V271, P15401, DOI 10.1074/jbc.271.26.15401; Edwards D, 1998, J EXP BOT, V49, P255, DOI 10.1093/jexbot/49.suppl_1.255; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joo H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002234; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; MCELWAIN JC, 1995, ANN BOT-LONDON, V76, P389, DOI 10.1006/anbo.1995.1112; Ohki S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1520; PATON JEAN A., 1957, TRANS BRIT BRYOL SOC, V3, P228; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Rychel AL, 2010, J PLANT RES, V123, P275, DOI 10.1007/s10265-010-0330-9; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torii KU, 2012, TRENDS PLANT SCI, V17, P711, DOI 10.1016/j.tplants.2012.06.013; Vaten A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-11	32	30	36	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65183	10.1371/journal.pone.0065183	http://dx.doi.org/10.1371/journal.pone.0065183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755192	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300056
J	Yuan, QY; Nsoesie, EO; Lv, BF; Peng, G; Chunara, R; Brownstein, JS				Yuan, Qingyu; Nsoesie, Elaine O.; Lv, Benfu; Peng, Geng; Chunara, Rumi; Brownstein, John S.			Monitoring Influenza Epidemics in China with Search Query from Baidu	PLOS ONE			English	Article							MEDIA	Several approaches have been proposed for near real-time detection and prediction of the spread of influenza. These include search query data for influenza related terms, which has been explored as a tool for augmenting traditional surveillance methods. In this paper, we present a method that uses Internet search query data from Baidu to model and monitor influenza activity in China. The objectives of the study are to present a comprehensive technique for: (i) keyword selection, (ii) keyword filtering, (iii) index composition and (iv) modeling and detection of influenza activity in China. Sequential time-series for the selected composite keyword index is significantly correlated with Chinese influenza case data. In addition, one-month ahead prediction of influenza cases for the first eight months of 2012 has a mean absolute percent error less than 11%. To our knowledge, this is the first study on the use of search query data from Baidu in conjunction with this approach for estimation of influenza activity in China.	[Yuan, Qingyu; Lv, Benfu; Peng, Geng] Univ Chinese Acad Sci, Sch Management, Beijing, Peoples R China; [Yuan, Qingyu; Nsoesie, Elaine O.; Chunara, Rumi; Brownstein, John S.] Boston Childrens Hosp, Childrens Hosp, Informat Program, Div Emergency Med, Boston, MA USA; [Nsoesie, Elaine O.; Chunara, Rumi; Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Nsoesie, Elaine O.] Virginia Tech, Network Dynam & Simulat Sci Lab, Virginia Bioinformat Inst, Blacksburg, VA USA; [Brownstein, John S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Virginia Polytechnic Institute & State University; McGill University	Yuan, QY (corresponding author), Univ Chinese Acad Sci, Sch Management, Beijing, Peoples R China.	Qingyu.Yuan@childrens.harvard.edu		Nsoesie, Elaine/0000-0001-9170-8714	National Library of Medicine; National Institutes of Health [5R01LM010812-03, 5G08LM009776-03]; National Natural Science Foundation of China [71202115, 71172199, 7103218]; Foundation of Dean of Graduate University of Chinese Academy of Sciences [Y15101QY00]; Postdoctoral Science Foundation [2011M500422]; NATIONAL LIBRARY OF MEDICINE [R01LM010812, G08LM009776] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Dean of Graduate University of Chinese Academy of Sciences; Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work supported by research grants from the National Library of Medicine, the National Institutes of Health (5R01LM010812-03 and 5G08LM009776-03), the National Natural Science Foundation of China under Grant 71202115, 71172199, 7103218, Foundation of Dean of Graduate University of Chinese Academy of Sciences under Grant Y15101QY00, and Postdoctoral Science Foundation under Grant 2011M500422. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki E., 2011, P C EMPIRICAL METHOD, P1568, DOI DOI 10.1016/J.DEUGALCDEP.2015.07.1199; Askitas N., 2009, APPL EC Q, V55, P107, DOI [10.1016/1047-2797(94)90062-0, DOI 10.1016/1047-2797(94)90062-0, DOI 10.3790/AEQ.55.2.107]; Boehm E.A., 2001, INDIAN ECON REV, V36, P1; Brownstein J, 2011, CNN; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Chen L, 2010, ACM MOBILE CLOUD COM, DOI 10.1145/1810931.1810935; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Choi H, 2009, PREDICITNG INITIAL C; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Christakis N. A., 2010, PLOS ONE, V5; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Chunquan O, 2007, CHINESE J HLTH STAT; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Culotta Aron, 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Doornik J.A., 2009, TECHNICAL REPORT, P1; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Francesco D.A., 2009, 18403 MPRA; Francesco DA, 2009, ISER WORKING PAPER S; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Kholodilin KA, 2009, DISCUSSION PAPERS DI; Lampos V, 2010, LECT NOTES ARTIF INT, V6323, P599, DOI 10.1007/978-3-642-15939-8_42; Liu Y, 2012, PREPROCESSING METHOD; Paul M.J., 2011, P 5 INT AAAI C WEBL, P265; Saaty TL, 2003, EUR J OPER RES, V145, P85, DOI 10.1016/S0377-2217(02)00227-8; Schmidt CW, 2012, ENVIRON HEALTH PERSP, V120, pA30, DOI 10.1289/ehp.120-a30; Schmidt T., 2009, RUHR EC PAPERS; Shiskin J., 1967, OCCASIONAL PAPER, V103; Shortridge KF, 1997, CHINESE MED J-PEKING, V110, P637; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Szomszor M., 2011, 2011 IEEE/WIC/ACM International Joint Conferences on Web Intelligence (WI) and Intelligent Agent Technologies, P320, DOI 10.1109/WI-IAT.2011.311; World Health Organization, 2009, J AM MED INFORM ASS; Wu L, 2009, ICIS 2009 P; Xin W, 2011, CHINA TROPICAL MED, DOI CNKI:SUN:RDYX.0.2011-06-005; Zhao Y, 2012, DIS SURVEILLANCE, DOI 10.3784/j.issn.1003-9961.2012.9.007	36	124	137	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e64323	10.1371/journal.pone.0064323	http://dx.doi.org/10.1371/journal.pone.0064323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23750192	Green Published, Green Submitted, gold			2022-12-25	WOS:000321394700043
J	Busch, SE; Moser, RD; Gurley, KE; Kelly-Spratt, KS; Liggitt, HD; Kemp, CJ				Busch, S. E.; Moser, R. D.; Gurley, K. E.; Kelly-Spratt, K. S.; Liggitt, H. D.; Kemp, C. J.			ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma	ONCOGENE			English	Article						p19(Arf); p14(ARF); ethyl carbamate; metastasis	P53-MEDIATED TUMOR SUPPRESSION; DNA-DAMAGE; MOUSE MODEL; CYCLE ARREST; WILD-TYPE; CANCER; P53; MICE; PATHWAY; LOCUS	Non-small-cell lung carcinoma (NSCLC) is among the deadliest of human cancers. The CDKN2A locus, which houses the INK4a and ARF tumor suppressor genes, is frequently altered in NSCLC. However, the specific role of ARF in pulmonary tumorigenesis remains unclear. KRAS and other oncogenes induce the expression of ARF, thus stabilizing p53 activity and arresting cell proliferation. To address the role of ARF in Kras-driven NSCLC, we compared the susceptibility of NIH/Ola strain wild-type and Arf-knockout mice to urethane-induced lung carcinogenesis. Lung tumor size, malignancy and associated morbidity were significantly increased in Arf(-/-) compared with Arf(+/+) animals at 25 weeks after induction. Pulmonary tumors from Arf-knockout mice exhibited increased cell proliferation and DNA damage compared with wild-type mice. A subgroup of tumors in Arf(-/-) animals presented as dedifferentiated and metastatic, with many characteristics of pulmonary sarcomatoid carcinoma, a neoplasm previously undocumented in mouse models. Our finding of a role for ARF in NSCLC is consistent with the observation that benign adenomas from Arf(+/+) mice robustly expressed ARF, while ARF expression was markedly reduced in malignant adenocarcinomas. ARF expression also frequently colocalized with the expression of p21(CIP1), a transcriptional target of p53, arguing that ARF induces the p53 checkpoint to arrest cell proliferation in vivo. Taken together, these findings demonstrate that induction of ARF is an early response in lung tumorigenesis that mounts a strong barrier against tumor growth and malignant progression.	[Busch, S. E.; Moser, R. D.; Gurley, K. E.; Kelly-Spratt, K. S.; Kemp, C. J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Busch, S. E.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Liggitt, H. D.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kemp, CJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1100 Fairview Ave North,Mail Stop C1-015, Seattle, WA 98109 USA.	cjkemp@fhcrc.org		Busch, Stephanie E/0000-0003-4073-5311	NCI MMHCC [U01 CA141550]; NIEHS [5 R01 ES020116]; PHS NRSA from NIGMS [T32 GM007270]; NATIONAL CANCER INSTITUTE [U01CA141550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	NCI MMHCC; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS NRSA from NIGMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Sue Knoblaugh for her assistance in analyzing tumor histopathology, and to numerous colleagues for their helpful commentary. This work was supported by NCI MMHCC U01 CA141550, and by NIEHS 5 R01 ES020116. SEB was supported by PHS NRSA T32 GM007270 from NIGMS.	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; Andrique L, 2012, CELL SIGNAL, V24, P1074, DOI 10.1016/j.cellsig.2012.01.002; [Anonymous], 1975, SEER CANC STAT REV 1; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Busch SE, 2012, J PATHOL, V227, P298, DOI 10.1002/path.4024; Cardiff RD, 2005, CLIN CANCER RES, V11, P8534, DOI 10.1158/1078-0432.CCR-05-2250; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; D'Amico M, 2004, CANCER RES, V64, P4122, DOI 10.1158/0008-5472.CAN-03-2519; Dacic S, 2002, AM J SURG PATHOL, V26, P510, DOI 10.1097/00000478-200204000-00015; Debies MT, 2008, J CLIN INVEST, V118, P51, DOI 10.1172/JCI33320; di Tommaso A, 2009, EXP CELL RES, V315, P1326, DOI 10.1016/j.yexcr.2009.01.010; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Eymin B, 2006, MOL CELL BIOL, V26, P4339, DOI 10.1128/MCB.02240-05; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Gao N, 2001, J CANCER RES CLIN, V127, P359, DOI 10.1007/s004320000184; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly-Spratt KS, 2009, ONCOGENE, V28, P3652, DOI 10.1038/onc.2009.226; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lavoie J N, 1996, Prog Cell Cycle Res, V2, P49; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Manenti G, 1997, CANCER RES, V57, P4164; Nicholson SA, 2001, CANCER RES, V61, P5636; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; Pelosi G, 2010, INT J SURG PATHOL, V18, P103, DOI 10.1177/1066896908330049; Philipp-Staheli J, 2002, CANCER CELL, V1, P355, DOI 10.1016/S1535-6108(02)00054-5; Pontano LL, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-12; QUELLE DE, 1995, CELL, V83, P993; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; ROGERS S, 1951, J EXP MED, V93, P427, DOI 10.1084/jem.93.5.427; Sanchez-Cespedes M, 1999, ONCOGENE, V18, P5843, DOI 10.1038/sj.onc.1203003; Saporita AJ, 2007, CURR MED CHEM, V14, P1815; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Tam AS, 2003, CARCINOGENESIS, V24, P121, DOI 10.1093/carcin/24.1.121; TANNENBAUM A, 1962, CANCER RES, V22, P1105; Thompson L, 1996, AM J SURG PATHOL, V20, P277, DOI 10.1097/00000478-199603000-00003; Tompkins VS, 2007, J BIOL CHEM, V282, P1322, DOI 10.1074/jbc.M609612200; Vonlanthen S, 1998, ONCOGENE, V17, P2779, DOI 10.1038/sj.onc.1202501; Wang Y, 2006, ONCOGENE, V25, P1277, DOI 10.1038/sj.onc.1209182; Wang Y, 2003, CANCER RES, V63, P4389; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107; Zeng YX, 2011, CANCER RES, V71, P2781, DOI 10.1158/0008-5472.CAN-10-3483; Zhang W, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-74; Zhang ZQ, 2002, ONCOGENE, V21, P5960, DOI 10.1038/sj.onc.1205725; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	60	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2665	2673		10.1038/onc.2013.208	http://dx.doi.org/10.1038/onc.2013.208			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23752194	Green Accepted			2022-12-25	WOS:000336502700012
J	Nandi, S; Cioce, M; Yeung, YG; Nieves, E; Tesfa, L; Lin, HS; Hsu, AW; Halenbeck, R; Cheng, HY; Gokhan, S; Mehler, MF; Stanley, ER				Nandi, Sayan; Cioce, Mario; Yeung, Yee-Guide; Nieves, Edward; Tesfa, Lydia; Lin, Haishan; Hsu, Amy W.; Halenbeck, Robert; Cheng, Hui-Yong; Gokhan, Solen; Mehler, Mark F.; Stanley, E. Richard			Receptor-type Protein-tyrosine Phosphatase zeta Is a Functional Receptor for Interleukin-34	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Cell Surface Receptor; Interleukin; Phosphotyrosine Signaling; Tyrosine Protein Phosphatase (Tyrosine Phosphatase); CSF-1 Receptor; Development; Glioblastoma; Neurobiology; Signal Transduction	STIMULATING FACTOR-I; CHONDROITIN SULFATE PROTEOGLYCAN; GROWTH-ASSOCIATED MOLECULE; HIGH-AFFINITY BINDING; TENASCIN-R; CSF-1 RECEPTOR; ZETA/RPTP-BETA; CELL-MIGRATION; RPTP-BETA; 6B4 PROTEOGLYCAN/PHOSPHACAN	Interleukin-34 (IL-34) is highly expressed in brain. IL-34 signaling via its cognate receptor, colony-stimulating factor-1 receptor (CSF-1R), is required for the development of microglia. However, the differential expression of IL-34 and the CSF-1R in brain suggests that IL-34 may signal via an alternate receptor. By IL-34 affinity chromatography of solubilized mouse brain membrane followed by mass spectrometric analysis, we identified receptor-type protein-tyrosine phosphatase (PTP-), a cell surface chondroitin sulfate (CS) proteoglycan, as a novel IL-34 receptor. PTP- is primarily expressed on neural progenitors and glial cells and is highly expressed in human glioblastomas. IL-34 selectively bound PTP- in CSF-1R-deficient U251 human glioblastoma cell lysates and inhibited the proliferation, clonogenicity, and motility of U251 cells in a PTP--dependent manner. These effects were correlated with an increase in tyrosine phosphorylation of the previously identified PTP- downstream effectors focal adhesion kinase and paxillin. IL-34 binding to U251 cells was abrogated by chondroitinase ABC treatment, and CS competed with IL-34 for binding to the extracellular domain of PTP- and to the cells, indicating a dependence of binding on PTP- CS moieties. This study identifies an alternate receptor for IL-34 that may mediate its action on novel cellular targets.	[Nandi, Sayan; Cioce, Mario; Yeung, Yee-Guide; Nieves, Edward; Tesfa, Lydia; Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Cheng, Hui-Yong] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Dept Neurol, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Dept Neurosci, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Dept Psychiat & Behav Sci, Bronx, NY 10461 USA; [Lin, Haishan; Hsu, Amy W.; Halenbeck, Robert] Five Prime Therapeut Inc, San Francisco, CA 94080 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Stanley, ER (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	richard.stanley@einstein.yu.edu	Stanley, Evan R/J-9154-2013; Cioce, Mario/R-9734-2017	Stanley, Evan R/0000-0002-2910-2065; Cioce, Mario/0000-0001-8129-6664	National Institutes of Health [CA32551, CA26504, 5P30-CA13330, NS071571, P30HD071593, 1S10RR019352]; F. M. Kirby Foundation; Alpern Family Foundation; Mildred and Bernard H. Kayden Foundation; Roslyn and Leslie Goldstein Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA026504, R01CA026504, R01CA032551, P30CA013330] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F. M. Kirby Foundation; Alpern Family Foundation; Mildred and Bernard H. Kayden Foundation; Roslyn and Leslie Goldstein Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA32551 and CA26504 (to E. R. S.), 5P30-CA13330 (a cancer center grant to the Albert Einstein College of Medicine), NS071571 and P30HD071593 (to M. F. M. and S. G.), and 1S10RR019352 (a shared instrumentation grant to the Einstein Laboratory for Macromolecular Analysis and Proteomics). This work was also supported by the F. M. Kirby, Alpern Family, Mildred and Bernard H. Kayden, and Roslyn and Leslie Goldstein Foundations (to M. F. M. and S. G.).	BARNEA G, 1994, J BIOL CHEM, V269, P14349; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Dai XM, 2004, J BONE MINER RES, V19, P1441, DOI 10.1359/JBMR.040514; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Diamantopoulou Z, 2012, J BIOL CHEM, V287, P40339, DOI 10.1074/jbc.M112.405852; Edmonds BT, 1996, J CELL SCI, V109, P2705; El Ayachi I, 2011, J COMP NEUROL, V519, P2379, DOI 10.1002/cne.22632; Feng ZJ, 2010, ONCOGENE, V29, P5416, DOI 10.1038/onc.2010.282; Foehr ED, 2006, CANCER RES, V66, P2271, DOI 10.1158/0008-5472.CAN-05-1221; Fujikawa A, 2011, J BIOL CHEM, V286, P37137, DOI 10.1074/jbc.M111.270140; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Fukazawa N, 2008, MOL CELL BIOL, V28, P4494, DOI 10.1128/MCB.00074-08; Garwood J, 1999, J NEUROSCI, V19, P3888; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guleria I, 2000, NAT MED, V6, P589, DOI 10.1038/75074; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; Lafont D, 2009, BEHAV BRAIN RES, V201, P29, DOI 10.1016/j.bbr.2009.01.025; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; LEVY JB, 1993, J BIOL CHEM, V268, P10573; LI W, 1991, EMBO J, V10, P277, DOI 10.1002/j.1460-2075.1991.tb07948.x; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu HL, 2012, BBA-PROTEINS PROTEOM, V1824, P938, DOI 10.1016/j.bbapap.2012.04.012; Lu KV, 2005, J BIOL CHEM, V280, P26953, DOI 10.1074/jbc.M502614200; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Mikelis C, 2009, FASEB J, V23, P1459, DOI 10.1096/fj.08-117564; Milev P, 1998, J BIOL CHEM, V273, P6998, DOI 10.1074/jbc.273.12.6998; Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Pariser H, 2005, BIOCHEM BIOPH RES CO, V335, P232, DOI 10.1016/j.bbrc.2005.07.060; Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pixley FJ, 2001, MOL CELL BIOL, V21, P1795, DOI 10.1128/MCB.21.5.1795-1809.2001; Polykratis A, 2005, J BIOL CHEM, V280, P22454, DOI 10.1074/jbc.M414407200; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Sakurai T, 1996, J NEUROSCI RES, V43, P694, DOI 10.1002/(SICI)1097-4547(19960315)43:6<694::AID-JNR6>3.3.CO;2-9; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; SHITARA K, 1994, J BIOL CHEM, V269, P20189; Ulbricht U, 2006, J NEUROCHEM, V98, P1497, DOI 10.1111/j.1471-4159.2006.04022.x; von Holst A, 2006, J NEUROSCI, V26, P4082, DOI 10.1523/JNEUROSCI.0422-06.2006; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Woodworth A, 2004, J BIOL CHEM, V279, P10413, DOI 10.1074/jbc.M312466200; Woodworth A, 2002, J BIOL CHEM, V277, P50941, DOI 10.1074/jbc.M209876200; Xiao ZC, 1997, J BIOL CHEM, V272, P32092, DOI 10.1074/jbc.272.51.32092; Yeung YG, 2008, ANAL BIOCHEM, V382, P135, DOI 10.1016/j.ab.2008.07.034; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yu WF, 2012, J BIOL CHEM, V287, P13694, DOI 10.1074/jbc.M112.355610; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013	80	101	114	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21972	10.1074/jbc.M112.442731	http://dx.doi.org/10.1074/jbc.M112.442731			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23744080	Green Published, hybrid			2022-12-25	WOS:000328841900044
J	Gummesson, B; Lovmar, M; Nystrom, T				Gummesson, Bertil; Lovmar, Martin; Nystrom, Thomas			A Proximal Promoter Element Required for Positive Transcriptional Control by Guanosine Tetraphosphate and DksA Protein during the Stringent Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNIVERSAL STRESS-PROTEIN; GROWTH-RATE CONTROL; ESCHERICHIA-COLI; RIBOSOMAL-RNA; RECOGNITION ELEMENT; SECONDARY CHANNEL; IN-VIVO; PPGPP; POLYMERASE; INITIATION	The alarmone guanosine tetraphosphate (ppGpp) acts as both a positive and a negative regulator of gene expression in the presence of DksA, but the underlying mechanisms of this differential control are unclear. Here, using uspA hybrid promoters, we show that an AT-rich discriminator region is crucial for positive control by ppGpp/DksA. The AT-rich discriminator makes the RNA polymerase-promoter complex extremely stable and therefore easily saturated with RNA polymerase. A more efficient transcription is achieved when the RNA polymerase-promoter complex is destabilized with ppGpp/DksA. We found that exchanging the AT-rich discriminator of uspA with the GC-rich rrnB-P1 discriminator made the uspA promoter negatively regulated by ppGpp/DksA both in vivo and in vitro. In addition, the GC-rich discriminator destabilized the RNA polymerase-promoter complex, and the effect of ppGpp/DksA on the kinetic properties of the promoter was reversed. We propose that the transcription initiation rate from promoters with GC-rich discriminators, in contrast to the uspA-promoter, is not limited by the stability of the open complex. The findings are discussed in view of models for both direct and indirect effects of ppGpp/DksA on transcriptional trade-offs.	[Gummesson, Bertil; Lovmar, Martin; Nystrom, Thomas] Gothenburg Univ, Dept Chem & Mol Biol, S-41390 Gothenburg, Sweden	University of Gothenburg	Nystrom, T (corresponding author), Gothenburg Univ, Dept Chem & Mol Biol, Medicinaregatan 9C, S-41390 Gothenburg, Sweden.	thomas.nystrom@cmb.gu.se	Gummesson, Bertil/AAG-5333-2019	Gummesson, Bertil/0000-0002-9814-885X	Swedish Natural Research Council; Knut and Alice Wallenberg Foundation (Wallenberg Scholar Award)	Swedish Natural Research Council(Swedish Research Council); Knut and Alice Wallenberg Foundation (Wallenberg Scholar Award)	This work was supported by grants from the Swedish Natural Research Council and the Knut and Alice Wallenberg Foundation (Wallenberg Scholar Award).	Aberg A, 2008, MOL MICROBIOL, V67, P1223, DOI 10.1111/j.1365-2958.2008.06115.x; ALBERTSON NH, 1994, FEMS MICROBIOL LETT, V117, P181, DOI 10.1111/j.1574-6968.1994.tb06762.x; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Bremer H, 2003, BIOCHIMIE, V85, P597, DOI 10.1016/S0300-9084(03)00105-6; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; CASHEL M, 1969, J BIOL CHEM, V244, P3133; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; DEBOER HA, 1979, CELL, V17, P201, DOI 10.1016/0092-8674(79)90308-8; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; Dykxhoorn DM, 1996, MOL MICROBIOL, V19, P483, DOI 10.1046/j.1365-2958.1996.384913.x; ELLIOTT T, 1984, CELL, V36, P211, DOI 10.1016/0092-8674(84)90091-6; Farewell A, 1996, J BACTERIOL, V178, P6443, DOI 10.1128/jb.178.22.6443-6450.1996; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gummesson B, 2009, EMBO J, V28, P2209, DOI 10.1038/emboj.2009.181; Gustavsson N, 2002, MOL MICROBIOL, V43, P107, DOI 10.1046/j.1365-2958.2002.02720.x; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; JENSEN KF, 1990, MICROBIOL REV, V54, P89, DOI 10.1128/MMBR.54.2.89-100.1990; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Kvint K, 2000, MOL MICROBIOL, V35, P435, DOI 10.1046/j.1365-2958.2000.01714.x; LEIRMO S, 1991, J MOL BIOL, V220, P555, DOI 10.1016/0022-2836(91)90100-K; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; Lennon CW, 2012, GENE DEV, V26, P2634, DOI 10.1101/gad.204693.112; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2003, J BIOL CHEM, V278, P968, DOI 10.1074/jbc.M209881200; Mechold U, 2013, NUCLEIC ACIDS RES, V41, P6175, DOI 10.1093/nar/gkt302; Miller JH., 1972, EXPT MOL GENETICS; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; Ross W, 2009, METHODS, V47, P13, DOI 10.1016/j.ymeth.2008.10.018; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; RYALS J, 1982, J BACTERIOL, V151, P1261, DOI 10.1128/JB.151.3.1261-1268.1982; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; STENT GS, 1961, P NATL ACAD SCI USA, V47, P2005, DOI 10.1073/pnas.47.12.2005; Teich A, 1999, BIOTECHNOL PROGR, V15, P123, DOI 10.1021/bp980102h; TRAVERS AA, 1980, J BACTERIOL, V141, P973, DOI 10.1128/JB.141.2.973-976.1980; TRAVERS AA, 1984, NUCLEIC ACIDS RES, V12, P2605, DOI 10.1093/nar/12.6.2605; Vinella D, 2005, MOL MICROBIOL, V56, P958, DOI 10.1111/j.1365-2958.2005.04601.x; Wagner R., 2000, TRANSCRIPTION REGULA, p[72, 309]; WANNER BL, 1977, J BACTERIOL, V130, P212, DOI 10.1128/JB.130.1.212-222.1977; XIAO H, 1991, J BIOL CHEM, V266, P5980; ZACHARIAS M, 1989, EMBO J, V8, P3357, DOI 10.1002/j.1460-2075.1989.tb08498.x; ZACHARIAS M, 1991, BIOCHIMIE, V73, P699, DOI 10.1016/0300-9084(91)90050-B; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908; Zuo YH, 2013, MOL CELL, V50, P430, DOI 10.1016/j.molcel.2013.03.020	60	22	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21055	21064		10.1074/jbc.M113.479998	http://dx.doi.org/10.1074/jbc.M113.479998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23749992	hybrid, Green Published			2022-12-25	WOS:000322014400026
J	Wang, F; Shao, NM; Cheng, YY				Wang, Fei; Shao, Naimin; Cheng, Yiyun			Paramagnetic NMR Investigation of Dendrimer-Based Host-Guest Interactions	PLOS ONE			English	Article							RELAXATION ENHANCEMENT; MOLECULAR ELECTRONICS; STARBURST DENDRIMERS; SURFACTANTS; DIFFUSION; ENCAPSULATION; COBALT(II); COMPLEXES; CHEMISTRY; DELIVERY	In this study, the host-guest behavior of poly(amidoamine) (PAMAM) dendrimers bearing amine, hydroxyl, or carboxylate surface functionalities were investigated by paramagnetic NMR studies. 2,2,6,6-Tetramethylpiperidinyloxy (TEMPO) derivatives were used as paramagnetic guest molecules. The results showed that TEMPO-COOH significantly broaden the H-1 NMR peaks of amine- and hydroxyl-terminated PAMAM dendrimers. In comparison, no paramagnetic relaxation enhancement (PRE) was observed between TEMPO-NH2, TEMPO-OH and the three types of PAMAM dendrimers. The PRE phenomenon observed is correlated with the encapsulation of TEMPO-COOH within dendrimer pockets. Protonation of the tertiary amine groups within PAMAM dendrimers plays an important role during this process. Interestingly, the absence of TEMPO-COOH encapsulation within carboxylate-terminated PAMAM dendrimer is observed due to the repulsion of TEMPO-COO- anion and anionic dendrimer surface. The combination of paramagnetic probes and H-1 NMR linewidth analysis can be used as a powerful tool in the analysis of dendrimer-based host-guest systems.	[Wang, Fei; Shao, Naimin; Cheng, Yiyun] E China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; [Cheng, Yiyun] E China Normal Univ, Dept Phys, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Cheng, YY (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.	yycheng@mail.ustc.edu.cn			Science and Technology of Shanghai Municipality [11DZ2260300]; Talent Program of East China Normal University [77202201]; Program for New Century Excellent Talents in University of Ministry of Education of China	Science and Technology of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Talent Program of East China Normal University; Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	The authors are thankful for financial support from the Science and Technology of Shanghai Municipality (11DZ2260300), the Talent Program of East China Normal University (No.77202201), and the Program for New Century Excellent Talents in University of Ministry of Education of China on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astruc D, 2008, ACCOUNTS CHEM RES, V41, P841, DOI 10.1021/ar8000074; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; Aulenta F, 2003, EUR POLYM J, V39, P1741, DOI 10.1016/S0014-3057(03)00100-9; Baars MWPL, 1997, CHEM COMMUN, P1959; Boisselier E, 2008, CHEM-EUR J, V14, P5577, DOI 10.1002/chem.200701607; Boisselier E, 2010, CHEM-EUR J, V16, P6056, DOI 10.1002/chem.200902995; Caminade AM, 2005, ADV DRUG DELIVER REV, V57, P2130, DOI 10.1016/j.addr.2005.09.011; Caminade AM, 2012, CHEM SOC REV, DOI [10.1039/C2CS35030K: ASAP, DOI 10.1039/C2CS35030K:ASAP]; Caminade AM, 2008, CHEM-EUR J, V14, P7422, DOI 10.1002/chem.200800584; Caminade AM, 2010, CHEM SOC REV, V39, P2034, DOI 10.1039/b926408f; Cheng YY, 2008, J PHYS CHEM B, V112, P12674, DOI 10.1021/jp804954j; Cheng YY, 2011, CHEM SOC REV, V40, P2673, DOI 10.1039/c0cs00097c; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; COHEN EA, 1975, ORG MAGN RESONANCE, V7, P605, DOI 10.1002/mrc.1270071210; D'Emanuele A, 2005, ADV DRUG DELIVER REV, V57, P2147, DOI 10.1016/j.addr.2005.09.012; Epperson JD, 1999, INORG CHEM, V38, P4498, DOI 10.1021/ic9906860; Epperson JD, 2001, J AM CHEM SOC, V123, P8583, DOI 10.1021/ja015856y; Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3; Fang M, 2012, J PHYS CHEM B, V116, P3075, DOI 10.1021/jp211384p; Fang M, 2010, J PHYS CHEM B, V114, P6048, DOI 10.1021/jp100805u; Feng XY, 2011, J PHYS CHEM B, V115, P3777, DOI 10.1021/jp2003613; Furtado F, 2011, ENVIRON SCI TECHNOL, V45, P8866, DOI 10.1021/es2010946; Hu JJ, 2012, CHEM REV, V112, P3856, DOI 10.1021/cr200333h; Hu JJ, 2009, J PHYS CHEM B, V113, P64, DOI 10.1021/jp8078919; JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226; JANSEN JFGA, 1995, ANGEW CHEM INT EDIT, V34, P1206, DOI 10.1002/anie.199512061; JANSEN JFGA, 1995, J AM CHEM SOC, V117, P4417, DOI 10.1021/ja00120a032; Menjoge AR, 2010, DRUG DISCOV TODAY, V15, P171, DOI 10.1016/j.drudis.2010.01.009; NAYLOR AM, 1989, J AM CHEM SOC, V111, P2339, DOI 10.1021/ja00188a079; Ottaviani MF, 1997, J PHYS CHEM B, V101, P6057, DOI 10.1021/jp963271y; Ottaviani MF, 1996, COLLOID SURFACE A, V115, P9, DOI 10.1016/0927-7757(96)03597-2; Pintacuda G, 2007, ACCOUNTS CHEM RES, V40, P206, DOI 10.1021/ar050087z; Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007; Tomalia DA, 2012, NEW J CHEM, V36, P264, DOI 10.1039/c1nj20501c; Tomalia DA, 2010, SOFT MATTER, V6, P456, DOI 10.1039/b917370f; van Duijvenbode RC, 2000, MACROMOLECULES, V33, P46, DOI 10.1021/ma990968j; Wang MM, 2011, J PHYS CHEM B, V115, P12728, DOI 10.1021/jp207817f; Xue Y, 2009, PROTEIN SCI, V18, P1401, DOI 10.1002/pro.153; Yang K, 2011, J PHYS CHEM B, V115, P2185, DOI 10.1021/jp111044k; Yang K, 2010, J PHYS CHEM B, V114, P7265, DOI 10.1021/jp1026493; Zhao LB, 2010, J AM CHEM SOC, V132, P13182, DOI 10.1021/ja106128u	41	2	2	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64722	10.1371/journal.pone.0064722	http://dx.doi.org/10.1371/journal.pone.0064722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762249	Green Published, Green Submitted, gold			2022-12-25	WOS:000320440500006
J	Jonnalagadda, M; Brown, CE; Chang, WC; Ostberg, JR; Forman, SJ; Jensen, MC				Jonnalagadda, Mahesh; Brown, Christine E.; Chang, Wen-Chung; Ostberg, Julie R.; Forman, Stephen J.; Jensen, Michael C.			Engineering Human T Cells for Resistance to Methotrexate and Mycophenolate Mofetil as an In Vivo Cell Selection Strategy	PLOS ONE			English	Article							HUMAN DIHYDROFOLATE-REDUCTASE; HEMATOPOIETIC STEM-CELLS; GENE-TRANSFER; IMMUNE-RESPONSES; VITRO SELECTION; LYMPHOCYTES; THERAPY; VECTOR; EXPANSION; TRANSPLANTATION	Gene transfer and drug selection systems that enforce ongoing transgene expression in vitro and in vivo which are compatible with human pharmaceutical drugs are currently underdeveloped. Here, we report on the utility of incorporating human enzyme muteins that confer resistance to the lymphotoxic/immunosuppressive drugs methotrexate (MTX) and mycophenolate mofetil (MMF) in a multicistronic lentiviral vector for in vivo T lymphocyte selection. We found that co-expression of human dihydrofolate reductase (DHFRFS; L22F, F31S) and inosine monophosphate dehydrogenase II (IMPDH2(IY); T333I, S351Y) conferred T cell resistance to the cytocidal and anti-proliferative effects of these drugs at concentrations that can be achieved clinically (up to 0.1 mu M MTX and 1.0 mu M MPA). Furthermore, using a immunodeficient mouse model that supports the engraftment of central memory derived human T cells, in vivo selection studies demonstrate that huEGFRt(+)DHFR(FS+)IMPDH2(IY+) T cells could be enriched following adoptive transfer either by systemic administration of MTX alone (4.4 -fold), MMF alone (2.9-fold), or combined MTX and MMF (4.9-fold). These findings demonstrate the utility of both DHFRFS/MTX and IMPDH2(IY)/MMF for in vivo selection of lentivirally transduced human T cells. Vectors incorporating these muteins in combination with other therapeutic transgenes may facilitate the selective engraftment of therapeutically active cells in recipients.	[Jonnalagadda, Mahesh; Brown, Christine E.; Chang, Wen-Chung; Ostberg, Julie R.; Forman, Stephen J.; Jensen, Michael C.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA; [Jonnalagadda, Mahesh; Brown, Christine E.; Chang, Wen-Chung; Ostberg, Julie R.; Forman, Stephen J.; Jensen, Michael C.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA; [Jensen, Michael C.] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Seattle Children's Hospital	Jensen, MC (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA USA.	michael.jensen@seattlechildrens.org		Brown, Christine/0000-0003-4915-8207	National Institutes of Health [P50 CA107399, PO1 CA030206]; Lymphoma Research Foundation; Tim Nesvig Lymphoma Research Foundation; Neidorf Foundation; Marcus Foundation; Timothy Lindenfelser; NATIONAL CANCER INSTITUTE [P01CA030206, P50CA107399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Tim Nesvig Lymphoma Research Foundation; Neidorf Foundation; Marcus Foundation; Timothy Lindenfelser; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institutes of Health P50 CA107399, PO1 CA030206, the Lymphoma Research Foundation, the Tim Nesvig Lymphoma Research Foundation, the Neidorf Foundation, the Marcus Foundation, and Timothy Lindenfelser. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abonour R, 2000, NAT MED, V6, P652, DOI 10.1038/76225; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; [Anonymous], 2005, MYC MOF CELLCEPT PAC; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; CATAPANO CV, 1995, MOL PHARMACOL, V47, P948; Dubus I, 2002, KIDNEY INT, V62, P857, DOI 10.1046/j.1523-1755.2002.00514.x; ErcikanAbali EA, 1996, CANCER RES, V56, P4142; FLASSHOVE M, 1995, LEUKEMIA, V9, pS34; FLASSHOVE M, 1995, BLOOD, V85, P566; Fossati E, 2008, J BIOMOL SCREEN, V13, P504, DOI 10.1177/1087057108318783; FRANKLIN TJ, 1994, ADV ENZYME REGUL, V34, P107, DOI 10.1016/0065-2571(94)90011-6; Gatlin J, 2000, HUM GENE THER, V11, P1949, DOI 10.1089/10430340050129558; Jena B, 2010, BLOOD, V116, P1035, DOI 10.1182/blood-2010-01-043737; Jonnalagadda M, 2013, GENE THER; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kalos M, 2011, SCI TRANSL MED, V3; LEWIS WS, 1995, J BIOL CHEM, V270, P5057, DOI 10.1074/jbc.270.10.5057; Lobo ED, 2003, J PHARM SCI-US, V92, P1654, DOI 10.1002/jps.10431; McIvor RS, 1996, BONE MARROW TRANSPL, V18, pS50; Milsom MD, 2004, J GENE MED, V6, P133, DOI 10.1002/jgm.533; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Muul LM, 2007, CURR GENE THER, V7, P361, DOI 10.2174/156652307782151489; NGUYEN BT, 1984, CANCER RES, V44, P2272; Pankiewicz KW, 1999, CURR MED CHEM, V6, P629; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Sangiolo D, 2007, GENE THER, V14, P1549, DOI 10.1038/sj.gt.3303018; Shimmura H, 2006, TRANSPLANTATION, V82, P175, DOI 10.1097/01.tp.0000226227.79142.31; Sorg UR, 2007, DNA REPAIR, V6, P1197, DOI 10.1016/j.dnarep.2007.03.021; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Treon SP, 1996, CLIN CHEM, V42, P1322; Volpato JP, 2011, J MOL RECOGNIT, V24, P188, DOI 10.1002/jmr.1037; Walker RE, 1998, NAT MED, V4, P852, DOI 10.1038/nm0798-852; Wang XL, 2012, J IMMUNOTHER, V35, P689, DOI 10.1097/CJI.0b013e318270dec7; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Yam P, 2006, MOL THER, V14, P236, DOI 10.1016/j.ymthe.2006.02.017	39	21	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65519	10.1371/journal.pone.0065519	http://dx.doi.org/10.1371/journal.pone.0065519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755242	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000074
J	Lorin, J; Guilland, JC; Korandji, C; Touzery, C; Bichat, F; Chagnon, A; Cottin, Y; Rochette, L; Vergely, C; Zeller, M				Lorin, Julie; Guilland, Jean-Claude; Korandji, Claudia; Touzery, Claude; Bichat, Florence; Chagnon, Aline; Cottin, Yves; Rochette, Luc; Vergely, Catherine; Zeller, Marianne			High Levels of Asymmetric Dimethylarginine Are Strongly Associated with Low HDL in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; NITRIC-OXIDE SYNTHASE; ENDOTHELIUM-DEPENDENT VASODILATION; RANDOMIZED CLINICAL-TRIAL; CARDIOVASCULAR-DISEASE; ENDOGENOUS INHIBITOR; METABOLIC SYNDROME; RENAL-FAILURE; HEART-DISEASE	Objectives: Low levels of high-density lipoprotein (HDL) cholesterol are associated with an increased risk of acute myocardial infarction possibly through impaired endothelial atheroprotection and decreased nitric oxide (NO) bioavailability. Asymmetric dimethylarginine (ADMA) mediates endothelial function by inhibiting nitric oxide synthase activity. In patients with acute myocardial infarction, we investigated the relationship between serum levels of HDL and ADMA. Approach and Results: Blood samples from 612 consecutive patients hospitalized for acute MI <24 hours after symptom onset were taken on admission. Serum levels of ADMA, its stereoisomer, symmetric dimethylarginine (SDMA) and L-arginine were determined using high-performance liquid chromatography. Patients with low HDL (<40 mg/dL for men and <50 mg/dL for women) were compared with patients with higher HDL. Most patients (59%) had low HDL levels. Median ADMA levels were markedly higher in the low HDL group (0.69 vs. 0.50 mmole/L, p<0.001). In contrast, SDMA and L-arginine levels were similar for the two groups (p = 0.120 and p = 0.064). Notably, ADMA, but not SDMA or L-arginine, was inversely correlated with HDL (r = 20.311, p<0.001). In stratified analysis, this relationship was only found for low HDL levels (r = 20.265, p<0.001), but not when HDL levels were higher (r = 20.077, p = 0.225). By multivariate logistic regression analysis, ADMA level was strongly associated with low HDL levels (OR(95% CI): 6.06(3.48-10.53), p<0.001), beyond traditional confounding factors. Conclusions: Our large population-based study showed for the first time a strong inverse relationship between HDL and ADMA in myocardial infarction patients, suggesting a functional interaction between HDL and endothelium, beyond metabolic conditions associated with low HDL levels.	[Lorin, Julie; Guilland, Jean-Claude; Korandji, Claudia; Cottin, Yves; Rochette, Luc; Vergely, Catherine; Zeller, Marianne] Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, INSERM, UMR866, Dijon, France; [Touzery, Claude; Bichat, Florence; Chagnon, Aline; Cottin, Yves] Univ Hosp, Dept Cardiol, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne	Zeller, M (corresponding author), Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, INSERM, UMR866, Dijon, France.	marianne.zeller@u-bourgogne.fr	COTTIN, YVES/ABA-4622-2020; Vergely, Catherine/L-9534-2015	Vergely, Catherine/0000-0003-4009-776X	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Agence Regionale de Sante (ARS) de Bourgogne; French Ministry of Research from the Institut National de la Sante et de la Recherche Medicale (INSERM); Regional Council of Burgundy	University Hospital of Dijon; Association de Cardiologie de Bourgogne; Agence Regionale de Sante (ARS) de Bourgogne(Region Bourgogne-Franche-Comte); French Ministry of Research from the Institut National de la Sante et de la Recherche Medicale (INSERM); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	This work was supported by the University Hospital of Dijon, the Association de Cardiologie de Bourgogne, and by grants from the Agence Regionale de Sante (ARS) de Bourgogne, the French Ministry of Research from the Institut National de la Sante et de la Recherche Medicale (INSERM) and from the Regional Council of Burgundy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; [Anonymous], JAMA, V285, P2486; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Besler C, 2012, EMBO MOL MED, V4, P251, DOI 10.1002/emmm.201200224; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Boger GI, 2007, J AM COLL CARDIOL, V49, P2274, DOI 10.1016/j.jacc.2007.02.051; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173; Boger RH, 2003, CARDIOVASC RES, V59, P824, DOI 10.1016/S0008-6363(03)00500-5; Chao CL, 2000, CIRCULATION, V101, P485, DOI 10.1161/01.CIR.101.5.485; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Fard A, 2000, ARTERIOSCL THROM VAS, V20, P2039, DOI 10.1161/01.ATV.20.9.2039; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023; Gossett LK, 2009, J CLIN LIPIDOL, V3, P372, DOI 10.1016/j.jacl.2009.10.008; Hermann F, 2009, THROMB RES, V123, P460, DOI 10.1016/j.thromres.2008.06.022; Ivanova M, 2010, CLIN CHIM ACTA, V411, P1632, DOI 10.1016/j.cca.2010.06.001; Juonala M, 2007, CIRCULATION, V116, P1367, DOI 10.1161/CIRCULATIONAHA.107.690016; Kajimoto H, 2012, KIDNEY INT, V81, P762, DOI 10.1038/ki.2011.476; Kontush A, 2006, NAT CLIN PRACT CARD, V3, P144, DOI 10.1038/ncpcardio0500; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Li XP, 2000, INT J CARDIOL, V73, P231, DOI 10.1016/S0167-5273(00)00221-7; Litvinov D, 2012, N AM J MED SCI, V4, P523, DOI 10.4103/1947-2714.103310; Luscher TF, 2012, EUR HEART J, V33, P857, DOI 10.1093/eurheartj/ehs019; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Meinitzer A, 2007, CLIN CHEM, V53, P273, DOI 10.1373/clinchem.2006.076711; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Paneni F, 2012, INT J CARDIOL, V158, P158, DOI 10.1016/j.ijcard.2012.04.032; Peng ZY, 2011, MOL CELL BIOCHEM, V351, P243, DOI 10.1007/s11010-011-0731-7; Prosser HC, 2012, CURR OPIN LIPIDOL, V23, P182, DOI 10.1097/MOL.0b013e328352c4dd; ROSENSON RS, 1993, J AM COLL CARDIOL, V22, P933; RYDER REJ, 1984, BRIT MED J, V289, P1651, DOI 10.1136/bmj.289.6459.1651; Spieker LE, 2002, CIRCULATION, V105, P1399, DOI 10.1161/01.CIR.0000013424.28206.8F; Thorne S, 1998, J AM COLL CARDIOL, V32, P110, DOI 10.1016/S0735-1097(98)00211-3; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; VALLANCE P, 1992, LANCET, V339, P572; Warnholtz A, 2009, ATHEROSCLEROSIS, V204, P216, DOI 10.1016/j.atherosclerosis.2008.08.003; WARNICK GR, 1990, SCAND J CLIN LAB INV, V50, P9, DOI 10.3109/00365519009091079; Witting PK, 2011, FREE RADICAL BIO MED, V51, P1390, DOI 10.1016/j.freeradbiomed.2011.06.031; Yasuda S, 2006, EUR HEART J, V27, P1159, DOI 10.1093/eurheartj/ehi876; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768; Zeller M, 2007, J AM COLL CARDIOL, V50, P1948, DOI 10.1016/j.jacc.2007.06.052; Zelzer S, 2011, CLIN CHIM ACTA, V412, P1345, DOI 10.1016/j.cca.2011.03.031; Zheng CY, 2012, J AM COLL CARDIOL, V60, P2380, DOI 10.1016/j.jacc.2012.08.999	47	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64796	10.1371/journal.pone.0064796	http://dx.doi.org/10.1371/journal.pone.0064796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755144	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000024
J	Schick, RS; Kraus, SD; Rolland, RM; Knowlton, AR; Hamilton, PK; Pettis, HM; Kenney, RD; Clark, JS				Schick, Robert S.; Kraus, Scott D.; Rolland, Rosalind M.; Knowlton, Amy R.; Hamilton, Philip K.; Pettis, Heather M.; Kenney, Robert D.; Clark, James S.			Using Hierarchical Bayes to Understand Movement, Health, and Survival in the Endangered North Atlantic Right Whale	PLOS ONE			English	Article							EUBALAENA-GLACIALIS; CAPTURE-RECAPTURE; BODY CONDITION; UNITED-STATES; REPRODUCTIVE STATUS; SUCCESS; POPULATIONS; DEMOGRAPHY; AUSTRALIS; TELEMETRY	Body condition is an indicator of health, and it plays a key role in many vital processes for mammalian species. While evidence of individual body condition can be obtained, these observations provide just brief glimpses into the health state of the animal. An analytical framework is needed for understanding how health of animals changes over space and time. Through knowledge of individual health we can better understand the status of populations. This is particularly important in endangered species, where the consequences of disruption of critical biological functions can push groups of animals rapidly toward extinction. Here we built a state-space model that provides estimates of movement, health, and survival. We assimilated 30+ years of photographic evidence of body condition and three additional visual health parameters in individual North Atlantic right whales, together with survey data, to infer the true health status as it changes over space and time. We also included the effect of reproductive status and entanglement status on health. At the population level, we estimated differential movement patterns in males and females. At the individual level, we estimated the likely animal locations each month. We estimated the relationship between observed and latent health status. Observations of body condition, skin condition, cyamid infestation on the blowholes, and rake marks all provided measures of the true underlying health. The resulting time series of individual health highlight both normal variations in health status and how anthropogenic stressors can affect the health and, ultimately, the survival of individuals. This modeling approach provides information for monitoring of health in right whales, as well as a framework for integrating observational data at the level of individuals up through the health status of the population. This framework can be broadly applied to a variety of systems - terrestrial and marine - where sporadic observations of individuals exist.	[Schick, Robert S.; Clark, James S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Schick, Robert S.] Univ St Andrews, Ctr Res Ecol & Environm Modeling, St Andrews, Fife, Scotland; [Kraus, Scott D.; Rolland, Rosalind M.; Knowlton, Amy R.; Hamilton, Philip K.; Pettis, Heather M.] New England Aquarium, John H Prescott Marine Lab, Boston, MA USA; [Kenney, Robert D.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	Duke University; University of St Andrews; University of Rhode Island	Schick, RS (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	rss5@st-andrews.ac.uk		Kraus, Scott/0000-0003-4367-6548	United States Office of Naval Research [N00014-10-1-0516, N00014-12-1-0286, N00014-12-1-0389]; Office of Naval Research [N00014-09-1-0896, N00014-12-1-0274]	United States Office of Naval Research(Office of Naval Research); Office of Naval Research(Office of Naval Research)	This work was supported by the United States Office of Naval Research grants N00014-10-1-0516 and N00014-12-1-0286 to Duke University and University of St. Andrews, as well as N00014-12-1-0389 to the New England Aquarium. This work benefited from discussions with participants in a working group supported by Office of Naval Research grants N00014-09-1-0896 to the University of California, Santa Barbara and N00014-12-1-0274 to the University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner MF, 2005, CAN J FISH AQUAT SCI, V62, P527, DOI 10.1139/F04-238; Bestley S, 2010, ECOLOGY, V91, P2373, DOI 10.1890/08-2019.1; Bradford AL, 2012, J MAMMAL, V93, P251, DOI 10.1644/11-MAMM-A-091.1; Brown Moira W., 2007, P105; Brown Moira W., 2001, Journal of Cetacean Research and Management Special Issue, V2, P245; CHASTEL O, 1995, ECOLOGY, V76, P2240, DOI 10.2307/1941698; Clark J. S, 2007, MODELS ECOLOGICAL DA; Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2; Clark JS, 2005, ECOLOGY, V86, P2232, DOI 10.1890/04-1348; CLOBERT J, 1985, BIOMETRICS, V41, P1031, DOI 10.2307/2530974; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Dupuis JA, 1995, BIOMETRIKA, V82, P761, DOI 10.1093/biomet/82.4.761; Festa-Bianchet M, 1998, ECOL LETT, V1, P91; Firestone J, 2008, BIOL CONSERV, V141, P221, DOI 10.1016/j.biocon.2007.09.024; Fonnesbeck Christopher J., 2008, Endangered Species Research, V6, P87, DOI 10.3354/esr00134; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Goldstein J, 2007, MAR BIOL, V151, P2063, DOI 10.1007/s00227-007-0638-8; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Hamilton P, 2007, URBAN WHALE N ATLANT; Hamilton P, 2012, N ATL RIGHT WHAL CON; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KENNEY RD, 1986, FISH B-NOAA, V84, P345; King R, 2012, INTERFACE FOCUS, V2, P190, DOI 10.1098/rsfs.2011.0078; Knowlton AR, 2012, MAR ECOL PROG SER, V466, P293, DOI 10.3354/meps09923; Knowlton Amy R., 2001, Journal of Cetacean Research and Management Special Issue, V2, P193; KNOWLTON AR, 1994, CAN J ZOOL, V72, P1297, DOI 10.1139/z94-173; KNOWLTON AR, 1992, MAR MAMMAL SCI, V8, P397, DOI 10.1111/j.1748-7692.1992.tb00054.x; Knowlton AR, 2002, RIGHT WHALE SIGHTING; Kraus S, 1986, USE PHOTOGRAPHS IDEN, V10, P145; Kraus S.D., 2009, URBAN WHALE N ATLANT; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Kraus SD, 1986, REP INT WHAL COMM, V10, P139; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Malik S, 1999, CAN J ZOOL, V77, P1217, DOI 10.1139/cjz-77-8-1217; Mate BR, 1997, J WILDLIFE MANAGE, V61, P1393, DOI 10.2307/3802143; Miller CA, 2012, MAR ECOL PROG SER, V459, P135, DOI 10.3354/meps09675; Miller CA, 2011, MAR ECOL PROG SER, V438, P267, DOI 10.3354/meps09174; Moore MJ, 2012, MARINE MAMMAL SCI; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; NMFS, 2005, REC PLAN N ATL RIGHT; Pettis HM, 2004, CAN J ZOOL, V82, P8, DOI [10.1139/z03-207, 10.1139/Z03-207]; Pettis HM, 2012, 2012 ANN N ATLANTIC; POLLOCK KH, 1991, J AM STAT ASSOC, V86, P225, DOI 10.2307/2289733; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Rolland Rosalind M., 2007, P273; Schick RS, 2009, CAN J FISH AQUAT SCI, V66, P1399, DOI 10.1139/F09-115; Schick RS, 2012, ESTIMATING RESOURCE; SHOOP CR, 1992, HERPETOL MONOGR, V6, P43; Vanderlaan Angelia S. M., 2008, Endangered Species Research, V4, P283, DOI 10.3354/esr00083; Weimerskirch H, 1997, ECOLOGY, V78, P2051; Weinrich MT, 2000, MAR MAMMAL SCI, V16, P326, DOI 10.1111/j.1748-7692.2000.tb00928.x; Winn H.E., 1986, Reports of the International Whaling Commission Special Issue, P129	53	39	41	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64166	10.1371/journal.pone.0064166	http://dx.doi.org/10.1371/journal.pone.0064166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762237	Green Published, gold			2022-12-25	WOS:000321099000006
J	Bruehl, H; Preissler, S; Heuser, I; Heekeren, HR; Roepke, S; Dziobek, I				Bruehl, Hannah; Preissler, Sandra; Heuser, Isabella; Heekeren, Hauke R.; Roepke, Stefan; Dziobek, Isabel			Increased Prefrontal Cortical Thickness Is Associated with Enhanced Abilities to Regulate Emotions in PTSD-Free Women with Borderline Personality Disorder	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; STRUCTURAL BRAIN ABNORMALITIES; HIPPOCAMPAL VOLUME; FEMALE-PATIENTS; PHYSICAL ABUSE; SEXUAL-ABUSE; GRAY-MATTER; AXIS-I; DSM-IV; AMYGDALA	Previous studies suggest that amygdala, insula and prefrontal cortex (PFC) disintegrity play a crucial role in the failure to adequately regulate emotions in Borderline Personality Disorder (BPD). However, prior results are confounded by the high rate of comorbidity with Posttraumatic Stress Disorder (PTSD), which itself has been associated with changes in frontolimbic circuitry. We thus scrutinized the link between PFC, amygdala, insula, and the ability to regulate emotions, contrasting 17 women with BPD without comorbid PTSD to 27 non-clinical control women and in addition to those with BPD and PTSD (n = 14). BPD women without PTSD, but not those with comorbid PTSD, had increased cortical thickness in the dorsolateral PFC (DLPFC) in comparison to control women. Furthermore, cortical thickness in the DLPFC of BPD women without PTSD positively correlated with emotion regulation scores and furthermore was positively associated with amygdala volume, as well as cortical thickness of the insula. Our findings highlight the importance of disentangling the impact of BPD and PTSD on the brain and suggest possible compensatory mechanisms for the impaired emotion regulation in BPD women without PTSD.	[Bruehl, Hannah; Heekeren, Hauke R.] Free Univ Berlin, Dept Psychol Emot & Affect Neurosci, Berlin, Germany; [Preissler, Sandra] Univ Jena, Dept Biol & Clin Psychol, Jena, Germany; [Heuser, Isabella; Roepke, Stefan] Charite, Dept Psychiat, D-13353 Berlin, Germany; [Heuser, Isabella; Heekeren, Hauke R.; Roepke, Stefan; Dziobek, Isabel] Free Univ Berlin, Berlin, Germany	Free University of Berlin; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Bruehl, H (corresponding author), Free Univ Berlin, Dept Psychol Emot & Affect Neurosci, Berlin, Germany.	hannah.bruehl@fu-berlin.de	Bruehl, Hannah/A-1610-2015; Dziobek, isabel/ABB-4928-2020	Heekeren, Hauke/0000-0001-7912-6826	German Federal Ministry of Education and Research [BMBF] [01GO0518, 01GW0783]	German Federal Ministry of Education and Research [BMBF](Federal Ministry of Education & Research (BMBF))	This study was supported by a grant from the German Federal Ministry of Education and Research [BMBF, No.: 01GO0518 and No.: 01GW0783]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, WST WORTSCHATZTEST; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Behr M., 2004, SKALEN ZUM ERLEBEN E; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Brambilla P, 2004, PSYCHIAT RES-NEUROIM, V131, P125, DOI 10.1016/j.pscychresns.2004.04.003; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; BROWNE A, 1986, PSYCHOL BULL, V99, P66, DOI 10.1037/0033-2909.99.1.66; Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dewey J, 2010, NEUROIMAGE, V51, P1334, DOI 10.1016/j.neuroimage.2010.03.033; Diaz-Marsa M, 2011, J AFFECT DISORD; Donegan NH, 2003, BIOL PSYCHIAT, V54, P1284, DOI 10.1016/S0006-3223(03)00636-X; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Dziobek I, 2010, ARCH GEN PSYCHIAT, V67, P397, DOI 10.1001/archgenpsychiatry.2010.31; Eckart C, 2011, J PSYCHIATR NEUROSCI, V36, P176, DOI 10.1503/jpn.100010; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; First M. B., 1997, STRUCTURED CLIN INTE; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Foa E.B., 1995, PDS POSTTRAUMATIC ST; Glenn CR, 2009, J PERS DISORD, V23, P20, DOI 10.1521/pedi.2009.23.1.20; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; Hazlett EA, 2005, BIOL PSYCHIAT, V58, P614, DOI 10.1016/j.biopsych.2005.04.029; Heffernan K, 2000, J NERV MENT DIS, V188, P589, DOI 10.1097/00005053-200009000-00005; Horn W., 1983, L P S LEISTUNGSPR FS, V2; Juengling FD, 2003, J PSYCHIAT RES, V37, P109, DOI 10.1016/S0022-3956(02)00084-5; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Koenigsberg HW, 2009, BIOL PSYCHIAT, V66, P854, DOI 10.1016/j.biopsych.2009.06.010; Koenigsberg HW, 2009, PSYCHIAT RES-NEUROIM, V172, P192, DOI 10.1016/j.pscychresns.2008.07.010; Kraus A, 2010, ACTA PSYCHIAT SCAND, V121, P41, DOI 10.1111/j.1600-0447.2009.01417.x; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Landre L, 2010, PSYCHIAT RES-NEUROIM, V183, P181, DOI 10.1016/j.pscychresns.2010.01.015; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Lis E, 2007, J PSYCHIATR NEUROSCI, V32, P162; Mauchnik J, 2010, CURR PSYCHIAT REP, V12, P46, DOI 10.1007/s11920-009-0089-7; Mazza M, 2013, EUR ARCH PSYCHIAT CL; Minzenberg MJ, 2008, J PSYCHIATR RES, V42, P727, DOI 10.1016/j.jpsychires.2007.07.015; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Nepon J, 2010, DEPRESS ANXIETY, V27, P791, DOI 10.1002/da.20674; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; Niedtfeld I, 2010, BIOL PSYCHIAT, V68, P383, DOI 10.1016/j.biopsych.2010.04.015; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; OGATA SN, 1990, AM J PSYCHIAT, V147, P1008; OLDHAM JM, 1995, AM J PSYCHIAT, V152, P571; Rodrigues E, 2011, EUR PSYCHIAT, V26, P452, DOI 10.1016/j.eurpsy.2010.07.005; Roth S, 1997, J TRAUMA STRESS, V10, P539, DOI 10.1002/jts.2490100403; Ruocco AC, 2013, BIOL PSYCHIAT, V73, P153, DOI 10.1016/j.biopsych.2012.07.014; Ruocco AC, 2012, PSYCHIAT RES-NEUROIM, V201, P245, DOI 10.1016/j.pscychresns.2012.02.012; Rusch N, 2003, NEUROIMAGE, V20, P385, DOI 10.1016/S1053-8119(03)00297-0; Sala M, 2011, J AFFECT DISORDERS, V131, P417, DOI 10.1016/j.jad.2010.11.036; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Schmahl C, 2006, J PSYCHIATR RES, V40, P419, DOI 10.1016/j.jpsychires.2005.08.011; Schmahl Christian, 2009, J Psychiatry Neurosci, V34, P289; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Silbersweig D, 2007, AM J PSYCHIAT, V164, P1832, DOI 10.1176/appi.ajp.2007.06010126; Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003; Soloff PH, 2003, PSYCHIAT RES-NEUROIM, V123, P153, DOI 10.1016/S0925-4927(03)00064-7; Takahashi T, 2009, PROG NEURO-PSYCHOPH, V33, P1395, DOI 10.1016/j.pnpbp.2009.07.017; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van Elst LT, 2003, BIOL PSYCHIAT, V54, P163, DOI 10.1016/S0006-3223(03)01743-2; Vrticka P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00095; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Weniger G, 2009, J PSYCHIATR NEUROSCI, V34, P383; Zanarini MC, 1998, AM J PSYCHIAT, V155, P1733, DOI 10.1176/ajp.155.12.1733; Zlotnick C, 1999, J NERV MENT DIS, V187, P296, DOI 10.1097/00005053-199905000-00005	73	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65584	10.1371/journal.pone.0065584	http://dx.doi.org/10.1371/journal.pone.0065584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755254	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400068
J	Burkert, NT; Rasky, E; Grossschadl, F; Muckenhuber, J; Freidl, W				Burkert, Nathalie T.; Rasky, Eva; Grossschaedl, Franziska; Muckenhuber, Johanna; Freidl, Wolfgang			The Influence of Socioeconomic Factors on Health Parameters in Overweight and Obese Adults	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; DETERMINANTS; INEQUALITIES; GRADIENT; MEN	The prevalence of being overweight and of obesity is increasing worldwide, and is associated with a high risk to health. Therefore, the aim of our study was to investigate whether normal weight, overweight and obese subjects of low, middle or high socioeconomic status (SES) differ with regard to their health behavior, health, quality of life, and the use of medical care. Data from the Austrian Health Interview Survey (ATHIS) 2006/07, comprising 3 groups of 1,077 individuals, each of whom were normal weight, overweight, or obese, respectively, and matched according to their age, sex and SES, were analyzed concerning health outcomes. The results show that subjects with a low SES differ significantly from those of high SES in terms of their health behavior, self-perceived health, levels of impairment, chronic conditions, quality of life, and health care. Additionally, obesity in adults is associated with sub-optimal dietary practices and worse health, poorer quality of life and medical care than normal weight and overweight individuals. A significant interaction between the weight class and SES was found concerning physical exercise, impairment due to health problems and chronic diseases. A low SES has a strong negative impact on health, especially in obese individuals. Therefore a continuous target group-oriented, nondiscriminatory public health program is required, prioritizing obese subjects with low SES.	[Burkert, Nathalie T.; Rasky, Eva; Grossschaedl, Franziska; Muckenhuber, Johanna; Freidl, Wolfgang] Med Univ Graz, Inst Social Med & Epidemiol, Graz, Styria, Austria	Medical University of Graz	Burkert, NT (corresponding author), Med Univ Graz, Inst Social Med & Epidemiol, Graz, Styria, Austria.	nathalie.burkert@medunigraz.at		Grossschadl, Franziska/0000-0002-6726-0443				Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Ahn S, 2012, INT J PUBLIC HEALTH, V57, P269, DOI 10.1007/s00038-011-0249-5; Amarasinghe A, 2009, INT J ENV RES PUB HE, V6, P2271, DOI 10.3390/ijerph6082271; [Anonymous], 2010, STRAT REV HLTH IN EN; Bauer GF, 2009, INT J PUBLIC HEALTH, V54, P23, DOI 10.1007/s00038-008-7077-2; Branca F., 2007, CHALLENGE OBESITY WH; Brennan SL, 2010, J MENS HEALTH, V7, P31, DOI 10.1016/j.jomh.2009.10.004; Brennan SL, 2009, PREV MED, V49, P165, DOI 10.1016/j.ypmed.2009.06.021; Burkert N, 2012, WIEN KLIN WOCHENSCHR, V124, P256, DOI 10.1007/s00508-012-0164-7; Burkert NT, 2012, WIEN KLIN WOCHENSCHR, V124, P271, DOI 10.1007/s00508-012-0160-y; Burkert NI, 2012, GESUNDHEITSWESEN, V2012, P11; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Grossschaedel F, 2012, WIEN KLIN WOCHENSCHR, V8-9, P560; Grossschadl F, 2013, EUR J PUBLIC HEALTH, V23, P306, DOI 10.1093/eurpub/cks033; Holstein BE, 2009, INT J PUBLIC HEALTH, V54, P260, DOI 10.1007/s00038-009-5418-4; Garcia-Mendizabal MJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-120; Kilicarslan A, 2006, J NATL MED ASSOC, V98, P1313; Kinge JM, 2010, SOC SCI MED, V71, P1864, DOI 10.1016/j.socscimed.2010.09.001; Klimont J, 2007, AUSTR HLTH INTERVIEW; Kuipers Y, 2010, FOCUSING OBESITY HLT; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; Leach Corinne R, 2007, Prev Chronic Dis, V4, pA95; Mackenbach, 2006, HLTH INEQUALITIES EU; Organization WH, 1996, WHOQOL BREF INTR ADM; Richardson Harriet, 2007, Open Med, V1, pe3; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Schumacher MC, 2008, CANCER CAUSE CONTROL, V19, P725, DOI 10.1007/s10552-008-9135-8; Toschke AM, 2005, INT J OBESITY, V29, P875, DOI 10.1038/sj.ijo.0802989; von Lengerke T, 2006, GESUNDHEITSWESEN, V68, P110, DOI 10.1055/s-2005-858994; Wamala SP, 1997, PREV MED, V26, P734, DOI 10.1006/pmed.1997.0199; Wee HL, 2010, INT J OBESITY, V34, P1034, DOI 10.1038/ijo.2010.24; WHO, 1998, CONS OB OB PREV MAN; Zago CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029894	33	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65407	10.1371/journal.pone.0065407	http://dx.doi.org/10.1371/journal.pone.0065407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755228	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400058
J	Lori, C; Lantella, A; Pasquo, A; Alexander, LT; Knapp, S; Chiaraluce, R; Consalvi, V				Lori, Clorinda; Lantella, Antonella; Pasquo, Alessandra; Alexander, Leila T.; Knapp, Stefan; Chiaraluce, Roberta; Consalvi, Valerio			Effect of Single Amino Acid Substitution Observed in Cancer on Pim-1 Kinase Thermodynamic Stability and Structure	PLOS ONE			English	Article							CIRCULAR-DICHROISM; INHIBITORS; MUTATION; ACTIVATION; PROTEINS; GENOMES	Pim-1 kinase, a serine/threonine protein kinase encoded by the pim proto-oncogene, is involved in several signalling pathways such as the regulation of cell cycle progression and apoptosis. Many cancer types show high expression levels of Pim kinases and particularly Pim-1 has been linked to the initiation and progression of the malignant phenotype. In several cancer tissues somatic Pim-1 mutants have been identified. These natural variants are nonsynonymous single nucleotide polymorphisms, variations of a single nucleotide occurring in the coding region and leading to amino acid substitutions. In this study we investigated the effect of amino acid substitution on the structural stability and on the activity of Pim-1 kinase. We expressed and purified some of the mutants of Pim-1 kinase that are expressed in cancer tissues and reported in the single nucleotide polymorphisms database. The point mutations in the variants significantly affect the conformation of the native state of Pim-1. All the mutants, expressed as soluble recombinant proteins, show a decreased thermal and thermodynamic stability and a lower activation energy values for kinase activity. The decreased stability accompanied by an increased flexibility suggests that Pim-1 variants may be involved in a wider network of protein interactions. All mutants bound ATP and ATP mimetic inhibitors with comparable IC50 values suggesting that the studied Pim-1 kinase mutants can be efficiently targeted with inhibitors developed for the wild type protein.	[Lori, Clorinda; Lantella, Antonella; Chiaraluce, Roberta; Consalvi, Valerio] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy; [Pasquo, Alessandra] UT BIORAD FARM CR Casaccia ENEA, Rome, Italy; [Alexander, Leila T.; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	Sapienza University Rome; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Oxford	Chiaraluce, R (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	roberta.chiaraluce@uniroma1.it	consalvi, valerio/F-1918-2011; Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494	Wellcome Trust [092809] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akagi T, 2009, HAEMATOL-HEMATOL J, V94, P1301, DOI 10.3324/haematol.2009.005744; Akue-Gedu R, 2009, J MED CHEM, V52, P6369, DOI 10.1021/jm901018f; Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Anizon F, 2010, CURR MED CHEM, V17, P4114, DOI 10.2174/092986710793348554; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Bromberg Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S8; Bullock AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007112; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; CUYPERS HT, 1984, CELL, V37, P141; Dixit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007485; Doudou S, 2010, J CHEM INF MODEL, V50, P368, DOI 10.1021/ci9003514; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; HOOVER D, 1991, J BIOL CHEM, V266, P14018; Huber K, 2012, J MED CHEM, V55, P403, DOI 10.1021/jm201286z; Hung HC, 2003, B MATH BIOL, V65, P553, DOI 10.1016/S0092-8240(03)00024-7; Muralidhar D, 2005, J BIOL CHEM, V280, P15569, DOI 10.1074/jbc.M414243200; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Patel S, 2004, BIOCHEMISTRY-US, V43, P1724, DOI 10.1021/bi0347104; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zhang Z, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/805827; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	33	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64824	10.1371/journal.pone.0064824	http://dx.doi.org/10.1371/journal.pone.0064824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755147	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400027
J	Poojari, S; Alabi, OJ; Fofanov, VY; Naidu, RA				Poojari, Sudarsana; Alabi, Olufemi J.; Fofanov, Viacheslav Y.; Naidu, Rayapati A.			A Leafhopper-Transmissible DNA Virus with Novel Evolutionary Lineage in the Family Geminiviridae Implicated in Grapevine Redleaf Disease by Next-Generation Sequencing	PLOS ONE			English	Article							RECOMBINATION EVENTS; COAT PROTEIN; SMALL RNAS; INFECTION; DIVERSITY; PLANTS; ALIGNMENT; SYNERGISM; REVEALS	A graft-transmissible disease displaying red veins, red blotches and total reddening of leaves in red-berried wine grape (Vitis vinifera L.) cultivars was observed in commercial vineyards. Next-generation sequencing technology was used to identify etiological agent(s) associated with this emerging disease, designated as grapevine redleaf disease (GRD). High quality RNA extracted from leaves of grape cultivars Merlot and Cabernet Franc with and without GRD symptoms was used to prepare cDNA libraries. Assembly of highly informative sequence reads generated from Illumina sequencing of cDNA libraries, followed by bioinformatic analyses of sequence contigs resulted in specific identification of taxonomically disparate viruses and viroids in samples with and without GRD symptoms. A single-stranded DNA virus, tentatively named Grapevine redleaf-associated virus (GRLaV), and Grapevine fanleaf virus were detected only in grapevines showing GRD symptoms. In contrast, Grapevine rupestris stem pitting-associated virus, Hop stunt viroid, Grapevine yellow speckle viroid 1, Citrus exocortis viroid and Citrus exocortis Yucatan viroid were present in both symptomatic and non-symptomatic grapevines. GRLaV was transmitted by the Virginia creeper leafhopper (Erythroneura ziczac Walsh) from grapevine-to-grapevine under greenhouse conditions. Molecular and phylogenetic analyses indicated that GRLaV, almost identical to recently reported Grapevine Cabernet Franc-associated virus from New York and Grapevine red blotch-associated virus from California, represents an evolutionarily distinct lineage in the family Geminiviridae with genome characteristics distinct from other leafhopper-transmitted geminiviruses. GRD significantly reduced fruit yield and affected berry quality parameters demonstrating negative impacts of the disease. Higher quantities of carbohydrates were present in symptomatic leaves suggesting their possible role in the expression of redleaf symptoms.	[Poojari, Sudarsana; Alabi, Olufemi J.; Naidu, Rayapati A.] Washington State Univ, Irrigated Agr Res & Extens Ctr, Dept Plant Pathol, Prosser, WA 99350 USA; [Fofanov, Viacheslav Y.] Eureka Genom, Sugar Land, TX USA	Washington State University	Naidu, RA (corresponding author), Washington State Univ, Irrigated Agr Res & Extens Ctr, Dept Plant Pathol, Prosser, WA 99350 USA.	naidu.rayapati@wsu.edu	Alabi, Olufemi J./ABD-9930-2020; Poojari, Sudarsana/Y-7587-2019	Alabi, Olufemi J./0000-0002-2471-7052; Poojari, Sudarsana/0000-0001-9258-1612; Rayapati, Naidu/0000-0002-7273-5116	Washington State University's Agricultural Research Center in the College of Agricultural, Human, and Natural Resource Sciences; Wine Advisory Committee of the Washington Wine Commission; USDA-Northwest Center for Small Fruits Research, USDA-NIFA Specialty Crop Research Initiative [2009-51181-06027]; Washington State Department of Agriculture Nursery Assessment Funds; Washington State Commission on Pesticide Registration; USDA-APHIS National Clean Plant Network	Washington State University's Agricultural Research Center in the College of Agricultural, Human, and Natural Resource Sciences; Wine Advisory Committee of the Washington Wine Commission; USDA-Northwest Center for Small Fruits Research, USDA-NIFA Specialty Crop Research Initiative; Washington State Department of Agriculture Nursery Assessment Funds; Washington State Commission on Pesticide Registration; USDA-APHIS National Clean Plant Network	This work was supported, in part, by Washington State University's Agricultural Research Center in the College of Agricultural, Human, and Natural Resource Sciences, Wine Advisory Committee of the Washington Wine Commission, USDA-Northwest Center for Small Fruits Research, USDA-NIFA Specialty Crop Research Initiative (Award Number 2009-51181-06027), Washington State Department of Agriculture Nursery Assessment Funds, Washington State Commission on Pesticide Registration and USDA-APHIS National Clean Plant Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Al Rwahnih M, 2012, P 17 C INT COUNC STU, P104; Alabi OJ, 2012, P 17 C INT COUNC STU, P170; Alabi OJ, 2012, MOL PLANT PATHOL, V13, P1060, DOI 10.1111/j.1364-3703.2012.00815.x; Alabi OJ, 2010, J GEN VIROL, V91, P265, DOI 10.1099/vir.0.014423-0; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Arnett R. H, 2000, AM INSECTS HDB INSEC, V2nd; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; BRIDDON RW, 1990, VIROLOGY, V177, P85, DOI 10.1016/0042-6822(90)90462-Z; Brown JK, 2011, VIRUS TAXONOMY CLASS, P251; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Herbers K, 2000, MOL PLANT PATHOL, V1, P51, DOI 10.1046/j.1364-3703.2000.00007.x; Iland P., 2000, TECHNIQUES CHEM ANAL; Isakov O, 2011, BIOINFORMATICS, V27, P2027, DOI 10.1093/bioinformatics/btr349; Jiang DM, 2009, ARCH VIROL, V154, P1563, DOI 10.1007/s00705-009-0454-1; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Kawaguchi-Ito Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008386; Kirthi N, 2003, ARCH VIROL, V148, P2369, DOI 10.1007/s00705-003-0174-x; Komar V, 2010, AM J ENOL VITICULT, V61, P68; KRAKE LR, 1999, GRAFT TRANSMITTED DI; Krenz B, 2012, J VIROL, V86, P7715, DOI 10.1128/JVI.00943-12; Kriesel JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031886; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latham JR, 2008, MOL PLANT PATHOL, V9, P85, DOI [10.1111/j.1364-3703.2007.00441.x, 10.1111/J.1364-3703.2007.00441.X]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Little A, 2003, VIROIDS, p[2003, 95]; Martelli GP, 2012, J PLANT PATHOL, V94, P7; Martelli G.P., 2006, OPTIONS MEDITERR B, V55, P11; MCKENZIE LM, 1972, CAN ENTOMOL, V104, P1229, DOI 10.4039/Ent1041229-8; Mekuria TA, 2009, PHYTOPATHOLOGY, V99, P1394, DOI 10.1094/PHYTO-99-12-1394; Nash TE, 2011, J VIROL, V85, P1182, DOI 10.1128/JVI.02143-10; Oliver JE, 2011, AM J ENOL VITICULT, V62, P438, DOI 10.5344/ajev.2011.11036; Olsen K, 1997, EXTENSION B WASHINGT, V1828; Olsen KN, 1998, ENVIRON ENTOMOL, V27, P401, DOI 10.1093/ee/27.2.401; Petrie PR, 2000, VITIS, V39, P31; Prosser SW, 2007, VIRUS RES, V124, P151, DOI 10.1016/j.virusres.2006.10.014; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Rayapati N, 2008, WASHINGTON STATE U E; Roossinck MJ, 2005, NAT REV MICROBIOL, V3, P917, DOI 10.1038/nrmicro1285; Rowhani A., 2000, P 13 INT COUNC STUD; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Soto MJ, 2005, VIROLOGY, V341, P257, DOI 10.1016/j.virol.2005.07.009; Sudarsana MR, 2012, GRAPEVINE RED BLOTCH; Szychowski JA, 1998, VIROLOGY, V248, P432, DOI 10.1006/viro.1998.9292; Szychowski JA, 1995, VITIS, V34, P229; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tecsi LI, 1996, PLANT PHYSIOL, V111, P975, DOI 10.1104/pp.111.4.975; Tsagris EM, 2008, CELL MICROBIOL, V10, P2168, DOI 10.1111/j.1462-5822.2008.01231.x; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Zapata C, 2004, J PLANT PHYSIOL, V161, P1031, DOI 10.1016/j.jplph.2003.11.009; Zhang Y, 2011, PHYTOPATHOLOGY, V101, P1081, DOI 10.1094/PHYTO-02-11-0034; Zhao D, 2010, CROP SCI, V50, P1537, DOI 10.2135/cropsci2009.09.0521; [No title captured]	58	88	96	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64194	10.1371/journal.pone.0064194	http://dx.doi.org/10.1371/journal.pone.0064194			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755117	Green Submitted, Green Published, gold			2022-12-25	WOS:000320579400010
J	Qaim, M; Kouser, S				Qaim, Matin; Kouser, Shahzad			Genetically Modified Crops and Food Security	PLOS ONE			English	Article							BT COTTON; GOLDEN-RICE; IMPACT; INDIA; WORLD; POOR; AGRICULTURE; ADOPTION; POVERTY; CHINA	The role of genetically modified (GM) crops for food security is the subject of public controversy. GM crops could contribute to food production increases and higher food availability. There may also be impacts on food quality and nutrient composition. Finally, growing GM crops may influence farmers' income and thus their economic access to food. Smallholder farmers make up a large proportion of the undernourished people worldwide. Our study focuses on this latter aspect and provides the first ex post analysis of food security impacts of GM crops at the micro level. We use comprehensive panel data collected over several years from farm households in India, where insect-resistant GM cotton has been widely adopted. Controlling for other factors, the adoption of GM cotton has significantly improved calorie consumption and dietary quality, resulting from increased family incomes. This technology has reduced food insecurity by 15-20% among cotton-producing households. GM crops alone will not solve the hunger problem, but they can be an important component in a broader food security strategy.	[Qaim, Matin; Kouser, Shahzad] Univ Gottingen, Dept Agr Econ & Rural Dev, Gottingen, Germany; [Kouser, Shahzad] Univ Agr Faisalabad, Inst Agr & Resource Econ, Faisalabad, Pakistan	University of Gottingen; University of Agriculture Faisalabad	Qaim, M (corresponding author), Univ Gottingen, Dept Agr Econ & Rural Dev, Gottingen, Germany.	mqaim@uni-goettingen.de	Qaim, Matin/P-4489-2016; Kouser, Shahzad/ABD-7680-2020	Qaim, Matin/0000-0003-4143-0763; 	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2010, J AGR ECON, V61, P175, DOI 10.1111/j.1477-9552.2009.00227.x; Borlaug N, 2007, SCIENCE, V318, P359, DOI 10.1126/science.1151062; BOUIS HE, 1994, J DEV ECON, V44, P199, DOI 10.1016/0304-3878(94)00012-3; Cameron C., 2005, MICROECONOMETRICS US, P1056; de Haen H, 2011, FOOD POLICY, V36, P760, DOI 10.1016/j.foodpol.2011.08.003; De Janvry A, 2002, J DEV STUD, V38, P1, DOI 10.1080/00220380412331322401; De Steur H, 2012, NEW BIOTECHNOL, V29, P432, DOI 10.1016/j.nbt.2011.11.012; European Commission, 2010, DECADE EU FUNDED GMO; FAO, 2013, STATE HUNGER BUILDIN; FAO, 2001, 1 FAO UN; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Friends of the Earth, 2011, WHO BEN GM CROPS IND; Gopalan C., 2004, NUTR VALUE INDIAN FO; Huang JK, 2010, SCI CHINA LIFE SCI, V53, P981, DOI 10.1007/s11427-010-4036-y; Jayaraman K, 2012, NAT BIOTECHNOL, V30, P1017, DOI 10.1038/nbt1112-1017a; Jensen R.T., 2010, REVEALED PREFERENCE; Juma C, 2011, NATURE, V479, P471, DOI 10.1038/479471a; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; Kouser S, 2011, ECOL ECON, V70, P2105, DOI 10.1016/j.ecolecon.2011.06.008; Krishna VV, 2012, AGR SYST, V107, P47, DOI 10.1016/j.agsy.2011.11.005; Leathers Howard, 2004, WORLD FOOD PROBLEM T; National Sample Survey Organization, 2007, 513 GOV IND NAT SAMP; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203; Rao C. H. H., 2005, AGR FOOD SECURITY PO; Sexton S., 2012, INTENDED UNINTENDED, P269, DOI DOI 10.7208/CHICAGO/9780226988061.003.0009; Shiva Vandana N., 2011, GMO EMPEROR HAS NO C; Stein AJ, 2008, WORLD DEV, V36, P144, DOI 10.1016/j.worlddev.2007.02.013; Subramanian A, 2010, J DEV STUD, V46, P295, DOI 10.1080/00220380903002954; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; United Nations, 2012, MILLENNIUM DEV GOALS; *WORLD BANK, 2007, WORLD DEV REP 2008 A	32	96	105	5	377	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64879	10.1371/journal.pone.0064879	http://dx.doi.org/10.1371/journal.pone.0064879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755155	gold, Green Published			2022-12-25	WOS:000320579400029
J	Huang, YH; Terabe, M; Pendleton, CD; Khursigara, DS; Bera, TK; Pastan, I; Berzofsky, JA				Huang, Yi-Hsiang; Terabe, Masaki; Pendleton, C. David; Khursigara, Deborah Stewart; Bera, Tapan K.; Pastan, Ira; Berzofsky, Jay A.			Identification and Enhancement of HLA-A2.1-Restricted CTL Epitopes in a New Human Cancer Antigen-POTE	PLOS ONE			English	Article							CLASS-I MOLECULES; PROSTATE-CANCER; T-LYMPHOCYTES; INDEPENDENT BINDING; PEPTIDE MOTIFS; SIPULEUCEL-T; IMMUNOTHERAPY; HLA-A2.1; VACCINES; MICE	Identification of CD8(+) T cell epitopes that can induce T cells to kill tumor cells is a fundamental step for development of a peptide cancer vaccine. POTE protein is a newly identified cancer antigen that was found to be expressed in a wide variety of human cancers, including prostate, colon, lung, breast, ovary and pancreas. Here, we determined HLA-A2.1-restricted cytotoxic T lymphocyte (CTL) epitopes in the POTE protein, and also designed enhanced epitopes by amino acid (AA) substitutions. Five 9-mer peptides were first selected and their binding affinity to HLA-A2 molecules was measured by the T2 binding assay. POTE 272-280 and POTE 323-331 showed the strongest HLA-A2 binding affinity. AA substituted peptides POTE 252-9V (with valine at position 9), POTE 553-1Y (with tyrosine at position 1) and POTE 323-3F (with phenylalanine at position 3) conferred higher affinity for HLA-A2, and induced CTL responses cross-reactive with wild type antigens. While POTE 252-9V was the strongest in this respect, POTE 323-3F had the greatest increase in immunogenicity compared to wild type. Importantly, two modified epitopes (POTE-553-1Y and POTE-323-3F) induced CTLs that killed NCI-H522, a POTE-expressing HLA-A2(+) human non-small cell lung cancer cell line, indicating natural endogenous processing of these epitopes. In conclusion, the immunogenicity of POTE epitopes can be enhanced by peptide modification to induce T cells that kill human cancer cells. A combination of POTE 553-1Y and POTE 323-3F epitopes might be an attractive vaccine strategy for HLA-A2 cancer patients to overcome tolerance induced by tumors and prevent escape.	[Huang, Yi-Hsiang] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Div Gastroenterol, Infect & Immun Res Ctr,Inst Clin Med, Taipei 112, Taiwan; [Huang, Yi-Hsiang; Terabe, Masaki; Pendleton, C. David; Khursigara, Deborah Stewart; Berzofsky, Jay A.] NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Bera, Tapan K.; Pastan, Ira] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Terabe, M (corresponding author), NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	terabe@mail.nih.gov; berzofsk@helix.nih.gov	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Huang, Yi-Hsiang/0000-0001-5241-5425	Taiwan Merit Scholarship [TMS-094-2-B-015]; NCI intramural funding from the NCI Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA; Taipei Veterans General Hospital [V97S5-002, V100C-104, V101C-147]; NATIONAL CANCER INSTITUTE [ZIABC008753, ZIASC004020] Funding Source: NIH RePORTER	Taiwan Merit Scholarship; NCI intramural funding from the NCI Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA; Taipei Veterans General Hospital(Taipei Veterans General Hospital); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Yi-Hsiang Huang was supported by Taiwan Merit Scholarship (TMS-094-2-B-015) and NCI intramural funding from the NCI Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA; and by funding from Taipei Veterans General Hospital (V97S5-002, V100C-104 and V101C-147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Andersen MLM, 2003, SCAND J IMMUNOL, V57, P21, DOI 10.1046/j.1365-3083.2003.01182.x; Bera TK, 2006, CANCER RES, V66, P52, DOI 10.1158/0008-5472.CAN-05-3014; Bera TK, 2004, GENE, V337, P45, DOI 10.1016/j.gene.2004.05.009; Bera TK, 2002, P NATL ACAD SCI USA, V99, P16975, DOI 10.1073/pnas.262655399; Berzofsky JA, 2005, CANC TREAT, V123, P115; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Berzofsky JA, 2004, J CLIN INVEST, V113, P1515, DOI 10.1172/JCI200421926; Berzofsky JA, 2011, VACCINE; Berzofsky JA, 2012, SEMIN ONCOL, V39, P348, DOI 10.1053/j.seminoncol.2012.02.002; Cheever MA, 2011, CLIN CANCER RES, V17, P3520, DOI 10.1158/1078-0432.CCR-10-3126; Cole DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1665; Denkberg G, 2002, P NATL ACAD SCI USA, V99, P9421, DOI 10.1073/pnas.132285699; Fauquembergue E, 2010, J IMMUNOTHER, V33, P402, DOI 10.1097/CJI.0b013e3181d366da; Firat H, 2001, EUR J IMMUNOL, V31, P3064, DOI 10.1002/1521-4141(2001010)31:10<3064::AID-IMMU3064>3.0.CO;2-L; Firat H, 2002, INT IMMUNOL, V14, P925, DOI 10.1093/intimm/dxf056; Godel P, 2012, J VIROL, V86, P12422, DOI 10.1128/JVI.01607-12; Gross DA, 2004, J CLIN INVEST, V113, P425, DOI 10.1172/JCI200419418; HOGAN KT, 1988, J IMMUNOL, V141, P2519; Huang YH, 2009, J HEPATOL, V50, P779, DOI 10.1016/j.jhep.2008.11.028; Hutchinson Lisa, 2012, Nat Rev Clin Oncol, V9, P487, DOI 10.1038/nrclinonc.2012.143; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kudrin A, 2012, HUM VACC IMMUNOTHER, V8, P1135, DOI 10.4161/hv.20474; Moingeon P, 2001, VACCINE, V19, P1305, DOI 10.1016/S0264-410X(00)00372-8; Newberg MH, 1996, J IMMUNOL, V156, P2473; NEWBERG MH, 1992, J IMMUNOL, V149, P136; NIJMAN HW, 1993, EUR J IMMUNOL, V23, P1215, DOI 10.1002/eji.1830230603; Oh S, 2004, CANCER RES, V64, P2610, DOI 10.1158/0008-5472.CAN-03-2183; Okazaki T, 2003, J IMMUNOL, V171, P2548, DOI 10.4049/jimmunol.171.5.2548; Ono T, 2001, P NATL ACAD SCI USA, V98, P3282, DOI 10.1073/pnas.041625098; PARKER KC, 1994, J IMMUNOL, V152, P163; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Peters B, 2003, BIOINFORMATICS, V19, P1765, DOI 10.1093/bioinformatics/btg247; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Schwaab T, 2011, EXPERT REV VACCINES, V10, P1113, DOI [10.1586/erv.11.85, 10.1586/ERV.11.85]; SHIRAI M, 1995, J IMMUNOL, V154, P2733; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Tourdot S, 2000, EUR J IMMUNOL, V30, P3411, DOI 10.1002/1521-4141(2000012)30:12<3411::AID-IMMU3411>3.0.CO;2-R; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883	42	8	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64365	10.1371/journal.pone.0064365	http://dx.doi.org/10.1371/journal.pone.0064365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750208	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900010
J	Karim, AM; Admassu, K; Schellenberg, J; Alemu, H; Getachew, N; Ameha, A; Tadesse, L; Betemariam, W				Karim, Ali Mehryar; Admassu, Kesetebirhane; Schellenberg, Joanna; Alemu, Hibret; Getachew, Nebiyu; Ameha, Agazi; Tadesse, Luche; Betemariam, Wuleta			Effect of Ethiopia's Health Extension Program on Maternal and Newborn Health Care Practices in 101 Rural Districts: A Dose-Response Study	PLOS ONE			English	Article							NEONATAL-MORTALITY; IMPACT; INTERVENTIONS; SERVICES; OUTCOMES; WORKERS	Background: Improving newborn survival is essential if Ethiopia is to achieve Millennium Development Goal 4. The national Health Extension Program (HEP) includes community-based newborn survival interventions. We report the effect of these interventions on changes in maternal and newborn health care practices between 2008 and 2010 in 101 districts, comprising 11.6 million people, or 16% of Ethiopia's population. Methods and Findings: Using data from cross-sectional surveys in December 2008 and December 2010 from a representative sample of 117 communities (kebeles), we estimated the prevalence of maternal and newborn care practices, and a program intensity score in each community. Women with children aged 0 to 11 months reported care practices for their most recent pregnancy and childbirth. The program intensity score ranged between zero and ten and was derived from four outreach activities of the HEP front-line health workers. Dose-response relationships between changes in program intensity and the changes in maternal and newborn health were investigated using regression methods, controlling for secular trend, respondents' background characteristics, and community-level factors. Between 2008 and 2010, median program intensity score increased 2.4-fold. For every unit increase in the score, the odds of receiving antenatal care increased by 1.13 times (95% CI 1.03-1.23); the odds of birth preparedness increased by 1.31 times (1.19-1.44); the odds of receiving postnatal care increased by 1.60 times (1.34-1.91); and the odds of initiating breastfeeding immediately after birth increased by 1.10 times (1.02-1.20). Program intensity score was not associated with skilled deliveries, nor with some of the other newborn health care indicators. Conclusions: The results of our analysis suggest that Ethiopia's HEP platform has improved maternal and newborn health care practices at scale. However, implementation research will be required to address the maternal and newborn care practices that were not influenced by the HEP outreach activities.	[Karim, Ali Mehryar; Alemu, Hibret; Getachew, Nebiyu; Ameha, Agazi; Tadesse, Luche; Betemariam, Wuleta] JSI Res & Training Inst Inc, Last Kilometers Project 10, Addis Ababa, Ethiopia; [Admassu, Kesetebirhane] Minist Hlth, Fed Democrat Republ Ethiopia, Addis Ababa, Ethiopia; [Schellenberg, Joanna] London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Karim, AM (corresponding author), JSI Res & Training Inst Inc, Last Kilometers Project 10, Addis Ababa, Ethiopia.	akarim@jsi.com	Karim, Ali/AAX-4495-2021; Ejeta, Luche Tadesse/J-8021-2019	Ejeta, Luche Tadesse/0000-0003-3529-8516; Schellenberg, Joanna/0000-0002-0708-3676	Bill & Melinda Gates Foundation; Regional Health Bureaus of Amhara; Oromia; Tigray; Southern Nations and Nationalities People's Regions	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Regional Health Bureaus of Amhara; Oromia; Tigray; Southern Nations and Nationalities People's Regions	Work was funded by the Bill & Melinda Gates Foundation. However, the views expressed in this study do not necessarily reflect the views of the foundation. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the health extension workers, community health promoters, and the women in the L10K areas for making this research possible. The supports from the Regional Health Bureaus of Amhara, Oromia, Tigray, and Southern Nations and Nationalities People's Regions, and the L10K implementing partners, i.e., Amhara Development Association, Bench Maji Development Association, Ethiopian Kale Hiwot Church, Fayyaa Integrated Development Organization, Illu Women and Children Integrated Development Association, Oromia Development Association, Relief Society of Tigray, Sheka Peoples' Development Association, Siltie Development Association, Southern Region's Women's Association, and Women's Association of Tigray were critical for the data collection. Logistics, supervision, and management supports throughout the study period by the L10K central and regional team members were fundamental for conducting the study. We are thankful to Mary Taylor for her support. The review of the paper by W Brown, S Hodgins and E Allen were very useful for finalizing the manuscript. Comments from S Cousens on an early analysis of the L10K baseline and follow-up survey data were very helpful. A Becker helped us with the illustrations.	Admassie A, 2009, J DEV EFFECT, V1, P430, DOI 10.1080/19439340903375724; Angeles G, 2005, SOCIOL METHOD RES, V34, P76, DOI 10.1177/0049124104273069; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Birhanu Z, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-74; Central Statistical Agency of Ethiopia, 2011, ETH DEM HLTH SURV 20; Croft T, 1991, DEMOGRAPHIC HLTH SUR, VII, P1337; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, HLTH EXT PROGR IMPL; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR, p[26, 58]; Federal Democratic Republic of Ethiopia Ministry of Health, 2008, HLTH SECT DEV PROGR; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, ANN PERF REP 2009 20; Federal Democratic Republic of Ethiopia Ministry of Health, 2011, HLTH HLTH REL IND 20; Feysia B, 2012, HLTH WORKFORCE ETHIO, DOI [10.1596/978-0-8213-8984-3, DOI 10.1596/978-0-8213-8984-3.ACCESSED]; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Friberg IK, 2010, INT J EPIDEMIOL, V39, P11, DOI 10.1093/ije/dyq017; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Karim AM, 2010, ETHIOP J HEALTH DEV, V24, P92; Koblinsky M, 2010, ETHIOP J HEALTH DEV, V24, P105; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Lemeshow S, 1985, World Health Stat Q, V38, P65; Marsh David R, 2002, J Perinatol, V22, P572, DOI 10.1038/sj.jp.7210793; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Morgenstern H, 1999, MODERN EPIDEMIOLOGY, P459; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Seward N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001180; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Soofi S, 2012, LANCET, V379, P1029, DOI 10.1016/S0140-6736(11)61877-1; StataCorp, 2011, STATA STAT SOFTWARE; StataCorp, 2011, LONG DAT PAN DAT REF, P11; The Partnership for Maternal Newborn & Child Health, 2011, ESS INT COMM GUID RE, P17; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; Wakabi W, 2008, LANCET, V372, P880, DOI 10.1016/S0140-6736(08)61381-1; Wooldridge JM, 2003, INTRO ECONOMETRICS M, P461	36	76	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65160	10.1371/journal.pone.0065160	http://dx.doi.org/10.1371/journal.pone.0065160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750240	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900042
J	Smart, CE; Morrison, BJ; Saunus, JM; Vargas, AC; Keith, P; Reid, L; Wockner, L; Amiri, MA; Sarkar, D; Simpson, PT; Clarke, C; Schmidt, CW; Reynolds, BA; Lakhani, SR; Lopez, JA				Smart, Chanel E.; Morrison, Brian J.; Saunus, Jodi M.; Vargas, Ana Cristina; Keith, Patricia; Reid, Lynne; Wockner, Leesa; Amiri, Marjan Askarian; Sarkar, Debina; Simpson, Peter T.; Clarke, Catherine; Schmidt, Chris W.; Reynolds, Brent A.; Lakhani, Sunil R.; Lopez, J. Alejandro			In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; STEM-CELLS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR HETEROGENEITY; CARCINOMA; POPULATION; TUMORIGENICITY; PROPAGATION; PHENOTYPE; CULTURE	Mammosphere and breast tumoursphere culture have gained popularity as in vitro assays for propagating and analysing normal and cancer stem cells. Whether the spheres derived from different sources or parent cultures themselves are indeed single entities enriched in stem/progenitor cells compared to other culture formats has not been fully determined. We surveyed sphere-forming capacity across 26 breast cell lines, immunophenotyped spheres from six luminal- and basal-like lines by immunohistochemistry and flow cytometry and compared clonogenicity between sphere, adherent and matrigel culture formats using in vitro functional assays. Analyses revealed morphological and molecular intra- and inter-sphere heterogeneity, consistent with adherent parental cell line phenotypes. Flow cytometry showed sphere culture does not universally enrich for markers previously associated with stem cell phenotypes, although we found some cell-line specific changes between sphere and adherent formats. Sphere-forming efficiency was significantly lower than adherent or matrigel clonogenicity and constant over serial passage. Surprisingly, self-renewal capacity of sphere-derived cells was similar/lower than other culture formats. We observed significant correlation between long-term-proliferating-cell symmetric division rates in sphere and adherent cultures, suggesting functional overlap between the compartments sustaining them. Experiments with normal primary human mammary epithelia, including sorted luminal (MUC1(+)) and basal/myoepithelial (CD10(+)) cells revealed distinct luminal-like, basal-like and mesenchymal entities amongst primary mammospheres. Morphological and colony-forming-cell assay data suggested mammosphere culture may enrich for a luminal progenitor phenotype, or induce reversion/relaxation of the basal/mesenchymal in vitro selection occurring with adherent culture. Overall, cell line tumourspheres and primary mammospheres are not homogenous entities enriched for stem cells, suggesting a more cautious approach to interpreting data from these assays and careful consideration of its limitations. Sphere culture may represent an alternative 3-dimensional culture system which rather than universally 'enriching' for stem cells, has utility as one of a suite of functional assays that provide a read-out of progenitor activity.	[Smart, Chanel E.; Saunus, Jodi M.; Vargas, Ana Cristina; Keith, Patricia; Reid, Lynne; Amiri, Marjan Askarian; Sarkar, Debina; Simpson, Peter T.; Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Smart, Chanel E.; Morrison, Brian J.; Keith, Patricia; Reid, Lynne; Wockner, Leesa; Simpson, Peter T.; Schmidt, Chris W.; Lopez, J. Alejandro] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Morrison, Brian J.; Lopez, J. Alejandro] Griffith Univ, Sch Biomol & Phys Sci, Brisbane, Qld 4111, Australia; [Reynolds, Brent A.] Univ Florida, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL USA; [Lakhani, Sunil R.] Pathol Queensland Royal Brisbane & Womens Hosp, Dept Anat Pathol, Brisbane, Qld, Australia; [Clarke, Catherine; Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; Griffith University; State University System of Florida; University of Florida; Royal Brisbane & Women's Hospital; University of Queensland	Smart, CE (corresponding author), Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia.	c.smart@uq.edu.au	Vargas, Ana/GSE-1963-2022; Sarkar, Debina/AAA-8212-2020; Saunus, Jodi/AAE-5291-2020; Simpson, Peter/F-1225-2010; Lakhani, Sunil R/I-1970-2018; Smart, Chanel E/C-9583-2011; Lopez, J. Alejandro/B-9290-2008; Askarian-Amiri, Marjan E./F-7910-2010; Lopez, J. Alejandro/P-4129-2019; Saunus, Jodi M/C-6657-2011; Schmidt, Christopher/A-4353-2009	Sarkar, Debina/0000-0002-6734-8875; Saunus, Jodi/0000-0002-4604-4709; Simpson, Peter/0000-0002-4816-8289; Lakhani, Sunil R/0000-0003-4067-2760; Lopez, J. Alejandro/0000-0001-9370-1516; Askarian-Amiri, Marjan E./0000-0003-3524-9626; Lopez, J. Alejandro/0000-0001-9370-1516; Saunus, Jodi M/0000-0002-4604-4709; Schmidt, Christopher/0000-0002-3955-5076; Wockner, Leesa/0000-0002-8921-9265	Australian National Health and Medical Research Council the Queensland Cancer Council; National Breast Cancer Foundation; Griffith University	Australian National Health and Medical Research Council the Queensland Cancer Council(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation; Griffith University(Griffith University)	The authors wish to acknowledge the Australian National Health and Medical Research Council the Queensland Cancer Council, the National Breast Cancer Foundation and Griffith University for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bachelard-Cascales E, 2010, STEM CELLS, V28, P1081, DOI 10.1002/stem.435; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chu JS, 1999, CANCER LETT, V142, P121, DOI 10.1016/S0304-3835(99)00161-5; Clarke CL, 2006, BRIT J CANCER, V95, P515, DOI 10.1038/sj.bjc.6603298; CROKER AK, 2008, J CELL MOL MED; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Heppner Gloria H., 1999, Breast J, V5, P122, DOI 10.1046/j.1524-4741.1999.00136.x; HIRSCHHAEUSER F, 2010, J BIOTECHNOL; HOLLESTELLE A, 2009, BREAST CANC RES TREA; INCH WR, 1970, GROWTH, V34, P271; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kern SE, 2007, CANCER RES, V67, P8985, DOI 10.1158/0008-5472.CAN-07-1971; Kok M, 2009, J PATHOL, V218, P316, DOI 10.1002/path.2544; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; KUREBAYASHI J, 1995, BRIT J CANCER, V71, P845, DOI 10.1038/bjc.1995.163; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Maguer-Satta V, 2011, P NATL ACAD SCI USA, V108, pE1264, DOI 10.1073/pnas.1116567108; MATILAINEN H, 2012, CANC LETT; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; PENG T, 2011, PLOS ONE, V0006; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl John, 2005, Methods Mol Biol, V290, P249; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; WHITEHEAD RH, 1983, J NATL CANCER I, V71, P1193; Wicha MS, 2007, STEM CELL REV, V3, P110, DOI 10.1007/s12015-007-0016-4; Xie GZ, 2012, CANCER LETT, V316, P53, DOI 10.1016/j.canlet.2011.10.018; Yoshino Kaori, 2006, Hum Cell, V19, P43, DOI 10.1111/j.1749-0774.2005.00007.x	55	52	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64388	10.1371/journal.pone.0064388	http://dx.doi.org/10.1371/journal.pone.0064388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750209	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900011
J	Bugler, M; Rempoulakis, P; Shacham, R; Keasar, T; Thuijsman, F				Buegler, Max; Rempoulakis, Polychronis; Shacham, Roei; Keasar, Tamar; Thuijsman, Frank			Sex Allocation in a Polyembryonic Parasitoid with Female Soldiers: An Evolutionary Simulation and an Experimental Test	PLOS ONE			English	Article							COPIDOSOMA-KOEHLERI HYMENOPTERA; LOCAL MATE COMPETITION; RATIO; WASP; CONFLICT; CONSPECIFICS; PROTOCOL; BEHAVIOR; SIZE	Parasitoid wasps are convenient subjects for testing sex allocation theory. However, their intricate life histories are often insufficiently captured in simple analytical models. In the polyembryonic wasp Copidosoma koehleri, a clone of genetically identical offspring develops from each egg. Male clones contain fewer individuals than female clones. Some female larvae develop into soldiers that kill within-host competitors, while males do not form soldiers. These features complicate the prediction of Copidosoma's sex allocation. We developed an individual-based simulation model, where numerous random starting strategies compete and recombine until a single stable sex allocation evolves. Life-history parameter values (e.g., fecundity, clone-sizes, larval survival) are estimated from experimental data. The model predicts a male-biased sex allocation, which becomes more extreme as the probability of superparasitism (hosts parasitized more than once) increases. To test this prediction, we reared adult parasitoids at either low or high density, mated them, and presented them with unlimited hosts. As predicted, wasps produced more sons than daughters in all treatments. Males reared at high density (a potential cue for superparasitism) produced a higher male bias in their offspring than low-density males. Unexpectedly, female density did not affect offspring sex ratios. We discuss possible mechanisms for paternal control over offspring sex.	[Buegler, Max] Tech Univ Munich, Chair Computat Modeling & Simulat, D-80290 Munich, Germany; [Rempoulakis, Polychronis; Keasar, Tamar] Univ Haifa, Tivon, Israel; [Shacham, Roei] Univ Haifa, IL-31999 Haifa, Israel; [Thuijsman, Frank] Maastricht Univ, Maastricht, Netherlands	Technical University of Munich; University of Haifa; University of Haifa; Maastricht University	Keasar, T (corresponding author), Univ Haifa, Tivon, Israel.	tkeasar@research.haifa.ac.il	Rempoulakis, Polychronis/P-2731-2019	Rempoulakis, Polychronis/0000-0002-3947-0064; Bugler, Maximilian/0000-0002-2591-017X	Israel Science Foundation [414/10]	Israel Science Foundation(Israel Science Foundation)	The study was supported by the Israel Science Foundation (http://www.isf.org.il/), grant number 414/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlinger M. J., 1997, TRENDS ENTOMOLOGY, V1, P137; BROCKMANN HJ, 1989, ANIM BEHAV, V37, P232, DOI 10.1016/0003-3472(89)90113-9; Colinet H, 2005, ECOL ENTOMOL, V30, P473, DOI 10.1111/j.0307-6946.2005.00716.x; Crowley PH, 2009, ECOL ENTOMOL, V34, P163, DOI 10.1111/j.1365-2311.2008.01052.x; Drewell RA, 2012, TRENDS ECOL EVOL, V27, P367, DOI 10.1016/j.tree.2012.02.005; Gardner A, 2007, AM NAT, V169, P519, DOI 10.1086/512107; Godfray H. C. J., 1994, Parasitoids: behavioral and evolutionary ecology.; Grant VJ, 2010, REPRODUCTION, V140, P425, DOI 10.1530/REP-10-0137; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Henter HJ, 2004, J EVOLUTION BIOL, V17, P886, DOI 10.1111/j.1420-9101.2004.00746.x; House CM, 2011, EVOL ECOL, V25, P363, DOI 10.1007/s10682-010-9423-0; HUNTER MS, 1993, OECOLOGIA, V93, P421, DOI 10.1007/BF00317887; Keasar T, 2006, ECOL ENTOMOL, V31, P277, DOI 10.1111/j.1365-2311.2006.00788.x; Keinan Y, 2012, BEHAV ECOL, V23, P1263, DOI 10.1093/beheco/ars111; KFIR R, 1981, ANN APPL BIOL, V99, P225, DOI 10.1111/j.1744-7348.1981.tb04790.x; King BH, 2012, BEHAV ECOL SOCIOBIOL, V66, P1165, DOI 10.1007/s00265-012-1369-5; King BH, 2002, BEHAV ECOL SOCIOBIOL, V52, P17, DOI 10.1007/s00265-002-0492-0; Lebreton S, 2010, BEHAV ECOL, V21, P107, DOI 10.1093/beheco/arp156; Lewis HM, 2010, J EVOLUTION BIOL, V23, P1708, DOI 10.1111/j.1420-9101.2010.02038.x; Lindsay CB, 2009, THESIS U GEORGIA; Macke E, 2011, SCIENCE, V334, P1127, DOI 10.1126/science.1212177; Morag N, 2011, ANIM BEHAV, V81, P865, DOI 10.1016/j.anbehav.2011.01.026; Ode PJ, 2002, BIOL CONTROL, V24, P31, DOI 10.1016/S1049-9644(02)00003-8; Seger J, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P2, DOI 10.1017/CBO9780511542053.002; Segoli M, 2009, ARTHROPOD STRUCT DEV, V38, P84, DOI 10.1016/j.asd.2008.05.003; Segoli M, 2010, PHYSIOL ENTOMOL, V35, P40, DOI 10.1111/j.1365-3032.2009.00708.x; Segoli M, 2009, BEHAV ECOL, V20, P761, DOI 10.1093/beheco/arp057; Shuker DM, 2007, ANIM BEHAV, V73, P971, DOI 10.1016/j.anbehav.2006.07.013; Shuker DM, 2009, BIOL LETTERS, V5, P682, DOI 10.1098/rsbl.2009.0427; Shuker DM, 2006, BEHAV ECOL SOCIOBIOL, V59, P829, DOI 10.1007/s00265-005-0129-1; Shuker DM, 2005, AM NAT, V166, P301, DOI 10.1086/432562; Sykes EM, 2007, BEHAV ECOL SOCIOBIOL, V61, P1751, DOI 10.1007/s00265-007-0407-1; Van Vugt JJFA, 2009, P ROY SOC B-BIOL SCI, V276, P4149, DOI 10.1098/rspb.2009.1238; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; West SA, 2009, MONOGR POPUL BIOL, V44, P1	37	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64780	10.1371/journal.pone.0064780	http://dx.doi.org/10.1371/journal.pone.0064780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755142	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300027
J	Mez, J; Cosentino, S; Brickman, AM; Huey, ED; Manly, JJ; Mayeux, R				Mez, Jesse; Cosentino, Stephanie; Brickman, Adam M.; Huey, Edward D.; Manly, Jennifer J.; Mayeux, Richard			Faster Cognitive and Functional Decline in Dysexecutive versus Amnestic Alzheimer's Subgroups: A Longitudinal Analysis of the National Alzheimer's Coordinating Center (NACC) Database	PLOS ONE			English	Article							DATA SET UDS; EXECUTIVE DYSFUNCTION; RACIAL-DIFFERENCES; OLDER-ADULTS; DISEASE; MILD; IMPAIRMENT; PHENOTYPES; EDUCATION	Objective: To compare the rate of cognitive and functional decline in dysexecutive, typical and amnestic subgroups of Alzheimer's disease. Methods: 943 participants from the National Alzheimer's Coordinating Center (NACC) database who had a diagnosis of probable AD were followed for a mean of 2.3 years. A dysexecutive subgroup (n = 165) was defined as having executive performance >1.5 SD worse than memory performance, an amnestic subgroup (n = 157) was defined as having memory performance >1.5 SD worse than executive performance and a typical subgroup (n = 621) was defined as having a difference in executive and memory performance of <1.5 SD. Generalized estimating equations (GEE) were used to model decline on the Folstein Mini Mental Status Exam (MMSE), rise on the Clinical Dementia Rating (CDR) sum of boxes and rise on the total Functional Assessment Questionnaire (FAQ). Results: Compared with the amnestic subgroup, the dysexecutive subgroup declined 2.2X faster on the Folstein MMSE (p < .001), rose 42% faster on the CDR sum of boxes (p = .03) and rose 33% faster on the total FAQ (p = .01). Rate of change for the typical subgroup fell between that of the amnestic and dysexecutive subgroups for the MMSE, CDR sum of boxes and total FAQ. Among a subset of participants (n = 129) who underwent autopsy, the dysexecutive, amnestic and typical subgroups did not differ in odds of having an AD pathologic diagnosis, suggesting that variation in non-AD pathologies across subtypes did not lead to the observed differences. Conclusions: A dysexecutive subgroup of AD has a unique disease course in addition to cognitive phenotype.	[Mez, Jesse; Cosentino, Stephanie; Brickman, Adam M.; Huey, Edward D.; Manly, Jennifer J.; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; [Mez, Jesse; Cosentino, Stephanie; Brickman, Adam M.; Huey, Edward D.; Manly, Jennifer J.; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Mez, Jesse; Cosentino, Stephanie; Brickman, Adam M.; Huey, Edward D.; Manly, Jennifer J.; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Mez, Jesse] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Huey, Edward D.; Mayeux, Richard] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Mayeux, Richard] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Mez, J (corresponding author), Columbia Univ, Coll Phys & Surg, Gertrude H Sergievsky Ctr, New York, NY 10027 USA.	jbm2154@columbia.edu	Mayeux, Richard/E-9788-2013	Mayeux, Richard/0000-0001-6519-9696; Mez, Jesse/0000-0003-1438-5442	National Institute of Neurological Disorders and Stroke [5T32NS007153-27]; National Institute on Aging [U01AG016976]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG027295, P50AG008702, U01AG016976] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by the National Institute of Neurological Disorders and Stroke 5T32NS007153-27. The NACC database is funded by the National Institute on Aging U01AG016976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alladi S, 2007, BRAIN, V130, P2636, DOI 10.1093/brain/awm213; Barnes LL, 2005, AM J GERIAT PSYCHIAT, V13, P959, DOI 10.1176/appi.ajgp.13.11.959; Beekly DL, 2004, ALZ DIS ASSOC DIS, V18, P270; Binetti G, 1996, J NEUROL NEUROSUR PS, V60, P91, DOI 10.1136/jnnp.60.1.91; Bondi MW, 2008, NEUROPSYCHOL REV, V18, P73, DOI 10.1007/s11065-008-9054-1; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; Bracco L, 2007, J NEUROL, V254, P1052, DOI 10.1007/s00415-006-0488-1; Chen ST, 1998, J NEUROPSYCH CLIN N, V10, P426, DOI 10.1176/jnp.10.4.426; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Dickerson BC, 2011, J NEUROL NEUROSUR PS, V82, P45, DOI 10.1136/jnnp.2009.199505; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Johnson JK, 1999, ARCH NEUROL-CHICAGO, V56, P1233, DOI 10.1001/archneur.56.10.1233; Johnson JK, 2004, DEMENT GERIATR COGN, V17, P360, DOI 10.1159/000078183; Marshall GA, 2011, ALZHEIMERS DEMENT, V7, P300, DOI 10.1016/j.jalz.2010.04.005; Mez J, 2013, ALZ DIS ASSOC DIS, V27, P218, DOI 10.1097/WAD.0b013e31826a94bd; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Razani J, 2007, APPL NEUROPSYCHOL, V14, P208, DOI 10.1080/09084280701509125; Sachs-Ericsson N, 2005, AM J GERIAT PSYCHIAT, V13, P968, DOI 10.1176/appi.ajgp.13.11.968; Scarmeas N, 2006, J NEUROL NEUROSUR PS, V77, P308, DOI 10.1136/jnnp.2005.072306; Snowden JS, 2007, CORTEX, V43, P835, DOI 10.1016/S0010-9452(08)70683-X; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Tekin S, 2001, AM J GERIAT PSYCHIAT, V9, P81, DOI 10.1176/appi.ajgp.9.1.81; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	28	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65246	10.1371/journal.pone.0065246	http://dx.doi.org/10.1371/journal.pone.0065246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755200	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300063
J	Sarathy, JP; Lee, E; Dartois, V				Sarathy, Jansy Passiflora; Lee, Edmund; Dartois, Veronique			Polyamines Inhibit Porin-Mediated Fluoroquinolone Uptake in Mycobacteria	PLOS ONE			English	Article							OUTER-MEMBRANE PERMEABILITY; MULTIDRUG EFFLUX PUMP; ESCHERICHIA-COLI; TUBERCULOSIS H37RV; PROTEIN EXPRESSION; SMEGMATIS; GENE; STARVATION; CHANNEL; DIFFUSION	Polyamines decrease the permeability of the outer membrane of Escherichia coli to fluoroquinolones and beta-lactams. In this study, we tested the effect of four polyamines (spermidine, spermine, cadaverine and putrescine) on fluoroquinolone uptake in Mycobacterium bovis BCG. Our results show that polyamines are also capable of reducing the permeability of the mycobacterial outer membrane to fluoroquinolones. Spermidine was most effective and demonstrated reversible dose-and pH-dependent inhibition of ciprofloxacin accumulation. The extent of this inhibition was demonstrated across the fluoroquinolone compound class to varying degrees. Furthermore, we have shown that the addition of spermidine increases the survival of M. bovis BCG after a 5-day exposure to ciprofloxacin by up to 25 times. The treatment of actively-replicating Mycobacterium tuberculosis with spermidine reduced ciprofloxacin accumulation by half while non-replicating nutrient-starved M. tuberculosis cultures lacked similar sensitivity to polyamines. Gene expression studies showed that several outer membrane proteins are significantly down-regulated during the shift to non-replication. Collectively, these characteristics of fluoroquinolone uptake in M. bovis BCG are consistent with facilitated transport by porin-like proteins and suggest that a reduction in intracellular uptake contributes to the phenotypic drug resistance demonstrated by M. tuberculosis in the non-replicating state.	[Sarathy, Jansy Passiflora; Dartois, Veronique] Novartis Inst Trop Dis Pte Ltd, Singapore, Singapore; [Lee, Edmund] Natl Univ Singapore, Yong Loo Lin Sch Med, Clin Res Ctr, Dept Pharmacol, Singapore 117595, Singapore; [Dartois, Veronique] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Novartis; National University of Singapore; National University of Singapore	Sarathy, JP (corresponding author), Publ Hlth Res Inst Ctr, Newark, NJ USA.	jansy_sarathy@hotmail.com		Sarathy, Jansy/0000-0002-1532-146X				Babbar N, 2011, RECENT RESULTS CANC, V188, P49, DOI 10.1007/978-3-642-10858-7_4; Basle A, 2004, BACTERIAL EUKARYOTIC, P79; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Chevalier J, 2000, BIOCHEM J, V348, P223, DOI 10.1042/0264-6021:3480223; CLARKE JR, 1991, J MED VIROL, V34, P212, DOI 10.1002/jmv.1890340403; COLOMBATTO S, 1989, BIOL CHEM H-S, V370, P745, DOI 10.1515/bchm3.1989.370.2.745; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08; Darcan C, 2009, POL J MICROBIOL, V58, P307; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; delaVega AL, 1996, J BACTERIOL, V178, P3715, DOI 10.1128/jb.178.13.3715-3721.1996; DELAVEGA AL, 1995, EMBO J, V14, P6058, DOI 10.1002/j.1460-2075.1995.tb00294.x; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; HAEMERS A, 1990, ANTIMICROB AGENTS CH, V34, P496, DOI 10.1128/AAC.34.3.496; Hillmann D, 2007, J BACTERIOL, V189, P958, DOI 10.1128/JB.01474-06; HIRSCH JG, 1952, J EXP MED, V95, P191, DOI 10.1084/jem.95.2.191; Hooper D.C., 2003, QUINOLONE ANTIMICROB, V3rd ed., P41, DOI [10.1128/9781555817817.ch3, DOI 10.1128/9781555817817.CH3]; Iyer R, 1997, J BIOL CHEM, V272, P18595, DOI 10.1074/jbc.272.30.18595; Liu J, 1996, J BACTERIOL, V178, P3791, DOI 10.1128/jb.178.13.3791-3795.1996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mah N, 2010, MICROBIOL-SGM, V156, P2506, DOI 10.1099/mic.0.040089-0; Mailaender C, 2004, MICROBIOL-SGM, V150, P853, DOI 10.1099/mic.0.26902-0; Ozkanca R, 2002, LETT APPL MICROBIOL, V35, P533, DOI 10.1046/j.1472-765X.2002.01230.x; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Pasca MR, 2005, ANTIMICROB AGENTS CH, V49, P4775, DOI 10.1128/AAC.49.11.4775-4777.2005; Pasca MR, 2004, ANTIMICROB AGENTS CH, V48, P3175, DOI 10.1128/AAC.48.8.3175-3178.2004; Piddock LJV, 2001, J ANTIMICROB CHEMOTH, V48, P787, DOI 10.1093/jac/48.6.787; ROCK DM, 1992, MOL PHARMACOL, V42, P157; Samartzidou H, 1999, J BACTERIOL, V181, P791, DOI 10.1128/JB.181.3.791-798.1999; Samartzidou H, 2003, J BACTERIOL, V185, P13, DOI 10.1128/JB.185.1.13-19.2003; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Senaratne RH, 1998, J BACTERIOL, V180, P3541, DOI 10.1128/JB.180.14.3541-3547.1998; Silva PEA, 2001, ANTIMICROB AGENTS CH, V45, P800, DOI 10.1128/AAC.45.3.800-804.2001; Siroy A, 2008, J BIOL CHEM, V283, P17827, DOI 10.1074/jbc.M800866200; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Teriete P, 2010, BIOCHEMISTRY-US, V49, P2768, DOI 10.1021/bi100158s; Xie ZF, 2005, ANTIMICROB AGENTS CH, V49, P4778, DOI 10.1128/AAC.49.11.4778-4780.2005	41	22	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65806	10.1371/journal.pone.0065806	http://dx.doi.org/10.1371/journal.pone.0065806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755283	Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300096
J	van Loenhout, MTJ; De Vlaminck, I; Flebus, B; den Blanken, JF; Zweifel, LP; Hooning, KM; Kerssemakers, JWJ; Dekker, C				van Loenhout, Marijn T. J.; De Vlaminck, Iwijn; Flebus, Benedetta; den Blanken, Johan F.; Zweifel, Ludovit P.; Hooning, Koen M.; Kerssemakers, Jacob W. J.; Dekker, Cees			Scanning a DNA Molecule for Bound Proteins Using Hybrid Magnetic and Optical Tweezers	PLOS ONE			English	Article							SINGLE; MACROMOLECULES; RESOLUTION	The functional state of the genome is determined by its interactions with proteins that bind, modify, and move along the DNA. To determine the positions and binding strength of proteins localized on DNA we have developed a combined magnetic and optical tweezers apparatus that allows for both sensitive and label-free detection. A DNA loop, that acts as a scanning probe, is created by looping an optically trapped DNA tether around a DNA molecule that is held with magnetic tweezers. Upon scanning the loop along the lambda-DNA molecule, EcoRI proteins were detected with similar to 17 nm spatial resolution. An offset of 33 +/- 5 nm for the detected protein positions was found between back and forwards scans, corresponding to the size of the DNA loop and in agreement with theoretical estimates. At higher applied stretching forces, the scanning loop was able to remove bound proteins from the DNA, showing that the method is in principle also capable of measuring the binding strength of proteins to DNA with a force resolution of 0.1 pN/root Hz. The use of magnetic tweezers in this assay allows the facile preparation of many single-molecule tethers, which can be scanned one after the other, while it also allows for direct control of the supercoiling state of the DNA molecule, making it uniquely suitable to address the effects of torque on protein-DNA interactions.	[van Loenhout, Marijn T. J.; De Vlaminck, Iwijn; Flebus, Benedetta; den Blanken, Johan F.; Zweifel, Ludovit P.; Hooning, Koen M.; Kerssemakers, Jacob W. J.; Dekker, Cees] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Delft, Netherlands.	c.dekker@tudelft.nl	De Vlaminck, Iwijn/P-6479-2015	De Vlaminck, Iwijn/0000-0001-6085-7311; Kerssemakers, Jacob Willem Jozef/0000-0002-6184-7913; Dekker, Cees/0000-0001-6273-071X	ERC-AdG Grant [247072 NANOFORBIO]	ERC-AdG Grant	This work was financially supported by ERC-2009-AdG Grant 247072 NANOFORBIO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.265506; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; De Vlaminck I, 2012, MOL CELL, V46, P616, DOI 10.1016/j.molcel.2012.03.029; De Vlaminck I, 2012, ANNU REV BIOPHYS, V41, P453, DOI 10.1146/annurev-biophys-122311-100544; Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Huisstede JHG, 2005, OPT EXPRESS, V13, P1113, DOI 10.1364/OPEX.13.001113; Kowalczyk SW, 2010, NANO LETT, V10, P324, DOI 10.1021/nl903631m; Le Gall A, 2010, OPT EXPRESS, V18, P26469, DOI 10.1364/OE.18.026469; LINDSAY SM, 1989, J BIOMOL STRUCT DYN, V7, P279, DOI 10.1080/07391102.1989.10507771; Moffitt JR, 2008, ANNU REV BIOCHEM, V77, P205, DOI 10.1146/annurev.biochem.77.043007.090225; Noom MC, 2007, NAT METHODS, V4, P1031, DOI 10.1038/nmeth1126; Spiering A, 2011, NANO LETT, V11, P2978, DOI 10.1021/nl201541y; STIGTER D, 1977, BIOPOLYMERS, V16, P1435, DOI 10.1002/bip.1977.360160705; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852; van Loenhout MTJ, 2012, BIOPHYS J, V102, P2362, DOI 10.1016/j.bpj.2012.03.073; Vermeulen KC, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2165568; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P697, DOI 10.1021/bi00002a037; Vucinic D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000699; Wallin AE, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940339; Wuite GJL, 2000, BIOPHYS J, V79, P1155, DOI 10.1016/S0006-3495(00)76369-7	29	16	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65329	10.1371/journal.pone.0065329	http://dx.doi.org/10.1371/journal.pone.0065329			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755219	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300075
J	Henkels, KM; Boivin, GP; Dudley, ES; Berberich, SJ; Gomez-Cambronero, J				Henkels, K. M.; Boivin, G. P.; Dudley, E. S.; Berberich, S. J.; Gomez-Cambronero, J.			Phospholipase D (PLD) drives cell invasion, tumor growth and metastasis in a human breast cancer xenograph model	ONCOGENE			English	Article						cell signaling; human breast cancer; PLD; cell invasion and metastasis; SCID mice; xenotransplant	PHOSPHATIDIC-ACID; OVEREXPRESSION; EXPRESSION; KINASE; TRANSFORMATION; INHIBITORS; MIGRATION; INSIGHTS; SURVIVAL; PROTEIN	Breast cancer is one of the most common malignancies in human females in the world. One protein that has elevated enzymatic lipase activity in breast cancers in vitro is phospholipase D (PLD), which is also involved in cell migration. We demonstrate that the PLD2 isoform, which was analyzed directly in the tumors, is crucial for cell invasion that contributes critically to the growth and development of breast tumors and lung metastases in vivo. We used three complementary strategies in a SCID mouse model and also addressed the underlying molecular mechanism. First, the PLD2 gene was silenced in highly metastatic, aggressive breast cancer cells (MDA-MB-231) with lentivirus-based short hairpin RNA, which were xenotransplanted in SCID mice. The resulting mouse primary mammary tumors were reduced in size (65%, P<0.05) and their onset delayed when compared with control tumors. Second, we stably overexpressed PLD2 in low-invasive breast cancer cells (MCF-7) with a biscistronic MIEG retroviral vector and observed that these cells were converted into a highly aggressive phenotype, as primary tumors that formed following xenotransplantation were larger, grew faster and developed lung metastases more readily. Third, we implanted osmotic pumps into SCID xenotransplanted mice that delivered two different small-molecule inhibitors of PLD activity (5-fluoro-2-indolyl deschlorohalopemide and N-[2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4,5]dec-8-yl)ethyl]-2-naphthalenecarboxamide). These inhibitors led to significant (>70%, P<0.05) inhibition of primary tumor growth, metastatic axillary tumors and lung metastases. In order to define the underlying mechanism, we determined that the machinery of PLD-induced cell invasion is mediated by phosphatidic acid, Wiscott-Aldrich Syndrome protein, growth receptor-bound protein 2 and Rac2 signaling events that ultimately affect actin polymerization and cell invasion. In summary, this study shows for the first time that PLD2 has a central role in the development, metastasis and level of aggressiveness of breast cancer, raising the possibility that PLD2 could be used as a new therapeutic target.	[Henkels, K. M.; Berberich, S. J.; Gomez-Cambronero, J.] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Boonshoft Sch Med, Dayton, OH 45435 USA; [Boivin, G. P.; Dudley, E. S.] Wright State Univ, Sch Med, Lab Anim Resources, Dayton, OH 45435 USA; [Boivin, G. P.] Vet Affairs Med Ctr, Cincinnati, OH 45267 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health (NIH/NHBLI) [HL056653]; Wright State University Boonshoft School of Medicine [229102]; State of Ohio Research Incentive [668372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056653, R29HL056653] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NHBLI); Wright State University Boonshoft School of Medicine; State of Ohio Research Incentive; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work has been supported by grant HL056653 from the National Institutes of Health (NIH/NHBLI) to JGC and from grants 229102 from Wright State University Boonshoft School of Medicine, and 668372 from the State of Ohio Research Incentive, also to JGC. We thank Dr Mary C Dinauer and Christophe Marchal for their help generating the pMIEG-PLD vectors and Dr Michael Frohman for providing the PA sensor and to Dr Frohman and to Dr H Alex Brown for guidance in the use of inhibitors. We also thank Dr Cambronero's lab members Qing Ye, Sam Kantonen, Madhu Mahankali, Nate Hatton and Ramya Ganesan, for their excellent help and care with the mice studies.	Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Cho JH, 2008, BBA-MOL CELL RES, V1783, P912, DOI 10.1016/j.bbamcr.2007.11.019; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Foster DA, 2003, MOL CANCER RES, V1, P789; Frondorf K, 2010, J BIOL CHEM, V285, P15837, DOI 10.1074/jbc.M109.070524; Gomez-Cambronero J, 2004, LEUKEMIA RES, V28, P755, DOI 10.1016/j.leukres.2003.11.012; Gomez-Cambronero J, 2012, J LEUKOCYTE BIOL, V92, P461, DOI 10.1189/jlb.0212073; Gomez-Cambronero J, 2010, THESCIENTIFICWORLDJO, V10, P1356, DOI 10.1100/tsw.2010.116; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henkels KM, 2013, CELL SIGNAL, V25, P198, DOI 10.1016/j.cellsig.2012.08.010; Henkels KM, 2011, J MOL BIOL, V408, P850, DOI 10.1016/j.jmb.2011.03.017; Henkels KM, 2010, MOL CELL BIOL, V30, P2251, DOI 10.1128/MCB.01239-09; Itoh T, 2009, SCI SIGNAL; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Joseph T, 2001, BIOCHEM BIOPH RES CO, V289, P1019, DOI 10.1006/bbrc.2001.6118; Kang DW, 2010, CANCER LETT, V294, P125, DOI 10.1016/j.canlet.2010.01.031; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Lorusso G, 2012, SEMIN CANCER BIOL, V22, P226, DOI 10.1016/j.semcancer.2012.03.007; Mahankali M, 2011, CELL SIGNAL, V23, P1291, DOI 10.1016/j.cellsig.2011.03.010; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Nielsen SE, 1999, BRIT J NUTR, V81, P447, DOI 10.1017/S000711459900080X; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Noh DY, 2000, CANCER LETT, V161, P207, DOI 10.1016/S0304-3835(00)00612-1; Park MH, 2009, CARCINOGENESIS, V30, P356, DOI 10.1093/carcin/bgn287; Peng HJ, 2011, MOL CELL BIOL, V31, P2227, DOI 10.1128/MCB.01348-10; Peng HJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206672; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; REICH R, 1995, CLIN EXP METASTAS, V13, P134, DOI 10.1007/BF00133618; Riebeling C, 2003, MELANOMA RES, V13, P555, DOI 10.1097/00008390-200312000-00003; Sanematsu F, 2013, J BIOL CHEM, V288, P8092, DOI 10.1074/jbc.M112.410423; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Scully OJ, 2012, CANCER GENOM PROTEOM, V9, P311; Shen YJ, 2002, BIOCHEM BIOPH RES CO, V293, P201, DOI 10.1016/S0006-291X(02)00204-8; Shi M, 2007, CANCER LETT, V258, P268, DOI 10.1016/j.canlet.2007.09.003; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Stasinopoulos I, 2007, MOL CANCER RES, V5, P435, DOI 10.1158/1541-7786.MCR-07-0010; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Su WJ, 2009, FUTURE ONCOL, V5, P1477, DOI [10.2217/fon.09.110, 10.2217/FON.09.110]; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Taves J, 2008, ARCH BIOCHEM BIOPHYS, V477, P60, DOI 10.1016/j.abb.2008.05.007; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Williger BT, 1999, J BIOL CHEM, V274, P735, DOI 10.1074/jbc.274.2.735; Yamada Y, 2003, J MOL MED, V81, P126, DOI 10.1007/s00109-002-0411-x; You JC, 2009, ENDOCRINOLOGY, V150, P1607, DOI 10.1210/en.2008-0616; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200; Zhong MG, 2003, BIOCHEM BIOPH RES CO, V302, P615, DOI 10.1016/S0006-291X(03)00229-8; Zouwail S, 2005, BIOCHEM J, V389, P207, DOI 10.1042/BJ20050085	61	93	97	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 5	2013	32	49					5551	5562		10.1038/onc.2013.207	http://dx.doi.org/10.1038/onc.2013.207			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	269XF	23752189	Green Accepted, hybrid			2022-12-25	WOS:000328276400006
J	Bombardier, E; Smith, IC; Gamu, D; Fajardo, VA; Vigna, C; Sayer, RA; Gupta, SC; Bal, NC; Periasamy, M; Tupling, AR				Bombardier, Eric; Smith, Ian C.; Gamu, Daniel; Fajardo, Val A.; Vigna, Chris; Sayer, Ryan A.; Gupta, Subash C.; Bal, Naresh C.; Periasamy, Muthu; Tupling, A. Russell			Sarcolipin trumps beta-adrenergic receptor signaling as the favored mechanism for muscle-based diet-induced thermogenesis	FASEB JOURNAL			English	Article						calcium cycling; energy expenditure; skeletal muscle; obesity	SKELETAL-MUSCLE; UNCOUPLING PROTEIN-3; HEAT-PRODUCTION; INDUCED OBESITY; CA2+-ATPASE; TRANSPORT; ABLATION; CA2+; UCP1; ATP	Sarcolipin (SLN) regulates muscle-based nonshivering thermogenesis and is up-regulated with high-fat feeding (HFF). To investigate whether other muscle-based thermogenic systems compensate for a lack of Sln and to firmly establish SLN as a mediator of diet-induced thermogenesis (DIT), we measured muscle and whole-body energy expenditure in chow- and high-fat-fed Sln(-/-) and wild-type (WT) mice. Following HFF, resting muscle metabolic rate (Vo(2), l/g/s) was increased similarly in WT (0.28 +/- 0.02 vs. 0.31 +/- 0.03) and Sln(-/-) (0.23 +/- 0.03 vs. 0.35 +/- 0.02) mice due to increased sympathetic nervous system activation in Sln(-/-) mice; however, whole-body metabolic rate (Vo(2), ml/kg/h) was lower in Sln(-/-) compared with WT mice following HFF but only during periods when the mice were active in their cages (WT, 2894 +/- 87 vs. Sln(-/-), 2708 +/- 61). Treatment with the -adrenergic receptor (-AR) antagonist propranolol during HFF completely prevented muscle-based DIT in Sln(-/-) mice; however, it had no effect in WT mice, resulting in greater differences in whole-body metabolic rate and diet-induced weight gain. Our results suggest that -AR signaling partially compensates for a lack of SLN to activate muscle-based DIT, but SLN is the primary and more effective mediator.Bombardier, E., Smith, I. C., Gamu, D., Fajardo, V. A., Vigna, C., Sayer, R. A., Gupta, S. C., Bal, N. C., Periasamy, M., Tupling, A. R. Sarcolipin trumps -adrenergic receptor signaling as the favored mechanism for muscle-based diet-induced thermogenesis.	[Bombardier, Eric; Smith, Ian C.; Gamu, Daniel; Fajardo, Val A.; Vigna, Chris; Sayer, Ryan A.; Tupling, A. Russell] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Gupta, Subash C.; Bal, Naresh C.; Periasamy, Muthu] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Periasamy, Muthu] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University of Waterloo; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Tupling, AR (corresponding author), Univ Waterloo, Dept Kinesiol, 200 Univ Ave W,Ext 33652, Waterloo, ON N2L 3G1, Canada.	rtupling@uwaterloo.ca	Gupta, Subash/AAF-2563-2019	Gupta, Subash/0000-0002-0418-1940; Smith, Ian/0000-0001-5269-1710; Tupling, A. Russell/0000-0002-3895-6767; Periasamy, Muthu/0000-0001-8834-5975	Canadian Institutes of Health Research (CIHR) [MOP 86618, MOP 47296]; U.S. National Institutes of Health [R01 HL-080551]; Natural Sciences and Engineering Research Council of Canada; CIHR; American Physiological Society; American Heart Association [10POST3360007]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR(Canadian Institutes of Health Research (CIHR)); American Physiological Society; American Heart Association(American Heart Association)	The authors thank Marg Burnett for excellent technical assistance. This work was supported in part by research grants from the Canadian Institutes of Health Research (CIHR; MOP 86618 and MOP 47296 to A. R. T.) and the U.S. National Institutes of Health (R01 HL-080551 to M. P.). E. B., I. C. S., and C. V. were supported by postgraduate scholarship doctoral awards from the Natural Sciences and Engineering Research Council of Canada. V. F. was supported by a doctoral award from CIHR. R. A. S. was supported by master's postgraduate scholarship awards from CIHR and from the Natural Sciences and Engineering Research Council of Canada. N.C.B. was supported by a postdoctoral fellowship from the American Physiological Society and the American Heart Association (10POST3360007). Author contributions: A. R. T. and E. B. conceived of the study idea and designed the experiments; I. C. S. conducted the resting muscle VO<INF>2</INF> TIOX studies; E. B. and R. A. S. conducted the HFD feeding and treadmill exercise experiments, glucose tolerance tests, adiposity and serum chemistry analyses; E. B. and D. G. conducted the propranolol experiments; E. B., C. V., and R. A. S. conducted the whole-body VO<INF>2</INF> CLAMS measurements; V. A. F. conducted the Western blot analyses on UCP-1; S. C. G. conducted the Western blot analyses on SLN; M. P. generated the Sln<SUP>-/-</SUP> mouse model; A. R. T., E. B., I. C. S., V. A. F., S. C. G., and N.C.B. analyzed the data and assembled the figures; A. R. T., E. B., and D. G. wrote the article. The authors declare no conflicts of interest.	Anunciado-Koza R, 2008, J BIOL CHEM, V283, P27688, DOI 10.1074/jbc.M804268200; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Barclay CJ, 2007, J MUSCLE RES CELL M, V28, P259, DOI 10.1007/s10974-007-9116-7; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; de Meis L, 2001, BIOSCIENCE REP, V21, P113, DOI 10.1023/A:1013640006611; Dulloo AG, 2002, SCIENCE, V297, P780, DOI 10.1126/science.1074923; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; GREEN HJ, 1991, CAN J PHYSIOL PHARM, V69, P1222, DOI 10.1139/y91-179; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Lehnart SE, 2004, ANN NY ACAD SCI, V1015, P144, DOI 10.1196/annals.1302.012; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; Masuo K, 2010, CURR DIABETES REV, V6, P58, DOI 10.2174/157339910790909396; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Roatta S, 2010, EXERC SPORT SCI REV, V38, P31, DOI 10.1097/JES.0b013e3181c5cde7; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Son C, 2004, DIABETOLOGIA, V47, P47, DOI 10.1007/s00125-003-1272-8; Szentesi P, 2001, J PHYSIOL-LONDON, V531, P393, DOI 10.1111/j.1469-7793.2001.0393i.x; Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010	27	38	38	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3871	3878		10.1096/fj.13-230631	http://dx.doi.org/10.1096/fj.13-230631			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23752204	Green Published			2022-12-25	WOS:000328840500044
J	Rolain, T; Bernard, E; Beaussart, A; Degand, H; Courtin, P; Egge-Jacobsen, W; Bron, PA; Morsomme, P; Kleerebezem, M; Chapot-Chartier, MP; Dufrene, YF; Hols, P				Rolain, Thomas; Bernard, Elvis; Beaussart, Audrey; Degand, Herve; Courtin, Pascal; Egge-Jacobsen, Wolfgang; Bron, Peter A.; Morsomme, Pierre; Kleerebezem, Michiel; Chapot-Chartier, Marie-Pierre; Dufrene, Yves F.; Hols, Pascal			O-Glycosylation as a Novel Control Mechanism of Peptidoglycan Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOBACILLUS-PLANTARUM WCFS1; DIAMINO ACID ENDOPEPTIDASE; LACTOCOCCUS-LACTIS; TEICHOIC-ACIDS; STAPHYLOCOCCUS-AUREUS; CELL-SEPARATION; BACTERIAL-PEPTIDOGLYCAN; N-ACETYLGLUCOSAMINIDASE; LISTERIA-MONOCYTOGENES; PROTEIN GLYCOSYLATION	Acm2, the major autolysin of Lactobacillus plantarum, is a tripartite protein. Its catalytic domain is surrounded by an O-glycosylated N-terminal region rich in Ala, Ser, and Thr (AST domain), which is of low complexity and unknown function, and a C-terminal region composed of five SH3b peptidoglycan (PG) binding domains. Here, we investigate the contribution of these two accessory domains and of O-glycosylation to Acm2 functionality. We demonstrate that Acm2 is an N-acetylglucosaminidase and identify the pattern of O-glycosylation (21 mono-N-acetylglucosamines) of its AST domain. The O-glycosylation process is species-specific as Acm2 purified from Lactococcus lactis is not glycosylated. We therefore explored the functional role of O-glycosylation by purifying different truncated versions of Acm2 that were either glycosylated or nonglycosylated. We show that SH3b domains are able to bind PG and are responsible for Acm2 targeting to the septum of dividing cells, whereas the AST domain and its O-glycosylation are not involved in this process. Notably, our data reveal that the lack of O-glycosylation of the AST domain significantly increases Acm2 enzymatic activity, whereas removal of SH3b PG binding domains dramatically reduces this activity. Based on this antagonistic role, we propose a model in which access of the Acm2 catalytic domain to its substrate may be hindered by the AST domain where O-glycosylation changes its conformation and/or mediates interdomain interactions. To the best of our knowledge, this is the first time that O-glycosylation is shown to control the activity of a bacterial enzyme.	[Rolain, Thomas; Bernard, Elvis; Beaussart, Audrey; Degand, Herve; Morsomme, Pierre; Dufrene, Yves F.; Hols, Pascal] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Bernard, Elvis; Courtin, Pascal; Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Bernard, Elvis; Courtin, Pascal; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Egge-Jacobsen, Wolfgang] Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; [Bron, Peter A.; Kleerebezem, Michiel] TI Food & Nutr, NL-6709 PA Wageningen, Netherlands; [Bron, Peter A.; Kleerebezem, Michiel] NIZO Food Res, NL-6718 ZB Ede, Netherlands; [Bron, Peter A.] Kluyver Ctr Genom Ind Fermentat, NL-2628 BC Delft, Netherlands; [Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, NL-6708 WD Wageningen, Netherlands	Universite Catholique Louvain; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; University of Oslo; Top Institute Food & Nutrition; NIZO Food Research; Wageningen University & Research	Hols, P (corresponding author), Catholic Univ Louvain, Inst Sci Vie, 5 Pl Croix Sud,L7-07-06, B-1348 Louvain, Belgium.	Pascal.Hols@uclouvain.be	Morsomme, Pierre/AAD-9600-2019; Beaussart, Audrey/N-5645-2016; Kleerebezem, Michiel/AAT-2078-2021	Beaussart, Audrey/0000-0002-4602-3019; Morsomme, Pierre/0000-0001-7780-7230; Dufrene, Yves/0000-0002-7289-4248; Kleerebezem, Michiel/0000-0001-8552-2235; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	National Foundation for Scientific Research (FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme); Research Department of the Communaute francaise de Belgique (Concerted Research Action); Institut National de la Recherche Agronomique; Research Foundation for Industry and Agriculture (FRIA); Marie Curie fellowship for Early Stage Research Training (EST) of the FP6 LabHealth project [MEST-CT-2004-514428]	National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme); Research Department of the Communaute francaise de Belgique (Concerted Research Action); Institut National de la Recherche Agronomique; Research Foundation for Industry and Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Marie Curie fellowship for Early Stage Research Training (EST) of the FP6 LabHealth project(European Commission)	This work was supported in part by the National Foundation for Scientific Research (FNRS), the Universite catholique de Louvain (Fonds Speciaux de Recherche), Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), and the Research Department of the Communaute francaise de Belgique (Concerted Research Action) (in support of the teams of P. H. and Y. F. D.) and by the Institut National de la Recherche Agronomique (Jeune Equipe grant in support of the team of M.-P. C.-C.).; Held a doctoral fellowship from the Research Foundation for Industry and Agriculture (FRIA).; Recipient of a Marie Curie fellowship for Early Stage Research Training (EST) of the FP6 LabHealth project (MEST-CT-2004-514428).	Andre G, 2008, J BACTERIOL, V190, P7079, DOI 10.1128/JB.00519-08; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charbonneau ME, 2012, MOL MICROBIOL, V83, P894, DOI 10.1111/j.1365-2958.2012.07973.x; Cheng Q, 2007, APPL MICROBIOL BIOT, V74, P1284, DOI 10.1007/s00253-006-0771-1; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; CORNETT JB, 1978, J BACTERIOL, V135, P153, DOI 10.1128/JB.135.1.153-160.1978; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Eldholm V, 2010, MOL MICROBIOL, V76, P905, DOI 10.1111/j.1365-2958.2010.07143.x; Eugster MR, 2012, J BACTERIOL, V194, P6498, DOI 10.1128/JB.00808-12; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65; Frankel MB, 2012, J BIOL CHEM, V287, P10460, DOI 10.1074/jbc.M111.336404; Fredriksen L, 2012, J BACTERIOL, V194, P325, DOI 10.1128/JB.06314-11; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Huard C, 2003, MICROBIOL-SGM, V149, P695, DOI 10.1099/mic.0.25875-0; KAWAMURA T, 1983, J BIOL CHEM, V258, P9514; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Kuipers OP, 1997, TRENDS BIOTECHNOL, V15, P135, DOI 10.1016/S0167-7799(97)01029-9; Layec S, 2009, MOL MICROBIOL, V71, P1205, DOI 10.1111/j.1365-2958.2009.06595.x; Lebeer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-15; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Lu JZQ, 2006, J BIOL CHEM, V281, P549, DOI 10.1074/jbc.M509691200; Moens S, 1997, ARCH MICROBIOL, V168, P169, DOI 10.1007/s002030050484; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Otzen D, 2012, MOL MICROBIOL, V83, P879, DOI 10.1111/j.1365-2958.2012.07972.x; Palumbo E, 2006, J BACTERIOL, V188, P3709, DOI 10.1128/JB.188.10.3709-3715.2006; Pavan S, 2000, APPL ENVIRON MICROB, V66, P4427, DOI 10.1128/AEM.66.10.4427-4432.2000; Perez-Dorado I, 2010, NAT STRUCT MOL BIOL, V17, P576, DOI 10.1038/nsmb.1817; Regulski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032301; Rodriguez-Rubio L, 2012, APPL ENVIRON MICROB, V78, P2241, DOI 10.1128/AEM.07621-11; Rolain T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-137; Ruggiero A, 2010, STRUCTURE, V18, P1184, DOI 10.1016/j.str.2010.06.007; Sambrook J., 2002, MOL CLONING LAB MANU; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Serrano LM, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-29; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Vik A, 2012, MOL MICROBIOL, V85, P1166, DOI 10.1111/j.1365-2958.2012.08166.x; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WEBSTER JR, 1981, APPL ENVIRON MICROB, V41, P371, DOI 10.1128/AEM.41.2.371-374.1981; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Yamamoto H, 2008, MOL MICROBIOL, V70, P297, DOI 10.1111/j.1365-2958.2008.06397.x; Yang DC, 2012, MOL MICROBIOL, V85, P768, DOI 10.1111/j.1365-2958.2012.08138.x; Zarschler K, 2010, GLYCOBIOLOGY, V20, P787, DOI 10.1093/glycob/cwq035	56	28	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22233	22247		10.1074/jbc.M113.470716	http://dx.doi.org/10.1074/jbc.M113.470716			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23760506	Green Published, hybrid			2022-12-25	WOS:000330596300006
J	Radu, M; Rawat, SJ; Beeser, A; Iliuk, A; Tao, WA; Chernoff, J				Radu, Maria; Rawat, Sonali J.; Beeser, Alexander; Iliuk, Anton; Tao, Weiguo Andy; Chernoff, Jonathan			ArhGAP15, a Rac-specific GTPase-activating Protein, Plays a Dual Role in Inhibiting Small GTPase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; MEMBRANE PROTRUSIONS; PAK KINASES; BINDING; P21-ACTIVATED-KINASE-1; PHOSPHORYLATION; REGULATORS; PATHWAY; GAPS	Signaling from small GTPases is a tightly regulated process. In this work we used a protein microarray screen to identify the Rac-specific GAP, ArhGAP15, as a substrate of the Rac effectors Pak1 and Pak2. In addition to serving as a substrate of Pak1/2, we found that ArhGAP15, via its PH domain, bound to these kinases. The association of ArhGAP15 to Pak1/2 resulted in mutual inhibition of GAP and kinase catalytic activity, respectively. Knock-down of ArhGAP15 resulted in activation of Pak1/2, both indirectly, as a result of Rac activation, and directly, as a result of disruption of the ArhGAP15/Pak complex. Our data suggest that ArhGAP15 plays a dual negative role in regulating small GTPase signaling, by acting at the level of the GTPase itself, as well interacting with its effector, Pak kinase.	[Radu, Maria; Beeser, Alexander; Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Rawat, Sonali J.] Drexel Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Iliuk, Anton; Tao, Weiguo Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Fox Chase Cancer Center; Drexel University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chernoff, J (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jonathan.Chernoff@fccc.edu	Tao, Weiguo/AAL-2777-2020; Tao, Andy/N-1290-2019; Rawat, Sonali/N-7827-2014; Chernoff, Jonathan/I-7631-2014	Tao, Weiguo/0000-0002-5535-5517; Chernoff, Jonathan/0000-0002-4803-7836; Iliuk, Anton/0000-0002-2914-1363	National Institutes of Health [R01 CA58836, R01 CA098830, R01 GM088317]; Fox Chase Cancer Center Grant [P30 CA006927]; state of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA058836, R01CA098830, R01CA142928, P30CA006927, T32CA009035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Chase Cancer Center Grant; state of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants R01 CA58836 and R01 CA098830 (to J. C.) and R01 GM088317 (to W. A. T.) from the National Institutes of Health and Fox Chase Cancer Center Grant P30 CA006927, as well as by an appropriation from the state of Pennsylvania.	Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bobak D, 1997, ONCOGENE, V15, P2179, DOI 10.1038/sj.onc.1201396; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Costa C, 2011, BLOOD, V118, P1099, DOI 10.1182/blood-2010-12-324756; De la Mota-Peynado A, 2011, J BIOL CHEM, V286, P13603, DOI 10.1074/jbc.M110.181743; DerMardirossian CM, 2006, METHOD ENZYMOL, V406, P80, DOI 10.1016/S0076-6879(06)06007-1; Ding F, 2011, CURR TOP MED CHEM, V11, P2879, DOI 10.2174/156802611798281357; Gamblin SJ, 1998, CURR OPIN STRUC BIOL, V8, P195, DOI 10.1016/S0959-440X(98)80038-9; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Geltz NR, 1998, BLOOD, V91, P930, DOI 10.1182/blood.V91.3.930.930_930_939; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Guo DG, 2010, MOL CELL BIOCHEM, V334, P99, DOI 10.1007/s11010-009-0327-7; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Iliuk A, 2011, METHODS MOL BIOL, V790, P277, DOI 10.1007/978-1-61779-319-6_21; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Pai SY, 2010, DIS MARKERS, V29, P177, DOI [10.1155/2010/380291, 10.3233/DMA-2010-0738]; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Seoh ML, 2003, FEBS LETT, V539, P131, DOI 10.1016/S0014-5793(03)00213-8; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Szczepanowska J, 2009, ACTA BIOCHIM POL, V56, P225; Van den Broeke C, 2011, VIRUS RES, V155, P376, DOI 10.1016/j.virusres.2010.11.003; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200	38	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21117	21125		10.1074/jbc.M113.459719	http://dx.doi.org/10.1074/jbc.M113.459719			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760270	Green Published, hybrid			2022-12-25	WOS:000322014400032
J	Young, LC; McDonald, DW; Hendzel, MJ				Young, Leah C.; McDonald, Darin W.; Hendzel, Michael J.			Kdm4b Histone Demethylase Is a DNA Damage Response Protein and Confers a Survival Advantage following gamma-Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFICATIONS PREDICT PROGNOSIS; H3 LYSINE 4; JMJD2 FAMILY; METHYLATION; CANCER; METHYLTRANSFERASE; HETEROCHROMATIN; TRIMETHYLATION; G9A; PROLIFERATION	DNA damage evokes a complex and highly coordinated DNA damage response (DDR) that is integral to the suppression of genomic instability. Double-strand breaks (DSBs) are considered the most deleterious form damage. Evidence suggests that trimethylation of histone H3 lysine 9 (H3K9me3) presents a barrier to DSB repair. Also, global levels of histone methylation are clinically predictive for several tumor types. Therefore, demethylation of H3K9 may be an important step in the repair of DSBs. The KDM4 subfamily of demethylases removes H3K9 tri- and dimethylation and contributes to the regulation of cellular differentiation and proliferation; mutation or aberrant expression of KDM4 proteins has been identified in several human tumors. We hypothesize that members of the KDM4 subfamily may be components of the DDR. We found that Kdm4b-enhanced GFP (EGFP) and KDM4D-EGFP were recruited rapidly to DNA damage induced by laser micro-irradiation. Focusing on the clinically relevant Kdm4b, we found that recruitment was dependent on poly(ADP-ribose) polymerase 1 activity as well as Kdm4b demethylase activity. The Kdm4 proteins did not measurably accumulate at gamma-irradiation-induced gamma H2AX foci. Nevertheless, increased levels of Kdm4b were associated with decreased numbers of gamma H2AX foci 6 h after irradiation as well as increased cell survival. Finally, we found that levels of H3K9me2 and H3K9me3 were decreased at early time points after 2 gray of gamma-irradiation. Taken together, these data demonstrate that Kdm4b is a DDR protein and that overexpression of Kdm4b may contribute to the failure of anti-cancer therapy that relies on the induction of DNA damage.	Univ Alberta, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Univ Alberta, Dept Expt Oncol, Fac Med & Dent, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta	Hendzel, MJ (corresponding author), Univ Alberta, Dept Oncol, Cross Canc Inst, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	mhendzel@ualberta.ca	Young, Leah/AAN-3579-2020; Young, Leah C/B-9051-2012; Hendzel, Michael/C-3391-2009	Young, Leah C/0000-0001-7156-1006; Hendzel, Michael/0000-0002-9603-7945	Alberta Cancer Foundation; Canadian Institutes of Health Research	Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Alberta Cancer Foundation and the Canadian Institutes of Health Research.	Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Casas-Delucchi CS, 2012, NUCLEIC ACIDS RES, V40, P159, DOI 10.1093/nar/gkr723; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Ellinger J, 2010, INT J CANCER, V127, P2360, DOI 10.1002/ijc.25250; Ellinger J, 2010, PROSTATE, V70, P61, DOI 10.1002/pros.21038; Elsheikh SE, 2009, CANCER RES, V69, P3802, DOI 10.1158/0008-5472.CAN-08-3907; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He CC, 2012, HUM PATHOL, V43, P1425, DOI 10.1016/j.humpath.2011.11.003; Heit R, 2009, J CELL SCI, V122, P2957, DOI 10.1242/jcs.045351; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Hoseok I, 2010, CANCER EPIDEM BIOMAR, V19, P566, DOI 10.1158/1055-9965.EPI-09-0980; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Kim TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034618; Kim TD, 2012, J CELL BIOCHEM, V113, P1368, DOI 10.1002/jcb.24009; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Li WJ, 2011, BIOCHEM BIOPH RES CO, V416, P372, DOI 10.1016/j.bbrc.2011.11.045; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; McManus KJ, 2006, J BIOL CHEM, V281, P8888, DOI 10.1074/jbc.M505323200; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Park YS, 2008, ANN SURG ONCOL, V15, P1968, DOI 10.1245/s10434-008-9927-9; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Robin P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r270; Rossetto D, 2010, CLIN CANCER RES, V16, P4543, DOI 10.1158/1078-0432.CCR-10-0513; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Song JS, 2012, PATHOL INT, V62, P182, DOI 10.1111/j.1440-1827.2011.02776.x; Sousa FG, 2012, CARCINOGENESIS, V33, P1433, DOI 10.1093/carcin/bgs132; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tamagawa H, 2012, ONCOL REP, V27, P637, DOI 10.3892/or.2011.1547; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Tzao C, 2009, MODERN PATHOL, V22, P252, DOI 10.1038/modpathol.2008.172; Wang JL, 2010, BIOL REPROD, V82, P105, DOI 10.1095/biolreprod.109.078055; Wei YK, 2008, MOL CARCINOGEN, V47, P701, DOI 10.1002/mc.20413; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Yin DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027154; Young LC, 2013, BIOCHEM CELL BIOL, V91, P369, DOI 10.1139/bcb-2012-0054; Zheng H, 2013, ONCOGENE, DOI [10.1038/onc.2013.6, DOI 10.1038/0NC.2013.6]	60	103	104	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21376	21388		10.1074/jbc.M113.491514	http://dx.doi.org/10.1074/jbc.M113.491514			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23744078	Green Published, hybrid			2022-12-25	WOS:000322014400056
J	Ma, JJ; Tian, L; Cheng, J; Chen, ZW; Xu, B; Wang, LW; Li, CY; Huang, Q				Ma, Jingjing; Tian, Ling; Cheng, Jin; Chen, Zhiwei; Xu, Bing; Wang, Liwei; Li, Chuanyuan; Huang, Qian			Sonic Hedgehog Signaling Pathway Supports Cancer Cell Growth during Cancer Radiotherapy	PLOS ONE			English	Article							REPOPULATION; PROLIFERATION; ACTIVATION; RADIATION; BLOCKADE; THERAPY	Tumor growth after radiotherapy is a commonly recognized cause of therapeutic failure. In this way, we examined tumor cell growth after radiotherapy by establishing a cancer cell growth model in vitro. We accomplished this model by seeding non-irradiated firefly luciferase2 and green fluorescent protein fusion gene (Fluc) labeled living cancer reporter cells onto a feeder layer of irradiated cancer cells. The living tumor cell growth was monitored by bioluminescence imaging. The living reporter cells grew faster when seeded onto lethally irradiated feeder cells than when seeded onto non-irradiated feeder cells or when seeded in the absence of feeder cells. We found that the expression levels of the Shh and Gli1 proteins, both of which are critical proteins in Sonic hedgehog (SHH) signaling, were increased after irradiation and that this expression was positively correlated with reporter cell growth. Moreover, the dying cell stimulation of living tumor cell growth was enhanced by the addition of SHH signaling agonists and inhibited by SHH signaling antagonists. SHH agonists also enhanced reporter cell growth in the absence of irradiated feeder cells, suggesting this mechanism plays a role in feeder cell growth stimulation. Given these results, we conclude that SHH signaling activation plays an important role during tumor repopulation after radiotherapy.	[Ma, Jingjing; Tian, Ling; Cheng, Jin; Huang, Qian] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Expt Res Ctr, Shanghai 200030, Peoples R China; [Chen, Zhiwei; Xu, Bing] Shanghai Jiao Tong Univ, Sch Med, Dept Radiat Oncol, Peoples Hosp 1, Shanghai 200030, Peoples R China; [Wang, Liwei] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Dept Oncol & Lab Pancreat Dis, Shanghai 200030, Peoples R China; [Li, Chuanyuan] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27706 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Duke University	Li, CY (corresponding author), Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27706 USA.	chuan.li@duke.edu; qhuang2007@gmail.com	Li, Chuan-Yuan/H-4148-2013		National Natural Science Foundation [81120108017, 81172030]; National Basic Research Program of China [2010CB529902]; United States National Cancer Institute [CA131408, CA136748, CA155270]; NATIONAL CANCER INSTITUTE [R01CA131408, R01CA136748, R01CA155270] Funding Source: NIH RePORTER	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); United States National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from National Natural Science Foundation (81120108017, 81172030) and National Basic Research Program of China (2010CB529902) (to Q Huang and L Tian) and in part by grants from the United States National Cancer Institute (CA131408, CA136748, CA155270)(to C-Y Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brade AM, 2006, J CLIN ONCOL, V24, P1020, DOI 10.1200/JCO.2005.04.9676; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Feldmann G, 2008, GUT, V57, P1420, DOI 10.1136/gut.2007.148189; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hu WG, 2007, ACTA PHARMACOL SIN, V28, P1224, DOI 10.1111/j.1745-7254.2007.00620.x; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Kelleher FC, 2011, CARCINOGENESIS, V32, P445, DOI 10.1093/carcin/bgq280; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Nishioka T, 2011, CELL STRUCT FUNCT, V36, P13, DOI 10.1247/csf.10008; Pazzaglia S, 2002, ONCOGENE, V21, P7580, DOI 10.1038/sj.onc.1205973; Rodova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046083; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Ryoo HD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008797; Shin K, 2011, NATURE, V472, P110, DOI 10.1038/nature09851; Sims-Mourtada J, 2006, CLIN CANCER RES, V12, P6565, DOI 10.1158/1078-0432.CCR-06-0176; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; WITHERS HR, 1988, ACTA ONCOL, V27, P131, DOI 10.3109/02841868809090333	25	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65032	10.1371/journal.pone.0065032	http://dx.doi.org/10.1371/journal.pone.0065032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762282	Green Published, gold, Green Submitted			2022-12-25	WOS:000320440500020
J	Fiorini, A; Koudriavtseva, T; Bucaj, E; Coccia, R; Foppoli, C; Giorgi, A; Schinina, ME; Di Domenico, F; De Marco, F; Perluigi, M				Fiorini, Ada; Koudriavtseva, Tatiana; Bucaj, Elona; Coccia, Raffaella; Foppoli, Cesira; Giorgi, Alessandra; Schinina, M. Eugenia; Di Domenico, Fabio; De Marco, Federico; Perluigi, Marzia			Involvement of Oxidative Stress in Occurrence of Relapses in Multiple Sclerosis: The Spectrum of Oxidatively Modified Serum Proteins Detected by Proteomics and Redox Proteomics Analysis	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; BINDING PROTEIN; GELSOLIN; PLASMA; PATHOGENESIS; ACTIN; BRAIN; NEURODEGENERATION; COAGULATION; EXPRESSION	Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous system. Several evidences suggest that MS can be considered a multi-factorial disease in which both genetics and environmental factors are involved. Among proposed candidates, growing results support the involvement of oxidative stress (OS) in MS pathology. The aim of this study was to investigate the role of OS in event of exacerbations in MS on serum of relapsing-remitting (RR-MS) patients, either in relapsing or remitting phase, with respect to serum from healthy subjects. We applied proteomics and redox proteomics approaches to identify differently expressed and oxidatively modified proteins in the low-abundant serum protein fraction. Among differently expressed proteins ceruloplasmin, antithrombin III, clusterin, apolipoprotein E, and complement C3, were up-regulated in MS patients compared with healthy controls. Further by redox proteomics, vitamin D-binding protein showed a progressive trend of oxidation from remission to relapse, respect with controls. Similarly, the increase of oxidation of apolipoprotein A-IV confirmed that levels of OS are elevated with the progression of the disease. Our findings support the involvement of OS in MS and suggest that dysfunction of target proteins occurs upon oxidative damage and correlates with the pathology.	[Fiorini, Ada; Coccia, Raffaella; Giorgi, Alessandra; Schinina, M. Eugenia; Di Domenico, Fabio; Perluigi, Marzia] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Koudriavtseva, Tatiana] Regina Elena Inst Canc Res, SSD Neurol, Rome, Italy; [Bucaj, Elona; De Marco, Federico] Regina Elena Inst Canc Res, Virol Lab, Rome, Italy; [Foppoli, Cesira] CNR, Inst Mol Biol & Pathol, Rome, Italy	Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	De Marco, F (corresponding author), Regina Elena Inst Canc Res, Virol Lab, Rome, Italy.	demarco@ifo.it; marzia.perluigi@uniroma1.it	Di Domenico, Fabio/AAA-9241-2022; perluigi, marzia/D-3260-2009; Koudriavtseva, Tatiana/H-8866-2017; Di Domenico, Fabio/J-4767-2018; De Marco, Federico/H-5160-2018; Foppoli, Cesira/AAL-4119-2021	Di Domenico, Fabio/0000-0002-2013-209X; Koudriavtseva, Tatiana/0000-0001-9984-1827; Di Domenico, Fabio/0000-0002-2013-209X; De Marco, Federico/0000-0002-1173-2843; COCCIA, Raffaella/0000-0001-5161-4094; FOPPOLI, CESIRA/0000-0001-9170-1336	FISM-Fondazione Italiana Sclerosi Multipla [2010/R/29]; Italian Ministry of Health; Italian Ministry of Foreign Affairs, DGSP; Ministry of Foreign Affairs, DGCS	FISM-Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Foreign Affairs, DGSP; Ministry of Foreign Affairs, DGCS	This work was supported by FISM-Fondazione Italiana Sclerosi Multipla grant 2010/R/29, by the Italian Ministry of Health and by the Italian Ministry of Foreign Affairs, DGSP. Dr Elona Bucaj was supported by a PhD fellowship granted by the Ministry of Foreign Affairs, DGCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaif M, 2012, PROTEOM CLIN APPL, V6, P297, DOI 10.1002/prca.201100061; Antequera D, 2009, NEUROBIOL DIS, V36, P42, DOI 10.1016/j.nbd.2009.06.018; Beilin O, 2005, J NEUROSCI RES, V79, P351, DOI 10.1002/jnr.20270; BERESFORD CH, 1990, INT J BIOCHEM, V22, P121, DOI 10.1016/0020-711X(90)90172-Y; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bijl M, 2003, ARTHRITIS RHEUM, V48, P248, DOI 10.1002/art.10737; Bizzozero OA, 2005, J NEUROSCI RES, V81, P687, DOI 10.1002/jnr.20587; Bradl M, 2009, SEMIN IMMUNOPATHOL, V31, P455, DOI 10.1007/s00281-009-0182-3; Butterfield DA, 2006, EUR J PHARMACOL, V545, P39, DOI 10.1016/j.ejphar.2006.06.026; Chapman J, 2006, AUTOIMMUN REV, V5, P528, DOI 10.1016/j.autrev.2006.02.011; Chiasserini D, 2008, EUR J NEUROL, V15, P998, DOI 10.1111/j.1468-1331.2008.02239.x; Cicala C, 1998, LIFE SCI, V62, P1817, DOI 10.1016/S0024-3205(97)01167-3; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; D'Aguanno S, 2008, J NEUROIMMUNOL, V193, P156, DOI 10.1016/j.jneuroim.2007.10.004; Dalle-Donne I, 2005, MASS SPECTROM REV, V24, P55, DOI 10.1002/mas.20006; Del Boccio P, 2011, J PROTEOMICS, V74, P2826, DOI 10.1016/j.jprot.2011.06.023; Disanto G, 2011, J NEUROL, V258, P353, DOI 10.1007/s00415-010-5797-8; Esmon CT, 2001, THROMB HAEMOSTASIS, V86, P51; Ortiz GG, 2009, DIS MARKERS, V26, P35, DOI [10.1155/2009/325847, 10.3233/DMA-2009-0602]; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Gonsette RE, 2008, J NEUROL SCI, V274, P48, DOI 10.1016/j.jns.2008.06.029; Greco A, 1999, NEUROLOGY, V53, P1876, DOI 10.1212/WNL.53.8.1876; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Inaba Y, 1999, CELL IMMUNOL, V198, P96, DOI 10.1006/cimm.1999.1588; Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343; Kulakowska A, 2008, EUR J NEUROL, V15, P584, DOI 10.1111/j.1468-1331.2008.02133.x; Kulakowska A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-107; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; LIND SE, 1986, J CLIN INVEST, V78, P736, DOI 10.1172/JCI112634; Liu SL, 2009, J CELL MOL MED, V13, P1586, DOI 10.1111/j.1582-4934.2009.00850.x; Luessi F, 2012, EXPERT REV NEUROTHER, V12, P1061, DOI [10.1586/ERN.12.59, 10.1586/ern.12.59]; Miller E, 2012, CLIN BIOCHEM, V45, P26, DOI 10.1016/j.clinbiochem.2011.09.021; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Oliveira SR, 2012, J NEUROL SCI, V321, P49, DOI 10.1016/j.jns.2012.07.045; Olmarker K, 1996, SPINE, V21, P411, DOI 10.1097/00007632-199602150-00002; Pappin Darryl J C, 2003, Methods Mol Biol, V211, P211; Perluigi M, 2009, J CELL MOL MED, V13, P1809, DOI 10.1111/j.1582-4934.2008.00465.x; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Rithidech KN, 2009, MULT SCLER J, V15, P455, DOI 10.1177/1352458508100047; Roussel BD, 2009, BRAIN, V132, P2219, DOI 10.1093/brain/awp162; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; Silber E, 1999, J NEUROL SCI, V170, P11, DOI 10.1016/S0022-510X(99)00178-1; Singh V, 2012, J NEUROIMMUNOL, V248, P40, DOI 10.1016/j.jneuroim.2011.11.004; Stavropoulou C, 2011, FREE RADICAL BIO MED, V51, P713, DOI 10.1016/j.freeradbiomed.2011.04.043; Stoop MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012442; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Tasset I, 2012, CLIN BIOCHEM, V45, P440, DOI 10.1016/j.clinbiochem.2012.01.023; Teunissen CE, 2011, MULT SCLER J, V17, P838, DOI 10.1177/1352458511399614; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Turk R, 2012, J PROTEOMICS, V75, P4412, DOI 10.1016/j.jprot.2012.05.021; Zipp F, 2000, CELL TISSUE RES, V301, P163, DOI 10.1007/s004410000179	55	63	66	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65184	10.1371/journal.pone.0065184	http://dx.doi.org/10.1371/journal.pone.0065184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762311	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800023
J	Ogawa, Y; Imajo, K; Yoneda, M; Kessoku, T; Tomeno, W; Shinohara, Y; Kato, S; Mawatari, H; Nozaki, Y; Fujita, K; Kirikoshi, H; Maeda, S; Saito, S; Wada, K; Nakajima, A				Ogawa, Yuji; Imajo, Kento; Yoneda, Masato; Kessoku, Takaomi; Tomeno, Wataru; Shinohara, Yoshiyasu; Kato, Shingo; Mawatari, Hironori; Nozaki, Yuichi; Fujita, Koji; Kirikoshi, Hiroyuki; Maeda, Shin; Saito, Satoru; Wada, Koichiro; Nakajima, Atsushi			Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							SAMPLING VARIABILITY; INSULIN-RESISTANCE; NATURAL-HISTORY; HEPATITIS; BIOPSY; DISEASE; NASH; ENDOTOXIN; CIRRHOSIS; RECEPTOR	Background & Aims: Liver inflammation is a risk factor for the progression of nonalcoholic fatty liver disease (NAFLD). However, the diagnosis of liver inflammation is very difficult and invasive liver biopsy is still the only method to reliably detect liver inflammation. We previously reported that overexpression of CD14 in Kupffer cells may trigger the progression to nonalcoholic steatohepatitis (NASH) via liver inflammation following hyper-reactivity to low-dose lipopolysaccharide. Therefore, the aim of this study was to investigate the relationship between soluble type of CD14 (sCD14) and histological features in patients with NAFLD. Methods: Our cohort consisted of 113 patients with liver biopsy-confirmed NAFLD and 21 age-matched healthy controls. Serum sCD14 levels were measured by an enzyme-linked immunosorbent assay. Results: Serum sCD14 levels were significantly associated with diagnosis of NASH and the area under the receiver operator characteristic curve (AUROC) to distinguish between not NASH and NASH was 0.802. Moreover, serum sCD14 levels were significantly associated with the disease activity based on NAFLD activity score and hepatic CD14 mRNA expression, which is correlated with membrane CD14 (mCD14) expression, in patients with NAFLD. In multiple regression analysis, the serum sCD14 levels were independently associated with liver inflammation. The AUROC to distinguish between mild and severe liver inflammation in patients with NAFLD was 0.752. Conclusions: We found that serum sCD14 levels increased significantly with increasing liver inflammation grade in patients with NAFLD, reflecting increased hepatic CD14 expression. Serum sCD14 is a promising tool to predict the worsening of liver inflammation, and may offer a potential biomarker for evaluation of therapeutic effects in NAFLD.	[Ogawa, Yuji; Imajo, Kento; Yoneda, Masato; Kessoku, Takaomi; Tomeno, Wataru; Shinohara, Yoshiyasu; Kato, Shingo; Mawatari, Hironori; Nozaki, Yuichi; Fujita, Koji; Kirikoshi, Hiroyuki; Maeda, Shin; Saito, Satoru; Nakajima, Atsushi] Yokohama City Univ, Grad Sch Med, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan; [Wada, Koichiro] Osaka Univ, Grad Sch Dent, Dept Pharmacol, Suita, Osaka, Japan	Yokohama City University; Osaka University	Nakajima, A (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Gastroenterol, Yokohama, Kanagawa 232, Japan.	nakajima-tky@umin.ac.jp	Imajo, Kento/AAF-5744-2020	Imajo, Kento/0000-0002-1931-6326; Kessoku, Takaomi/0000-0002-5587-1386	Japan Science and Technology Agency (JST); Kiban-B, Shingakujuturyouiki; Japanese Ministry of Health, Labour and Welfare	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Kiban-B, Shingakujuturyouiki; Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	Work in the authors' laboratory was supported by the program "Step A'' from the Japan Science and Technology Agency (JST) and Kiban-B, Shingakujuturyouiki. In addition, the present work was supported in part by grants-in-aid from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDI W, 1979, ARCH INTERN MED, V139, P667, DOI 10.1001/archinte.139.6.667; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; BAZIL V, 1991, J IMMUNOL, V147, P1567; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Cadranel JF, 2002, GASTROEN CLIN BIOL, V26, P823; Chitturi S, 2001, SEMIN LIVER DIS, V21, P27, DOI 10.1055/s-2001-12927; Chou MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034903; Day CP, 2002, GUT, V50, P585, DOI 10.1136/gut.50.5.585; Day CP, 2002, J GASTROEN HEPATOL, V17, P377, DOI DOI 10.1046/J.1440-1746.17.S3.31.X; Fan JG, 2007, J GASTROEN HEPATOL, V22, P1086, DOI 10.1111/j.1440-1746.2006.04781.x; Farrell GC, 2003, J GASTROEN HEPATOL, V18, P124, DOI 10.1046/j.1440-1746.2003.02989.x; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Hui JM, 2003, HEPATOLOGY, V38, P420, DOI 10.1053/jhep.2003.50320; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kornek M, 2012, GASTROENTEROLOGY, V143, P448, DOI 10.1053/j.gastro.2012.04.031; Kugelmas M, 2003, HEPATOLOGY, V38, P413, DOI 10.1053/jhep.2003.50316; Luan X, 2012, TRANSPL P, V44, P937, DOI 10.1016/j.transproceed.2011.11.001; MAHARAJ B, 1986, LANCET, V1, P523; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Sanyal A. J., 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sanyal AJ, 2002, J GASTROEN HEPATOL, V17, P385, DOI DOI 10.1046/j.1440-1746.17.s3.32.x; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; SOLOWAY RD, 1971, AM J DIG DIS, V16, P1082, DOI 10.1007/BF02235164; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283	36	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65211	10.1371/journal.pone.0065211	http://dx.doi.org/10.1371/journal.pone.0065211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762319	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800026
J	Taegtmeyer, M; Davies, A; Mwangome, M; van der Elst, EM; Graham, SM; Price, MA; Sanders, EJ				Taegtmeyer, Miriam; Davies, Alun; Mwangome, Mary; van der Elst, Elisabeth M.; Graham, Susan M.; Price, Matt A.; Sanders, Eduard J.			Challenges in Providing Counselling to MSM in Highly Stigmatized Contexts: Results of a Qualitative Study from Kenya	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; MALE SEX WORKERS; HIV-INFECTION; SOCIAL CONSTRUCTION; AFRICAN MEN; CAPE-TOWN; RISK; MOMBASA; PREVENTION; PERCEPTIONS	The role of men who have sex with men (MSM) in the African HIV epidemic is gaining recognition yet capacity to address the HIV prevention needs of this group is limited. HIV testing and counselling is not only a critical entry point for biomedical HIV prevention interventions, such as pre-exposure prophylaxis, rectal microbicides and early treatment initiation, but is also an opportunity for focused risk reduction counselling that can support individuals living in difficult circumstances. For prevention efforts to succeed, however, MSM need to access services and they will only do so if these are non-judgmental, informative, focused on their needs, and of clear benefit. This study aimed to understand Kenyan providers' attitudes towards and experiences with counselling MSM in a research clinic targeting this group for HIV prevention. We used in-depth interviews to explore values, attitudes and cognitive and social constructs of 13 counsellors and 3 clinicians providing services to MSM at this clinic. Service providers felt that despite their growing experience, more targeted training would have been helpful to improve their effectiveness in MSM-specific risk reduction counselling. They wanted greater familiarity with MSM in Kenya to better understand the root causes of MSM risk-taking (e. g., poverty, sex work, substance abuse, misconceptions about transmission, stigma, and sexual desire) and felt frustrated at the perceived intractability of some of their clients' issues. In addition, they identified training needs on how to question men about specific risk behaviours, improved strategies for negotiating risk reduction with counselling clients, and improved support supervision from senior counsellors. This paper describes the themes arising from these interviews and makes practical recommendations on training and support supervision systems for nascent MSM HIV prevention programmes in Africa.	[Taegtmeyer, Miriam] Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England; [Taegtmeyer, Miriam; Davies, Alun; Mwangome, Mary; van der Elst, Elisabeth M.; Graham, Susan M.; Sanders, Eduard J.] Ctr Geog Med Res Coast, Kenya Med Res Inst, Kilifi, Kenya; [Graham, Susan M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Price, Matt A.] Int AIDS Vaccine Initiat, Dept Med Affairs, New York, NY USA; [Price, Matt A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Sanders, Eduard J.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	Liverpool School of Tropical Medicine; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; University of California System; University of California San Francisco; University of Oxford	Taegtmeyer, M (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Int Publ Hlth, Liverpool, Merseyside, England.	M.Taegtmeyer@liverpool.ac.uk	Graham, Susan/W-6133-2019; Price, Matt/AAK-6881-2021	Graham, Susan/0000-0001-7847-8686; Price, Matt/0000-0002-2918-1373; Taegtmeyer, Miriam/0000-0002-5377-2536; Davies, Alun/0000-0001-7784-9000	International AIDS Vaccine Initiative, New York, United States of America; United States Agency for International Development (USAID); University of Washington's Center for AIDS Research [AI-27757]; National Institutes of Health [HD-055864]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD055864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative, New York, United States of America; United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); University of Washington's Center for AIDS Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by the International AIDS Vaccine Initiative, New York, United States of America, and included support from the United States Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the United States Government. Support is also provided by the University of Washington's Center for AIDS Research (grant AI-27757) and the National Institutes of Health (grant HD-055864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral S, 2012, AIDS BEHAV, V19, P19; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-766; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Bowers R, 2005, INT J ADV COUNS, V27, P471, DOI 10.1007/s10447-005-8207-7; Brown B, 2011, MEN WHO HAVE SEX MEN; Cloete A, 2008, AIDS CARE, V20, P1105, DOI 10.1080/09540120701842720; Das P, 2012, LANCET, V380, P309, DOI 10.1016/S0140-6736(12)61074-5; Eden A, 2003, KENYA NATL MANUAL TR; Fay H, 2011, AIDS BEHAV, V15, P1088, DOI 10.1007/s10461-010-9861-2; Geibel S, 2008, SEX TRANSM DIS, V35, P746, DOI 10.1097/OLQ.0b013e318170589d; Geibel S, 2007, AIDS, V21, P1349, DOI 10.1097/QAD.0b013e328017f843; Geibel S, 2012, SEX TRANSM INFECT, V88, P357, DOI 10.1136/sextrans-2011-050224; GERGEN KJ, 1985, AM PSYCHOL, V40, P266, DOI 10.1037/0003-066X.40.3.266; Graham SM, 2013, AIDS BEHAV, V15, P15; Grijsen ML, 2008, SEX TRANSM INFECT, V84, P364, DOI 10.1136/sti.2007.028852; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hamilton C, 2008, HEALTH POLICY PLANN, V23, P390, DOI 10.1093/heapol/czn029; Hamilton CJ, 2009, J COUNS PSYCHOL, V56, P132, DOI 10.1037/a0014440; Johnson CA, 2007, MAP HIV AIDS PROGRAM; Knox J, 2011, INT J STD AIDS, V22, P709, DOI 10.1258/ijsa.2011.010350; Kyomya M, 2012, LANCET, V380, P310, DOI 10.1016/S0140-6736(12)60682-5; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; Lane T, 2011, AIDS BEHAV, V15, P626, DOI 10.1007/s10461-009-9598-y; Lewis J, 2003, QUALITATIVE RES PRAC, P47; Marum E, 2006, JAMA-J AM MED ASSOC, V296, P859, DOI 10.1001/jama.296.7.859; Muraguri N, 2012, SAHARA J-J SOC ASP H, V9, P137, DOI 10.1080/17290376.2012.744176; Mutua G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033103; National AIDS and STI Control Programme Ministry of Public Health and Sanitation Kenya, 2008, GUID HIV TEST COUNS; Nel JA, 2012, AIDS BEHAV, V4, P4; Nzioka C, 1996, AIDS CARE, V8, P565, DOI 10.1080/09540129650125524; Okal J, 2009, CULT HEALTH SEX, V11, P811, DOI 10.1080/13691050902906488; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Poteat T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028760; Pretty J, 1993, PARTICIPATORY INQUIR, P13; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Raymond HF, 2009, AIDS BEHAV, V13, P677, DOI 10.1007/s10461-009-9557-7; RINGHEIM K, 1995, SOC SCI MED, V40, P1691, DOI 10.1016/0277-9536(94)00279-3; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Sanders EJ, 2012, HIGH HIV 1 INCIDENCE; Semugoma P, 2012, LANCET, V380, P312, DOI 10.1016/S0140-6736(12)60901-5; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shefer T, 2002, QUAL HEALTH RES, V12, P1373, DOI 10.1177/1049732302238749; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Stromdahl S, 2012, AIDS RES HUM RETROV, V28, P1756, DOI [10.1089/aid.2012.0070, 10.1089/AID.2012.0070]; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Thoreson R, 2011, NOWHERE TURN BLACKMA; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; Turnbull S., 2002, ADV DEV HUM RESOUR, V4, P317, DOI DOI 10.1177/1523422302043006; Van der Elst EM, 2012, AIDS BEHAV, V19, P19; Vernon RF, 1998, COUNS PSYCHOL, V11, P201; Villaneuva MLM, 1998, SOCIAL CONSTRUCTION; Whitman N, 1993, Fam Med, V25, P517; *WHO, 2008, PRIOR INT HIV AIDS P	56	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64527	10.1371/journal.pone.0064527	http://dx.doi.org/10.1371/journal.pone.0064527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173QU	23762241	Green Accepted, Green Published, gold			2022-12-25	WOS:000321094800007
J	Li, BQ; Niu, B; Chen, L; Wei, ZJ; Huang, T; Jiang, M; Lu, J; Zheng, MY; Kong, XY; Cai, YD				Li, Bi-Qing; Niu, Bing; Chen, Lei; Wei, Ze-Jun; Huang, Tao; Jiang, Min; Lu, Jing; Zheng, Ming-Yue; Kong, Xiang-Yin; Cai, Yu-Dong			Identifying Chemicals with Potential Therapy of HIV Based on Protein-Protein and Protein-Chemical Interaction Network	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE INHIBITORS; SMALL-MOLECULE INHIBITORS; T-CELL RESPONSES; NF-KAPPA-B; IFN-GAMMA; HUMAN CD4; COMPLEX; CCR5; ANTAGONIST	Acquired immune deficiency syndrome (AIDS) is a severe infectious disease that causes a large number of deaths every year. Traditional anti-AIDS drugs directly targeting the HIV-1 encoded enzymes including reverse transcriptase (RT), protease (PR) and integrase (IN) usually suffer from drug resistance after a period of treatment and serious side effects. In recent years, the emergence of numerous useful information of protein-protein interactions (PPI) in the HIV life cycle and related inhibitors makes PPI a new way for antiviral drug intervention. In this study, we identified 26 core human proteins involved in PPI between HIV-1 and host, that have great potential for HIV therapy. In addition, 280 chemicals that interact with three HIV drugs targeting human proteins can also interact with these 26 core proteins. All these indicate that our method as presented in this paper is quite promising. The method may become a useful tool, or at least plays a complementary role to the existing method, for identifying novel anti-HIV drugs.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Niu, Bing] Shanghai Univ, Coll Life Sci, Shanghai, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Wei, Ze-Jun; Jiang, Min; Kong, Xiang-Yin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol Inst Hlth Sci, Shanghai, Peoples R China; [Huang, Tao] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Lu, Jing; Zheng, Ming-Yue] Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Kong, XY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol Inst Hlth Sci, Shanghai, Peoples R China.	xykong@sibs.ac.cn; cai_yud@yahoo.com.cn	Chen, Lei/A-2275-2011; Zheng, Mingyue/AAJ-8027-2020; Zheng, Mingyue/HHZ-4062-2022; Zheng, Mingyue/Z-3582-2019; Zheng, Mingyue/B-4860-2010	Chen, Lei/0000-0003-3068-1583; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; National Natural Science Foundation of China [81001399]; grant of "The First-class Discipline of Universities in Shanghai"	National Basic Research Program of China(National Basic Research Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); grant of "The First-class Discipline of Universities in Shanghai"	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), National Natural Science Foundation of China (Grant 81001399) and the grant of "The First-class Discipline of Universities in Shanghai". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Bovolenta C, 1999, J IMMUNOL, V162, P323; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Busschots K, 2009, MOL BIOSYST, V5, P21, DOI 10.1039/b810306b; Cesarini S, 2008, BIOORGAN MED CHEM, V16, P4160, DOI 10.1016/j.bmc.2007.12.050; Chan JK, 2012, IMMUNOL REV, V246, P286, DOI 10.1111/j.1600-065X.2012.01094.x; Chan JKL, 2011, CURR OPIN HIV AIDS, V6, P12, DOI 10.1097/COH.0b013e32834124fd; Chen HF, 2010, CURR MED CHEM, V17, P750, DOI 10.2174/092986710790514444; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056517; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; DANLEY DE, 1989, BIOCHEM BIOPH RES CO, V165, P1043, DOI 10.1016/0006-291X(89)92707-1; De Clercq E, 2009, REV MED VIROL, V19, P287, DOI 10.1002/rmv.624; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DeClercq E, 1996, MED RES REV, V16, P125, DOI 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO;2-2; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Dieffenbach CW, 2011, ANN INTERN MED, V154, P766, DOI 10.7326/0003-4819-154-11-201106070-00345; DING J, 1995, STRUCTURE, V3, P365, DOI 10.1016/S0969-2126(01)00168-X; DING JP, 1995, NAT STRUCT BIOL, V2, P407, DOI 10.1038/nsb0595-407; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gerrard JA, 2007, MINI-REV MED CHEM, V7, P151, DOI 10.2174/138955707779802561; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; HO DD, 1994, J VIROL, V68, P2016, DOI 10.1128/JVI.68.3.2016-2020.1994; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones RB, 2009, J VIROL, V83, P8722, DOI 10.1128/JVI.00433-09; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Ju SM, 2012, MOL CELLS, V33, P335, DOI 10.1007/s10059-012-2287-0; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kino T, 2004, DNA CELL BIOL, V23, P193, DOI 10.1089/104454904773819789; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kryworuchko M, 2003, CLIN EXP IMMUNOL, V131, P422, DOI 10.1046/j.1365-2249.2003.02065.x; Krzysztof A, 1993, PERSPECT DRUG DISCOV, V1, P23, DOI [10.1007/BF02171654, DOI 10.1007/BF02171654]; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Li BQ, 2012, BIOCHIMIE, V94, P1910, DOI 10.1016/j.biochi.2012.05.005; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li W, 2011, J IMMUNOL, V186, P6771, DOI 10.4049/jimmunol.1100099; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; Ng TTC, 1997, J IMMUNOL, V158, P2984; Nishikawa M, 2005, ANTIMICROB AGENTS CH, V49, P4708, DOI 10.1128/AAC.49.11.4708-4715.2005; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Perry CM, 2009, DRUGS, V69, P843, DOI 10.2165/00003495-200969070-00005; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Reitano KN, 2009, AIDS RES HUM RETROV, V25, P1029, DOI 10.1089/aid.2008.0311; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; REN JS, 1995, STRUCTURE, V3, P915, DOI 10.1016/S0969-2126(01)00226-X; RICE AP, 2007, FUTURE HIV THER, V1, P369; Rom S, 2011, BBA-MOL CELL RES, V1813, P1836, DOI 10.1016/j.bbamcr.2011.06.012; RYU SE, 1994, STRUCTURE, V2, P59, DOI 10.1016/S0969-2126(00)00008-3; Shao W, 1997, P NATL ACAD SCI USA, V94, P2243, DOI 10.1073/pnas.94.6.2243; Spallarossa A, 2008, BIOCHEM BIOPH RES CO, V365, P764, DOI 10.1016/j.bbrc.2007.11.036; Spallarossa A, 2009, EUR J MED CHEM, V44, P1650, DOI 10.1016/j.ejmech.2008.09.024; TIERNEY M, 1995, J ACQ IMMUN DEF SYND, V10, P549, DOI 10.1097/00042560-199510050-00008; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Wang Y, 2009, MINI-REV MED CHEM, V9, P379, DOI 10.2174/1389557510909030379; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; White Alex W., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000641; Wonderlich ER, 2011, J VIROL, V85, P12216, DOI 10.1128/JVI.00056-11; Yu MY, 2009, MINI-REV MED CHEM, V9, P60, DOI 10.2174/138955709787001677; Zhan P, 2010, CURR MED CHEM, V17, P495, DOI 10.2174/092986710790416335; Zhan P, 2009, CURR MED CHEM, V16, P3903, DOI 10.2174/092986709789178019; Zoughlami Y, 2012, BLOOD, V119, P2024, DOI 10.1182/blood-2011-06-364828	79	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65207	10.1371/journal.pone.0065207	http://dx.doi.org/10.1371/journal.pone.0065207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762317	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000044
J	Pang, H; Yu, Q; Guo, BP; Jiang, Y; Wan, L; Li, J; Wu, YJ; Wan, KL				Pang, Hui; Yu, Qin; Guo, Buping; Jiang, Yi; Wan, Li; Li, Jun; Wu, Yanjun; Wan, Kanglin			Frequency of Regulatory T-Cells in the Peripheral Blood of Patients with Pulmonary Tuberculosis from Shanxi Province, China	PLOS ONE			English	Article							CYTOKINE RESPONSES; SUPPRESSION; GROWTH; BETA	Background: Tuberculosis (TB) is a disease caused by the chronic and continuous infection of the pathogen Mycobacterium tuberculosis (M. tuberculosis). M. tuberculosis is an intracellular bacterial pathogen and is eliminated mainly through CD4(+) effector Th cells. M. tuberculosis induces regulatory T lymphocytes (Tregs) that mediate immune suppression by cell-to-cell contact or by secreting cytokines such as transforming growth factor-beta (TGF-beta). To understand the role of regulatory T-cells in the pathogenesis of TB, we have measured the in vivo frequency of regulatory T-cells and associated in vivo cytokine production in pulmonary tuberculosis patients. Methodology/Principal Findings: In this study, we analyzed blood samples from 3 different populations (Group 1: patients with active TB, Group 2: patients recovered from TB and Group 3: healthy controls). We measured natural regulatory T-cell expression in peripheral blood using flow cytometry, and levels of blood serum IFN-gamma and TGF-beta 1 using ELISA. The in vivo function of inductive regulatory T cells was mainly indicated by the expression of IFN-gamma, TGF-beta 1, etc. Frequency of natural regulatory T cells and inductive regulatory T cells in the peripheral blood samples from Group 1 patients were all significantly higher (P<0.05) than those from Groups 2 and 3. Conclusion/Significance: Our results indicate that frequency of natural regulatory T cells and inductive regulatory T cells are significantly higher in the peripheral blood of patients with active pulmonary tuberculosis. These findings have potential application in improving TB diagnostic methods.	[Pang, Hui; Wu, Yanjun] Changzhi Med Coll, Dept Immunol, Changzhi, Shanxi Province, Peoples R China; [Yu, Qin; Jiang, Yi; Wan, Li; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Guo, Buping] Changzhi Med Coll, Dept Lab Med, Changzhi, Shanxi Province, Peoples R China; [Yu, Qin] Univ South China, Pathogen Biol Inst, Hengyang, Peoples R China; [Li, Jun] Peoples Hosp Changzhi City, Changzhi City, Shanxi Province, Peoples R China	Changzhi Medical College; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Changzhi Medical College; University of South China	Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	wankanglin@icdc.cn			National Key Program of Mega Infectious Disease [2008ZX100/03-010-02]	National Key Program of Mega Infectious Disease	This work was funded by the project "Transmission Mode of Tuberculosis'' (2008ZX100/03-010-02) of National Key Program of Mega Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinese Antituberculosis Association, 1996, CHINESE J ANTITURBER, V18, P80; Chinese Centers for Disease Control and Prevention Chinese Anti-tuberculosis Association Chinese Medical Association, 2008, INSTR MAN ANT DRUGS, P6; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Handzel ZT, 2007, ISR MED ASSOC J, V9, P479; He XY, 2010, EUR J CLIN MICROBIOL, V29, P643, DOI 10.1007/s10096-010-0908-0; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; IDIGBE EO, 1986, J TROP MED HYG, V89, P143; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kochi A, 2001, B WORLD HEALTH ORGAN, V79, P71; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Mitra DK, 2009, MICROBES INFECT, V11, P1122, DOI 10.1016/j.micinf.2009.08.006; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Rahman S, 2009, AM J PATHOL, V174, P2211, DOI 10.2353/ajpath.2009.080941; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; TORRES M, 1994, CLIN EXP IMMUNOL, V96, P75, DOI 10.1111/j.1365-2249.1994.tb06233.x; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vrabelova Z, 2008, SCAND J IMMUNOL, V67, P404, DOI 10.1111/j.1365-3083.2008.02074.x; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; Welsh KJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/307631; Winkler S, 2005, MICROBES INFECT, V7, P1161, DOI 10.1016/j.micinf.2005.03.020; Yi HF, 2006, CELL MOL IMMUNOL, V3, P189; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	27	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65496	10.1371/journal.pone.0065496	http://dx.doi.org/10.1371/journal.pone.0065496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755239	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000073
J	Wang, LL; Tang, YF; Liu, S; Mao, ST; Ling, Y; Liu, D; He, XY; Wang, XG				Wang, Lingling; Tang, Yufu; Liu, Shuo; Mao, Shitao; Ling, Yuan; Liu, Dan; He, Xiaoyu; Wang, Xiaoge			Metabonomic Profiling of Serum and Urine by H-1 NMR-Based Spectroscopy Discriminates Patients with Chronic Obstructive Pulmonary Disease and Healthy Individuals	PLOS ONE			English	Article							AMINO-ACID; CARDIOVASCULAR RISK; SKELETAL-MUSCLE; COPD; INFLAMMATION; METABOLISM; EXPRESSION; PROTEIN; BURDEN; PLASMA	Chronic obstructive pulmonary disease (COPD) has seriously impacted the health of individuals and populations. In this study, proton nuclear magnetic resonance (H-1 NMR)-based metabonomics combined with multivariate pattern recognition analysis was applied to investigate the metabolic signatures of patients with COPD. Serum and urine samples were collected from COPD patients (n = 32) and healthy controls (n = 21), respectively. Samples were analyzed by high resolution H-1 NMR (600 MHz), and the obtained spectral profiles were then subjected to multivariate data analysis. Consistent metabolic differences have been found in serum as well as in urine samples from COPD patients and healthy controls. Compared to healthy controls, COPD patients displayed decreased lipoprotein and amino acids, including branched-chain amino acids (BCAAs), and increased glycerolphosphocholine in serum. Moreover, metabolic differences in urine were more significant than in serum. Decreased urinary 1-methylnicotinamide, creatinine and lactate have been discovered in COPD patients in comparison with healthy controls. Conversely, acetate, ketone bodies, carnosine, m-hydroxyphenylacetate, phenylace-tyglycine, pyruvate and alpha-ketoglutarate exhibited enhanced expression levels in COPD patients relative to healthy subjects. Our results illustrate the potential application of NMR-based metabonomics in early diagnosis and understanding the mechanisms of COPD.	[Wang, Lingling; Liu, Shuo; Mao, Shitao; Ling, Yuan; Liu, Dan; He, Xiaoyu; Wang, Xiaoge] China Med Univ, Affiliated Hosp 4, Dept Resp Med, Shenyang, Peoples R China; [Tang, Yufu] Chinese PLA, Hosp 202, Dept Gen Surg, Shenyang, Peoples R China	China Medical University	Wang, XG (corresponding author), China Med Univ, Affiliated Hosp 4, Dept Resp Med, Shenyang, Peoples R China.	cm4hwxgn2005@126.com			National Science & Technology Pillar Program of China [2007BAI24B04]; Science Foundation of Chinese Medical Association [07010320040, 08020680146]; Foundation of Science and Technology Bureau of Shenyang City [F12-277-1-71]	National Science & Technology Pillar Program of China; Science Foundation of Chinese Medical Association; Foundation of Science and Technology Bureau of Shenyang City	This study was supported by grants from the National Science & Technology Pillar Program of China during the Eleventh Five-year Plan Period (No. 2007BAI24B04); the Science Foundation of Chinese Medical Association (No. 07010320040 and No. 08020680146), and the Foundation of Science and Technology Bureau of Shenyang City (No. F12-277-1-71). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Baraldo S, 2007, CHEST, V132, P1733, DOI 10.1378/chest.06-2819; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Basili S, 1999, ATHEROSCLEROSIS, V147, P249, DOI 10.1016/S0021-9150(99)00192-6; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Berger JS, 2004, AM J CARDIOL, V94, P649, DOI 10.1016/j.amjcard.2004.05.034; Biedron R, 2008, ARCH IMMUNOL THER EX, V56, P127, DOI 10.1007/s00005-008-0009-2; Carrola J, 2011, J PROTEOME RES, V10, P221, DOI 10.1021/pr100899x; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403, DOI 10.1080/10408399409527669; Churg A, 2005, CURR OPIN PULM MED, V11, P153, DOI 10.1097/01.mcp.0000149592.51761.e3; de Laurentiis G, 2008, EUR RESPIR J, V32, P1175, DOI 10.1183/09031936.00072408; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Demedts IK, 2007, AM J RESP CRIT CARE, V175, P998, DOI 10.1164/rccm.200608-1113OC; Devereux G, 2006, BRIT MED J, V332, P1142, DOI 10.1136/bmj.332.7550.1142; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Duarte IF, 2007, NMR BIOMED, V20, P401, DOI 10.1002/nbm.1073; Engelen MPKJ, 2000, AM J CLIN NUTR, V72, P1480; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Fang XC, 2011, CHEST, V139, P920, DOI 10.1378/chest.10-1393; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; Griffin JL, 2003, CURR OPIN CHEM BIOL, V7, P648, DOI 10.1016/j.cbpa.2003.08.008; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; HOFFORD JM, 1990, AM REV RESPIR DIS, V141, P902, DOI 10.1164/ajrccm/141.4_Pt_1.902; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; HOHMANN S, 1991, J BACTERIOL, V173, P7963, DOI 10.1128/jb.173.24.7963-7969.1991; Kao CC, 2012, J APPL PHYSIOL, V112, P42, DOI 10.1152/japplphysiol.00599.2011; Kennedy Susan M, 2007, Proc Am Thorac Soc, V4, P692, DOI 10.1513/pats.200707-094SD; Kim HC, 2010, AM J RESP CRIT CARE, V181, P797, DOI 10.1164/rccm.200906-0936OC; Klebanov GI, 1998, BIOL MEMBRANY, V15, P74; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Makinen VP, 2012, J INTERN MED; Marsh S, 2006, EUR RESPIR J, V28, P883, DOI 10.1183/09031936.06.00074806; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McClay JL, 2010, J PROTEOME RES, V9, P3083, DOI 10.1021/pr1000048; Nathell L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-89; Nicholson JK, 2011, PHARMACOGENOMICS, V12, P103, DOI 10.2217/PGS.10.157; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Odunsi K, 2005, INT J CANCER, V113, P782, DOI 10.1002/ijc.20651; Ohta Y, 2010, INTERNAL MED, V49, P1483, DOI 10.2169/internalmedicine.49.3406; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Qiu YP, 2010, J PROTEOME RES, V9, P1627, DOI 10.1021/pr901081y; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rocha CM, 2011, J PROTEOME RES, V10, P4314, DOI 10.1021/pr200550p; Rogers D, 2005, J BIOMOL SCREEN, V10, P682, DOI 10.1177/1087057105281365; Schmidt CW, 2004, ENVIRON HEALTH PERSP, V112, pA410, DOI 10.1289/ehp.112-a410; Schols A M, 1993, Monaldi Arch Chest Dis, V48, P546; Shariff MIF, 2010, J PROTEOME RES, V9, P1096, DOI 10.1021/pr901058t; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; TISI GM, 1981, METABOLISM, V30, P340, DOI 10.1016/0026-0495(81)90113-X; Ubhi BK, 2012, MOL BIOSYST, V8, P3125, DOI 10.1039/c2mb25194a; Ubhi BK, 2012, EUR RESPIR J, V40, P345, DOI 10.1183/09031936.00112411; Wang J, 2012, J INTERN MED, V272, P562, DOI 10.1111/j.1365-2796.2012.02562.x; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; YOUNG LH, 1991, J CLIN INVEST, V87, P554, DOI 10.1172/JCI115030	59	56	60	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65675	10.1371/journal.pone.0065675	http://dx.doi.org/10.1371/journal.pone.0065675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755267	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000090
J	Wu, W; Xu, WB; Chen, L; Chen, HL; Liu, Q; Wang, DL; Chen, YJ; Yao, W; Li, G; Feng, B; Shu, BH; Zhou, YK; He, YQ				Wu, Wei; Xu, Wen-Bo; Chen, Long; Chen, Hui-Ling; Liu, Qu; Wang, Dong-Li; Chen, Ying-Jian; Yao, Wei; Li, Gang; Feng, Bin; Shu, Bai-Hua; Zhou, Yi-Kai; He, Ya-Qing			Molecular Identification and Analysis of Human Enteroviruses Isolated from Healthy Children in Shenzhen, China from 2010 to 2011	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUS; MOUTH-DISEASE; SPECIES C; OUTBREAK; INFECTIONS; CIRCULATION; HAND; EPIDEMIC; COXSACKIEVIRUSES; POLIOMYELITIS	Objective: To determine the prevalence and distribution of human enteroviruses (HEVs) among healthy children in Shenzhen, China. Method: Clinical specimens were obtained from 320 healthy children under 5 years old in Shenzhen, China from 2010 to 2011. The specimens were evaluated using real-time PCR and cell cultures. The positive specimens were further tested using reverse transcription-seminested PCR (RT-snPCR). Molecular typing and phylogenetic analysis were based on the sequence determined. Results: Among the 320 samples, 34 were tested positive for HEVs (10.6%) and 22 different serotypes were identified using RT-snPCR. PV1 and PV2 were also detected. The predominant serotype observed was EV71 (17.6%), followed by CV-B4 (14.7%). HEV-B was detected most frequently, with an overall prevalence of 47.1%. HEV-A and HEV-C were found in 32.3% and 20.6% of the samples, respectively. No HEV-D was identified. Molecular phylogeny indicated that all EV71 strains were of C4 genotype. Conclusion: Although a variety of HEVs was detected in healthy children, HEV-B was relatively more prevalent than other HEV species. Considering HEV-A is more prevalent than HEV-B among patients with hand-foot-mouth disease, additional long-term surveillance of HEV is warranted in both asymptomatic and symptomatic populations.	[Wu, Wei; Chen, Hui-Ling; Shu, Bai-Hua; Zhou, Yi-Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth,Inst Environm Med, Wuhan 430074, Hubei, Peoples R China; [Xu, Wen-Bo] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Chen, Long] Shenzhen Univ, Sch Life Sci, Shenzhen, Peoples R China; [He, Ya-Qing] Shenzhen Ctr Dis Control & Prevent, Major Infect Dis Control Key Lab, Shenzhen, Peoples R China; [Liu, Qu; Chen, Ying-Jian; Yao, Wei; Li, Gang] Shenzhen Longgang Dist Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Wang, Dong-Li; Feng, Bin] Shenzhen Guangming Dist Ctr Dis Control & Prevent, Shenzhen, Peoples R China	Huazhong University of Science & Technology; Chinese Center for Disease Control & Prevention; Shenzhen University; Shenzhen Center for Disease Control & Prevention (SZCDC)	Zhou, YK (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth,Inst Environm Med, Wuhan 430074, Hubei, Peoples R China.	zhouyikai_tongji@163.com; heyaqing1019@126.com	Chen, Long/N-4705-2019; chen, hui/HDO-2955-2022	Chen, Long/0000-0003-1110-6495; 	Key Projects in the National Science and Technology Pillar Program in the Eleventh Five-year Plan Period	Key Projects in the National Science and Technology Pillar Program in the Eleventh Five-year Plan Period	This study was financed by the Key Projects in the National Science and Technology Pillar Program in the Eleventh Five-year Plan Period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar S, 1999, SCAND J INFECT DIS, V31, P331, DOI 10.1080/00365549950163734; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P169; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P337; [Anonymous], 2001, FIELDS VIROLOGY; Bahri O, 2005, J MED MICROBIOL, V54, P63, DOI 10.1099/jmm.0.45695-0; Bhambhani V, 2007, TROP DOCT, V37, P188, DOI 10.1258/004947507781524728; Bingjun T, 2008, J MED VIROL, V80, P670, DOI 10.1002/jmv.21122; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Brown BA, 2009, J GEN VIROL, V90, P1713, DOI 10.1099/vir.0.008540-0; Combelas N, 2011, VIRUSES-BASEL, V3, P1460, DOI 10.3390/v3081460; COOK I, 1969, MED J AUSTRALIA, V2, P789, DOI 10.5694/j.1326-5377.1969.tb107421.x; Faden H, 2006, PEDIATR INFECT DIS J, V25, P687, DOI 10.1097/01.inf.0000226842.23106.a2; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kim H, 2012, SPACE, P38; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KyoungAh B, 2011, VIROL J, V8; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; Liu HM, 2003, J VIROL, V77, P10994, DOI 10.1128/JVI.77.20.10994-11005.2003; Lo CW, 2010, J MICROBIOL IMMUNOL, V43, P354, DOI 10.1016/S1684-1182(10)60056-4; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nasri D, 2007, EXPERT REV MOL DIAGN, V7, P419, DOI 10.1586/14737159.7.4.419; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Romero JR, 2009, REVERSE TRANSCRIPTIO; Rose TM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-20; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; ROTBART HA, 1995, CLIN INFECT DIS, V20, P971, DOI 10.1093/clinids/20.4.971; Roth B, 2007, J MED VIROL, V79, P956, DOI 10.1002/jmv.20917; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Sano T, 2008, JPN J INFECT DIS, V61, P162; Simonen-Tikka ML, 2012, J MED VIROL, V84, P923, DOI 10.1002/jmv.23284; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Tsao KC, 2010, J VIROL METHODS, V165, P330, DOI 10.1016/j.jviromet.2010.03.001; Witso E, 2006, J CLIN MICROBIOL, V44, P4095, DOI 10.1128/JCM.00653-06; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xu AQ, 2011, VIRUS GENES, V42, P323, DOI 10.1007/s11262-011-0584-x; Yamashita T, 2005, JPN J INFECT DIS, V58, P390; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Yang Y, 2009, HUM PATHOL, V40, P1288, DOI 10.1016/j.humpath.2009.01.015	41	5	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64889	10.1371/journal.pone.0064889	http://dx.doi.org/10.1371/journal.pone.0064889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762262	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000027
J	Yang, CY; Chen, JB; Tsai, TF; Tsai, YC; Tsai, CY; Liang, PH; Hsu, TL; Wu, CY; Netea, MG; Wong, CH; Hsieh, SL				Yang, Chih-Ya; Chen, Jiun-Bo; Tsai, Ting-Fen; Tsai, Yi-Chen; Tsai, Ching-Yen; Liang, Pi-Hui; Hsu, Tsui-Ling; Wu, Chung-Yi; Netea, Mihai G.; Wong, Chi-Huey; Hsieh, Shie-Liang			CLEC4F Is an Inducible C-Type Lectin in F4/80-Positive Cells and Is Involved in Alpha-Galactosylceramide Presentation in Liver	PLOS ONE			English	Article							FUCOSE-CONTAINING GLYCOPROTEINS; MOUSE YOLK-SAC; KILLER T-CELLS; KUPFFER CELLS; BINDING-SPECIFICITY; LANGERHANS CELLS; DENDRITIC CELLS; HEPATIC LECTINS; RECEPTORS; MACROPHAGES	CLEC4F, a member of C-type lectin, was first purified from rat liver extract with high binding affinity to fucose, galactose (Gal), N-acetylgalactosamine (GalNAc), and un-sialylated glucosphingolipids with GalNAc or Gal terminus. However, the biological functions of CLEC4F have not been elucidated. To address this question, we examined the expression and distribution of murine CLEC4F, determined its binding specificity by glycan array, and investigated its function using CLEC4F knockout (Clec4f(-/-)) mice. We found that CLEC4F is a heavily glycosylated membrane protein co-expressed with F4/80 on Kupffer cells. In contrast to F4/80, CLEC4F is detectable in fetal livers at embryonic day 11.5 (E11.5) but not in yolk sac, suggesting the expression of CLEC4F is induced as cells migrate from yolk cells to the liver. Even though CLEC4F is not detectable in tissues outside liver, both residential Kupffer cells and infiltrating mononuclear cells surrounding liver abscesses are CLEC4F-positive upon Listeria monocytogenes (L. monocytogenes) infection. While CLEC4F has strong binding to Gal and GalNAc, terminal fucosylation inhibits CLEC4F recognition to several glycans such as Fucosyl GM1, Globo H, Bb3 similar to 4 and other fucosyl-glycans. Moreover, CLEC4F interacts with alpha-galactosylceramide (alpha-GalCer) in a calcium-dependent manner and participates in the presentation of alpha-GalCer to natural killer T (NKT) cells. This suggests that CLEC4F is a C-type lectin with diverse binding specificity expressed on residential Kupffer cells and infiltrating monocytes in the liver, and may play an important role to modulate glycolipids presentation on Kupffer cells.	[Yang, Chih-Ya; Chen, Jiun-Bo; Tsai, Yi-Chen; Hsieh, Shie-Liang] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Yang, Chih-Ya] Natl Yang Ming Univ, Program Mol Med, Taipei 112, Taiwan; [Yang, Chih-Ya] Acad Sinica, Taipei 115, Taiwan; [Tsai, Ting-Fen] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Tsai, Ting-Fen] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Tsai, Ching-Yen] Acad Sinica, Inst Mol Biol, Transgen Core Facil, Taipei, Taiwan; [Liang, Pi-Hui] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 10764, Taiwan; [Hsu, Tsui-Ling; Wu, Chung-Yi; Wong, Chi-Huey; Hsieh, Shie-Liang] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Hsieh, Shie-Liang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Hsieh, Shie-Liang] Natl Yang Ming Univ, Infect & Immun Ctr, Taipei 112, Taiwan; [Hsieh, Shie-Liang] Taipei Vet Gen Hosp, Ctr Immunol, Taipei, Taiwan; [Hsieh, Shie-Liang] Taipei Med Univ, Coll Med Sci & Technol, Inst Canc Biol & Drug Discovery, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; Radboud University Nijmegen; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Medical University	Hsieh, SL (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	slhsieh@gate.sinica.edu.tw	Hsu, Tsui-Ling/AAE-8821-2019; Liang, Pi-hui/D-4166-2012; Hsu, Tsui-Ling/H-6704-2015; Netea, Mihai/N-5155-2014; Wu, Chung-Yi/K-8334-2018; Hsieh, Shie-Liang Edmond/ABA-9184-2021; Tsai, Ching-Yen/AEX-9366-2022	Hsu, Tsui-Ling/0000-0002-2912-3261; Liang, Pi-hui/0000-0001-6668-4642; Tsai, Ching-Yen/0000-0001-7964-6661; Hsieh, Shie-Liang/0000-0001-9415-346X	National Science Council [NSC 101-2325-B-010-006, NSC 101-2321-B-010-003]; Academia Sinica, Thematic Research Project [AS-101-TP-B06-2]; Infection and Immunity Center, National Yang-Ming University, Taiwan; Ministry of Education, Aim for the Top University Plan; Taipei Veterans General Hospital [V102E4-003]; Taichung Veterans General Hospital [TCVGH-YM1010202]; National Research Program for Biopharmaceuticals (NRPB) at the National Science Council (NSC) of Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica, Thematic Research Project; Infection and Immunity Center, National Yang-Ming University, Taiwan; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taichung Veterans General Hospital; National Research Program for Biopharmaceuticals (NRPB) at the National Science Council (NSC) of Taiwan	This work was supported by the National Science Council (NSC 101-2325-B-010-006 and NSC 101-2321-B-010-003), Academia Sinica, Thematic Research Project (AS-101-TP-B06-2) and in part by the Infection and Immunity Center, National Yang-Ming University, Taiwan (a grant from Ministry of Education, Aim for the Top University Plan), Taipei Veterans General Hospital (V102E4-003), Taichung Veterans General Hospital (TCVGH-YM1010202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the; We thank the Taiwan Mouse Clinic which is funded by the National Research Program for Biopharmaceuticals (NRPB) at the National Science Council (NSC) of Taiwan and BioLegend for their technique support and related antibody preparation. We are also grateful to the technical services provided by the "Transgenic Mouse Model Core Facility of the National Core Facility Program for Biotechnology, National Science Council'' and the "Gene Knockout Mouse Core Laboratory of National Taiwan University Center of Genomic Medicine".manuscript.	Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; Biburger M, 2008, J LEUKOCYTE BIOL, V84, P264, DOI 10.1189/jlb.0607352; Chang YJ, 2007, P NATL ACAD SCI USA, V104, P10299, DOI 10.1073/pnas.0703824104; Coombs PJ, 2006, GLYCOBIOLOGY, V16, p1C, DOI 10.1093/glycob/cwj126; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; CROFTON RW, 1978, J EXP MED, V148, P1, DOI 10.1084/jem.148.1.1; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Dory D, 2003, J LEUKOCYTE BIOL, V74, P49, DOI 10.1189/jlb.0302133; Eberl G, 1999, J IMMUNOL, V162, P6410; Fadden AJ, 2003, GLYCOBIOLOGY, V13, P529, DOI 10.1093/glycob/cwg068; Filler SG, 2006, CURR OPIN MICROBIOL, V9, P333, DOI 10.1016/j.mib.2006.06.005; Gehring S, 2009, WORLD J GASTROENTERO, V15, P1708, DOI 10.3748/wjg.15.1708; GOOSSENS PL, 1991, J IMMUNOL, V147, P3514; HALTIWANGER RS, 1986, J BIOL CHEM, V261, P7433; Hammond KJL, 2003, CURR OPIN IMMUNOL, V15, P683, DOI 10.1016/j.coi.2003.09.014; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; HIRSCH S, 1981, J EXP MED, V154, P713, DOI 10.1084/jem.154.3.713; HOYLE GW, 1988, J BIOL CHEM, V263, P7487; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7412; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7426; Liang PH, 2008, J AM CHEM SOC, V130, P12348, DOI 10.1021/ja8012787; MATTHEWS CJ, 1985, J REPROD IMMUNOL, V7, P315, DOI 10.1016/0165-0378(85)90026-9; Naito M, 1996, J LEUKOCYTE BIOL, V59, P133, DOI 10.1002/jlb.59.2.133; Naito Makoto, 2004, Medical Electron Microscopy, V37, P16, DOI 10.1007/s00795-003-0228-x; OHTEKI T, 1994, J EXP MED, V180, P699, DOI 10.1084/jem.180.2.699; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; PRAANINGVANDALEN DP, 1982, FEBS LETT, V141, P229, DOI 10.1016/0014-5793(82)80054-9; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schmieg J, 2005, P NATL ACAD SCI USA, V102, P1127, DOI 10.1073/pnas.0408288102; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; TIEDEMANN K, 1977, CELL TISSUE RES, V183, P71; TIEMEYER M, 1992, J BIOL CHEM, V267, P12252; Trobonjaca Z, 2001, J IMMUNOL, V167, P1413, DOI 10.4049/jimmunol.167.3.1413; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang N, 2011, JOVE-J VIS EXP, DOI 10.3791/3076; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; WEINBERG SR, 1976, BRIT J HAEMATOL, V32, P543, DOI 10.1111/j.1365-2141.1976.tb00958.x; Yamamoto T, 1996, AM J PATHOL, V149, P1271; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603	50	61	64	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65070	10.1371/journal.pone.0065070	http://dx.doi.org/10.1371/journal.pone.0065070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762286	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000030
J	Clarin, TMA; Ruczynski, I; Page, RA; Siemers, BM				Clarin, Theresa M. A.; Ruczynski, Ireneusz; Page, Rachel A.; Siemers, Bjoern M.			Foraging Ecology Predicts Learning Performance in Insectivorous Bats	PLOS ONE			English	Article							MYOTIS-CAPACCINII BONAPARTE; LONG-FINGERED BAT; MOUSE-EARED BATS; ECHOLOCATION BEHAVIOR; EXPLORATORY-BEHAVIOR; HABITAT SELECTION; HUNTING BEHAVIOR; PREY DETECTION; BRAIN SIZE; EVOLUTION	Bats are unusual among mammals in showing great ecological diversity even among closely related species and are thus well suited for studies of adaptation to the ecological background. Here we investigate whether behavioral flexibility and simple- and complex-rule learning performance can be predicted by foraging ecology. We predict faster learning and higher flexibility in animals hunting in more complex, variable environments than in animals hunting in more simple, stable environments. To test this hypothesis, we studied three closely related insectivorous European bat species of the genus Myotis that belong to three different functional groups based on foraging habitats: M. capaccinii, an open water forager, M. myotis, a passive listening gleaner, and M. emarginatus, a clutter specialist. We predicted that M. capaccinii would show the least flexibility and slowest learning reflecting its relatively unstructured foraging habitat and the stereotypy of its natural foraging behavior, while the other two species would show greater flexibility and more rapid learning reflecting the complexity of their natural foraging tasks. We used a purposefully unnatural and thus species-fair crawling maze to test simple- and complex-rule learning, flexibility and re-learning performance. We found that M. capaccinii learned a simple rule as fast as the other species, but was slower in complex rule learning and was less flexible in response to changes in reward location. We found no differences in re-learning ability among species. Our results corroborate the hypothesis that animals' cognitive skills reflect the demands of their ecological niche.	[Clarin, Theresa M. A.; Ruczynski, Ireneusz; Siemers, Bjoern M.] Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany; [Ruczynski, Ireneusz] Mammal Res Inst PAS, Bialowieza, Poland; [Page, Rachel A.] Smithonian Trop Res Inst, Panama City, Panama	Max Planck Society; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Smithsonian Institution; Smithsonian Tropical Research Institute	Clarin, TMA (corresponding author), Max Planck Inst Ornithol, Sensory Ecol Grp, Seewiesen, Germany.	tclarin@orn.mpg.de	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Page, Rachel/AAE-4816-2021; Page, Rachel A/GQQ-2818-2022	Page, Rachel A/0000-0001-7072-0669; Ruczynski, Ireneusz/0000-0002-2308-3211	Polish Ministry of Science and Higher Education; Tabachka Bat Research Station Team	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Tabachka Bat Research Station Team	The study was undertaken with the budget of the Max Planck Society (www.mpg.de). IR was supported by the Polish Ministry of Science and Higher Education (http://www.nauka.gov.pl). Program: "Support for International Mobility of Scientists". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Angela Clarin and Katharina Clarin for help with the logistic flow of the experiment, Renate Heckel and Leonie Baier for drawing the bats in figure 1 and 2, the Tabachka Bat Research Station Team 2010 for support, and John Ratcliffe and Irmgard Teschke for helpful comments on the manuscript. Our work was supported by the International Max Planck Research School (IMPRS) for Organismal Biology. Sadly, PD Dr. Bjorn Siemers, head of the Sensory Ecology Group in Seewiesen, Germany, passed away in May 2012. We are deeply thankful for his support, friendship, and inspiration.	Aihartza J, 2008, ACTA CHIROPTEROL, V10, P287, DOI 10.3161/150811008X414863; Aihartza JR, 2003, ACTA CHIROPTEROL, V5, P193, DOI 10.3161/001.005.0204; Almenar D, 2006, ACTA CHIROPTEROL, V8, P157, DOI 10.3161/1733-5329(2006)8[157:HSASUB]2.0.CO;2; Arlettaz R, 1997, J ANIM ECOL, V66, P897, DOI 10.2307/6005; Arlettaz R, 1996, ANIM BEHAV, V51, P1, DOI 10.1006/anbe.1996.0001; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Biscardi S, 2007, J ZOOL, V273, P372, DOI 10.1111/j.1469-7998.2007.00337.x; BITTERMAN ME, 1975, SCIENCE, V188, P699, DOI 10.1126/science.188.4189.699; Boonman AM, 1998, BEHAV ECOL SOCIOBIOL, V44, P99, DOI 10.1007/s002650050521; Byrne RW, 2007, CURR BIOL, V17, pR714, DOI 10.1016/j.cub.2007.05.069; Ciechanowski M, 2007, CAN J ZOOL, V85, P1249, DOI 10.1139/Z07-090; Ciechanowski M, 2010, ACTA THERIOL, V55, P301, DOI 10.4098/j.at.0001-7051.093.2009; Day LB, 1999, ANIM BEHAV, V57, P393, DOI 10.1006/anbe.1998.1007; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; Dietz C., 2009, BATS BRITAIN EUROPE; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Dukas R., 2009, COGNITIVE ECOLOGY; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; EISENBERG JF, 1978, EVOLUTION, V32, P740, DOI 10.1111/j.1558-5646.1978.tb04627.x; Flaquer C, 2008, ACTA CHIROPTEROL, V10, P61, DOI 10.3161/150811008X331090; Gibson BM, 2005, LEARN BEHAV, V33, P59; Godfrey-Smith P, 2002, EVOLUTION OF INTELLIGENCE, P223; Goerlitz HR, 2007, FUNCT ECOL, V21, P143, DOI 10.1111/j.1365-2435.2006.01212.x; Greif S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1110; Haupt M, 2010, ANIM COGN, V13, P783, DOI 10.1007/s10071-010-0327-8; Henry M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023773; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jones PL, 2011, BEHAV ECOL SOCIOBIOL, V65, P333, DOI 10.1007/s00265-010-1050-9; KALKO EKV, 1989, BEHAV ECOL SOCIOBIOL, V24, P225, DOI 10.1007/BF00295202; KRAPP F., 2011, FLEDERMAUSE EUROPAS; KRULL D, 1991, BEHAV ECOL SOCIOBIOL, V28, P247; Lefebvre L, 2008, BRAIN BEHAV EVOLUT, V72, P135, DOI 10.1159/000151473; Levin E, 2006, MAMM BIOL, V71, P139, DOI 10.1016/j.mambio.2006.01.002; Mettke-Hofmann C, 2003, P NATL ACAD SCI USA, V100, P5863, DOI 10.1073/pnas.1037505100; Meyer CFJ, 2005, J MAMMAL, V86, P587, DOI 10.1644/1545-1542(2005)86[587:HSASPO]2.0.CO;2; Micheli F, 1997, ANIM BEHAV, V53, P1149, DOI 10.1006/anbe.1996.0349; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Overington SE, 2008, BEHAV ECOL, V19, P836, DOI 10.1093/beheco/arn037; Page RA, 2012, ANIM COGN, V15, P495, DOI 10.1007/s10071-012-0474-1; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; R Development Core Team, 2012, R LANG ENV STAT COMP; Ratcliffe JM, 2006, BRAIN BEHAV EVOLUT, V67, P165, DOI 10.1159/000090980; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; ROZIN P, 1971, PSYCHOL REV, V78, P459, DOI 10.1037/h0031878; Ruczynski I, 2011, BIOL LETTERS, V7, P153, DOI 10.1098/rsbl.2010.0585; Russo D, 2007, J EXP BIOL, V210, P166, DOI 10.1242/jeb.02644; Safi K, 2005, P ROY SOC B-BIOL SCI, V272, P179, DOI 10.1098/rspb.2004.2924; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHNITZLER HU, 1994, BEHAV ECOL SOCIOBIOL, V35, P327, DOI 10.1007/BF00184422; SCHUMM A, 1991, BEHAV ECOL SOCIOBIOL, V28, P255; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2006, CURR BIOL, V16, pR157, DOI 10.1016/j.cub.2006.02.056; Siemers BM, 2005, NATURWISSENSCHAFTEN, V92, P272, DOI 10.1007/s00114-005-0622-4; Siemers BM, 2001, ACTA CHIROPTEROL, V3, P211; Siemers BM, 2001, J EXP BIOL, V204, P3843; Simmons NB, 2005, SCIENCE, V307, P527, DOI 10.1126/science.1108871; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Tebbich S, 2012, ETHOLOGY, V118, P135, DOI 10.1111/j.1439-0310.2011.02001.x; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Wang J, 2010, MAMMALIA, V74, P257, DOI 10.1515/MAMM.2010.034; Weinbeer M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1337, DOI 10.1007/s00265-007-0364-8; Zahn A, 2009, EUROPEAN J WILDLIFE, V56, P395	67	20	20	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64823	10.1371/journal.pone.0064823	http://dx.doi.org/10.1371/journal.pone.0064823			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755146	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400026
J	Ketley, A; Warren, A; Holmes, E; Gering, M; Aboobaker, AA; Brook, JD				Ketley, Ami; Warren, Anne; Holmes, Emily; Gering, Martin; Aboobaker, A. Aziz; Brook, J. David			The miR-30 MicroRNA Family Targets smoothened to Regulate Hedgehog Signalling in Zebrafish Early Muscle Development	PLOS ONE			English	Article							PROTEIN-KINASE-A; SONIC-HEDGEHOG; POLARITY GENE; FEEDBACK LOOP; NEURAL-TUBE; EXPRESSION; INDUCTION; GROWTH; MUTATIONS; MEMBERS	The importance of microRNAs in development is now widely accepted. However, identifying the specific targets of individual microRNAs and understanding their biological significance remains a major challenge. We have used the zebrafish model system to evaluate the expression and function of microRNAs potentially involved in muscle development and study their interaction with predicted target genes. We altered expression of the miR-30 microRNA family and generated phenotypes that mimicked misregulation of the Hedgehog pathway. Inhibition of the miR-30 family increases activity of the pathway, resulting in elevated ptc1 expression and increased numbers of superficial slow-muscle fibres. We show that the transmembrane receptor smoothened is a target of this microRNA family. Our results indicate that fine coordination of smoothened activity by the miR-30 family allows the correct specification and differentiation of distinct muscle cell types during zebrafish embryonic development.	[Ketley, Ami; Warren, Anne; Holmes, Emily; Gering, Martin; Aboobaker, A. Aziz; Brook, J. David] Univ Nottingham, Ctr Genet & Gen, Nottingham NG7 2RD, England	University of Nottingham	Brook, JD (corresponding author), Univ Nottingham, Ctr Genet & Gen, Nottingham NG7 2RD, England.	David.Brook@nottingham.ac.uk		Aboobaker, Aziz/0000-0003-4902-5797; Gering, Martin/0000-0003-3763-0885; Brook, John David/0000-0002-5946-6740	British Heart Foundation; Muscular Dystrophy Campaign; Muscular Dystrophy Association; Wellcome Trust; Medical Research Council; British Heart Foundation [RG/07/010/23676] Funding Source: researchfish; Medical Research Council [MR/J000841/1, G0601134, G0802629] Funding Source: researchfish; MRC [G0601134, MR/J000841/1, G0802629] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Muscular Dystrophy Association(Muscular Dystrophy Association); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the British Heart Foundation, Muscular Dystrophy Campaign, Muscular Dystrophy Association and Wellcome Trust. A.K. was supported by a Medical Research Council PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bazzini AA, 2011, DEV CELL, V20, P3, DOI 10.1016/j.devcel.2010.12.013; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; CHANG DT, 1994, DEVELOPMENT, V120, P3339; Chen WB, 2001, DEVELOPMENT, V128, P2385; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Friggi-Grelin F, 2008, GENETICS, V179, P429, DOI 10.1534/genetics.107.083733; Gao L, 2013, CELL SIGNAL; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Henry CA, 2004, DEV CELL, V7, P917, DOI 10.1016/j.devcel.2004.09.017; Hofacker IL, 2007, NAT GENET, V39, P1191, DOI 10.1038/ng1007-1191; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li Y, 2012, MOL BIOL CELL, V23, P1423, DOI 10.1091/mbc.E11-09-0777; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; MARIGO V, 1995, GENOMICS, V28, P44, DOI 10.1006/geno.1995.1104; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; MOHLER J, 1988, GENETICS, V120, P1061; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Ozcan S, 2009, ISLETS, V1, P283, DOI 10.4161/isl.1.3.9968; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Staton AA, 2011, NAT PROTOC, V6, P2035, DOI 10.1038/nprot.2011.423; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Xiao JN, 2007, J CELL PHYSIOL, V212, P285, DOI 10.1002/jcp.21062; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503	64	28	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65170	10.1371/journal.pone.0065170	http://dx.doi.org/10.1371/journal.pone.0065170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755189	Green Published, gold			2022-12-25	WOS:000320579400044
J	Lattuada, D; Crotta, K; Tonna, N; Casnici, C; Benfante, R; Fornasari, D; Bianco, F; Longhi, R; Marelli, O				Lattuada, Donatella; Crotta, Katia; Tonna, Noemi; Casnici, Claudia; Benfante, Roberta; Fornasari, Diego; Bianco, Fabio; Longhi, Renato; Marelli, Ornella			The Expression of GHS-R in Primary Neurons Is Dependent upon Maturation Stage and Regional Localization	PLOS ONE			English	Article							HORMONE SECRETAGOGUE-RECEPTOR; GROWTH-HORMONE; MESSENGER-RNA; GHRELIN RECEPTOR; SPATIAL MEMORY; RAT; MOUSE; HYPOTHALAMUS; BRAIN	Ghrelin is a hormone with a crucial role in the regulation of appetite, regulation of inflammation, glucose metabolism and cell proliferation. In the brain ghrelin neurons are located in the cortex (sensorimotor area, cingular gyrus), and the fibres of ghrelin neurons in hypothalamus project directly to the dorsal vagal complex (DVC). Ghrelin binds the growth hormone secretagogue receptor (GHS-R) a G-protein-coupled receptor with a widespread tissue distribution, indeed these receptors are localized both in nonnervous, organs/tissues (i.e. adipose tissue, myocardium, adrenals, gonads, lung, liver, arteries, stomach, pancreas, thyroid, and kidney) as well as in central nervous system (CNS) and higher levels of expression in the pituitary gland and the hypothalamus and lower levels of expression in other organs, including brain. A GHS-R specific monoclonal antibody has been developed and characterized and through it we demonstrate that GHS-R is expressed in primary neurons and that its expression is dependent upon their developmental stage and shows differences according to the brain region involved, with a more pronounced expression in hippocampal rather than cortical neurons. A characterization of GHS-R within the central nervous system is of extreme importance in order to gain insights on its role in the modulation of neurodegenerative events such as Alzheimer's disease.	[Lattuada, Donatella; Crotta, Katia; Casnici, Claudia; Benfante, Roberta; Fornasari, Diego; Marelli, Ornella] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Tonna, Noemi; Bianco, Fabio] NeuroZone Srl, Milan, Italy; [Benfante, Roberta] CNR, Inst Neurosci, I-20133 Milan, Italy; [Longhi, Renato] CNR, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Marelli, O (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy.	ornella.marelli@unimi.it	Benfante, Roberta/C-1513-2015; lattuada, donatella/F-1438-2016	Benfante, Roberta/0000-0001-5396-5429; MARELLI, ORNELLA/0000-0001-8522-9418; Fornasari, Diego/0000-0002-9668-3103; Casnici, Claudia/0000-0002-5478-0239	Santarelli Foundation, Lichtenstein; Regione Lombardia	Santarelli Foundation, Lichtenstein; Regione Lombardia(Regione Lombardia)	The study was supported by the Santarelli Foundation, Lichtenstein. Dr. Crotta would like to thank the Regione Lombardia for financial support related to the grant-Dote ricercatori: FSE, Regione Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Albarran-Zeckler RG, 2012, BEHAV BRAIN RES, V232, P13, DOI 10.1016/j.bbr.2012.03.012; Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Bossard C, 2007, PEPTIDES, V28, P2030, DOI 10.1016/j.peptides.2007.06.030; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Cassoni P, 2004, EUR J ENDOCRINOL, V150, P173, DOI 10.1530/eje.0.1500173; Chen LA, 2011, EUR J NEUROSCI, V33, P266, DOI 10.1111/j.1460-9568.2010.07491.x; Chollet C, 2009, J PEPT SCI, V15, P711, DOI 10.1002/psc.1177; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Gahete MD, 2011, PEPTIDES, V32, P2225, DOI 10.1016/j.peptides.2011.09.019; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Hou ZC, 2006, REGUL PEPTIDES, V134, P126, DOI 10.1016/j.regpep.2006.02.005; Koon HW, 2009, P NATL ACAD SCI USA, V106, P8766, DOI 10.1073/pnas.0903499106; Lago F, 2005, VITAM HORM, V71, P405, DOI 10.1016/S0083-6729(05)71014-1; Liu YJ, 2006, CHINESE J PHYSIOL, V49, P244; Lu S, 2002, NEUROSCI LETT, V321, P157, DOI 10.1016/S0304-3940(01)02544-7; Miao YY, 2007, BIOCHEM BIOPH RES CO, V359, P795, DOI 10.1016/j.bbrc.2007.05.192; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nakazawa M, 2010, METHODS MOL BIOL, V657, P75, DOI 10.1007/978-1-60761-783-9_6; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; Pozzi D, 2008, P NATL ACAD SCI USA, V105, P323, DOI 10.1073/pnas.0706211105; Shuto YJ, 2001, LIFE SCI, V68, P991, DOI 10.1016/S0024-3205(00)01001-8; Tannenbaum GS, 1998, ENDOCRINOLOGY, V139, P4420, DOI 10.1210/en.139.10.4420; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; WILLIAMS G, 1991, METABOLISM, V40, P1112, DOI 10.1016/0026-0495(91)90139-N; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	32	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64183	10.1371/journal.pone.0064183	http://dx.doi.org/10.1371/journal.pone.0064183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755116	Green Published, gold			2022-12-25	WOS:000320579400009
J	Ouellet, JF; Vanpe, C; Guillemette, M				Ouellet, Jean-Francois; Vanpe, Cecile; Guillemette, Magella			The Body Size-Dependent Diet Composition of North American Sea Ducks in Winter	PLOS ONE			English	Article							EIDERS SOMATERIA-MOLLISSIMA; WHITE-WINGED SCOTERS; LONG-TAILED DUCKS; SAN-FRANCISCO BAY; COMMON-EIDERS; HARLEQUIN DUCKS; HABITAT SELECTION; SURF SCOTERS; TEMPORARY FLIGHTLESSNESS; FORAGING DECISIONS	Daily food requirements scale with body mass and activity in animals. While small species of birds have higher mass-specific field metabolic rates than larger species, larger species have higher absolute energy costs. Under energy balance, we thus expect the small species to have a higher energy value diet. Also the weight and time constraints for flighted and diurnal foragers should set a maximum to the amount of prey items taken in one meal and to the daily number of meals, respectively. Further, avoidance of competition causes the species to reduce the amount of shared prey in their diet. Some diet segregation is therefore to be expected between species. We tested these hypotheses and investigated the role of body mass in the diet composition of 12 sea duck species (Somateria mollissima, Somateria spectabilis, Somateria fischeri, Polysticta stelleri, Bucephala clangula, Bucephala islandica, Bucephala albeola, Melanitta nigra, Melanitta perspicillata, Melanitta deglandi, Histrionicus histrionicus and Clangula hyemalis) wintering in North America. This study was based on a literature survey with special emphasis given to the diet data from the former US Bureau of Biological Survey. The data supported our hypothesis that the energy value of winter diet of sea ducks scales negatively with body mass. Diet diversity also scaled negatively with body mass. Our results suggest the existence of a minimum for the energy value of avian diets.	[Ouellet, Jean-Francois; Vanpe, Cecile; Guillemette, Magella] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada; [Ouellet, Jean-Francois] Univ Laval, Quebec City, PQ G1K 7P4, Canada	University of Quebec; Laval University	Ouellet, JF (corresponding author), Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ G5L 3A1, Canada.	jean-francois_ouellet03@uqar.ca		Vanpe, Cecile/0000-0001-8136-1657	Fonds quebecois de la Recherche sur la Nature et les Technologies; CREPUQ; French Rhone-Alpes region	Fonds quebecois de la Recherche sur la Nature et les Technologies(FQRNT); CREPUQ; French Rhone-Alpes region(Region Auvergne-Rhone-Alpes)	JFO was supported by a grant from the Fonds quebecois de la Recherche sur la Nature et les Technologies. CV was supported by a CREPUQ international exchange grant from the French Rhone-Alpes region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EM, 2008, CONDOR, V110, P285, DOI 10.1525/cond.2008.8458; BECK DD, 1995, J HERPETOL, V29, P211, DOI 10.2307/1564558; BELOVSKY GE, 1986, AM ZOOL, V26, P51; Bond JC, 2006, CAN J ZOOL, V84, P1223, DOI 10.1139/Z06-111; BRAWN VM, 1968, J FISH RES BOARD CAN, V25, P1803, DOI 10.1139/f68-166; Bustnes JO, 2001, WATERBIRDS, V24, P407, DOI 10.2307/1522072; CARACO T, 1980, ANIM BEHAV, V28, P820, DOI 10.1016/S0003-3472(80)80142-4; CARACO T, 1990, ANIM BEHAV, V39, P338, DOI 10.1016/S0003-3472(05)80879-6; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; de Leeuw JJ, 1999, J AVIAN BIOL, V30, P182, DOI 10.2307/3677128; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; EDWARDS J, 1983, OECOLOGIA, V60, P185, DOI 10.1007/BF00379520; Ellis Hugh I., 2002, P359; Farnsworth KD, 1998, FUNCT ECOL, V12, P74, DOI 10.1046/j.1365-2435.1998.00163.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fischer JB, 2000, WILSON BULL, V112, P318, DOI 10.1676/0043-5643(2000)112[0318:FBAFHO]2.0.CO;2; FITZNER RE, 1994, NORTHWEST SCI, V68, P172; FRENCH TW, 1981, WILSON BULL, V93, P279; GOUDIE RI, 1988, ORNIS SCAND, V19, P249, DOI 10.2307/3676718; GOUDIE RI, 1986, ECOLOGY, V67, P1475, DOI 10.2307/1939078; Guillemette M, 1998, FUNCT ECOL, V12, P123, DOI 10.1046/j.1365-2435.1998.00164.x; Guillemette M, 2005, IBIS, V147, P301, DOI 10.1111/j.1474-919x.2005.00402.x; Guillemette M, 2005, IBIS, V147, P293, DOI 10.1111/j.1474-919x.2005.00401.x; GUILLEMETTE M, 1994, AUK, V111, P900, DOI 10.2307/4088822; GUILLEMETTE M, 1992, J ANIM ECOL, V61, P599, DOI 10.2307/5615; GUILLEMETTE M, 1993, CAN J ZOOL, V71, P1259, DOI 10.1139/z93-172; Guillemette M, 1991, THESIS U LAVAL QUEBE; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Heard DJ, 2008, J WILDLIFE DIS, V44, P486, DOI 10.7589/0090-3558-44.2.486; Heath JP, 2010, MAR ECOL PROG SER, V403, P279, DOI 10.3354/meps08482; Henny C.J., 1981, Wildfowl, V32, P117; Holm HJ, 2002, WATERBIRDS, V25, P312; Jamieson SE, 2001, WATERBIRDS, V24, P129, DOI 10.2307/1522253; Jenssen B.M., 1989, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V173, P147; JENSSEN BM, 1989, CAN J ZOOL, V67, P669, DOI 10.1139/z89-096; JORDE DG, 1988, J WILDLIFE MANAGE, V52, P209, DOI 10.2307/3801224; Kacelnik A, 1996, AM ZOOL, V36, P402; KARASOV WH, 1986, AUK, V103, P453, DOI 10.1093/auk/103.3.453; Kirk MK, 2007, CAN J ZOOL, V85, P1207, DOI 10.1139/Z07-105; Koehl PS, 1982, MARINE BIRDS THEIR F, P1; Larsen JK, 2000, MAR ECOL PROG SER, V201, P301, DOI 10.3354/meps201301; Lewis TL, 2005, CONDOR, V107, P637, DOI 10.1650/0010-5422(2005)107[0637:NFBOWS]2.0.CO;2; LIFJELD JT, 1989, OIKOS, V55, P397, DOI 10.2307/3565600; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LIVEZEY BC, 1995, CONDOR, V97, P233, DOI 10.2307/1368999; Livezey BC, 1997, ANN CARNEGIE MUS, V66, P457; Longcore J. R., 2000, BIRDS N AM ONLINE; Lovvorn JR, 2003, POLAR BIOL, V26, P259, DOI 10.1007/s00300-003-0477-0; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; McNab BK, 2003, COMP BIOCHEM PHYS A, V135, P229, DOI 10.1016/S1095-6433(03)00085-0; Miller MR, 2006, CONDOR, V108, P166, DOI 10.1650/0010-5422(2006)108[0166:TARBRM]2.0.CO;2; Moore PG, 2001, J MAR BIOL ASSOC UK, V81, P1067; Morton E.S., 1978, P123; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; OHLENDORF HM, 1991, ENVIRON MONIT ASSESS, V18, P105, DOI 10.1007/BF00394973; Ouellet JF, 2008, CAN J ZOOL, V86, P462, DOI 10.1139/Z08-021; Ouellet JF, 2010, CAN J ZOOL, V88, P306, DOI 10.1139/Z09-144; Pelletier D, 2008, P ROY SOC B-BIOL SCI, V275, P2117, DOI 10.1098/rspb.2008.0422; Petersen Margaret R., 1999, Wildfowl, V49, P124; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Richman SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P316, DOI 10.1086/660008; Richman SE, 2009, J ANIM ECOL, V78, P1033, DOI 10.1111/j.1365-2656.2009.01556.x; Richman SE, 2004, ECOL APPL, V14, P1217, DOI 10.1890/03-5032; Richman SE, 2003, MAR ECOL PROG SER, V261, P283, DOI 10.3354/meps261283; Rizzolo DJ, 2005, CONDOR, V107, P173, DOI 10.1650/7611; Robert M, 2006, WATERBIRDS, V29, P437, DOI 10.1675/1524-4695(2006)29[437:TSLREA]2.0.CO;2; Rodway MS, 2003, CAN J ZOOL, V81, P504, DOI 10.1139/Z03-032; Rumohr H., 1987, BALT MAR BIOL, V9, P1; RYAN RR, 1972, J WILDLIFE MANAGE, V36, P759, DOI 10.2307/3799428; Savard JPL, 1990, SERIE RAPPORTS TECHN, V89; SECOR SM, 1995, J EXP BIOL, V198, P1313; STEIMLE F W JR, 1985, Journal of Northwest Atlantic Fishery Science, V6, P117; Stephens D.W., 1986, pi; STOTT RS, 1973, ECOLOGY, V54, P996, DOI 10.2307/1935566; STRANECK R, 1983, CONDOR, V85, P255, DOI 10.2307/1367268; SWANSON GA, 1970, J WILDLIFE MANAGE, V34, P739, DOI 10.2307/3799138; Systad GH, 2000, AUK, V117, P33, DOI 10.1642/0004-8038(2000)117[0033:BRTDDL]2.0.CO;2; THAYER GW, 1973, FISH B-NOAA, V71, P289; TODD CS, 1982, J WILDLIFE MANAGE, V46, P636, DOI 10.2307/3808554; TYLER AV, 1973, MAR BIOL, V19, P258, DOI 10.1007/BF02097146; Van Gils JA, 2005, J ANIM ECOL, V74, P105, DOI 10.1111/j.1365-2656.2004.00903.x; van Gils JA, 2004, J ANIM ECOL, V73, P386, DOI 10.1111/j.0021-8790.2004.00812.x; Vang Hirsh K, 1980, THESIS U WASHINGTON; Vermeer K., 1982, Wildfowl, V33, P22; VERMEER K, 1986, Murrelet, V67, P1, DOI 10.2307/3535529; WATSON J, 1992, IBIS, V134, P27, DOI 10.1111/j.1474-919X.1992.tb07225.x; Whelan CJ, 2005, OIKOS, V110, P481, DOI 10.1111/j.0030-1299.2005.13387.x; White TP, 2009, WATERBIRDS, V32, P293, DOI 10.1675/063.032.0209; Wright J, 1998, J ANIM ECOL, V67, P620, DOI 10.1046/j.1365-2656.1998.00221.x	90	14	14	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65667	10.1371/journal.pone.0065667	http://dx.doi.org/10.1371/journal.pone.0065667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755266	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400073
J	Reissland, N; Francis, B; Mason, J				Reissland, Nadja; Francis, Brian; Mason, James			Can Healthy Fetuses Show Facial Expressions of "Pain" or "Distress"?	PLOS ONE			English	Article							SEX-DIFFERENCES; FETAL PAIN; 4-DIMENSIONAL SONOGRAPHY; NORMAL-PREGNANCY; ULTRASOUND; MOVEMENTS; RESPONSES; INFANTS; BRAIN; NEUROBEHAVIOR	Background: With advances of research on fetal behavioural development, the question of whether we can identify fetal facial expressions and determine their developmental progression, takes on greater importance. In this study we investigate longitudinally the increasing complexity of combinations of facial movements from 24 to 36 weeks gestation in a sample of healthy fetuses using frame-by-frame coding of 4-D ultrasound scans. The primary aim was to examine whether these complex facial movements coalesce into a recognisable facial expression of pain/distress. Methodology/Findings: Fifteen fetuses (8 girls, 7 boys) were observed four times in the second and third trimester of pregnancy. Fetuses showed significant progress towards more complex facial expressions as gestational age increased. Statistical analysis of the facial movements making up a specific facial configuration namely "pain/distress" also demonstrates that this facial expression becomes significantly more complete as the fetus matures. Conclusions/Significance: The study shows that one can determine the normal progression of fetal facial movements. Furthermore, our results suggest that healthy fetuses progress towards an increasingly complete pain/distress expression as they mature. We argue that this is an adaptive process which	[Reissland, Nadja] Univ Durham, Dept Psychol, Durham DH1 3HP, England; [Francis, Brian] Univ Lancaster, Dept Math & Stat, Lancaster, England; [Mason, James] Univ Durham, Sch Med Pharm & Hlth, Stockton On Tees DH1 3HP, England	Durham University; Lancaster University; Durham University	Reissland, N (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3HP, England.	n.n.reissland@durham.ac.uk	Mason, James M/D-9904-2011; Reissland, Nadja/B-6079-2008; Francis, Brian J/A-1953-2011	Mason, James M/0000-0001-9210-4082; Reissland, Nadja/0000-0003-4976-7117; Francis, Brian J/0000-0001-7926-9085	Durham University; ESRC [RES-576-25-0019]	Durham University; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funding was provided by Durham University (http://www.dur.ac.uk). The analysis of the data was supported by ESRC grant RES-576-25-0019 (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; ANAND KJS, 1987, NEW ENGL J MED, V317, P1321, DOI 10.1056/NEJM198711193172105; Azumendi G, 2003, ULTRASOUND REV OBSTE, V3, P160; Bartocci M, 2006, PAIN, V122, P109, DOI 10.1016/j.pain.2006.01.015; Benatar D, 2001, BIOETHICS, V15, P57, DOI 10.1111/1467-8519.00212; Christensen R.H.B., 2011, ANAL ORDINAL DATA CU; Craig K. D., 2001, HDB PAIN ASSESSMENT, P153; CRAIG KD, 1993, PAIN, V52, P287, DOI 10.1016/0304-3959(93)90162-I; CRAIG KD, 1994, J PEDIATR PSYCHOL, V19, P305, DOI 10.1093/jpepsy/19.3.305; CRAIG KD, 1985, J PERS SOC PSYCHOL, V48, P1080, DOI 10.1037/0022-3514.48.4.1089; Craig KD, 1991, PAIN CHILDREN CLIN R, P171; Derbyshire SWG, 2010, BEST PRACT RES CL OB, V24, P647, DOI 10.1016/j.bpobgyn.2010.02.013; DEVRIES JIP, 1982, EARLY HUM DEV, V7, P301, DOI 10.1016/0378-3782(82)90033-0; Fernandez-Dols JM, 2013, EMOT REV, V5, P24, DOI 10.1177/1754073912457229; Friesen E., 1978, CONSULTING PSYCHOL P, V3, P1; GIANNAKOULOPOULOS X, 1994, LANCET, V344, P77, DOI 10.1016/S0140-6736(94)91279-3; GRUNAU RVE, 1990, PAIN, V42, P295, DOI 10.1016/0304-3959(90)91142-6; Hartzel J, 2001, STAT MODEL, V1, P81, DOI 10.1177/1471082X0100100201; Hata T, 2010, INFANT CHILD DEV, V19, P99, DOI 10.1002/icd.659; Hepper PG, 2012, DEVELOPMENTAL SCI, V15, P373, DOI 10.1111/j.1467-7687.2011.01132.x; Hepper PG, 1997, LANCET, V350, P1820, DOI 10.1016/S0140-6736(05)63635-5; Humprey T, 1967, 2 S OR SENS PERC, P195; Kawai N, 2010, INFANT CHILD DEV, V19, P55, DOI 10.1002/icd.654; Kisilevsky BS, 2010, INFANT CHILD DEV, V19, P60, DOI 10.1002/icd.655; Kisilevsky BS, 2003, PSYCHOL SCI, V14, P220, DOI 10.1111/1467-9280.02435; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kurjak A, 2005, J PERINAT MED, V33, P46, DOI 10.1515/JPM.2005.008; Kurjak A, 2006, J PERINAT MED, V34, P56, DOI 10.1515/JPM.2006.007; Kurjak A, 2003, J PERINAT MED, V31, P496, DOI 10.1515/JPM.2003.076; Kurjak A, 2002, J PERINAT MED, V30, P57, DOI 10.1515/JPM.2002.008; Kurjak A, 2010, J PERINAT MED, V38, P77, DOI [10.1515/JPM.2010.012, 10.1515/jpm.2010.012]; Kurjak A, 2008, J MATERN-FETAL NEO M, V21, P675, DOI 10.1080/14767050802212166; Lee SJ, 2005, JAMA-J AM MED ASSOC, V294, P947, DOI 10.1001/jama.294.8.947; LERESCHE L, 1988, PAIN, V35, P71, DOI 10.1016/0304-3959(88)90278-3; LERESCHE L, 1982, J NONVERBAL BEHAV, V7, P46, DOI 10.1007/BF01001777; Mathew PJ, 2003, POSTGRAD MED J, V79, P438, DOI 10.1136/pmj.79.934.438; Mellor DJ, 2005, BRAIN RES REV, V49, P455, DOI 10.1016/j.brainresrev.2005.01.006; Miller JL, 2006, DEV MED CHILD NEUROL, V48, P465, DOI 10.1017/S0012162206001009; Oberlander TF, 2002, PEDIATRICS, V110, P570, DOI 10.1542/peds.110.3.570; PATRICK CJ, 1986, J PERS SOC PSYCHOL, V50, P1291, DOI 10.1037/0022-3514.50.6.1291; Piontelli A, 2010, DEVELOPMENT OF NORMAL FETAL MOVEMENTS: THE FIRST 25 WEEKS OF GESTATION, P1, DOI 10.1007/978-88-470-1402-2; Prkachin KM, 2005, WHAT FACE REVEALS BA, P181; Reissland N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050569; Reissland N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024081; ROODENBURG PJ, 1991, EARLY HUM DEV, V25, P19, DOI 10.1016/0378-3782(91)90203-F; Slater R, 2006, J NEUROSCI, V26, P3662, DOI 10.1523/JNEUROSCI.0348-06.2006; Slater R, 2008, PLOS MED, V5, P928, DOI 10.1371/journal.pmed.0050129; Smith RP, 2000, EUR J OBSTET GYN R B, V92, P161, DOI 10.1016/S0301-2115(00)00441-3; Tutz G, 1996, COMPUT STAT DATA AN, V22, P537, DOI 10.1016/0167-9473(96)00004-7; Waxman SG, 1996, PROG BRAIN RES, V107, P595; Yan F, 2006, INT J GYNECOL OBSTET, V94, P108, DOI 10.1016/j.ijgo.2006.05.004	51	36	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65530	10.1371/journal.pone.0065530	http://dx.doi.org/10.1371/journal.pone.0065530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755245	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000320579400062
J	Vitale, A; Thorne, N; Lovell, S; Battaile, KP; Hu, X; Shen, M; D'Auria, S; Auld, DS				Vitale, Annalisa; Thorne, Natasha; Lovell, Scott; Battaile, Kevin P.; Hu, Xin; Shen, Min; D'Auria, Sabato; Auld, Douglas S.			Physicochemical Characterization of a Thermostable Alcohol Dehydrogenase from Pyrobaculum aerophilum	PLOS ONE			English	Article							CLOSTRIDIUM-BEIJERINCKII; CRYSTAL-STRUCTURE; ZINC; BINDING; IDENTIFICATION; SPECIFICITY; VALIDATION; STABILITY; SUBSTRATE; RESIDUES	In this work we characterize an alcohol dehydrogenase (ADH) from the hyperthermophilic archaeon Pyrobaculum aerophilum (PyAeADHII). We have previously found that PyAeADHII has no activity when standard ADH substrates are used but is active when alpha-tetralone is used as substrate. Here, to gain insights into enzyme function, we screened several chemical libraries for enzymatic modulators using an assay employing alpha-tetralone. The results indicate that PyAeADHII activity in the presence of alpha-tetralone was inhibited by compounds such as flunarizine. We also examined metal coordination of the enzyme in solution by performing metal substitution of the enzyme-bound zinc (Zn2+) with cobalt. The solution-based absorption spectra for cobalt substituted PyAeADHII supports substitution at the structural Zn2+ site. To gain structural insight, we obtained the crystal structure of both wild-type and cobalt-substituted PyAeADHII at 1.75 angstrom and 2.20 angstrom resolution, respectively. The X-ray data confirmed one metal ion per monomer present only at the structural site with otherwise close conservation to other ADH enzymes. We next determined the co-crystal structure of the NADPH-bound form of the enzyme at 2.35 angstrom resolution to help define the active site region of the enzyme and this data shows close structural conservation with horse ADH, despite the lack of a catalytic Zn2+ ion in PyAeADHII. Modeling of alpha-tetralone into the NADPH bound structure suggests an arginine as a possible catalytic residue. The data presented here can yield a better understanding of alcohol dehydrogenases lacking the catalytic zinc as well as the structural features inherent to thermostable enzymes.	[Vitale, Annalisa; Thorne, Natasha; Hu, Xin; Shen, Min; Auld, Douglas S.] Natl Ctr Adv Translat Sci, Bethesda, MD USA; [Vitale, Annalisa; D'Auria, Sabato] NRC, Inst Prot Biochem, Naples, Italy; [Lovell, Scott] Univ Kansas, Prot Struct Lab, Del Shankel Struct Biol Ctr, Lawrence, KS 66045 USA; [Battaile, Kevin P.] Hauptman Woodward Med Res Inst, Ind Macromol Crystallog Assoc Collaborat Access T, Argonne, IL USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Kansas; Hauptman Woodward Medical Research Institute	Auld, DS (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	douglas.auld@novartis.com		Battaile, Kevin/0000-0003-0833-3259	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research; National Human Genome Research Institute, National Institutes of Health; Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; National Center for Research Resources [5P20RR017708-10]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103420-10]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000002] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103420] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research and the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the KU COBRE-PSF Protein Structure Laboratory was supported by grants from the National Center for Research Resources (5P20RR017708-10) and the National Institute of General Medical Sciences (8 P20 GM103420-10) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1; Barzegar A, 2009, ENZYME MICROB TECH, V45, P73, DOI 10.1016/j.enzmictec.2009.04.007; Bergman T, 2008, CELL MOL LIFE SCI, V65, P4019, DOI 10.1007/s00018-008-8379-5; Bogin O, 1998, PROTEIN SCI, V7, P1156, DOI 10.1002/pro.5560070509; BUHNER M, 1969, EUR J BIOCHEM, V11, P73, DOI 10.1111/j.1432-1033.1969.tb00741.x; Burdette DS, 2002, APPL ENVIRON MICROB, V68, P1914, DOI 10.1128/AEM.68.4.1914-1918.2002; Case D, 2010, AMBER, V11; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; EKLUND H, 1976, J MOL BIOL, V102, P27, DOI 10.1016/0022-2836(76)90072-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esposito L, 2002, J MOL BIOL, V318, P463, DOI 10.1016/S0022-2836(02)00088-8; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; Hu X, 2012, BIOCHEMISTRY-US, V51, P1199, DOI 10.1021/bi200987b; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; KAGI JHR, 1960, J BIOL CHEM, V235, P3188; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Korkhin Y, 1998, J MOL BIOL, V278, P967, DOI 10.1006/jmbi.1998.1750; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Littlechild JA, 2004, BIOCHEM SOC T, V32, P255, DOI 10.1042/BST0320255; Louie AY, 1998, P NATL ACAD SCI USA, V95, P6663, DOI 10.1073/pnas.95.12.6663; MARET W, 1979, EUR J BIOCHEM, V98, P501, DOI 10.1111/j.1432-1033.1979.tb13211.x; MARET W, 1989, BIOCHEMISTRY-US, V28, P9944, DOI 10.1021/bi00452a011; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pennacchio A, 2008, APPL ENVIRON MICROB, V74, P3949, DOI 10.1128/AEM.00217-08; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Radianingtyas H, 2003, FEMS MICROBIOL REV, V27, P593, DOI 10.1016/S0168-6445(03)00068-8; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shukla SJ, 2009, ASSAY DRUG DEV TECHN, V7, P143, DOI 10.1089/adt.2009.193; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vitale A, 2010, GENE, V461, P26, DOI 10.1016/j.gene.2010.04.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	45	6	6	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e63828	10.1371/journal.pone.0063828	http://dx.doi.org/10.1371/journal.pone.0063828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755111	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400006
J	Calizza, E; Rossi, L; Costantini, ML				Calizza, Edoardo; Rossi, Loreto; Costantini, Maria Letizia			Predators and Resources Influence Phosphorus Transfer along an Invertebrate Food Web through Changes in Prey Behaviour	PLOS ONE			English	Article							CHEMICAL STIMULI; BOTTOM-UP; RESPONSES; RISK; POPULATIONS; COEXISTENCE; COMPETITION; MECHANISMS; LANDSCAPE; STABILITY	Predators play a fundamental role in prey trophic behaviour, with indirect consequences for species coexistence and ecosystem functioning. Resource quality and availability also influence prey trophic behaviour, with potential effects on predator-prey dynamics. Although many studies have addressed these topics, little attention has been paid to the combined effects of predators and resources on prey species coexistence and nutrient transfer along food chains, especially in detritus-based systems. To determine the influence of predators and resource quality on the movement and P uptake of detritivores, we carried out a field experiment on the River Kelvin (Scotland) using P-32 to test the hypothesis of reduced prey vagility among resource patches as a strategy to avoid predation. Thirty leaf sacks containing alder leaves and two detritivore prey populations (Asellus aquaticus and Lymnaea peregra) were placed in cages, half of them with two predator species (Dendrocoelum lacteum and Erpobdella octoculata) and the other half without predators. Five alder leaf bags, each individually inoculated with a different fungus strain to simulate a patchy habitat, were placed inside each leaf sack. One bag in each sack was labelled with P-32, in order to assess the proportion of detritivores using it as food and thus their movement among the five resource patches. Three replicates for each labelled fungus and each predation treatment (i.e. with and without predators) were left on the riverbed for 7 days. The presence of predators had negligible effects on the number of detritivores in the leaf bags, but it did reduce the proportion of P-32-labelled detritivores and their P uptake. The most strongly affected species was A. aquaticus, whose vagility, trophic overlap with L. peregra and P uptake were all reduced. The results confirm the importance of bottom-up and top-down forces acting simultaneously to regulate nutrient transfer along food chains in patchy habitats.	[Calizza, Edoardo; Rossi, Loreto; Costantini, Maria Letizia] Univ Roma La Sapienza, Dept Environm Biol, Rome, Italy	Sapienza University Rome	Rossi, L (corresponding author), Univ Roma La Sapienza, Dept Environm Biol, Rome, Italy.	loreto.rossi@uniroma1.it		Calizza, Edoardo/0000-0002-9457-4229; ROSSI, LORETO/0000-0001-8014-5397; Costantini, Maria Letizia/0000-0001-6242-558X	National Academy of Lincei; PNRA (Ministero dell'istruzione, dell'universitae della ricerca); Provincia di Latina (Presidenza and Assessorato Ambiente)	National Academy of Lincei; PNRA (Ministero dell'istruzione, dell'universitae della ricerca); Provincia di Latina (Presidenza and Assessorato Ambiente)	Funding for experiment provided by National Academy of Lincei. Funding for numerical analysis provided by PNRA 2010 (Ministero dell'istruzione, dell'universitae della ricerca, http://www.istruzione.it/) and Provincia di Latina (Presidenza and Assessorato Ambiente) 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminot A, 1996, WATER RES, V30, P2805, DOI 10.1016/S0043-1354(96)00192-3; BASSET A, 1990, FUNCT ECOL, V4, P685, DOI 10.2307/2389737; Beisner BE, 2003, ECOLOGY, V84, P1563, DOI 10.1890/0012-9658(2003)084[1563:VOLOTL]2.0.CO;2; Bell AV, 2009, THEOR POPUL BIOL, V76, P52, DOI 10.1016/j.tpb.2009.03.008; BROWMAN HI, 1987, HOLARCTIC ECOL, V10, P163; Browman HI, 2011, MAR BIOL, V158, P2653, DOI 10.1007/s00227-011-1763-y; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Bundschuh M, 2012, ARCH ENVIRON CON TOX, V63, P77, DOI 10.1007/s00244-011-9743-2; Calizza E, 2012, FRESHWATER BIOL, V57, P2613, DOI 10.1111/fwb.12033; Chesson P, 2008, NATURE, V456, P235, DOI 10.1038/nature07248; COOPER SD, 1990, ECOLOGY, V71, P1503, DOI 10.2307/1938287; Costantini ML, 2010, FRESHWATER BIOL, V55, P2281, DOI 10.1111/j.1365-2427.2010.02433.x; Costantini ML, 2005, MAR FRESHWATER RES, V56, P997, DOI 10.1071/MF04272; COSTANTINI ML, 1995, HYDROBIOLOGIA, V302, P81, DOI 10.1007/BF00006401; COVICH AP, 1994, J N AM BENTHOL SOC, V13, P283, DOI 10.2307/1467246; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Dahl J, 1998, OECOLOGIA, V117, P217, DOI 10.1007/s004420050651; Davis J, 2010, FRESHWATER BIOL, V55, P5, DOI 10.1111/j.1365-2427.2009.02376.x; DUSSART GBJ, 1979, HYDROBIOLOGIA, V67, P223, DOI 10.1007/BF00023179; Eroukhmanoff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006173; Faithfull CL, 2011, OIKOS, V120, P311, DOI 10.1111/j.1600-0706.2010.18683.x; Ferreira V, 2011, OECOLOGIA, V167, P279, DOI 10.1007/s00442-011-1976-2; Fry B., 2006, STABLE ISOTOPE ECOLO; Gessner M. O., 2007, P301; Gripenberg S, 2007, OIKOS, V116, P181, DOI [10.1111/j.2006.0030-1299.15266.x, 10.1111/j.0030-1299.2007.15266.x]; HAM L, 1995, ARCH ENVIRON CON TOX, V29, P358, DOI 10.1007/BF00212501; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Henry J.-P., 1983, Bulletin Mensuel de la Societe Linneenne de Lyon, V52, P319; HERRMANN J, 1984, HYDROBIOLOGIA, V114, P3, DOI 10.1007/BF00016595; HEWS DK, 1988, ANIM BEHAV, V36, P125, DOI 10.1016/S0003-3472(88)80255-0; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; LANCASTER J, 1991, J ANIM ECOL, V60, P625, DOI 10.2307/5302; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; MACAN TT, 1977, BIOL REV, V52, P45, DOI 10.1111/j.1469-185X.1977.tb01345.x; MATHIS A, 1993, ANIM BEHAV, V46, P645, DOI 10.1006/anbe.1993.1241; Meissner K, 2009, ANN ZOOL FENN, V46, P193, DOI 10.5735/086.046.0304; Morrison LW, 1999, OECOLOGIA, V121, P113, DOI 10.1007/s004420050912; Mulder C, 2006, NATURWISSENSCHAFTEN, V93, P467, DOI 10.1007/s00114-006-0130-1; Mulder C, 2012, ADV ECOL RES, V46, P1, DOI 10.1016/B978-0-12-396992-7.00001-0; Mulder C, 2011, ADV ECOL RES, V44, P277, DOI 10.1016/B978-0-12-374794-5.00005-5; Orr MV, 2007, J EXP BIOL, V210, P4150, DOI 10.1242/jeb.010173; Orrock JL, 2008, ECOLOGY, V89, P2426, DOI 10.1890/07-1024.1; OSENBERG CW, 1988, THESIS MICHIGAN STAT; Palkovacs EP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018879; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Peckarsky BL, 1998, OECOLOGIA, V113, P565, DOI 10.1007/s004420050410; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Preisser EL, 2009, ECOL LETT, V12, P315, DOI 10.1111/j.1461-0248.2009.01290.x; REYNOLDSON TB, 1979, J ZOOL, V189, P459; REYNOLDSON TB, 1970, J ANIM ECOL, V39, P599, DOI 10.2307/2857; ROSSI L, 1983, MYCOLOGIA, V75, P887, DOI 10.2307/3792781; ROSSI L, 1985, OIKOS, V44, P175, DOI 10.2307/3544059; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; SEABY RMH, 1995, FRESHWATER BIOL, V34, P21, DOI 10.1111/j.1365-2427.1995.tb00419.x; SIH A, 1992, ECOLOGY, V73, P1418, DOI 10.2307/1940687; SIH A, 1979, J ANIM ECOL, V48, P79, DOI 10.2307/4101; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Thaler JS, 2012, P NATL ACAD SCI USA, V109, P12075, DOI 10.1073/pnas.1208070109; Tikkanen P, 1996, ANIM BEHAV, V51, P1391, DOI 10.1006/anbe.1996.0142; Verovnik R, 2005, MOL ECOL, V14, P4355, DOI 10.1111/j.1365-294X.2005.02745.x; Whittaker R, 1961, ECOL MONOGR, V1, P57; Wirsing AJ, 2010, ANIM BEHAV, V79, P531, DOI 10.1016/j.anbehav.2009.12.014; Wisenden BD, 1997, J CHEM ECOL, V23, P137, DOI 10.1023/B:JOEC.0000006350.66424.3d; Withers PJA, 2008, SCI TOTAL ENVIRON, V400, P379, DOI 10.1016/j.scitotenv.2008.08.002; WOOSTER D, 1995, OIKOS, V73, P3, DOI 10.2307/3545718; Wudkevich K, 1997, J CHEM ECOL, V23, P1163, DOI 10.1023/B:JOEC.0000006393.92013.36; YOUNG JO, 1980, HYDROBIOLOGIA, V68, P209, DOI 10.1007/BF00018828	75	26	26	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65186	10.1371/journal.pone.0065186	http://dx.doi.org/10.1371/journal.pone.0065186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750242	gold, Green Published, Green Submitted			2022-12-25	WOS:000319961900044
J	Huang, XD; Grace, P; Hu, WB; Rowlings, D; Mengersen, K				Huang, Xiaodong; Grace, Peter; Hu, Wenbiao; Rowlings, David; Mengersen, Kerrie			Spatial Prediction of N2O Emissions in Pasture: A Bayesian Model Averaging Analysis	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; SOIL; UNCERTAINTY; VARIABILITY; CH4	Nitrous oxide (N2O) is one of the greenhouse gases that can contribute to global warming. Spatial variability of N2O can lead to large uncertainties in prediction. However, previous studies have often ignored the spatial dependency to quantify the N2O - environmental factors relationships. Few researches have examined the impacts of various spatial correlation structures (e.g. independence, distance-based and neighbourhood based) on spatial prediction of N2O emissions. This study aimed to assess the impact of three spatial correlation structures on spatial predictions and calibrate the spatial prediction using Bayesian model averaging (BMA) based on replicated, irregular point-referenced data. The data were measured in 17 chambers randomly placed across a 271 m(2) field between October 2007 and September 2008 in the southeast of Australia. We used a Bayesian geostatistical model and a Bayesian spatial conditional autoregressive (CAR) model to investigate and accommodate spatial dependency, and to estimate the effects of environmental variables on N2O emissions across the study site. We compared these with a Bayesian regression model with independent errors. The three approaches resulted in different derived maps of spatial prediction of N2O emissions. We found that incorporating spatial dependency in the model not only substantially improved predictions of N2O emission from soil, but also better quantified uncertainties of soil parameters in the study. The hybrid model structure obtained by BMA improved the accuracy of spatial prediction of N2O emissions across this study region.	[Huang, Xiaodong; Mengersen, Kerrie] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Huang, Xiaodong; Grace, Peter; Rowlings, David] Queensland Univ Technol, Inst Sustainable Resources, Brisbane, Qld 4001, Australia; [Hu, Wenbiao] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland	Huang, XD (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	xiaodong.huang@student.qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Mengersen, Kerrie/0000-0001-8625-9168; Grace, Peter/0000-0003-4136-4129; Hu, Wenbiao/0000-0001-6422-9240	Institute of Sustainable Resources (ISR); University of Technology (QUT); Australian Research Council (ARC)	Institute of Sustainable Resources (ISR); University of Technology (QUT); Australian Research Council (ARC)(Australian Research Council)	The authors thank the Institute of Sustainable Resources (ISR), Queensland University of Technology (QUT), and the Australian Research Council (ARC) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Ambus P, 2005, NUTR CYCL AGROECOSYS, V72, P189, DOI 10.1007/s10705-005-1269-4; Anselin L., 2003, GEODA 0 9 US GUID; Banerjee S., 2004, HIERARCHICAL MODELIN; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Best N, 2005, STAT METHODS MED RES, V14, P35, DOI 10.1191/0962280205sm388oa; Boone EL, 2008, J APPL STAT, V35, P967, DOI 10.1080/02664760802185845; Borgonovo E, 2006, RISK ANAL, V26, P1349, DOI 10.1111/j.1539-6924.2006.00806.x; BOUWMAN AF, 1995, J GEOPHYS RES-ATMOS, V100, P2785, DOI 10.1029/94JD02946; Bouwman AF, 1996, NUTR CYCL AGROECOSYS, V46, P53, DOI 10.1007/BF00210224; Bouwman AF, 1998, NATURE, V392, P866, DOI 10.1038/31809; Clyde M, 2000, ENVIRONMETRICS, V11, P745, DOI 10.1002/1099-095X(200011/12)11:6<745::AID-ENV431>3.0.CO;2-N; Cressie N. A. C., 1993, STAT SPATIAL DATA WI; Davidson EA, 1991, MICROBIAL PRODUCTION; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; DRAPER D, 1995, J R STAT SOC B, V57, P45, DOI 10.1111/j.2517-6161.1995.tb02015.x; Gelman A, 2004, BAYESIAN DATA ANLYSI; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; GOODROAD LL, 1984, SOIL BIOL BIOCHEM, V16, P39, DOI 10.1016/0038-0717(84)90123-8; Goovaerts P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-6; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Huang XD, 2013, SCI TOTAL ENVIRON, V454, P206, DOI 10.1016/j.scitotenv.2013.03.013; Huang XD, 2012, SOIL RES, V50, P596, DOI 10.1071/SR11100; Huang XD, 2011, SCI TOTAL ENVIRON, V409, P4572, DOI 10.1016/j.scitotenv.2011.07.044; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Jackson CH, 2009, J R STAT SOC A STAT, V172, P383, DOI 10.1111/j.1467-985X.2008.00573.x; Kamp T, 1998, BIOL FERT SOILS, V27, P307, DOI 10.1007/s003740050438; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Kelsall J., 1999, BAYESIAN STAT; Maag M, 1996, APPL SOIL ECOL, V4, P5, DOI 10.1016/0929-1393(96)00106-0; Machefert SE, 2004, WATER AIR SOIL POLL, V4, P427, DOI DOI 10.1023/B:WAF0.0000028369.86947.9F; Robertson G, 2003, SOIL RES, V41, P65; Robertson G.P., 2008, GS GEOSTATISTICS ENV; Rowlings DW, 2012, GLOBAL CHANGE BIOL, V18, P726, DOI 10.1111/j.1365-2486.2011.02563.x; Saggar S, 2004, NUTR CYCL AGROECOSYS, V68, P243, DOI 10.1023/B:FRES.0000019463.92440.a3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Thomas A, 2002, GEOBUGS US MAN VERS; Thomas A, 2004, GEOBUGS US MAN VERS; Wackerly D.D., 2008, MATH STAT APPL; Wall MM, 2004, J STAT PLAN INFER, V121, P311, DOI 10.1016/S0378-3758(03)00111-3; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124; Yan YP, 2008, J ENVIRON SCI, V20, P207, DOI 10.1016/S1001-0742(08)60033-9	45	3	3	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65039	10.1371/journal.pone.0065039	http://dx.doi.org/10.1371/journal.pone.0065039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750227	Green Submitted, Green Published, gold			2022-12-25	WOS:000319961900029
J	Teixeira-Silva, A; Silva, RM; Carneiro, J; Amorim, A; Azevedo, L				Teixeira-Silva, Ana; Silva, Raquel M.; Carneiro, Joao; Amorim, Antonio; Azevedo, Luisa			The Role of Recombination in the Origin and Evolution of Alu Subfamilies	PLOS ONE			English	Article							HUMAN GENOMIC DIVERSITY; GENE CONVERSION; HUMAN-DISEASE; HOT-SPOTS; ELEMENTS; DELETIONS; RETROTRANSPOSITION; REPEATS; HUMANS; REARRANGEMENTS	Alus are the most abundant and successful short interspersed nuclear elements found in primate genomes. In humans, they represent about 10% of the genome, although few are retrotransposition-competent and are clustered into subfamilies according to the source gene from which they evolved. Recombination between them can lead to genomic rearrangements of clinical and evolutionary significance. In this study, we have addressed the role of recombination in the origin of chimeric Alu source genes by the analysis of all known consensus sequences of human Alus. From the allelic diversity of Alu consensus sequences, validated in extant elements resulting from whole genome searches, distinct events of recombination were detected in the origin of particular subfamilies of AluS and AluY source genes. These results demonstrate that at least two subfamilies are likely to have emerged from ectopic Alu-Alu recombination, which stimulates further research regarding the potential of chimeric active Alus to punctuate the genome.	[Teixeira-Silva, Ana; Silva, Raquel M.; Carneiro, Joao; Amorim, Antonio; Azevedo, Luisa] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Teixeira-Silva, Ana; Carneiro, Joao; Amorim, Antonio] Univ Porto, FCUP Fac Sci, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Azevedo, L (corresponding author), Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lazevedo@ipatimup.pt	Carneiro, Joao/A-6289-2009; Silva, Raquel M/B-8337-2008; Azevedo, Luisa/J-4051-2013; Amorim, Antonio/A-7938-2008	Carneiro, Joao/0000-0002-5153-2395; Silva, Raquel M/0000-0001-5926-8042; Azevedo, Luisa/0000-0002-3157-7342; Amorim, Antonio/0000-0002-7518-6247; Teixeira-Silva, Ana/0000-0002-9011-9501	FCT (Portuguese governmental institution); MCTES national funding; European Social Fund;  [PTDC/BIA-PRO/099888/2008]	FCT (Portuguese governmental institution); MCTES national funding; European Social Fund(European Social Fund (ESF)); 	This work was supported by FCT (Portuguese governmental institution) through the program Ciencia2007 (Hiring of PhDs for the SCTN - financed by POPH - QREN - Tipology 4.2 - Promoting Scientific Employment, co-financed by MCTES national funding and The European Social Fund and the research project PTDC/BIA-PRO/099888/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Comeaux MS, 2009, GENOME RES, V19, P545, DOI 10.1101/gr.089789.108; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; DEININGER PL, 1986, TRENDS GENET, V2, P76, DOI 10.1016/0168-9525(86)90183-6; Dobrovolny R, 2011, HUM MUTAT, V32, P688, DOI 10.1002/humu.21474; Drummond AJ., 2011, GENEIOUS PRO 5 4; Franke G, 2009, HUM MUTAT, V30, P776, DOI 10.1002/humu.20948; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Johanning K, 2003, J MOL EVOL, V56, P658, DOI 10.1007/s00239-002-2433-y; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kapitonov V, 1996, J MOL EVOL, V42, P59, DOI 10.1007/BF00163212; Kuiper RP, 2011, HUM MUTAT, V32, P407, DOI 10.1002/humu.21446; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MATERA AG, 1990, NUCLEIC ACIDS RES, V18, P6019, DOI 10.1093/nar/18.20.6019; McVean G, 2010, PHILOS T R SOC B, V365, P1213, DOI 10.1098/rstb.2009.0299; Mighell AJ, 1997, FEBS LETT, V417, P1, DOI 10.1016/S0014-5793(97)01259-3; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Nachman MW, 2000, GENETICS, V156, P297; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Park ES, 2005, GENES GENET SYST, V80, P415, DOI 10.1266/ggs.80.415; Pereira MC, 2012, GENET MED, V14, P143, DOI 10.1038/gim.2011.7; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Quental R, 2009, CLIN GENET, V75, P457, DOI 10.1111/j.1399-0004.2009.01172.x; Ray DA, 2005, BMC EVOLUTIONARY BIO, V5; ROGERS JH, 1985, INT REV CYTOL, V93, P187, DOI 10.1016/S0074-7696(08)61375-3; Roy AM, 2000, GENOME RES, V10, P1485, DOI 10.1101/gr.152300; Roy-Engel AM, 2002, J MOL BIOL, V316, P1033, DOI 10.1006/jmbi.2001.5380; Salem AH, 2003, MOL BIOL EVOL, V20, P1349, DOI 10.1093/molbev/msg150; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; Styles P, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-102; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WILLARD C, 1987, J MOL EVOL, V26, P180, DOI 10.1007/BF02099850; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Zhi DG, 2007, GENE, V390, P117, DOI 10.1016/j.gene.2006.09.030	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64884	10.1371/journal.pone.0064884	http://dx.doi.org/10.1371/journal.pone.0064884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750218	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900020
J	Ansmann, IC; Lanyon, JM; Seddon, JM; Parra, GJ				Ansmann, Ina C.; Lanyon, Janet M.; Seddon, Jennifer M.; Parra, Guido J.			Monitoring Dolphins in an Urban Marine System: Total and Effective Population Size Estimates of Indo-Pacific Bottlenose Dolphins in Moreton Bay, Australia	PLOS ONE			English	Article							CAPTURE-RECAPTURE DATA; LINKAGE DISEQUILIBRIUM; TURSIOPS-TRUNCATUS; MARKED ANIMALS; DOUBTFUL SOUND; POWER ANALYSIS; ABUNDANCE; CONSERVATION; ADUNCUS; TRENDS	Moreton Bay, Queensland, Australia is an area of high biodiversity and conservation value and home to two sympatric sub-populations of Indo-Pacific bottlenose dolphins (Tursiops aduncus). These dolphins live in close proximity to major urban developments. Successful management requires information regarding their abundance. Here, we estimate total and effective population sizes of bottlenose dolphins in Moreton Bay using photo-identification and genetic data collected during boat-based surveys in 2008-2010. Abundance (N-e) was estimated using open population mark-recapture models based on sighting histories of distinctive individuals. Effective population size (Ne) was estimated using the linkage disequilibrium method based on nuclear genetic data at 20 microsatellite markers in skin samples, and corrected for bias caused by overlapping generations (N(e)c). A total of 174 sightings of dolphin groups were recorded and 365 different individuals identified. Over the whole of Moreton Bay, a population size N of 554 +/- 22.2 (SE) (95% CI: 510-598) was estimated. The southern bay sub-population was small at an estimated N = 193 +/- 6.4 (SE) (95% CI: 181-207), while the North sub-population was more numerous, with 446 +/- 56 (SE) (95% CI: 336-556) individuals. The small estimated effective population size of the southern sub-population (N(e)c = 56, 95% CI: 33-128) raises conservation concerns. A power analysis suggested that to reliably detect small (5%) declines in size of this population would require substantial survey effort (>4 years of annual mark-recapture surveys) at the precision levels achieved here. To ensure that ecological as well as genetic diversity within this population of bottlenose dolphins is preserved, we consider that North and South sub-populations should be treated as separate management units. Systematic surveys over smaller areas holding locally-adapted sub-populations are suggested as an alternative method for increasing ability to detect abundance trends.	[Ansmann, Ina C.; Lanyon, Janet M.] Univ Queensland, Sch Biol Sci, Marine Vertebrate Ecol Res Grp, St Lucia, Qld, Australia; [Seddon, Jennifer M.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Parra, Guido J.] Flinders Univ S Australia, Sch Biol Sci, Cetacean Ecol Behav & Evolut Lab, Adelaide, SA 5001, Australia; [Parra, Guido J.] SARDI, West Beach, SA, Australia	University of Queensland; University of Queensland; Flinders University South Australia	Ansmann, IC (corresponding author), Univ Queensland, Sch Biol Sci, Marine Vertebrate Ecol Res Grp, St Lucia, Qld, Australia.	a.ina@gmx.net	Seddon, Jennifer/A-1402-2010; Seddon, Jennifer/AAM-3827-2021	Seddon, Jennifer/0000-0003-3789-6878; Seddon, Jennifer/0000-0003-3789-6878; Parra, Guido J./0000-0002-1284-4898; Lanyon, Janet/0000-0003-1453-5594	Winifred V. Scott Foundation; University of Queensland Research Scholarship (UQRS); University of Queensland International Research Award (UQIRA)	Winifred V. Scott Foundation; University of Queensland Research Scholarship (UQRS)(University of Queensland); University of Queensland International Research Award (UQIRA)(University of Queensland)	This study was supported by the Winifred V. Scott Foundation. ICA was supported during the course of this study by a University of Queensland Research Scholarship (UQRS) and University of Queensland International Research Award (UQIRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Ansmann I. C., 2011, THESIS U QUEENSLAND; Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x; Australian Bureau of Statistics, 2006, POP PROJ AUSTR 2004; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chilvers B. L., 2001, THESIS J COOK U TOWN; Chilvers BL, 2005, BIOL CONSERV, V122, P559, DOI 10.1016/j.biocon.2004.08.013; Chilvers BL, 2003, MAR MAMMAL SCI, V19, P85, DOI 10.1111/j.1748-7692.2003.tb01094.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Choy Darryl Low, 1998, P621; CORKERON PJ, 1989, THESIS U QUEENSLAND; Cunningham-Smith Petra, 2006, Aquatic Mammals, V32, P346, DOI 10.1578/AM.32.3.2006.346; DAFF, 2012, RECR FISH DAT; Davie P., 2011, WILD GUIDE MORETON B, V1; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; GILBERT RO, 1973, BIOMETRICS, V29, P501, DOI 10.2307/2529173; Hale P. T., 2000, Aquatic Mammals, V26, P101; Hale Peter, 1998, P477; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; Hooker Sascha K., 2011, Endangered Species Research, V13, P203, DOI 10.3354/esr00322; Hooker SK, 2004, BIOSCIENCE, V54, P27, DOI 10.1641/0006-3568(2004)054[0027:MRAATF]2.0.CO;2; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kendall WL, 1997, ECOLOGY, V78, P563; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; Lear RJ, 1980, AUSTR NATL PARKS WIL, V4, P1; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lukoschek V, 2008, WILDLIFE RES, V35, P593, DOI 10.1071/WR07021; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Mann J, 2000, BEHAV ECOL, V11, P210, DOI 10.1093/beheco/11.2.210; Nater A, 2009, MOL ECOL RESOUR, V9, P531, DOI 10.1111/j.1755-0998.2008.02246.x; Neil David T., 1998, P3; NUNNEY L, 1994, CONSERV BIOL, V8, P175, DOI 10.1046/j.1523-1739.1994.08010175.x; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Parra GJ, 2006, BIOL CONSERV, V129, P167, DOI 10.1016/j.biocon.2005.10.031; Pollock KH, 1990, WILDLIFE MONOGR, P3; Pradel R., 1993, P29; Preen AR, 1997, WILDLIFE RES, V24, P185, DOI 10.1071/WR95078; Pritchard JK, 2000, GENETICS, V155, P945; Robinson JD, 2013, EVOL APPL, V6, P290, DOI 10.1111/j.1752-4571.2012.00289.x; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Shinohara M, 1997, MOL ECOL, V6, P695, DOI 10.1046/j.1365-294X.1997.00231.x; Skinner James L., 1998, P67; State of Queensland, 2008, MAR PARKS MOR BAY ZO; Tallmon DA, 2010, MOL ECOL RESOUR, V10, P684, DOI 10.1111/j.1755-0998.2010.02831.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thompson PM, 2000, CONSERV BIOL, V14, P1253, DOI 10.1046/j.1523-1739.2000.00099-410.x; Waples R.S., 1991, Reports of the International Whaling Commission Special Issue, P279; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Wells R. S., 2002, ENCY MARINE MAMMALS, P122; Wells RS, 1998, FISH B-NOAA, V96, P647; Wells RS, 1987, CURRENT MAMMALOGY, P247; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; WILLIAMS JA, 1993, CAN J ZOOL, V71, P2080, DOI 10.1139/z93-293; Wright S, 1931, GENETICS, V16, P0097; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43	67	23	23	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65239	10.1371/journal.pone.0065239	http://dx.doi.org/10.1371/journal.pone.0065239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755197	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300060
J	Manojlovic, Z; Blackmon, J; Stefanovic, B				Manojlovic, Zarko; Blackmon, John; Stefanovic, Branko			Tacrolimus (FK506) Prevents Early Stages of Ethanol Induced Hepatic Fibrosis by Targeting LARP6 Dependent Mechanism of Collagen Synthesis	PLOS ONE			English	Article							ALPHA-1(I) MESSENGER-RNA; INDUCED LIVER FIBROSIS; STELLATE CELLS; CARBON-TETRACHLORIDE; CYCLOSPORINE-A; KUPFFER CELLS; IN-VIVO; NEUTROPHIL INFILTRATION; REPERFUSION INJURY; BINDING-PROTEIN	Tacrolimus (FK506) is a widely used immunosuppressive drug. Its effects on hepatic fibrosis have been controversial and attributed to immunosuppression. We show that in vitro FK506, inhibited synthesis of type I collagen polypeptides, without affecting expression of collagen mRNAs. In vivo, administration of FK506 at a dose of 4 mg/kg completely prevented development of alcohol/carbon tetrachloride induced liver fibrosis in rats. Activation of hepatic stellate cells (HSCs) was absent in the FK506 treated livers and expression of collagen alpha 2(I) mRNA was at normal levels. Collagen alpha 1(I) mRNA was increased in the FK506 treated livers, but this mRNA was not translated into alpha 1(I) polypeptide. No significant inflammation was associated with the fibrosis model used. FK506 binding protein 3 (FKBP3) is one of cellular proteins which binds FK506 with high affinity. We discovered that FKBP3 interacts with LARP6 and LARP6 is the major regulator of translation and stability of collagen mRNAs. In the presence of FK506 the interaction between FKBP3 and LARP6 is weakened and so is the pull down of collagen mRNAs with FKBP3. We postulate that FK506 inactivates FKBP3 and that lack of interaction of LARP6 and FKBP3 results in aberrant translation of collagen mRNAs and prevention of fibrosis. This is the first report of such activity of FK506 and may renew the interest in using this drug to alleviate hepatic fibrosis.	[Manojlovic, Zarko; Blackmon, John; Stefanovic, Branko] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Stefanovic, B (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	branko.stefanovic@med.fsu.edu			National Institutes of Health [5R01DK059466-08]; National Institute on Alcohol Abuse and Alcoholism, National Research Service Award [AA019845-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA019845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism, National Research Service Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding: R01 National Institutes of Health 5R01DK059466-08 to BS, F31 National Institute on Alcohol Abuse and Alcoholism, National Research Service Award AA019845-01A1 to ZM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYCOCK RS, 1989, CONNECT TISSUE RES, V23, P19, DOI 10.3109/03008208909103901; BITTERMAN PB, 1991, CHEST, V99, pS81, DOI 10.1378/chest.99.3_Supplement.81S; Cai L, 2010, J MOL BIOL, V401, P564, DOI 10.1016/j.jmb.2010.06.057; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Cetinkale O, 1999, BURNS, V25, P105, DOI 10.1016/S0305-4179(98)00147-8; Challa AA, 2011, MOL CELL BIOL, V31, P3773, DOI 10.1128/MCB.05263-11; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; Friedman S L, 1996, Prog Liver Dis, V14, P101; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; Friedman SL, 1999, ALCOHOL CLIN EXP RES, V23, P904, DOI 10.1097/00000374-199905000-00020; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; FRIZELL E, 1994, GASTROENTEROLOGY, V107, P492, DOI 10.1016/0016-5085(94)90176-7; GarciaCriado FJ, 1997, TRANSPLANTATION, V64, P594, DOI 10.1097/00007890-199708270-00008; Gotkin MG, 1997, MOL BIOL CELL, V8, P2617; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guo MZ, 2002, ACTA PHARMACOL SIN, V23, P739; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Iwasaki K, 2007, DRUG METAB PHARMACOK, V22, P328, DOI 10.2133/dmpk.22.328; JIN YJ, 1992, J BIOL CHEM, V267, P10942; JIN YJ, 1993, P NATL ACAD SCI USA, V90, P7769, DOI 10.1073/pnas.90.16.7769; KAWANO K, 1994, EUR SURG RES, V26, P108, DOI 10.1159/000129325; Keeley EC, 2010, INT J BIOCHEM CELL B, V42, P535, DOI 10.1016/j.biocel.2009.10.014; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Kivirikko KI, 1998, MATRIX BIOL, V16, P355, DOI 10.1016/S0945-053X(98)90008-7; Kondo H, 2004, J RHEUMATOL, V31, P243; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lindquist JN, 2004, J BIOL CHEM, V279, P23822, DOI 10.1074/jbc.M314060200; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111; McCaughan GW, 2000, IMMUNOL REV, V174, P172, DOI 10.1034/j.1600-0528.2002.017420.x; MICHNICK SW, 1991, SCIENCE, V252, P836, DOI 10.1126/science.1709301; Nagano J, 2006, EUR RESPIR J, V27, P460, DOI 10.1183/09031936.06.00070705; Nieto N, 2006, HEPATOLOGY, V44, P1487, DOI 10.1002/hep.21427; Ochocka AM, 2009, FEBS LETT, V583, P621, DOI 10.1016/j.febslet.2009.01.009; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; PANDURO A, 1988, HEPATOLOGY, V8, P259, DOI 10.1002/hep.1840080212; Patsenker E, 2011, J HEPATOL, V55, P388, DOI 10.1016/j.jhep.2010.10.044; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Ripley CR, 1997, EXP CELL RES, V236, P147, DOI 10.1006/excr.1997.3707; Sakuma S, 2000, BRIT J PHARMACOL, V130, P1655, DOI 10.1038/sj.bjp.0703472; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; SIEGERS CP, 1982, AGENTS ACTIONS, V12, P743, DOI 10.1007/BF01965096; Stefanovic A, 2000, NUCLEIC ACIDS RES, V28, P641, DOI 10.1093/nar/28.2.641; Stefanovic B, 1999, MOL CELL BIOL, V19, P4334; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Stefanovic B, 2003, J BIOL CHEM, V278, P927, DOI 10.1074/jbc.M209175200; STEINMANN B, 1991, LANCET, V337, P439, DOI 10.1016/0140-6736(91)91225-J; Stienstra R, 2011, HEPATOLOGY, V53, P1415, DOI 10.1002/hep.24258; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG640, DOI 10.1152/ajpgi.00253.2001; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Takeda Y, 2002, CIRCULATION, V105, P677, DOI 10.1161/hc0602.104675; Tunon MJ, 2003, BIOCHEM PHARMACOL, V66, P439, DOI 10.1016/S0006-2952(03)00288-0; Uchida J, 1998, JPN J PHARMACOL, V76, P39, DOI 10.1254/jjp.76.39; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; WIEDERRECHT G, 1993, ANN NY ACAD SCI, V696, P9, DOI 10.1111/j.1749-6632.1993.tb17137.x; Yang WM, 2001, EMBO J, V20, P4814, DOI 10.1093/emboj/20.17.4814; YOUNES M, 1983, XENOBIOTICA, V13, P47, DOI 10.3109/00498258309052214; Zhang X, 2004, WORLD J GASTROENTERO, V10, P610, DOI 10.3748/wjg.v10.i4.610; Zimmermann M, 2009, CYTOTECHNOLOGY, V61, P145, DOI 10.1007/s10616-009-9246-4	66	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65897	10.1371/journal.pone.0065897	http://dx.doi.org/10.1371/journal.pone.0065897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755290	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300097
J	Osgood, RS; Upham, BL; Hill, T; Helms, KL; Velmurugan, K; Babica, P; Bauer, AK				Osgood, Ross S.; Upham, Brad L.; Hill, Thomas, III; Helms, Katherine L.; Velmurugan, Kalpana; Babica, Pavel; Bauer, Alison K.			Polycyclic Aromatic Hydrocarbon-Induced Signaling Events Relevant to Inflammation and Tumorigenesis in Lung Cells Are Dependent on Molecular Structure	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; LIVER EPITHELIAL-CELLS; OBSTRUCTIVE PULMONARY-DISEASE; PROTEIN-KINASE PATHWAY; MOUSE LUNG; RAT-LIVER; TUMOR PROMOTION; TOBACCO-SMOKE; BUTYLATED HYDROXYTOLUENE; PHOSPHORYLATION SITES	Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental and occupational toxicants, which are a major human health concern in the U.S. and abroad. Previous research has focused on the genotoxic events caused by high molecular weight PAHs, but not on non-genotoxic events elicited by low molecular weight PAHs. We used an isomeric pair of low molecular weight PAHs, namely 1-Methylanthracene (1-MeA) and 2-Methylanthracene (2-MeA), in which only 1-MeA possessed a bay-like region, and hypothesized that 1-MeA, but not 2-MeA, would affect non-genotoxic endpoints relevant to tumor promotion in murine C10 lung cells, a non-tumorigenic type II alveolar pneumocyte and progenitor cell type of lung adenocarcinoma. The non-genotoxic endpoints assessed were dysregulation of gap junction intercellular communication function and changes in the major pulmonary connexin protein, connexin 43, using fluorescent redistribution and immunoblots, activation of mitogen activated protein kinases (MAPK) using phosphospecific MAPK antibodies for immunoblots, and induction of inflammatory genes using quantitative RT-PCR. 2-MeA had no effect on any of the endpoints, but 1-MeA dysregulated gap junctional communication in a dose and time dependent manner, reduced connexin 43 protein expression, and altered membrane localization. 1-MeA also activated ERK1/2 and p38 MAP kinases. Inflammatory genes, such as cyclooxygenase 2, and chemokine ligand 2 (macrophage chemoattractant 2), were also upregulated in response to 1-MeA only. These results indicate a possible structure-activity relationship of these low molecular weight PAHs relevant to non-genotoxic endpoints of the promoting aspects of cancer. Therefore, our novel findings may improve the ability to predict outcomes for future studies with additional toxicants and mixtures, identify novel targets for biomarkers and chemotherapeutics, and have possible implications for future risk assessment for these PAHs.	[Osgood, Ross S.] Univ Colorado Anschutz, Med Ctr, Dept Pharmaceut Sci, Aurora, CO USA; [Hill, Thomas, III; Velmurugan, Kalpana; Bauer, Alison K.] Univ Colorado Anschutz, Med Ctr, Dept Environm & Occupat Hlth, Aurora, CO USA; [Upham, Brad L.; Helms, Katherine L.; Babica, Pavel] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Michigan State University	Bauer, AK (corresponding author), Univ Colorado Anschutz, Med Ctr, Dept Environm & Occupat Hlth, Aurora, CO USA.	Alison.bauer@ucdenver.edu	Babica, Pavel/GWC-6437-2022; Babica, Pavel/B-2587-2013; Bauer, Alison/AHD-3288-2022; Bauer, Alison K./K-2372-2019	Babica, Pavel/0000-0001-6399-3554; Bauer, Alison/0000-0003-4477-9899; Upham, Brad/0000-0003-4905-9145; Hill III, Thomas/0000-0002-7507-7331	intramural Colorado School of Public Health, CU funds; NIEHS [ES013268-01A2]; Department of Pharmaceutical Sciences Toxicology Graduate Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013268, R56ES013268] Funding Source: NIH RePORTER	intramural Colorado School of Public Health, CU funds; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Pharmaceutical Sciences Toxicology Graduate Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by intramural Colorado School of Public Health, CU funds (A.K.B.), NIEHS ES013268-01A2 (B.L.U.), and the Department of Pharmaceutical Sciences Toxicology Graduate Program (RSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2003, J BIOL CHEM, V278, P38360, DOI 10.1074/jbc.M306785200; Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; American Cancer Society, 2012, WHAT IS NONSM CELL L; ATSDR, 2005, TOX PROF POL HYDR; Avanzo JL, 2004, CARCINOGENESIS, V25, P1973, DOI 10.1093/carcin/bgh193; Bauer AK, 2009, VET PATHOL, V46, P369, DOI 10.1354/vp.08-VP-0217-B-REV; Bauer AK, 2004, AM J PHYSIOL-LUNG C, V287, pL685, DOI 10.1152/ajplung.00223.2003; Bauer AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026590; Bauer AK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-107; BENLEVY R, 1995, EMBO J, V14, P5920, DOI 10.1002/j.1460-2075.1995.tb00280.x; Bernert H, 2003, MOL CARCINOGEN, V38, P117, DOI 10.1002/mc.10151; Blaha L, 2002, TOXICOL SCI, V65, P43, DOI 10.1093/toxsci/65.1.43; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Caixeta Roberta B., 2012, Morbidity and Mortality Weekly Report, V61, P877; CHAUDHURI R, 1993, CANCER LETT, V71, P11, DOI 10.1016/0304-3835(93)90090-V; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; COHEN BH, 1977, LANCET, V2, P523; Duperron C, 1997, CARCINOGENESIS, V18, P1001, DOI 10.1093/carcin/18.5.1001; Dwyer-Nield LD, 2005, CARCINOGENESIS, V26, P1196, DOI 10.1093/carcin/bgi061; Eugenin EA, 2012, J NEUROIMMUNE PHARM, V7, P499, DOI 10.1007/s11481-012-9352-5; Feng FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051690; Fujino N, 2012, BMJ OPEN, P2; Ghoshal S, 1999, ENVIRON SCI TECHNOL, V33, P1044, DOI 10.1021/es9809511; Guadagni F, 2007, IN VIVO, V21, P147; GUAN X, 1995, CARCINOGENESIS, V16, P2575, DOI 10.1093/carcin/16.10.2575; Guan XJ, 1996, MOL CARCINOGEN, V16, P157; Hazelton WD, 2005, CANCER EPIDEM BIOMAR, V14, P1171, DOI 10.1158/1055-9965.EPI-04-0756; He Y, 2012, CHEST; Huang RC, 2002, CANCER RES, V62, P2806; Husoy T, 2001, CARCINOGENESIS, V22, P221, DOI 10.1093/carcin/22.2.221; Ito S, 2010, BIOCHEM BIOPH RES CO, V400, P230, DOI 10.1016/j.bbrc.2010.08.045; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Johnson LN, 2009, ANTIOXID REDOX SIGN, V11, P355, DOI 10.1089/ars.2008.2183; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kisley LR, 2002, CANCER RES, V62, P6850; Klaunig JE, 2000, HUM EXP TOXICOL, V19, P543, DOI 10.1191/096032700701546442; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lee HL, 2010, CHEMOSPHERE, DOI [10.1016/j.chemosphere.2010.09.045, DOI 10.1016/J.CHEM0SPHERE.2010.09.045]; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lloyd CM, 2010, NAT MED, V16, P273, DOI 10.1038/nm0310-273; Malkinson AM, 1997, TOXICOLOGY, V123, P53, DOI 10.1016/S0300-483X(97)00108-X; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; Meyer AM, 2006, AM J PHYSIOL-LUNG C, V290, pL1260, DOI 10.1152/ajplung.00182.2005; Miller RL, 2004, CHEST, V126, P1071, DOI 10.1378/chest.126.4.1071; Moghaddam SJ, 2011, INT J CHRONIC OBSTR, V6, P113, DOI 10.2147/COPD.S15417; Moir D, 2008, CHEM RES TOXICOL, V21, P494, DOI 10.1021/tx700275p; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Pahujaa M, 2007, EXP CELL RES, V313, P4083, DOI 10.1016/j.yexcr.2007.09.010; PALITTI F, 1986, MUTAT RES, V174, P125, DOI 10.1016/0165-7992(86)90102-8; Rice PL, 2010, EXP LUNG RES, V36, P558, DOI 10.3109/01902148.2010.491891; Rivedal E, 2001, CARCINOGENESIS, V22, P1543, DOI 10.1093/carcin/22.9.1543; Rondini EA, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-9; Rosenkranz M, 1997, MUTAT RES-FUND MOL M, V381, P171, DOI 10.1016/S0027-5107(97)00165-6; ROSZINSKYKOCHER G, 1979, MUTAT RES, V66, P65, DOI 10.1016/0165-1218(79)90008-9; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Rummel AM, 1999, TOXICOL SCI, V49, P232, DOI 10.1093/toxsci/49.2.232; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Schottenfeld D, 2000, LUNG CANC PRINCIPLES, P367; Services USDoHaH, 2002, TOX PROF WOOD CREOS, P225; Smith LA, 2010, IMMUNOL RES, V46, P94, DOI 10.1007/s12026-009-8133-6; Sorensen CM, 2012, MICROCIRCULATION, V19, P451, DOI 10.1111/j.1549-8719.2011.00149.x; Sung FL, 2001, MOL CELL BIOCHEM, V216, P121, DOI 10.1023/A:1017383916068; Tacheau C, 2008, J CELL PHYSIOL, V216, P438, DOI 10.1002/jcp.21412; Tai MH, 2007, INT J CANCER, V120, P1855, DOI 10.1002/ijc.22530; Thompson DC, 1998, AM J PHYSIOL-LUNG C, V274, pL922, DOI 10.1152/ajplung.1998.274.6.L922; Tithof PK, 2002, FASEB J, V16, P1463, DOI 10.1096/fj.02-0092fje; Tong QS, 2006, AM J RESP CELL MOL, V34, P28, DOI 10.1165/rcmb.2005-0172OC; Trosko JE, 2001, MOL CARCINOGEN, V30, P131; Trovato-Salinaro A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-122; UPHAM BL, 1994, FUND APPL TOXICOL, V23, P470, DOI 10.1006/faat.1994.1129; Upham BL, 1998, ENVIRON HEALTH PERSP, V106, P975, DOI 10.2307/3434140; Upham BL, 1996, FUND APPL TOXICOL, V34, P260, DOI 10.1006/faat.1996.0195; Upham BL, 2008, CANCER SCI, V99, P696, DOI 10.1111/j.1349-7006.2008.00752.x; Upham Brad L, 2011, Curr Protoc Toxicol, VChapter 2, DOI 10.1002/0471140856.tx0218s47; Upham BL, 2009, ENVIRON HEALTH PERSP, V117, P545, DOI 10.1289/ehp.11728; Van Laere S, 2010, CANCER-AM CANCER SOC, V116, P2794, DOI 10.1002/cncr.25180; VANG O, 1995, ARCH TOXICOL, V69, P415, DOI 10.1007/s002040050193; Walters DM, 2005, AM J PATHOL, V167, P1221, DOI 10.1016/S0002-9440(10)61210-2; Wan B, 2006, SAR QSAR ENVIRON RES, V17, P597, DOI 10.1080/10629360601033374; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; WARSHAWSKY D, 1993, FUND APPL TOXICOL, V20, P376, DOI 10.1006/faat.1993.1048; Wattenberg LW, 1997, CARCINOGENESIS, V18, P2015, DOI 10.1093/carcin/18.10.2015; Weis LM, 1998, ENVIRON HEALTH PERSP, V106, P17, DOI 10.1289/ehp.9810617; Wilson KM, 2011, PEDIATRICS, V127, P85, DOI 10.1542/peds.2010-2046; Woodruff ML, 1999, AM J PHYSIOL-LUNG C, V276, pL669, DOI 10.1152/ajplung.1999.276.4.L669; WU AH, 1995, AM J EPIDEMIOL, V141, P1023, DOI 10.1093/oxfordjournals.aje.a117366; Yan ZP, 2000, J BIOL CHEM, V275, P4949, DOI 10.1074/jbc.275.7.4949; Yang SR, 2005, J VET MED SCI, V67, P291, DOI 10.1292/jvms.67.291	88	37	37	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65150	10.1371/journal.pone.0065150	http://dx.doi.org/10.1371/journal.pone.0065150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755184	Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300052
J	van der Linde, RM; Mavaddat, N; Luben, R; Brayne, C; Simmons, RK; Khaw, KT; Kinmonth, AL				van der Linde, Rianne M.; Mavaddat, Nahal; Luben, Robert; Brayne, Carol; Simmons, Rebecca K.; Khaw, Kay Tee; Kinmonth, Ann Louise			Self-Rated Health and Cardiovascular Disease Incidence: Results from a Longitudinal Population-Based Cohort in Norfolk, UK	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BIOMEDICAL RISK-FACTORS; EPIC-NORFOLK; PRIMARY PREVENTION; REPORTED HEALTH; MORTALITY; WOMEN; MEN; CANCER; LIFE	Introduction: Self-rated health (SRH) predicts chronic disease morbidity including cardiovascular disease (CVD). In a population-based cohort, we examined the association between SRH and incident CVD and whether this association was independent of socio-demographic, clinical and behavioural participant characteristics. Methods: Population-based prospective cohort study (European Prospective Investigation of Cancer-Norfolk). 20,941 men and women aged 39-74 years without prevalent CVD attended a baseline health examination (1993-1998) and were followed for CVD events/death until March 2007 (mean 11 years). We used a Cox proportional hazards model to quantify the association between baseline SRH (reported on a four point scale - excellent, good, fair, poor) and risk of developing CVD at follow-up after adjusting for socio-demographic, clinical and behavioural risk factors. Results: Baseline SRH was reported as excellent by 17.8% participants, good by 65.1%, fair by 16.0% and poor by 1.2%. During 225,508 person-years of follow-up, there were 55 (21.2%) CVD events in the poor SRH group and 259 (7.0%) in the excellent SRH group (HR 3.7, 95% CI 2.8-4.9). The HR remained significant after adjustment for behavioural risk factors (HR 2.6, 95% CI 1.9-3.5) and after adjustment for all socio-demographic, clinical and behavioural risk factors (HR 3.3, 95% CI 2.4-4.4). Associations were strong for both fatal and non-fatal events and remained strong over time. Conclusions: SRH is a strong predictor of incident fatal and non-fatal CVD events in this healthy, middle-aged population. Some of the association is explained by lifestyle behaviours, but SRH remains a strong predictor after adjustment for sociodemographic, clinical and behavioural risk factors and after a decade of follow-up. This easily accessible patient-centred measure of health status may be a useful indicator of individual and population health for those working in primary care and public health.	[van der Linde, Rianne M.; Mavaddat, Nahal; Luben, Robert; Brayne, Carol; Khaw, Kay Tee; Kinmonth, Ann Louise] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, Cambs, England; [Simmons, Rebecca K.] Univ Cambridge, Epidemiol Unit, Med Res Council, Cambridge, Cambs, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge	van der Linde, RM (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, Cambs, England.	rmv23@medschl.cam.ac.uk	Khaw, Kay-Tee/AAZ-3209-2021; Brayne, Carol/AAA-4285-2020; Luben, Robert N/H-5519-2015	Brayne, Carol/0000-0001-5307-663X; Luben, Robert N/0000-0002-5088-6343; Simmons, Rebecca/0000-0002-7726-8529	Medical Research Council and Cancer Research UK; NIHR National School of Primary Care Research; NIHR Clinical Lectureship in Primary Care Research; MRC [MC_UU_12015/4, G0200391, MC_U106179474] Funding Source: UKRI; Medical Research Council [G1000143, MC_U106179474, G0200391, MC_UU_12015/4, G0401527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10072, CL-2008-14-006] Funding Source: researchfish	Medical Research Council and Cancer Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR National School of Primary Care Research; NIHR Clinical Lectureship in Primary Care Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The EPIC-Norfolk study is supported by programme grants from the Medical Research Council and Cancer Research UK. The work was funded by the NIHR National School of Primary Care Research. Ann Louise Kinmonth and Kay Tee Khaw are NIHR Senior Investigators. Nahal Mavaddat was funded by an NIHR Clinical Lectureship in Primary Care Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appels A, 1996, SOC SCI MED, V42, P681, DOI 10.1016/0277-9536(95)00195-6; Bailis DS, 2003, SOC SCI MED, V56, P203, DOI 10.1016/S0277-9536(02)00020-5; Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Benyamini Y, 2000, J GERONTOL B-PSYCHOL, V55, pP107, DOI 10.1093/geronb/55.2.P107; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Day N, 1999, BRIT J CANCER, V80, P95; DeSalvo KB, 2006, QUAL LIFE RES, V15, P191, DOI 10.1007/s11136-005-0887-2; Ellison RC, 2004, AM HEART J, V147, P529, DOI 10.1016/j.ahj.2003.10.033; Emmelin M, 2003, J HYPERTENS, V21, P887, DOI 10.1097/00004872-200305000-00012; Heidrich J, 2002, ANN EPIDEMIOL, V12, P338, DOI 10.1016/S1047-2797(01)00300-3; Heistaro S, 2001, J EPIDEMIOL COMMUN H, V55, P227, DOI 10.1136/jech.55.4.227; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2006, J CLIN EPIDEMIOL, V59, P465, DOI 10.1016/j.jclinepi.2005.12.004; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS26, DOI 10.1093/ije/26.suppl_1.S26; Kamphuis MH, 2009, J AFFECT DISORDERS, V114, P184, DOI 10.1016/j.jad.2008.07.005; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kaplan GA, 1996, INT J EPIDEMIOL, V25, P259, DOI 10.1093/ije/25.2.259; Kennedy BS, 2001, AM J EPIDEMIOL, V153, P232, DOI 10.1093/aje/153.3.232; Kuper H, 2006, AM J EPIDEMIOL, V164, P349, DOI 10.1093/aje/kwj212; LEAVEY R, 1988, SOC SCI MED, V27, P269, DOI 10.1016/0277-9536(88)90131-1; Lekander M, 2004, PSYCHOSOM MED, V66, P559, DOI 10.1097/01.psy.0000130491.95823.94; Lundberg O, 1996, SCAND J SOC MED, V24, P218, DOI 10.1177/140349489602400314; May M, 2006, HEART, V92, P1396, DOI 10.1136/hrt.2005.085381; McFadden E, 2009, SOC SCI MED, V68, P275, DOI 10.1016/j.socscimed.2008.10.012; McFadden E, 2008, EUR J EPIDEMIOL, V23, P449, DOI 10.1007/s10654-008-9262-2; McFadden E, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-230; Moller L, 1996, J EPIDEMIOL COMMUN H, V50, P423, DOI 10.1136/jech.50.4.423; Myint PK, 2007, PSYCHOSOM MED, V69, P410, DOI 10.1097/psy.0b013e318068fcd4; Newell SA, 1999, AM J PREV MED, V17, P211, DOI 10.1016/S0749-3797(99)00069-0; RIEMERSMA RA, 1990, EUR J CLIN NUTR, V44, P143; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Rutledge T, 2010, PSYCHOSOM MED, V72, P549, DOI 10.1097/PSY.0b013e3181dc0259; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Surtees P, 2003, AM J EPIDEMIOL, V158, P1202, DOI 10.1093/aje/kwg272; Surtees PG, 2008, AM J PSYCHIAT, V165, P515, DOI 10.1176/appi.ajp.2007.07061018; WANNAMETHEE G, 1991, INT J EPIDEMIOL, V20, P239, DOI 10.1093/ije/20.1.239; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Weinehall L, 1998, J INTERN MED, V243, P99	40	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65290	10.1371/journal.pone.0065290	http://dx.doi.org/10.1371/journal.pone.0065290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	157CD	23755212	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300070
J	Vogler, S; Pannicke, T; Hollborn, M; Grosche, A; Busch, S; Hoffmann, S; Wiedemann, P; Reichenbach, A; Hammes, HP; Bringmann, A				Vogler, Stefanie; Pannicke, Thomas; Hollborn, Margrit; Grosche, Antje; Busch, Stephanie; Hoffmann, Sigrid; Wiedemann, Peter; Reichenbach, Andreas; Hammes, Hans-Peter; Bringmann, Andreas			Muller Cell Reactivity in Response to Photoreceptor Degeneration in Rats with Defective Polycystin-2	PLOS ONE			English	Article							RETINAL GLIAL-CELLS; OXIDATIVE STRESS; PHENOTYPIC IMPACT; MAMMALIAN RETINA; DIABETES ALTERS; MOUSE RETINA; NITRIC-OXIDE; IN-VITRO; APOPTOSIS; ISCHEMIA	Background: Retinal degeneration in transgenic rats that express a mutant cilia gene polycystin-2 (CMV-PKD2(1/ 703) HA) is characterized by initial photoreceptor degeneration and glial activation, followed by vasoregression and neuronal degeneration (Feng et al., 2009, PLoS One 4: e7328). It is unknown whether glial activation contributes to neurovascular degeneration after photoreceptor degeneration. We characterized the reactivity of Muller glial cells in retinas of rats that express defective polycystin-2. Methods: Age-matched Sprague-Dawley rats served as control. Retinal slices were immunostained for intermediate filaments, the potassium channel Kir4.1, and aquaporins 1 and 4. The potassium conductance of isolated Muller cells was recorded by whole-cell patch clamping. The osmotic swelling characteristics of Muller cells were determined by superfusion of retinal slices with a hypoosmotic solution. Findings: Muller cells in retinas of transgenic rats displayed upregulation of GFAP and nestin which was not observed in control cells. Whereas aquaporin-1 labeling of photoreceptor cells disappeared along with the degeneration of the cells, aquaporin-1 emerged in glial cells in the inner retina of transgenic rats. Aquaporin-4 was upregulated around degenerating photoreceptor cells. There was an age-dependent redistribution of Kir4.1 in retinas of transgenic rats, with a more even distribution along glial membranes and a downregulation of perivascular Kir4.1. Muller cells of transgenic rats displayed a slight decrease in their Kir conductance as compared to control. Muller cells in retinal tissues from transgenic rats swelled immediately under hypoosmotic stress; this was not observed in control cells. Osmotic swelling was induced by oxidativenitrosative stress, mitochondrial dysfunction, and inflammatory lipid mediators. Interpretation: Cellular swelling suggests that the rapid water transport through Muller cells in response to osmotic stress is altered as compared to control. The dislocation of Kir4.1 will disturb the retinal potassium and water homeostasis, and osmotic generation of free radicals and inflammatory lipids may contribute to neurovascular injury.	[Vogler, Stefanie; Pannicke, Thomas; Grosche, Antje; Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Hollborn, Margrit; Wiedemann, Peter; Bringmann, Andreas] Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany; [Hollborn, Margrit; Wiedemann, Peter; Bringmann, Andreas] Univ Leipzig, Hosp Eye, D-04109 Leipzig, Germany; [Busch, Stephanie; Hammes, Hans-Peter] Heidelberg Univ, Med Fac Mannheim, Dept Med 5, Mannheim, Germany; [Hoffmann, Sigrid] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, Mannheim, Germany	Leipzig University; Leipzig University; Leipzig University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Bringmann, A (corresponding author), Univ Leipzig, Dept Ophthalmol, D-04109 Leipzig, Germany.	bria@medizin.uni-leipzig.de	Reichenbach, Andreas/B-2510-2017; Pannicke, Thomas/A-5078-2017; Hammes, Hans-Peter/S-3719-2019; Grosche, Antje/N-1978-2014	Pannicke, Thomas/0000-0001-7435-9540; Grosche, Antje/0000-0003-0338-7530	Deutsche Forschungsgemeinschaft [GRK 1097, RE 849/10-2, RE 849/12-2, PA615/2-1, GRK 880]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (GRK 1097, RE 849/10-2, and RE 849/12-2 to AR; PA615/2-1 to TP; GRK 880 to HPH). SB is medical graduate of GRK 880, project 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 1987, Acta Neurochir Suppl (Wien), V41, P85; Balboa MA, 2006, BBA-MOL CELL BIOL L, V1761, P385, DOI 10.1016/j.bbalip.2006.03.014; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beretta S, 2006, NEUROBIOL DIS, V24, P308, DOI 10.1016/j.nbd.2006.07.016; Bringmann A, 2005, ACTA OPHTHALMOL SCAN, V83, P528, DOI 10.1111/j.1600-0420.2005.00565.x; Bringmann A, 2004, OPHTHALMIC RES, V36, P241, DOI 10.1159/000081203; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Connors NC, 2002, J NEUROSCI, V22, P4321, DOI 10.1523/JNEUROSCI.22-11-04321.2002; CROMPTON M, 1988, BIOCHEM J, V255, P357; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; Deltas CC, 2001, HUM MUTAT, V18, P13, DOI 10.1002/humu.1145; Dmitriev AV, 1999, VISUAL NEUROSCI, V16, P1157, DOI 10.1017/S095252389916615X; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Felmy F, 2001, GLIA, V34, P190, DOI 10.1002/glia.1053; Feng YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016865; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Fuks B, 2005, EUR J PHARMACOL, V519, P24, DOI 10.1016/j.ejphar.2005.06.046; Fukuda M, 2010, EXP EYE RES, V90, P17, DOI 10.1016/j.exer.2009.09.003; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hansson MJ, 2010, J BIOL CHEM, V285, P741, DOI 10.1074/jbc.M109.017731; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Iandiev I, 2005, NEUROSCI LETT, V388, P96, DOI 10.1016/j.neulet.2005.06.046; Iandiev I, 2008, INVEST OPHTH VIS SCI, V49, P3559, DOI 10.1167/iovs.08-1723; Iandiev I, 2007, NEUROSCI LETT, V421, P132, DOI 10.1016/j.neulet.2007.04.076; Iandiev I, 2006, NEUROSCI LETT, V408, P108, DOI 10.1016/j.neulet.2006.08.084; Iandiev L, 2008, NEUROSCI LETT, V434, P317, DOI 10.1016/j.neulet.2008.02.026; Jablonski EM, 2004, AM J PHYSIOL-CELL PH, V286, pC975, DOI 10.1152/ajpcell.00180.2003; Karl A, 2011, GLIA, V59, P256, DOI 10.1002/glia.21095; Kaur C, 2007, J PATHOL, V212, P429, DOI 10.1002/path.2195; Kim IB, 2002, J COMP NEUROL, V452, P178, DOI 10.1002/cne.10359; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Kohno H, 2006, GRAEF ARCH CLIN EXP, V244, P90, DOI 10.1007/s00417-005-0030-7; Krugel K, 2011, EXP EYE RES, V92, P87, DOI 10.1016/j.exer.2010.11.007; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Landiev I, 2006, EXP EYE RES, V82, P449, DOI 10.1016/j.exer.2005.07.018; Landino LM, 1996, P NATL ACAD SCI USA, V93, P15069, DOI 10.1073/pnas.93.26.15069; LEES GJ, 1991, BRAIN RES REV, V16, P283, DOI 10.1016/0165-0173(91)90011-V; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Miller JW, 2010, JPN J OPHTHALMOL, V54, P523, DOI 10.1007/s10384-010-0863-4; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Owada S, 1999, J BIOL CHEM, V274, P2000, DOI 10.1074/jbc.274.4.2000; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Pannicke T, 2005, J NEUROIMMUNOL, V161, P145, DOI 10.1016/j.jneuroim.2005.01.003; Pannicke T, 2005, GLIA, V50, P1, DOI 10.1002/glia.20151; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Qin YW, 2009, EXP EYE RES, V89, P741, DOI 10.1016/j.exer.2009.06.020; STAUB F, 1994, J CEREBR BLOOD F MET, V14, P1030, DOI 10.1038/jcbfm.1994.135; Thanos S, 2001, GRAEF ARCH CLIN EXP, V239, P794, DOI 10.1007/s004170100362; Uckermann O, 2006, J NEUROSCI RES, V83, P538, DOI 10.1002/jnr.20760; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wurm A, 2011, PROG RETIN EYE RES, V30, P324, DOI 10.1016/j.preteyeres.2011.06.001; Xue LP, 2006, NEUROSCIENCE, V143, P117, DOI 10.1016/j.neuroscience.2006.07.044; Xue LP, 2011, INT J EXP PATHOL, V92, P377, DOI 10.1111/j.1365-2613.2011.00786.x; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Zheng Z, 2009, DIABETES, V58, P954, DOI 10.2337/db07-1524; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	62	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e61631	10.1371/journal.pone.0061631	http://dx.doi.org/10.1371/journal.pone.0061631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755094	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300002
J	Anderson, EL; Fraser, A; McNally, W; Sattar, N; Lashen, H; Fleming, R; Nelson, SM; Lawlor, DA				Anderson, Emma L.; Fraser, Abigail; McNally, William; Sattar, Naveed; Lashen, Hany; Fleming, Richard; Nelson, Scott M.; Lawlor, Debbie A.			Anti-Mullerian Hormone Is Not Associated with Cardiometabolic Risk Factors in Adolescent Females	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; INTIMA-MEDIA THICKNESS; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; SERUM-LEVELS; WOMEN; AGE; AMH; ADULTHOOD; CHILDREN	Objectives: Epidemiological evidence for associations of Anti-Mullerian hormone (AMH) with cardiometabolic risk factors is lacking. Existing evidence comes from small studies in select adult populations, and findings are conflicting. We aimed to assess whether AMH is associated with cardiometabolic risk factors in a general population of adolescent females. Methods: AMH, fasting insulin, glucose, HDLc, LDLc, triglycerides and C-reactive protein (CRP) were measured at a mean age 15.5 years in 1,308 female participants in the Avon Longitudinal Study of Parents and Children (ALSPAC). Multivariable linear regression was used to examine associations of AMH with these cardiometabolic outcomes. Results: AMH values ranged from 0.16-35.84 ng/ml and median AMH was 3.57 ng/ml (IQR: 2.41, 5.49). For females classified as post-pubertal (n = 848) at the time of assessment median (IQR) AMH was 3.81 ng/ml (2.55, 5.82) compared with 3.25 ng/ml (2.23, 5.05) in those classed as early pubertal (n = 460, P <= 0.001). After adjusting for birth weight, gestational age, pubertal stage, age, ethnicity, socioeconomic position, adiposity and use of hormonal contraceptives, there were no associations with any of the cardiometabolic outcomes. For example fasting insulin changed by 0% per doubling of AMH (95% CI: -3%,+2%) p = 0.70, with identical results if HOMA-IR was used. Results were similar after additional adjustment for smoking, physical activity and age at menarche, after exclusion of 3% of females with the highest AMH values, after excluding those that had not started menarche and after excluding those using hormonal contraceptives. Conclusion: Our results suggest that in healthy adolescent females, AMH is not associated with cardiometabolic risk factors.	[Anderson, Emma L.; Fraser, Abigail; Lawlor, Debbie A.] Univ Bristol, MRC CAiTE Ctr, Bristol, Avon, England; [McNally, William; Fleming, Richard; Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland; [Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Lashen, Hany] Univ Sheffield, Sect Reprod & Dev Med, Sheffield, S Yorkshire, England	University of Bristol; University of Glasgow; University of Glasgow; University of Sheffield	Anderson, EL (corresponding author), Univ Bristol, MRC CAiTE Ctr, Oakfield House, Bristol, Avon, England.	emma.louise.anderson@bristol.ac.uk	Lashen, Hany/A-6936-2008	Lashen, Hany/0000-0002-7219-3492; Anderson, Emma/0000-0002-1508-0598; Nelson, Scott/0000-0002-9099-3047; Fraser, Abigail/0000-0002-7741-9470; Lawlor, Debbie A/0000-0002-6793-2262	Glasgow Centre for Reproductive Medicine Ltd.; Wellcome Trust [WT087997, WT076467]; United States National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK077659]; UK Medical Research Council (MRC) [G0600705]; UK MRC [G0600705, 0701594, G074882]; University of Bristol; MRC [G0600705, G0701594, MC_UU_12013/5] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077659] Funding Source: NIH RePORTER; Medical Research Council [1046610, G0701594, G0600705, MC_UU_12013/5] Funding Source: researchfish	Glasgow Centre for Reproductive Medicine Ltd.; Wellcome Trust(Wellcome TrustEuropean Commission); United States National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Glasgow Centre for Reproductive Medicine Ltd., Wellcome Trust (Grant ref: WT087997) and United States National Institutes of Health (NIH): National Institute of Diabetes and Digestive and Kidney Diseases (Grant ref: R01 DK077659). EA is funded by a UK Medical Research Council (MRC) studentship (Grant ref: G0600705). AF is funded by a UK MRC research fellowship (Grant ref: 0701594). The UK MRC (Grant ref: G074882), the Wellcome Trust (Grant ref: WT076467) and the University of Bristol provide core funding support for ALSPAC. The UK MRC (Grant ref: G0600705) and the University of Bristol provide core funding for the MRC Centre of Causal Analyses in Translational Epidemiology. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2010, J CLIN ENDOCR METAB, V95, P5357, DOI 10.1210/jc.2010-1207; Appt SE, 2012, MENOPAUSE; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Bayrak A, 2007, FERTIL STERIL, V87, P870, DOI 10.1016/j.fertnstert.2006.08.096; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Blanck HM, 2000, EPIDEMIOLOGY, V11, P641, DOI 10.1097/00001648-200011000-00005; Boyd A., 2012, INT J EPIDEMIOLOGY, DOI 10.1093/ije/dys064; Buyuk E, 2011, FERTIL STERIL, V95, P2364, DOI 10.1016/j.fertnstert.2011.03.081; Chen MJ, 2008, HUM REPROD, V23, P952, DOI 10.1093/humrep/den015; Chu MC, 2003, HUM REPROD, V18, P1570, DOI 10.1093/humrep/deg330; Codner E, 2011, CLIN ENDOCRINOL, V74, P73, DOI 10.1111/j.1365-2265.2010.03887.x; Fleming R, 2012, FERTIL STERIL, V98, P1097, DOI 10.1016/j.fertnstert.2012.07.1114; Fraser A, 2012, INT J EPIDEMIOLOGY; Freeman EW, 2007, FERTIL STERIL, V87, P101, DOI 10.1016/j.fertnstert.2006.05.074; Freour T, 2008, REPROD BIOMED ONLINE, V16, P96, DOI 10.1016/S1472-6483(10)60561-5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gladen BC, 2000, J PEDIATR-US, V136, P490, DOI 10.1016/S0022-3476(00)90012-X; Gungor N, 2004, J PEDIATR-US, V144, P47, DOI 10.1016/j.jpeds.2003.09.045; Hagen CP, 2012, HUM REPROD, V27, P861, DOI 10.1093/humrep/der435; Hagen CP, 2010, J CLIN ENDOCR METAB, V95, P5003, DOI 10.1210/jc.2010-0930; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Hart R, 2010, FERTIL STERIL, V94, P1118, DOI 10.1016/j.fertnstert.2009.11.002; Hehenkamp WJK, 2007, HUM REPROD, V22, P1996, DOI 10.1093/humrep/dem105; Hergenroeder AC, 1999, J ADOLESCENT HEALTH, V24, P201, DOI 10.1016/S1054-139X(98)00110-4; Hickey M, 2011, HUM REPROD, V26, P1469, DOI 10.1093/humrep/der102; Hu FB, 1999, ARCH INTERN MED, V159, P1061, DOI 10.1001/archinte.159.10.1061; Johnstone EB, 2010, J CLIN ENDOCR METAB, V95, P4965, DOI 10.1210/jc.2010-0202; Juonala M, 2010, CIRCULATION, V122, P2514, DOI 10.1161/CIRCULATIONAHA.110.966465; Kelsey TW, 2012, MOL HUM REPROD, V18, P79, DOI 10.1093/molehr/gar059; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Kerkhof GF, 2010, EUR J ENDOCRINOL, V163, P937, DOI 10.1530/EJE-10-0528; La Marca A, 2004, FERTIL STERIL, V82, P970, DOI 10.1016/j.fertnstert.2004.06.001; La Marca A, 2012, EUR J OBSTET GYN R B, V163, P180, DOI 10.1016/j.ejogrb.2012.04.013; Lawlor DA, 2010, BMJ, V341; Levy-Marchal C, 2010, J CLIN ENDOCR METAB, V95, P5189, DOI 10.1210/jc.2010-1047; Lin YH, 2011, FERTIL STERIL, V96, P230, DOI 10.1016/j.fertnstert.2011.04.003; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; McCarron P, 2000, LANCET, V355, P1430, DOI 10.1016/S0140-6736(00)02146-2; MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471; Nardo LG, 2009, HUM REPROD, V24, P2917, DOI 10.1093/humrep/dep225; Nelson SM, 2010, FERTIL STERIL, V93, P1356, DOI 10.1016/j.fertnstert.2009.07.1676; Palomba S, 2009, ENDOCR REV, V30, P1, DOI 10.1210/er.2008-0030; Park HT, 2010, CLIN ENDOCRINOL, V72, P26, DOI 10.1111/j.1365-2265.2009.03614.x; Piouka A, 2009, AM J PHYSIOL-ENDOC M, V296, pE238, DOI 10.1152/ajpendo.90684.2008; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Rockett JC, 2004, ENVIRON HEALTH PERSP, V112, P105, DOI 10.1289/ehp.6265; Schwartz B, 2008, DIABETES CARE, V31, P783, DOI 10.2337/dc07-1376; Sir-Petermann T, 2006, J CLIN ENDOCR METAB, V91, P3105, DOI 10.1210/jc.2005-2693; Skalba P, 2011, EUR J OBSTET GYN R B, V158, P254, DOI 10.1016/j.ejogrb.2011.06.006; Steiner AZ, 2010, CONTRACEPTION, V81, P245, DOI 10.1016/j.contraception.2009.10.004; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Thomson RL, 2009, HUM REPROD, V24, P1976, DOI 10.1093/humrep/dep101; van Rooij Ilse A J, 2004, Menopause, V11, P601, DOI 10.1097/01.GME.0000123642.76105.6E; vanderSchouw YT, 1996, LANCET, V347, P714, DOI 10.1016/S0140-6736(96)90075-6; Villarroel C, 2011, HUM REPROD, V26, P2861, DOI 10.1093/humrep/der223; Wallace AM, 2011, ANN CLIN BIOCHEM, V48, P370, DOI 10.1258/acb.2011.010172; Woo HY, 2012, ENDOCR J, V59, P781, DOI 10.1507/endocrj.EJ12-0055	59	26	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2013	8	5							e64510	10.1371/journal.pone.0064510	http://dx.doi.org/10.1371/journal.pone.0064510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156DC	23762215	Green Published, gold, Green Accepted			2022-12-25	WOS:000319799900046
J	Boccardi, V; Barbieri, M; Rizzo, MR; Marfella, R; Esposito, A; Marano, L; Paolisso, G				Boccardi, Virginia; Barbieri, Michelangela; Rizzo, Maria Rosaria; Marfella, Raffaele; Esposito, Antonietta; Marano, Luigi; Paolisso, Giuseppe			A new pleiotropic effect of statins in elderly: modulation of telomerase activity	FASEB JOURNAL			English	Article						aging; health span; cellular senescence	ENDOTHELIAL PROGENITOR CELLS; CARDIOVASCULAR-DISEASE; STRESS; SENESCENCE; COMPONENT; THERAPY; LENGTH; SPAN; RISK; GENE	Recent evidence suggests a link between statins and telomere biology. Whether statin treatment may modulate telomerase activity and affect telomere erosion rate is unknown. We aimed at investigating the potential impact of statin therapy on peripheral blood mononuclear cells telomerase activity, its implication on LTL variability, and its association with telomere shortening rates along with aging. The cross-sectional study was conducted in 230 subjects (age range: 30-86 y) stratified according to statins treatment. LTL was measured by quantitative polymerase chain reaction and telomerase activity by a PCR-ELISA protocol. Subjects on statin treatment showed higher telomerase activity (P<0.0001) and longer LTL (P=0.028) levels compared to the nonstatin group. Statin therapy was associated with higher telomerase activity independently of multiple covariates, including age, gender, smoking habits, lipid, systemic inflammation, glucose, and blood pressure levels (P=0.019). Indeed, subjects on statin treatment showed significant lower telomere erosion along with aging. Every 1 y increment in age, LTL decreases by 0.058 Kb in no statin and 0.033 Kb in statin groups, respectively, as well as the major difference in telomere attrition between groups was found after the age of 65 yr (P<0.0001). In summary, statins, modulating telomerase activity, affect telomere erosion along with aging.Boccardi, V., Barbieri, M., Rizzo, M. R., Marfella, R., Esposito, A., Marano, L., Paolisso, G. A new pleiotropic effect of statins in elderly: modulation of telomerase activity	[Boccardi, Virginia; Barbieri, Michelangela; Rizzo, Maria Rosaria; Marfella, Raffaele; Esposito, Antonietta; Marano, Luigi; Paolisso, Giuseppe] Univ Naples 2, Dept Internal Med Surg Neurol Metab Dis & Geriatr, I-80138 Naples, Italy	Universita della Campania Vanvitelli	Paolisso, G (corresponding author), Univ Naples 2, Dept Internal Med Surg Neurol Metab Dis & Geriatr, Div Internal Med 6, Pzza Miraglia 2, I-80138 Naples, Italy.	giuseppe.paolisso@unina2.it	Boccardi, Virginia/K-2630-2016; Rizzo, Maria Rosaria/AHH-3649-2022; Barbieri, Michelangela/K-2192-2016; Marano, Luigi/K-4944-2013; paolisso, giuseppe/AAP-8516-2020; rizzo, maria rosaria R/J-1968-2016; Marfella, Raffaele/AAH-2595-2019; Rizzo, Maria/HGD-6576-2022	Boccardi, Virginia/0000-0003-2134-1122; Rizzo, Maria Rosaria/0000-0002-1023-4260; Barbieri, Michelangela/0000-0002-9223-5792; Marano, Luigi/0000-0002-9777-9588; paolisso, giuseppe/0000-0002-2137-455X; rizzo, maria rosaria R/0000-0002-1023-4260; Marfella, Raffaele/0000-0003-3960-9270; 				Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; de Jesus BB, 2011, AGING CELL, V10, P604, DOI 10.1111/j.1474-9726.2011.00700.x; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Boccardi V, 2012, EMBO MOL MED, V4, P685, DOI 10.1002/emmm.201200246; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Daubenmier J, 2012, PSYCHONEUROENDOCRINO, V37, P917, DOI 10.1016/j.psyneuen.2011.10.008; Epel ES, 2006, PSYCHONEUROENDOCRINO, V31, P277, DOI 10.1016/j.psyneuen.2005.08.011; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Muezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003; Saliques S, 2011, ATHEROSCLEROSIS, V219, P753, DOI 10.1016/j.atherosclerosis.2011.09.011; Satoh M, 2009, CLIN SCI, V116, P827, DOI 10.1042/CS20080404; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; Silvestre D. C., 2010, GENOME DYN, V7, P29; Spindler S. R., 2012, PLOS ONE, V7; Spyridopoulos I, 2004, CIRCULATION, V110, P3136, DOI 10.1161/01.CIR.0000142866.50300.EB; Taylor F, 2011, COCHRANE DATABASE SY, V19, DOI 10.1002/14651858.CD004816.pub5; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	28	44	49	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3879	3885		10.1096/fj.13-232066	http://dx.doi.org/10.1096/fj.13-232066			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23748973				2022-12-25	WOS:000328840500045
J	Nishimura, T; Zhao, XM; Gan, HX; Koyasu, S; Remold, HG				Nishimura, Tomoyasu; Zhao, Xiaomin; Gan, Huixian; Koyasu, Shigeo; Remold, Heinz G.			The prostaglandin E-2 receptor EP4 is integral to a positive feedback loop for prostaglandin E-2 production in human macrophages infected with Mycobacterium tuberculosis	FASEB JOURNAL			English	Article						cyclooxygenase 2; Toll-like receptor 2; p38 mitogen-activated protein kinase	ACTIVATED PROTEIN-KINASE; FACTOR-KAPPA-B; PROSTANOID RECEPTORS; DENDRITIC CELLS; UP-REGULATION; NITRIC-OXIDE; E SYNTHASE; EXPRESSION; CYCLOOXYGENASE-2; PGE(2)	Prostaglandin E-2 (PGE(2)) is an important biological mediator involved in the defense against Mycobacterium tuberculosis (Mtb) infection. Previously, we reported that in macrophages (M phi s), infection with avirulent Mtb H37Ra resulted in inhibition of necrosis by an inhibitory effect on mitochondrial permeability transition via the PGE(2) receptor EP2. However, human M phi s also express EP4, a PGE(2) receptor functionally closely related to EP2 that also couples to stimulatory guanine nucleotide binding protein, but the functional differences between EP2 and EP4 in Mtb-infected M phi s have been unclear. EP4 antagonist addition to H37Ra-infected M phi s inhibited the expression of cyclooxygenase 2 (COX2) and microsomal prostaglandin E synthase-1 (mPGES-1), which are involved in PGE(2) production. Moreover, H37Ra infection induced PGE(2) production through the Toll-like receptor (TLR) 2/p38 mitogen-activated protein kinase (MAPK) signaling pathway. Induction of COX2 and mPGES-1 expression by TLR2 stimulation or Mtb infection was increased after additional stimulation with EP4 agonist. Hence, in Mtb-infected M phi s, PGE(2) production induced by pathogen recognition receptors/p38 MAPK signaling is up-regulated by EP4-triggered signaling to maintain an effective PGE(2) concentration.Nishimura, T., Zhao, X., Gan, H., Koyasu, S., and Remold, H. G. The prostaglandin E-2 receptor EP4 is integral to a positive feedback loop for prostaglandin E-2 production in human macrophages infected with Mycobacterium tuberculosis.	[Nishimura, Tomoyasu; Zhao, Xiaomin; Gan, Huixian; Remold, Heinz G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy,Dept Med, Boston, MA 02115 USA; [Nishimura, Tomoyasu; Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Nishimura, Tomoyasu] Keio Univ, Sch Med, Div Pulm Med, Dept Med, Tokyo, Japan; [Koyasu, Shigeo] RIKEN Res Ctr Allergy & Immunol, Lab Immune Cell Syst, Yokohama, Kanagawa, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Keio University; Keio University; RIKEN	Remold, HG (corresponding author), Brigham & Womens Hosp, Smith Bldg,526B,1 Jimmy Fund Way, Boston, MA 02115 USA.	hremold@partners.org	Koyasu, Shigeo/J-5583-2015	Koyasu, Shigeo/0000-0001-9585-3038	U.S. National Institutes of Health [AI072143]; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (Japan Society of the Promotion of Science); Grants-in-Aid for Scientific Research [22229004] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072143] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (Japan Society of the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors are grateful to Dr. Eileen Remold-O'Donnell for helpful discussions. H. G. R. and T.N. conceived of and designed the experiments, analyzed the data and wrote the article; T.N. did the experiments with assistance from H. G. and X.Z.; S. K. provided intellectual input. The authors declare no conflicts of interest. This work is funded by the U.S. National Institutes of Health (grant AI072143). T.N. is supported by Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation (Japan Society of the Promotion of Science).	Arakawa T, 1996, J BIOL CHEM, V271, P29569, DOI 10.1074/jbc.271.47.29569; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chen M, 2008, ARTHRITIS RHEUM, V58, P1354, DOI 10.1002/art.23453; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; COLEMAN RA, 1994, PROSTAGLANDINS, V47, P151, DOI 10.1016/0090-6980(94)90084-1; Diaz-Munoz MD, 2012, BIOCHEM J, V443, P451, DOI 10.1042/BJ20111052; Diaz-Munoz MD, 2010, CELL SIGNAL, V22, P1427, DOI 10.1016/j.cellsig.2010.05.011; Drage MG, 2009, CELL IMMUNOL, V258, P29, DOI 10.1016/j.cellimm.2009.03.008; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Ferronato S, 2011, EUR J VASC ENDOVASC, V41, P358, DOI 10.1016/j.ejvs.2010.11.019; FORSTERMANN U, 1983, J PHARM PHARMACOL, V35, P724; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Gan HX, 2005, J INFECT DIS, V191, P1292, DOI 10.1086/428906; Guan ZH, 1997, J BIOL CHEM, V272, P8083, DOI 10.1074/jbc.272.12.8083; Hiraiwa H, 2011, INFLAMM RES, V60, P1039, DOI 10.1007/s00011-011-0365-y; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Iona E, 2012, MICROBES INFECT, V14, P959, DOI 10.1016/j.micinf.2012.04.003; Katsuyama M, 1998, BIOCHEM BIOPH RES CO, V251, P727, DOI 10.1006/bbrc.1998.9540; Khan KMF, 2012, J IMMUNOL, V188, P1970, DOI 10.4049/jimmunol.1102383; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005; Legler DF, 2010, INT J BIOCHEM CELL B, V42, P198, DOI 10.1016/j.biocel.2009.09.015; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Matsumoto H, 1997, BIOCHEM BIOPH RES CO, V230, P110, DOI 10.1006/bbrc.1996.5894; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Oikawa A, 2007, J PERIODONTAL RES, V42, P367, DOI 10.1111/j.1600-0765.2006.00959.x; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Rand L, 2009, J IMMUNOL, V182, P5865, DOI 10.4049/jimmunol.0801935; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Serezani CH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002448; Shoji M, 2006, LIFE SCI, V78, P2012, DOI 10.1016/j.lfs.2005.09.019; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Stenger S, 2002, CURR OPIN IMMUNOL, V14, P452, DOI 10.1016/S0952-7915(02)00355-2; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Sugimoto Y, 2000, PROG LIPID RES, V39, P289, DOI 10.1016/S0163-7827(00)00008-4; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tabata H, 2002, BIOCHEM BIOPH RES CO, V298, P398, DOI 10.1016/S0006-291X(02)02455-5; Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405; Vichai V, 2005, INFLAMM RES, V54, P163, DOI 10.1007/s00011-004-1338-1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilson RJ, 2004, EUR J PHARMACOL, V501, P49, DOI 10.1016/j.ejphar.2004.08.025; Zaslona Z, 2012, BLOOD, V119, P2358, DOI 10.1182/blood-2011-08-374207	51	33	36	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3827	3836		10.1096/fj.13-228858	http://dx.doi.org/10.1096/fj.13-228858			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23759445	Green Published			2022-12-25	WOS:000328840500040
J	Kim, HS; Montana, V; Jang, HJ; Parpura, V; Kim, JA				Kim, Hae-Suk; Montana, Vedrana; Jang, Hyun-Ju; Parpura, Vladimir; Kim, Jeong-a			Epigallocatechin Gallate (EGCG) Stimulates Autophagy in Vascular Endothelial Cells A POTENTIAL ROLE FOR REDUCING LIPID ACCUMULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GREEN TEA POLYPHENOL; ENDOPLASMIC-RETICULUM STRESS; MAMMALIAN AUTOPHAGY; INSULIN-RESISTANCE; ENERGETIC BALANCE; GLUTAMATE RELEASE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; METABOLISM	Epigallocatechin gallate (EGCG) is a major polyphenol in green tea that has beneficial effects in the prevention of cardiovascular disease. Autophagy is a cellular process that protects cells from stressful conditions. To determine whether the beneficial effect of EGCG is mediated by a mechanism involving autophagy, the roles of the EGCG-stimulated autophagy in the context of ectopic lipid accumulation were investigated. Treatment with EGCG increased formation of LC3-II and autophagosomes in primary bovine aortic endothelial cells (BAEC). Activation of calmodulin-dependent protein kinase kinase beta was required for EGCG-induced LC3-II formation, as evidenced by the fact that EGCG-induced LC3-II formation was significantly impaired by knockdown of calmodulin-dependent protein kinase kinase beta. This effect is most likely due to cytosolic Ca2+ load. To determine whether EGCG affects palmitate-induced lipid accumulation, the effects of EGCG on autophagic flux and co-localization of lipid droplets and autophagolysosomes were examined. EGCG normalized the palmitate-induced impairment of autophagic flux. Accumulation of lipid droplets by palmitate was markedly reduced by EGCG. Blocking autophagosomal degradation opposed the effect of EGCG in ectopic lipid accumulation, suggesting the action of EGCG is through autophagosomal degradation. The mechanism for this could be due to the increased co-localization of lipid droplets and autophagolysosomes. Co-localization of lipid droplets with LC3 and lysosome was dramatically increased when the cells were treated with EGCG and palmitate compared with the cells treated with palmitate alone. Collectively, these findings suggest that EGCG regulates ectopic lipid accumulation through a facilitated autophagic flux and further imply that EGCG may be a potential therapeutic reagent to prevent cardiovascular complications.	[Kim, Hae-Suk; Jang, Hyun-Ju; Kim, Jeong-a] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Kim, Jeong-a] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Civitan Int Res Ctr,Dept Mol Cellular Pathol, Ctr Glial Biol Med,Atom Force Microscopy & Nanote, Birmingham, AL 35294 USA; [Montana, Vedrana; Parpura, Vladimir] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Civitan Int Res Ctr,Dept Neurobiol, Ctr Glial Biol Med,Atom Force Microscopy & Nanote, Birmingham, AL 35294 USA; [Kim, Jeong-a] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Parpura, Vladimir] Univ Rijeka, Dept Biotechnol, Rijeka 51000, Croatia	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Rijeka	Kim, JA (corresponding author), Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA.	jakim@uab.edu			National Institutes of Health [P60 DK-079626]; American Diabetes Association [1-09-JF-33, 1-12-BS-99]; American Heart Association [13GRNT17220057]; National Science Foundation [CBET 0943343]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P60 DK-079626 (to University of Alabama at Birmingham Diabetes Research Training Center-sponsored Pilot and Feasibility Program). This work was also supported by American Diabetes Association Grants 1-09-JF-33 and 1-12-BS-99 (to J. K.), American Heart Association Grant 13GRNT17220057 (to J. K.), and National Science Foundation Grant CBET 0943343 (to V. P.).	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Ahn J, 2008, J HEPATOL, V49, P1019, DOI 10.1016/j.jhep.2008.08.012; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052347; Chimal-Monroy J, 2011, IUBMB LIFE, V63, P922, DOI 10.1002/iub.563; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; de Boer VCJ, 2006, MECH AGEING DEV, V127, P618, DOI 10.1016/j.mad.2006.02.007; De Meyer GRY, 2009, BBA-MOL CELL RES, V1793, P1485, DOI 10.1016/j.bbamcr.2008.12.011; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Huang CH, 2009, MOL NUTR FOOD RES, V53, P1156, DOI 10.1002/mnfr.200800592; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kim JA, 2007, J BIOL CHEM, V282, P13736, DOI 10.1074/jbc.M609725200; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Lara-Castro C, 2008, ENDOCRIN METAB CLIN, V37, P841, DOI 10.1016/j.ecl.2008.09.002; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Lee MS, 2009, PHYTOTHER RES, V23, P1088, DOI 10.1002/ptr.2737; Lee William, 2008, Front Neuroeng, V1, P2, DOI 10.3389/neuro.16.002.2008; Li W, 2011, BIOCHEM PHARMACOL, V81, P1152, DOI 10.1016/j.bcp.2011.02.015; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reiter CEN, 2010, ENDOCRINOLOGY, V151, P103, DOI 10.1210/en.2009-0997; Reyes RC, 2009, NEUROCHEM INT, V55, P2, DOI 10.1016/j.neuint.2008.12.018; Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109; Satoh M, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-19; Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860; Singh R, 2011, AGING-US, V3, P934, DOI 10.18632/aging.100393; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2010, RESULTS PROBL CELL D, V52, P35, DOI 10.1007/978-3-642-14426-4_4; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sohle J, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-20; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Stout RF, 2011, CELL CALCIUM, V50, P98, DOI 10.1016/j.ceca.2011.05.016; Suganami T, 2012, ENDOCR J, V59, P849, DOI 10.1507/endocrj.EJ12-0271; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Weidberg H, 2009, DEV CELL, V16, P628, DOI 10.1016/j.devcel.2009.05.001; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Younce C, 2012, CELL PHYSIOL BIOCHEM, V30, P307, DOI 10.1159/000339066; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046749; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009	65	141	153	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22693	22705		10.1074/jbc.M113.477505	http://dx.doi.org/10.1074/jbc.M113.477505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23754277	hybrid, Green Published			2022-12-25	WOS:000330596300048
J	Lee, JKH; Pearson, JD; Maser, BE; Ingham, RJ				Lee, Jason K. H.; Pearson, Joel D.; Maser, Brandon E.; Ingham, Robert J.			Cleavage of the JunB Transcription Factor by Caspases Generates a Carboxyl-terminal Fragment That Inhibits Activator Protein-1 Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP-1 Transcription Factor; Apoptosis; Caspase; Gene Transcription; Jun Transcription Factor; Inflammasome	LARGE-CELL LYMPHOMA; NF-KAPPA-B; REED-STERNBERG CELLS; C-JUN; NPM-ALK; DOWN-REGULATION; MEDIATED CLEAVAGE; HODGKIN LYMPHOMA; CD30 PROMOTER; IN-VITRO	The activator protein-1 (AP-1) family transcription factor, JunB, is an important regulator of proliferation, apoptosis, differentiation, and the immune response. In this report, we show that JunB is cleaved in a caspase-dependent manner in apoptotic anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma cell lines and that ectopically expressed JunB is cleaved in murine RAW 264.7 macrophage cells treated with the NALP1b inflammasome activator, anthrax lethal toxin. In both cases, we identify aspartic acid 137 as the caspase cleavage site and demonstrate that JunB can be directly cleaved in vitro by multiple caspases at this site. Cleavage of JunB at aspartic acid 137 separates the N-terminal transactivation domain from the C-terminal DNA binding and dimerization domains, and we show that the C-terminal cleavage fragment retains both DNA binding activity and the ability to interact with AP-1 family transcription factors. Furthermore, this fragment interferes with the binding of full-length JunB to AP-1 sites and inhibits AP-1-dependent transcription. In summary, we have identified and characterized a novel mechanism of JunB post-translational modification and demonstrate that the C-terminal JunB caspase cleavage product functions as a potent inhibitor of AP-1-dependent transcription.	[Lee, Jason K. H.; Pearson, Joel D.; Maser, Brandon E.; Ingham, Robert J.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada	University of Alberta	Ingham, RJ (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Katz Grp Ctr Pharm & Hlth Res 6 065, Edmonton, AB T6G 2E1, Canada.	ringham@ualberta.ca	Pearson, Joel/AFK-9248-2022	Maser, Brandon/0000-0002-9427-0022; Lee, Jason/0000-0001-8875-607X	Natural Sciences and Engineering Research Council of Canada; Alberta Cancer Foundation/Alberta Innovates Health Solutions	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Cancer Foundation/Alberta Innovates Health Solutions	This work was supported by operating grants from the Natural Sciences and Engineering Research Council of Canada and the Alberta Cancer Foundation/Alberta Innovates Health Solutions (to R.J.I.).	Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Barkett M, 2001, BBA-GEN SUBJECTS, V1526, P25, DOI 10.1016/S0304-4165(01)00092-7; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BROWN PH, 1994, ONCOGENE, V9, P791; BROWN PH, 1993, ONCOGENE, V8, P877; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Charvet C, 2003, ONCOGENE, V22, P4557, DOI 10.1038/sj.onc.1206778; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; Darnowski JW, 2006, J BIOL CHEM, V281, P17707, DOI 10.1074/jbc.M600088200; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Drakos E, 2004, MODERN PATHOL, V17, P109, DOI 10.1038/modpathol.3800039; Farras R, 2008, MOL CELL BIOL, V28, P4173, DOI 10.1128/MCB.01620-07; Flygare J, 2000, EUR J BIOCHEM, V267, P5977, DOI 10.1046/j.1432-1327.2000.01675.x; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Han Y, 2006, LEUKEMIA, V20, P1602, DOI 10.1038/sj.leu.2404323; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; Hsu FYY, 2007, CANCER INVEST, V25, P240, DOI 10.1080/07357900701206372; Inghirami G, 2011, SEMIN DIAGN PATHOL, V28, P190, DOI 10.1053/j.semdp.2011.03.002; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; King P, 1998, J BIOL CHEM, V273, P8699, DOI 10.1074/jbc.273.15.8699; Krippner-Heidenreich A, 2005, MOL CELL BIOL, V25, P3704, DOI 10.1128/MCB.25.9.3704-3714.2005; Laimer D, 2012, NAT MED, V18, P1699, DOI 10.1038/nm.2966; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Narayanan K, 2004, J BIOL CHEM, V279, P44294, DOI 10.1074/jbc.M403511200; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Pearson JD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-229; Pearson JD, 2011, INT J CLIN EXP PATHO, V4, P124; Perez-Benavente B, 2013, ONCOGENE, V32, P2189, DOI 10.1038/onc.2012.235; Rassidakis GZ, 2005, MODERN PATHOL, V18, P1365, DOI 10.1038/modpathol.3800419; Ravi R, 1998, CANCER RES, V58, P882; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Staber PB, 2007, BLOOD, V110, P3374, DOI 10.1182/blood-2007-02-071258; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Watanabe M, 2003, AM J PATHOL, V163, P633, DOI 10.1016/S0002-9440(10)63690-5; Watanabe M, 2005, CANCER RES, V65, P7628, DOI 10.1158/0008-5472.CAN-05-0925; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x; Zhao M, 2009, BIOCHEM BIOPH RES CO, V382, P508, DOI 10.1016/j.bbrc.2009.03.024	52	4	4	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21482	21495		10.1074/jbc.M113.485672	http://dx.doi.org/10.1074/jbc.M113.485672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23749999	Green Published, hybrid			2022-12-25	WOS:000328841900002
J	Ahmed, N; Owen, TE; Rubinger, M; Williams, G; Nugent, Z; Ahmed, S; Cooke, A				Ahmed, Naseer; Owen, Timothy E.; Rubinger, Morel; Williams, Gaynor; Nugent, Zoann; Ahmed, Shahida; Cooke, Andrew			Early Stage WHO Grade I and II Follicular Lymphoma Treated with Radiation Therapy Alone	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; TERM-FOLLOW-UP; INTERNATIONAL PROGNOSTIC INDEX; INITIAL THERAPY; RADIOTHERAPY; FIELD; DISEASE; RECOMMENDATIONS; CLASSIFICATION; TRIAL	Objectives: This retrospective study was undertaken to evaluate the outcome of patients with stage I or II (limited stage), grade I-II follicular non-Hodgkin's lymphoma (FL) treated with radiation therapy (RT) alone as initial management. Methods: Patients with stage I or II and pathologically confirmed WHO grade I or II FL treated initially with RT alone between 1982 and 2008 were identified from a population based cancer registry. Results: Forty patients with a mean age 61.3 years at diagnosis were identified. The median follow up was 6.9 years from the end of radiation therapy. Stage was I (n = 26) and II (n = 14). None had B symptoms. The Follicular Lymphoma International Prognostic Index (FLIPI) was low risk in 26 patients and intermediate risk in 5. Doses ranged from 15 Gy to 48 Gy, with a median dose of 35 Gy. All patients achieved a complete clinical response (CR). 5 and 10 year overall survival (OS) was 86% and 59%, progression free survival (PFS) 67% and 54%. Age >= 60 at diagnosis was associated with reduced OS, p = 0.029, but did not affect PFS. No other clinical features including grade or FLIPI were significant for outcomes. Local failure was uncommon occurring in 8% (3/40) although this was 21% (3/14) of all recurrences. Conclusions: OS and PFS outcomes for radiation alone in limited stage low grade FL patients from this single institution study are consistent with previously published data. No predictors were prognostic for PFS. A dose of <= 35 Gy may be appropriate. In this highly selected homogeneous group the FLIPI loses discriminating ability. Local control is excellent, and a majority of patients are free of disease after 5 years.	[Ahmed, Naseer; Rubinger, Morel; Williams, Gaynor; Ahmed, Shahida; Cooke, Andrew] Univ Manitoba, Winnipeg, MB, Canada; [Ahmed, Naseer; Rubinger, Morel; Nugent, Zoann; Ahmed, Shahida; Cooke, Andrew] CancerCare Manitoba, Winnipeg, MB, Canada; [Owen, Timothy E.] Queens Univ, Kingston, ON, Canada; [Owen, Timothy E.] Canc Ctr Southeastern Ontario, Kingston, ON, Canada	University of Manitoba; CancerCare Manitoba Foundation; Queens University - Canada	Ahmed, N (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.	naseer.ahmed@cancercare.mb.ca						Advani R, 2004, J CLIN ONCOL, V22, P1454, DOI 10.1200/JCO.2004.10.086; CARBONE PP, 1971, CANCER RES, V31, P1860; Chan WC, 1997, BLOOD, V89, P3909; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Dancey JE, 2009, EUR J CANCER, V45, P281, DOI 10.1016/j.ejca.2008.10.042; Dreyling M, 2009, ANN ONCOL, V20, P119, DOI 10.1093/annonc/mdp148; Eich HT, 2009, STRAHLENTHER ONKOL, V185, P288, DOI 10.1007/s00066-009-1937-4; Engelhard M, 2007, STRAHLENTHER ONKOL, V183, P129; Friedberg JW, 2012, J CLIN ONCOL, V30, P3368, DOI 10.1200/JCO.2011.40.6546; GOSPODAROWICZ MK, 1984, INT J RADIAT ONCOL, V10, P489, DOI 10.1016/0360-3016(84)90028-2; Group GLGLS, 2010, RIT INV FIELD RAD EA; Guadagnolo BA, 2006, INT J RADIAT ONCOL, V64, P928, DOI 10.1016/j.ijrobp.2005.08.010; Heinzelmann F, 2010, STRAHLENTHER ONKOL, V186, P191, DOI 10.1007/s00066-010-2090-9; HUDSON BV, 1994, BRIT J CANCER, V69, P1088, DOI 10.1038/bjc.1994.213; Kamath SS, 1999, INT J RADIAT ONCOL, V44, P563, DOI 10.1016/S0360-3016(99)00051-6; Katz MH, 2006, MULTIVARIABLE ANALYSIS: A PRACTICAL GUIDE FOR CLINICIANS, 2ND EDITION, P1, DOI 10.1017/CBO9780511811692; KELSEY SM, 1994, MED ONCOL, V11, P19, DOI 10.1007/BF02990087; Lowry L, 2011, RADIOTHER ONCOL, V100, P86, DOI 10.1016/j.radonc.2011.05.013; MacManus MP, 1996, J CLIN ONCOL, V14, P1282, DOI 10.1200/JCO.1996.14.4.1282; Neumann H, 2003, STRAHLENTHER ONKOL, V179, P840, DOI 10.1007/s00066-003-1025-0; Ott OJ, 2003, STRAHLENTHER ONKOL, V179, P694, DOI 10.1007/s00066-003-1062-8; PENDLEBURY S, 1995, RADIOTHER ONCOL, V36, P167, DOI 10.1016/0167-8140(95)01600-L; Petersen PM, 2004, J CLIN ONCOL, V22, p563S; Plancarte F, 2006, EUR J HAEMATOL, V76, P58, DOI 10.1111/j.1600-0609.2005.00564.x; Pugh TJ, 2010, CANCER-AM CANCER SOC, V116, P3843, DOI 10.1002/cncr.25149; Pulsoni A, 2007, BRIT J HAEMATOL, V137, P216, DOI 10.1111/j.1365-2141.2007.06545.x; Saad ED, 2009, ANN ONCOL, V20, P460, DOI 10.1093/annonc/mdn670; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Stuschke M, 1997, CANCER-AM CANCER SOC, V80, P2273, DOI 10.1002/(SICI)1097-0142(19971215)80:12<2273::AID-CNCR9>3.0.CO;2-V; Swerdlow E., 2008, WHO CLASSIFICATION T; Tsang RW, 2007, SEMIN RADIAT ONCOL, V17, P198, DOI 10.1016/j.semradonc.2007.02.006; Tsang RW, 2005, HEMATOL ONCOL, V23, P10, DOI 10.1002/hon.743; Wilder RB, 2001, INT J RADIAT ONCOL, V51, P1219, DOI 10.1016/S0360-3016(01)01747-3	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65156	10.1371/journal.pone.0065156	http://dx.doi.org/10.1371/journal.pone.0065156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762303	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000036
J	Chen, B; Xue, Z; Yang, GH; Shi, BY; Yang, B; Yan, YM; Wang, X; Han, DS; Huang, Y; Dong, WJ				Chen, Bo; Xue, Zheng; Yang, Guanghui; Shi, Bingyang; Yang, Ben; Yan, Yuemin; Wang, Xue; Han, Daishu; Huang, Yue; Dong, Wenji			Akt-Signal Integration Is Involved in the Differentiation of Embryonal Carcinoma Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; LEUKEMIA-INITIATING CELLS; NANOG EXPRESSION; F9 CELLS; SATB1; PHOSPHORYLATION; PLURIPOTENCY; QUIESCENCE; GROWTH; OCT4	The mechanism by which Akt modulates stem cell homeostasis is still incompletely defined. Here we demonstrate that Akt phosphorylates special AT-rich sequences binding protein 1 (SATB1) at serine 47 and protects SATB1 from apoptotic cleavage. Meanwhile, Akt phosphorylates Oct4 at threonine 228 and Klf4 at threonine 399, and accelerates their degradation. Moreover, PI3K/Akt signaling enhances the binding of SATB1 to Sox2, thereby probably impairing the formation of Oct4/Sox2 regulatory complexes. During retinoic acid (RA)-induced differentiation of mouse F9 embryonal carcinoma cells (ECCs), the Akt activation profile as well as its substrate spectrum is strikingly correlated with the down-regulation of Oct4, Klf4 and Nanog, which suggests Akt activation is coupled to the onset of differentiation. Accordingly, Akt-mediated phosphorylation is crucial for the capability of SATB1 to repress Nanog expression and to activate transcription of Bcl2 and Nestin genes. Taken together, we conclude that Akt is involved in the differentiation of ECCs through coordinated phosphorylations of pluripotency/differentiation factors.	[Chen, Bo; Shi, Bingyang; Yang, Ben; Yan, Yuemin; Han, Daishu; Dong, Wenji] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Cell Biol, Beijing 100730, Peoples R China; [Chen, Bo; Xue, Zheng; Yang, Guanghui; Shi, Bingyang; Yang, Ben; Yan, Yuemin; Wang, Xue; Han, Daishu; Huang, Yue; Dong, Wenji] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xue, Zheng; Yang, Guanghui] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem, Beijing 100730, Peoples R China; [Wang, Xue; Huang, Yue] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100730, Peoples R China; [Xue, Zheng; Yang, Guanghui; Wang, Xue; Huang, Yue] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Huang, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Med Genet, Beijing 100730, Peoples R China.	huangyue@pumc.edu.cn; wdong@ibms.pumc.edu.cn	Yang, Ben/AAA-5607-2021	Huang, Yue/0000-0003-1800-1282	National Basic Research Program of China [2011CB965203]; National High Technology Research and Development Program of China [2011AA020118];  [2010PY05]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); 	This work was supported by the National Basic Research Program of China (2011CB965203 to WD and YH); the National High Technology Research and Development Program of China (2011AA020118 to WD); and the intra-institutional funding program (2010PY05 to WD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Bastien J, 2006, ONCOGENE, V25, P2040, DOI 10.1038/sj.onc.1209241; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brumbaugh J, 2012, P NATL ACAD SCI USA, V109, P7162, DOI 10.1073/pnas.1203874109; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Ganguly S, 2010, AM J PATHOL, V177, P2701, DOI 10.2353/ajpath.2010.100617; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kim JS, 2010, ARCH PHARM RES, V33, P1117, DOI 10.1007/s12272-010-0719-y; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Matsuoka S, 2008, GENE DEV, V22, P986, DOI 10.1101/gad.1621808; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nechanitzky R, 2012, DEV CELL, V23, P866, DOI 10.1016/j.devcel.2012.09.018; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan JAT, 2008, J BIOL CHEM, V283, P18124, DOI 10.1074/jbc.M800512200; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	37	29	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64877	10.1371/journal.pone.0064877	http://dx.doi.org/10.1371/journal.pone.0064877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762260	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000026
J	Thomas, S; Sharma, N; Gonzalez, R; Pao, PW; Hofman, FM; Chen, TC; Louie, SG; Pirrung, MC; Schonthal, AH				Thomas, Simmy; Sharma, Natasha; Gonzalez, Reyna; Pao, Peng-Wen; Hofman, Florence M.; Chen, Thomas C.; Louie, Stan G.; Pirrung, Michael C.; Schoenthal, Axel H.			Repositioning of Verrucosidin, a Purported Inhibitor of Chaperone Protein GRP78, as an Inhibitor of Mitochondrial Electron Transport Chain Complex I	PLOS ONE			English	Article							COLON-CARCINOMA CELLS; ENDOPLASMIC-RETICULUM-STRESS; DOWN-REGULATOR; GLUCOSE DEPRIVATION; BREAST-CANCER; RESPIRATORY-CHAIN; OXIDATIVE-PHOSPHORYLATION; ANTITUMOR-ACTIVITY; CHEMICAL GENOMICS; BETA-SUBUNIT	Verrucosidin (VCD) belongs to a group of fungal metabolites that were identified in screening programs to detect molecules that preferentially kill cancer cells under glucose-deprived conditions. Its mode of action was proposed to involve inhibition of increased GRP78 (glucose regulated protein 78) expression during hypoglycemia. Because GRP78 plays an important role in tumorigenesis, inhibitors such as VCD might harbor cancer therapeutic potential. We therefore sought to characterize VCD's anticancer activity in vitro. Triple-negative breast cancer cell lines MDA-MB-231 and MDA-MB-468 were treated with VCD under different conditions known to trigger increased expression of GRP78, and a variety of cellular processes were analyzed. We show that VCD was highly cytotoxic only under hypoglycemic conditions, but not in the presence of normal glucose levels, and VCD blocked GRP78 expression only when glycolysis was impaired (due to hypoglycemia or the presence of the glycolysis inhibitor 2-deoxyglucose), but not when GRP78 was induced by other means (hypoxia, thapsigargin, tunicamycin). However, VCD's strictly hypoglycemia-specific toxicity was not due to the inhibition of GRP78. Rather, VCD blocked mitochondrial energy production via inhibition of complex I of the electron transport chain. As a result, cellular ATP levels were quickly depleted under hypoglycemic conditions, and common cellular functions, including general protein synthesis, deteriorated and resulted in cell death. Altogether, our study identifies mitochondria as the primary target of VCD. The possibility that other purported GRP78 inhibitors (arctigenin, biguanides, deoxyverrucosidin, efrapeptin, JBIR, piericidin, prunustatin, pyrvinium, rottlerin, valinomycin, versipelostatin) might act in a similar GRP78-independent fashion will be discussed.	[Thomas, Simmy; Gonzalez, Reyna; Pao, Peng-Wen; Schoenthal, Axel H.] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Sharma, Natasha] Univ So Calif, Dept Pharmaceut Sci, Los Angeles, CA USA; [Hofman, Florence M.] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Chen, Thomas C.] Univ So Calif, Dept Neurosurg, Los Angeles, CA USA; [Louie, Stan G.] Univ So Calif, Dept Clin Pharm & Pharmaceut Econ & Policy, Los Angeles, CA USA; [Pirrung, Michael C.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of California System; University of California Riverside	Schonthal, AH (corresponding author), Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA.	schontha@usc.edu	Schonthal, Axel/ABH-3846-2020; Sharma, Natasha/AAY-3656-2021; Sharma, Natasha/AAI-9816-2021	Sharma, Natasha/0000-0001-8046-1752; Schonthal, Axel/0000-0003-0662-5653				Alberts B, 2008, MOL BIOL CELL; Apraiz Aintzane, 2011, Cancers (Basel), V3, P1042, DOI 10.3390/cancers3011042; Bost F, 2012, CURR OPIN ONCOL, V24, P103, DOI 10.1097/CCO.0b013e32834d8155; Bryden W. L., 1989, Proceedings of the Nutrition Society of Australia., V14, P45; Bui T, 2006, CANCER CELL, V9, P419, DOI 10.1016/j.ccr.2006.05.012; BURKA LT, 1983, J CHEM SOC CHEM COMM, P544, DOI 10.1039/c39830000544; Chen TC, 2011, CANCER LETT, V302, P100, DOI 10.1016/j.canlet.2010.11.008; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Choo SJ, 2005, J ANTIBIOT, V58, P210, DOI 10.1038/ja.2005.26; de Ruijter TC, 2011, J CANCER RES CLIN, V137, P183, DOI 10.1007/s00432-010-0957-x; DEMETRAKOPOULOS GE, 1982, CANCER BIOCHEM BIOPH, V6, P65; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; ELBANNA AA, 1987, SYST APPL MICROBIOL, V10, P42, DOI 10.1016/S0723-2020(87)80008-5; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; GALLAGHER RT, 1977, NEW ZEAL J AGR RES, V20, P431, DOI 10.1080/00288233.1977.10427356; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; GAUSE EM, 1981, J BIOL CHEM, V256, P557; Haga N, 2010, CANCER SCI, V101, P1125, DOI 10.1111/j.1349-7006.2010.01525.x; Hai T, 1999, GENE EXPRESSION, V7, P321; Hayakawa Y, 2008, J ANTIBIOT, V61, P365, DOI 10.1038/ja.2008.51; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Huang SL, 2012, DIABETOLOGIA, V55, P1469, DOI 10.1007/s00125-011-2366-3; Hwang JH, 2008, J CELL PHYSIOL, V215, P243, DOI 10.1002/jcp.21308; Inai Y, 1997, CELL STRUCT FUNCT, V22, P555, DOI 10.1247/csf.22.555; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Kim JY, 2010, J CELL PHYSIOL, V224, P33, DOI 10.1002/jcp.22085; King T.E., 1967, METHOD ENZYMOL, V10, P275, DOI DOI 10.1016/0076-6879(67)10055-4; KOHLBRENNER WE, 1979, ARCH BIOCHEM BIOPHYS, V198, P598, DOI 10.1016/0003-9861(79)90536-8; Kozone I, 2009, J ANTIBIOT, V62, P593, DOI 10.1038/ja.2009.79; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Li QX, 2008, CELL DEATH DIFFER, V15, P1197, DOI 10.1038/cdd.2008.48; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; LUNARDI J, 1986, J BIOL CHEM, V261, P5350; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; MATTSON MP, 1993, EXP NEUROL, V121, P1, DOI 10.1006/exnr.1993.1066; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; NISHIOKA H, 1994, J ANTIBIOT, V47, P447, DOI 10.7164/antibiotics.47.447; Osweiler G.D, 1996, TOXICOLOGY; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Park HR, 2007, TOXICOLOGY, V229, P253, DOI 10.1016/j.tox.2006.11.049; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; PENNINGTON R, 1961, BIOCHEM J, V80, P649, DOI 10.1042/bj0800649; Pyrko P, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-19; Reddy KB, 2011, CURR ONCOL, V18, pE173; REDEGELD FAM, 1992, EUR J PHARM-ENVIRON, V228, P229, DOI 10.1016/0926-6917(92)90034-A; Robinson GL, 2012, ONCOGENE, V31, P4996, DOI 10.1038/onc.2012.13; Ryoo IJ, 2006, BIOL PHARM BULL, V29, P817, DOI 10.1248/bpb.29.817; Saito S, 2011, METHOD ENZYMOL, V491, P327, DOI 10.1016/B978-0-12-385928-0.00018-3; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Sausville EA, 2004, J NATL CANCER I, V96, P1266, DOI 10.1093/jnci/djh276; SAYOOD SF, 1989, ARCH BIOCHEM BIOPHYS, V270, P714, DOI 10.1016/0003-9861(89)90554-7; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Sun SR, 2011, PLANTA MED, V77, P141, DOI 10.1055/s-0030-1250179; Tomitsuka E, 2012, J BIOCHEM, V152, P171, DOI 10.1093/jb/mvs041; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Umeda Y, 2005, J ANTIBIOT, V58, P206, DOI 10.1038/ja.2005.25; vanRaaij MJ, 1996, P NATL ACAD SCI USA, V93, P6913, DOI 10.1073/pnas.93.14.6913; Wang J, 2009, J CELL MOL MED, V13, P3888, DOI 10.1111/j.1582-4934.2009.00873.x; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; WHANG K, 1990, J AM CHEM SOC, V112, P8985, DOI 10.1021/ja00180a057; WILSON BJ, 1981, J AM VET MED ASSOC, V179, P480; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xi H, 2013, BIOCH PHARM; YAMANISHI K, 1984, J CELL PHYSIOL, V119, P163, DOI 10.1002/jcp.1041190204; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951; Zhang LH, 2010, J CELL BIOCHEM, V110, P1299, DOI 10.1002/jcb.22679	76	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65695	10.1371/journal.pone.0065695	http://dx.doi.org/10.1371/journal.pone.0065695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755268	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000094
J	Warnier, MJ; Blom, MT; Bardai, A; Berdowksi, J; Souverein, PC; Hoes, AW; Rutten, FH; de Boer, A; Koster, RW; De Bruin, ML; Tan, HL				Warnier, Miriam Jacoba; Blom, Marieke Tabo; Bardai, Abdennasser; Berdowksi, Jocelyn; Souverein, Patrick Cyriel; Hoes, Arno Wilhelmus; Rutten, Frans Hendrik; de Boer, Anthonius; Koster, Rudolph Willem; De Bruin, Marie Louise; Tan, Han Liong			Increased Risk of Sudden Cardiac Arrest in Obstructive Pulmonary Disease: A Case-Control Study	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; BETA-BLOCKERS; HEART-RATE; ASTHMA; DEATH; DETERMINANTS; SURVIVAL; AGONISTS; SAFETY; COPD	Background: We aimed to determine whether (1) patients with obstructive pulmonary disease (OPD) have an increased risk of sudden cardiac arrest (SCA) due to ventricular tachycardia or fibrillation (VT/VF), and (2) the SCA risk is mediated by cardiovascular risk-profile and/or respiratory drug use. Methods: A community-based case-control study was performed, with 1310 cases of SCA of the ARREST study and 5793 age, sex and SCA-date matched non-SCA controls from the PHARMO database. Only incident SCA cases, age older than 40 years, that resulted from unequivocal cardiac causes with electrocardiographic documentation of VT/VF were included. Conditional logistic regression analysis was used to assess the association between SCA and OPD. Pre-specified subgroup analyses were performed regarding age, sex, cardiovascular risk-profile, disease severity, and current use of respiratory drugs. Results: A higher risk of SCA was observed in patients with OPD (n = 190 cases [15%], 622 controls [11%]) than in those without OPD (OR adjusted for cardiovascular risk-profile 1.4 [1.2-1.6]). In OPD patients with a high cardiovascular risk-profile (OR 3.5 [2.7-4.4]) a higher risk of SCA was observed than in those with a low cardiovascular risk-profile (OR 1.3 [0.9-1.9]) The observed SCA risk was highest among OPD patients who received short-acting b2-adrenoreceptor agonists (SABA) or anticholinergics (AC) at the time of SCA (SABA OR: 3.9 [1.7-8.8], AC OR: 2.7 [1.5-4.8] compared to those without OPD). Conclusions: OPD is associated with an increased observed risk of SCA. The most increased risk was observed in patients with a high cardiovascular risk-profile, and in those who received SABA and, possibly, those who received AC at the time of SCA.	[Warnier, Miriam Jacoba; Souverein, Patrick Cyriel; de Boer, Anthonius; De Bruin, Marie Louise] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Warnier, Miriam Jacoba; Hoes, Arno Wilhelmus; Rutten, Frans Hendrik; De Bruin, Marie Louise] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Blom, Marieke Tabo; Bardai, Abdennasser; Tan, Han Liong] Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands; [Bardai, Abdennasser] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Berdowksi, Jocelyn; Koster, Rudolph Willem; Tan, Han Liong] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam	Tan, HL (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Heart, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.l.tan@amc.nl	, Bardai/AAL-2340-2020; De Bruin, Marie Louise/O-5349-2016	De Bruin, Marie Louise/0000-0001-9197-7068; Blom, Marieke Tabo/0000-0002-8088-1105; Souverein, Patrick/0000-0002-7452-0477	Netherlands Organization for Scientific Research (NWO) [ZonMW Vici 918.86.616, Mozaiek 017.003.084]; Dutch Medicines Evaluation Board (MEB/CBG); European Community [241679]; BBMRI-NL; Dutch government [NWO 184-021-007]; Utrecht University; Utrecht University Medical Center; Dutch Medicines Evaluation Board (CBG-MEB)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Medicines Evaluation Board (MEB/CBG); European Community(European Commission); BBMRI-NL; Dutch government; Utrecht University; Utrecht University Medical Center; Dutch Medicines Evaluation Board (CBG-MEB)	H.L. Tan was supported by the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616), the Dutch Medicines Evaluation Board (MEB/CBG), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement nr. 241679 - the ARITMO project, and BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184-021-007). This study was conducted with unrestricted institutional funding from Utrecht University and the Utrecht University Medical Center. H.L. Tan was supported by the Netherlands Organization for Scientific Research (NWO, grant ZonMW Vici 918.86.616), the Dutch Medicines Evaluation Board (MEB/CBG), and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement nr. 241679 - the ARITMO project and BBMRI-NL, a research infrastructure financed by the Dutch government (NWO 184-021-007). A. Bardai was supported by the Netherlands Organization for Scientific Research (NWO, grant Mozaiek 017.003.084). Both grants are unrestricted. M.L. De Bruin was supported by the Dutch Medicines Evaluation Board (CBG-MEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton SL, 2009, J ALLERGY CLIN IMMUN, V123, P124, DOI 10.1016/j.jaci.2008.10.032; Bardai A, 2011, J AM COLL CARDIOL, V57, P1822, DOI 10.1016/j.jacc.2010.11.054; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Blais L, 1998, THORAX, V53, P1025, DOI 10.1136/thx.53.12.1025; Blom MT, 2012, RESUSCITATI IN PRESS, DOI [10.1016/j.resuscitation.2012.10.009, DOI 10.1016/J.RESUSCITA-TI0N.2012.10.009]; Buurma H, 2008, J CLIN PHARM THER, V33, P17, DOI 10.1111/j.1365-2710.2008.00878.x; Canto JG, 2007, ARCH INTERN MED, V167, P2405, DOI 10.1001/archinte.167.22.2405; Celli B, 2009, AM J RESP CRIT CARE, V180, P948, DOI 10.1164/rccm.200906-0876OC; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; Engdahl J, 2000, AM J CARDIOL, V86, P610, DOI 10.1016/S0002-9149(00)01037-7; Engdahl J, 2002, RESUSCITATION, V52, P235, DOI 10.1016/S0300-9572(01)00464-6; Engstrom G, 2001, CIRCULATION, V103, P3086, DOI 10.1161/01.CIR.103.25.3086; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Han MK, 2007, CIRCULATION, V116, P2992, DOI 10.1161/CIRCULATIONAHA.106.685206; Hua W, 2009, J AM COLL CARDIOL, V54, P1110, DOI 10.1016/j.jacc.2009.06.016; Jensen MT, 2013, EUR RESPIR J, V42, P341, DOI 10.1183/09031936.00072212; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; KENDALL MJ, 1995, ANN INTERN MED, V123, P358, DOI 10.7326/0003-4819-123-5-199509010-00007; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; LIPWORTH BJ, 1992, BRIT J CLIN PHARMACO, V33, P129, DOI 10.1111/j.1365-2125.1992.tb04014.x; Magnussen Helgo, 2009, Proc Am Thorac Soc, V6, P648, DOI 10.1513/pats.200906-053DP; Matsue Y, 2013, INT J CARDIOL, V165, P519, DOI 10.1016/j.ijcard.2011.09.037; Michele TM, 2010, NEW ENGL J MED, V363, P1097, DOI 10.1056/NEJMp1008502; Myerburg RJ, 2001, J CARDIOVASC ELECTR, V12, P369, DOI 10.1046/j.1540-8167.2001.00369.x; Myerburg RJ., 2007, BRAUNWALDS HEART DIS, P933; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824; REID DD, 1976, LANCET, V2, P979; Salpeter S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003566.pub2; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Salpeter SR, 2004, DRUG AGING, V21, P405, DOI 10.2165/00002512-200421060-00005; Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Suissa S, 1996, AM J RESP CRIT CARE, V154, P1598, DOI 10.1164/ajrccm.154.6.8970341; Teerlink JR, 2000, J CARD FAIL, V6, P25; VAUGHANWILLIAMS EM, 1975, PHARMACOL THER PT B, V1, P115; Velthove KJ, 2010, PHARMACOEPIDEM DR S, V19, P367, DOI 10.1002/pds.1892; Verrier RL, 2009, HEART RHYTHM, V6, pS68, DOI 10.1016/j.hrthm.2009.07.017; Wong CC, 2009, J COMMUN HEALTH, V34, P472, DOI 10.1007/s10900-009-9182-4; WONG CS, 1990, LANCET, V336, P1396, DOI 10.1016/0140-6736(90)93099-B; Wood LG, 2012, CHEST, V142, P86, DOI 10.1378/chest.11-1838; Wood-Baker R, 2010, INTERN MED J, V40, P94, DOI 10.1111/j.1445-5994.2009.02109.x	43	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65638	10.1371/journal.pone.0065638	http://dx.doi.org/10.1371/journal.pone.0065638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755262	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000084
J	Young, HT; Edwards, SA; Grater, F				Young, Hui T.; Edwards, Scott A.; Graeter, Frauke			How Fast Does a Signal Propagate through Proteins?	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; HAIR-CELLS; MECHANOTRANSDUCTION; BIOMOLECULES; CRYSTALS; FLOW	As the molecular basis of signal propagation in the cell, proteins are regulated by perturbations, such as mechanical forces or ligand binding. The question arises how fast such a signal propagates through the protein molecular scaffold. As a first step, we have investigated numerically the dynamics of force propagation through a single (Ala) 40 protein following a sudden increase in the stretching forces applied to its end termini. The force propagates along the backbone into the center of the chain on the picosecond scale. Both conformational and tension dynamics are found in good agreement with a coarse-grained theory of force propagation through semiflexible polymers. The speed of force propagation of 50 angstrom ps(-1) derived from these simulations is likely to determine an upper speed limit of mechanical signal transfer in allosteric proteins or molecular machines.	[Young, Hui T.; Graeter, Frauke] CAS MPG Partner Inst, Shanghai, Peoples R China; [Young, Hui T.; Graeter, Frauke] Key Lab Computat Biol, Shanghai, Peoples R China; [Young, Hui T.] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Graeter, Frauke] Heidelberg Inst Theoret Studies GGmbH, Heidelberg, Germany; [Edwards, Scott A.] Shenzhen Univ, Coll Phys & Technol, Shenzhen, Guangdong, Peoples R China	Max Planck Society; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Heidelberg Institute for Theoretical Studies; Shenzhen University	Grater, F (corresponding author), CAS MPG Partner Inst, Shanghai, Peoples R China.	frauke.graeter@h-its.org	Gräter, Frauke/D-3450-2009	Gräter, Frauke/0000-0003-2891-3381	Klaus Tschira Foundation	Klaus Tschira Foundation	The authors thank the Klaus Tschira Foundation (http://www.klaus-tschira-stiftung.de) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATCHELOR GK, 1970, J FLUID MECH, V44, P419, DOI 10.1017/S002211207000191X; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X; Botan V, 2007, P NATL ACAD SCI USA, V104, P12749, DOI 10.1073/pnas.0701762104; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Gomez GA, 2011, TRENDS CELL BIOL, V21, P499, DOI 10.1016/j.tcb.2011.05.006; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Hallatschek O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.077804; Hallatschek O, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031905; Hallatschek O, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031906; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Nam JH, 2008, BIOPHYS J, V95, P4948, DOI 10.1529/biophysj.108.138560; Obermayer B, 2007, EUR PHYS J E, V23, P375, DOI 10.1140/epje/i2006-10221-y; Obermayer B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.040801; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Samuel J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.050801; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Shroff H, 2005, NANO LETT, V5, P1509, DOI 10.1021/nl050875h; Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Snow CD, 2005, ANNU REV BIOPH BIOM, V34, P43, DOI 10.1146/annurev.biophys.34.040204.144447; Stacklies W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-101; Takada S, 2012, CURR OPIN STRUC BIOL, V22, P130, DOI 10.1016/j.sbi.2012.01.010; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Xu ZP, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061910; Yu X, 2003, J PHYS CHEM B, V107, P1698, DOI 10.1021/jp026462b	35	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64746	10.1371/journal.pone.0064746	http://dx.doi.org/10.1371/journal.pone.0064746			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762251	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000018
J	Inman, DM; Lambert, WS; Calkins, DJ; Horner, PJ				Inman, Denise M.; Lambert, Wendi S.; Calkins, David J.; Horner, Philip J.			alpha-Lipoic Acid Antioxidant Treatment Limits Glaucoma-Related Retinal Ganglion Cell Death and Dysfunction	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; DBA/2J MOUSE MODEL; OXIDATIVE STRESS; NITRIC-OXIDE; TRABECULAR MESHWORK; PROTECTIVE ROLE; IRIS ATROPHY; RAT MODEL; KAPPA-B; NEURODEGENERATION	Oxidative stress has been implicated in neurodegenerative diseases, including glaucoma. However, due to the lack of clinically relevant models and expense of long-term testing, few studies have modeled antioxidant therapy for prevention of neurodegeneration. We investigated the contribution of oxidative stress to the pathogenesis of glaucoma in the DBA/2J mouse model of glaucoma. Similar to other neurodegenerative diseases, we observed lipid peroxidation and upregulation of oxidative stress-related mRNA and protein in DBA/2J retina. To test the role of oxidative stress in disease progression, we chose to deliver the naturally occurring, antioxidant alpha-lipoic acid (ALA) to DBA/2J mice in their diet. We used two paradigms for ALA delivery: an intervention paradigm in which DBA/2J mice at 6 months of age received ALA in order to intervene in glaucoma development, and a prevention paradigm in which DBA/2J mice were raised on a diet supplemented with ALA, with the goal of preventing glaucoma development. At 10 and 12 months of age (after 4 and 11 months of dietary ALA respectively), we measured changes in genes and proteins related to oxidative stress, retinal ganglion cell (RGC) number, axon transport, and axon number and integrity. Both ALA treatment paradigms showed increased antioxidant gene and protein expression, increased protection of RGCs and improved retrograde transport compared to control. Measures of lipid peroxidation, protein nitrosylation, and DNA oxidation in retina verified decreased oxidative stress in the prevention and intervention paradigms. These data demonstrate the utility of dietary therapy for reducing oxidative stress and improving RGC survival in glaucoma.	[Inman, Denise M.; Horner, Philip J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Lambert, Wendi S.; Calkins, David J.] Vanderbilt Univ, Vanderbilt Eye Inst, Dept Ophthalmol & Visual Sci, Nashville, TN 37235 USA	University of Washington; University of Washington Seattle; Vanderbilt University	Inman, DM (corresponding author), Northeast Ohio Med Univ, Dept Pharmaceut Sci, Rootstown, OH 44272 USA.	dinman@neomed.edu	Inman, Denise/AAA-8074-2019; Horner, Philip J./AAF-7012-2021	Inman, Denise/0000-0002-8522-4112; Calkins, David/0000-0002-8475-9959	Glaucoma Research Foundation's Catalyst for a Cure initiative; Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation	Glaucoma Research Foundation's Catalyst for a Cure initiative; Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation	This study was supported by the Glaucoma Research Foundation's Catalyst for a Cure initiative and a grant from the Melza M. and Frank Theodore Barr Foundation through the Glaucoma Research Foundation (DJC and PJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Aslan M, 2006, FREE RADICAL RES, V40, P147, DOI 10.1080/10715760500456219; Baltan S, 2010, J NEUROSCI, V30, P5644, DOI 10.1523/JNEUROSCI.5956-09.2010; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Biewenga GP, 1997, GEN PHARMACOL, V29, P315, DOI 10.1016/S0306-3623(96)00474-0; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741; Chauhan BC, 2006, INVEST OPHTH VIS SCI, V47, P634, DOI 10.1167/iovs.05-1206; Chen F, 1999, CLIN CHEM, V45, P7; Chen H, 2004, BRAIN RES, V1011, P99, DOI 10.1016/j.brainres.2004.03.024; Chidlow G, 2002, NEUROPHARMACOLOGY, V43, P1015, DOI 10.1016/S0028-3908(02)00129-6; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; Cremer DR, 2006, REGUL TOXICOL PHARM, V46, P193, DOI 10.1016/j.yrtph.2006.06.003; dos Santos J, 2011, INVEST OPHTHALMOL, P1; Feilchenfeld Z, 2008, EXP EYE RES, V87, P409, DOI 10.1016/j.exer.2008.07.011; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Gionfriddo JR, 2009, VET OPHTHALMOL, V12, P325, DOI 10.1111/j.1463-5224.2009.00722.x; Hirooka K, 2004, CURR EYE RES, V28, P153, DOI 10.1076/ceyr.28.3.153.26246; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925; Inoue K, 1999, J BIOL CHEM, V274, P27069, DOI 10.1074/jbc.274.38.27069; Javadiyan S, 2012, INVEST OPHTH VIS SCI, V53, P1923, DOI 10.1167/iovs.11-8420; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Ko ML, 2005, FREE RADICAL BIO MED, V39, P365, DOI 10.1016/j.freeradbiomed.2005.03.025; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Lambert WS, 2008, INVEST OPHTHALMOL VI, V49; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Libby RT, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-108; Liu YB, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-98; Luna C, 2009, FOOD CHEM TOXICOL, V47, P198, DOI 10.1016/j.fct.2008.10.029; Moreno MC, 2004, FREE RADICAL BIO MED, V37, P803, DOI 10.1016/j.freeradbiomed.2004.06.001; Onouchi H, 2012, INVEST OPHTHALMOL VI, DOI 10.11; Papadopoulos MC, 1998, NEUROSCIENCE, V82, P915; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P5360, DOI 10.1167/iovs.07-0254; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Reljanovic M, 1999, FREE RADICAL RES, V31, P171, DOI 10.1080/10715769900300721; Rema M., 1995, Indian Journal of Ophthalmology, V43, P17; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Rozen S, 2000, Methods Mol Biol, V132, P365; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Schipper HM, 2004, AGEING RES REV, V3, P265, DOI 10.1016/j.arr.2004.02.001; Schuettauf F, 2002, VISION RES, V42, P2333, DOI 10.1016/S0042-6989(02)00188-8; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Smith AR, 2004, CURR MED CHEM, V11, P1135, DOI 10.2174/0929867043365387; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Sullivan TA, 2011, HUM GENE THER, V22, P1191, DOI 10.1089/hum.2011.052; Tezel G, 2005, INVEST OPHTH VIS SCI, V46, P3177, DOI 10.1167/iovs.05-0208; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ward MS, 2006, NEUROPROTECTION RETI, P1, DOI [10.1002/jps, DOI 10.1002/JPS]; Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901; Wong AA, 2012, INVEST OPHTH VIS SCI, V53, P5956, DOI 10.1167/iovs.12-10020; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yildirim O, 2005, EYE, V19, P580, DOI 10.1038/sj.eye.6701565; Zhong LC, 2007, INVEST OPHTH VIS SCI, V48, P1212, DOI 10.1167/iovs.06-0757; Zhou XH, 2007, DEV NEUROBIOL, V67, P603, DOI 10.1002/dneu.20373; ZIEGLER D, 1995, DIABETOLOGIA, V38, P1425, DOI 10.1007/BF00400603; Ziegler Dan, 2004, Treat Endocrinol, V3, P173, DOI 10.2165/00024677-200403030-00005	69	97	97	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65389	10.1371/journal.pone.0065389	http://dx.doi.org/10.1371/journal.pone.0065389			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755225	Green Published, Green Submitted, gold			2022-12-25	WOS:000320579400056
J	Knappova, J; Knapp, M; Munzbergova, Z				Knappova, Jana; Knapp, Michal; Muezbergova, Zuzana			Spatio-Temporal Variation in Contrasting Effects of Resident Vegetation on Establishment, Growth and Reproduction of Dry Grassland Plants: Implications for Seed Addition Experiments	PLOS ONE			English	Article							RECRUITMENT LIMITATION; SPECIES-RICHNESS; RESOURCE COMPETITION; MYCORRHIZAL FUNGI; SOIL DISTURBANCE; RESTORATION; COMMUNITIES; COLONIZATION; INVASIBILITY; FACILITATION	Successful establishment of plants is limited by both biotic and abiotic conditions and their interactions. Seedling establishment is also used as a direct measure of habitat suitability, but transient changes in vegetation might provide windows of opportunity allowing plant species to colonize sites which otherwise appear unsuitable. We aimed to study spatio-temporal variability in the effects of resident vegetation on establishment, growth and reproduction of dry grassland species in abandoned arable fields representing potentially suitable habitats. Seeds were sown in disturbed (bare of vegetation and roots) and undisturbed plots in three fields abandoned in the last 20 years. To assess the effects of temporal variation on plant establishment, we initiated our experiments in two years (2007 and 2008). Seventeen out of the 35 sown species flowered within two years after sowing, while three species completely failed to become established. The vegetation in the undisturbed plots facilitated seedling establishment only in the year with low spring precipitation, and the effect did not hold for all species. In contrast, growth and flowering rate were consistently much greater in the disturbed plots, but the effect size differed between the fields and years of sowing. We show that colonization is more successful when site opening by disturbance coincide with other suitable conditions such as weather or soil characteristics. Seasonal variability involved in our study emphasizes the necessity of temporal replication of sowing experiments. Studies assessing habitat suitability by seed sowing should either involve both vegetation removal treatments and untreated plots or follow the gradient of vegetation cover. We strongly recommend following the numbers of established individuals, their sizes and reproductive success when assessing habitat suitability by seed sowing since one can gain completely different results in different phases of plant life cycle.	[Knappova, Jana; Muezbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Knappova, Jana; Muezbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Knapp, Michal] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Knappova, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	jana.knappova@ibot.cas.cz	Knappová, Jana/I-7197-2016; Münzbergová, Zuzana/F-6321-2013; Knapp, Michal/AAF-4864-2020	Knappová, Jana/0000-0002-8095-2583; Münzbergová, Zuzana/0000-0002-4026-6220; Knapp, Michal/0000-0003-4487-7317	Czech Science Foundation [P504/10/0456]; Czech Academy of Sciences [RVO 67985939]; Institute of Botany, Academy of Sciences, and by Ministry of Education; Czech Republic via Department of Botany, Faculty of Science, Charles University, Prague	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences); Institute of Botany, Academy of Sciences, and by Ministry of Education; Czech Republic via Department of Botany, Faculty of Science, Charles University, Prague	The study was supported by the Czech Science Foundation (P504/10/0456) (www.gacr.cz), and partly by the Czech Academy of Sciences (RVO 67985939) (www.cas.cz) via the Institute of Botany, Academy of Sciences, and by Ministry of Education (www.msmt.cz) of the Czech Republic via Department of Botany, Faculty of Science, Charles University, Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Bakker JD, 2003, ECOL APPL, V13, P137, DOI 10.1890/1051-0761(2003)013[0137:COGROY]2.0.CO;2; Bartha S, 2003, APPL VEG SCI, V6, P205, DOI 10.1111/j.1654-109X.2003.tb00581.x; Bonser SP, 1998, ECOSCIENCE, V5, P207, DOI 10.1080/11956860.1998.11682462; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; COTTRELL HJ, 1947, NATURE, V159, P748, DOI 10.1038/159748a0; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Dahlstrom A, 2010, APPL VEG SCI, V13, P305, DOI 10.1111/j.1654-109X.2009.01068.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeSimone SA, 1999, ECOLOGY, V80, P2018, DOI 10.1890/0012-9658(1999)080[2018:SSRIUC]2.0.CO;2; Dickson TL, 2008, J ECOL, V96, P937, DOI 10.1111/j.1365-2745.2008.01420.x; Dickson TL, 2011, ECOL LETT, V14, P380, DOI 10.1111/j.1461-0248.2011.01599.x; DOERR TB, 1984, J RANGE MANAGE, V37, P135, DOI 10.2307/3898900; Ehrlen J, 2006, J ECOL, V94, P1224, DOI 10.1111/j.1365-2745.2006.01169.x; Ejrnaes R, 2006, ECOLOGY, V87, P1225, DOI 10.1890/0012-9658(2006)87[1225:CAIEGS]2.0.CO;2; Ellenberg H., 1992, ZEIGERWERTE GEFASSPL; Eriksson A, 1997, NORD J BOT, V17, P469, DOI 10.1111/j.1756-1051.1997.tb00344.x; Fagan KC, 2008, J APPL ECOL, V45, P1293, DOI 10.1111/j.1365-2664.2008.01492.x; Fayolle A, 2009, OECOLOGIA, V159, P817, DOI 10.1007/s00442-008-1254-0; Francis B, 1993, GLIM 4 STAT SYSTEM G, pxiv; GOLDBERG DE, 1991, J ECOL, V79, P1013, DOI 10.2307/2261095; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Hellstrom K, 2009, J NAT CONSERV, V17, P236, DOI 10.1016/j.jnc.2009.04.007; Hofmann M, 2004, APPL VEG SCI, V7, P193, DOI 10.1111/j.1654-109X.2004.tb00610.x; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Howard TG, 2001, ECOLOGY, V82, P979, DOI 10.1890/0012-9658(2001)082[0979:CRHFGG]2.0.CO;2; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; Janssens F, 1998, PLANT SOIL, V202, P69, DOI 10.1023/A:1004389614865; JASPER DA, 1991, NEW PHYTOL, V118, P471, DOI 10.1111/j.1469-8137.1991.tb00029.x; Jutila HM, 2002, J ECOL, V90, P291, DOI 10.1046/j.1365-2745.2001.00665.x; Kahmen S, 2004, J VEG SCI, V15, P21, DOI 10.1111/j.1654-1103.2004.tb02233.x; Kleijn D, 2003, RESTOR ECOL, V11, P131, DOI 10.1046/j.1526-100X.2003.00015.x; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; Kosola KR, 1999, OECOLOGIA, V118, P69, DOI 10.1007/s004420050704; Lanta V, 2011, PERSPECT PLANT ECOL, V13, P189, DOI 10.1016/j.ppees.2011.05.003; Lavorel S, 1999, OIKOS, V84, P480, DOI 10.2307/3546427; McLellan AJ, 1997, J ECOL, V85, P479, DOI 10.2307/2960571; Milbau A, 2003, NEW PHYTOL, V159, P657, DOI 10.1046/j.1469-8137.2003.00833.x; Munzbergova Z, 2005, OECOLOGIA, V145, P1, DOI 10.1007/s00442-005-0052-1; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Oster M, 2009, J APPL ECOL, V46, P1266, DOI 10.1111/j.1365-2664.2009.01721.x; Pakeman RJ, 2002, APPL VEG SCI, V5, P75, DOI 10.1658/1402-2001(2002)005[0075:SSAPIF]2.0.CO;2; Pankova H, 2008, OECOLOGIA, V157, P211, DOI 10.1007/s00442-008-1064-4; Pywell RF, 2002, J APPL ECOL, V39, P294, DOI 10.1046/j.1365-2664.2002.00718.x; READER RJ, 1993, J ECOL, V81, P169, DOI 10.2307/2261232; Renne IJ, 2006, ECOLOGY, V87, P2264, DOI 10.1890/0012-9658(2006)87[2264:SIGIEO]2.0.CO;2; Roberts RE, 2010, APPL VEG SCI, V13, P270, DOI 10.1111/j.1654-109X.2009.01073.x; Roscher C, 2009, OIKOS, V118, P1524, DOI 10.1111/j.1600-0706.2009.17601.x; ROSS MA, 1972, J ECOL, V60, P77, DOI 10.2307/2258041; Ruprecht E, 2006, RESTOR ECOL, V14, P473, DOI 10.1111/j.1526-100X.2006.00155.x; RYSER P, 1993, J VEG SCI, V4, P195, DOI 10.2307/3236105; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Seabloom EW, 2011, OIKOS, V120, P291, DOI 10.1111/j.1600-0706.2010.18781.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Tutin TG, 1980, FLORA EUROPAEA, P5; Vaughn KJ, 2010, RESTOR ECOL, V18, P59, DOI 10.1111/j.1526-100X.2010.00714.x; Veblen KE, 2008, ECOLOGY, V89, P1532, DOI 10.1890/07-0973.1; Vitova A, 2011, PLANT ECOL, V212, P1231, DOI 10.1007/s11258-011-9900-8; Walker KJ, 2004, BIOL CONSERV, V119, P1, DOI 10.1016/j.biocon.2003.10.020; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Zeiter M, 2006, ECOLOGY, V87, P942, DOI 10.1890/0012-9658(2006)87[942:RLCLSR]2.0.CO;2; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	69	23	23	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65879	10.1371/journal.pone.0065879	http://dx.doi.org/10.1371/journal.pone.0065879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755288	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400080
J	Chen, LF; Ho, HC; Su, YC; Lee, MS; Hung, SK; Chou, P; Lee, CCJ; Lin, LC; Lee, CC				Chen, Li-Fu; Ho, Hsu-Chueh; Su, Yu-Chieh; Lee, Moon-Sing; Hung, Shih-Kai; Chou, Pesus; Lee, Ching-Chieh J.; Lin, Li-Chu; Lee, Ching-Chih			Association between Provider Volume and Healthcare Expenditures of Patients with Oral Cancer in Taiwan: A Population-Based Study	PLOS ONE			English	Article							HOSPITAL VOLUME; 5-YEAR SURVIVAL; SURGEON; COSTS; EXPERIENCE; MORTALITY; OUTCOMES; BURDEN; RATES	Background: Oral cancer requires considerable utilization of healthcare services. Wide resection of the tumor and reconstruction with free flap are widely used. Due to high recurrence rate, close follow-up is mandatory. This study was conducted to explore the relationship between the healthcare expenditure of oncological surgery and one-year follow up and provider volume. Methods: From the National Health Insurance Research Database published by the Taiwanese National Health Research Institute, the authors selected a total of 1300 oral cancer patients who underwent tumor resection and free flap reconstruction in 2008. Hierarchical linear regression analysis was subsequently performed to explore the relationship between provider volume and expenditures of oncological surgery and one-year follow-up period. Emergency department (ED) visits and 30-day readmission rates were also analyzed. Results: The mean expenditure for oncological surgery was $11080 +/- 4645 (all costs are given in U. S. dollars) and $10129 +/- 9248 for one-year follow up. For oncological surgery expenditure, oral cancer patients treated by low-volume surgeons had an additional $845 than those in high-volume surgeons in mixed model. For one-year follow-up expenditure, patients in low-volume hospitals had an additional $3439 than those in high-volume hospitals; patient in low-volume surgeons and medium-volume surgeons incurred an additional expenditure of $2065 and $1811 than those in high-volume surgeons. Oral cancer patients treated in low-volume hospitals incurred higher risk of 30-day readmission rate (odds ratio, 6.6; 95% confidence interval, 1.6-27). Conclusions: After adjusting for physician, hospital, and patient characteristics, low-volume provider performing wide excision with reconstructive surgery in oral cancer patients incurred significantly higher expenditure for oncological surgery and one-year healthcare per patient than did others with higher volumes. Treatment strategies adapted by high-volume providers should be further analyzed.	[Chen, Li-Fu] Natl Yang Ming Univ Hosp, Dept Emergency, Ilan, Taiwan; [Ho, Hsu-Chueh; Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Lee, Moon-Sing; Hung, Shih-Kai] Buddhist Dalin Tzu Chi Gen Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Ho, Hsu-Chueh; Su, Yu-Chieh; Lee, Moon-Sing; Hung, Shih-Kai; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chieh J.] Municipal Hsiao Kang Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Lin, Li-Chu] Buddhist Dalin Tzu Chi Gen Hosp, Dept Med Res, Chiayi, Taiwan; [Lin, Li-Chu] Natl Chung Cheng Univ, Grad Inst Elder Educ, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tzu Chi University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Chung Cheng University	Lee, CC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan.	hematcd@hotmail.com	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017; Hung, Shih-Kai/0000-0002-4945-528X	Department of Health, The Executive Yuan, Taiwan [DOH98-TD-PH-01]; Buddhist Dain Tzu Chi General Hospital [DTCRD 100(2)-I-12]	Department of Health, The Executive Yuan, Taiwan; Buddhist Dain Tzu Chi General Hospital	Financial support for this work was provided by a research grant from the Department of Health, The Executive Yuan, Taiwan (number DOH98-TD-PH-01). This study is based on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health, Taiwan, and managed by the National Health Research Institute. The interpretations and conclusions contained herein do not represent those of the Bureau of National Health Insurance, the Department of Health, or the National Health Research Institute. This study was funded in part by the Buddhist Dain Tzu Chi General Hospital [DTCRD 100(2)-I-12]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040590; Cheng SH, 2004, QUAL SAF HEALTH CARE, V13, P98, DOI 10.1136/qshc.2003.006981; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gruen RL, 2009, CA-CANCER J CLIN, V59, P192, DOI 10.3322/caac.20018; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hammond JW, 2003, J BONE JOINT SURG AM, V85A, P2318, DOI 10.2106/00004623-200312000-00008; Ho TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050337; Lang K, 2004, ARCH OTOLARYNGOL, V130, P1269, DOI 10.1001/archotol.130.11.1269; Lee Jennifer M, 2004, Eur J Health Econ, V5, P70, DOI 10.1007/s10198-003-0204-3; Lin CC, 2008, SURGERY, V143, P343, DOI 10.1016/j.surg.2007.09.033; Lin CS, 2008, PLAST RECONSTR SURG, V122, P133, DOI 10.1097/PRS.0b013e3181773d71; Lin HC, 2007, STROKE, V38, P1565, DOI 10.1161/STROKEAHA.106.474841; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; LUFT HS, 1987, HEALTH SERV RES, V22, P157; Maetzel A, 2004, ANN RHEUM DIS, V63, P395, DOI 10.1136/ard.2003.006031; Mignogna MD, 2004, EUR J CANCER PREV, V13, P139, DOI 10.1097/00008469-200404000-00008; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Shook TL, 1996, AM J CARDIOL, V77, P331, DOI 10.1016/S0002-9149(97)89359-9; Yang YH, 2005, J ORAL PATHOL MED, V34, P596, DOI 10.1111/j.1600-0714.2005.00266.x	24	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65077	10.1371/journal.pone.0065077	http://dx.doi.org/10.1371/journal.pone.0065077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750234	Green Submitted, Green Published, gold			2022-12-25	WOS:000319961900036
J	Kunhi Mouvenchery, Y; Jaeger, A; Aquino, AJA; Tunega, D; Diehl, D; Bertmer, M; Schaumann, GE				Kunhi Mouvenchery, Yamuna; Jaeger, Alexander; Aquino, Adelia J. A.; Tunega, Daniel; Diehl, Doerte; Bertmer, Marko; Schaumann, Gabriele Ellen			Restructuring of a Peat in Interaction with Multivalent Cations: Effect of Cation Type and Aging Time	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; GAUSSIAN-BASIS SETS; MOLECULAR-STRUCTURE; NMR RELAXOMETRY; ATOMS LI; SORPTION; WATER; PARTICLES; KINETICS; SAMPLES	It is assumed to be common knowledge that multivalent cations cross-link soil organic matter (SOM) molecules via cation bridges (CaB). The concept has not been explicitly demonstrated in solid SOM by targeted experiments, yet. Therefore, the requirements for and characteristics of CaB remain unidentified. In this study, a combined experimental and molecular modeling approach was adopted to investigate the interaction of cations on a peat OM from physicochemical perspective. Before treatment with salt solutions of Al3+, Ca2+ or Na+, respectively, the original exchangeable cations were removed using cation exchange resin. Cation treatment was conducted at two different values of pH prior to adjusting pH to 4.1. Cation sorption is slower (>>2 h) than deprotonation of functional groups (<2 h) and was described by a Langmuir model. The maximum uptake increased with pH of cation addition and decreased with increasing cation valency. Sorption coefficients were similar for all cations and at both pH. This contradicts the general expectations for electrostatic interactions, suggesting that not only the interaction chemistry but also spatial distribution of functional groups in OM determines binding of cations in this peat. The reaction of contact angle, matrix rigidity due to water molecule bridges (WaMB) and molecular mobility of water (NMR analysis) suggested that cross-linking via CaB has low relevance in this peat. This unexpected finding is probably due to the low cation exchange capacity, resulting in low abundance of charged functionalities. Molecular modeling demonstrates that large average distances between functionalities (similar to 3 nm in this peat) cannot be bridged by CaB-WaMB associations. However, aging strongly increased matrix rigidity, suggesting successive increase of WaMB size to connect functionalities and thus increasing degree of cross-linking by CaB-WaMB associations. Results thus demonstrated that the physicochemical structure of OM is decisive for CaB and aging-induced structural reorganisation can enhance cross-link formation.	[Kunhi Mouvenchery, Yamuna; Jaeger, Alexander; Diehl, Doerte; Schaumann, Gabriele Ellen] Univ Koblenz Landau, Inst Environm Sci, Dept Environm & Soil Chem, Landau, Germany; [Jaeger, Alexander; Bertmer, Marko] Univ Leipzig, Inst Expt Phys 2, Fac Phys & Earth Sci, D-04109 Leipzig, Germany; [Aquino, Adelia J. A.; Tunega, Daniel] Univ Nat Resources & Life Sci, Vienna Inst Soil Res, Vienna, Austria	University of Koblenz & Landau; Leipzig University; University of Natural Resources & Life Sciences, Vienna	Schaumann, GE (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Dept Environm & Soil Chem, Landau, Germany.	schaumann@uni-landau.de	Aquino, Adelia J.A./F-3226-2016; Schaumann, Gabriele E/B-4283-2015	Schaumann, Gabriele E/0000-0003-1788-2751; Tunega, Daniel/0000-0003-0822-1580; Diehl, Doerte/0000-0001-6868-3627	DFG [SPP 1315];  [SCHA849/8];  [GE 1676/1]	DFG(German Research Foundation (DFG)); ; 	This work was supported by DFG within the priority programme SPP 1315 "Biogeochemical Interfaces in Soil'', projects SCHA849/8 and GE 1676/1 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson A. W., 1967, PHYS CHEM SURFACES; AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Aquino AJA, 2008, CHEM PHYS, V349, P69, DOI 10.1016/j.chemphys.2008.02.063; Aquino AJA, 2011, INT J QUANTUM CHEM, V111, P1531, DOI 10.1002/qua.22693; Aquino AJA, 2011, GEODERMA, V169, P20, DOI 10.1016/j.geoderma.2010.12.006; Aquino AJA, 2009, J PHYS CHEM C, V113, P16468, DOI 10.1021/jp9054796; BACHE BW, 1976, J SCI FOOD AGR, V27, P273, DOI 10.1002/jsfa.2740270313; Bayer J.V., 2010, OPEN MAGNETIC RESONA, V3, P15, DOI DOI 10.2174/1874769801003010015; BENDALL MR, 1983, J MAGN RESON, V53, P365, DOI 10.1016/0022-2364(83)90211-1; Diehl D, 2010, GEODERMA, V158, P375, DOI 10.1016/j.geoderma.2010.06.005; Diehl D, 2009, EUR J SOIL SCI, V60, P557, DOI 10.1111/j.1365-2389.2009.01150.x; Diehl D, 2009, ROLE ORGANIC MATTER; Frimmel FH, 2006, P 13 M INT HUM SUBST, P833; Huang PM, 2011, HDB SOIL SCI PROPERT; Hurrass J, 2005, ENVIRON SCI TECHNOL, V39, P9534, DOI 10.1021/es051588i; Iskrenova-Tchoukova E, 2010, LANGMUIR, V26, P15909, DOI 10.1021/la102535n; Jaeger A, 2011, ORGANIC GEOCHEMISTRY, V42, P917, DOI DOI 10.1016/J.ORGGEOCHEM.2011.03.021; Jaeger F., 2010, OPEN MAGN RESON J, V3, P27, DOI [10.2174/1874769801003020027, DOI 10.2174/1874769801003020027]; Jaeger F, 2008, SOIL SCI SOC AM J, V72, P1694, DOI 10.2136/sssaj2007.0427; Kunhi Mouvenchery Y, 2012, REV ENVIRON SCI BIO, V11, P41, DOI 10.1007/s11157-011-9258-3; Lu YF, 2004, J ENVIRON QUAL, V33, P1314, DOI 10.2134/jeq2004.1314; Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984; McBride M. B., 1994, ENV CHEM SOILS; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Schaumann GE, 2008, EUR J SOIL SCI, V59, P423, DOI 10.1111/j.1365-2389.2007.00959.x; Schaumann GE, 2011, GEODERMA, V169, P55, DOI 10.1016/j.geoderma.2011.11.001; Schaumann GE, 2000, J PLANT NUTR SOIL SC, V163, P523, DOI 10.1002/1522-2624(200010)163:5<523::AID-JPLN523>3.0.CO;2-J; Schaumann GE, 2006, J PLANT NUTR SOIL SC, V169, P145, DOI 10.1002/jpln.200521785; Schaumann GE, 2006, J PLANT NUTR SOIL SC, V169, P157, DOI 10.1002/jpln.200521791; Schaumann GE, 2005, PLANT SOIL, V275, P1, DOI 10.1007/s11104-005-1708-7; Schaumann GE, 2005, COLLOID SURFACE A, V265, P163, DOI 10.1016/j.colsurfa.2005.02.040; Schaumann GE, 2005, ENVIRON SCI TECHNOL, V39, P800, DOI 10.1021/es0490931; Schaumann GE, 2006, P 13 M INT HUM SUBST, P941; Schulten HR, 2000, BIOL FERT SOILS, V30, P399, DOI 10.1007/s003740050020; Soriano MCH, 2012, ROLE ALUMINUM ORGANO; Stewart R.E., 1971, CLASSIFICATION NATUR; Tipping E, 2004, CATION BINDING HUMIC; Volkov AG, 1997, BIOELECTROCH BIOENER, V42, P153, DOI 10.1016/S0302-4598(96)05097-0; Xing BS, 1996, ENVIRON SCI TECHNOL, V30, P2432, DOI 10.1021/es950350z; Xu X, 2006, GEOCHIM COSMOCHIM AC, V70, P4319, DOI 10.1016/j.gca.2006.06.1552; Yuan GS, 2001, SOIL SCI, V166, P107, DOI 10.1097/00010694-200102000-00004	42	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65359	10.1371/journal.pone.0065359	http://dx.doi.org/10.1371/journal.pone.0065359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750256	gold, Green Submitted, Green Published			2022-12-25	WOS:000319961900058
J	Sapkota, Y; Mackey, JR; Lai, R; Franco-Villalobos, C; Lupichuk, S; Robson, PJ; Kopciuk, K; Cass, CE; Yasui, Y; Damaraju, S				Sapkota, Yadav; Mackey, John R.; Lai, Raymond; Franco-Villalobos, Conrado; Lupichuk, Sasha; Robson, Paula J.; Kopciuk, Karen; Cass, Carol E.; Yasui, Yutaka; Damaraju, Sambasivarao			Assessing SNP-SNP Interactions among DNA Repair, Modification and Metabolism Related Pathway Genes in Breast Cancer Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RISK; POLYMORPHISMS; MUTATIONS; CAPACITY; P53; PREDICTION; ALLELES; LINKAGE	Genome-wide association studies (GWASs) have identified low-penetrance common variants (i.e., single nucleotide polymorphisms, SNPs) associated with breast cancer susceptibility. Although GWASs are primarily focused on single-locus effects, gene-gene interactions (i.e., epistasis) are also assumed to contribute to the genetic risks for complex diseases including breast cancer. While it has been hypothesized that moderately ranked (P value based) weak single-locus effects in GWASs could potentially harbor valuable information for evaluating epistasis, we lack systematic efforts to investigate SNPs showing consistent associations with weak statistical significance across independent discovery and replication stages. The objectives of this study were i) to select SNPs showing single-locus effects with weak statistical significance for breast cancer in a GWAS and/or candidate-gene studies; ii) to replicate these SNPs in an independent set of breast cancer cases and controls; and iii) to explore their potential SNP-SNP interactions contributing to breast cancer susceptibility. A total of 17 SNPs related to DNA repair, modification and metabolism pathway genes were selected since these pathways offer a priori knowledge for potential epistatic interactions and an overall role in breast carcinogenesis. The study design included predominantly Caucasian women (2,795 cases and 4,505 controls) from Alberta, Canada. We observed two two-way SNP-SNP interactions (APEX1-rs1130409 and RPAP1-rs2297381; MLH1-rs1799977 and MDM2-rs769412) in logistic regression that conferred elevated risks for breast cancer (P-interaction < 7.3 x 10(-3)). Logic regression identified an interaction involving four SNPs (MBD2-rs4041245, MLH1-rs1799977, MDM2-rs769412, BRCA2-rs1799943) (P-permutation = 2.4 x 10(-3)). SNPs involved in SNP-SNP interactions also showed single-locus effects with weak statistical significance, while BRCA2-rs1799943 showed stronger statistical significance (P-correlation/trend = 3.2 x 10(-4)) than the others. These single-locus effects were independent of body mass index. Our results provide a framework for evaluating SNPs showing statistically weak but reproducible singlelocus effects for epistatic effects contributing to disease susceptibility.	[Sapkota, Yadav; Mackey, John R.; Cass, Carol E.; Damaraju, Sambasivarao] Alberta Hlth Serv, Cross Canc Inst, Edmonton, AB, Canada; [Sapkota, Yadav; Lai, Raymond; Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Mackey, John R.; Cass, Carol E.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Franco-Villalobos, Conrado; Yasui, Yutaka] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Lupichuk, Sasha; Kopciuk, Karen] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Robson, Paula J.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Kopciuk, Karen] Univ Calgary, Dept Math & Stat, Calgary, AB T2N 1N4, Canada; [Robson, Paula J.] Alberta Hlth Serv Canc Care, Edmonton, AB, Canada; [Lupichuk, Sasha] Alberta Hlth Serv, Tom Baker Canc Ctr, Calgary, AB, Canada	Alberta Health Services (AHS); University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Calgary; University of Alberta; University of Calgary; Alberta Health Services (AHS); Alberta Health Services (AHS); Tom Baker Cancer Clinic; University of Calgary	Damaraju, S (corresponding author), Alberta Hlth Serv, Cross Canc Inst, Edmonton, AB, Canada.	Sambasivarao.Damaraju@albertahealthservices.ca	Robson, Paula J/Q-3351-2017; Yasui, Yutaka/E-2564-2015; Sapkota, Yadav/O-2142-2015	Robson, Paula J/0000-0003-4640-1371; Yasui, Yutaka/0000-0002-7717-8638; Sapkota, Yadav/0000-0001-5943-9454	Alberta Cancer Research Institute; Canadian Breast Cancer Foundation (CBCF); Alberta Cancer Board; CBCF-Prairies/NWT Region; Alberta Cancer Foundation; Alberta Cancer Prevention and Legacy Fund; Alberta Cancer Prevention Legacy	Alberta Cancer Research Institute; Canadian Breast Cancer Foundation (CBCF); Alberta Cancer Board; CBCF-Prairies/NWT Region(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine); Alberta Cancer Foundation; Alberta Cancer Prevention and Legacy Fund; Alberta Cancer Prevention Legacy	This work was supported by Alberta Cancer Research Institute, Canadian Breast Cancer Foundation (CBCF) operating grants and Alberta Cancer Board operating grants to SD. The CBCF Tumor Bank was funded by the CBCF-Prairies/NWT Region, Alberta Cancer Foundation, Alberta Cancer Prevention and Legacy Fund (managed by the Alberta Innovates-Health Solutions). Funding for the Tomorrow Project was provided by the Alberta Cancer Foundation and the Alberta Cancer Prevention Legacy (managed by Alberta Innovates - ealth Solutions) and the Canadian Partnership Against Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Conde J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-344; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Dinu I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043035; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Economopoulos KP, 2010, BREAST CANCER RES TR, V121, P439, DOI 10.1007/s10549-009-0562-3; Feng QH, 2005, JNCI-J NATL CANCER I, V97, P273, DOI 10.1093/jnci/dji041; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gochhait S, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1780; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kooperberg C, 2012, LOGICREG LOGIC REGRE; Leng SG, 2008, CANCER EPIDEM BIOMAR, V17, P2062, DOI 10.1158/1055-9965.EPI-08-0308; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lo SH, 2008, P NATL ACAD SCI USA, V105, P12387, DOI 10.1073/pnas.0805242105; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Mitra AK, 2008, ONCOL RES, V17, P127, DOI 10.3727/096504008785055567; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R LANG ENV STAT COMP; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rajaraman P, 2008, INT J CANCER, V123, P2713, DOI 10.1002/ijc.23779; Rao NM, 1998, CANCER GENET CYTOGEN, V102, P65, DOI 10.1016/S0165-4608(97)00303-8; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096; Sapkota Y, 2012, EUR J HUM GENET, V20, P682, DOI 10.1038/ejhg.2011.273; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sehrawat B, 2011, HUM GENET, V130, P529, DOI 10.1007/s00439-011-0973-1; Shen J, 2006, CANCER EPIDEM BIOMAR, V15, P1614, DOI 10.1158/1055-9965.EPI-06-0218; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	44	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64896	10.1371/journal.pone.0064896	http://dx.doi.org/10.1371/journal.pone.0064896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755158	Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300037
J	Tan, BK; Sivakumar, K; Bari, MF; Vatish, M; Randeva, HS				Tan, Bee K.; Sivakumar, Kavitha; Bari, Muhammad F.; Vatish, Manu; Randeva, Harpal S.			Lower Cerebrospinal Fluid/Plasma Fibroblast Growth Factor 21 (FGF21) Ratios and Placental FGF21 Production in Gestational Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC REGULATOR; OBESE WOMEN; PREGNANCY; MELLITUS; LEPTIN; BRAIN; ADIPONECTIN; GLUCOSE; FGF-21	Objectives: Circulating Fibroblast Growth Factor 21 (FGF21) levels are increased in insulin resistant states such as obesity, type 2 diabetes mellitus and gestational diabetes mellitus (GDM). In addition, GDM is associated with serious maternal and fetal complications. We sought to study human cerebrospinal fluid (CSF) and corresponding circulating FGF21 levels in women with gestational diabetes mellitus (GDM) and in age and BMI matched control subjects. We also assessed FGF21 secretion from GDM and control human placental explants. Design: CSF and corresponding plasma FGF21 levels of 24 women were measured by ELISA [12 GDM (age: 26-47 years, BMI: 24.3-36.3 kg/m(2)) and 12 controls (age: 22-40 years, BMI: 30.1-37.0 kg/m(2))]. FGF21 levels in conditioned media were secretion from GDM and control human placental explants were also measured by ELISA. Results: Glucose, HOMA-IR and circulating NEFA levels were significantly higher in women with GDM compared to control subjects. Plasma FGF21 levels were significantly higher in women with GDM compared to control subjects [234.3 (150.2-352.7) vs. 115.5 (60.5-188.7) pg/ml; P<0.05]. However, there was no significant difference in CSF FGF21 levels in women with GDM compared to control subjects. Interestingly, CSF/Plasma FGF21 ratio was significantly lower in women with GDM compared to control subjects [0.4 (0.3-0.6) vs. 0.8 (0.5-1.6); P<0.05]. FGF21 secretion into conditioned media was significantly lower in human placental explants from women with GDM compared to control subjects (P<0.05). Conclusions: The central actions of FGF21 in GDM subjects maybe pivotal in the pathogenesis of insulin resistance in GDM subjects. The significance of FGF21 produced by the placenta remains uncharted and maybe crucial in our understanding of the patho-physiology of GDM and its associated maternal and fetal complications. Future research should seek to elucidate these points.	[Tan, Bee K.; Sivakumar, Kavitha; Bari, Muhammad F.; Randeva, Harpal S.] Univ Warwick, Warwick Med Sch, Div Metab & Vasc Hlth, Coventry CV4 7AL, W Midlands, England; [Tan, Bee K.; Sivakumar, Kavitha; Bari, Muhammad F.; Randeva, Harpal S.] Univ Warwick, Warwick Med Sch, Div Reprod, Coventry CV4 7AL, W Midlands, England; [Vatish, Manu] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	University of Warwick; University of Warwick; University of Oxford	Vatish, M (corresponding author), Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England.	Manu.Vatish@obs-gyn.ox.ac.uk	Vatish, Manu/B-4458-2018; vatish, manu/AAY-8750-2020	vatish, manu/0000-0002-6012-2574	Coventry General Charities	Coventry General Charities	This work was funded by a grant from Coventry General Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal MM, 2005, DIABETIC MED, V22, P1731, DOI 10.1111/j.1464-5491.2005.01706.x; Baptiste-Roberts K, 2009, AM J MED, V122, P207, DOI 10.1016/j.amjmed.2008.09.034; Butte NF, 2000, AM J CLIN NUTR, V71, p1256S, DOI 10.1093/ajcn/71.5.1256s; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Chen J, 2006, DIABETOLOGIA, V49, P1292, DOI 10.1007/s00125-006-0194-7; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Hsuchou H, 2007, PEPTIDES, V28, P2382, DOI 10.1016/j.peptides.2007.10.007; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Lappas M, 2005, J ENDOCRINOL, V186, P457, DOI 10.1677/joe.1.06227; Li K, 2009, EUR J ENDOCRINOL, V161, P391, DOI 10.1530/EJE-09-0335; Li L, 2008, DIABETES RES CLIN PR, V82, P209, DOI 10.1016/j.diabres.2008.07.012; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morkrid K, 2012, EUR J ENDOCRINOL, V167, P579, DOI 10.1530/EJE-12-0452; Nam SY, 2001, J CLIN ENDOCR METAB, V86, P4849, DOI 10.1210/jc.86.10.4849; Pathmaperuma AN, 2010, PLACENTA, V31, P230, DOI 10.1016/j.placenta.2009.12.013; Salihu HM, 2009, OBSTET GYNECOL, V114, P333, DOI 10.1097/AOG.0b013e3181ae9a47; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Smirnakis KV, 2005, DIABETES CARE, V28, P1207, DOI 10.2337/diacare.28.5.1207; Tan BK, 2011, DIABETES, V60, P2758, DOI 10.2337/db11-0672; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V277, P494, DOI 10.1006/bbrc.2000.3696; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	27	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65254	10.1371/journal.pone.0065254	http://dx.doi.org/10.1371/journal.pone.0065254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755203	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300066
J	Wilhelmi, V; Fischer, U; Weighardt, H; Schulze-Osthoff, K; Nickel, C; Stahlmecke, B; Kuhlbusch, TAJ; Scherbart, AM; Esser, C; Schins, RPF; Albrecht, C				Wilhelmi, Verena; Fischer, Ute; Weighardt, Heike; Schulze-Osthoff, Klaus; Nickel, Carmen; Stahlmecke, Burkhard; Kuhlbusch, Thomas A. J.; Scherbart, Agnes M.; Esser, Charlotte; Schins, Roel P. F.; Albrecht, Catrin			Zinc Oxide Nanoparticles Induce Necrosis and Apoptosis in Macrophages in a p47phox-and Nrf2-Independent Manner	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; SIGNALING PATHWAYS; CELL-DEATH; NRF2; ACTIVATION; PROTEIN; STRESS; LUNG; P53; DISSOLUTION	In view of the steadily increasing use of zinc oxide nanoparticles in various industrial and consumer applications, toxicological investigations to evaluate their safety are highly justified. We have investigated mechanisms of ZnO nanoparticle-induced apoptosis and necrosis in macrophages in relation to their important role in the clearance of inhaled particulates and the regulation of immune responses during inflammation. In the murine macrophage RAW 264.7 cell line, ZnO treatment caused a rapid induction of nuclear condensation, DNA fragmentation, and the formation of hypodiploid DNA nuclei and apoptotic bodies. The involvement of the essential effector caspase-3 in ZnO-mediated apoptosis could be demonstrated by immunocytochemical detection of activated caspase-3 in RAW 264.7 cells. ZnO specifically triggered the intrinsic apoptotic pathway, because Jurkat T lymphocytes deficient in the key mediator caspase-9 were protected against ZnO-mediated toxicity whereas reconstituted cells were not. ZnO also caused DNA strand breakage and oxidative DNA damage in the RAW 264.7 cells as well as p47(phox) NADPH oxidase-dependent superoxide generation in bone marrow-derived macrophages. However, ZnO-induced cell death was not affected in bone marrow-derived macrophages of mice deficient in p47(phox) or the oxidant responsive transcription factor Nrf2. Taken together, our data demonstrate that ZnO nanoparticles trigger p47(phox) NADPH oxidase-mediated ROS formation in macrophages, but that this is dispensable for caspase-9/3-mediated apoptosis. Execution of apoptotic cell death by ZnO nanoparticles appears to be NADPH oxidase and Nrf2-independent but rather triggered by alternative routes.	[Wilhelmi, Verena; Weighardt, Heike; Scherbart, Agnes M.; Esser, Charlotte; Schins, Roel P. F.; Albrecht, Catrin] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Fischer, Ute] Univ Dusseldorf, Fac Med, Ctr Child & Adolescent Hlth, Clin Pediat Oncol Haematol & Clin Immunol, D-40225 Dusseldorf, Germany; [Schulze-Osthoff, Klaus] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Nickel, Carmen; Stahlmecke, Burkhard; Kuhlbusch, Thomas A. J.] Air Qual & Sustainable Nanotechnol, Inst Energy & Environm Technol, Duisburg, Germany	Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; University of Duisburg Essen	Albrecht, C (corresponding author), IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany.	catrin.albrecht@uni-duesseldorf.de	Ibrahim, Essam Hassan/G-1960-2018; Schulze-Osthoff, Klaus/N-9025-2013	Ibrahim, Essam Hassan/0000-0003-0130-2257; Schulze-Osthoff, Klaus/0000-0003-1443-2720; Wolf, Carmen/0000-0001-9362-942X; Kuhlbusch, Thomas/0000-0001-7847-9304; Stahlmecke, Burkhard/0000-0001-8035-5589	Research Commission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf; German Research Council (Graduate Schools) [GRK1033, GRK1427]	Research Commission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf; German Research Council (Graduate Schools)	This study was financially supported by the Research Commission of the Medical Faculty of the Heinrich-Heine-University Dusseldorf as well as the German Research Council (Graduate Schools GRK1033 and GRK1427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2011, NANOMED-NANOTECHNOL, V7, P904, DOI 10.1016/j.nano.2011.04.011; Akhtar MJ, 2012, INT J NANOMED, V7, P845, DOI 10.2147/IJN.S29129; Castranova V, 2004, FREE RADICAL BIO MED, V37, P916, DOI 10.1016/j.freeradbiomed.2004.05.032; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho WS, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-27; Cho WS, 2010, ENVIRON HEALTH PERSP, V118, P1699, DOI 10.1289/ehp.1002201; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Geiser M, 2010, J AEROSOL MED PULM D, V23, P207, DOI 10.1089/jamp.2009.0797; Gerloff K., 2012, NANOTOXICOLOGY; Gerloff K, 2012, CHEM RES TOXICOL, V25, P646, DOI 10.1021/tx200334k; Gerloff K, 2009, NANOTOXICOLOGY, V3, P355, DOI 10.3109/17435390903276933; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Iyer R, 1996, TOXICOL APPL PHARM, V141, P84, DOI 10.1006/taap.1996.0263; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Kang SJ, 2012, TOXICOL APPL PHARM, V258, P89, DOI 10.1016/j.taap.2011.10.011; Kelleher P, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3454405; Kermanizadeh A, 2012, NANOTOXICOLOGY; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kumar MA, 2011, SENSORS-BASEL, V11, P5087, DOI 10.3390/s110505087; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Lin WS, 2009, J NANOPART RES, V11, P25, DOI 10.1007/s11051-008-9419-7; Meyer K, 2011, TOXICOL IN VITRO, V25, P1721, DOI 10.1016/j.tiv.2011.08.011; Moos PJ, 2010, CHEM RES TOXICOL, V23, P733, DOI 10.1021/tx900203v; Morito N, 2003, ONCOGENE, V22, P9275, DOI 10.1038/sj.onc.1207024; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Musee N, 2011, J ENVIRON MONITOR, V13, P1164, DOI 10.1039/c1em10023h; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Park JB, 2003, EXP MOL MED, V35, P325, DOI 10.1038/emm.2003.44; Rasmussen JW, 2010, EXPERT OPIN DRUG DEL, V7, P1063, DOI 10.1517/17425247.2010.502560; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Samraj AK, 2007, MOL BIOL CELL, V18, P84, DOI 10.1091/mbc.E06-04-0263; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schilling K, 2010, PHOTOCH PHOTOBIO SCI, V9, P495, DOI 10.1039/b9pp00180h; Sharma V, 2011, MUTAT RES, V745, P84; Sharma V, 2012, APOPTOSIS, V17, P852, DOI 10.1007/s10495-012-0705-6; Shi YG, 2002, STRUCTURE, V10, P285, DOI 10.1016/S0969-2126(02)00732-3; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Speit G, 2004, TOXICOL LETT, V146, P151, DOI 10.1016/j.toxlet.2003.09.010; Stone V, 2009, CRIT REV TOXICOL, V39, P613, DOI 10.1080/10408440903120975; Tankhiwale R, 2012, COLLOID SURFACE B, V90, P16, DOI 10.1016/j.colsurfb.2011.09.031; Taylor RNK, 2011, ADV MATER, V23, P2554, DOI 10.1002/adma.201100541; Turney TW, 2012, CHEM RES TOXICOL; Unfried K, 2007, NANOTOXICOLOGY, V1, P52, DOI 10.1080/00222930701314932; van Berlo D, 2010, FREE RADICAL BIO MED, V49, P1685, DOI 10.1016/j.freeradbiomed.2010.08.031; Wells MA, 2012, NANOTOXICOLOGY, V6, P837, DOI 10.3109/17435390.2011.625131; Wilhelmi V, 2012, TOXICOL IN VITRO, V26, P323, DOI 10.1016/j.tiv.2011.12.006; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Yu JY, 2011, TOXICOL IN VITRO, V25, P1654, DOI 10.1016/j.tiv.2011.07.002; Zhang JY, 2012, J HAZARD MATER, V219, P148, DOI 10.1016/j.jhazmat.2012.03.069	55	90	92	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65704	10.1371/journal.pone.0065704	http://dx.doi.org/10.1371/journal.pone.0065704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755271	gold, Green Submitted, Green Published			2022-12-25	WOS:000319872300092
J	Zhang, CF; Qiu, SF; Wang, Y; Qi, LH; Hao, RZ; Liu, XL; Shi, Y; Hu, XF; An, DZ; Li, ZJ; Li, P; Wang, LG; Cui, JJ; Wang, P; Huang, LY; Klena, JD; Song, HB				Zhang, Chuanfu; Qiu, Shaofu; Wang, Yong; Qi, Lihua; Hao, Rongzhang; Liu, Xuelin; Shi, Yun; Hu, Xiaofeng; An, Daizhi; Li, Zhenjun; Li, Peng; Wang, Ligui; Cui, Jiajun; Wang, Pan; Huang, Liuyu; Klena, John D.; Song, Hongbin			Higher Isolation of NDM-1 Producing Acinetobacter baumannii from the Sewage of the Hospitals in Beijing	PLOS ONE			English	Article							WASTE-WATER TREATMENT; HUMAN HEALTH; IDENTIFICATION; BACTERIA	Multidrug resistant microbes present in the environment are a potential public health risk. In this study, we investigate the presence of New Delhi metallo-beta-lactamase 1 (NDM-1) producing bacteria in the 99 water samples in Beijing City, including river water, treated drinking water, raw water samples from the pools and sewage from 4 comprehensive hospitals. For the bla(NDM)-1 positive isolate, antimicrobial susceptibility testing was further analyzed, and Pulsed Field Gel Electrophoresis (PFGE) was performed to determine the genetic relationship among the NDM-1 producing isolates from sewage and human, as well as the clinical strains without NDM-1. The results indicate that there was a higher isolation of NDM-1 producing Acinetobacter baumannii from the sewage of the hospitals, while no NDM-1 producing isolates were recovered from samples obtained from the river, drinking, or fishpond water. Surprisingly, these isolates were markedly different from the clinical isolates in drug resistance and pulsed field gel electrophoresis profiles, suggesting different evolutionary relationships. Our results showed that the hospital sewage may be one of the diffusion reservoirs of NDM-1 producing bacteria.	[Zhang, Chuanfu; Qiu, Shaofu; Wang, Yong; Qi, Lihua; Hao, Rongzhang; Liu, Xuelin; Shi, Yun; Hu, Xiaofeng; An, Daizhi; Li, Peng; Wang, Ligui; Cui, Jiajun; Wang, Pan; Huang, Liuyu; Song, Hongbin] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China; [Li, Zhenjun] China Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Klena, John D.] China US Collaborat Program Emerging & Reemerging, US Ctr Dis Control & Prevent, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Chinese Center for Disease Control & Prevention	Qiu, SF (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	qiushf0613@hotmail.com; hongbinsong@263.net	Qi, LI/AAF-3389-2019; Qiu, Shaofu/CAJ-0602-2022		National Science and technology Major Project of China [2012ZX10004-215, 2013ZX10004-218, 2013ZX10004-07, 2012ZX10004-801, 2013ZX10004-203, 2013ZX10004-217-002]; National Natural Science Foundation of China [81000723, 81070969, 81171554]	National Science and technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Science and technology Major Project of China (2012ZX10004-215, 2013ZX10004-218, 2013ZX10004-07, 2012ZX10004-801, 2013ZX10004-203, 2013ZX10004-217-002) and the National Natural Science Foundation of China (81000723, 81070969, 81171554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushnell G, 2013, INT J INFECT DIS, V17, pE325, DOI 10.1016/j.ijid.2012.11.025; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Guardabassi L, 2002, WATER RES, V36, P1955, DOI 10.1016/S0043-1354(01)00429-8; Kim S, 2007, J TOXICOL ENV HEAL B, V10, P559, DOI 10.1080/15287390600975137; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Toleman MA, 2012, ANTIMICROB AGENTS CH, V56, P2773, DOI 10.1128/AAC.06297-11; Vila J, 1996, J MED MICROBIOL, V44, P482, DOI 10.1099/00222615-44-6-482; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wang XS, 2013, CLIN INFECT DIS, V56, P161, DOI 10.1093/cid/cis782; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhou ZW, 2012, CAN J MICROBIOL, V58, P112, DOI [10.1139/W11-112, 10.1139/w11-112]; Zong ZY, 2013, J ANTIMICROB CHEMOTH, V68, P1007, DOI 10.1093/jac/dks505	13	42	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64857	10.1371/journal.pone.0064857	http://dx.doi.org/10.1371/journal.pone.0064857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755152	gold, Green Published			2022-12-25	WOS:000319872300032
J	Orre, LM; Panizza, E; Kaminskyy, VO; Vernet, E; Graslund, T; Zhivotovsky, B; Lehtio, J				Orre, L. M.; Panizza, E.; Kaminskyy, V. O.; Vernet, E.; Graslund, T.; Zhivotovsky, B.; Lehtio, J.			S100A4 interacts with p53 in the nucleus and promotes p53 degradation	ONCOGENE			English	Article						S100A4; p53; interaction study; proximity ligation assay; immunoprecipitation	METASTASIS-INDUCING PROTEIN; HUMAN BREAST-CANCER; CALCIUM-BINDING PROTEIN; TUMOR-SUPPRESSOR P53; N-TERMINAL DOMAIN; CELL LUNG-CANCER; COLORECTAL-CANCER; E-CADHERIN; DIFFERENTIAL EXPRESSION; PROGNOSTIC-SIGNIFICANCE	S100A4 is a small calcium-binding protein that is commonly overexpressed in a range of different tumor types, and it is widely accepted that S100A4 has an important role in the process of cancer metastasis. In vitro binding assays has shown that S100A4 interacts with the tumor suppressor protein p53, indicating that S100A4 may have additional roles in tumor development. In the present study, we show that endogenous S100A4 and p53 interact in complex samples, and that the interaction increases after inhibition of MDM2-dependent p53 degradation using Nutlin-3A. Further, using proximity ligation assay, we show that the interaction takes place in the cell nucleus. S100A4 knockdown experiments in two p53 wild-type cell lines, A549 and HeLa, resulted in stabilization of p53 protein, indicating that S100A4 is promoting p53 degradation. Finally, we demonstrate that S100A4 knockdown leads to p53-dependent cell cycle arrest and increased cisplatin-induced apoptosis. Thus, our data add a new layer to the oncogenic properties of S100A4 through its inhibition of p53-dependent processes.	[Orre, L. M.; Panizza, E.; Lehtio, J.] Karolinska Inst, Sci Life Lab, Dept Pathol & Oncol, S-17121 Stockholm, Sweden; [Kaminskyy, V. O.; Zhivotovsky, B.] Karolinska Inst, Inst Environm Med, Div Toxicol, S-17121 Stockholm, Sweden; [Vernet, E.; Graslund, T.] AlbaNova Univ Ctr, Royal Inst Technol, KTH, Div Mol Biotechnol,Sch Biotechnol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology	Orre, LM (corresponding author), Karolinska Inst, Sci Life Lab, Dept Pathol & Oncol, POB 1031, S-17121 Stockholm, Sweden.	lukas.orre@ki.se	Vernet, Erik/O-1880-2019; Zhivotovsky, Boris/A-4346-2014; Vernet, Erik/G-8520-2011	Vernet, Erik/0000-0002-4175-1244; Zhivotovsky, Boris/0000-0002-2238-3482; Vernet, Erik/0000-0002-4175-1244; Kaminskyy, Vitaliy/0000-0002-8151-5270; Lehtio, Janne/0000-0002-8100-9562; Orre, Lukas/0000-0002-0384-1003; Panizza, Elena/0000-0003-3490-4107	Swedish Cancer Society; Swedish Research Foundation; Swedish Research council; Swedish Childhood Cancer Society; European Union; Swedish Institute; Karolinska Institutet; Karolinska Institutet KID funding; Stockholm Cancer Society	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Foundation; Swedish Research council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Society; European Union(European Commission); Swedish Institute; Karolinska Institutet(Karolinska Institutet); Karolinska Institutet KID funding(Karolinska Institutet); Stockholm Cancer Society	We thank Professor Didier Trono at the School of Life Sciences, EPFL, Lausanne, Switzerland for providing the helper plasmids for viral vector production, pG32231 and pMD2.G. We also thank the group of Professor Hjalmar Brismar for assistance in the use of confocal microscopy. This study was supported by grants from the Swedish and Stockholm Cancer Societies, the Swedish Research Foundation, the Swedish Research council, the Swedish Childhood Cancer Society, the European Union (Chemores and Apo-Sys). VOK was supported by a fellowship from the Swedish Institute and Karolinska Institutet. EP was supported by Karolinska Institutet KID funding.	Ambartsumian NS, 1996, ONCOGENE, V13, P1621; Berge G, 2011, AMINO ACIDS, V41, P875, DOI 10.1007/s00726-010-0514-6; Berge G, 2011, AMINO ACIDS, V41, P863, DOI 10.1007/s00726-010-0497-3; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chen HL, 2001, BIOCHEM BIOPH RES CO, V286, P1212, DOI 10.1006/bbrc.2001.5517; Cho YG, 2003, APMIS, V111, P539, DOI 10.1034/j.1600-0463.2003.1110502.x; Cho YG, 2005, WORLD J GASTROENTERO, V11, P4852, DOI 10.3748/wjg.v11.i31.4852; DAVIES BR, 1993, ONCOGENE, V8, P999; Davies BR, 2002, J PATHOL, V196, P292, DOI 10.1002/path.1051; De Petris L, 2009, LUNG CANCER, V63, P410, DOI 10.1016/j.lungcan.2008.06.003; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Flatmark K, 2003, J PATHOL, V200, P589, DOI 10.1002/path.1381; Gongoll S, 2002, GASTROENTEROLOGY, V123, P1478, DOI 10.1053/gast.2002.36606; Grigorian M, 1996, INT J CANCER, V67, P831, DOI 10.1002/(SICI)1097-0215(19960917)67:6<831::AID-IJC13>3.0.CO;2-4; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gupta S, 2003, J CLIN ONCOL, V21, P106, DOI 10.1200/JCO.2003.03.024; Heizmann Claus W, 2002, Methods Mol Biol, V172, P69; Hemandas AK, 2006, J SURG ONCOL, V93, P498, DOI 10.1002/jso.20460; Hjerpe R, 2010, INT J BIOCHEM CELL B, V42, P725, DOI 10.1016/j.biocel.2010.01.010; Ismail TM, 2010, J BIOL CHEM, V285, P914, DOI 10.1074/jbc.M109.010892; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; Kaminskyy VO, 2012, AUTOPHAGY, V8, P1032, DOI 10.4161/auto.20123; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kim JH, 2009, ONCOL REP, V22, P41, DOI 10.3892/or_00000404; Kimura K, 2000, INT J ONCOL, V16, P1125; Kriajevska M, 2000, BBA-MOL CELL RES, V1498, P252, DOI 10.1016/S0167-4889(00)00100-2; Lee WY, 2004, ONCOLOGY-BASEL, V66, P429, DOI 10.1159/000079496; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Matsubara D, 2005, CANCER SCI, V96, P844, DOI 10.1111/j.1349-7006.2005.00121.x; Matsumoto K, 2007, UROLOGY, V70, P602, DOI 10.1016/j.urology.2007.04.007; Oida Y, 2006, ONCOL REP, V16, P457; Orre LM, 2007, MOL CELL PROTEOMICS, V6, P2122, DOI 10.1074/mcp.M700202-MCP200; Pedersen KB, 2002, BRIT J CANCER, V87, P1281, DOI 10.1038/sj.bjc.6600624; Platt-Higgins AM, 2000, INT J CANCER, V89, P198, DOI 10.1002/(SICI)1097-0215(20000320)89:2<198::AID-IJC16>3.0.CO;2-L; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Rosty C, 2002, AM J PATHOL, V160, P45, DOI 10.1016/S0002-9440(10)64347-7; Rudland PS, 2000, CANCER RES, V60, P1595; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; van Dieck J, 2010, ONCOGENE, V29, P2024, DOI 10.1038/onc.2009.490; van Dieck J, 2010, FEBS LETT, V584, P3269, DOI 10.1016/j.febslet.2010.06.024; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Xie R, 2007, MODERN PATHOL, V20, P1045, DOI 10.1038/modpathol.3800940; Zou M, 2005, BRIT J CANCER, V93, P1277, DOI 10.1038/sj.bjc.6602856	52	69	71	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 5	2013	32	49					5531	5540		10.1038/onc.2013.213	http://dx.doi.org/10.1038/onc.2013.213			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	269XF	23752197	hybrid			2022-12-25	WOS:000328276400004
J	Ghazi-Visser, L; Laman, JD; Nagel, S; van Meurs, M; van Riel, D; Tzankov, A; Frank, S; Adams, H; Wolk, K; Terracciano, L; Melief, MJ; Sabat, R; Gunthert, U				Ghazi-Visser, Lizette; Laman, Jon D.; Nagel, Sabine; van Meurs, Marjan; van Riel, Debby; Tzankov, Alexandar; Frank, Stephan; Adams, Heiner; Wolk, Kerstin; Terracciano, Luigi; Melief, Marie-Jose; Sabat, Robert; Guenthert, Ursula			CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells	FASEB JOURNAL			English	Article						multiple sclerosis; apoptosis; Th1	CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; EXPRESSION; INDUCTION; APOPTOSIS; ANTIBODY; DISEASE; LESIONS; CNS; INFLAMMATION	CD44 variant (CD44(v)) isoforms play important roles in the development of autoimmune disorders, including colitis and arthritis, but their role in multiple sclerosis (MS) has been explored only to a limited extent. We determined the functional relevance of CD44(v) isoforms in MS and its animal model, experimental autoimmune encephalomyelitis (EAE). Genetic ablation of CD44(v7) and CD44(v10) isoforms significantly reduced the clinical EAE burden, as well as the number of inflammatory infiltrates. CD44(v7) and CD44(v10) expression on both memory T and antigen-presenting cells, participated in the development of adoptive transfer EAE. Significantly reduced mRNA expression of Th1 signature genes was detected in the brains of CD44(v10-/-) mice compared with those of CD44(WT) mice. Furthermore, forkhead transcription factor 3 (Foxp3), Bcl-2, and inducible nitric oxide synthase (iNOS) levels were reduced in CD44(v10-/-) brains, whereas active caspase-3 was elevated. Brain-infiltrating CD4(hi)CD44(v10+) T cells preceded EAE onset and paralleled disease severity in wild-type but not in CD44(v7-/-) and CD44(v10-/-) mice. CD44(v7) and CD44(v10) expression contributed to EAE by increasing the longevity of autoreactive CD4(hi)panCD44(hi) T cells. Accordingly, the absence of CD44(v7) and CD44(v10) led to increased apoptosis in the inflammatory infiltrates and reduced Th1 responses, resulting in marked disease reduction. Although absent in noninflamed human brains, we detected CD44(v3), CD44(v7), and CD44(v10) isoforms on glial cells and on perivascular infiltrating cells of MS lesions. We conclude that CD44(v7) and CD44(v10), expressed on autoreactive CD4(hi)panCD44(hi) T cells, are critically involved in the pathogenesis of classic EAE by increasing their life span. Targeting these short CD44(v) isoform regions may reduce inflammatory processes and clinical symptoms in MS.Ghazi-Visser, L., Laman, J. D., Nagel, S., van Meurs, M., van Riel, D., Tzankov, A., Frank, S., Adams, H., Wolk, K., Terracciano, L., Melief, M.-J., Sabat, R., Gunthert, U. CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.	[Ghazi-Visser, Lizette; Laman, Jon D.; van Meurs, Marjan; van Riel, Debby; Melief, Marie-Jose] Univ Med Ctr Rotterdam, Dept Immunol, Rotterdam, Netherlands; [Ghazi-Visser, Lizette; Laman, Jon D.; van Meurs, Marjan; van Riel, Debby; Melief, Marie-Jose] Univ Med Ctr Rotterdam, Multiple Sclerosis MS Ctr ErasMS, Erasmus Med Ctr, Rotterdam, Netherlands; [Nagel, Sabine; Tzankov, Alexandar; Frank, Stephan; Adams, Heiner; Terracciano, Luigi; Guenthert, Ursula] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Wolk, Kerstin; Sabat, Robert] Univ Hosp Charite, Interdisciplinary Grp Mol Immunopathol, Berlin, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Basel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gunthert, U (corresponding author), Univ Basel Hosp, Inst Pathol, Schonbeinstr 40, CH-4031 Basel, Switzerland.	ursula.guenthert@unibas.ch	Terracciano, Luigi M./AAB-5335-2022; Wolk, Kerstin/O-1205-2013; Tzankov, Alexandar/H-5656-2019	Terracciano, Luigi M./0000-0002-9393-9660; Tzankov, Alexandar/0000-0002-1100-3819; van Riel, Debby/0000-0001-9753-3564; Wolk, Kerstin/0000-0002-7689-4130	Swiss National Fund [3100-067084.01]; Dutch MS Research Foundation; European Commission COST consortium Neurinfnet [BM0603]	Swiss National Fund(Swiss National Science Foundation (SNSF)); Dutch MS Research Foundation; European Commission COST consortium Neurinfnet	The authors thank Drs. P. Ruiz (Charite University Medicine, Berlin, Germany), I. Zlobec (Institute of Pathology, Basel, Switzerland), U. Eriksson (University Hospitals, Basel and Zurich, Switzerland), and R. Q. Hintzen (Erasmus MC, Rotterdam, The Netherlands) for critical reading of the manuscript and valuable comments; H. Kohler (cell sorting facility of the Basel Institute for Immunology, now Friedrich Miescher Institute, Basel, Switzerland) for expert cell sorting; U. Muller (transgenic unit of the Basel Institute for Immunology, now Friedrich Miescher Institute, Basel, Switzerland), B. Johansson, P. Hirschmann, S. Schneider, A. Mielgo, and P. Schmidt for excellent technical support; T. van Os for microphotography; and K. Stauffer and S. Eckervogt (Basel) for expert animal care. Human brain tissue was obtained from the Netherlands Brain Bank (Amsterdam, The Netherlands). This work was supported by the Swiss National Fund (3100-067084.01). Work at the MS Center ErasMS is supported by the Dutch MS Research Foundation and the European Commission COST consortium Neurinfnet (BM0603). The authors declare no conflicts of interest.	Aheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022841; Baaten BJG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00023; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; Braitch Manjit, 2010, Inflammation & Allergy Drug Targets, V9, P249; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Crispin JC, 2010, ARTHRITIS RHEUM-US, V62, P1431, DOI 10.1002/art.27385; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Elyaman W, 2008, AM J PATHOL, V173, P411, DOI 10.2353/ajpath.2008.080142; Engelhardt B, 2010, CLIN EXP NEUROIMMUNO, V1, P79, DOI DOI 10.1111/J.1759-1961.2010.009.X; Garin T, 2007, J NEUROL SCI, V258, P17, DOI 10.1016/j.jns.2007.01.079; Ghosh SC, 2012, EXPERT OPIN THER TAR, V16, P635, DOI 10.1517/14728222.2012.687374; GIRGRAH N, 1991, J NEUROPATH EXP NEUR, V50, P779, DOI 10.1097/00005072-199111000-00009; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Guan HB, 2011, J IMMUNOL, V186, P6955, DOI 10.4049/jimmunol.1004043; HAEGEL H, 1993, J CELL BIOL, V122, P1067, DOI 10.1083/jcb.122.5.1067; Haegel-Kronenberger H, 1998, J IMMUNOL, V161, P3902; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hoffmann U, 2007, CELL DEATH DIFFER, V14, P1542, DOI 10.1038/sj.cdd.4402153; Huss DJ, 2011, EUR J IMMUNOL, V41, P2987, DOI 10.1002/eji.201141666; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Kaaijk P, 1997, J NEUROIMMUNOL, V73, P70, DOI 10.1016/S0165-5728(96)00167-1; Kandagaddala LD, 2012, EXP TOXICOL PATHOL, V64, P109, DOI 10.1016/j.etp.2010.07.002; Kleine TO, 2006, CYTOM PART A, V69A, P147, DOI 10.1002/cyto.a.20225; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Laman JD, 1998, MULT SCLER, V4, P147, DOI 10.1177/135245859800400312; Laman JD, 1998, J NEUROIMMUNOL, V86, P30, DOI 10.1016/S0165-5728(98)00024-1; Li J, 2007, J NEUROIMMUNOL, V192, P57, DOI 10.1016/j.jneuroim.2007.09.004; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; MACKAY CR, 1994, J CELL BIOL, V124, P71, DOI 10.1083/jcb.124.1.71; Maniati E, 2008, J PATHOL, V214, P190, DOI 10.1002/path.2270; Masuko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029728; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Mielgo A, 2006, CELL DEATH DIFFER, V13, P465, DOI 10.1038/sj.cdd.4401763; Mix E, 2010, PROG NEUROBIOL, V92, P386, DOI 10.1016/j.pneurobio.2010.06.005; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Mycko MP, 2003, BRAIN, V126, P1048, DOI 10.1093/brain/awg107; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Naor D, 2007, ANN NY ACAD SCI, V1110, P233, DOI 10.1196/annals.1423.025; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; Rothhammer V, 2011, J EXP MED, V208, P2465, DOI 10.1084/jem.20110434; Runnels HA, 2010, ADV THER, V27, P168, DOI 10.1007/s12325-010-0010-0; Schwarzler C, 2001, EUR J IMMUNOL, V31, P2997, DOI 10.1002/1521-4141(2001010)31:10<2997::AID-IMMU2997>3.0.CO;2-J; Seiter S, 1999, J INVEST DERMATOL, V113, P11, DOI 10.1046/j.1523-1747.1999.00635.x; Soilu-Hanninen M, 2005, J NEUROIMMUNOL, V166, P189, DOI 10.1016/j.jneuroim.2005.05.008; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; van der Valk P, 2000, NEUROPATH APPL NEURO, V26, P2, DOI 10.1046/j.1365-2990.2000.00217.x; Visser L, 2002, J NEUROIMMUNOL, V132, P156, DOI 10.1016/S0165-5728(02)00306-5; Weimann TK, 2001, J INVEST DERMATOL, V117, P949, DOI 10.1046/j.0022-202x.2001.01467.x; Wittig B, 1997, IMMUNOL LETT, V57, P217, DOI 10.1016/S0165-2478(97)00060-6; Wittig B, 1999, LAB INVEST, V79, P747; Wittig BM, 2000, J EXP MED, V191, P2053, DOI 10.1084/jem.191.12.2053; Wittig BM, 2002, PATHOBIOLOGY, V70, P184, DOI 10.1159/000068152; Wolk K, 2009, J MOL MED, V87, P523, DOI 10.1007/s00109-009-0457-0; Yoshinari C, 1999, MELANOMA RES, V9, P223, DOI 10.1097/00008390-199906000-00003; ZEINE R, 1992, J NEUROIMMUNOL, V40, P57, DOI 10.1016/0165-5728(92)90213-5; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	61	12	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3683	3701		10.1096/fj.13-228809	http://dx.doi.org/10.1096/fj.13-228809			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23752202	Green Submitted			2022-12-25	WOS:000328840500027
J	Shih, DM; Shaposhnik, Z; Meng, YH; Rosales, M; Wang, XP; Wu, J; Ratiner, B; Zadini, F; Zadini, G; Lusis, AJ				Shih, Diana M.; Shaposhnik, Zory; Meng, Yonghong; Rosales, Melenie; Wang, Xuping; Wu, Judy; Ratiner, Boris; Zadini, Filiberto; Zadini, Giorgio; Lusis, Aldons J.			Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice	FASEB JOURNAL			English	Article						bile acid; intestinal cholesterol absorption; low-density lipoprotein; high-density lipoprotein; reverse cholesterol transport	HYDROPHILIC BILE-ACIDS; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; URSODEOXYCHOLIC ACID; CHOLESTEROL LEVELS; BRACHIOCEPHALIC ARTERY; CARDIOVASCULAR-DISEASE; OXIDIZED PHOSPHOLIPIDS; HYOCHOLIC ACID; AORTIC ROOT	We examined the effects of a natural secondary bile acid, hyodeoxycholic acid (HDCA), on lipid metabolism and atherosclerosis in LDL receptor-null (LDLRKO) mice. Female LDLRKO mice were maintained on a Western diet for 8 wk and then divided into 2 groups that received chow, or chow + 1.25% HDCA, diets for 15 wk. We observed that mice fed the HDCA diet were leaner and exhibited a 37% (P<0.05) decrease in fasting plasma glucose level. HDCA supplementation significantly decreased atherosclerotic lesion size at the aortic root region, the entire aorta, and the innominate artery by 44% (P<0.0001), 48% (P<0.01), and 94% (P<0.01), respectively, as compared with the chow group. Plasma VLDL/IDL/LDL cholesterol levels were significantly decreased, by 61% (P<0.05), in the HDCA group as compared with the chow diet group. HDCA supplementation decreased intestinal cholesterol absorption by 76% (P<0.0001) as compared with the chow group. Furthermore, HDL isolated from the HDCA group exhibited significantly increased ability to mediate cholesterol efflux ex vivo as compared with HDL of the chow diet group. In addition, HDCA significantly increased the expression of genes involved in cholesterol efflux, such as Abca1, Abcg1, and Apoe, in a macrophage cell line. Thus, HDCA is a candidate for antiatherosclerotic drug therapy.Shih, D. M., Shaposhnik, Z., Meng, Y., Rosales, M., Wang, X., Wu, J., Ratiner, B., Zadini, F., Zadini, G., Lusis, A. J. Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice.	[Shih, Diana M.; Shaposhnik, Zory; Meng, Yonghong; Rosales, Melenie; Wang, Xuping; Wu, Judy; Lusis, Aldons J.] Univ Calif Los Angeles, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA; [Shaposhnik, Zory] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Ratiner, Boris; Zadini, Filiberto; Zadini, Giorgio] AtheroNova Inc, Irvine, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Shih, DM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, 10833 Le Conte Ave,A2-237 CHS, Los Angeles, CA 90095 USA.	dshih@mednet.ucla.edu			AtheroNova, Inc.; U.S. National Heart, Lung, and Blood Institute [1R01-HL-094322-04, 2-P01-HL-030568-26A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094322, P01HL030568] Funding Source: NIH RePORTER	AtheroNova, Inc.; U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Lawrence Castellani, Sarada Charugundla, Yu-Rong Xia, Carmen Volpe, and Zhiqiang Zhou for excellent technical support. The authors thank Balbir Brar for critical reading of the manuscript. This study was supported in part by AtheroNova, Inc., and by U.S. National Heart, Lung, and Blood Institute grants 1R01-HL-094322-04 (to A.J.L.) and 2-P01-HL-030568-26A1 (to D.M.S.).	BACHRACH WH, 1982, DIGEST DIS SCI, V27, P737, DOI 10.1007/BF01393771; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Barter P, 2011, TRENDS PHARMACOL SCI, V32, P694, DOI 10.1016/j.tips.2011.07.004; Batta AK, 2004, METABOLISM, V53, P556, DOI 10.1016/j.metabol.2003.12.003; Beltroy EP, 2007, J LIPID RES, V48, P869, DOI 10.1194/jlr.M600488-JLR200; Bennett BJ, 2009, ARTERIOSCL THROM VAS, V29, P348, DOI 10.1161/ATVBAHA.108.176685; BROUGHTON G, 1994, AM J MED SCI, V307, P54, DOI 10.1097/00000441-199401000-00011; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; COHENSOLAL C, 1995, BBA-LIPID LIPID MET, V1257, P189, DOI 10.1016/0005-2760(95)00073-L; Couture P, 2013, CURR OPIN LIPIDOL, V24, P227, DOI 10.1097/MOL.0b013e3283613a55; Davidson MH, 2011, CURR ATHEROSCLER REP, V13, P95, DOI 10.1007/s11883-010-0151-2; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P582, DOI 10.1161/ATVBAHA.111.236315; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Eyssen HJ, 1999, APPL ENVIRON MICROB, V65, P3158; FOLCH J, 1957, J BIOL CHEM, V226, P497; GRUNDY SM, 1988, NEW ENGL J MED, V319, P24; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; KOOPMAN BJ, 1984, CLIN CHIM ACTA, V142, P103, DOI 10.1016/0009-8981(84)90105-0; KRAUSS RM, 1987, LANCET, V2, P62; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; MEHRABIAN M, 1993, ARTERIOSCLER THROMB, V13, P1, DOI 10.1161/01.ATV.13.1.1; NAGANO Y, 1991, P NATL ACAD SCI USA, V88, P6457, DOI 10.1073/pnas.88.15.6457; Navab M, 2004, J LIPID RES, V45, P993, DOI 10.1194/jlr.R400001-JLR200; Navab M, 2001, J LIPID RES, V42, P1308; Orozco LD, 2007, CIRC RES, V100, P1703, DOI 10.1161/CIRCRESAHA.107.151720; PEDERSEN TR, 1994, LANCET, V344, P1383; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; QIAO JH, 1994, ARTERIOSCLER THROMB, V14, P1480, DOI 10.1161/01.ATV.14.9.1480; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Ramachandran S, 2005, ATHEROSCLEROSIS, V178, P33, DOI 10.1016/j.atherosclerosis.2004.08.010; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Sehayek E, 2001, J LIPID RES, V42, P1250; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; SINGHAL AK, 1984, J LIPID RES, V25, P539; SINGHAL AK, 1984, J LIPID RES, V25, P564; Song C, 2000, STEROIDS, V65, P423, DOI 10.1016/S0039-128X(00)00127-6; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Tsimikas S, 2000, ARTERIOSCL THROM VAS, V20, P689, DOI 10.1161/01.ATV.20.3.689; Uy MC, 2008, OBES SURG, V18, P1532, DOI 10.1007/s11695-008-9587-7; VANDEHEIJNING BJM, 1994, J LIPID RES, V35, P1002; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wang DQH, 2003, AM J PHYSIOL-GASTR L, V285, pG494, DOI 10.1152/ajpgi.00156.2003; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watson CE, 2011, J LIPID RES, V52, P361, DOI 10.1194/jlr.M011098; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	54	27	31	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3805	3817		10.1096/fj.12-223008	http://dx.doi.org/10.1096/fj.12-223008			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23752203	Green Published			2022-12-25	WOS:000328840500038
J	Sussman, RT; Stanek, TJ; Esteso, P; Gearhart, JD; Knudsen, KE; Mcmahon, SB				Sussman, Robyn T.; Stanek, Timothy J.; Esteso, Paul; Gearhart, John D.; Knudsen, Karen E.; Mcmahon, Steven B.			The Epigenetic Modifier Ubiquitin-specific Protease 22 (USP22) Regulates Embryonic Stem Cell Differentiation via Transcriptional Repression of Sex-determining Region Y-box 2 (SOX2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2B UBIQUITYLATION; SAGA COMPLEX; PLURIPOTENCY FACTORS; HUMAN FIBROBLASTS; MOUSE; EXPRESSION; GENES; RNA; H3; METHYLATION	Pluripotent embryonic stem cells (ESCs) undergo self-renewal until stimulated to differentiate along specific lineage pathways. Many of the transcriptional networks that drive reprogramming of a self-renewing ESC to a differentiating cell have been identified. However, fundamental questions remain unanswered about the epigenetic programs that control these changes in gene expression. Here we report that the histone ubiquitin hydrolase ubiquitin-specific protease 22 (USP22) is a critical epigenetic modifier that controls this transition from self-renewal to differentiation. USP22 is induced as ESCs differentiate and is necessary for differentiation into all three germ layers. We further report that USP22 is a transcriptional repressor of the locus encoding the core pluripotency factor sex-determining region Y-box 2 (SOX2) in ESCs, and this repression is required for efficient differentiation. USP22 occupies the Sox2 promoter and hydrolyzes monoubiquitin from ubiquitylated histone H2B and blocks transcription of the Sox2 locus. Our study reveals an epigenetic mechanism that represses the core pluripotency transcriptional network in ESCs, allowing ESCs to transition from a state of self-renewal into lineage-specific differentiation programs.	[Sussman, Robyn T.; Stanek, Timothy J.; Knudsen, Karen E.; Mcmahon, Steven B.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Canc Biol, Philadelphia, PA 19107 USA; [Esteso, Paul; Gearhart, John D.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA	Jefferson University; University of Pennsylvania	Mcmahon, SB (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Canc Biol, 233 S 10th St,609 BLSB, Philadelphia, PA 19107 USA.	Steven.McMahon@jefferson.edu		McMahon, Steven/0000-0002-3405-1768; Knudsen, Karen/0000-0002-1301-890X; Sussman, Robyn/0000-0002-4057-9622; Stanek, Timothy/0000-0001-9192-4978	CellCentric Ltd.; NATIONAL CANCER INSTITUTE [F31CA165475] Funding Source: NIH RePORTER	CellCentric Ltd.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	S. B. McMahon and K. K. Knudsen are paid scientific consultants to CellCentric Ltd., a biotechnology company focused on identification of small molecules targeting epigenetic regulators.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Andreu-Agullo C, 2012, NATURE, V481, P195, DOI 10.1038/nature10712; Atanassov BS, 2011, EMBO REP, V12, P924, DOI 10.1038/embor.2011.140; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bazzoli E, 2012, CELL STEM CELL, V11, P836, DOI 10.1016/j.stem.2012.09.012; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chipumuro E, 2012, FASEB J, V26, P842, DOI 10.1096/fj.11-189498; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; GOLDSTEIN DJ, 1980, P NATL ACAD SCI-BIOL, V77, P2857, DOI 10.1073/pnas.77.5.2857; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Lopez-Juarez A, 2012, CELL STEM CELL, V10, P531, DOI 10.1016/j.stem.2012.04.008; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Parsons XH, 2011, JOVE-J VIS EXP, DOI 10.3791/3273; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pera MF, 2000, J CELL SCI, V113, P5; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; Weake VM, 2011, GENE DEV, V25, P1499, DOI 10.1101/gad.2046211; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zhang XY, 2008, CELL CYCLE, V7, P1522, DOI 10.4161/cc.7.11.5962; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhao WX, 2012, MOLECULES, V17, P6196, DOI 10.3390/molecules17066196; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	70	59	63	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24234	24246		10.1074/jbc.M113.469783	http://dx.doi.org/10.1074/jbc.M113.469783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23760504	Green Published, hybrid			2022-12-25	WOS:000330611400061
J	Xu, J; Xu, M; Brown, T; Rossi, GC; Hurd, YL; Inturrisi, CE; Pasternak, GW; Pan, YX				Xu, Jin; Xu, Ming; Brown, Taylor; Rossi, Grace C.; Hurd, Yasmin L.; Inturrisi, Charles E.; Pasternak, Gavril W.; Pan, Ying-Xian			Stabilization of the mu-Opioid Receptor by Truncated Single Transmembrane Splice Variants through a Chaperone-like Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; UP-REGULATION; MORPHINE-6-BETA-GLUCURONIDE ANALGESIA; ANTISENSE OLIGODEOXYNUCLEOTIDES; MORPHINE ANALGESIA; OPIATE RECEPTORS; QUALITY-CONTROL; BINDING-SITES; MOR-1; PROTEIN	The mu-opioid receptor gene, OPRM1, undergoes extensive alternative pre-mRNA splicing, as illustrated by the identification of an array of splice variants generated by both 5' and 3' alternative splicing. The current study reports the identification of another set of splice variants conserved across species that are generated through exon skipping or insertion that encodes proteins containing only a single transmembrane (TM) domain. Using a Tet-Off system, we demonstrated that the truncated single TM variants can dimerize with the full-length 7-TM mu-opioid receptor (MOR-1) in the endoplasmic reticulum, leading to increased expression of MOR-1 at the protein level by a chaperone-like function that minimizes endoplasmic reticulum-associated degradation. In vivo antisense studies suggested that the single TM variants play an important role in morphine analgesia, presumably through modulation of receptor expression levels. Our studies suggest the functional roles of truncated receptors in other G protein-coupled receptor families.	[Xu, Jin; Xu, Ming; Brown, Taylor; Pasternak, Gavril W.; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Xu, Jin; Xu, Ming; Brown, Taylor; Pasternak, Gavril W.; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Rossi, Grace C.] Long Isl Univ, CW Post Coll, Dept Psychol, Brookville, NY 11568 USA; [Hurd, Yasmin L.] Mt Sinai Sch Med, Dept Psychiat & Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Inturrisi, Charles E.; Pasternak, Gavril W.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Cornell University	Pasternak, GW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10065 USA.	pasterng@mskcc.org; pany@mskcc.org	Rossi, Grace/AIC-2739-2022	Brown, Taylor/0000-0001-9817-2094	National Institutes of Health, NIDA [DA013997, DA029244, DA02615, DA06241, DA07242, DA15446, DA01457, DA07274, DA05130]; NCI, National Institutes of Health [CA08748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013997, R01DA015446, T32DA007274, P60DA005130, R01DA007242, T32DA007242, R01DA002615, R01DA001457, P50DA005130, R01DA006241, R37DA007242, R56DA002615, R21DA029244] Funding Source: NIH RePORTER	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health, NIDA, Grants DA013997 and DA029244 (to Y. X. P.); DA02615, DA06241, and DA07242 (to G. W. P.); DA15446 (to Y. L. H.); and DA01457, DA07274, and DA05130 (to C. E. I.); and Core Grant CA08748 from the NCI, National Institutes of Health (to Memorial Sloan-Kettering Cancer Center).	Abbadie C, 2000, NEUROSCIENCE, V100, P141, DOI 10.1016/S0306-4522(00)00248-7; Abbadie C, 2000, J COMP NEUROL, V419, P244, DOI 10.1002/(SICI)1096-9861(20000403)419:2<244::AID-CNE8>3.0.CO;2-R; Abbadie C, 2001, NEUROREPORT, V12, P3069, DOI 10.1097/00001756-200110080-00017; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BARAN A, 1975, LIFE SCI, V17, P633, DOI 10.1016/0024-3205(75)90101-0; BARE LA, 1994, FEBS LETT, V354, P213, DOI 10.1016/0014-5793(94)01129-X; Bolan EA, 2004, SYNAPSE, V51, P11, DOI 10.1002/syn.10277; Chaipatikul V, 2003, J PHARMACOL EXP THER, V305, P909, DOI 10.1124/jpet.102.046219; Chaipatikul V, 2003, MOL PHARMACOL, V64, P32, DOI 10.1124/mol.64.1.32; Chang A, 1998, EUR J PHARMACOL, V351, P189, DOI 10.1016/S0014-2999(98)00366-5; CHEN Y, 1993, MOL PHARMACOL, V44, P8; Chen Y, 2006, J PHARMACOL EXP THER, V319, P765, DOI 10.1124/jpet.106.107987; Choi HS, 2006, BIOCHEM BIOPH RES CO, V343, P1132, DOI 10.1016/j.bbrc.2006.03.084; CONNELLY CD, 1994, LIFE SCI, V54, pPL369, DOI 10.1016/0024-3205(94)90037-X; Du Y.-L., 1996, Society for Neuroscience Abstracts, V22, P1766; Du Y.-L., 1997, Society for Neuroscience Abstracts, V23, P1206; EPPLER CM, 1993, J BIOL CHEM, V268, P26447; Foley K.M, 1985, N ENGL J MED, V313, P84; Foley KM, 1996, SCI AM, V275, P164, DOI 10.1038/scientificamerican0996-164; GaveriauxRuff C, 1997, MOL BRAIN RES, V48, P298, DOI 10.1016/S0169-328X(97)00109-5; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kolesnikov YA, 1997, P NATL ACAD SCI USA, V94, P8220, DOI 10.1073/pnas.94.15.8220; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Lupp A, 2011, REGUL PEPTIDES, V167, P9, DOI 10.1016/j.regpep.2010.09.004; Majumdar S, 2012, J MED CHEM, V55, P6352, DOI 10.1021/jm300305c; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; MILLAN MJ, 1988, J PHARMACOL EXP THER, V247, P721; Mogil JS, 1996, J PHARMACOL EXP THER, V276, P532; Pan YX, 2009, P NATL ACAD SCI USA, V106, P4917, DOI 10.1073/pnas.0811586106; Pan YX, 1999, MOL PHARMACOL, V56, P396, DOI 10.1124/mol.56.2.396; Pan YX, 2003, BIOCHEM BIOPH RES CO, V301, P1057, DOI 10.1016/S0006-291X(03)00089-5; Pan YX, 2001, P NATL ACAD SCI USA, V98, P14084, DOI 10.1073/pnas.241296098; Pan YX, 1998, FEBS LETT, V435, P65, DOI 10.1016/S0014-5793(98)01039-4; Pan YX, 2002, GENE, V295, P97, DOI 10.1016/S0378-1119(02)00825-9; Pasternak G.W., 2013, PHARM REV IN PRESS; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; Payne R, 1992, PRINCIPLES DRUG THER, P268; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; PICK CG, 1993, J PHARMACOL EXP THER, V265, P166; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; ROSSI G, 1994, LIFE SCI, V54, pPL375, DOI 10.1016/0024-3205(94)90038-8; ROSSI GC, 1995, NEUROSCI LETT, V198, P99, DOI 10.1016/0304-3940(95)11977-5; ROSSI GC, 1995, FEBS LETT, V369, P192, DOI 10.1016/0014-5793(95)00757-Z; Rossi GC, 1996, NEUROSCI LETT, V216, P1; ROTHMAN RB, 1991, PEPTIDES, V12, P151, DOI 10.1016/0196-9781(91)90182-O; Schuller AGP, 1999, NAT NEUROSCI, V2, P151, DOI 10.1038/5706; STANDIFER KM, 1994, NEURON, V12, P805, DOI 10.1016/0896-6273(94)90333-6; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; THOMPSON RC, 1993, NEURON, V11, P903, DOI 10.1016/0896-6273(93)90120-G; WANG JB, 1993, P NATL ACAD SCI USA, V90, P10230, DOI 10.1073/pnas.90.21.10230; Wannemacher KM, 2007, J PHARMACOL EXP THER, V323, P614, DOI 10.1124/jpet.107.125500; WOLOZIN BL, 1981, P NATL ACAD SCI-BIOL, V78, P6181, DOI 10.1073/pnas.78.10.6181; Xu J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-41; Xu J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-9; Xu J, 2009, J NEUROCHEM, V108, P962, DOI 10.1111/j.1471-4159.2008.05833.x; Yang CM, 2007, P NATL ACAD SCI USA, V104, P15394, DOI 10.1073/pnas.0610878104; YOBURN BC, 1985, LIFE SCI, V36, P2325, DOI 10.1016/0024-3205(85)90322-4; YOBURN BC, 1988, LIFE SCI, V42, P1689, DOI 10.1016/0024-3205(88)90034-3; ZIMPRICH A, 1995, FEBS LETT, V359, P142, DOI 10.1016/0014-5793(95)00028-8; ZIMPRICH A, 1994, REGUL PEPTIDES, V54, P347, DOI 10.1016/0167-0115(94)90531-2; Zimprich A, 1995, NEUROREPORT, V7, P54, DOI 10.1097/00001756-199512000-00012	69	45	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21211	21227		10.1074/jbc.M113.458687	http://dx.doi.org/10.1074/jbc.M113.458687			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760268	Green Published, hybrid			2022-12-25	WOS:000322014400043
J	Essack, M; Radovanovic, A; Bajic, VB				Essack, Magbubah; Radovanovic, Aleksandar; Bajic, Vladimir B.			Information Exploration System for Sickle Cell Disease and Repurposing of Hydroxyfasudil	PLOS ONE			English	Article							FETAL-HEMOGLOBIN; RHO-KINASE; BETA-THALASSEMIA; DRAGON DATABASE; MINING TOOL; GENE; EXPRESSION; GLOBIN; HYDROXYUREA; IDENTIFICATION	Background: Sickle cell disease (SCD) is a fatal monogenic disorder with no effective cure and thus high rates of morbidity and sequelae. Efforts toward discovery of disease modifying drugs and curative strategies can be augmented by leveraging the plethora of information contained in available biomedical literature. To facilitate research in this direction we have developed a resource, Dragon Exploration System for Sickle Cell Disease (DESSCD) (http://cbrc.kaust.edu.sa/desscd/) that aims to promote the easy exploration of SCD-related data. Description: The Dragon Exploration System (DES), developed based on text mining and complemented by data mining, processed 419,612 MEDLINE abstracts retrieved from a PubMed query using SCD-related keywords. The processed SCD-related data has been made available via the DESSCD web query interface that enables: a/information retrieval using specified concepts, keywords and phrases, and b/the generation of inferred association networks and hypotheses. The usefulness of the system is demonstrated by: a/reproducing a known scientific fact, the "Sickle_Cell_Anemia-Hydroxyurea" association, and b/generating novel and plausible "Sickle_Cell_Anemia-Hydroxyfasudil" hypothesis. A PCT patent (PCT/US12/55042) has been filed for the latter drug repurposing for SCD treatment. Conclusion: We developed the DESSCD resource dedicated to exploration of text-mined and data-mined information about SCD. No similar SCD-related resource exists. Thus, we anticipate that DESSCD will serve as a valuable tool for physicians and researchers interested in SCD.	[Essack, Magbubah; Radovanovic, Aleksandar; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology	Bajic, VB (corresponding author), King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Radovanovic, Aleksandar/M-3687-2019; Essack, Magbubah/R-2773-2019; Essack, Magbubah/G-5008-2013; Radovanovic, Aleksandar/D-1313-2012; Bajic, Vladimir/D-2810-2009	Radovanovic, Aleksandar/0000-0002-8749-7608; Essack, Magbubah/0000-0003-2709-5356; Radovanovic, Aleksandar/0000-0002-8749-7608; Bajic, Vladimir/0000-0001-5435-4750	KAUST CBRC Base Funds; KAUST Base Research Funds	KAUST CBRC Base Funds; KAUST Base Research Funds	ME and AR are supported by KAUST CBRC Base Funds of VBB. VBB is supported by KAUST Base Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2008, ORG BIOMOL CHEM, V6, P1665, DOI 10.1039/b801671b; Al Arrayed S, 2005, COMMUNITY GENET, V8, P52, DOI 10.1159/000083340; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bernaudin F, 2007, BLOOD, V110, P2749, DOI 10.1182/blood-2007-03-079665; Bryan L, 2008, MOL CANCER RES, V6, P1469, DOI 10.1158/1541-7786.MCR-08-0082; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Cokic VP, 2003, J CLIN INVEST, V111, P231, DOI 10.1172/JCI200316672; Conran N, 2004, BRIT J HAEMATOL, V124, P547, DOI 10.1111/j.1365-2141.2004.04810.x; Conran N, 2007, ANN HEMATOL, V86, P255, DOI 10.1007/s00277-006-0246-6; Costa FC, 2007, BRIT J HAEMATOL, V136, P333, DOI 10.1111/j.1365-2141.2006.06424.x; Dai ZK, 2011, PEDIATR PULM, V46, P45, DOI 10.1002/ppul.21323; Dawe AS, 2012, REPROD TOXICOL, V33, P99, DOI 10.1016/j.reprotox.2011.12.007; Ding J, 2010, J NEUROCHEM, V114, P1619, DOI 10.1111/j.1471-4159.2010.06876.x; Dvir E, 2007, CNS DRUG REV, V13, P260, DOI 10.1111/j.1527-3458.2007.00014.x; ESSACK M, Patent No. 1255042; Essack M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-219; Fathallah Hassana, 2006, Hematology Am Soc Hematol Educ Program, P58; Ferry AE, 1997, J BIOL CHEM, V272, P20030, DOI 10.1074/jbc.272.32.20030; Fibach E, 2006, EUR J HAEMATOL, V77, P437, DOI 10.1111/j.1600-0609.2006.00731.x; Fontaine JF, 2009, NUCLEIC ACIDS RES, V37, pW141, DOI 10.1093/nar/gkp353; Gambero S, 2007, EUR J HAEMATOL, V78, P144, DOI 10.1111/j.1600-0609.2006.00788.x; Goble C, 2008, J BIOMED INFORM, V41, P687, DOI 10.1016/j.jbi.2008.01.008; Hur J, 2009, BIOINFORMATICS, V25, P838, DOI 10.1093/bioinformatics/btp049; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kaur M, 2009, NUCLEIC ACIDS RES, V37, pD820, DOI 10.1093/nar/gkn593; Kumkhaek C, 2008, BRIT J HAEMATOL, V141, P254, DOI 10.1111/j.1365-2141.2008.07045.x; Kwofie SK, 2011, INFECT GENET EVOL, V11, P1971, DOI 10.1016/j.meegid.2011.09.001; Kwofie SK, 2011, INFECT GENET EVOL, V11, P734, DOI 10.1016/j.meegid.2010.12.006; Lanaro C, 2009, J LEUKOCYTE BIOL, V85, P235, DOI 10.1189/jlb.0708445; Lapoumeroulie C, 2005, HAEMATOLOGICA, V90, P401; Laurance S, 2010, PHARMACOGENET GENOM, V20, P257, DOI 10.1097/FPC.0b013e32833854d6; Lee A, 1995, BRIT MED J, V311, P1600, DOI 10.1136/bmj.311.7020.1600; LEY TJ, 1983, BLOOD, V62, P370; Liu K, 2010, BLOOD CELL MOL DIS, V45, P269, DOI 10.1016/j.bcmd.2010.09.004; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Makis AC, 2004, HAEMATOLOGICA, V89, P360; Maqungo M, 2011, NUCLEIC ACIDS RES, V39, pD980, DOI 10.1093/nar/gkq849; McGann PT, 2011, CURR OPIN HEMATOL, V18, P158, DOI 10.1097/MOH.0b013e32834521dd; MEILER SE, 2011, BLOOD; Natarajan J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-373; Patel N, 2010, J BIOL CHEM, V285, P20570, DOI 10.1074/jbc.M110.119495; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Sadelain M, 2006, CURR OPIN HEMATOL, V13, P142, DOI 10.1097/01.moh.0000219658.57915.d4; Sagar S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-622; Saleh AW, 1999, ACTA HAEMATOL-BASEL, V102, P31, DOI 10.1159/000040964; Santen S, 2010, INT J COLORECTAL DIS, V25, P1063, DOI 10.1007/s00384-010-0997-3; Satoh S, 2010, BRAIN RES BULL, V81, P191, DOI 10.1016/j.brainresbull.2009.08.021; Shiotani S, 2004, TRANSPLANTATION, V78, P375, DOI 10.1097/01.TP.0000128618.41619.E7; Smalheiser NR, 1996, NEUROLOGY, V46, P583, DOI 10.1212/WNL.46.2.583; Stein LD, 2003, NAT REV GENET, V4, P337, DOI 10.1038/nrg1065; Takata K, 2008, MOL CANCER THER, V7, P1551, DOI 10.1158/1535-7163.MCT-07-0428; Tsukamoto S, 2007, J NAT PROD, V70, P1658, DOI 10.1021/np070246i; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; WASHIDA N, 2011, NEPHROL DIAL TRANSPL; Weeber M, 2000, J AM MED INFORM ASSN, P903; Witt O, 2003, BLOOD, V101, P2001, DOI 10.1182/blood-2002-08-2617; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Zein S, 2010, EXP BIOL MED, V235, P1385, DOI 10.1258/ebm.2010.010129	60	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65190	10.1371/journal.pone.0065190	http://dx.doi.org/10.1371/journal.pone.0065190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762313	Green Published, Green Submitted, gold			2022-12-25	WOS:000320440500031
J	Ayer, A; Sanwald, J; Pillay, BA; Meyer, AJ; Perrone, GG; Dawes, IW				Ayer, Anita; Sanwald, Julia; Pillay, Bethany A.; Meyer, Andreas J.; Perrone, Gabriel G.; Dawes, Ian W.			Distinct Redox Regulation in Sub-Cellular Compartments in Response to Various Stress Conditions in Saccharomyces cerevisiae	PLOS ONE			English	Article							MITOCHONDRIAL INTERMEMBRANE SPACE; INDUCED CELL-DEATH; OXIDATIVE-STRESS; TRANSCRIPTIONAL RESPONSE; HYDROGEN-PEROXIDE; YEAST-CELLS; GLUTATHIONE; PROTEIN; SHOCK; PH	Responses to many growth and stress conditions are assumed to act via changes to the cellular redox status. However, direct measurement of pH-adjusted redox state during growth and stress has never been carried out. Organellar redox state (E-GSH) was measured using the fluorescent probes roGFP2 and pHluorin in Saccharomyces cerevisiae. In particular, we investigated changes in organellar redox state in response to various growth and stress conditions to better understand the relationship between redox-, oxidative-and environmental stress response systems. E-GSH values of the cytosol, mitochondrial matrix and peroxisome were determined in exponential and stationary phase in various media. These values (-340 to -350 mV) were more reducing than previously reported. Interestingly, sub-cellular redox state remained unchanged when cells were challenged with stresses previously reported to affect redox homeostasis. Only hydrogen peroxide and heat stress significantly altered organellar redox state. Hydrogen peroxide stress altered the redox state of the glutathione disulfide/glutathione couple (GSSG, 2H(+)/2GSH) and pH. Recovery from moderate hydrogen peroxide stress was most rapid in the cytosol, followed by the mitochondrial matrix, with the peroxisome the least able to recover. Conversely, the bulk of the redox shift observed during heat stress resulted from alterations in pH and not the GSSG, 2H(+)/2GSH couple. This study presents the first direct measurement of pH-adjusted redox state in sub-cellular compartments during growth and stress conditions. Redox state is distinctly regulated in organelles and data presented challenge the notion that perturbation of redox state is central in the response to many stress conditions.	[Ayer, Anita; Sanwald, Julia; Pillay, Bethany A.; Dawes, Ian W.] Univ New S Wales, Sydney, NSW, Australia; [Meyer, Andreas J.] Univ Bonn, INRES Chem Signalling, Bonn, Germany; [Perrone, Gabriel G.] Univ Western Sydney, Penrith, NSW 1797, Australia	University of New South Wales Sydney; University of Bonn; Western Sydney University	Dawes, IW (corresponding author), Univ New S Wales, Sydney, NSW, Australia.	i.dawes@unsw.edu.au	Meyer, Andreas J/C-4734-2013	Meyer, Andreas J/0000-0001-8144-4364; Rex, Julia/0000-0002-8189-9243; Ayer, Anita/0000-0002-7073-2835; Pillay, Bethany/0000-0001-7964-544X	Australian Research council; Deutsche Forschungsgemeinschaft (DFG) [ME1567/5-1]	Australian Research council(Australian Research Council); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was funded by Australian postgraduate award (AA), Discovery grant from (IWD and GGP) from the Australian Research council. Work in AJM's laboratory was funded by the Deutsche Forschungsgemeinschaft (DFG) (grant ME1567/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Ayer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044278; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; Bjornberg O, 2006, ANTIOXID REDOX SIGN, V8, P354, DOI 10.1089/ars.2006.8.354; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; COHEN G, 1985, MOL GEN GENET, V200, P74, DOI 10.1007/BF00383315; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329, DOI 10.1099/00221287-138-2-329; CORTASSA S, 1995, BIOTECHNOL BIOENG, V47, P193, DOI 10.1002/bit.260470211; Dardalhon M, 2012, FREE RADICAL BIO MED, V52, P2254, DOI 10.1016/j.freeradbiomed.2012.04.004; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; Evans MV, 1998, J BACTERIOL, V180, P483, DOI 10.1128/JB.180.3.483-490.1998; FLATTERYOBRIEN J, 1993, J GEN MICROBIOL, V139, P501, DOI 10.1099/00221287-139-3-501; GALIAZZO F, 1993, FEBS LETT, V315, P197, DOI 10.1016/0014-5793(93)81162-S; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Henke B, 1998, J BIOL CHEM, V273, P3702, DOI 10.1074/jbc.273.6.3702; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; JAMIESON DJ, 1992, J BACTERIOL, V174, P6678, DOI 10.1128/JB.174.20.6678-6681.1992; JENSEN MA, 1984, BIOCHIM BIOPHYS ACTA, V764, P310, DOI 10.1016/0005-2728(84)90101-4; Kojer K, 2012, EMBO J, V31, P3169, DOI 10.1038/emboj.2012.165; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; LEE F-J, 1985, Journal of Free Radicals in Biology and Medicine, V1, P319, DOI 10.1016/0748-5514(85)90138-2; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Ng CH, 2008, FREE RADICAL BIO MED, V44, P1131, DOI 10.1016/j.freeradbiomed.2007.12.008; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Petrova VY, 2004, BIOCHEM J, V380, P393, DOI 10.1042/BJ20040042; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; REICH JG, 1981, ENERGY METABOLISM CE; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Sugiyama K, 2000, J BIOL CHEM, V275, P15535, DOI 10.1074/jbc.275.20.15535; Sugiyama K, 2000, BIOCHEM J, V352, P71, DOI 10.1042/0264-6021:3520071; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Tucker CL, 2004, COMP FUNCT GENOM, V5, P216, DOI 10.1002/cfg.391; van Lith M, 2011, J CELL SCI, V124, P2349, DOI 10.1242/jcs.085530; van Roermund CWT, 2004, J CELL SCI, V117, P4231, DOI 10.1242/jcs.01305; WARDMAN P, 1989, J PHYS CHEM REF DATA, V18, P1637, DOI 10.1063/1.555843; Yano T, 2010, MOL CELL BIOL, V30, P3758, DOI 10.1128/MCB.00121-10; ZEHAVIWILLNER T, 1971, BIOCHIM BIOPHYS ACTA, V228, P245, DOI 10.1016/0005-2787(71)90564-8; ZEHAVIWILLNER T, 1973, ISRAEL J MED SCI, V9, P129	55	35	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65240	10.1371/journal.pone.0065240	http://dx.doi.org/10.1371/journal.pone.0065240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762325	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800029
J	Chao, LL; DeCarli, C; Kriger, S; Truran, D; Zhang, Y; Laxamana, J; Villeneuve, S; Jagust, WJ; Sanossian, N; Mack, WJ; Chui, HC; Weiner, MW				Chao, Linda L.; DeCarli, Charles; Kriger, Stephen; Truran, Diana; Zhang, Yu; Laxamana, Joel; Villeneuve, Sylvia; Jagust, William J.; Sanossian, Nerses; Mack, Wendy J.; Chui, Helena C.; Weiner, Michael W.			Associations between White Matter Hyperintensities and beta Amyloid on Integrity of Projection, Association, and Limbic Fiber Tracts Measured with Diffusion Tensor MRI	PLOS ONE			English	Article							MILD-COGNITIVE-IMPAIRMENT; MAGNETIC-RESONANCE DIFFUSION; VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; POSTERIOR CINGULATE; ELDERLY SUBJECTS; MOUSE MODEL; DEMENTIA; LESIONS; DEGENERATION	The goal of this study was to assess the relationship between A beta deposition and white matter pathology (i.e., white matter hyperintensities, WMH) on microstructural integrity of the white matter. Fifty-seven participants (mean age: 78 +/- 7 years) from an ongoing multi-site research program who spanned the spectrum of normal to mild cognitive impairment (Clinical dementia rating 0-0.5) and low to high risk factors for arteriosclerosis and WMH pathology (defined as WMH volume >0.5% total intracranial volume) were assessed with positron emission tomography (PET) with Pittsburg compound B (PiB) and magnetic resonance and diffusion tensor imaging (DTI). Multivariate analysis of covariance were used to investigate the relationship between A beta deposition and WMH pathology on fractional anisotropy (FA) from 9 tracts of interest (i.e., corona radiata, internal capsule, cingulum, parahippocampal white matter, corpus callosum, superior longitudinal, superior and inferior front-occipital fasciculi, and fornix). WMH pathology was associated with reduced FA in projection (i.e., internal capsule and corona radiate) and association (i.e., superior longitudinal, superior and inferior fronto-occipital fasciculi) fiber tracts. A beta deposition (i.e., PiB positivity) was associated with reduced FA in the fornix and splenium of the corpus callosum. There were interactions between PiB and WMH pathology in the internal capsule and parahippocampal white matter, where A beta deposition reduced FA more among subjects with WMH pathology than those without. However, accounting for apoE epsilon 4 genotype rendered these interactions insignificant. Although this finding suggests that apoE4 may increase amyloid deposition, both in the parenchyma (resulting in PiB positivity) and in blood vessels (resulting in amyloid angiopathy and WMH pathology), and that these two factors together may be associated with compromised white matter microstructural integrity in multiple brain regions, additional studies with a longitudinal design will be necessary to resolve this issue.	[Chao, Linda L.; Zhang, Yu; Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Chao, Linda L.; Kriger, Stephen; Truran, Diana; Zhang, Yu; Laxamana, Joel; Weiner, Michael W.] Vet Affairs Med Ctr, Ctr Imaging Neurodegenerat Dis, San Francisco, CA 94121 USA; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Villeneuve, Sylvia; Jagust, William J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Jagust, William J.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Sanossian, Nerses; Chui, Helena C.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Mack, Wendy J.] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Davis; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Southern California; University of Southern California	Chao, LL (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	linda.chao@ucsf.edu	DeCarli, Charles/B-5541-2009; Jagust, William/ABE-6426-2020	Chao, Linda/0000-0002-8593-2434	National Institutes of Health (NIH)/National Institute on Aging (NIA) [PO1 AG012435]; NIH/NIA [P30AG010129]; NIH/National Center for Research Resources [P41RR023953]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR023953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, P01AG012435] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH)/National Institute on Aging (NIA) PO1 AG012435, NIH/NIA P30AG010129 and the NIH/National Center for Research Resources P41RR023953, which were administered by the Northern California Institute for Research and Education, and with resources of the Veterans Affairs Medical Center, San Francisco, California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bendlin BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037720; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Buffon F, 2005, J CEREBR BLOOD F MET, V25, P641, DOI 10.1038/sj.jcbfm.9600054; Chabriat H, 1999, STROKE, V30, P2637, DOI 10.1161/01.STR.30.12.2637; Chen YW, 2006, NEUROLOGY, V67, P83, DOI 10.1212/01.wnl.0000223613.57229.24; Choo IH, 2010, NEUROBIOL AGING, V31, P772, DOI 10.1016/j.neurobiolaging.2008.06.015; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Chua TC, 2009, AM J GERIAT PSYCHIAT, V17, P602, DOI 10.1097/JGP.0b013e3181a76e0b; Chui HC, 2006, ANN NEUROL, V60, P677, DOI 10.1002/ana.21009; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077; de Leeuw FE, 2000, STROKE, V31, P425, DOI 10.1161/01.STR.31.2.425; DECARLI C, 1995, NEUROLOGY, V45, P2077, DOI 10.1212/WNL.45.11.2077; Delano-Wood L, 2010, NEUROBIOL AGING, V31, P1721, DOI 10.1016/j.neurobiolaging.2008.09.013; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Esiri MM, 2001, LANCET, V357, P169; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Gupta RK, 2006, J MAGN RESON IMAGING, V24, P549, DOI 10.1002/jmri.20677; Gurol ME, 2012, ANN NEUROL; Hadjidemetriou S, 2008, LECT NOTES COMPUT SC, V5241, P450, DOI 10.1007/978-3-540-85988-8_54; Hadjidemetriou S, 2009, MED IMAGE ANAL, V13, P36, DOI 10.1016/j.media.2008.05.003; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jagust WJ, 2008, ANN NEUROL, V63, P72, DOI 10.1002/ana.21296; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lee DY, 2009, NEUROLOGY, V73, P1722, DOI 10.1212/WNL.0b013e3181c33afb; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Lee JH, 2011, NEUROLOGY, V77, P18, DOI 10.1212/WNL.0b013e318221acee; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Mielke MM, 2009, NEUROIMAGE, V46, P47, DOI 10.1016/j.neuroimage.2009.01.054; Mielke MM, 2012, ALZHEIMERS DEMENT, V8, P105, DOI 10.1016/j.jalz.2011.05.2416; Mormino EC, 2012, NEUROIMAGE, V59, P1152, DOI 10.1016/j.neuroimage.2011.07.098; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mungas D, 2005, NEUROLOGY, V65, P565, DOI 10.1212/01.wnl.0000172913.88973.0d; Mungas D, 2001, NEUROLOGY, V57, P2229, DOI 10.1212/WNL.57.12.2229; MUNOZ DG, 1993, ARCH NEUROL-CHICAGO, V50, P492, DOI 10.1001/archneur.1993.00540050044013; Nowrangi MA, 2012, ALZHEIMERS DEMENT; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; PRINCE M, 1994, NEUROLOGY, V44, P97; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P293, DOI 10.3233/JAD-2010-1361; Ramanan VK, 2013, MOL PSYCHIAT; Reed BR, 2012, NEUROBIOL AGING, V33, P1979, DOI 10.1016/j.neurobiolaging.2011.10.002; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P835, DOI 10.1001/archneurol.2010.136; Salat DH, 2006, STROKE, V37, P1759, DOI 10.1161/01.STR.0000227328.86353.a7; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Sexton CE, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.019; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sun SW, 2005, EXP NEUROL, V191, P77, DOI 10.1016/j.expneurol.2004.09.006; Tao R., 2009, INF PROCESS MED IMAG, V21, P651; Ukmar M, 2008, RADIOL MED, V113, P915, DOI 10.1007/s11547-008-0286-1; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; Viswanathan A, 2009, NEUROLOGY, V72, P368, DOI 10.1212/01.wnl.0000341271.90478.8e; Werring DJ, 2000, J NEUROL NEUROSUR PS, V69, P269, DOI 10.1136/jnnp.69.2.269; Xu Q, 2010, DEMENT GERIATR COGN, V30, P317, DOI 10.1159/000320491; Zhan W, 2009, NEUROIMAGE, V47, pT58, DOI 10.1016/j.neuroimage.2009.02.004; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01	70	66	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65175	10.1371/journal.pone.0065175	http://dx.doi.org/10.1371/journal.pone.0065175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762308	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000039
J	Jiang, YQ; Zhang, HG; Wang, YG; Chen, M; Ye, SF; Hou, ZQ; Ren, L				Jiang, Yuanqin; Zhang, Honggang; Wang, Yange; Chen, Min; Ye, Shefang; Hou, Zhenqing; Ren, Lei			Modulation of Apoptotic Pathways of Macrophages by Surface-Functionalized Multi-Walled Carbon Nanotubes	PLOS ONE			English	Article							FACTOR-KAPPA-B; OXIDATIVE STRESS; INDUCE APOPTOSIS; TOXICITY; MECHANISMS; CYTOTOXICITY; RESPONSES; FIBROSIS	Biomedical applications of carbon nanotubes (CNTs) often involve improving their hydrophilicity and dispersion in biological media by modifying them through noncovalent or covalent functionalization. However, the potential adverse effects of surface-functionalized CNTs have not been well characterized. In this study, we functionalized multi-walled CNTs (MWCNTs) via carboxylation, to produce MWCNTs-COOH, and via poly (ethylene glycol) linking, to produce MWCNTs-PEG. We used these functionalized MWCNTs to study the effect of surface functionalization on MWCNTs-induced toxicity to macrophages, and elucidate the underlying mechanisms of action. Our results revealed that MWCNTs-PEG were less cytotoxic and were associated with less apoptotic cell death of macrophages than MWCNTs-COOH. Additionally, MWCNTs-PEG induced less generation of reactive oxygen species (ROS) involving less activation of NADPH oxidase compared with MWCNTs-COOH, as evidenced by membrane translocation of p47(phox) and p67(phox) in macrophages. The less cytotoxic and apoptotic effect of MWCNTs-PEG compared with MWCNTs-COOH resulted from the lower cellular uptake of MWCNTs-PEG, which resulted in less activation of oxidative stress-responsive pathways, such as p38 mitogen-activated protein kinases (MAPK) and nuclear factor (NF)-kappa B. These results demonstrate that surface functionalization of CNTs may alter ROS-mediated cytotoxic and apoptotic response by modulating apoptotic signaling pathways. Our study thus provides new insights into the molecular basis for the surface properties affecting CNTs toxicity.	[Jiang, Yuanqin; Zhang, Honggang; Wang, Yange; Chen, Min; Ye, Shefang; Hou, Zhenqing; Ren, Lei] Xiamen Univ, Coll Mat, Dept Biomat, Xiamen, Peoples R China; [Jiang, Yuanqin] Xiamen Univ, Chenggong Hosp, Dept ENT, Xianmen, Peoples R China	Xiamen University; Xiamen University	Ye, SF (corresponding author), Xiamen Univ, Coll Mat, Dept Biomat, Xiamen, Peoples R China.	yeshefang@xmu.edu.cn	ren, lei/G-3459-2010	ren, lei/0000-0003-2131-1601; Ye, Shefang/0000-0002-9129-7123	National Natural Science Foundation of China [31271071, 30901175]; National Basic Research Program of China [2010CB732402]; Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese People's Liberation Army [09Z019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese People's Liberation Army	This study was financially supported by grants from the National Natural Science Foundation of China (31271071, 30901175), the National Basic Research Program of China (2010CB732402), and the Medical Science and Technology Innovation Foundation of Nanjing Military Command of Chinese People's Liberation Army (09Z019). The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Andon FT, 2012, ACC CHEM RES; Azad N, 2013, NANOTOXICOLOGY, V7, P157, DOI 10.3109/17435390.2011.647929; Bottini M, 2011, BIOMACROMOLECULES, V12, P3381, DOI 10.1021/bm201020h; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Chen X, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105104; Cheng C, 2009, BIOMATERIALS, V30, P4152, DOI 10.1016/j.biomaterials.2009.04.019; Cheng JP, 2011, TOXICOL APPL PHARM, V250, P184, DOI 10.1016/j.taap.2010.10.012; Cui HF, 2010, CHEM RES TOXICOL, V23, P1131, DOI 10.1021/tx100050h; Dahiya Y, 2010, FEBS LETT, V584, P4227, DOI 10.1016/j.febslet.2010.09.009; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o; He XQ, 2011, CHEM RES TOXICOL, V24, P2237, DOI 10.1021/tx200351d; Horie M, 2012, CHEM RES TOXICOL, V25, P605, DOI 10.1021/tx200470e; Jain KK, 2012, EXPERT OPIN DRUG DIS, V7, P1029, DOI 10.1517/17460441.2012.722078; Johnston HJ, 2010, NANOTOXICOLOGY, V4, P207, DOI 10.3109/17435390903569639; Krajcik R, 2008, BIOCHEM BIOPH RES CO, V369, P595, DOI 10.1016/j.bbrc.2008.02.072; Lehmann K, 2009, BIOCHEM J, V419, P603, DOI 10.1042/BJ20081268; Lin CL, 2011, COLLOID SURFACE B, V83, P367, DOI 10.1016/j.colsurfb.2010.12.011; Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966; Mu QX, 2009, NANO LETT, V9, P4370, DOI 10.1021/nl902647x; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Saito N, 2009, CHEM SOC REV, V38, P1897, DOI 10.1039/b804822n; Selim KMK, 2007, BIOMATERIALS, V28, P710, DOI 10.1016/j.biomaterials.2006.09.014; Shvedova AA, 2012, TOXICOL APPL PHARM, V261, P121, DOI 10.1016/j.taap.2012.03.023; Srivastava RK, 2011, NANOTOXICOLOGY, V5, P195, DOI 10.3109/17435390.2010.503944; Tabet L, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-3; Wang X, 2010, J NANOSCI NANOTECHNO, V10, P8516, DOI 10.1166/jnn.2010.2688; Wang X, 2012, TOXICOL IN VITRO, V26, P799, DOI 10.1016/j.tiv.2012.05.010; Wang X, 2012, NANO LETT, V12, P3050, DOI 10.1021/nl300895y; Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055; Ye SF, 2012, J NANOSCI NANOTECHNO, V12, P2101, DOI 10.1166/jnn.2012.5677; Ye SF, 2011, J NANOSCI NANOTECHNO, V11, P3773, DOI 10.1166/jnn.2011.3862; Zhang DY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/17/175101; Zhang LW, 2009, TOXICOL SCI, V110, P138, DOI 10.1093/toxsci/kfp087; Zhang T, 2012, J HAZARD MATER, V219, P203, DOI 10.1016/j.jhazmat.2012.03.079; Zhang YB, 2011, ACS NANO, V5, P7020, DOI 10.1021/nn2016259; Zhou FF, 2011, SMALL, V7, P2727, DOI 10.1002/smll.201100669	37	207	210	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65756	10.1371/journal.pone.0065756	http://dx.doi.org/10.1371/journal.pone.0065756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755279	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000101
J	Lesiak, A; Pelz, C; Ando, H; Zhu, MY; Davare, M; Lambert, TJ; Hansen, KF; Obrietan, K; Appleyard, SM; Impey, S; Wayman, GA				Lesiak, Adam; Pelz, Carl; Ando, Hideaki; Zhu, Mingyan; Davare, Monika; Lambert, Talley J.; Hansen, Katelin F.; Obrietan, Karl; Appleyard, Suzanne M.; Impey, Soren; Wayman, Gary A.			A Genome-Wide Screen of CREB Occupancy Identifies the RhoA Inhibitors Par6C and Rnd3 as Regulators of BDNF-Induced Synaptogenesis	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CAMP-RESPONSE ELEMENT; CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; DENDRITIC SPINE MORPHOGENESIS; TRANSCRIPTION FACTOR-BINDING; CYCLIC-AMP; INDUCED PHOSPHORYLATION; NEUROTROPHIC FACTOR; SECONDARY STRUCTURE	Neurotrophin-regulated gene expression is believed to play a key role in long-term changes in synaptic structure and the formation of dendritic spines. Brain-derived neurotrophic factor (BDNF) has been shown to induce increases in dendritic spine formation, and this process is thought to function in part by stimulating CREB-dependent transcriptional changes. To identify CREB-regulated genes linked to BDNF-induced synaptogenesis, we profiled transcriptional occupancy of CREB in hippocampal neurons. Interestingly, de novo motif analysis of hippocampal ChIP-Seq data identified a non-canonical CRE motif (TGGCG) that was enriched at CREB target regions and conferred CREB-responsiveness. Because cytoskeletal remodeling is an essential element of the formation of dendritic spines, within our screens we focused our attention on genes previously identified as inhibitors of RhoA GTPase. Bioinformatic analyses identified dozens of candidate CREB target genes known to regulate synaptic architecture and function. We showed that two of these, the RhoA inhibitors Par6C (Pard6A) and Rnd3 (RhoE), are BDNF-induced CREB-regulated genes. Interestingly, CREB occupied a cluster of non-canonical CRE motifs in the Rnd3 promoter region. Lastly, we show that BDNF-stimulated synaptogenesis requires the expression of Par6C and Rnd3, and that overexpression of either protein is sufficient to increase synaptogenesis. Thus, we propose that BDNF can regulate formation of functional synapses by increasing the expression of the RhoA inhibitors, Par6C and Rnd3. This study shows that genome-wide analyses of CREB target genes can facilitate the discovery of new regulators of synaptogenesis.	[Lesiak, Adam; Zhu, Mingyan; Lambert, Talley J.; Appleyard, Suzanne M.; Wayman, Gary A.] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Program Neurosci, Pullman, WA 99164 USA; [Davare, Monika] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Pelz, Carl; Ando, Hideaki; Impey, Soren] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97201 USA; [Impey, Soren] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Hansen, Katelin F.; Obrietan, Karl] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	Washington State University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University System of Ohio; Ohio State University	Impey, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97201 USA.	impeys@ohsu.edu; waymang@vetmed.wsu.edu	Lambert, Talley/B-4024-2015; Lambert, Talley/V-7602-2019; Ando, Hideaki/D-3876-2017	Lambert, Talley/0000-0002-2409-0181; Lambert, Talley/0000-0002-2409-0181; Davare, Monika/0000-0003-1802-7597; Lesiak, Atom/0000-0001-8413-6340	Hope for Depression Research Foundation; National institutes of medicine: NIMH [MH086032]; NIDDK [RDK083452]; NINS [NS066345]; HINS [NS066345]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066345] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23500458] Funding Source: KAKEN	Hope for Depression Research Foundation; National institutes of medicine: NIMH; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINS(National Institutes of Natural Sciences (NINS) - Japan); HINS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by: Hope for Depression Research Foundation (GW, AL), National institutes of medicine: NIMH MH086032 (GW), NIDDK RDK083452 (SMA) NINS NS066345 (SI) HINS NS066345 (KO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Blanquet PR, 2003, NEUROSCIENCE, V118, P477, DOI 10.1016/S0306-4522(02)00963-6; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; CAESER M, 1991, J COMP NEUROL, V307, P87, DOI 10.1002/cne.903070109; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; CHU HM, 1991, NUCLEIC ACIDS RES, V19, P2721, DOI 10.1093/nar/19.10.2721; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; GALOFRE E, 1987, J NEUROL SCI, V81, P185, DOI 10.1016/0022-510X(87)90095-5; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Goh LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012409; Gomes RA, 2006, J NEUROSCI, V26, P11487, DOI 10.1523/JNEUROSCI.2364-06.2006; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; HYMAN SE, 1988, MOL CELL BIOL, V8, P4225, DOI 10.1128/MCB.8.10.4225; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Jiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105; Kasai H, 2010, EUR J NEUROSCI, V32, P241, DOI 10.1111/j.1460-9568.2010.07344.x; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kim JH, 2012, J NEUROCHEM, V120, P210, DOI 10.1111/j.1471-4159.2011.07555.x; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Korkotian E, 1999, NEUROREPORT, V10, P2875, DOI 10.1097/00001756-199909090-00032; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Mocholi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019236; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Papa M, 1996, NEUROSCIENCE, V71, P1005, DOI 10.1016/0306-4522(95)00490-4; Pavesi Giulio, 2006, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0211s15; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; SchildPoulter C, 1996, NUCLEIC ACIDS RES, V24, P4751, DOI 10.1093/nar/24.23.4751; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Segal M, 1998, NEURAL PLAST, V6, P1, DOI 10.1155/NP.1998.1; Sfakianos MK, 2007, J NEUROSCI, V27, P10982, DOI 10.1523/JNEUROSCI.0793-07.2007; Shen WH, 2006, NEURON, V50, P401, DOI 10.1016/j.neuron.2006.03.017; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Sinha S, 2003, NUCLEIC ACIDS RES, V31, P3586, DOI 10.1093/nar/gkg618; SPIRO C, 1993, P NATL ACAD SCI USA, V90, P4606, DOI 10.1073/pnas.90.10.4606; SPIRO C, 1995, J BIOL CHEM, V270, P27702, DOI 10.1074/jbc.270.46.27702; Spiro C, 1997, J BIOL CHEM, V272, P33145, DOI 10.1074/jbc.272.52.33145; STOLTENBURGDIDINGER G, 1983, DEV BRAIN RES, V11, P119, DOI 10.1016/0165-3806(83)90206-7; Storey John D, 2003, Methods Mol Biol, V224, P149; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhao L, 2005, NEUROSCIENCE, V132, P299, DOI 10.1016/j.neuroscience.2004.11.054; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	83	49	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64658	10.1371/journal.pone.0064658	http://dx.doi.org/10.1371/journal.pone.0064658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762244	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000012
J	Abel, O; Powell, JF; Andersen, PM; Al-Chalabi, A				Abel, Olubunmi; Powell, John F.; Andersen, Peter M.; Al-Chalabi, Ammar			Credibility Analysis of Putative Disease-Causing Genes Using Bioinformatics	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPEARMANS RHO; DIAGNOSIS; CRITERIA; FAMILY; ALS	Background: Genetic studies are challenging in many complex diseases, particularly those with limited diagnostic certainty, low prevalence or of old age. The result is that genes may be reported as disease-causing with varying levels of evidence, and in some cases, the data may be so limited as to be indistinguishable from chance findings. When there are large numbers of such genes, an objective method for ranking the evidence is useful. Using the neurodegenerative and complex disease amyotrophic lateral sclerosis (ALS) as a model, and the disease-specific database ALSoD, the objective is to develop a method using publicly available data to generate a credibility score for putative disease-causing genes. Methods: Genes with at least one publication suggesting involvement in adult onset familial ALS were collated following an exhaustive literature search. SQL was used to generate a score by extracting information from the publications and combined with a pathogenicity analysis using bioinformatics tools. The resulting score allowed us to rank genes in order of credibility. To validate the method, we compared the objective ranking with a rank generated by ALS genetics experts. Spearman's Rho was used to compare rankings generated by the different methods. Results: The automated method ranked ALS genes in the following order: SOD1, TARDBP, FUS, ANG, SPG11, NEFH, OPTN, ALS2, SETX, FIG4, VAPB, DCTN1, TAF15, VCP, DAO. This compared very well to the ranking of ALS genetics experts, with Spearman's Rho of 0.69 (P = 0.009). Conclusion: We have presented an automated method for scoring the level of evidence for a gene being disease-causing. In developing the method we have used the model disease ALS, but it could equally be applied to any disease in which there is genotypic uncertainty.	[Abel, Olubunmi; Al-Chalabi, Ammar] Kings Coll London, Kings Hlth Partners Ctr Neurodegenerat Res, Dept Clin Neurosci, London WC2R 2LS, England; [Powell, John F.] Kings Coll London, Dept Neurosci, London WC2R 2LS, England; [Andersen, Peter M.] Umea Univ, Inst Pharmacol & Clin Neurosci, Neurol Sect, Umea, Sweden; [Andersen, Peter M.] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany	King's Health Partners; University of London; King's College London; University of London; King's College London; Umea University; Ulm University	Al-Chalabi, A (corresponding author), Kings Coll London, Kings Hlth Partners Ctr Neurodegenerat Res, Dept Clin Neurosci, London WC2R 2LS, England.	al-chalabi@kcl.ac.uk	Al-Chalabi, Ammar/E-5361-2010; Powell, John F/G-4412-2011	Al-Chalabi, Ammar/0000-0002-4924-7712; Powell, John F/0000-0001-6124-439X	ALS Association; ALS Canada; MNDA Iceland; ALS Therapy Alliance; European Community's Health Seventh Framework Programme [259867]; National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London; Maudsley NHS Foundation Trust; King's College London; MND Association of Great Britain and Northern Ireland	ALS Association; ALS Canada; MNDA Iceland; ALS Therapy Alliance; European Community's Health Seventh Framework Programme; National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London(General Electric); MND Association of Great Britain and Northern Ireland	The authors are especially grateful for the long-standing and continued funding of this project from the ALS Association and the MND Association of Great Britain and Northern Ireland. They also thank ALS Canada, MNDA Iceland and the ALS Therapy Alliance for support. The research leading to these results has received funding from the European Community's Health Seventh Framework Programme FP7/2007-2013 under grant agreement number 259867. AA-C receives salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Aleks Radunovic, Nigel Leigh, and Ian Gowrie originally conceived ALSoD. ALSoD is a joint project of the World Federation of Neurology (WFN) and European Network for the Cure ALS (ENCALS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2005, BRAIN, V128, P451, DOI 10.1093/brain/awh426; Al-Chalabi A, 2011, HUM HERED, V71, P281, DOI 10.1159/000330167; Andersen PM, 2011, NATURE REV NEUROLOGY; Boeve BF, 2011, NEURON; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; Charcot J-M, 1869, ARCH PHYSL NORM PATH, V2, P744; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; DAVID FN, 1961, BIOMETRIKA, V48, P19, DOI 10.2307/2333126; Eisen A, 2008, AMYOTROPH LATERAL SC, V9, P108, DOI 10.1080/17482960801900073; Fong GCY, 2006, AMYOTROPH LATERAL SC, V7, P142, DOI 10.1080/17482960600732412; Hamosh A, 2000, HUM MUTAT, V15, P57, DOI 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G; Hanby MF, 2011, BRAIN; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Lill CM, 2011, AMYOTROPH LATERAL SC, V12, P238, DOI 10.3109/17482968.2011.584629; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; RAMSEY PH, 1989, J EDUC STAT, V14, P245, DOI 10.3102/10769986014003245; Renton AE, 2011, NEURON; Rosen D, 1993, MUTATIONS CU ZN SUPE; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7	25	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64899	10.1371/journal.pone.0064899	http://dx.doi.org/10.1371/journal.pone.0064899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755159	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400030
J	Kamei, A; Watanabe, Y; Kondo, K; Okada, S; Shinozaki, F; Ishijima, T; Nakai, Y; Kondo, T; Arai, S; Abe, K				Kamei, Asuka; Watanabe, Yuki; Kondo, Kaori; Okada, Shinji; Shinozaki, Fumika; Ishijima, Tomoko; Nakai, Yuji; Kondo, Takashi; Arai, Soichi; Abe, Keiko			Influence of a Short-Term Iron-Deficient Diet on Hepatic Gene Expression Profiles in Rats	PLOS ONE			English	Article							KEY REGULATOR; HEPCIDIN; POWERFUL; ANEMIA; GLOBIN	Iron is an essential mineral for the body, and iron deficiency generally leads to anemia. However, because non-anemic iron deficiency can exist, we performed a comprehensive transcriptome analysis of the liver to define the effects of this condition on the body. Four-week-old male rats were fed a low-iron diet (approximately 3 ppm iron) for 3 days and compared with those fed a normal diet (48 ppm iron) by pair feeding as a control. The rats in the iron-deficient diet group developed a non-anemic iron-deficient state. DNA microarray analysis revealed that during this short time, this state conferred a variety of effects on nutrient metabolism in the liver. In comparison with long-term (17 days) iron-deficiency data from a previous study, some of the changed genes were found to be common to both short-and long-term iron deficiency models, some were specific to the short-term iron deficiency model, and the others were oppositely regulated between the two feeding terms. Taken together, these data suggest that although the blood hemoglobin level itself remains unchanged during non-anemic iron deficiency, a variety of metabolic processes involved in the maintenance of the energy balance are altered.	[Kamei, Asuka; Watanabe, Yuki; Shinozaki, Fumika; Ishijima, Tomoko; Nakai, Yuji; Arai, Soichi; Abe, Keiko] Kanagawa Acad Sci & Technol, Life Sci & Environm Res Ctr, Project Hlth & Antiaging, Kawasaki, Kanagawa, Japan; [Kondo, Kaori; Kondo, Takashi] RIKEN, Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan; [Okada, Shinji; Ishijima, Tomoko; Nakai, Yuji; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Arai, Soichi] Tokyo Univ Agr, Gen Res Inst, Setagaya Ku, Tokyo, Japan	Kanagawa Academy Science & Technology; RIKEN; University of Tokyo; Tokyo University of Agriculture	Abe, K (corresponding author), Kanagawa Acad Sci & Technol, Life Sci & Environm Res Ctr, Project Hlth & Antiaging, 4F C-4, Kawasaki, Kanagawa, Japan.	aka7308@mail.ecc.u-tokyo.ac.jp	Kamei, Asuka/GXH-4934-2022; NAKAI, Yuji/G-3433-2014	NAKAI, Yuji/0000-0002-2458-3875; Okada, Shinji/0000-0002-4465-9961	Kanagawa Academy of Science and Technology; grant-in-aid for science research [24780139, 24657115, 24700820, 23300273, 20380183]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23300273, 24780139] Funding Source: KAKEN	Kanagawa Academy of Science and Technology; grant-in-aid for science research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by a grant from the Kanagawa Academy of Science and Technology (http://www.newkast.or.jp/english/index.html). This work was also supported in part by grant-in-aid for science research 24780139 (to AK), 24657115 (to SO), 24700820 (to TI), 23300273 (to YN), 20380183 (to KA) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.jsps.go.jp/english/index.html).	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; BENESCH R, 1967, BIOCHEM BIOPH RES CO, V26, P162, DOI 10.1016/0006-291X(67)90228-8; BENESCH R, 1968, P NATL ACAD SCI USA, V59, P526, DOI 10.1073/pnas.59.2.526; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; dos Santos CO, 2008, J BIOL CHEM, V283, P26956, DOI 10.1074/jbc.M802421200; Frazer DM, 2005, AM J PHYSIOL-GASTR L, V289, pG631, DOI 10.1152/ajpgi.00220.2005; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kadota K, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-7; Kamei A, 2010, PHYSIOL GENOMICS, V42, P149, DOI 10.1152/physiolgenomics.00150.2009; LU SJ, 1994, P NATL ACAD SCI USA, V91, P8398, DOI 10.1073/pnas.91.18.8398; Matsuo M, 2010, BIOSCI BIOTECH BIOCH, V74, P899, DOI 10.1271/bbb.90921; Mendel RR, 2007, NAT PROD REP, V24, P963, DOI 10.1039/b703112m; Mollan TL, 2010, ANTIOXID REDOX SIGN, V12, P219, DOI 10.1089/ars.2009.2780; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; R Development Core Team, 2006, R LANG ENV STAT COMP; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Uchida Tatsumi, 2004, Rinsho Ketsueki, V45, P1085; Viatte L, 2009, BIOCHIMIE, V91, P1223, DOI 10.1016/j.biochi.2009.06.012; Voon HPJ, 2008, HAEMATOL-HEMATOL J, V93, P1868, DOI 10.3324/haematol.13490	31	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65732	10.1371/journal.pone.0065732	http://dx.doi.org/10.1371/journal.pone.0065732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755274	Green Submitted, Green Published, gold			2022-12-25	WOS:000320579400074
J	Sauco, S; Gomez, J; Barboza, FR; Lercari, D; Defeo, O				Sauco, Sebastian; Gomez, Julio; Barboza, Francisco R.; Lercari, Diego; Defeo, Omar			Modified Whole Effluent Toxicity Test to Assess and Decouple Wastewater Effects from Environmental Gradients	PLOS ONE			English	Article							CONTAMINATION; DISCHARGE; SEDIMENTS; BIOAVAILABILITY; COMMUNITY; STRESSORS; POLLUTION; IMPACT	Environmental gradients and wastewater discharges produce aggregated effects on marine populations, obscuring the detection of human impact. Classical assessment methods do not include environmental effects in toxicity tests designs, which could lead to incorrect conclusions. We proposed a modified Whole Effluent Toxicity test (mWET) that includes environmental gradients in addition to effluent dilutions, together with the application of Generalized Linear Mixed Models (GLMM) to assess and decouple those effects. We tested this approach, analyzing the lethal effects of wastewater on a marine sandy beach bivalve affected by an artificial canal freshwater discharge used for rice crops irrigation. To this end, we compared bivalve mortality between canal water dilutions (CWd) and salinity controls (SC: without canal water). CWd were prepared by diluting the water effluent (sampled during the pesticide application period) with artificial marine water. The salinity gradient was included in the design by achieving the same final salinities in both CWd and SC, allowing us to account for the effects of salinity by including this variable as a random factor in the GLMM. Our approach detected significantly higher mortalities in CWd, indicating potential toxic effects of the effluent discharge. mWET represents an improvement over the internationally standardized WET tests, since it considers environmental variability and uses appropriate statistical analyses.	[Sauco, Sebastian; Gomez, Julio; Barboza, Francisco R.; Lercari, Diego; Defeo, Omar] Univ Republica, Fac Ciencias, Dept Ecol & Evoluc, UNDECIMAR, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Sauco, S (corresponding author), Univ Republica, Fac Ciencias, Dept Ecol & Evoluc, UNDECIMAR, Montevideo, Uruguay.	sebastiansauco@gmail.com		Barboza, Francisco Rafael/0000-0002-9100-2962; Defeo, Omar/0000-0001-8318-528X; Lercari, Diego/0000-0001-7980-2193	Environmental Facility [GCP URU 030 GFF]; Comision Sectorial de Investigacion Cientifica (CSIC Uruguay-Project) [2025]; Pew Charitable Trusts	Environmental Facility; Comision Sectorial de Investigacion Cientifica (CSIC Uruguay-Project); Pew Charitable Trusts	Fundings from Environmental Facility (GCP URU 030 GFF), Comision Sectorial de Investigacion Cientifica (CSIC Uruguay-Project 2025) and The Pew Charitable Trusts are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2011, IME4 LINEAR MIXED EF; Carbonell G, 2010, B ENVIRON CONTAM TOX, V85, P72, DOI 10.1007/s00128-010-0035-8; Castilla JC, 2001, REV FISH BIOL FISHER, V11, P1, DOI 10.1023/A:1014235924952; Chapman PM, 2007, ENVIRON INT, V33, P492, DOI 10.1016/j.envint.2006.09.001; Chapman PM, 2001, ENVIRON TOXICOL CHEM, V20, P3, DOI [10.1002/etc.5620200102, 10.1897/1551-5028(2001)020&lt;0003:ASCIE&gt;2.0.CO;2]; Dauvin JC, 2008, MAR POLLUT BULL, V57, P160, DOI 10.1016/j.marpolbul.2007.10.012; DEFEO O, 1992, J COASTAL RES, V8, P830; Defeo O., 1989, FISHBYTE, V7, P21; DELOSCAMPOS O, 1987, REV AGRARIA, V31, P21; Derycke S, 2007, AQUAT TOXICOL, V82, P110, DOI 10.1016/j.aquatox.2007.02.002; *DINAMA, 2011, MON PLAY TEMP 2010 2; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Eggleton J, 2004, ENVIRON INT, V30, P973, DOI 10.1016/j.envint.2004.03.001; Fent K, 2004, TOXICOLOGY, V205, P223, DOI 10.1016/j.tox.2004.06.060; Fiori S, 2006, J COASTAL RES, V22, P872, DOI 10.2112/04-0409.1; Goodsell PJ, 2009, MAR POLLUT BULL, V58, P323, DOI 10.1016/j.marpolbul.2008.10.011; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; *INE, 2004, CENS 2004 UR; Lercari D, 2003, ESTUAR COAST SHELF S, V58, P17, DOI 10.1016/S0272-7714(03)00043-X; Lercari D, 1999, ESTUAR COAST SHELF S, V49, P457, DOI 10.1006/ecss.1999.0521; Lozoya JP, 2006, MAR FRESHWATER RES, V57, P421, DOI 10.1071/MF05067; McKnight US, 2012, SCI TOTAL ENVIRON, V427, P319, DOI 10.1016/j.scitotenv.2012.04.011; Ramos MC, 2006, J ENVIRON MANAGE, V78, P97, DOI 10.1016/j.jenvman.2005.04.010; Relyea R, 2006, ECOL LETT, V9, P1157, DOI 10.1111/j.1461-0248.2006.00966.x; Sauco S, 2010, MAR ENVIRON RES, V70, P300, DOI 10.1016/j.marenvres.2010.06.002; Tang WZ, 2010, J HAZARD MATER, V176, P945, DOI 10.1016/j.jhazmat.2009.11.131; Traina SJ, 1999, P NATL ACAD SCI USA, V96, P3365, DOI 10.1073/pnas.96.7.3365; USEPA, 2002, METH MEAS AC TOX EFF, P275; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zuur Alain F., 2009, P1	31	5	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e66285	10.1371/journal.pone.0066285	http://dx.doi.org/10.1371/journal.pone.0066285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755304	Green Published, Green Submitted, gold			2022-12-25	WOS:000320579400084
J	Ellis, JS; Turner, LM; Knight, ME				Ellis, Jonathan S.; Turner, Lucy M.; Knight, Mairi E.			Lack of Variation at Phosphoglucose Isomerase (Pgi) in Bumblebees: Implications for Conservation Genetics Studies	PLOS ONE			English	Article							BALANCING SELECTION; PHYSIOLOGICAL CONSEQUENCES; SELF-INCOMPATIBILITY; NATURAL-POPULATIONS; FITNESS DIFFERENCES; DNA POLYMORPHISM; BEES HYMENOPTERA; FLIGHT MUSCLES; NEST DENSITY; BOMBUS	Assessing genetic variation underlying ecologically important traits is increasingly of interest and importance in population and conservation genetics. For some groups generally useful markers exist for examining the relative role of selection and drift in shaping genetic diversity e.g. the major histocompatibility complex in vertebrates and self-incompatibility loci in plants. For invertebrates there is no such generally useful locus. However, phosphoglucose isomerase (Pgi) has been proposed as a useful functional marker in the conservation genetics of invertebrates. Where thermal microclimate varies, balanced polymorphisms may be maintained due to trade-offs between thermally stable and kinetically advantageous allelic forms. We here report very low levels of Pgi variation in bumblebees rendering this locus to be of little use as an adaptive marker in a conservation genetics context in this group. Potential explanations for this lack of variation are considered.	[Ellis, Jonathan S.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester, Greater Manches, England; [Turner, Lucy M.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England; [Ellis, Jonathan S.; Knight, Mairi E.] Univ Plymouth, Sch Biomed & Biol Sci, Plymouth PL4 8AA, Devon, England	Manchester Metropolitan University; University of Plymouth; University of Plymouth	Ellis, JS (corresponding author), Manchester Metropolitan Univ, Sch Sci & Environm, Manchester, Greater Manches, England.	j.ellis@mmu.ac.uk	Turner, Lucy/B-8495-2013; Turner, Lucy/GRR-1515-2022	Turner, Lucy/0000-0002-9052-9498; Ellis, Jonathan/0000-0002-6655-4685	Leverhulme Trust [F/00 568/S]	Leverhulme Trust(Leverhulme Trust)	This work was funded by the Leverhulme Trust (F/00 568/S (http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Akashi H, 1997, GENETICS, V146, P295; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Castric V, 2004, MOL ECOL, V13, P2873, DOI 10.1111/j.1365-294X.2004.02267.x; CHAPPELL MA, 1983, OECOLOGIA, V56, P126, DOI 10.1007/BF00378228; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; Charman TG, 2010, MOL ECOL, V19, P2661, DOI 10.1111/j.1365-294X.2010.04697.x; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; Darvill B, 2006, MOL ECOL, V15, P601, DOI 10.1111/j.1365-294X.2006.02797.x; EDWARDS R, 2005, PROVISIONAL ATLAS 5; Edwards R., 2002, PROVISIONAL ATLAS 4; Ekblom R, 2010, GENETICA, V138, P453, DOI 10.1007/s10709-008-9335-x; Ellis JS, 2006, MOL ECOL, V15, P4375, DOI 10.1111/j.1365-294X.2006.03121.x; Ellis JS, 2012, GENETICA, V140, P205, DOI 10.1007/s10709-012-9672-7; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; ESTOUP A, 1995, MOL ECOL, V4, P89, DOI 10.1111/j.1365-294X.1995.tb00195.x; Fussell M., 1993, Entomologist's Monthly Magazine, V129, P1; FUSSELL M, 1991, J APICULT RES, V30, P87, DOI 10.1080/00218839.1991.11101239; Gillespie J. H., 2004, POPULATION GENETICS; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson Dave, 2001, British Journal of Entomology and Natural History, V14, P129; GRAUR D, 1985, EVOLUTION, V39, P190, DOI 10.1111/j.1558-5646.1985.tb04091.x; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hedrick AV, 2002, J COMP PHYSIOL A, V188, P799, DOI 10.1007/s00359-002-0368-9; Hedrick PW, 1997, ANNU REV ECOL SYST, V28, P55, DOI 10.1146/annurev.ecolsys.28.1.55; HEINRICH B, 1973, J EXP BIOL, V58, P677; HEINRICH B, 1976, J EXP BIOL, V64, P561; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hohenlohe PA, 2010, INT J PLANT SCI, V171, P1059, DOI 10.1086/656306; Kammer AE, 1968, J COMP PHYSIOL A, V68, P334; Karl I, 2009, ECOGRAPHY, V32, P488, DOI 10.1111/j.1600-0587.2008.05660.x; Katz LA, 1997, GENETICS, V147, P609; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Kohn MH, 2006, TRENDS ECOL EVOL, V21, P629, DOI 10.1016/j.tree.2006.08.001; Kraus FB, 2009, J ANIM ECOL, V78, P247, DOI 10.1111/j.1365-2656.2008.01479.x; Lawrence MJ, 2000, ANN BOT-LONDON, V85, P221, DOI 10.1006/anbo.1999.1044; Lozier JD, 2011, MOL ECOL, V20, P4870, DOI 10.1111/j.1365-294X.2011.05314.x; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Metzger MJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P549, DOI 10.1111/j.1466-822x.2005.00190.x; NEWSHOLME EA, 1972, BIOCHEM J, V128, P89, DOI 10.1042/bj1280089; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Oh HK, 2009, GENES GENOM, V31, P293, DOI 10.1007/BF03191202; Orsini L, 2009, J EVOLUTION BIOL, V22, P367, DOI 10.1111/j.1420-9101.2008.01653.x; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; PAMILO P, 1981, GENETICS, V98, P199; Piertney SB, 2010, GENETICA, V138, P419, DOI 10.1007/s10709-008-9322-2; Rank NE, 2002, EVOLUTION, V56, P2278, DOI 10.1111/j.0014-3820.2002.tb00151.x; RIDDOCH BJ, 1993, BIOL J LINN SOC, V50, P1, DOI 10.1111/j.1095-8312.1993.tb00915.x; ROSS KG, 1995, AM NAT, V146, P325, DOI 10.1086/285803; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saastamoinen M, 2008, AM NAT, V171, pE701, DOI 10.1086/587531; Saunders P., 2008, BOMBUS MUSCORUM BOMB; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; Staples JF, 2004, J EXP BIOL, V207, P749, DOI 10.1242/jeb.00825; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ujvari B, 2011, INT J MOL SCI, V12, P5168, DOI 10.3390/ijms12085168; WATT WB, 1983, GENETICS, V103, P691; Watt WB, 1992, P NATL ACAD SCI, V89, P01608; Wheat CW, 2010, CONSERV GENET, V11, P387, DOI 10.1007/s10592-009-0042-7; Wheat CW, 2010, MOL BIOL EVOL, V27, P267, DOI 10.1093/molbev/msp227; Wheat CW, 2006, MOL BIOL EVOL, V23, P499, DOI 10.1093/molbev/msj062; Widmer A, 1998, HEREDITY, V81, P563, DOI 10.1046/j.1365-2540.1998.00407.x; Widmer A, 1999, MOL ECOL, V8, P387, DOI 10.1046/j.1365-294X.1999.00584.x	67	2	2	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65600	10.1371/journal.pone.0065600	http://dx.doi.org/10.1371/journal.pone.0065600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750269	Green Submitted, Green Published, gold			2022-12-25	WOS:000319961900071
J	Fallon, BP; Curnutte, B; Maupin, KA; Partyka, K; Choi, S; Brand, RE; Langmead, CJ; Tembe, W; Haab, BB				Fallon, Brian P.; Curnutte, Bryan; Maupin, Kevin A.; Partyka, Katie; Choi, Sunguk; Brand, Randall E.; Langmead, Christopher J.; Tembe, Waibhav; Haab, Brian B.			The Marker State Space (MSS) Method for Classifying Clinical Samples	PLOS ONE			English	Article							CA-19-9 ANTIGEN; LUNG-CANCER; DIAGNOSIS; PROTEINS; CLASSIFICATION; BIOMARKERS; CELL; GLYCOSYLATION; SPECIFICITY; PREVALENCE	The development of accurate clinical biomarkers has been challenging in part due to the diversity between patients and diseases. One approach to account for the diversity is to use multiple markers to classify patients, based on the concept that each individual marker contributes information from its respective subclass of patients. Here we present a new strategy for developing biomarker panels that accounts for completely distinct patient subclasses. Marker State Space (MSS) defines "marker states'' based on all possible patterns of high and low values among a panel of markers. Each marker state is defined as either a case state or a control state, and a sample is classified as case or control based on the state it occupies. MSS was used to define multi-marker panels that were robust in cross validation and training-set/test-set analyses and that yielded similar classification accuracy to several other classification algorithms. A three-marker panel for discriminating pancreatic cancer patients from control subjects revealed subclasses of patients based on distinct marker states. MSS provides a straightforward approach for modeling highly divergent subclasses of patients, which may be adaptable for diverse applications.	[Fallon, Brian P.; Curnutte, Bryan; Maupin, Kevin A.; Partyka, Katie; Haab, Brian B.] Van Andel Inst, Lab Canc Immunodiagnost, Grand Rapids, MI USA; [Choi, Sunguk; Langmead, Christopher J.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Brand, Randall E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Tembe, Waibhav] Translat Genom Res Inst, Phoenix, AZ USA	Van Andel Institute; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Translational Genomics Research Institute	Haab, BB (corresponding author), Van Andel Inst, Lab Canc Immunodiagnost, Grand Rapids, MI USA.	Brian.haab@vai.org		Langmead, Christopher/0000-0001-7521-6736	National Institutes of Health [R33 CA122890, 1U01CA152653, 1U01CA168896]; Van Andel Institute; NATIONAL CANCER INSTITUTE [U01CA168896, U01CA152653, R33CA122890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Van Andel Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funding of this work is from the National Institutes of Health (R33 CA122890, 1U01CA152653, and 1U01CA168896) and the Van Andel Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alonzo Todd A., 2007, V404, P89, DOI 10.1007/978-1-59745-530-5_6; Baek S, 2009, BRIEF BIOINFORM, V10, P537, DOI 10.1093/bib/bbp016; Bergsma D, 2010, MOL CELL PROTEOMICS, V9, P446, DOI 10.1074/mcp.M900418-MCP200; Bouwman K, 2003, PROTEOMICS, V3, P2200, DOI 10.1002/pmic.200300611; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; CHEN S, 2007, CLIN PROTEOMICS; Chen SM, 2007, NAT METHODS, V4, P437, DOI 10.1038/NMETH1035; COOK EF, 1984, J CHRON DIS, V37, P721, DOI 10.1016/0021-9681(84)90041-9; DILLMAN RO, 1983, CANCER RES, V43, P417; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; GAIL MH, 1988, J NATL CANCER I, V80, P97, DOI 10.1093/jnci/80.2.97; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Haab BB, 2010, ANN SURG, V251, P937, DOI 10.1097/SLA.0b013e3181d7738d; Haab BB, 2010, EXPERT REV PROTEOMIC, V7, P9, DOI 10.1586/EPR.09.102; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Hoggatt J, 2011, MOL DIAGN THER, V15, P53, DOI 10.2165/11534880-000000000-00000; Kloppel G, 2009, ARCH PATHOL LAB MED, V133, P382, DOI 10.1043/1543-2165-133.3.382; Koziol JA, 2003, CLIN CANCER RES, V9, P5120; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; LOMBARDI C, 1990, CHEST, V97, P639, DOI 10.1378/chest.97.3.639; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Lukes M, 2001, FOLIA BIOL-PRAGUE, V47, P41; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; Orchekowski R, 2005, CANCER RES, V65, P11193, DOI 10.1158/0008-5472.CAN-05-1436; Partyka K, 2012, PROTEOMICS, V12, P2212, DOI 10.1002/pmic.201100676; Porter A, 2010, GLYCOBIOLOGY, V20, P369, DOI 10.1093/glycob/cwp187; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang CY, 2010, BIOSTATISTICS, V11, P195, DOI 10.1093/biostatistics/kxp052; Wu YM, 2009, J PROTEOME RES, V8, P1876, DOI 10.1021/pr8008379; Yue TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029180; Yue TT, 2011, PROTEOMICS, V11, P3665, DOI 10.1002/pmic.201000827; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200; Zhang HP, 2003, P NATL ACAD SCI USA, V100, P4168, DOI 10.1073/pnas.0230559100	37	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65905	10.1371/journal.pone.0065905	http://dx.doi.org/10.1371/journal.pone.0065905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750276	Green Accepted, Green Published, gold			2022-12-25	WOS:000319961900078
J	Lincoln, S; Allen, M; Cox, CL; Walker, LP; Malphrus, K; Qiu, YS; Nguyen, T; Rowley, C; Kouri, N; Crook, J; Pankratz, VS; Younkin, S; Younkin, L; Carrasquillo, M; Zou, FG; Abdul-Hay, SO; Springer, W; Sando, SB; Aasly, JO; Barcikowska, M; Wszolek, ZK; Lewis, JM; Dickson, D; Graff-Radford, NR; Petersen, RC; Eckman, E; Younkin, SG; Ertekin-Taner, N				Lincoln, Sarah; Allen, Mariet; Cox, Claire L.; Walker, Louise P.; Malphrus, Kimberly; Qiu, Yushi; Thuy Nguyen; Rowley, Christopher; Kouri, Naomi; Crook, Julia; Pankratz, V. Shane; Younkin, Samuel; Younkin, Linda; Carrasquillo, Minerva; Zou, Fanggeng; Abdul-Hay, Samer O.; Springer, Wolfdieter; Sando, Sigrid B.; Aasly, Jan O.; Barcikowska, Maria; Wszolek, Zbigniew K.; Lewis, Jada M.; Dickson, Dennis; Graff-Radford, Neill R.; Petersen, Ronald C.; Eckman, Elizabeth; Younkin, Steven G.; Ertekin-Taner, Niluefer			LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer's Disease (LOAD)	PLOS ONE			English	Article							ALPHA-T-CATENIN; AMYLOID-PRECURSOR PROTEIN; GENETIC ASSOCIATION; BETA; LINKAGE; BRAIN; SUSCEPTIBILITY; CHROMOSOME-10; POLYMORPHISMS; EXPRESSION	Leucine rich repeat transmembrane protein 3 (LRRTM3) is member of a synaptic protein family. LRRTM3 is a nested gene within alpha-T catenin (CTNNA3) and resides at the linkage peak for late-onset Alzheimer's disease (LOAD) risk and plasma amyloid beta (Ab) levels. In-vitro knock-down of LRRTM3 was previously shown to decrease secreted Ab, although the mechanism of this is unclear. In SH-SY5Y cells overexpressing APP and transiently transfected with LRRTM3 alone or with BACE1, we showed that LRRTM3 co-localizes with both APP and BACE1 in early endosomes, where BACE1 processing of APP occurs. Additionally, LRRTM3 co-localizes with APP in primary neuronal cultures from Tg2576 mice transduced with LRRTM3-expressing adeno-associated virus. Moreover, LRRTM3 co-immunoprecipitates with both endogenous APP and overexpressed BACE1, in HEK293T cells transfected with LRRTM3. SH-SY5Y cells with knock-down of LRRTM3 had lower BACE1 and higher CTNNA3 mRNA levels, but no change in APP. Brain mRNA levels of LRRTM3 showed significant correlations with BACE1, CTNNA3 and APP in similar to 400 humans, but not in LRRTM3 knock-out mice. Finally, we assessed 69 single nucleotide polymorphisms (SNPs) within and flanking LRRTM3 in 1,567 LOADs and 2,082 controls and identified 8 SNPs within a linkage disequilibrium block encompassing 5'UTR-Intron 1 of LRRTM3 that formed multilocus genotypes (MLG) with suggestive global association with LOAD risk (p = 0.06), and significant individual MLGs. These 8 SNPs were genotyped in an independent series (1,258 LOADs and 718 controls) and had significant global and individual MLG associations in the combined dataset (p = 0.02-0.05). Collectively, these results suggest that protein interactions between LRRTM3, APP and BACE1, as well as complex associations between mRNA levels of LRRTM3, CTNNA3, APP and BACE1 in humans might influence APP metabolism and ultimately risk of AD.	[Lincoln, Sarah; Allen, Mariet; Cox, Claire L.; Walker, Louise P.; Malphrus, Kimberly; Qiu, Yushi; Thuy Nguyen; Rowley, Christopher; Kouri, Naomi; Younkin, Samuel; Younkin, Linda; Carrasquillo, Minerva; Zou, Fanggeng; Abdul-Hay, Samer O.; Springer, Wolfdieter; Dickson, Dennis; Eckman, Elizabeth; Younkin, Steven G.; Ertekin-Taner, Niluefer] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA; [Crook, Julia] Mayo Clin Florida, Biostat Unit, Jacksonville, FL USA; [Pankratz, V. Shane] Mayo Clin Minnesto, Dept Biostat, Rochester, MN USA; [Sando, Sigrid B.; Aasly, Jan O.] St Olavs Hosp, Dept Neurol, Trondheim, Norway; [Sando, Sigrid B.; Aasly, Jan O.] Norwegian Univ Sci & Technol, NTNU, Dept Neurosci, N-7034 Trondheim, Norway; [Barcikowska, Maria] Polish Acad Sci, Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland; [Wszolek, Zbigniew K.; Graff-Radford, Neill R.; Ertekin-Taner, Niluefer] Mayo Clin Florida, Dept Neurol, Jacksonville, FL USA; [Lewis, Jada M.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Petersen, Ronald C.] Mayo Clin Minnesota, Dept Neurol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Polish Academy of Sciences; Mayo Clinic; State University System of Florida; University of Florida	Ertekin-Taner, N (corresponding author), Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA.	taner.nilufer@mayo.edu	Eckman, Elizabeth/AAL-7316-2021; Wszolek, Zbigniew K./AAB-1431-2019; Kouri, Naomi/G-6695-2013	Rowley, Christopher/0000-0002-5307-1748; Eckman, Elizabeth/0000-0002-5391-4960; Kouri, N/0000-0002-6841-9882; Springer, Wolfdieter/0000-0002-1178-3149; Barcikowska, Maria/0000-0001-5657-9670; Dickson, Dennis W/0000-0001-7189-7917	National Institutes of Health (NIH) grants: National Institute on Aging [R01 032990, R01 AG018023]; Mayo Alzheimer's Disease Research Center [P50 AG016574]; Mayo Alzheimer's Disease Patient Registry [U01 AG006576]; National Institute on Aging [AG025711, AG017216, AG003949]; NIH [KL2 RR024151]; Siragusa Foundation; GHR Foundation; Research Council of Norway [153487/V50]; Ministry of Science (Poland) [N N401 235134]; NIH/NINDS [P50 NS072187]; Mayo Clinic Florida Research Committee CR program; Dystonia Medical Research Foundation; Genentech, Inc; MMRC; Elan Pharmaceutical Research; Pfizer Pharmaceuticals; Medivation; Pfizer Incorporated; Janssen Alzheimer Immunotherapy; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS072187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017216, P01AG003949, P50AG016574, R01AG018023, P50AG025711] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grants: National Institute on Aging; Mayo Alzheimer's Disease Research Center; Mayo Alzheimer's Disease Patient Registry; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siragusa Foundation; GHR Foundation; Research Council of Norway(Research Council of Norway); Ministry of Science (Poland); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayo Clinic Florida Research Committee CR program; Dystonia Medical Research Foundation; Genentech, Inc(Roche HoldingGenentech); MMRC; Elan Pharmaceutical Research; Pfizer Pharmaceuticals(Pfizer); Medivation; Pfizer Incorporated; Janssen Alzheimer Immunotherapy; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this research was provided by these National Institutes of Health (NIH) grants: National Institute on Aging (R01 032990 to NET and R01 AG018023 to NRG-R and SGY), Mayo Alzheimer's Disease Research Center (P50 AG016574 to RCP, DWD, NRG-R, SGY, and NET), Mayo Alzheimer's Disease Patient Registry (U01 AG006576 to RCP), National Institute on Aging (AG025711, AG017216, AG003949 to DWD). NET is the recipient of NIH (KL2 RR024151) and Siragusa Foundation grants. This project was also generously supported by the Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (to RCP, DWD, NRG-R, and SGY) and by the Palumbo Professorship in Alzheimer's Disease Research (to SGY). MMC and WS are supported partly by GHR Foundation grants. SBS was supported by the Research Council of Norway (153487/V50). MB is partly supported by Ministry of Science (Poland) grant (N N401 235134). ZKWis partially supported by the NIH/NINDS P50 NS072187, Mayo Clinic Florida Research Committee CR program, and Dystonia Medical Research Foundation. The mouse strain used for this research project, B6; 129S5-Lrrtm3tm1Lex/Mmcd, identification number 032451-UCD was donated to the Mutant Mouse Regional Resource Center MMRRC by Genentech, Inc. MMRC is a NCRR-NIH funded strain repository. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We have the following interests: N. Graff-Radford has served as a consultant to Codman and received grant support from Elan Pharmaceutical Research, Pfizer Pharmaceuticals, Medivation, and Forrest. R.C. Petersen has been a consultant to GE Healthcare and Elan Pharmaceuticals, has served on a data safety monitoring board in clinical trials sponsored by Pfizer Incorporated and Janssen Alzheimer Immunotherapy, and gave a CME lecture at Novartis Incorporated. The mouse strain used for this research project, B6; 129S5-Lrrtm3tm1Lex/Mmcd, identification number 032451-UCD was donated to the Mutant Mouse Regional Resource Center MMRRC by Genentech, Inc. MMRC is a NCRR-NIH-funded strain repository. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Allen M, 2012, NEUROLOGY, V79, P221, DOI 10.1212/WNL.0b013e3182605801; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bertram L, 2007, J MED GENET, V44, DOI 10.1136/jmg.2005.039263; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blomqvist MEL, 2004, NEUROSCI LETT, V358, P220, DOI 10.1016/j.neulet.2004.01.032; Busby V, 2004, NEUROMOL MED, V5, P133, DOI 10.1385/NMM:5:2:133; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Cellini E, 2005, ALZ DIS ASSOC DIS, V19, P246, DOI 10.1097/01.wad.0000189030.50826.86; EDWARDS TL, 2008, AM J MED GENET B; Ertekin-Taner N, 2005, HUM MOL GENET, V14, P447, DOI 10.1093/hmg/ddi041; Ertekin-Taner N, 2003, HUM MOL GENET, V12, P3133, DOI 10.1093/hmg/ddg343; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jurinke C, 2004, MOL BIOTECHNOL, V26, P147, DOI 10.1385/MB:26:2:147; Kask M, 2011, BIOCHEM BIOPH RES CO, V411, P56, DOI 10.1016/j.bbrc.2011.06.085; Klimkowicz-Mrowiec A, 2009, DEMENT GERIATR COGN, V28, P461, DOI 10.1159/000259460; Laakso T, 2012, J ALZHEIMERS DIS, V31, P759, DOI 10.3233/JAD-2012-120193; Lauren J, 2003, GENOMICS, V81, P411, DOI 10.1016/S0888-7543(03)00030-2; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Martin ER, 2005, J MED GENET, V42, P787, DOI 10.1136/jmg.2004.029553; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyashita A, 2007, HUM MOL GENET, V16, P2854, DOI 10.1093/hmg/ddm244; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REITZ C, 2012, ARCH NEUROLOGY; Sando SB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-9; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Smith JD, 2011, CELL MOL LIFE SCI, V68, P2493, DOI 10.1007/s00018-011-0728-0; Sousa I, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-7; Thornton-Wells TA, 2008, GENET EPIDEMIOL, V32, P187, DOI 10.1002/gepi.20294; van Dijk M, 2010, J ALZHEIMERS DIS, V19, P673, DOI 10.3233/JAD-2010-1265; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zou F, 2010, NEUROLOGY, V74, P480, DOI 10.1212/WNL.0b013e3181d07654	36	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64164	10.1371/journal.pone.0064164	http://dx.doi.org/10.1371/journal.pone.0064164			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750206	Green Submitted, Green Published, gold			2022-12-25	WOS:000319961900008
J	Pfitzner, R; Gorzelniak, L; Heinrich, J; von Berg, A; Klumper, C; Bauer, CP; Koletzko, S; Berdel, D; Horsch, A; Schulz, H				Pfitzner, Rebecca; Gorzelniak, Lukas; Heinrich, Joachim; von Berg, Andrea; Kluemper, Claudia; Bauer, Carl P.; Koletzko, Sibylle; Berdel, Dietrich; Horsch, Alexander; Schulz, Holger		GINIplus Study Grp	Physical Activity in German Adolescents Measured by Accelerometry and Activity Diary: Introducing a Comprehensive Approach for Data Management and Preliminary Results	PLOS ONE			English	Article							ECONOMIC COSTS; ILL HEALTH; CHILDREN; INACTIVITY; OBESITY; BURDEN; VALIDATION; TIME; LIFE	Introduction: Surveillance of physical activity (PA) is increasingly based on accelerometry. However, data management guidelines are lacking. We propose an approach for combining accelerometry and diary based PA information for assessment of PA in adolescents and provide an example of this approach using data from German adolescents. Methods: The 15-year-old participants comprised a subsample the GINIplus birth cohort (n = 328, 42.4% male). Data on PA was obtained from hip-worn accelerometers (ActiGraph GT3X) for seven consecutive days, combined with a prospective activity diary. Major aspects of data management were validity of wear time, handling of non-wear time and diary comments. After data cleaning, PA and percentage of adolescents meeting the recommendations for moderate-to-vigorous activity (MVPA) per day were determined. Results: From the 2224 recorded days 493 days (25%) were invalid, mainly due to uncertainties relating to non-wear time (322 days). Ultimately, 269 of 328 subjects (82%) with valid data for at least three weekdays and one weekend day were included in the analysis. Mean MVPA per day was 39.1 minutes (SD +/- 25.0), with boys being more active than girls (41.8 +/- 21.5 minutes vs. 37.1 +/- 27.8 minutes, p<0.001). Accordingly, 24.7% of boys and 17.2% of girls (p<0.01) met the WHO recommendations for PA. School sport accounted for only 6% of weekly MVPA. In fact, most MVPA was performed during leisure time, with the majority of adolescents engaging in ball sports (25.4%) and endurance sports (19.7%). Girls also frequently reported dancing and gymnastics (23%). Conclusion: For assessment of PA in adolescents, collecting both accelerometry and diary-based information is recommended. The diary is vital for the identification of invalid data and non-compliant participants. Preliminary results suggest that four out of five German adolescents do not meet WHO recommendations for PA and that school sport contributes only little to MVPA.	[Pfitzner, Rebecca; Heinrich, Joachim; Schulz, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Gorzelniak, Lukas; Horsch, Alexander] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [von Berg, Andrea; Berdel, Dietrich] Marien Hosp, Dept Pediat, Wesel, Germany; [Kluemper, Claudia] Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany; [Bauer, Carl P.] Tech Univ Munich, Dept Pediat, D-80290 Munich, Germany; [Koletzko, Sibylle] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; St. Marien Hospital; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Technical University of Munich; University of Munich	Schulz, H (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany.	schulz@helmholtz-muenchen.de	Heinrich, Joachim/N-1720-2013; Horsch, Alexander/W-8322-2018; Schulz, Holger/J-5643-2015	Heinrich, Joachim/0000-0002-9620-1629; Horsch, Alexander/0000-0001-7745-0139; Schulz, Holger/0000-0002-1157-200X	Helmholtz Zentrum Munchen, German Research Center for Environmental Health; Graduate School of Information Science in Health (GSISH); TUM Graduate School	Helmholtz Zentrum Munchen, German Research Center for Environmental Health(Helmholtz Association); Graduate School of Information Science in Health (GSISH); TUM Graduate School	Accelerometers were funded by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health. The research was also supported by the Graduate School of Information Science in Health (GSISH) and the TUM Graduate School. All institutions are no external funding sources rather governmental run scientific institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807; Andrews F. M., 1976, SOCIAL INDICATORS WE; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Cain KL, J PHYS ACT IN PRESS; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Chung AE, 2012, CLIN PEDIATR, V51, P122, DOI 10.1177/0009922811417291; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; Colley Rachel, 2010, Health Rep, V21, P63; Currie C, 2012, HLTH BEHAV SCH AGED; De Meester F, 2011, PUBLIC HEALTH NUTR, V14, P2124, DOI 10.1017/S1368980011001868; Esliger DW, 2007, APPL PHYSIOL NUTR ME, V32, pS195, DOI 10.1139/H07-107; Fox KR, 2000, P NUTR SOC, V59, P497, DOI 10.1017/S0029665100000720; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Guinhouya CB, 2006, OBESITY, V14, P774, DOI 10.1038/oby.2006.89; Heinrich J, 2012, BUNDESGESUNDHEITSBLA, V55, P864, DOI 10.1007/s00103-012-1485-4; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kahlert D, 2011, DEUT Z SPORTMED, V62, P36; Kaminsky LA, 2012, PHYSIOL MEAS, V33, P1869, DOI 10.1088/0967-3334/33/11/1869; Katzmarzyk PT, 2004, CAN J APPL PHYSIOL, V29, P90, DOI 10.1139/h04-008; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lampert T, 2007, BUNDESGESUNDHEITSBLA, V50, P634, DOI 10.1007/s00103-007-0224-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; Mcclain JJ, 2008, MED SCI SPORT EXER, V40, P2080, DOI 10.1249/MSS.0b013e3181824d98; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; National Cancer Institute, SAS PROGR AN NHANES; Olds T, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-43; Ottevaere C, 2011, J SPORT SCI, V29, P103, DOI 10.1080/02640414.2010.521169; R Core Team, 2022, R LANG ENV STAT COMP; Ridley K, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-45; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; von Berg A, 2003, J ALLERGY CLIN IMMUN, V111, P533, DOI 10.1067/mai.2003.101; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2009, GLOB HLTH RISKS MORT	42	22	23	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65192	10.1371/journal.pone.0065192	http://dx.doi.org/10.1371/journal.pone.0065192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750243	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000319961900045
J	Rao, JH; Qin, JJ; Qian, XF; Lu, L; Wang, P; Wu, ZS; Zhai, Y; Zhang, F; Li, GQ; Wang, XH				Rao, Jianhua; Qin, Jianjie; Qian, Xiaofeng; Lu, Ling; Wang, Ping; Wu, Zhengshan; Zhai, Yuan; Zhang, Feng; Li, Guoqiang; Wang, Xuehao			Lipopolysaccharide Preconditioning Protects Hepatocytes from Ischemia/Reperfusion Injury (IRI) through Inhibiting ATF4-CHOP Pathway in Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; LIVER ISCHEMIA; TNF-ALPHA; CELL-DEATH; ER STRESS; IL-6 PRODUCTION; ACTIVATION; APOPTOSIS	Background: Low-dose lipopolysaccharide (LPS) preconditioning-induced liver protection has been demonstrated during ischemia-reperfusion injury (IRI) in several organs but has not been sufficiently elucidated underlying causal mechanism. This study investigated the role of low-dose LPS preconditioning on ATF4-CHOP pathway as well as the effects of the pathway on tissue injury and inflammation in a mouse model of liver partial-warm IRI. Methods: LPS (100 mg/kg/d) was injected intraperitoneally two days before ischemia. Hepatic injury was evaluated based on serum alanine aminotransferase levels, histopathology, and caspase-3 activity. The ATF4-CHOP pathway and its related apoptotic molecules were investigated after reperfusion. The role of LPS preconditioning on apoptosis and ATF4-CHOP pathway was examined in vitro. Moreover, the effects of the ATF4-CHOP pathway on apoptosis, Caspase-12, and Caspase-3 were determined with ATF4 small interfering RNA (siRNA). Inflammatory cytokine expression was also checked after reperfusion. Inflammatory cytokines and related signaling pathways were analyzed in vitro in macrophages treated by LPS preconditioning or ATF4 siRNA. Results: LPS preconditioning significantly attenuated liver injury after IRI. As demonstrated by in vitro experiments, LPS preconditioning significantly reduced the upregulation of the ATF4-CHOP pathway and inhibited Caspase-12 and Caspase-3 activation after IRI. Later experiments showed that ATF4 knockdown significantly suppressed CHOP, cleaved caspase-12 and caspase-3 expression, as well as inhibited hepatocellular apoptosis. In addition, in mice pretreated with LPS, TNF-alpha and IL-6 were inhibited after reperfusion, whereas IL-10 was upregulated. Similarly, low-dose LPS significantly inhibited TNF-alpha, IL-6, ATF4-CHOP pathway, NF-kappa B pathway, and ERK1/2 in high-dose LPS-stimulated macrophages, whereas IL-10 and cytokine signaling (SOCS)-3 suppressor were induced. Importantly, ATF4 siRNA is consistent with results of LPS preconditioning in macrophages. Conclusions: This work is the first time to provide evidence for LPS preconditioning protects hepatocytes from IRI through inhibiting ATF4-CHOP pathway, which may be critical to reducing related apoptosis molecules and modulating innate inflammation.	[Zhang, Feng] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China; Minist Publ Hlth, Key Lab Living Donor Liver Transplantat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhang, F (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.	zhangf@njmu.edu.cn; liguoqiang@njmu.edu.cn; xuehaowang@hotmail.com	lu, lu/HGA-0894-2022; lu, lu/HII-7530-2022		International Collaboration Foundation of Jiangsu Province [BZ2011041, BK2009439, ZX05 200904, WS2011106, W201201, BZ2012058]; Development of Innovative Research Team in the First Affiliated Hospital of NJMU; National Nature Science Foundation of China [81100270, 81070380, 81310108001, 81210108017, 81273261, 81270583]; Health Department of Jiangsu Province [ZX05200903]	International Collaboration Foundation of Jiangsu Province; Development of Innovative Research Team in the First Affiliated Hospital of NJMU; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Jiangsu Province	This study was supported by the International Collaboration Foundation of Jiangsu Province (BZ2011041, BK2009439, ZX05 200904, WS2011106, W201201, BZ2012058), Development of Innovative Research Team in the First Affiliated Hospital of NJMU and the National Nature Science Foundation of China (81100270, 81070380, 81310108001, 81210108017, 81273261, 81270583). Open project of the program of "Science and Education to Promote Health'' from Health Department of Jiangsu Province (ZX05200903). First Innovation Team Foundation of Jiangsu province Hospital (for Sun BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Azzolina A, 2003, BBA-MOL CELL RES, V1643, P75, DOI 10.1016/j.bbamcr.2003.09.003; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Blohmke CJ, 2012, J IMMUNOL, V189, P5467, DOI 10.4049/jimmunol.1103661; COLLETTI LM, 1994, J SURG RES, V57, P337, DOI 10.1006/jsre.1994.1152; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Franco PJ, 2008, INVEST OPHTH VIS SCI, V49, P4604, DOI 10.1167/iovs.08-2054; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Godet C, 2006, SHOCK, V25, P384, DOI 10.1097/01.shk.0000209528.35743.54; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; Hatano E, 2001, AM J PHYSIOL-GASTR L, V281, pG1357, DOI 10.1152/ajpgi.2001.281.6.G1357; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jeong HJ, 2002, CYTOKINE, V18, P252, DOI 10.1006/cyto.2002.0894; Ke BB, 2009, HUM GENE THER, V20, P1133, DOI 10.1089/hum.2009.049; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Korhonen L, 2005, MOL CELL NEUROSCI, V28, P85, DOI 10.1016/j.mcn.2004.08.015; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Liu J, 2012, TRANSPLANTATION, V94, P211, DOI 10.1097/TP.0b013e318259d38e; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moniz H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.88; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Obermaier R, 2003, PANCREAS, V27, pE51, DOI 10.1097/00006676-200310000-00020; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Que XY, 2004, J SURG RES, V116, P262, DOI 10.1016/j.jss.2003.07.005; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ren F, 2011, HEPATOLOGY, V54, P687, DOI 10.1002/hep.24419; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Rudiger HA, 2003, J INVEST SURG, V16, P149, DOI 10.1080/08941930390205764; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sano T, 2011, TRANSPLANTATION, V91, P1082, DOI 10.1097/TP.0b013e31821457cb; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Srinivasan K, 2012, LIFE SCI, V90, P154, DOI 10.1016/j.lfs.2011.10.017; SUZUKI S, 1991, TRANSPLANTATION, V52, P978, DOI 10.1097/00007890-199112000-00008; Urban P, 2012, MOL CELL BIOCHEM, V362, P133, DOI 10.1007/s11010-011-1135-4; Vekich JA, 2012, J MOL CELL CARDIOL, V53, P259, DOI 10.1016/j.yjmcc.2012.05.005; Vilatoba M, 2005, SURGERY, V138, P342, DOI 10.1016/j.surg.2005.04.019; Wang ZJ, 2009, CELL BIOL INT, V33, P665, DOI 10.1016/j.cellbi.2009.03.006; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wu CX, 2011, J SURG RES, V166, pE205, DOI 10.1016/j.jss.2010.10.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373	51	42	47	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65568	10.1371/journal.pone.0065568	http://dx.doi.org/10.1371/journal.pone.0065568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750267	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900069
J	Zelazny, AM; Ding, L; Goldberg, JB; Mijares, LA; Conlan, S; Conville, PS; Stock, F; Ballentine, SJ; Olivier, KN; Sampaio, EP; Murray, PR; Holland, SM				Zelazny, Adrian M.; Ding, Li; Goldberg, Joanna B.; Mijares, Lilia A.; Conlan, Sean; Conville, Patricia S.; Stock, Frida; Ballentine, Samuel J.; Olivier, Kenneth N.; Sampaio, Elizabeth P.; Murray, Patrick R.; Holland, Steven M.			Adaptability and Persistence of the Emerging Pathogen Bordetella petrii	PLOS ONE			English	Article							O-ANTIGEN BIOSYNTHESIS; GENE-TRANSFER; SP NOV.; IDENTIFICATION; INFECTIONS	The first described, environmentally isolated, Bordetella petrii was shown to undergo massive genomic rearrangements in vitro. More recently, B. petrii was isolated from clinical samples associated with jaw, ear bone, cystic fibrosis and chronic pulmonary disease. However, the in vivo consequences of B. petrii genome plasticity and its pathogenicity remain obscure. B. petrii was identified from four sequential respiratory samples and a post-mortem spleen sample of a woman presenting with bronchiectasis and cavitary lung disease associated with nontuberculous mycobacterial infection. Strains were compared genetically, phenotypically and by antibody recognition from the patient and from inoculated mice. The successive B. petrii strains exhibited differences in growth, antibiotic susceptibility and recognition by the patient's antibodies. Antibodies from mice inoculated with these strains recapitulated the specificity and strain dependent response that was seen with the patient's serum. Finally, we characterize one strain that was poorly recognized by the patient's antibodies, due to a defect in the lipopolysaccharide O-antigen, and identify a mutation associated with this phenotype. We propose that B. petrii is remarkably adaptable in vivo, providing a possible connection between immune response and bacterial evasion and supporting infection persistence.	[Zelazny, Adrian M.; Ding, Li; Ballentine, Samuel J.; Olivier, Kenneth N.; Sampaio, Elizabeth P.; Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Zelazny, Adrian M.; Mijares, Lilia A.; Conville, Patricia S.; Stock, Frida; Murray, Patrick R.] NIH, Microbiol Serv, Ctr Clin, Bethesda, MD 20892 USA; [Goldberg, Joanna B.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [Conlan, Sean] NHGRI, NIH, Bethesda, MD 20892 USA; [Sampaio, Elizabeth P.] Fiocruz MS, Inst Oswaldo Cruz, Leprosy Lab, BR-21045900 Rio De Janeiro, Brazil	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Virginia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Fundacao Oswaldo Cruz	Zelazny, AM (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	azelazny@mail.nih.gov	Conlan, Sean/B-4401-2008	Conlan, Sean/0000-0001-6848-3465	Division of Intramural Research; National Human Genome Research Institute; Clinical Center at the National Institutes of Health; National Institute of Allergy and Infectious Diseases; CLINICAL CENTER [ZIACL080013] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Clinical Center at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	This work was financially supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute and Clinical Center at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Buboltz AM, 2009, INFECT IMMUN, V77, P3249, DOI 10.1128/IAI.01448-08; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; CLSI, 2018, PERFORMANCE STANDARD; Cunneen MM, 2007, MOL BIOL EVOL, V24, P1355, DOI 10.1093/molbev/msm058; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Fry NK, 2005, EMERG INFECT DIS, V11, P1131, DOI 10.3201/eid1107.050046; Goebel EM, 2008, INFECT IMMUN, V76, P1774, DOI 10.1128/IAI.01629-07; Gross R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-449; Iguchi A, 2008, MICROBIOL-SGM, V154, P559, DOI 10.1099/mic.0.2007/013334-0; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Ko KS, 2005, J CLIN MICROBIOL, V43, P2516, DOI 10.1128/JCM.43.5.2516-2519.2005; Le Coustumier A, 2011, EMERG INFECT DIS, V17, P612, DOI 10.3201/eid1704.101480; Lechner M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-141; Lee MS, 2006, DIAGN MICR INFEC DIS, V56, P217, DOI 10.1016/j.diagmicrobio.2006.03.017; MacArthur L, 2007, J ENDOTOXIN RES, V13, P243, DOI 10.1177/0968051907082609; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Moissenet D, 2005, PATHOL BIOL, V53, P500, DOI 10.1016/j.patbio.2005.06.004; Mooi FR, 1997, TRENDS MICROBIOL, V5, P161, DOI 10.1016/S0966-842X(96)10086-X; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Shepard CW, 2004, CLIN INFECT DIS, V38, P799, DOI 10.1086/381888; Spilker T, 2008, CLIN MICROBIOL INFEC, V14, P504, DOI 10.1111/j.1469-0691.2008.01968.x; Stark D, 2007, J MED MICROBIOL, V56, P435, DOI 10.1099/jmm.0.46976-0; Tang YW, 1998, CLIN INFECT DIS, V26, P389, DOI 10.1086/516323; Vandamme P, 1996, INT J SYST BACTERIOL, V46, P849, DOI 10.1099/00207713-46-4-849; von Wintzingerode F, 2001, INT J SYST EVOL MICR, V51, P1257, DOI 10.1099/00207713-51-4-1257; WEISS AA, 1984, INFECT IMMUN, V43, P263, DOI 10.1128/IAI.43.1.263-269.1984; Zelazny AM, 2009, INFECT IMMUN, V77, P4337, DOI 10.1128/IAI.00259-09; Zhang XQ, 2009, INFECT IMMUN, V77, P5050, DOI 10.1128/IAI.00667-09	30	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65102	10.1371/journal.pone.0065102	http://dx.doi.org/10.1371/journal.pone.0065102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750235	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900037
J	Sanchez-Zauco, NA; Torres, J; Perez-Figueroa, GE; Alvarez-Arellano, L; Camorlinga-Ponce, M; Gomez, A; Giono-Cerezo, S; Maldonado-Bernal, C				Angelica Sanchez-Zauco, Norma; Torres, Javier; Erandi Perez-Figueroa, Gloria; Alvarez-Arellano, Lourdes; Camorlinga-Ponce, Margarita; Gomez, Alejandro; Giono-Cerezo, Silvia; Maldonado-Bernal, Carmen			Impact of cagPAI and T4SS on the Inflammatory Response of Human Neutrophils to Helicobacter pylori Infection	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; KAPPA-B ACTIVATION; PATHOGENICITY ISLAND; MUCOSAL INTERLEUKIN-8; VIRULENCE FACTORS; IMMUNE-RESPONSE; IV SECRETION; HOST-CELLS; CAGA	Helicobacter pylori contains a pathogenicity island, cagPAI, with genes homologous to components of the type IV secretion system (T4SS) of Agrobacterium tumefaciens. The T4SS components assemble a structure that transfers CagA protein and peptidoglycan into host epithelial cells, causing the increased release of interleukin 8 (IL8) from the cells. The Toll-like receptors on neutrophils recognize H. pylori, initiating signaling pathways that enhance the activation of NF-kappa B. However, the roles of cagPAI and T4SS in the inflammatory response of neutrophils are unknown. We evaluated the participation of cagPAI and T4SS in the response of human neutrophils to H. pylori infection. Neutrophils were isolated from the blood of healthy donors and infected with H. pylori cagPAI(+), cagPAI(-), and cagPAI mutant strains virB4(-) and virD4(-). Whereas cagPAI(+) strain 26695 induced the greatest IL8 production, a proinflammatory response, cagPAI(-) strain 8822 induced the greatest IL10 production, an anti-inflammatory response. In contrast, the virB4(-) and virD4(-) mutant strains produced significantly more of the two proinflammatory cytokines IL1 beta and tumor necrosis factor athan the cagPAI(+) strain 26695. We observed that H. pylori downregulated the expression of TLRs 2 and 5 but upregulated TLR9 expression in a cagPAI and T4SS-independent manner. These results show for the first time that the response of human neutrophils to H. pylori may vary from a pro-inflammatory to an anti-inflammatory response, depending on cagPAI and the integrity of T4SS.	[Angelica Sanchez-Zauco, Norma; Erandi Perez-Figueroa, Gloria; Maldonado-Bernal, Carmen] Hosp Infantil Mexico Dr Federico Gomez, SS, Unidad Invest Enfermedades Oncol, Mexico City, DF, Mexico; [Angelica Sanchez-Zauco, Norma; Torres, Javier; Erandi Perez-Figueroa, Gloria; Camorlinga-Ponce, Margarita; Gomez, Alejandro] IMSS, Ctr Med Nacl Siglo 21, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Alvarez-Arellano, Lourdes] UNAM, Inst Biotecnol, Dept Med Mol & Bioproc, Lab Neuroinmunol, Cuernavaca, Morelos, Mexico; [Angelica Sanchez-Zauco, Norma; Giono-Cerezo, Silvia] IPN, Escuela Nacl Ciencias Biol, Lab Bacteriol Med, Mexico City 07738, DF, Mexico	Hospital Infantil de Mexico Federico Gomez; Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Maldonado-Bernal, C (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, SS, Unidad Invest Enfermedades Oncol, Mexico City, DF, Mexico.	cmaldobe@yahoo.com	Gómez, Alejandro/HGE-5641-2022	GIONO, SILVIA/0000-0003-1835-6788; Sanchez-Zauco, Norma/0000-0001-8375-1499; Maldonado-Bernal, Carmen/0000-0003-0663-2888; Alvarez-Arellano, Lourdes/0000-0002-3469-1407	Instituto Mexicano del Seguro Social (IMSS) [FIS/IMSS/PROT/C2007/053]	Instituto Mexicano del Seguro Social (IMSS)	This work was supported by Instituto Mexicano del Seguro Social (IMSS), grant FIS/IMSS/PROT/C2007/053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsadik A, 2011, HUM IMMUNOL, V72, P1188, DOI 10.1016/j.humimm.2011.08.015; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alvarez-Arellano L, 2007, FEMS IMMUNOL MED MIC, V51, P473, DOI 10.1111/j.1574-695X.2007.00327.x; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Backhed F, 2003, J INFECT DIS, V187, P829; Basso D, 1996, INT J CLIN LAB RES, V26, P207, DOI 10.1007/BF02592984; BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720, DOI 10.1016/0016-5085(92)90126-J; Camorlinga-Ponce M, 1998, AM J GASTROENTEROL, V93, P1264, DOI 10.1111/j.1572-0241.1998.00407.x; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; CRABTREE JE, 1994, EUR J GASTROEN HEPAT, V6, pS33; DEKIGAI H, 1995, DIGEST DIS SCI, V40, P1332, DOI 10.1007/BF02065547; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Fiorentino M, 2013, INFECT IMMUN, V81, P876, DOI 10.1128/IAI.01406-12; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Glocker E, 1998, INFECT IMMUN, V66, P2346, DOI 10.1128/IAI.66.5.2346-2348.1998; Graham DY, 2004, GUT, V53, P1235, DOI 10.1136/gut.2003.037499; Hofman V, 2000, INFECT IMMUN, V68, P5225, DOI 10.1128/IAI.68.9.5225-5233.2000; Ismail HF, 2003, J IMMUNOL, V170, P3782, DOI 10.4049/jimmunol.170.7.3782; Koller B, 2009, EUR J CLIN INVEST, V39, P535, DOI 10.1111/j.1365-2362.2009.02145.x; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Naumann M, 2005, INT J MED MICROBIOL, V295, P335, DOI 10.1016/j.ijmm.2005.06.007; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ogura K, 2000, J EXP MED, V192, P1601, DOI 10.1084/jem.192.11.1601; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; Pinto-Santini DM, 2009, J BACTERIOL, V191, P7343, DOI 10.1128/JB.00946-09; Sabroe I, 2005, CLIN INFECT DIS, V41, pS421, DOI 10.1086/431992; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sujanuma M, 2008, INT J CANCER, V123, P117, DOI 10.1002/ijc.23484; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Uno K, 2007, AM J PHYSIOL-GASTR L, V293, pG1004, DOI 10.1152/ajpgi.00096.2007; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; WALLACE JL, 1991, SCAND J GASTROENTERO, V26, P65, DOI 10.3109/00365529109098226; Yamaoka Y, 2000, P NATL ACAD SCI USA, V97, P7533, DOI 10.1073/pnas.130079797; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; Yamaoka Y, 1997, GUT, V41, P442, DOI 10.1136/gut.41.4.442; Yoshiyama H, 2000, MICROBES INFECT, V2, P55, DOI 10.1016/S1286-4579(00)00285-9; Zhao Y, 2007, J MED MICROBIOL, V56, P154, DOI 10.1099/jmm.0.46882-0	44	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64623	10.1371/journal.pone.0064623	http://dx.doi.org/10.1371/journal.pone.0064623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755130	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300020
J	Catania, KC; Catania, EH; Sawyer, EK; Leitch, DB				Catania, Kenneth C.; Catania, Elizabeth H.; Sawyer, Eva K.; Leitch, Duncan B.			Barrelettes without Barrels in the American Water Shrew	PLOS ONE			English	Article							STEM TRIGEMINAL COMPLEX; ARCHITECTONIC VIBRISSAL REPRESENTATIONS; BRAIN-STEM; COLUMNAR ORGANIZATION; CEREBRAL-CORTEX; STRUCTURAL ORGANIZATION; CORTICAL COLUMN; SOREX-PALUSTRIS; DEFICIENT MICE; LAYER 4	Water shrews (Sorex palustris) depend heavily on their elaborate whiskers to navigate their environment and locate prey. They have small eyes and ears with correspondingly small optic and auditory nerves. Previous investigations have shown that water shrew neocortex is dominated by large representations of the whiskers in primary and secondary somatosensory cortex (S1 and S2). Flattened sections of juvenile cortex processed for cytochrome oxidase revealed clear borders of the whisker pad representation in S1, but no cortical barrels. We were therefore surprised to discover prominent barrelettes in brainstem of juvenile water shrews in the present investigation. These distinctive modules were found in the principal trigeminal nucleus (PrV), and in two of the three spinal trigeminal subnuclei (interpolaris - SpVi and caudalis - SpVc). Analysis of the shrew's whisker pad revealed the likely relationship between whiskers and barrelettes. Barrelettes persisted in adult water shrew PrV, but barrels were also absent from adult cortex. Thus in contrast to mice and rats, which have obvious barrels in primary somatosensory cortex and less clear barrelettes in the principal nucleus, water shrews have clear barrelettes in the brainstem and no barrels in the neocortex. These results highlight the diverse ways that similar mechanoreceptors can be represented in the central nervous systems of different species.	[Catania, Kenneth C.; Catania, Elizabeth H.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Sawyer, Eva K.; Leitch, Duncan B.] Vanderbilt Univ, Grad Program Neurosci, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	ken.catania@vanderbilt.edu	Leitch, Duncan/AAU-6744-2020	Leitch, Duncan/0000-0002-8513-888X	National Science Foundation [0844743]; MacArthur Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0844743] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); MacArthur Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by National Science Foundation Award # 0844743 and the MacArthur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; [Anonymous], 1984, SCALING WHY IS ANIMA; BATES CA, 1985, J COMP NEUROL, V240, P265, DOI 10.1002/cne.902400305; BELFORD GR, 1979, J COMP NEUROL, V188, P63, DOI 10.1002/cne.901880106; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; CARROLL EW, 1984, J COMP NEUROL, V222, P1, DOI 10.1002/cne.902220102; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Catania KC, 2005, NATURE, V433, P519, DOI 10.1038/nature03250; Catania KC, 1999, J COMP NEUROL, V410, P55; Catania KC, 2013, J COMP PHYSL A; Catania KC, 2008, P NATL ACAD SCI USA, V105, P571, DOI 10.1073/pnas.0709534104; Catania KC, 2006, NATURE, V444, P1024, DOI 10.1038/4441024a; Catania KC, 2011, PHILOS T R SOC B, V366, P3016, DOI 10.1098/rstb.2011.0128; da Costa NM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00016; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; Erzurumlu RS, 2010, NAT REV NEUROSCI, V11, P252, DOI 10.1038/nrn2804; Erzurumlu RS, 2006, ANAT REC PART A, V288A, P121, DOI 10.1002/ar.a.20285; Feldmeyer D, 2012, PROG NEUROBIOL; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fox K, 2008, BARREL CORTEX, P1, DOI 10.1017/CBO9780511541636.003; Gusztak RW, 2005, J COMP PHYSIOL B, V175, P87, DOI 10.1007/s00360-004-0465-x; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; Hsaki K, 2006, NEUROSCIENCE, V141, P1899, DOI 10.1016/j.neuroscience.2006.04.082; Jones EG, 2010, CEREB CORTEX, V20, P2261, DOI 10.1093/cercor/bhq127; Jurgens KD, 2002, J EXP BIOL, V205, P2161; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; KILLACKEY HP, 1985, DEV BRAIN RES, V22, P141, DOI 10.1016/0165-3806(85)90077-X; Kim U, 1999, J COMP NEUROL, V408, P489; LEE KJ, 1975, BRAIN RES, V99, P349, DOI 10.1016/0006-8993(75)90035-9; Lee LJ, 2005, J COMP NEUROL, V485, P57, DOI 10.1002/cne.20514; Leitch DB, 2011, BRAIN BEHAV EVOLUT, V78, P261, DOI 10.1159/000330832; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; MA PM, 1993, J COMP NEUROL, V327, P376, DOI 10.1002/cne.903270306; MA PM, 1991, J COMP NEUROL, V309, P161, DOI 10.1002/cne.903090202; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Naumann RK, 2012, J COMP NEUROL, V520, P2512, DOI 10.1002/cne.23053; Rockland KS, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00022; Sehara K, 2011, MOL NEUROBIOL, V43, P155, DOI 10.1007/s12035-011-8170-8; SORENSON M. W., 1962, AMER MIDLAND NAT, V68, P445, DOI 10.2307/2422750; SWINDALE NV, 1990, TRENDS NEUROSCI, V13, P487, DOI 10.1016/0166-2236(90)90082-L; TOWE AL, 1975, BRAIN BEHAV EVOLUT, V11, P16, DOI 10.1159/000123621; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	44	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65975	10.1371/journal.pone.0065975	http://dx.doi.org/10.1371/journal.pone.0065975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755296	Green Published, gold			2022-12-25	WOS:000319872300100
J	Li, L; Ding, C; Duan, JL; Yang, MF; Sun, Y; Wang, XQ; Xu, Y				Li, Lu; Ding, Cheng; Duan, Jun-lan; Yang, Mi-fang; Sun, Ying; Wang, Xiao-qian; Xu, Yan			A New Functional Site W115 in CdtA Is Critical for Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin	PLOS ONE			English	Article							CELL-CYCLE ARREST; HUMAN T-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; BACTERIAL GENOTOXIN; G(2) ARREST; 3 SUBUNITS; IN-VITRO; EXPRESSION; PROTEIN; FAMILY	Aggregatibacter actinomycetemcomitans, a specific pathogen of localized aggressive periodontitis, produces a cytolethal distending toxin (CDT) that arrests eukaryotic cells irreversibly in G0/G1 or G2/M phase of the cell cycle. Although structural studies show that the aromatic patch region of CdtA plays an important role in its biological activity, the functional sites of CdtA have not been firmly established. In this study, site-specific mutagenesis strategy was employed for cdtA point mutations construction so as to examine the contributions of individual amino acids to receptor binding and the biological activity of holotoxin. The binding ability was reduced in CdtA(Y181A)BC holotoxin and the biological function of CDT was not weaken in CdtA(Y105A)BC, CdtA(Y125A)BC, CdtA(F109A)BC and CdtA(S106N)BC holotoxin suggesting that these sites were not critical to CDT. But the binding activity and cell cycle arrest ability of holotoxin complexes were inhibited in CdtA(W115G)BC. And this site did not affect the holotoxin assembly by size exclusion chromatography. Therefore, W115 might be a critical site of CdtA binding ability. These findings suggest that the functional sites of CdtA are not only in the aromatic patch region. W115, the new functional site is critical for receptor binding and cell cycle arrest, which provides potential targets for pharmacological disruption of CDT activity.	[Li, Lu; Ding, Cheng; Duan, Jun-lan; Yang, Mi-fang; Sun, Ying; Wang, Xiao-qian; Xu, Yan] Nanjing Med Univ, Inst Stomatol, Lab Oral Infect & Immunol, Nanjing, Jiangsu, Peoples R China; [Li, Lu; Ding, Cheng; Duan, Jun-lan; Sun, Ying; Wang, Xiao-qian; Xu, Yan] Nanjing Med Univ, Sch Stomatol, Dept Periodontol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Xu, Y (corresponding author), Nanjing Med Univ, Inst Stomatol, Lab Oral Infect & Immunol, Nanjing, Jiangsu, Peoples R China.	yanxu@njmu.edu.cn			National Natural Science Foundation of China [81170962]; Project of Science and Technology Department of Jiangsu Province [BK2011763]; Graduate student innovation project of Jiangsu province [CXZZ11_0732]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD2011-2013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology Department of Jiangsu Province; Graduate student innovation project of Jiangsu province; Priority Academic Program Development of Jiangsu Higher Education Institutions	This study is supported by grants from the National Natural Science Foundation of China (Grant No. 81170962), Project of Science and Technology Department of Jiangsu Province (Grant No. BK2011763), Graduate student innovation project of Jiangsu province (Grant No. CXZZ11_0732) and Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Grant No. PAPD2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akifusa S, 2005, MICROBIOL-SGM, V151, P1395, DOI 10.1099/mic.0.27671-0; Alaoui-El-Azher M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011714; Ando ES, 2010, J PERIODONTAL RES, V45, P471, DOI 10.1111/j.1600-0765.2009.01260.x; Belibasakis GN, 2008, APMIS, V116, P499, DOI 10.1111/j.1600-0463.2008.01017.x; Cao L, 2005, MOL MICROBIOL, V58, P1303, DOI 10.1111/j.1365-2958.2005.04905.x; Cao L, 2008, INFECT IMMUN, V76, P2812, DOI 10.1128/IAI.00126-08; Cao LS, 2006, INFECT IMMUN, V74, P4990, DOI 10.1128/IAI.00697-06; DiRienzo JM, 2009, FEMS MICROBIOL LETT, V291, P222, DOI 10.1111/j.1574-6968.2008.01457.x; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Eshraghi A, 2010, J BIOL CHEM, V285, P18199, DOI 10.1074/jbc.M110.112912; Heywood W, 2005, J MED MICROBIOL, V54, P207, DOI 10.1099/jmm.0.45694-0; Kanno F, 2005, J PERIODONTOL, V76, P1189, DOI 10.1902/jop.2005.76.7.1189; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2002, TRENDS MICROBIOL, V10, P147, DOI 10.1016/S0966-842X(02)02316-8; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; Lewis DA, 2001, INFECT IMMUN, V69, P5626, DOI 10.1128/IAI.69.9.5626-5634.2001; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; Mayer MPA, 1999, INFECT IMMUN, V67, P1227, DOI 10.1128/IAI.67.3.1227-1237.1999; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nesic D, 2005, PLOS PATHOG, V1, P214, DOI 10.1371/journal.ppat.0010028; Ohara M, 2004, INFECT IMMUN, V72, P871, DOI 10.1128/IAI.72.2.871-879.2004; Pickett CL, 1999, TRENDS MICROBIOL, V7, P292, DOI 10.1016/S0966-842X(99)01537-1; Shenker BJ, 2005, J IMMUNOL, V174, P2228, DOI 10.4049/jimmunol.174.4.2228; Shenker BJ, 2004, J IMMUNOL, V172, P410, DOI 10.4049/jimmunol.172.1.410; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Stevens MK, 1999, INFECT IMMUN, V67, P3900, DOI 10.1128/IAI.67.8.3900-3908.1999; Wising C, 2010, APMIS, V118, P143, DOI 10.1111/j.1600-0463.2009.02573.x; Yamada T, 2006, PROTEIN SCI, V15, P362, DOI 10.1110/ps.051790506; Yamamoto K, 2004, EUR J ORAL SCI, V112, P445, DOI 10.1111/j.1600-0722.2004.00157.x	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65729	10.1371/journal.pone.0065729	http://dx.doi.org/10.1371/journal.pone.0065729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755273	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300094
J	Hu, JC; Choi, JH; Gaddameedhi, S; Kemp, MG; Reardon, JT; Sancar, A				Hu, Jinchuan; Choi, Jun-Hyuk; Gaddameedhi, Shobhan; Kemp, Michael G.; Reardon, Joyce T.; Sancar, Aziz			Nucleotide Excision Repair in Human Cells FATE OF THE EXCISED OLIGONUCLEOTIDE CARRYING DNA DAMAGE IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-COUPLED REPAIR; REPLICATION PROTEIN-A; RNA-POLYMERASE-II; XERODERMA-PIGMENTOSUM; PYRIMIDINE DIMERS; THYMINE DIMER; HUMAN-FIBROBLASTS; COCKAYNE-SYNDROME; NUCLEASE; MECHANISM	Nucleotide excision repair is the sole mechanism for removing the major UV photoproducts from genomic DNA in human cells. In vitro with human cell-free extract or purified excision repair factors, the damage is removed from naked DNA or nucleosomes in the form of 24- to 32-nucleotide-long oligomers (nominal 30-mer) by dual incisions. Whether the DNA damage is removed from chromatin in vivo in a similar manner and what the fate of the excised oligomer was has not been known previously. Here, we demonstrate that dual incisions occur in vivo identical to the in vitro reaction. Further, we show that transcription-coupled repair, which operates in the absence of the XPC protein, also generates the nominal 30-mer in UV-irradiated XP-C mutant cells. Finally, we report that the excised 30-mer is released from the chromatin in complex with the repair factors TFIIH and XPG. Taken together, our results show the congruence of in vivo and in vitro data on nucleotide excision repair in humans.	[Hu, Jinchuan; Choi, Jun-Hyuk; Gaddameedhi, Shobhan; Kemp, Michael G.; Reardon, Joyce T.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Choi, Jun-Hyuk] Korea Res Inst Stand & Sci, Dept Metrol Qual Life, Ctr Bioanal, Taejon 305340, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Korea Research Institute of Standards & Science (KRISS)	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	GADDAMEEDHI, SHOBHAN/M-4358-2014; GADDAMEEDHI, SHOBHAN/GZM-8298-2022; gaddameedhi, shobhan/N-8695-2013; Kemp, Michael G./AAT-1545-2021; Hu, Jinchuan/V-9913-2017	GADDAMEEDHI, SHOBHAN/0000-0002-4978-6951; Kemp, Michael G./0000-0001-8203-0745; Hu, Jinchuan/0000-0001-7096-0195	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32833.	Araujo SJ, 2001, MOL CELL BIOL, V21, P2281, DOI 10.1128/MCB.21.7.2281-2291.2001; BOLING ME, 1966, BIOCHIM BIOPHYS ACTA, V123, P26, DOI 10.1016/0005-2787(66)90155-9; Cleaver JE, 1999, HUM MUTAT, V14, P9, DOI 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.3.CO;2-Y; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; DOETSCH PW, 1985, NUCLEIC ACIDS RES, V13, P3285, DOI 10.1093/nar/13.9.3285; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gaddameedhi S, 2010, CANCER RES, V70, P4922, DOI 10.1158/0008-5472.CAN-10-0095; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hara R, 2002, MOL CELL BIOL, V22, P6779, DOI 10.1128/MCB.22.19.6779-6787.2002; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; LABELLE M, 1982, PHOTOCHEM PHOTOBIOL, V36, P319, DOI 10.1111/j.1751-1097.1982.tb04381.x; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Mu D, 1997, J BIOL CHEM, V272, P7570, DOI 10.1074/jbc.272.12.7570; Mu D, 1997, J BIOL CHEM, V272, P28971, DOI 10.1074/jbc.272.46.28971; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; Wang D, 2003, BIOCHEMISTRY-US, V42, P6747, DOI 10.1021/bi034264k; WEINFELD M, 1986, BIOCHEMISTRY-US, V25, P2656, DOI 10.1021/bi00357a055; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	36	66	67	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20918	20926		10.1074/jbc.M113.482257	http://dx.doi.org/10.1074/jbc.M113.482257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23749995	Green Published, hybrid			2022-12-25	WOS:000322014400015
J	Baglo, Y; Gabrielsen, M; Sylte, I; Gederaas, OA				Baglo, Yan; Gabrielsen, Mari; Sylte, Ingebrigt; Gederaas, Odrun A.			Homology Modeling of Human gamma-Butyric Acid Transporters and the Binding of Pro-Drugs 5-Aminolevulinic Acid and Methyl Aminolevulinic Acid Used in Photodynamic Therapy	PLOS ONE			English	Article							GABA TRANSPORTERS; PROTOPORPHYRIN-IX; NEUROTRANSMITTER; CLONING; IDENTIFICATION; SYSTEM; LEUT; CLASSIFICATION; INHIBITOR; MECHANISM	Photodynamic therapy (PDT) is a safe and effective method currently used in the treatment of skin cancer. In ALA-based PDT, 5-aminolevulinic acid (ALA), or ALA esters, are used as pro-drugs to induce the formation of the potent photosensitizer protoporphyrin IX (PpIX). Activation of PpIX by light causes the formation of reactive oxygen species (ROS) and toxic responses. Studies have indicated that ALA and its methyl ester (MAL) are taken up into the cells via c-butyric acid (GABA) transporters (GATs). Uptake via GATs into peripheral sensory nerve endings may also account for one of the few adverse side effects of ALA-based PDT, namely pain. In the present study, homology models of the four human GAT subtypes were constructed using three x-ray crystal structures of the homologous leucine transporter (LeuT) as templates. Binding of the native substrate GABA and the possible substrates ALA and MAL was investigated by molecular docking of the ligands into the central putative substrate binding sites in the outward-occluded GAT models. Electrostatic potentials (ESPs) of the putative substrate translocation pathway of each subtype were calculated using the outward-open and inward-open homology models. Our results suggested that ALA is a substrate of all four GATs and that MAL is a substrate of GAT-2, GAT-3 and BGT-1. The ESP calculations indicated that differences likely exist in the entry pathway of the transporters (i.e. in outward-open conformations). Such differences may be exploited for development of inhibitors that selectively target specific GAT subtypes and the homology models may hence provide tools for design of therapeutic inhibitors that can be used to reduce ALA-induced pain.	[Baglo, Yan; Gederaas, Odrun A.] Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Gabrielsen, Mari; Sylte, Ingebrigt] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Tromso, Norway	Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso	Gederaas, OA (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	odrun.gederaas@ntnu.no	Gederaas, Odrun Arna/ABE-4912-2020	Gederaas, Odrun Arna/0000-0003-4877-4729; Gabrielsen, Mari/0000-0003-3898-1193; Sylte, Ingebrigt/0000-0002-3290-3736	BioStruct (the Norwegian national graduate school in structural biology)	BioStruct (the Norwegian national graduate school in structural biology)	The authors gratefully acknowledge support and training from BioStruct (the Norwegian national graduate school in structural biology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Issa MCA, 2010, AN BRAS DERMATOL, V85, P501, DOI 10.1590/S0365-05962010000400011; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Anderson CM, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq028; [Anonymous], PHOTODYNAMIC THERAPY; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; BORDEN LA, 1995, J NEUROCHEM, V64, P977; BORDEN LA, 1994, RECEPTOR CHANNEL, V2, P207; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Christiansen B, 2007, J BIOL CHEM, V282, P19331, DOI 10.1074/jbc.M702111200; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Coyle JT, 2004, BIOCHEM PHARMACOL, V68, P1507, DOI 10.1016/j.bcp.2004.07.034; Di Venosa G, 2006, J PHOTOCH PHOTOBIO B, V83, P129, DOI 10.1016/j.jphotobiol.2006.01.002; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; DOUGHERTY TJ, 1984, CRC CR REV ONCOL-HEM, V2, P83, DOI 10.1016/S1040-8428(84)80016-5; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gederaas OA, 2001, PHOTOCHEM PHOTOBIOL, V73, P164, DOI 10.1562/0031-8655(2001)073<0164:AAMETO>2.0.CO;2; Gholam P, 2011, DERMATOLOGY, V222, P358, DOI 10.1159/000329025; Goldberg NR, 2003, EUR J PHARMACOL, V479, P3, DOI 10.1016/j.ejphar.2003.08.052; Grapengiesser S, 2002, CLIN EXP DERMATOL, V27, P493, DOI 10.1046/j.1365-2230.2002.01065.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jasmin L, 2004, CNS NEUROL DISORD-DR, V3, P487, DOI 10.2174/1568007043336716; Kasche A, 2006, J Drugs Dermatol, V5, P353; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Moloney FJ, 2007, BRIT J DERMATOL, V157, P87, DOI 10.1111/j.1365-2133.2007.07946.x; Morton CA, 2008, BRIT J DERMATOL, V159, P1245, DOI 10.1111/j.1365-2133.2008.08882.x; NELSON H, 1990, FEBS LETT, V269, P181, DOI 10.1016/0014-5793(90)81149-I; NEMETHY G, 1992, J PHYS CHEM-US, V96, P6472, DOI 10.1021/j100194a068; Novak B, 2011, N-S ARCH PHARMACOL, V384, P583, DOI 10.1007/s00210-011-0683-1; Pagliaro J, 2004, DERMATOL SURG, V30, P63, DOI 10.1111/j.1524-4725.2004.30011.x; Pallo A, 2009, BIOCHEM BIOPH RES CO, V385, P210, DOI 10.1016/j.bbrc.2009.05.040; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Rodriguez L, 2006, BRIT J PHARMACOL, V147, P825, DOI 10.1038/sj.bjp.0706668; Rud E, 2000, PHOTOCHEM PHOTOBIOL, V71, P640, DOI 10.1562/0031-8655(2000)071<0640:AABNAA>2.0.CO;2; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Salat K, 2011, FUTURE MED CHEM, V3, P211, DOI 10.4155/FMC.10.298; Sarup A, 2003, CNS NEUROL DISORD-DR, V2, P269, DOI 10.2174/1568007033482788; Schapira M, 2003, J MED CHEM, V46, P3045, DOI 10.1021/jm0300173; SCHOENFELD N, 1988, CANCER LETT, V43, P43, DOI 10.1016/0304-3835(88)90211-X; Schulten R, 2012, NAUNYN SCHMIEDEBERGS; Scott J, 1955, BIOSYNTHESIS PORPHYR, P54; Shackley DC, 2002, BJU INT, V89, P665, DOI 10.1046/j.1464-410X.2002.02743.x; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Skovstrup S, 2010, CHEMMEDCHEM, V5, P986, DOI 10.1002/cmdc.201000100; Steinbauer JM, 2009, PHOTOCH PHOTOBIO SCI, V8, P1111, DOI 10.1039/b823378k; TANFORD C, 1983, P NATL ACAD SCI-BIOL, V80, P3701, DOI 10.1073/pnas.80.12.3701; Wein T, 2010, J MOL MODEL, V16, P155, DOI 10.1007/s00894-009-0520-3; Wong CGT, 2003, ANN NEUROL, V54, pS3, DOI 10.1002/ana.10696; Wu SM, 2003, CANCER LETT, V200, P123, DOI 10.1016/S0304-3835(03)00271-4; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	59	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65200	10.1371/journal.pone.0065200	http://dx.doi.org/10.1371/journal.pone.0065200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762315	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800024
J	Rossi, MA; Sukharnikova, T; Hayrapetyan, VY; Yang, LC; Yin, HH				Rossi, Mark A.; Sukharnikova, Tatyana; Hayrapetyan, Volodya Y.; Yang, Lucie; Yin, Henry H.			Operant Self-Stimulation of Dopamine Neurons in the Substantia Nigra	PLOS ONE			English	Article							OPTOGENETIC INTERROGATION; NUCLEUS-ACCUMBENS; IN-VIVO; REWARD; BRAIN; RECOMBINASE; MECHANISMS	We examined the contribution of the nigrostriatal DA system to instrumental learning and behavior using optogenetics in awake, behaving mice. Using Cre-inducible channelrhodopsin-2 (ChR2) in mice expressing Cre recombinase driven by the tyrosine hydroxylase promoter (Th-Cre), we tested whether selective stimulation of DA neurons in the substantia nigra pars compacta (SNC), in the absence of any natural rewards, was sufficient to promote instrumental learning in naive mice. Mice expressing ChR2 in SNC DA neurons readily learned to press a lever to receive laser stimulation, but unlike natural food rewards the lever pressing did not decline with satiation. When the number of presses required to receive a stimulation was altered, mice adjusted their rate of pressing accordingly, suggesting that the rate of stimulation was a controlled variable. Moreover, extinction, i.e. the cessation of action-contingent stimulation, and the complete reversal of the relationship between action and outcome by the imposition of an omission contingency, rapidly abolished lever pressing. Together these results suggest that selective activation of SNC DA neurons can be sufficient for acquisition and maintenance of a new instrumental action.	[Rossi, Mark A.; Sukharnikova, Tatyana; Hayrapetyan, Volodya Y.; Yang, Lucie; Yin, Henry H.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27710 USA; [Yin, Henry H.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Yin, Henry H.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; Duke University; Duke University	Yin, HH (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC 27710 USA.	Hy43@duke.edu		Rossi, Mark/0000-0002-5724-3615	NIH [AA021074]; National Science Foundation fellowship; Duke University; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021074] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation fellowship(National Science Foundation (NSF)); Duke University; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by NIH grant AA021074 to HHY, a National Science Foundation fellowship to MAR, and Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Fan D, 2012, J NEUROSCI, V32, P5534, DOI 10.1523/JNEUROSCI.5924-11.2012; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; HOWARTH CI, 1962, SCIENCE, V137, P35, DOI 10.1126/science.137.3523.35; Kim KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033612; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; OLDS J, 1958, SCIENCE, V127, P315, DOI 10.1126/science.127.3294.315; Rossi M. A, 2012, CURR PROTOC NEUROSCI; Rossi MA, 2012, J NEUROPHYSIOL, V108, P1211, DOI 10.1152/jn.01060.2011; Salamone JD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.013.2009; SANGHERA MK, 1984, NEUROSCIENCE, V12, P793, DOI 10.1016/0306-4522(84)90171-4; Satoh T, 2003, J NEUROSCI, V23, P9913; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; WISE RA, 1981, BRAIN RES, V213, P190, DOI 10.1016/0006-8993(81)91260-9; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yu CX, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00014; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	26	72	72	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65799	10.1371/journal.pone.0065799	http://dx.doi.org/10.1371/journal.pone.0065799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755282	Green Submitted, Green Published, gold			2022-12-25	WOS:000320579400078
J	Albert, MV; McCarthy, C; Valentin, J; Herrmann, M; Kording, K; Jayaraman, A				Albert, Mark V.; McCarthy, Cliodhna; Valentin, Juliana; Herrmann, Megan; Kording, Konrad; Jayaraman, Arun			Monitoring Functional Capability of Individuals with Lower Limb Amputations Using Mobile Phones	PLOS ONE			English	Article							PATIENT ACTIVITY MONITOR; TRANSFEMORAL AMPUTEES; OSSEOINTEGRATED FIXATION; ACTIVITY RECOGNITION; LONG-TERM; QUESTIONNAIRE; ACCELEROMETRY; VALIDITY; WALKING; PERFORMANCE	To be effective, a prescribed prosthetic device must match the functional requirements and capabilities of each patient. These capabilities are usually assessed by a clinician and reported by the Medicare K-level designation of mobility. However, it is not clear how the K-level designation objectively relates to the use of prostheses outside of a clinical environment. Here, we quantify participant activity using mobile phones and relate activity measured during real world activity to the assigned K-levels. We observe a correlation between K-level and the proportion of moderate to high activity over the course of a week. This relationship suggests that accelerometry-based technologies such as mobile phones can be used to evaluate real world activity for mobility assessment. Quantifying everyday activity promises to improve assessment of real world prosthesis use, leading to a better matching of prostheses to individuals and enabling better evaluations of future prosthetic devices.	[Albert, Mark V.; Kording, Konrad] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Albert, Mark V.; Kording, Konrad; Jayaraman, Arun] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [McCarthy, Cliodhna] MIT, Cambridge, MA 02139 USA; [Valentin, Juliana] Boston Univ, Boston, MA 02215 USA; [Albert, Mark V.; McCarthy, Cliodhna; Valentin, Juliana; Herrmann, Megan; Jayaraman, Arun] Northwestern Univ, Rehabil Inst Chicago, Max Nader Ctr Rehabil Technol & Outcomes Res, Chicago, IL 60611 USA; [Albert, Mark V.; Herrmann, Megan; Jayaraman, Arun] Northwestern Univ, Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Massachusetts Institute of Technology (MIT); Boston University; Northwestern University; Shirley Ryan AbilityLab; Northwestern University; Shirley Ryan AbilityLab	Albert, MV (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	markvalbert@gmail.com	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499	Max Nader Center for Rehabilitation Technologies and Outcomes; National Institutes of Health [R01NS057814, 1R01NS063399, 2P01NS044393]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057814, R01NS063399, P01NS044393] Funding Source: NIH RePORTER	Max Nader Center for Rehabilitation Technologies and Outcomes; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by philanthropic funds through the Max Nader Center for Rehabilitation Technologies and Outcomes. The authors also thank the National Institutes of Health (grants R01NS057814, 1R01NS063399 and 2P01NS044393) for their support of authors MVA and KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M., 2012, FRONTIERS NEUROLOGY, V3; Albert MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036556; Arya AP, 2008, J BONE JOINT SURG BR, V90B, P1414, DOI 10.1302/0301-620X.90B11.21131; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Boone DA., 2006, J PROSTHET ORTHOT, V18, P68, DOI DOI 10.1097/00008526-200601001-00008; Bourke AK, 2007, GAIT POSTURE, V26, P194, DOI 10.1016/j.gaitpost.2006.09.012; Brezmes T, 2009, LECT NOTES COMPUT SC, V5518, P796, DOI 10.1007/978-3-642-02481-8_120; Dourado KCC, 2010, REV SOC BRAS MED TRO, V43, P405, DOI 10.1590/S0037-86822010000400014; Condie E, 2006, PROCEEDINGS OF THE AMERICAN ACADEMY OF ORTHOTISTS AND PROSTHETISTS, pP13; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; Dijkstra B, 2008, AGE AGEING, V37, P436, DOI 10.1093/ageing/afn097; Dudek NL, 2008, J REHABIL RES DEV, V45, P577, DOI 10.1682/JRRD.2007.05.0069; Estrin D, 2009, AMBULATION TOOL MONI, P927; Fernandes HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020290; Frossard L, 2011, J PROSTHETICS ORTHOT, V23; Frossard L, 2010, J PROSTHET ORTHOT, V22, P11, DOI [10.1097/JPO.0b013-3181ccc53d, DOI 10.1097/JPO.0B013E3181CCC53D]; Frossard L., 2003, J PROSTHET ORTHOT, V15, P135, DOI DOI 10.1097/00008526-200310000-00005; Frossard L, 2009, IEEE T NEUR SYS REH, V17, P9, DOI 10.1109/TNSRE.2008.2010478; Frossard LA, 2010, PROSTHET ORTHOT INT, V34, P472, DOI 10.3109/03093646.2010.520057; Frossard LA, 2010, PROSTHET ORTHOT INT, V34, P85, DOI 10.3109/03093640903585024; Gailey RS, 2002, ARCH PHYS MED REHAB, V83, P613, DOI 10.1053/ampr.2002.32309; GAUTHIERGAGNON C, 1994, ARCH PHYS MED REHAB, V75, P1309; Grise MC, 2006, J PROSTHETICS ORTHOT, V18, P68; Gyorbiro N, 2009, MOBILE NETW APPL, V14, P82, DOI 10.1007/s11036-008-0112-y; Hafner BJ, 2007, ARCH PHYS MED REHAB, V88, P207, DOI 10.1016/j.apmr.2006.10.030; Hagberg K, 2004, J REHABIL RES DEV, V41, P695, DOI 10.1682/JRRD.2003.11.0167; Heinemann AW, 2003, PROSTHET ORTHOT INT, V27, P191, DOI 10.1080/03093640308726682; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; Lee R, 2011, RUNNING THE WORLDS MARKETS: THE GOVERNANCE OF FINANCIAL INFRASTRUCTURE, P40; Lee WCC, 2008, MED ENG PHYS, V30, P825, DOI 10.1016/j.medengphy.2007.09.003; Lee WCC, 2007, CLIN BIOMECH, V22, P665, DOI 10.1016/j.clinbiomech.2007.02.005; Legro MW, 1998, ARCH PHYS MED REHAB, V79, P931, DOI 10.1016/S0003-9993(98)90090-9; MAHONEY F I, 1965, Md State Med J, V14, P61; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; Mathie MJ, 2004, PHYSIOL MEAS, V25, pR1, DOI 10.1088/0967-3334/25/2/R01; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Meier MR, 2012, J REHABIL RES DEV, V49, P583, DOI 10.1682/JRRD.2010.05.0094; MUELLER MJ, 1985, PHYS THER, V65, P1037, DOI 10.1093/ptj/65.7.1037; Neumann E.S., 2012, J PROSTHET ORTHOT, V24, P160, DOI [DOI 10.1097/JP0.0B013E31826F66F0, 10.1097/JPO.0b013-31826f66f0, DOI 10.1097/JPO.0B013-31826F66F0]; Neumann ES, 2012, PROSTHET ORTHOT INT, V36, P203, DOI 10.1177/0309364612436408; Office UGP, HCFA COMM PROC COD S; Parker K, 2010, ARCH PHYS MED REHAB, V91, P543, DOI 10.1016/j.apmr.2009.12.009; Ramstrand N, 2007, PROSTHET ORTHOT INT, V31, P157, DOI 10.1080/03093640600988617; Ryall NH, 2003, DISABIL REHABIL, V25, P833, DOI 10.1080/0963828021000056460; SANDERS JE, 1995, J REHABIL RES DEV, V32, P210; Smeathers JE, 2005, CLASSIFICATION DAILY; Stepien JM, 2007, ARCH PHYS MED REHAB, V88, P896, DOI 10.1016/j.apmr.2007.03.016; Sup F, 2011, IEEE T NEUR SYS REH, V19, P71, DOI 10.1109/TNSRE.2010.2087360; Sup Frank, 2009, IEEE Int Conf Rehabil Robot, V2009, P638, DOI 10.1109/ICORR.2009.5209625; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	52	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65340	10.1371/journal.pone.0065340	http://dx.doi.org/10.1371/journal.pone.0065340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750254	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900056
J	Fragkias, M; Lobo, J; Strumsky, D; Seto, KC				Fragkias, Michail; Lobo, Jose; Strumsky, Deborah; Seto, Karen C.			Does Size Matter? Scaling of CO2 Emissions and US Urban Areas	PLOS ONE			English	Article							ENERGY-USE; METABOLISM; CITIES; URBANIZATION; INNOVATION; CITY; AGGLOMERATION; GROWTH; MODEL	Urban areas consume more than 66% of the world's energy and generate more than 70% of global greenhouse gas emissions. With the world's population expected to reach 10 billion by 2100, nearly 90% of whom will live in urban areas, a critical question for planetary sustainability is how the size of cities affects energy use and carbon dioxide (CO2) emissions. Are larger cities more energy and emissions efficient than smaller ones? Do larger cities exhibit gains from economies of scale with regard to emissions? Here we examine the relationship between city size and CO2 emissions for U.S. metropolitan areas using a production accounting allocation of emissions. We find that for the time period of 1999-2008, CO2 emissions scale proportionally with urban population size. Contrary to theoretical expectations, larger cities are not more emissions efficient than smaller ones.	[Fragkias, Michail] Boise State Univ, Dept Econ, Boise, ID 83725 USA; [Lobo, Jose] Arizona State Univ, Sch Sustainabil, Tempe, AZ USA; [Strumsky, Deborah] Univ N Carolina, Dept Geog & Earth Sci, Charlotte, NC 28223 USA; [Seto, Karen C.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT USA	Idaho; Boise State University; Arizona State University; Arizona State University-Tempe; University of North Carolina; University of North Carolina Charlotte; Yale University	Fragkias, M (corresponding author), Boise State Univ, Dept Econ, Boise, ID 83725 USA.	michailfragkias@boisestate.edu	Lobo, Jose/AAG-2746-2021; Seto, Karen C./C-2722-2008; Fragkias, Michail/B-5785-2008	Lobo, Jose/0000-0002-0814-7168; Seto, Karen C./0000-0002-4928-2446; 	Direct For Social, Behav & Economic Scie [1229429] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [0937777] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; Arbesman S, 2011, PHYSICA A, V390, P2155, DOI 10.1016/j.physa.2011.02.013; Baccini P, 1997, J URBAN TECHNOL, V4, P27, DOI 10.1080/10630739708724555; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Bettencourt LMA, 2012, 1209014 SANT FE I; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bonner J.T., 2006, WHY SIZE MATTERS; Brown JH, 2011, BIOSCIENCE, V61, P19, DOI 10.1525/bio.2011.61.1.7; Burger JR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001345; Carlino GA, 2007, J URBAN ECON, V61, P389, DOI 10.1016/j.jue.2006.08.003; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Ewing R, 2010, J AM PLANN ASSOC, V76, P265, DOI 10.1080/01944361003766766; Gabaix X., 2004, HDB REGIONAL URBAN E, P2341, DOI DOI 10.1016/S1574-0080(04)80010-5; Gandy M., 2004, CITY, V8, P363, DOI [DOI 10.1080/1360481042000313509, 10.1080/1360481042000313509]; Glaeser E.L., 2004, HDB REG URBAN EC, V4, P2481, DOI [DOI 10.1016/S1574-0080(04)80013-0, 10.1016/S1574-0080(04)80013-0]; Glaeser EL, 2010, J URBAN ECON, V67, P404, DOI 10.1016/j.jue.2009.11.006; Glaeser EL, 2010, J REGIONAL SCI, V50, P221, DOI 10.1111/j.1467-9787.2009.00635.x; Golubiewski N, 2012, AMBIO, V41, P751, DOI 10.1007/s13280-011-0232-7; Gurney KR, 2009, ENVIRON SCI TECHNOL, V43, P5535, DOI 10.1021/es900806c; Gurney KR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005373; IEA, 2012, WORLD EN OUTL 2012; Johansson TB, 2012, GLOBAL ENERGY ASSESS; JONES DW, 1991, ENERG POLICY, V19, P621, DOI 10.1016/0301-4215(91)90094-5; Katz JS, 2006, RES POLICY, V35, P893, DOI 10.1016/j.respol.2006.03.007; Kaya Y., 1990, INT PAN CLIM CHANG E; Kaya Y, 1990, INT PAN CLIM CHANG E; Kennedy C, 2007, J IND ECOL, V11, P43, DOI 10.1162/jie.2007.1107; Kennedy C, 2009, ENVIRON SCI TECHNOL, V43, P7297, DOI 10.1021/es900213p; Kleiber M., 1961, FIRE LIFE INTRO ANIM; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; Kuil P, 2017, P 24 ANN EUROPEAN RE; Lobo J, 2008, J URBAN ECON, V63, P871, DOI 10.1016/j.jue.2007.07.005; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Newman PWG, 1999, LANDSCAPE URBAN PLAN, V44, P219, DOI 10.1016/S0169-2046(99)00009-2; PARIKH J, 1995, GLOBAL ENVIRON CHANG, V5, P87, DOI 10.1016/0959-3780(95)00015-G; Payne JE, 2010, J ECON STUD, V37, P53, DOI 10.1108/01443581011012261; Puga D, 2010, J REGIONAL SCI, V50, P203, DOI 10.1111/j.1467-9787.2009.00657.x; Rappaport J, 2008, J URBAN ECON, V63, P715, DOI 10.1016/j.jue.2007.04.008; Rees W.E., 1996, OUR ECOLOGICAL FOOTP; Rosenthal S. S., 2004, HDB REGIONAL URBAN E, V4, P2119, DOI [DOI 10.1016/S1574-0080(04)80006-3, 10.1016/S1574-0080(04)80006-3]; Sedgley N, 2011, AM J ECON SOCIOL, V70, P86, DOI 10.1111/j.1536-7150.2010.00764.x; Seto K. C., 2012, P NATL ACAD SCI; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Seto KC, 2010, ANNU REV ENV RESOUR, V35, P167, DOI 10.1146/annurev-environ-100809-125336; Smil Vaclav, 2008, ENERGY NATURE SOC GE; SORNETTE D, 2004, SPRINGER SERIES SYNE, P1; Strumsky D, 2009, ENVIRON SCI TECHNOL; United Nations, 2012, WORLD URB PROSP 2011; USLANER EM, 1976, AM J POLIT SCI, V20, P125, DOI 10.2307/2110513; Weinzettel J, 2013, GLOBAL ENVIRON CHANG, V23, P433, DOI 10.1016/j.gloenvcha.2012.12.010; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wilson G., 2012, 2010 CENSUS SPECIAL; WOLMAN A, 1965, SCI AM, V213, P179; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	58	169	174	18	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64727	10.1371/journal.pone.0064727	http://dx.doi.org/10.1371/journal.pone.0064727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158IE	23750213	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900015
J	Kim, JK; Jackson, TL				Kim, Jae Kyoung; Jackson, Trachette L.			Mechanisms That Enhance Sustainability of p53 Pulses	PLOS ONE			English	Article							P53-MDM2 FEEDBACK LOOP; MAMMALIAN CIRCADIAN CLOCK; SINGLE NUCLEOTIDE POLYMORPHISM; DNA-DAMAGE RESPONSE; STOCHASTIC SIMULATION; SELECTIVE COMMUNICATION; P53-MEDIATED APOPTOSIS; HUMAN-CELLS; OSCILLATIONS; DYNAMICS	The tumor suppressor p53 protein shows various dynamic responses depending on the types and extent of cellular stresses. In particular, in response to DNA damage induced by gamma-irradiation, cells generate a series of p53 pulses. Recent research has shown the importance of sustaining repeated p53 pulses for recovery from DNA damage. However, far too little attention has been paid to understanding how cells can sustain p53 pulses given the complexities of genetic heterogeneity and intrinsic noise. Here, we explore potential molecular mechanisms that enhance the sustainability of p53 pulses by developing a new mathematical model of the p53 regulatory system. This model can reproduce many experimental results that describe the dynamics of p53 pulses. By simulating the model both deterministically and stochastically, we found three potential mechanisms that improve the sustainability of p53 pulses: 1) the recently identified positive feedback loop between p53 and Rora allows cells to sustain p53 pulses with high amplitude over a wide range of conditions, 2) intrinsic noise can often prevent the dampening of p53 pulses even after mutations, and 3) coupling of p53 pulses in neighboring cells via cytochrome-c significantly reduces the chance of failure in sustaining p53 pulses in the presence of heterogeneity among cells. Finally, in light of these results, we propose testable experiments that can reveal important mechanisms underlying p53 dynamics.	[Kim, Jae Kyoung; Jackson, Trachette L.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jackson, TL (corresponding author), Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA.	tjacks@umich.edu	Kim, Jae Kyoung/F-1297-2015	Kim, Jae Kyoung/0000-0001-7842-2172	NSF [DMS-1026317]; Human Frontiers of Science Foundation [RPG 24/2012]; JSMF [220020079/SCS]	NSF(National Science Foundation (NSF)); Human Frontiers of Science Foundation; JSMF	This work was supported by NSF DMS-1026317 for computing resources, the Human Frontiers of Science Foundation (RPG 24/2012) and JSMF - 220020079/SCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Antoch MP, 2010, CIRC RES, V106, P68, DOI 10.1161/CIRCRESAHA.109.207076; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Banaz-Yasar F, 2008, J CELL BIOCHEM, V103, P149, DOI 10.1002/jcb.21395; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Barik D, 2008, BIOPHYS J, V95, P3563, DOI 10.1529/biophysj.108.129155; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Brown TM, 2007, J NEUROPHYSIOL, V97, P2553, DOI 10.1152/jn.01206.2006; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; Deguin-Chambon V, 2000, ONCOGENE, V19, P5831, DOI 10.1038/sj.onc.1203960; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gonze D, 2002, J BIOL PHYS, V28, P637, DOI 10.1023/A:1021286607354; Hamstra DA, 2006, CANCER RES, V66, P7482, DOI 10.1158/0008-5472.CAN-06-1405; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; He M, 2011, ONCOGENE, V30, P1947, DOI 10.1038/onc.2010.567; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; HODGKIN AL, 1948, J PHYSIOL-LONDON, V107, P165, DOI 10.1113/jphysiol.1948.sp004260; Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Hunziker A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-94; Iwamoto K, 2011, BIOSYSTEMS, V103, P384, DOI 10.1016/j.biosystems.2010.11.011; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2002, BIOSYSTEMS, V67, P95, DOI 10.1016/S0303-2647(02)00067-9; Izhikevich EM, 2003, TRENDS NEUROSCI, V26, P161, DOI 10.1016/S0166-2236(03)00034-1; Jin SK, 2001, J CELL SCI, V114, P4139; Josic K, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002264; Kim H, 2011, MOL CELL, V44, P797, DOI 10.1016/j.molcel.2011.09.023; Kim JK, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.62; Kim JR, 2010, J CELL SCI, V123, P537, DOI 10.1242/jcs.060061; Kim J, 2007, PLOS COMPUT BIOL, V3, P2190, DOI 10.1371/journal.pcbi.0030218; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Li QS, 2007, BIOPHYS CHEM, V129, P23, DOI 10.1016/j.bpc.2007.05.001; Li Z, 2010, J THEORETICAL BIOL; Little JB, 2006, MUTAT RES-FUND MOL M, V597, P113, DOI 10.1016/j.mrfmmm.2005.12.001; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; MACKEY MC, 1977, SCIENCE, V197, P287, DOI 10.1126/science.267326; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Moortgat KT, 2000, J NEUROPHYSIOL, V83, P984, DOI 10.1152/jn.2000.83.2.984; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Ojima M, 2011, RADIAT RES, V175, P90, DOI 10.1667/RR2223.1; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Ouattara DA, 2010, J THEOR BIOL, V264, P1177, DOI 10.1016/j.jtbi.2010.03.031; Peixoto PM, 2009, BIOCHEM BIOPH RES CO, V390, P38, DOI 10.1016/j.bbrc.2009.09.054; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Rosenblum M, 2003, CONTEMP PHYS, V44, P401, DOI 10.1080/00107510310001603129; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SAVAGEAU MA, 1989, THEORETICAL BIOLOGY, P42; Sturrock M, 2011, J THEOR BIOL, V273, P15, DOI 10.1016/j.jtbi.2010.12.016; Sun TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027882; Sun TZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-190; Toettcher JE, 2010, P NATL ACAD SCI USA, V107, P17047, DOI 10.1073/pnas.1005615107; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034921; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705	73	35	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65242	10.1371/journal.pone.0065242	http://dx.doi.org/10.1371/journal.pone.0065242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755198	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300061
J	Prokop, JW; Santos, RAS; Milsted, A				Prokop, Jeremy W.; Santos, Robson A. S.; Milsted, Amy			Differential Mechanisms of Activation of the Ang Peptide Receptors AT1, AT2, and MAS: Using In Silico Techniques to Differentiate the Three Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ANGIOTENSIN-II RECEPTOR; AT(1) RECEPTOR; TRANSMEMBRANE DOMAIN; LIGAND-BINDING; BLOOD-PRESSURE; AGONIST; IDENTIFICATION; PHOSPHORYLATION; CONFORMATION	The renin-angiotensin system is involved in multiple conditions ranging from cardiovascular disorders to cancer. Components of the pathway, including ACE, renin and angiotensin receptors are targets for disease treatment. This study addresses three receptors of the pathway: AT1, AT2, and MAS and how the receptors are similar and differ in activation by angiotensin peptides. Combining biochemical and amino acid variation data with multiple species sequence alignments, structural models, and docking site predictions allows for visualization of how angiotensin peptides may bind and activate the receptors; allowing identification of conserved and variant mechanisms in the receptors. MAS differs from AT1 favoring Ang-(1-7) and not Ang II binding, while AT2 recently has been suggested to preferentially bind Ang III. A new model of Ang peptide binding to AT1 and AT2 is proposed that correlates data from site directed mutagenesis and photolabled experiments that were previously considered conflicting. Ang II binds AT1 and AT2 through a conserved initial binding mode involving amino acids 111 (consensus 325) of AT1 (Asn) interacting with Tyr (4) of Ang II and 199 and 256 (consensus 512 and 621, a Lys and His respectively) interacting with Phe (8) of Ang II. In MAS these sites are not conserved, leading to differential binding and activation by Ang-(1-7). In both AT1 and AT2, the Ang II peptide may internalize through Phe (8) of Ang II propagating through the receptors' conserved aromatic amino acids to the final photolabled positioning relative to either AT1 (amino acid 294, Asn, consensus 725) or AT2 (138, Leu, consensus 336). Understanding receptor activation provides valuable information for drug design and identification of other receptors that can potentially bind Ang peptides.	[Prokop, Jeremy W.; Milsted, Amy] Univ Akron, Dept Biol, Program Integrated Biosci, Akron, OH 44325 USA; [Santos, Robson A. S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil	University of Akron; Universidade Federal de Minas Gerais	Milsted, A (corresponding author), Univ Akron, Dept Biol, Program Integrated Biosci, Akron, OH 44325 USA.	milsted@uakron.edu	Prokop, Jeremy/AAG-4931-2019; Santos, Robson A S/C-9336-2011	Santos, Robson A S/0000-0001-8738-5852; Prokop, Jeremy/0000-0002-1818-9695	Choose Ohio First Bioinformatics scholarship; University of Akron; American Heart Association [11PRE7380033]; Brazilian National Institute of Science and Technology in Hormones and Women's Health; Federal University of Minas Gerais	Choose Ohio First Bioinformatics scholarship; University of Akron; American Heart Association(American Heart Association); Brazilian National Institute of Science and Technology in Hormones and Women's Health; Federal University of Minas Gerais	Funding was through Choose Ohio First Bioinformatics scholarship, University of Akron, American Heart Association award 11PRE7380033, Brazilian National Institute of Science and Technology in Hormones and Women's Health, and Federal University of Minas Gerais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; AUMELAS A, 1985, P NATL ACAD SCI USA, V82, P1881, DOI 10.1073/pnas.82.7.1881; Baleanu-Gogonea C, 2006, J MOL MODEL, V12, P325, DOI 10.1007/s00894-005-0049-z; Danser AHJ, 2007, NEPHROL DIAL TRANSPL, V22, P1288, DOI 10.1093/ndt/gfl846; DeMello WC, 2010, RENIN ANGIOTENSIN SY; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; FENG YH, 1995, J BIOL CHEM, V270, P12846, DOI 10.1074/jbc.270.21.12846; Ferre S, 2010, CURR OPIN PHARMACOL, V10, P1, DOI 10.1016/j.coph.2009.11.002; Gembardt F, 2008, MOL CELL BIOCHEM, V319, P115, DOI 10.1007/s11010-008-9884-4; Hines J, 2003, BIOCHEM PHARMACOL, V66, P251, DOI 10.1016/S0006-2952(03)00257-0; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Hunyady L, 2003, TRENDS PHARMACOL SCI, V24, P81, DOI 10.1016/S0165-6147(02)00050-0; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; Kemp BA, 2012, HYPERTENSION, V60, P387, DOI 10.1161/HYPERTENSIONAHA.112.191403; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Morales R, 2012, J MOL BIOL, V421, P100, DOI 10.1016/j.jmb.2012.05.003; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; Nikiforovich GV, 2001, BIOCHEM BIOPH RES CO, V286, P1204, DOI 10.1006/bbrc.2001.5526; NODA K, 1995, J BIOL CHEM, V270, P28511, DOI 10.1074/jbc.270.48.28511; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Padia SH, 2013, PFLUG ARCH EUR J PHY, V465, P99, DOI 10.1007/s00424-012-1146-3; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Pulakat L, 1998, REGUL PEPTIDES, V73, P51, DOI 10.1016/S0167-0115(97)01059-8; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozenfeld R, 2011, EMBO J, V30, P2350, DOI 10.1038/emboj.2011.139; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; SCHORB W, 1993, CIRC RES, V72, P1245, DOI 10.1161/01.RES.72.6.1245; Servant G, 1997, J BIOL CHEM, V272, P8653, DOI 10.1074/jbc.272.13.8653; Skold C, 2008, J MOL GRAPH MODEL, V26, P991, DOI 10.1016/j.jmgm.2007.08.005; Spyroulias GA, 2003, EUR J BIOCHEM, V270, P2163, DOI 10.1046/j.1432-1033.2003.03573.x; Steckelings UM, 2012, CURR OPIN NEPHROL HY, V21, P142, DOI 10.1097/MNH.0b013e328350261b; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Szalai B, 2012, BIOCHEM PHARMACOL, V84, P477, DOI 10.1016/j.bcp.2012.04.014; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; Turner CA, 1999, BIOCHEM BIOPH RES CO, V257, P704, DOI 10.1006/bbrc.1999.0207; Underwood D J, 1994, Chem Biol, V1, P211, DOI 10.1016/1074-5521(94)90013-2; Vauquelin G, 2005, FUND CLIN PHARMACOL, V19, P45, DOI 10.1111/j.1472-8206.2005.00319.x; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S; Yasuda N, 2008, N-S ARCH PHARMACOL, V377, P393, DOI 10.1007/s00210-007-0215-1; Yasuda N, 2008, EMBO REP, V9, P179, DOI 10.1038/sj.embor.7401157; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	54	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65307	10.1371/journal.pone.0065307	http://dx.doi.org/10.1371/journal.pone.0065307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755216	gold, Green Submitted, Green Published			2022-12-25	WOS:000319872300073
J	Chaudhuri, AD; Yelamanchili, SV; Marcondes, MCG; Fox, HS				Chaudhuri, Amrita Datta; Yelamanchili, Sowmya V.; Marcondes, Maria Cecilia G.; Fox, Howard S.			Up-regulation of microRNA-142 in simian immunodeficiency virus encephalitis leads to repression of sirtuin1	FASEB JOURNAL			English	Article						HIV; HAND; dementia; neurodegeneration; SIRT1	CHRONIC INFLAMMATORY REACTION; REPEAT LTR TRANSACTIVATION; SIRT1 EXPRESSION; DOWN-REGULATION; INHIBITION; TARGETS; MODELS; DEACETYLASE; ACTIVATION; CORRELATE	MicroRNA (miR)-142 is up-regulated in the brain in HIV and SIV encephalitis (SIVE). We identified the cell types where miR-142 is up-regulated and its relevant downstream target. Fluorescent in situ hybridization combined with immunofluorescent labeling revealed that miR-142-3p and -5p are expressed within hippocampal neurons and myeloid cells in SIVE. Sirtuin1 (SIRT1) was predicted as a potential miR-142 target by analysis of its 3-UTR and bioinformatic analysis of factors linked to altered hippocampal gene expression profile in SIVE. Overexpression of pre-miR-142 in HEK293T cells led to a 3.7-fold decrease in SIRT1 protein level. Examination of the individual effects of miR-142-5p and miR-142-3p through overexpression and inhibition studies revealed that significant effects on SIRT1 occurred only with miR-142-5p. Luciferase reporter assays revealed a 2.3-fold inhibition of expression due to interaction of miR-142 with the SIRT1 3-UTR, mutation analysis revealed that only the miR-142-5p target site was active. MiR-142 expression in primary human neurons led to a small (1.3-fold) but significant decrease in SIRT1 protein level. Furthermore, qRT-PCR revealed up-regulation of miR-142-3p (6.4-fold) and -5p (3.9-fold) and down-regulation of SIRT1 (33-fold) in macrophages/microglia from animals with SIVE. We have therefore elucidated a miR-mediated mechanism of regulation of SIRT1 expression in SIVE.Chaudhuri, A. D., Yelamanchili, S. V., Marcondes, M. C. G., Fox, H. S. Up-regulation of microRNA-142 in simian immunodeficiency virus encephalitis leads to repression of sirtuin1.	[Chaudhuri, Amrita Datta; Yelamanchili, Sowmya V.; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Marcondes, Maria Cecilia G.] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA	University of Nebraska System; University of Nebraska Medical Center; Scripps Research Institute	Fox, HS (corresponding author), Dept Pharmacol & Expt Neurosci, 985800 Nebraska Med Ctr,DRC 3008, Omaha, NE 68198 USA.	hfox@unmc.edu		Fox, Howard/0000-0003-2032-374X	U.S. National Institutes of Health [P30 MH062261, R01 MH073490, R21 DA029491]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073490, P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029491] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by U.S. National Institutes of Health grants P30 MH062261 and R01 MH073490 to H. S. F., and R21 DA029491 to M. C. G. M. The authors declare no conflicts of interest. The authors thank Katy Emanuel for assisting with qRT-PCR, Benjamin Lamberty for help with lentivirus preparation, Brenda Morsey for primary human neuronal culture, Jessica Winkler for IPA, Phillip Purnell for suggestions and discussion, and members of the laboratory of H. S. F. for useful comments.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bissels U, 2011, STEM CELLS, V29, P847, DOI 10.1002/stem.627; Blazek D, 2008, MOL CELL, V29, P539, DOI 10.1016/j.molcel.2008.02.007; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Burdo TH, 2005, AIDS, V19, P1704, DOI 10.1097/01.aids.0000186823.76230.33; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Crews L, 2008, J NEUROVIROL, V14, P327, DOI 10.1080/13550280802132840; del Palacio M, 2012, REV MED VIROL, V22, P33, DOI 10.1002/rmv.711; Donmez G, 2012, J NEUROSCI, V32, P124, DOI 10.1523/JNEUROSCI.3442-11.2012; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; EVERALL IP, 1991, LANCET, V337, P1119, DOI 10.1016/0140-6736(91)92786-2; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Gersten M, 2009, J NEUROSCI, V29, P12467, DOI 10.1523/JNEUROSCI.3180-09.2009; Gorospe M, 2008, TRENDS CELL BIOL, V18, P77, DOI 10.1016/j.tcb.2007.11.007; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Loscher CJ, 2008, EXP EYE RES, V87, P529, DOI 10.1016/j.exer.2008.08.016; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marcondes MCG, 2001, J IMMUNOL, V167, P5429, DOI 10.4049/jimmunol.167.9.5429; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Nishiyama T, 2012, BIOCHEM BIOPH RES CO, V425, P755, DOI 10.1016/j.bbrc.2012.07.148; Noorbakhsh F, 2010, FASEB J, V24, P1799, DOI 10.1096/fj.09-147819; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Quintas A, 2012, EXP GERONTOL, V47, P198, DOI 10.1016/j.exger.2011.11.010; Rom S, 2010, FASEB J, V24, P2292, DOI 10.1096/fj.09-143503; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Takeda-Watanabe A, 2012, BIOCHEM BIOPH RES CO, V427, P191, DOI 10.1016/j.bbrc.2012.09.042; Tatro ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010337; Thakur BK, 2012, BIOCHEM BIOPH RES CO, V424, P245, DOI 10.1016/j.bbrc.2012.06.084; Wang X, 2009, JOVE-J VIS EXP, V32, pe1499, DOI DOI 10.3791/1499; WATRY D, 1995, AM J PATHOL, V146, P914; WILEY CA, 1994, ANN NEUROL, V36, P673, DOI 10.1002/ana.410360422; Wojcik M, 2009, MINI-REV MED CHEM, V9, P386, DOI 10.2174/1389557510909030386; Wu D, 2011, NEUROSCIENCE, V190, P386, DOI 10.1016/j.neuroscience.2011.06.017; Xie J, 2013, PHARMACOL RES, V67, P60, DOI 10.1016/j.phrs.2012.10.010; Yelamanchili SV, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.56; Yelamanchili SV, 2010, J NEUROIMMUNE PHARM, V5, P63, DOI 10.1007/s11481-009-9172-4; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Yoshida N, 2013, OPHTHALMOLOGY, V120, P100, DOI 10.1016/j.ophtha.2012.07.006; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Yu ZP, 2012, J BIOL CHEM, V287, P22560, DOI 10.1074/jbc.M112.357582; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001; Zhang HS, 2012, FEBS LETT, V586, P4203, DOI 10.1016/j.febslet.2012.10.023; Zhang HS, 2012, BBA-MOL CELL RES, V1823, P1017, DOI 10.1016/j.bbamcr.2012.02.014; Zhang HS, 2009, VIRUS RES, V146, P51, DOI 10.1016/j.virusres.2009.08.005	64	55	55	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3720	3729		10.1096/fj.13-232678	http://dx.doi.org/10.1096/fj.13-232678			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23752207	Green Published, Bronze			2022-12-25	WOS:000328840500030
J	Geetha, T; Rege, SD; Mathews, SE; Meakin, SO; White, MF; Babu, JR				Geetha, Thangiah; Rege, Shraddha D.; Mathews, Salome E.; Meakin, Susan O.; White, Morris F.; Babu, Jeganathan Ramesh			Nerve Growth Factor Receptor TrkA, a New Receptor in Insulin Signaling Pathway in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL GLUCOSE-UPTAKE; TROPHIC FACTORS; ALZHEIMER-TYPE; SUBSTRATE-1; PROTEIN; SURVIVAL; BINDING; KINASE; IRS-1; DIFFERENTIATION	TrkA is a cell surface transmembrane receptor tyrosine kinase for nerve growth factor (NGF). TrkA has an NPXY motif and kinase regulatory loop similar to insulin receptor (INSR) suggesting that NGF -> TrkA signaling might overlap with insulin -> INSR signaling. During insulin or NGF stimulation TrkA, insulin receptor substrate-1 (IRS-1), INSR (and presumably other proteins) forms a complex in PC12 cells. In PC12 cells, tyrosine phosphorylation of INSR and IRS-1 is dependent upon the functional TrkA kinase domain. Moreover, expression of TrkA kinase-inactive mutant blocked the activation of Akt and Erk5 in response to insulin or NGF. Based on these data, we propose that TrkA participates in insulin signaling pathway in PC12 cells.	[Geetha, Thangiah; Rege, Shraddha D.; Mathews, Salome E.; Babu, Jeganathan Ramesh] Auburn Univ, Dept Nutr Dietet & Hospitality Management, Auburn, AL 36849 USA; [Geetha, Thangiah] Auburn Univ, Dept Phys Sci, Montgomery, AL 36117 USA; [Meakin, Susan O.] Univ Western Ontario, Robarts Res Inst, Lab Neural Signaling, Mol Brain Res Grp, London, ON N6A 5K8, Canada; [White, Morris F.] Childrens Hosp Boston, Dept Endocrinol, Boston, MA 02115 USA; [White, Morris F.] Howard Hughes Med Inst, Boston, MA 02115 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Western University (University of Western Ontario); Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Geetha, T (corresponding author), Auburn Univ, Dept Nutr Dietet & Hospitality Management, Auburn, AL 36849 USA.	thangge@auburn.edu; jeganrb@auburn.edu	Meakin, Susan/K-8823-2013; Thangiah, Geetha/W-6796-2019	Meakin, Susan/0000-0003-2469-6615; Ramesh Babu, Jeganathan/0000-0002-3719-932X; Rege, Shraddha/0000-0002-6942-4878	New Faculty Startup Fund from Auburn University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038712, R01DK098655] Funding Source: NIH RePORTER	New Faculty Startup Fund from Auburn University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the New Faculty Startup Fund from Auburn University (to J. R. B.).	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERG MM, 1992, J BIOL CHEM, V267, P13; Chao MV, 2000, J NEUROSCI RES, V59, P353, DOI 10.1002/(SICI)1097-4547(20000201)59:3<353::AID-JNR8>3.3.CO;2-J; CHEN DI, 1995, MOL CELL BIOL, V15, P4711; Craft S, 1996, NEUROBIOL AGING, V17, P123, DOI 10.1016/0197-4580(95)02002-0; CRAFT S, 1993, BEHAV NEUROSCI, V107, P926; Delahaye L, 2000, ENDOCRINOLOGY, V141, P621, DOI 10.1210/en.141.2.621; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; FUJISAWA Y, 1991, BIOL PSYCHIAT, V30, P1219, DOI 10.1016/0006-3223(91)90158-I; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Geetha T, 2012, J BIOL CHEM, V287, P29672, DOI 10.1074/jbc.M111.322404; Greenlee MHW, 2003, J NEUROSCI RES, V73, P518, DOI 10.1002/jnr.10684; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; HE WM, 1995, J BIOL CHEM, V270, P23258, DOI 10.1074/jbc.270.40.23258; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Hoyer S, 1996, ANN NY ACAD SCI, V777, P374, DOI 10.1111/j.1749-6632.1996.tb34448.x; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Lee J, 1997, BIOCHEMISTRY-US, V36, P2701, DOI 10.1021/bi961815g; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Miranda C, 2001, J CELL PHYSIOL, V186, P35; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; SawkaVerhelle D, 1996, J BIOL CHEM, V271, P5980, DOI 10.1074/jbc.271.11.5980; Uemura E, 2006, EXP NEUROL, V198, P48, DOI 10.1016/j.expneurol.2005.10.035; Uemura E, 2001, EXP NEUROL, V170, P270, DOI 10.1006/exnr.2001.7719; Valverde AM, 2001, MOL CELL BIOL, V21, P2269, DOI 10.1128/MCB.21.7.2269-2280.2001; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Watson RT, 2001, RECENT PROG HORM RES, V56, P175, DOI 10.1210/rp.56.1.175; Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	36	19	20	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23807	23813		10.1074/jbc.M112.436279	http://dx.doi.org/10.1074/jbc.M112.436279			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23749991	Green Published, hybrid			2022-12-25	WOS:000330611400020
J	Ebel, P; Dorp, KV; Petrasch-Parwez, E; Zlomuzica, A; Kinugawa, K; Mariani, J; Minich, D; Ginkel, C; Welcker, J; Degen, J; Eckhardt, M; Dere, E; Dormann, P; Willecke, K				Ebel, Philipp; Dorp, Katharina vom; Petrasch-Parwez, Elisabeth; Zlomuzica, Armin; Kinugawa, Kiyoka; Mariani, Jean; Minich, David; Ginkel, Christina; Welcker, Jochen; Degen, Joachim; Eckhardt, Matthias; Dere, Ekrem; Doermann, Peter; Willecke, Klaus			Inactivation of Ceramide Synthase 6 in Mice Results in an Altered Sphingolipid Metabolism and Behavioral Abnormalities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(DIHYDRO)CERAMIDE SYNTHASE; MEMBRANE-LIPIDS; EXPRESSION; BRAIN; SPECIFICITY; INHIBITION; PRINCIPLES; ABLATION; MEMBERS; SYSTEM	The N-acyl chain length of ceramides is determined by the specificity of different ceramide synthases (CerS). The CerS family in mammals consists of six members with different substrate specificities and expression patterns. We have generated and characterized a mouse line harboring an enzymatically inactive ceramide synthase 6 (CerS6KO) gene and lacz reporter cDNA coding for beta-galactosidase directed by the CerS6 promoter. These mice display a decrease in C16:0 containing sphingolipids. Relative to wild type tissues the amount of C16:0 containing sphingomyelin in kidney is similar to 35%, whereas we find a reduction of C16:0 ceramide content in the small intestine to about 25%. The CerS6KO mice show behavioral abnormalities including a clasping abnormality of their hind limbs and a habituation deficit. LacZ reporter expression in the brain reveals CerS6 expression in hippocampus, cortex, and the Purkinje cell layer of the cerebellum. Using newly developed antibodies that specifically recognize the CerS6 protein we show that the endogenous CerS6 protein is N-glycosylated and expressed in several tissues of mice, mainly kidney, small and large intestine, and brain.	[Ebel, Philipp; Minich, David; Ginkel, Christina; Degen, Joachim; Willecke, Klaus] Univ Bonn, Mol Genet Life & Med Sci Inst LIMES, D-53115 Bonn, Germany; [Dorp, Katharina vom; Doermann, Peter] Univ Bonn, Inst Mol Physiol & Biotechnol Plants, D-53115 Bonn, Germany; [Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Petrasch-Parwez, Elisabeth] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44801 Bochum, Germany; [Zlomuzica, Armin; Dere, Ekrem] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, D-44780 Bochum, Germany; [Kinugawa, Kiyoka; Mariani, Jean; Dere, Ekrem] Hop Charles Foix, Inst Longevite, F-94205 Paris, France; [Kinugawa, Kiyoka; Mariani, Jean; Dere, Ekrem] Univ Paris 06, F-75005 Paris, France; [Welcker, Jochen] Max Delbrueck Ctr, Dept Neurosci, D-13125 Berlin, Germany	University of Bonn; University of Bonn; University of Bonn; Ruhr University Bochum; Ruhr University Bochum; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Willecke, K (corresponding author), Univ Bonn, Mol Genet Life & Med Sci Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	k.willecke@uni-bonn.de	Dere, Ekrem/Y-3872-2019; Dere, Ekrem/F-3879-2018; Kinugawa, Kiyoka/AAM-7853-2020	Dere, Ekrem/0000-0001-7823-7778; Kinugawa, Kiyoka/0000-0001-6914-6102; Mariani, Jean/0000-0002-2701-1581	German Research Foundation through Collaborative Research Centre [SFB-645, B2, B5, Z4];  [DE1149/6-1]	German Research Foundation through Collaborative Research Centre; 	This work was supported by the German Research Foundation through Collaborative Research Centre Grants SFB-645 projects B2 (to K. W.), B5 (to M. E.), and Z4 (to P. D.), and DE1149/6-1 (to E. D.).	Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Dere E, 2002, J NEUROSCI METH, V122, P65, DOI 10.1016/S0165-0270(02)00274-1; Dere E, 2002, GENES BRAIN BEHAV, V1, P204, DOI 10.1034/j.1601-183X.2002.10402.x; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Gantois I, 2007, P NATL ACAD SCI USA, V104, P4182, DOI 10.1073/pnas.0611625104; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Homma D, 2011, J BIOL CHEM, V286, P1445, DOI 10.1074/jbc.M110.159426; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Kim HJ, 2012, J LIPID RES, V53, P1701, DOI 10.1194/jlr.D025627; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; Petrasch-Parwez E, 2007, J COMP NEUROL, V501, P716, DOI 10.1002/cne.21272; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Requardt RP, 2009, GLIA, V57, P680, DOI 10.1002/glia.20796; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schiffmann S, 2012, J IMMUNOL, V188, P5723, DOI 10.4049/jimmunol.1103109; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Sun Y, 2008, HUM MOL GENET, V17, P2345, DOI 10.1093/hmg/ddn135; Tabatadze N, 2010, J NEUROSCI RES, V88, P2940, DOI 10.1002/jnr.22438; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271; VANECHTEN G, 1993, J BIOL CHEM, V268, P5341; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Wells D, 1993, Methods Mol Biol, V18, P217, DOI 10.1385/0-89603-245-0:217; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wewer V, 2011, J LIPID RES, V52, P1039, DOI 10.1194/jlr.D013987; Wheeler D, 2008, BRAIN, V131, P3092, DOI 10.1093/brain/awn190; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Yamashita T, 2005, GENESIS, V43, P175, DOI 10.1002/gene.20167; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063; Zlomuzica A, 2012, DEV NEUROSCI-BASEL, V34, P277, DOI 10.1159/000339305	49	55	56	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21433	21447		10.1074/jbc.M113.479907	http://dx.doi.org/10.1074/jbc.M113.479907			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760501	Green Published, hybrid			2022-12-25	WOS:000322014400061
J	Bugaut, H; Bruchard, M; Berger, H; Derangere, V; Odoul, L; Euvrard, R; Ladoire, S; Chalmin, F; Vegran, F; Rebe, C; Apetoh, L; Ghiringhelli, F; Mignot, G				Bugaut, Helene; Bruchard, Melanie; Berger, Helene; Derangere, Valentin; Odoul, Ludivine; Euvrard, Romain; Ladoire, Sylvain; Chalmin, Fanny; Vegran, Frederique; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois; Mignot, Gregoire			Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells	PLOS ONE			English	Article							CALRETICULIN EXPOSURE; PULMONARY-FIBROSIS; SUPPRESSOR-CELLS; MESSENGER-RNA; CUTTING EDGE; LUNG; RESPONSES; VINBLASTINE; MECHANISMS; EXPRESSION	Bleomycin (BLM) is an anticancer drug currently used for the treatment of testis cancer and Hodgkin lymphoma. This drug triggers cancer cell death via its capacity to generate radical oxygen species (ROS). However, the putative contribution of anticancer immune responses to the efficacy of BLM has not been evaluated. We make here the observation that BLM induces immunogenic cell death. In particular, BLM is able to induce ROS-mediated reticulum stress and autophagy, which result in the surface exposure of chaperones, including calreticulin and ERp57, and liberation of HMBG1 and ATP. BLM induces anti-tumor immunity which relies on calreticulin, CD8(+) T cells and interferon-gamma. We also find that, in addition to its capacity to trigger immunogenic cell death, BLM induces expansion of Foxp3+ regulatory T (Treg) cells via its capacity to induce transforming growth factor beta (TGF beta) secretion by tumor cells. Accordingly, Treg cells or TGF beta depletion dramatically potentiates the antitumor effect of BLM. We conclude that BLM induces both anti-tumor CD8(+) T cell response and a counteracting Treg proliferation. In the future, TGF beta or Treg inhibition during BLM treatment could greatly enhance BLM anti-tumor efficacy.	[Bugaut, Helene; Bruchard, Melanie; Berger, Helene; Derangere, Valentin; Euvrard, Romain; Ladoire, Sylvain; Chalmin, Fanny; Vegran, Frederique; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois; Mignot, Gregoire] INSERM, U866, Dijon, France; [Bugaut, Helene; Bruchard, Melanie; Berger, Helene; Derangere, Valentin; Euvrard, Romain; Ladoire, Sylvain; Chalmin, Fanny; Vegran, Frederique; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois; Mignot, Gregoire] INSERM, AVENIR Team, Dijon, France; [Bugaut, Helene; Bruchard, Melanie; Berger, Helene; Derangere, Valentin; Euvrard, Romain; Ladoire, Sylvain; Chalmin, Fanny; Vegran, Frederique; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois; Mignot, Gregoire] Univ Bourgogne, Fac Med, Dijon, France; [Odoul, Ludivine] Univ Bern, Inst Pathol, Bern, Switzerland; [Ladoire, Sylvain; Rebe, Cedric; Ghiringhelli, Francois] Ctr Georges Francois Leclerc, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University of Bern; UNICANCER; Centre Georges-Francois Leclerc	Ghiringhelli, F (corresponding author), INSERM, U866, Dijon, France.	fghiringhelli@cgfl.fr; gregoire.mignot@free.fr	Apetoh, Lionel/G-3310-2014; Mignot, Grégoire/R-4976-2017; REBE, Cédric/AAD-4316-2019; VEGRAN, Frederique/O-9986-2018; Apetoh, Lionel/AIC-2384-2022; VEGRAN, Frédérique/H-4792-2017; Bruchard, Melanie/E-6508-2017	Apetoh, Lionel/0000-0002-2774-438X; Mignot, Grégoire/0000-0002-0682-0152; REBE, Cédric/0000-0001-8831-145X; VEGRAN, Frederique/0000-0002-4377-1441; Apetoh, Lionel/0000-0002-2774-438X; Bruchard, Melanie/0000-0003-0004-2887; LADOIRE, Sylvain/0000-0002-0331-9194; Chalmin, Fanny/0000-0002-0855-9453; EUVRARD, Romain/0000-0001-8259-2107; ghiringhelli, francois/0000-0002-5465-8305	Fondation de France; Association pour la Recherche sur le Cancer; Institut National de la Sante et de la Recherche Medicale; Ligue Contre le Cancer (Region Bourgogne); Fondation pour la Recherche Medicale; Institut National du Cancer; Ligue Nationale contre le cancer; Agence Nationale pour la Recherche [ANR-10-PDOC-014-01]; Ecole de l'Inserm Liliane Bettencourt	Fondation de France(Fondation de France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Contre le Cancer (Region Bourgogne); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ecole de l'Inserm Liliane Bettencourt	This work was supported by special grants from the Fondation de France, the Association pour la Recherche sur le Cancer, the Institut National de la Sante et de la Recherche Medicale, the Ligue Contre le Cancer (Region Bourgogne), the Fondation pour la Recherche Medicale, and the Institut National du Cancer. GM was funded by the Association pour la Recherche sur le Cancer and FV by the Ligue Nationale contre le cancer. LA was supported by Agence Nationale pour la Recherche [ANR-10-PDOC-014-01]. HB is funded by Ecole de l'Inserm Liliane Bettencourt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Apetoh L, 2011, SEMIN IMMUNOL, V23, P42, DOI 10.1016/j.smim.2011.01.003; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BREEN E, 1992, AM J RESP CELL MOL, V6, P146, DOI 10.1165/ajrcmb/6.2.146; Bruchard M, 2012, NAT MED; BURGER RM, 1981, J BIOL CHEM, V256, P1636; Calone I., 2012, Experimental Oncology, V34, P9; CASPARY WJ, 1982, BIOCHEMISTRY-US, V21, P334, DOI 10.1021/bi00531a021; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; DRESP J, 1978, MUTAT RES, V56, P341, DOI 10.1016/0027-5107(78)90203-8; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Gauldie Jack, 2006, Proc Am Thorac Soc, V3, P696, DOI 10.1513/pats.200605-125SF; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; Hervieu A, 2012, J INVEST DERMATOL; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; KHALIL N, 1991, CIBA F SYMP, V157, P194; Li HC, 1996, CHINESE MED J-PEKING, V109, P533; Melencio L, 2006, INT IMMUNOL, V18, P1461, DOI 10.1093/intimm/dxl079; Menger L, 2012, NAT REV IMMUNOL, V2, P389; Meyer RM, 2012, NEW ENGL J MED, V366, P399, DOI 10.1056/NEJMoa1111961; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mignot G, 2008, J IMMUNOL, V180, P6477, DOI 10.4049/jimmunol.180.10.6477; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Panaretakis T, 2008, CELL DEATH DIFFER, V15, P1499, DOI 10.1038/cdd.2008.67; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x; RYZHKOV V K, 1977, Vestnik Rentgenologii i Radiologii, P41; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Tanaka H, 2009, CANCER RES, V69, P6987, DOI 10.1158/0008-5472.CAN-09-1106; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton CA, 2004, J IMMUNOL, V173, P3084, DOI 10.4049/jimmunol.173.5.3084; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wallach-Dayan SB, 2006, AM J PHYSIOL-LUNG C, V290, pL790, DOI 10.1152/ajplung.00300.2004; WILLIAMS SD, 1987, NEW ENGL J MED, V316, P1435, DOI 10.1056/NEJM198706043162302	43	76	79	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65181	10.1371/journal.pone.0065181	http://dx.doi.org/10.1371/journal.pone.0065181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762310	gold, Green Published, Green Submitted			2022-12-25	WOS:000321094800022
J	Miyamoto, DT; Viswanathan, AN				Miyamoto, David T.; Viswanathan, Akila N.			Concurrent Chemoradiation for Vaginal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GYNECOLOGIC-ONCOLOGY-GROUP; HIGH-DOSE-RATE; CERVICAL-CANCER; PREOPERATIVE CHEMORADIATION; INTERSTITIAL BRACHYTHERAPY; RADIATION-THERAPY; CHEMOTHERAPY; VULVA; OUTCOMES	Background: It is not known whether the addition of chemotherapy to radiation therapy improves outcomes in primary vaginal cancer. Here, we review clinical outcomes in patients with primary vaginal cancer treated with radiation therapy (RT) or concurrent chemoradiation therapy (CRT). Methods: Seventy-one patients with primary vaginal cancer treated with definitive RT with or without concurrent chemotherapy at a single institution were identified and their records reviewed. A total of 51 patients were treated with RT alone; 20 patients were treated with CRT. Recurrences were analyzed. Overall survival (OS) and disease-free survival (DFS) rates were estimated using the Kaplan-Meier method. Cox regression analysis was performed. Results: The median age at diagnosis was 61 years (range, 18-92 years) and the median follow-up time among survivors was 3.0 years. Kaplan-Meier estimates for OS and DFS differed significantly between the RT and CRT groups (3-yr OS = 56% vs. 79%, log-rank p=0.037; 3-yr DFS = 43% vs. 73%, log-rank p=0.011). Twenty-three patients (45%) in the RT group had a relapse at any site compared to 3 (15%) in the CRT group (p=0.027). With regard to the sites of first relapse, 10 patients (14%) had local only, 4 (6%) had local and regional, 9 (13%) had regional only, 1 (1%) had regional and distant, and 2 (3%) had distant only relapse. On univariate analysis, the use of concurrent chemotherapy, FIGO stage, tumor size, and date of diagnosis were significant predictors of DFS. On multivariate analysis, the use of concurrent chemotherapy remained a significant predictor of DFS (hazard ratio 0.31 (95% CI, 0.10-0.97; p = 0.04)). Conclusions: Vaginal cancer results in poor outcomes. Adequate radiation dose is essential to ensure curative management. Concurrent chemotherapy should be considered for vaginal cancer patients.	[Miyamoto, David T.] Harvard Univ, Sch Med, Harvard Radiat Oncol Program, Boston, MA USA; [Viswanathan, Akila N.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute	Viswanathan, AN (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA.	aviswanathan@lroc.harvard.edu		viswaanathan, akila/0000-0002-1896-2924	St. Laurent Family Fund	St. Laurent Family Fund	This research was supported by a donation to Dr Viswanathan by the St. Laurent Family Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beriwal S, 2012, BRACHYTHERAPY, V11, P68, DOI 10.1016/j.brachy.2011.06.008; Cardenes H, 2007, PRINCIPLES PRACTICE, P1657; Creasman WT, 1998, CANCER, V83, P1033, DOI 10.1002/(SICI)1097-0142(19980901)83:5<1033::AID-CNCR30>3.0.CO;2-6; Dalrymple JL, 2004, INT J GYNECOL CANCER, V14, P110, DOI 10.1111/j.1048-891x.2004.014066.x; Frank SJ, 2005, INT J RADIAT ONCOL, V62, P138, DOI 10.1016/j.ijrobp.2004.09.032; Hellman K, 2004, INT J GYNECOL CANCER, V14, P491, DOI 10.1111/j.1048-891x.2004.014310.x; Kapur T, 2012, MAGN RESON IMAGING, V30, P1279, DOI 10.1016/j.mri.2012.06.003; Landrum LM, 2008, GYNECOL ONCOL, V108, P584, DOI 10.1016/j.ygyno.2007.11.010; Lee LJ, 2012, INT J RADIAT ONCOL, V84, P1192, DOI 10.1016/j.ijrobp.2012.01.085; Mak RH, 2011, GYNECOL ONCOL, V120, P101, DOI 10.1016/j.ygyno.2010.09.004; Montana GS, 2000, INT J RADIAT ONCOL, V48, P1007, DOI 10.1016/S0360-3016(00)00762-8; Moore DH, 1998, INT J RADIAT ONCOL, V42, P79, DOI 10.1016/S0360-3016(98)00193-X; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Nashiro T, 2008, INT J CLIN ONCOL, V13, P335, DOI 10.1007/s10147-007-0758-7; PEREZ CA, 1988, INT J RADIAT ONCOL, V15, P1283, DOI 10.1016/0360-3016(88)90222-2; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; Samant R, 2007, INT J RADIAT ONCOL, V69, P746, DOI 10.1016/j.ijrobp.2007.04.015; Shah CA, 2009, OBSTET GYNECOL, V113, P1038, DOI 10.1097/AOG.0b013e31819fe844; Stewart AJ, 2006, CANCER, V107, P908, DOI 10.1002/cncr.22054; Tran PT, 2007, GYNECOL ONCOL, V105, P641, DOI 10.1016/j.ygyno.2007.01.033; Viswanathan AN, 2006, INT J RADIAT ONCOL, V66, P91, DOI 10.1016/j.ijrobp.2006.04.037; Viswanathan AN, 2011, GYNECOLOGIC RADIATION THERAPY: NOVEL APPROACHES TO IMAGE-GUIDANCE AND MANAGEMENT, P1	22	35	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65048	10.1371/journal.pone.0065048	http://dx.doi.org/10.1371/journal.pone.0065048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762284	gold, Green Published, Green Submitted			2022-12-25	WOS:000321094800016
J	Wang, CJ; Lin, YS; Lin, YH; Chung, WH				Wang, Chaojen; Lin, Yisheng; Lin, Yinghong; Chung, Wenhsin			Modified Primers for the Identification of Nonpathogenic Fusarium oxysporum Isolates That Have Biological Control Potential against Fusarium Wilt of Cucumber in Taiwan	PLOS ONE			English	Article							INTERGENIC SPACER REGION; GENETIC DIVERSITY; PSEUDOMONAS-PUTIDA; BIOCONTROL AGENTS; SEQUENCE DATA; PATHOGENICITY; POPULATIONS; RDNA; DNA; DIFFERENTIATION	Previous investigations demonstrated that Fusarium oxysporum (Fo), which is not pathogenic to cucumbers, could serve as a biological control agent for managing Fusarium wilt of cucumber caused by Fo f. sp. cucumerinum (Foc) in Taiwan. However, thus far it has not been possible to separate the populations of pathogenic Fo from the nonpathogenic isolates that have biological control potential through their morphological characteristics. Although these two populations can be distinguished from one another using a bioassay, the work is laborious and time-consuming. In this study, a fragment of the intergenic spacer (IGS) region of ribosomal DNA from an Fo biological control agent, Fo366, was PCR-amplified with published general primers, FIGS11/FIGS12 and sequenced. A new primer, NPIGS-R, which was designed based on the IGS sequence, was paired with the FIGS11 primer. These primers were then evaluated for their specificity to amplify DNA from nonpathogenic Fo isolates that have biological control potential. The results showed that the modified primer pair, FIGS11/ NPIGS-R, amplified a 500-bp DNA fragment from five of seven nonpathogenic Fo isolates. These five Fo isolates delayed symptom development of cucumber Fusarium wilt in greenhouse bioassay tests. Seventy-seven Fo isolates were obtained from the soil and plant tissues and then subjected to amplification using the modified primer pair; six samples showed positive amplification. These six isolates did not cause symptoms on cucumber seedlings when grown in peat moss infested with the isolates and delayed disease development when the same plants were subsequently inoculated with a virulent isolate of Foc. Therefore, the modified primer pair may prove useful for the identification of Fo isolates that are nonpathogenic to cucumber which can potentially act as biocontrol agents for Fusarium wilt of cucumber.	[Wang, Chaojen; Lin, Yinghong; Chung, Wenhsin] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Lin, Yisheng] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Chung Hsing University; Asia University Taiwan	Chung, WH (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan.	wenchung@dragon.nchu.edu.tw		Lin, Ying-Hong/0000-0002-7055-0652	Bureau of Animal and Plant Health Inspection and Quarantine in Taiwan [98AS-9.2.1-BQ-B2, 99AS-9.2.2-BQ-B3]	Bureau of Animal and Plant Health Inspection and Quarantine in Taiwan	Funding for this project was provided by the Bureau of Animal and Plant Health Inspection and Quarantine in Taiwan. The project numbers were 98AS-9.2.1-BQ-B2 and 99AS-9.2.2-BQ-B3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabouvette C, 1996, MANAGING SOILBORNE P, P192; Appel DJ, 1996, MOL PLANT MICROBE IN, V9, P125, DOI 10.1094/MPMI-9-0125; APPEL DJ, 1995, EXP MYCOL, V19, P120, DOI 10.1006/emyc.1995.1014; Chen JF, 1999, THESIS NATL CHUNG HS; Deacon JW, 2006, FUNGAL BIOL, P158; Dissanayake MLMC, 2009, J GEN PLANT PATHOL, V75, P37, DOI 10.1007/s10327-008-0135-z; Edel-Hermann V, 2012, PLANT PATHOL, V61, P787, DOI 10.1111/j.1365-3059.2011.02551.x; Erwin D.C., 1981, FUNGAL WILT DIS PLAN, P563; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Fravel D, 2003, NEW PHYTOL, V157, P493, DOI 10.1046/j.1469-8137.2003.00700.x; Gordon TR, 1992, MOL ECOL, V1, P241, DOI 10.1111/j.1365-294X.1992.tb00183.x; GORDON TR, 1992, PHYTOPATHOLOGY, V82, P73, DOI 10.1094/Phyto-82-73; GORDON TR, 1990, PHYTOPATHOLOGY, V80, P381, DOI 10.1094/Phyto-80-381; Gorokhova E, 2002, P ROY SOC B-BIOL SCI, V269, P2373, DOI 10.1098/rspb.2002.2145; Guetsky R, 2002, PHYTOPATHOLOGY, V92, P976, DOI 10.1094/PHYTO.2002.92.9.976; Jurado M, 2006, SYST APPL MICROBIOL, V29, P681, DOI 10.1016/j.syapm.2006.01.014; Kawabe Masato, 2007, Journal of General Plant Pathology, V73, P353, DOI 10.1007/s10327-007-0036-6; Kawabe Masato, 2005, Journal of General Plant Pathology, V71, P263, DOI 10.1007/s10327-005-0203-6; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Larkin RP, 1999, PHYTOPATHOLOGY, V89, P1152, DOI 10.1094/PHYTO.1999.89.12.1152; Lazarovits G, 2001, AUSTRALAS PLANT PATH, V30, P111, DOI 10.1071/AP01009; LEMANCEAU P, 1992, APPL ENVIRON MICROB, V58, P2978, DOI 10.1128/AEM.58.9.2978-2982.1992; Lievens B, 2008, PEST MANAG SCI, V64, P781, DOI 10.1002/ps.1564; Lin YH, 2009, EUR J PLANT PATHOL, V123, P353, DOI 10.1007/s10658-008-9372-4; Lori G, 2004, PHYTOPATHOLOGY, V94, P661, DOI 10.1094/PHYTO.2004.94.6.661; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mbofung GY, 2007, PHYTOPATHOLOGY, V97, P87, DOI 10.1094/PHYTO-97-0087; NASH SM, 1962, PHYTOPATHOLOGY, V52, P567; O'Donnell K, 2004, J CLIN MICROBIOL, V42, P5109, DOI 10.1128/JCM.42.11.5109-5120.2004; O'Donnell K, 2009, FUNGAL GENET BIOL, V46, P936, DOI 10.1016/j.fgb.2009.08.006; Ogura K, 1984, ANN PHYTOPATHOL SOC, p[50, 1]; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; RAMBAUT A, 2000, SE AL SEQUENCE ALIGN; Recorbet G, 2003, NEW PHYTOL, V159, P73, DOI 10.1046/j.1469-8137.2003.00795.x; Saitoh Ken-ichiro, 2006, Journal of General Plant Pathology, V72, P348, DOI 10.1007/s10327-006-0300-1; SCHER FM, 1982, PHYTOPATHOLOGY, V72, P1567, DOI 10.1094/Phyto-72-1567; Schilling AG, 1996, PHYTOPATHOLOGY, V86, P515, DOI 10.1094/Phyto-86-515; Srinivasan K, 2012, PHYTOPARASITICA, V40, P157, DOI 10.1007/s12600-011-0207-z; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vakalounakis DJ, 1999, PHYTOPATHOLOGY, V89, P161, DOI 10.1094/PHYTO.1999.89.2.161; Wang CJ, 2006, THESIS NATL CHUNG HS; Wilson A, 2004, FEMS MICROBIOL LETT, V233, P69, DOI 10.1016/j.femsle.2004.01.040; Xu XM, 2011, PHYTOPATHOLOGY, V101, P1024, DOI 10.1094/PHYTO-08-10-0216; Yergeau E, 2005, J MICROBIOL METH, V60, P143, DOI 10.1016/j.mimet.2004.09.006; Zhang Z, 2001, PHYTOPATHOLOGY, V91, P204, DOI 10.1094/PHYTO.2001.91.2.204	46	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65093	10.1371/journal.pone.0065093	http://dx.doi.org/10.1371/journal.pone.0065093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762289	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800017
J	Thaa, B; Sinhadri, BC; Tielesch, C; Krause, E; Veit, M				Thaa, Bastian; Sinhadri, Balaji Chandrasekhar; Tielesch, Claudia; Krause, Eberhard; Veit, Michael			Signal Peptide Cleavage from GP5 of PRRSV: A Minor Fraction of Molecules Retains the Decoy Epitope, a Presumed Molecular Cause for Viral Persistence	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; MAJOR ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES; PASSIVE TRANSFER; N-GLYCOSYLATION; STRAIN VR-2332; CELL-CULTURE; PIGS; INFECTION; IDENTIFICATION	Porcine reproductive and respiratory syndrome virus (PRRSV) is the major pathogen in the pig industry. Variability of the antigens and persistence are the biggest challenges for successful control and elimination of the disease. GP5, the major glycoprotein of PRRSV, is considered an important target of neutralizing antibodies, which however appear only late in infection. This was attributed to the presence of a "decoy epitope'' located near a hypervariable region of GP5. This region also harbors the predicted signal peptide cleavage sites and (dependent on the virus strain) a variable number of potential N-glycosylation sites. Molecular processing of GP5 has not been addressed experimentally so far: whether and where the signal peptide is cleaved and (as a consequence) whether the "decoy epitope'' is present in virus particles. We show that the signal peptide of GP5 from the American type 2 reference strain VR-2332 is cleaved, both during in vitro translation in the presence of microsomes and in transfected cells. This was found to be independent of neighboring glycosylation sites and occurred in a variety of porcine cells for GP5 sequences derived from various type 2 strains. The exact signal peptide cleavage site was elucidated by mass spectrometry of virus-derived and recombinant GP5. The results revealed that the signal peptide of GP5 is cleaved at two sites. As a result, a mixture of GP5 proteins exists in virus particles, some of which still contain the "decoy epitope'' sequence. Heterogeneity was also observed for the use of glycosylation sites in the hypervariable region. Lastly, GP5 mutants were engineered where one of the signal peptide cleavage sites was blocked. Wildtype GP5 exhibited exactly the same SDS-PAGE mobility as the mutant that is cleavable at site 2 only. This indicates that the overwhelming majority of all GP5 molecules does not contain the "decoy epitope''.	[Thaa, Bastian; Sinhadri, Balaji Chandrasekhar; Tielesch, Claudia; Veit, Michael] Free Univ Berlin, Dept Vet Med, Inst Virol, Berlin, Germany; [Krause, Eberhard] Leibniz Inst Mol Pharmacol FMP, Berlin, Germany	Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Veit, M (corresponding author), Free Univ Berlin, Dept Vet Med, Inst Virol, Berlin, Germany.	mveit@zedat.fu-berlin.de		Veit, Michael/0000-0002-7638-1829	German Research Foundation [Ve 141/11-1]; German Research Foundation through the Collaborative Research Center 740; EU FP7 through the Marie Curie Initial Trainig Network "Molecular Mechanism of cell entry of enveloped viruses"; Boehringer Ingelheim Vetmedica GmbH	German Research Foundation(German Research Foundation (DFG)); German Research Foundation through the Collaborative Research Center 740; EU FP7 through the Marie Curie Initial Trainig Network "Molecular Mechanism of cell entry of enveloped viruses"; Boehringer Ingelheim Vetmedica GmbH(Boehringer Ingelheim)	Funding was provided by the German Research Foundation (www.DFG.de) through project Ve 141/11-1 and through the Collaborative Research Center 740 (www.SFB740.de), by the EU FP7 through the Marie Curie Initial Trainig Network "Molecular Mechanism of cell entry of enveloped viruses" (www2.huberlin.de/virusentry) and by Boehringer Ingelheim Vetmedica GmbH through a PRRSV Research Award (www.boehringer-ingelheim.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende R, 2000, J VIROL, V74, P10834, DOI 10.1128/JVI.74.22.10834-10837.2000; Allende R, 2000, ARCH VIROL, V145, P1149, DOI 10.1007/s007050070115; Ansari IH, 2006, J VIROL, V80, P3994, DOI 10.1128/JVI.80.8.3994-4004.2006; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852; Chand RJ, 2012, CURR OPIN VIROL, V2, P256, DOI 10.1016/j.coviro.2012.02.002; Chang CC, 2002, J VIROL, V76, P4750, DOI 10.1128/JVI.76.10.4750-4763.2002; Chavan M, 2006, TRENDS BIOCHEM SCI, V31, P17, DOI 10.1016/j.tibs.2005.11.010; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Cleveland SM, 2000, VIROLOGY, V266, P66, DOI 10.1006/viro.1999.0041; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; COOPER VL, 1995, J VET DIAGN INVEST, V7, P313, DOI 10.1177/104063879500700303; Das PB, 2010, J VIROL, V84, P1731, DOI 10.1128/JVI.01774-09; Delisle B, 2012, INFECT GENET EVOL, V12, P1111, DOI 10.1016/j.meegid.2012.03.015; Done SH, 1996, BRIT VET J, V152, P153, DOI 10.1016/S0007-1935(96)80071-6; Ephraim E, 2009, EUR VET IMM WORKSH E, P45; Faaberg KS, 2006, VIRAL IMMUNOL, V19, P294, DOI 10.1089/vim.2006.19.294; FAABERG KS, 1995, VIROLOGY, V212, P512, DOI 10.1006/viro.1995.1509; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gonin P, 1999, J VET DIAGN INVEST, V11, P20, DOI 10.1177/104063879901100103; Green M. R., 2012, MOL CLONING LAB MANU, V4th; Han J, 2007, J VIROL, V81, P9878, DOI 10.1128/JVI.00562-07; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kwon B, 2008, VIROLOGY, V380, P371, DOI 10.1016/j.virol.2008.07.030; Lee YJ, 2010, J VIROL METHODS, V163, P410, DOI 10.1016/j.jviromet.2009.11.003; Li J, 2012, VIROLOGY, V433, P367, DOI 10.1016/j.virol.2012.08.026; Lopez OJ, 2007, CLIN VACCINE IMMUNOL, V14, P269, DOI 10.1128/CVI.00304-06; Lopez OJ, 2004, VET IMMUNOL IMMUNOP, V102, P155, DOI 10.1016/j.vetimm.2004.09.005; Lu ZC, 2012, VIROLOGY, V432, P99, DOI 10.1016/j.virol.2012.05.022; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Osorio FA, 2002, VIROLOGY, V302, P9, DOI 10.1006/viro.2002.1612; Ostrowski M, 2002, J VIROL, V76, P4241, DOI 10.1128/JVI.76.9.4241-4250.2002; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pirzadeh B, 1997, J GEN VIROL, V78, P1867, DOI 10.1099/0022-1317-78-8-1867; Plagemann PGW, 2002, ARCH VIROL, V147, P2327, DOI 10.1007/s00705-002-0887-2; Rowland RRR, 1999, VIROLOGY, V259, P262, DOI 10.1006/viro.1999.9789; Snijder EJ, 2003, J VIROL, V77, P97, DOI 10.1128/JVI.77.1.97-104.2003; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Thanawongnuwech Roongroje, 2000, Animal Health Research Reviews, V1, P95, DOI 10.1017/S1466252300000086; Tian DB, 2012, J VIROL, V86, P3701, DOI 10.1128/JVI.06836-11; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; Vanhee M, 2010, VIRAL IMMUNOL, V23, P403, DOI 10.1089/vim.2010.0025; Veit Michael, 2002, Methods Mol Biol, V194, P159; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Vu HLX, 2011, J VIROL, V85, P5555, DOI 10.1128/JVI.00189-11; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wills RW, 2003, J CLIN MICROBIOL, V41, P58, DOI 10.1128/JCM.41.1.58-62.2003; Wissink EHJ, 2005, J VIROL, V79, P12495, DOI 10.1128/JVI.79.19.12495-12506.2005; Wissink EHJ, 2003, J GEN VIROL, V84, P1535, DOI 10.1099/vir.0.18957-0; Yang L, 2000, ARCH VIROL, V145, P1599, DOI 10.1007/s007050070079; YOON IJ, 1994, J VET DIAGN INVEST, V6, P289; Zhou L, 2010, VIRUS RES, V154, P31, DOI 10.1016/j.virusres.2010.07.016	57	42	47	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65548	10.1371/journal.pone.0065548	http://dx.doi.org/10.1371/journal.pone.0065548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755249	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000077
J	Cipriano, M; Haggstrom, J; Hammarsten, P; Fowler, CJ				Cipriano, Mariateresa; Haggstrom, Jenny; Hammarsten, Peter; Fowler, Christopher J.			Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ENDOCANNABINOID SYSTEM; ANDROGEN RECEPTOR; GLEASON SCORE; CELL-GROWTH; PC-3 CELLS; ACTIVATION; APOPTOSIS; PHOSPHORYLATION; PATHWAYS	Background: In prostate cancer, tumour expression of cannabinoid CB1 receptors is associated with a poor prognosis. One explanation for this association comes from experiments with transfected astrocytoma cells, where a high CB receptor expression recruits the Akt signalling survival pathway. In the present study, we have investigated the association between CB1 receptor expression and the Akt pathway in a well-characterised prostate cancer tissue microarray. Methodology/Principal Findings: Phosphorylated Akt immunoreactivity (pAkt-IR) scores were available in the database. CB1 receptor immunoreactivity (CB1IR) was rescored from previously published data using the same scale as pAkt-IR. There was a highly significant correlation between CB1IR and pAkt-IR. Further, cases with high expression levels of both biomarkers were much more likely to have a more severe form of the disease at diagnosis than those with low expression levels. The two biomarkers had additive effects, rather than an interaction, upon disease-specific survival. Conclusions/Significance: The present study provides data that is consistent with the hypothesis that at a high CB1 receptor expression, the Akt signalling pathway becomes operative.	[Cipriano, Mariateresa; Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Haggstrom, Jenny] Umea Univ, Dept Stat, Umea Sch Business & Econ, S-90187 Umea, Sweden; [Hammarsten, Peter] Umea Univ, Dept Med Biosci, Umea, Sweden	Umea University; Umea University; Umea University	Fowler, CJ (corresponding author), Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874; Cipriano, Mariateresa/0000-0001-6644-7137; Haggstrom, Jenny/0000-0002-9086-7403	Swedish Research Council [12158]; Swedish Cancer Society [CAN2010/437]; Lion's Cancer Research Foundation; Umea University; Research Funds of the Medical Faculty	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Lion's Cancer Research Foundation; Umea University; Research Funds of the Medical Faculty	The authors thank the Swedish Research Council (Grant no. 12158, medicine); the Swedish Cancer Society (Grant no. CAN2010/437); Lion's Cancer Research Foundation, Umea University and the Research Funds of the Medical Faculty, Umea University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; Czifra G, 2009, J CANCER RES CLIN, V135, P507, DOI 10.1007/s00432-008-0482-3; del Pulgar T, 2000, BIOCHEM J, V347, P369, DOI 10.1042/bj3470369; delPeso L, 1997, SCIENCE, V278, P687; Diaz-Laviada I, 2011, NAT REV UROL, V8, P553, DOI 10.1038/nrurol.2011.130; Egevad L, 2002, BJU INT, V89, P538, DOI 10.1046/j.1464-410X.2002.02669.x; Endsley MP, 2008, INT J CANCER, V123, P1318, DOI 10.1002/ijc.23674; Fowler CJ, 2010, CURR TOP MED CHEM, V10, P814; Freimuth N, 2010, J PHARMACOL EXP THER, V332, P336, DOI 10.1124/jpet.109.157735; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Guindon J, 2011, BRIT J PHARMACOL, V163, P1447, DOI 10.1111/j.1476-5381.2011.01327.x; Gustafsson SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023003; Hammarsten P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047994; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Islam TC, 2003, LEUKEMIA, V17, P1880, DOI 10.1038/sj.leu.2403057; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Le Page C, 2006, BRIT J CANCER, V94, P1906, DOI 10.1038/sj.bjc.6603184; Le Page C, 2012, PROSTATE, V72, P777, DOI 10.1002/pros.21483; Lehmann R., 1977, BIOMETRICAL J, V19, P229; Malik SN, 2002, CLIN CANCER RES, V8, P1168; McCall P, 2008, BRIT J CANCER, V98, P1094, DOI 10.1038/sj.bjc.6604152; Melck D, 2000, ENDOCRINOLOGY, V141, P118, DOI 10.1210/en.141.1.118; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; Mimeault M, 2011, MOL MED, V17, P949, DOI 10.2119/molmed.2011.00115; Nithipatikom K, 1994, CANCER RES, V64, P8826; Nithipatikom K, 2012, ENDOCRINOLOGY, V153, P29, DOI 10.1210/en.2011-1144; Nithipatikom K, 2011, PROSTAG OTH LIPID M, V94, P34, DOI 10.1016/j.prostaglandins.2010.12.002; Nomura DK, 2011, CHEM BIOL, V18, P846, DOI 10.1016/j.chembiol.2011.05.009; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pisanti S, 2013, TRENDS PHARMACOL SCI, V34, P273, DOI 10.1016/j.tips.2013.03.003; R Core Team, 2012, R LANG ENV STAT COMP; Ruiz L, 1999, FEBS LETT, V458, P400, DOI 10.1016/S0014-5793(99)01073-X; Ruiz-Llorente L, 2003, PROSTATE, V54, P95, DOI 10.1002/pros.10165; Samatoro D, 2006, MOL PHARM, V70, P1298; Sanchez MG, 2003, FEBS LETT, V555, P561, DOI 10.1016/S0014-5793(03)01349-8; Sanchez MG, 2003, CELL SIGNAL, V15, P851, DOI 10.1016/S0898-6568(03)00036-6; Santoro A, 2009, INT J CANCER, V125, P996, DOI 10.1002/ijc.24483; Sarfaraz S, 2005, CANCER RES, V65, P1635, DOI 10.1158/0008-5472.CAN-04-3410; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; Sreevalsan S, 2011, ANTICANCER RES, V31, P3799; Thors L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012275; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014	51	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65798	10.1371/journal.pone.0065798	http://dx.doi.org/10.1371/journal.pone.0065798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755281	Green Submitted, Green Published, gold			2022-12-25	WOS:000320579400077
J	Biggs, BC				Biggs, Brendan C.			Harnessing Natural Recovery Processes to Improve Restoration Outcomes: An Experimental Assessment of Sponge-Mediated Coral Reef Restoration	PLOS ONE			English	Article							LONG-TERM; ECOLOGICAL INTERACTIONS; ARTIFICIAL SUBSTRATUM; SETTLEMENT-PATTERNS; REHABILITATION; RECRUITMENT; DIVERSITY; ABUNDANCE; GROWTH; MANAGEMENT	Background: Restoration is increasingly implemented to reestablish habitat structure and function following physical anthropogenic disturbance, but scientific knowledge of effectiveness of methods lags behind demand for guidelines. On coral reefs, recovery is largely dependent on coral reestablishment, and substratum stability is critical to the survival of coral fragments and recruits. Concrete is often used to immobilize rubble, but its ecological performance has not been rigorously evaluated, and restoration has generally fallen short of returning degraded habitat to pre-disturbance conditions. Fragments of erect branching sponges mediate reef recovery by facilitating rubble consolidation, yet such natural processes have been largely overlooked in restoring reefs. Methods: On two reefs in Curacao, four treatments - coral rubble alone, rubble seeded with sponge fragments, rubble bound by concrete, and concrete "rubble'' bound by concrete - were monitored over four years to investigate rubble consolidation with and without sponges and the ecological performance of treatments in terms of the number and diversity of coral recruits. Species specific rates of sponge fragment attachment to rubble, donor sponge growth and tissue replacement, and fragment survival inside rubble piles were also investigated to evaluate sponge species performance and determine rates for sustainably harvesting tissue. Findings/Significance: Rubble piles seeded with sponges retained height and shape to a significantly greater degree, lost fewer replicates to water motion, and were significantly more likely to be consolidated over time than rubble alone. Significantly more corals recruited to sponge-seeded rubble than to all other treatments. Coral diversity was also greatest for rubble with sponges and it was the only treatment to which framework building corals recruited. Differences in overall sponge species performance suggest species selection is important to consider. Employing organisms that jump start successional pathways and facilitate recovery can significantly improve restoration outcomes; however, best practices require techniques be tailored to each system.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Biggs, BC (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	Biggs@bio.fsu.edu			Royal Caribbean Cruise Lines (marine conservation grant); National Science Foundation [OCE-0550599]	Royal Caribbean Cruise Lines (marine conservation grant); National Science Foundation(National Science Foundation (NSF))	This research was supported by Royal Caribbean Cruise Lines (marine conservation grant to B. Biggs) and by the National Science Foundation under grant number OCE-0550599 (J. Wulff). Other than J. Wulff, the authors' major professor, funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2008, MAR FRESHWATER RES, V59, P304, DOI 10.1071/MF07165; Aerts LAM, 1997, MAR ECOL PROG SER, V148, P125, DOI 10.3354/meps148125; Aerts LAM, 2000, DYNAMICS STANDOFF IN; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BINGHAM BL, 1991, MAR BIOL, V109, P19, DOI 10.1007/BF01320227; Bowden-Kerby A, 2001, B MAR SCI, V69, P915; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burt J, 2011, ECOL ENG, V37, P191, DOI 10.1016/j.ecoleng.2010.09.004; Burt J, 2009, J EXP MAR BIOL ECOL, V373, P72, DOI 10.1016/j.jembe.2009.03.009; Castro J, 2004, RESTOR ECOL, V12, P352, DOI 10.1111/j.1061-2971.2004.0316.x; CHANAS B, 1995, MAR ECOL PROG SER, V127, P195, DOI 10.3354/meps127195; Clark S, 1999, AQUAT CONSERV, V9, P5, DOI 10.1002/(SICI)1099-0755(199901/02)9:1<5::AID-AQC330>3.3.CO;2-L; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cote IM, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 0521671450; Crawley MJ., 2007, R BOOK; Curtis C, 1985, P 5 INT COR REEF C T, V6, P471; Diaz MC, 2001, B MAR SCI, V69, P535; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Epstein N, 2003, AQUAT CONSERV, V13, P387, DOI 10.1002/aqc.558; Fox HE, 2005, CONSERV BIOL, V19, P98, DOI 10.1111/j.1523-1739.2005.00261.x; Fox HE, 2004, MAR ECOL PROG SER, V269, P131, DOI 10.3354/meps269131; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; GOREAU TF, 1966, SCIENCE, V151, P343, DOI 10.1126/science.151.3708.343; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hilderbrand RH, 2005, ECOL SOC, V10; Hill MS, 1999, BIOL BULL, V202, P86; Hudson J.H., 1988, P231; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Irving AD, 2010, J APPL ECOL, V47, P1119, DOI 10.1111/j.1365-2664.2010.01852.x; Jaap WC, 2000, ECOL ENG, V15, P345, DOI 10.1016/S0925-8574(00)00085-9; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Leong W, 2010, MAR ECOL PROG SER, V406, P71, DOI 10.3354/meps08541; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; Lirman D, 1997, J COASTAL RES, V13, P67; Lockwood Julie L., 1999, P363, DOI 10.1017/CBO9780511542237.014; Lutz Steven J., 2006, P25, DOI 10.1201/9781420003796.ch2; McGrath E, 2012, THESIS NOVA SE U; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Miller MW, 2009, MAR ECOL PROG SER, V387, P147, DOI 10.3354/meps08097; Miller MW, 2001, B MAR SCI, V69, P395; Miller MW, 2000, P 9 INT COR REEF S, V2, P977; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Nystrom M, 2012, ECOSYSTEMS, V15, P695, DOI 10.1007/s10021-012-9530-6; Palmer MA, 1997, RESTOR ECOL, V5, P291, DOI 10.1046/j.1526-100X.1997.00543.x; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Pile A.J., 1997, P1403; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; PORTER JW, 1988, BIOL BULL, V175, P230, DOI 10.2307/1541563; Precht WF, 2001, B MAR SCI, V69, P1001; Precht William F., 2006, P1, DOI 10.1201/9781420003796.ch1; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; Pywell RF, 2003, J APPL ECOL, V40, P65, DOI 10.1046/j.1365-2664.2003.00762.x; RANDALL JE, 1968, MAR BIOL, V1, P216, DOI 10.1007/BF00347115; Rasser MW, 2002, CORAL REEFS, V21, P57, DOI 10.1007/s00338-001-0206-5; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Requena N, 2001, APPL ENVIRON MICROB, V67, P495, DOI 10.1128/AEM.67.2.495-498.2001; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Reyes MZ, 2001, B MAR SCI, V69, P559; Rinkevich B, 2000, MAR BIOL, V136, P807, DOI 10.1007/s002270000293; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Rogers CS, 2001, B MAR SCI, V69, P793; Schittone J, 2010, REV BIOL TROP, V58, P151; Smith RS, 2003, J APPL ECOL, V40, P51, DOI 10.1046/j.1365-2664.2003.00780.x; Spieler RE, 2001, B MAR SCI, V69, P1013; STODDART DR, 1965, NATURE, V207, P589, DOI 10.1038/207589a0; SULLIVAN B, 1983, SCIENCE, V221, P1175, DOI 10.1126/science.221.4616.1175; Sutton L, 2008, 11 INT COR REEF S FL, V24, P48; Van Duyl F. C, 1985, ATLAS LIVING REEFS C; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119; Vermeij MJA, 2006, CORAL REEFS, V25, P59, DOI 10.1007/s00338-005-0056-7; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Weidenmeyer F, 1977, SHALLOW WATER SPONGE; Wilkinson C., 2008, STATUS CORAL REEFS W; Wulff J, 2001, B MAR SCI, V69, P831; Wulff JL, 2006, FUNCT ECOL, V20, P699, DOI 10.1111/j.1365-2435.2006.01143.x; Wulff J. L., 1985, P 5 INT COR REEF C, V5, P119; Wulff J, 2012, ADV MAR BIOL, V61, P273, DOI 10.1016/B978-0-12-387787-1.00003-9; Wulff JL, 2008, MAR ECOL-EVOL PERSP, V29, P193, DOI 10.1111/j.1439-0485.2008.00224.x; Wulff JL, 2008, AM NAT, V171, P597, DOI 10.1086/587067; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; WULFF JL, 1979, NATURE, V281, P474, DOI 10.1038/281474a0; Wulff JL, 1997, ECOLOGY, V78, P146; WULFF JL, 1995, CORAL REEFS, V14, P55, DOI 10.1007/BF00304073; WULFF JL, 1991, J EXP MAR BIOL ECOL, V149, P227, DOI 10.1016/0022-0981(91)90047-Z; WULFF JL, 1994, SPONGES IN TIME AND SPACE, P265; WULFF JL, 1984, CORAL REEFS, V3, P157, DOI 10.1007/BF00301960; Zedler JB, 2001, BIOSCIENCE, V51, P1005, DOI 10.1641/0006-3568(2001)051[1005:DBWSMA]2.0.CO;2; Zhao HL, 2007, ECOL ENG, V31, P1, DOI 10.1016/j.ecoleng.2007.04.010; Zimmer Beth, 2006, P39; Zuur Alain F., 2009, P1	99	22	22	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64945	10.1371/journal.pone.0064945	http://dx.doi.org/10.1371/journal.pone.0064945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750219	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900021
J	Ito, H; Kawahara, T; Terao, H; Ogawa, T; Yao, M; Kubota, Y; Matsuzaki, J				Ito, Hiroki; Kawahara, Takashi; Terao, Hideyuki; Ogawa, Takehiko; Yao, Masahiro; Kubota, Yoshinobu; Matsuzaki, Junichi			Utility and Limitation of Cumulative Stone Diameter in Predicting Urinary Stone Burden at Flexible Ureteroscopy with Holmium Laser Lithotripsy: A Single-Center Experience	PLOS ONE			English	Article							PLAIN RADIOGRAPHY; CALCULI; SIZE; TOMOGRAPHY; CM	Purpose: To retrospectively assess the clinical utility in ureteroscopy (URS) planning of cumulative stone diameter (CSD), which does not account for stone width or depth, as a predictor of URS outcome and compare it with stone volume. Materials and Methods: Patients with renal stones treated at a single institute by flexible URS were retrospectively evaluated. To assess the clinical utility of CSD, relationships between stone-free (SF) status and stone burden (CSD and volume) were analyzed using the area under the receiver operating characteristics (AUROC) curve. To identify stone number impact on CSD, the AUROC of CSD divided by stone number was evaluated. Correlation coefficients of CSD and stone volume were also calculated for groups by stone number. Results: In cases with CSD <20.0 mm, CSD and stone volume revealed equal ability to predict SF status. In cases with CSD >= 20.0 mm, stone volume showed higher predictive ability. The ROC curves for cases with >= 4 stones showed that CSD was less predictive of SF status than stone volume. The correlation coefficients of CSD and stone volume by stone number were 0.922 for 1 stone, 0.900 for 2-3 stones, and 0.661 for >= 4 stones. Conclusions: In cases with CSD >= 20.0 mm or >= 4 stones, we should evaluate stone volume for a more predictive stone burden, and pretreatment non-contrast CT seems sufficient. In cases with CSD <20.0 mm or 1-3 stones, CSD was as valid a predictor of preoperative stone burden as stone volume, so preoperative kidney-ureter-bladder (KUB) films may be sufficient.	[Ito, Hiroki; Kawahara, Takashi; Terao, Hideyuki; Matsuzaki, Junichi] Ohguchi E Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Ito, Hiroki; Kawahara, Takashi; Ogawa, Takehiko; Yao, Masahiro; Kubota, Yoshinobu] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan	Yokohama City University	Ito, H (corresponding author), Ohguchi E Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan.	pug_daikichi@yahoo.co.jp						Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Breda A, 2009, EUR UROL, V55, P1190, DOI 10.1016/j.eururo.2008.06.019; Dundee P, 2006, J ENDOUROL, V20, P1005, DOI 10.1089/end.2006.20.1005; Eisner BH, 2009, J UROLOGY, V181, P1710, DOI 10.1016/j.juro.2008.11.116; Hyams ES, 2010, J ENDOUROL, V24, P1411, DOI 10.1089/end.2009.0645; Ito H, 2012, J ENDOUROL, V26, P1125, DOI 10.1089/end.2012.0154; Ito H, 2012, UROLOGY, V80, P524, DOI 10.1016/j.urology.2012.04.001; LAM HS, 1992, J UROLOGY, V147, P1219, DOI 10.1016/S0022-5347(17)37522-5; Mariani AJ, 2007, J UROLOGY, V177, P168, DOI 10.1016/j.juro.2006.08.066; Narepalem N, 2002, J UROLOGY, V167, P1235, DOI 10.1016/S0022-5347(05)65272-X; Parsons JK, 2003, J ENDOUROL, V17, P725, DOI 10.1089/089277903770802245; Preminger GM, 2007, J UROLOGY, V178, P2418, DOI 10.1016/j.juro.2007.09.107; Riley JM, 2009, J ENDOUROL, V23, P1395, DOI 10.1089/end.2009.0391; Tan P. K., 1995, Singapore Medical Journal, V36, P53; Tiselius HG, 2001, EUR UROL, V40, P362, DOI 10.1159/000049803	15	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65060	10.1371/journal.pone.0065060	http://dx.doi.org/10.1371/journal.pone.0065060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750229	Green Submitted, Green Published, gold			2022-12-25	WOS:000319961900031
J	Khademvatan, S; Rahim, F; Tavalla, M; Abdizadeh, R; Hashemitabar, M				Khademvatan, Shahram; Rahim, Fakher; Tavalla, Mahdi; Abdizadeh, Rahman; Hashemitabar, Mahmoud			PCR-Based Molecular Characterization of Toxocara spp. Using Feces of Stray Cats: A Study from Southwest Iran	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PARASITES; CANIS; INFECTIONS; DOGS; IDENTIFICATION; CONSUMPTION; NEUROSPORA; INFERENCE; MRBAYES	Feces of stray cat are potential sources of gastrointestinal parasites and play a crucial role in spreading and transmitting parasite eggs, larvae, and oocysts through contamination of soil, food, or water. In this study, we investigated the prevalence of Toxocara spp. infection in stray cats in Ahvaz city, southwest Iran. Eggs of Toxocara spp. in feces of stray cats were detected by the sucrose flotation method, and identification was conducted by polymerase chain reaction (PCR) and DNA sequencing. Of the 140 fecal samples that were randomly collected from public environments during the months of January to May 2012, 45% were found to harbour Toxocara spp. eggs. The highest prevalence of Toxocara spp. eggs was found in the central area of Ahvaz city (28.6%). T. canis eggs were found in 4 (6.34%) of the 63 positive samples. Stray cats are found in parks, playgrounds, and other public places and may be a potential contamination risk. Identification of Toxocara spp. using molecular methods is sufficiently sensitive to detect low levels of parasites and identify the different Toxocara spp. in feces. The relatively high prevalence of Toxocara spp. infection may continue to increase due to lack of effective environmental hygiene control in Iran. Consequently, there is a need to plan adequate programs to detect, identify, and control this infection as well as stray cats in the region.	[Khademvatan, Shahram; Hashemitabar, Mahmoud] Ahvaz Jundishapur Univ Med Sci, Cellular & Mol Res Ctr, Ahvaz, Iran; [Khademvatan, Shahram; Tavalla, Mahdi; Abdizadeh, Rahman] Ahvaz Jundishapur Univ Med Sci, Dept Med Parasitol, Ahvaz, Iran; [Rahim, Fakher] Ahvaz Jundishapur Univ Med Sci, Toxicol Res Ctr, Ahvaz, Iran	Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS)	Khademvatan, S (corresponding author), Ahvaz Jundishapur Univ Med Sci, Cellular & Mol Res Ctr, Ahvaz, Iran.	khademvatan@yahoo.com; Fakherraheem@yahoo.com	rahim, fakher/AAC-3905-2019; Hashemitabar, Mahmoud/ABI-6615-2020; Abdizadeh, Rahman/K-2521-2017	rahim, fakher/0000-0002-2857-4562; Abdizadeh, Rahman/0000-0002-9977-1344; Tavalla, Mehdi/0000-0002-8337-6673; hashemitabar, mahmoud/0000-0002-8800-3761	Research Project of the Ahvaz Jundishpur University of Medical Science [CMRC-56]	Research Project of the Ahvaz Jundishpur University of Medical Science	This study was supported by the Research Project of the Ahvaz Jundishpur University of Medical Science, no: CMRC-56. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao N, 2007, PARASITOL INT, V56, P87, DOI 10.1016/j.parint.2007.01.009; Arbabi M, 2009, TROP BIOMED, V26, P16; BHOWMICK DILIP KUMAR, 1964, Z PARASITENK, V24, P121; Borecka A, 2008, J HELMINTHOL, V82, P119, DOI 10.1017/S0022149X07877522; DEOLIVEIRA CAF, 1992, REV SAUDE PUBL, V26, P332, DOI 10.1590/S0034-89101992000500006; Dettman JR, 2006, MYCOLOGIA, V98, P436, DOI 10.3852/mycologia.98.3.436; Dettman JR, 2003, EVOLUTION, V57, P2721; Durant JF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-288; Fahrion AS, 2011, VET PARASITOL, V177, P186, DOI 10.1016/j.vetpar.2010.11.028; Fisher M, 2003, TRENDS PARASITOL, V19, P167, DOI 10.1016/S1471-4922(03)00027-8; Fogt-Wyrwas R, 2007, J HELMINTHOL, V81, P75, DOI 10.1017/S0022149X07241872; Gawor J, 2008, VET PARASITOL, V155, P217, DOI 10.1016/j.vetpar.2008.05.016; Hoffmeister B, 2007, AM J TROP MED HYG, V76, P600, DOI 10.4269/ajtmh.2007.76.600; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishiwata K, 2004, PARASITOL RES, V92, P50, DOI 10.1007/s00436-003-1010-7; Jacobs DE, 1997, ACTA TROP, V68, P191, DOI 10.1016/S0001-706X(97)00093-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee ACY, 2010, TRENDS PARASITOL, V26, P155, DOI 10.1016/j.pt.2010.01.002; Li MW, 2007, MOL CELL PROBE, V21, P349, DOI 10.1016/j.mcp.2007.04.004; Magnaval Jean-Francois, 2001, Korean Journal of Parasitology, V39, P1, DOI 10.3347/kjp.2001.39.1.1; Ogden TH, 2007, SYST BIOL, V56, P182, DOI 10.1080/10635150701281102; Okulewicz A, 2012, HELMINTHOLOGIA, V49, P3, DOI 10.2478/s11687-012-0001-6; OLORCAIN P, 1994, J HELMINTHOL, V68, P331, DOI 10.1017/S0022149X00001590; Quattrocchi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001775; Rai SK, 2000, CONTAMINATION SOIL H; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roth B, 1971, BERL MUNCH TIERARZTL, V22, P436; Rubinsky-Elefant G, 2010, ANN TROP MED PARASIT, V104, P3, DOI 10.1179/136485910X12607012373957; Sadjjadi Seyed Mahmoud, 2001, Veterinarski Arhiv, V71, P149; Sharif M, 2007, J HELMINTHOL, V81, P63, DOI 10.1017/S0022149X07214117; Smith H, 2009, TRENDS PARASITOL, V25, P182, DOI 10.1016/j.pt.2009.01.006; Szabova E, 2007, HELMINTHOLOGIA, V44, P170, DOI 10.2478/s11687-007-0027-3; Talvik H, 2006, ACTA VET HUNG, V54, P399, DOI 10.1556/AVet.54.2006.3.10; Uga S, 2000, VET PARASITOL, V92, P287, DOI 10.1016/S0304-4017(00)00323-X; Uga S, 2009, Nepal Med Coll J, V11, P75; Walker MD, 2005, SEMIN NEUROL, V25, P252, DOI 10.1055/s-2005-917662; Wu ZL, 1997, J HELMINTHOL, V71, P77, DOI 10.1017/S0022149X00000845; Yaman M, 2005, TURKIYE PARAZITOLOJI, V30, P200; Yoshikawa M, 2008, PARASITOL INT, V57, P525, DOI 10.1016/j.parint.2008.08.002	39	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65293	10.1371/journal.pone.0065293	http://dx.doi.org/10.1371/journal.pone.0065293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755213	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300071
J	Li, C; Xu, WC; Xie, ZS; Pan, K; Hu, J; Chen, J; Pang, DW; Yang, FQ; Liang, Y				Li, Cheng; Xu, Wen-Chang; Xie, Zhen-Sheng; Pan, Kai; Hu, Jiao; Chen, Jie; Pang, Dai-Wen; Yang, Fu-Quan; Liang, Yi			Cupric Ions Induce the Oxidation and Trigger the Aggregation of Human Superoxide Dismutase 1	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ISOTHERMAL TITRATION CALORIMETRY; METAL-BINDING; CU,ZN-SUPEROXIDE DISMUTASE; MUTANT SOD1; MOUSE MODEL; TRANSPORTER YIIP; COPPER CHAPERONE; TRANSGENIC MICE; CYSTEINE 111	Background: Amyotrophic lateral sclerosis (ALS), partly caused by the mutations and aggregation of human copper, zinc superoxide dismutase (SOD1), is a fatal degenerative disease of motor neurons. Because SOD1 is a major copper-binding protein present at relatively high concentration in motor neurons and copper can be a harmful pro-oxidant, we want to know whether aberrant copper biochemistry could underlie ALS pathogenesis. In this study, we have investigated and compared the effects of cupric ions on the aggregation of ALS-associated SOD1 mutant A4V and oxidized wild-type SOD1. Methodology/Principal Findings: As revealed by 90 degrees light scattering, dynamic light scattering, SDS-PAGE, and atomic force microscopy, free cupric ions in solution not only induce the oxidation of either apo A4V or Zn-2-A4V and trigger the oligomerization and aggregation of oxidized A4V under copper-mediated oxidative conditions, but also trigger the aggregation of non-oxidized form of such a pathogenic mutant. As evidenced by mass spectrometry and SDS-PAGE, Cys-111 is a primary target for oxidative modification of pathological human SOD1 mutant A4V by either excess Cu2+ or hydrogen peroxide. The results from isothermal titration calorimetry show that A4V possesses two sets of independent binding sites for Cu2+: a moderate-affinity site (10(6) M-1) and a high-affinity site (10(8) M-1). Furthermore, Cu2+ binds to wildtype SOD1 oxidized by hydrogen peroxide in a way similar to A4V, triggering the aggregation of such an oxidized form. Conclusions/ Significance: We demonstrate that excess cupric ions induce the oxidation and trigger the aggregation of A4V SOD1, and suggest that Cu2+ plays a key role in the mechanism of aggregation of both A4V and oxidized wild-type SOD1. A plausible model for how pathological SOD1 mutants aggregate in ALS-affected motor neurons with the disruption of copper homeostasis has been provided.	[Li, Cheng; Xu, Wen-Chang; Pan, Kai; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Xie, Zhen-Sheng; Yang, Fu-Quan] Chinese Acad Sci, Inst Biophys, Lab Prote, Beijing 100080, Peoples R China; [Hu, Jiao; Pang, Dai-Wen] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China; [Hu, Jiao; Pang, Dai-Wen] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Wuhan University; Wuhan University	Liang, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Liang, Yi/V-1396-2017	Liang, Yi/0000-0002-7349-8300	National Key Basic Research Foundation of China [2013CB910702, 2012CB911003]; National Natural Science Foundation of China [31170744, 30970599]; Fundamental Research Funds for the Central Universities of China [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant nos. 2013CB910702 and 2012CB911003, YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, Grant nos. 31170744 and 30970599, YL), and Fundamental Research Funds for the Central Universities of China (http://www.moe.edu.cn/, Grant no. 1104006, YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Anderson M, 2006, J MOL BIOL, V358, P580, DOI 10.1016/j.jmb.2006.02.007; Barmada S, 2010, NAT NEUROSCI, V13, P1303, DOI 10.1038/nn1110-1303; Beckman JS, 2002, FREE RADICAL BIO MED, V33, P1433, DOI 10.1016/S0891-5849(02)01092-4; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bounds PL, 2002, METHOD ENZYMOL, V349, P115, DOI 10.1016/S0076-6879(02)49327-5; Brotherton TE, 2012, P NATL ACAD SCI USA, V109, P5505, DOI 10.1073/pnas.1115009109; Bush AI, 2002, NAT NEUROSCI, V5, P919, DOI 10.1038/nn1002-919a; Chang YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002849; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chen XP, 2012, NEUROCHEM RES, V37, P835, DOI 10.1007/s11064-011-0679-8; COLOMBO MF, 1987, CAN J CHEM, V65, P821, DOI 10.1139/v87-139; DE Beus MD, 2004, PROTEIN SCI, V13, P1347, DOI 10.1110/ps.03576904; Desai V, 2008, AM J CLIN NUTR, V88, p855S, DOI 10.1093/ajcn/88.3.855S; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Ghai R, 2012, J MOL RECOGNIT, V25, P32, DOI 10.1002/jmr.1167; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; Hwang YM, 2010, J BIOL CHEM, V285, P41701, DOI 10.1074/jbc.M110.113696; Ip P, 2011, J MOL BIOL, V409, P839, DOI 10.1016/j.jmb.2011.04.027; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Kiaei M, 2004, J NEUROSCI, V24, P7945, DOI 10.1523/JNEUROSCI.2000-04.2004; Kim HK, 2011, ARCH BIOCHEM BIOPHYS, V509, P177, DOI 10.1016/j.abb.2011.02.014; Kishigami H, 2010, FREE RADICAL BIO MED, V48, P945, DOI 10.1016/j.freeradbiomed.2010.01.008; Kong FL, 2011, CHEM-BIOL INTERACT, V194, P69, DOI 10.1016/j.cbi.2011.08.003; Leinartaite L, 2010, J AM CHEM SOC, V132, P13495, DOI 10.1021/ja1057136; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; Michel E, 2005, ARCH BIOCHEM BIOPHYS, V439, P234, DOI 10.1016/j.abb.2005.05.016; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Nagano S, 2003, EXP NEUROL, V179, P176, DOI 10.1016/S0014-4886(02)00014-6; Nagano S, 2011, AMYOTROPHIC LATERAL SCLEROSIS, P301; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Prudencio M, 2012, J NEUROCHEM, V121, P475, DOI 10.1111/j.1471-4159.2012.07690.x; Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Tokuda E, 2008, EXP NEUROL, V213, P122, DOI 10.1016/j.expneurol.2008.05.011; Tokuda E, 2009, J NEUROCHEM, V111, P181, DOI 10.1111/j.1471-4159.2009.06310.x; Trumbull KA, 2009, ANTIOXID REDOX SIGN, V11, P1627, DOI 10.1089/ARS.2009.2574; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe S, 2007, FREE RADICAL BIO MED, V42, P1534, DOI 10.1016/j.freeradbiomed.2007.02.004; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Yim HS, 1997, J BIOL CHEM, V272, P8861; Yu JS, 2007, J BIOL CHEM, V282, P8895, DOI 10.1074/jbc.M609317200; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025020; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	72	7	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65287	10.1371/journal.pone.0065287	http://dx.doi.org/10.1371/journal.pone.0065287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755211	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300069
J	Lu, YC; Wu, CC; Yang, TH; Lin, YH; Yu, IS; Lin, SW; Chang, Q; Lin, X; Wong, JM; Hsu, CJ				Lu, Ying-Chang; Wu, Chen-Chi; Yang, Ting-Hua; Lin, Yin-Hung; Yu, I-Shing; Lin, Shu-Wha; Chang, Qing; Lin, Xi; Wong, Jau-Min; Hsu, Chuan-Jen			Differences in the Pathogenicity of the p.H723R Mutation of the Common Deafness-Associated SLC26A4 Gene in Humans and Mice	PLOS ONE			English	Article							ENLARGED VESTIBULAR AQUEDUCT; NONSYNDROMIC HEARING IMPAIRMENT; GENOTYPE-PHENOTYPE CORRELATION; KCNJ10 PROTEIN EXPRESSION; PENDRED-SYNDROME GENE; SYNDROME MOUSE MODEL; INNER-EAR; UNIQUE SPECTRUM; PDS GENE; CELLS	Mutations in the SLC26A4 gene are a common cause of human hereditary hearing impairment worldwide. Previous studies have demonstrated that different SLC26A4 mutations have different pathogenetic mechanisms. By using a genotype-driven approach, we established a knock-in mouse model (i.e., Slc26a4(tm2Dontuh/tm2Dontuh) mice) homozygous for the common p.H723R mutation in the East Asian population. To verify the pathogenicity of the p. H723R allele in mice, we further generated mice with compound heterozygous mutations (i.e., Slc26a4(tm1Dontuh/tm2Dontuh)) by intercrossing Slc26a4(+/tm2Dontuh) mice with Slc26a4(tm1Dontuh/tm1Dontuh) mice, which segregated the c.919-2A>G mutation with an abolished Slc26a4 function. Mice were then subjected to audiologic assessments, a battery of vestibular evaluations, inner ear morphological studies, and noise exposure experiments. The results were unexpected; both Slc26a4(tm2Dontuh/tm2Dontuh) and Slc26a4(tm1Dontuh/tm2Dontuh) mice showed normal audiovestibular phenotypes and inner ear morphology, and they did not show significantly higher shifts in hearing thresholds after noise exposure than the wild-type mice. The results indicated not only the p. H723R allele was non-pathogenic in mice, but also a single p.H723R allele was sufficient to maintain normal inner ear physiology in heterozygous compound mice. There might be discrepancies in the pathogenicity of specific SLC26A4 mutations in humans and mice; therefore, precautions should be taken when extrapolating the results of animal studies to humans.	[Lu, Ying-Chang; Wong, Jau-Min] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lu, Ying-Chang; Wu, Chen-Chi; Yang, Ting-Hua; Lin, Yin-Hung; Hsu, Chuan-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Wu, Chen-Chi] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Yu, I-Shing; Lin, Shu-Wha] Natl Taiwan Univ, Res Ctr Med Excellence, Transgen Mouse Models Core, Div Genom Med, Taipei 10764, Taiwan; [Chang, Qing; Lin, Xi] Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA USA; [Hsu, Chuan-Jen] Natl Taiwan Univ, Coll Med, Dept Otolaryngol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Emory University; National Taiwan University	Hsu, CJ (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.	cjhsu@ntu.edu.tw	lin, xi/GZL-4959-2022	LIN, SHU-WHA/0000-0001-6748-5581; WU, CHEN-CHI/0000-0002-5047-2204	National Health Research Institute [NHRI-EX101-10147PI]; National Science Council of the Executive Yuan of the Republic of China [NSC-99-2314-B-002-056-MY3]; National Taiwan University Hospital [NTUH-100-001597]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council of the Executive Yuan of the Republic of China(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This study was supported by research grants from the National Health Research Institute (NHRI-EX101-10147PI), National Science Council of the Executive Yuan of the Republic of China (NSC-99-2314-B-002-056-MY3), and National Taiwan University Hospital (NTUH-100-001597). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Azaiez H, 2007, HUM GENET, V122, P451, DOI 10.1007/s00439-007-0415-2; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Choi BY, 2011, J CLIN INVEST, V121, P4516, DOI 10.1172/JCI59353; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Dror AA, 2010, J BIOL CHEM, V285, P21724, DOI 10.1074/jbc.M110.120188; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Ishihara K, 2010, HEARING RES, V270, P110, DOI 10.1016/j.heares.2010.08.015; King KA, 2010, LARYNGOSCOPE, V120, P384, DOI 10.1002/lary.20722; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Lu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022150; Mori T, 2008, J OTOLARYNGOL-HEAD N, V37, P112, DOI 10.2310/7070.2008.0016; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Ohlemiller KK, 2007, HEARING RES, V224, P34, DOI 10.1016/j.heares.2006.11.005; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Pearson H, 2002, NATURE, V415, P8, DOI 10.1038/415008a; Pryor SP, 2005, J MED GENET, V42, P159, DOI 10.1136/jmg.2004.024208; Royaux IE, 2000, ENDOCRINOLOGY, V141, P839, DOI 10.1210/en.141.2.839; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Scott DA, 2000, HUM MOL GENET, V9, P1709, DOI 10.1093/hmg/9.11.1709; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Su KY, 2007, J NEUROSCI, V27, P2513, DOI 10.1523/JNEUROSCI.4497-06.2007; Sugiura M, 2005, EUR ARCH OTO-RHINO-L, V262, P737, DOI 10.1007/s00405-004-0884-z; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wangemann P, 2009, AM J PHYSIOL-RENAL, V297, pF1435, DOI 10.1152/ajprenal.00011.2009; Wu CC, 2005, LARYNGOSCOPE, V115, P1060, DOI 10.1097/01.MLG.0000163339.61909.D0; Wu CC, 2008, AUDIOL NEURO-OTOL, V13, P172, DOI 10.1159/000112425; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014; Yoon JS, 2008, J MED GENET, V45, P411, DOI 10.1136/jmg.2007.054635; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049984	42	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64906	10.1371/journal.pone.0064906	http://dx.doi.org/10.1371/journal.pone.0064906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755160	Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300038
J	Stretch, C; Khan, S; Asgarian, N; Eisner, R; Vaisipour, S; Damaraju, S; Graham, K; Bathe, OF; Steed, H; Greiner, R; Baracos, VE				Stretch, Cynthia; Khan, Sheehan; Asgarian, Nasimeh; Eisner, Roman; Vaisipour, Saman; Damaraju, Sambasivarao; Graham, Kathryn; Bathe, Oliver F.; Steed, Helen; Greiner, Russell; Baracos, Vickie E.			Effects of Sample Size on Differential Gene Expression, Rank Order and Prediction Accuracy of a Gene Signature	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; FALSE DISCOVERY RATE; MICROARRAY DATA; BREAST-CANCER; SEX; CLASSIFICATION; LIMITATIONS; SELECTION; PROFILES	Top differentially expressed gene lists are often inconsistent between studies and it has been suggested that small sample sizes contribute to lack of reproducibility and poor prediction accuracy in discriminative models. We considered sex differences (69 male, 65 female) in 134 human skeletal muscle biopsies using DNA microarray. The full dataset and subsamples (n = 10 (5 male, 5 female) to n = 120 (60 male, 60 female)) thereof were used to assess the effect of sample size on the differential expression of single genes, gene rank order and prediction accuracy. Using our full dataset (n = 134), we identified 717 differentially expressed transcripts (p<0.0001) and we were able predict sex with similar to 90% accuracy, both within our dataset and on external datasets. Both p-values and rank order of top differentially expressed genes became more variable using smaller subsamples. For example, at n = 10 (5 male, 5 female), no gene was considered differentially expressed at p < 0.0001 and prediction accuracy was similar to 50% (no better than chance). We found that sample size clearly affects microarray analysis results; small sample sizes result in unstable gene lists and poor prediction accuracy. We anticipate this will apply to other phenotypes, in addition to sex.	[Stretch, Cynthia; Damaraju, Sambasivarao; Graham, Kathryn; Steed, Helen; Baracos, Vickie E.] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada; [Khan, Sheehan; Asgarian, Nasimeh; Eisner, Roman; Vaisipour, Saman; Greiner, Russell] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Bathe, Oliver F.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Bathe, Oliver F.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Asgarian, Nasimeh; Eisner, Roman; Vaisipour, Saman; Greiner, Russell] Alberta Innovates Ctr Machine Learning, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Calgary; University of Calgary; Alberta Innovates	Baracos, VE (corresponding author), Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada.	vickie.baracos@albertahealthservices.ca	Greiner, Russell/AAQ-4502-2020	Greiner, Russell/0000-0001-8327-934X; Baracos, Vickie/0000-0002-9609-1001; Stretch, Cynthia/0000-0002-5152-2728	Canadian Institutes of Health Research; Alberta Innovates Centre for Machine Learning; Natural Sciences and Engineering Research Council of Canada; Alberta Cancer Foundation; Alberta Cancer Prevention Legacy Fund; Canadian Breast Cancer Foundation-Prairies/NWT chapter	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Centre for Machine Learning; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Cancer Foundation; Alberta Cancer Prevention Legacy Fund; Canadian Breast Cancer Foundation-Prairies/NWT chapter	This work was supported by the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca), the Alberta Innovates Centre for Machine Learning (www.aicml.ca) and Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The tumor bank was funded by the Alberta Cancer Foundation (www.albertacancer.ca), Alberta Cancer Prevention Legacy Fund and Canadian Breast Cancer Foundation-Prairies/NWT chapter (www.cbcf.org/prairies/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Damavandi B., 2012, ESTIMATING OVERLAP T; Diaz LK, 2005, ADV ANAT PATHOL, V12, P10, DOI 10.1097/00125480-200501000-00003; Dobbin KK, 2008, CLIN CANCER RES, V14, P108, DOI 10.1158/1078-0432.CCR-07-0443; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Eisner R, 2011, METABOLOMICS, V7, P25, DOI 10.1007/s11306-010-0232-9; Fluck M, 2005, J APPL PHYSIOL, V99, P397, DOI 10.1152/japplphysiol.00050.2005; Kim SY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-147; Klebanov L, 2007, BIOINFORMATION, V1, P429, DOI 10.6026/97320630001429; Kuo CL, 2011, GENETICS, V189, P329, DOI 10.1534/genetics.111.130542; Liu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-659; Maher AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006335; Matsui S, 2009, STAT MED, V28, P2801, DOI 10.1002/sim.3666; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Murphy RA, 2011, CANCER-AM CANCER SOC, V117, P1775, DOI 10.1002/cncr.25709; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Pusztai L, 2006, ONCOLOGIST, V11, P868, DOI 10.1634/theoncologist.11-8-868; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Roth SM, 2002, PHYSIOL GENOMICS, V10, P181, DOI 10.1152/physiolgenomics.00028.2002; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timmons JA, 2006, IUBMB LIFE, V58, P15, DOI 10.1080/15216540500507390; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; Virtanen C, 2008, APPL PHYSIOL NUTR ME, V33, P124, DOI 10.1139/H07-150; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5	28	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65380	10.1371/journal.pone.0065380	http://dx.doi.org/10.1371/journal.pone.0065380			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755224	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300077
J	Wang, HJ; Liang, YG; Li, SX; Chang, JB				Wang, Hongjun; Liang, Youguang; Li, Sixin; Chang, Jianbo			Acute Toxicity, Respiratory Reaction, and Sensitivity of Three Cyprinid Fish Species Caused by Exposure to Four Heavy Metals	PLOS ONE			English	Article							MINNOW PIMEPHALES-PROMELAS; BLUEGILL LEPOMIS-MACROCHIRUS; BIOMONITORING SYSTEM; REAL-TIME; CADMIUM; REPRODUCTION; RAFINESQUE; SURVIVAL; BEHAVIOR; GROWTH	Using 3 cyprinid fish species zebra fish, rare minnow, and juvenile grass carp, we conducted assays of lethal reaction and ventilatory response to analyze sensitivity of the fish to 4 heavy metals. Our results showed that the 96 h LC50 of Hg2+ to zebra fish, juvenile grass carp, and rare minnow were 0.14 mg L-1, 0.23 mg L-1, and 0.10 mg L-1, respectively; of Cu2+ 0.17 mg L-1, 0.09 mg L-1, and 0.12 mg L-1 respectively; of Cd2+ 6.5 mg L-1, 18.47 mg L-1, 5.36 mg L-1, respectively; and of Zn2+ 44.48 mg L-1, 31.37 mg L-1, and 12.74 mg L-1, respectively. Under a 1-h exposure, the ventilatory response to the different heavy metals varied. Ventilatory frequency (Vf) and amplitude (Va) increased in zebra fish, juvenile grass carp, and rare minnows exposed to Hg2+ and Cu2+ (P<0.05), and the Vf and Va of the 3 species rose initially and then declined when exposed to Cd2+. Zn2+ had markedly different toxic effects than the other heavy metals, whose Vf and Va gradually decreased with increasing exposure concentration (P<0.05). The rare minnow was the most highly susceptible of the 3 fish species to the heavy metals, with threshold effect concentrations (TEC) of 0.019 mg L-1, 0.046 mg L-1, 2.142 mg L-1, and 0.633 mg L-1 for Hg2+, Cu2+, Cd2+, and Zn2+, respectively. Therefore, it is feasible to use ventilatory parameters as a biomarker for evaluating the pollution toxicity of metals and to recognize early warning signs by using rare minnows as a sensor.	[Wang, Hongjun] Minist Water Resources, Key Lab Ecol Impacts Hydraul Projects & Restorat, Inst Hydroecol, Wuhan, Peoples R China; Chinese Acad Sci, Wuhan, Peoples R China	Chinese Academy of Sciences; Ministry of Water Resources; Chinese Academy of Sciences	Wang, HJ (corresponding author), Minist Water Resources, Key Lab Ecol Impacts Hydraul Projects & Restorat, Inst Hydroecol, Wuhan, Peoples R China.	whj103392@163.com	Chang, Jianbo/F-6831-2013	Chang, Jianbo/0000-0002-1053-2540; Li, Sixin/0000-0001-9866-411X	National Science and Technology Major Project of Water Pollution Control and Management of China [2009ZX07528-003]; agricultural scientific and technological achievements of China [2011GB23320006]; National Natural Science Foundation of China [51209150]	National Science and Technology Major Project of Water Pollution Control and Management of China; agricultural scientific and technological achievements of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science and Technology Major Project of Water Pollution Control and Management of China (Grant No. 2009ZX07528-003), the transforming program of agricultural scientific and technological achievements of China (Grant NO. 2011GB23320006) and National Natural Science Foundation of China (Grant 51209150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Testing and Materials (ASTM) E96, 1995, E96 ASTM, P1; BENOIT DA, 1975, T AM FISH SOC, V104, P353, DOI 10.1577/1548-8659(1975)104&lt;353:CEOCOS&gt;2.0.CO;2; BRUNGS WA, 1969, T AM FISH SOC, V98, P272, DOI 10.1577/1548-8659(1969)98[272:CTOZTT]2.0.CO;2; Cairns Jr J, 1971, WATER POLLUT CONTROL, P1; Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471; Cunha SR, 2008, ECOTOXICOLOGY, V17, P558, DOI 10.1007/s10646-008-0216-y; DIAMOND JM, 1990, ENVIRON TOXICOL CHEM, V9, P3, DOI 10.1002/etc.5620090102; Diehl P, 2006, HANDB ENVIRON CHEM, V5, P99; Drummond RA, 1977, ECOLOGICAL RES SERIE, P1; Duarte RM, 2009, ECOTOX ENVIRON SAFE, V72, P693, DOI 10.1016/j.ecoenv.2008.10.003; EATON JG, 1974, T AM FISH SOC, V103, P729, DOI 10.1577/1548-8659(1974)103&lt;729:CCTTTB&gt;2.0.CO;2; Felten V, 2008, AQUAT TOXICOL, V86, P413, DOI 10.1016/j.aquatox.2007.12.002; FIRTH BK, 1990, TAPPI J, V73, P169; Gail M, 1999, ECOTOXICOLOGY ENV SA, V42, P253; GERHARDT A, 1999, BIOMONITORING POLLUT, P95; GRUBER D, 1981, HYDROBIOLOGIA, V83, P387, DOI 10.1007/BF02187035; Gruber D, 2007, P 15 INT C SOFTW TEL, P1; [江敏 Jiang Min], 2005, [环境科学学报, Acta Scientiae Circumstantiae], V25, P1253; Kramer K.J.M., 1991, P95; MCKIM JM, 1971, J FISH RES BOARD CAN, V28, P655, DOI 10.1139/f71-097; MORGAN WSG, 1979, J WATER POLLUT CON F, V51, P580; MORGAN WSG, 1982, WATER SCI TECHNOL, V14, P151, DOI 10.2166/wst.1982.0095; Orun I, 2008, FRESEN ENVIRON BULL, V17, P1242; PICKERING QH, 1972, J FISH RES BOARD CAN, V29, P1099, DOI 10.1139/f72-164; Shedd TR, 2001, B ENVIRON CONTAM TOX, V66, P392; SLOOFF W, 1979, B ENVIRON CONTAM TOX, V23, P517, DOI 10.1007/BF01769997; SNARSKI VM, 1982, AQUAT TOXICOL, V2, P143, DOI 10.1016/0166-445X(82)90012-1; SPEHAR RL, 1976, J FISH RES BOARD CAN, V33, P1939, DOI 10.1139/f76-247; States S, 2007, P WAT TECHN C AL VA, P16; Svecevicius G, 2009, B ENVIRON CONTAM TOX, V82, P564, DOI 10.1007/s00128-009-9657-0; *USEPA, 2002, SHORT TIM METH EST C; van der Schalie WH, 2001, BIOSENS BIOELECTRON, V16, P457, DOI 10.1016/S0956-5663(01)00160-9	32	32	34	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65282	10.1371/journal.pone.0065282	http://dx.doi.org/10.1371/journal.pone.0065282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755209	gold, Green Published			2022-12-25	WOS:000319872300068
J	Newsome, TM; Ballard, GA; Dickman, CR; Fleming, PJS; Howden, C				Newsome, Thomas M.; Ballard, Guy-Anthony; Dickman, Christopher R.; Fleming, Peter J. S.; Howden, Chris			Anthropogenic Resource Subsidies Determine Space Use by Australian Arid Zone Dingoes: An Improved Resource Selection Modelling Approach	PLOS ONE			English	Article							ESTIMATING EQUATIONS; TANAMI DESERT; WILD DOGS; ECOLOGY; FRAMEWORK; HABITAT	Dingoes (Canis lupus dingo) were introduced to Australia and became feral at least 4,000 years ago. We hypothesized that dingoes, being of domestic origin, would be adaptable to anthropogenic resource subsidies and that their space use would be affected by the dispersion of those resources. We tested this by analyzing Resource Selection Functions (RSFs) developed from GPS fixes (locations) of dingoes in arid central Australia. Using Generalized Linear Mixed-effect Models (GLMMs), we investigated resource relationships for dingoes that had access to abundant food near mine facilities, and for those that did not. From these models, we predicted the probability of dingo occurrence in relation to anthropogenic resource subsidies and other habitat characteristics over similar to 18,000 km(2). Very small standard errors and subsequent pervasively high P-values of results will become more important as the size of data sets, such as our GPS tracking logs, increases. Therefore, we also investigated methods to minimize the effects of serial and spatio-temporal correlation among samples and unbalanced study designs. Using GLMMs, we accounted for some of the correlation structure of GPS animal tracking data; however, parameter standard errors remained very small and all predictors were highly significant. Consequently, we developed an alternative approach that allowed us to review effect sizes at different spatial scales and determine which predictors were sufficiently ecologically meaningful to include in final RSF models. We determined that the most important predictor for dingo occurrence around mine sites was distance to the refuse facility. Away from mine sites, close proximity to human-provided watering points was predictive of dingo dispersion as were other landscape factors including palaeochannels, rocky rises and elevated drainage depressions. Our models demonstrate that anthropogenically supplemented food and water can alter dingo-resource relationships. The spatial distribution of such resources is therefore critical for the conservation and management of dingoes and other top predators.	[Newsome, Thomas M.; Dickman, Christopher R.] Univ Sydney, Sch Biol Sci, Inst Wildlife Res, Sydney, NSW 2006, Australia; [Newsome, Thomas M.] Univ Canberra, Invas Anim Cooperat Res Ctr, Canberra, ACT 2601, Australia; [Ballard, Guy-Anthony] Univ New England, Vertebrate Pest Res Unit, NSW Dept Primary Ind, Armidale, NSW, Australia; [Fleming, Peter J. S.] NSW Dept Primary Ind, Vertebrate Pest Res Unit, Orange, NSW, Australia; [Howden, Chris] Tricky Solut, Sydney, NSW, Australia	University of Sydney; University of Canberra; NSW Department of Primary Industries; University of New England; NSW Department of Primary Industries	Newsome, TM (corresponding author), Univ Sydney, Sch Biol Sci, Inst Wildlife Res, Heydon Laurence Bldg, Sydney, NSW 2006, Australia.	tnew5216@uni.sydney.edu.au	Newsome, Thomas M/AET-0276-2022; Dickman, Christopher/Q-4662-2019; Newsome, Thomas M/ABE-8451-2021	Newsome, Thomas M/0000-0003-3457-3256; Dickman, Christopher/0000-0002-1067-3730; Newsome, Thomas M/0000-0003-3457-3256; Fleming, Peter/0000-0002-3490-6148	University of Sydney, NSW; Invasive Animals CRC; Newmont Pty Ltd; NSW Department of Primary Industries; Central Land Council	University of Sydney, NSW; Invasive Animals CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Newmont Pty Ltd; NSW Department of Primary Industries; Central Land Council	The work presented was funded by The University of Sydney, NSW (http://sydney.edu.au/), the Invasive Animals CRC (http://www.invasiveanimals.com/), Newmont Pty Ltd (http://www.newmont.com/), the NSW Department of Primary Industries (http://www.dpi.nsw.gov.au/) and the Central Land Council (http://www.clc.org.au/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than in the form of the authors being employees or students within one or two of the organisations.	Allen BL, 2012, AUST MAMMAL, V34, P251, DOI 10.1071/AM12012; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Ardalan A, 2012, GENETICA, V140, P65, DOI 10.1007/s10709-012-9658-5; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bureau of Meteorology, 2010, RABB FLAT NO TERR SE; Calange C, 2009, STAT RULES THUMB; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; Claridge AW, 2009, FOREST ECOL MANAG, V258, P814, DOI 10.1016/j.foreco.2009.05.030; Corbett L. K., 1995, DINGO AUSTR ASIA; Dickman Chris R., 2009, P238, DOI 10.1002/9781444312034.ch11; Domahidy G, 1990, HYDROGEOLOGY GRANITE; Earth Observing System Data and Information System, 2008, EARTH OBS SYST CLEAR; Erickson Wallace P., 1998, Journal of Agricultural Biological and Environmental Statistics, V3, P296, DOI 10.2307/1400584; Faraday JJ, 2006, EXTENDING LINEAR MOD; Fieberg J, 2012, PHILOS T R SOC LON B, V365, P2233; Fieberg J, 2009, J APPL ECOL, V46, P1018, DOI 10.1111/j.1365-2664.2009.01692.x; Fleming P., 2001, MANAGING IMPACTS DIN; Geoscience Australia, 2006, GEODATA TOPO 250K 3, V3; Gibson LA, 2004, J APPL ECOL, V41, P213, DOI 10.1111/j.0021-8901.2004.00896.x; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Green R. H., 1979, Sampling design and statistical methods for environmental biologists.; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hurlbert SH, 2009, ANN ZOOL FENN, V46, P311, DOI 10.5735/086.046.0501; Jarvis A., 2008, HOLE FILLED SEAMLESS; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Kenward RE., 2000, MANUAL WILDLIFE RADI; Koper N, 2009, J APPL ECOL, V46, P590, DOI 10.1111/j.1365-2664.2009.01642.x; LUNDIEJENKINS G, 1993, WILDLIFE RES, V20, P495, DOI 10.1071/WR9930495; Manly B., 2007, RESOURCE SELECTION A; Manly B.F.J., 2002, RESOURCE SELECTION A; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Morton SR, 2011, J ARID ENVIRON, V75, P313, DOI 10.1016/j.jaridenv.2010.11.001; Navman Wireless OEM Solutions, 2006, JUP 31 GPS REC MOD D; NEWSOME AE, 1983, AUST J ECOL, V8, P345, DOI 10.1111/j.1442-9993.1983.tb01332.x; Newsome TM, 2013, ECOGRAPHY, V36, P914, DOI 10.1111/j.1600-0587.2013.00056.x; Newsome TM, 2011, THESIS U SYDNEY SYDN; Purcell B, 2010, DINGO; R Core Team, 2021, R LANG ENV STAT COMP; Robley Alan, 2010, Australian Mammalogy, V32, P23, DOI 10.1071/AM09030; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Southgate R, 2007, J ARID ENVIRON, V68, P438, DOI 10.1016/j.jaridenv.2006.06.006; STAFFORD SMITH DM, 1990, J ARID ENVIRON, V18, P255, DOI 10.1016/S0140-1963(18)30837-1; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; Van Belle G., 2008, STAT RULES THUMB; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J., 2002, R NEWS, V2, P12	50	31	33	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2013	8	5							e63931	10.1371/journal.pone.0063931	http://dx.doi.org/10.1371/journal.pone.0063931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177SC	23750191	Green Published, gold, Green Submitted			2022-12-25	WOS:000321394700021
J	Balasuriya, D; Goetze, TA; Barrera, NP; Stewart, AP; Suzuki, Y; Edwardson, JM				Balasuriya, Dilshan; Goetze, Tom A.; Barrera, Nelson P.; Stewart, Andrew P.; Suzuki, Yuki; Edwardson, J. Michael			alpha-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) and N-Methyl-D-aspartate (NMDA) Receptors Adopt Different Subunit Arrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy; Cell Surface Receptor; Glutamate Receptors; Ionotropic (AMPA; NMDA); Protein Complexes; Single-particle Analysis	ATOMIC-FORCE MICROSCOPY; CRYSTAL-STRUCTURE; STOICHIOMETRY; REVEALS	Ionotropic glutamate receptors are widely distributed in the central nervous system and play a major role in excitatory synaptic transmission. All three ionotropic glutamate subfamilies (i.e. AMPA-type, kainate-type, and NMDA-type) assemble as tetramers of four homologous subunits. There is good evidence that both heteromeric AMPA and kainate receptors have a 2:2 subunit stoichiometry and an alternating subunit arrangement. Recent studies based on presumed structural homology have indicated that NMDA receptors adopt the same arrangement. Here, we use atomic force microscopy imaging of receptor-antibody complexes to show that whereas the GluA1/GluA2 AMPA receptor assembles with an alternating (i.e. 1/2/1/2) subunit arrangement, the GluN1/GluN2A NMDA receptor adopts an adjacent (i.e. 1/1/2/2) arrangement. We conclude that the two types of ionotropic glutamate receptor are built in different ways from their constituent subunits. This surprising finding necessitates a reassessment of the assembly of these important receptors.	[Balasuriya, Dilshan; Goetze, Tom A.; Stewart, Andrew P.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Barrera, Nelson P.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago, Chile; [Suzuki, Yuki] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	University of Cambridge; Pontificia Universidad Catolica de Chile; Kyoto University	Edwardson, JM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	jme1000@cam.ac.uk	Suzuki, Yuki/H-9950-2015; Goetze, Tom/I-1891-2013	Suzuki, Yuki/0000-0003-1848-0105; Barrera, Nelson/0000-0001-7825-1406	Wellcome Trust; Millennium Science Initiative [P10-035F, Fondecyt 1120169]; Jean Shanks Foundation; James Baird Fund of the University of Cambridge	Wellcome Trust(Wellcome TrustEuropean Commission); Millennium Science Initiative; Jean Shanks Foundation; James Baird Fund of the University of Cambridge	This work was supported in part by the Wellcome Trust (to J. M. E.), the Millennium Science Initiative P10-035F and Fondecyt 1120169 (to N. P. B.), the Jean Shanks Foundation (to A. P. S.), and the James Baird Fund of the University of Cambridge (to A. P. S.).	Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Clayton A, 2009, J MOL BIOL, V392, P1125, DOI 10.1016/j.jmb.2009.07.082; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Lee CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017165; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P2053, DOI 10.1093/nar/gkp042; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; Riou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035134; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stroebel D, 2011, NEUROPHARMACOLOGY, V60, P151, DOI 10.1016/j.neuropharm.2010.07.003; Suzuki Y, 2013, J BIOL CHEM, V288, P778, DOI 10.1074/jbc.M112.422311; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510	27	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21987	10.1074/jbc.M113.469205	http://dx.doi.org/10.1074/jbc.M113.469205			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760273	hybrid, Green Published			2022-12-25	WOS:000328841900045
J	Ammar, ED; Alessandro, R; Shatters, RG; Hall, DG				Ammar, El-Desouky; Alessandro, Rocco; Shatters, Robert G., Jr.; Hall, David G.			Behavioral, Ultrastructural and Chemical Studies on the Honeydew and Waxy Secretions by Nymphs and Adults of the Asian Citrus Psyllid Diaphorina citri (Hemiptera: Psyllidae)	PLOS ONE			English	Article							GREENING DISEASE; FINE-STRUCTURE; SURFACE WAX; PHLOEM-SAP; CICADELLIDAE; HOMOPTERA; PLANT; STERNORRHYNCHA; HYMENOPTERA; FORMICIDAE	The Asian citrus psyllid (ACP), Diaphorina citri (Hemiptera: Psyllidae) is the primary vector of the bacterium causing citrus huanglongbing (citrus greening), the most serious disease of citrus worldwide. Psyllids and other hemipterans produce large amounts of honeydew, which has been used previously as an indicator of phloem sap composition and insect feeding or metabolism. Behavioral, ultrastructural and chemical studies on ACP, its honeydew and waxy secretions showed important differences between nymphs, males and females, and suggested some mechanisms by which the psyllids, especially nymphs and adult females, can minimize their contamination with honeydew excretions. The anal opening in ACP, near the posterior end of the abdomen, is on the ventral side in nymphs and on the dorsal side in adult males and females. Video recordings showed that adult males produce clear sticky droplets of honeydew gently deposited behind their body on the leaf surface, whereas adult females produce whitish honeydew pellets powerfully propelled away from the female body, probably to get their excretions away from eggs and newly hatched nymphs. ACP nymphs produce long ribbons or tubes of honeydew that frequently stay attached to the exuviae after molting, or drop when feeding on the lower side of citrus leaves. Furthermore, honeydew excretions of both nymphs and adult females are covered with a thin layer of whitish waxy material ultrastructurally composed of a convoluted network of long fine filaments or ribbons. This material is extruded from intricate arrays of wax pores in the circumanal ring (around the anus) that is found in nymphs and females but not in males of ACP or other psyllid species. Infrared microscopy and mass spectroscopy revealed that, in addition to various sugars, honeydew excretions of ACP nymphs and females are covered with a thin layer of wax similar in profile to ester waxes.	[Ammar, El-Desouky; Alessandro, Rocco; Shatters, Robert G., Jr.; Hall, David G.] ARS, USDA, Hort Res Lab, Ft Pierce, FL USA	United States Department of Agriculture (USDA)	Ammar, ED (corresponding author), ARS, USDA, Hort Res Lab, Ft Pierce, FL USA.	Eldesouky.ammar@ars.usda.gov		Alessandro, Rocco/0000-0001-7983-0557; Shatters, Robert/0000-0002-3903-772X	Florida Citrus Research Foundation	Florida Citrus Research Foundation	Funding was provided by the Florida Citrus Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar E, 2013, J ECON ENTOMOL, V106, P25, DOI 10.1603/EC12245; Ammar E, 2011, FLA ENTOMOL, V94, P340, DOI 10.1653/024.094.0229; Avery PB, 2011, BIOCONTROL SCI TECHN, V21, P1065, DOI 10.1080/09583157.2011.596927; Bove JM, 2006, J PLANT PATHOL, V88, P7; Brentassi ME, 2007, ANN SOC ENTOMOL FR, V43, P205, DOI 10.1080/00379271.2007.10697512; Brittain W. H., 1923, Proceedings Acadian Ent Soc Fredericton NB, V8, P23; Buckner JS, 1999, COMP BIOCHEM PHYS B, V124, P201, DOI 10.1016/S0305-0491(99)00117-0; CATLING HD, 1970, FAO PLANT PROTECT B, V18, P8; De Miranda MP, 2008, REV BRAS FRUTIC, V30, P913, DOI 10.1590/S0100-29452008000400013; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; FOLDI I, 1985, INT J INSECT MORPHOL, V14, P259, DOI 10.1016/0020-7322(85)90041-8; Gaigher R, 2011, BIOL INVASIONS, V13, P1717, DOI 10.1007/s10530-010-9934-1; Golan K, 2011, EUR J ENTOMOL, V108, P705, DOI 10.14411/eje.2011.090; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2010, ANN ENTOMOL SOC AM, V103, P611, DOI 10.1603/AN10004; Hirae M, 2008, JPN J APPL ENTOMOL Z, V52, P207, DOI 10.1303/jjaez.2008.207; Husain M. A., 1927, MEMOIRS DEP AGR INDI, V10, P1; Jones ME, 2012, ENTOMOL EXP APPL, V143, P280, DOI 10.1111/j.1570-7458.2012.01261.x; Killiny N, 2012, ANN M ENT SOC AM NOV; Kumar V, 1997, ITAL J ZOOL, V64, P307, DOI 10.1080/11250009709356218; Lucchi A, 2004, ANN ENTOMOL SOC AM, V97, P1294, DOI 10.1603/0013-8746(2004)097[1294:WPIAOP]2.0.CO;2; Mansour R, 2012, BIOCONTROL SCI TECHN, V22, P527, DOI 10.1080/09583157.2012.665832; MENSAH RK, 1992, ENTOMOL EXP APPL, V62, P261, DOI 10.1007/BF00353445; Merritt SZ, 1996, J CHEM ECOL, V22, P1133, DOI 10.1007/BF02027950; MESFIN T, 1995, B ENTOMOL RES, V85, P387, DOI 10.1017/S0007485300036129; Milanez JM, 2003, FLA ENTOMOL, V86, P154, DOI 10.1653/0015-4040(2003)086[0154:FASOCS]2.0.CO;2; Moog J, 2005, INSECT SOC, V52, P169, DOI 10.1007/s00040-005-0791-3; Nelson DR, 2000, COMP BIOCHEM PHYS B, V125, P265, DOI 10.1016/S0305-0491(99)00177-7; Nelson DR, 1997, COMP BIOCHEM PHYS B, V117, P241, DOI 10.1016/S0305-0491(97)00047-3; Nelson DR, 1998, COMP BIOCHEM PHYS B, V119, P655, DOI 10.1016/S0305-0491(98)00041-8; Pyati P, 2011, J INSECT PHYSIOL, V57, P881, DOI 10.1016/j.jinsphys.2011.03.024; Rogers ME, 2006, ENY739 EDIS; Salvucci ME, 1998, ARCH INSECT BIOCHEM, V39, P155, DOI 10.1002/(SICI)1520-6327(1998)39:4&lt;155::AID-ARCH3&gt;3.0.CO;2-#; Smith RG, 1999, J NAT HIST, V33, P513, DOI 10.1080/002229399300227; Steiner FM, 2004, EUR J ENTOMOL, V101, P689, DOI 10.14411/eje.2004.090; Taylor SH, 2012, ENTOMOL EXP APPL, V142, P121, DOI 10.1111/j.1570-7458.2011.01206.x; Tsai JH, 2000, J ECON ENTOMOL, V93, P1721, DOI 10.1603/0022-0493-93.6.1721; WAKU Y, 1978, J MORPHOL, V158, P243, DOI 10.1002/jmor.1051580302; Wang J, 2012, ENTOMOL EXP APPL, V144, P191, DOI 10.1111/j.1570-7458.2012.01278.x	42	24	28	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64938	10.1371/journal.pone.0064938	http://dx.doi.org/10.1371/journal.pone.0064938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762268	gold, Green Published, Green Submitted			2022-12-25	WOS:000320440500011
J	Yebyo, HG; Kendall, C; Nigusse, D; Lemma, W				Yebyo, Henock Gebremedhin; Kendall, Carl; Nigusse, Daniel; Lemma, Wuleta			Outpatient Therapeutic Feeding Program Outcomes and Determinants in Treatment of Severe Acute Malnutrition in Tigray, Northern Ethiopia: A Retrospective Cohort Study	PLOS ONE			English	Article							CHILDREN; NUTRITION	Background: Outpatient Therapeutic feeding Program (OTP) brings the services for management of Severe Acute Malnutrition (SAM) closer to the community by making services available at decentralized treatment points within the primary health care settings, through the use of ready-to-use therapeutic foods, community outreach and mobilization. Little is known about the program outcomes. This study revealed the levels of program outcome indictors and determinant factors to recovery rate. Methods: A retrospective cohort study was conducted on 628 children who had been managed for SAM under OTP from April/2008 to January/2012. The children were selected using systematic random sampling from 12 health posts and 4 health centers. The study relied on information of demographic characteristics, anthropometries, Plumpy'Nut, medical problems and routine medications intakes. The results were estimated using Kaplan-Meier survival curves, log-rank test and Cox-regression. Results: The recovery, defaulter, mortality and weight gain rates were 61.78%, 13.85%, 3.02% and 5.23 gm/kg/day, respectively. Routine medications were administered partially and children with medical problems were managed inappropriately under the program. As a child consumed one more sachet of Plumpy'Nut, the recovery rate from SAM increased by 4% (HR = 1.04, 95%-CI = 1.03, 1.05, P < 0.001). The adjusted hazard ratios to recovery of children with diarrhea, appetite loss with Plumpy'Nut and failure to gain weight were 2.20 (HR = 2.20, 95%-CI = 1.31, 3.41, P = 0.001), 4.49 (HR = 1.74, 95%-CI = 1.07, 2.83, P = 0.046) and 3.88 (HR = 1.95, 95%-CI = 1.17, 3.23, P < 0.001), respectively. Children who took amoxicillin and de-worming had 95% (HR = 1.95, 95%-CI = 1.17, 3.23) and 74% (HR = 1.74, 95%-CI = 1.07, 2.83) more probability to recover from SAM as compared to those who didn't take them. Conclusions: The OTP was partially successful. Management of children with comorbidities under the program and partial administration of routine drugs were major threats for the program effectiveness. The stakeholders should focus on creating the capacity of the OTP providers on proper management of SAM to achieve fully effective program.	[Yebyo, Henock Gebremedhin; Nigusse, Daniel] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia; [Kendall, Carl; Lemma, Wuleta] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA	Mekelle University; Tulane University	Yebyo, HG (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia.	henokyebyo@yahoo.com	Kendall, Carl/F-9002-2012	Kendall, Carl/0000-0002-0794-4333; Yebyo, Henock/0000-0001-5400-2448				Anna T, 2002, FIELD ARTICL, V16, P26; [Anonymous], TITLE ERROR; Briend A, 2010, INDIAN PEDIATR, V47, P655, DOI 10.1007/s13312-010-0094-2; [Central Statistical Agency [Ethiopia] ICF International], 2012, ETHIOPIA DEMOGRAPHIC; Central Statistical Authority, 2008, THE 2007 POPULATION; Chaiken MS, 2006, FOOD NUTR BULL, V27, P95, DOI 10.1177/156482650602700201; Chamois S, 2011, FILED ARTICLE, V2011, P39; Collins S, 2002, LANCET, V360, P1824, DOI 10.1016/S0140-6736(02)11770-3; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Defourny I, 2006, FIELD EXCHANGE, V28, P2; Del R, 2008, MADAGASCARS PILOT PR; Econinck H, 2008, REVIEW OF COMMUNITY; Eklund M, 2008, FIELD EXCHANGE; Esubalew D, 2009, COMMUNITY BASED EMER; Federal Ministry of Health, 2008, TRAINING GUIDE LINE; Federal Ministry of Health, 2010, HEALTH SECTOR DEVELO; Federal Ministry of Health, 2007, PROTOCOL FOR THE MAN; Gera T, 2010, INDIAN PEDIATR, V47, P709, DOI 10.1007/s13312-010-0095-1; Hamois S, 2009, FIELD ARTICLE, V36, P12; Lapidus N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000039; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; Shils ME, 2006, MODERN NUTR HLTH DIS, V10th; Taylor A, 2002, FIELD EXCHANGE; UNICEF, 2007, TRAIN GUID COMM BAS; [WHO UNICEF SCN], 2005, INFORMAL CONSULTATIO; World Health Organization World Food Programme United Nations System Standing Committee on Nutrition The United Nations Children's Fund, 2007, COMMUNITY BASED MANA	26	51	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65840	10.1371/journal.pone.0065840	http://dx.doi.org/10.1371/journal.pone.0065840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755286	gold, Green Submitted, Green Published			2022-12-25	WOS:000321099000111
J	Chen, X; Wen, ZK; Xu, W; Xiong, SD				Chen, Xi; Wen, Zhenke; Xu, Wei; Xiong, Sidong			Granulin Exacerbates Lupus Nephritis via Enhancing Macrophage M2b Polarization	PLOS ONE			English	Article							EPITHELIN PRECURSOR; GROWTH-FACTOR; HOST-DEFENSE; MURINE LUPUS; PROGRANULIN; ACTIVATION; INFLAMMATION; DISEASE; DNA; ERYTHEMATOSUS	Background and Aims: Lupus nephritis (LN), with considerable morbidity and mortality, is one of the most severe manifestations of systemic lupus erythematosus (SLE). Yet, the pathogenic mechanisms of LN have not been clearly elucidated, and efficient therapies are still in great need. Granulin (GRN), a multifunctional protein linked to inflammatory diseases, has recently been reported to correlate with the disease activity of autoimmune diseases. However, the role of GRN in the pathogenic process of LN still remains obscure. In this study, we explored its potential role and underlying mechanism in the pathogenesis of LN. Methodology/Principal Findings: We found that serum GRN levels were significantly up-regulated and were positively correlated with the severity of LN. Overexpression of GRN in vivo by transgenic injection remarkably exacerbated LN, whereas down-regulation of GRN with shRNA ameliorated LN, firmly demonstrating the critical role of GRN in the pathogenesis of LN. Notably, macrophage phenotype analysis revealed that overexpression of GRN could enhance macrophage polarization to M2b, a key mediator of the initiation and progression of LN. On the contrary, down-regulation of GRN resulted in impaired M2b differentiation, thus ameliorating LN. Moreover, we found that MAPK signals were necessary for the effect of GRN on macrophage M2b polarization. Conclusion/Significance: We first demonstrated that GRN could aggravate lupus nephritis (LN) via promoting macrophage M2b polarization, which might provide insights into the pathogenesis of LN as well as potential therapeutic strategies against LN.	[Chen, Xi; Wen, Zhenke; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Inst Immunobiol, Shanghai 200433, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Biol & Med Sci, Suzhou, Peoples R China	Fudan University; Soochow University - China	Xiong, SD (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Immunobiol, Shanghai 200433, Peoples R China.	sdxiongfd@126.com			National Natural Science Foundation of China [30890141, 81273300]; Major State Basic Research Development Program of China [2013CB530501]; Jiangsu Provincial Innovative Research Team; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT-IRT1075]; Jiangsu "333" project of cultivation of high-level talents; Qing Lan Project of the Jiangsu higher education institutions; Jiangsu "Pan-Deng" Project [BK2010004]; Shanghai STC grant [10JC1401400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Jiangsu Provincial Innovative Research Team; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Jiangsu "333" project of cultivation of high-level talents; Qing Lan Project of the Jiangsu higher education institutions; Jiangsu "Pan-Deng" Project; Shanghai STC grant	This work was supported by grants from the National Natural Science Foundation of China (30890141, 81273300), Major State Basic Research Development Program of China (2013CB530501), Jiangsu Provincial Innovative Research Team, Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT-IRT1075), Jiangsu "333" project of cultivation of high-level talents, Qing Lan Project of the Jiangsu higher education institutions, Jiangsu "Pan-Deng" Project (BK2010004), Shanghai STC grant (10JC1401400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Chen M, 2011, MOL IMMUNOL, V48, P1532, DOI 10.1016/j.molimm.2011.04.016; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gui J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046515; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; Jian J, 2012, J LEUKOC BIOL; Justen H P, 2000, Mol Cell Biol Res Commun, V3, P165, DOI 10.1006/mcbr.2000.0211; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Lewis E, 2005, LUPUS, V14, P31, DOI 10.1191/0961203305lu2056oa; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Mok CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/638413; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; NEWCOMB JR, 1993, J IMMUNOL, V150, P499; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Paulson JC, 2007, CELL, V130, P589, DOI 10.1016/j.cell.2007.08.009; PERRONE RD, 1992, CLIN CHEM, V38, P1933; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Qiao B, 2005, RHEUMATOLOGY, V44, P1108, DOI 10.1093/rheumatology/keh656; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Tanaka A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4087; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Vercellino M, 2011, MULT SCLER J, V17, P1194, DOI 10.1177/1352458511406164; Wen Z, 2012, LUPUS, V21, P508, DOI 10.1177/0961203311434940; Wen ZK, 2007, RHEUMATOLOGY, V46, P1796, DOI 10.1093/rheumatology/kem275; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022659; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	52	17	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65542	10.1371/journal.pone.0065542	http://dx.doi.org/10.1371/journal.pone.0065542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755248	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400064
J	Nieuwenhuis, ILC; Folia, V; Forkstam, C; Jensen, O; Petersson, KM				Nieuwenhuis, Ingrid L. C.; Folia, Vasiliki; Forkstam, Christian; Jensen, Ole; Petersson, Karl Magnus			Sleep Promotes the Extraction of Grammatical Rules	PLOS ONE			English	Article							SLOW-WAVE SLEEP; MEMORY CONSOLIDATION; ARTIFICIAL GRAMMARS; CHUNK STRENGTH; KNOWLEDGE; SYNTAX; CLASSIFICATION; NEUROBIOLOGY; ABSTRACTION; ACQUISITION	Grammar acquisition is a high level cognitive function that requires the extraction of complex rules. While it has been proposed that offline time might benefit this type of rule extraction, this remains to be tested. Here, we addressed this question using an artificial grammar learning paradigm. During a short-term memory cover task, eighty-one human participants were exposed to letter sequences generated according to an unknown artificial grammar. Following a time delay of 15 min, 12 h (wake or sleep) or 24 h, participants classified novel test sequences as Grammatical or Non-Grammatical. Previous behavioral and functional neuroimaging work has shown that classification can be guided by two distinct underlying processes: (1) the holistic abstraction of the underlying grammar rules and (2) the detection of sequence chunks that appear at varying frequencies during exposure. Here, we show that classification performance improved after sleep. Moreover, this improvement was due to an enhancement of rule abstraction, while the effect of chunk frequency was unaltered by sleep. These findings suggest that sleep plays a critical role in extracting complex structure from separate but related items during integrative memory processing. Our findings stress the importance of alternating periods of learning with sleep in settings in which complex information must be acquired.	[Nieuwenhuis, Ingrid L. C.; Folia, Vasiliki; Forkstam, Christian; Jensen, Ole; Petersson, Karl Magnus] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Nieuwenhuis, Ingrid L. C.] Univ Calif Berkeley, Dept Psychol, Sleep & Neuroimaging Lab, Berkeley, CA 94720 USA; [Folia, Vasiliki; Forkstam, Christian; Petersson, Karl Magnus] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Folia, Vasiliki] Dept Clin Neurosci, Karolinska Inst, Stockholm Brain Inst, Cognit Neurophysiol Res Grp, Stockholm, Sweden; [Forkstam, Christian; Petersson, Karl Magnus] Univ Algarve, Cognit Neurosci Res Grp, Inst Biotechnol & Bioengn, Ctr Mol & Struct Biomed, Faro, Portugal	Radboud University Nijmegen; University of California System; University of California Berkeley; Max Planck Society; Karolinska Institutet; Universidade do Algarve	Nieuwenhuis, ILC (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	inieuwenhuis@berkeley.edu	GNC, GNC/B-5716-2013; Jensenq, Ole/D-2120-2010; Petersson, Karl Magnus/E-8188-2012; Petersson, Karl Magnus/HDO-0143-2022	Jensenq, Ole/0000-0001-8193-8348; Petersson, Karl Magnus/0000-0002-8245-0392; Petersson, Karl Magnus/0000-0002-8245-0392; Folia, Vasiliki/0000-0002-2159-7032	Dutch National Science Foundation [NWO 051-04-100]; Fundacao para a Ciencia e Tecnologia [PTDC/PSI-PCO/110734/2009]; Max Planck Institute for Psycholinguistics; Donders Institute for Brain; Cognition and Behaviour; Vetenskapsradet; Fundação para a Ciência e a Tecnologia [PTDC/PSI-PCO/110734/2009] Funding Source: FCT	Dutch National Science Foundation(Netherlands Organization for Scientific Research (NWO)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Max Planck Institute for Psycholinguistics(Max Planck Society); Donders Institute for Brain; Cognition and Behaviour; Vetenskapsradet(Swedish Research Council); Fundação para a Ciência e a Tecnologia	This work was supported by grants from the Dutch National Science Foundation (grant numbers NWO 051-04-100), Fundacao para a Ciencia e Tecnologia (PTDC/PSI-PCO/110734/2009; IBB/CBME, LA, FEDER/POCI 2010), Max Planck Institute for Psycholinguistics, Donders Institute for Brain, Cognition and Behaviour, and Vetenskapsradet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai DJ, 2009, P NATL ACAD SCI USA, V106, P10130, DOI 10.1073/pnas.0900271106; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Dienes Z, 2005, PSYCHOL RES-PSYCH FO, V69, P338, DOI 10.1007/s00426-004-0208-3; Dienes Z, 2010, CONSCIOUS COGN, V19, P674, DOI 10.1016/j.concog.2009.09.009; Durrant SJ, 2011, NEUROPSYCHOLOGIA, V49, P1322, DOI 10.1016/j.neuropsychologia.2011.02.015; Ellenbogen JM, 2007, P NATL ACAD SCI USA, V104, P7723, DOI 10.1073/pnas.0700094104; Folia V, 2011, BIOLINGUISTICS, V5, P105; Folia V, 2008, ANN NY ACAD SCI, V1145, P132, DOI 10.1196/annals.1416.012; Forkstam C, 2005, CURR OPIN NEUROL, V18, P435, DOI 10.1097/01.wco.0000171951.82995.c4; Forkstam C, 2008, BRAIN RES, V1221, P80, DOI 10.1016/j.brainres.2008.05.005; Forkstam C, 2006, NEUROIMAGE, V32, P956, DOI 10.1016/j.neuroimage.2006.03.057; Frankland PW, 2006, P NATL ACAD SCI USA, V103, P509, DOI 10.1073/pnas.0510133103; Gomez RL, 2006, PSYCHOL SCI, V17, P670, DOI 10.1111/j.1467-9280.2006.01764.x; Keppel G., 2004, DESIGN ANAL RES HDB; Knowlton BJ, 1996, J EXP PSYCHOL LEARN, V22, P169, DOI 10.1037/0278-7393.22.1.169; Kouider S, 2010, TRENDS COGN SCI, V14, P301, DOI 10.1016/j.tics.2010.04.006; Lau H, 2010, NEUROBIOL LEARN MEM, V93, P554, DOI 10.1016/j.nlm.2010.02.003; Lieberman MD, 2004, J COGNITIVE NEUROSCI, V16, P427, DOI 10.1162/089892904322926764; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; MCANDREWS MP, 1985, MEM COGNITION, V13, P469, DOI 10.3758/BF03198460; Meulemans T, 1997, J EXP PSYCHOL LEARN, V23, P1007; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; PERRUCHET P, 1990, J EXP PSYCHOL GEN, V119, P264, DOI 10.1037/0096-3445.119.3.264; Petersson KM, 2012, PHILOS T R SOC B, V367, P1971, DOI 10.1098/rstb.2012.0101; Petersson KM, 2012, BRAIN LANG, V120, P83, DOI 10.1016/j.bandl.2010.08.003; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; Rudoy JD, 2009, SCIENCE, V326, P1079, DOI 10.1126/science.1179013; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; SERVANSCHREIBER E, 1990, J EXP PSYCHOL LEARN, V16, P592, DOI 10.1037/0278-7393.16.4.592; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Stadler M.A., 1998, HDB IMPLICIT LEARNIN; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Udden J, 2008, BRAIN RES, V1224, P69, DOI 10.1016/j.brainres.2008.05.070; Udden J, 2012, COGNITIVE SCI, V36, P1078, DOI 10.1111/j.1551-6709.2012.01235.x; Walker MP, 2010, NAT REV NEUROSCI, V11, DOI 10.1038/nrn2762-c1; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8	40	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65046	10.1371/journal.pone.0065046	http://dx.doi.org/10.1371/journal.pone.0065046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755173	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400037
J	Raitsos, DE; Pradhan, Y; Brewin, RJW; Stenchikov, G; Hoteit, I				Raitsos, Dionysios E.; Pradhan, Yaswant; Brewin, Robert J. W.; Stenchikov, Georgiy; Hoteit, Ibrahim			Remote Sensing the Phytoplankton Seasonal Succession of the Red Sea	PLOS ONE			English	Article							GENERAL-CIRCULATION; CLIMATE-CHANGE; OCEAN; MODEL	The Red Sea holds one of the most diverse marine ecosystems, primarily due to coral reefs. However, knowledge on large-scale phytoplankton dynamics is limited. Analysis of a 10-year high resolution Chlorophyll-a (Chl-a) dataset, along with remotely-sensed sea surface temperature and wind, provided a detailed description of the spatiotemporal seasonal succession of phytoplankton biomass in the Red Sea. Based on MODIS (Moderate-resolution Imaging Spectroradiometer) data, four distinct Red Sea provinces and seasons are suggested, covering the major patterns of surface phytoplankton production. The Red Sea Chl-a depicts a distinct seasonality with maximum concentrations seen during the winter time (attributed to vertical mixing in the north and wind-induced horizontal intrusion of nutrient-rich water in the south), and minimum concentrations during the summer (associated with strong seasonal stratification). The initiation of the seasonal succession occurs in autumn and lasts until early spring. However, weekly Chl-a seasonal succession data revealed that during the month of June, consistent anti-cyclonic eddies transfer nutrients and/or Chl-a to the open waters of the central Red Sea. This phenomenon occurs during the stratified nutrient depleted season, and thus could provide an important source of nutrients to the open waters. Remotely-sensed synoptic observations highlight that Chl-a does not increase regularly from north to south as previously thought. The Northern part of the Central Red Sea province appears to be the most oligotrophic area (opposed to southern and northern domains). This is likely due to the absence of strong mixing, which is apparent at the northern end of the Red Sea, and low nutrient intrusion in comparison with the southern end. Although the Red Sea is considered an oligotrophic sea, sporadic blooms occur that reach mesotrophic levels. The water temperature and the prevailing winds control the nutrient concentrations within the euphotic zone and enable the horizontal transportation of nutrients.	[Raitsos, Dionysios E.; Stenchikov, Georgiy; Hoteit, Ibrahim] King Abdullah Univ Sci & Technol, Earth Sci & Engn ErSE, Thuwal, Saudi Arabia; [Raitsos, Dionysios E.; Brewin, Robert J. W.] Plymouth Marine Lab, Remote Sensing Grp, Plymouth, Devon, England; [Pradhan, Yaswant] Met Off, Exeter, Devon, England	King Abdullah University of Science & Technology; Plymouth Marine Laboratory; Met Office - UK	Raitsos, DE (corresponding author), King Abdullah Univ Sci & Technol, Earth Sci & Engn ErSE, Thuwal, Saudi Arabia.	dra@pml.ac.uk	Raitsos, Dionysios/AAA-3031-2021; Pradhan, Yaswant/G-2040-2010; Stenchikov, Georgiy/AAA-4371-2022; Georgiy, Stenchikov/J-8569-2013	Raitsos, Dionysios/0000-0002-6714-2180; Pradhan, Yaswant/0000-0002-3680-4751; Hoteit, Ibrahim/0000-0002-3751-4393; Stenchikov, Georgiy Lvovich/0000-0001-9033-4925; Brewin, Robert/0000-0001-5134-8291	King Abdullah University for Science and Technology (KAUST), Kingdom of Saudi Arabia; NERC [earth010003, pml010009, pml010008] Funding Source: UKRI; Natural Environment Research Council [pml010008, pml010009, earth010003] Funding Source: researchfish	King Abdullah University for Science and Technology (KAUST), Kingdom of Saudi Arabia(King Abdullah University of Science & Technology); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the King Abdullah University for Science and Technology (KAUST), Kingdom of Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acker J, 2008, J MARINE SYST, V69, P191, DOI 10.1016/j.jmarsys.2005.12.006; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Baars Martien A., 1998, P143; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Brown O.B., 1999, U MIAMI, V31, P098; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Edwards F.J., 1987, KEY ENV RED SEA, P45, DOI [10.1016/B978-0-08-028873-4.50008-6, DOI 10.1016/B978-0-08-028873-4.50008-6]; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Eshel G, 1997, J PHYS OCEANOGR, V27, P1233, DOI 10.1175/1520-0485(1997)027<1233:CCJCIW>2.0.CO;2; Feldman G. C., 2012, OCEAN COLOR WEB MODI; Irigoien X, 2002, NATURE, V419, P387, DOI 10.1038/nature01055; Johns WE, 1999, 20000160 RSMAS U MIA; Koblentz-Mishke OJ, 1970, SCI EXPLORATION S PA, P183; Lo-Yat A, 2011, GLOBAL CHANGE BIOL, V17, P1695, DOI 10.1111/j.1365-2486.2010.02355.x; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Maritorena S, 2002, APPL OPTICS, V41, P2705, DOI 10.1364/AO.41.002705; McClain CR, 2009, ANNU REV MAR SCI, V1, P19, DOI 10.1146/annurev.marine.010908.163650; Meissner T, 2009, IEEE T GEOSCI REMOTE, V47, P3065, DOI 10.1109/TGRS.2009.2027012; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Monterey G., 1997, NOAA ATLAS NESDIS; Morel A, 2007, REMOTE SENS ENVIRON, V111, P69, DOI 10.1016/j.rse.2007.03.012; Munday PL, 2008, FISH FISH, V9, P261, DOI 10.1111/j.1467-2979.2008.00281.x; Nybakken J. W., 1997, MARINE BIOL ECOLOGIC; OReilly J.E., 2000, SEAWIFS POSTLAUNCH C, P9; Paerl HW, 2003, BIOSCIENCE, V53, P953, DOI 10.1641/0006-3568(2003)053[0953:PPAIOE]2.0.CO;2; Papadopoulos VP, 2013, J CLIMATE, V26, P1685, DOI 10.1175/JCLI-D-12-00267.1; Raitsos DE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047984; Sathyendranath S., 2000, REM SENS OC COL COAS, V3; Sofianos SS, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001185; Sofianos SS, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001184; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Weikert H., 1987, P90; Wilson C, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017770; Wilson C, 2008, PROG OCEANOGR, V78, P107, DOI 10.1016/j.pocean.2008.05.002	34	191	193	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64909	10.1371/journal.pone.0064909	http://dx.doi.org/10.1371/journal.pone.0064909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755161	Green Published, Green Submitted, gold			2022-12-25	WOS:000320579400031
J	Zhang, RW; Liu, ZJ; Qu, YX; Xu, Y; Yang, Q				Zhang, Renwen; Liu, Zhijie; Qu, Youxing; Xu, Ying; Yang, Qing			Two Distinct Calmodulin Binding Sites in the Third Intracellular Loop and Carboxyl Tail of Angiotensin II (AT(1A)) Receptor	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-KINASE-C; INTERACTING PROTEINS; SIGNAL-TRANSDUCTION; PARATHYROID-HORMONE; COUPLED RECEPTORS; G-BETA; PHOSPHORYLATION; TERMINUS; COMPLEX	In this study, we present data that support the presence of two distinct calmodulin binding sites within the angiotensin II receptor (AT(1A)), at juxtamembrane regions of the N-terminus of the third intracellular loop (i3, amino acids 214-231) and carboxyl tail of the receptor (ct, 302-317). We used bioluminescence resonance energy transfer assays to document interactions of calmodulin with the AT(1A) holo-receptor and GST-fusion protein pull-downs to demonstrate that i3 and ct interact with calmodulin in a Ca2+-dependent fashion. The former is a 1-12 motif and the latter belongs to 1-5-10 calmodulin binding motif. The apparent Kd of calmodulin for i3 is 177.0 +/- 9.1 nM, and for ct is 79.4 +/- 7.9 nM as assessed by dansyl-calmodulin fluorescence. Replacement of the tryptophan (W219) for alanine in i3, and phenylalanine (F309 or F313) for alanine in ct reduced their binding affinities for calmodulin, as predicted by computer docking simulations. Exogenously applied calmodulin attenuated interactions between G protein beta gamma-subunits and i3 and ct, somewhat more so for ct than i3. Mutations W219A, F309A, and F313A did not alter G beta gamma binding, but reduced the ability of calmodulin to compete with G beta gamma, suggesting that calmodulin and G beta gamma have overlapping, but not identical, binding requirements for i3 and ct. Calmodulin interference with the G beta gamma binding to i3 and ct regions of the AT(1A) receptor strongly suggests that calmodulin plays critical roles in regulating G beta gamma-dependent signaling of the receptor.	[Zhang, Renwen; Yang, Qing] Jilin Univ, Bethune Coll Med, Dept Pathogenobiol, Changchun 130023, Jilin, Peoples R China; [Liu, Zhijie; Qu, Youxing; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Jilin University; University System of Georgia; University of Georgia	Yang, Q (corresponding author), Jilin Univ, Bethune Coll Med, Dept Pathogenobiol, Changchun 130023, Jilin, Peoples R China.	yangq@jlu.edu.cn	Yang, Qing/H-5342-2012	Yang, Qing/0000-0002-5068-6085	National Institutes of Health [DK63252]; Jilin University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK063252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jilin University(Jilin University); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by the National Institutes of Health (DK63252 to Qing Yang, www2.niddk.nih.gov) and the Tang Aoqing professor award of Jilin University to Qing Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airas JM, 2001, FEBS LETT, V494, P60, DOI 10.1016/S0014-5793(01)02311-0; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Boute N, 2002, TRENDS PHARMACOL SCI, V23, P351, DOI 10.1016/S0165-6147(02)02062-X; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Buck F, 2000, ENDOCRINOLOGY, V141, P3717, DOI 10.1210/en.141.10.3717; Choi KY, 2011, J NEUROSCI, V31, P5921, DOI 10.1523/JNEUROSCI.6253-10.2011; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; Dev KK, 2001, TRENDS PHARMACOL SCI, V22, P355, DOI 10.1016/S0165-6147(00)01684-9; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Foord SM, 1999, TRENDS PHARMACOL SCI, V20, P184, DOI 10.1016/S0165-6147(99)01347-4; Guhan N, 2004, TRENDS NEUROSCI, V27, P645, DOI 10.1016/j.tins.2004.08.011; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; Hultschig C, 2004, J MOL BIOL, V343, P559, DOI 10.1016/j.jmb.2004.08.012; Ishikawa K, 1999, GENES CELLS, V4, P381, DOI 10.1046/j.1365-2443.1999.00269.x; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kim KM, 2005, J BIOL CHEM, V280, P12774, DOI 10.1074/jbc.M408901200; KINCAID RL, 1988, METHOD ENZYMOL, V159, P605; Kurokawa H, 2001, J MOL BIOL, V312, P59, DOI 10.1006/jmbi.2001.4822; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; Liu ZJ, 2004, J AM CHEM SOC, V126, P8515, DOI 10.1021/ja032018q; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Marrero MB, 1998, AM J PHYSIOL-CELL PH, V275, pC1216, DOI 10.1152/ajpcell.1998.275.5.C1216; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Minakami R, 1997, J BIOL CHEM, V272, P20291, DOI 10.1074/jbc.272.32.20291; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Mukhopadhyay S, 2002, CHEM PHYS LIPIDS, V121, P91, DOI 10.1016/S0009-3084(02)00153-6; Nakajima Y, 1999, J BIOL CHEM, V274, P27573, DOI 10.1074/jbc.274.39.27573; Nanoff C, 1997, PHYSIOL RES, V46, P79; Nickols HH, 2004, J BIOL CHEM, V279, P46969, DOI 10.1074/jbc.M407351200; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Taylor JM, 1996, J BIOL CHEM, V271, P3336; Thomas WG, 1999, FEBS LETT, V455, P367, DOI 10.1016/S0014-5793(99)00904-7; Turner JH, 2005, J BIOL CHEM, V280, P30741, DOI 10.1074/jbc.M501696200; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Venema RC, 1998, J BIOL CHEM, V273, P7703, DOI 10.1074/jbc.273.13.7703; VORHERR T, 1990, BIOCHEMISTRY-US, V29, P355, DOI 10.1021/bi00454a008; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang DX, 1999, J BIOL CHEM, V274, P22081, DOI 10.1074/jbc.274.31.22081	59	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65266	10.1371/journal.pone.0065266	http://dx.doi.org/10.1371/journal.pone.0065266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755207	Green Published, Green Submitted, gold			2022-12-25	WOS:000320579400049
J	Lin, YH; Ho, YC; Lin, SH; Yeh, YH; Liu, CY; Kuo, TBJ; Yang, CCH; Yang, AC				Lin, Yu-Hsuan; Ho, Yen-Cheng; Lin, Sheng-Hsuan; Yeh, Yao-Hsien; Liu, Chia-Yih; Kuo, Terry B. J.; Yang, Cheryl C. H.; Yang, Albert C.			On-Call Duty Effects on Sleep-State Physiological Stability in Male Medical Interns	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; CIRCADIAN-RHYTHMS; DEPRIVATION; DURATION; HUMANS; ACTIGRAPHY; PHYSICIANS; WORK	Background: On-call duty among medical interns is characterized by sleep deprivation and stressful working conditions, both of which alter cardiac autonomic modulation. We hypothesized that sleep stability decreased in medical interns during on-call duty. We used cardiopulmonary-coupling (CPC) analysis to test our hypothesis. Methods: We used electrocardiogram (ECG)-based CPC analysis to quantify physiological parameters of sleep stability in 13 medical interns during on-call and on-call duty-free periods. There were ten 33.5-h on-call duty shifts per month for interns, each followed by 2 on-call duty-free days, over 3 months. Measurements during sleep were collected before, during, and after an on-call shift. Measurements were repeated 3 months later during an on-call duty-free period. Results: The medical interns had significantly reduced stable sleep, and displayed increased latency to the first epoch of stable sleep during the on-call night shift, compared to the pre-call and on-call duty-free nights. Interns also had significantly increased rapid-eye-movement (REM) sleep during the on-call night shift, compared to the pre-call and on-call duty-free nights. Conclusion: Medical interns suffer disrupted sleep stability and continuity during on-call night shifts. The ECG-based CPC analysis provides a straightforward means to quantify sleep quality and stability in medical staff performing shift work under stressful conditions.	[Lin, Yu-Hsuan] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Ho, Yen-Cheng; Liu, Chia-Yih] Chang Gung Univ, Sch Med, Taoyuan Cty, Taiwan; [Ho, Yen-Cheng; Liu, Chia-Yih] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan Cty, Taiwan; [Lin, Sheng-Hsuan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Yeh, Yao-Hsien] Taipei City Hosp, Ren Ai Branch, Dept Internal Med, Taipei, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Sleep Res Ctr, Taipei 112, Taiwan; [Yang, Albert C.] Natl Yang Ming Univ, Div Psychiat, Sch Med, Taipei 112, Taiwan; [Yang, Albert C.] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Chang Gung University; Chang Gung Memorial Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Yang, AC (corresponding author), Natl Yang Ming Univ, Div Psychiat, Sch Med, Taipei 112, Taiwan.	accyang@gmail.com		Lin, Sheng-Hsuan/0000-0003-0714-2354; Lin, Yu-Hsuan/0000-0001-9393-3886; Yang, Albert Chih-Chieh/0000-0003-2794-9649	NSC [NSC 100-2911-I-008-001, NSC101-2314-B-075-041-MY3]	NSC(Ministry of Science and Technology, Taiwan)	Funding was provided by NSC101-2314-B-075-041-MY3 (http://web1.nsc.gov.tw/), and NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 100-2911-I-008-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Arora VM, 2008, JAMA-J AM MED ASSOC, V300, P1146, DOI 10.1001/jama.300.10.1146; Baldwin DC, 2004, SLEEP, V27, P217, DOI 10.1093/sleep/27.2.217; Carter JR, 2012, J APPL PHYSL; Dumont M, 2004, CLIN NEUROPHYSIOL, V115, P2031, DOI 10.1016/j.clinph.2004.04.007; Goldschmidt-Clermont PJ, 2012, NAT REV CARDIOL; Heslop Pauline, 2002, Sleep Med, V3, P305, DOI 10.1016/S1389-9457(02)00016-3; Kang MY, 2012, J OCCUP ENVIRON MED, V54, P532, DOI 10.1097/JOM.0b013e31824fe192; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Kuo TBJ, 2008, SLEEP, V31, P311, DOI 10.1093/sleep/31.3.311; Kuo TBJ, 2010, ENDOCRINOLOGY, V151, P2613, DOI 10.1210/en.2009-1410; Kuo TBJ, 2009, EXP NEUROL, V217, P38, DOI 10.1016/j.expneurol.2009.01.012; Lin YH, 2012, STRESS, V15, P21, DOI 10.3109/10253890.2011.572208; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Liu CC, 2003, AM J PHYSIOL-HEART C, V285, pH2188, DOI 10.1152/ajpheart.00256.2003; Malmberg B, 2011, INT ARCH OCC ENV HEA, V84, P293, DOI 10.1007/s00420-010-0593-4; Mansukhani MP, 2012, POSTGRAD MED, V124, P241, DOI 10.3810/pgm.2012.07.2583; Moody G.B., 1986, COMPUT CARDIOL, V13, P507; Rauchenzauner M, 2009, EUR HEART J, V30, P2606, DOI 10.1093/eurheartj/ehp268; Sabanayagam C, 2010, SLEEP, V33, P1037, DOI 10.1093/sleep/33.8.1037; Shankar A, 2008, AM J EPIDEMIOL, V168, P1367, DOI 10.1093/aje/kwn281; Thomas RJ, 2005, SLEEP, V28, P1151, DOI 10.1093/sleep/28.9.1151; Thomas RJ, 2007, SLEEP, V30, P1756, DOI 10.1093/sleep/30.12.1756; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Weng WH, 2013, PSYCHOPHYSIOLOGY; Yang CCH, 2002, NEUROSCI LETT, V329, P213, DOI 10.1016/S0304-3940(02)00661-4; Yang CH, 2010, PSYCHOPHYSIOLOGY; Yeragani V, 2005, CARDIOVASC ENG, V5, P135; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004	29	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65072	10.1371/journal.pone.0065072	http://dx.doi.org/10.1371/journal.pone.0065072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750232	Green Submitted, Green Published, gold			2022-12-25	WOS:000319961900034
J	Olguin, CA; Landete-Castillejos, T; Ceacero, F; Garcia, AJ; Gallego, L				Olguin, Cesar A.; Landete-Castillejos, Tomas; Ceacero, Francisco; Garcia, Andres J.; Gallego, Laureano			Effects of Feed Supplementation on Mineral Composition, Mechanical Properties and Structure in Femurs of Iberian Red Deer Hinds (Cervus elaphus hispanicus)	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; PHYSIOLOGICAL EFFORT; ORGANIC MATRIX; KIDNEY FAT; BONE; ANTLER; CALCIUM; GROWTH; LACTATION; WEIGHT	Few studies in wild animals have assessed changes in mineral profile in long bones and their implications for mechanical properties. We examined the effect of two diets differing in mineral content on the composition and mechanical properties of femora from two groups each with 13 free-ranging red deer hinds. Contents of Ca, P, Mg, K, Na, S, Cu, Fe, Mn, Se, Zn, B and Sr, Young's modulus of elasticity (E), bending strength and work of fracture were assessed in the proximal part of the diaphysis (PD) and the mid-diaphysis (MD). Whole body measures were also recorded on the hinds. Compared to animals on control diets, those on supplemented diets increased live weight by 6.5 kg and their kidney fat index (KFI), but not carcass weight, body or organ size, femur size or cortical thickness. Supplemental feeding increased Mn content of bone by 23%, Cu by 9% and Zn by 6%. These differences showed a mean fourfold greater content of these minerals in supplemental diet, whereas femora did not reflect a 5.4 times greater content of major minerals (Na and P) in the diet. Lower content of B and Sr in supplemented diet also reduced femur B by 14% and Sr by 5%. There was a subtle effect of diet only on E and none on other mechanical properties. Thus, greater availability of microminerals but not major minerals in the diet is reflected in bone composition even before marked body effects, bone macro-structure or its mechanical properties are affected.	[Olguin, Cesar A.; Landete-Castillejos, Tomas; Garcia, Andres J.; Gallego, Laureano] IREC UCLM CSIC JCCM, IREC Sec Albacete, Appl Wildlife Management Res Grp, Albacete, Spain; [Olguin, Cesar A.; Landete-Castillejos, Tomas; Garcia, Andres J.; Gallego, Laureano] UCLM, IDR, Grp Recursos Cineget, Albacete, Spain; [Landete-Castillejos, Tomas; Garcia, Andres J.; Gallego, Laureano] UCLM, ETSIA, Dept Ciencia & Tecnol Agroforestal & Genet, Albacete, Spain; [Ceacero, Francisco] Czech Univ Life Sci, Fac Trop AgriSci, Dept Anim Sci & Food Proc Trop & Subtrop, Prague, Czech Republic	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Czech University of Life Sciences Prague	Landete-Castillejos, T (corresponding author), IREC UCLM CSIC JCCM, IREC Sec Albacete, Appl Wildlife Management Res Grp, Campus UCLM, Albacete, Spain.	tomas.landete@uclm.es	Ceacero, Francisco/C-1088-2009; Garcia Diaz, Andres Jose/A-9162-2012; Gallego, Laureano/G-9715-2015	Ceacero, Francisco/0000-0001-9014-147X; Landete Castillejos, Tomas/0000-0001-9753-5295; Garcia Diaz, Andres Jose/0000-0002-4662-2185; Gallego, Laureano/0000-0001-8219-087X	Consejo Nacional de Ciencia y Tecnologia (Mexico) [302198]; Czech University of Life Sciences (Czech Republic) [99830/1181/1822]; MINECO [CGL2011-24811, AGL2012-38898]	Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Czech University of Life Sciences (Czech Republic); MINECO(Spanish Government)	CAO was funded by the Postgraduate Scholarship 302198 of the Consejo Nacional de Ciencia y Tecnologia (Mexico). FC was supported by a post-doc grant at Czech University of Life Sciences no. 99830/1181/1822 (Czech Republic). This paper has been funded by projects MINECO CGL2011-24811 and AGL2012-38898. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gomez JA, 2008, WILDLIFE BIOL, V14, P331, DOI 10.2981/0909-6396(2008)14[331:LGIMCO]2.0.CO;2; [Anonymous], 2003, MINERALS ANIMAL HUMA, DOI DOI 10.1016/B978-0-444-51367-0.50006-4; *ASAB, 2009, ANIM BEHAV, V77, pR1; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P105, DOI 10.1016/0040-5809(78)90007-2; BLOOD DA, 1966, J WILDLIFE MANAGE, V30, P135, DOI 10.2307/3797893; Burr DB, 2002, BONE, V31, P8, DOI 10.1016/S8756-3282(02)00815-3; Ceacero F, 2009, LIVEST SCI, V122, P345, DOI 10.1016/j.livsci.2008.08.002; Cook RC, 2003, WILDLIFE SOC B, V31, P536; Corah L, 1996, ANIM FEED SCI TECH, V59, P61, DOI 10.1016/0377-8401(95)00887-X; Currey J.D., 2002, BONES STRUCTURE MECH; CURREY JD, 2009, OPEN BONE J, V1, P38; Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7; DAUPHINE TC, 1975, J WILDLIFE MANAGE, V39, P379, DOI 10.2307/3799918; Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002; DESOUSA JC, 1978, J ANIM SCI S1, V47, P342; Estevez JA, 2010, ANIM PROD SCI, V50, P177, DOI 10.1071/AN09012; Estevez JA, 2009, ACTA THERIOL, V54, P235, DOI 10.4098/j.at.0001-7051.070.2008; FINGER SE, 1981, J WILDLIFE MANAGE, V45, P964, DOI 10.2307/3808104; Gaspar-Lopez E, 2008, EUR J WILDLIFE RES, V54, P753, DOI 10.1007/s10344-008-0185-8; Gomez JA, 2006, LIVEST SCI, V105, P27, DOI 10.1016/j.livsci.2006.04.028; Gomez S, 2013, BONE, V52, P506, DOI 10.1016/j.bone.2012.09.015; Grace ND, 2008, NEW ZEAL J AGR RES, V51, P439, DOI 10.1080/00288230809510473; Grace ND, 2002, NEW ZEAL VET J, V50, P252, DOI 10.1080/00480169.2002.36321; Gustafson MB, 1996, J BIOMECH, V29, P1191, DOI 10.1016/0021-9290(96)00020-6; Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466; Kelly R. W., 1975, Applied Animal Ethology, V1, P293, DOI 10.1016/0304-3762(75)90022-X; KIE JG, 1987, PSW106, P1; Kotha SP, 2007, J BIOMECH, V40, P36, DOI 10.1016/j.jbiomech.2005.11.016; Landete-Castilleijos T, 2007, BONE, V41, P794, DOI 10.1016/j.bone.2007.07.013; Landete-Castillejos T, 2007, BONE, V40, P1095, DOI 10.1016/j.bone.2006.11.022; Landete-Castillejos T, 2007, BONE, V40, P230, DOI 10.1016/j.bone.2006.07.009; Landete-Castillejos T, 2012, BONE, V50, P245, DOI 10.1016/j.bone.2011.10.026; Landete-Castillejos T, 2010, BONE, V47, P815, DOI 10.1016/j.bone.2010.07.021; Landete-Castillejos T, 2002, BIOL REPROD, V67, P1613, DOI 10.1095/biolreprod.102.004507; Landete-Castillejos Tomas, 2012, Front Biosci (Elite Ed), V4, P1385; MCCOY H, 1994, ENVIRON HEALTH PERSP, V102, P49, DOI 10.2307/3431962; McDowell LR, 1996, ANIM FEED SCI TECH, V60, P247, DOI 10.1016/0377-8401(96)00983-2; Minson D.J., 1990, FORAGE RUMINANT NUTR, P9, DOI [10.1016/b978-0-12-498310-6.50008-0, DOI 10.1016/B978-0-12-498310-6.50008-0]; Naghii MR, 2006, BIOFACTORS, V28, P195, DOI 10.1002/biof.5520280306; Nazarian A, 2009, J BIOMECH, V42, P82, DOI 10.1016/j.jbiomech.2008.09.037; Nicol AM, 2007, NZ SOC ANIMAL PRODUC, V14, P151; NORRIS LC, 1972, J NUTR, V102, P1085, DOI 10.1093/jn/102.8.1085; Paik I, 2001, ASIAN AUSTRAL J ANIM, V14, P191; Palacios C, 2006, CRIT REV FOOD SCI, V46, P621, DOI 10.1080/10408390500466174; PEEK JM, 2002, ELK N AM ECOLOGY MAN, P614; RINEY T, 1995, NZ J SCI B, V36, P429; Rodan GA, 1998, P NATL ACAD SCI USA, V95, P13361, DOI 10.1073/pnas.95.23.13361; RODRIGUEZBERROCAL J, 1978, ARCH ZOOTEC, V27, P73; Spears JW, 1996, ANIM FEED SCI TECH, V58, P151, DOI 10.1016/0377-8401(95)00881-0; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Varley PF, 2011, ANIM FEED SCI TECH, V165, P201, DOI 10.1016/j.anifeedsci.2011.02.017; Wysolmerski JJ, 2002, J MAMMARY GLAND BIOL, V7, P267, DOI 10.1023/A:1022800716196	52	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65461	10.1371/journal.pone.0065461	http://dx.doi.org/10.1371/journal.pone.0065461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750262	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900064
J	Erra, EO; Korhonen, EM; Voutilainen, L; Huhtamo, E; Vapalahti, O; Kantele, A				Erra, Elina O.; Korhonen, Essi M.; Voutilainen, Liina; Huhtamo, Eili; Vapalahti, Olli; Kantele, Anu			Dengue in Travelers: Kinetics of Viremia and NS1 Antigenemia and Their Associations with Clinical Parameters	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; DISEASE SEVERITY; NONSTRUCTURAL PROTEIN-1; HEMORRHAGIC-FEVER; VIRUS-INFECTIONS; SHOCK SYNDROME; IMMUNE STATUS; DIAGNOSIS; SEROTYPE; ASSAY	Despite the increasing numbers of travel-acquired dengue, few studies have assessed virologic markers of the disease in non-endemic populations. We examined the kinetics of diagnostic markers and their associations with clinical parameters in 93 patients with travel-acquired dengue fever. Kinetics analyses suggested a longer average duration for viremia (9 days, CI95%: 8-10) and non-structural protein 1 (NS1) antigenemia (15 days, CI95%: 12-20) than reported in endemic populations. While none of the tests sufficed alone, the best diagnostic coverage was achieved by combining antibody detection with RNA or NS1 testing. Studied by regression models, early relative levels of viremia and NS1 antigenemia proved to be significantly associated with several clinical parameters: high viremia predicted greater likelihood and increased length of hospitalization, the degree of NS1 antigenemia correlated positively with hematocrit and liver transaminases, and both viremia and NS1 antigenemia levels negatively with platelet counts in follow-up. Levels of viremia and NS1 antigenemia may serve as predictors of the clinical manifestations in travel-acquired dengue.	[Erra, Elina O.; Kantele, Anu] Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland; [Erra, Elina O.; Kantele, Anu] Univ Helsinki, Fac Med, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland; [Korhonen, Essi M.; Voutilainen, Liina; Huhtamo, Eili; Vapalahti, Olli] Univ Helsinki, Fac Med, Haartman Inst, Dept Virol, Helsinki, Finland; [Voutilainen, Liina] Finnish Forest Res Inst, Vantaa Res Unit, Vantaa, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Natural Resources Institute Finland (Luke)	Erra, EO (corresponding author), Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland.	elina.erra@gmail.com	Huhtamo, Eili/GOJ-9502-2022; Kantele, Anu/AAS-4131-2021; Korhonen, Essi Marjaana/CAF-5553-2022	Kantele, Anu/0000-0002-0004-1000; Korhonen, Essi/0000-0003-4730-7715; Vapalahti, Olli/0000-0003-2270-6824; Huhtamo, Eili/0000-0001-9640-6547	Finnish governmental subsidy for health science research; Academy of Finland; Finnish Medical Foundation	Finnish governmental subsidy for health science research; Academy of Finland(Academy of Finland); Finnish Medical Foundation	This work was supported by the Finnish governmental subsidy for health science research, the Academy of Finland, and the Finnish Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Baaten GGG, 2011, EMERG INFECT DIS, V17, P821, DOI 10.3201/eid1705.101125; Barton K., 2011, MUMIN MULTIMODEL INF; Burnham KP, 2000, MODEL SELECTION INFE, P353; Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244; Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06; Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014; Fox A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000967; Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47; Huhtamo E, 2008, EMERG INFECT DIS, V14, P80, DOI 10.3201/eid1401.070865; Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001; Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lehtinen VA, 2008, J CLIN VIROL, V43, P93, DOI 10.1016/j.jcv.2008.05.001; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lindegren G, 2005, J CLIN MICROBIOL, V43, P2850, DOI 10.1128/JCM.43.6.2850-2855.2005; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Tran NBC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000657; Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; VENE S, 1995, CLIN DIAGN VIROL, V4, P43, DOI 10.1016/0928-0197(94)00060-8; WHO, 1997, DENG HAEM FEV DIAGN; Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680; Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927; Wood S., 2011, R PACKAGE VERSION, V0, P1; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, DENG SEV DENG	37	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65900	10.1371/journal.pone.0065900	http://dx.doi.org/10.1371/journal.pone.0065900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755291	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300098
J	Pierno, S; Camerino, GM; Cannone, M; Liantonio, A; De Bellis, M; Digennaro, C; Gramegna, G; De Luca, A; Germinario, E; Danieli-Betto, D; Betto, R; Dobrowolny, G; Rizzuto, E; Musaro, A; Desaphy, JF; Camerino, DC				Pierno, Sabata; Camerino, Giulia M.; Cannone, Maria; Liantonio, Antonella; De Bellis, Michela; Digennaro, Claudio; Gramegna, Gianluca; De Luca, Annamaria; Germinario, Elena; Danieli-Betto, Daniela; Betto, Romeo; Dobrowolny, Gabriella; Rizzuto, Emanuele; Musaro, Antonio; Desaphy, Jean-Francois; Camerino, Diana Conte			Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice	PLOS ONE			English	Article							GROWTH-FACTOR-I; CHANNEL REGULATION; GENE-EXPRESSION; ATROPHY; PROTEIN; ACTIVATION; EXERCISE; REGENERATION; HYPERTROPHY; SOLEUS	Slow-twitch muscles, devoted to postural maintenance, experience atrophy and weakness during muscle disuse due to bed-rest, aging or spaceflight. These conditions impair motion activities and can have survival implications. Human and animal studies demonstrate the anabolic role of IGF-1 on skeletal muscle suggesting its interest as a muscle disuse countermeasure. Thus, we tested the role of IGF-1 overexpression on skeletal muscle alteration due to hindlimb unloading (HU) by using MLC/mIgf-1 transgenic mice expressing IGF-1 under the transcriptional control of MLC promoter, selectively activated in skeletal muscle. HU produced atrophy in soleus muscle, in terms of muscle weight and fiber cross-sectional area (CSA) reduction, and up-regulation of atrophy gene MuRF1. In parallel, the disuse-induced slow-to-fast fiber transition was confirmed by an increase of the fast-type of the Myosin Heavy Chain (MHC), a decrease of PGC-1 alpha expression and an increase of histone deacetylase-5 (HDAC5). Consistently, functional parameters such as the resting chloride conductance (gCl) together with ClC-1 chloride channel expression were increased and the contractile parameters were modified in soleus muscle of HU mice. Surprisingly, IGF-1 overexpression in HU mice was unable to counteract the loss of muscle weight and the decrease of fiber CSA. However, the expression of MuRF1 was recovered, suggesting early effects on muscle atrophy. Although the expression of PGC-1 alpha and MHC were not improved in IGF-1-HU mice, the expression of HDAC5 was recovered. Importantly, the HU-induced increase of gCl was fully contrasted in IGF-1 transgenic mice, as well as the changes in contractile parameters. These results indicate that, even if local expression does not seem to attenuate HU-induced atrophy and slow-to-fast phenotype transition, it exerts early molecular effects on gene expression which can counteract the HU-induced modification of electrical and contractile properties. MuRF1 and HDAC5 can be attractive therapeutic targets for pharmacological countermeasures and then deserve further investigations.	[Pierno, Sabata; Camerino, Giulia M.; Cannone, Maria; Liantonio, Antonella; De Bellis, Michela; Digennaro, Claudio; Gramegna, Gianluca; De Luca, Annamaria; Desaphy, Jean-Francois; Camerino, Diana Conte] Univ Bari Aldo Moro, Dept Pharm & Drug Sci, Pharmacol Sect, Bari, Italy; [Germinario, Elena] Univ Padua, Dept Biomed Sci, Padua, Italy; [Betto, Romeo] CNR, Inst Neurosci, Padua, Italy; [Dobrowolny, Gabriella; Musaro, Antonio] Sapienza Univ Roma, Ist Italiano Tecnol, DAHFMO Unit Histol & Med Embryol, Inst Pasteur Cenci Bolognetti,IIM, Rome, Italy; [Rizzuto, Emanuele] Sapienza Univ Roma, Dept Mech & Aerosp Engn, IIM, Rome, Italy	Universita degli Studi di Bari Aldo Moro; University of Padua; Consiglio Nazionale delle Ricerche (CNR); Fondazione Cenci Bolognetti; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; Sapienza University Rome	Pierno, S (corresponding author), Univ Bari Aldo Moro, Dept Pharm & Drug Sci, Pharmacol Sect, Bari, Italy.	sabata.pierno@uniba.it	Rizzuto, Emanuele/K-9437-2016; Musaro, Antonio/P-2953-2019; Musarò, Antonio/K-9598-2016; Desaphy, Jean-Francois/T-6191-2019; De Bellis, Michela/ABE-2595-2020; Camerino, Giulia Maria/I-6896-2013	Rizzuto, Emanuele/0000-0003-2314-6128; Musaro, Antonio/0000-0002-2944-9739; Musarò, Antonio/0000-0002-2944-9739; Desaphy, Jean-Francois/0000-0001-8816-9369; Pierno, Sabata/0000-0003-3121-2666; Dobrowolny, Gabriella/0000-0001-8693-0724; Liantonio, Antonella/0000-0002-4103-7577; DANIELI, DANIELA/0000-0002-6186-8327; De Luca, Annamaria/0000-0002-5652-7341; De Bellis, Michela/0000-0001-8706-2885; Camerino, Giulia Maria/0000-0003-1410-6327	Italian Space Agency	Italian Space Agency(Agenzia Spaziale Italiana (ASI))	This work was supported by the Italian Space Agency grants to D. Conte Camerino (project OSMA Osteoporosis and Muscle Atrophy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GR, 2003, J APPL PHYSIOL, V95, P2185, DOI 10.1152/japplphysiol.00346.2003; Adams GR, 1998, J APPL PHYSIOL, V84, P1716, DOI 10.1152/jappl.1998.84.5.1716; Alamdari N, 2013, METABOLISM, V62, P1, DOI 10.1016/j.metabol.2012.03.019; Alamdari N, 2010, AM J PHYSIOL-REG I, V299, pR509, DOI 10.1152/ajpregu.00858.2009; Alzghoul MB, 2004, FASEB J, V18, P221, DOI 10.1096/fj.03-0293fje; Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Awede B, 1999, FEBS LETT, V461, P263, DOI 10.1016/S0014-5793(99)01469-6; Bae SK, 2012, J APPL PHYSIOL, V113, P114, DOI 10.1152/japplphysiol.00431.2011; Bajotto G, 2006, J NUTR SCI VITAMINOL, V52, P233, DOI 10.3177/jnsv.52.233; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Brocca L, 2010, EXP PHYSIOL, V95, P331, DOI 10.1113/expphysiol.2009.050245; BRYANT SH, 1991, PFLUG ARCH EUR J PHY, V417, P605, DOI 10.1007/BF00372958; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chrysis D, 2011, HORM-INT J ENDOCRINO, V10, P46, DOI 10.14310/horm.2002.1292; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Criswell DS, 1998, AM J PHYSIOL-ENDOC M, V275, pE373; D'Andrea M, 2006, J CELL PHYSIOL, V207, P379, DOI 10.1002/jcp.20585; De Luca A, 1998, BRIT J PHARMACOL, V125, P477, DOI 10.1038/sj.bjp.0702107; De Luca A, 1999, NEUROMUSCULAR DISORD, V9, P11, DOI 10.1016/S0960-8966(98)00092-3; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; Del Prete Z, 2008, ANN BIOMED ENG, V36, P1281, DOI 10.1007/s10439-008-9496-x; Delbono O, 2000, J Nutr Health Aging, V4, P162; DELUCA A, 1992, PFLUG ARCH EUR J PHY, V420, P407, DOI 10.1007/BF00374477; Desaphy JF, 2010, PHARMACOL RES, V61, P553, DOI 10.1016/j.phrs.2010.01.012; Desaphy JF, 2005, NEUROBIOL DIS, V18, P356, DOI 10.1016/j.nbd.2004.09.016; Desaphy JF, 2001, BRAIN, V124, P1100, DOI 10.1093/brain/124.6.1100; Dumont N, 2010, AM J PATHOL, V176, P2228, DOI 10.2353/ajpath.2010.090884; Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009; Fraysse B, 2006, NEUROBIOL DIS, V21, P372, DOI 10.1016/j.nbd.2005.07.012; Fraysse B, 2003, FASEB J, V17, P1916, DOI 10.1096/fj.02-1012fje; Goldspink G, 2004, EXP GERONTOL, V39, P1433, DOI 10.1016/j.exger.2004.08.010; Goldspink G, 2006, INT J BIOCHEM CELL B, V38, P480, DOI 10.1016/j.biocel.2005.10.013; Gonzalez E, 2003, J PHYSIOL-LONDON, V552, P833, DOI 10.1113/jphysiol.2003.048165; Gundersen K, 2010, BIOL REV CAMB PHILOS, V86, P564; Kim SJ, 2008, J APPL PHYSIOL, V105, P1246, DOI 10.1152/japplphysiol.90668.2008; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lawler JM, 2012, MED SCI SPORT EXER, V44, P600, DOI 10.1249/MSS.0b013e31823ab37a; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; LINDERMAN JK, 1994, AM J PHYSIOL, V267, pR365, DOI 10.1152/ajpregu.1994.267.2.R365; Mcgee SL, 2011, J APPL PHYSIOL, V110, P258, DOI 10.1152/japplphysiol.00979.2010; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Murton AJ, 2008, BBA-MOL BASIS DIS, V1782, P730, DOI 10.1016/j.bbadis.2008.10.011; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Pierno S, 2002, BRAIN, V125, P1510, DOI 10.1093/brain/awf162; Pierno S, 2009, BRIT J PHARMACOL, V156, P1206, DOI 10.1111/j.1476-5381.2008.00079.x; Pierno S, 1999, FEBS LETT, V449, P12, DOI 10.1016/S0014-5793(99)00202-1; Pierno S, 2007, J PHYSIOL-LONDON, V584, P983, DOI 10.1113/jphysiol.2007.141358; Pierno S, 2012, AMINO ACIDS, V43, P431, DOI 10.1007/s00726-011-1099-4; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rinaldi C, 2012, MOL MED, DOI [10.2119/molmed.2012.00271, DOI 10.2119/M0LMED.2012.00271.[]; Ringseis R, 2013, BBA-GEN SUBJECTS, V1830, P2105, DOI 10.1016/j.bbagen.2012.09.024; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schertzer JD, 2006, GENE THER, V13, P1657, DOI 10.1038/sj.gt.3302817; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Scicchitano BM, 2009, AGING-US, V1, P451, DOI 10.18632/aging.100050; Shavlakadze T, 2010, J APPL PHYSIOL, V108, P1829, DOI 10.1152/japplphysiol.00312.2010; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Vernikos J, 1996, BIOESSAYS, V18, P1029, DOI 10.1002/bies.950181215; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Wu H, 2002, J CLIN INVEST, V109, P1327, DOI 10.1172/JCI200215417; Yang SY, 1996, J MUSCLE RES CELL M, V17, P487, DOI 10.1007/BF00123364	72	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65167	10.1371/journal.pone.0065167	http://dx.doi.org/10.1371/journal.pone.0065167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755187	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300053
J	Akiyama, BM; Gomez, A; Stone, MD				Akiyama, Benjamin M.; Gomez, Anastassia; Stone, Michael D.			A Conserved Motif in Tetrahymena thermophila Telomerase Reverse Transcriptase Is Proximal to the RNA Template and Is Essential for Boundary Definition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ribonuclear Protein (RNP); RNA; RNA-binding Protein; Telomerase; Telomeres	CATALYTIC SUBUNIT TERT; BINDING DOMAIN; PROTEIN; RIBONUCLEOPROTEIN; HOLOENZYME; SEQUENCE; LOOP; DNA	The ends of linear chromosomes are extended by telomerase, a ribonucleoprotein complex minimally consisting of a protein subunit called telomerase reverse transcriptase (TERT) and the telomerase RNA (TER). TERT functions by reverse transcribing a short template region of TER into telomeric DNA. Proper assembly of TERT and TER is essential for telomerase activity; however, a detailed understanding of how TERT interacts with TER is lacking. Previous studies have identified an RNA binding domain (RBD) within TERT, which includes three evolutionarily conserved sequence motifs: CP2, CP, and T. Here, we used site-directed hydroxyl radical probing to directly identify sites of interaction between the TERT RBD and TER, revealing that the CP2 motif is in close proximity to a conserved region of TER known as the template boundary element (TBE). Gel shift assays on CP2 mutants confirmed that the CP2 motif is an RNA binding determinant. Our results explain previous work that established that mutations to the CP2 motif of TERT and to the TBE of TER both permit misincorporation of nucleotides into the growing DNA strand beyond the canonical template. Taken together, these results suggest a model in which the CP2 motif binds the TBE to strictly define which TER nucleotides can be reverse transcribed.	[Akiyama, Benjamin M.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Gomez, Anastassia; Stone, Michael D.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Akiyama, Benjamin M.; Stone, Michael D.] Univ Calif Santa Cruz, Ctr RNA Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Stone, MD (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, 1156 High St, Santa Cruz, CA 95064 USA.	mds@ucsc.edu			National Institutes of Health [GM095850, T32 GM8646, T34 GM007910-31]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095850, T34GM007910, T32GM008646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095850 (to M. D. S.) and National Institutes of Health Training Grants T32 GM8646 (to B. M. A.) and T34 GM007910-31 (to A. G.).	Akiyama BM, 2012, RNA, V18, P653, DOI 10.1261/rna.031377.111; Berman AJ, 2011, NAT STRUCT MOL BIOL, V18, P1371, DOI 10.1038/nsmb.2174; Berman AJ, 2010, MOL CELL BIOL, V30, P4965, DOI 10.1128/MCB.00827-10; Bosoy D, 2003, J BIOL CHEM, V278, P3882, DOI 10.1074/jbc.M210645200; Bryan TM, 2000, MOL CELL, V6, P493, DOI 10.1016/S1097-2765(00)00048-4; Culver GM, 2000, METHOD ENZYMOL, V318, P461; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; HEILEK GM, 1995, P NATL ACAD SCI USA, V92, P1113, DOI 10.1073/pnas.92.4.1113; Hengesbach M, 2011, CURR OPIN CHEM BIOL, V15, P845, DOI 10.1016/j.cbpa.2011.10.008; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Lin J, 2004, P NATL ACAD SCI USA, V101, P14713, DOI 10.1073/pnas.0405879101; Miller MC, 2000, EMBO J, V19, P4412, DOI 10.1093/emboj/19.16.4412; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Richards RJ, 2006, NUCLEIC ACIDS RES, V34, P816, DOI 10.1093/nar/gkj481; Robart AR, 2010, RNA, V16, P563, DOI 10.1261/rna.1936410; Rouda S, 2007, STRUCTURE, V15, P1403, DOI 10.1016/j.str.2007.09.007; Sperger JM, 2001, BIOCHEMISTRY-US, V40, P7005, DOI 10.1021/bi0103359; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Wu JY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1033	30	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22141	22149		10.1074/jbc.M113.452425	http://dx.doi.org/10.1074/jbc.M113.452425			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760279	Green Published, hybrid			2022-12-25	WOS:000328841900057
J	de la Cueva, A; de Molina, AR; Alvarez-Ayerza, N; Ramos, MA; Cebrian, A; del Pulgar, TG; Lacal, JC				de la Cueva, Ana; Ramirez de Molina, Ana; Alvarez-Ayerza, Nestor; Angeles Ramos, Ma; Cebrian, Arancha; Gomez del Pulgar, Teresa; Carlos Lacal, Juan			Combined 5-FU and ChoK alpha Inhibitors as a New Alternative Therapy of Colorectal Cancer: Evidence in Human Tumor-Derived Cell Lines and Mouse Xenografts	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE EXPRESSION; CHOLINE KINASE-ALPHA; PHOSPHOLIPID-METABOLISM; PROTEIN EXPRESSION; 1ST-LINE TREATMENT; PLUS IRINOTECAN; HUMAN BREAST; PHASE-II; 5-FLUOROURACIL; FLUOROURACIL	Background: Colorectal cancer (CRC) is the third major cause of cancer related deaths in the world. 5-fluorouracil (5-FU) is widely used for the treatment of colorectal cancer but as a single-agent renders low response rates. Choline kinase alpha (ChoK alpha), an enzyme that plays a role in cell proliferation and transformation, has been reported overexpressed in many different tumors, including colorectal tumors. ChoK alpha inhibitors have recently entered clinical trials as a novel antitumor strategy. Methodology/Principal Findings: ChoK alpha specific inhibitors, MN58b and TCD-717, have demonstrated a potent antitumoral activity both in vitro and in vivo against several tumor-derived cell line xenografts including CRC-derived cell lines. The effect of ChoK alpha inhibitors in combination with 5-FU as a new alternative for the treatment of colon tumors has been investigated both in vitro in CRC-tumour derived cell lines, and in vivo in mouse xenografts models. The effects on thymidilate synthase (TS) and thymidine kinase (TK1) levels, two enzymes known to play an essential role in the mechanism of action of 5-FU, were analyzed by western blotting and quantitative PCR analysis. The combination of 5-FU with ChoK alpha inhibitors resulted in a synergistic effect in vitro in three different human colon cancer cell lines, and in vivo against human colon xenografts in nude mice. ChoK alpha inhibitors modulate the expression levels of TS and TK1 through inhibition of E2F production, providing a rational for its mechanism of action. Conclusion/Significance: Our data suggest that both drugs in combination display a synergistic antitumoral effect due to ChoK alpha inhibitors-driven modulation of the metabolization of 5-FU. The clinical relevance of these findings is strongly supported since TCD-717 has recently entered Phase I clinical trials against solid tumors.	[de la Cueva, Ana; Ramirez de Molina, Ana; Alvarez-Ayerza, Nestor; Angeles Ramos, Ma; Cebrian, Arancha; Gomez del Pulgar, Teresa; Carlos Lacal, Juan] CSIC, Inst Invest Biomed, Traslat Oncol Unit, Madrid, Spain; [Carlos Lacal, Juan] Inst Invest Sanitaria IdiPAZ, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Lacal, JC (corresponding author), CSIC, Inst Invest Biomed, Traslat Oncol Unit, Madrid, Spain.	jclacal@iib.uam.es	de Molina, Ana Ramirez/AAA-3848-2019; Lacal, Juan Carlos/AAL-2235-2020; Gomez del Pulgar, Teresa/GXV-5256-2022; Lacal, Juan Carlos/N-9064-2015	Lacal, Juan Carlos/0000-0002-1908-2777; Cebrian Aranda, Arancha/0000-0002-6260-1376	Comunidad de Madrid [S-BIO/0280/2006, S2010/BMD-2326]; Ministerio de Ciencia e Innovacion [SAF2008-03750, SAF2011-29699, RD06-0020-0016, RD12/0036/0019]; EU [259737]	Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); EU(European Commission)	This work has been funded by the following grants: Comunidad de Madrid (S-BIO/0280/2006 and S2010/BMD-2326), Ministerio de Ciencia e Innovacion (SAF2008-03750, SAF2011-29699, RD06-0020-0016 and RD12/0036/0019) and EU #259737. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2007, WORLD J GASTROENTERO, V13, P5888, DOI 10.3748/wjg.v13.i44.5888; Campos J, 2001, EUR J MED CHEM, V36, P215, DOI 10.1016/S0223-5234(01)01219-3; CANNON JG, 1994, MED RES REV, V14, P505, DOI 10.1002/med.2610140503; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; CHU E, 1991, MOL PHARMACOL, V39, P136; Chua BT, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-131; Clem BF, 2011, ONCOGENE, V30, P3370, DOI 10.1038/onc.2011.51; COPUR S, 1995, BIOCHEM PHARMACOL, V49, P1419, DOI 10.1016/0006-2952(95)00067-A; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; DOU QP, 1992, P NATL ACAD SCI USA, V89, P3256, DOI 10.1073/pnas.89.8.3256; Douillard JY, 2003, ANN ONCOL, V14, P7, DOI 10.1093/annonc/mdg723; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136; GREM JL, 1989, PHARMACOL THERAPEUT, V40, P349, DOI 10.1016/0163-7258(89)90084-3; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Hernandez-Alcoceba R, 1999, CANCER RES, V59, P3112; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; Hernando E, 2009, ONCOGENE, V28, P2425, DOI 10.1038/onc.2009.91; Hong BS, 2010, J BIOL CHEM, V285, P16330, DOI 10.1074/jbc.M109.039024; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Johnston PG, 2003, J CLIN ONCOL, V21, P815, DOI 10.1200/JCO.2003.07.039; JOHNSTON PG, 1994, J CLIN ONCOL, V12, P2640, DOI 10.1200/JCO.1994.12.12.2640; JOHNSTON PG, 1992, CANCER RES, V52, P4306; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Lacal J C, 2001, IDrugs, V4, P419; Lebedeva IV, 2007, ONCOGENE, V26, P733, DOI 10.1038/sj.onc.1209813; LLOVERAS J, 1985, BIOCHEM PHARMACOL, V34, P3987, DOI 10.1016/0006-2952(85)90377-6; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Machover D, 1996, ANN ONCOL, V7, P95; Milanese L, 2006, CHEMMEDCHEM, V1, P1216, DOI 10.1002/cmdc.200600158; Mizutani Y, 2003, CLIN CANCER RES, V9, P1453; Mori N, 2007, CANCER RES, V67, P11284, DOI 10.1158/0008-5472.CAN-07-2728; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Nomura T, 2002, INT J UROL, V9, P368, DOI 10.1046/j.1442-2042.2002.00479.x; PETERS GJ, 1991, ANN ONCOL, V2, P469, DOI 10.1093/oxfordjournals.annonc.a057994; Popat S, 2004, J CLIN ONCOL, V22, P529, DOI 10.1200/JCO.2004.05.064; Rahman L, 2004, CANCER CELL, V5, P341, DOI 10.1016/S1535-6108(04)00080-7; Rajesh D, 1999, MOL PHARMACOL, V56, P515, DOI 10.1124/mol.56.3.515; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; Rodriguez-Gonzalez A, 2005, INT J ONCOL, V26, P999; Rodriguez-Gonzalez A, 2004, ONCOGENE, V23, P8247, DOI 10.1038/sj.onc.1208045; Russo P, 2002, INT J CANCER, V100, P266, DOI 10.1002/ijc.10461; Salonga D, 2000, CLIN CANCER RES, V6, P1322; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Srivani P, 2009, J MOL GRAPH MODEL, V27, P676, DOI 10.1016/j.jmgm.2008.10.010; Van Cutsem E, 1998, ANN ONCOL, V9, P1199, DOI 10.1023/A:1008478405634; Yalcin A, 2010, ONCOGENE, V29, P139, DOI 10.1038/onc.2009.317	53	38	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64961	10.1371/journal.pone.0064961	http://dx.doi.org/10.1371/journal.pone.0064961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762272	gold, Green Submitted, Green Published			2022-12-25	WOS:000320440500015
J	Khanolkar, A; Williams, MA; Harty, JT				Khanolkar, Aaruni; Williams, Matthew A.; Harty, John T.			Antigen Experience Shapes Phenotype and Function of Memory Th1 Cells	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LISTERIA-MONOCYTOGENES INFECTION; CD8(+) T-CELLS; NEUTRALIZING-ANTIBODY; ANTIVIRAL IMMUNITY; VIRAL-INFECTIONS; CLASS-II; RESPONSES; CD4(+); EFFECTOR	Primary and secondary (boosted) memory CD8 T cells exhibit differences in gene expression, phenotype and function. The impact of repeated antigen stimulations on memory CD4 T cells is largely unknown. To address this issue, we utilized LCMV and Listeria monocytogenes infection of mice to characterize primary and secondary antigen (Ag)-specific Th1 CD4 T cell responses. Ag-specific primary memory CD4 T cells display a CD62L(lo)CCR7(hi)CD27(hi)CD127(hi) phenotype and are polyfunctional (most produce IFN gamma, TNF alpha and IL-2). Following homologous prime-boost immunization we observed pathogen-specific differences in the rate of CD62L and CCR7 upregulation on memory CD4 T cells as well as in IL-2+IFN gamma co-production by secondary effectors. Phenotypic and functional plasticity of memory Th1 cells was observed following heterologous prime-boost immunization, wherein secondary memory CD4 T cells acquired phenotypic and functional characteristics dictated by the boosting agent rather than the primary immunizing agent. Our data also demonstrate that secondary memory Th1 cells accelerated neutralizing Ab formation in response to LCMV infection, suggesting enhanced capacity of this population to provide quality help for antibody production. Collectively these data have important implications for prime-boost vaccination strategies that seek to enhance protective immune responses mediated by Th1 CD4 T cell responses.	[Khanolkar, Aaruni; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Khanolkar, Aaruni; Williams, Matthew A.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Harty, John T.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; Utah System of Higher Education; University of Utah; University of Iowa; University of Iowa	Williams, MA (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	matthew.williams@path.utah.edu; john-harty@uiowa.edu		Williams, Matthew/0000-0002-4721-4482; Harty, John/0000-0001-7266-2802	National Institutes of Health [R37AI042767-14, RO1AI080830]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042767, R01AI080830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R37AI042767-14 (JTH) and RO1AI080830 (MAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2003, NAT IMMUNOL, V4, P212, DOI 10.1038/ni0303-212; Barron L, 2010, J IMMUNOL, V185, P6426, DOI 10.4049/jimmunol.0903940; BATTEGAY M, 1993, J IMMUNOL, V151, P5408; Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Colpitts SL, 2010, J IMMUNOL, V185, P2416, DOI 10.4049/jimmunol.1000483; Condotta SA, 2012, ADV IMMUNOL, V113, P51, DOI 10.1016/B978-0-12-394590-7.00005-1; Corbin GA, 2004, J IMMUNOL, V173, P5679, DOI 10.4049/jimmunol.173.9.5679; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Fuller MJ, 2004, J IMMUNOL, V172, P4204, DOI 10.4049/jimmunol.172.7.4204; Harrington LE, 2008, NATURE, V452, P356, DOI 10.1038/nature06672; Jabbari A, 2006, J EXP MED, V203, P919, DOI 10.1084/jem.20052237; Jabbari A, 2006, J IMMUNOL METHODS, V313, P161, DOI 10.1016/j.jim.2006.04.005; Khanolkar A, 2002, IMMUNOL RES, V26, P309, DOI 10.1385/IR:26:1-3:309; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Kim C, 2012, J IMMUNOL, V189, P2348, DOI 10.4049/jimmunol.1200244; Ludewig B, 1998, J VIROL, V72, P3812, DOI 10.1128/JVI.72.5.3812-3818.1998; MacLeod MKL, 2008, P NATL ACAD SCI USA, V105, P14521, DOI 10.1073/pnas.0807449105; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086; Nolz JC, 2011, IMMUNITY, V34, P781, DOI 10.1016/j.immuni.2011.03.020; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Oxenius A, 1995, EUR J IMMUNOL, V25, P3402, DOI 10.1002/eji.1830251230; Pearce EL, 2007, J IMMUNOL, V179, P2074, DOI 10.4049/jimmunol.179.4.2074; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pinschewer DD, 2004, J CLIN INVEST, V114, P988, DOI 10.1172/JCI200422374; Planz O, 1997, P NATL ACAD SCI USA, V94, P6874, DOI 10.1073/pnas.94.13.6874; Planz O, 1996, NATURE, V382, P726, DOI 10.1038/382726a0; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Seiler P, 2000, J VIROL, V74, P5896, DOI 10.1128/JVI.74.13.5896-5901.2000; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Subramanian H, 2012, J IMMUNOL, V188, P3223, DOI 10.4049/jimmunol.1101032; Tvinnereim AR, 2002, INFECT IMMUN, V70, P153, DOI 10.1128/IAI.70.1.153-162.2002; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; WEIBEL D, 1993, RES VIROLOGY, V144, P471, DOI 10.1016/S0923-2516(06)80062-2; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	44	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65234	10.1371/journal.pone.0065234	http://dx.doi.org/10.1371/journal.pone.0065234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762323	Green Submitted, gold, Green Published			2022-12-25	WOS:000321094800028
J	Wang, JX; Chen, L; Wang, Y; Zhang, JF; Liang, YC; Xu, D				Wang, Juexin; Chen, Liang; Wang, Yan; Zhang, Jingfen; Liang, Yanchun; Xu, Dong			A Computational Systems Biology Study for Understanding Salt Tolerance Mechanism in Rice	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; QUANTITATIVE TRAIT LOCI; HIGH-SALINITY STRESSES; ORYZA-SATIVA; DIFFERENTIAL EXPRESSION; ION HOMEOSTASIS; DROUGHT; PROTEIN; COLD; BIOSYNTHESIS	Salinity is one of the most common abiotic stresses in agriculture production. Salt tolerance of rice (Oryza sativa) is an important trait controlled by various genes. The mechanism of rice salt tolerance, currently with limited understanding, is of great interest to molecular breeding in improving grain yield. In this study, a gene regulatory network of rice salt tolerance is constructed using a systems biology approach with a number of novel computational methods. We developed an improved volcano plot method in conjunction with a new machine-learning method for gene selection based on gene expression data and applied the method to choose genes related to salt tolerance in rice. The results were then assessed by quantitative trait loci (QTL), co-expression and regulatory binding motif analysis. The selected genes were constructed into a number of network modules based on predicted protein interactions including modules of phosphorylation activity, ubiquity activity, and several proteinase activities such as peroxidase, aspartic proteinase, glucosyltransferase, and flavonol synthase. All of these discovered modules are related to the salt tolerance mechanism of signal transduction, ion pump, abscisic acid mediation, reactive oxygen species scavenging and ion sequestration. We also predicted the three-dimensional structures of some crucial proteins related to the salt tolerance QTL for understanding the roles of these proteins in the network. Our computational study sheds some new light on the mechanism of salt tolerance and provides a systems biology pipeline for studying plant traits in general.	[Wang, Juexin; Chen, Liang; Wang, Yan; Liang, Yanchun; Xu, Dong] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Wang, Juexin; Zhang, Jingfen; Xu, Dong] Univ Missouri, Dept Comp Sci, Digital Biol Lab, Columbia, MO USA; [Wang, Juexin; Zhang, Jingfen; Xu, Dong] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA	Jilin University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Liang, YC (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China.	ycliang@jlu.edu.cn; xudong@missouri.edu	Wang, Juexin/HHN-5377-2022; Chen, Liang/Y-4460-2018	Chen, Liang/0000-0001-6644-477X	National Natural Science Foundation of China [61073075, 61272207]; Science-Technology Development Project from Jilin Province of China [20120730]; National Institutes of Health [R21/R33-GM078601, R01-GM100701]; National Science Foundation [DBI-0421620]; Department of Energy [DE-SC0004898]; Direct For Biological Sciences [1025752] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078601, R01GM100701] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science-Technology Development Project from Jilin Province of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to the support of National Natural Science Foundation of China (grants 61073075 and 61272207), the Science-Technology Development Project from Jilin Province of China (grant 20120730), National Institutes of Health (R21/R33-GM078601 and R01-GM100701), National Science Foundation (#DBI-0421620), and Department of Energy (DE-SC0004898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balibrea ME, 2000, PHYSIOL PLANTARUM, V110, P503, DOI 10.1111/j.1399-3054.2000.1100412.x; Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Caesar R, 2004, J BIOL CHEM, V279, P38532, DOI 10.1074/jbc.M402939200; Chen XH, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-37; Chitteti BR, 2007, J PROTEOME RES, V6, P1718, DOI 10.1021/pr060678z; Cotsaftis O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039865; Cotsaftis O, 2011, MOL PLANT, V4, P25, DOI 10.1093/mp/ssq056; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Ding YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S12; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Duan K, 2004, CIBCB 04, V7-8, P49; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Furlanello C, 2003, NEURAL NETWORKS, V16, P641, DOI 10.1016/S0893-6080(03)00103-5; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gupta K, 2012, ACTA PHYSIOL PLANT, V34, P29, DOI 10.1007/s11738-011-0802-0; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jacoby RP, 2010, J PROTEOME RES, V9, P6595, DOI 10.1021/pr1007834; Jannink JL, 2001, TRENDS PLANT SCI, V6, P337, DOI 10.1016/S1360-1385(01)02017-9; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kitahata N, 2005, BIOORGAN MED CHEM, V13, P4491, DOI 10.1016/j.bmc.2005.04.036; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Komatsu S, 1999, THEOR APPL GENET, V98, P1304, DOI 10.1007/s001220051196; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; [来海锋 Lai Haifeng], 2010, [生物物理学报, Acta Biophysica Sinica], V26, P833; Liang YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021750; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Maas E. V., 1977, Journal of the Irrigation and Drainage Division, American Society of Civil Engineers, V103, P115; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Mito T, 2011, PLANT BIOTECHNOL J, V9, P736, DOI 10.1111/j.1467-7652.2010.00578.x; Mizuno H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-121; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Niu XM, 1996, PLANT PHYSIOL, V111, P679, DOI 10.1104/pp.111.3.679; Ogawa I, 2009, PLANT SOIL, V325, P97, DOI 10.1007/s11104-009-0116-9; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pauli S, 2004, J VIROL, V78, P12120, DOI 10.1128/JVI.78.22.12120-12128.2004; Pons R, 2011, PLANT PHYSIOL BIOCH, V49, P1399, DOI 10.1016/j.plaphy.2011.09.011; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Sapkota A, 2011, MOL BIOSYST, V7, P2615, DOI 10.1039/c1mb05120b; Schmidt R, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls011; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sreenivasulu N, 2012, GENE, V506, P265, DOI 10.1016/j.gene.2012.06.076; Tanji K.K., 1990, AGR SALINITY ASSESSM, P1; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Thiery L, 2004, J BIOL CHEM, V279, P14812, DOI 10.1074/jbc.M308456200; Turoczy Z, 2011, PLANT MOL BIOL, V75, P399, DOI 10.1007/s11103-011-9735-7; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vashisht AA, 2006, J PHOTOCH PHOTOBIO B, V84, P150, DOI 10.1016/j.jphotobiol.2006.02.010; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Walia H, 2005, PLANT PHYSIOL, V139, P822, DOI 10.1104/pp.105.065961; Wang RS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-216; Wang Y, 2000, J HORTIC SCI BIOTECH, V75, P623, DOI 10.1080/14620316.2000.11511297; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; WISE RR, 1987, PLANT PHYSIOL, V83, P278, DOI 10.1104/pp.83.2.278; WU R, 2003, ENG RICE PLANTS TREH; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang JF, 2011, PROTEINS, V79, P172, DOI 10.1002/prot.23184; Zhang JF, 2010, PROTEINS, V78, P1137, DOI 10.1002/prot.22634; Zhang T, 2006, PLANT PHYSIOL BIOCH, V44, P274, DOI 10.1016/j.plaphy.2006.06.004; Zhang XH, 2011, PLANT CELL TISS ORG, V107, P1, DOI 10.1007/s11240-011-9950-6; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	88	22	22	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64929	10.1371/journal.pone.0064929	http://dx.doi.org/10.1371/journal.pone.0064929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762267	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800010
J	Hoppe, AD; Scott, BL; Welliver, TP; Straight, SW; Swanson, JA				Hoppe, Adam D.; Scott, Brandon L.; Welliver, Timothy P.; Straight, Samuel W.; Swanson, Joel A.			N-Way FRET Microscopy of Multiple Protein-Protein Interactions in Live Cells	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; LIVING CELLS; FLUORESCENT PROTEIN; STOICHIOMETRY; ACTIVATION; CDC42	Fluorescence Resonance Energy Transfer (FRET) microscopy has emerged as a powerful tool to visualize nanoscale protein-protein interactions while capturing their microscale organization and millisecond dynamics. Recently, FRET microscopy was extended to imaging of multiple donor-acceptor pairs, thereby enabling visualization of multiple biochemical events within a single living cell. These methods require numerous equations that must be defined on a case-by-case basis. Here, we present a universal multispectral microscopy method (N-Way FRET) to enable quantitative imaging for any number of interacting and non-interacting FRET pairs. This approach redefines linear unmixing to incorporate the excitation and emission couplings created by FRET, which cannot be accounted for in conventional linear unmixing. Experiments on a three-fluorophore system using blue, yellow and red fluorescent proteins validate the method in living cells. In addition, we propose a simple linear algebra scheme for error propagation from input data to estimate the uncertainty in the computed FRET images. We demonstrate the strength of this approach by monitoring the oligomerization of three FP-tagged HIV Gag proteins whose tight association in the viral capsid is readily observed. Replacement of one FP-Gag molecule with a lipid raft-targeted FP allowed direct observation of Gag oligomerization with no association between FP-Gag and raft-targeted FP. The N-Way FRET method provides a new toolbox for capturing multiple molecular processes with high spatial and temporal resolution in living cells.	[Hoppe, Adam D.; Scott, Brandon L.] S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA; [Welliver, Timothy P.; Swanson, Joel A.] Univ Michigan, Sch Med, Program Immunol, Ann Arbor, MI USA; [Straight, Samuel W.; Swanson, Joel A.] Univ Michigan, Sch Med, Ctr Live Cell Imaging, Ann Arbor, MI USA; [Swanson, Joel A.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	South Dakota State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hoppe, AD (corresponding author), S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA.	adam.hoppe@sdstate.edu	Hoppe, Adam/U-8563-2019; Swanson, Joel A/P-4362-2014	Hoppe, Adam/0000-0003-4180-0840; Swanson, Joel A/0000-0003-0900-8212; Scott, Brandon/0000-0002-1950-0748	National Science Foundation [0953561]; South Dakota Governor's 2010 center for the Biological Control and Analysis by Applied Photonics (BCAAP); South Dakota State University Chemistry and Biochemistry startup funds; Department of Education GAANN Fellowship [P200A100103]; University of Michigan Basic Biomedical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079414] Funding Source: NIH RePORTER; Direct For Biological Sciences [0953561] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); South Dakota Governor's 2010 center for the Biological Control and Analysis by Applied Photonics (BCAAP); South Dakota State University Chemistry and Biochemistry startup funds; Department of Education GAANN Fellowship(US Department of Education); University of Michigan Basic Biomedical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based on work supported by the National Science Foundation under Grant No. 0953561, the South Dakota Governor's 2010 center for the Biological Control and Analysis by Applied Photonics (BCAAP), and South Dakota State University Chemistry and Biochemistry startup funds to ADH. A Department of Education GAANN Fellowship No. P200A100103 supported BLS. Construction of one of the microscopes was supported by funds from the University of Michigan Basic Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; Becker PL, 1996, FLUORESCENCE IMAGING, P1; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Beemiller P, 2010, MOL BIOL CELL, V21, P470, DOI 10.1091/mbc.E08-05-0494; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Bro R., 1998, MULTIWAY ANAL FOOD I; Bro R, 2009, J CHEMOMETR, V23, P324, DOI 10.1002/cem.1206; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Chen YC, 2011, J MICROSC-OXFORD, V244, P21, DOI 10.1111/j.1365-2818.2011.03488.x; Clegg R. M, 1996, FLUORESCENCE IMAGING, V137, P179; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hogue IB, 2009, J VIROL; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hoppe AD, 2008, 3D FRET RECONSTRUCTI; Hoppe Adam D., 2007, P157, DOI 10.1007/978-3-540-71331-9_6; Hoppe AD, 2009, CELL MICROBIOL, V11, P540, DOI 10.1111/j.1462-5822.2009.01283.x; Kawata S, 1996, FLUORESCENCE IMAGING, P55; Kim J, 2012, CYTOM PART A, V81A, P112, DOI 10.1002/cyto.a.21150; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, pR23; Lee J, 2010, ANGEW CHEM INT EDIT, V49, P9922, DOI 10.1002/anie.201005402; Lichten CA, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-10; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Meyer S., 1992, DATA ANAL SCI ENG; Nadrigny F, 2006, EUR BIOPHYS J BIOPHY, V35, P533, DOI 10.1007/s00249-005-0040-8; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Neher RA, 2004, MICROSC RES TECHNIQ, V64, P185, DOI 10.1002/jemt.20078; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shirakawa H, 2004, BIOPHYS J, V86, P1739, DOI 10.1016/S0006-3495(04)74242-3; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Sun YS, 2010, BIOPHYS J, V99, P1274, DOI 10.1016/j.bpj.2010.06.004; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Woehler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061096; Woehler A, 2010, BIOPHYS J, V99, P2344, DOI 10.1016/j.bpj.2010.07.053; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1	45	44	45	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64760	10.1371/journal.pone.0064760	http://dx.doi.org/10.1371/journal.pone.0064760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762252	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000019
J	Inusa, BPD; Oyewo, A; Brokke, F; Santhikumaran, G; Jogeesvaran, KH				Inusa, Baba P. D.; Oyewo, Adeola; Brokke, Felicity; Santhikumaran, Gayathriy; Jogeesvaran, K. Haran			Dilemma in Differentiating between Acute Osteomyelitis and Bone Infarction in Children with Sickle Cell Disease: The Role of Ultrasound	PLOS ONE			English	Article							VASOOCCLUSIVE CRISIS; ENHANCED MRI; ULTRASONOGRAPHY; ANEMIA	Background: Distinguishing between acute presentations of osteomyelitis (OM) and vaso-occlusive crisis (VOC) bone infarction in children with sickle cell disease (SCD) remains challenging for clinicians, particularly in culture-negative cases. We examined the combined role of ultrasound scan (USS), C -reactive protein and White blood counts (WCC) in aiding early diagnosis in children with SCD presenting acutely with non-specific symptoms such as bone pain, fever or swelling which are common in acute osteomyelitis or VOC. Methods: We reviewed the records of all children with SCD who were discharged from our department from October 2003 to December 2010 with a diagnosis of osteomyelitis based on clinical features and the results of radiological and laboratory investigations. A case control group with VOC who were investigated for OM were identified over the same period. Results: In the osteomyelitis group, USS finding of periosteal elevation and/or fluid collection was reported in 76% cases with the first scan (day 0-6). Overall 84% were diagnosed with USS (initial + repeat). 16% had negative USS. With VOC group, USS showed no evidence of fluid collection in 53/58 admissions (91%), none of the repeated USS showed any fluid collection. Mean C-reactive protein (CRP), and white cell count (WCC) were significantly higher in the OM. Conclusion: The use of Ultrasound in combination with CRP and WCC is a reliable, cost-effective diagnostic tool for differentiating osteomyelitis from VOC bone infarction in SCD. A repeat ultrasound and/or magnetic resonance imaging (MRI) scan may be is necessary to confirm the diagnosis.	[Inusa, Baba P. D.; Oyewo, Adeola; Brokke, Felicity] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Evelina Childrens Hosp, Dept Paediat, London, England; [Santhikumaran, Gayathriy] Kings Coll London, Sch Med, London WC2R 2LS, England; [Jogeesvaran, K. Haran] Guys & St Thomas NHS Fdn Trust, Evelina Childrens Hosp, Dept Paediat Radiol, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Inusa, BPD (corresponding author), Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Evelina Childrens Hosp, Dept Paediat, London, England.	baba.inusa@gstt.nhs.uk	Inusa, Baba/R-7447-2017	Inusa, Baba/0000-0003-2643-765X				Almeida A, 2005, BRIT J HAEMATOL, V129, P482, DOI 10.1111/j.1365-2141.2005.05476.x; Berger E, 2009, ARCH PEDIAT ADOL MED, V163, P251, DOI 10.1001/archpediatrics.2008.545; BONNEROT V, 1994, PEDIATR RADIOL, V24, P92, DOI 10.1007/BF02020160; Jain R, 2008, CLIN RADIOL, V63, P59, DOI 10.1016/j.crad.2007.07.017; KEELEY K, 1982, J PEDIATR-US, V101, P170, DOI 10.1016/S0022-3476(82)80111-X; Malcius D, 2009, MEDICINA-LITHUANIA, V45, P624, DOI 10.3390/medicina45080081; PIEHL FC, 1993, J PEDIATR ORTHOPED, V13, P225; Rifai A, 1997, ACTA RADIOL, V38, P139; Sadat-Ali M, 1998, J PEDIATR ORTHOPED, V18, P552, DOI 10.1097/00004694-199807000-00030; Skaggs DL, 2001, J BONE JOINT SURG AM, V83A, P1810, DOI 10.2106/00004623-200112000-00007; Streetly A, 2009, J CLIN PATHOL, V62, P26, DOI 10.1136/jcp.2008.058859; Umans H, 2000, MAGN RESON IMAGING, V18, P255, DOI 10.1016/S0730-725X(99)00137-X; William RR, 2000, CLIN RADIOL, V55, P307, DOI 10.1053/crad.1999.0377; Wong AL, 2001, PEDIATR EMERG CARE, V17, P60, DOI 10.1097/00006565-200102000-00018	14	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65001	10.1371/journal.pone.0065001	http://dx.doi.org/10.1371/journal.pone.0065001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755165	Green Published, gold			2022-12-25	WOS:000321099000029
J	Liu, X; Liao, S; Zhu, L; Xu, ZW; Zhou, YC				Liu, Xiao; Liao, Shan; Zhu, Ling; Xu, Zhiwen; Zhou, Yuancheng			Molecular Epidemiology of Porcine Cytomegalovirus (PCMV) in Sichuan Province, China: 2010-2012	PLOS ONE			English	Article							GLYCOPROTEIN-B GENE; HUMAN ENTEROVIRUSES; SEQUENCE; IDENTIFICATION; PACKAGE; DISEASE; PIGS	Porcine cytomegalovirus (PCMV) is an immunosuppressive virus that mainly inhibits the immune function of the macrophage and T-cell lymphatic systems, and has caused huge economic losses to the porcine breeding industry. Molecular epidemiological investigation of PCMV is important for prevention and treatment, and this study is the first such investigation in Sichuan Province, Southwest China. A PCMV positive infection rate of 84.4% (865/1025) confirmed that PCMV is widely distributed in Sichuan Province. A phylogenetic tree was constructed based on the PCMV glycoprotein B gene (gB) nucleotide and amino acid sequences from 24 novel Sichuan isolates and 18 other PCMV gB sequences from Genbank. PCMV does not appear to have evolved into different serotypes, and two distinct sequence groups were identified (A and B). However, whether PCMV from this region has evolved into different genotypes requires further research. Analysis of the amino acid sequences confirmed the conservation of gB, but amino acid substitutions in the major epitope region have caused antigenic drift, which may have altered the immunogenicity of PCMV.	[Liu, Xiao; Liao, Shan; Zhu, Ling; Xu, Zhiwen; Zhou, Yuancheng] Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China; [Xu, Zhiwen] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Xu, ZW (corresponding author), Sichuan Agr Univ, Coll Vet Med, Anim Biotechnol Ctr, Yaan, Peoples R China.	abtcxzw@126.com		Zhu, Ling/0000-0003-0950-5905; Xu, Zhiwen/0000-0002-9508-6593; Zhu, Ling/0000-0002-8822-5460; Zhou, Yuancheng/0000-0001-5295-826X	Fund Project for Youth Science and Technology in Sichuan Province (FPYSTSP) [200930421]	Fund Project for Youth Science and Technology in Sichuan Province (FPYSTSP)	This study was supported by Fund Project for Youth Science and Technology in Sichuan Province (FPYSTSP; Project No. 200930421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BOOTH JC, 1967, RES VET SCI, V8, P338; Clark DA, 2003, XENOTRANSPLANTATION, V10, P142, DOI 10.1034/j.1399-3089.2003.01128.x; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; CORNER AH, 1964, J COMP PATHOL THERAP, V74, P192, DOI 10.1016/S0368-1742(64)80024-2; CRANAGE MP, 1986, EMBO J, V5, P3057, DOI 10.1002/j.1460-2075.1986.tb04606.x; EDINGTON N, 1976, J COMP PATHOL, V86, P191, DOI 10.1016/0021-9975(76)90043-8; Edington N, 1986, DIS SWINE, V138, P330; Gollackner B, 2003, TRANSPLANTATION, V75, P1841, DOI 10.1097/01.TP.0000065806.90840.C1; Goltz M, 2000, VIRUS GENES, V21, P249, DOI 10.1023/A:1008156017758; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kumar S, 2012, BIOINFORMATICS, V10, P1; McGregor A, 2004, J VIROL, V78, P9872, DOI 10.1128/JVI.78.18.9872-9889.2004; Mitchell DK, 2002, PEDIATR INFECT DIS J, V21, P133, DOI 10.1097/00006454-200202000-00009; Mocarski ES, 1996, INTERVIROLOGY, V39, P320, DOI 10.1159/000150503; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; PLOWRIGHT W, 1976, J HYG-CAMBRIDGE, V76, P125, DOI 10.1017/S0022172400055017; Roizmann B. (Corresponding Author), 1992, Archives of Virology, V123, P425, DOI 10.1007/BF01317276; Rupasinghe V, 2001, J VET MED SCI, V63, P609, DOI 10.1292/jvms.63.609; SCHLEISS MR, 1994, VIROLOGY, V202, P173, DOI 10.1006/viro.1994.1333; STACZEK J, 1990, MICROBIOL REV, V54, P247, DOI 10.1128/MMBR.54.3.247-265.1990; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tucker A, 1999, TRANSPLANTATION, V31, P1460; Widen F, 2001, VIRUS GENES, V23, P339, DOI 10.1023/A:1012581508733; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	31	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64648	10.1371/journal.pone.0064648	http://dx.doi.org/10.1371/journal.pone.0064648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762243	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000011
J	Keane, BP; Lu, HJ; Papathomas, TV; Silverstein, SM; Kellman, PJ				Keane, Brian P.; Lu, Hongjing; Papathomas, Thomas V.; Silverstein, Steven M.; Kellman, Philip J.			Reinterpreting Behavioral Receptive Fields: Lightness Induction Alters Visually Completed Shape	PLOS ONE			English	Article							ILLUSORY CONTOUR; CLASSIFICATION IMAGES; BRIGHTNESS; TRANSPARENCY; PERCEPTION; MECHANISMS; CONTRAST; POLARITY	Background: A classification image (CI) technique has shown that static luminance noise near visually completed contours affects the discrimination of fat and thin Kanizsa shapes. These influential noise regions were proposed to reveal "behavioral receptive fields'' of completed contours-the same regions to which early cortical cells respond in neurophysiological studies of contour completion. Here, we hypothesized that 1) influential noise regions correspond to the surfaces that distinguish fat and thin shapes (hereafter, key regions); and 2) key region noise biases a "fat'' response to the extent that its contrast polarity (lighter or darker than background) matches the shape's filled-in surface color. Results: To test our hypothesis, we had observers discriminate fat and thin noise-embedded rectangles that were defined by either illusory or luminance-defined contours (Experiment 1). Surrounding elements ("inducers'') caused the shapes to appear either lighter or darker than the background-a process sometimes referred to as lightness induction. For both illusory and luminance-defined rectangles, key region noise biased a fat response to the extent that its contrast polarity (light or dark) matched the induced surface color. When lightness induction was minimized, luminance noise had no consistent influence on shape discrimination. This pattern arose when pixels immediately adjacent to the discriminated boundaries were excluded from the analysis (Experiment 2) and also when the noise was restricted to the key regions so that the noise never overlapped with the physically visible edges (Experiment 3). The lightness effects did not occur in the absence of enclosing boundaries (Experiment 4). Conclusions: Under noisy conditions, lightness induction alters visually completed shape. Moreover, behavioral receptive fields derived in CI studies do not correspond to contours per se but to filled-in surface regions contained by those contours. The relevance of lightness to two-dimensional shape completion supplies a new constraint for models of object perception.	[Keane, Brian P.; Papathomas, Thomas V.] Rutgers State Univ, Ctr Cognit Sci, Piscataway, NJ 08855 USA; [Keane, Brian P.; Silverstein, Steven M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Psychiat, Piscataway, NJ 08854 USA; [Keane, Brian P.; Silverstein, Steven M.] Univ Med & Dent New Jersey, Univ Behav HealthCare, Piscataway, NJ 08854 USA; [Keane, Brian P.; Lu, Hongjing; Kellman, Philip J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Papathomas, Thomas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California Los Angeles; Rutgers State University New Brunswick	Keane, BP (corresponding author), Rutgers State Univ, Ctr Cognit Sci, Piscataway, NJ 08855 USA.	Brian.Keane@gmail.com		Keane, Brian/0000-0002-7011-3380; Silverstein, Steven/0000-0002-0699-0960	UCLA Dissertation Year Fellowship; NIMH National Research Service Award [F32MH094102];  [NSF BCS-0843880]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH094102] Funding Source: NIH RePORTER	UCLA Dissertation Year Fellowship; NIMH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a UCLA Dissertation Year Fellowship and NIMH National Research Service Award (F32MH094102) to BPK, and also by a grant award (NSF BCS-0843880) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; Ahumada AJ, 1996, PERCEPTION, V25, P18; Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bressan P, 2006, PSYCHOL REV, V113, P526, DOI 10.1037/0033-295X.113.3.526; Dakin SC, 2003, P ROY SOC B-BIOL SCI, V270, P2341, DOI 10.1098/rspb.2003.2528; Dillenburger B, 2010, J NEUROPHYSIOL, V103, P55, DOI 10.1152/jn.00001.2009; Field DJ, 2000, SPATIAL VISION, V13, P51, DOI 10.1163/156856800741018; Gold JM, 2006, J VISION, V6, P356, DOI 10.1167/6.4.5; Gold JM, 2000, CURR BIOL, V10, P663, DOI 10.1016/S0960-9822(00)00523-6; Green DM, 1966, SIGNAL DETECTION THE; Grossberg S, 2005, VISION RES, V45, P1725, DOI 10.1016/j.visres.2005.01.006; Heitger F, 1998, IMAGE VISION COMPUT, V16, P407, DOI 10.1016/S0262-8856(97)00083-8; HERSHBERGER W, 1984, PERCEPT PSYCHOPHYS, V36, P92, DOI 10.3758/BF03206358; KEANE BP, 2007, J VISION, V7, P603; Keane BP, 2007, VISION RES, V47, P3460, DOI 10.1016/j.visres.2007.10.003; Keane BP, 2012, COGNITION, V123, P404, DOI 10.1016/j.cognition.2012.02.004; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Matthews N, 1997, PERCEPTION, V26, P1431, DOI 10.1068/p261431; Murray RF, 2005, J VISION, V5, P139, DOI 10.1167/5.2.5; Murray RF, 2011, J VISION, V11, DOI 10.1167/11.5.2; Nagai M, 2008, J VISION, V8, DOI 10.1167/8.7.25; Palmer EM, 2006, J EXP PSYCHOL GEN, V135, P513, DOI 10.1037/0096-3445.135.4.513; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pereverzeva M, 2009, J VISION, V9, DOI 10.1167/9.2.19; Pillow J, 2002, NEURON, V33, P805, DOI 10.1016/S0896-6273(02)00605-0; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; Ringach DL, 1996, VISION RES, V36, P3037, DOI 10.1016/0042-6989(96)00062-4; Rossi AF, 1996, VISION RES, V36, P1391, DOI 10.1016/0042-6989(95)00206-5; TAKEICHI H, 1992, PERCEPTION, V21, P313, DOI 10.1068/p210313; TJAN BS, 1995, VISION RES, V35, P3053, DOI 10.1016/0042-6989(95)00070-G; Tse PU, 2005, VISION RES, V45, P1095, DOI 10.1016/j.visres.2004.11.001; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Williams LR, 1997, NEURAL COMPUT, V9, P837, DOI 10.1162/neco.1997.9.4.837; Zhou JW, 2008, J VISION, V8, DOI 10.1167/8.12.2	35	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e62505	10.1371/journal.pone.0062505	http://dx.doi.org/10.1371/journal.pone.0062505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158IE	23750200	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900002
J	Tramacere, F; Beccai, L; Kuba, M; Gozzi, A; Bifone, A; Mazzolai, B				Tramacere, Francesca; Beccai, Lucia; Kuba, Michael; Gozzi, Alessandro; Bifone, Angelo; Mazzolai, Barbara			The Morphology and Adhesion Mechanism of Octopus vulgaris Suckers	PLOS ONE			English	Article							CEPHALOPODS	The octopus sucker represents a fascinating natural system performing adhesion on different terrains and substrates. Octopuses use suckers to anchor the body to the substrate or to grasp, investigate and manipulate objects, just to mention a few of their functions. Our study focuses on the morphology and adhesion mechanism of suckers in Octopus vulgaris. We use three different techniques (MRI, ultrasonography, and histology) and a 3D reconstruction approach to contribute knowledge on both morphology and functionality of the sucker structure in O. vulgaris. The results of our investigation are two-fold. First, we observe some morphological differences with respect to the octopus species previously studied (i.e., Octopus joubini, Octopus maya, Octopus bimaculoides/bimaculatus and Eledone cirrosa). In particular, in O. vulgaris the acetabular chamber, that is a hollow spherical cavity in other octopuses, shows an ellipsoidal cavity which roof has an important protuberance with surface roughness. Second, based on our findings, we propose a hypothesis on the sucker adhesion mechanism in O. vulgaris. We hypothesize that the process of continuous adhesion is achieved by sealing the orifice between acetabulum and infundibulum portions via the acetabular protuberance. We suggest this to take place while the infundibular part achieves a completely flat shape; and, by sustaining adhesion through preservation of sucker configuration. In vivo ultrasonographic recordings support our proposed adhesion model by showing the sucker in action. Such an underlying physical mechanism offers innovative potential cues for developing bioinspired artificial adhesion systems. Furthermore, we think that it could possibly represent a useful approach in order to investigate any potential difference in the ecology and in the performance of adhesion by different species.	[Tramacere, Francesca; Beccai, Lucia; Mazzolai, Barbara] Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy; [Tramacere, Francesca] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy; [Kuba, Michael] Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel; [Kuba, Michael] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neuronal Computat, Jerusalem, Israel; [Gozzi, Alessandro; Bifone, Angelo] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst, Rovereto, Italy	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Istituto Italiano di Tecnologia - IIT	Tramacere, F (corresponding author), Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy.	francesca.tramacere@iit.it; barbara.mazzolai@iit.it	Mazzolai, Barbara/I-8876-2016; Kuba, Michael J/AAE-7934-2022; Kuba, Michael/ABH-8394-2020; Gozzi, Alessandro/K-6342-2016	Mazzolai, Barbara/0000-0003-0722-8350; Kuba, Michael J/0000-0003-2688-736X; Gozzi, Alessandro/0000-0002-5731-4137; Beccai, Lucia/0000-0002-8754-5155				BERENGUERES J, 2007, 2007 IEEE INT C ROB, P1256; Boyle PR, 1991, UFAW HDB CARE MANAGE; De Laoaze-Duthiers H, 1884, ARCH ZOOLOGIE EXPT G, P379; Grasso FW, 2008, AM MALACOL BULL, V24, P13, DOI 10.4003/0740-2783-24.1.13; Grasso FW, 2007, BIOINSPIR BIOMIM, V2, pS170, DOI 10.1088/1748-3182/2/4/S06; GRAZIADEI P, 1962, NATURE, V195, P57, DOI 10.1038/195057a0; GRAZIADEI PPC, 1976, TISSUE CELL, V8, P229, DOI 10.1016/0040-8166(76)90049-5; GRAZIADEI PPC, 1976, J MORPHOL, V150, P639, DOI 10.1002/jmor.1051500304; Guerin J, 1908, ARCH ZOOLOGIE EXPT G, P1; KIER W M, 1992, P205; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Kier WM, 2002, INTEGR COMP BIOL, V42, P1146, DOI 10.1093/icb/42.6.1146; KIER WM, 1990, BIOL BULL, V178, P126, DOI 10.2307/1541971; Kuba M.J., 2006, INT J COMP PSYCHOL, V19, P426; MESSENGER JB, 1985, COMP BIOCHEM PHYS C, V82, P203, DOI 10.1016/0742-8413(85)90230-0; Nachtigall W., 1974, BIOL MECH ATTACHMENT; Naef A, 1972, FAUNA FLORA BAY NAPL; Niemiec J, 1885, RECHERCHES MORPHOLOG; NIXON M, 1977, S ZOOL SOC LOND, V38, P447; Packard A., 1988, P37; Rossi F, 1958, NOUVELLES CONTRIBUTI, P1; SMITH AM, 1991, J EXP BIOL, V157, P257; Varenberg M, 2008, J R SOC INTERFACE, V5, P383, DOI 10.1098/rsif.2007.1171; Varenberg M, 2007, J R SOC INTERFACE, V4, P721, DOI 10.1098/rsif.2007.0222; Wells M.J., 1978, OCTOPUS PHYSL BEHAV, V1st; WELLS MJ, 1964, J EXP BIOL, V41, P433; Young J. Z., 1971, ANATOMY NERVOUS SYST	27	72	74	8	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65074	10.1371/journal.pone.0065074	http://dx.doi.org/10.1371/journal.pone.0065074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750233	Green Published, gold			2022-12-25	WOS:000319961900035
J	Alexander, JC; Browne, S; Pandit, A; Rochev, Y				Alexander, Jennifer C.; Browne, Shane; Pandit, Abhay; Rochev, Yury			Biomaterial Constructs for Delivery of Multiple Therapeutic Genes: A Spatiotemporal Evaluation of Efficacy Using Molecular Beacons	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; NITRIC-OXIDE SYNTHASE; MESSENGER-RNA; LIVING CELLS; INTERLEUKIN-10; EXPRESSION; HYBRIDIZATION; PREDICTION; DISEASE; GROWTH	Gene therapy is emerging as a potential therapeutic approach for cardiovascular pathogenesis. An appropriate therapy may require multiple genes to enhance therapeutic outcome by modulating inflammatory response and angiogenesis in a controlled and time-dependent manner. Thus, the aim of this research was to assess the spatiotemporal efficacy of a dualgene therapy model based on 3D collagen scaffolds loaded with the therapeutic genes interleukin 10 (IL-10), a potent anti-inflammatory cytokine, and endothelial nitric oxide synthase (eNOS), a promoter of angiogenesis. A collagen-based scaffold loaded with plasmid IL-10 polyplexes and plasmid eNOS polyplexes encapsulated into microspheres was used to transfect HUVECs and HMSCs cells. The therapeutic efficacy of the system was monitored at 2, 7 and 14 days for eNOS and IL-10 mRNA expression using RT-PCR and live cell imaging molecular beacon technology. The dual gene releasing collagen-based scaffold provided both sustained and delayed release of functional polyplexes in vitro over a 14 day period which was corroborated with variation in expression levels seen using RT-PCR and MB imaging. Maximum fold increases in IL-10 mRNA and eNOS mRNA expression levels occurred at day 7 in HMSCs and HUVECs. However, IL-10 mRNA expression levels seemed dependent on frequency of media changes and/or ease of transfection of the cell type. It was demonstrated that molecular beacons are able to monitor changes in mRNA levels at various time points, in the presence of a 3D scaffolding gene carrier system and the results complemented those of RT-PCR.	[Alexander, Jennifer C.; Browne, Shane; Pandit, Abhay; Rochev, Yury] Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland; [Rochev, Yury] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Rochev, Y (corresponding author), Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway, Ireland.	yury.rochev@nuigalway.ie	Pandit, Abhay/B-6187-2008; Rochev, Yury/M-9077-2014	Pandit, Abhay/0000-0002-6292-4933; Rochev, Yury/0000-0003-4213-9476; Browne, Shane/0000-0002-1005-1712	Science Foundation Ireland; European Research Development Fund [07/SRC/B1163]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Development Fund	This material is based upon works supported by the Science Foundation Ireland and the European Research Development Fund [Grant no. 07/SRC/B1163]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JC, 2011, LAB CHIP, V11, P3908, DOI 10.1039/c1lc20447e; [Anonymous], 2012, EURO SURVEILL, P17; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bratu Diana P., 2006, V319, P1; Browne S, 2012, MOL PHARM; Cannon RO, 1998, CLIN CHEM, V44, P1809; Cattaruzza M, 2003, J BIOL CHEM, V278, P37874, DOI 10.1074/jbc.M301670200; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Curtis MW, 2009, J CARDIOVASC NURS, V24, P87, DOI 10.1097/01.JCN.0000343562.06614.49; Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Helary C, 2012, ACTA BIOMATER; Hosseinkhani H, 2006, BIOMATERIALS, V27, P4269, DOI 10.1016/j.biomaterials.2006.02.033; Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014; Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Mooney E, 2008, NANO LETT, V8, P2137, DOI 10.1021/nl073300o; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rhee WJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn039; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rissanen TT, 2007, MOL THER, V15, P1233, DOI 10.1038/sj.mt.6300175; Santangelo PJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh062; Sase K, 1997, TRENDS CARDIOVAS MED, V7, P28, DOI 10.1016/S1050-1738(96)00121-1; Schinkothe T, 2008, STEM CELLS DEV, V17, P199, DOI 10.1089/scd.2007.0175; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tsutsui M, 2009, CIRC J, V73, P986, DOI 10.1253/circj.CJ-09-0208; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694; Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65749	10.1371/journal.pone.0065749	http://dx.doi.org/10.1371/journal.pone.0065749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755278	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300095
J	Gao, J; Sun, L; Yang, XE; Liu, JX				Gao, Jun; Sun, Ling; Yang, Xiaoe; Liu, Jian-Xiang			Transcriptomic Analysis of Cadmium Stress Response in the Heavy Metal Hyperaccumulator Sedum alfredii Hance	PLOS ONE			English	Article							CRASSULACEAN ACID METABOLISM; RNA-SEQ; SUBCELLULAR-DISTRIBUTION; ARABIDOPSIS; ZINC; TOLERANCE; ECOTYPE; PLANTS; PHYTOREMEDIATION; SEQUESTRATION	The Sedum alfredii Hance hyperaccumulating ecotype (HE) has the ability to hyperaccumulate cadmium (Cd), as well as zinc (Zn) and lead (Pb) in above-ground tissues. Although many physiological studies have been conducted with these plants, the molecular mechanisms underlying their hyper-tolerance to heavy metals are largely unknown. Here we report on the generation of 9.4 gigabases of adaptor-trimmed raw sequences and the assembly of 57,162 transcript contigs in S. alfredii Hance (HE) shoots by the combination of Roche 454 and Illumina/Solexa deep sequencing technologies. We also have functionally annotated the transcriptome and analyzed the transcriptome changes upon Cd hyperaccumulation in S. alfredii Hance (HE) shoots. There are 110 contigs and 123 contigs that were up-regulated (Fold Change >= 2.0) and down-regulated (Fold Change <= 0.5) by chronic Cd treatment in S. alfredii Hance (HE) at q-value cutoff of 0.005, respectively. Quantitative RT-PCR was employed to compare gene expression patterns between S. alfredii Hance (HE) and non-hyperaccumulating ecotype (NHE). Our results demonstrated that several genes involved in cell wall modification, metal translocation and remobilization were more induced or constitutively expressed at higher levels in HE shoots than that in NHE shoots in response to Cd exposure. Together, our study provides large-scale expressed sequence information and genome-wide transcriptome profiling of Cd responses in S. alfredii Hance (HE) shoots.	[Gao, Jun; Yang, Xiaoe] Zhejiang Univ, Coll Nat Resource & Environm Sci, MOE Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Ling; Liu, Jian-Xiang] Fudan Univ, Sch Life Sci, Inst Plant Biol, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Zhejiang University; Fudan University	Yang, XE (corresponding author), Zhejiang Univ, Coll Nat Resource & Environm Sci, MOE Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	xyang581@gmail.com; jianxiangliu@fudan.edu.cn	Liu, Jian-Xiang/L-8784-2019	Liu, Jian-Xiang/0000-0003-0791-1301	Education Ministry of China [310003]; National Basic Research Program of China (973 Program) [2012CB910500]; National Natural Science Foundation of China [30630046, 21177107, 31070233, 31171157]; Shanghai Pujiang Talent Program [11PJ1400700]; Fundamental Research Funds [2013FZA6005]	Education Ministry of China(Ministry of Education, China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Talent Program; Fundamental Research Funds	This study was financially supported by grants from the Education Ministry of China (#310003), the National Basic Research Program of China (973 Program, 2012CB910500), the National Natural Science Foundation of China (#30630046; #21177107; #31070233; #31171157), Shanghai Pujiang Talent Program (11PJ1400700), and the Fundamental Research Funds for the Central Universities (2013FZA6005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borland AM, 2011, NEW PHYTOL, V191, P619, DOI 10.1111/j.1469-8137.2011.03781.x; Cai XN, 2006, J EXP BOT, V57, P2563, DOI 10.1093/jxb/erl022; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; DalCorso G, 2010, PLANT SIGNAL BEHAV, V5, P663, DOI 10.4161/psb.5.6.11425; Davin LB, 2008, NAT PROD REP, V25, P1015, DOI 10.1039/b510386j; Gupta PK, 1996, CURR SCI INDIA, V70, P45; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kaneda M, 2011, J EXP BOT, V62, P2063, DOI 10.1093/jxb/erq416; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Li TQ, 2006, PEDOSPHERE, V16, P616, DOI 10.1016/S1002-0160(06)60095-7; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Lu LL, 2008, J EXP BOT, V59, P3203, DOI 10.1093/jxb/ern174; Mallona I, 2011, PLANT PHYSIOL, V156, P1978, DOI 10.1104/pp.111.179275; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nawrot T, 2006, LANCET ONCOL, V7, P119, DOI 10.1016/S1470-2045(06)70545-9; Ni TH, 2003, ACTA BOT SIN, V45, P925; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Pilon-Smits E, 2002, CRIT REV PLANT SCI, V21, P439, DOI 10.1080/0735-260291044313; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roosens NHCJ, 2008, TRENDS PLANT SCI, V13, P208, DOI 10.1016/j.tplants.2008.02.006; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; Tian SK, 2009, NEW PHYTOL, V182, P116, DOI 10.1111/j.1469-8137.2008.02740.x; Tian SK, 2011, PLANT PHYSIOL, V157, P1914, DOI 10.1104/pp.111.183947; Tian SK, 2010, ENVIRON SCI TECHNOL, V44, P5920, DOI 10.1021/es903921t; Ueno D, 2011, PLANT J, V66, P852, DOI 10.1111/j.1365-313X.2011.04548.x; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie F., 2011, PLOS ONE, V6; Xiong YH, 2004, J ENVIRON SCI HEAL A, V39, P2925, DOI 10.1081/LESA-200034269; Yang X, 2002, CHINESE SCI BULL, V47, P1634, DOI 10.1360/02tb9359; Yang XE, 2004, PLANT SOIL, V259, P181, DOI 10.1023/B:PLSO.0000020956.24027.f2; Yang X, 2006, PLANTA, V224, P185, DOI 10.1007/s00425-005-0194-8; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	85	93	9	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64643	10.1371/journal.pone.0064643	http://dx.doi.org/10.1371/journal.pone.0064643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755133	Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300021
J	Morizane, R; Monkawa, T; Fujii, S; Yamaguchi, S; Homma, K; Matsuzaki, Y; Okano, H; Itoh, H				Morizane, Ryuji; Monkawa, Toshiaki; Fujii, Shizuka; Yamaguchi, Shintaro; Homma, Koichiro; Matsuzaki, Yumi; Okano, Hideyuki; Itoh, Hiroshi			Kidney Specific Protein-Positive Cells Derived from Embryonic Stem Cells Reproduce Tubular Structures In Vitro and Differentiate into Renal Tubular Cells	PLOS ONE			English	Article							VASCULAR PROGENITOR CELLS; KSP-CADHERIN; GROWTH-FACTOR; MOUSE KIDNEY; EXPRESSION; METANEPHROS; CLONING; FAMILY; ADULT; ROLES	Embryonic stem cells and induced pluripotent stem cells have the ability to differentiate into various organs and tissues, and are regarded as new tools for the elucidation of disease mechanisms as well as sources for regenerative therapies. However, a method of inducing organ-specific cells from pluripotent stem cells is urgently needed. Although many scientists have been developing methods to induce various organ-specific cells from pluripotent stem cells, renal lineage cells have yet to be induced in vitro because of the complexity of kidney structures and the diversity of kidney-component cells. Here, we describe a method of inducing renal tubular cells from mouse embryonic stem cells via the cell purification of kidney specific protein (KSP)-positive cells using an anti-KSP antibody. The global gene expression profiles of KSP-positive cells derived from ES cells exhibited characteristics similar to those of cells in the developing kidney, and KSP-positive cells had the capacity to form tubular structures resembling renal tubular cells when grown in a 3D culture in Matrigel. Moreover, our results indicated that KSP-positive cells acquired the characteristics of each segment of renal tubular cells through tubular formation when stimulated with Wnt4. This method is an important step toward kidney disease research using pluripotent stem cells, and the development of kidney regeneration therapies.	[Morizane, Ryuji; Monkawa, Toshiaki; Fujii, Shizuka; Yamaguchi, Shintaro; Homma, Koichiro; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo, Japan; [Matsuzaki, Yumi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan	Keio University; Keio University	Monkawa, T (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo, Japan.	monkawa@z5.keio.jp	Monkawa, Toshiaki/F-2361-2010; Homma, Koichiro/J-3146-2015; Okano, Hideyuki/I-7584-2019; Morizane, R/AAC-3215-2021	Monkawa, Toshiaki/0000-0002-7876-7661; Morizane, R/0000-0002-0377-5667; Yamaguchi, Shintaro/0000-0002-4917-033X; Matsuzaki, Yumi/0000-0002-3729-2997	KAKENHI [23890203, 21591038, 24591211]; Daiwa Securities Health Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Daiwa Securities Health Foundation	This work was supported in part by Grant-in-Aid for Scientific Research (KAKENHI, 23890203, 21591038, 24591211) and a grant from Daiwa Securities Health Foundation (http://www.daiwa-grp.jp/dsh/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Batchelder CA, 2009, DIFFERENTIATION, V78, P45, DOI 10.1016/j.diff.2009.05.001; Bruce SJ, 2007, DIFFERENTIATION, V75, P337, DOI 10.1111/j.1432-0436.2006.00149.x; ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; HAMMERMAN MR, 1994, J AM SOC NEPHROL, V5, P1; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V336, P585, DOI 10.1016/j.bbrc.2005.08.136; Mae SI, 2010, BIOCHEM BIOPH RES CO, V393, P877, DOI 10.1016/j.bbrc.2010.02.111; Morizane R, 2009, BIOCHEM BIOPH RES CO, V390, P1334, DOI 10.1016/j.bbrc.2009.10.148; Nishinakamura R, 2006, J PHYSIOL SCI, V56, P131, DOI 10.2170/physiolsci.M95; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Prozialeck Walter C, 2004, BMC Physiol, V4, P10, DOI 10.1186/1472-6793-4-10; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; ROGERS SA, 1991, J CELL BIOL, V113, P1447, DOI 10.1083/jcb.113.6.1447; Schmitt R, 1999, AM J PHYSIOL-RENAL, V276, pF367, DOI 10.1152/ajprenal.1999.276.3.F367; Sekine M, 2006, J BIOL CHEM, V281, P1008, DOI 10.1074/jbc.M509307200; Sekine M, 2012, TRANSGENIC RES, V21, P51, DOI 10.1007/s11248-011-9504-z; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016443.50138.CD; Sone M, 2003, CIRCULATION, V107, P2085, DOI 10.1161/01.CIR.0000070022.78747.1B; TAUB M, 1990, P NATL ACAD SCI USA, V87, P4002, DOI 10.1073/pnas.87.10.4002; Thomson RB, 1999, AM J PHYSIOL-RENAL, V277, pF146, DOI 10.1152/ajprenal.1999.277.1.F146; THOMSON RB, 1995, J BIOL CHEM, V270, P17594, DOI 10.1074/jbc.270.29.17594; Vigneau C, 2007, J AM SOC NEPHROL, V18, P1709, DOI 10.1681/ASN.2006101078; WOOLF AS, 1995, J CELL BIOL, V128, P171, DOI 10.1083/jcb.128.1.171; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yurugi-Kobayashi T, 2003, BLOOD, V101, P2675, DOI 10.1182/blood-2002-06-1877; Yurugi-Kobayashi T, 2006, ARTERIOSCL THROM VAS, V26, P1977, DOI 10.1161/01.ATV.0000234978.10658.41	30	36	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64843	10.1371/journal.pone.0064843	http://dx.doi.org/10.1371/journal.pone.0064843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755150	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300030
J	Harikumar, KG; Cawston, EE; Lam, PCH; Patil, A; Orry, A; Henke, BR; Abagyan, R; Christopoulos, A; Sexton, PM; Miller, LJ				Harikumar, Kaleeckal G.; Cawston, Erin E.; Lam, Polo C. H.; Patil, Achyut; Orry, Andrew; Henke, Brad R.; Abagyan, Ruben; Christopoulos, Arthur; Sexton, Patrick M.; Miller, Laurence J.			Molecular Basis for Benzodiazepine Agonist Action at the Type 1 Cholecystokinin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING; LIGAND; OPTIMIZATION; 3-(1H-INDAZOL-3-YLMETHYL)-1,5-BENZODIAZEPINES; 1,5-BENZODIAZEPINES; POCKETOME; DISCOVERY	Understanding the molecular basis of drug action can facilitate development of more potent and selective drugs. Here, we explore the molecular basis for action of a unique small molecule ligand that is a type 1 cholecystokinin (CCK) receptor agonist and type 2 CCK receptor antagonist, GI181771X. We characterize its binding utilizing structurally related radioiodinated ligands selective for CCK receptor subtypes that utilize the same allosteric ligand-binding pocket, using wild-type receptors and chimeric constructs exchanging the distinct residues lining this pocket. Intracellular calcium assays were performed to determine biological activity. Molecular models for docking small molecule agonists to the type 1 CCK receptor were developed using a ligand-guided refinement approach. The optimal model was distinct from the previous antagonist model for the same receptor and was mechanistically consistent with the current mutagenesis data. This study revealed a key role for Leu(7.39) that was predicted to interact with the isopropyl group in the N1 position of the benzodiazepine that acts as a "trigger" for biological activity. The molecular model was predictive of binding of other small molecule agonists, effectively distinguishing these from 1065 approved drug decoys with an area under curve value of 99%. The model also selectively enriched for agonist compounds, with 130 agonists identified by ROC analysis when seeded in 2175 non-agonist ligands of the type 1 CCK receptor (area under curve 78%). Benzodiazepine agonists in this series docked in consistent pose within this pocket, with a key role played by Leu7.39, whereas the role of this residue was less clear for chemically distinct agonists.	[Harikumar, Kaleeckal G.; Cawston, Erin E.; Patil, Achyut; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C. H.; Orry, Andrew; Abagyan, Ruben] Molsoft LLC, La Jolla, CA 92037 USA; [Henke, Brad R.] GlaxoSmithKline Inc, Metab Pathways & Cardiovasc Therapy Area Unit, Res Triangle Pk, NC 27709 USA; [Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA; [Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Dept Drug Discovery Biol, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	Mayo Clinic; Mayo Clinic Phoenix; GlaxoSmithKline; University of California System; University of California San Diego; Monash University; Monash University	Miller, LJ (corresponding author), 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013	Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Patil, Achyut/0000-0002-5151-3207	National Institutes of Health [R01 DK032878, U01 GM094612, U54 GM094618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, U01GM094612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK032878 (to L. J. M.), U01 GM094612 (to R. A.), and U54 GM094618 (to R. A.).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Akgun E, 2009, J MED CHEM, V52, P2138, DOI 10.1021/jm801439x; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; [Anonymous], 2004, AM J PHYSIOL-GASTR L; Aquino CJ, 1996, J MED CHEM, V39, P562, DOI 10.1021/jm950626d; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; Cawston EE, 2012, J BIOL CHEM, V287, P18618, DOI 10.1074/jbc.M111.335646; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dockray GJ, 2004, BEST PRACT RES CL EN, V18, P555, DOI 10.1016/j.beem.2004.07.003; Dockray GJ, 2012, CURR OPIN ENDOCRINOL, V19, P8, DOI 10.1097/MED.0b013e32834eb77d; Gao F, 2008, BIOORG MED CHEM LETT, V18, P4401, DOI 10.1016/j.bmcl.2008.06.053; Hadac EM, 2006, J MED CHEM, V49, P850, DOI 10.1021/jm049072h; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Harikumar KG, 2013, LIPIDS, V48, P231, DOI 10.1007/s11745-012-3744-4; Harikumar KG, 2002, J BIOL CHEM, V277, P18552, DOI 10.1074/jbc.M201164200; Henke BR, 1996, J MED CHEM, V39, P2655, DOI 10.1021/jm960249k; Henke BR, 1997, J MED CHEM, V40, P2706, DOI 10.1021/jm970265x; Hirst GC, 1996, J MED CHEM, V39, P5236, DOI 10.1021/jm9601664; Katritch V, 2010, PROTEINS, V78, P197, DOI 10.1002/prot.22507; Kufareva I, 2012, NUCLEIC ACIDS RES, V40, pD535, DOI 10.1093/nar/gkr825; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; PEARSON R K, 1987, Pancreas, V2, P79, DOI 10.1097/00006676-198701000-00012; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Totrov M, 2008, CHEM BIOL DRUG DES, V71, P15, DOI 10.1111/j.1747-0285.2007.00605.x; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Warr W, 2009, J COMPUT AID MOL DES, V23, P195, DOI 10.1007/s10822-009-9260-9	31	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21082	21095		10.1074/jbc.M113.480715	http://dx.doi.org/10.1074/jbc.M113.480715			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754289	Green Published, hybrid			2022-12-25	WOS:000322014400029
J	Ren, A; Li, MJ; Shi, L; Mu, DS; Jiang, AL; Han, Q; Zhao, MW				Ren, Ang; Li, Meng-Jiao; Shi, Liang; Mu, Da-Shuai; Jiang, Ai-Liang; Han, Qin; Zhao, Ming-Wen			Profiling and Quantifying Differential Gene Transcription Provide Insights into Ganoderic Acid Biosynthesis in Ganoderma lucidum in Response to Methyl Jasmonate	PLOS ONE			English	Article							SECONDARY METABOLISM; OXIDATIVE STRESS; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; GENOME SEQUENCE; HIGHER FUNGI; EXPRESSION; REDUCTASE; ANTITUMOR	Ganoderma lucidum is a mushroom with traditional medicinal properties that has been widely used in China and other countries in Eastern Asia. Ganoderic acids (GA) produced by G. lucidum exhibit important pharmacological activities. Previous studies have demonstrated that methyl jasmonate (MeJA) is a potent inducer of GA biosynthesis and the expression of genes involved in the GA biosynthesis pathway in G. lucidum. To further explore the mechanism of GA biosynthesis, cDNA-Amplified Fragment Length Polymorphism (cDNA-AFLP) was used to identify genes that are differentially expressed in response to MeJA. Using 64 primer combinations, over 3910 transcriptionally derived fragments (TDFs) were obtained. Reliable sequence data were obtained for 390 of 458 selected TDFs. Ninety of these TDFs were annotated with known functions through BLASTX searching the GenBank database, and 12 annotated TDFs were assigned into secondary metabolic pathways by searching the KEGGPATHWAY database. Twenty-five TDFs were selected for qRT-PCR analysis to confirm the expression patterns observed with cDNA-AFLP. The qRT-PCR results were consistent with the altered patterns of gene expression revealed by the cDNA-AFLP technique. Additionally, the transcript levels of 10 genes were measured at the mycelium, primordia, and fruiting body developmental stages of G. lucidum. The greatest expression levels were reached during primordia for all of the genes except cytochrome b2 reached its highest expression level in the mycelium stage. This study not only identifies new candidate genes involved in the regulation of GA biosynthesis but also provides further insight into MeJA-induced gene expression and secondary metabolic response in G. lucidum.	[Ren, Ang; Li, Meng-Jiao; Shi, Liang; Mu, Da-Shuai; Jiang, Ai-Liang; Han, Qin; Zhao, Ming-Wen] Nanjing Agr Univ, Key Lab Microbiol Engn Agr Environm, Coll Life Sci, Dept Microbiol,Minist Agr, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Zhao, MW (corresponding author), Nanjing Agr Univ, Key Lab Microbiol Engn Agr Environm, Coll Life Sci, Dept Microbiol,Minist Agr, Nanjing, Jiangsu, Peoples R China.	mwzhao@njau.edu.cn	Zhao, Ming-Wen/AAS-1510-2020	zhao, mingwen/0000-0002-9413-1743	National Natural Science Foundation of China [30970042]; Fundamental Research Funds for the Central Uni-versities [KYZ201121]; Chinese National Key Technology RD Program [2013BAD16B02]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Uni-versities(Fundamental Research Funds for the Central Universities); Chinese National Key Technology RD Program(National Key Technology R&D Program); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (Project No. 30970042), the Fundamental Research Funds for the Central Uni-versities (Project No. KYZ201121), the Chinese National Key Technology R&D Program (Project No. 2013BAD16B02) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atoui A, 2008, APPL ENVIRON MICROB, V74, P3596, DOI 10.1128/AEM.02842-07; Bayram O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002816; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; CHOI D, 1994, P NATL ACAD SCI USA, V91, P2329, DOI 10.1073/pnas.91.6.2329; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CREELMAN RA, 1992, P NATL ACAD SCI USA, V89, P4938, DOI 10.1073/pnas.89.11.4938; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; Hajjaj H, 2005, APPL ENVIRON MICROB, V71, P3653, DOI 10.1128/AEM.71.7.3653-3658.2005; HIROTANI M, 1990, J CHEM SOC PERK T 1, P2751, DOI 10.1039/p19900002751; Hong SY, 2008, APPL ENVIRON MICROB, V74, P6385, DOI 10.1128/AEM.01185-08; Hoppert M, 2001, ARCH MICROBIOL, V176, P285, DOI 10.1007/s002030100324; Jedinak A, 2011, INT J ONCOL, V38, P761, DOI 10.3892/ijo.2011.898; Joseph S, 2011, ACTA PHARMACEUT, V61, P335, DOI 10.2478/v10007-011-0030-6; Kimura Y, 2002, ANTICANCER RES, V22, P3309; LENDENFELD T, 1993, J BIOL CHEM, V268, P665; Li N, 2006, J MICROBIOL BIOTECHN, V16, P1940; Liang CX, 2010, APPL MICROBIOL BIOT, V86, P1367, DOI 10.1007/s00253-009-2415-8; Lin ZB, 1979, ACTA PHARM SIN, V14, P183; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mach-Aigner AR, 2010, APPL ENVIRON MICROB, V76, P1770, DOI 10.1128/AEM.02746-09; Meimaroglou Dido Maria, 2009, Int J Microbiol, V2009, P842626, DOI 10.1155/2009/842626; Mendez-Alvarez S, 2000, BIOCHEM BIOPH RES CO, V267, P953, DOI 10.1006/bbrc.1999.2070; Miyamoto I, 2009, EUR J PHARMACOL, V602, P1, DOI 10.1016/j.ejphar.2008.11.005; Mo C, 2003, BBA-MOL CELL BIOL L, V1633, P68, DOI 10.1016/S1388-1981(03)00088-X; Mu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043737; Munemasa S, 2011, PLANT PHYSIOL, V155, P553, DOI 10.1104/pp.110.162750; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Oh SY, 2005, INT J MOL MED, V16, P833; Quetglas JI, 2012, J VIROL, V86, P1758, DOI 10.1128/JVI.05666-11; Raina SK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-134; Raudaskoski M, 2012, BIOTECHNOL GENET ENG, V28, P61, DOI 10.5661/bger-28-61; Ren A, 2013, WORLD J MICROB BIOT, V29, P523, DOI 10.1007/s11274-012-1206-z; Ren A, 2010, BIORESOURCE TECHNOL, V101, P6785, DOI 10.1016/j.biortech.2010.03.118; Rochat T, 2006, APPL ENVIRON MICROB, V72, P5143, DOI 10.1128/AEM.00482-06; Shang CH, 2008, BIOSCI BIOTECH BIOCH, V72, P1333, DOI 10.1271/bbb.80011; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; Shi L, 2012, MOL BIOL REP, V39, P6149, DOI 10.1007/s11033-011-1431-9; Shi LA, 2010, APPL MICROBIOL BIOT, V88, P1243, DOI 10.1007/s00253-010-2871-1; SHIAO MS, 1992, J CHIN CHEM SOC-TAIP, V39, P669, DOI 10.1002/jccs.199200102; Sirikantaramas Supaart, 2008, Phytochemistry Reviews, V7, P467, DOI 10.1007/s11101-007-9080-2; Song J, 2006, AM J PHYSIOL-CELL PH, V290, pC1469, DOI 10.1152/ajpcell.00486.2005; Tang YJ, 2009, BIORESOURCE TECHNOL, V100, P1852, DOI 10.1016/j.biortech.2008.10.005; Vergopoulou S, 2001, J AGR FOOD CHEM, V49, P3494, DOI 10.1021/jf010074+; Vuylsteke M, 2007, NAT PROTOC, V2, P1399, DOI 10.1038/nprot.2007.174; Xu JW, 2012, APPL ENVIRON MICROB, V78, P7968, DOI 10.1128/AEM.01263-12; Xu YN, 2012, BIOTECHNOL ADV, V30, P1301, DOI 10.1016/j.biotechadv.2011.10.001; Yao HJ, 2005, J APPL MICROBIOL, V98, P941, DOI 10.1111/j.1365-2672.2004.02531.x; Yin WB, 2012, MOL MICROBIOL, V83, P1024, DOI 10.1111/j.1365-2958.2012.07986.x; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; You BJ, 2012, FOOD RES INT, V49, P634, DOI 10.1016/j.foodres.2012.09.003; You BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053616; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; Zhang BB, 2011, J AGR FOOD CHEM, V59, P1210, DOI 10.1021/jf104425w; Zhang WX, 2010, BIOPROC BIOSYST ENG, V33, P683, DOI 10.1007/s00449-009-0379-9; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106; Zheng W, 2009, FUNGAL GENET BIOL, V46, P450, DOI 10.1016/j.fgb.2009.03.005; Zhong JJ, 2009, ADV BIOCHEM ENG BIOT, V113, P79, DOI 10.1007/10_2008_26	62	41	50	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65027	10.1371/journal.pone.0065027	http://dx.doi.org/10.1371/journal.pone.0065027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762280	gold, Green Published, Green Submitted			2022-12-25	WOS:000321094800015
J	Halford, WP; Geltz, J; Gershburg, E				Halford, William P.; Geltz, Joshua; Gershburg, Edward			Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2	PLOS ONE			English	Article							CD8(+) T-CELLS; PLACEBO-CONTROLLED TRIAL; GENITAL HERPES; GLYCOPROTEIN-D; HSV-1 REACTIVATION; IMMUNE-RESPONSES; NEURONAL SPREAD; ANIMAL-MODELS; DOUBLE-BLIND; DNA VACCINE	We lack a correlate of immunity to herpes simplex virus 2 (HSV-2) that may be used to differentiate whether a HSV-2 vaccine elicits robust or anemic protection against genital herpes. This gap in knowledge is often attributed to a failure to measure the correct component of the adaptive immune response to HSV-2. However, efforts to identify a correlate of immunity have focused on subunit vaccines that contain less than 3% of HSV-2 ' s 40,000-amino-acid proteome. We were interested to determine if a correlate of immunity might be more readily identified if 1. animals were immunized with a polyvalent immunogen such as a live virus and/or 2. the magnitude of the vaccine-induced immune response was gauged in terms of the IgG antibody response to all of HSV-2 ' s antigens (pan-HSV-2 IgG). Pre-challenge pan-HSV-2 IgG levels and protection against HSV-2 were compared in mice and/or guinea pigs immunized with a gD-2 subunit vaccine, wild-type HSV-2, or one of several attenuated HSV-2 ICP0- 2 viruses (0 Delta 254, 0 Delta 810, 0 Delta RING, or 0 Delta NLS). These six HSV-2 immunogens elicited a wide range of pan-HSV-2 IgG levels spanning an similar to 500-fold range. For 5 of the 6 immunogens tested, pre-challenge levels of pan-HSV-2 IgG quantitatively correlated with reductions in HSV-2 challenge virus shedding and increased survival frequency following HSV-2 challenge. Collectively, the results suggest that pan-HSV-2 IgG levels may provide a simple and useful screening tool for evaluating the potential of a HSV-2 vaccine candidate to elicit protection against HSV-2 genital herpes.	[Halford, William P.; Geltz, Joshua; Gershburg, Edward] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA	Southern Illinois University System; Southern Illinois University	Halford, WP (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA.	halford@siumed.edu		Gershburg, Edward/0000-0003-3584-9947	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health to study the Development of an Effective Genital Herpes Vaccine [R21 AI81072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072] Funding Source: NIH RePORTER	Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine; National Institutes of Health to study the Development of an Effective Genital Herpes Vaccine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Excellence in Academic Medicine Committee of the Southern Illinois University School of Medicine, as well as a grant from the National Institutes of Health to study the Development of an Effective Genital Herpes Vaccine (R21 AI81072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN E M, 1990, Viral Immunology, V3, P207, DOI 10.1089/vim.1990.3.207; Amanna IJ, 2008, HUM VACCINES, V4, P316, DOI 10.4161/hv.4.4.5751; Aurelian L, 1999, VACCINE, V17, P1951, DOI 10.1016/S0264-410X(98)00470-8; Awasthi S, 2012, J VIROL, V86, P4586, DOI 10.1128/JVI.07203-11; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bernstein D, 2005, EXPERT REV VACCINES, V4, P615, DOI 10.1586/14760584.4.5.615; Bernstein DI, 2011, VACCINE, V29, P2071, DOI 10.1016/j.vaccine.2011.01.005; Bernstein DI, 2010, VACCINE, V28, P3748, DOI 10.1016/j.vaccine.2009.10.025; Bourne N, 2005, J INFECT DIS, V192, P2117, DOI 10.1086/498247; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Brans R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-163; Brittle EE, 2008, J VIROL, V82, P8431, DOI 10.1128/JVI.00551-08; Chentoufi AA, 2010, J IMMUNOL, V184, P2561, DOI 10.4049/jimmunol.0902322; Chu CF, 2008, J REPROD IMMUNOL, V78, P58, DOI 10.1016/j.jri.2007.08.004; Cohen J, 2010, SCIENCE, V330, P304, DOI 10.1126/science.330.6002.304; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; Delagrave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046714; Divito S, 2006, IMMUNOL RES, V36, P119, DOI 10.1385/IR:36:1:119; Dropulic LK, 2012, EXPERT REV VACCINES, V11, P1429, DOI [10.1586/ERV.12.129, 10.1586/erv.12.129]; Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020; Eo SK, 2001, J IMMUNOL, V166, P5473, DOI 10.4049/jimmunol.166.9.5473; GILMAN SC, 1981, INFECT IMMUN, V34, P880, DOI 10.1128/IAI.34.3.880-887.1981; Gyotoku T, 2002, VACCINE, V20, P2796, DOI 10.1016/S0264-410X(02)00199-8; Halford WP, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-56; Halford WP, 2011, VIRUSES AND INTERFERON: CURRENT RESEARCH, P85; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Halford WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012251; Halford WP, 2005, J THEOR BIOL, V234, P439, DOI 10.1016/j.jtbi.2004.12.007; Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022; Hosken N, 2006, J VIROL, V80, P5509, DOI 10.1128/JVI.02659-05; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Karem KL, 1997, J GEN VIROL, V78, P427, DOI 10.1099/0022-1317-78-2-427; Khanna KM, 2004, TRENDS IMMUNOL, V25, P230, DOI 10.1016/j.it.2004.02.010; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Khodai T, 2011, CLIN VACCINE IMMUNOL, V18, P1702, DOI 10.1128/CVI.05071-11; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Kuklin N, 1997, J VIROL, V71, P3138, DOI 10.1128/JVI.71.4.3138-3145.1997; Laing KJ, 2012, CLIN EXP IMMUNOL, V167, P47, DOI 10.1111/j.1365-2249.2011.04502.x; Laing KJ, 2010, J CLIN IMMUNOL, V30, P703, DOI 10.1007/s10875-010-9441-2; Ledford H, 2012, NATURE, DOI [10.1038/nature.2012.9739, DOI 10.1038/NATURE.2012.9739]; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; MANICKAN E, 1995, J VIROL, V69, P4711, DOI 10.1128/JVI.69.8.4711-4716.1995; McClements WL, 1996, P NATL ACAD SCI USA, V93, P11414, DOI 10.1073/pnas.93.21.11414; MEIGNIER B, 1988, J INFECT DIS, V158, P602, DOI 10.1093/infdis/158.3.602; MERTZ GJ, 1990, J INFECT DIS, V161, P653, DOI 10.1093/infdis/161.4.653; Morello CS, 2012, VACCINE, V30, P6541, DOI 10.1016/j.vaccine.2012.08.049; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Morrison LA, 2002, DRUGS, V62, P1119, DOI 10.2165/00003495-200262080-00001; Morrison LA, 2001, J VIROL, V75, P1195, DOI 10.1128/JVI.75.3.1195-1204.2001; NAGAFUCHI S, 1979, J GEN VIROL, V44, P715, DOI 10.1099/0022-1317-44-3-715; Natuk RJ, 2006, J VIROL, V80, P4447, DOI 10.1128/JVI.80.9.4447-4457.2006; Nicola AV, 1996, J VIROL, V70, P3815, DOI 10.1128/JVI.70.6.3815-3822.1996; OAKES JE, 1975, INFECT IMMUN, V12, P166, DOI 10.1128/IAI.12.1.166-172.1975; Orr MT, 2007, J IMMUNOL, V178, P4731, DOI 10.4049/jimmunol.178.8.4731; Posavad CM, 2010, J IMMUNOL, V184, P3250, DOI 10.4049/jimmunol.0900722; Preacher K. J., 2001, CALCULATION FISHERS; Prichard MN, 2005, VACCINE, V23, P5424, DOI 10.1016/j.vaccine.2005.02.028; Pyles RB, 2002, J VIROL, V76, P11387, DOI 10.1128/JVI.76.22.11387-11396.2002; Rouse BT, 2006, CLIN INFECT DIS, V42, P810, DOI 10.1086/500141; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Schrimpf JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022772; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shlapobersky M, 2012, J GEN VIROL, V93, P1305, DOI 10.1099/vir.0.040055-0; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; SKINNER GRB, 1992, MED MICROBIOL IMMUN, V180, P305, DOI 10.1007/BF00191551; Skinner GRB, 1997, MED MICROBIOL IMMUN, V186, P31, DOI 10.1007/s004300050043; SKINNER GRB, 1978, MED MICROBIOL IMMUN, V166, P119, DOI 10.1007/BF02121141; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; STAATS HF, 1991, J VIROL, V65, P6008, DOI 10.1128/JVI.65.11.6008-6014.1991; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103; STRAUS SE, 1994, LANCET, V343, P1460, DOI 10.1016/S0140-6736(94)92581-X; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Tirabassi RS, 2011, VACCINE, V29, P1090, DOI 10.1016/j.vaccine.2010.11.076; WEIR JP, 1989, J GEN VIROL, V70, P2587, DOI 10.1099/0022-1317-70-10-2587; Whitley RJ, 2002, J CLIN INVEST, V110, P145, DOI [10.1172/JCI200216126, 10.1172/JCI0216126]; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	80	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65523	10.1371/journal.pone.0065523	http://dx.doi.org/10.1371/journal.pone.0065523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755244	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000076
J	Kuroda, T; Hirohashi, Y; Torigoe, T; Yasuda, K; Takahashi, A; Asanuma, H; Morita, R; Mariya, T; Asano, T; Mizuuchi, M; Saito, T; Sato, N				Kuroda, Takafumi; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Yasuda, Kazuyo; Takahashi, Akari; Asanuma, Hiroko; Morita, Rena; Mariya, Tasuku; Asano, Takuya; Mizuuchi, Masahito; Saito, Tsuyoshi; Sato, Noriyuki			ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; INITIATING CELLS; CD133 EXPRESSION; IDENTIFICATION; DEFINES; POPULATION; CARCINOMAS; MARKER; SOX2	Cancer stem-like cells (CSCs)/cancer-initiating cells (CICs) are defined as a small population of cancer cells that have high tumorigenicity. Furthermore, CSCs/CICs are resistant to several cancer therapies, and CSCs/CICs are therefore thought to be responsible for cancer recurrence after treatment and distant metastasis. In epithelial ovarian cancer (EOC) cases, disease recurrence after chemotherapy is frequently observed, suggesting ovarian CSCs/CICs are involved. There are four major histological subtypes in EOC, and serous adenocarcinoma and clear cell adenocarcinoma are high-grade malignancies. We therefore analyzed ovarian CSCs/CICs from ovarian carcinoma cell lines (serous adenocarcinoma and clear cell adenocarcinoma) and primary ovarian cancer cells in this study. We isolated ovarian CSCs/CICs as an aldehyde dehydrogenase 1 high (ALDH1 high) population from 6 EOC cell lines (3 serous adenocarcinomas and 3 clear cell adenocarcinomas) by the ALDEFLUOR assay. ALDH1 high cells showed greater sphere-forming ability, higher tumorigenicity and greater invasive capability, indicating that ovarian CSCs/CICs are enriched in ALDH1 high cells. ALDH1 high cells could also be isolated from 8 of 11 primary ovarian carcinoma samples. Immunohistochemical staining revealed that higher ALDH1 expression levels in ovary cancer cases are related to poorer prognosis in both serous adenocarcinoma cases and clear cell adenocarcinoma cases. Taken together, the results indicate that ALDH1 is a marker for ovarian CSCs/CICs and that the expression level of ALDH1 might be a novel biomarker for prediction of poor prognosis.	[Kuroda, Takafumi; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Yasuda, Kazuyo; Takahashi, Akari; Asanuma, Hiroko; Morita, Rena; Mariya, Tasuku; Asano, Takuya; Mizuuchi, Masahito; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan; [Kuroda, Takafumi; Mariya, Tasuku; Asano, Takuya; Mizuuchi, Masahito; Saito, Tsuyoshi] Sapporo Med Univ, Sch Med, Dept Obstet & Gynecol, Chuo Ku, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University	Hirohashi, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, Sapporo, Hokkaido, Japan.	hirohash@sapmed.ac.jp; torigoe@sapmed.ac.jp	Hirohashi, Yoshihiko/AFQ-4227-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency, and for Cancer Research [16209013, 17016061, 15659097]; Ministry of Health, Labor and Welfare of Japan [15-17, 19-14]; Ono Cancer Research Fund; Takeda Science Foundation; National Cancer Center Research and Development Fund [23-A-44]; Grants-in-Aid for Scientific Research [24659165] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, and for Cancer Research; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ono Cancer Research Fund(Ono Cancer Research Fund); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant numbers 16209013, 17016061 and 15659097) for Practical Application Research from the Japan Science and Technology Agency, and for Cancer Research (15-17 and 19-14) from the Ministry of Health, Labor and Welfare of Japan, Ono Cancer Research Fund (to NS) and Takeda Science Foundation (to YH). This work was supported in part by the National Cancer Center Research and Development Fund (23-A-44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Burkert J, 2008, J PATHOL, V214, P564, DOI 10.1002/path.2307; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Chang B, 2009, MODERN PATHOL, V22, P817, DOI 10.1038/modpathol.2009.35; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Gangavarpu KJ, 2011, CURR PROTOC TOXICOL; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goff B, 2012, CLIN OBSTET GYNECOL, V55, P36, DOI 10.1097/GRF.0b013e3182480523; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hirohashi Y, 2012, ONCOIMMUNOLOGY, V1, P124, DOI 10.4161/onci.1.1.18075; Hirohashi Y, 2010, IMMUNOTHERAPY-UK, V2, P201, DOI 10.2217/IMT.10.10; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ishiwata I, 1987, Nihon Sanka Fujinka Gakkai Zasshi, V39, P831; Kitamura H, 2012, MOD PATHOL; Kobayashi S, 2012, STEM CELLS; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Michifuri Y, 2012, PATHOL INT, V62, P684, DOI 10.1111/j.1440-1827.2012.02851.x; Miyamoto M, 2013, J GYNECOL ONCOL, V24, P37, DOI 10.3802/jgo.2013.24.1.37; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nishida S, 2012, J UROLOGY, V188, P294, DOI 10.1016/j.juro.2012.02.2555; Parmar MKB, 2003, LANCET, V361, P2099; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Shi MF, 2010, CELL MOL LIFE SCI, V67, P3915, DOI 10.1007/s00018-010-0420-9; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Vathipadiekal V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029079; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015; Yabushita H, 1989, Nihon Sanka Fujinka Gakkai Zasshi, V41, P888; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	40	74	81	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65158	10.1371/journal.pone.0065158	http://dx.doi.org/10.1371/journal.pone.0065158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762304	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000037
J	Lukoschek, V; Cross, P; Torda, G; Zimmerman, R; Willis, BL				Lukoschek, Vimoksalehi; Cross, Peter; Torda, Gergely; Zimmerman, Rachel; Willis, Bette L.			The Importance of Coral Larval Recruitment for the Recovery of Reefs Impacted by Cyclone Yasi in the Central Great Barrier Reef	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; SCLERACTINIAN CORALS; TROPICAL CYCLONES; CLIMATE-CHANGE; PHASE-SHIFTS; DISTURBANCE; DISPERSAL; ACROPORA; GROWTH; HURRICANES	Cyclone Yasi, one of the most severe tropical storms on record, crossed the central Great Barrier Reef (GBR) in February 2011, bringing wind speeds of up to 285 km hr(-1) and wave heights of at least 10 m, and causing massive destruction to exposed reefs in the Palm Island Group. Following the cyclone, mean (+/- S.E.) hard coral cover ranged from just 2.1 (0.2) % to 5.3 (0.4) % on exposed reefs and no reproductively mature colonies of any species of Acropora remained. Although no fragments of Acropora were found at impacted exposed sites following the cyclone, small juvenile colonies of Acropora (<10 cm diameter) were present, suggesting that their small size and compact morphologies enabled them to survive the cyclone. By contrast, sheltered reefs appeared to be unaffected by the cyclone. Mean (+/- S.E.) hard coral cover ranged from 18.2 (2.4) % to 30.0 (1.0) % and a large proportion of colonies of Acropora were reproductively mature. Macroalgae accounted for 8 to 16% of benthic cover at exposed sites impacted by cyclone Yasi but were absent at sheltered sites. Mean (+/- S.E.) recruitment of acroporids to settlement tiles declined from 25.3 (4.8) recruits tile(-1) in the pre-cyclone spawning event (2010) to 15.4 (2.2) recruits tile(-1) in the first post-cyclone spawning event (2011). Yet, post-cyclone recruitment did not differ between exposed (15.2 +/- 2.1 S.E.) and sheltered sites (15.6 +/- 2.2 S.E.), despite the loss of reproductive colonies at the exposed sites, indicating larval input from external sources. Spatial variation in impacts, the survival of small colonies, and larval replenishment to impacted reefs suggest that populations of Acropora have the potential to recover from this severe disturbance, provided that the Palm Islands are not impacted by acute disturbances or suffer additional chronic stressors in the near future.	[Lukoschek, Vimoksalehi; Torda, Gergely; Zimmerman, Rachel; Willis, Bette L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Cross, Peter; Torda, Gergely; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Torda, Gergely] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Torda, Gergely] 4AIMS JCU, Townsville, Qld, Australia	James Cook University; James Cook University; Australian Institute of Marine Science	Lukoschek, V (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	vimoksalehi.lukoschek@jcu.edu.au	Torda, Gergely/ABE-6388-2020; Torda, Gergely/ABE-6400-2020	Torda, Gergely/0000-0002-4585-3045	Queensland Smart Future Fellowship; ARC Centre of Excellence for Coral Reef Studies at James Cook University; Australian Research Council through the ARC Centre of Excellence for Coral Reef Studies' [ARC COE CEO561435]	Queensland Smart Future Fellowship; ARC Centre of Excellence for Coral Reef Studies at James Cook University(Australian Research Council); Australian Research Council through the ARC Centre of Excellence for Coral Reef Studies'(Australian Research Council)	Research funding was provided by a Queensland Smart Future Fellowship to V. Lukoschek (http://www.business.qld.gov.au/industry/science/smart-futures-fund/smart-futures-fellowships) co-sponsored by the ARC Centre of Excellence for Coral Reef Studies at James Cook University, and by the Australian Research Council (ARC COE CEO561435; http://www.arc.gov.au/) through the ARC Centre of Excellence for Coral Reef Studies' (http://www.coralcoe.org.au/) funding allocation to B. Willis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Andutta FP, 2012, ESTUAR COAST SHELF S, V101, P54, DOI 10.1016/j.ecss.2012.02.013; Ayre DJ, 2000, EVOLUTION, V54, P1590; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; Babcock RC, 2003, ZOOL STUD, V42, P211; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; BLACK KP, 1991, MAR ECOL PROG SER, V74, P1, DOI 10.3354/meps074001; Brinkman R, 2011, HYDRODYNAMICS WHOLE; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Callaghan J, 2011, CLIM DYNAM, V37, P647, DOI 10.1007/s00382-010-0883-2; Coles SL, 2007, CORAL REEFS, V26, P705, DOI 10.1007/s00338-007-0257-3; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Crabbe MJC, 2008, MAR ENVIRON RES, V65, P364, DOI 10.1016/j.marenvres.2007.11.006; Crabbe MJC, 2002, B MAR SCI, V70, P939; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Done TJ, 2010, CORAL REEFS, V29, P815, DOI 10.1007/s00338-010-0637-y; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; FISK DA, 1990, MAR BIOL, V107, P485, DOI 10.1007/BF01313433; GBRMPA, 2011, IMP TROP CYCL YAS GR; Gilmour JP, 2009, MAR BIOL, V156, P1297, DOI 10.1007/s00227-009-1171-8; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Graham NAJ, 2011, CORAL REEFS, V30, P283, DOI 10.1007/s00338-010-0717-z; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Harmelin-Vivien M.L., 1994, J COASTAL RES, P211, DOI DOI 10.1111/NYAS.13322; HARRIOTT VJ, 1988, AUST J MAR FRESH RES, V39, P409; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison P. L, 2006, P 10 INT COR REEF S, P78; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; HIGHSMITH RC, 1980, OECOLOGIA, V46, P322, DOI 10.1007/BF00346259; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hughes TP, 2002, ECOLOGY, V83, P436, DOI 10.2307/2680026; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kool JT, 2011, GLOBAL ECOL BIOGEOGR, V20, P695, DOI 10.1111/j.1466-8238.2010.00637.x; Mallela J, 2009, MAR ENVIRON RES, V68, P158, DOI 10.1016/j.marenvres.2009.06.001; Markham C, 1999, TOP CONSULTANT; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Mundy CN, 2000, CORAL REEFS, V19, P124, DOI 10.1007/s003380000081; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Puotinen ML, 2007, INT J GEOGR INF SCI, V21, P97, DOI 10.1080/1365SS10600852230; Roff G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2100; Salvat, 1985, P 5 INT COR REEF S, V5, P315; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Smith LD, 2005, MAR POLLUT BULL, V51, P399, DOI 10.1016/j.marpolbul.2004.11.021; Souter P, 2010, MAR ECOL PROG SER, V416, P35, DOI 10.3354/meps08740; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; van Oppen MJH, 2011, MOL ECOL, V20, P4899, DOI 10.1111/j.1365-294X.2011.05328.x; Veron J. E., 2000, CORALS WORLD, V1-3; Wachenleld D, 1995, GBRMPA WORKSHOP SERI, V23, P134; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; WALLACE CC, 1985, MAR ECOL PROG SER, V21, P289, DOI 10.3354/meps021289; WALLACE CC, 1985, MAR BIOL, V88, P217, DOI 10.1007/BF00392585; Ward S, 2000, P 9 INT COR REEF S, V2, P1123; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Wilkinson C., 2004, STATUS CORAL REEFS W; Willis B.L., 1988, P853; Willis B. L., 1985, P 5 INT CORAL REEF C, P343; WILLIS BL, 1990, OPHELIA, V32, P145, DOI 10.1080/00785236.1990.10422029; WOLANSKI E, 1989, CONT SHELF RES, V9, P479, DOI 10.1016/0278-4343(89)90011-3; Woolsey E, 2012, MAR BIOL, V159, P793, DOI 10.1007/s00227-011-1855-8	70	40	40	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65363	10.1371/journal.pone.0065363	http://dx.doi.org/10.1371/journal.pone.0065363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755223	Green Published, gold, Green Accepted			2022-12-25	WOS:000320579400055
J	Pan, DN; Mao, CX; Wang, YX				Pan, Dongning; Mao, Chunxiao; Wang, Yong-Xu			Suppression of Gluconeogenic Gene Expression by LSD1-Mediated Histone Demethylation	PLOS ONE			English	Article							GLYCOGEN-STORAGE-DISEASE; HEPATOCELLULAR-CARCINOMA; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; STEM-CELLS; LSD1; COMPLEX; GLUCOSE-6-PHOSPHATASE; DIFFERENTIATION; ACTIVATION	Aberrant gluconeogenic gene expression is associated with diabetes, glycogen storage disease, and liver cancer. However, little is known how these genes are regulated at the chromatin level. In this study, we investigated in HepG2 cells whether histone demethylation is a potential mechanism. We found that knockdown or pharmacological inhibition of histone demethylase LSD1 causes remarkable transcription activation of two gluconeogenic genes, FBP1 and G6Pase, and consequently leads to increased de novo glucose synthesis and decreased intracellular glycogen content. Mechanistically, LSD1 occupies the promoters of FBP1 and G6Pase, and modulates their H3K4 dimethylation levels. Thus, our work identifies an epigenetic pathway directly governing gluconeogenic gene expression, which might have important implications in metabolic physiology and diseases.	[Wang, Yong-Xu] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Wang, YX (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	yongxu.wang@umassmed.edu	Pan, Dongning/P-6523-2019	Pan, Dongning/0000-0001-5463-8155	NIH/NIDDK [R01DK076118]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520, R01DK076118] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH/NIDDK (R01DK076118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2011, NAT CELL BIOL, V13, P652, DOI 10.1038/ncb2246; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bannasch P, 1997, J BIOENERG BIOMEMBR, V29, P303, DOI 10.1023/A:1022438528634; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chen MQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025564; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Chou JY, 2010, NAT REV ENDOCRINOL, V6, P676, DOI 10.1038/nrendo.2010.189; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; Franco LM, 2005, J INHERIT METAB DIS, V28, P153, DOI 10.1007/s10545-005-7500-2; Hall RK, 2007, MOL ENDOCRINOL, V21, P550, DOI 10.1210/me.2006-0307; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Herzog B, 2000, BIOCHEM J, V351, P385, DOI 10.1042/0264-6021:3510385; Kunert O, 2003, DIABETES, V52, P2475, DOI 10.2337/diabetes.52.10.2475; Labrune P, 1997, J PEDIATR GASTR NUTR, V24, P276, DOI 10.1097/00005176-199703000-00008; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lin BC, 1997, BIOCHEMISTRY-US, V36, P14096, DOI 10.1021/bi9703249; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Mutel E, 2011, J HEPATOL, V54, P529, DOI 10.1016/j.jhep.2010.08.014; Okamoto T, 2009, ARCH BIOCHEM BIOPHYS, V491, P46, DOI 10.1016/j.abb.2009.09.015; Pan DN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002761; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Rake JP, 2002, EUR J PEDIATR, V161, pS20, DOI 10.1007/s00431-002-0999-4; Roesler WJ, 2000, MOL CELL ENDOCRINOL, V162, P1, DOI 10.1016/S0303-7207(00)00198-2; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schmidt DMZ, 2007, BIOCHEMISTRY-US, V46, P4408, DOI 10.1021/bi0618621; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; TALENTE GM, 1994, ANN INTERN MED, V120, P218, DOI 10.7326/0003-4819-120-3-199402010-00008; Vander Kooi BT, 2005, MOL ENDOCRINOL, V19, P3001, DOI 10.1210/me.2004-0497; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454	42	28	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e66294	10.1371/journal.pone.0066294	http://dx.doi.org/10.1371/journal.pone.0066294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755305	Green Published, gold			2022-12-25	WOS:000320579400085
J	Rosenbluth, KH; Gimenez, F; Kells, AP; Salegio, EA; Mittermeyer, GM; Modera, K; Kohal, A; Bankiewicz, KS				Rosenbluth, Kathryn Hammond; Gimenez, Francisco; Kells, Adrian P.; Salegio, Ernesto A.; Mittermeyer, Gabriele M.; Modera, Kevin; Kohal, Anmol; Bankiewicz, Krystof S.			Automated Segmentation Tool for Brain Infusions	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; RECURRENT MALIGNANT GLIOMA; GENE-THERAPY; PARKINSON-DISEASE; NEUROTROPHIC FACTOR; IMAGE SEGMENTATION; PRIMATE BRAIN; MR-IMAGES; PHASE-I; TRIAL	This study presents a computational tool for auto-segmenting the distribution of brain infusions observed by magnetic resonance imaging. Clinical usage of direct infusion is increasing as physicians recognize the need to attain high drug concentrations in the target structure with minimal off-target exposure. By co-infusing a Gadolinium-based contrast agent and visualizing the distribution using real-time using magnetic resonance imaging, physicians can make informed decisions about when to stop or adjust the infusion. However, manual segmentation of the images is tedious and affected by subjective preferences for window levels, image interpolation and personal biases about where to delineate the edge of the sloped shoulder of the infusion. This study presents a computational technique that uses a Gaussian Mixture Model to efficiently classify pixels as belonging to either the high-intensity infusate or low-intensity background. The algorithm was implemented as a distributable plug-in for the widely used imaging platform OsiriX (R). Four independent operators segmented fourteen anonymized datasets to validate the tool's performance. The datasets were intra-operative magnetic resonance images of infusions into the thalamus or putamen of non-human primates. The tool effectively reproduced the manual segmentation volumes, while significantly reducing intra-operator variability by 67 +/- 18%. The tool will be used to increase efficiency and reduce variability in upcoming clinical trials in neuro-oncology and gene therapy.	[Rosenbluth, Kathryn Hammond; Gimenez, Francisco; Kells, Adrian P.; Salegio, Ernesto A.; Mittermeyer, Gabriele M.; Modera, Kevin; Kohal, Anmol; Bankiewicz, Krystof S.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rosenbluth, KH (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	Kate.Rosenbluth@ucsf.edu			NIH [PO1 CA118816]; NATIONAL CANCER INSTITUTE [P01CA118816] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH PO1 CA118816. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankiewicz KS, 2006, MOL THER, V14, P564, DOI 10.1016/j.ymthe.2006.05.005; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Dalrymple LS, 2007, CLIN J AM SOC NEPHRO, V2, P715, DOI 10.2215/CJN.00470107; Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Fiandaca MS, 2011, TOXINS, V3, P369, DOI 10.3390/toxins3040369; Jagannathan J, 2008, J NEUROSURG, V109, P547, DOI 10.3171/JNS/2008/109/9/0547; Krauze MT, 2007, NEURO-ONCOLOGY, V9, P393, DOI 10.1215/15228517-2007-019; Krauze MT, 2005, J NEUROSURG, V103, P923, DOI 10.3171/jns.2005.103.5.0923; Kunwar S, 2007, J CLIN ONCOL, V25, P837, DOI 10.1200/JCO.2006.08.1117; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LEI TH, 1992, IEEE T MED IMAGING, V11, P62, DOI 10.1109/42.126911; LIANG ZR, 1994, IEEE T MED IMAGING, V13, P441, DOI 10.1109/42.310875; Lidar Z, 2004, J NEUROSURG, V100, P472, DOI 10.3171/jns.2004.100.3.0472; Lonser RR, 2007, J NEUROSURG, V107, P190, DOI 10.3171/JNS-07/07/0190; Morrison PF, 2007, J NEUROSURG, V107, P74, DOI 10.3171/JNS-07/07/0074; Murad GJA, 2007, J NEUROSURG, V106, P351, DOI 10.3171/jns.2007.106.2.351; Nguyen TT, 2003, J NEUROSURG, V98, P584, DOI 10.3171/jns.2003.98.3.0584; Noble CO, 2006, CANCER RES, V66, P2801, DOI 10.1158/0008-5472.CAN-05-3535; Ostertag D, 2012, NEURO-ONCOLOGY, V14, P145, DOI 10.1093/neuonc/nor199; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Richardson RM, 2011, NEUROSURGERY, V69, P154, DOI 10.1227/NEU.0b013e318217217e; Richardson RM, 2011, MOL THER, V19, P1048, DOI 10.1038/mt.2011.11; Richardson RM, 2011, STEREOT FUNCT NEUROS, V89, P141, DOI 10.1159/000323544; Rosenbluth KH, 2012, NEUROIMAGE, V59, P2423, DOI 10.1016/j.neuroimage.2011.08.107; Saito R, 2004, CANCER RES, V64, P2572, DOI 10.1158/0008-5472.CAN-03-3631; SAMPSON JH, 2009, J NEUROSURG; Sampson JH, 2007, NEURO-ONCOLOGY, V9, P343, DOI 10.1215/15228517-2007-007; Sampson JH, 2007, AM J ROENTGENOL, V188, P703, DOI 10.2214/AJR.06.0428; Sampson JH, 2011, NEUROSURGERY, V69, P668, DOI 10.1227/NEU.0b013e3182181ba8; San Sebastian W, 2012, HUM GENE THER, V23, P210, DOI 10.1089/hum.2011.162; Su XM, 2009, HUM GENE THER, V20, P1627, DOI 10.1089/hum.2009.103; Tai CK, 2005, MOL THER, V12, P842, DOI 10.1016/j.ymthe.2005.03.017; Titterington D.M., 1985, STAT ANAL FINITE MIX; Valles F, 2010, NEUROSURGERY, V67, P1377, DOI 10.1227/NEU.0b013e3181f53a5c; Yin DL, 2011, NEUROIMAGE, V54, pS196, DOI 10.1016/j.neuroimage.2009.08.069	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64452	10.1371/journal.pone.0064452	http://dx.doi.org/10.1371/journal.pone.0064452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755125	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400016
J	Scally, A; Yngvadottir, B; Xue, YL; Ayub, Q; Durbin, R; Tyler-Smith, C				Scally, Aylwyn; Yngvadottir, Bryndis; Xue, Yali; Ayub, Qasim; Durbin, Richard; Tyler-Smith, Chris			A Genome-Wide Survey of Genetic Variation in Gorillas Using Reduced Representation Sequencing	PLOS ONE			English	Article							ALLELE FREQUENCY-SPECTRUM; EVOLUTIONARY HISTORY; DEMOGRAPHIC HISTORY; ECOLOGY; DIVERSITY; TAXONOMY; INSIGHTS; COMPLEX	All non-human great apes are endangered in the wild, and it is therefore important to gain an understanding of their demography and genetic diversity. Whole genome assembly projects have provided an invaluable foundation for understanding genetics in all four genera, but to date genetic studies of multiple individuals within great ape species have largely been confined to mitochondrial DNA and a small number of other loci. Here, we present a genome-wide survey of genetic variation in gorillas using a reduced representation sequencing approach, focusing on the two lowland subspecies. We identify 3,006,670 polymorphic sites in 14 individuals: 12 western lowland gorillas (Gorilla gorilla gorilla) and 2 eastern lowland gorillas (Gorilla beringei graueri). We find that the two species are genetically distinct, based on levels of heterozygosity and patterns of allele sharing. Focusing on the western lowland population, we observe evidence for population substructure, and a deficit of rare genetic variants suggesting a recent episode of population contraction. In western lowland gorillas, there is an elevation of variation towards telomeres and centromeres on the chromosomal scale. On a finer scale, we find substantial variation in genetic diversity, including a marked reduction close to the major histocompatibility locus, perhaps indicative of recent strong selection there. These findings suggest that despite their maintaining an overall level of genetic diversity equal to or greater than that of humans, population decline, perhaps associated with disease, has been a significant factor in recent and long-term pressures on wild gorilla populations.	[Scally, Aylwyn; Yngvadottir, Bryndis; Xue, Yali; Ayub, Qasim; Durbin, Richard; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Scally, Aylwyn] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Yngvadottir, Bryndis] Univ Cambridge, Div Biol Anthropol, Cambridge, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, Cambs, England.	cts@sanger.ac.uk	Durbin, Richard/AAE-7178-2019	Durbin, Richard/0000-0002-9130-1006; Ayub, Qasim/0000-0003-3291-0917	Wellcome Trust [098051]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust (grant number 098051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2010, EVOLUTION, V64, P271, DOI 10.1111/j.1558-5646.2009.00858.x; Alexander DH, 2009, GENOME RES, P1664; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anthony NM, 2007, P NATL ACAD SCI USA, V104, P20432, DOI 10.1073/pnas.0704816105; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Becquet C, 2009, EVOLUTION, V63, P2547, DOI 10.1111/j.1558-5646.2009.00662.x; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Brelsford A, 2012, MOL ECOL; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Clifford SL, 2004, MOL ECOL, V13, P1551, DOI 10.1111/j.1365-294X.2004.02140.x; De Groot NG, 2008, MOL ECOL, V17, P2074, DOI 10.1111/j.1365-294X.2008.03716.x; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dupont LM, 2000, PALAEOGEOGR PALAEOCL, V155, P95, DOI 10.1016/S0031-0182(99)00095-4; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; FOSSEY D, 1983, GORILLAS MIST; Garner KJ, 1996, MOL PHYLOGENET EVOL, V6, P39, DOI 10.1006/mpev.1996.0056; Gautier M, 2012, MOL ECOL; GROVES CP, 1967, NATURE, V213, P890, DOI 10.1038/213890a0; IUCN, 2022, IUCN RED LIST THREAT; Jensen-Seaman MI, 2001, MOL ECOL, V10, P2241, DOI 10.1046/j.0962-1083.2001.01365.x; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lie BA, 2005, CURR OPIN IMMUNOL, V17, P526, DOI 10.1016/j.coi.2005.07.001; Luca F, 2011, GENOME RES, V21, P1087, DOI 10.1101/gr.119792.110; Lukas D, 2004, MOL ECOL, V13, P3389, DOI 10.1111/j.1365-294X.2004.02353.x; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pilbrow V, 2010, J HUM EVOL, V59, P16, DOI 10.1016/j.jhevol.2010.01.009; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sarmiento EE, 2003, CAM S BIO EVOL ANTHR, V35, P432; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; Sepil I, 2012, MOL ECOL; Thalmann O, 2005, MOL ECOL, V14, P179, DOI 10.1111/j.1365-294X.2004.02382.x; Thalmann OH, 2007, MOL BIOL EVOL, V24, P146, DOI 10.1093/molbev/msl160; Thalmann O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-85; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566	39	15	15	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65066	10.1371/journal.pone.0065066	http://dx.doi.org/10.1371/journal.pone.0065066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750230	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900032
J	Papafragkou, E; Hewitt, J; Park, GW; Greening, G; Vinje, J				Papafragkou, Efstathia; Hewitt, Joanne; Park, Geun Woo; Greening, Gail; Vinje, Jan			Challenges of Culturing Human Norovirus in Three-Dimensional Organoid Intestinal Cell Culture Models	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; BLOOD-GROUP ANTIGEN; NORWALK VIRUS; DENDRITIC CELLS; UNITED-STATES; REPLICATION; BINDING; CACO-2; TISSUE; AMPLIFICATION	Human noroviruses are the most common cause of acute gastroenteritis worldwide. Recently, cell culture systems have been described using either human embryonic intestinal epithelial cells (Int-407) or human epithelial colorectal adenocarcinoma cells (Caco-2) growing on collagen-I porous micro carrier beads in a rotating bioreactor under conditions of physiological fluid shear. Here, we describe the efforts from two independent laboratories to implement this three dimensional (3D) cell culture system for the replication of norovirus. Int-407 and Caco-2 were grown in a rotating bioreactor for up to 28 days. Prior to infection, cells were screened for the presence of microvilli by electron microscopy and stained for junction proteins (zonula occludens-1, claudin-1, and b-catenin). Differentiated 3D cells were transferred to 24-well plates and infected with bacteria-free filtrates of various norovirus genotypes (GI. 1, GI. 3, GI. 8, GII. 2, GII. 4, GII. 7, and GII. 8). At 12 h, 24 h, and 48 h post inoculation, viral RNA from both cells and supernatants were collected and analyzed for norovirus RNA by real-time reverse transcription PCR. Despite observations of high expression of junction proteins and microvilli development in stained thin sections, our data suggest no significant increase in viral titer based on norovirus RNA copy number during the first 48 h after inoculation for the different samples and virus culture conditions tested. Our combined efforts demonstrate that 3D cell culture models using Int-407 or Caco-2 cells do not support norovirus replication and highlight the complexity and difficulty of developing a reproducible in vitro cell culture system for human norovirus.	[Papafragkou, Efstathia; Park, Geun Woo; Vinje, Jan] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA; [Papafragkou, Efstathia] US FDA, Ctr Food Safety & Appl Nutr, Div Mol Biol, Laurel, MD USA; [Hewitt, Joanne; Greening, Gail] Inst Environm Sci & Res Ltd, Kenepuru Sci Ctr, Porirua, New Zealand	Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); Institute of Environmental Science & Research (ESR) - New Zealand	Vinje, J (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA.	jvinje@cdc.gov	Vinje, Jan/ABE-6336-2020	Vinje, Jan/0000-0002-1530-3675; Hewitt, Joanne/0000-0003-0370-6394	ASM/CDC Fellowship Program in Infectious Disease and Public Health Microbiology; ESR Capability Fund	ASM/CDC Fellowship Program in Infectious Disease and Public Health Microbiology; ESR Capability Fund	This research was funded in part by the ASM/CDC Fellowship Program in Infectious Disease and Public Health Microbiology for EP. The New Zealand study was funded by the ESR Capability Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano J, 1999, J BIOL CHEM, V274, P21209, DOI 10.1074/jbc.274.30.21209; Ando T, 1997, J CLIN MICROBIOL, V35, P570, DOI 10.1128/JCM.35.3.570-577.1997; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Chan MCW, 2011, J VIROL, V85, P8427, DOI 10.1128/JVI.05016-11; DAGAN R, 1986, J MED VIROL, V19, P219, DOI 10.1002/jmv.1890190304; DOLIN R, 1975, AM J MED, V59, P761, DOI 10.1016/0002-9343(75)90461-1; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Herbst-Kralovetz MM, 2013, EMERG INFECT DIS, V19, P431, DOI 10.3201/eid1903.121029; Howell JC, 2011, REGEN MED, V6, P743, DOI [10.2217/RME.11.90, 10.2217/rme.11.90]; Huang PW, 2005, J VIROL, V79, P6714, DOI 10.1128/JVI.79.11.6714-6722.2005; Hughes JH, 1996, NASA BIOT C HOUST TX; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Lay MK, 2010, VIROLOGY, V406, P1, DOI 10.1016/j.virol.2010.07.001; Lelkes PI, 1997, IN VITRO CELL DEV-AN, V33, P344; Leung WK, 2010, HONG KONG MED J, V16, pS8; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu PB, 2010, J MED VIROL, V82, P1612, DOI 10.1002/jmv.21851; Long JP, 1998, AVIAT SPACE ENVIR MD, V69, P851; Metcalfe MG, 2008, MICROSC MICROANAL, V14, P1548; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Park GW, 2010, J FOOD PROTECT, V73, P2232, DOI 10.4315/0362-028X-73.12.2232; PINTO RM, 1994, J MED VIROL, V44, P310, DOI 10.1002/jmv.1890440317; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Straub TM, 2007, EMERG INFECT DIS, V13, P396, DOI 10.3201/eid1303.060549; Straub TM, 2011, J WATER HEALTH, V9, P225, DOI 10.2166/wh.2010.106; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; White LJ, 1996, J VIROL, V70, P6589, DOI 10.1128/JVI.70.10.6589-6597.1996; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wu SC, 2002, BIOTECHNOL PROGR, V18, P124, DOI 10.1021/bp010120q; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	39	82	88	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63485	10.1371/journal.pone.0063485	http://dx.doi.org/10.1371/journal.pone.0063485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755105	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300010
J	Wang, MQ; Ge, BS; Li, RM; Wang, XQ; Lao, J; Huang, F				Wang, Mingqing; Ge, Baosheng; Li, Renmin; Wang, Xiaoqiang; Lao, Jun; Huang, Fang			Milligram Production and Biological Activity Characterization of the Human Chemokine Receptor CCR3	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; EOSINOPHIL EOTAXIN RECEPTOR; HETEROLOGOUS EXPRESSION; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; PURIFICATION; SOLUBILIZATION; GPCR; TRAFFICKING; RECRUITMENT	Human chemokine receptor CCR3 (hCCR3) belongs to the G protein-coupled receptors (GPCRs) superfamily of membrane proteins and plays major roles in allergic diseases and angiogenesis. In order to study the structural and functional mechanism of hCCR3, it is essential to produce pure protein with biological functions on a milligram scale. Here we report the expression of hCCR3 gene in a tetracycline-inducible stable mammalian cell line. A cell clone with high hCCR3 expression was selected from 46 stably transfected cell clones and from this cell line pure hCCR3 on a milligram scale was obtained after two-step purification. Circular dichroism spectrum with a characteristic shape and magnitude for alpha-helix indicated proper folding of hCCR3 after purification. The biological activity of purified hCCR3 was verified by its high binding affinity with its endogenous ligands CCL11 and CCL24, with K-D in the range of 10(-8) M to 10(-6) M.	[Wang, Mingqing; Ge, Baosheng; Wang, Xiaoqiang; Lao, Jun; Huang, Fang] China Univ Petr Huadong, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China; [Wang, Mingqing; Ge, Baosheng; Wang, Xiaoqiang; Lao, Jun; Huang, Fang] China Univ Petr Huadong, Ctr Bioengn & Biotechnol, Qingdao, Shandong, Peoples R China; [Li, Renmin] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China	China University of Petroleum; China University of Petroleum; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Huang, F (corresponding author), China Univ Petr Huadong, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China.	fhuang@upc.edu.cn	Ge, Baosheng/AAT-4788-2020	Ge, Baosheng/0000-0001-9906-2081	National Key Basic Research Program of China [2012CB518000]; National Natural Science Foundation of China [31000377, 21073236, 21033005]; Shandong Province Natural Science Foundation [ZR2010BQ016]; program for New Century Excellent Talents in University of Ministry of Education of China [NCET-10-0815]; Natural Science Foundation for Distinguished Young Scholar of Shandong Province [JQ201008]; Fundamental Research Funds for the Central Universities [11CX04030A]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation for Distinguished Young Scholar of Shandong Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported in part by the National Key Basic Research Program of China (2012CB518000), the National Natural Science Foundation of China (No. 31000377, 21073236, 21033005), Shandong Province Natural Science Foundation (No. ZR2010BQ016), the program for New Century Excellent Talents in University of Ministry of Education of China (NCET-10-0815), the Natural Science Foundation for Distinguished Young Scholar of Shandong Province (No. JQ201008), and the Fundamental Research Funds for the Central Universities (No. 11CX04030A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Allen SJ, 2009, PROTEIN EXPRES PURIF, V66, P73, DOI 10.1016/j.pep.2009.03.001; Bane SE, 2007, PROTEIN EXPRES PURIF, V52, P348, DOI 10.1016/j.pep.2006.10.017; Bennett LD, 2011, IMMUNOLOGY, V134, P246, DOI 10.1111/j.1365-2567.2011.03485.x; Blackburn PE, 2004, BIOCHEM J, V379, P263, DOI 10.1042/BJ20031266; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Corin K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00172; Corin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025067; Corin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023036; Dairaghi DJ, 1997, J BIOL CHEM, V272, P28206, DOI 10.1074/jbc.272.45.28206; Daugherty BL, 1996, J EXP MED, V183, P2349, DOI 10.1084/jem.183.5.2349; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Forssmann U, 1997, J EXP MED, V185, P2171, DOI 10.1084/jem.185.12.2171; Grodecka M, 2012, GLYCOCONJUGATE J, V29, P93, DOI 10.1007/s10719-011-9367-9; Gutierrez J, 2004, J BIOL CHEM, V279, P14726, DOI 10.1074/jbc.M309689200; Huwiler KG, 2010, ASSAY DRUG DEV TECHN, V8, P356, DOI 10.1089/adt.2009.0257; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kitaura M, 1999, J BIOL CHEM, V274, P27975, DOI 10.1074/jbc.274.39.27975; Kitaura M, 1996, J BIOL CHEM, V271, P7725, DOI 10.1074/jbc.271.13.7725; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; O'Malley MA, 2009, PROTEIN SCI, V18, P2356, DOI 10.1002/pro.246; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roth BL, 2012, NATURE, V492, P57, DOI 10.1038/492057a; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Shukla AK, 2007, INT J BIOCHEM CELL B, V39, P931, DOI 10.1016/j.biocel.2007.01.016; Stone MJ, 2009, NEW BIOTECHNOL, V25, P299, DOI 10.1016/j.nbt.2009.03.011; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Vukoti K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046290; Wang XQ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00102; Wang XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023076; Wang XQ, 2011, P NATL ACAD SCI USA, V108, P9049, DOI 10.1073/pnas.1018185108; Wise E, 2007, BIOCHEM SOC T, V35, P755, DOI 10.1042/BST0350755; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xia HY, 2008, BBA-BIOMEMBRANES, V1778, P2203, DOI 10.1016/j.bbamem.2008.05.017; Zhang LW, 2002, J BIOL CHEM, V277, P33799, DOI 10.1074/jbc.M205488200; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v; Zidek L, 1999, NAT STRUCT BIOL, V6, P1118; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	47	13	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65500	10.1371/journal.pone.0065500	http://dx.doi.org/10.1371/journal.pone.0065500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755240	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300084
J	Zhang, H; Yu, C; Dai, J; Keller, JM; Hua, A; Sottnik, JL; Shelley, G; Hall, CL; Park, SI; Yao, Z; Zhang, J; McCauley, LK; Keller, ET				Zhang, H.; Yu, C.; Dai, J.; Keller, J. M.; Hua, A.; Sottnik, J. L.; Shelley, G.; Hall, C. L.; Park, S. I.; Yao, Z.; Zhang, J.; McCauley, L. K.; Keller, E. T.			Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of beta-catenin activation of the DKK1 promoter in prostate cancer	ONCOGENE			English	Article						prostate cancer; DKK1; PTHrP; Wnt/beta-catenin signaling; skeletal metastasis	WNT ANTAGONIST DICKKOPF-1; BONE METASTASES; RECEPTOR; GROWTH; CELLS; PTHRP; TUMOR; GENE; TRANSCRIPTION; TARGET	Prostate cancer (PCa) bone metastases are unique in that majority of them induce excessive mineralized bone matrix, through undefined mechanisms, as opposed to most other cancers that induce bone resorption. Parathyroid hormone-related protein (PTHrP) is produced by PCa cells and intermittent PTHrP exposure has bone anabolic effects, suggesting that PTHrP could contribute to the excess bone mineralization. Wnts are bone-productive factors produced by PCa cells, and the Wnt inhibitor Dickkopfs-1 (DKK1) has been shown to promote PCa progression. These findings, in conjunction with the observation that PTHrP expression increases and DKK1 expression decreases as PCa progresses, led to the hypothesis that PTHrP could be a negative regulator of DKK1 expression in PCa cells and, hence, allow the osteoblastic activity of Wnts to be realized. To test this, we first demonstrated that PTHrP downregulated DKK1 mRNA and protein expression. We then found through multiple mutated DKK1 promoter assays that PTHrP, through c-Jun activation, downregulated the DKK1 promoter through a transcription factor (TCF) response element site. Furthermore, chromatin immunoprecipitation (ChIP) and re-ChIP assays revealed that PTHrP mediated this effect through inducing c-Jun to bind to a transcriptional activator complex consisting of beta-catenin, which binds the most proximal DKK1 promoter, the TCF response element. Together, these results demonstrate a novel signaling linkage between PTHrP and Wnt signaling pathways that results in downregulation of a Wnt inhibitor allowing for Wnt activity that could contribute the osteoblastic nature of PCa.	[Zhang, H.; Yu, C.; Dai, J.; Keller, J. M.; Hua, A.; Sottnik, J. L.; Shelley, G.; Hall, C. L.; Keller, E. T.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; [Yu, C.; Yao, Z.] Tianjin Med Univ, Dept Immunol, Tianjin Key Lab Cellular & Mol Immunol, Key Lab Educ Minist, Tianjin, Peoples R China; [Park, S. I.; McCauley, L. K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Zhang, J.] Guangxi Med Univ, Ctr Translat Med Res, Guangxi, Peoples R China; [McCauley, L. K.; Keller, E. T.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Tianjin Medical University; University of Michigan System; University of Michigan; Guangxi Medical University; University of Michigan System; University of Michigan	Keller, ET (corresponding author), Univ Michigan, Sch Med, Dept Urol, 5308 CC,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.	etkeller@umich.edu	Keller, Evan T/M-1446-2016; Park, Serk In/D-2840-2011; Dai, Jin/GVT-2414-2022; ZHANG, JIAN/Q-6334-2018	Keller, Evan T/0000-0002-7592-7535; Park, Serk In/0000-0001-8643-5096; Dai, Jin/0000-0003-3063-746X; Hall, Christopher/0000-0003-1421-1733	NIH [PO1-CA939000]; US Department of Defense [W81XWH-10-1-0546]; NATIONAL CANCER INSTITUTE [P01CA093900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000114] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NIH PO1-CA939000 (ETK and LKM), and the US Department of Defense W81XWH-10-1-0546 (SIP).	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Asadi F, 1996, HUM PATHOL, V27, P1319, DOI 10.1016/S0046-8177(96)90344-5; Azarani A, 1996, J BIOL CHEM, V271, P14931, DOI 10.1074/jbc.271.25.14931; Azari S, 2007, BIOLOGICALS, V35, P195, DOI 10.1016/j.biologicals.2006.10.001; BROWN PH, 1994, ONCOGENE, V9, P791; Chirgwin J. M., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P308; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; Deftos LJ, 2005, BIOCHEM BIOPH RES CO, V327, P468, DOI 10.1016/j.bbrc.2004.11.162; Dennler S, 2000, J BIOL CHEM, V275, P28858, DOI 10.1074/jbc.M910358199; Dougherty KM, 1999, CANCER RES, V59, P6015; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; GUISE TA, 1993, J CLIN ENDOCR METAB, V77, P40, DOI 10.1210/jc.77.1.40; Hall CL, 2008, PROSTATE, V68, P1396, DOI 10.1002/pros.20805; Hall CL, 2006, CANCER METAST REV, V25, P551, DOI 10.1007/s10555-006-9022-2; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; HENDERSON E, 1994, MOL CELL BIOL, V14, P655, DOI 10.1128/MCB.14.1.655; IWAMURA M, 1993, CANCER RES, V53, P1724; Kane N, 2008, MOL ENDOCRINOL, V22, P716, DOI 10.1210/me.2007-0316; Keller ET, 2004, J CELL BIOCHEM, V91, P718, DOI 10.1002/jcb.10662; Kitagawa Y, 2005, CANCER RES, V65, P10921, DOI 10.1158/0008-5472.CAN-05-1809; Koh AJ, 1999, ENDOCRINOLOGY, V140, P3154, DOI 10.1210/en.140.7.3154; Koppen A, 2007, CANCER LETT, V256, P218, DOI 10.1016/j.canlet.2007.06.011; Kremer R, 2012, ADV EXP MED BIOL, V720, P145, DOI 10.1007/978-1-4614-0254-1_12; Lee J, 2008, GYNECOL ONCOL, V109, P270, DOI 10.1016/j.ygyno.2008.01.034; Lee YC, 2011, CANCER RES, V71, P5194, DOI 10.1158/0008-5472.CAN-10-4374; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Li ZG, 2008, J CLIN INVEST, V118, P2697, DOI 10.1172/JCI33093; Liao JH, 2008, INT J CANCER, V123, P2267, DOI 10.1002/ijc.23602; Lu Y, 2007, CANCER RES, V67, P3646, DOI 10.1158/0008-5472.CAN-06-1210; Lupp A, 2010, EUR J ENDOCRINOL, V162, P979, DOI 10.1530/EJE-09-0821; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maehata T, 2008, WORLD J GASTROENTERO, V14, P2702, DOI 10.3748/wjg.14.2702; McCauley LK, 2012, J BONE MINER RES, V27, P1231, DOI 10.1002/jbmr.1617; Muller M, 2009, INT J MOL MED, V24, P373, DOI 10.3892/ijmm_00000242; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Navarro D, 2010, CARCINOGENESIS, V31, P394, DOI 10.1093/carcin/bgp317; Nelson JB, 2003, J UROLOGY, V169, P1143, DOI 10.1097/01.ju.0000042162.08938.27; Perez-Martinez FC, 2007, J CLIN PATHOL, V60, P290, DOI 10.1136/jcp.2006.037853; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Rabbani SA, 1999, INT J CANCER, V80, P257, DOI 10.1002/(SICI)1097-0215(19990118)80:2<257::AID-IJC15>3.3.CO;2-V; Robinson DR, 2008, CURR DRUG TARGETS, V9, P571; Sepulveda VAT, 2002, REGUL PEPTIDES, V105, P109, DOI 10.1016/S0167-0115(02)00007-1; Thompson EJ, 2002, MOL CARCINOGEN, V35, P157, DOI 10.1002/mc.10090; UY HL, 1995, ENDOCRINOLOGY, V136, P3207, DOI 10.1210/en.136.8.3207; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377; Zhong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022129	52	15	20	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2464	2477		10.1038/onc.2013.203	http://dx.doi.org/10.1038/onc.2013.203			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23752183	Green Accepted			2022-12-25	WOS:000336033600006
J	LeMaoult, J; Daouya, M; Wu, J; Loustau, M; Horuzsko, A; Carosella, ED				LeMaoult, Joel; Daouya, Marina; Wu, Juan; Loustau, Maria; Horuzsko, Anatolij; Carosella, Edgardo D.			Synthetic HLA-G proteins for therapeutic use in transplantation	FASEB JOURNAL			English	Article						engineered molecules; immune regulation; therapy; tolerance	NATURAL-KILLER-CELLS; G EXPRESSION; INHIBITORY RECEPTOR; DENDRITIC CELLS; UP-REGULATION; G MOLECULE; G ANTIGEN; T-CELLS; CRYSTAL-STRUCTURE; PATHWAY	The human leukocyte antigen (HLA)-G is a tolerogenic molecule, whose expression by allografts is associated with better acceptance. An increasing interest in producing HLA-G as a clinical-grade molecule for therapy use is impaired by its complexity and limited stability. Our purpose was to engineer simpler and more stable HLA-G-derived molecules than the full-length HLA-G trimolecular complex that are also tolerogenic, functional as soluble molecules, and compatible with good manufacturing practice (GMP) production conditions. We present two synthetic molecules: ((3)-L)(x2) and ((1)-(3))(x2) polypeptides. We show their capability to bind the HLA-G receptor LILRB2 and their functions in vitro and in vivo. The ((1)-(3))(x2) polypeptide proved to be a potent tolerogenic molecule in vivo: One treatment of skin allograft recipient mice with ((1)-(3))(x2) was sufficient to significantly prolong graft survival, and four weekly treatments induced complete tolerance. Furthermore, ((1)-(3))(x2) was active as a soluble molecule and capable of inhibiting the proliferation of tumor cell lines, as does the full length HLA-G trimolecular complex. Thus, the synthetic ((1)-(3))(x2) polypeptide is a stable and simpler alternative to the full-length HLA-G molecule. It can be produced under GMP conditions, it functions as a soluble molecule, and it is at least as tolerogenic as HLA-G in vivo.LeMaoult, J., Daouya, M., Wu, J., Loustau, M., Horuzsko, A., Carosella, E. D. Synthetic HLA-G proteins for therapeutic use in transplantation.	[LeMaoult, Joel; Daouya, Marina; Loustau, Maria; Carosella, Edgardo D.] Commissariat Energie Atom & Energies Alternat CEA, Inst Emerging Dis & Innovat Therapies iMETI, Res Div Hematol & Immunol SRHI, Paris, France; [LeMaoult, Joel; Daouya, Marina; Loustau, Maria; Carosella, Edgardo D.] Univ Paris Diderot, Sorbonne Paris Cite, Unite Mixte Rech UMR E 5, Inst Univ Hematol,St Louis Hosp, Paris, France; [Wu, Juan; Horuzsko, Anatolij] Georgia Hlth Sci Univ, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA USA	CEA; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University System of Georgia; Augusta University	LeMaoult, J (corresponding author), Hop St Louis, CEA IMETI SRHI, 1 Ave Claude Vellefaux, F-75475 Paris, France.	joel.lemaoult@cea.fr	LeMaoult, Joel/E-9583-2011	LeMaoult, Joel/0000-0002-4513-9482	Commissariat a l'Energie Atomique et aux Energies Alternatives; U.S. National Institutes of Health [R56 AI055923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055923] Funding Source: NIH RePORTER	Commissariat a l'Energie Atomique et aux Energies Alternatives; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Commissariat a l'Energie Atomique et aux Energies Alternatives, and by U.S. National Institutes of Health grant R56 AI055923 (to A.H.). The authors declare no conflicts of interest.	Agaugue S, 2011, BLOOD, V117, P7021, DOI 10.1182/blood-2010-07-294389; Aractingi S, 2001, AM J PATHOL, V159, P71, DOI 10.1016/S0002-9440(10)61675-6; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Caumartin J, 2007, EMBO J, V26, P1423, DOI 10.1038/sj.emboj.7601570; Cirulli V, 2006, DIABETES, V55, P1214, DOI 10.2337/db05-0731; Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102; Colonna M, 1998, J IMMUNOL, V160, P3096; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Davies B, 2001, AM J REPROD IMMUNOL, V45, P103, DOI 10.1111/j.8755-8920.2001.450207.x; El Ibrahim E, 2004, INT J CANCER, V108, P243, DOI 10.1002/ijc.11456; Favier B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021011; Gonen-Gross T, 2005, J IMMUNOL, V175, P4866, DOI 10.4049/jimmunol.175.8.4866; Gonen-Gross T, 2003, J IMMUNOL, V171, P1343, DOI 10.4049/jimmunol.171.3.1343; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; HoWangYin KY, 2012, CELL MOL LIFE SCI, V69, P4041, DOI 10.1007/s00018-012-1069-3; Ibrahim EC, 2001, CANCER RES, V61, P6838; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Lefebvre S, 2002, J PATHOL, V196, P266, DOI 10.1002/path.1039; LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101; Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105; Liang SY, 2002, EUR J IMMUNOL, V32, P2418, DOI 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L; Lila N, 2000, LANCET, V355, P2138, DOI 10.1016/S0140-6736(00)02386-2; Lopes CT, 2008, TRANSPL P, V40, P856, DOI 10.1016/j.transproceed.2008.02.051; Lozano JM, 2002, AIDS, V16, P347, DOI 10.1097/00002030-200202150-00005; Mallet V, 1999, INT IMMUNOL, V11, P889, DOI 10.1093/intimm/11.6.889; McMaster M, 1998, J IMMUNOL, V160, P5922; Naji A, 2007, BLOOD, V110, P3936, DOI 10.1182/blood-2007-04-083139; Nuckel H, 2005, BLOOD, V105, P1694, DOI 10.1182/blood-2004-08-3335; Paul P, 1998, P NATL ACAD SCI USA, V95, P4510, DOI 10.1073/pnas.95.8.4510; Polakova K, 2000, NEOPLASMA, V47, P342; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Real LM, 1999, INT J CANCER, V81, P512; Rebmann V, 2007, SEMIN CANCER BIOL, V17, P422, DOI 10.1016/j.semcancer.2007.06.010; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Rouas-Freiss N, 1999, SEMIN CANCER BIOL, V9, P3, DOI 10.1006/scbi.1998.0103; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P5249, DOI 10.1073/pnas.94.10.5249; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Shiroishi M, 2009, PROTEIN PEPTIDE LETT, V16, P447, DOI 10.2174/092986609787848108; Urosevic M, 2002, BLOOD, V99, P609, DOI 10.1182/blood.V99.2.609; Urosevic M, 2001, AM J PATHOL, V159, P817, DOI 10.1016/S0002-9440(10)61756-7; Verloes A, 2011, J IMMUNOL, V186, P2663, DOI 10.4049/jimmunol.1001081	49	29	36	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3643	3651		10.1096/fj.13-228247	http://dx.doi.org/10.1096/fj.13-228247			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23752205	Green Published			2022-12-25	WOS:000328840500023
J	Ghosh, A; Saminathan, H; Kanthasamy, A; Anantharam, V; Jin, HJ; Sondarva, G; Harischandra, DS; Qian, ZQ; Rana, A; Kanthasamy, AG				Ghosh, Anamitra; Saminathan, Hariharan; Kanthasamy, Arthi; Anantharam, Vellareddy; Jin, Huajun; Sondarva, Gautam; Harischandra, Dilshan S.; Qian, Ziqing; Rana, Ajay; Kanthasamy, Anumantha G.			The Peptidyl-prolyl Isomerase Pin1 Up-regulation and Proapoptotic Function in Dopaminergic Neurons RELEVANCE TO THE PATHOGENESIS OF PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dopamine; Neurobiology; Neurodegenerative Diseases; Neuroprotection; Parkinson Disease; MPTP; Pin1; Caspase-3; Juglone	COUPLED RECEPTOR KINASES; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; CIS/TRANS ISOMERASES; NONMOTOR SYMPTOMS; MOUSE MODEL; CELL-DEATH; SERINE 129; PROTEIN; PHOSPHORYLATION	Parkinson disease (PD) is a chronic neurodegenerative disease characterized by a slow and progressive degeneration of dopaminergic neurons in substantia nigra. The pathophysiological mechanisms underlying PD remain unclear. Pin1, a major peptidyl-prolyl isomerase, has recently been associated with certain diseases. Notably, Ryo et al. (Ryo, A., Togo, T., Nakai, T., Hirai, A., Nishi, M., Yamaguchi, A., Suzuki, K., Hirayasu, Y., Kobayashi, H., Perrem, K., Liou, Y. C., and Aoki, I. (2006) J. Biol. Chem. 281, 4117-4125) implicated Pin1 in PD pathology. Therefore, we sought to systematically characterize the role of Pin1 in PD using cell culture and animal models. To our surprise we observed a dramatic up-regulation of Pin1 mRNA and protein levels in dopaminergic MN9D neuronal cells treated with the parkinsonian toxicant 1-methyl-4-phenylpyridinium (MPP+) as well as in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model. Notably, a marked expression of Pin1 was also observed in the substantia nigra of human PD brains along with a high co-localization of Pin1 within dopaminergic neurons. In functional studies, siRNA-mediated knockdown of Pin1 almost completely prevented MPP+-induced caspase-3 activation and DNA fragmentation, indicating that Pin1 plays a proapoptotic role. Interestingly, multiple pharmacological Pin1 inhibitors, including juglone, attenuated MPP+-induced Pin1 up-regulation, -synuclein aggregation, caspase-3 activation, and cell death. Furthermore, juglone treatment in the MPTP mouse model of PD suppressed Pin1 levels and improved locomotor deficits, dopamine depletion, and nigral dopaminergic neuronal loss. Collectively, our findings demonstrate for the first time that Pin1 is up-regulated in PD and has a pathophysiological role in the nigrostriatal dopaminergic system and suggest that modulation of Pin1 levels may be a useful translational therapeutic strategy in PD.	[Harischandra, Dilshan S.; Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Iowa Ctr Adv Neurotoxicol, Ames, IA 50011 USA; [Sondarva, Gautam; Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, Maywood, IL 60153 USA; [Qian, Ziqing] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Rana, Ajay] Hines Vet Affairs Med Ctr, Hines, IL 60141 USA	Iowa State University; Loyola University Chicago; University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Kanthasamy, AG (corresponding author), Iowa State Univ, Dept Biomed Sci, Iowa Ctr Adv Neurotoxicol, Ames, IA 50011 USA.	akanthas@iastate.edu	Ghosh, Anamitra/C-5118-2015; Qian, Ziqing/N-9887-2014; Rana, Ajay/ABE-3739-2020	Qian, Ziqing/0000-0001-9452-1007; Rana, Ajay/0000-0003-0951-2566; Saminathan, Hariharan/0000-0003-0009-7028; Kanthasamy, Arthi/0000-0003-4654-9907; Ghosh, Anamitra/0000-0001-9740-2070; Harischandra, Dilshan/0000-0003-3220-8765; Kanthasamy, Anumantha/0000-0002-6454-4264	National Institutes of Health RO1 [N5074443, NS65167, GM55835]; Veterans Affairs Merit Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065167, R01NS074443] Funding Source: NIH RePORTER	National Institutes of Health RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants N5074443 (to A. G. K.), NS65167 (to A. K.), and GM55835 (to A. R.).; Recipient of a Veterans Affairs Merit Award.	Ai ZhengHua, 2009, Asian Cardiovasc Thorac Ann, V17, P157, DOI 10.1177/0218492309103297; Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Anantharam V, 2007, NEUROTOXICOLOGY, V28, P988, DOI 10.1016/j.neuro.2007.08.008; Atchison FW, 2004, FRONT BIOSCI-LANDMRK, V9, P3248, DOI 10.2741/1476; Barone MC, 2008, J NEUROCHEM, V106, P734, DOI 10.1111/j.1471-4159.2008.05427.x; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Becker EBE, 2007, CELL CYCLE, V6, P1332, DOI 10.4161/cc.6.11.4316; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x; Castro DS, 2001, J BIOL CHEM, V276, P43277, DOI 10.1074/jbc.M107013200; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Esnault S, 2008, CRIT REV IMMUNOL, V28, P45, DOI 10.1615/CritRevImmunol.v28.i1.30; Esnault S, 2007, J ALLERGY CLIN IMMUN, V120, P1082, DOI 10.1016/j.jaci.2007.06.024; Ghosh A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-241; Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hu XM, 2011, J NEUROSCI, V31, P247, DOI 10.1523/JNEUROSCI.4589-10.2011; Hutton M, 2001, TRENDS MOL MED, V7, P467, DOI 10.1016/S1471-4914(01)02123-2; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Jeong HG, 2009, J IMMUNOL, V183, P6689, DOI 10.4049/jimmunol.0901431; Joseph James D, 2003, Prog Cell Cycle Res, V5, P477; KASTNER A, 1992, J NEUROCHEM, V59, P1080, DOI 10.1111/j.1471-4159.1992.tb08350.x; Kesavapany S, 2007, MOL BIOL CELL, V18, P3645, DOI 10.1091/mbc.E07-03-0237; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lee KY, 2011, MOL CELLS, V32, P107, DOI 10.1007/s10059-011-0074-y; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li HY, 2006, ONCOL REP, V16, P491; Li QM, 2007, J NEUROSCI, V27, P8395, DOI 10.1523/JNEUROSCI.2478-07.2007; Liu T, 2010, J MED CHEM, V53, P2494, DOI 10.1021/jm901778v; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Lv L, 2010, APOPTOSIS, V15, P41, DOI 10.1007/s10495-009-0409-8; Machiya Y, 2010, J BIOL CHEM, V285, P40732, DOI 10.1074/jbc.M110.141952; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Martinez-Martin P, 2009, NEUROLOGY, V73, P1584, DOI 10.1212/WNL.0b013e3181c0d416; Maruszak A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-115; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Miyashita H, 2003, ONCOL REP, V10, P455; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Rangasamy V, 2012, P NATL ACAD SCI USA, V109, P8149, DOI 10.1073/pnas.1200804109; Roy A., 2012, PLOS ONE, V7; Rudrabhatla P, 2010, J ALZHEIMERS DIS, V19, P389, DOI 10.3233/JAD-2010-1243; Rudrabhatla P, 2009, J NEUROSCI, V29, P14869, DOI 10.1523/JNEUROSCI.4469-09.2009; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Song C, 2010, MOL PHARMACOL, V77, P621, DOI 10.1124/mol.109.062174; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Sun F, 2005, J PHARMACOL EXP THER, V315, P69, DOI 10.1124/jpet.105.084632; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669	66	58	62	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21955	10.1074/jbc.M112.444224	http://dx.doi.org/10.1074/jbc.M112.444224			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23754278	hybrid, Green Published			2022-12-25	WOS:000328841900043
J	Wang, XC; Jin, CY; Tang, Y; Tang, LY; Zhang, YE				Wang, Xiangchun; Jin, Chaoyang; Tang, Yi; Tang, Liu-Ya; Zhang, Ying E.			Ubiquitination of Tumor Necrosis Factor Receptor-associated Factor 4 (TRAF4) by Smad Ubiquitination Regulatory Factor 1 (Smurf1) Regulates Motility of Breast Epithelial and Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Migration; E3 Ubiquitin Ligase; Rac1; Tight Junctions; TRAF; Ubiquitination; Smurf1; TRAF4; Monoubiquitination	LIGASE SMURF2; TRAF4-DEFICIENT MICE; TGF-BETA; DEGRADATION; POLARITY; PATHWAY; MIGRATION; TARGETS; PROTEIN; DIFFERENTIATION	Smad ubiquitin regulatory factors (Smurfs) are HECT-domain ubiquitin E3 ligases that regulate diverse cellular processes, including normal and tumor cell migration. However, the underlying mechanism of the Smurfs' role in cell migration is not fully understood. Here we show that Smurf1 induces ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) at K190. Using the K190R mutant of TRAF4, we demonstrate that Smurf1-induced ubiquitination is required for proper localization of TRAF4 to tight junctions in confluent epithelial cells. We further show that TRAF4 is essential for the migration of both normal mammary epithelial and breast cancer cells. The ability of TRAF4 to promote cell migration is also dependent on Smurf1-mediated ubiquitination, which is associated with Rac1 activation by TRAF4. These results reveal a new regulatory circuit for cell migration, consisting of Smurf1-mediated ubiquitination of TRAF4 and Rac1 activation.	[Wang, Xiangchun; Jin, Chaoyang; Tang, Yi; Tang, Liu-Ya; Zhang, Ying E.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhang, YE (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, 37 Convent Dr,Bldg 37,Room 2056B, Bethesda, MD 20892 USA.	zhangyin@mail.nih.gov	Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601	National Institutes of Health, NCI, Center for Cancer Research [ZIA BC 011168]; NATIONAL CANCER INSTITUTE [ZIABC011168] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program of the National Institutes of Health, NCI, Center for Cancer Research (ZIA BC 011168).	Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Cherfils-Vicini J, 2008, IMMUNOLOGY, V124, P562, DOI 10.1111/j.1365-2567.2008.02810.x; Chung JY, 2002, J CELL SCI, V115, P679; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Dai Wen-Bo, 2007, Ai Zheng, V26, P1095; Fukuchi M, 2002, CANCER RES, V62, P7162; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; Kalkan T, 2009, MOL BIOL CELL, V20, P3436, DOI 10.1091/mbc.E08-03-0325; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kedinger V, 2007, ADV EXP MED BIOL, V597, P60; Kedinger V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003518; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kornegoor R, 2012, BREAST CANCER RES TR, V135, P49, DOI 10.1007/s10549-012-2051-3; Kwei KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023924; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Regnier CH, 2002, P NATL ACAD SCI USA, V99, P5585, DOI 10.1073/pnas.052124799; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Xing LP, 2010, J CELL BIOCHEM, V110, P554, DOI 10.1002/jcb.22586; Yamaguchi K, 2008, BIOL CHEM, V389, P405, DOI 10.1515/BC.2008.036; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Ying SX, 2003, J BIOL CHEM, V278, P39029, DOI 10.1074/jbc.M301193200; Zhang H, 2008, J CELL PHYSIOL, V215, P613, DOI 10.1002/jcp.21337; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	44	34	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21784	10.1074/jbc.M113.472704	http://dx.doi.org/10.1074/jbc.M113.472704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760265	hybrid, Green Published			2022-12-25	WOS:000328841900028
J	Wu, X; Mao, QY; Yao, X; Chen, P; Chen, XM; Shao, J; Gao, F; Yu, X; Zhu, FC; Li, RC; Li, WH; Liang, ZL; Wang, JZ; Lu, FM				Wu, Xing; Mao, Qunying; Yao, Xin; Chen, Pan; Chen, Xiangmei; Shao, Jie; Gao, Fan; Yu, Xiang; Zhu, Fengcai; Li, Rongcheng; Li, Wenhui; Liang, Zhenglun; Wang, Junzhi; Lu, Fengmin			Development and Evaluation of a Pseudovirus-Luciferase Assay for Rapid and Quantitative Detection of Neutralizing Antibodies against Enterovirus 71	PLOS ONE			English	Article							COXSACKIEVIRUS A16; INFECTION; STRAINS; TAIWAN; ANTIGENICITY; IMMUNIZATION; VALIDATION; EPIDEMIC; PROTECTS; IMMUNITY	The level of neutralizing antibodies (NtAb) induced by vaccine inoculation is an important endpoint to evaluate the efficacy of EV71 vaccine. In order to evaluate the efficacy of EV71 vaccine, here, we reported the development of a novel pseudovirus system expression firefly luciferase (PVLA) for the quantitative measurement of NtAb. We first evaluated and validated the sensitivity and specificity of the PVLA method. A total of 326 serum samples from an epidemiological survey and 144 serum specimens from 3 clinical trials of EV71 vaccines were used, and the level of each specimen's neutralizing antibodies (NtAb) was measured in parallel using both the conventional CPE-based and PVLA-based assay. Against the standard neutralization assay based on the inhibition of the cytopathic effect (CPE), the sensitivity and specificity of the PVLA method are 98% and 96%, respectively. Then, we tested the potential interference of NtAb against hepatitis A virus, Polio-I, Polio-II, and Polio-III standard antisera (WHO) and goat anti-G10/CA16 serum, the PVLA based assay showed no cross-reactivity with NtAb against other specific sera. Importantly, unlike CPE based method, no live replication-competent EV71 is used during the measurement. Taken together, PVLA is a rapid and specific assay with higher sensitivity and accuracy. It could serve as a valuable tool in assessing the efficacy of EV71 vaccines in clinical trials and disease surveillance in epidemiology studies.	[Wu, Xing; Chen, Xiangmei; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China; [Wu, Xing; Chen, Xiangmei; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Ctr Infect Dis, Beijing 100871, Peoples R China; [Wu, Xing; Mao, Qunying; Yao, Xin; Shao, Jie; Gao, Fan; Liang, Zhenglun; Wang, Junzhi] Minist Hlth Res Qual & Standardizat Biotech Prod, Natl Inst Food & Drug Control, Dept Hepatitis Vaccine, Key Lab, Beijing, Peoples R China; [Chen, Pan; Li, Wenhui] Natl Inst Biol Sci, Beijing, Peoples R China; [Yu, Xiang] Hualan Biol Engn Inc, Xinxiang, Henan, Peoples R China; [Zhu, Fengcai] Jiangsu Prov Ctr Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China; [Li, Rongcheng] Guangxi Zhuang Automomous Reg, Ctr Dis Control & Prevent, Nanning, Peoples R China	Peking University; Peking University; National Institute of Food & Drug Control - China; National Institute of Biological Sciences, Beijing; Chinese Center for Disease Control & Prevention	Liang, ZL (corresponding author), Minist Hlth Res Qual & Standardizat Biotech Prod, Natl Inst Food & Drug Control, Dept Hepatitis Vaccine, Key Lab, Beijing, Peoples R China.	lzlun@yahoo.com; lu.fengmin@hsc.pku.edu.cn		Li, Wenhui/0000-0003-1305-7404; Chen, Xiangmei/0000-0003-0302-6866	National Science Project [2008BAI69B01]; National 11th Five Major Special Projects Funding Program [2009ZX10004-804]	National Science Project; National 11th Five Major Special Projects Funding Program	The current study was sponsored by the National Science Project (No. 2008BAI69B01) and the National 11th Five Major Special Projects Funding Program (No. 2009ZX10004-804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2000, NEW ENGL J MED, V342, P355; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cambron P, 2009, CLIN VACCINE IMMUNOL, V16, P1236, DOI 10.1128/CVI.00431-08; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chen P, 2012, J BIOL CHEM, V287, P6406, DOI 10.1074/jbc.M111.301622; Chen YX, 2013, VACCINE, V31, P425, DOI 10.1016/j.vaccine.2012.10.032; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Earl PL, 2003, J VIROL, V77, P10684, DOI 10.1128/JVI.77.19.10684-10688.2003; Findlay JWA, 2000, J PHARMACEUT BIOMED, V21, P1249, DOI 10.1016/S0731-7085(99)00244-7; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Huang ML, 2010, J VIROL METHODS, V165, P42, DOI 10.1016/j.jviromet.2009.12.015; Kung SH, 2007, CLIN MICROBIOL INFEC, V13, P782, DOI 10.1111/j.1469-0691.2007.01745.x; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu TC, 2007, J VIROL, V81, P10310, DOI 10.1128/JVI.00372-07; Wu XL, 2009, J MED VIROL, V81, P693, DOI 10.1002/jmv.21435; Yao Xin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P729; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	30	45	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64116	10.1371/journal.pone.0064116	http://dx.doi.org/10.1371/journal.pone.0064116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755115	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400008
J	Agra, N; Cidre, F; Garcia-Garcia, L; de la Parra, J; Alonso, J				Agra, Noelia; Cidre, Florencia; Garcia-Garcia, Laura; de la Parra, Juan; Alonso, Javier			Lysyl Oxidase Is Downregulated by the EWS/FLI1 Oncoprotein and Its Propeptide Domain Displays Tumor Supressor Activities in Ewing Sarcoma Cells	PLOS ONE			English	Article							MESSENGER-RNA; CANCER-CELLS; MOLECULAR PATHOGENESIS; ONCOGENIC PHENOTYPE; SUPPRESSOR ACTIVITY; PROSTATE-CANCER; FUSION PROTEIN; BREAST-CANCER; DIRECT TARGET; GENE	Ewing sarcoma is the second most common bone malignancy in children and young adults. It is driven by oncogenic fusion proteins (i.e. EWS/FLI1) acting as aberrant transcription factors that upregulate and downregulate target genes, leading to cellular transformation. Thus, identificating these target genes and understanding their contribution to Ewing sarcoma tumorigenesis are key for the development of new therapeutic strategies. In this study we show that lysyl oxidase (LOX), an enzyme involved in maintaining structural integrity of the extracellular matrix, is downregulated by the EWS/FLI1 oncoprotein and in consequence it is not expressed in Ewing sarcoma cells and primary tumors. Using a doxycycline inducible system to restore LOX expression in an Ewing sarcoma derived cell line, we showed that LOX displays tumor suppressor activities. Interestingly, we showed that the tumor suppressor activity resides in the propeptide domain of LOX (LOX-PP), an N-terminal domain produced by proteolytic cleavage during the physiological processing of LOX. Expression of LOX-PP reduced cell proliferation, cell migration, anchorage-independent growth in soft agar and formation of tumors in immunodeficient mice. By contrast, the C-terminal domain of LOX, which contains the enzymatic activity, had the opposite effects, corroborating that the tumor suppressor activity of LOX is mediated exclusively by its propeptide domain. Finally, we showed that LOX-PP inhibits ERK/MAPK signalling pathway, and that many pathways involved in cell cycle progression were significantly deregulated by LOX-PP, providing a mechanistic explanation to the cell proliferation inhibition observed upon LOX-PP expression. In summary, our observations indicate that deregulation of the LOX gene participates in Ewing sarcoma development and identify LOX-PP as a new therapeutic target for one of the most aggressive paediatric malignancies. These findings suggest that therapeutic strategies based on the administration of LOX propeptide or functional analogues could be useful for the treatment of this devastating paediatric cancer.	[Agra, Noelia; Cidre, Florencia; Garcia-Garcia, Laura; de la Parra, Juan; Alonso, Javier] Inst Salud Carlos III, Inst Invest Enfermedades Raras, Unidad Tumores Solidos Infantiles, Area Genet Humana, Madrid, Spain	Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER)	Alonso, J (corresponding author), Inst Salud Carlos III, Inst Invest Enfermedades Raras, Unidad Tumores Solidos Infantiles, Area Genet Humana, Madrid, Spain.	fjalonso@isciii.es	Alonso, Javier/B-6012-2013	Alonso, Javier/0000-0002-6287-8391; Cidre Aranaz, Florencia/0000-0002-0246-7179; GARCIA, LAURA/0000-0002-8585-849X	Ministerio de Ciencia e Innovacion [SAF2009-10158]; Fundacion Cientifica de la Cientifica Espanola Contra el Cancer; Fundacion Maria Francisca de Roviralta; Fundacion General de la U.A.M.	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Cientifica de la Cientifica Espanola Contra el Cancer; Fundacion Maria Francisca de Roviralta; Fundacion General de la U.A.M.	This study was funded by grants of the Ministerio de Ciencia e Innovacion (SAF2009-10158), the Fundacion Cientifica de la Cientifica Espanola Contra el Cancer and the Fundacion Maria Francisca de Roviralta. N. Agra was supported by the Fundacion General de la U.A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Ban J, 2011, ONCOGENE, V30, P2173, DOI 10.1038/onc.2010.581; Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Bouez C, 2006, CLIN CANCER RES, V12, P1463, DOI 10.1158/1078-0432.CCR-05-1456; Carrillo J, 2007, CLIN CANCER RES, V13, P2429, DOI 10.1158/1078-0432.CCR-06-1762; Csiszar K, 2002, INT J CANCER, V97, P636, DOI 10.1002/ijc.10035; De Vito C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023592; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; Garcia-Aragoncillo E, 2008, ONCOGENE, V27, P6034, DOI 10.1038/onc.2008.203; Giampuzzi M, 2001, J BIOL CHEM, V276, P29226, DOI 10.1074/jbc.M101695200; Grunewald TGP, 2012, MOL CANCER RES, V10, P52, DOI 10.1158/1541-7786.MCR-11-0524; Guo Y, 2007, AM J PHYSIOL-CELL PH, V292, pC2095, DOI 10.1152/ajpcell.00613.2006; Hahm KB, 1999, NAT GENET, V23, P222, DOI 10.1038/13854; HAJNAL A, 1993, CANCER RES, V53, P4670; HAMALAINEN ER, 1995, J BIOL CHEM, V270, P21590, DOI 10.1074/jbc.270.37.21590; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Kovar H, 2010, GENOME MED, V2, DOI 10.1186/gm129; KUIVANIEMI H, 1986, FEBS LETT, V195, P261, DOI 10.1016/0014-5793(86)80172-7; Lessnick SL, 2011, ANN REV PATHOL; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Luo W, 2009, ONCOGENE, V28, P4126, DOI 10.1038/onc.2009.262; Mackintosh C, 2010, CANCER BIOL THER, V9, P655, DOI 10.4161/cbt.9.9.11511; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2010, J CELL BIOCHEM, V111, P1160, DOI 10.1002/jcb.22828; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; Nakatani F, 2003, J BIOL CHEM, V278, P15105, DOI 10.1074/jbc.M211470200; Nakatani F, 2012, J PATHOL, V226, P796, DOI 10.1002/path.3007; Navarro D, 2010, CARCINOGENESIS, V31, P394, DOI 10.1093/carcin/bgp317; NAVARRO S, 1990, VIRCHOWS ARCH A, V416, P383, DOI 10.1007/BF01605142; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Potratz J, 2012, PEDIATR HEMAT ONCOL, V29, P1, DOI 10.3109/08880018.2011.622034; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Ren CZ, 1998, CANCER RES, V58, P1285; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Sankar S, 2012, ONCOGENE; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200	58	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66281	10.1371/journal.pone.0066281	http://dx.doi.org/10.1371/journal.pone.0066281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750284	Green Published, gold			2022-12-25	WOS:000319961900086
J	Kitagawa, M; Fung, SYS; Onishi, N; Saya, H; Lee, SH				Kitagawa, Mayumi; Fung, Suet Yin Sarah; Onishi, Nobuyuki; Saya, Hideyuki; Lee, Sang Hyun			Targeting Aurora B to the Equatorial Cortex by MKlp2 Is Required for Cytokinesis	PLOS ONE			English	Article							CENTRAL SPINDLE; CELL-DIVISION; KINESIN; COMPLEX; CENTRALSPINDLIN; PHOSPHORYLATION; MIDZONE; MYOSIN; ACTIN; RHOA	Although Aurora B is important in cleavage furrow ingression and completion during cytokinesis, the mechanism by which kinase activity is targeted to the cleavage furrow and the molecule(s) responsible for this process have remained elusive. Here, we demonstrate that an essential mitotic kinesin MKlp2 requires myosin-II for its localization to the equatorial cortex, and this event is required to recruit Aurora B to the equatorial cortex in mammalian cells. This recruitment event is also required to promote the highly focused accumulation of active RhoA at the equatorial cortex and stable ingression of the cleavage furrow in bipolar cytokinesis. Specifically, in drug-induced monopolar cytokinesis, targeting Aurora B to the cell cortex by MKlp2 is essential for cell polarization and furrow formation. Once the furrow has formed, MKlp2 further recruits Aurora B to the growing furrow. This process together with continuous Aurora B kinase activity at the growing furrow is essential for stable furrow propagation and completion. In contrast, a MKlp2 mutant defective in binding myosin-II does not recruit Aurora B to the cell cortex and does not promote furrow formation during monopolar cytokinesis. This mutant is also defective in maintaining the ingressing furrow during bipolar cytokinesis. Together, these findings reveal that targeting Aurora B to the cell cortex (or the equatorial cortex) by MKlp2 is essential for the maintenance of the ingressing furrow for successful cytokinesis.	[Kitagawa, Mayumi; Fung, Suet Yin Sarah; Lee, Sang Hyun] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Onishi, Nobuyuki; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan	National University of Singapore; Keio University	Lee, SH (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.	sanghyun.lee@duke-nus.edu.sg	ONISHI, Nobuyuki/L-6296-2013; Saya, Hideyuki/J-4325-2013	Saya, Hideyuki/0000-0001-6610-1902; Fung, Suet Yin Sarah/0000-0002-9448-2826	National Research Foundation (NRF) Research Fellowship in Singapore [NRFRF2010-02]	National Research Foundation (NRF) Research Fellowship in Singapore	This work was supported by the National Research Foundation (NRF) Research Fellowship (NRFRF2010-02) in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Douglas ME, 2010, CURR BIOL, V20, P927, DOI 10.1016/j.cub.2010.03.055; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Lee SH, 2010, J CELL BIOL, V191, P1069, DOI 10.1083/jcb.201003095; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Murata-Hori M, 2002, J CELL BIOL, V159, P45, DOI 10.1083/jcb.200207014; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	18	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64826	10.1371/journal.pone.0064826	http://dx.doi.org/10.1371/journal.pone.0064826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750214	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900016
J	Sabbah, S; Zhu, CH; Hornsby, MAW; Kamermans, M; Hawryshyn, CW				Sabbah, Shai; Zhu, Changhai; Hornsby, Mark A. W.; Kamermans, Maarten; Hawryshyn, Craig W.			Feedback from Horizontal Cells to Cones Mediates Color Induction and May Facilitate Color Constancy in Rainbow Trout	PLOS ONE			English	Article							ULTRAVIOLET-POLARIZATION SENSITIVITY; 2-AMINO-4-PHOSPHONOBUTYRIC ACID; CHROMATIC ADAPTATION; SPECTRAL SENSITIVITY; ONCORHYNCHUS-MYKISS; OUTER RETINA; B-WAVE; GOLDFISH; PRIMATE; ORGANIZATION	Color vision is most beneficial when the visual system is color constant and can correct the excitations of photoreceptors for differences in environmental irradiance. A phenomenon related to color constancy is color induction, where the color of an object shifts away from the color of its surroundings. These two phenomena depend on chromatic spatial integration, which was suggested to originate at the feedback synapse from horizontal cells (HC) to cones. However, the exact retinal site was never determined. Using the electroretinogram and compound action potential recordings, we estimated the spectral sensitivity of the photoresponse of cones, the output of cones, and the optic nerve in rainbow trout. Recordings were performed before and following pharmacological inhibition of HC-cone feedback, and were repeated under two colored backgrounds to estimate the efficiency of color induction. No color induction could be detected in the photoresponse of cones. However, the efficiency of color induction in the cone output and optic nerve was substantial, with the efficiency in the optic nerve being significantly higher than in the cone output. We found that the efficiency of color induction in the cone output and optic nerve decreased significantly with the inhibition of HC-cone feedback. Therefore, our findings suggest not only that color induction originates as a result of HC-cone feedback, but also that this effect of HC-cone feedback is further amplified at downstream retinal elements, possibly through feedback mechanisms at the inner plexiform layer. This study provides evidence for an important role of HC-cone feedback in mediating color induction, and therefore, likely also in mediating color constancy.	[Sabbah, Shai; Zhu, Changhai; Hornsby, Mark A. W.; Hawryshyn, Craig W.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Kamermans, Maarten] Netherlands Inst Neurosci, Res Unit Retinal Signal Proc, Amsterdam, Netherlands; [Kamermans, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands; [Hawryshyn, Craig W.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada	Queens University - Canada; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Queens University - Canada	Sabbah, S (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	shai_sabbah@brown.edu		Sabbah, Shai/0000-0002-4752-3832	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [106102-07]; NSERC Research Tools and Instrumentation Grant [359714-2008]; Ontario Innovation Trust [202821]; Canada Research Chair Program; Vanier Canada Graduate Scholarship from NSERC; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Research Tools and Instrumentation Grant; Ontario Innovation Trust; Canada Research Chair Program(Canada Research Chairs); Vanier Canada Graduate Scholarship from NSERC; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant [106102-07], NSERC Research Tools and Instrumentation Grant [359714-2008], Canada Foundation for Innovation, Ontario Innovation Trust [202821], and the Canada Research Chair Program to CWH. SS was supported by a Vanier Canada Graduate Scholarship from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCAR VJ, 1972, J NEUROCHEM, V19, P2657, DOI 10.1111/j.1471-4159.1972.tb01325.x; BARON WS, 1975, J PHYSIOL-LONDON, V246, P311, DOI 10.1113/jphysiol.1975.sp010892; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; BLOOMFIELD SA, 1985, J NEUROPHYSIOL, V53, P699, DOI 10.1152/jn.1985.53.3.699; BROWMAN HI, 1992, VISION RES, V32, P2303, DOI 10.1016/0042-6989(92)90094-Y; BROWMAN HI, 1994, VISION RES, V34, P1397, DOI 10.1016/0042-6989(94)90139-2; BROWMAN HI, 1994, J EXP BIOL, V193, P191; Bush RA, 1996, J OPT SOC AM A, V13, P557, DOI 10.1364/JOSAA.13.000557; Connaughton VP, 2010, J NEUROPHYSIOL, V104, P2407, DOI 10.1152/jn.00644.2009; Dacey DM, 1996, SCIENCE, V271, P656, DOI 10.1126/science.271.5249.656; DAW NW, 1984, TRENDS NEUROSCI, V7, P330, DOI 10.1016/S0166-2236(84)80082-X; Dong CJ, 2002, VISION RES, V42, P1081, DOI 10.1016/S0042-6989(02)00032-9; Dong CJ, 2000, VISION RES, V40, P579, DOI 10.1016/S0042-6989(99)00203-5; Dorr S, 1997, VISION RES, V37, P1581, DOI 10.1016/S0042-6989(96)00320-3; Dorr S, 1996, PERCEPTION, V25, P243, DOI 10.1068/p250243; DOWLING JE, 1972, J GEN PHYSIOL, V60, P698, DOI 10.1085/jgp.60.6.698; Edgington E. S., 1995, RANDOMIZATION TESTS; Efron B., 1994, INTRO BOOTSTRAP; Fahrenfort I, 2004, VISUAL NEUROSCI, V21, P501, DOI 10.1017/S095252380421402X; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; HAROSI FI, 1994, VISION RES, V34, P1359, DOI 10.1016/0042-6989(94)90134-1; Hawryshyn CW, 2010, J EXP BIOL, V213, P3187, DOI 10.1242/jeb.038760; HAWRYSHYN CW, 1994, VISION RES, V34, P1385, DOI 10.1016/0042-6989(94)90137-6; Hirasawa H, 2003, J GEN PHYSIOL, V122, P657, DOI 10.1085/jgp.200308863; INGLE DJ, 1985, SCIENCE, V227, P651, DOI 10.1126/science.3969555; Joselevitch C, 2009, VISION RES, V49, P943, DOI 10.1016/j.visres.2008.07.019; Kamermans M, 1998, VISUAL NEUROSCI, V15, P787, DOI 10.1017/S0952523898154172; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; KAMERMANS M, 1991, J GEN PHYSIOL, V97, P819, DOI 10.1085/jgp.97.4.819; KANEKO A, 1986, J PHYSIOL-LONDON, V373, P463, DOI 10.1113/jphysiol.1986.sp016058; Klaassen LJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001107; Kraaij DA, 1998, VISUAL NEUROSCI, V15, P799, DOI 10.1017/S0952523898154184; Li P, 2005, J EXP BIOL, V208, P497, DOI 10.1242/jeb.01424; Li YN, 2009, J COMP NEUROL, V516, P442, DOI 10.1002/cne.22135; Liu X, J PHYSL; MASSEY SC, 1983, VISION RES, V23, P1607, DOI 10.1016/0042-6989(83)90174-8; NAKA K, 1971, J NEUROPHYSIOL, V34, P785, DOI 10.1152/jn.1971.34.5.785; NAKA K, 1972, J PHYSIOL-LONDON, V223, P449, DOI 10.1113/jphysiol.1972.sp009857; NAKA KI, 1977, J NEUROPHYSIOL, V40, P26, DOI 10.1152/jn.1977.40.1.26; Neumeyer C, 2002, PERCEPTION, V31, P171, DOI 10.1068/p05sp; NEUMEYER C, 1981, J COMP PHYSIOL, V144, P543, DOI 10.1007/BF01326839; NORTON AL, 1968, SCIENCE, V160, P1021, DOI 10.1126/science.160.3831.1021; NOVALESFLAMARIQUE I, 1992, J EXP BIOL, V169, P121; PARKYN DC, 1993, J COMP PHYSIOL A, V172, P493, DOI 10.1007/BF00213531; Parkyn DC, 2000, J EXP BIOL, V203, P1173; Ramsden SD, 2008, J EXP BIOL, V211, P1376, DOI 10.1242/jeb.015941; Rinner O, 2000, VISION RES, V40, P1813, DOI 10.1016/S0042-6989(00)00050-X; Sabbah S, 2010, BMC BIOL, V8, DOI [10.1186/1741-7007-1188-1133, DOI 10.1186/1741-7007-1188-1133]; Sabbah S, 2013, J NEUROSCI, V33, P7428, DOI 10.1523/JNEUROSCI.5815-12.2013; Sabbah S, 2012, J EXP BIOL, V215, P2684, DOI 10.1242/jeb.069922; Sabbah S, 2011, J EXP BIOL, V214, P487, DOI 10.1242/jeb.051284; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SPERLING HC, 1971, SCIENCE, V172, P180, DOI 10.1126/science.172.3979.180; STELL WK, 1975, J COMP NEUROL, V159, P473, DOI 10.1002/cne.901590404; STELL WK, 1975, SCIENCE, V190, P989, DOI 10.1126/science.1188380; SVAETICHIN G, 1958, ANN NY ACAD SCI, V74, P385, DOI 10.1111/j.1749-6632.1958.tb39560.x; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; THORESON WB, 1990, VISUAL NEUROSCI, V5, P571, DOI 10.1017/S0952523800000730; Vanleeuwen MT, 2007, VISUAL NEUROSCI, V24, P277, DOI 10.1017/S0952523807070058; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; Verweij J, 2003, J NEUROSCI, V23, P10249; Vigh J, 1999, VISUAL NEUROSCI, V16, P159, DOI 10.1017/S095252389916111X; WAKABAYASHI K, 1988, INVEST OPHTH VIS SCI, V29, P1615; Winkler BS, 2003, EXP EYE RES, V77, P115, DOI 10.1016/S0014-4835(03)00085-X; ZEKI S, 1980, NATURE, V284, P412, DOI 10.1038/284412a0	65	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66216	10.1371/journal.pone.0066216	http://dx.doi.org/10.1371/journal.pone.0066216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750282	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900084
J	De Sanctis, T; Tarantino, V; Straulino, E; Begliomini, C; Castiello, U				De Sanctis, Teresa; Tarantino, Vincenza; Straulino, Elisa; Begliomini, Chiara; Castiello, Umberto			Co-Registering Kinematics and Evoked Related Potentials during Visually Guided Reach-to-Grasp Movements	PLOS ONE			English	Article							ANTERIOR INTRAPARIETAL SULCUS; CONTINGENT NEGATIVE-VARIATION; VENTRAL PREMOTOR AREA; 2 CORTICAL SYSTEMS; MACAQUE MONKEY; PARIETAL CORTEX; PREHENSION MOVEMENTS; FUNCTIONAL-PROPERTIES; VISUOMOTOR CONTROL; PRAXIS MOVEMENTS	Background: In non-human primates grasp-related sensorimotor transformations are accomplished in a circuit involving the anterior intraparietal sulcus (area AIP) and both the ventral and the dorsal sectors of the premotor cortex (vPMC and dPMC, respectively). Although a human homologue of such a circuit has been identified, the time course of activation of these cortical areas and how such activity relates to specific kinematic events has yet to be investigated. Methodology/Principal Findings: We combined kinematic and event-related potential techniques to explicitly test how activity within human grasping-related brain areas is modulated in time. Subjects were requested to reach towards and grasp either a small stimulus using a precision grip (i.e., the opposition of index finger and thumb) or a large stimulus using a whole hand grasp (i.e., the flexion of all digits around the stimulus). Results revealed a time course of activation starting at the level of parietal regions and continuing at the level of premotor regions. More specifically, we show that activity within these regions was tuned for specific grasps well before movement onset and this early tuning was carried over - as evidenced by kinematic analysis - during the preshaping period of the task. Conclusions/Significance: Data are discussed in terms of recent findings showing a marked differentiation across different grasps during premovement phases which was carried over into subsequent movement phases. These findings offer a substantial contribution to the current debate about the nature of the sensorimotor transformations underlying grasping. And provide new insights into the detailed movement information contained in the human preparatory activity for specific hand movements.	[De Sanctis, Teresa; Tarantino, Vincenza; Straulino, Elisa; Begliomini, Chiara; Castiello, Umberto] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Castiello, U (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it	BEGLIOMINI, CHIARA/D-1516-2014	BEGLIOMINI, CHIARA/0000-0001-7433-0414; Castiello, Umberto/0000-0003-0629-1286; Tarantino, Vincenza/0000-0002-5836-3811	Italian Ministry of University and Research [2008YTNXXZ]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Italian Ministry of University and Research (Grant Number- 2008YTNXXZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; Battaglini PP, 2002, EXP BRAIN RES, V144, P419, DOI 10.1007/s00221-002-1099-4; Begliomini C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001108; Begliomini C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003388; Berthier NE, 1996, J MOTOR BEHAV, V28, P187, DOI 10.1080/00222895.1996.9941744; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Bozzacchi C, 2012, BIOL PSYCHOL, V89, P503, DOI 10.1016/j.biopsycho.2011.12.020; Brochier T, 2004, J NEUROPHYSIOL, V92, P1770, DOI 10.1152/jn.00976.2003; Brochier T, 2007, CURR OPIN NEUROBIOL, V17, P637, DOI 10.1016/j.conb.2007.12.002; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; Castiello U, 2008, NEUROSCIENTIST, V14, P157, DOI 10.1177/1073858407312080; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Chapman H, 2002, EUR J NEUROSCI, V15, P2037, DOI 10.1046/j.1460-9568.2002.02021.x; CHIEFFI S, 1993, EXP BRAIN RES, V94, P471; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2007, J NEUROSCI, V27, P3974, DOI 10.1523/JNEUROSCI.0426-07.2007; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2002, J NEUROSCI, V22, P5074, DOI 10.1523/JNEUROSCI.22-12-05074.2002; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; Fattori P, 2001, EUR J NEUROSCI, V13, P2309, DOI 10.1046/j.0953-816x.2001.01618.x; Fattori P, 2010, J NEUROSCI, V30, P342, DOI 10.1523/JNEUROSCI.3800-09.2010; Fattori P, 2009, J NEUROSCI, V29, P1928, DOI 10.1523/JNEUROSCI.4998-08.2009; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; GAILLARD AWK, 1977, PSYCHOPHYSIOLOGY, V14, P563, DOI 10.1111/j.1469-8986.1977.tb01200.x; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; GODSCHALK M, 1981, EXP BRAIN RES, V44, P113; GORDON AM, 1994, NEUROPSYCHOLOGIA, V32, P555, DOI 10.1016/0028-3932(94)90144-9; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Gregoriou GG, 2003, NEUROIMAGE, V19, P959, DOI 10.1016/S1053-8119(03)00176-9; Grol MJ, 2007, J NEUROSCI, V27, P11877, DOI 10.1523/JNEUROSCI.3923-07.2007; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1981, ATTENTION PERFORM, P153; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Kourtis D, 2012, PSYCHOL RES-PSYCH FO, V76, P514, DOI 10.1007/s00426-012-0418-z; Kroliczak G, 2007, J NEUROPHYSIOL, V97, P2410, DOI 10.1152/jn.00778.2006; Leuthold H, 2004, J PSYCHOPHYSIOL, V18, P77, DOI 10.1027/0269-8803.18.23.77; Leuthold H, 2009, PSYCHOPHYSIOLOGY, V46, P539, DOI 10.1111/j.1469-8986.2009.00799.x; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; MOLL L, 1977, SCIENCE, V198, P317, DOI 10.1126/science.410103; Muller-Gethmann H, 2000, PSYCHOPHYSIOLOGY, V37, P507, DOI 10.1111/1469-8986.3740507; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olivier E, 2007, CURR OPIN NEUROBIOL, V17, P644, DOI 10.1016/j.conb.2008.01.008; PASSINGHAM RE, 1987, CIBA F SYMP, V132, P151; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; Raos V, 2006, J NEUROPHYSIOL, V95, P709, DOI 10.1152/jn.00463.2005; Raos V, 2004, J NEUROPHYSIOL, V92, P1990, DOI 10.1152/jn.00154.2004; Rice NJ, 2006, J NEUROSCI, V26, P8176, DOI 10.1523/JNEUROSCI.1641-06.2006; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rohrbaugh J.W., 1983, TUTORIALS ERP RES EN, P269, DOI 10.1016/S0166-4115(08)62044-0; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tunik E, 2007, NEUROIMAGE, V36, pT77, DOI 10.1016/j.neuroimage.2007.03.026; Umilta MA, 2007, J NEUROPHYSIOL, V98, P488, DOI 10.1152/jn.01094.2006; Verhagen L, 2012, J NEUROSCI, V32, P4508, DOI 10.1523/JNEUROSCI.5451-11.2012; WALTER W G, 1964, Arch Psychiatr Nervenkr, V206, P309, DOI 10.1007/BF00341700; WEINRICH M, 1982, J NEUROSCI, V2, P1329; Wheaton LA, 2005, EXP BRAIN RES, V163, P535, DOI 10.1007/s00221-005-2314-x; Wheaton LA, 2005, CLIN NEUROPHYSIOL, V116, P1201, DOI 10.1016/j.clinph.2005.01.001; Xiao J, 2006, EXP BRAIN RES, V168, P106, DOI 10.1007/s00221-005-0074-2; Zaepffel M, 2012, PSYCHOPHYSIOLOGY, V49, P17, DOI 10.1111/j.1469-8986.2011.01277.x	83	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65508	10.1371/journal.pone.0065508	http://dx.doi.org/10.1371/journal.pone.0065508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755241	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300085
J	Karasawa, T; Sibrian-Vazquez, M; Strongin, RM; Steyger, PS				Karasawa, Takatoshi; Sibrian-Vazquez, Martha; Strongin, Robert M.; Steyger, Peter S.			Identification of Cisplatin-Binding Proteins Using Agarose Conjugates of Platinum Compounds	PLOS ONE			English	Article							INDUCED OTOTOXICITY; CHAPERONE-ACTIVITY; STATISTICAL-MODEL; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; HAIR-CELLS; DNA; CHILDREN; CANCER; CARBOPLATIN	Cisplatin is widely used as an antineoplastic drug, but its ototoxic and nephrotoxic side-effects, as well as the inherent or acquired resistance of some cancers to cisplatin, remain significant clinical problems. Cisplatin's selectivity in killing rapidly proliferating cancer cells is largely dependent on covalent binding to DNA via cisplatin's chloride sites that had been aquated. We hypothesized that cisplatin's toxicity in slowly proliferating or terminally differentiated cells is primarily due to drug-protein interactions, instead of drug-DNA binding. To identify proteins that bind to cisplatin, we synthesized two different platinum-agarose conjugates, one with two amino groups and another with two chlorides attached to platinum that are available for protein binding, and conducted pull-down assays using cochlear and kidney cells. Mass spectrometric analysis on protein bands after gel electrophoresis and Coomassie blue staining identified several proteins, including myosin IIA, glucose-regulated protein 94 (GRP94), heat shock protein 90 (HSP90), calreticulin, valosin containing protein (VCP), and ribosomal protein L5, as cisplatin-binding proteins. Future studies on the interaction of these proteins with cisplatin will elucidate whether these drug-protein interactions are involved in ototoxicity and nephrotoxicity, or contribute to tumor sensitivity or resistance to cisplatin treatment.	[Karasawa, Takatoshi; Steyger, Peter S.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Sibrian-Vazquez, Martha; Strongin, Robert M.] Portland State Univ, Dept Chem, Portland, OR 97207 USA	Oregon Health & Science University; Portland State University	Karasawa, T (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	karasawa@ohsu.edu	Strongin, Robert M./F-1026-2010; Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237	National Institute on Deafness and Other Communication Disorders at the National Institutes of Health [R21 DC010231]; Medical Research Foundation of Oregon; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC010231] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Medical Research Foundation of Oregon; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Other Communication Disorders at the National Institutes of Health (R21 DC010231) and Medical Research Foundation of Oregon grants to P.S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; APPLETON TG, 1970, INORG CHEM, V9, P1800, DOI 10.1021/ic50090a005; Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Baliga R, 1999, DRUG METAB REV, V31, P971, DOI 10.1081/DMR-100101947; Benoist E, 1998, SYNTHESIS-STUTTGART, P1113; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Campbell KCM, 1996, HEARING RES, V102, P90, DOI 10.1016/S0378-5955(96)00152-9; Casini A, 2007, CHEM COMMUN, P156, DOI 10.1039/b611122j; Chen XZ, 2010, ASIAN J CHEM, V22, P6493; Chinnaswamy G, 2008, BRIT J CANCER, V99, P894, DOI 10.1038/sj.bjc.6604612; Dickey DT, 2005, J PHARMACOL EXP THER, V314, P1052, DOI 10.1124/jpet.105.087601; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Espreafico EM, 1998, P NATL ACAD SCI USA, V95, P8636, DOI 10.1073/pnas.95.15.8636; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; FICHTINGERSCHEPMAN AMJ, 1985, BIOCHEMISTRY-US, V24, P707, DOI 10.1021/bi00324a025; Francis SP, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.76; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Helliwell JR, 2013, ACTA CRYSTALLOGR D, V69, P121, DOI 10.1107/S090744491204423X; HILL JM, 1982, ANTICANCER RES, V2, P173; Horibe T, 2004, BIOCHEM BIOPH RES CO, V323, P281, DOI 10.1016/j.bbrc.2004.08.099; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; Ishida R, 2008, FEBS LETT, V582, P3879, DOI 10.1016/j.febslet.2008.10.029; ISHIKAWA T, 1993, J BIOL CHEM, V268, P20116; Itoh H, 1999, BIOCHEM J, V343, P697, DOI 10.1042/0264-6021:3430697; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jiang CC, 2009, CARCINOGENESIS, V30, P197, DOI 10.1093/carcin/bgn220; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; Karasawa T, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.80; Karasawa T, 2008, J CELL SCI, V121, P2871, DOI 10.1242/jcs.023705; Karasawa T, 2011, TOXICOL SCI, V124, P378, DOI 10.1093/toxsci/kfr196; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knight KRG, 2005, J CLIN ONCOL, V23, P8588, DOI 10.1200/JCO.2004.00.5355; Knight KR, 2007, J CLIN ONCOL, V25, P1190, DOI 10.1200/JCO.2006.07.9723; KNOX RJ, 1986, CANCER RES, V46, P1972; KOCH G, 1986, J CELL SCI, V86, P217; Kopke RD, 1997, AM J OTOL, V18, P559; Lai MD, 2007, CURR GENOMICS, V8, P43; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Lalwani AK, 2008, BRAIN RES, V1197, P13, DOI 10.1016/j.brainres.2007.12.058; Lin YD, 2011, LUNG CANCER, V71, P291, DOI 10.1016/j.lungcan.2010.06.004; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035800; Molenaar C, 2000, J BIOL INORG CHEM, V5, P655, DOI 10.1007/s007750000153; Mukherjea D, 2011, ANTIOXID REDOX SIGN, V14, P999, DOI 10.1089/ars.2010.3497; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Priqueler JRL, 2006, APPL SPECTROSC REV, V41, P185, DOI 10.1080/05704920600620311; Qaddoumi I, 2012, J CLIN ONCOL, V30, P1034, DOI 10.1200/JCO.2011.36.9744; Ramesh G, 2005, AM J PHYSIOL-RENAL, V289, pF166, DOI 10.1152/ajprenal.00401.2004; Seri M, 2000, NAT GENET, V26, P103; Skinner R, 1998, BRIT J CANCER, V77, P1677, DOI 10.1038/bjc.1998.276; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Thomas JP, 2006, MOL PHARMACOL, V70, P23, DOI 10.1124/mol.106.022244; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wilmarth Phillip A, 2009, J Ocul Biol Dis Infor, V2, P223	55	39	39	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66220	10.1371/journal.pone.0066220	http://dx.doi.org/10.1371/journal.pone.0066220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755301	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300104
J	Vera-Cabrera, L; Ortiz-Lopez, R; Elizondo-Gonzalez, R; Ocampo-Candiani, J				Vera-Cabrera, Lucio; Ortiz-Lopez, Rocio; Elizondo-Gonzalez, Ramiro; Ocampo-Candiani, Jorge			Complete Genome Sequence Analysis of Nocardia brasiliensis HUJEG-1 Reveals a Saprobic Lifestyle and the Genes Needed for Human Pathogenesis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PHOSPHOLIPASE-C; CELL-WALL; IN-VITRO; SUPEROXIDE-DISMUTASE; ACTINOMYCETOMA; SUSCEPTIBILITY; IDENTIFICATION; BIOGENESIS; RESISTANCE	Nocardia brasiliensis is an important etiologic agent of mycetoma. These bacteria live as a saprobe in soil or organic material and enter the tissue via minor trauma. Mycetoma is characterized by tumefaction and the production of fistula and abscesses, with no spontaneous cure. By using mass sequencing, we determined the complete genomic nucleotide sequence of the bacteria. According to our data, the genome is a circular chromosome 9,436,348-bp long with 68% G+C content that encodes 8,414 proteins. We observed orthologs for virulence factors, a higher number of genes involved in lipid biosynthesis and catabolism, and gene clusters for the synthesis of bioactive compounds, such as antibiotics, terpenes, and polyketides. An in silico analysis of the sequence supports the conclusion that the bacteria acquired diverse genes by horizontal transfer from other soil bacteria, even from eukaryotic organisms. The genome composition reflects the evolution of bacteria via the acquisition of a large amount of DNA, which allows it to survive in new ecological niches, including humans.	[Vera-Cabrera, Lucio; Ocampo-Candiani, Jorge] Univ Nacl Colombia, Univ Hosp, Serv Dermatol, Lab Interdisciplinario Invest Dermatol, Monterrey, NL, Mexico; [Ortiz-Lopez, Rocio] Univ Autonoma Nuevo Leon, Dept Bioquim & Med Mol, Monterrey, NL, Mexico; [Ortiz-Lopez, Rocio; Elizondo-Gonzalez, Ramiro] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, NL, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon	Vera-Cabrera, L (corresponding author), Univ Nacl Colombia, Univ Hosp, Serv Dermatol, Lab Interdisciplinario Invest Dermatol, Monterrey, NL, Mexico.	drluciovera@yahoo.com	Ocampo-Candiani, Jorge/B-6853-2015; Ortiz-Lopez, Rocio/N-4827-2018; Vera-Cabrera, Lucio/AAM-3641-2020; Ortiz-Lopez, Rocio/F-7020-2014	Ocampo-Candiani, Jorge/0000-0002-0213-0031; Ortiz-Lopez, Rocio/0000-0002-7783-026X; Vera-Cabrera, Lucio/0000-0002-0890-9660; Ortiz-Lopez, Rocio/0000-0002-7783-026X	CONACYT grant [155892]	CONACYT grant(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CONACYT grant No. 155892. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Al Akhrass F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032945; Almaguer-Chavez JA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-290; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Barkan D, 2012, INFECT IMMUN, V80, P1958, DOI 10.1128/IAI.00021-12; BEAMAN BL, 1985, INFECT IMMUN, V47, P135, DOI 10.1128/IAI.47.1.135-141.1985; Beisson F, 2012, NAT CHEM BIOL, V8, P603, DOI 10.1038/nchembio.1004; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Bryant AE, 2000, J INFECT DIS, V182, P808, DOI 10.1086/315757; Chitale S, 2001, CELL MICROBIOL, V3, P247, DOI 10.1046/j.1462-5822.2001.00110.x; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crawford JT, 2003, INT J TUBERC LUNG D, V7, pS453; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Doroghazi JR, 2010, ISME J, V4, P1136, DOI 10.1038/ismej.2010.45; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Gebhardt H, 2007, MICROBIOL-SGM, V153, P1424, DOI 10.1099/mic.0.2006/003541-0; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Gioffre A, 2005, MICROBES INFECT, V7, P325, DOI 10.1016/j.micinf.2004.11.007; Gomez-Flores A, 2004, ANTIMICROB AGENTS CH, V48, P832, DOI 10.1128/AAC.48.3.832-837.2004; Gonzalez-Burgos E, 2012, CURR MED CHEM; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hayashi Y, 2008, J ANTIBIOT, V61, P164, DOI 10.1038/ja.2008.126; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Trevino-Villarreal JH, 2012, INFECT IMMUN, V80, P3587, DOI 10.1128/IAI.00446-12; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Kaltenpoth M, 2012, APPL ENVIRON MICROB, V78, P822, DOI 10.1128/AEM.06809-11; Lai CC, 2011, ANTIMICROB AGENTS CH, V55, P2084, DOI 10.1128/AAC.01808-10; Larruskain J, 2011, ANTIMICROB AGENTS CH, V55, P2995, DOI 10.1128/AAC.01279-10; Licon-Trillo A, 2003, FEMS IMMUNOL MED MIC, V37, P37, DOI 10.1016/S0928-8244(03)00102-0; Liu H, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00013; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Martinez-Reyes A, 2008, REV MED UV, V8, P19; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0; Mikami Yuzuru, 2010, Nihon Ishinkin Gakkai Zasshi, V51, P179; MISHRA SK, 1980, J CLIN MICROBIOL, V11, P728, DOI 10.1128/JCM.11.6.728-736.1980; N'Goma JCB, 2010, BBA-MOL CELL BIOL L, V1801, P1305, DOI 10.1016/j.bbalip.2010.08.007; Ni B, 2012, APPL MICROBIOL BIOTE; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Revol A, 2006, CAN J MICROBIOL, V52, P1255, DOI 10.1139/W06-075; Santos CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046758; Seo KS, 2012, INFECT IMMUN, V80, P3559, DOI 10.1128/IAI.00294-12; Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Trost E, 2012, J BACTERIOL, V194, P3199, DOI 10.1128/JB.00183-12; Ubhayasekera Wimal, 2012, BMC Res Notes, V5, P581, DOI 10.1186/1756-0500-5-581; Vera-Cabrera L, 1999, J CLIN MICROBIOL, V37, P1971, DOI 10.1128/JCM.37.6.1971-1976.1999; Vera-Cabrera L, 2012, ANTIMICROB AGENTS CH, V56, P3984, DOI 10.1128/AAC.00115-12; Vera-Cabrera L, 2012, J BACTERIOL, V194, P2761, DOI 10.1128/JB.00210-12; Vera-Cabrera L, 2010, ANTIMICROB AGENTS CH, V54, P2191, DOI 10.1128/AAC.01520-09; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Waksman SA, 2010, ANN NY ACAD SCI, V1213, P112, DOI 10.1111/j.1749-6632.2010.05861.x; WALLACE RJ, 1988, ANTIMICROB AGENTS CH, V32, P1776, DOI 10.1128/AAC.32.12.1776; Wargo MJ, 2011, AM J RESP CRIT CARE, V184, P345, DOI 10.1164/rccm.201103-0374OC; Welsh O, 2012, CLIN DERMATOL, V30, P372, DOI 10.1016/j.clindermatol.2011.06.027; Welsh O, 2011, INT J DERMATOL, V50, P854, DOI 10.1111/j.1365-4632.2011.04874.x; Wilson JW, 2012, MAYO CLIN PROC, V87, P403, DOI 10.1016/j.mayocp.2011.11.016; Wu G, 2006, ANTON LEEUW INT J G, V89, P135, DOI 10.1007/s10482-005-9016-z; Zoropogui A, 2012, J BACTERIOL, V194, P2098, DOI 10.1128/JB.00161-12	68	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65425	10.1371/journal.pone.0065425	http://dx.doi.org/10.1371/journal.pone.0065425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755230	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000319872300080
J	Vogel, JP; Souza, JP; Gulmezoglu, AM				Vogel, Joshua P.; Souza, Joao Paulo; Gulmezoglu, A. Metin			Patterns and Outcomes of Induction of Labour in Africa and Asia: A Secondary Analysis of the WHO Global Survey on Maternal and Neonatal Health	PLOS ONE			English	Article							ELECTIVE INDUCTION	Background: Labour induction should be performed where benefit outweighs potential harm, however epidemiology of induction in lower-income countries is not well described. We used the WHO Global Survey dataset to describe the epidemiology and outcomes of labour induction in 192,538 deliveries in 253 facilities across 16 countries in Africa and Asia. Methods: Data was analyzed separately for Africa and Asia. Prevalence of indications, methods, success and characteristics associated with labour induction were determined. Multilevel logistic regression was used to determine the relationship between induction (with medical indication and elective) and maternal/perinatal outcomes. Results: Induction accounted for 4.4% (Africa) and 12.1% (Asia) of deliveries. Oxytocin alone was the most common method (45.9% and 37.5%) and success rates were generally over 80%. Medically indicated inductions were associated with increased adjusted odds of Apgar <7 at 5 minutes, low birthweight, NICU admission and fresh stillbirth in both regions. The odds of caesarean section in Africa were reduced (Adj OR 0.61, 95% CI 0.42-0.88). Elective induction was associated with increased adjusted odds of NICU (Africa) and ICU (Asia) admissions. Discussion: Induction was generally less common than in higher-income countries. Prostaglandin use was uncommon despite evidence supporting use. Induction for medical indications may be associated with poorer outcomes due to maternal baseline risks. Despite one-third of elective inductions occurring at <39 weeks, the risk of maternal, fetal and neonatal mortality was not elevated following elective inductions.	[Vogel, Joshua P.] Univ Western Australia, Sch Populat Hlth, Fac Med, Dent & Hlth Sci, Perth, WA 6009, Australia; [Vogel, Joshua P.; Souza, Joao Paulo; Gulmezoglu, A. Metin] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dev & Res Training Human Reprod HRP, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	University of Western Australia; The World Bank; United Nations Population Fund; World Health Organization	Vogel, JP (corresponding author), Univ Western Australia, Sch Populat Hlth, Fac Med, Dent & Hlth Sci, Perth, WA 6009, Australia.	vogeljo@who.int	Souza, João Paulo/G-1982-2010; Vogel, Joshua/K-7649-2019	Souza, João Paulo/0000-0002-2288-4244; Vogel, Joshua/0000-0002-3214-7096	Australian Postgraduate Award; A & A Saw Scholarship; Government of China; Government of India; Government of Japan; United States Agency for International Development (USAID)	Australian Postgraduate Award(Australian Government); A & A Saw Scholarship; Government of China; Government of India; Government of Japan; United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	JPV is supported by an Australian Postgraduate Award and the A & A Saw Scholarship. The WHO Global Survey on Maternal and Perinatal Health was funded by the Governments of China, India and Japan, and the United States Agency for International Development (USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, P386; Blanchard K, 2002, OBSTET GYNECOL, V99, P316, DOI 10.1016/S0029-7844(01)01701-X; Bukola F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-722; Cunningham F, 2009, WILLIAMS OBSTET, V23rd; Fernandez MM, 2009, INT J GYNECOL OBSTET, V105, P180, DOI 10.1016/j.ijgo.2008.12.016; Gibbons L, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.026; Guerra GV, 2009, BJOG-INT J OBSTET GY, V116, P1762, DOI 10.1111/j.1471-0528.2009.02348.x; Guerra GV, 2011, B WORLD HEALTH ORGAN, V89, P657, DOI 10.2471/BLT.08.061226; Gulmezoglu A, 2012, COCHRANE DB SYST REV; IBM Corporation, PASW STAT 20; Induction of Labour, 2008, IND LAB; Laughon SK, 2012, AM J OBSTET GYNECOL, V206, pS47, DOI 10.1016/j.ajog.2012.03.014; Lydon-Rochelle MT, 2007, MED CARE, V45, P505, DOI 10.1097/MLR.0b013e3180330e26; MACER JA, 1992, AM J OBSTET GYNECOL, V166, P1690, DOI 10.1016/0002-9378(92)91558-R; Mozurkewich E, 2009, BJOG-INT J OBSTET GY, V116, P626, DOI 10.1111/j.1471-0528.2008.02065.x; Nicholson J, 2007, ANN FAM MED; Rathnayake R, 2010, SRI LANKA J OBSTET G, V31, P97; Rayburn WF, 2002, OBSTET GYNECOL, V100, P164, DOI 10.1016/S0029-7844(02)02047-1; Reddy UM, 2011, OBSTET GYNECOL, V117, P1279, DOI 10.1097/AOG.0b013e3182179e28; Sanchez-Ramos L, 2005, OBSTET GYN CLIN N AM, V32, P181, DOI 10.1016/j.ogc.2004.12.004; Senanayake H, 2011, BJOG-INT J OBSTET GY, V118, P78, DOI 10.1111/j.1471-0528.2011.03115.x; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Stock SJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2838; WHO, 2011, WHO REC IND LAB; Yeast JD, 1999, AM J OBSTET GYNECOL, V180, P628, DOI 10.1016/S0002-9378(99)70265-6; Zhang J, 2002, J REPROD MED, V47, P120	27	61	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65612	10.1371/journal.pone.0065612	http://dx.doi.org/10.1371/journal.pone.0065612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755259	gold, Green Published			2022-12-25	WOS:000319872300087
J	Yang, YF; Gu, CQ; Liao, YH; Luo, QP; Hu, XY; Zhang, WP; Shao, HB; Cheng, GF				Yang, Yifei; Gu, Changqin; Liao, Yonghong; Luo, Qingping; Hu, Xueying; Zhang, Wanpo; Shao, Huabin; Cheng, Guofu			Protein Expressions and Their Immunogenicity from Riemerella anatipestifer Cultured in Iron Restriction Medium	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; IMMOBILIZED PH GRADIENTS; 2-DIMENSIONAL ELECTROPHORESIS; IDENTIFICATION; SEQUENCE; ANTIGENS; GENES; MOTIF	Riemerella anatipestifer was cultured in both iron restriction media and normal media. Two-dimensional gel electrophoresis identified 23 proteins that significantly increased in the iron restriction media. Of them 12 proteins were analyzed with mass spectrography. Nine of 12 proteins belong to 6 different protein families: fibronectin type iii domain protein, secreted subtilase family protein, phosphoglycerate kinase, translation elongation factor, leucine-rich repeat-containing protein, and Galactose-binding domain-like protein. Other 3 proteins were novel with unknown function. Two novel proteins (Riean_1750 and Riean_1752) were expressed in prokaryotic expression systems. The specificities of these 2 novel proteins to R. anatipestifer were confirmed by western-blotting analysis. The ducks immunized with either protein had low mortality challenged by R. anatipestifer, 33.3% and 16.7%, respectively. The ducks developed 100% immunity when immunized with combined Riean_1750 and Riean_1752 proteins. The data suggested 2 novel proteins play important roles in the bacterial survival in the iron restricted environment. They could be used as subunit vaccines of R. anatipestifer.	[Yang, Yifei; Gu, Changqin; Hu, Xueying; Zhang, Wanpo; Cheng, Guofu] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China; [Liao, Yonghong; Luo, Qingping; Shao, Huabin] Acad Agr Sci Hubei Prov, Inst Anim Sci, Wuhan, Peoples R China; [Yang, Yifei] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China	Huazhong Agricultural University; China Agricultural University	Shao, HB (corresponding author), Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China.	shb1961@yahoo.com.cn; chengguofu@mail.hzau.edu.cn	Cheng, GF/GRS-2598-2022		Chinese Special Fund for Agro-scientific Research in the Public Interest [201003012]	Chinese Special Fund for Agro-scientific Research in the Public Interest	This work was supported by Chinese Special Fund for Agro-scientific Research in the Public Interest (201003012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brogden K.A., 1989, PASTEURELLA PASTEURE, P115; Brown JS, 2002, MICROBES INFECT, V4, P1149, DOI 10.1016/S1286-4579(02)01640-4; Cheng AnChun, 2003, Chinese Journal of Veterinary Science, V23, P320; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; GAY NJ, 1991, FEBS LETT, V291, P87, DOI 10.1016/0014-5793(91)81110-T; GOLDONI P, 1991, J MED MICROBIOL, V34, P113, DOI 10.1099/00222615-34-2-113; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gorg A, 1997, ELECTROPHORESIS, V18, P328, DOI 10.1002/elps.1150180306; Hu QH, 2012, VET MICROBIOL, V157, P428, DOI 10.1016/j.vetmic.2012.01.009; Huang B, 1999, VET MICROBIOL, V67, P213, DOI 10.1016/S0378-1135(99)00032-2; Jung TS, 2007, J VET SCI, V8, P255, DOI 10.4142/jvs.2007.8.3.255; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Lim Y, 1998, FEMS MICROBIOL LETT, V163, P19, DOI 10.1111/j.1574-6968.1998.tb13020.x; Mavromatis K, 2011, STAND GENOMIC SCI, V4, P144, DOI [10.4056/sigs.1553865, 10.4056/sigs.1553862]; Metcalf DS, 2007, CAN J VET RES, V71, P181; Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005; Pathanasophon P, 2002, AVIAN PATHOL, V31, P267, DOI 10.1080/03079450220136576; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Ryll M, 2001, J VET MED B, V48, P537, DOI 10.1046/j.1439-0450.2001.00471.x; Sandhu T.S., 1997, DIS POULTRY, P161; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; SEGERS P, 1993, INT J SYST BACTERIOL, V43, P768, DOI 10.1099/00207713-43-4-768; WATSON HC, 1982, EMBO J, V1, P1635, DOI 10.1002/j.1460-2075.1982.tb01366.x; Wu ZF, 2012, J INTEGR AGR, V11, P1517; Xie QY, 2009, BIOMETALS, V22, P907, DOI 10.1007/s10534-009-9243-2; Xu Wen-liang, 2004, Wuhan University Journal of Natural Sciences, V9, P498, DOI 10.1007/BF02830451; [杨依霏 Yang Yifei], 2012, [动物医学进展, Progress in Veterinary Medicine], V33, P13; Zhai ZP, 2013, VET MICROBIOL, V162, P850, DOI 10.1016/j.vetmic.2012.11.002; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007; Zhang H, 2010, THESIS HUAZHONG AGR, P24; Zhou ZT, 2009, AVIAN PATHOL, V38, P321, DOI 10.1080/03079450903071311	33	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65901	10.1371/journal.pone.0065901	http://dx.doi.org/10.1371/journal.pone.0065901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755292	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300099
J	Tetreault, P; Beaudet, N; Perron, A; Belleville, K; Rene, A; Cavelier, F; Martinez, J; Stroh, T; Jacobi, AM; Rose, SD; Behlke, MA; Sarret, P				Tetreault, Pascal; Beaudet, Nicolas; Perron, Amelie; Belleville, Karine; Rene, Adeline; Cavelier, Florine; Martinez, Jean; Stroh, Thomas; Jacobi, Ashley M.; Rose, Scott D.; Behlke, Mark A.; Sarret, Philippe			Spinal NTS2 receptor activation reverses signs of neuropathic pain	FASEB JOURNAL			English	Article						GPCR; allodynia; incapacitance; weight-bearing deficits	PERIPHERAL-NERVE INJURY; ROSTRAL VENTROMEDIAL MEDULLA; NEUROTENSIN RECEPTORS; ANIMAL-MODELS; TONIC PAIN; RAT MODEL; PHARMACOLOGICAL CHARACTERIZATION; BURROWING BEHAVIOR; HIGHLY POTENT; CANCER PAIN	Management of painful peripheral neuropathies remains challenging, since patients with chronic pain respond poorly to the available pharmacopeia. In recent years, the G-protein-coupled receptor neurotensin (NT) type 2 (NTS2) emerged as an attractive target for treating transitory pain states. To date, however, there is no evidence for its role in the regulation of chronic peripheral neuropathies. Here, we found that NTS2 receptors were largely localized to primary afferent fibers and superficial dorsal horns. Changes in the time course of the gene expression profile of NT, NTS1, and NTS2 were observed over a 28-d period following the sciatic nerve constriction [chronic constriction injury (CCI) model]. We next determined the effects of central delivery of selective-NTS2 agonists to CCI-treated rats on both mechanical allodynia (evoked withdrawal responses) and weight-bearing deficits (discomfort and quality-of-life proxies). The NTS2 analogs JMV431, levocabastine, and -lactotensin were all effective in reducing ongoing tactile allodynia in CCI-treated rats. Likewise, amitriptyline, pregabalin, and morphine significantly attenuated CCI-induced mechanical hypersensitivity. NTS2 agonists were also efficient in reversing weight-bearing and postural deficits caused by nerve damage, unlike reference analgesics currently used in the clinic. Thus, NTS2 agonists may offer new treatment avenues for limiting pain associated with peripheral neuropathies and improve functional rehabilitation and well-being.Tetreault, P., Beaudet, N., Perron, A., Belleville, K., Rene, A., Cavelier, F., Martinez, J., Stroh, T., Jacobi, A. M., Rose, S. D., Behlke, M. A., Sarret, P. Spinal NTS2 receptor activation reverses signs of neuropathic pain.	[Tetreault, Pascal; Beaudet, Nicolas; Belleville, Karine; Sarret, Philippe] Univ Sherbrooke, Dept Physiol & Biophys, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada; [Perron, Amelie] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Rene, Adeline; Cavelier, Florine; Martinez, Jean] Univ Montpellier I, Inst Biomol Max Mousseron, Unite Mixte Rech Ctr Natl Rech Sci UMR CNRS 5247, Montpellier, France; [Rene, Adeline; Cavelier, Florine; Martinez, Jean] Univ Montpellier 2, Inst Biomol Max Mousseron, Unite Mixte Rech Ctr Natl Rech Sci UMR CNRS 5247, Montpellier, France; [Stroh, Thomas] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Jacobi, Ashley M.; Rose, Scott D.; Behlke, Mark A.] Integrated DNA Technol Inc, Coralville, IA USA	University of Sherbrooke; Kyoto University; Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; McGill University	Sarret, P (corresponding author), Univ Sherbrooke, Dept Physiol & Biophys, Fac Med & Hlth Sci, 3001,12th Ave North, Sherbrooke, PQ J1H 5N4, Canada.	philippe.sarret@usherbrooke.ca	Martinez, Jean/R-9421-2019; Tétreault, Pascal/O-2583-2019; Cavelier, Florine/C-5659-2011; Tétreault, Pascal/F-1584-2016	Martinez, Jean/0000-0002-9267-4621; Tétreault, Pascal/0000-0001-9061-0635; Cavelier, Florine/0000-0001-5308-6416; Tétreault, Pascal/0000-0001-9061-0635; Behlke, Mark/0000-0002-4218-857X; Sarret, Philippe/0000-0002-7627-701X; Beaudet, Nicolas/0000-0003-2349-2362	Canadian Institutes of Health Research (CIHR) [MOP-74618]; Canada Research Chair in Neurophysiopharmacology of Chronic Pain; Fonds de Recherche du Quebec en Sante (FRQS); FRQS	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Neurophysiopharmacology of Chronic Pain; Fonds de Recherche du Quebec en Sante (FRQS); FRQS	This work is supported by a grant from the Canadian Institutes of Health Research (CIHR; MOP-74618; awarded to P. S.). P. S. is recipient of the Canada Research Chair in Neurophysiopharmacology of Chronic Pain, director of the Sherbrooke Neuroscience Centre, and member of the Fonds de Recherche du Quebec en Sante (FRQS)-funded Centre de Recherche Clinique Etienne Lebel. P. T. holds a doctoral scholarship from the FRQS.	ALRODHAN NRF, 1991, BRAIN RES, V557, P227, DOI 10.1016/0006-8993(91)90139-M; Andrews N, 2012, EUR J PAIN, V16, P485, DOI 10.1016/j.ejpain.2011.07.012; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Attal Nadine, 2012, Continuum (Minneap Minn), V18, P161, DOI 10.1212/01.CON.0000411564.41709.2d; Backonja MM, 2004, J PAIN, V5, P491, DOI 10.1016/j.jpain.2004.09.001; Baliki M, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-18; BEHBEHANI MM, 1984, BRAIN RES, V324, P35, DOI 10.1016/0006-8993(84)90619-X; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Berrocoso E, 2011, EUR J PHARMACOL, V655, P46, DOI 10.1016/j.ejphar.2011.01.022; Boules M, 2009, BRAIN RES, V1294, P22, DOI 10.1016/j.brainres.2009.07.086; Boules M, 2011, BEHAV PHARMACOL, V22, P573, DOI 10.1097/FBP.0b013e3283474a3a; Boules M, 2010, BRAIN RES, V1308, P35, DOI 10.1016/j.brainres.2009.10.050; Bredeloux P, 2008, J MED CHEM, V51, P1610, DOI 10.1021/jm700925k; Brocco M, 2002, PHARMACOL BIOCHEM BE, V71, P667, DOI 10.1016/S0091-3057(01)00701-8; Buhler AV, 2008, PAIN, V135, P280, DOI 10.1016/j.pain.2007.06.010; Buhler AV, 2005, PAIN, V114, P285, DOI 10.1016/j.pain.2004.12.031; CLINESCHMIDT BV, 1979, EUR J PHARMACOL, V54, P129, DOI 10.1016/0014-2999(79)90415-1; CLINESCHMIDT BV, 1977, EUR J PHARMACOL, V46, P395, DOI 10.1016/0014-2999(77)90236-9; Davoody L, 2011, J PAIN, V12, P868, DOI 10.1016/j.jpain.2011.01.010; de Leon-Casasola O, 2011, PAIN MED, V12, pS100, DOI 10.1111/j.1526-4637.2011.01160.x; de Leon-Casasola OA, 2013, AM J MED, V126, pS3, DOI 10.1016/j.amjmed.2012.11.011; De Vry J, 2004, EUR J PHARMACOL, V491, P137, DOI 10.1016/j.ejphar.2004.03.051; Devulder J, 2005, CURR MED RES OPIN, V21, P1555, DOI 10.1185/030079905X65321; Ding HK, 2005, J PAIN, V6, P411, DOI 10.1016/j.jpain.2005.01.361; Dobner PR, 2006, PEPTIDES, V27, P2405, DOI 10.1016/j.peptides.2006.04.025; Dore-Savard L, 2008, MOL THER, V16, P1331, DOI 10.1038/mt.2008.98; Dore-Savard L, 2013, CLIN EXP METASTAS, V30, P225, DOI 10.1007/s10585-012-9530-0; Dowdall T, 2005, PHARMACOL BIOCHEM BE, V80, P93, DOI 10.1016/j.pbb.2004.10.016; Dubuc I, 1999, J NEUROSCI, V19, P503, DOI 10.1523/JNEUROSCI.19-01-00503.1999; DUBUC I, 1992, EUR J PHARMACOL, V219, P327, DOI 10.1016/0014-2999(92)90314-T; Dubuc I, 1999, EUR J PHARMACOL, V381, P9, DOI 10.1016/S0014-2999(99)00554-3; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Feifel D, 2010, NEUROPHARMACOLOGY, V58, P195, DOI 10.1016/j.neuropharm.2009.07.001; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Gilron I, 2006, CAN MED ASSOC J, V175, P265, DOI 10.1503/cmaj.060146; Goss James R, 2007, Expert Rev Neurother, V7, P487, DOI 10.1586/14737175.7.5.487; Guillemette A, 2012, EUR J PAIN, V16, P473, DOI 10.1016/j.ejpain.2011.07.008; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Hughes FM, 2010, J MED CHEM, V53, P4623, DOI 10.1021/jm100092s; Jaggi AS, 2011, FUND CLIN PHARMACOL, V25, P1, DOI 10.1111/j.1472-8206.2009.00801.x; Jirkof P, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00165; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Kennedy JD, 2007, J MED CHEM, V50, P2547, DOI 10.1021/jm061023c; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Kissin I, 2010, ANESTH ANALG, V110, P780, DOI 10.1213/ANE.0b013e3181cde882; Kleczkowska P, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-86; Kumar N, 2010, J NEUROCHEM, V113, P552, DOI 10.1111/j.1471-4159.2010.06625.x; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; LaBuda CJ, 2005, J NEUROSCI METH, V144, P175, DOI 10.1016/j.jneumeth.2004.11.008; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; Maeno H, 2004, BRAIN RES, V998, P122, DOI 10.1016/j.brainres.2003.11.039; Maj J, 1998, EUR J PHARMACOL, V351, P31, DOI 10.1016/S0014-2999(98)00297-0; Mao JR, 2012, TRENDS PHARMACOL SCI, V33, P568, DOI 10.1016/j.tips.2012.08.001; Mauderli AP, 2000, J NEUROSCI METH, V97, P19, DOI 10.1016/S0165-0270(00)00160-6; Mechanic JA, 2009, EUR NEUROPSYCHOPHARM, V19, P466, DOI 10.1016/j.euroneuro.2009.01.004; Moller KA, 2008, J NEUROSCI METH, V174, P1, DOI 10.1016/j.jneumeth.2008.06.017; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mogil JS, 2004, PAIN, V112, P12, DOI 10.1016/j.pain.2004.09.028; Niikura K, 2008, NEUROSCI LETT, V435, P257, DOI 10.1016/j.neulet.2008.02.059; OSBAHR AJ, 1981, J PHARMACOL EXP THER, V217, P645; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Patrycja P. K., 2013, EUR J PHARM, V13, P00177; Perron A, 2006, BIOCHEM BIOPH RES CO, V343, P799, DOI 10.1016/j.bbrc.2006.03.047; Pettibone DJ, 2002, J PHARMACOL EXP THER, V300, P305, DOI 10.1124/jpet.300.1.305; Pradhan AAA, 2010, EUR J PAIN, V14, P503, DOI 10.1016/j.ejpain.2009.08.010; Rice ASC, 2008, PAIN, V139, P243, DOI 10.1016/j.pain.2008.08.017; Rossi GC, 2010, J PHARMACOL EXP THER, V334, P1075, DOI 10.1124/jpet.109.165282; Roussy G, 2008, J NEUROCHEM, V105, P1100, DOI 10.1111/j.1471-4159.2007.05205.x; Roussy G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-38; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Sarhan S, 1997, PEPTIDES, V18, P1223, DOI 10.1016/S0196-9781(97)00145-9; Sarret P, 2005, J NEUROSCI, V25, P8188, DOI 10.1523/JNEUROSCI.0810-05.2005; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; Sarret P, 2003, J COMP NEUROL, V461, P520, DOI 10.1002/cne.10718; SARRET P, 2003, HAND CHEM N, V20, P323; Smith DJ, 1997, J PHARMACOL EXP THER, V282, P899; Smith KE, 2012, BEHAV BRAIN RES, V232, P93, DOI 10.1016/j.bbr.2012.03.044; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Stone LS, 2009, MOL INTERV, V9, P234, DOI 10.1124/mi.9.5.7; SUFKA KJ, 1994, PAIN, V58, P355, DOI 10.1016/0304-3959(94)90130-9; Sullivan MD, 2012, ARCH INTERN MED, V172, P433, DOI 10.1001/archinternmed.2011.2156; Tetreault P, 2011, PHYSIOL BEHAV, V104, P495, DOI 10.1016/j.physbeh.2011.05.015; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Tyler BM, 1998, FEBS LETT, V421, P280, DOI 10.1016/S0014-5793(97)01575-5; Tyler-McMahon BM, 2000, EUR J PHARMACOL, V390, P107, DOI 10.1016/S0014-2999(99)00877-8; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; Vachon P, 2004, CAN J VET RES, V68, P86; Wang LLX, 2003, ADV DRUG DELIVER REV, V55, P949, DOI 10.1016/S0169-409X(03)00098-X; Woolf CJ, 2010, NAT MED, V16, P1241, DOI 10.1038/nm.2230; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Xu B, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-15; Yamauchi R, 2003, LIFE SCI, V73, P1917, DOI 10.1016/S0024-3205(03)00546-0; Yang LA, 2004, EUR J NEUROSCI, V19, P871, DOI 10.1111/j.0953-816X.2004.03121.x; Zhang X, 1996, NEUROSCI RES, V25, P359	95	30	33	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3741	3752		10.1096/fj.12-225540	http://dx.doi.org/10.1096/fj.12-225540			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23756650				2022-12-25	WOS:000328840500032
J	Lacruz, RS; de Castro, JMB; Martinon-Torres, M; O'Higgins, P; Paine, ML; Carbonell, E; Arsuaga, JL; Bromage, TG				Lacruz, Rodrigo S.; Bermudez de Castro, Jose Maria; Martinon-Torres, Maria; O'Higgins, Paul; Paine, Michael L.; Carbonell, Eudald; Luis Arsuaga, Juan; Bromage, Timothy G.			Facial Morphogenesis of the Earliest Europeans	PLOS ONE			English	Article							LOWER PLEISTOCENE; GEOMETRIC MORPHOMETRICS; ATAPUERCA; HOMININ; HOMO; AUSTRALOPITHECUS; MORPHOLOGY; ONTOGENY; GROWTH; ORIGIN	The modern human face differs from that of our early ancestors in that the facial profile is relatively retracted (orthognathic). This change in facial profile is associated with a characteristic spatial distribution of bone deposition and resorption: growth remodeling. For humans, surface resorption commonly dominates on anteriorly-facing areas of the subnasal region of the maxilla and mandible during development. We mapped the distribution of facial growth remodeling activities on the 900-800 ky maxilla ATD6-69 assigned to H. antecessor, and on the 1.5 My cranium KNM-WT 15000, part of an associated skeleton assigned to African H. erectus. We show that, as in H. sapiens, H. antecessor shows bone resorption over most of the subnasal region. This pattern contrasts with that seen in KNM-WT 15000 where evidence of bone deposition, not resorption, was identified. KNM-WT 15000 is similar to Australopithecus and the extant African apes in this localized area of bone deposition. These new data point to diversity of patterns of facial growth in fossil Homo. The similarities in facial growth in H. antecessor and H. sapiens suggest that one key developmental change responsible for the characteristic facial morphology of modern humans can be traced back at least to H. antecessor.	[Lacruz, Rodrigo S.; Paine, Michael L.] Univ So Calif, Ctr Craniofacial Mol Biol, Ostrow Sch Dent, Los Angeles, CA 90033 USA; [Lacruz, Rodrigo S.; Paine, Michael L.] Univ So Calif, Dept Anthropol, Los Angeles, CA USA; [Bermudez de Castro, Jose Maria; Martinon-Torres, Maria] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [O'Higgins, Paul] Univ York, Hull York Med Sch, Ctr Anat & Human Sci, York YO10 5DD, N Yorkshire, England; [Carbonell, Eudald] Inst Catala Paleoecol Humana & Evolucio Social, Tarragona, Spain; [Luis Arsuaga, Juan] Univ Complutense Madrid, Inst Carlos UCM ISCIII 3, Ctr Invest Evoluc & Comportamiento Humanos, Madrid, Spain; [Bromage, Timothy G.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Bromage, Timothy G.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY USA	University of Southern California; University of Southern California; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of Hull; University of York - UK; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Complutense University of Madrid; New York University; New York University	Lacruz, RS (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	rodrigo@usc.edu	Lacruz, Rodrigo/AGY-8090-2022; Carbonell, Eudald/G-3003-2015; bromage, timothy/H-8621-2015	Martinon-Torres, Maria/0000-0002-2750-4554; O'Higgins, Paul/0000-0002-9797-0809; Arsuaga, Juan Luis/0000-0001-5361-2295; LACRUZ, RODRIGO/0000-0002-0776-6143; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; bromage, timothy/0000-0002-9843-7993	Leakey Foundation; National Institutes of Health (K99/R00 grant DE) [022799]; Spanish "Ministerio de Ciencia e Innovacion [CGL2009-12703-C03]; Junta de Castilla y Leon (JCyL) [GR249]; Max Planck Research Award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K99DE022799, R00DE022799] Funding Source: NIH RePORTER	Leakey Foundation; National Institutes of Health (K99/R00 grant DE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish "Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon (JCyL)(Junta de Castilla y Leon); Max Planck Research Award(Max Planck Society); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	RSL thanks the Leakey Foundation for financial support and the National Institutes of Health (K99/R00 grant DE # 022799). Research was also funded by Spanish "Ministerio de Ciencia e Innovacion (Project NoCGL2009-12703-C03) and from Junta de Castilla y Leon (JCyL) (Project GR249). Additional support provided to TGB and RSL by the 2010 Max Planck Research Award, administered by the Max Planck Society and the Alexander von Humboldt Foundation in respect of the Hard Tissue Research Program in Human Paleobiomics. Fieldwork supported by the Consejeria de Cultura y Turismo from the JCyL; Fundacion Atapuerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsuaga JL, 1999, J HUM EVOL, V37, P431, DOI 10.1006/jhev.1999.0309; Begun D, 1993, ENDOCAST NARIOKOTOME, P326; Berger GW, 2008, J HUM EVOL, V55, P300, DOI 10.1016/j.jhevol.2008.02.012; Bermudez de Castro JM, 2010, P NATL ACAD SCI USA, V107, P4210; Boyde A, 1972, DEV ASPECTS ORAL BIO, P243; Brauer G, 2008, EVOL ANTHROPOL, V17, P22, DOI 10.1002/evan.20157; Bromage TG, 2009, SCANNING, V31, P1, DOI 10.1002/sca.20139; Bromage T.G., 1985, P239; Bromage T. G., 2008, ESSENTIALS FACIAL GR, P319; BROMAGE TG, 1985, J MICROSC-OXFORD, V137, P209, DOI 10.1111/j.1365-2818.1985.tb02578.x; BROMAGE TG, 1989, J HUM EVOL, V18, P751, DOI 10.1016/0047-2484(89)90088-2; Bromage TG, 2008, J CLIN PEDIATR DENT, V33, P43, DOI 10.17796/jcpd.33.1.8168115j12103nut; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; CARBONELL E, 1995, SCIENCE, V269, P826, DOI 10.1126/science.7638598; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Cobb SN, 2004, J EXP ZOOL PART B, V302B, P302, DOI 10.1002/jez.b.21005; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean MC, 2008, GROWTH DEV NARIOKOTO, P101; deCastro JMB, 1997, SCIENCE, V276, P1392; ENLOW DH, 1965, AMER J ORTHODONTICS, V51, P446, DOI 10.1016/0002-9416(65)90242-3; ENLOW DH, 1966, AMER J ORTHODONTICS, V52, P283, DOI 10.1016/0002-9416(66)90169-2; Enlow DH, 1996, ESSENTIALS FACIAL GR; Harvati K, 2010, J HUM EVOL, V59, P445, DOI 10.1016/j.jhevol.2010.06.005; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; KURIHARA S, 1980, ANGLE ORTHOD, V50, P98; Lacruz RS, 2008, J ANAT, V213, P148, DOI 10.1111/j.1469-7580.2008.00938.x; Lieberman DE, 1999, J HUM EVOL, V36, P487, DOI 10.1006/jhev.1998.0287; Lieberman DE, 2003, P NATL ACAD SCI USA, V300, P1134; Marcucio RS, 2011, GENESIS, V49, P177, DOI 10.1002/dvg.20710; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; McCollum MA, 1999, SCIENCE, V284, P301, DOI 10.1126/science.284.5412.301; McCollum MA, 2008, J HUM EVOL, V54, P2, DOI 10.1016/j.jhevol.2007.05.013; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; MOSS ML, 1969, AMER J ORTHODONTICS, V55, P566, DOI 10.1016/0002-9416(69)90034-7; O'Higgins P, 2013, EVOL BIOL IN PRESS; Rightmire GP, 2008, EVOL ANTHROPOL, V17, P8, DOI 10.1002/evan.20160; Rightmire GP, 2004, AM J PHYS ANTHROPOL, V124, P109, DOI 10.1002/ajpa.10346; Rightmire GP, 1998, AM J PHYS ANTHROPOL, V106, P61, DOI 10.1002/(SICI)1096-8644(199805)106:1<61::AID-AJPA5>3.3.CO;2-U; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Rosas A, 2010, J HUM EVOL, V58, P127, DOI [10.1016/j.jhevol.2009.10.002, 10.1016/j.jhevo1.2009.10.002]; Smith A, 2008, J VERTEBR PALEONTOL, V28, p143A; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; Walker A., 1993, NARIOKOTOME HOMO ERE; Wood Bernard, 1994, Courier Forschungsinstitut Senckenberg, V171, P159	44	31	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65199	10.1371/journal.pone.0065199	http://dx.doi.org/10.1371/journal.pone.0065199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762314	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000321099000042
J	Wu, XF; Chen, G; Lu, JP; Zhu, WF; Qiu, JT; Chen, JX; Xie, SS; Zhuo, SM; Yan, J				Wu, Xiufeng; Chen, Gang; Lu, Jianping; Zhu, Weifeng; Qiu, Jingting; Chen, Jianxin; Xie, Shusen; Zhuo, Shuangmu; Yan, Jun			Label-Free Detection of Breast Masses Using Multiphoton Microscopy	PLOS ONE			English	Article							TUMOR-STROMA INTERACTIONS; IN-VIVO; ENDOSCOPY; CELLS	Histopathology forms the gold standard for the diagnosis of breast cancer. Multiphoton microscopy (MPM) has been proposed to be a potentially powerful adjunct to current histopathological techniques. A label-free imaging based on two-photon excited fluorescence and second-harmonic generation is developed for differentiating normal breast tissues, benign, as well as breast cancer tissues. Human breast biopsies (including human normal breast tissues, benign as well as breast cancer tissues) that are first imaged (fresh, unfixed, and unstained) with MPM and are then processed for routine H-E histopathology. Our results suggest that the MPM images, obtained from these unprocessed biopsies, can readily distinguish between benign lesions and breast cancers. In the tissues of breast cancers, MPM showed that the tumor cells displayed marked cellular and nuclear pleomorphism. The tumor cells, characterized by irregular size and shape, enlarged nuclei, and increased nuclear-cytoplasmic ratio, infiltrated into disrupted connective tissue, leading to the loss of second-harmonic generation signals. For breast cancer, MPM diagnosis was 100% correct because the tissues of breast cancers did not have second-harmonic generation signals in MPM imaging. On the contrary, in benign breast masses, second-harmonic generation signals could be seen easily in MPM imaging. These observations indicate that MPM could be an important potential tool to provide label-free noninvasive diagnostic impressions that can guide surgeon in biopsy and patient management.	[Wu, Xiufeng; Yan, Jun] Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Surg, Fuzhou, Fujian, Peoples R China; [Chen, Gang; Lu, Jianping; Zhu, Weifeng] Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Pathol, Fuzhou, Fujian, Peoples R China; [Qiu, Jingting; Chen, Jianxin; Xie, Shusen; Zhuo, Shuangmu] Fujian Normal Univ, Inst Laser & Optoelect Technol, Fujian Prov Key Lab Photon Technol, Key Lab OptoElect Sci & Technol Med,Minist Educ, Fuzhou, Peoples R China; [Chen, Gang; Yan, Jun] Fujian Univ Tradit Chinese Med, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Normal University; Fujian University of Traditional Chinese Medicine	Zhuo, SM (corresponding author), Fujian Normal Univ, Inst Laser & Optoelect Technol, Fujian Prov Key Lab Photon Technol, Key Lab OptoElect Sci & Technol Med,Minist Educ, Fuzhou, Peoples R China.	shuangmuzhuo@gmail.com; ynjun@yahoo.com	Zhuo, Shuangmu/F-4826-2012	Zhuo, Shuangmu/0000-0001-5767-5197	National Natural Science Foundation of China [81272574, 61275006, 81271620]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1115]; Natural Science Foundation of Fujian Province [2010J01136, 2011J01341]; Education Bureau of Fujian Province [JA12057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Education Bureau of Fujian Province	This work was supported by the National Natural Science Foundation of China (81272574, 61275006 and 81271620), the Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT1115), the Natural Science Foundation of Fujian Province (2010J01136 and 2011J01341), and the Program from Education Bureau of Fujian Province (JA12057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao HC, 2009, OPT EXPRESS, V17, P10098, DOI 10.1364/OE.17.010098; Bird D, 2003, OPT LETT, V28, P1552, DOI 10.1364/OL.28.001552; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Georgakoudi I, 2002, AM J OBSTET GYNECOL, V186, P374, DOI 10.1067/mob.2002.121075; Helmchen F, 2002, CURR OPIN NEUROBIOL, V12, P593, DOI 10.1016/S0959-4388(02)00362-8; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Heppner KJ, 1996, AM J PATHOL, V149, P273; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Koehler MJ, 2006, OPT LETT, V31, P2879, DOI 10.1364/OL.31.002879; Konig K, 2008, J BIOPHOTONICS, V1, P13, DOI 10.1002/jbio.200710022; Laiho LH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1891370; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Liu GJ, 2009, OPT LETT, V34, P2249, DOI 10.1364/OL.34.002249; McLaughlin SA, 2008, J AM COLL SURGEONS, V206, P76, DOI 10.1016/j.jamcollsurg.2007.07.021; Mueller MM, 2002, DIFFERENTIATION, V70, P486, DOI 10.1046/j.1432-0436.2002.700903.x; Muller MG, 2003, CANCER-AM CANCER SOC, V97, P1681, DOI 10.1002/cncr.11255; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Pavlova I, 2003, PHOTOCHEM PHOTOBIOL, V77, P550, DOI 10.1562/0031-8655(2003)077<0550:MABOON>2.0.CO;2; Schedin P, 2010, J MAMMARY GLAND BIOL, V15, P275, DOI 10.1007/s10911-010-9191-z; Tang S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3127203; Turkoz FP, 2012, BREAST, V12, P00173; Wilder-Smith P, 2004, LASER SURG MED, V35, P96, DOI 10.1002/lsm.20079; Zhuo SM, 2006, OPT EXPRESS, V14, P7810, DOI 10.1364/OE.14.007810; Zhuo SM, 2007, PHYS MED BIOL, V52, P4967, DOI 10.1088/0031-9155/52/16/017; Zigrino P, 2005, BIOCHIMIE, V87, P321, DOI 10.1016/j.biochi.2004.10.025; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	28	34	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65933	10.1371/journal.pone.0065933	http://dx.doi.org/10.1371/journal.pone.0065933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755295	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000120
J	Yu, HP; Liu, FC; Tsai, YF; Hwang, TL				Yu, Huang-Ping; Liu, Fu-Chao; Tsai, Yung-Fong; Hwang, Tsong-Long			Osthole Attenuates Hepatic Injury in a Rodent Model of Trauma-Hemorrhage	PLOS ONE			English	Article							INFLAMMATORY CYTOKINE PRODUCTION; RECEPTOR-RELATED PATHWAY; DEPENDENT UP-REGULATION; ACUTE LUNG INJURY; MEDIATED ATTENUATION; IMPROVES SURVIVAL; RATS; EXPRESSION; MECHANISM; HEMEOXYGENASE-1	Recent evidences show that osthole possesses anti-inflammatory properties and protective effects following shock-like states, but the mechanism of these effects remains unknown. The p38 mitogen-activated protein kinase (p38 MAPK) pathway exerts anti-inflammatory effects in injury. The aim of this study was to investigate whether p38 MAPK plays any role in the osthole-mediated attenuation of hepatic injury after trauma-hemorrhage. Male Sprague-Dawley rats underwent trauma-hemorrhage (mean blood pressure maintained at approximately 35-40 mmHg for 90 minutes), followed by fluid resuscitation. During resuscitation, a single dose of osthole (3 mg/kg, intravenously) with and without a p38 MAPK inhibitor SB-203580 (2 mg/kg, intravenously), SB-203580 or vehicle was administered. Plasma alanine aminotransferase (ALT) with aspartate aminotransferase (AST) concentrations and various hepatic parameters were measured (n = 8 rats/group) at 24 hours after resuscitation. The results showed that trauma-hemorrhage increased hepatic myeloperoxidase activity, intercellular adhesion molecule-1 and interleukin-6 levels, and plasma ALT and AST concentrations. These parameters were significantly improved in the osthole-treated rats subjected to trauma-hemorrhage. Osthole treatment also increased hepatic phospho-p38 MAPK expression compared with vehicle-treated trauma-hemorrhaged rats. Co-administration of SB-203580 with osthole abolished the osthole-induced beneficial effects on the above parameters and hepatic injury. These results suggest that the protective effect of osthole administration on alleviation of hepatic injury after trauma-hemorrhage, which is, at least in part, through p38 MAPK-dependent pathway.	[Yu, Huang-Ping; Liu, Fu-Chao; Tsai, Yung-Fong] Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan; [Yu, Huang-Ping; Liu, Fu-Chao; Tsai, Yung-Fong] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Tsai, Yung-Fong] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Grad Inst Nat Prod, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Yu, HP (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan.	yuhp2001@adm.cgmh.org.tw; htl@mail.cgu.edu.tw	Hwang, Tsong-Long/AAE-6944-2020; Liu, Fu-Chao/AAB-3780-2021	Hwang, Tsong-Long/0000-0002-5780-3977; Liu, F-C/0000-0003-1712-4053	National Science Council [NSC101-2314-B-182A-010]; Chang Gung Memorial Hospital [CMRPG3B1051]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was partially supported by grants from the National Science Council (NSC101-2314-B-182A-010) and Chang Gung Memorial Hospital (CMRPG3B1051) to HPY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao XD, 2010, BRAIN RES, V1363, P206, DOI 10.1016/j.brainres.2010.09.052; Dong WP, 2013, INT J MOL MED, V31, P1367, DOI 10.3892/ijmm.2013.1347; Douzinas EE, 2012, CRIT CARE MED, V40, P1348, DOI 10.1097/CCM.0b013e31823e9501; Fang Y, 2011, J TRAUMA, V71, P1297, DOI 10.1097/TA.0b013e3182127d48; He YL, 2012, BRAIN RES, V1433, P127, DOI 10.1016/j.brainres.2011.11.027; Hsu JT, 2008, SHOCK, V30, P372, DOI 10.1097/SHK.0b013e318164f25c; Hsu JT, 2008, AM J PHYSIOL-REG I, V294, pR1825, DOI 10.1152/ajpregu.00112.2008; Huang YS, 2011, CHINESE J PHYSIOL, V54, P183, DOI 10.4077/CJP.2011.AMM024; Jang HJ, 2012, ANTIOXID REDOX SIGN, V17, P878, DOI 10.1089/ars.2011.3994; Jiang SY, 2012, MOL VIS, V18, P2096; Kim H, 2010, J TRAUMA, V69, P1266, DOI 10.1097/TA.0b013e3181dbb0b2; Li F, 2012, BIOL PHARM BULL, V35, P1686, DOI 10.1248/bpb.b12-00133; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Liu FC, 2008, ACTA ANAESTH SCAND, V52, P635, DOI 10.1111/j.1399-6576.2008.01592.x; Liu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053203; Liu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025907; Liu FC, 2011, RESUSCITATION, V82, P335, DOI 10.1016/j.resuscitation.2010.11.007; Liu FC, 2009, ANESTH ANALG, V108, P1855, DOI 10.1213/ane.0b013e3181a1a194; Selzner N, 2002, HEPATOLOGY, V36, P812, DOI 10.1053/jhep.2002.35535; Shah KG, 2010, J TRAUMA, V69, P1415, DOI 10.1097/TA.0b013e3181f661ba; Shi Y, 2013, EUR J PHARM SCI, V48, P819, DOI 10.1016/j.ejps.2012.12.031; Shimizu T, 2007, ANN SURG, V245, P297, DOI 10.1097/01.sla.0000232523.88621.17; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Suda K, 2010, SHOCK, V33, P526, DOI 10.1097/SHK.0b013e3181cc064b; Yu HP, 2008, SHOCK, V30, P324, DOI 10.1097/SHK.0b013e318164f013; Yu HP, 2011, SHOCK, V35, P517, DOI 10.1097/SHK.0b013e318209e931; Yu HP, 2010, SURGERY, V148, P103, DOI 10.1016/j.surg.2009.12.008; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596; Zheng Y, J SURG RES IN PRESS	29	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65916	10.1371/journal.pone.0065916	http://dx.doi.org/10.1371/journal.pone.0065916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755293	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000118
J	Zerouali, Y; Lina, JM; Jemel, B				Zerouali, Younes; Lina, Jean-Marc; Jemel, Boutheina			Optimal Eye-Gaze Fixation Position for Face-Related Neural Responses	PLOS ONE			English	Article							RETINA; BRAIN; PARTS	It is generally agreed that some features of a face, namely the eyes, are more salient than others as indexed by behavioral diagnosticity, gaze-fixation patterns and evoked-neural responses. However, because previous studies used unnatural stimuli, there is no evidence so far that the early encoding of a whole face in the human brain is based on the eyes or other facial features. To address this issue, scalp electroencephalogram (EEG) and eye gaze-fixations were recorded simultaneously in a gaze-contingent paradigm while observers viewed faces. We found that the N170 indexing the earliest face-sensitive response in the human brain was the largest when the fixation position is located around the nasion. Interestingly, for inverted faces, this optimal fixation position was more variable, but mainly clustered in the upper part of the visual field (around the mouth). These observations extend the findings of recent behavioral studies, suggesting that the early encoding of a face, as indexed by the N170, is not driven by the eyes per se, but rather arises from a general perceptual setting (upper-visual field advantage) coupled with the alignment of a face stimulus to a stored face template.	[Zerouali, Younes] Ecole Technol Super, Montreal, PQ, Canada; [Zerouali, Younes; Lina, Jean-Marc; Jemel, Boutheina] Hop Riviere Prairies, Montreal, PQ, Canada; [Lina, Jean-Marc] Univ Montreal, Ctr Rech Math, Montreal, PQ H3C 3J7, Canada; [Jemel, Boutheina] Univ Montreal, Fac Med, Sch Speech Language Pathol, Montreal, PQ H3C 3J7, Canada	University of Quebec; Ecole de Technologie Superieure - Canada; Universite de Montreal; Universite de Montreal; Universite de Montreal	Zerouali, Y (corresponding author), Ecole Technol Super, Montreal, PQ, Canada.	youness.zerouali-boukhal.1@ens.etsmtl.ca		Jemel, Boutheina/0000-0003-3125-5914	Natural Sciences and Engineering Research Council of Canada [OGP0007551]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a grant from the Natural Sciences and Engineering Research Council of Canada, #OGP0007551, awarded to BJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 2010, BRAIN TOPOGR, V23, P227, DOI 10.1007/s10548-010-0154-x; Amblard C, 2004, IEEE T BIOMED ENG, V51; BANKS MS, 1991, J OPT SOC AM A, V8, P1775, DOI 10.1364/JOSAA.8.001775; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bindemann M, 2009, J VISION, V9, DOI 10.1167/9.2.7; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Danckert J, 2001, EXP BRAIN RES, V137, P303; de Xivry JJO, 2008, J NEUROPSYCHOL, V2, P245, DOI 10.1348/174866407X260199; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Eimer M, 1998, NEUROREPORT, V9, P2945, DOI 10.1097/00001756-199809140-00005; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Grutzner C, 2010, J NEUROSCI, V30, P8342, DOI 10.1523/JNEUROSCI.5434-09.2010; Haig ND, 1986, PERCEPTION, V15, P505; Hills P, 2012, BR J PSYCHOL; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Itier RJ, 2007, J COGNITIVE NEUROSCI, V19, P1815, DOI 10.1162/jocn.2007.19.11.1815; Jacques C, 2007, CEREB CORTEX, V17, P1055, DOI 10.1093/cercor/bhl015; Jemel B, 2003, NEUROREPORT, V14, P2035, DOI 10.1097/00001756-200311140-00006; Levine MW, 2005, VISION RES, V45, P2820, DOI 10.1016/j.visres.2005.04.001; McPartland J, 2010, NEUROPSYCHOLOGIA, V48, P3657, DOI 10.1016/j.neuropsychologia.2010.07.020; NOWAGK R, 1996, ANN REPORT MAX PLANK; Perry JS, 2002, P SOC PHOTO-OPT INS, V4662, P57, DOI 10.1117/12.469554; PERRY VH, 1985, VISION RES, V25, P1795, DOI 10.1016/0042-6989(85)90004-5; Portin K, 1999, J OPT SOC M A, V16, P755; Rakover SS, 1997, PERCEPT PSYCHOPHYS, V59, P752, DOI 10.3758/BF03206021; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Rousselet GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-98; Saether L, 2009, VISION RES, V49, P2870, DOI 10.1016/j.visres.2009.09.001; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Slotnick SD, 1999, CLIN NEUROPHYSIOL, V110, P1793, DOI 10.1016/S1388-2457(99)00135-2; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Williams CC, 2007, MEM COGNITION, V35, P1977, DOI 10.3758/BF03192930	36	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e60128	10.1371/journal.pone.0060128	http://dx.doi.org/10.1371/journal.pone.0060128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762224	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000001
J	Nowak, MD; Smith, AB; Simpson, C; Zwickl, DJ				Nowak, Michael D.; Smith, Andrew B.; Simpson, Carl; Zwickl, Derrick J.			A Simple Method for Estimating Informative Node Age Priors for the Fossil Calibration of Molecular Divergence Time Analyses	PLOS ONE			English	Article							RELAXED PHYLOGENETICS; SOFTWARE PACKAGE; EVOLUTIONARY; ORIGINATION; UNCERTAINTY; EXTINCTION; CLOCK; DIVERSIFICATION; RECONSTRUCTION; TIMESCALES	Molecular divergence time analyses often rely on the age of fossil lineages to calibrate node age estimates. Most divergence time analyses are now performed in a Bayesian framework, where fossil calibrations are incorporated as parametric prior probabilities on node ages. It is widely accepted that an ideal parameterization of such node age prior probabilities should be based on a comprehensive analysis of the fossil record of the clade of interest, but there is currently no generally applicable approach for calculating such informative priors. We provide here a simple and easily implemented method that employs fossil data to estimate the likely amount of missing history prior to the oldest fossil occurrence of a clade, which can be used to fit an informative parametric prior probability distribution on a node age. Specifically, our method uses the extant diversity and the stratigraphic distribution of fossil lineages confidently assigned to a clade to fit a branching model of lineage diversification. Conditioning this on a simple model of fossil preservation, we estimate the likely amount of missing history prior to the oldest fossil occurrence of a clade. The likelihood surface of missing history can then be translated into a parametric prior probability distribution on the age of the clade of interest. We show that the method performs well with simulated fossil distribution data, but that the likelihood surface of missing history can at times be too complex for the distribution-fitting algorithm employed by our software tool. An empirical example of the application of our method is performed to estimate echinoid node ages. A simulation-based sensitivity analysis using the echinoid data set shows that node age prior distributions estimated under poor preservation rates are significantly less informative than those estimated under high preservation rates.	[Nowak, Michael D.] Univ Zurich, Inst Systemat Bot, Zurich, Switzerland; [Smith, Andrew B.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Simpson, Carl] Humboldt Univ, Museum Nat Kunde, D-10099 Berlin, Germany; [Zwickl, Derrick J.] Univ Kansas, Dept Ecol & Evolut, Lawrence, KS 66045 USA	University of Zurich; Natural History Museum London; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Kansas	Nowak, MD (corresponding author), Univ Zurich, Inst Systemat Bot, Zurich, Switzerland.	michael.nowak@systbot.uzh.ch	Smith, Andrew B/B-9849-2009; Nowak, Michael/M-3747-2017	Nowak, Michael/0000-0001-8924-6506; Simpson, Carl/0000-0003-0719-4437	Society of Systematic Biologists Graduate Student Research Award; National Evolutionary Synthesis Center (NESCent); Google Summer of Code	Society of Systematic Biologists Graduate Student Research Award; National Evolutionary Synthesis Center (NESCent)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Google Summer of Code(Google Incorporated)	This work was financially supported through a Society of Systematic Biologists Graduate Student Research Award to MN, the National Evolutionary Synthesis Center (NESCent), and Google Summer of Code. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro M, 2006, POSTERIOR PRIOR BAYE; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2010, PALAEONTOLOGY, V53, P1211, DOI 10.1111/j.1475-4983.2010.01011.x; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton Michael J., 2009, P35; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Clayton JW, 2009, SYST BIOL, V58, P395, DOI 10.1093/sysbio/syp041; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Dornburg A, 2011, SYST BIOL, V60, P519, DOI 10.1093/sysbio/syr019; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 1996, FOSSIL PRESERVATION, P121; Friedman M, 2010, P R SOC B, V278, P439, DOI [10.1038/463040a, DOI 10.1038/463040A]; Gradstein F, 2009, TIMETREE LIFE; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Himmelmann L, 2009, BIOINFORMATICS, V25, P2440, DOI 10.1093/bioinformatics/btp417; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Inoue J, 2010, SYST BIOL, V59, P74, DOI 10.1093/sysbio/syp078; Kenrick P, 2011, NEW PHYTOL, V192, P3, DOI 10.1111/j.1469-8137.2011.03856.x; Kroh A, 2010, J SYST PALAEONTOL, V8, P147, DOI 10.1080/14772011003603556; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lee MSY, 2009, MOL PHYLOGENET EVOL, V50, P661, DOI 10.1016/j.ympev.2008.11.024; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; Marshall CR, 2008, AM NAT, V171, P726, DOI 10.1086/587523; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pyron RA, 2010, SYST BIOL, V59, P185, DOI 10.1093/sysbio/syp090; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; RAUP DM, 1985, PALEOBIOLOGY, V11, P42, DOI 10.1017/S0094837300011386; Renner SS, 2005, TRENDS PLANT SCI, V10, P550, DOI 10.1016/j.tplants.2005.09.010; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Sallam HM, 2009, P NATL ACAD SCI USA, V106, P16722, DOI 10.1073/pnas.0908702106; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Shaul S, 2002, GENE, V300, P59, DOI 10.1016/S0378-1119(02)00851-X; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; Tavare S, 2002, NATURE, V416, P726, DOI 10.1038/416726a; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Warnock RCM, 2012, BIOL LETTERS, V8, P156, DOI 10.1098/rsbl.2011.0710; Wilkinson RD, 2011, SYST BIOL, V60, P16, DOI 10.1093/sysbio/syq054; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Zuckerkandl E, 1965, EVOLVING GENES PROTE, V97, P166	51	35	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e66245	10.1371/journal.pone.0066245	http://dx.doi.org/10.1371/journal.pone.0066245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755303	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000320579400083
J	Srivastava, P; Moorthy, GS; Gross, R; Barrett, JS				Srivastava, Praveen; Moorthy, Ganesh S.; Gross, Robert; Barrett, Jeffrey S.			A Sensitive and Selective Liquid Chromatography/Tandem Mass Spectrometry Method for Quantitative Analysis of Efavirenz in Human Plasma	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITOR; HIV-PROTEASE INHIBITORS; ANTIRETROVIRAL AGENTS; RITONAVIR; QUANTIFICATION; AMPRENAVIR; SAQUINAVIR; LOPINAVIR; DRUGS; SERUM	A selective and a highly sensitive method for the determination of the non-nucleoside reverse transcriptase inhibitor (NNRTI), efavirenz, in human plasma has been developed and fully validated based on high performance liquid chromatography tandem mass spectrometry (LC-MS/MS). Sample preparation involved protein precipitation followed by one to one dilution with water. The analyte, efavirenz was separated by high performance liquid chromatography and detected with tandem mass spectrometry in negative ionization mode with multiple reaction monitoring. Efavirenz and C-13(6)-efavirenz (Internal Standard), respectively, were detected via the following MRM transitions: m/z 314.20243.90 and m/z 320.20249.90. A gradient program was used to elute the analytes using 0.1% formic acid in water and 0.1% formic acid in acetonitrile as mobile phase solvents, at a flow-rate of 0.3 mL/min. The total run time was 5 min and the retention times for the internal standard (C-13(6)-efavirenz) and efavirenz was approximately 2.6 min. The calibration curves showed linearity (coefficient of regression, r>0.99) over the concentration range of 1.0-2,500 ng/mL. The intraday precision based on the standard deviation of replicates of lower limit of quantification (LLOQ) was 9.24% and for quality control (QC) samples ranged from 2.41% to 6.42% and with accuracy from 112% and 100-111% for LLOQ and QC samples. The inter day precision was 12.3% and 3.03-9.18% for LLOQ and quality controls samples, and the accuracy was 108% and 95.2-108% for LLOQ and QC samples. Stability studies showed that efavirenz was stable during the expected conditions for sample preparation and storage. The lower limit of quantification for efavirenz was 1 ng/mL. The analytical method showed excellent sensitivity, precision, and accuracy. This method is robust and is being successfully applied for therapeutic drug monitoring and pharmacokinetic studies in HIV-infected patients.	[Srivastava, Praveen; Moorthy, Ganesh S.; Barrett, Jeffrey S.] Childrens Hosp Philadelphia, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA; [Gross, Robert; Barrett, Jeffrey S.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gross, Robert; Barrett, Jeffrey S.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gross, Robert; Barrett, Jeffrey S.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Moorthy, GS (corresponding author), Childrens Hosp Philadelphia, Div Clin Pharmacol & Therapeut, Philadelphia, PA 19104 USA.	moorthyg@email.chop.edu		Barrett, Jeff/0000-0003-0879-1743	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work has been funded by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JC, 1998, DRUGS, V56, P1055, DOI 10.2165/00003495-199856060-00014; [Anonymous], 2001, FDA GUID IND BIOAN M; Aymard G, 2000, J CHROMATOGR B, V744, P227, DOI 10.1016/S0378-4347(00)00225-5; Choi SO, 2007, J PHARMACEUT BIOMED, V43, P1562, DOI 10.1016/j.jpba.2006.11.017; D'Avolio A, 2007, J CHROMATOGR B, V859, P234, DOI 10.1016/j.jchromb.2007.10.003; D'Avolio A, 2010, J PHARMACEUT BIOMED, V52, P774, DOI 10.1016/j.jpba.2010.02.026; De Meulder M, 2008, J CHROMATOGR B, V870, P8, DOI 10.1016/j.jchromb.2008.04.041; Gross R, 2008, JAIDS-J ACQ IMM DEF, V49, P336, DOI 10.1097/QAI.0b013e31817c1ed0; Kappelhoff BS, 2003, J CHROMATOGR B, V792, P353, DOI 10.1016/S1570-0232(03)00325-8; Langmann P, 2001, J CHROMATOGR B, V755, P151, DOI 10.1016/S0378-4347(01)00059-7; Marzolini C, 2000, J CHROMATOGR B, V740, P43, DOI 10.1016/S0378-4347(99)00573-3; Matthews CZ, 2002, J PHARMACEUT BIOMED, V28, P925, DOI 10.1016/S0731-7085(01)00709-9; Mogatle S, 2009, J PHARMACEUT BIOMED, V49, P1308, DOI 10.1016/j.jpba.2009.03.008; Nirogi R, 2009, BIOMED CHROMATOGR, V23, P371, DOI 10.1002/bmc.1125; Notari S, 2006, J CHROMATOGR B, V831, P258, DOI 10.1016/j.jchromb.2005.12.016; Pereira EA, 2005, J CHROMATOGR A, V1091, P169, DOI 10.1016/j.chroma.2005.07.031; Ramachandran G, 2006, J CHROMATOGR B, V835, P131, DOI 10.1016/j.jchromb.2006.03.014; Rezk NL, 2004, J CHROMATOGR B, V805, P241, DOI 10.1016/j.jchromb.2004.03.002; Rouzes A, 2004, J CHROMATOGR B, V813, P209, DOI 10.1016/j.jchromb.2004.09.041; Sailaja AL, 2007, CHROMATOGRAPHIA, V65, P359, DOI 10.1365/s10337-006-0170-x; Sarasa-Nacenta M, 2001, J CHROMATOGR B, V763, P53, DOI 10.1016/S0378-4347(01)00357-7; Simon VA, 2001, J CHROMATOGR A, V913, P447, DOI 10.1016/S0021-9673(00)01092-X; Theron A, 2010, J CHROMATOGR B, V878, P2886, DOI 10.1016/j.jchromb.2010.08.051; Titier K, 2002, THER DRUG MONIT, V24, P417, DOI 10.1097/00007691-200206000-00015; Turner ML, 2003, J CHROMATOGR B, V784, P331, DOI 10.1016/S1570-0232(02)00822-X; Usami Y, 2003, CHEM PHARM BULL, V51, P715; Van Eeckhaut A, 2009, J CHROMATOGR B, V877, P2198, DOI 10.1016/j.jchromb.2009.01.003; Veldkamp AI, 1999, J CHROMATOGR B, V734, P55, DOI 10.1016/S0378-4347(99)00336-9; Villani P, 1999, THER DRUG MONIT, V21, P346, DOI 10.1097/00007691-199906000-00018; Weller DR, 2007, J CHROMATOGR B, V848, P369, DOI 10.1016/j.jchromb.2006.10.022; YOUNG SD, 1995, ANTIMICROB AGENTS CH, V39, P2602, DOI 10.1128/AAC.39.12.2602	31	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e63305	10.1371/journal.pone.0063305	http://dx.doi.org/10.1371/journal.pone.0063305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755102	gold, Green Submitted, Green Published			2022-12-25	WOS:000320579400004
J	Yamashita, A; Fujita, Y; Yamamoto, M				Yamashita, Akira; Fujita, Yoshihiro; Yamamoto, Masayuki			Proper Microtubule Structure Is Vital for Timely Progression through Meiosis in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; NUCLEAR-MOVEMENT; BINDING PROTEIN; MUTANTS; COMPLEX; CYCLE; GENE; IDENTIFICATION; SPORULATION; JAPONICUS	Cells of the fission yeast Schizosaccharomyces pombe normally reproduce by mitotic division in the haploid state. When subjected to nutrient starvation, two haploid cells fuse and undergo karyogamy, forming a diploid cell that initiates meiosis to form four haploid spores. Here, we show that deletion of the mal3 gene, which encodes a homolog of microtubule regulator EB1, produces aberrant asci carrying more than four spores. The mal3 deletion mutant cells have a disordered cytoplasmic microtubule structure during karyogamy and initiate meiosis before completion of karyogamy, resulting in twin haploid meiosis in the zygote. Treatment with anti-microtubule drugs mimics this phenotype. Mutants defective in karyogamy or mutants prone to initiate haploid meiosis exaggerate the phenotype of the mal3 deletion mutant. Our results indicate that proper microtubule structure is required for ordered progression through the meiotic cycle. Furthermore, the results of our study suggest that fission yeast do not monitor ploidy during meiosis.	[Yamashita, Akira; Yamamoto, Masayuki] Kazusa DNA Res Inst, Lab Gene Fuct, Kisarazu, Chiba, Japan; [Fujita, Yoshihiro; Yamamoto, Masayuki] Univ Tokyo, Dept Biochem & Biophys, Grad Sch Sci, Tokyo, Japan	Kazusa DNA Research Institute; University of Tokyo	Yamashita, A (corresponding author), Kazusa DNA Res Inst, Lab Gene Fuct, Kisarazu, Chiba, Japan.	ymst@kazusa.or.jp	Yamashita, Akira/A-5278-2015	Yamashita, Akira/0000-0002-1805-1434	Japan Society for the Promotion of Science [23570223, 21227007]; Grants-in-Aid for Scientific Research [21227007] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) (23570223) to A. Y. and (S) (21227007) to M. Y. from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa K, 2005, EMBO REP, V6, P1194, DOI 10.1038/sj.embor.7400540; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beinhauer JD, 1997, J CELL BIOL, V139, P717, DOI 10.1083/jcb.139.3.717; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; EGEL R, 1974, EXP CELL RES, V88, P127, DOI 10.1016/0014-4827(74)90626-0; Fujita I, 2010, GENES CELLS, V15, P359, DOI 10.1111/j.1365-2443.2010.01386.x; Furuya K, 2009, YEAST, V26, P221, DOI 10.1002/yea.1662; Gibeaux R, 2013, GENE DEV, V27, P335, DOI 10.1101/gad.206318.112; GUTZ H, 1967, SCIENCE, V158, P796, DOI 10.1126/science.158.3802.796; Gutz H., 1974, HDB GENETICS; IINO Y, 1985, MOL GEN GENET, V198, P416, DOI 10.1007/BF00332932; Li P, 1996, CELL, V87, P869, DOI 10.1016/S0092-8674(00)81994-7; MCLEOD M, 1987, EMBO J, V6, P729, DOI 10.1002/j.1460-2075.1987.tb04814.x; Molk JN, 2006, J CELL BIOL, V172, P27, DOI 10.1083/jcb.200510032; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Niccoli T, 2004, J CELL SCI, V117, P5543, DOI 10.1242/jcs.01475; NURSE P, 1985, MOL GEN GENET, V198, P497, DOI 10.1007/BF00332946; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; SU LK, 1995, CANCER RES, V55, P2972; TANAKA K, 1982, J CELL SCI, V56, P263; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Venkatram S, 2004, MOL BIOL CELL, V15, P2287, DOI 10.1091/mbc.E03-10-0728; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; WILLER M, 1995, MOL CELL BIOL, V15, P4964; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamamoto M, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P297; Yamamoto M., 1997, MATING SPORULATION S, P1037; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676	30	4	4	7	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65082	10.1371/journal.pone.0065082	http://dx.doi.org/10.1371/journal.pone.0065082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755176	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400038
J	Yang, C; Ge, SN; Zhang, JR; Chen, L; Yan, ZQ; Heng, LJ; Zhao, TZ; Li, WX; Jia, D; Zhu, JL; Gao, GD				Yang, Chen; Ge, Shun-Nan; Zhang, Jia-Rui; Chen, Lei; Yan, Zhi-Qiang; Heng, Li-Jun; Zhao, Tian-Zhi; Li, Wei-Xin; Jia, Dong; Zhu, Jun-Ling; Gao, Guo-Dong			Systemic Blockade of Dopamine D2-Like Receptors Increases High-Voltage Spindles in the Globus Pallidus and Motor Cortex of Freely Moving Rats	PLOS ONE			English	Article							HZ CORTICAL OSCILLATIONS; BASAL GANGLIA NETWORK; BRAIN; MODULATION; NUCLEUS; SPIKE; THALAMUS; ORGANIZATION; DEPLETION; DYNAMICS	High-voltage spindles (HVSs) have been reported to appear spontaneously and widely in the cortical-basal ganglia networks of rats. Our previous study showed that dopamine depletion can significantly increase the power and coherence of HVSs in the globus pallidus (GP) and motor cortex of freely moving rats. However, it is unclear whether dopamine regulates HVS activity by acting on dopamine D-1-like receptors or D-2-like receptors. We employed local-field potential and electrocorticogram methods to simultaneously record the oscillatory activities in the GP and primary motor cortex (M1) in freely moving rats following systemic administration of dopamine receptor antagonists or saline. The results showed that the dopamine D-2-like receptor antagonists, raclopride and haloperidol, significantly increased the number and duration of HVSs, and the relative power associated with HVS activity in the GP and M1 cortex. Coherence values for HVS activity between the GP and M1 cortex area were also significantly increased by dopamine D-2-like receptor antagonists. On the contrary, the selective dopamine D-1-like receptor antagonist, SCH23390, had no significant effect on the number, duration, or relative power of HVSs, or HVS-related coherence between M1 and GP. In conclusion, dopamine D-2-like receptors, but not D1-like receptors, were involved in HVS regulation. This supports the important role of dopamine D-2-like receptors in the regulation of HVSs. An siRNA knock-down experiment on the striatum confirmed our conclusion.	[Yang, Chen; Ge, Shun-Nan; Chen, Lei; Heng, Li-Jun; Zhao, Tian-Zhi; Li, Wei-Xin; Jia, Dong; Zhu, Jun-Ling; Gao, Guo-Dong] Fourth Mil Med Univ, Dept Neurosurg, Xian 710032, Peoples R China; [Zhang, Jia-Rui] Fourth Mil Med Univ, Dept Pathol, Tangdu Hosp, Xian 710032, Peoples R China; [Yan, Zhi-Qiang] Lanzhou Mil Command, Urumqi Gen Hosp, Dept Neurosurg, Urumqi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhu, JL (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xian 710032, Peoples R China.	zhujl65@fmmu.edu.cn; tdgguodong@163.com		yang, chen/0000-0002-3575-3163	Key Program of the National Science Foundation of China [30930095]	Key Program of the National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Key Program of the National Science Foundation of China (No. 30930095, to GDG and JLZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendse HW, 2007, PARKINSONISM RELAT D, V13, pS440, DOI 10.1016/S1353-8020(08)70046-4; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; BUONAMICI M, 1986, NEUROPHARMACOLOGY, V25, P323, DOI 10.1016/0028-3908(86)90259-5; BUZSAKI G, 1990, NEUROSCIENCE, V36, P1, DOI 10.1016/0306-4522(90)90345-5; BUZSAKI G, 1991, EUR J NEUROSCI, V3, P222, DOI 10.1111/j.1460-9568.1991.tb00083.x; BUZSAKI G, 1988, J NEUROSCI, V8, P4007; BUZSAKI G, 1990, NEUROSCIENCE, V38, P323, DOI 10.1016/0306-4522(90)90031-X; Dejean C, 2008, J NEUROPHYSIOL, V100, P385, DOI 10.1152/jn.90466.2008; Dejean C, 2007, EUR J NEUROSCI, V25, P772, DOI 10.1111/j.1460-9568.2007.05305.x; Dejean C, 2011, J NEUROSCI, V31, P6098, DOI 10.1523/JNEUROSCI.3311-09.2011; Fontanini A, 2005, J NEUROPHYSIOL, V93, P2832, DOI 10.1152/jn.01035.2004; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Gasca-Martinez D, 2010, NEUROSCIENCE, V169, P1672, DOI 10.1016/j.neuroscience.2010.05.048; Ge SN, 2012, BRAIN RES, V1465, P66, DOI 10.1016/j.brainres.2012.05.002; GINGRICH JA, 1993, ANNU REV NEUROSCI, V16, P299, DOI 10.1146/annurev.ne.16.030193.001503; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hosp JA, 2009, NEUROSCIENCE, V159, P692, DOI 10.1016/j.neuroscience.2008.12.056; Magill PJ, 2005, NEUROSCIENCE, V132, P659, DOI 10.1016/j.neuroscience.2005.01.006; Magill PJ, 2004, J NEUROPHYSIOL, V92, P2122, DOI 10.1152/jn.00333.2004; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nicolelis MAL, 2002, NAT NEUROSCI, V5, P517, DOI 10.1038/nn0602-517; Noori-Daloii MR, 2012, MOL BIOL REP, V39, P2003, DOI 10.1007/s11033-011-0947-3; Paz JT, 2005, J NEUROSCI, V25, P2092, DOI 10.1523/JNEUROSCI.4689-04.2005; Pinault D, 2003, J PHYSIOL-LONDON, V552, P881, DOI 10.1113/jphysiol.2003.046573; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Sadek AR, 2007, J NEUROSCI, V27, P6352, DOI 10.1523/JNEUROSCI.0953-07.2007; Sakata S, 2005, NEUROSCIENCE, V134, P1099, DOI 10.1016/j.neuroscience.2005.05.018; Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; Smith Y, 1998, NEUROSCIENCE, V86, P353; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sun FT, 2005, NEUROIMAGE, V28, P227, DOI 10.1016/j.neuroimage.2005.05.043; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tancredi V, 2000, J NEUROPHYSIOL, V84, P1093, DOI 10.1152/jn.2000.84.2.1093; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	41	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64637	10.1371/journal.pone.0064637	http://dx.doi.org/10.1371/journal.pone.0064637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755132	Green Submitted, gold, Green Published			2022-12-25	WOS:000320579400021
J	Liu, Y; Guo, YL; Jiang, GL; Zhou, SJ; Sun, Q; Chen, X; Chang, XJ; Xing, AY; Du, FJ; Jia, HY; Zhang, ZD				Liu, Yang; Guo, Yan-Ling; Jiang, Guang-Lu; Zhou, Shi-Jie; Sun, Qi; Chen, Xi; Chang, Xiu-Jun; Xing, Ai-Ying; Du, Feng-Jiao; Jia, Hong-Yan; Zhang, Zong-De			Application of Hyperbranched Rolling Circle Amplification for Direct Detection of Mycobacterium Tuberculosis in Clinical Sputum Specimens	PLOS ONE			English	Article								Background: Global tuberculosis (TB) control is encumbered by the lack of a rapid and simple detection method for diagnosis, especially in low-resource areas. An isothermal amplification method, hyperbranched rolling circle amplification (HRCA), was optimized to detect Mycobacterium tuberculosis (Mtb) in clinical sputum specimens. Methods: A clinical validation study was performed to assess the diagnostic accuracy of HRCA. In order to analyze the detection limit of HRCA under optimal conditions, the method was initially used to detect purified H37Rv strain DNA and culture suspensions. Next, three strains of Mycobacterium tuberculosis complex (MTC) and eight strains of non-tuberculosis mycobacterium (NTM) were analyzed in order to evaluate specificity. Sputum specimens from 136 patients with diagnosed pulmonary TB, 38 lung cancer patients, and 34 healthy donors were tested by HRCA to validate the clinical application of HRCA for the rapid detection of Mtb. Results: The detection limit of HRCA for purified H37Rv DNA and culture suspensions was 740 aM and 200cfu/ml, respectively. The results of all MTC strains were positive in contrast to the NTM specimens which were all negative. The detection sensitivity for the 136 sputum specimens from TB patients was 77.2% (105/136), which was slightly lower than that of quantitative real-time PCR(79.4%, 108/136) and culture (80.9%, 110/136). The sensitivity of all three methods was statistically higher than smear microscopy (44.9%, 61/136). The overall specificity of HRCA was 98.6% (71/72) which was similar to that of quantitative real-time PCR (qRT-PCR) and smear/culture methods (100%, 72/72). Conclusions: Use of the HRCA assay for detection of Mtb within clinical sputum specimens was demonstrated to be highly sensitive and specific. Moreover, the performance of HRCA is simple and cost-effective compared with qRT-PCR and is less time consuming than culture. Therefore, HRCA is a promising TB diagnostic tool that can be used routinely in low-resource clinical settings.	[Liu, Yang; Guo, Yan-Ling; Jiang, Guang-Lu; Zhou, Shi-Jie; Sun, Qi; Chen, Xi; Chang, Xiu-Jun; Xing, Ai-Ying; Du, Feng-Jiao; Jia, Hong-Yan; Zhang, Zong-De] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Lab Mol Biol TB, Beijing, Peoples R China	Capital Medical University	Zhang, ZD (corresponding author), Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Lab Mol Biol TB, Beijing, Peoples R China.	zzd417@163.com			Beijing new star project of science and technology [2008A40]; Beijing talents project [2012D003034000006]; cooperation program of basic and clinical research at Capital Medical University [11JL64]	Beijing new star project of science and technology; Beijing talents project; cooperation program of basic and clinical research at Capital Medical University	This work was supported by Beijing new star project of science and technology (No. 2008A40), Beijing talents project (2012D003034000006), and the cooperation program of basic and clinical research at Capital Medical University (No. 11JL64). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras SC, 2001, MOL BIOTECHNOL, V19, P29, DOI 10.1385/MB:19:1:029; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; George G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021007; HOFMANNTHIEL S, 2010, BMC MICROBIOL, V31, P10; Kaocharoen S, 2008, ELECTROPHORESIS, V29, P3183, DOI 10.1002/elps.200700903; Kim JH, 2011, J CLIN MICROBIOL, V49, P173, DOI 10.1128/JCM.00694-10; Lighter Jennifer, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P61, DOI 10.1016/j.cppeds.2008.12.003; Nyendak MR, 2009, CURR OPIN INFECT DIS, V22, P174, DOI 10.1097/QCO.0b013e3283262fe9; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; *ROCH MOL SYST INC, 2007, COBAS TAQMAN MTB TES; Scherer LC, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-15; Sohn H, 2009, EXPERT REV ANTI-INFE, V7, P723, DOI [10.1586/eri.09.52, 10.1586/ERI.09.52]; WHO, 2009, WHO TECH REP SER, V958, P1; World Health Organization, 1998, LAB SERV TUB CONTR; Yang YC, 2011, J CLIN MICROBIOL, V49, P797, DOI 10.1128/JCM.01839-10; Yi JZ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl261; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	17	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64583	10.1371/journal.pone.0064583	http://dx.doi.org/10.1371/journal.pone.0064583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750210	gold, Green Submitted, Green Published			2022-12-25	WOS:000319961900012
J	Pietraszewska-Bogiel, A; Lefebvre, B; Koini, MA; Klaus-Heisen, D; Takken, FLW; Geurts, R; Cullimore, JV; Gadella, TWJ				Pietraszewska-Bogiel, Anna; Lefebvre, Benoit; Koini, Maria A.; Klaus-Heisen, Doerte; Takken, Frank L. W.; Geurts, Rene; Cullimore, Julie V.; Gadella, Theodorus W. J.			Interaction of Medicago truncatula Lysin Motif Receptor-Like Kinases, NFP and LYK3, Produced in Nicotiana benthamiana Induces Defence- Like Responses	PLOS ONE			English	Article							PHOSPHOLIPID SIGNALING PATHWAYS; PLANT INNATE IMMUNITY; NOD FACTOR PERCEPTION; ROOT HAIRS; CELL-DEATH; FLUORESCENT PROTEINS; ARABIDOPSIS-THALIANA; MOLECULAR-PATTERNS; CA2+ SPIKING; NODULATION	Receptor(-like) kinases with Lysin Motif (LysM) domains in their extracellular region play crucial roles during plant interactions with microorganisms; e.g. Arabidopsis thaliana CERK1 activates innate immunity upon perception of fungal chitin/chitooligosaccharides, whereas Medicago truncatula NFP and LYK3 mediate signalling upon perception of bacterial lipo-chitooligosaccharides, termed Nod factors, during the establishment of mutualism with nitrogen-fixing rhizobia. However, little is still known about the exact activation and signalling mechanisms of MtNFP and MtLYK3. We aimed at investigating putative molecular interactions of MtNFP and MtLYK3 produced in Nicotiana benthamiana. Surprisingly, heterologous co-production of these proteins resulted in an induction of defence-like responses, which included defence-related gene expression, accumulation of phenolic compounds, and cell death. Similar defence-like responses were observed upon production of AtCERK1 in N. benthamiana leaves. Production of either MtNFP or MtLYK3 alone or their co-production with other unrelated receptor(-like) kinases did not induce cell death in N. benthamiana, indicating that a functional interaction between these LysM receptor-like kinases is required for triggering this response. Importantly, structure-function studies revealed that the MtNFP intracellular region, specific features of the MtLYK3 intracellular region (including several putative phosphorylation sites), and MtLYK3 and AtCERK1 kinase activity were indispensable for cell death induction, thereby mimicking the structural requirements of nodulation or chitin-induced signalling. The observed similarity of N. benthamiana response to MtNFP and MtLYK3 co-production and AtCERK1 production suggests the existence of parallels between Nod factor-induced and chitin-induced signalling mediated by the respective LysM receptor(-like) kinases. Notably, the conserved structural requirements for MtNFP and MtLYK3 biological activity in M. truncatula (nodulation) and in N. benthamiana (cell death induction) indicates the relevance of the latter system for studies on these, and potentially other symbiotic LysM receptor-like kinases.	[Pietraszewska-Bogiel, Anna; Koini, Maria A.; Gadella, Theodorus W. J.] Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, Amsterdam, Netherlands; [Lefebvre, Benoit; Klaus-Heisen, Doerte; Cullimore, Julie V.] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Lefebvre, Benoit; Klaus-Heisen, Doerte; Cullimore, Julie V.] CNRS, LIPM, UMR2594, F-31326 Castanet Tolosan, France; [Takken, Frank L. W.] Univ Amsterdam, Swammerdam Inst Life Sci, Sect Plant Pathol, Amsterdam, Netherlands; [Geurts, Rene] Wageningen Univ, Mol Biol Lab, Dept Plant Sci, NL-6700 AP Wageningen, Netherlands	University of Amsterdam; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; University of Amsterdam; Wageningen University & Research	Gadella, TWJ (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Sect Mol Cytol, Amsterdam, Netherlands.	Th.W.J.Gadella@uva.nl	lefebvre, benoit/G-2028-2012; Takken, Frank/C-8051-2012	Takken, Frank/0000-0003-2655-3108; Lefebvre, Benoit/0000-0002-3810-605X; Gadella, Theodorus/0000-0002-7639-219X; Cullimore, Julie/0000-0001-8804-4849	European Community [MRTN-CT-2006-035546]; French National Research Agency (ANR) [ANR-10-LABX-41]	European Community(European Commission); French National Research Agency (ANR)(French National Research Agency (ANR))	This work was supported by the European Community Marie Curie Research Training Network Programme through contract MRTN-CT-2006-035546 "NODPERCEPTION''. Work in Toulouse was supported by the French National Research Agency (ANR) through contracts "NodBindsLysM", "SYMPASIGNAL" and "LCOinNONLEGUMES", and has been done as part of the Laboratoire d'Excellence (LABEX) entitled TULIP (ANR-10-LABX-41). FLWT acknowledges the Centre for BioSystems Genomics and Netherlands Genomics Initiative program. RG acknowledges the Dutch Science Organisation NWO (VIDI 864.06.007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Bensmihen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026114; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Broghammer A, 2012, P NATL ACAD SCI USA, V109, P13859, DOI 10.1073/pnas.1205171109; Bueno P, 2001, NEW PHYTOL, V152, P91, DOI 10.1046/j.0028-646x.2001.00246.x; Capoen W, 2010, NEW PHYTOL, V186, P340, DOI 10.1111/j.1469-8137.2009.03124.x; Cardenas L, 2008, PLANT J, V56, P802, DOI 10.1111/j.1365-313X.2008.03644.x; Charron D, 2004, PLANT PHYSIOL, V136, P3582, DOI 10.1104/pp.104.051110; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; CORNELISSEN BJC, 1987, NUCLEIC ACIDS RES, V15, P6799, DOI 10.1093/nar/15.17.6799; Czaja LF, 2012, PLANT PHYSIOL, V159, P1671, DOI 10.1104/pp.112.195990; den Hartog M, 2003, PLANT PHYSIOL, V132, P311, DOI 10.1104/pp.102.017954; den Hartog M, 2001, PLANT J, V25, P55, DOI 10.1046/j.1365-313x.2001.00931.x; Ditt RF, 2006, MOL PLANT MICROBE IN, V19, P665, DOI 10.1094/MPMI-19-0665; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Erbs G, 2008, CHEM BIOL, V15, P438, DOI 10.1016/j.chembiol.2008.03.017; Frey NFD, 2012, PLANT PHYSIOL, V159, P798, DOI 10.1104/pp.111.192575; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Gust AA, 2012, TRENDS PLANT SCI, V17, P495, DOI 10.1016/j.tplants.2012.04.003; Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9; Han Z, 2012, SCIENCE, V336, P221; Haney CH, 2011, PLANT CELL, V23, P2774, DOI 10.1105/tpc.111.086389; Hayashi T, 2010, PLANT J, V63, P141, DOI 10.1111/j.1365-313X.2010.04228.x; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hogslund N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006556; Ke DX, 2012, PLANT PHYSIOL, V159, P131, DOI 10.1104/pp.112.197269; Kishi-Kaboshi M, 2010, PLANT J, V63, P599, DOI 10.1111/j.1365-313X.2010.04264.x; Klaus-Heisen D, 2011, J BIOL CHEM, V286, P11202, DOI 10.1074/jbc.M110.186171; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kwaaitaal M, 2011, BIOCHEM J, V440, P355, DOI 10.1042/BJ20111112; Lefebvre B, 2012, J BIOL CHEM, V287, P10812, DOI 10.1074/jbc.M111.281634; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Limpens E, 2005, P NATL ACAD SCI USA, V102, P10375, DOI 10.1073/pnas.0504284102; Liu B, 2012, PLANT CELL, V24, P3406, DOI 10.1105/tpc.112.102475; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Martinez-Abarca F, 1998, MOL PLANT MICROBE IN, V11, P153, DOI 10.1094/MPMI.1998.11.2.153; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Miwa H, 2006, MOL PLANT MICROBE IN, V19, P914, DOI 10.1094/MPMI-19-0914; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Murray J, 2006, MOL PLANT MICROBE IN, V19, P1082, DOI 10.1094/MPMI-19-1082; Nakagawa T, 2011, PLANT J, V65, P169, DOI 10.1111/j.1365-313X.2010.04411.x; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Oh CS, 2010, TRENDS PLANT SCI, V16, P1360; Oh MH, 2012, P NATL ACAD SCI USA, V109, P327, DOI 10.1073/pnas.1108321109; Olah B, 2005, PLANT J, V44, P195, DOI 10.1111/j.1365-313X.2005.02522.x; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Peleg-Grossman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008399; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rey T, 2013, NEW PHYTOL, V198, P875, DOI 10.1111/nph.12198; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Serna-Sanz A, 2011, MOL PLANT MICROBE IN, V24, P932, DOI 10.1094/MPMI-09-10-0222; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw SL, 2003, PLANT PHYSIOL, V131, P976, DOI 10.1104/pp.005546; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Sieberer BJ, 2009, PLANT PHYSIOL, V151, P1197, DOI 10.1104/pp.109.142851; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Streng A, 2011, PLANT SIGNAL BEHAV, V6, P1510, DOI 10.4161/psb.6.10.17444; Taguchi F, 2009, PHYSIOL MOL PLANT P, V74, P11, DOI 10.1016/j.pmpp.2009.08.001; Takahashi Y, 2007, PLANT J, V49, P1030, DOI 10.1111/j.1365-313X.2006.03022.x; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wan JR, 2012, PLANT PHYSIOL, V160, P396, DOI 10.1104/pp.112.201699; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Zhang XC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-183	84	63	66	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65055	10.1371/journal.pone.0065055	http://dx.doi.org/10.1371/journal.pone.0065055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750228	Green Published, gold			2022-12-25	WOS:000319961900030
J	Hessle, L; Stordalen, GA; Wenglen, C; Petzold, C; Tanner, EK; Brorson, SH; Baekkevold, ES; Onnerfjord, P; Reinholt, FP; Heinegard, D				Hessle, Lovisa; Stordalen, Gunhild A.; Wenglen, Christina; Petzold, Christiane; Tanner, Elizabeth K.; Brorson, Sverre-Henning; Baekkevold, Espen S.; Onnerfjord, Patrik; Reinholt, Finn P.; Heinegard, Dick			The Skeletal Phenotype of Chondroadherin Deficient Mice	PLOS ONE			English	Article							BONE SIALOPROTEIN; OSTEOBLAST DIFFERENTIATION; PROTEIN CHONDROADHERIN; TARGETED DISRUPTION; MATRIX PROTEINS; INDIAN HEDGEHOG; SKIN FRAGILITY; IN-VITRO; OSTEOPONTIN; CARTILAGE	Chondroadherin, a leucine rich repeat extracellular matrix protein with functions in cell to matrix interactions, binds cells via their alpha 2b1 integrin as well as via cell surface proteoglycans, providing for different sets of signals to the cell. Additionally, the protein acts as an anchor to the matrix by binding tightly to collagens type I and II as well as type VI. We generated mice with inactivated chondroadherin gene to provide integrated studies of the role of the protein. The null mice presented distinct phenotypes with affected cartilage as well as bone. At 3-6 weeks of age the epiphyseal growth plate was widened most pronounced in the proliferative zone. The proteome of the femoral head articular cartilage at 4 months of age showed some distinct differences, with increased deposition of cartilage intermediate layer protein 1 and fibronectin in the chondroadherin deficient mice, more pronounced in the female. Other proteins show decreased levels in the deficient mice, particularly pronounced for matrilin-1, thrombospondin-1 and notably the members of the alpha 1-antitrypsin family of proteinase inhibitors as well as for a member of the bone morphogenetic protein growth factor family. Thus, cartilage homeostasis is distinctly altered. The bone phenotype was expressed in several ways. The number of bone sialoprotein mRNA expressing cells in the proximal tibial metaphysic was decreased and the osteoid surface was increased possibly indicating a change in mineral metabolism. Micro-CT revealed lower cortical thickness and increased structure model index, i.e. the amount of plates and rods composing the bone trabeculas. The structural changes were paralleled by loss of function, where the null mice showed lower femoral neck failure load and tibial strength during mechanical testing at 4 months of age. The skeletal phenotype points at a role for chondroadherin in both bone and cartilage homeostasis, however, without leading to altered longitudinal growth.	[Hessle, Lovisa; Wenglen, Christina; Onnerfjord, Patrik; Heinegard, Dick] Lund Univ, Dept Clin Sci Lund, Sect Mol Skeletal Biol, Lund, Sweden; [Hessle, Lovisa; Wenglen, Christina; Onnerfjord, Patrik; Heinegard, Dick] Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden; [Stordalen, Gunhild A.; Brorson, Sverre-Henning; Baekkevold, Espen S.; Reinholt, Finn P.] Univ Oslo, Dept Pathol, Oslo, Norway; [Stordalen, Gunhild A.; Brorson, Sverre-Henning; Baekkevold, Espen S.; Reinholt, Finn P.] Oslo Univ Hosp, Rikshosp, N-0027 Oslo, Norway; [Petzold, Christiane] Univ Oslo, Fac Odontol, Oslo, Norway; [Tanner, Elizabeth K.] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland; [Tanner, Elizabeth K.] Lund Univ, Dept Clin Sci Lund, Sect Orthopaed, Lund, Sweden	Lund University; Lund University; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Glasgow; Lund University	Stordalen, GA (corresponding author), Univ Oslo, Dept Pathol, Oslo, Norway.	gunhild@stordalenfoundation.no	Tanner, Elizabeth/E-9242-2010; Onnerfjord, Patrik/R-3131-2019	Tanner, Elizabeth/0000-0003-2257-0218; Onnerfjord, Patrik/0000-0002-2345-2937	European Union (OSTEOGENE) [FP6-502491]; Swedish Research Council, Konung Gustaf V's 80-A rsfond, Sweden; South-Eastern Regional Health Authority, Norway	European Union (OSTEOGENE); Swedish Research Council, Konung Gustaf V's 80-A rsfond, Sweden; South-Eastern Regional Health Authority, Norway	Grants were obtained from the European Union (OSTEOGENE, FP6-502491), the Swedish Research Council, Konung Gustaf V's 80-A rsfond, Sweden, and South-Eastern Regional Health Authority, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P193, DOI 10.1177/41.2.8419459; BRORSON SH, 1994, MICRON, V25, P453, DOI 10.1016/0968-4328(94)00035-2; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Franzen A, 2008, J ORTHOP RES, V26, P721, DOI 10.1002/jor.20544; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Haglund L, 2010, J BIOL CHEM; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HEINEGARD D, 1999, DYNAMICS BONE CARTIL, P59; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; HULTENBY K, 1991, MATRIX, V11, P206, DOI 10.1016/S0934-8832(11)80160-5; HULTENBY K, 1994, EUR J CELL BIOL, V63, P230; HUNTER GK, 1994, BIOCHEM J, V302, P175, DOI 10.1042/bj3020175; Johnson J, 2006, MOL VIS, V12, P1057; Kojima H, 2004, J BIOCHEM, V136, P377, DOI 10.1093/jb/mvh136; Landgren C, 1998, GENOMICS, V47, P84, DOI 10.1006/geno.1997.5085; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LARSSON T, 1991, J BIOL CHEM, V266, P20428; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; Mizuno M, 1996, CALCIFIED TISSUE INT, V59, P163, DOI 10.1007/s002239900103; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Shen ZX, 1998, BIOCHEM J, V330, P549, DOI 10.1042/bj3300549; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SOMMARIN Y, 1989, EXP CELL RES, V184, P181, DOI 10.1016/0014-4827(89)90376-5; Sommarin Y, 1998, J BIOL CHEM, V273, P16723, DOI 10.1074/jbc.273.27.16723; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; WHITEHOUSE WJ, 1974, J MICROSC-OXFORD, V101, P153, DOI 10.1111/j.1365-2818.1974.tb03878.x; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zhou HY, 2007, ANN NY ACAD SCI, V1116, P323, DOI 10.1196/annals.1402.023	36	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63080	10.1371/journal.pone.0063080	http://dx.doi.org/10.1371/journal.pone.0063080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755099	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000319872300005
J	Mucksch, C; Urbassek, HM				Muecksch, Christian; Urbassek, Herbert M.			Enhancing Protein Adsorption Simulations by Using Accelerated Molecular Dynamics	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; HYDROPHOBIC SURFACE; GRAPHITE SURFACE; SOLID-SURFACES; LIQUID WATER; BMP-2; OSTEOINTEGRATION; EFFICIENT; LYSOZYME; SYSTEMS	The atomistic modeling of protein adsorption on surfaces is hampered by the different time scales of the simulation (<< 1 ms) and experiment (up to hours), and the accordingly different 'final' adsorption conformations. We provide evidence that the method of accelerated molecular dynamics is an efficient tool to obtain equilibrated adsorption states. As a model system we study the adsorption of the protein BMP-2 on graphite in an explicit salt water environment. We demonstrate that due to the considerably improved sampling of conformational space, accelerated molecular dynamics allows to observe the complete unfolding and spreading of the protein on the hydrophobic graphite surface. This result is in agreement with the general finding of protein denaturation upon contact with hydrophobic surfaces.	[Urbassek, Herbert M.] Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany; Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany	University of Kaiserslautern; University of Kaiserslautern	Urbassek, HM (corresponding author), Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany.	urbassek@rhrk.uni-kl.de	Urbassek, Herbert/D-4361-2019	Urbassek, Herbert/0000-0002-7739-4453				Aijun Zuo, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P888; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Oliveira CAF, 2006, J PHYS CHEM B, V110, P22695, DOI 10.1021/jp062845o; Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168; Fowkes FM, 1940, J AM CHEM SOC, V62, P3377, DOI 10.1021/ja01869a029; Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001; Grimme S., 2008, ANGEW CHEM, V120, P3478; GRUBMULLER H, 1995, PHYS REV E, V52, P2893, DOI 10.1103/PhysRevE.52.2893; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jennissen HP, 2002, ANN NY ACAD SCI, V961, P139, DOI 10.1111/j.1749-6632.2002.tb03067.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lange OE, 2006, J COMPUT CHEM, V27, P1693, DOI 10.1002/jcc.20473; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mucksch C, 2011, CHEM PHYS LETT, V510, P252, DOI 10.1016/j.cplett.2011.05.036; Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4; Oliveira AF, 2010, MATERIALWISS WERKST, V41, P1048, DOI 10.1002/mawe.201000707; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Raffaini G, 2004, J PHYS CHEM B, V108, P13850, DOI 10.1021/jp0477452; Raffaini G, 2003, LANGMUIR, V19, P3403, DOI 10.1021/la026853h; Raffaini G, 2010, LANGMUIR, V26, P5679, DOI 10.1021/la903769c; Rajesh C., 2009, J CHEM PHYS, V130; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Stone, 1998, EFFICIENT LIB PARALL; Sun Y, 2007, J COMPUT CHEM, V28, P1883, DOI 10.1002/jcc.20716; Svaldo-Lanero T, 2008, SOFT MATTER, V4, P965, DOI 10.1039/b800621k; Utesch T, 2011, LANGMUIR, V27, P13144, DOI 10.1021/la202489w; Voter AF, 1997, PHYS REV LETT, V78, P3908, DOI 10.1103/PhysRevLett.78.3908; Wang F, 2008, BIOINTERPHASES, V3, P9, DOI 10.1116/1.2840054; Wang Y, 2011, J CHEM THEORY COMPUT, V7, P3199, DOI 10.1021/ct200430c; Wang YK, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.015002; Wei T, 2011, LANGMUIR, V27, P12074, DOI 10.1021/la202622s; Werder T., 2002, J AM CHEM SOC, V107, P1345; Wereszczynski J, 2012, METHODS MOL BIOL, V819, P515, DOI 10.1007/978-1-61779-465-0_30; Winter M, 2009, CHIR MAIN, V28, P158, DOI 10.1016/j.main.2009.02.003; Xin Y, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3432761; Zuckerman DM, 2011, ANNU REV BIOPHYS, V40, P41, DOI 10.1146/annurev-biophys-042910-155255	43	28	28	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64883	10.1371/journal.pone.0064883	http://dx.doi.org/10.1371/journal.pone.0064883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755156	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300035
J	Muscatello, DJ; Newall, AT; Dwyer, DE; MacIntyre, CR				Muscatello, David J.; Newall, Anthony T.; Dwyer, Dominic E.; MacIntyre, C. Raina			Mortality Attributable to Seasonal and Pandemic Influenza, Australia, 2003 to 2009, Using a Novel Time Series Smoothing Approach	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; NEW-SOUTH-WALES; UNITED-STATES; DEATHS; PNEUMONIA; MATTER; VIRUS	Background: Official statistics under-estimate influenza deaths. Time series methods allow the estimation of influenza-attributable mortality. The methods often model background, non-influenza mortality using a cyclic, harmonic regression model based on the Serfling approach. This approach assumes that the seasonal pattern of non-influenza mortality is the same each year, which may not always be accurate. Aim: To estimate Australian seasonal and pandemic influenza-attributable mortality from 2003 to 2009, and to assess a more flexible influenza mortality estimation approach. Methods: We used a semi-parametric generalized additive model (GAM) to replace the conventional seasonal harmonic terms with a smoothing spline of time ('spline model') to estimate influenza-attributable respiratory, respiratory and circulatory, and all-cause mortality in persons aged <65 and >= 65 years. Influenza A(H1N1)pdm09, seasonal influenza A and B virus laboratory detection time series were used as independent variables. Model fit and estimates were compared with those of a harmonic model. Results: Compared with the harmonic model, the spline model improved model fit by up to 20%. In <65 year-olds, the estimated respiratory mortality attributable to pandemic influenza A(H1N1)pdm09 was 0.5 (95% confidence interval (CI), 0.3, 0.7) per 100,000; similar to that of the years with the highest seasonal influenza A mortality, 2003 and 2007 (A/H3N2 years). In >= 65 year-olds, the highest annual seasonal influenza A mortality estimate was 25.8 (95% CI 22.2, 29.5) per 100,000 in 2003, five-fold higher than the non-statistically significant 2009 pandemic influenza estimate in that age group. Seasonal influenza B mortality estimates were negligible. Conclusions: The spline model achieved a better model fit. The study provides additional evidence that seasonal influenza, particularly A/H3N2, remains an important cause of mortality in Australia and that the epidemic of pandemic influenza A (H1N1)pdm09 virus in 2009 did not result in mortality greater than seasonal A/H3N2 influenza mortality, even in younger age groups.	[Muscatello, David J.; Newall, Anthony T.; MacIntyre, C. Raina] Univ New S Wales, Sch Publ Hlth & Community Med, Kensington, NSW 2033, Australia; [Dwyer, Dominic E.] Univ Sydney, Ctr Infect Dis, Sydney, NSW 2006, Australia; [Dwyer, Dominic E.] Univ Sydney, Microbiol Lab Serv, Inst Clin Pathol & Med Res, Westmead Hosp, Sydney, NSW 2006, Australia; [Dwyer, Dominic E.] Univ Sydney, Sydney Inst Emerging Infect & Biosecur, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney	Muscatello, DJ (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, POB 1, Kensington, NSW 2033, Australia.	dmusc@doh.health.nsw.gov.au	Muscatello, David/HDO-2537-2022; Muscatello, David/AAD-9134-2019	Newall, Anthony/0000-0003-0836-1065; MacIntyre, C Raina/0000-0002-3060-0555				*AUSTR GOV DEP HLT, 2009, INFL SURV REP, V23; *AUSTR GOV DEP HLT, 2009, INFL SURV REP, V32; Australian Bureau of Statistics, 2010, 3101 0 AUSTR DEM STA; Australian Bureau of Statistics, 2009, CAUS DEATH AUSTR 200; Barreca AI, 2012, AM J EPIDEMIOL, V176, pS114, DOI 10.1093/aje/kws259; Blyth CC, 2009, NEW ENGL J MED, V361, P2493, DOI 10.1056/NEJMc0909049; BOWIE C, 1981, INT J EPIDEMIOL, V10, P87, DOI 10.1093/ije/10.1.87; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Charu V, 2011, CLIN INFECT DIS, V53, P985, DOI 10.1093/cid/cir644; Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425; Collins SD, 1930, PUBLIC HEALTH REP, V45, P2277, DOI 10.2307/4579795; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dawood F., 2012, LANCET INFECT DIS; Diggle P, 1990, TIME SERIES BIOSTATI; Dominici F, 2002, AM J EPIDEMIOL, V156, P193, DOI 10.1093/aje/kwf062; FARR W, 1885, VITAL STATISTICS, P330; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Hardelid P, 2012, INFLUENZA OTHER RESP; Hastie TJ., 1990, GEN ADDITIVE MODELS; Iwasenko JM, 2010, CLIN INFECT DIS, V51, P70, DOI 10.1086/653610; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; LANGMUIR AD, 1969, B WORLD HEALTH ORGAN, V41, P393; Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051; McCullagh P, 1989, GEN LINEAR MODELS; Muscatello DJ, 2011, EMERG INFECT DIS, V17, P1240, DOI 10.3201/eid1707.101173; *NEW S WAL PUBL HL, 2009, EURO SURVEILL, V14; Newall AT, 2010, EPIDEMIOL INFECT, V138, P836, DOI 10.1017/S095026880999118X; Nicoll A, 2012, EURO SURVEILL, V3, P17; Nielsen J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-350; Nunes B, 2011, STAT METHODS MED RES, V20, P331, DOI 10.1177/0962280209340201; Nunes B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020661; Ostro B, 2006, ENVIRON HEALTH PERSP, V114, P29, DOI 10.1289/ehp.8335; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; Samoli E, 2005, ENVIRON HEALTH PERSP, V113, P88, DOI 10.1289/ehp.7387; *SAS I, 2008, GAM PROC; Schaffer A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-869; Schwartz J, 1996, J EPIDEMIOL COMMUN H, V50, pS3, DOI 10.1136/jech.50.Suppl_1.S3; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; SHUMWAY RH, 2000, TIME SERIES ANAL ITS; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; *UN DOEASA PD, 2011, WORLD POP PROSP 2010; *US CDCP, 2004, MMWR-MORBID MORTAL W, V53, P8; van den Wijngaard CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031197; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Vichit-Vadakan N, 2008, ENVIRON HEALTH PERSP, V116, P1179, DOI 10.1289/ehp.10849; World Health Organization, FLUNET; Yang L, 2011, EPIDEMIOL INFECT, P1; Yang L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-342; Yohannes Keflemariam, 2004, Commun Dis Intell Q Rep, V28, P160; Yu WW, 2012, INT J BIOMETEOROL, V56, P569, DOI 10.1007/s00484-011-0497-3	52	33	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64734	10.1371/journal.pone.0064734	http://dx.doi.org/10.1371/journal.pone.0064734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755139	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300026
J	Reddy, AS; Patel, JR; Vogler, C; Klein, RS; Sands, MS				Reddy, Adarsh S.; Patel, Jigisha R.; Vogler, Carole; Klein, Robyn S.; Sands, Mark S.			Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; MURINE MODEL; ATHEROSCLEROTIC LESIONS; TWITCHER MOUSE; GENE-THERAPY; SPINAL-CORD; EXPRESSION; OLIGODENDROCYTES; MICE; INTERLEUKIN-8	Globoid-cell Leukodystrophy (GLD; Krabbes disease) is a rapidly progressing inherited demyelinating disease caused by a deficiency of the lysosomal enzyme Galactosylceramidase (GALC). Deficiency of GALC leads to altered catabolism of galactosylceramide and the cytotoxic lipid, galactosylsphingosine (psychosine). This leads to a rapidly progressive fatal disease with spasticity, cognitive disability and seizures. The murine model of GLD (Twitcher; GALC-/-) lacks the same enzyme and has similar clinical features. The deficiency of GALC leads to oligodendrocyte death, profound neuroinflammation, and the influx of activated macrophages into the CNS. We showed previously that keratinocyte chemoattractant factor (KC) is highly elevated in the CNS of untreated Twitcher mice and significantly decreases after receiving a relatively effective therapy (bone marrow transplantation combined with gene therapy). The action of KC is mediated through the CXCR2 receptor and is a potent chemoattractant for macrophages and microglia. KC is also involved in oligodendrocyte migration and proliferation. Based on the commonalities between the disease presentation and the functions of KC, we hypothesized that KC and/or CXCR2 contribute to the pathogenesis of GLD. Interestingly, the course of the disease is not significantly altered in KC- or CXCR2-deficient Twitcher mice. There is also no alteration in inflammation or demyelination patterns in these mice. Furthermore, transplantation of CXCR2-deficient bone marrow does not alter the progression of the disease as it does in other models of demyelination. This study highlights the role of multiple redundant cytokines and growth factors in the pathogenesis of GLD.	[Reddy, Adarsh S.; Klein, Robyn S.; Sands, Mark S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Patel, Jigisha R.; Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Vogler, Carole] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Sands, MS (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	msands@dom.wustl.edu		Sands, Mark/0000-0002-5559-0832	National Institutes of Health (NIH) [R01 HD055461]; NIH [R01 NS 043205]; Hunters Hope foundation; National Tay-Sachs and Allied Diseases Association [RG4371 NMSS, R01 NS 052632]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052632, R01NS084861, R01NS043205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hunters Hope foundation; National Tay-Sachs and Allied Diseases Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health (NIH) R01 HD055461 and NIH R01 NS 043205 (MS), Hunters Hope foundation and National Tay-Sachs and Allied Diseases Association (AR), RG4371 NMSS grant and R01 NS 052632 (RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGIOLINI M, 1995, INT J IMMUNOPHARMACO, V17, P103, DOI 10.1016/0192-0561(94)00088-6; Biswas S, 2001, J NEUROSCI RES, V65, P298, DOI 10.1002/jnr.1154; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Ezoe T, 2000, J NEUROSCI RES, V59, P179, DOI 10.1002/(SICI)1097-4547(20000115)59:2<179::AID-JNR4>3.3.CO;2-E; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; HOOGERBRUGGE PM, 1988, J CLIN INVEST, V81, P1790, DOI 10.1172/JCI113521; Horuk R, 1997, J IMMUNOL, V158, P2882; Hulse RE, 2004, J NEUROSCI METH, V136, P87, DOI 10.1016/j.jneumeth.2003.12.023; IDA H, 1990, MOL CHEM NEUROPATHOL, V13, P195, DOI 10.1007/BF03159922; IGISU H, 1984, SCIENCE, V224, P753, DOI 10.1126/science.6719111; KOBAYASHI T, 1980, BRAIN RES, V202, P479, DOI 10.1016/0006-8993(80)90159-6; LEVINE SM, 1992, BRAIN RES, V587, P348, DOI 10.1016/0006-8993(92)91018-A; LeVine SM, 1997, J NEUROIMMUNOL, V73, P47, DOI 10.1016/S0165-5728(96)00166-X; Lin DH, 2007, MOL THER, V15, P44, DOI 10.1038/sj.mt.6300026; Liu LP, 2010, J NEUROSCI, V30, P9074, DOI 10.1523/JNEUROSCI.1238-10.2010; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Luzi P, 2009, BRAIN RES, V1300, P146, DOI 10.1016/j.brainres.2009.09.017; MATSUSHIMA GK, 1994, CELL, V78, P645, DOI 10.1016/0092-8674(94)90529-0; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Patel JR, 2011, FEBS LETT, V585, P3730, DOI 10.1016/j.febslet.2011.04.037; Reddy AS, 2011, J NEUROSCI, V31, P9945, DOI 10.1523/JNEUROSCI.1802-11.2011; Ripoll CB, 2011, STEM CELLS, V29, P67, DOI 10.1002/stem.555; Robinson S, J NEUROSCIENCE OFF J, V18, P10457; Sakai N, 1996, J NEUROCHEM, V66, P1118, DOI 10.1046/j.1471-4159.1996.66031118.x; SANDS MS, 1993, LAB INVEST, V68, P676; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Tani M, 1996, J CLIN INVEST, V98, P529, DOI 10.1172/JCI118821; TANIIKE M, 1995, J NEUROSCI RES, V40, P325, DOI 10.1002/jnr.490400306; Taniike M, 1999, J NEUROPATH EXP NEUR, V58, P644, DOI 10.1097/00005072-199906000-00009; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Wenger DA, 2007, GALACTOSYLCERAMIDE L; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Wu Q, 2000, J NEUROSCI, V20, P2609; Wu YP, 2001, J NEUROPATH EXP NEUR, V60, P1062, DOI 10.1093/jnen/60.11.1062; YEAGER AM, 1984, SCIENCE, V225, P1052, DOI 10.1126/science.6382609	42	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64647	10.1371/journal.pone.0064647	http://dx.doi.org/10.1371/journal.pone.0064647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755134	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300022
J	Sharma, N; Sequea, DA; Castorena, CM; Arias, EB; Qi, NR; Cartee, GD				Sharma, Naveen; Sequea, Donel A.; Castorena, Carlos M.; Arias, Edward B.; Qi, Nathan R.; Cartee, Gregory D.			Heterogeneous Effects of Calorie Restriction on In Vivo Glucose Uptake and Insulin Signaling of Individual Rat Skeletal Muscles	PLOS ONE			English	Article							BRIEF DIETARY RESTRICTION; INCREASES INSULIN; AKT2 PHOSPHORYLATION; RECEPTOR SUBSTRATE-1; FOOD RESTRICTION; TRANSPORT; SENSITIVITY; EXERCISE; PROTEIN; GLUT4	Calorie restriction (CR) (consuming,60% of ad libitum, AL, intake) improves whole body insulin sensitivity and enhances insulin-stimulated glucose uptake by isolated skeletal muscles. However, little is known about CR-effects on in vivo glucose uptake and insulin signaling in muscle. Accordingly, 9-month-old male AL and CR (initiated when 3-months-old) Fischer 344xBrown Norway rats were studied using a euglycemic-hyperinsulinemic clamp with plasma insulin elevated to a similar level (similar to 140 mu U/ml) in each diet group. Glucose uptake (assessed by infusion of [C-14]-2-deoxyglucose, 2-DG), phosphorylation of key insulin signaling proteins (insulin receptor, Akt and Akt substrate of 160kDa, AS160), abundance of GLUT4 and hexokinase proteins, and muscle fiber type composition (myosin heavy chain, MHC, isoform percentages) were determined in four predominantly fast-twitch (epitrochlearis, gastrocnemius, tibialis anterior, plantaris) and two predominantly slow-twitch (soleus, adductor longus) muscles. CR did not result in greater GLUT4 or hexokinase abundance in any of the muscles, and there were no significant diet-related effects on percentages of MHC isoforms. Glucose infusion was greater for CR versus AL rats (P<0.05) concomitant with significantly (P<0.05) elevated 2-DG uptake in 3 of the 4 fast-twitch muscles (epitrochlearis, gastrocnemius, tibialis anterior), without a significant diet-effect on 2-DG uptake by the plantaris or either slow-twitch muscle. Each of the muscles with a CR-related increase in 2-DG uptake was also characterized by significant (P<0.05) increases in phosphorylation of both Akt and AS160. Among the 3 muscles without a CR-related increase in glucose uptake, only the soleus had significant (P<0.05) CR-related increases in Akt and AS160 phosphorylation. The current data revealed that CR leads to greater whole body glucose disposal in part attributable to elevated in vivo insulin-stimulated glucose uptake by fast-twitch muscles. The results also demonstrated that CR does not uniformly enhance either insulin signaling or insulin-stimulated glucose uptake in all muscles in vivo.	[Sharma, Naveen; Castorena, Carlos M.; Arias, Edward B.; Cartee, Gregory D.] Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA; [Sequea, Donel A.; Cartee, Gregory D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Qi, Nathan R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Cartee, Gregory D.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cartee, GD (corresponding author), Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA.	gcartee@umich.edu	Sharma, Naveen/K-6672-2015	Sharma, Naveen/0000-0003-4705-5116; Cartee, Gregory/0000-0001-5311-1722	National Institutes of Health [AG-010026, AG-013283, T32-AG000114, DK-089503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000114, R01AG010026, P30AG013283, R29AG010026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG-010026, AG-013283, T32-AG000114, and DK-089503. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciero PJ, 1999, J APPL PHYSIOL, V86, P1930, DOI 10.1152/jappl.1999.86.6.1930; CARTEE GD, 1994, AM J PHYSIOL, V266, pR1443, DOI 10.1152/ajpregu.1994.266.5.R1443; CARTEE GD, 1994, AM J PHYSIOL, V266, pE946, DOI 10.1152/ajpendo.1994.266.6.E946; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Cartee GD, 2009, EXERC SPORT SCI REV, V37, P188, DOI 10.1097/JES.0b013e3181b7b7c5; Davidson RT, 2002, AM J PHYSIOL-ENDOC M, V282, pE270, DOI 10.1152/ajpendo.00232.2001; Dean DJ, 1996, J GERONTOL A-BIOL, V51, pB208, DOI 10.1093/gerona/51A.3.B208; Dean DJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE957, DOI 10.1152/ajpendo.1998.275.6.E957; Dean DJ, 1998, AGING-CLIN EXP RES, V10, P303, DOI 10.1007/BF03339792; Dean DJ, 2000, ACTA PHYSIOL SCAND, V169, P133, DOI 10.1046/j.1365-201x.2000.00723.x; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Escriva F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043; Feuers RJ, 1995, DIETARY RESTRICTION, P181; Gazdag AC, 2000, J GERONTOL A-BIOL, V55, pB44; Gazdag AC, 2000, AM J PHYSIOL-REG I, V278, pR504, DOI 10.1152/ajpregu.2000.278.2.R504; Gazdag AC, 1999, DIABETES, V48, P1930, DOI 10.2337/diabetes.48.10.1930; Gazdag AC, 1998, BIOCHEM BIOPH RES CO, V252, P733, DOI 10.1006/bbrc.1998.9713; Geiger PC, 2003, J APPL PHYSIOL, V95, P611, DOI 10.1152/japplphysiol.00862.2002; Gupta G, 2000, AM J PHYSIOL-REG I, V278, pR111, DOI 10.1152/ajpregu.2000.278.1.R111; Halseth AE, 1999, AM J PHYSIOL-ENDOC M, V276, pE70, DOI 10.1152/ajpendo.1999.276.1.E70; Halseth AE, 2001, AM J PHYSIOL-ENDOC M, V280, pE994, DOI 10.1152/ajpendo.2001.280.6.E994; HENRIKSEN EJ, 1990, AM J PHYSIOL, V259, pE593, DOI 10.1152/ajpendo.1990.259.4.E593; IVY JL, 1991, MECH AGEING DEV, V61, P123, DOI 10.1016/0047-6374(91)90011-N; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; KEMNITZ JW, 1994, AM J PHYSIOL, V266, pE540, DOI 10.1152/ajpendo.1994.266.4.E540; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Lang G., 1974, METHODS ENZYMATIC AN, P1238; Lawler DF, 2008, BRIT J NUTR, V99, P793, DOI 10.1017/S0007114507871686; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; McCurdy CE, 2005, AM J PHYSIOL-ENDOC M, V288, pE996, DOI 10.1152/ajpendo.00566.2004; McCurdy CE, 2003, AM J PHYSIOL-ENDOC M, V285, pE693, DOI 10.1152/ajpendo.00224.2003; Petersen HA, 2003, AM J PHYSIOL-ENDOC M, V284, pE541, DOI 10.1152/ajpendo.00323.2002; Petersen KF, 2012, P NATL ACAD SCI US; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Sequea DA, 2012, J GERONTOL A; Sharma N, 2012, AM J PHYSL REGUL INT; Sharma N, 2012, BBA-MOL BASIS DIS, V1822, P1735, DOI 10.1016/j.bbadis.2012.07.012; Sharma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038835; Sharma N, 2011, AM J PHYSIOL-ENDOC M, V300, pE966, DOI 10.1152/ajpendo.00659.2010; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Tonge DP, 2010, OSTEOARTHR CARTILAGE, V18, P555, DOI 10.1016/j.joca.2009.11.014; WING RR, 1994, DIABETES CARE, V17, P30, DOI 10.2337/diacare.17.1.30	45	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65118	10.1371/journal.pone.0065118	http://dx.doi.org/10.1371/journal.pone.0065118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755179	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300049
J	Puebla-Osorio, N; Kim, J; Ojeda, S; Zhang, H; Tavana, O; Li, S; Wang, Y; Ma, Q; Schluns, KS; Zhu, C				Puebla-Osorio, N.; Kim, J.; Ojeda, S.; Zhang, H.; Tavana, O.; Li, S.; Wang, Y.; Ma, Q.; Schluns, K. S.; Zhu, C.			A novel Ku70 function in colorectal homeostasis separate from nonhomologous end joining	ONCOGENE			English	Article						nonhomologous end joining; Ku70; colorectal cancer; senescence; beta-catenin; Wnt signaling	DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; DNA-DAMAGE; STEM-CELLS; CYCLIN D1; REPAIR; GENE; TUMORIGENESIS; BINDING; CANCER	Ku70, a known nonhomologous end-joining (NHEJ) factor, also functions in tumor suppression, although this molecular mechanism remains uncharacterized. Previously, we showed that mice deficient for DNA ligase IV (Lig4), another key NHEJ factor, succumbed to aggressive lymphoma in the absence of tumor suppressor p53. However, the tumor phenotype is abrogated by the introduction of a hypomorphic mutant p53(R172P), which impaired p53-mediated apoptosis but not cell-cycle arrest. However, Lig4(-/-)p53(R172P) mice succumbed to severe diabetes. To further elucidate the role of NHEJ and p53-mediated apoptosis in vivo, we bred Ku70(-/-) p53(R172P) mice. Unexpectedly, these mice were free of diabetes, although 80% of the mutant mice had abnormally enlarged colons with pronounced inflammation. Remarkably, most of these mutant mice progressed to dysplasia, adenoma and adenocarcinoma; this is in contrast to the Lig4(-/-) p53(R172P) phenotype, strongly suggesting an NHEJ-independent function of Ku70. Significantly, our analyses of Ku70(-/-) p53(R172P) colonic epithelial cells show nuclear stabilization of beta-catenin accompanied by higher expression of cyclin D1 and c-Myc in affected colon sections than in control samples. This is not due to the p53 mutation, as Ku70(-/-) mice share this phenotype. Our results not only unravel a novel function of Ku70 essential for colon homeostasis, but also establish an excellent in vivo model in which to study how chronic inflammation and abnormal cellular proliferation underlie tumorigenesis and tumor progression in the colon.	[Puebla-Osorio, N.; Kim, J.; Ojeda, S.; Zhang, H.; Tavana, O.; Li, S.; Wang, Y.; Schluns, K. S.; Zhu, C.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Tavana, O.; Ma, Q.; Schluns, K. S.; Zhu, C.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Ma, Q.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Zhu, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Unit 902,1515 Holcombe Blvd, Houston, TX 77030 USA.	czhu@mdanderson.org	Zhang, Huiyuan/J-2784-2016; Schluns, Kimberly/R-5635-2019	Zhang, Huiyuan/0000-0002-1532-2462; Tavana, Omid/0000-0001-8401-4546; Puebla, Nahum/0000-0001-6498-5230	Institutional Research Grant; sister Institution Fund from The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Institutional Research Grant; sister Institution Fund from The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the histology core facility from the Department of Immunology at The University of Texas MD Anderson Cancer Center. We thank Dr James You for the help with pathology and Mei Sang for her technical assistance. This study was partially supported by an Institutional Research Grant (CZ) and a sister Institution Fund from The University of Texas MD Anderson Cancer Center (CZ).	Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; Becker C, 2005, CELL CYCLE, V4, P217; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Erdman SE, 2010, TOXICOL PATHOL, V38, P76, DOI 10.1177/0192623309354110; Fearnhead NS, 2002, BRIT MED BULL, V64, P27, DOI 10.1093/bmb/64.1.27; Fell VL, 2012, MOL CELL BIOL, V32, P76, DOI 10.1128/MCB.05661-11; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P146, DOI 10.1309/87BD0C6UCGUG126J; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoverter NP, 2012, MOL CELL BIOL, V32, P3648, DOI 10.1128/MCB.06769-11; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kavela S, 2013, CANCER RES, V73, P205, DOI 10.1158/0008-5472.CAN-12-1394; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Lefrancois L, 2001, CURR PROTOC IMMUNOL, V3; Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Novac O, 2001, MOL BIOL CELL, V12, P3386, DOI 10.1091/mbc.12.11.3386; Pfingsten JS, 2012, CELL, V148, P922, DOI 10.1016/j.cell.2012.01.033; Puebla-Osorio N, 2008, IMMUNOL RES, V41, P103, DOI 10.1007/s12026-008-8015-3; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Saif MW, 2010, CANCER J, V16, P196, DOI 10.1097/PPO.0b013e3181e076af; Sekiguchi JM, 2006, CELL, V124, P260, DOI 10.1016/j.cell.2006.01.010; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sipos F, 2012, WORLD J GASTROENTERO, V18, P295, DOI 10.3748/wjg.v18.i4.295; Subramanian C, 2005, P NATL ACAD SCI USA, V102, P4842, DOI 10.1073/pnas.0408351102; Tavana O, DIABETES; Tavana O, 2010, DIABETES, V59, P135, DOI 10.2337/db09-0792; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Van Nguyen T, 2007, J EXP MED, V204, P1453, DOI 10.1084/jem.20062453; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Westbrook AM, 2010, MUTAT RES-REV MUTAT, V705, P40, DOI 10.1016/j.mrrev.2010.03.001; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Zaanan A, 2011, CELL ONCOL, V34, P155, DOI 10.1007/s13402-011-0024-x; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	50	12	12	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2748	2757		10.1038/onc.2013.234	http://dx.doi.org/10.1038/onc.2013.234			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23752193	Green Accepted			2022-12-25	WOS:000337231700008
J	Chandrakesan, P; Roy, B; Jakkula, LUMR; Ahmed, I; Ramamoorthy, P; Tawfik, O; Papineni, R; Houchen, C; Anant, S; Umar, S				Chandrakesan, P.; Roy, B.; Jakkula, L. U. M. R.; Ahmed, I.; Ramamoorthy, P.; Tawfik, O.; Papineni, R.; Houchen, C.; Anant, S.; Umar, S.			Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis	ONCOGENE			English	Article						bacterial infection; Wnt; Notch; EMT; MET; hyperplasia; inflammation; colon cancer	NF-KAPPA-B; HYPERPLASIA AND/OR COLITIS; TRANSCRIPTION FACTOR SNAIL; BETA-CATENIN EXPRESSION; FUNCTIONAL CROSS-TALK; E-CADHERIN; CITROBACTER-RODENTIUM; STEM-CELLS; TRANSEPITHELIAL MIGRATION; TUMOR PROGRESSION	DCLK1 and Lgr5 have recently been identified as markers of quiescent and cycling stem cells in the small intestinal crypts, respectively. Epithelial-mesenchymal transition (EMT) is a key development program that is often activated during cancer invasion and metastasis, and also imparts a self-renewal capability to disseminating cancer cells. Utilizing the Citrobacter rodentium (CR)-induced transmissible murine colonic hyperplasia (TMCH) model, we observed a relative decrease in DCLK1 expression in the colonic crypts, with significant shift towards stromal staining at peak (12 days post infection) hyperplasia, whereas staining for Lgr5 and Msi-1 increased several fold. When hyperplasia was regressing (days 20-34), an expansion of DCLK1 + ve cells in the CR-infected crypts compared with that seen in uninfected control was recorded. Purified colonic crypt cells exhibiting epigenetic modulation of the transforming growth factor-beta (TGF beta), Wnt and Notch pathways on 12 or 34 days post infection formed monolayers in vitro, and underwent trans-differentiation into fibroblast-like cells that stained positive for vimentin, fibronectin and DCLK1. These cells when trypsinized and regrown in soft agar, formed colonospheres/organoids that developed into crypt-like structures (colonoids) in Matrigel and stained positive for DCLK1. Mice exhibiting 12 or 34 days of TMCH were given azoxymethane once for 8 h (Gp1) or weekly for 3 weeks (Gp2), and subjected to crypt isolation. Crypt cells from Gp1 animals formed monolayers as well as colonospheres in soft agar and nodules/tumors in nude mice. Crypt cells isolated from Gp2 animals failed to form the monolayers, but developed into colonospheres in soft agar and nodules/tumors in nude mice. Thus, both hyperplasia and increased presence of DCLK1 + ve cells promote cellular transformation in response to a second hit. The TMCH model, therefore, provides an excellent template to study how alterations in intestinal stem cells promote trans-differentiation, crypt regeneration or colon carcinogenesis following bacterial infection.	[Chandrakesan, P.; Houchen, C.] Dept Internal Med, Div Gastroenterol, Oklahoma City, OK USA; [Roy, B.; Jakkula, L. U. M. R.; Ahmed, I.; Ramamoorthy, P.; Anant, S.; Umar, S.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Tawfik, O.] Univ Kansas, Med Ctr, Dept Anat & Surg Pathol, Kansas City, KS 66160 USA; [Papineni, R.] Carestream Mol Imaging, Woodbridge, CT USA; [Anant, S.; Umar, S.] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Umar, S (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, 3901 Rainbow Blvd,4028 Wahl Hall East, Kansas City, KS 66160 USA.	sumar@kumc.edu	Anant, Shrikant/AAF-8020-2020; Chandrakesan, Parthasarathy/AAB-9136-2020	Chandrakesan, Parthasarathy/0000-0002-7587-9553	National Institutes of Health [R01 CA131413]; NIDDK's [U01DK085508-04S1]; University of Kansas Medical Center, Kansas City, KS, USA; NATIONAL CANCER INSTITUTE [R01CA131413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK's; University of Kansas Medical Center, Kansas City, KS, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grant R01 CA131413 (to SU), NIDDK's U01DK085508-04S1 (to CWH) and start-up funds from the University of Kansas Medical Center, Kansas City, KS, USA.	Ahmed I, 2013, AM J PHYSIOL-GASTR L, V304, pG356, DOI 10.1152/ajpgi.00372.2012; Ahmed I, 2012, INFECT IMMUN, V80, P3107, DOI 10.1128/IAI.00236-12; Ali N, 2011, J VIROL, V85, P12292, DOI 10.1128/JVI.05920-11; BARTHOLD SW, 1978, VET PATHOL, V15, P223, DOI 10.1177/030098587801500209; BARTHOLD SW, 1977, CANCER RES, V37, P4352; Bataille F, 2008, INFLAMM BOWEL DIS, V14, P1514, DOI 10.1002/ibd.20590; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Betis F, 2003, INFECT IMMUN, V71, P1774, DOI 10.1128/IAI.71.4.1774-1783.2003; Betis F, 2003, INFECT IMMUN, V71, P1068, DOI 10.1128/IAI.71.3.1068-1074.2003; Bierne H, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010272; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Brown JB, 2011, INFECT IMMUN, V79, P1863, DOI 10.1128/IAI.01025-10; Cane G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001359; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chandrakesan P, 2012, INFECT IMMUN, V80, P753, DOI 10.1128/IAI.06101-11; Chandrakesan P, 2010, J BIOL CHEM, V285, P33485, DOI 10.1074/jbc.M110.129353; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Cun DM, 2011, EUR J PHARM BIOPHARM, V77, P26, DOI 10.1016/j.ejpb.2010.11.008; Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Flier SN, 2010, J BIOL CHEM, V285, P20202, DOI 10.1074/jbc.M110.102012; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Franci C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005595; Gilles C, 2003, CANCER RES, V63, P2658; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Hofman P, 2012, GUT MICROBES, V3, P1; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hongpaisan J, 2000, CELL BIOL INT, V24, P1, DOI 10.1006/cbir.1999.0448; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kwatra D, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/702869; Liu XW, 2012, HEPATOL RES, V42, P1024, DOI 10.1111/j.1872-034X.2012.01011.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pilpilidis I, 2011, J SURG RES, V166, P255, DOI 10.1016/j.jss.2010.02.012; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ponnurangam S, 2012, MOL CANCER THER, V11, P963, DOI 10.1158/1535-7163.MCT-11-0999; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rubio D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001398; Saito Y, 2010, J EXP MED, V207, P2157, DOI 10.1084/jem.20100602; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Sellin JH, 2001, CANCER RES, V61, P2899; Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019; Sipos F, 2011, WORLD J GASTROENTERO, V17, P2981, DOI 10.3748/wjg.v17.i25.2981; Subramaniam D, 2011, MOL CANCER THER, V10, P2146, DOI 10.1158/1535-7163.MCT-11-0399; SUN NC, 1979, P NATL ACAD SCI USA, V76, P1819, DOI 10.1073/pnas.76.4.1819; Sureban SM, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-40; Sureban SM, 2009, GASTROENTEROLOGY, V137, P649, DOI 10.1053/j.gastro.2009.05.004; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Umar S, 2008, ONCOGENE, V27, P5599, DOI 10.1038/onc.2008.169; Umar S, 2005, ONCOGENE, V24, P6709, DOI 10.1038/sj.onc.1208820; Umar S, 2003, CELL PROLIFERAT, V36, P361, DOI 10.1046/j.1365-2184.2003.00291.x; Umar S, 2007, AM J PHYSIOL-GASTR L, V292, pG599, DOI 10.1152/ajpgi.00343.2006; Umar S, 2009, J BIOL CHEM, V284, P22274, DOI 10.1074/jbc.M109.020941; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Xi Y, 2013, ONCOGENE, V32, P5048, DOI 10.1038/onc.2012.530; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yin YF, 2010, GUT, V59, P1037, DOI 10.1136/gut.2009.199794; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang Q, 2013, CARCINOGENESIS, V34, P962, DOI 10.1093/carcin/bgt027; Zhao LJ, 2011, J SURG RES, V171, P819, DOI 10.1016/j.jss.2010.04.059	77	45	46	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2639	2654		10.1038/onc.2013.210	http://dx.doi.org/10.1038/onc.2013.210			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23752178	Green Accepted			2022-12-25	WOS:000336502700010
J	Fernandez, TF; Samal, AB; Bedwell, GJ; Chen, YB; Saad, JS				Fernandez, Timothy F.; Samal, Alexandra B.; Bedwell, Gregory J.; Chen, Yabing; Saad, Jamil S.			Structural and Biophysical Characterization of the Interactions between the Death Domain of Fas Receptor and Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Calmodulin; Fas; NMR; Surface Plasmon Resonance (SPR); Cholangiocarcinoma	SIZE-DISTRIBUTION ANALYSIS; TARGET RECOGNITION; BINDING DOMAIN; ANALYTICAL ULTRACENTRIFUGATION; CHOLANGIOCARCINOMA CELLS; PEPTIDE INTERACTION; MEDIATED APOPTOSIS; NMR-SPECTROSCOPY; EF-HANDS; COMPLEX	The extrinsic apoptotic pathway is initiated by cell surface death receptors such as Fas. Engagement of Fas by Fas ligand triggers a conformational change that allows Fas to interact with adaptor protein Fas-associated death domain (FADD) via the death domain, which recruits downstream signaling proteins to form the death-inducing signaling complex (DISC). Previous studies have shown that calmodulin (CaM) is recruited into the DISC in cholangiocarcinoma cells, suggesting a novel role of CaM in Fas-mediated signaling. CaM antagonists induce apoptosis through a Fas-related mechanism in cholangiocarcinoma and other cancer cell lines possibly by inhibiting Fas-CaM interactions. The structural determinants of Fas-CaM interaction and the underlying molecular mechanisms of inhibition, however, are unknown. Here we employed NMR and biophysical techniques to elucidate these mechanisms. Our data show that CaM binds to the death domain of Fas (FasDD) with an apparent dissociation constant (K-d) of approximate to 2 m and 2:1 CaM:FasDD stoichiometry. The interactions between FasDD and CaM are endothermic and entropically driven, suggesting that hydrophobic contacts are critical for binding. We also show that both the N- and C-terminal lobes of CaM are important for binding. NMR and surface plasmon resonance data show that three CaM antagonists (N-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide, tamoxifen, and trifluoperazine) greatly inhibit Fas-CaM interactions by blocking the Fas-binding site on CaM. Our findings provide the first structural evidence for Fas-CaM interactions and mechanism of inhibition and provide new insight into the molecular basis for a novel role of CaM in regulating Fas-mediated apoptosis.	[Fernandez, Timothy F.; Samal, Alexandra B.; Bedwell, Gregory J.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Chen, Yabing] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Chen, Yabing] Birmingham Vet Affairs Med Ctr, Res Dept, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Saad, JS (corresponding author), 845 19th St S, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484	NCI, National Institutes of Health (NIH) [P30CA13148]; NIH [1S10RR026478]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank members of our laboratories and Dr. Jay McDonald (University of Alabama at Birmingham) for helpful discussions. We thank Diego Esposito and Paul Driscoll (Medical Research Council National Institute for Medical Research, United Kingdom) for providing NMR signal assignments of FasDD. We thank the University of Alabama Comprehensive Cancer Center X-ray core facility, funded by NCI, National Institutes of Health (NIH) Grant P30CA13148, which houses the Auto-ITC<INF>200</INF>, acquired through NIH Grant 1S10RR026478.	Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Ahn EY, 2003, AM J PATHOL, V163, P2053, DOI 10.1016/S0002-9440(10)63563-8; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Chen YB, 2008, J CELL BIOCHEM, V103, P788, DOI 10.1002/jcb.21447; Chen YB, 2006, AM J PATHOL, V169, P1833, DOI 10.2353/ajpath.2006.060234; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; COOK WJ, 1994, BIOCHEMISTRY-US, V33, P15259, DOI 10.1021/bi00255a006; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dewhurst LO, 1997, BRIT J CANCER, V75, P860, DOI 10.1038/bjc.1997.153; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Feldkamp MD, 2010, PROTEINS, V78, P2265, DOI 10.1002/prot.22739; Ferguson BJ, 2007, CELL DEATH DIFFER, V14, P1717, DOI 10.1038/sj.cdd.4402191; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; GIETZEN K, 1982, BIOCHEM J, V207, P541, DOI 10.1042/bj2070541; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; ITO H, 1991, ANTICANCER RES, V11, P249; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jing G, 2012, LAB INVEST, V92, P82, DOI 10.1038/labinvest.2011.131; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; Lafitte D, 1999, EUR J BIOCHEM, V261, P337, DOI 10.1046/j.1432-1327.1999.00284.x; Larsson G, 2005, BIOPHYS J, V89, P1214, DOI 10.1529/biophysj.104.055780; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Moorthy AK, 2001, J BIOMOL STRUCT DYN, V19, P47, DOI 10.1080/07391102.2001.10506719; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Pan G, 1999, AM J PATHOL, V155, P193, DOI 10.1016/S0002-9440(10)65113-9; Park WS, 2001, J PATHOL, V193, P162; Pawar P, 2009, CLIN CANCER RES, V15, P1288, DOI 10.1158/1078-0432.CCR-08-1150; Pawar PS, 2008, BIOCHEM J, V412, P459, DOI 10.1042/BJ20071507; Peter M E, 1999, Results Probl Cell Differ, V23, P25; Que FG, 1999, HEPATOLOGY, V30, P1398, DOI 10.1002/hep.510300618; RASMUSSEN CD, 1992, J PHYSIOL-PARIS, V86, P83, DOI 10.1016/S0928-4257(05)80011-7; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Stec B, 2012, FEBS LETT, V586, P1675, DOI 10.1016/j.febslet.2012.04.026; Suever JD, 2008, BIOPHYS J, V95, P5913, DOI 10.1529/biophysj.108.130542; Takakuwa T, 2001, CANCER RES, V61, P1382; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; Vertessy BG, 1998, BIOCHEMISTRY-US, V37, P15300, DOI 10.1021/bi980795a; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vickers SM, 2002, ANN SURG, V235, P872, DOI 10.1097/00000658-200206000-00016; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEI JW, 1982, CANCER RES, V42, P2571; WU ZN, 1995, J BIOL CHEM, V270, P16045, DOI 10.1074/jbc.270.27.16045; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan KY, 2011, J BIOL CHEM, V286, P24776, DOI 10.1074/jbc.M110.202804; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328	68	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21898	10.1074/jbc.M113.471821	http://dx.doi.org/10.1074/jbc.M113.471821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760276	hybrid, Green Published			2022-12-25	WOS:000328841900038
J	Shamas-Din, A; Bindner, S; Zhu, WJ; Zaltsman, Y; Campbell, C; Gross, A; Leber, B; Andrews, DW; Fradin, C				Shamas-Din, Aisha; Bindner, Scott; Zhu, Weijia; Zaltsman, Yehudit; Campbell, Clinton; Gross, Atan; Leber, Brian; Andrews, David W.; Fradin, Cecile			tBid Undergoes Multiple Conformational Changes at the Membrane Required for Bax Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bax; Bcl-2 Proteins; Fluorescence Correlation Spectroscopy; Fluorescence Resonance Energy Transfer (FRET); Protein Conformation; Bid; Mtch2; Fluorescence Spectroscopy; tBid	CYTOCHROME-C RELEASE; HOMOLOG 2 MTCH2; OUTER-MEMBRANE; CELL-DEATH; APOPTOSIS; MITOCHONDRIA; BCL-2; PROTEIN; BINDING; SURFACE	Bid is a Bcl-2 family protein that promotes apoptosis by activating Bax and eliciting mitochondrial outer membrane permeabilization (MOMP). Full-length Bid is cleaved in response to apoptotic stimuli into two fragments, p7 and tBid (p15), that are held together by strong hydrophobic interactions until the complex binds to membranes. The detailed mechanism(s) of fragment separation including tBid binding to membranes and release of the p7 fragment to the cytoplasm remain unclear. Using liposomes or isolated mitochondria with fluorescently labeled proteins at physiological concentrations as in vitro models, we report that the two components of the complex quickly separate upon interaction with a membrane. Once tBid binds to the membrane, it undergoes slow structural rearrangements that result in an equilibrium between two major tBid conformations on the membrane. The conformational change of tBid is a prerequisite for interaction with Bax and is, therefore, a novel step that can be modulated to promote or inhibit MOMP. Using automated high-throughput image analysis in cells, we show that down-regulation of Mtch2 causes a significant delay between tBid and Bax relocalization in cells. We propose that by promoting insertion of tBid via a conformational change at the mitochondrial outer membrane, Mtch2 accelerates tBid-mediated Bax activation and MOMP. Thus the interaction of Mtch2 and tBid is a potential target for therapeutic control of Bid initiated cell death.	[Shamas-Din, Aisha; Bindner, Scott; Zhu, Weijia; Campbell, Clinton; Leber, Brian; Andrews, David W.; Fradin, Cecile] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Leber, Brian] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Zaltsman, Yehudit; Gross, Atan] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Fradin, Cecile] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	McMaster University; McMaster University; Weizmann Institute of Science; McMaster University	Fradin, C (corresponding author), McMaster Univ, Dept Phys & Astron, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	fradin@physics.mcmaster.ca	Gross, Atan/ABC-2640-2020; Campbell, Clinton/Z-1986-2019; Fradin, Cécile/D-9302-2011	Campbell, Clinton/0000-0002-8896-1134; Fradin, Cécile/0000-0001-8329-4953; Leber, Brian/0000-0001-5502-1480; Andrews, David/0000-0002-9266-7157	Canadian Institute of Health Research [FRN86657, FRN12517]; Ontario Graduate Scholarship in Science and Technology; Natural Sciences and Engineering Council	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship in Science and Technology; Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institute of Health Research Grants FRN86657 (to C. F.) and FRN12517 (to D. W. A. and B. L.).; Recipient of the Ontario Graduate Scholarship in Science and Technology.; Holds a Canada Research Chair funded by the Natural Sciences and Engineering Council. To whom correspondence should be addressed: Dept. of Biochemistry and Biomedical Sciences, Dept. of Physics and Astronomy, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8S 4M1. Tel.: 905-525-9140 (ext. 23181); Fax: 905-546-1252; E-mail: fradin@physics.mcmaster.ca.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Alder NN, 2008, CELL, V134, P439, DOI 10.1016/j.cell.2008.06.007; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hamilton NA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-110; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Hu X, 2003, APOPTOSIS, V8, P277, DOI 10.1023/A:1023676906857; Katz C, 2012, J BIOL CHEM, V287, P15016, DOI 10.1074/jbc.M111.328377; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Polster BM, 2003, J NEUROSCI, V23, P2735; Robinson AJ, 2012, EXP CELL RES, V318, P1316, DOI 10.1016/j.yexcr.2012.01.026; Satsoura D, 2012, BBA-BIOMEMBRANES, V1818, P384, DOI 10.1016/j.bbamem.2011.10.007; Shamas-Din A., 2013, COLD SPRING HARB PER, V5; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan KO, 1999, J BIOL CHEM, V274, P23687, DOI 10.1074/jbc.274.34.23687; Veresov VG, 2007, EUR BIOPHYS J BIOPHY, V37, P19, DOI 10.1007/s00249-007-0149-z; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yamaguchi R, 2007, CELL DEATH DIFFER, V14, P616, DOI 10.1038/sj.cdd.4402035; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	47	68	72	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22111	22127		10.1074/jbc.M113.482109	http://dx.doi.org/10.1074/jbc.M113.482109			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23744079	hybrid, Green Published			2022-12-25	WOS:000328841900055
J	Ortega-Roldan, JL; Ossa, F; Schnell, JR				Ortega-Roldan, Jose Luis; Ossa, Felipe; Schnell, Jason R.			Characterization of the Human Sigma-1 Receptor Chaperone Domain Structure and Binding Immunoglobulin Protein (BiP) Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR GRPE; STEROID-BINDING; BENZODIAZEPINE-RECEPTOR; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; SITE; CHOLESTEROL; EXPRESSION; DYNAMICS; SYSTEM	The sigma-1 receptor (S1R) is a ligand-regulated membrane protein chaperone involved in the ER stress response. S1R activity is implicated in diseases of the central nervous system including amnesia, schizophrenia, depression, Alzheimer disease, and addiction. S1R has been shown previously to regulate the Hsp70 binding immunoglobulin protein (BiP) and the inositol triphosphate receptor calcium channel through a C-terminal domain. We have developed methods for bacterial expression and reconstitution of the chaperone domain of human S1R into detergent micelles that enable its study by solution NMR spectroscopy. The chaperone domain is found to contain a helix at the N terminus followed by a largely dynamic region and a structured, helical C-terminal region that encompasses a membrane associated domain containing four helices. The helical region at residues similar to 198-206 is strongly amphipathic and proposed to anchor the chaperone domain to micelles and membranes. Three of the helices in the C-terminal region closely correspond to previously identified cholesterol and drug recognition sites. In addition, it is shown that the chaperone domain interacts with full-length BiP or the isolated nucleotide binding domain of BiP, but not the substrate binding domain, suggesting that the nucleotide binding domain is sufficient for S1R interactions.	[Ortega-Roldan, Jose Luis; Ossa, Felipe; Schnell, Jason R.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Schnell, JR (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	jason.schnell@bioch.ox.ac.uk	Orega-Roldan, Jose/K-4396-2019; Ossa, Felipe/A-9627-2016	Orega-Roldan, Jose/0000-0002-6316-4390; Ossa, Felipe/0000-0002-3968-6447	Wellcome Trust [094872]; Medical Research Council [MR/K018590/1] Funding Source: researchfish; MRC [MR/K018590/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Herwig Schuler (Karolinska Institutet) for providing expression constructs of human BiP and the Wellcome Trust (Grant 094872) for upgrade of the 600 MHz spectrometer used in the studies.	Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Chen YM, 2007, BIOCHEMISTRY-US, V46, P3532, DOI 10.1021/bi061727o; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fontanilla D, 2008, BIOCHEMISTRY-US, V47, P7205, DOI 10.1021/bi800564j; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Guitart X, 2004, PSYCHOPHARMACOLOGY, V174, P301, DOI 10.1007/s00213-004-1920-9; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Pal A, 2012, EUR J PHARMACOL, V682, P12, DOI 10.1016/j.ejphar.2012.01.030; Pal A, 2008, J BIOL CHEM, V283, P19646, DOI 10.1074/jbc.M802192200; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Ramachandran S, 2009, EUR J PHARMACOL, V609, P19, DOI 10.1016/j.ejphar.2009.03.003; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Seth P, 2001, BBA-MOL CELL RES, V1540, P59, DOI 10.1016/S0167-4889(01)00117-3; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sherratt AR, 2009, BBA-BIOMEMBRANES, V1788, P2444, DOI 10.1016/j.bbamem.2009.09.003; Shioda N, 2012, J BIOL CHEM, V287, P23318, DOI 10.1074/jbc.M112.349142; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Stefanski R, 2004, PSYCHOPHARMACOLOGY, V175, P68, DOI 10.1007/s00213-004-1779-9; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Suzuki M, 2007, NAT PROTOC, V2, P1802, DOI 10.1038/nprot.2007.252; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Vasudevan SV, 2010, P NATL ACAD SCI USA, V107, P6847, DOI 10.1073/pnas.0911817107; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x; WEISSMAN AD, 1988, J PHARMACOL EXP THER, V247, P29; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Wu CC, 2012, J BIOL CHEM, V287, P21461, DOI 10.1074/jbc.M112.344358; Wu ZP, 2008, J BIOL CHEM, V283, P28198, DOI 10.1074/jbc.M802099200; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	50	62	65	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21448	21457		10.1074/jbc.M113.450379	http://dx.doi.org/10.1074/jbc.M113.450379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760505	Green Published, hybrid			2022-12-25	WOS:000322014400062
J	Johnson, MS; Couto, EG; Pinto, OB; Milesi, J; Amorim, RSS; Messias, IAM; Biudes, MS				Johnson, Mark S.; Couto, Eduardo Guimaraes; Pinto, Osvaldo B., Jr.; Milesi, Juliana; Amorim, Ricardo S. Santos; Messias, Indira A. M.; Biudes, Marcelo Sacardi			Soil CO2 Dynamics in a Tree Island Soil of the Pantanal: The Role of Soil Water Potential	PLOS ONE			English	Article							CARBON-DIOXIDE; MATO-GROSSO; RESPIRATION; EFFLUX; FOREST; CONSERVATION; EVERGLADES; LITTERFALL; WETLAND; FLUXES	The Pantanal is a biodiversity hotspot comprised of a mosaic of landforms that differ in vegetative assemblages and flooding dynamics. Tree islands provide refuge for terrestrial fauna during the flooding period and are particularly important to the regional ecosystem structure. Little soil CO2 research has been conducted in this region. We evaluated soil CO2 dynamics in relation to primary controlling environmental parameters ( soil temperature and soil water). Soil respiration was computed using the gradient method using in situ infrared gas analyzers to directly measure CO2 concentration within the soil profile. Due to the cost of the sensors and associated equipment, this study was unreplicated. Rather, we focus on the temporal relationships between soil CO2 efflux and related environmental parameters. Soil CO2 efflux during the study averaged 3.53 mu mol CO2 m(-2) s(-1), and was equivalent to an annual soil respiration of 1220 g C m(-2) y(-1). This efflux value, integrated over a year, is comparable to soil C stocks for 0-20 cm. Soil water potential was the measured parameter most strongly associated with soil CO2 concentrations, with high CO2 values observed only once soil water potential at the 10 cm depth approached zero. This relationship was exhibited across a spectrum of timescales and was found to be significant at a daily timescale across all seasons using conditional nonparametric spectral Granger causality analysis. Hydrology plays a significant role in controlling CO2 efflux from the tree island soil, with soil CO2 dynamics differing by wetting mechanism. During the wet-up period, direct precipitation infiltrates soil from above and results in pulses of CO2 efflux from soil. The annual flood arrives later, and saturates soil from below. While CO2 concentrations in soil grew very high under both wetting mechanisms, the change in soil CO2 efflux was only significant when soils were wet from above.	[Johnson, Mark S.] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada; [Johnson, Mark S.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Couto, Eduardo Guimaraes; Milesi, Juliana; Amorim, Ricardo S. Santos; Messias, Indira A. M.] Univ Fed Mato Grosso, Dept Soil Sci, Cuiaba, MG, Brazil; [Couto, Eduardo Guimaraes] Univ Fed Mato Grosso, Program Trop Agr, Cuiaba, MG, Brazil; [Couto, Eduardo Guimaraes] Univ Fed Mato Grosso, Program Ecol & Biodivers, Cuiaba, MG, Brazil; [Pinto, Osvaldo B., Jr.; Biudes, Marcelo Sacardi] Univ Fed Mato Grosso, Dept Environm Biophys, Cuiaba, MG, Brazil	University of British Columbia; University of British Columbia; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso	Johnson, MS (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada.	mark.johnson@ubc.ca	Couto, Eduardo Guimarães/E-4240-2010; Biudes, Marcelo Sacardi/G-6900-2012; Pinto, Osvaldo/C-2756-2013; Johnson, Mark S./B-4445-2008; Couto, Eduardo Guimarães/AAF-5790-2019; AMORIM, RICARDO S S/K-2587-2012	Couto, Eduardo Guimarães/0000-0002-5271-9709; Biudes, Marcelo Sacardi/0000-0002-0795-8946; Pinto, Osvaldo/0000-0003-2653-5460; Johnson, Mark S./0000-0001-5070-7539; Couto, Eduardo Guimarães/0000-0002-5271-9709; AMORIM, RICARDO S S/0000-0002-4570-1770; Jose de Messias Reason, Iara/0000-0002-5573-260X	National Science and Engineering Research Council of Canada (NSERC); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (Brazilian National Council for Science and Technology (CNPq)) [MCT/CNPq 15/2007]; Brazilian National Research Institute for Humid Areas - Instituto Nacional de Areas Umidas (INAU)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (Brazilian National Council for Science and Technology (CNPq))(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian National Research Institute for Humid Areas - Instituto Nacional de Areas Umidas (INAU)	The research was supported by Discovery Grant funding to MSJ from the National Science and Engineering Research Council of Canada (NSERC) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (Brazilian National Council for Science and Technology (CNPq)) funding to EGC through the program Edital MCT/CNPq 15/2007. Funding was also provided by the Brazilian National Research Institute for Humid Areas - Instituto Nacional de Areas Umidas (INAU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi D, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000063; Batalha M. A., 2005, Braz. J. Biol., V65, P735, DOI 10.1590/S1519-69842005000400021; Bauer J, 2012, BIOGEOCHEMISTRY, V108, P119, DOI 10.1007/s10533-011-9583-1; Bengtsson H, 2013, RBASIC R CLASS LIB S; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Cardoso EL, 2009, PESQUI AGROPECU BRAS, V44, P631, DOI 10.1590/S0100-204X2009000600012; Cook FJ, 2008, SOIL BIOL BIOCHEM, V40, P1013, DOI 10.1016/j.soilbio.2007.12.012; Couto E.G., 2011, PANTANAL ECOLOGY BIO, P71; Detto M, 2012, AM NAT, V179, P524, DOI 10.1086/664628; Dominguez E, 2011, J HYDROINFORM, V13, P429, DOI 10.2166/hydro.2010.116; Fierer N, 2003, SOIL SCI SOC AM J, V67, P798, DOI 10.2136/sssaj2003.0798; Fischer T, 2009, SOIL BIOL BIOCHEM, V41, P1577, DOI 10.1016/j.soilbio.2009.04.009; Flechard CR, 2007, AGR FOREST METEOROL, V142, P66, DOI 10.1016/j.agrformet.2006.11.006; Girard P, 2010, HYDROBIOLOGIA, V638, P223, DOI 10.1007/s10750-009-0046-9; Gouhier T. C., 2012, **DATA OBJECT**; GRANGER CWJ, 1988, J ECONOMETRICS, V39, P199, DOI 10.1016/0304-4076(88)90045-0; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Haase R, 1999, FOREST ECOL MANAG, V117, P129, DOI 10.1016/S0378-1127(98)00477-0; Hanan EJ, 2010, LANDSCAPE ECOL, V25, P463, DOI 10.1007/s10980-009-9426-9; Hatala JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051303; Jassal R, 2005, AGR FOREST METEOROL, V130, P176, DOI 10.1016/j.agrformet.2005.03.005; Jassal RS, 2004, AGR FOREST METEOROL, V124, P219, DOI 10.1016/j.agrformet.2004.01.013; Jauhiainen J, 2005, GLOBAL CHANGE BIOL, V11, P1788, DOI 10.1111/j.1365-2486.2005.001031.x; Johnson MS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034619; Junk WJ, 2005, ECOL ENG, V24, P391, DOI 10.1016/j.ecoleng.2004.11.012; Junk WJ, 2006, AQUAT SCI, V68, P278, DOI 10.1007/s00027-006-0851-4; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Keddy PA, 2009, BIOSCIENCE, V59, P39, DOI 10.1525/bio.2009.59.1.8; Kim DG, 2012, BIOGEOSCIENCES, V9, P2459, DOI 10.5194/bg-9-2459-2012; Lafleur PM, 2009, GEOGR COMPASS, V3, P560, DOI 10.1111/j.1749-8198.2008.00212.x; Lambrakis N, 2004, WATER RES, V38, P1862, DOI 10.1016/j.watres.2004.01.009; Lavigne MB, 2004, TREE PHYSIOL, V24, P415, DOI 10.1093/treephys/24.4.415; Maia SMF, 2010, GLOBAL CHANGE BIOL, V16, P2775, DOI 10.1111/j.1365-2486.2009.02105.x; Maier M, 2011, AGR FOREST METEOROL, V151, P1723, DOI 10.1016/j.agrformet.2011.07.006; Milesi de Mello J, REV BRAS CIENC SOLO; Myklebust MC, 2008, AGR FOREST METEOROL, V148, P1894, DOI 10.1016/j.agrformet.2008.06.016; ORCHARD VA, 1983, SOIL BIOL BIOCHEM, V15, P447, DOI 10.1016/0038-0717(83)90010-X; Oyj Vaisala, 2008, VAISALA CARBOCAP CAR; PARLANGE JY, 1976, WATER RESOUR RES, V12, P224, DOI 10.1029/WR012i002p00224; Pasini A, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034020; Pingintha N, 2010, TELLUS B, V62, P47, DOI 10.1111/j.1600-0889.2009.00445.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Riveros-Iregui DA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030938; Sanderman J, 2013, GLOBAL CHANGE BIOL, V19, P264, DOI 10.1111/gcb.12030; Selva EC, 2007, J TROP ECOL, V23, P329, DOI 10.1017/S0266467406003956; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Soil Survey Staff, 2010, KEYS SOIL TAX; Stoy PC, 2014, PHOTOSYNTH RES, V119, P49, DOI 10.1007/s11120-013-9799-0; Tang JW, 2003, AGR FOREST METEOROL, V118, P207, DOI 10.1016/S0168-1923(03)00112-6; Tans P., 2012, TRENDS ATMOSPHERIC C; Troxler Gann TG, 2005, FOREST ECOL MANAG, V214, P11, DOI 10.1016/j.foreco.2005.03.065; Turcu VE, 2005, VADOSE ZONE J, V4, P1161, DOI 10.2136/vzj2004.0164; Unger S, 2010, SOIL BIOL BIOCHEM, V42, P1800, DOI 10.1016/j.soilbio.2010.06.019; van der Valk AG, 2009, PLANT ECOL, V200, P1, DOI 10.1007/s11258-008-9469-z; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Vourlitis GL, 2011, SOIL SCI SOC AM J, V75, P1554, DOI 10.2136/sssaj2010.0412; WEBSTER R, 1990, STAT METHODS SOIL LA; Wetzel PR, 2005, FRONT ECOL ENVIRON, V3, P370, DOI 10.2307/3868586	59	31	33	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64874	10.1371/journal.pone.0064874	http://dx.doi.org/10.1371/journal.pone.0064874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762259	Green Published, gold, Green Submitted			2022-12-25	WOS:000320440500007
J	Wang, J; Zhao, Z; Lin, E; Zhao, W; Qian, XJ; Freire, D; Bilski, AE; Cheng, A; Vempati, P; Ho, L; Ono, K; Yamada, M; Pasinetti, GM				Wang, Jun; Zhao, Zhong; Lin, Emi; Zhao, Wei; Qian, Xianjuan; Freire, Daniel; Bilski, Amanda E.; Cheng, Alice; Vempati, Prashant; Ho, Lap; Ono, Kenjiro; Yamada, Masahito; Pasinetti, Giulio M.			Unintended Effects of Cardiovascular Drugs on the Pathogenesis of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; ANTIHYPERTENSIVE-MEDICATION-USE; MOUSE MODEL; SYNAPTIC PLASTICITY; NATURAL OLIGOMERS; MEMORY; A-BETA(1-42); PREVENTION; DEMENTIA; THERAPY	Alzheimer's disease (AD) is rapidly becoming one of the leading causes of disability and mortality in the elderly. As life-expectancy increases, an increasing number of people will rely on modern medicines to treat age-associated disorders. Among these medications, some might benefit, while others might exacerbate, the pathogenesis of AD. We screened 1,600 FDA approved drugs for beta-amyloid (A beta)-modifying activity and identified drugs that can potentially influence amyloid precursor protein processing. In this study, we focused on cardiovascular drugs and demonstrated that some hypertensive medication can differentially modulate A beta, both in vitro and in vivo. Our study suggests that some commonly prescribed drugs might exert unintended effects and modulate AD and provides the basis for continuing investigation of the role of individual drugs on a case-by-case basis. This line of investigation will lead to the identification of common medications that are potentially beneficial or detrimental to AD as a reference for physicians to consider when prescribing the most appropriate drugs for their patients, particularly for treating chronic disorders among the growing geriatric population.	[Wang, Jun; Zhao, Zhong; Zhao, Wei; Qian, Xianjuan; Freire, Daniel; Bilski, Amanda E.; Cheng, Alice; Vempati, Prashant; Ho, Lap; Pasinetti, Giulio M.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Lin, Emi] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wang, Jun; Ho, Lap; Pasinetti, Giulio M.] James J Peters Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, New York, NY USA; [Ono, Kenjiro; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol & Aging, Kanazawa, Ishikawa, Japan	Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Geriatric Research Education & Clinical Center; Kanazawa University	Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY USA.	giulio.pasinetti@mssm.edu		Ling, Emi/0000-0001-5287-0284; Pasinetti, Giulio/0000-0002-1524-5196; Zhao, Wei/0000-0002-3449-2395	National Institutes of Health [UO1 (AG29310)]; Department of Veterans Affairs; Altschul Foundation; NATIONAL INSTITUTE ON AGING [U01AG029310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Altschul Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health UO1 (AG29310) and Department of Veterans Affairs to GMP, and in part by Altschul Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta-Cruz I, 2010, J ALZHEIMERS DIS, V21, P649, DOI 10.3233/JAD-2010-100225; Braak H, 1997, Int Psychogeriatr, V9 Suppl 1, P257, DOI 10.1017/S1041610297004973; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cummings Jeffrey L, 2004, Rev Neurol Dis, V1, P60; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Diaz-Ruiz C., 2009, CARDIOVASC PSYCHIAT, V2009; Emilien G, 2000, ARCH NEUROL-CHICAGO, V57, P176, DOI 10.1001/archneur.57.2.176; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Fox C, 2011, J AM GERIATR SOC, V59, P1477, DOI 10.1111/j.1532-5415.2011.03491.x; Guo ZC, 1999, ARCH NEUROL-CHICAGO, V56, P991, DOI 10.1001/archneur.56.8.991; Gylys KH, 2003, J NEUROCHEM, V84, P1442, DOI 10.1046/j.1471-4159.2003.01643.x; Hajjar I, 2012, ARCH NEUROL-CHICAGO, V10, P1; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lonergan M. H., 2012, J PSYCHIATR NEUROSCI, V37; Lopez-Arrieta J. M., 2002, COCHRANE DB SYST REV, V3; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sano M, 2003, CNS SPECTRUMS, V8, P846, DOI 10.1017/S1092852900019283; Schwabe L, 2013, BIOL PSYCHOL, V92, P227, DOI 10.1016/j.biopsycho.2012.10.003; Schwabe L, 2012, BIOL PSYCHIAT, V71, P380, DOI 10.1016/j.biopsych.2011.10.028; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wang J, 2010, NEUROBIOL AGING; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Zou K, 2007, J NEUROSCI, V27, P8628, DOI 10.1523/JNEUROSCI.1549-07.2007	36	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65232	10.1371/journal.pone.0065232	http://dx.doi.org/10.1371/journal.pone.0065232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762322	gold, Green Submitted, Green Published			2022-12-25	WOS:000321099000046
J	Xing, CS; Fu, XY; Sun, XD; Guo, P; Li, M; Dong, JT				Xing, Changsheng; Fu, Xiaoying; Sun, Xiaodong; Guo, Peng; Li, Mei; Dong, Jin-Tang			Different Expression Patterns and Functions of Acetylated and Unacetylated Klf5 in the Proliferation and Differentiation of Prostatic Epithelial Cells	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-5; TRANSCRIPTION FACTORS; SELF-RENEWAL; STEM-CELLS; CANCER; BETA; GROWTH; MORPHOGENESIS; TUMORIGENESIS; DEGRADATION	KLF5 is a basic transcription factor that regulates multiple biological processes. While it was identified as a putative tumor suppressor in prostate cancer, likely due to its function as an effector of TGF-beta in the inhibition of cell proliferation, KLF5 is unacetylated and promotes cell proliferation in the absence of TGF-beta. In this study, we evaluated the expression and function of KLF5 in prostatic epithelial homeostasis and tumorigenesis using mouse prostates and human prostate epithelial cells in 3-D culture. Histological and molecular analyses demonstrated that unacetylated-Klf5 was expressed in basal or undifferentiated cells, whereas acetylated-Klf5 was expressed primarily in luminal and/or differentiated cells. Androgen depletion via castration increased both the level of Klf5 expression and the number of Klf5-positive cells in the remaining prostate. Functionally, knockdown of KLF5 in the human RWPE-1 prostate cell line decreased the number of spheres formed in 3-D culture. In addition, knockout of Klf5 in prostate epithelial cells, mediated by probasin promoter-driven Cre expression, did not cause neoplasia but promoted cell proliferation and induced hyperplasia when one Klf5 allele was knocked out. Knockout of both Klf5 alleles however, caused apoptosis rather than cell proliferation in the epithelium. In castrated mice, knockout of Klf5 resulted in more severe shrinkage of the prostate. These results suggest that KLF5 plays a role in the proliferation and differentiation of prostatic epithelial cells, yet loss of KLF5 alone is insufficient to induce malignant transformation in epithelial cells.	[Xing, Changsheng; Dong, Jin-Tang] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China; [Xing, Changsheng; Fu, Xiaoying; Sun, Xiaodong; Guo, Peng; Li, Mei; Dong, Jin-Tang] Emory Univ, Sch Med, Emory Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA; [Fu, Xiaoying] Tianjin Univ Tradit Chinese Med, Dept Pathol, Tianjin, Peoples R China	Nankai University; Emory University; Tianjin University of Traditional Chinese Medicine	Dong, JT (corresponding author), Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China.	j.dong@emory.edu	guo, peng/AAG-4052-2019; Guo, Peng/GWC-0572-2022	Xing, Changsheng/0000-0001-6582-9037; Guo, Peng/0000-0002-4575-8443; Dong, Jin-Tang/0000-0003-2349-5782	National Cancer Institute, National Institutes of Health [R01CA87921, R01CA171189]; National Natural Science Foundation of China [81130044]; NATIONAL CANCER INSTITUTE [R01CA087921, R01CA171189] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01CA87921 and R01CA171189 from the National Cancer Institute, National Institutes of Health and grant 81130044 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2000, J BIOL CHEM, V275, P37798, DOI 10.1074/jbc.M006323200; Bell SM, 2013, DEV BIOL, V375, P128, DOI 10.1016/j.ydbio.2012.12.010; Bell SM, 2011, DEV BIOL, V358, P79, DOI 10.1016/j.ydbio.2011.07.020; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen CS, 2001, GENE CHROMOSOME CANC, V31, P333, DOI 10.1002/gcc.1152; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Dong JT, 2001, CANCER METAST REV, V20, P173, DOI 10.1023/A:1015575125780; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Frigo DE, 2009, MOL ENDOCRINOL, V23, P1385, DOI 10.1210/me.2009-0010; Guo P, 2009, J BIOL CHEM, V284, P28243, DOI 10.1074/jbc.M109.036160; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; Guo P, 2009, J BIOL CHEM, V284, P6071, DOI 10.1074/jbc.M806270200; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hudson DL, 2003, CYTOTECHNOLOGY, V41, P189, DOI 10.1023/A:1024887009081; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Lang SH, 2001, BRIT J CANCER, V85, P590, DOI 10.1054/bjoc.2001.1967; Lang SH, 2006, IN VITRO CELL DEV-AN, V42, P273; Li XH, 2009, DIFFERENTIATION, V77, P95, DOI 10.1016/j.diff.2008.09.012; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; Nakajima Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001551; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-63; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Oldridge EE, 2012, MOL CELL ENDOCRINOL, V360, P14, DOI 10.1016/j.mce.2011.07.008; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Parisi S, 2011, VITAM HORM, V87, P381, DOI 10.1016/B978-0-12-386015-6.00037-8; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Pascal LE, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-46; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Shen MM, 2008, COLD SH Q B, V73, P529, DOI 10.1101/sqb.2008.73.050; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Sun XD, 2012, GENESIS, V50, P819, DOI 10.1002/dvg.22041; Sur I, 2006, J CELL SCI, V119, P3593, DOI 10.1242/jcs.03070; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Tyson DR, 2007, PROSTATE, V67, P1601, DOI 10.1002/pros.20628; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; van Leenders GJLH, 2001, J PATHOL, V195, P563, DOI 10.1002/path.993; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang XD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r255; WAYMOUTH C, 1983, JNCI-J NATL CANCER I, V70, P199; Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Zhao KW, 2011, BIOCHEM J, V437, P323, DOI 10.1042/BJ20101388; Zhao Y, 2008, ONCOGENE, V27, P1, DOI 10.1038/sj.onc.1210625; Zhu NX, 2006, J BIOL CHEM, V281, P14711, DOI 10.1074/jbc.M513810200	56	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65538	10.1371/journal.pone.0065538	http://dx.doi.org/10.1371/journal.pone.0065538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755247	Green Submitted, gold, Green Published			2022-12-25	WOS:000320579400063
J	Chu, C; Zhang, XJ; Ma, W; Li, L; Wang, W; Shang, L; Fu, P				Chu, Cheng; Zhang, Xinjiang; Ma, Wei; Li, Li; Wang, Wei; Shang, Lu; Fu, Peng			Induction of Autophagy by a Novel Small Molecule Improves A beta Pathology and Ameliorates Cognitive Deficits	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; IN-VITRO; RAPAMYCIN; NEURODEGENERATION; PROTEIN; TOXICITY; PEPTIDE; MTOR; AKT	Growing evidence has demonstrated a neuroprotective role of autophagy in Alzheimer's disease (AD). Thus, autophagy has been regarded as a potential therapeutic target, attracting increasing interest in pharmaceutical autophagy modulation by small molecules. We designed a two-cycle screening strategy on the basis of imaging high-throughout screening (HTS) and cellular toxicity assay, and have identified a novel autophagy inducer known as GTM-1. We further showed that GTM-1 exhibits dual activities, such as autophagy induction and antagonism against A beta-oligomer toxicity. GTM-1 modulates autophagy in an Akt-independent and mTOR-independent manner. In addition, we demonstrated that GTM-1 enhances autophagy clearance and reverses the downregulation of autophagy flux by thapsigargin and asparagine. Furthermore, administration of GTM-1 attenuated Ab pathology and ameliorated cognitive deficits in AD mice.	[Chu, Cheng; Zhang, Xinjiang; Wang, Wei] First Peoples Hosp Yangzhou, Dept Neurol, Yangzhou, Jiangsu, Peoples R China; [Chu, Cheng; Li, Li] Second Mil Med Univ, Changzheng Hosp, Dept Neurol, Shanghai, Peoples R China; [Ma, Wei] Mu Danjiang Med Coll, Heilongjiang, Peoples R China; [Shang, Lu] Shanghai Corps, Detachment Hlth Team CAPF 8, Shanghai, Jiangsu, Peoples R China; [Fu, Peng] Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Fu, P (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China.	fuajneg@163.com			First People's Hospital of Yangzhou and Changzheng Hospital	First People's Hospital of Yangzhou and Changzheng Hospital	This study was supported by the First People's Hospital of Yangzhou and Changzheng Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Anekonda TS, 2011, J ALZHEIMERS DIS, V23, P21, DOI 10.3233/JAD-2010-101287; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bonda DJ, 2010, CURR OPIN DRUG DISC, V13, P235; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Desplat V, 2010, J ENZYM INHIB MED CH, V25, P204, DOI 10.3109/14756360903169881; Florez-McClure ML, 2007, AUTOPHAGY, V3, P569, DOI 10.4161/auto.4776; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HOYVIK H, 1991, J CELL BIOL, V113, P1305, DOI 10.1083/jcb.113.6.1305; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Jekabsone A, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-24; Jeong JK, 2013, NEUROBIOL AGING, V34, P146, DOI 10.1016/j.neurobiolaging.2012.04.002; Jimenez-Sanchez M, 2012, PROG NEUROBIOL, V97, P67, DOI 10.1016/j.pneurobio.2011.08.013; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; Ling DJ, 2009, AUTOPHAGY, V5, P738, DOI 10.4161/auto.5.5.8626; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Madeo F, 2009, GENE DEV, V23, P2253, DOI 10.1101/gad.1858009; Maezawa I, 2006, J NEUROCHEM, V98, P57, DOI 10.1111/j.1471-4159.2006.03862.x; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Smita M, 2011, POLS ONE, V6; Son SM, 2012, AUTOPHAGY, V8, P1842, DOI 10.4161/auto.21861; SOPHER BL, 1994, MOL BRAIN RES, V26, P207, DOI 10.1016/0169-328X(94)90092-2; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Wadsworth TL, 2008, J ALZHEIMERS DIS, V14, P225; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zheng L, 2006, NEUROSCI LETT, V394, P184, DOI 10.1016/j.neulet.2005.10.035; Zheng L, 2006, ANN NY ACAD SCI, V1067, P248, DOI 10.1196/annals.1354.032	44	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65367	10.1371/journal.pone.0065367	http://dx.doi.org/10.1371/journal.pone.0065367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750258	gold, Green Submitted, Green Published			2022-12-25	WOS:000319961900060
J	Delort, L; Lequeux, C; Dubois, V; Dubouloz, A; Billard, H; Mojallal, A; Damour, O; Vasson, MP; Caldefie-Chezet, F				Delort, Laetitia; Lequeux, Charlotte; Dubois, Virginie; Dubouloz, Alice; Billard, Hermine; Mojallal, Ali; Damour, Odile; Vasson, Marie-Paule; Caldefie-Chezet, Florence			Reciprocal Interactions between Breast Tumor and Its Adipose Microenvironment Based on a 3D Adipose Equivalent Model	PLOS ONE			English	Article							MAMMARY TUMORIGENESIS; CANCER CELLS; ADIPONECTIN; LEPTIN; GROWTH; EXPRESSION; ESTROGEN; TISSUE; ADIPOCYTES; PREADIPOCYTES	Breast cancer has become the most common cancer among women in industrialized countries. Obesity is well established as a risk factor, in particular owing to the attendant secretion of the entities called adipokines; there is growing evidence for a role of cells and factors present in the mammary tumor microenvironment such as fibroblasts, preadipocytes, adipocytes and their secretions. To study how the microenvironment influences breast cancer growth, we developed a novel tridimensional adipose model epithelialized with normal human keratinocytes or with breast cancer cell lines. These mimicked a breast tumor in contact with an adipose microenvironment and allowed monitoring of the interactions between the cells. Leptin and adiponectin, two major adipokines, and their respective receptors, ObRt and AdipoR1, were expressed in the model, but not the second adiponectin receptor, AdipoR2. The differentiation of preadipocytes into adipocytes was greater when they were in contact with the breast cancer cell lines. The contact of breast cancer cell lines with the microenvironment completely modified their transcriptional programs by increasing the expression of genes involved in cell proliferation (cyclinD1, MAPK), angiogenesis (MMP9, VEGF) and hormonal pathways (ESR1, IL6). This tridimensional adipose model provides new insights into the interactions between breast cancer cells and their adipose microenvironment, and provides a tool to develop new drugs for the treatment of both cancer and obesity.	[Delort, Laetitia; Dubois, Virginie; Billard, Hermine; Vasson, Marie-Paule; Caldefie-Chezet, Florence] Univ Auvergne, Clermont Univ, UFR Pharm, Lab SVFp, Clermont Ferrand, France; [Delort, Laetitia; Dubois, Virginie; Billard, Hermine; Vasson, Marie-Paule; Caldefie-Chezet, Florence] CRNH Auvergne, ECRIN, INRA, UMR 1019, Clermont Ferrand, France; [Vasson, Marie-Paule] Ctr Jean Perrin, Unite Nutr, Clermont Ferrand, France; [Lequeux, Charlotte; Dubouloz, Alice; Mojallal, Ali; Damour, Odile] Hop Edouard Herriot, Banque Tissus & Cellules, Lyon, France; [Mojallal, Ali] Hop Edouard Herriot, Serv Chirurg Plast Reconstruct & Esthet, Lyon, France	Universite Clermont Auvergne (UCA); INRAE; UNICANCER; Centre Jean Perrin; CHU Lyon; CHU Lyon	Delort, L (corresponding author), Univ Auvergne, Clermont Univ, UFR Pharm, Lab SVFp, Clermont Ferrand, France.	laetitia.delort@udamail.fr	delort, laetitia/C-3838-2014; FLORENCE, CALDEFIE-CHEZET FCC/U-3378-2018; vasson, marie-paule/ABA-2486-2021		Ligue Nationale contre le Cancer; French Ministry of Research and Technology fellowship	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); French Ministry of Research and Technology fellowship	This study received financial support from "Ligue Nationale contre le Cancer" (comite du Puy-de-Dome, Prof. F. Caldefie-Chezet) and "Canceropole Lyon-Auvergne-Rhone-Alpes". Virginie Dubois is supported by a French Ministry of Research and Technology fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg N, 1999, P NATL ACAD SCI USA, V96, P6249, DOI 10.1073/pnas.96.11.6249; Binai NA, 2010, INT J CANCER, V127, P55, DOI 10.1002/ijc.25010; BJORNTORP P, 1982, METABOLISM, V31, P366, DOI 10.1016/0026-0495(82)90112-3; Black AF, 2005, TISSUE ENG, V11, P723, DOI 10.1089/ten.2005.11.723; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; Caldefie-Chezet F, 2005, BIOCHEM BIOPH RES CO, V334, P737, DOI 10.1016/j.bbrc.2005.06.077; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cleary Margot P, 2009, Front Biosci (Schol Ed), V1, P329, DOI 10.2741/e30; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Dos Santos E, 2008, ONCOL REP, V20, P971, DOI 10.3892/or_00000098; Dubois V, 2010, ANTICANCER RES, V30, P2919; Ferlay J, 2010, INT J CANC; Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542; GODDEN J, 1992, ANTICANCER RES, V12, P1683; Guerrero J, 2010, BREAST CANCER RES TR, V119, P497, DOI 10.1007/s10549-009-0491-1; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Jarde T, 2008, HISTOPATHOLOGY, V53, P484, DOI 10.1111/j.1365-2559.2008.03121.x; Jarde T, 2009, ENDOCR-RELAT CANCER, V16, P1197, DOI 10.1677/ERC-09-0043; Jarde T, 2011, EUR J CANCER, V47, P33, DOI 10.1016/j.ejca.2010.09.005; Kang JH, 2005, ARCH PHARM RES, V28, P1263, DOI 10.1007/BF02978210; La Vecchia C, 2006, EUR J CANCER PREV, V15, P117, DOI 10.1097/01.cej.0000179274.24200.9d; Lequeux C, 2009, BIO-MED MATER ENG, V19, P283, DOI 10.3233/BME-2009-0593; Maccio A, 2009, OBES REV, V10, P660, DOI 10.1111/j.1467-789X.2009.00592.x; Maccio A, 2010, J MOL MED, V88, P677, DOI 10.1007/s00109-010-0611-8; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; Mawson A, 2005, MOL CELL ENDOCRINOL, V229, P161, DOI 10.1016/j.mce.2004.08.002; Moinfar F, 2000, CANCER RES, V60, P2562; Mojallal A, 2008, BIO-MED MATER ENG, V18, P193, DOI 10.3233/BME-2008-0524; O'Brien SN, 1999, BIOCHEM BIOPH RES CO, V259, P695, DOI 10.1006/bbrc.1999.0843; Ozbay T, 2008, MOL CANCER RES, V6, P1052, DOI 10.1158/1541-7786.MCR-07-2126; Purohit A, 2002, BREAST CANCER RES, V4, P65, DOI 10.1186/bcr425; Renehan AG, 2010, EUR J CANCER, V46, P2581, DOI 10.1016/j.ejca.2010.07.052; Takahata C, 2007, CANCER LETT, V250, P229, DOI 10.1016/j.canlet.2006.10.006; Tworoger SS, 2007, J CLIN ENDOCR METAB, V92, P1510, DOI 10.1210/jc.2006-1975; Vona-Davis L, 2007, OBES REV, V8, P395, DOI 10.1111/j.1467-789X.2007.00396.x; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Yee D, 2000, J MAMMARY GLAND BIOL, V5, P107, DOI 10.1023/A:1009575518338	39	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66284	10.1371/journal.pone.0066284	http://dx.doi.org/10.1371/journal.pone.0066284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750285	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900087
J	Hamilton, RT; Bhattacharya, A; Walsh, ME; Shi, Y; Wei, R; Zhang, YQ; Rodriguez, KA; Buffenstein, R; Chaudhuri, AR; Van Remmen, H				Hamilton, Ryan T.; Bhattacharya, Arunabh; Walsh, Michael E.; Shi, Yun; Wei, Rochelle; Zhang, Yiqiang; Rodriguez, Karl A.; Buffenstein, Rochelle; Chaudhuri, Asish R.; Van Remmen, Holly			Elevated Protein Carbonylation, and Misfolding in Sciatic Nerve from db/db and Sod1(-/-) Mice: Plausible Link between Oxidative Stress and Demyelination	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PERIPHERAL MYELIN PROTEIN-22; ALDOSE REDUCTASE INHIBITION; ALZHEIMERS-DISEASE BRAIN; DIABETIC-NEUROPATHY; LIPID-PEROXIDATION; SKELETAL-MUSCLE; CONDUCTION-VELOCITY; NITROSATIVE STRESS; ADVANCED GLYCATION	Diabetic peripheral polyneuropathy is associated with decrements in motor/sensory neuron myelination, nerve conduction and muscle function; however, the mechanisms of reduced myelination in diabetes are poorly understood. Chronic elevation of oxidative stress may be one of the potential determinants for demyelination as lipids and proteins are important structural constituents of myelin and highly susceptible to oxidation. The goal of the current study was to determine whether there is a link between protein oxidation/misfolding and demyelination. We chose two distinct models to test our hypothesis: 1) the leptin receptor deficient mouse (dbdb) model of diabetic polyneuropathy and 2) superoxide dismutase 1 knockout (Sod1 2/2) mouse model of in vivo oxidative stress. Both experimental models displayed a significant decrement in nerve conduction, increase in tail distal motor latency as well as reduced myelin thickness and fiber/axon diameter. Further biochemical studies demonstrated that oxidative stress is likely to be a potential key player in the demyelination process as both models exhibited significant elevation in protein carbonylation and alterations in protein conformation. Since peripheral myelin protein 22 (PMP22) is a key component of myelin sheath and has been found mutated and aggregated in several peripheral neuropathies, we predicted that an increase in carbonylation and aggregation of PMP22 may be associated with demyelination in dbdb mice. Indeed, PMP22 was found to be carbonylated and aggregated in sciatic nerves of dbdb mice. Sequence-driven hydropathy plot analysis and in vitro oxidation-induced aggregation of purified PMP22 protein supported the premise for oxidation-dependent aggregation of PMP22 in dbdb mice. Collectively, these data strongly suggest for the first time that oxidation-mediated protein misfolding and aggregation of key myelin proteins may be linked to demyelination and reduced nerve conduction in peripheral neuropathies.	[Hamilton, Ryan T.; Bhattacharya, Arunabh; Walsh, Michael E.; Shi, Yun; Zhang, Yiqiang; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Rodriguez, Karl A.; Buffenstein, Rochelle; Van Remmen, Holly] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Chaudhuri, Asish R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Hamilton, Ryan T.; Bhattacharya, Arunabh; Shi, Yun; Wei, Rochelle; Zhang, Yiqiang; Rodriguez, Karl A.; Buffenstein, Rochelle; Chaudhuri, Asish R.; Van Remmen, Holly] Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX USA; [Chaudhuri, Asish R.; Van Remmen, Holly] South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Chaudhuri, AR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	chaudhuria@uthscsa.edu; vanremmen@uthscsa.edu	Zhang, Yiqiang/AAA-3143-2019		National Service Research Award; Program project at the National Institute of Aging [AG20591]; University of Michigan Grant; Go Grant at the National institute of Aging project [RCA2AG036613]; Glenn Award (Research in Biological Mechanisms of Aging); Ellison Medical Foundation [AGSS-178006]; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [P01AG020591, RC2AG036613, T32AG021890] Funding Source: NIH RePORTER	National Service Research Award; Program project at the National Institute of Aging; University of Michigan Grant; Go Grant at the National institute of Aging project; Glenn Award (Research in Biological Mechanisms of Aging); Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by T32 AG021890-08 (NIA) National Service Research Award to Postdoctoral Fellow Training Grant on the Biology of Aging to Steven N. Austad for trainees (RTH, KAR) AG20591 Program project at the National Institute of Aging (HV) (Project 2: Does Superoxide-Induced Mitochondrial Dysfunction Lead to Muscle Atrophy?) University of Michigan Grant (Subcontract), RCA2AG036613 Go Grant at the National institute of Aging project 8 (WW and HV) (Effect of rapa on removal of protein by the autophagic and/or proteasomal pathways) under (AR) (Can rapamycin retard aging?), Glenn Award (Research in Biological Mechanisms of Aging) (http://glennfoundation.org/), AGSS-178006 (RB is PI) Ellison Medical Foundation (Genomic Stability in the Naked Mole-Rat: A Role for Cancer Resistance and Extended Longevity) (http://www.ellisonfoundation.org/), and Glenn Foundation for Medical Research (RB is PI). (Comparative biological mechanisms of aging, insights from the longest lived rodent, the naked mole-rat) (http://glennfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraibar MA, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/919832; Bhattacharya A, 2011, AGING CELL, V10, P720, DOI 10.1111/j.1474-9726.2011.00712.x; Bizzozero OA, 2005, J NEUROSCI RES, V81, P687, DOI 10.1002/jnr.20587; Butterfield DA, 2006, EUR J PHARMACOL, V545, P39, DOI 10.1016/j.ejphar.2006.06.026; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Coppey LJ, 2006, DIABETES, V55, P341, DOI 10.2337/diabetes.55.02.06.db05-0885; Delaney CL, 2001, J NEUROPATH EXP NEUR, V60, P147, DOI 10.1093/jnen/60.2.147; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Fortun J, 2006, NEUROBIOL DIS, V22, P153, DOI 10.1016/j.nbd.2005.10.010; Fortun J, 2005, J NEUROCHEM, V92, P1531, DOI 10.1111/j.1471-4159.2004.02987.x; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Grigsby J, 2012, CURR EYE RES, V37, P1045, DOI 10.3109/02713683.2012.713152; Gurpinar T, 2011, BIOTECH HISTOCHEM, V86, P373, DOI 10.3109/10520295.2010.506159; Ilnytska O, 2006, DIABETES, V55, P1686, DOI 10.2337/db06-0067; Jang YC, 2012, AGING CELL, V11, P770, DOI 10.1111/j.1474-9726.2012.00843.x; Jang YC, 2011, EXP GERONTOL, V46, P193, DOI 10.1016/j.exger.2010.08.029; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Juretic D, 1998, COMPUT CHEM, V22, P279, DOI 10.1016/S0097-8485(97)00070-3; Kalia LV, 2012, ANN NEUROL; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Miyata T, 2000, J AM SOC NEPHROL, V11, P1744, DOI 10.1681/ASN.V1191744; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Obrosova IG, 2005, DIABETES, V54, P234, DOI 10.2337/diabetes.54.1.234; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Oh SS, 2010, NEUROSCI LETT, V483, P127, DOI 10.1016/j.neulet.2010.07.076; Padua L, 2011, MUSCLE NERVE, V43, P652, DOI 10.1002/mus.21935; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Pierce A, 2006, BIOCHEMISTRY-US, V45, P3077, DOI 10.1021/bi052031i; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Pierce AP, 2007, FREE RADICAL BIO MED, V43, P1584, DOI 10.1016/j.freeradbiomed.2007.08.019; Pillon NJ, 2012, ENDOCRINOLOGY, V153, P2099, DOI 10.1210/en.2011-1957; Poon HF, 2005, FREE RADICAL BIO MED, V39, P453, DOI 10.1016/j.freeradbiomed.2005.03.030; Poon HF, 2005, NEUROBIOL DIS, V18, P492, DOI 10.1016/j.nbd.2004.12.009; Rangaraju S, 2008, NEUROBIOL DIS, V32, P105, DOI 10.1016/j.nbd.2008.06.015; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Rosso G, 2012, J MOL RECOGNIT, V25, P247, DOI 10.1002/jmr.2176; Salmon AB, 2009, FASEB J, V23, P2317, DOI 10.1096/fj.08-122523; Schmeichel AM, 2003, DIABETES, V52, P165, DOI 10.2337/diabetes.52.1.165; Shao CH, 2012, MOL PHARMACOL, V82, P383, DOI 10.1124/mol.112.078352; SHAW PJ, 1995, ANN NEUROL, V38, P691, DOI 10.1002/ana.410380424; Sherman DL, 2012, J NEUROSCI, V32, P1817, DOI 10.1523/JNEUROSCI.4814-11.2012; SHIRASAKI N, 1991, J NEUROCYTOL, V20, P573, DOI 10.1007/BF01215265; Thomas PK, 1997, CLIN NEUROSCI, V4, P341; Tobler AR, 2002, P NATL ACAD SCI USA, V99, P483, DOI 10.1073/pnas.012593399; Vareniuk I, 2007, EXP NEUROL, V205, P425, DOI 10.1016/j.expneurol.2007.03.019; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Voziyan P, 2013, CLIN CHEM LAB MED, P1; Wang L, 2011, NEUROSCIENCE, V193, P399, DOI 10.1016/j.neuroscience.2011.07.039; Wei Q, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-13; Yamada K, 2003, J PEPT RES, V62, P78, DOI 10.1034/j.1399-3011.2003.00073.x; Yamamoto A, 2011, NEUROBIOL DIS, V43, P17, DOI 10.1016/j.nbd.2010.08.015	53	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65725	10.1371/journal.pone.0065725	http://dx.doi.org/10.1371/journal.pone.0065725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750273	gold, Green Published, Green Submitted			2022-12-25	WOS:000319961900075
J	Li, L; Ma, P; Liu, YJ; Huang, C; O, WS; Tang, F; Zhang, JV				Li, Lei; Ma, Ping; Liu, Yongjun; Huang, Chen; O, Wai-sum; Tang, Fai; Zhang, Jian V.			Intermedin Attenuates LPS-induced Inflammation in the Rat Testis	PLOS ONE			English	Article							OXIDATIVE STRESS; INTERMEDIN/ADRENOMEDULLIN 2; TESTICULAR MACROPHAGES; MALE-INFERTILITY; LEYDIG-CELLS; IN-VITRO; LIPOPOLYSACCHARIDE; PEPTIDE; SERTOLI; ADRENOMEDULLIN-2	First reported as a vasoactive peptide in the cardiovascular system, intermedin (IMD), also known as adrenomedullin 2 (ADM2), is a hormone with multiple potent roles, including its antioxidant action on the pulmonary, central nervous, cardiovascular and renal systems. Though IMD may play certain roles in trophoblast cell invasion, early embryonic development and cumulus cell-oocyte interaction, the role of IMD in the male reproductive system has yet to be investigated. This paper reports our findings on the gene expression of IMD, its receptor components and its protein localization in the testes. In a rat model, bacterial lippolysaccharide (LPS) induced atypical orchitis, and LPS treatment upregulated the expression of IMD and one of its receptor component proteins, i.e. receptor activity modifying protein 2 (RAMP2). IMD decreased both plasma and testicular levels of reactive oxygen species (ROS) production, attenuated the increase in the gene expression of the proinflammatory cytokines tumor necrosis factor alpha (TNF alpha), interleukin 6 (IL6) and interleukin 1 beta (IL1 beta), rescued spermatogenesis, and prevented the decrease in plasma testosterone levels caused by LPS. The restorative effect of IMD on steroidogenesis was also observed in hydrogen peroxide-treated rat primary Leydig cells culture. Our results indicate IMD plays an important protective role in spermatogenesis and steroidogenesis, suggesting therapeutic potential for IMD in pathological conditions such as orchitis.	[Li, Lei; Ma, Ping; Liu, Yongjun; Huang, Chen; Zhang, Jian V.] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Res Ctr Gene & Cell Engn, Shenzhen, Peoples R China; [O, Wai-sum] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Tang, Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Jian V.] Shenzhen Engn Lab Single Mol Detect & Instrument, Shenzhen, Peoples R China; [Zhang, Jian V.] Innovat Pharmacol & Biotherapy Preclin Test Publ, Shenzhen, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Hong Kong; University of Hong Kong	Zhang, JV (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Res Ctr Gene & Cell Engn, Shenzhen, Peoples R China.	jian.zhang@siat.ac.cn		Li, Lei/0000-0002-4485-1937	One-hundred Talent Program of Chinese Academy Of Sciences of China; National Natural Science Foundation of China [31100850, 81200434]; Shenzhen City of China [SW201110059]; National Major Basic Research Program of China [2013CB945503]	One-hundred Talent Program of Chinese Academy Of Sciences of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen City of China; National Major Basic Research Program of China(National Basic Research Program of China)	JZ was supported by One-hundred Talent Program of Chinese Academy Of Sciences of China, Grant 31100850 from National Natural Science Foundation of China, Grant SW201110059 from Shenzhen City of China, and the National Major Basic Research Program of China 2013CB945503; LL was supported by Grant 81200434 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; Allen JA, 2004, ENDOCRINE, V25, P265, DOI 10.1385/ENDO:25:3:265; Guazzone VA, 2009, MICROSC RES TECHNIQ, V72, P620, DOI 10.1002/jemt.20704; Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; BOOCKFOR FR, 1994, ENDOCRINOLOGY, V134, P2150, DOI 10.1210/en.134.5.2150; Borahay M, 2013, J CLIN ENDOCRINOL ME; Bryniarski K, 2005, J IMMUNOL METHODS, V301, P186, DOI 10.1016/j.jim.2005.04.002; Chang CL, 2011, J BIOL CHEM, V286, P43193, DOI 10.1074/jbc.M111.297358; Chauhan M, 2011, BIOL REPROD, V85, P1232, DOI 10.1095/biolreprod.110.086835; Chauhan M, 2011, REGUL PEPTIDES, V170, P65, DOI 10.1016/j.regpep.2011.05.011; Chauhan M, 2009, BIOL REPROD, V81, P777, DOI 10.1095/biolreprod.108.074419; Chen L, 2006, BRAIN RES, V1086, P42, DOI 10.1016/j.brainres.2006.02.128; Cudicini C, 1997, ENDOCRINOLOGY, V138, P2863, DOI 10.1210/en.138.7.2863; DE SK, 1993, ENDOCRINOLOGY, V133, P389, DOI 10.1210/en.133.1.389; Hagiwara M, 2008, AM J PHYSIOL-RENAL, V295, pF1735, DOI 10.1152/ajprenal.90427.2008; KERN S, 1995, BIOL REPROD, V53, P1407, DOI 10.1095/biolreprod53.6.1407; Kuwasako K, 2004, MOL PHARMACOL, V65, P207, DOI 10.1124/mol.65.1.207; Li L, 2008, MOL CELL ENDOCRINOL, V283, P96, DOI 10.1016/j.mce.2007.11.028; McLachlan RI, 2001, MED J AUSTRALIA, V174, P116, DOI 10.5694/j.1326-5377.2001.tb143180.x; Muller-Redetzky HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035832; O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238; Reddy MM, 2006, REPROD TOXICOL, V22, P493, DOI 10.1016/j.reprotox.2006.03.003; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Stephan JP, 1997, MOL CELL ENDOCRINOL, V134, P109, DOI 10.1016/S0303-7207(97)00172-X; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; Taylor MM, 2005, AM J PHYSIOL-REG I, V288, pR919, DOI 10.1152/ajpregu.00744.2004; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Turner TT, 2008, J ANDROL, V29, P488, DOI 10.2164/jandrol.108.005132; Victor VM, 2003, PHYSIOL RES, V52, P789; WEI RQ, 1988, BIOL REPROD, V38, P830, DOI 10.1095/biolreprod38.4.830; Zhao L, 2012, PEPTIDES, V33, P329, DOI 10.1016/j.peptides.2011.12.016	31	22	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65278	10.1371/journal.pone.0065278	http://dx.doi.org/10.1371/journal.pone.0065278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750251	Green Submitted, Green Published, gold			2022-12-25	WOS:000319961900053
J	Valbuena-Urena, E; Amat, F; Carranza, S				Valbuena-Urena, Emilio; Amat, Felix; Carranza, Salvador			Integrative Phylogeography of Calotriton Newts (Amphibia, Salamandridae), with Special Remarks on the Conservation of the Endangered Montseny Brook Newt (Calotriton arnoldi)	PLOS ONE			English	Article							CLIMATIC OSCILLATIONS; GENETIC CONSEQUENCES; BIOGEOGRAPHY; MITOCHONDRIAL; RANGE; POPULATIONS; PHYLOGENETICS; COLONIZATION; EVOLUTION; LINEAGES	The genus Calotriton includes two species of newts highly adapted to live in cold and fast-flowing mountain springs. The Pyrenean brook newt (Calotriton asper), restricted to the Pyrenean region, and the Montseny brook newt (Calotriton arnoldi), endemic to the Montseny massif and one of the most endangered amphibian species in Europe. In the present manuscript, we use an integrative approach including species distribution modeling (SDM), molecular analyses of mitochondrial and nuclear DNA sequence data and morphology to unravel the historical processes that have contributed to shaping the biogeography and genetic structure of the genus Calotriton, with special emphasis on the conservation of C. arnoldi. The results of the molecular analyses confirm that, despite having originated recently, being ecologically similar and geographically very close, there is no signal of hybridization between C. asper and C. arnoldi. SDM results suggest that tough environmental conditions on mountains tops during glacial periods, together with subsequent warmer periods could have prevented the contact between the two species. Within the critically endangered C. arnoldi, a high genetic structure is revealed despite its extremely small distribution range compared to C. asper. Haplotype networks, AMOVA and SAMOVA analyses suggest that two distinct groups of populations can be clearly differentiated with absence of gene flow. This is in concordance with morphological differentiation and correlates with its geographical distribution, as the two groups are situated on the eastern and western sides of a river valley that acts as a barrier. The genetic and morphological results are highly important for the ongoing conservation program of C. arnoldi and strongly justify the management of this species into at least two independent evolutionary significant units (eastern and western sectors) to guarantee the long-term population viability.	[Valbuena-Urena, Emilio] Univ Autonoma Barcelona, Fac Biociencies, Unitat Zool, Cerdanyola Del Valles, Catalonia, Spain; [Valbuena-Urena, Emilio] Forestal Catalana, Ctr Fauna Salvatge Torreferrussa, Barcelona, Catalonia, Spain; [Amat, Felix] Museu Ciencies Nat Granollers, Area Herpetol, Granollers, Catalonia, Spain; [Carranza, Salvador] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Catalonia, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University	Valbuena-Urena, E (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Unitat Zool, Cerdanyola Del Valles, Catalonia, Spain.	emiliojavier.valbuena@uab.cat	Carranza, Salvador/A-2126-2012	Carranza, Salvador/0000-0002-5378-3008; Valbuena-Urena, Emilio/0000-0002-6771-4038	Forestal Catalana, S.A.; DAAM of the Generalitat de Catalunya; Miloca and Zoo de Barcelona [PRIC-2011]	Forestal Catalana, S.A.; DAAM of the Generalitat de Catalunya; Miloca and Zoo de Barcelona	This work was funded by Forestal Catalana, S.A., and DAAM of the Generalitat de Catalunya. Miloca and Zoo de Barcelona (PRIC-2011) also helped with the funding of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2012, J BIOGEOGR, V39, P970, DOI 10.1111/j.1365-2699.2011.02654.x; Amat F, 2007, CONSERVACIO TRITO MO, P1; Amat F, 2007, P 15 MED C CONTR AUT, P1; Amat F., 2005, 6 TROBADA ESTUDIOSOS, P119; Amat F, 2005, ESTUDI DEMOGRAFIC TR, P85; Amat F, 2004, DISTRIBUCIO TRITO PI, P90; [Anonymous], 1996, J APPL ECOL, DOI DOI 10.2307/2404927; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bardaji T, 2009, GEOMORPHOLOGY, V104, P22, DOI 10.1016/j.geomorph.2008.05.027; Beukema W, 2010, BIOL J LINN SOC, V101, P626, DOI 10.1111/j.1095-8312.2010.01506.x; Beukema W, 2008, ACTA HERPETOL, V3, P77; Bisconti R, 2011, MOL ECOL, V20, P5313, DOI 10.1111/j.1365-294X.2011.05363.x; Bosch J, 2009, IUCN 2012 IUCN RED L; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Carranza S, 2005, ZOOL J LINN SOC-LOND, V145, P555, DOI 10.1111/j.1096-3642.2005.00197.x; Carranza S, 2000, P ROY SOC B-BIOL SCI, V267, P637, DOI 10.1098/rspb.2000.1050; Carranza S, 2009, IUCN 2012 IUCN RED L; Carranza S, 2008, AMPHIBIA-REPTILIA, V29, P579, DOI 10.1163/156853808786230389; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; de Pous P, 2011, AMPHIBIA-REPTILIA, V32, P385, DOI 10.1163/017353711X587732; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Elith J, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P39; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garcia-Porta J, 2012, MOL PHYLOGENET EVOL, V63, P113, DOI 10.1016/j.ympev.2011.12.019; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Lecis R, 2004, BIOL CONSERV, V119, P263, DOI 10.1016/j.biocon.2003.11.011; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Llobet S., 1975, REV GEOGRAFIA, V9, P35; Lowe J.J., 2015, RECONSTRUCTING QUATE, V3rd ed.; Lopez-Garcia JM, 2010, NATURWISSENSCHAFTEN, V97, P753, DOI 10.1007/s00114-010-0695-6; Martinez-Rica J. P., 1980, STUDIA OECOLOGICA, V2, P135; Mattoccia M, 2011, BIOL J LINN SOC, V104, P903, DOI 10.1111/j.1095-8312.2011.01747.x; Mila B, 2010, MOL ECOL, V19, P108, DOI 10.1111/j.1365-294X.2009.04441.x; Montori A., 1991, B ASOC HERPETOL ESPA, V2, P10; Montori A., 1988, ESTUDIO BIOL ECOLOGI; Montori A., 2004, AMPHIBIA LISSAMPHIBI, P43; Montori A, 2008, AMPHIBIA-REPTILIA, V29, P371, DOI 10.1163/156853808785112048; Montori A, 2008, ZOOTAXA, P39, DOI 10.11646/zootaxa.1945.1.2; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Perera A, 2010, MOL PHYLOGENET EVOL, V54, P634, DOI 10.1016/j.ympev.2009.10.020; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Riberon A, 2001, MOL ECOL, V10, P2555, DOI 10.1046/j.1365-294X.2001.01373.x; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Serra-Cobo J, 2000, BELG J ZOOL, V130, P39; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Shepard DB, 2011, MOL PHYLOGENET EVOL, V59, P399, DOI 10.1016/j.ympev.2011.03.007; Shepard DB, 2009, MOL ECOL, V18, P2243, DOI 10.1111/j.1365-294X.2009.04164.x; Shepard DB, 2008, MOL ECOL, V17, P5315, DOI 10.1111/j.1365-294X.2008.03998.x; SPSS Inc, 2009, SPSS WIND REL 17 0; Steinfartz S, 2000, MOL ECOL, V9, P397, DOI 10.1046/j.1365-294x.2000.00870.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TEMPLETON AR, 1992, GENETICS, V132, P619; THIESMEIER B, 1990, Salamandra, V26, P63; Van Liedekerke M., 2006, EUROPEAN SOIL DATABA; Wake DB, 2006, ANN MO BOT GARD, V93, P8, DOI 10.3417/0026-6493(2006)93[8:PWSPAP]2.0.CO;2; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; WEITZMAN ML, 1992, Q J ECON, V107, P363, DOI 10.2307/2118476; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wilson JS, 2012, DIVERS DISTRIB, V18, P1139, DOI 10.1111/j.1472-4642.2012.00902.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020	74	17	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e62542	10.1371/journal.pone.0062542	http://dx.doi.org/10.1371/journal.pone.0062542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750201	gold, Green Published, Green Submitted			2022-12-25	WOS:000319961900003
J	Aouida, M; Texeira, MR; Thevelein, JM; Poulin, R; Ramotar, D				Aouida, Mustapha; Texeira, Marta Rubio; Thevelein, Johan M.; Poulin, Richard; Ramotar, Dindial			Agp2, a Member of the Yeast Amino Acid Permease Family, Positively Regulates Polyamine Transport at the Transcriptional Level	PLOS ONE			English	Article							SR PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; POTASSIUM TRANSPORTER; ION HOMEOSTASIS; DRUG BLEOMYCIN; BUDDING YEAST; PATHWAY; GENE; ACTIVATION; TOLERANCE	Agp2 is a plasma membrane protein of the Saccharomyces cerevisiae amino acid transporter family, involved in high-affinity uptake of various substrates including L-carnitine and polyamines. The discovery of two high affinity polyamine permeases, Dur3 and Sam3, prompted us to investigate whether Agp2 directly transports polyamines or acts instead as a regulator. Herein, we show that neither dur3 Delta nor sam3 Delta single mutant is defective in polyamine transport, while the dur3 Delta sam3 Delta double mutant exhibits a sharp decrease in polyamine uptake and an increased resistance to polyamine toxicity similar to the agp2 Delta mutant. Studies of Agp2 localization indicate that in the double mutant dur3 Delta sam3 Delta, Agp2-GFP remains plasma membrane-localized, even though transport of polyamines is strongly reduced. We further demonstrate that Agp2 controls the expression of several transporter genes including DUR3 and SAM3, the carnitine transporter HNM1 and several hexose, nucleoside and vitamin permease genes, in addition to SKY1 encoding a SR kinase that positively regulates low-affinity polyamine uptake. Furthermore, gene expression analysis clearly suggests that Agp2 is a strong positive regulator of additional biological processes. Collectively, our data suggest that Agp2 might respond to environmental cues and thus regulate the expression of several genes including those involved in polyamine transport.	[Aouida, Mustapha] King Abdullah Univ Sci & Technol, Ctr Desert Agr, Thuwal, Saudi Arabia; [Texeira, Marta Rubio; Thevelein, Johan M.] Inst Bot & Microbiol, Mol Cell Biol Lab, Louvain, Belgium; [Texeira, Marta Rubio; Thevelein, Johan M.] Flanders Inst Biotechnol, Dept Mol Microbiol, Flanders, Belgium; [Poulin, Richard] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1K 7P4, Canada; [Ramotar, Dindial] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ, Canada	King Abdullah University of Science & Technology; Flanders Institute for Biotechnology (VIB); Laval University; Universite de Montreal	Aouida, M (corresponding author), King Abdullah Univ Sci & Technol, Ctr Desert Agr, Thuwal, Saudi Arabia.	Mustapha.aouida@kaust.edu.sa; dramotar.hmr@ssss.gouv.qc.ca	Aouida, Mustapha/AEJ-4513-2022; Thevelein, Johan M./AAK-4203-2021	Aouida, Mustapha/0000-0001-7945-5320; Thevelein, Johan/0000-0002-2626-0180	Canadian Institute of Health Research [MOP-93573, MOP-67196]; Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network [P6/14, P7]; Research Fund of the KU Leuven (Concerted Research Actions); Hercules Foundation (Flanders); EC-Marie-Curie; Fonds Wetenschappelijk Onderzoek (FWO); Flanders Institute of Biotechnology (VIB); King Abdullah University of Science and Technology, Saudi Arabia	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network(Belgian Federal Science Policy OfficeFWO); Research Fund of the KU Leuven (Concerted Research Actions); Hercules Foundation (Flanders); EC-Marie-Curie; Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Flanders Institute of Biotechnology (VIB); King Abdullah University of Science and Technology, Saudi Arabia(King Abdullah University of Science & Technology)	This work was supported by the Canadian Institute of Health Research (MOP-93573 and MOP-67196 to DR) and by grants from the Fund for Scientific Research-Flanders, Interuniversity Attraction Poles Network P6/14 and P7, the Research Fund of the KU Leuven (Concerted Research Actions) and the Hercules Foundation (Flanders) to JMT. This work was also supported by EC-Marie-Curie, Fonds Wetenschappelijk Onderzoek (FWO) visiting fellowship and Flanders Institute of Biotechnology (VIB) contract all to MRT, and by the King Abdullah University of Science and Technology, Saudi Arabia, to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2005, J BIOL CHEM, V280, P24267, DOI 10.1074/jbc.M503071200; Aouida M, 2004, CANCER RES, V64, P1102, DOI 10.1158/0008-5472.CAN-03-2729; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Erez O, 2001, MOL CELL BIOL, V21, P175, DOI 10.1128/MCB.21.1.175-184.2001; Erez O, 2002, BIOCHEM BIOPH RES CO, V295, P1142, DOI 10.1016/S0006-291X(02)00823-9; Forment J, 2002, BBA-BIOMEMBRANES, V1565, P36, DOI 10.1016/S0005-2736(02)00503-5; Fox RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-126; Gaber RF, 2003, EUKARYOT CELL, V2, P922, DOI 10.1128/EC.2.5.922-929.2003; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; Guthrie C, 1991, METHOD ENZYMOL, P3; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Kaouass M, 1997, MOL CELL BIOL, V17, P2994, DOI 10.1128/MCB.17.6.2994; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Lahav R, 2007, MOL CELL BIOL, V27, P818, DOI 10.1128/MCB.00439-06; Leduc A, 2003, MOL GENET GENOMICS, V269, P78, DOI 10.1007/s00438-003-0812-8; Lee J, 2002, MOL CELLS, V13, P407; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; Poschmann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023159; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Rubio-Texeira M, 2010, FEMS YEAST RES, V10, P134, DOI 10.1111/j.1567-1364.2009.00587.x; Ruiz A, 2004, FEBS LETT, V578, P58, DOI 10.1016/j.febslet.2004.10.069; Schreve JL, 2004, BIOCHEM BIOPH RES CO, V313, P745, DOI 10.1016/j.bbrc.2003.11.172; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; SHERMAN F, 1983, LAB COURSE MANUAL ME; Strijbis K, 2010, EUKARYOT CELL, V9, P1809, DOI 10.1128/EC.00172-10; Strijbis K, 2010, IUBMB LIFE, V62, P357, DOI 10.1002/iub.323; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; van Roermund CWT, 1999, EMBO J, V18, P5843, DOI 10.1093/emboj/18.21.5843; Van Zeebroeck G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024275; White WH, 2001, J BIOL CHEM, V276, P10794, DOI 10.1074/jbc.M009804200; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005	47	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65717	10.1371/journal.pone.0065717	http://dx.doi.org/10.1371/journal.pone.0065717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755272	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300093
J	Del Re, AC; Spielmans, GI; Fluckiger, C; Wampold, BE				Del Re, A. C.; Spielmans, Glen I.; Flueckiger, Christoph; Wampold, Bruce E.			Efficacy of New Generation Antidepressants: Differences Seem Illusory	PLOS ONE			English	Article							REPORTING BIAS; METAANALYSIS; TRIALS; PUBLICATION; HYPOTHESIS	Background: Recently, Cipriani and colleagues examined the relative efficacy of 12 new-generation antidepressants on major depression using network meta-analytic methods. They found that some of these medications outperformed others in patient response to treatment. However, several methodological criticisms have been raised about network meta-analysis and Cipriani's analysis in particular which creates the concern that the stated superiority of some antidepressants relative to others may be unwarranted. Materials and Methods: A Monte Carlo simulation was conducted which involved replicating Cipriani's network meta-analysis under the null hypothesis (i.e., no true differences between antidepressants). The following simulation strategy was implemented: (1) 1000 simulations were generated under the null hypothesis (i.e., under the assumption that there were no differences among the 12 antidepressants), (2) each of the 1000 simulations were network meta-analyzed, and (3) the total number of false positive results from the network meta-analyses were calculated. Findings: Greater than 7 times out of 10, the network meta-analysis resulted in one or more comparisons that indicated the superiority of at least one antidepressant when no such true differences among them existed. Interpretation: Based on our simulation study, the results indicated that under identical conditions to those of the 117 RCTs with 236 treatment arms contained in Cipriani et al.'s meta-analysis, one or more false claims about the relative efficacy of antidepressants will be made over 70% of the time. As others have shown as well, there is little evidence in these trials that any antidepressant is more effective than another. The tendency of network meta-analyses to generate false positive results should be considered when conducting multiple comparison analyses.	[Del Re, A. C.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Del Re, A. C.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Spielmans, Glen I.] Metropolitan State Univ, St Paul, MN USA; [Flueckiger, Christoph] Univ Zurich, Zurich, Switzerland; [Wampold, Bruce E.] Univ Wisconsin, Madison, WI USA; [Wampold, Bruce E.] Modum Bad Psychiat Ctr, Res Inst, Vikersund, Norway	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Minnesota State Colleges & Universities; Metropolitan State University; University of Zurich; University of Wisconsin System; University of Wisconsin Madison	Del Re, AC (corresponding author), VA Palo Alto Hlth Care Syst, Palo Alto, CA USA.	acdelre@gmail.com	Del Re, A. C./N-2616-2014; Christoph, Flückiger/H-8169-2014	Del Re, A. C./0000-0002-9571-7623; Christoph, Flückiger/0000-0003-3058-5815	Center for Health Care Evaluation at the VA Palo Alto Health Care System; University of Zurich; Metropolitan State University; University of Wisconsin - Madison and Modum Bad Psychiatric Center	Center for Health Care Evaluation at the VA Palo Alto Health Care System; University of Zurich; Metropolitan State University; University of Wisconsin - Madison and Modum Bad Psychiatric Center	Dr. AD is supported by a postdoctoral affiliation with the Center for Health Care Evaluation at the VA Palo Alto Health Care System. Dr. CF is supported by the University of Zurich. Dr. GS is supported by Metropolitan State University. Dr. BW is supported by the University of Wisconsin - Madison and Modum Bad Psychiatric Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Del Re AC, 2013, RCMDRPLUGIN MA GRAPH; Del Re AC, 2012, MAD METAANALYSIS MEA; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Gartlehner G, 2011, ANN INTERN MED, V155, P772, DOI 10.7326/0003-4819-155-11-201112060-00009; Gartlehner G, 2009, LANCET, V373, P1761, DOI 10.1016/S0140-6736(09)60978-8; Howard GS, 2000, PSYCHOL METHODS, V5, P315, DOI 10.1037//1082-989X.5.3.315; Imberger G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028422; Ioannidis JPA, 2009, LANCET, V373, P1759, DOI 10.1016/S0140-6736(09)60974-0; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; ROSNOW RL, 1988, J COUNS PSYCHOL, V35, P203, DOI 10.1037/0022-0167.35.2.203; Svensson S, 2004, PSYCHOTHER PSYCHOSOM, V73, P10, DOI 10.1159/000074435; Trinquart L, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/JOURNAL.PONE.0035219; Trinquart L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-150; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Valkenhoef G, 2013, GEMTC GEMTC NETWORK; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WAMPOLD BE, 1990, J CONSULT CLIN PSYCH, V58, P360, DOI 10.1037/0022-006X.58.3.360; Wampold BE, 2013, QUALITY QUA IN PRESS, DOI DOI 10.1007/S11135-012-9800-6.IN	21	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63509	10.1371/journal.pone.0063509	http://dx.doi.org/10.1371/journal.pone.0063509			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755107	gold, Green Published			2022-12-25	WOS:000319872300012
J	Osawa, Y; Hoshi, M; Yasuda, I; Saibara, T; Moriwaki, H; Kozawa, O				Osawa, Yosuke; Hoshi, Masato; Yasuda, Ichiro; Saibara, Toshiji; Moriwaki, Hisataka; Kozawa, Osamu			Tumor Necrosis Factor-alpha Promotes Cholestasis-Induced Liver Fibrosis in the Mouse through Tissue Inhibitor of Metalloproteinase-1 Production in Hepatic Stellate Cells	PLOS ONE			English	Article							BILE-DUCT LIGATION; FAS-MEDIATED APOPTOSIS; HEPATOCYTE APOPTOSIS; FACTOR RECEPTOR; TNF-ALPHA; MATRIX METALLOPROTEINASES; CARBON-TETRACHLORIDE; GENE-EXPRESSION; MESSENGER-RNA; KUPFFER CELLS	Tumor necrosis factor (TNF)-alpha, which is a mediator of hepatotoxicity, has been implicated in liver fibrosis. However, the roles of TNF-alpha on hepatic stellate cell (HSC) activation and liver fibrosis are complicated and remain controversial. To explore this issue, the role of TNF-alpha in cholestasis-induced liver fibrosis was examined by comparing between TNF-alpha(-/-) mice and TNF-alpha(+/)+mice after bile duct ligation (BDL). Serum TNF-alpha levels in mice were increased by common BDL combined with cystic duct ligation (CBDL+CDL). TNF-alpha deficiency reduced liver fibrosis without affecting liver injury, inflammatory cell infiltration, and liver regeneration after CBDL+CDL. Increased expression levels of collagen a1(I) mRNA, transforming growth factor (TGF)-beta mRNA, and alpha-smooth muscle actin (alpha SMA) protein by CBDL+CDL in the livers of TNF-alpha(-/-) mice were comparable to those in TNF-alpha(+/)+mice. Exogenous administration of TNF-a decreased collagen alpha 1(I) mRNA expression in isolated rat HSCs. These results suggest that the reduced fibrosis in TNF-alpha(-/-) mice is regulated in post-transcriptional level. Tissue inhibitor of metalloproteinase (TIMP)-1 plays a crucial role in the pathogenesis of liver fibrosis. TIMP-1 expression in HSCs in the liver was increased by CBDL+CDL, and the induction was lower in TNF-alpha(-/-) mice than in TNF-alpha(+/)+mice. Fibrosis in the lobe of TIMP-1(-/-) mice with partial BDL was also reduced. These findings indicate that TNF-alpha produced by cholestasis can promote liver fibrosis via TIMP-1 production from HSCs. Thus, targeting TNF-alpha and TIMP-1 may become a new therapeutic strategy for treating liver fibrosis in cholestatic liver injury.	[Osawa, Yosuke; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan; [Osawa, Yosuke; Yasuda, Ichiro; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Gastroenterol, Gifu, Japan; [Hoshi, Masato] Suzuka Univ Med Sci, Fac Hlth Sci, Suzuka, Mie, Japan; [Saibara, Toshiji] Kochi Univ, Sch Med, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan	Gifu University; Gifu University; Kochi University	Osawa, Y (corresponding author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan.	osawa-gif@umin.ac.jp			Takeda Science Foundation; Kondou Kinen Medical Foundation; Kurozumi Medical Foundation; Yasuda Medical Foundation; Senshin Medical Research Foundation; Ministry of Education, Science, Sports, and Culture of Japan [23790787]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Kondou Kinen Medical Foundation; Kurozumi Medical Foundation(Kurozumi Medical Foundation); Yasuda Medical Foundation; Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Takeda Science Foundation, the Kondou Kinen Medical Foundation, the Kurozumi Medical Foundation, the Yasuda Medical Foundation, the Senshin Medical Research Foundation, and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (23790787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Bahr MJ, 1999, HEPATOLOGY, V29, P839, DOI 10.1002/hep.510290333; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; BEMELMANS MHA, 1992, HEPATOLOGY, V15, P1132, DOI 10.1002/hep.1840150626; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Doyle GAR, 1997, BIOCHEMISTRY-US, V36, P2492, DOI 10.1021/bi962161e; Duarte S, 2012, HEPATOLOGY, V56, P1074, DOI 10.1002/hep.25710; Gabele E, 2009, BIOCHEM BIOPH RES CO, V378, P348, DOI 10.1016/j.bbrc.2008.10.155; HernandezMunoz I, 1997, GASTROENTEROLOGY, V113, P625, DOI 10.1053/gast.1997.v113.pm9247485; Higuchi H, 2003, AM J PHYSIOL-GASTR L, V284, pG734, DOI 10.1152/ajpgi.00491.2002; Houglum K, 1998, AM J PHYSIOL-GASTR L, V274, pG840, DOI 10.1152/ajpgi.1998.274.5.G840; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; Jaeschke Hartmut, 2002, Hepatology, V35, P964, DOI 10.1053/jhep.2002.0350964; Jang JH, 2012, HEPATOLOGY, V56, P209, DOI 10.1002/hep.25626; Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5; Mohammed FF, 2005, HEPATOLOGY, V41, P857, DOI 10.1002/hep.20618; Nagaki M, 1999, J HEPATOL, V31, P997, DOI 10.1016/S0168-8278(99)80311-0; Nagaki M, 2000, HEPATOLOGY, V32, P1272, DOI 10.1053/jhep.2000.20239; Osawa Y, 2005, HEPATOLOGY, V42, P1320, DOI 10.1002/hep.20967; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Osawa Y, 2001, LIVER, V21, P309, DOI 10.1034/j.1600-0676.2001.210503.x; Osawa Y, 2001, J CELL PHYSIOL, V187, P374, DOI 10.1002/jcp.1088; Osawa Y, 2013, J CLIN INVEST; Osawa Y, 2006, LIVER INT, V26, P1138, DOI 10.1111/j.1478-3231.2006.01346.x; Osawa Y, 2010, HEPATOLOGY, V51, P237, DOI 10.1002/hep.23262; Park YJ, 2008, HEPATOLOGY, V47, P1578, DOI 10.1002/hep.22196; Parsons CJ, 2004, HEPATOLOGY, V40, P1106, DOI 10.1002/hep.20425; Reeves HL, 2000, J HEPATOL, V32, P465, DOI 10.1016/S0168-8278(00)80398-0; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Roderfeld M, 2006, LIVER INT, V26, P579, DOI 10.1111/j.1478-3231.2006.01271.x; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Sokol RJ, 2006, J PEDIATR GASTR NUTR, V43, pS4, DOI 10.1097/01.mpg.0000226384.71859.16; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Sudo K, 2005, CYTOKINE, V29, P236, DOI 10.1016/j.cyto.2004.11.001; Tarrats N, 2011, HEPATOLOGY, V54, P319, DOI 10.1002/hep.24388; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Trim JE, 2000, J BIOL CHEM, V275, P6657, DOI 10.1074/jbc.275.9.6657; Varela-Rey M, 2007, CYTOKINE, V37, P212, DOI 10.1016/j.cyto.2007.03.013; Wang H, 2011, PROTECTING PRIVACY IN CHINA: A RESEARCH ON CHINAS PRIVACY STANDARDS AND THE POSSIBILITY OF ESTABLISHING THE RIGHT TO PRIVACY AND THE INFORMATION PRIVACY PROTECTION LEGISLATION IN MODERN CHINA, P1, DOI 10.1007/978-3-642-21750-0_1; Wielockx B, 2001, NAT MED, V7, P1202, DOI 10.1038/nm1101-1202; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521	46	51	55	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65251	10.1371/journal.pone.0065251	http://dx.doi.org/10.1371/journal.pone.0065251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755201	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300064
J	Park, KH; Shin, JH; Lee, SY; Kim, SH; Jang, MO; Kang, SJ; Jung, SI; Chung, EK; Ko, KS; Jang, HC				Park, Kyung-Hwa; Shin, Jong-Hee; Lee, Seung Yeop; Kim, Soo Hyun; Jang, Mi Ok; Kang, Seung-Ji; Jung, Sook-In; Chung, Eun-Kyung; Ko, Kwan Soo; Jang, Hee-Chang			The Clinical Characteristics, Carbapenem Resistance, and Outcome of Acinetobacter Bacteremia According to Genospecies	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; INTENSIVE-CARE UNITS; BAUMANNII; COLISTIN; IDENTIFICATION; EMERGENCE; KOREA	Background: Few clinical data are available on the relationship between genospecies and outcome of Acinetobacter bacteremia, and the results are inconsistent. We performed this study to evaluate the relationship between genospecies and the outcome of Acinetobacter bacteremia. Methods: Clinical data from 180 patients who had Acinetobacter bacteremia from 2003 to 2010 were reviewed retrospectively. The genospecies were identified by rpoB gene sequence analysis. The clinical features and outcomes of 90 patients with A. baumannii bacteremia were compared to those of 90 patients with non-baumannii Acinetobacter bacteremia (60 with A. nosocomialis, 17 with Acinetobacter species "close to 13 TU'', 11 with A. pittii, and two with A. calcoaceticus). Results: A. baumannii bacteremia was associated with intensive care unit-onset, mechanical ventilation, pneumonia, carbapenem resistance, and higher APACHE II scores, compared to non-baumannii Acinetobacter bacteremia (P<0.05). In univariate analyses, age, pneumonia, multidrug resistance, carbapenem resistance, inappropriate empirical antibiotics, higher APACHE II scores, and A. baumannii genospecies were risk factors for mortality (P<0.05). Multivariate analysis revealed A. baumannii genospecies (OR, 3.60; 95% CI, 1.56-8.33), age, pneumonia, and higher APACHE II scores to be independent risk factors for mortality (P<0.05). Conclusion: A. baumannii genospecies was an independent risk factor for mortality in patients with Acinetobacter bacteremia. Our results emphasize the importance of correct species identification of Acinetobacter blood isolates.	[Park, Kyung-Hwa; Jang, Mi Ok; Kang, Seung-Ji; Jung, Sook-In; Jang, Hee-Chang] Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea; [Shin, Jong-Hee; Lee, Seung Yeop; Kim, Soo Hyun] Chonnam Natl Univ, Sch Med, Dept Lab Med, Kwangju, South Korea; [Chung, Eun-Kyung] Chonnam Natl Univ, Sch Med, Dept Med Educ, Kwangju, South Korea; [Ko, Kwan Soo] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Sungkyunkwan University (SKKU)	Jang, HC (corresponding author), Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea.	haroc153@naver.com		Kang, Seung ji/0000-0002-3298-0520; Ko, Kwan Soo/0000-0002-0978-1937; Jang, Hee-Chang/0000-0002-3407-8493				Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Chuang YC, 2011, CLIN INFECT DIS, V52, P352, DOI 10.1093/cid/ciq154; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Houang ETS, 2003, ANTIMICROB AGENTS CH, V47, P1472, DOI 10.1128/AAC.47.4.1472-1475.2003; Jang HC, 2009, CLIN INFECT DIS, V49, P395, DOI 10.1086/600295; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Ko KS, 2007, J ANTIMICROB CHEMOTH, V60, P1163, DOI 10.1093/jac/dkm305; Kwon KT, 2007, J ANTIMICROB CHEMOTH, V59, P525, DOI 10.1093/jac/dkl499; Lee YC, 2011, J ANTIMICROB CHEMOTH, V66, P1839, DOI 10.1093/jac/dkr200; Lim YM, 2007, J CLIN MICROBIOL, V45, P902, DOI 10.1128/JCM.01573-06; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Nemec A, 2009, INT J SYST EVOL MICR, V59, P118, DOI 10.1099/ijs.0.001230-0; Ntusi NBA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052452; Park YK, 2009, DIAGN MICR INFEC DIS, V64, P43, DOI 10.1016/j.diagmicrobio.2009.01.012; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046984; Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287; Shields RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052349; Tabah A, 2012, INTENS CARE MED, V38, P1930, DOI 10.1007/s00134-012-2695-9; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008	23	31	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65026	10.1371/journal.pone.0065026	http://dx.doi.org/10.1371/journal.pone.0065026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755171	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300043
J	Vidal-Laliena, M; Gallastegui, E; Mateo, F; Martinez-Balbas, M; Pujol, MJ; Bachs, O				Vidal-Laliena, Miriam; Gallastegui, Edurne; Mateo, Francesca; Martinez-Balbas, Marian; Jesus Pujol, Maria; Bachs, Oriol			Histone Deacetylase 3 Regulates Cyclin A Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE CHECKPOINT; S-PHASE; COMPLEX; MITOSIS; PHOSPHORYLATION; DESTRUCTION; DEGRADATION; SPECIFICITY; PROTEOLYSIS; PROGRESSION	PCAF and GCN5 acetylate cyclin A at specific lysine residues targeting it for degradation at mitosis. We report here that histone deacetylase 3 (HDAC3) directly interacts with and deacetylates cyclin A. HDAC3 interacts with a domain included in the first 171 aa of cyclin A, a region involved in the regulation of its stability. In cells, overexpression of HDAC3 reduced cyclin A acetylation whereas the knocking down of HDAC3 increased its acetylation. Moreover, reduction of HDAC3 levels induced a decrease of cyclin A that can be reversed by proteasome inhibitors. These results indicate that HDAC3 is able to regulate cyclin A degradation during mitosis via proteasome. Interestingly, HDAC3 is abruptly degraded at mitosis also via proteasome thus facilitating cyclin A acetylation by PCAF/GCN5, which will target cyclin A for degradation. Because cyclin A is crucial for S phase progression and mitosis entry, the knock down of HDAC3 affects cell cycle progression specifically at both, S phase and G2/M transition. In summary we propose here that HDAC3 regulates cyclin A stability by counteracting the action of the acetylases PCAF/GCN5.	[Vidal-Laliena, Miriam; Gallastegui, Edurne; Jesus Pujol, Maria; Bachs, Oriol] Univ Barcelona, Dept Cell Biol Immunol & Neurosci, IDIBAPS, E-08036 Barcelona, Spain; [Mateo, Francesca] CSIC, Dept Cell Biol, Barcelona Inst Mol Biol, E-08028 Barcelona, Spain; [Martinez-Balbas, Marian] CSIC, Dept Mol Biol, Barcelona Inst Mol Biol, E-08028 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC)	Bachs, O (corresponding author), Univ Barcelona, Dept Cell Biol Immunol & Neurosci, IDIBAPS, E-08036 Barcelona, Spain.	obachs@ub.edu	Mateo, Francesca/K-7746-2015	Mateo, Francesca/0000-0002-2342-7010; Martinez-Balbas, Marian/0000-0003-0173-0964; Gallastegui Calvache, Edurne/0000-0003-0768-8648	Ministerio de Ciencia e Innovacion of Spain [SAF2009-07769]; Istituto de Salud Carlos III [RD06/0020/0010]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Istituto de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported by Grants SAF2009-07769 from the Ministerio de Ciencia e Innovacion of Spain and Reticc RD06/0020/0010 from the Istituto de Salud Carlos III.	Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Canela N, 2006, J BIOL CHEM, V281, P35942, DOI 10.1074/jbc.M603511200; Chae HD, 2011, BMB REP, V44, P553, DOI 10.5483/BMBRep.2011.44.8.553; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fung TK, 2005, CELL CYCLE, V4, P1411, DOI 10.4161/cc.4.10.2046; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jeyakumar M, 2007, J BIOL CHEM, V282, P9312, DOI 10.1074/jbc.M609009200; Kang DS, 2012, BIOCHEM BIOPH RES CO, V420, P822, DOI 10.1016/j.bbrc.2012.03.081; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Marais A, 2010, J BIOL CHEM, V285, P35728, DOI 10.1074/jbc.M110.154005; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; Mateo F, 2009, NUCLEIC ACIDS RES, V37, P7072, DOI 10.1093/nar/gkp777; Moore NL, 2007, STEROIDS, V72, P202, DOI 10.1016/j.steroids.2006.11.025; Orpinell M, 2010, EMBO J, V29, P2381, DOI 10.1038/emboj.2010.125; PAGANO M, 1991, Progress in Growth Factor Research, V3, P267, DOI 10.1016/0955-2235(91)90004-N; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; ROSENBERG AR, 1995, ONCOGENE, V10, P1501; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Suryadinata R, 2011, J BIOL CHEM, V286, P5108, DOI 10.1074/jbc.M110.198473; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	36	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21096	21104		10.1074/jbc.M113.458323	http://dx.doi.org/10.1074/jbc.M113.458323			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760262	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000322014400030
J	Clerget, E; Andres, M; Olivier, E				Clerget, Emeline; Andres, Michael; Olivier, Etienne			Deficit in Complex Sequence Processing after a Virtual Lesion of Left BA45	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DORSAL PREMOTOR CORTEX; BROCAS AREA; HIERARCHICAL ORGANIZATION; PREFRONTAL CORTEX; COGNITIVE CONTROL; FRONTAL-CORTEX; LANGUAGE; BEHAVIOR; APHASIA	Although the contribution of Broca's area to motor cognition is generally accepted, its exact role remains controversial. A previous functional imaging study has suggested that Broca's area implements hierarchically organised motor behaviours and, in particular, that its anterior (Brodmann area 45, BA45) and posterior (BA44) parts process, respectively, higher and lower-level hierarchical elements. This function of Broca's area could generalize to other cognitive functions, including language. However, because of the correlative nature of functional imaging data, the causal relationship between Broca's region activation and its behavioural significance cannot be ascertained. To circumvent this limitation, we used on-line repetitive transcranial magnetic stimulation to disrupt neuronal processing in left BA45, left BA44 or left dorsal premotor cortex, three areas that have been shown to exhibit a phasic activation when participants performed hierarchically organised motor behaviours. The experiment was conducted in healthy volunteers performing the same two key-press sequences as those used in a previous imaging study, and which differed in terms of hierarchical organisation. The performance of the lower-order hierarchical task (Experiment #1) was unaffected by magnetic stimulation. In contrast, in the higher-order hierarchical task (Experiment #2, "superordinate" task), we found that a virtual lesion of the anterior part of Broca's area (left BA45) delayed the processing of the cue initiating the sequence in an effector-independent way. Interestingly, in this task, the initiation cue only informed the subjects about the rules to be applied to produce the appropriate response but did not allow them to anticipate the entire motor sequence. A second important finding was a RT decrease following left PMd virtual lesions in the superordinate task, a result compatible with the view that PMd plays a critical role in impulse control. The present study therefore demonstrates the role of left BA45 in planning the higher-order hierarchical levels of motor sequences.	[Clerget, Emeline; Olivier, Etienne] Catholic Univ Louvain, Neurophysiol Lab, Inst Neurosci, B-1200 Brussels, Belgium; [Andres, Michael] Univ Ghent, Fac Psychol, Dept Expt Psychol, B-9000 Ghent, Belgium	Universite Catholique Louvain; Ghent University	Olivier, E (corresponding author), Catholic Univ Louvain, Neurophysiol Lab, Inst Neurosci, B-1200 Brussels, Belgium.	etienne.olivier@uclouvain.be	Andres, Michael/I-2306-2019	Andres, Michael/0000-0002-7505-8157	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); Fonds Speciaux de Recherche (FSR) of the Universite Catholique de Louvain; Fonds de la Recherche Scientifique Medicale (FRSM); Actions de Recherche Concertees (ARC) [07/12-007]	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Fonds Speciaux de Recherche (FSR) of the Universite Catholique de Louvain; Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees (ARC)	This work was supported by grants from the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA), from the Actions de Recherche Concertees (ARC, grant 07/12-007, Communaute Francaise de Belgique), from the Fonds Speciaux de Recherche (FSR) of the Universite Catholique de Louvain, from the Fonds de la Recherche Scientifique Medicale (FRSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Badre D, 2010, NEURON, V66, P315, DOI 10.1016/j.neuron.2010.03.025; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bahlmann J, 2009, BRAIN RES, V1298, P161, DOI 10.1016/j.brainres.2009.08.017; Botvinick MM, 2008, TRENDS COGN SCI, V12, P201, DOI 10.1016/j.tics.2008.02.009; Botvinick MM, 2007, PHILOS T R SOC B, V362, P1615, DOI 10.1098/rstb.2007.2056; Burns MS, 2010, TOP STROKE REHABIL, V17, P401, DOI 10.1310/tsr1706-401; Clerget E, 2013, BROCAS AREA IN PRESS; Clerget E, 2012, J COGNITIVE NEUROSCI, V24, P80, DOI 10.1162/jocn_a_00108; Clerget E, 2011, NEUROREPORT, V22, P965, DOI 10.1097/WNR.0b013e32834d87cd; Clerget E, 2009, NEUROREPORT, V20, P1496, DOI 10.1097/WNR.0b013e3283329be8; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2007, J NEUROSCI, V27, P3974, DOI 10.1523/JNEUROSCI.0426-07.2007; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; Dominey PF, 2003, BRAIN LANG, V86, P207, DOI 10.1016/S0093-934X(02)00529-1; Duque J, 2012, J NEUROSCI, V32, P806, DOI 10.1523/JNEUROSCI.4299-12.2012; Duque J, 2010, J COGNITIVE NEUROSCI, V22, P526, DOI 10.1162/jocn.2009.21213; Fadiga L, 2009, ANN NY ACAD SCI, V1169, P448, DOI 10.1111/j.1749-6632.2009.04582.x; Fazio P, 2009, BRAIN, V132, P1980, DOI 10.1093/brain/awp118; Fedorenko E, 2012, CURR BIOL, V22, P2059, DOI 10.1016/j.cub.2012.09.011; Fedorenko E, 2011, LANG LINGUIST COMPAS, V5, P78, DOI 10.1111/j.1749-818x.2010.00264.x; Friederici AD, 2006, CEREB CORTEX, V16, P1709, DOI 10.1093/cercor/bhj106; Friederici AD, 2011, BIOLINGUISTICS, V5, P87; Friedrich R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005599; GROSSMAN M, 1980, NEUROPSYCHOLOGIA, V18, P299, DOI 10.1016/0028-3932(80)90125-6; Hickok G, 1996, NEUROCASE, V2, P373, DOI 10.1080/13554799608402412; Hoen M, 2006, CORTEX, V42, P605, DOI 10.1016/S0010-9452(08)70398-8; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Noirhomme Q, 2004, IEEE T BIO-MED ENG, V51, P1994, DOI 10.1109/TBME.2004.834266; O'Shea J, 2007, EUR J NEUROSCI, V26, P2085, DOI 10.1111/j.1460-9568.2007.05795.x; O'Shea J, 2007, NEURON, V54, P479, DOI 10.1016/j.neuron.2007.04.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Pammi VSC, 2012, NEUROIMAGE, V59, P1180, DOI 10.1016/j.neuroimage.2011.08.006; Santi A, 2007, NEUROIMAGE, V37, P8, DOI 10.1016/j.neuroimage.2007.04.047; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Sparing R, 2008, HUM BRAIN MAPP, V29, P82, DOI 10.1002/hbm.20360; Terao Y, 1997, EXP BRAIN RES, V115, P541, DOI 10.1007/PL00005724; Tettamanti M, 2006, CORTEX, V42, P491, DOI 10.1016/S0010-9452(08)70384-8; Tyler LK, 2010, CEREB CORTEX, V20, P352, DOI 10.1093/cercor/bhp105; Verwey WB, 2001, ACTA PSYCHOL, V106, P69, DOI 10.1016/S0001-6918(00)00027-5; Ward NS, 2010, J NEUROSCI, V30, P9216, DOI 10.1523/JNEUROSCI.4499-09.2010; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wymbs NF, 2012, NEURON, V74, P936, DOI 10.1016/j.neuron.2012.03.038	51	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e63722	10.1371/journal.pone.0063722	http://dx.doi.org/10.1371/journal.pone.0063722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762232	Green Published, gold			2022-12-25	WOS:000320440500004
J	Kumar, SR; Khader, SMS; Kiener, TK; Szyporta, M; Kwang, J				Kumar, Subaschandrabose Rajesh; Khader, Syed Musthaq Syed; Kiener, Tanja K.; Szyporta, Milene; Kwang, Jimmy			Intranasal Immunization of Baculovirus Displayed Hemagglutinin Confers Complete Protection against Mouse Adapted Highly Pathogenic H7N7 Reassortant Influenza Virus	PLOS ONE			English	Article							A VIRUS; RECEPTOR SPECIFICITY; INFECTION; VACCINE; IMMUNITY; MICE; IMMUNOGENICITY; CONJUNCTIVITIS; INACTIVATION; CHALLENGE	Background: Avian influenza A H7N7 virus poses a pandemic threat to human health because of its ability for direct transmission from domestic poultry to humans and from human to human. The wide zoonotic potential of H7N7 combined with an antiviral immunity inhibition similar to pandemic 1918 H1N1 and 2009 H1N1 influenza viruses is disconcerting and increases the risk of a putative H7N7 pandemic in the future, underlining the urgent need for vaccine development against this virus. Methodology/Principal Findings: In this study, we developed a recombinant vaccine by expressing the H7N7-HA protein on the surface of baculovirus (Bac-HA). The protective efficacy of the live Bac-HA vaccine construct was evaluated in a mouse model by challenging mice immunized intranasally (i.n.) or subcutaneously (s.c.) with high pathogenic mouse adapted H7N7 reassorted strain. Although s.c. injection of live Bac-HA induced higher specific IgG than i.n. immunization, the later resulted in an elevated neutralization titer. Interestingly, 100% protection from the lethal viral challenge was only observed for the mice immunized intranasally with live Bac-HA, whereas no protection was achieved in any other s.c. or i.n. immunized mice groups. In addition, we also observed higher mucosal IgA as well as increased IFN-gamma and IL-4 responses in the splenocytes of the surviving mice coupled with a reduced viral titer and diminished histopathological signs in the lungs. Conclusion: Our results indicated that protection from high pathogenic H7N7 (NL/219/03) virus requires both mucosal and systemic immune responses in mice. The balance between Th1 and Th2 cytokines is also required for the protection against the H7N7 pathogen. Intranasal administration of live Bac-HA induced all these immune responses and protected the mice from lethal viral challenge. Therefore, live Bac-HA is an effective vaccine candidate against H7N7 viral infections.	[Kumar, Subaschandrabose Rajesh; Khader, Syed Musthaq Syed; Kiener, Tanja K.; Szyporta, Milene; Kwang, Jimmy] Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore; [Kwang, Jimmy] Natl Univ Singapore, Fac Med, Dept Microbiol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Kwang, J (corresponding author), Natl Univ Singapore, Temasek Lifesci Lab, Singapore 117548, Singapore.	kwang@tll.org.sg			Temasek Life Sciences laboratory	Temasek Life Sciences laboratory(National University of Singapore)	This study was supported by Temasek Life Sciences laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Abe T, 2003, J IMMUNOL, V171, P1133, DOI 10.4049/jimmunol.171.3.1133; Abe T, 2009, J VIROL, V83, P7629, DOI 10.1128/JVI.00679-09; BAHNEMANN HG, 1990, VACCINE, V8, P299, DOI 10.1016/0264-410X(90)90083-X; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2011, J INFECT DIS, V203, P40, DOI 10.1093/infdis/jiq018; Blissard GW, 1996, CYTOTECHNOLOGY, V20, P73, DOI 10.1007/BF00350390; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; de Wit E, 2005, J VIROL, V79, P12401, DOI 10.1128/JVI.79.19.12401-12407.2005; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fukushi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021207; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Giri PK, 2005, FEMS IMMUNOL MED MIC, V45, P87, DOI 10.1016/j.femsim.2005.02.009; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Gronowski AM, 1999, J VIROL, V73, P9944, DOI 10.1128/JVI.73.12.9944-9951.1999; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kurtz J, 1996, LANCET, V348, P901, DOI 10.1016/S0140-6736(05)64783-6; Madhan S, 2010, CURR GENE THER, V10, P201, DOI 10.2174/156652310791321233; MAGNUSSON KE, 1982, IMMUNOLOGY, V45, P239; MCINTOSH AH, 1980, INTERVIROLOGY, V13, P331; Meng T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021757; Mogens D, 1994, FUNCTION MUCOSAL IMM; Munster VJ, 2007, J INFECT DIS, V196, P258, DOI 10.1086/518792; Musthaq SS, 2009, VIROLOGY, V391, P315, DOI 10.1016/j.virol.2009.06.017; National Institutes of Health and Centers for Disease Control and Prevention, 1999, BIOS MICR BIOM LAB, P777; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Prabakaran M, 2008, VIROLOGY, V380, P412, DOI 10.1016/j.virol.2008.08.002; Prabakaran M, 2011, CLIN VACCINE IMMUNOL, V18, P1582, DOI 10.1128/CVI.05114-11; Prabakaran M, 2010, J VIROL, V84, P3201, DOI 10.1128/JVI.02175-09; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; Rueda P, 2000, VACCINE, V19, P726, DOI 10.1016/S0264-410X(00)00259-0; Sandra HS, 2007, J IMMUNOL, V178, P2361; Sarachai C, 2010, THAI J VET MED, V40, P41; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Tang XC, 2010, VACCINE, V28, P6821, DOI 10.1016/j.vaccine.2010.08.040; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Wang BZ, 2010, PLOS ONE, V5; WEBSTER RG, 1981, NEW ENGL J MED, V304, P911; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B	48	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e63856	10.1371/journal.pone.0063856	http://dx.doi.org/10.1371/journal.pone.0063856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762234	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800004
J	Yang, ZH; Zhang, YX; Wang, L				Yang, Zhihong; Zhang, Yuxia; Wang, Li			A Feedback Inhibition between miRNA-127 and TGF beta/c-Jun Cascade in HCC Cell Migration via MMP13	PLOS ONE			English	Article							SMALL HETERODIMER PARTNER; NUCLEAR RECEPTOR SHP; HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION; DOWN-REGULATION; MIR-127; CANCER; METASTASIS; MIR-433; LIVER	Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and is increasing in frequency in the U. S. The major reason for the low postoperative survival rate of HCC is widespread intrahepatic metastasis or invasion, and activation of TGF beta signaling is associated with the invasive phenotype. This study aims at determining the novel function of miR-127 in modulating HCC migration. Overexpression of miR-127 inhibits HCC cell migration, invasion and tumor growth in nude mice. MiR-127 directly represses matrix metalloproteinase 13 (MMP13) 3'UTR activity and protein expression, and diminishes MMP13/TGF beta-induced HCC migration. In turn, TGF beta decreases miR-127 expression by enhancing c-Jun-mediated inhibition of miR-127 promoter activity. In contrast, p53 transactivates miR-127 promoter and induces miR-127 expression, which is antagonized by c-Jun. The inhibition of miR-127 by c-Jun is through TGF beta-mediated ERK and JNK pathways. The lower miR-127 expression shows a negative correlation with the higher MMP13 expression in a subset of human HCC specimens. This is the first report elucidating a feedback regulation between miR-127 and the TGF beta/c-Jun cascade in HCC migration via MMP13 that involves a crosstalk between the oncogene c-Jun and tumor suppressor p53.	[Wang, Li] Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Wang, L (corresponding author), Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	l.wang@hsc.utah.edu			National Institutes of Health [R01 DK080440];  [P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is in part supported by National Institutes of Health R01 DK080440 to L. W. The authors acknowledge the use of core facilities (Cell Imaging Core, Flow Cytometry Core) supported by the P30 CA042014 grant to the Huntsman Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Lee CF, 2009, WORLD J GASTROENTERO, V15, P356, DOI 10.3748/wjg.15.356; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Leivonen SK, 2006, ONCOGENE, V25, P2588, DOI 10.1038/sj.onc.1209291; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Robertus JL, 2009, MODERN PATHOL, V22, P547, DOI 10.1038/modpathol.2009.10; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007829; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Sume SS, 2010, AM J PATHOL, V177, P208, DOI 10.2353/ajpath.2010.090952; Tryndyak VP, 2009, MOL CARCINOGEN, V48, P479, DOI 10.1002/mc.20484; Xie T, 2012, J IMMUNOL, V188, P2437, DOI 10.4049/jimmunol.1101070; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yang ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039789; Yang ZH, 2012, BIOCHEM BIOPH RES CO, V417, P744, DOI 10.1016/j.bbrc.2011.12.027; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhang YX, 2011, BIOCHEM BIOPH RES CO, V416, P135, DOI 10.1016/j.bbrc.2011.11.011; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zhou TF, 2010, J BIOL CHEM, V285, P24871, DOI 10.1074/jbc.M110.133280	35	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65256	10.1371/journal.pone.0065256	http://dx.doi.org/10.1371/journal.pone.0065256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762330	Green Submitted, gold, Green Published			2022-12-25	WOS:000321094800031
J	Horikawa, DD; Cumbers, J; Sakakibara, I; Rogoff, D; Leuko, S; Harnoto, R; Arakawa, K; Katayama, T; Kunieda, T; Toyoda, A; Fujiyama, A; Rothschild, LJ				Horikawa, Daiki D.; Cumbers, John; Sakakibara, Iori; Rogoff, Dana; Leuko, Stefan; Harnoto, Raechel; Arakawa, Kazuharu; Katayama, Toshiaki; Kunieda, Takekazu; Toyoda, Atsushi; Fujiyama, Asao; Rothschild, Lynn J.			Analysis of DNA Repair and Protection in the Tardigrade Ramazzottius varieornatus and Hypsibius dujardini after Exposure to UVC Radiation	PLOS ONE			English	Article							THYMINE DIMERS; NEW-MODEL; IN-VIVO; TOLERANCE	Tardigrades inhabiting terrestrial environments exhibit extraordinary resistance to ionizing radiation and UV radiation although little is known about the mechanisms underlying the resistance. We found that the terrestrial tardigrade Ramazzottius varieornatus is able to tolerate massive doses of UVC irradiation by both being protected from forming UVC-induced thymine dimers in DNA in a desiccated, anhydrobiotic state as well as repairing the dimers that do form in the hydrated animals. In R. varieornatus accumulation of thymine dimers in DNA induced by irradiation with 2.5 kJ/m(2) of UVC radiation disappeared 18 h after the exposure when the animals were exposed to fluorescent light but not in the dark. Much higher UV radiation tolerance was observed in desiccated anhydrobiotic R. varieornatus compared to hydrated specimens of this species. On the other hand, the freshwater tardigrade species Hypsibius dujardini that was used as control, showed much weaker tolerance to UVC radiation than R. varieornatus, and it did not contain a putative phrA gene sequence. The anhydrobiotes of R. varieornatus accumulated much less UVC-induced thymine dimers in DNA than hydrated one. It suggests that anhydrobiosis efficiently avoids DNA damage accumulation in R. varieornatus and confers better UV radiation tolerance on this species. Thus we propose that UV radiation tolerance in tardigrades is due to the both high capacities of DNA damage repair and DNA protection, a two-pronged survival strategy.	[Horikawa, Daiki D.; Cumbers, John; Rogoff, Dana; Leuko, Stefan; Rothschild, Lynn J.] NASA Ames Res Ctr, Biospher Sci Branch, Moffett Field, CA USA; [Horikawa, Daiki D.; Rothschild, Lynn J.] Brown Univ, NASA Astrobiol Inst, Providence, RI 02912 USA; [Cumbers, John; Rothschild, Lynn J.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Sakakibara, Iori] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Sakakibara, Iori] CNRS, UMR 8104, Paris, France; [Sakakibara, Iori] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Harnoto, Raechel] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA; [Arakawa, Kazuharu] Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa, Japan; [Katayama, Toshiaki] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Kunieda, Takekazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Toyoda, Atsushi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Fujiyama, Asao] Natl Inst Informat, Principles Informat Res Div, Tokyo, Japan	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Brown University; National Aeronautics & Space Administration (NASA); Brown University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; California State University System; California Polytechnic State University San Luis Obispo; Keio University; University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Horikawa, DD (corresponding author), NASA Ames Res Ctr, Biospher Sci Branch, Moffett Field, CA USA.	horikawadd@gmail.com; Lynn.J.Rothschild@nasa.gov	Kunieda, Takekazu/G-4946-2014	Arakawa, Kazuharu/0000-0002-2893-4919; Kunieda, Takekazu/0000-0002-6256-1335	NASA Ames Research Center; NASA	NASA Ames Research Center(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA))	This research was supported by an appointment to the NASA Postdoctoral Program at the NASA Ames Research Center, administered by Oak Ridge Associated Universities through a contract with NASA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiero T, 2011, J ZOOL SYST EVOL RES, V49, P104, DOI 10.1111/j.1439-0469.2010.00607.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BOLLUM FJ, 1963, BIOCHIM BIOPHYS ACTA, V68, P599; Bonifacio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050162; DONNELLAN JE, 1965, SCIENCE, V149, P308, DOI 10.1126/science.149.3681.308; Drummond AJ, 2008, GENEIOUS VERSION 4 6; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Hengherr S, 2009, J EXP BIOL, V212, P802, DOI 10.1242/jeb.025973; Horikawa DD, 2008, ASTROBIOLOGY, V8, P549, DOI 10.1089/ast.2007.0139; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Johnson CG, 1940, ANN APPL BIOL, V27, P295, DOI 10.1111/j.1744-7348.1940.tb07499.x; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Mali B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-168; MAY RAOUL-MICHEL, 1964, BULL BIOL FRANCE BELG, V98, P349; Ng WO, 2000, ARCH MICROBIOL, V173, P412, DOI 10.1007/s002030000164; Nilsson CEJ, 2011, INT J RADIAT BIOL, V86, P420; PROTICSABLJIC M, 1986, MOL CELL BIOL, V6, P3349, DOI 10.1128/MCB.6.10.3349; RIKLIS E, 1965, CAN J BIOCHEM CELL B, V43, P1207, DOI 10.1139/o65-132; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Rozen S, 2000, Methods Mol Biol, V132, P365; Sancar A, 2008, J BIOL CHEM, V283, P32153, DOI 10.1074/jbc.R800052200; SETLOW P, 1995, ANNU REV MICROBIOL, V49, P29, DOI 10.1146/annurev.mi.49.100195.000333; Sinha RP, 2001, ACTA PROTOZOOL, V40, P187; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; WESTH P, 1991, J EXP ZOOL, V258, P303, DOI 10.1002/jez.1402580305	31	50	51	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64793	10.1371/journal.pone.0064793	http://dx.doi.org/10.1371/journal.pone.0064793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762256	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000023
J	Kasahara, DI; Williams, AS; Benedito, LA; Ranscht, B; Kobzik, L; Hug, C; Shore, SA				Kasahara, David I.; Williams, Alison S.; Benedito, Leandro A.; Ranscht, Barbara; Kobzik, Lester; Hug, Christopher; Shore, Stephanie A.			Role of the Adiponectin Binding Protein, T-Cadherin (cdh13), in Pulmonary Responses to Subacute Ozone	PLOS ONE			English	Article							INDUCED LUNG INFLAMMATION; AIRWAY INFLAMMATION; CELL-PROLIFERATION; B6C3F1 MICE; EXPOSURE; HYPERRESPONSIVENESS; RECEPTOR; SUSCEPTIBILITY; INHALATION; EXPRESSION	Adiponectin, an adipose derived hormone with pleiotropic functions, binds to several proteins, including T-cadherin. We have previously reported that adiponectin deficient (Adipo(-/-)) mice have increased IL-17A-dependent neutrophil accumulation in their lungs after subacute exposure to ozone (0.3 ppm for 72 hrs). The purpose of this study was to determine whether this anti-inflammatory effect of adiponectin required adiponectin binding to T-cadherin. Wildtype, Adipo(-/-), T-cadherin deficient (T-cad(-/-)), and bideficient (Adipo(-/-) /T-cad(-/-)) mice were exposed to subacute ozone or air. Compared to wildtype mice, ozone-induced increases in pulmonary IL-17A mRNA expression were augmented in T-cad(-/-) and Adipo(-/-) mice. Compared to T-cad(-/-) mice, there was no further increase in IL-17A in Adipo(-/-)/T-cad(-/-) mice, indicating that adiponectin binding to T-cadherin is required for suppression of ozone-induced IL-17A expression. Similar results were obtained for pulmonary mRNA expression of saa3, an acute phase protein capable of inducing IL-17A expression. Comparison of lung histological sections across genotypes also indicated that adiponectin attenuation of ozone-induced inflammatory lesions at bronchiolar branch points required T-cadherin. BAL neutrophils and G-CSF were augmented in T-cad(-/-) mice and further augmented in Adipo(-/-)/T-cad(-/-) mice. Taken together with previous observations indicating that augmentation of these moieties in ozone exposed Adipo(-/-) mice is partially IL-17A dependent, the results indicate that effects of T-cadherin deficiency on BAL neutrophils and G-CSF are likely secondary to changes in IL-17A, but that adiponectin also acts via T-cadherin independent pathways. Our results indicate that T-cadherin is required for the ability of adiponectin to suppress some but not all aspects of ozone-induced pulmonary inflammation.	[Kasahara, David I.; Williams, Alison S.; Benedito, Leandro A.; Kobzik, Lester; Shore, Stephanie A.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Ranscht, Barbara] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Hug, Christopher] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Pulm Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard Medical School	Shore, SA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	sshore@hsph.harvard.edu			U.S. National Institute of Health [HL-084044, ES-013307, ES-00002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013307, P30ES000002] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the U.S. National Institute of Health [HL-084044, ES-013307, and ES-00002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Backus GS, 2010, ENVIRON HEALTH PERSP, V118, P1721, DOI 10.1289/ehp.1002182; Bauer AK, 2011, ENVIRON HEALTH PERSP, V119, P1091, DOI 10.1289/ehp.1003326; Bothe GWM, 2004, GENES BRAIN BEHAV, V3, P149, DOI 10.1111/j.1601-183x.2004.00064.x; Cho HY, 2001, AM J PHYSIOL-LUNG C, V280, pL537, DOI 10.1152/ajplung.2001.280.3.L537; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Herbert RA, 1996, TOXICOL PATHOL, V24, P539, DOI 10.1177/019262339602400502; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Johnston RA, 2005, AM J PHYSIOL-LUNG C, V288, pL390, DOI 10.1152/ajplung.00007.2004; Kasahara DI, 2012, J IMMUNOL, V188, P4558, DOI 10.4049/jimmunol.1102363; Kierstein S, 2008, ALLERGY, V63, P438, DOI 10.1111/j.1398-9995.2007.01587.x; Kleeberger SR, 1997, NAT GENET, V17, P475, DOI 10.1038/ng1297-475; KLEEBERGER SR, 1993, AM J PHYSIOL, V264, pL15, DOI 10.1152/ajplung.1993.264.1.L15; Koller E, 1996, J BIOL CHEM, V271, P30061, DOI 10.1074/jbc.271.47.30061; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Kuzmenko YS, 1998, FEBS LETT, V434, P183, DOI 10.1016/S0014-5793(98)00977-6; Mautz WJ, 2001, TOXICOL SCI, V61, P331, DOI 10.1093/toxsci/61.2.331; Nakanishi K, 2011, AM J RESP CRIT CARE, V183, P1164, DOI 10.1164/rccm.201007-1091OC; Niermann T, 2000, BIOCHEM BIOPH RES CO, V276, P1240, DOI 10.1006/bbrc.2000.3465; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Philippova M, 2009, CELL SIGNAL, V21, P1035, DOI 10.1016/j.cellsig.2009.01.035; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; Resink TJ, 1999, FEBS LETT, V463, P29, DOI 10.1016/S0014-5793(99)01594-X; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Shore SA, 2002, J APPL PHYSIOL, V92, P1019, DOI 10.1152/japplphysiol.00381.2001; Shore SA, 2006, J ALLERGY CLIN IMMUN, V118, P389, DOI 10.1016/j.jaci.2006.04.021; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Takeuchi T, 2001, VIRCHOWS ARCH, V438, P370, DOI 10.1007/s004280000385; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Williams AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041088; Williams AS, 2012, PULM PHARMACOL THER; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yu M, 2002, TOXICOL SCI, V65, P99, DOI 10.1093/toxsci/65.1.99; Zhao QY, 1998, AM J PHYSIOL-LUNG C, V274, pL39, DOI 10.1152/ajplung.1998.274.1.L39; Zhu M, 2010, AM J RESP CELL MOL, V43, P487, DOI 10.1165/rcmb.2009-0086OC	42	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65829	10.1371/journal.pone.0065829	http://dx.doi.org/10.1371/journal.pone.0065829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755285	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000110
J	Yao, L; Meng, JJ; Zhang, DG; Sheng, XJ; Zhu, XY				Yao, Lin; Meng, Jianjun; Zhang, Dingguo; Sheng, Xinjun; Zhu, Xiangyang			Selective Sensation Based Brain-Computer Interface via Mechanical Vibrotactile Stimulation	PLOS ONE			English	Article							SOMATOSENSORY-EVOKED POTENTIALS; STEADY-STATE RESPONSES; MOTOR CORTEX; MEDIAN NERVE; EEG; SYNCHRONIZATION; TRANSIENT; MOVEMENT; INPUTS	In this work, mechanical vibrotactile stimulation was applied to subjects' left and right wrist skins with equal intensity, and a selective sensation perception task was performed to achieve two types of selections similar to motor imagery Brain-Computer Interface. The proposed system was based on event-related desynchronization/synchronization (ERD/ERS), which had a correlation with processing of afferent inflow in human somatosensory system, and attentional effect which modulated the ERD/ERS. The experiments were carried out on nine subjects (without experience in selective sensation), and six of them showed a discrimination accuracy above 80%, three of them above 95%. Comparative experiments with motor imagery (with and without presence of stimulation) were also carried out, which further showed the feasibility of selective sensation as an alternative BCI task complementary to motor imagery. Specifically there was significant improvement (P<0.01) from near 65% in motor imagery (with and without presence of stimulation) to above 80% in selective sensation on some subjects. The proposed BCI modality might well cooperate with existing BCI modalities in the literature in enlarging the widespread usage of BCI system.	[Yao, Lin; Meng, Jianjun; Zhang, Dingguo; Sheng, Xinjun; Zhu, Xiangyang] Shanghai Jiao Tong Univ, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Sheng, XJ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Mech Syst & Vibrat, Shanghai 200030, Peoples R China.	xjsheng@sjtu.edu.cn	Meng, Jianjun/T-3584-2019; Meng, Jianjun/ADC-6288-2022	Meng, Jianjun/0000-0003-0813-652X; Sheng, Xinjun/0000-0001-6124-8665; Yao, Lin/0000-0003-2065-7280	National Basic Research Program (973 Program) of China [2011CB013305]; National Natural Science Foundation of China [51075265]; Science and Technology Commission of Shanghai Municipality [11JC1406000]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Basic Research Program (973 Program) of China (Grant No. 2011CB013305), and the National Natural Science Foundation of China (Grant No. 51075265), and the Science and Technology Commission of Shanghai Municipality (Grant No. 11JC1406000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026007; Breitwieser C, 2012, MED BIOL ENG COMPUT, P1; Cassim F, 2000, CLIN NEUROPHYSIOL, V111, P2032, DOI 10.1016/S1388-2457(00)00455-7; Chen R, 1999, EXP BRAIN RES, V129, P77, DOI 10.1007/s002210050938; Colon E, 2012, NEUROPHYSIOLOGIE CLI; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Dockstader C., 2010, NEUROIMAGE; Fukunaga K., 1990, INTRO STAT PATTERN R, V1, P2; Giabbiconi CM, 2004, COGNITIVE BRAIN RES, V20, P58, DOI 10.1016/j.cogbrainres.2004.01.004; Hesterberg T, 2005, INTROD PRACT STAT, V5, P1; Houdayer E, 2006, CLIN NEUROPHYSIOL, V117, P628, DOI 10.1016/j.clinph.2005.12.001; Ishibashi H, 2000, CLIN NEUROPHYSIOL, V111, P1095, DOI 10.1016/S1388-2457(00)00266-2; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Muller-Putz GR, 2006, IEEE T NEUR SYS REH, V14, P30, DOI 10.1109/TNSRE.2005.863842; Nangini C, 2006, NEUROIMAGE, V33, P252, DOI 10.1016/j.neuroimage.2006.05.045; Neuper C, 2001, INT J PSYCHOPHYSIOLO; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V103, P642, DOI 10.1016/S0013-4694(97)00080-1; Pfurtscheller G, 2000, Suppl Clin Neurophysiol, V53, P196, DOI 10.1016/S1567-424X(09)70157-6; Pfurtscheller G, 2005, NEUROSCI LETT, V378, P156, DOI 10.1016/j.neulet.2004.12.034; Pfurtscheller G, 2002, NEUROSCI LETT, V323, P113, DOI 10.1016/S0304-3940(02)00119-2; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2010, FRONTIERS NEUROSCIEN, V4; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Severens M, 2010, CLIN NEUROPHYSIOL, V121, P2090, DOI 10.1016/j.clinph.2010.05.016; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Teplan M., 2002, MEAS SCI REV, V2; Tobimatsu S, 1999, CLIN NEUROPHYSIOL, V110, P1953, DOI 10.1016/S1388-2457(99)00146-7; Vidaurre C, 2011, NEURAL COMPUT, V23, P791, DOI 10.1162/NECO_a_00089; Vidaurre C, 2010, BRAIN TOPOGR, V23, P194, DOI 10.1007/s10548-009-0121-6; Voisin JIA, 2011, NEUROSCI LETT, V493, P33, DOI 10.1016/j.neulet.2011.02.015; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	34	28	30	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64784	10.1371/journal.pone.0064784	http://dx.doi.org/10.1371/journal.pone.0064784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762253	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000020
J	Mao, ZP; Zhao, LJ; Pu, LC; Wang, MX; Zhang, Q; He, DZZ				Mao, Zhongping; Zhao, Lijun; Pu, Lichun; Wang, Mingxiao; Zhang, Qian; He, David Z. Z.			How Well Can Centenarians Hear?	PLOS ONE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; PURE-TONE THRESHOLDS; DPOAE GROWTH-BEHAVIOR; RISK-FACTORS; AUDITORY FUNCTION; ADULT-POPULATION; AGE; MICE; PRESBYCUSIS; PREVALENCE	With advancements in modern medicine and significant improvements in life conditions in the past four decades, the elderly population is rapidly expanding. There is a growing number of those aged 100 years and older. While many changes in the human body occur with physiological aging, as many as 35% to 50% of the population aged 65 to 75 years have presbycusis. Presbycusis is a progressive sensorineural hearing loss that occurs as people get older. There are many studies of the prevalence of age-related hearing loss in the United States, Europe, and Asia. However, no audiological assessment of the population aged 100 years and older has been done. Therefore, it is not clear how well centenarians can hear. We measured middle ear impedance, pure-tone behavioral thresholds, and distortion-product otoacoustic emission from 74 centenarians living in the city of Shaoxing, China, to evaluate their middle and inner ear functions. We show that most centenarian listeners had an "As" type tympanogram, suggesting reduced static compliance of the tympanic membrane. Hearing threshold tests using pure-tone audiometry show that all centenarian subjects had varying degrees of hearing loss. More than 90% suffered from moderate to severe (41 to 80 dB) hearing loss below 2,000 Hz, and profound (>81 dB) hearing loss at 4,000 and 8,000 Hz. Otoacoustic emission, which is generated by the active process of cochlear outer hair cells, was undetectable in the majority of listeners. Our study shows the extent and severity of hearing loss in the centenarian population and represents the first audiological assessment of their middle and inner ear functions.	[Mao, Zhongping; Zhao, Lijun; Pu, Lichun; Wang, Mingxiao] Shaoxing Second Hosp, Dept Otolaryngol Head & Neck Surg, Shaoxing, Peoples R China; [Zhang, Qian; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [He, David Z. Z.] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China	Creighton University; Ningbo University	Mao, ZP (corresponding author), Shaoxing Second Hosp, Dept Otolaryngol Head & Neck Surg, Shaoxing, Peoples R China.	mzp575@gmail.com; hed@creighton.edu	Zhang, Qian/P-7110-2015	He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	Committee of Science and Technology of the city of Shaoxing, China; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	Committee of Science and Technology of the city of Shaoxing, China; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work has been supported by a grant from the Committee of Science and Technology of the city of Shaoxing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2009, OTOL NEUROTOL, V30, P139, DOI 10.1097/MAO.0b013e318192483c; Blanchet C, 2008, OTOL NEUROTOL, V29, P432, DOI 10.1097/MAO.0b013e3181719746; BONFILS P, 1988, AUDIOLOGY, V27, P27; BRANT LJ, 1990, J ACOUST SOC AM, V88, P813, DOI 10.1121/1.399731; Cilento BW, 2003, OTOLARYNG HEAD NECK, V129, P382, DOI 10.1016/S0194-5998(03)00637-5; COLLET L, 1990, ANN OTO RHINOL LARYN, V99, P993, DOI 10.1177/000348949009901212; Cruickshanks KJ, 1998, AM J EPIDEMIOL, V148, P879; Dazert S, 1996, HEARING RES, V100, P101, DOI 10.1016/0378-5955(96)00100-1; Deppe C, 2013, EAR HEARING, V34, P122, DOI 10.1097/AUD.0b013e31826709c3; Dom PA, 1998, J ACOUST SOC AM, V104, P964, DOI 10.1121/1.423339; Fransen E, 2003, EXP GERONTOL, V38, P353, DOI 10.1016/S0531-5565(03)00032-9; Frisina RD, 2006, HEARING RES, V216, P216, DOI 10.1016/j.heares.2006.02.003; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; GATES GA, 1990, EAR HEARING, V11, P247, DOI 10.1097/00003446-199008000-00001; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; Gehr DD, 2004, HEARING RES, V193, P9, DOI 10.1016/j.heares.2004.03.018; GORGA MP, 1993, J ACOUST SOC AM, V93, P2050, DOI 10.1121/1.406691; Helleman HW, 2010, INT J AUDIOL, V49, P410, DOI 10.3109/14992020903527616; Herzog M, 2001, EUR ARCH OTO-RHINO-L, V258, P61, DOI 10.1007/s004050000310; Hoffman HJ, 2012, EAR HEARING, V33, P437, DOI 10.1097/AUD.0b013e3182362790; Jimenez AM, 1999, HEARING RES, V138, P91, DOI 10.1016/S0378-5955(99)00154-9; Jonsson R, 1998, SCAND AUDIOL, V27, P81, DOI 10.1080/010503998420324; Jonsson R, 1998, AUDIOLOGY, V37, P207; KEAY DG, 1988, CLIN OTOLARYNGOL, V13, P31, DOI 10.1111/j.1365-2273.1988.tb00278.x; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; KIMBERLEY BP, 1994, EAR HEARING, V15, P199, DOI 10.1097/00003446-199406000-00001; Lee FS, 2005, EAR HEARING, V26, P1, DOI 10.1097/00003446-200502000-00001; Lin CY, 2007, INT J AUDIOL, V46, P732, DOI 10.1080/14992020701448986; LONSBURYMARTIN BL, 1991, J ACOUST SOC AM, V89, P1749, DOI 10.1121/1.401009; MARTIN GK, 1990, ANN OTO RHINOL LARYN, V99, P30, DOI 10.1177/00034894900990S503; Mathers C, 2000, GLOBAL BURDEN DIS, V2000, P1; Mazelova J, 2003, EXP GERONTOL, V38, P87, DOI 10.1016/S0531-5565(02)00155-9; Moller M B, 1981, Am J Otolaryngol, V2, P22, DOI 10.1016/S0196-0709(81)80005-1; MOSCICKI EK, 1985, EAR HEARING, V6, P184, DOI 10.1097/00003446-198507000-00003; National Center for Health Statistics, 1994, PREV CHAR PERS HEAR, V88; Olzowy B, 2010, J ACOUST SOC AM, V128, P1845, DOI 10.1121/1.3474898; Pacala JT, 2012, JAMA-J AM MED ASSOC, V307, P1185, DOI 10.1001/jama.2012.305; PEDERSEN KE, 1989, AUDIOLOGY, V28, P194; Pichora-Fuller MK, 2003, INT J AUDIOL, V42, pS11; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; Roth TN, 2011, EUR ARCH OTO-RHINO-L, V268, P1101, DOI 10.1007/s00405-011-1597-8; Samuelsson SM, 1997, INT J AGING HUM DEV, V45, P223, DOI 10.2190/XKG9-YP7Y-QJTK-BGPG; Sanford CA, 2009, EAR HEARING, V30, P635, DOI 10.1097/AUD.0b013e3181b61cdc; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; Spongr VP, 1997, J ACOUST SOC AM, V101, P3546, DOI 10.1121/1.418315; STOVER L, 1993, J ACOUST SOC AM, V94, P2670, DOI 10.1121/1.407351; Tremblay KL, 2003, CLIN NEUROPHYSIOL, V114, P1332, DOI 10.1016/S1388-2457(03)00114-7; Uchida Y, 2008, EAR HEARING, V29, P176, DOI 10.1097/AUD.0b013e3181634eb8; WILLOTT JF, 1986, J NEUROPHYSIOL, V56, P391, DOI 10.1152/jn.1986.56.2.391; Zhang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062786	50	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65565	10.1371/journal.pone.0065565	http://dx.doi.org/10.1371/journal.pone.0065565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755251	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400065
J	Poff, AM; Ari, C; Seyfried, TN; D'Agostino, DP				Poff, Angela M.; Ari, Csilla; Seyfried, Thomas N.; D'Agostino, Dominic P.			The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer	PLOS ONE			English	Article							LOW-CARBOHYDRATE DIETS; KETONE-BODIES; TUMOR-GROWTH; WEIGHT-LOSS; PROSTATE-CANCER; GENE-EXPRESSION; BRAIN-TUMOR; MOUSE MODEL; ENERGY RESTRICTION; VASCULAR DENSITY	Introduction: Abnormal cancer metabolism creates a glycolytic-dependency which can be exploited by lowering glucose availability to the tumor. The ketogenic diet (KD) is a low carbohydrate, high fat diet which decreases blood glucose and elevates blood ketones and has been shown to slow cancer progression in animals and humans. Abnormal tumor vasculature creates hypoxic pockets which promote cancer progression and further increase the glycolytic-dependency of cancers. Hyperbaric oxygen therapy (HBO2T) saturates tumors with oxygen, reversing the cancer promoting effects of tumor hypoxia. Since these non-toxic therapies exploit overlapping metabolic deficiencies of cancer, we tested their combined effects on cancer progression in a natural model of metastatic disease. Methods: We used the firefly luciferase-tagged VM-M3 mouse model of metastatic cancer to compare tumor progression and survival in mice fed standard or KD ad libitum with or without HBO2T (2.5 ATM absolute, 90 min, 3x/week). Tumor growth was monitored by in vivo bioluminescent imaging. Results: KD alone significantly decreased blood glucose, slowed tumor growth, and increased mean survival time by 56.7% in mice with systemic metastatic cancer. While HBO2T alone did not influence cancer progression, combining the KD with HBO2T elicited a significant decrease in blood glucose, tumor growth rate, and 77.9% increase in mean survival time compared to controls. Conclusions: KD and HBO2T produce significant anti-cancer effects when combined in a natural model of systemic metastatic cancer. Our evidence suggests that these therapies should be further investigated as potential non-toxic treatments or adjuvant therapies to standard care for patients with systemic metastatic disease.	[Poff, Angela M.; Ari, Csilla; D'Agostino, Dominic P.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Seyfried, Thomas N.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	State University System of Florida; University of South Florida; Boston College	Poff, AM (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	abennett@health.usf.edu	D'Agostino, Dominic/I-6194-2012; D'Agostino, Dominic/GPJ-9744-2022	Seyfried, Thomas/0000-0003-1491-3989	Office of Naval Research, ONR [N000140610105, N000140210643]	Office of Naval Research, ONR(Office of Naval Research)	This work was supported by the Office of Naval Research, ONR grant N000140610105 and ONR-DURIP equipment grant N000140210643 (http://www.onr.navy.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Al-Waili NS, 2005, MED SCI MONITOR, V11, pRA279; Astrup A, 2000, BRIT J NUTR, V83, pS25; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Bennett A, 2012, FASEB J; Bennett M, 2008, CANCER TREAT REV, V34, P577, DOI 10.1016/j.ctrv.2008.01.001; Bergamo A, 1999, J PHARMACOL EXP THER, V289, P559; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Champ CE, 2012, INT J BREAST CANC, DOI DOI 10.1155/2012/506868; D'Agostino D, 2012, FASEB SAN DIEGO CA; D'agostino DP, 2009, NEUROSCIENCE, V159, P1011, DOI 10.1016/j.neuroscience.2009.01.062; D'Agostino DP, 2013, AM J PHYSL REGULATOR; Daruwalla J, 2006, WORLD J SURG, V30, P2112, DOI 10.1007/s00268-006-0190-6; Duranti L, 2012, TUMORI J, V98, P175, DOI 10.1700/1088.11927; Fine EJ, 2012, NUTRITION, V28, P1028, DOI 10.1016/j.nut.2012.05.001; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Frezza C, 2011, J MOL MED, V89, P213, DOI 10.1007/s00109-011-0728-4; Gill AL, 2004, QJM, V97; Graeme M, 2004, CLIN ONCOLOGY, V16, P549; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hoogsteen IJ, 2007, CLIN ONCOL-UK, V19, P385, DOI 10.1016/j.clon.2007.03.001; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; Hussain TA, 2012, NUTRITION, V28, P1016, DOI 10.1016/j.nut.2012.01.016; Huysentruyt LC, 2008, INT J CANCER, V123, P73, DOI 10.1002/ijc.23492; Huysentruyt LC, 2011, ASN NEURO, V3, P183, DOI 10.1042/AN20110011; Huysentruyt LC, 2010, INT J CANCER, V126, P65, DOI 10.1002/ijc.24649; Johnstone AM, 2008, AM J CLIN NUTR, V87, P44, DOI 10.1093/ajcn/87.1.44; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Katyal NG, 2000, CLIN PEDIATR, V39, P153, DOI 10.1177/000992280003900303; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704, DOI 10.7326/0003-4819-100-5-704; MAGEE BA, 1979, AUST J EXP BIOL MED, V57, P529, DOI 10.1038/icb.1979.54; Manninen AH, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-9; Marsh J, 2008, CLIN CANCER RES, V14, P7751, DOI 10.1158/1078-0432.CCR-08-0213; Marsh J, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-33; Martinez-Outschoorn UE, 2012, CELL CYCLE, V11, P3964, DOI 10.4161/cc.22137; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P1271, DOI 10.4161/cc.10.8.15330; Masko EM, 2010, CANCER PREV RES, V3, P1124, DOI 10.1158/1940-6207.CAPR-10-0071; Maurer GD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-315; Mavropoulos JC, 2006, UROLOGY, V68, P15, DOI 10.1016/j.urology.2006.03.073; Mavropoulos JC, 2009, CANCER PREV RES, V2, P557, DOI 10.1158/1940-6207.CAPR-08-0188; McGuire WP, 1996, SEMIN ONCOL, V23, P40; Moen I, 2012, TARGET ONCOL, V7, P233, DOI 10.1007/s11523-012-0233-x; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; Mukherjee P, 1999, JNCI-J NATL CANCER I, V91, P512, DOI 10.1093/jnci/91.6.512; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; Mukherjee P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-37; NEBELING LC, 1995, J AM DIET ASSOC, V95, P693, DOI 10.1016/S0002-8223(95)00189-1; NEBELING LC, 1995, J AM COLL NUTR, V14, P202; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Paoli A, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-34; Petre PM, 2003, J THORAC CARDIOV SUR, V125, P85, DOI 10.1067/mtc.2003.90; Pilla R, 2012, 3 INT S DIET THER EP; ROSSIFANELLI F, 1991, CLIN NUTR, V10, P228, DOI 10.1016/0261-5614(91)90043-C; Salem AF, 2012, CELL CYCLE, V11, P2545, DOI 10.4161/cc.20920; Sawai M, 2004, ANTICANCER RES, V24, P2213; Scheck AC, 2012, EPILEPSY RES, V100, P327, DOI 10.1016/j.eplepsyres.2011.09.022; Schmidt M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-54; Seyfried IN, 2012, CANC METABOLIC DIS O; Seyfried TN, 2010, LANCET ONCOL, V11, P811, DOI 10.1016/S1470-2045(10)70166-2; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Shelton LM, 2010, J NEURO-ONCOL, V99, P165, DOI 10.1007/s11060-010-0115-y; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Skinner R, 2009, J PEDIATR SURG, V44, P212, DOI 10.1016/j.jpedsurg.2008.10.042; Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74; Stuhr LEB, 2004, CANCER LETT, V210, P35, DOI 10.1016/j.canlet.2004.02.012; Stuhr LEB, 2007, J NEURO-ONCOL, V85, P191, DOI 10.1007/s11060-007-9407-2; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Takiguchi N, 2001, CANCER CHEMOTH PHARM, V47, P11, DOI 10.1007/s002800000190; Thompson HJ, 2004, CANCER RES, V64, P5643, DOI 10.1158/0008-5472.CAN-04-0787; Thompson HJ, 2004, CANCER RES, V64, P1541, DOI 10.1158/0008-5472.CAN-03-3108; Thompson HJ, 2003, J MAMMARY GLAND BIOL, V8, P133, DOI 10.1023/A:1025743607445; TISDALE MJ, 1987, BRIT J CANCER, V56, P39, DOI 10.1038/bjc.1987.149; TISDALE MJ, 1983, BRIT J CANCER, V47, P293, DOI 10.1038/bjc.1983.38; TISDALE MJ, 1988, BRIT J CANCER, V58, P580, DOI 10.1038/bjc.1988.263; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Veech RL, 2001, IUBMB LIFE, V51, P241; Volek Js, 2004, Nutr Metab (Lond), V1, P13, DOI 10.1186/1743-7075-1-13; Volek JS, 2002, METABOLISM, V51, P864, DOI 10.1053/meta.2002.32037; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wheatley KE, 2008, NUTR CANCER, V60, P61, DOI 10.1080/01635580701510150; Wouters BG, 2004, DRUG RESIST UPDATE, V7, P25, DOI 10.1016/j.drup.2003.12.004; WU GY, 1988, BIOCHEM J, V255, P139, DOI 10.1042/bj2550139; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zhu ZJ, 2005, MOL CARCINOGEN, V42, P170, DOI 10.1002/mc.20071; Zuccoli G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-33	93	106	113	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65522	10.1371/journal.pone.0065522	http://dx.doi.org/10.1371/journal.pone.0065522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755243	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400061
J	Ruskin, DN; Svedova, J; Cote, JL; Sandau, U; Rho, JM; Kawamura, M; Boison, D; Masino, SA				Ruskin, David N.; Svedova, Julia; Cote, Jessica L.; Sandau, Ursula; Rho, Jong M.; Kawamura, Masahito, Jr.; Boison, Detlev; Masino, Susan A.			Ketogenic Diet Improves Core Symptoms of Autism in BTBR Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; K-ATP CHANNELS; LOW-CARBOHYDRATE; SPECTRUM DISORDERS; ADULT RATS; EPILEPSY; ADENOSINE; METABOLISM; CHILDREN; BRAIN	Autism spectrum disorders share three core symptoms: impaired sociability, repetitive behaviors and communication deficits. Incidence is rising, and current treatments are inadequate. Seizures are a common comorbidity, and since the 1920's a high-fat, low-carbohydrate ketogenic diet has been used to treat epilepsy. Evidence suggests the ketogenic diet and analogous metabolic approaches may benefit diverse neurological disorders. Here we show that a ketogenic diet improves autistic behaviors in the BTBR mouse. Juvenile BTBR mice were fed standard or ketogenic diet for three weeks and tested for sociability, self-directed repetitive behavior, and communication. In separate experiments, spontaneous intrahippocampal EEGs and tests of seizure susceptibility (6 Hz corneal stimulation, flurothyl, SKF83822, pentylenetetrazole) were compared between BTBR and control (C57Bl/6) mice. Ketogenic diet-fed BTBR mice showed increased sociability in a three-chamber test, decreased self-directed repetitive behavior, and improved social communication of a food preference. Although seizures are a common comorbidity with autism, BTBR mice fed a standard diet exhibit neither spontaneous seizures nor abnormal EEG, and have increased seizure susceptibility in just one of four tests. Thus, behavioral improvements are dissociable from any antiseizure effect. Our results suggest that a ketogenic diet improves multiple autistic behaviors in the BTBR mouse model. Therefore, ketogenic diets or analogous metabolic strategies may offer novel opportunities to improve core behavioral symptoms of autism spectrum disorders.	[Ruskin, David N.; Svedova, Julia; Cote, Jessica L.; Masino, Susan A.] Trinity Coll, Neurosci Program, Hartford, CT 06106 USA; [Ruskin, David N.; Masino, Susan A.] Trinity Coll, Dept Psychol, Hartford, CT 06106 USA; [Sandau, Ursula; Boison, Detlev] Legacy Res Inst, Robert Stone Dow Neurobiol Labs, Portland, OR USA; [Rho, Jong M.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Fac Med, Calgary, AB T2N 1N4, Canada; [Rho, Jong M.] Univ Calgary, Dept Clin Neurosci, Alberta Childrens Hosp, Fac Med, Calgary, AB T2N 1N4, Canada; [Kawamura, Masahito, Jr.] Jikei Univ, Sch Med, Dept Pharmacol, Tokyo, Japan	Trinity College; Trinity College; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; Jikei University	Masino, SA (corresponding author), Trinity Coll, Neurosci Program, Hartford, CT 06106 USA.	susan.masino@trincoll.edu	Boison, Detlev/ABE-6302-2020	Cote, Jessica/0000-0001-8967-2396; Boison, Detlev/0000-0002-7740-5781	National Institutes of Health [R01 NS065957, R01 NS061844, R01 NS070267]; National Science Foundation [IOS-0843585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061844, R01NS065957, R15NS066392, R01NS070267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institutes of Health R01 NS065957, R01 NS061844 and R01 NS070267 (www.nih.gov), and National Science Foundation IOS-0843585 (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4; Baranano Kristin W, 2008, Curr Treat Options Neurol, V10, P410, DOI 10.1007/s11940-008-0043-8; Brinkworth GD, 2009, ARCH INTERN MED, V169, P1873, DOI 10.1001/archinternmed.2009.329; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Chadman KK, 2012, EXPERT OPIN DRUG DIS, V7, P407, DOI 10.1517/17460441.2012.678828; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; Eapen V, 2011, AUTISM NEURODEVELOPM, P103; El-Ansary A, 2010, CLIN BIOCHEM, V43, P63, DOI 10.1016/j.clinbiochem.2009.09.008; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Evangeliou A, 2003, J CHILD NEUROL, V18, P113, DOI 10.1177/08830738030180020501; Forsythe CE, 2008, LIPIDS, V43, P65, DOI 10.1007/s11745-007-3132-7; Frye RE, 2011, PEDIATR RES, V69, p41R, DOI 10.1203/PDR.0b013e318212f16b; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Halyburton AK, 2007, AM J CLIN NUTR, V86, P580, DOI 10.1093/ajcn/86.3.580; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; Kawamura M, 2010, J NEUROSCI, V30, P3886, DOI 10.1523/JNEUROSCI.0055-10.2010; Kim DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035476; Lund TM, 2009, J NEUROCHEM, V110, P80, DOI 10.1111/j.1471-4159.2009.06115.x; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Masino SA, 2009, CURR NEUROPHARMACOL, V7, P257, DOI 10.2174/157015909789152164; Masino SA, 2012, NEUROSCIENCE; Masino SA, 2013, NEUROPHARMACOLOGY, V68, P116, DOI 10.1016/j.neuropharm.2012.08.013; Masino Susan A, 2010, Open Neurosci J, V4, P58; Masino SA, 2011, NEUROSCI LETT, V500, P1, DOI 10.1016/j.neulet.2011.06.007; Masino SA, 2011, J CLIN INVEST, V121, P2679, DOI 10.1172/JCI57813; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Meidenbauer JJ, 2011, EPILEPSIA, V52, P347, DOI 10.1111/j.1528-1167.2010.02898.x; Milllward C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003498.pub3; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Park CR, 2001, BIOL PSYCHIAT, V50, P994, DOI 10.1016/S0006-3223(01)01255-0; Patel A, 2010, EPILEPSIA, V51, P1277, DOI 10.1111/j.1528-1167.2009.02488.x; Patterson PH, 2011, PEDIATR RES, V69, p34R, DOI 10.1203/PDR.0b013e318212b80f; Perez-Guisado J, 2011, J MED FOOD, V14, P677, DOI 10.1089/jmf.2011.0075; Pobbe RLH, 2011, BEHAV BRAIN RES, V216, P446, DOI 10.1016/j.bbr.2010.08.039; Ruskin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008349; Sansa G, 2011, EPILEPSIA, V52, P1071, DOI 10.1111/j.1528-1167.2011.03069.x; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Sirven J, 1999, EPILEPSIA, V40, P1721, DOI 10.1111/j.1528-1157.1999.tb01589.x; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Stafstrom CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00059; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Tendler D, 2007, DIGEST DIS SCI, V52, P589, DOI 10.1007/s10620-006-9433-5; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wilder R., 1921, MAY CLIN B, P308; Yudkoff M, 2007, ANNU REV NUTR, V27, P415, DOI 10.1146/annurev.nutr.27.061406.093722; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29	47	100	106	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65021	10.1371/journal.pone.0065021	http://dx.doi.org/10.1371/journal.pone.0065021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755170	Green Published, gold			2022-12-25	WOS:000320579400036
J	Vilardo, E; Rossmanith, W				Vilardo, Elisa; Rossmanith, Walter			The Amyloid-beta-SDR5C1(ABAD) Interaction Does Not Mediate a Specific Inhibition of Mitochondrial RNase P	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; BINDING ALCOHOL-DEHYDROGENASE; ALZHEIMERS-DISEASE; A-BETA; PROTEIN; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; IDENTIFICATION; ACCUMULATION; ARABIDOPSIS; DYSFUNCTION	The amyloid-beta peptide (A beta) is suggested to cause mitochondrial dysfunction in Alzheimer's disease. The mitochondrial dehydrogenase SDR5C1 (also known as ABAD) was shown to bind A beta and was proposed to thereby mediate mitochondrial toxicity, but the molecular mechanism has not been clarified. We recently identified SDR5C1 as an essential component of human mitochondrial RNase P and its associated tRNA:m(1) R9 methyltransferase, the enzymes responsible for tRNA 5'-end processing and methylation of purines at tRNA position 9, respectively. With this work we investigated whether SDR5C1's role as a subunit of these two tRNA-maturation activities represents the mechanistic link between A beta and mitochondrial dysfunction. Using recombinant enzyme components, we tested RNase P and methyltransferase activity upon titration of A beta. Micromolar concentrations of monomeric or oligomerized A beta were required to inhibit tRNA 5'-end processing and position 9 methylation catalyzed by the SDR5C1-containing enzymes, yet similar concentrations of A beta also inhibited related RNase P and methyltransferase activities, which do not contain an SDR5C1 homolog. In conclusion, the proposed deleterious effect of A beta on mitochondrial function cannot be explained by a specific inhibition of mitochondrial RNase P or its tRNA:m(1) R9 methyltransferase subcomplex, and the molecular mechanism of SDR5C1-mediated A beta toxicity remains unclear.	[Vilardo, Elisa; Rossmanith, Walter] Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria	Medical University of Vienna	Rossmanith, W (corresponding author), Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria.	walter.rossmanith@meduniwien.ac.at	Rossmanith, Walter/F-3662-2010; Vilardo, Elisa/F-3656-2010	Rossmanith, Walter/0000-0003-2337-2248; Vilardo, Elisa/0000-0003-2733-6009	Agouron Institute [AI-ALZ2.10.1]	Agouron Institute(Pfizer)	This work was supported by research grant AI-ALZ2.10.1 from the Agouron Institute (www.agi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Binstock J F, 1981, Methods Enzymol, V71 Pt C, P403; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chen JX, 2010, J ALZHEIMERS DIS, V20, pS569, DOI 10.3233/JAD-2010-100357; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Gutmann B, 2012, GENE DEV, V26, P1022, DOI 10.1101/gad.189514.112; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He XY, 1998, J BIOL CHEM, V273, P10741, DOI 10.1074/jbc.273.17.10741; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Morais VA, 2010, J ALZHEIMERS DIS, V20, pS255, DOI 10.3233/JAD-2010-100345; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Oppermann UCT, 1999, FEBS LETT, V451, P238, DOI 10.1016/S0014-5793(99)00586-4; Pavlova LV, 2012, CHEMBIOCHEM, V13, P2270, DOI 10.1002/cbic.201200434; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rauschenberger K, 2010, EMBO MOL MED, V2, P51, DOI 10.1002/emmm.200900055; Rossmanith W, 2012, BBA-GENE REGUL MECH, V1819, P1017, DOI 10.1016/j.bbagrm.2011.11.003; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Taschner A, 2012, CELL REP, V2, P19, DOI 10.1016/j.celrep.2012.05.021; Tillement L, 2011, MITOCHONDRION, V11, P13, DOI 10.1016/j.mito.2010.08.009; Vilardo E, 2012, NUCLEIC ACIDS RES, V40, P11583, DOI 10.1093/nar/gks910; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yan SD, 1997, NATURE, V389, P689; Yan SD, 2000, J BIOL CHEM, V275, P27100; Yan YL, 2007, BIOCHEMISTRY-US, V46, P1724, DOI 10.1021/bi061314n; Yang SY, 2005, TRENDS ENDOCRIN MET, V16, P167, DOI 10.1016/j.tem.2005.03.006; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011; Yoon EJ, 2009, EXP MOL MED, V41, P611, DOI 10.3858/emm.2009.41.9.067	36	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65609	10.1371/journal.pone.0065609	http://dx.doi.org/10.1371/journal.pone.0065609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755257	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400070
J	Yamazaki, T; Yamori, M; Asai, K; Nakano-Araki, I; Yamaguchi, A; Takahashi, K; Sekine, A; Matsuda, F; Kosugi, S; Nakayama, T; Inagaki, N; Bessho, K				Yamazaki, Toru; Yamori, Masashi; Asai, Keita; Nakano-Araki, Ikuko; Yamaguchi, Akihiko; Takahashi, Katsu; Sekine, Akihiro; Matsuda, Fumihiko; Kosugi, Shinji; Nakayama, Takeo; Inagaki, Nobuya; Bessho, Kazuhisa		Nagahama Study Collaboration Grp	Mastication and Risk for Diabetes in a Japanese Population: A Cross-Sectional Study	PLOS ONE			English	Article							CHANGEABLE CHEWING GUM; EATING FAST LEADS; BODY-MASS-INDEX; NUTRITIONAL-STATUS; MAGNESIUM INTAKE; NUTRIENT INTAKE; OCCLUSAL FORCE; FIBER INTAKE; ORAL HEALTH; PERFORMANCE	Background: Associations between mastication and insufficient nutrient intake, obesity, and glucose metabolism have been shown in previous studies. However, the association between mastication and diabetes has not been clarified. Our objective was to examine the association between mastication, namely masticatory performance or rate of eating, and diabetes in a population-based cohort. Methods: We conducted a cross-sectional study of the association between mastication and diabetes in the Nagahama Prospective Cohort Study, an ongoing study which recruits citizens of Nagahama City in Shiga Prefecture, central Japan. 2,283 male and 4,544 female residents aged 40-74 years were enrolled from July 2009 to November 2010. Masticatory performance was evaluated by spectrophotometric measurement of color changes after masticating color-changeable chewing gum. Categorical rate of eating (fast, intermediate or slow) was self-assessed using a questionnaire. Results: 177 males (7.7%) and 112 (2.4%) females were diagnosed with diabetes. We divided participants into four groups by quartile of masticatory performance, namely Q1 (lowest), 2, and 3 and 4 (highest). Compared to the lowest performance group, the multivariable adjusted odds ratio (OR) of diabetes was 0.91 (95% confidence interval (CI), 0.58-1.4) in Q2, 0.77 (95% CI, 0.48-1.2) in Q3, and 0.53 (95% CI, 0.31-0.90) in the highest group in males, and 1.2 (95% CI, 0.73-2.0), 0.95 (95% CI, 0.54-1.6) and 0.56 (95% CI, 0.30-1.0) in females. We also estimated ORs of diabetes by rate of eating. Compared to the fast eating group, ORs in males were 0.87 (95% CI, 0.61-1.2) in the intermediate group and 0.38 (95% CI, 0.16-0.91) in the slow group, and ORs in females were 0.92 (95% CI, 0.59-1.4) and 1.5 (95% CI, 0.73-3.0). Conclusions: These findings support the hypothesis that higher masticatory performance and slow eating prevent the occurrence of diabetes.	[Yamazaki, Toru; Yamori, Masashi; Asai, Keita; Takahashi, Katsu; Bessho, Kazuhisa] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan; [Nakano-Araki, Ikuko; Yamaguchi, Akihiko] Nagahama City Hosp, Dept Oral & Maxillofacial Surg, Nagahama, Japan; [Sekine, Akihiro] Kyoto Univ, Grad Sch Med, EBM Res Ctr, Kyoto, Japan; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Unit Human Dis Genom, Ctr Genom Med, Kyoto, Japan; [Kosugi, Shinji] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Med Eth, Kyoto, Japan; [Nakayama, Takeo] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Yamori, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan.	yamori@kuhp.kyoto-u.ac.jp	KOSUGI, Shinji/GYR-2946-2022; NAKAYAMA, Takeo/HCH-0537-2022; Kadotani, Hiroshi/A-7908-2015; KOSUGI, Shinji/HCH-0631-2022	Kadotani, Hiroshi/0000-0001-7474-3315; Nakayama, Takeo/0000-0002-7918-6252; Inagaki, Nobuya/0000-0001-8261-2593	Kyoto University; Takeda Science Foundation; Mitsui Sumitomo Insurance Welfare Foundation; Ministry of Health, Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [24592985] Funding Source: KAKEN	Kyoto University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the grants-in-aid from the following organizations: Kyoto University (2006), Takeda Science Foundation (2008), Mitsui Sumitomo Insurance Welfare Foundation (2010), and the Ministry of Health, Labour and Welfare, Japan (2009-2013). The chewing gum was provided by the Lion Foundation for Dental Health and Lotte Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS4, DOI 10.2337/dc11-S004; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Corcodel N, 2010, EUR J ORAL SCI, V118, P311, DOI 10.1111/j.1600-0722.2010.00730.x; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Endo T, 2012, ODONTOLOGY; Hayakawa I, 1998, INT J PROSTHODONT, V11, P173; Ikebe K, 2011, ARCH ORAL BIOL, V56, P991, DOI 10.1016/j.archoralbio.2011.03.019; Ikebe K, 2010, INT J PROSTHODONT, V23, P521; Ishikawa Yasutaka, 2007, Journal of Medical and Dental Sciences, V54, P65; Kamiyama M, 2010, J PROSTHODONT RES, V54, P24, DOI 10.1016/j.jpor.2009.08.001; Kokkinos A, 2010, J CLIN ENDOCR METAB, V95, P333, DOI 10.1210/jc.2009-1018; Komagamine Y, 2012, J ORAL REHABIL, V39, P847, DOI 10.1111/joor.12004; Komagamine Y, 2011, J ORAL REHABIL, V38, P555, DOI 10.1111/j.1365-2842.2011.02204.x; KUEHNI RG, 1976, J OPT SOC AM, V66, P497, DOI 10.1364/JOSA.66.000497; Lee JS, 2004, AM J CLIN NUTR, V79, P295; Marshall TA, 2002, J AM DENT ASSOC, V133, P1369, DOI 10.14219/jada.archive.2002.0052; Maruyama K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2002; Mealey BL, 2007, PERIODONTOL 2000, V44, P127, DOI 10.1111/j.1600-0757.2006.00193.x; Montonen J, 2003, AM J CLIN NUTR, V77, P622, DOI 10.1093/ajcn/77.3.622; Moriya S, 2012, GERODONTOLOGY; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Murakami K, 2007, AM J CLIN NUTR, V86, P206, DOI 10.1093/ajcn/86.1.206; Nakayama Takeo, 2010, JAP J GENET COUNSEL, P31; Nojima K, 2006, DIABETES RES CLIN PR, V74, P1, DOI 10.1016/j.diabres.2006.03.031; Ohira A, 2011, INT J PAEDIAT DENT; Ohkuma T, 2013, DIABETOLOGIA, V56, P70, DOI 10.1007/s00125-012-2746-3; Oka K, 2003, J DENT RES, V82, P491, DOI 10.1177/154405910308200617; Okada K, 2010, GERIATR GERONTOL INT, V10, P56, DOI 10.1111/j.1447-0594.2009.00560.x; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Otsuka R, 2008, PREV MED, V46, P154, DOI 10.1016/j.ypmed.2007.07.031; Otsuka R, 2006, J EPIDEMIOL, V16, P117, DOI 10.2188/jea.16.117; Oueis H, 2009, INT J PAEDIATR DENT, V19, P201, DOI 10.1111/j.1365-263X.2008.00965.x; Pedersen AM, 2002, ORAL DIS, V8, P117, DOI 10.1034/j.1601-0825.2002.02851.x; Reis JP, 2011, ANN INTERN MED, V155, P292, DOI 10.7326/0003-4819-155-5-201109060-00006; Saito A, 2012, APPETITE, V59, P252, DOI 10.1016/j.appet.2012.05.009; Sakata T, 1995, METHOD FIND EXP CLIN, V17, P51; Sakurai M, 2012, METABOLISM, V61, P1566, DOI 10.1016/j.metabol.2012.04.005; Schillinger T, 2006, STROKE, V37, P2271, DOI 10.1161/01.STR.0000236495.82545.2e; Schulze MB, 2007, ARCH INTERN MED, V167, P956, DOI 10.1001/archinte.167.9.956; Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Sheiham A, 2001, J DENT RES, V80, P408, DOI 10.1177/00220345010800020201; Slavin JL, 1999, AM J CLIN NUTR, V70, p459S, DOI 10.1093/ajcn/70.3.459s; Sonoki K, 2012, ENDOCR J; Suzuki H, 2005, METABOLISM, V54, P1593, DOI 10.1016/j.metabol.2005.06.006; Tanihara S, 2011, APPETITE, V57, P179, DOI 10.1016/j.appet.2011.04.017; Tong X, 2011, EUR J CLIN NUTR, V65, P1027, DOI 10.1038/ejcn.2011.62; Villegas R, 2009, AM J CLIN NUTR, V89, P1059, DOI 10.3945/ajcn.2008.27182; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	51	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64113	10.1371/journal.pone.0064113	http://dx.doi.org/10.1371/journal.pone.0064113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755114	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400007
J	Bryson, JL; Griffith, AV; Hughes, B; Saito, F; Takahama, Y; Richie, ER; Manley, NR				Bryson, Jerrod L.; Griffith, Ann V.; Hughes, Bernard, III; Saito, Fumi; Takahama, Yousuke; Richie, Ellen R.; Manley, Nancy R.			Cell-Autonomous Defects in Thymic Epithelial Cells Disrupt Endothelial-Perivascular Cell Interactions in the Mouse Thymus	PLOS ONE			English	Article							NEURAL CREST; GROWTH-FACTOR; PERICYTE LOSS; ADULT THYMUS; T-CELLS; VEGF-A; DIFFERENTIATION; MICE; MICROENVIRONMENTS; ORGANOGENESIS	The thymus is composed of multiple stromal elements comprising specialized stromal microenvironments responsible for the development of self-tolerant and self-restricted T cells. Here, we investigated the ontogeny and maturation of the thymic vasculature. We show that endothelial cells initially enter the thymus at E13.5, with PDGFR-beta(+) mesenchymal cells following at E14.5. Using an allelic series of the thymic epithelial cell (TEC) specific transcription factor Foxn1, we showed that these events are delayed by 1-2 days in Foxn1(Delta/Delta) mice, and this phenotype was exacerbated with reduced Foxn1 dosage. At subsequent stages there were fewer capillaries, leaky blood vessels, disrupted endothelium - perivascular cell interactions, endothelial cell vacuolization, and an overall failure of vascular organization. The expression of both VEGF-A and PDGF-B, which are both primarily expressed in vasculature-associated mesenchyme or endothelium in the thymus, were reduced at E13.5 and E15.5 in Foxn1(Delta/Delta) mice compared with controls. These data suggest that Foxn1 is required in TECs both to recruit endothelial cells and for endothelial cells to communicate with thymic mesenchyme, and for the differentiation of vascular-associated mesenchymal cells. These data show that Foxn1 function in TECs is required for normal thymus size and to generate the cellular and molecular environment needed for normal thymic vascularization. These data further demonstrate a novel TEC-mesenchyme-endothelial interaction required for proper fetal thymus organogenesis.	[Bryson, Jerrod L.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Griffith, Ann V.; Richie, Ellen R.] Univ Texas MD Anderson Canc Ctr, Dept Carcinogenesis, Div Sci Pk Res, Smithville, TX USA; [Hughes, Bernard, III; Manley, Nancy R.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Saito, Fumi; Takahama, Yousuke] Univ Tokushima, Inst Genome Res, Div Expt Immunol, Tokushima 770, Japan	University System of Georgia; University of Georgia; University of Texas System; UTMD Anderson Cancer Center; University System of Georgia; University of Georgia; Tokushima University	Manley, NR (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	nmanley@uga.edu	Griffith, Ann/N-5624-2016; Takahama, Yousuke/A-5863-2010	Griffith, Ann/0000-0001-5345-0222; Takahama, Yousuke/0000-0002-4992-9174; Richie, Ellen/0000-0003-0786-973X	National Institutes of Health, National Institute of Allergy and Infectious Disease [AI055001, AI075244]; Grants-in-Aid for Scientific Research [24111004] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055001, R21AI075244] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health, National Institute of Allergy and Infectious Disease (AI055001 and AI075244) to NRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2000, INT IMMUNOL, V12, P1105, DOI 10.1093/intimm/12.7.1105; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bryson JL, 2011, JOVE-J VIS EXP, DOI 10.3791/3267; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Cuddihy AR, 2009, BLOOD, V113, P2723, DOI 10.1182/blood-2008-06-162040; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Griffith AV, 2009, DEV BIOL, V327, P216, DOI 10.1016/j.ydbio.2008.12.019; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Jin SW, 2009, ARTERIOSCL THROM VAS, V29, P623, DOI 10.1161/ATVBAHA.107.161539; Kato S, 1997, MICROSC RES TECHNIQ, V38, P287, DOI 10.1002/(SICI)1097-0029(19970801)38:3<287::AID-JEMT9>3.0.CO;2-J; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; MOORE MAS, 1967, J EXP MED, V126, P715, DOI 10.1084/jem.126.4.715; Mori K, 2007, INT IMMUNOL, V19, P745, DOI 10.1093/intimm/dxm041; Mori K, 2010, CELL IMMUNOL, V260, P66, DOI 10.1016/j.cellimm.2009.09.007; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Muller SM, 2005, P NATL ACAD SCI USA, V102, P10587, DOI 10.1073/pnas.0502752102; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; USHIKI T, 1986, CELL TISSUE RES, V244, P285; Xiao SY, 2008, J IMMUNOL, V180, P914, DOI 10.4049/jimmunol.180.2.914; Xiao SY, 2007, J IMMUNOL, V179, P8153, DOI 10.4049/jimmunol.179.12.8153	50	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65196	10.1371/journal.pone.0065196	http://dx.doi.org/10.1371/journal.pone.0065196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750244	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900046
J	Oles, K; Gudowska-Nowak, E; Kleczkowski, A				Oles, Katarzyna; Gudowska-Nowak, Ewa; Kleczkowski, Adam			Efficient Control of Epidemics Spreading on Networks: Balance between Treatment and Recovery	PLOS ONE			English	Article							DISEASE SPREAD; COMPLEX; TRANSMISSION; STRATEGIES; INFECTION; LANDSCAPE; IMPACT; SCALE	We analyse two models describing disease transmission and control on regular and small-world networks. We use simulations to find a control strategy that minimizes the total cost of an outbreak, thus balancing the costs of disease against that of the preventive treatment. The models are similar in their epidemiological part, but differ in how the removed/recovered individuals are treated. The differences in models affect choice of the strategy only for very cheap treatment and slow spreading disease. However for the combinations of parameters that are important from the epidemiological perspective (high infectiousness and expensive treatment) the models give similar results. Moreover, even where the choice of the strategy is different, the total cost spent on controlling the epidemic is very similar for both models.	[Oles, Katarzyna; Gudowska-Nowak, Ewa] Jagiellonian Univ, M Kac Complex Syst Res Ctr, Krakow, Poland; [Oles, Katarzyna; Gudowska-Nowak, Ewa] Jagiellonian Univ, M Smoluchowski Inst Phys, Krakow, Poland; [Oles, Katarzyna; Kleczkowski, Adam] Univ Stirling, Dept Comp Sci & Math, Stirling FK9 4LA, Scotland	Jagiellonian University; Jagiellonian University; University of Stirling	Oles, K (corresponding author), Jagiellonian Univ, M Kac Complex Syst Res Ctr, Krakow, Poland.	kas@cs.stir.ac.uk	Kleczkowski, Adam/B-2016-2009; Gudowska-Nowak, Ewa/A-7622-2014; Oles, Katarzyna/AAH-1828-2021	Kleczkowski, Adam/0000-0003-1384-4352; Gudowska-Nowak, Ewa/0000-0001-5604-094X; Oles, Katarzyna/0000-0001-6821-9904	European Regional Development Fund covering [MPD/2009/6]; Jagiellonian University International Ph.D. Studies in Physics of Complex Systems; European Science Foundation (ESF)	European Regional Development Fund covering; Jagiellonian University International Ph.D. Studies in Physics of Complex Systems; European Science Foundation (ESF)(European Science Foundation (ESF))	Project operated within the Foundation for Polish Science International Ph.D. Projects Programme co-financed by the European Regional Development Fund covering, under the agreement no. MPD/2009/6, the Jagiellonian University International Ph.D. Studies in Physics of Complex Systems and was co-financed by the European Development Fund in the framework of the "Innovative Economy Programme'' and within the framework of "Exploring the Physics of Small Devices (EPSD)'' of European Science Foundation (ESF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksiejuk A, 2002, PHYSICA A, V310, P260, DOI 10.1016/S0378-4371(02)00740-9; Andersson H., 1999, MATH SCI, V24, P128; Bianconi G, 2001, PHYS REV LETT, V86, P5632, DOI 10.1103/PhysRevLett.86.5632; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Dybiec B, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066145; Dybiec B, 2005, ACTA PHYS POL B, V36, P1509; Dye C, 2003, SCIENCE, V300, P1884, DOI 10.1126/science.1086925; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Filipe JAN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002328; Forster GA, 2007, P NATL ACAD SCI USA, V104, P4984, DOI 10.1073/pnas.0607900104; Gersovitz M, 2004, ECON J, V114, P1, DOI 10.1046/j.0013-0133.2003.0174.x; Gilligan CA, 2007, J R SOC INTERFACE, V4, P925, DOI 10.1098/rsif.2007.1019; Gomez-Gardenes J, 2006, EUR PHYS J B, V49, P259, DOI 10.1140/epjb/e2006-00041-1; Gottwald TR, 2001, PHYTOPATHOLOGY, V91, P30, DOI 10.1094/PHYTO.2001.91.1.30; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Kao RR, 2002, TRENDS MICROBIOL, V10, P279, DOI 10.1016/S0966-842X(02)02371-5; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kleczkowski A, 2012, J R SOC INTERFACE, V9, P158, DOI 10.1098/rsif.2011.0216; Klepac P, 2011, P NATL ACAD SCI USA, V108, P14366, DOI 10.1073/pnas.1101694108; Meentemeyer RK, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00192.1; Meloni S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00062; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Oles K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036026; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Stacey AJ, 2004, PHYTOPATHOLOGY, V94, P209, DOI 10.1094/PHYTO.2004.94.2.209; Stoner BP, 2000, SEX TRANSM DIS, V27, P215, DOI 10.1097/00007435-200004000-00006; Verdasca J, 2005, J THEOR BIOL, V233, P553, DOI 10.1016/j.jtbi.2004.10.031; Watts Duncan J., 2003, SMALL WORLDS DYNAMIC; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661	40	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e63813	10.1371/journal.pone.0063813	http://dx.doi.org/10.1371/journal.pone.0063813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750205	Green Published, gold, Green Accepted			2022-12-25	WOS:000319961900007
J	Liao, Y; Miao, DM; Huan, Y; Yin, H; Xi, YB; Liu, XF				Liao, Yang; Miao, Danmin; Huan, Yi; Yin, Hong; Xi, Yibin; Liu, Xufeng			Altered Regional Homogeneity with Short-term Simulated Microgravity and Its Relationship with Changed Performance in Mental Transformation	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; PROLONGED WEIGHTLESSNESS; RESPONSE-INHIBITION; FRONTAL-CORTEX; BODY PARTS; BRAIN; ROTATION; FMRI; NETWORKS; SYSTEM	In order to further the insight into the explanation of changed performance in mental transformation under microgravity, we discuss the change of performance in mental transformation and its relationship with altered regional homogeneity (ReHo) in resting-state brain by using simulated weightlessness model. Twelve male subjects with age between 24 and 31 received resting-state fMRI scan and mental transformation test both in normal condition and immediately after 72 hours -6 degrees head down tilt (HDT). A paired sample t-test was used to test the difference of behavior performance and brain activity between these two conditions. Compare with normal condition, subjects showed a changed performance in mental transformation with short term simulated microgravity and appeared to be falling. Meanwhile, decreased ReHo were found in right inferior frontal gyrus (IFG) and left inferior parietal lobule (IPL) after 72 hours -6 degrees HDT, while increased ReHo were found in bilateral medial frontal gyrus (MFG) and left superior frontal gyrus (SFG) (P<0.05, corrected). Particularly, there was a significant correlation between ReHo values in left IPL and velocity index of mental transformation. Our findings indicate that gravity change may disrupt the function of right IFG and left IPL in the resting-state, among of which functional change in left IPL may contribute to changed abilities of mental transformation. In addition, the enhanced activity of the bilateral MFG and decreased activity of right IFG found in the current study maybe reflect a complementation effect on inhibitory control process.	[Liao, Yang; Miao, Danmin; Liu, Xufeng] Fourth Mil Med Univ, Dept Psychol, Xian 710032, Shaanxi, Peoples R China; [Huan, Yi; Yin, Hong; Xi, Yibin] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Miao, DM (corresponding author), Fourth Mil Med Univ, Dept Psychol, Xian 710032, Shaanxi, Peoples R China.	psych@fmmu.edu.cn; lllfmmu@fmmu.edu.cn	Yin, Hong/AAC-5784-2020; Yin, Hong/G-3877-2014; Liao, Yang/A-6479-2016	Yin, Hong/0000-0002-5215-1455; Liao, Yang/0000-0003-0969-235X	National Science Foundation of China [81071616, 81272174]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China, Grant No. 81071616 and No. 81272174. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; BAISCH F, 1992, ACTA PHYSIOL SCAND, V144, P1; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Cutini S, 2008, NEUROIMAGE, V42, P945, DOI 10.1016/j.neuroimage.2008.05.013; Dalecki M, 2012, HUM MOVEMENT SCI, V31, P1151, DOI 10.1016/j.humov.2011.12.001; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eddy DR, 1998, ACTA ASTRONAUT, V43, P193, DOI 10.1016/S0094-5765(98)00154-4; Grabherr L, 2007, J VESTIBUL RES-EQUIL, V17, P279; Grigoriev A I, 1992, Adv Space Biol Med, V2, P1, DOI 10.1016/S1569-2574(08)60016-7; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Jenkin MR, 2011, SEEING PERCEIVING, V24, P53, DOI 10.1163/187847511X555292; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Leone G, 1995, ACTA ASTRONAUT, V36, P743, DOI 10.1016/0094-5765(95)00165-4; Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026; Liao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052558; Lin XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043373; Liu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048181; Liu DQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00024; Martino J, 2011, NEUROSCIENCE, V179, P131, DOI 10.1016/j.neuroscience.2011.01.047; MATSAKIS Y, 1993, EXP BRAIN RES, V94, P152; McLellan TL, 2012, NEUROSCI LETT, V531, P149, DOI 10.1016/j.neulet.2012.10.039; Messerotti Benvenuti S, 2011, PHYSIOL BEHAV, V104, P503, DOI 10.1016/j.physbeh.2011.05.019; Morphew M.E., 2001, MCGILL J MED, V6, P74; Newberg AB, 1998, ADV SPACE RES-SERIES, V22, P185, DOI 10.1016/S0273-1177(98)80010-0; Ni L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042016; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Overney  LS, 2005, COGNITIVE BRAIN RES, V25, P722, DOI 10.1016/j.cogbrainres.2005.09.024; Palinkas L A, 2001, Gravit Space Biol Bull, V14, P25; Pattyn N, 2009, ACTA ASTRONAUT, V65, P325, DOI 10.1016/j.actaastro.2009.01.063; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; RAU H, 1993, PSYCHOPHYSIOLOGY, V30, P322, DOI 10.1111/j.1469-8986.1993.tb03359.x; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Sandal G M, 2001, Gravit Space Biol Bull, V14, P47; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Slagter HA, 2006, COGN AFFECT BEHAV NE, V6, P175, DOI 10.3758/CABN.6.3.175; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Talairach J., 1988, COPLANAR STEREOTAXIC; Vaitl D, 1996, BIOL PSYCHOL, V42, P87, DOI 10.1016/0301-0511(95)05148-1; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Villard E, 2005, NEUROREPORT, V16, P1395, DOI 10.1097/01.wnr.0000174060.34274.3e; Vingerhoets G, 2002, NEUROIMAGE, V17, P1623, DOI 10.1006/nimg.2002.1290; Wang DY, 2012, NEUROREPORT, V23, P873, DOI 10.1097/WNR.0b013e3283587c96; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; You H, 2011, NEUROSCI LETT, V502, P18, DOI 10.1016/j.neulet.2011.07.015; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	57	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64931	10.1371/journal.pone.0064931	http://dx.doi.org/10.1371/journal.pone.0064931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755162	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300039
J	Balakrishnan, A; Jordan, F; Nathan, CF				Balakrishnan, Anand; Jordan, Frank; Nathan, Carl F.			Influence of Allosteric Regulators on Individual Steps in the Reaction Catalyzed by Mycobacterium tuberculosis 2-Hyd roxy-3-oxoadipate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Allosteric Regulation; Bacteria; Metabolism; Mycobacterium tuberculosis; 2-Hydroxy-3-oxoadipate Synthase; Thiamin Diphosphate-dependent Enzymes	GLYOXYLATE CARBOLIGASE ACTIVITY; ALPHA-KETOGLUTARATE; ACETOHYDROXYACID SYNTHASE; THIAMIN DIPHOSPHATE; PYRUVATE-DEHYDROGENASE; RATE CONSTANTS; PROTEIN; IDENTIFICATION; ACID; COMPLEX	Allosteric regulation often controls key branch points in metabolic processes. Mycobacterium tuberculosis 2-hydroxy-3-oxoadipate synthase (HOAS), a thiamin diphosphate (ThDP)-dependent enzyme, produces 2-hydroxy-3-oxoadipate using 2-ketoglutarate and glyoxylate. The proposed chemical mechanism in analogy with other ThDP-dependent carboligases involves multiple ThDP-bound covalent intermediates. Acetyl coenzyme A is an activator, and GarA, a forkhead association domain-containing protein known to regulate glutamate metabolism, is an allosteric inhibitor of HOAS. Steady state kinetics using assays to study the first half and the full catalytic cycle suggested that the regulators act at different steps in the overall mechanism. To explore the modes of regulation and to test the effects on individual catalytic steps, we performed circular dichroism (CD) studies using a non-decarboxylatable 2-ketoglutarate analog and determined the distribution of ThDP-bound covalent intermediates during the steady state of the HOAS reaction using one-dimensional H-1 gradient carbon heteronuclear single quantum coherence NMR. The results suggest that acetyl coenzyme A acts as a mixed V and K type activator and predominantly affects the predecarboxylation steps. GarA does not inhibit the formation of the predecarboxylation analog and does not affect the accumulation of the postdecarboxylation covalent intermediate derived from 2-ketoglutarate; however, it decreases the abundance of the product ThDP adduct in the HOAS pathway. Thus, the two regulators act on different halves of the catalytic cycle in an unusual regulatory regime.	[Balakrishnan, Anand; Nathan, Carl F.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA	Cornell University; Rutgers State University Newark; Rutgers State University New Brunswick	Nathan, CF (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA.	cnathan@med.cornell.edu		Balakrishnan, Anand/0000-0002-5778-3857	National Institutes of Health [R01 A1064768, GM 050380]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 A1064768 (to C.F.N.) and GM 050380 (to F.J.).	Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; Balakrishnan A, 2012, J AM CHEM SOC, V134, P3873, DOI 10.1021/ja211139c; Baykal A, 2006, BIOORG CHEM, V34, P380, DOI 10.1016/j.bioorg.2006.09.006; Beigi M, 2013, ORG LETT, V15, P452, DOI 10.1021/ol3031186; Belenky I, 2012, FEBS J, V279, P1967, DOI 10.1111/j.1742-4658.2012.08577.x; Bott M, 2007, TRENDS MICROBIOL, V15, P417, DOI 10.1016/j.tim.2007.08.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brammer LA, 2011, J BIOL CHEM, V286, P36522, DOI 10.1074/jbc.M111.259747; Bunik VI, 2005, BIOCHEMISTRY-US, V44, P10552, DOI 10.1021/bi0503100; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Chipman D, 1998, BBA-PROTEIN STRUCT M, V1385, P401, DOI 10.1016/S0167-4838(98)00083-1; Choi KJ, 2005, FEBS LETT, V579, P4903, DOI 10.1016/j.febslet.2005.07.055; Cleland W W, 1979, Methods Enzymol, V63, P500; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; de Souza GA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-316; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Kaplun A, 2008, NAT CHEM BIOL, V4, P113, DOI 10.1038/nchembio.62; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; MENTCH F, 1987, BIOCHEMISTRY-US, V26, P921, DOI 10.1021/bi00377a037; Meyer D, 2011, J AM CHEM SOC, V133, P3609, DOI 10.1021/ja110236w; Nemeria N, 2005, J BIOL CHEM, V280, P21473, DOI 10.1074/jbc.M502691200; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; OFALLON JV, 1977, BIOCHIM BIOPHYS ACTA, V499, P321, DOI 10.1016/0304-4165(77)90063-0; Patel H, 2012, J AM CHEM SOC, V134, P18374, DOI 10.1021/ja307315u; Porat I, 2004, J BACTERIOL, V186, P570, DOI 10.1128/JB.186.2.570-574.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHLOSSB.MA, 1968, BIOCHEMISTRY-US, V7, P333, DOI 10.1021/bi00841a042; Schramm VL, 1998, ANNU REV BIOCHEM, V67, P693, DOI 10.1146/annurev.biochem.67.1.693; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; Shim DJ, 2011, BIOCHEMISTRY-US, V50, P7705, DOI 10.1021/bi200936n; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Tittmann K, 2005, P NATL ACAD SCI USA, V102, P553, DOI 10.1073/pnas.0408210101; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Vinogradov M, 2005, ANAL BIOCHEM, V342, P126, DOI 10.1016/j.ab.2005.03.049; Wagner T, 2011, CHEM BIOL, V18, P1011, DOI 10.1016/j.chembiol.2011.06.004; Werther T, 2008, J BIOL CHEM, V283, P5344, DOI 10.1074/jbc.M706569200; YAMASAKI H, 1971, BIOCHIM BIOPHYS ACTA, V242, P637, DOI 10.1016/0005-2744(71)90156-2; YAMASAKI H, 1970, BIOCHEM BIOPH RES CO, V38, P638, DOI 10.1016/0006-291X(70)90628-5; YAMASAKI H, 1970, BIOCHEM BIOPH RES CO, V39, P790, DOI 10.1016/0006-291X(70)90392-X	44	17	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21688	21702		10.1074/jbc.M113.465419	http://dx.doi.org/10.1074/jbc.M113.465419			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760263	Green Published, hybrid			2022-12-25	WOS:000328841900021
J	Ellerbe, CN; Gebregziabher, M; Korte, JE; Mauldin, J; Hunt, KJ				Ellerbe, Caitlyn N.; Gebregziabher, Mulugeta; Korte, Jeffrey E.; Mauldin, Jill; Hunt, Kelly J.			Quantifying the Impact of Gestational Diabetes Mellitus, Maternal Weight and Race on Birthweight via Quantile Regression	PLOS ONE			English	Article							PIMA-INDIANS; INTRAUTERINE ENVIRONMENT; PREGNANCY OUTCOMES; GLUCOSE-TOLERANCE; NORTH-CAROLINA; WHITE INFANTS; UNITED-STATES; RISK-FACTORS; WOMEN; BLACK	Background: Quantile regression, a robust semi-parametric approach, was used to examine the impact of gestational diabetes mellitus (GDM) across birthweight quantiles with a focus on maternal prepregnancy body mass index (BMI) and gestational weight gain (GWG). Methods: Using linked birth certificate, inpatient hospital and prenatal claims data we examined live singleton births to non-Hispanic white (NHW, 135,119) and non-Hispanic black (NHB, 76,675) women in South Carolina who delivered 28-44 weeks gestation in 2004-2008. Results: At a maternal BMI of 30 kg/m(2) at the 90th quantile of birthweight, exposure to GDM was associated with birthweights 84 grams (95% CI 57, 112) higher in NHW and 132 grams (95% CI: 104, 161) higher in NHB. Results at the 50th quantile were 34 grams (95% CI: 17, 51) and 78 grams (95% CI: 56, 100), respectively. At a maternal GWG of 13.5 kg at the 90th quantile of birthweight, exposure to GDM was associated with birthweights 83 grams (95% CI: 57, 109) higher in NHW and 135 grams (95% CI: 103, 167) higher in NHB. Results at the 50th quantile were 55 grams (95% CI: 40, 71) and 69 grams (95% CI: 46, 92), respectively. Summary: Our findings indicate that GDM, maternal prepregnancy BMI and GWG increase birthweight more in NHW and NHB infants who are already at the greatest risk of macrosomia or being large for gestational age (LGA), that is those at the 90th rather than the median of the birthweight distribution.	[Ellerbe, Caitlyn N.; Gebregziabher, Mulugeta; Korte, Jeffrey E.; Hunt, Kelly J.] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Gebregziabher, Mulugeta; Hunt, Kelly J.] Med Univ S Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA; [Mauldin, Jill] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Hunt, KJ (corresponding author), Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.	huntke@musc.edu		Gebregziabher, Mulugeta/0000-0002-4826-481X; Meinzer, Caitlyn/0000-0002-9905-4329	National Center on Minority Health and Health Disparities [R01-MD004251]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [R01MD004251] Funding Source: NIH RePORTER	National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a grant from the National Center on Minority Health and Health Disparities (R01-MD004251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrevaya J., 2001, EMPIR ECON, V26, P247, DOI DOI 10.1007/S001810000052; Alexander G R, 1999, Matern Child Health J, V3, P71, DOI 10.1023/A:1021849209722; Alexander GR, 1996, PUBLIC HEALTH REP, V111, P408; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; BERKOWITZ GS, 1992, AM J EPIDEMIOL, V135, P965, DOI 10.1093/oxfordjournals.aje.a116408; Boardman JD, 2002, DEMOGRAPHY, V39, P353, DOI 10.2307/3088343; BUESCHER PA, 1993, AM J PUBLIC HEALTH, V83, P1163, DOI 10.2105/AJPH.83.8.1163; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; DelPriore G, 1997, OBSTET GYNECOL, V89, P351, DOI 10.1016/S0029-7844(96)00504-2; DORNHORST A, 1992, DIABETIC MED, V9, P820, DOI 10.1111/j.1464-5491.1992.tb01900.x; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Froslie KF, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-103; Gaete X, 2010, FERTIL STERIL, V94, P1822, DOI 10.1016/j.fertnstert.2009.08.039; Gebregziabher M, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-88; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1317, DOI 10.1016/S0002-9378(96)70048-0; HANSON RL, 1995, AM J HUM GENET, V57, P160; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; Hunt KJ, 2012, DIABETOLOGIA; Hunt KJ, 2012, MATERN CHILD HLTH J; *I MED NAT RES COU, 2009, WEIGHT GAIN PREGN RE; Kieffer EC, 1998, AM J EPIDEMIOL, V147, P1053; Kim SY, 2011, EXP DIABETES RES, DOI 10.1155/2011/541308; KOENKER R., 2010, QUANTREG QUANTILE RE; KRAMER MS, 1988, JAMA-J AM MED ASSOC, V260, P3306, DOI 10.1001/jama.260.22.3306; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Lederman S A, 1998, Matern Child Health J, V2, P123; Lydon-Rochelle MT, 2005, AM J OBSTET GYNECOL, V193, P125, DOI 10.1016/j.ajog.2005.02.096; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; OSULLIVAN JB, 1966, OBSTET GYNECOL, V27, P683; Park S, 2009, MATERN CHILD HLTH J; PETTITT DJ, 1980, DIABETES CARE, V3, P458, DOI 10.2337/diacare.3.3.458; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Pettitt DJ, 1998, DIABETES CARE, V21, pB138; PETTITT DJ, 1987, DIABETES CARE, V10, P76, DOI 10.2337/diacare.10.1.76; R Development Core Team R, 2009, R LANG ENV STAT COMP; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Saldana TM, 2003, DIABETES CARE, V26, P656, DOI 10.2337/diacare.26.3.656; Scholl TO, 2002, AM J EPIDEMIOL, V156, P498, DOI 10.1093/aje/kwf080; SILVERMAN BL, 1991, DIABETES, V40, P121, DOI 10.2337/diab.40.2.S121; Singh KA, 2010, OBSTET GYNECOL, V115, P998, DOI 10.1097/AOG.0b013e3181da901a; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Strotmeyer ES, 2003, DIABETES CARE, V26, P1016, DOI 10.2337/diacare.26.4.1016; Terry MB, 2007, AM J EPIDEMIOL, V166, P5, DOI 10.1093/aje/kwm094; Wei Y, 2006, STAT MED, V25, P1369, DOI 10.1002/sim.2271; WILCOX A, 1990, J PEDIATR-US, V116, P7, DOI 10.1016/S0022-3476(05)81638-5; ZHANG SM, 1995, BRIT MED J, V311, P1139, DOI 10.1136/bmj.311.7013.1139	51	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65017	10.1371/journal.pone.0065017	http://dx.doi.org/10.1371/journal.pone.0065017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762279	gold, Green Published, Green Submitted			2022-12-25	WOS:000320440500018
J	Lin, YH; Lin, SH; Li, P; Huang, WL; Chen, CY				Lin, Yu-Hsuan; Lin, Sheng-Hsuan; Li, Peng; Huang, Wei-Lieh; Chen, Ching-Yen			Prevalent Hallucinations during Medical Internships: Phantom Vibration and Ringing Syndromes	PLOS ONE			English	Article							TRIDIMENSIONAL PERSONALITY QUESTIONNAIRE; POSTTRAUMATIC-STRESS-DISORDER; AUDITORY HALLUCINATIONS; SCHIZOPHRENIA; EXPERIENCES; INVENTORY; ANXIETY; REWARD; MODEL	Background: Phantom vibration syndrome is a type of hallucination reported among mobile phone users in the general population. Another similar perception, phantom ringing syndrome, has not been previously described in the medical literature. Methods: A prospective longitudinal study of 74 medical interns (46 males, 28 females; mean age, 24.8 +/- 1.2 years) was conducted using repeated investigations of the prevalence and associated factors of phantom vibration and ringing. The accompanying symptoms of anxiety and depression were evaluated with the Beck Anxiety and Depression Inventories before the internship began, and again at the third, sixth, and twelfth internship months, and two weeks after the internship ended. Results: The baseline prevalence of phantom vibration was 78.1%, which increased to 95.9% and 93.2% in the third and sixth internship months. The prevalence returned to 80.8% at the twelfth month and decreased to 50.0% 2 weeks after the internship ended. The baseline prevalence of phantom ringing was 27.4%, which increased to 84.9%, 87.7%, and 86.3% in the third, sixth, and twelfth internship months, respectively. This returned to 54.2% two weeks after the internship ended. The anxiety and depression scores also increased during the internship, and returned to baseline two weeks after the internship. There was no significant correlation between phantom vibration/ringing and symptoms of anxiety or depression. The incidence of both phantom vibration and ringing syndromes significantly increased during the internship, and subsequent recovery. Conclusion: This study suggests that phantom vibration and ringing might be entities that are independent of anxiety or depression during evaluation of stress-associated experiences during medical internships.	[Lin, Yu-Hsuan; Huang, Wei-Lieh] Natl Taiwan Univ Hosp, Dept Psychiat, Yun Lin Branch, Yunlin, Taiwan; [Lin, Sheng-Hsuan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Li, Peng; Chen, Ching-Yen] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan; [Li, Peng; Chen, Ching-Yen] Chang Gung Mem Hosp Lin Kou, Dept Psychiat, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Chang Gung University; Chang Gung Memorial Hospital	Chen, CY (corresponding author), Chang Gung Univ, Sch Med, Tao Yuan, Taiwan.	psycychen@yahoo.com.tw	Huang, Wei-Lieh/AAB-4851-2022	Lin, Sheng-Hsuan/0000-0003-0714-2354; Lin, Yu-Hsuan/0000-0001-9393-3886	National Science Council in Taiwan [NSC 100-2815-C-182A-002-B]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council in Taiwan (NSC 100-2815-C-182A-002-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2003, SCHIZOPHR RES, V64, P175, DOI 10.1016/S0920-9964(03)00060-4; Baillie DWH, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d299; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bermpohl F, 2008, PSYCHIAT RES-NEUROIM, V164, P81, DOI 10.1016/j.pscychresns.2007.12.019; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Camm AJ, 1996, CIRCULATION, V93, P1043; Che HH, 2006, FORMOSAN J MED, V10, P447, DOI DOI 10.6320/FJM.2006.10(4).05; Chen WJ, 2002, COMPR PSYCHIAT, V43, P158, DOI 10.1053/comp.2002.30797; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; Cotter D, 2002, BRIT J PSYCHIAT, V181, P363, DOI 10.1192/bjp.181.5.363; EYSENCK HJ, 1992, PERS INDIV DIFFER, V13, P757, DOI 10.1016/0191-8869(92)90050-Y; Heinz A, 1999, NERVENARZT, V70, P391, DOI 10.1007/s001150050454; Javitt DC, 2008, NAT REV DRUG DISCOV, V7, P68, DOI 10.1038/nrd2463; Langer AI, 2011, INT J PSYCHOL, V46, P46, DOI 10.1080/00207594.2010.503760; Lin YH, 2013, PSYCHOPHYSIOLOGY, V50, P521, DOI 10.1111/psyp.12038; Lin YH, 2012, STRESS, V15, P21, DOI 10.3109/10253890.2011.572208; MUESER KT, 1987, AM J PSYCHIAT, V144, P299; PENNEBAKER JW, 1981, J PERS SOC PSYCHOL, V41, P213, DOI 10.1037/0022-3514.41.2.213; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; REES WD, 1971, BRIT MED J, V4, P37, DOI 10.1136/bmj.4.5778.37; Rothberg MB, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6914; SHEK DTL, 1990, J CLIN PSYCHOL, V46, P35, DOI 10.1002/1097-4679(199001)46:1<35::AID-JCLP2270460106>3.0.CO;2-W; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Steel C, 2011, J NERV MENT DIS, V199, P709, DOI 10.1097/NMD.0b013e318229d6e8; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Os J, 2005, CURR OPIN PSYCHIATR, V18, P141, DOI 10.1097/00001504-200503000-00006; Vellante M, 2012, J NERV MENT DIS, V200, P310, DOI 10.1097/NMD.0b013e31824cb2ba; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P683, DOI 10.1093/schbul/sbs045; Welham J, 2009, SCHIZOPHRENIA BULL, V35, P603, DOI 10.1093/schbul/sbn084; WILCOX J, 1991, COMPR PSYCHIAT, V32, P320, DOI 10.1016/0010-440X(91)90080-V; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	33	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65152	10.1371/journal.pone.0065152	http://dx.doi.org/10.1371/journal.pone.0065152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	164VY	23762302	Green Published, gold, Green Submitted			2022-12-25	WOS:000320440500029
J	Georgakopoulos, P; Lockington, RA; Kelly, JM				Georgakopoulos, Paraskevi; Lockington, Robin A.; Kelly, Joan M.			The Spt-Ada-Gcn5 Acetyltransferase (SAGA) Complex in Aspergillus nidulans	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; HISTONE H3 ACETYLATION; SACCHAROMYCES-CEREVISIAE; NUCLEOSOME ACETYLATION; ELONGATION-FACTORS; YEAST; TRANSCRIPTION; DEUBIQUITINATION; COMPONENTS; GENE	A mutation screen in Aspergillus nidulans uncovered mutations in the acdX gene that led to altered repression by acetate, but not by glucose. AcdX of A. nidulans is highly conserved with Spt8p of Saccharomyces cerevisiae, and since Spt8p is a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) complex, the SAGA complex may have a role in acetate repression in A. nidulans. We used a bioinformatic approach to identify genes encoding most members of the SAGA complex in A. nidulans, and a proteomic analysis to confirm that most protein components identified indeed exist as a complex in A. nidulans. No apparent compositional differences were detected in mycelia cultured in acetate compared to glucose medium. The methods used revealed apparent differences between Yeast and A. nidulans in the deubiquitination (DUB) module of the complex, which in S. cerevisiae consists of Sgf11p, Sus1p, and Ubp8p. Although a convincing homologue of S. cerevisiae Ubp8p was identified in the A. nidulans genome, there were no apparent homologues for Sus1p and Sgf11p. In addition, when the SAGA complex was purified from A. nidulans, members of the DUB module were not co-purified with the complex, indicating that functional homologues of Sus1p and Sgf11p were not part of the complex. Thus, deubiquitination of H2B-Ub in stress conditions is likely to be regulated differently in A. nidulans compared to S. cerevisiae.	[Georgakopoulos, Paraskevi; Lockington, Robin A.; Kelly, Joan M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Kelly, JM (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	joan.kelly@adelaide.edu.au	Nagamune, Teruyuki/R-7708-2017; Lockington, Robin/F-3715-2013	Nagamune, Teruyuki/0000-0002-2435-0270; 	University of Adelaide; School of Molecular and Biomedical Science	University of Adelaide; School of Molecular and Biomedical Science	Paraskevi Georgakopolous was supported by a University of Adelaide Post-graduate Research Scholarship. The research was funded internally with School of Molecular and Biomedical Science funds, with no external sources of funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; David H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r108; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Georgakopoulos P, 2012, G3-GENES GENOM GENET, V2, P1357, DOI 10.1534/g3.112.003913; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, MOL CELL, V2, P863, DOI 10.1016/S1097-2765(00)80300-7; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Kelly JM, 2004, MYCOTA, V3, P385; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Liu XH, 2008, MOL CELL BIOL, V28, P108, DOI 10.1128/MCB.01402-07; Lockington RA, 2001, MOL MICROBIOL, V40, P1311, DOI 10.1046/j.1365-2958.2001.02474.x; Malavazi I, 2006, EUKARYOT CELL, V5, P1688, DOI 10.1128/EC.00167-06; Masuo S, 2010, MOL GENET GENOMICS, V284, P415, DOI 10.1007/s00438-010-0576-x; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Mutiu AI, 2007, GENETICS, V177, P151, DOI 10.1534/genetics.107.074476; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Nutzmann HW, 2011, P NATL ACAD SCI USA, V108, P14282, DOI 10.1073/pnas.1103523108; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Reyes-Dominguez Y, 2008, EUKARYOT CELL, V7, P656, DOI 10.1128/EC.00184-07; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; Tran HG, 2000, EMBO J, V19, P2323, DOI 10.1093/emboj/19.10.2323	38	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65221	10.1371/journal.pone.0065221	http://dx.doi.org/10.1371/journal.pone.0065221			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762321	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000321094800027
J	Franzi, S; Salajegheh, M; Nazareno, R; Greenberg, SA				Franzi, Sara; Salajegheh, Mohammad; Nazareno, Remedios; Greenberg, Steven A.			Type 1 Interferons Inhibit Myotube Formation Independently of Upregulation of Interferon-Stimulated Gene 15	PLOS ONE			English	Article							TUBULORETICULAR INCLUSIONS; DISEASE-ACTIVITY; I INTERFERON; DERMATOMYOSITIS; EXPRESSION; CELLS; ISG15; CONJUGATION; MUSCLE; BETA	Introduction: Type 1 interferon (IFN)-inducible genes and their inducible products are upregulated in dermatomyositis muscle. Of these, IFN-stimulated gene 15 (ISG15) is one of the most upregulated, suggesting its possible involvement in the pathogenesis of this disease. To test this postulate, we developed a model of type 1 IFN mediated myotube toxicity and assessed whether or not downregulation of ISG15 expression prevents this toxicity. Methods: Mouse myoblasts (C2C12 cell line) were cultured in the presence of type 1 or type 2 IFNs and ISG15 expression assessed by microarray analysis. The morphology of newly formed myotubes was assessed by measuring their length, diameter, and area on micrographs using imaging software. ISG15 expression was silenced through transfection with small interference RNA. Results: Type 1 IFNs, especially IFN-beta, increased ISG15 expression in C2C12 cells and impaired myotube formation. Silencing of ISG15 resulted in knockdown of ISG15 protein, but without phenotypic rescue of myotube formation. Discussion: IFN-beta affects myoblast differentiation ability and myotube morphology in vitro. These studies provide evidence that ISG15, which is highly upregulated in dermatomyositis muscle, does not appear to play a key role in IFN-betamediated C2C12 myoblast cell fusion.	[Franzi, Sara; Salajegheh, Mohammad; Greenberg, Steven A.] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Franzi, Sara] Fdn Ist Neurol Carlo Besta, Dept Neurol Neuromuscular Dis & Neuroimmunol 4, Milan, Italy; [Salajegheh, Mohammad; Nazareno, Remedios; Greenberg, Steven A.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Salajegheh, Mohammad; Greenberg, Steven A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; IRCCS Istituto Neurologico Besta; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Greenberg, SA (corresponding author), Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA.	sagreenberg@partners.org	Franzi, Sara/AAB-7683-2020	Franzi, Sara/0000-0003-1767-3431	Muscular Dystrophy Association [MDA56979]	Muscular Dystrophy Association(Muscular Dystrophy Association)	This study was sponsored by the Muscular Dystrophy Association (grant MDA56979 to Dr. Greenberg). No additional external funding was received for this study. The named funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Dr. Franzi, Dr. Salajegheh, Mrs. Nazareno, and Dr. Greenberg report no further financial disclosures in regards to this study.	Cappelletti C, 2011, NEUROLOGY, V76, P2079, DOI 10.1212/WNL.0b013e31821f440a; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; de Padilla CML, 2007, ARTHRITIS RHEUM, V56, P1658, DOI 10.1002/art.22558; FELDMAN D, 1988, LAB INVEST, V58, P584; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Greenberg SA, 2012, GENES IMMUN, V13, P207, DOI 10.1038/gene.2011.61; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Greenberg SA, 2002, NEUROLOGY, V59, P1170, DOI 10.1212/WNL.59.8.1170; GRIMLEY PM, 1984, CANCER RES, V44, P3480; KUYAMA J, 1986, ULTRASTRUCT PATHOL, V10, P77, DOI 10.3109/01913128609015565; Liao AP, 2011, ANN RHEUM DIS, V70, P831, DOI 10.1136/ard.2010.139949; Magro CM, 2010, J CUTAN PATHOL, V37, P659, DOI 10.1111/j.1600-0560.2009.01443.x; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; RICH SA, 1983, LANCET, V1, P127; Salaiegheh M, 2010, ANN NEUROL, V67, P53, DOI 10.1002/ana.21805; Schirmer SH, 2010, J BIOL CHEM, V285, P34677, DOI 10.1074/jbc.M110.164350; Shrestha S, 2010, ARTHRITIS RHEUM-US, V62, P2813, DOI 10.1002/art.27529; Slaton JW, 1999, CLIN CANCER RES, V5, P2726; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tezak Z, 2002, J IMMUNOL, V168, P4154, DOI 10.4049/jimmunol.168.8.4154; Walsh RJ, 2007, ARTHRITIS RHEUM, V56, P3784, DOI 10.1002/art.22928; Wong D, 2011, PLOS ONE, V7; Xiao HB, 2011, GENE THER; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	25	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65362	10.1371/journal.pone.0065362	http://dx.doi.org/10.1371/journal.pone.0065362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750257	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900059
J	Loggi, E; Bihl, FK; Cursaro, C; Granieri, C; Galli, S; Brodosi, L; Furlini, G; Bernardi, M; Brander, C; Andreone, P				Loggi, Elisabetta; Bihl, Florian K.; Cursaro, Carmela; Granieri, Camilla; Galli, Silvia; Brodosi, Lucia; Furlini, Giuliano; Bernardi, Mauro; Brander, Christian; Andreone, Pietro			Virus-Specific Immune Response in HBeAg-Negative Chronic Hepatitis B: Relationship with Clinical Profile and HBsAg Serum Levels	PLOS ONE			English	Article							CD8(+) T-CELLS; SURFACE-ANTIGEN; CORE; QUANTIFICATION	Background & Aims: The immune impairment characterizing chronic hepatitis B (cHBV) infection is thought to be the consequence of persistent exposure to viral antigens. However, the immune correlates of different clinical stages of cHBV and their relation with different levels of HBsAg have not been investigated. The aim of the present study was to evaluate the relationship between HBV-specific T cells response and the degree of in vivo HBV control and HBsAg serum levels in HBeAg-HBeAb+ cHBV. Methods: Peripheral blood mononuclear cells from 42 patients with different clinical profiles (treatment-suppressed, inactive carriers and active hepatitis) of cHBV, 6 patients with resolved HBV infection and 10 HBV-uninfected individuals were tested with overlapping peptides spanning the entire HBV proteome. The frequency and magnitude of HBV-specific T cell responses was assessed by IFN gamma ELISPOT assay. Serum HBsAg was quantified with a chemiluminescent immunoassay. Results: The total breadth and magnitude of HBV-specific T cell responses did not differ significantly between the four groups. However, inactive carriers targeted preferentially the core region. In untreated patients, the breadth of the anti-core specific T cell response was inversely correlated with serum HBsAg concentrations as well as HBV-DNA and ALT levels and was significantly different in patients with HBsAg levels either above or below 1000 IU/mL. The same inverse association between anti-core T cell response and HBsAg levels was found in treated patients. Conclusions: Different clinical outcomes of cHBV infection are associated with the magnitude, breadth and specificity of the HBV-specific T cell response. Especially, robust anti-core T cell responses were found in the presence of reduced HBsAg serum levels, suggesting that core-specific T cell responses can mediate a protective effect on HBV control.	[Loggi, Elisabetta; Cursaro, Carmela; Granieri, Camilla; Brodosi, Lucia; Bernardi, Mauro; Andreone, Pietro] Univ Bologna, Dept Med & Surg Scinces, Bologna, Italy; [Bihl, Florian K.] EOC, Osped Reg Bellinzona & Valli, Gastroenterol Sect, Bellinzona, Switzerland; [Galli, Silvia; Furlini, Giuliano] Univ Bologna, Microbiol Sect, Dept Clin & Expt Med, Bologna, Italy; [Brander, Christian] Autonomous Univ Barcelona, Hosp Germans Trias & Pujol, AIDS Res Inst IrsiCaixa HIVACAT, Barcelona, Spain; [Brander, Christian] ICREA, Barcelona, Spain	University of Bologna; Regional Hospital of Bellinzona & Valleys, San Giovanni; University of Bologna; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; ICREA	Andreone, P (corresponding author), Univ Bologna, Dept Med & Surg Scinces, Bologna, Italy.	pietro.andreone@unibo.it	Furlini, Giuliano/ABB-1290-2020; Brodosi, Lucia/ABF-6692-2020; Andreone, Pietro/K-8050-2016; Loggi, Elisabetta/K-7848-2016	Brodosi, Lucia/0000-0002-7735-7847; Andreone, Pietro/0000-0002-4794-9809; Loggi, Elisabetta/0000-0003-4985-9783; Cursaro, Carmela/0000-0002-5644-2508; Brander, Christian/0000-0002-0548-5778	Focused Fundamental Research by the Ministry of Education, University and Research, Italy; ICREA Funding Source: Custom	Focused Fundamental Research by the Ministry of Education, University and Research, Italy; ICREA(ICREA)	Partial support by Focused Fundamental Research by the Ministry of Education, University and Research, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Bertoletti A, 2012, GUT, V61, P1754, DOI 10.1136/gutjnl-2011-301073; Bihl FK, 2005, J TRANSL MED, V3; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Brunetto MR, 2010, GASTROENTEROLOGY, V139, P483, DOI 10.1053/j.gastro.2010.04.052; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; FERRARI C, 1991, J CLIN INVEST, V88, P214, DOI 10.1172/JCI115280; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; Gehring AJ, 2007, J VIROL, V81, P2940, DOI 10.1128/JVI.02415-06; Heeg MHJ, 2007, J HEPATOL, V46, pS294, DOI 10.1016/S0168-8278(07)62380-0; Hsu CW, 2011, HEPATOLOGY, V54, P101, DOI 10.1002/hep.24363; Liaw YF, 2011, HEPATOLOGY, V54, pE1, DOI 10.1002/hep.24473; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Maini MK, 2010, J HEPATOL, V52, P616, DOI 10.1016/j.jhep.2009.12.017; Manesis EK, 2011, J HEPATOL, V55, P61, DOI 10.1016/j.jhep.2010.10.027; Menne S, 2002, J VIROL, V76, P1769, DOI 10.1128/JVI.76.4.1769-1780.2002; Milich DR, 1998, J IMMUNOL, V160, P2013; Moucari R, 2011, LIVER INT, V31, P122, DOI 10.1111/j.1478-3231.2010.02390.x; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pollicino T, 2012, HEPATOLOGY, V56, P434, DOI 10.1002/hep.25592; Rodella A, 2006, J CLIN VIROL, V37, P206, DOI 10.1016/j.jcv.2006.06.011; Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Thompson AJV, 2010, HEPATOLOGY, V51, P1933, DOI 10.1002/hep.23571; TSAI SL, 1992, J CLIN INVEST, V89, P87, DOI 10.1172/JCI115590; Volz T, 2007, GASTROENTEROLOGY, V133, P843, DOI 10.1053/j.gastro.2007.06.057; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006	30	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65327	10.1371/journal.pone.0065327	http://dx.doi.org/10.1371/journal.pone.0065327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750252	gold, Green Published, Green Submitted			2022-12-25	WOS:000319961900054
J	Tamburri, A; Dudilot, A; Licea, S; Bourgeois, C; Boehm, J				Tamburri, Albert; Dudilot, Anthony; Licea, Sara; Bourgeois, Catherine; Boehm, Jannic			NMDA-Receptor Activation but Not Ion Flux Is Required for Amyloid-Beta Induced Synaptic Depression	PLOS ONE			English	Article							LONG-TERM POTENTIATION; REGULATED PROTEIN-KINASE; ALZHEIMERS-DISEASE; IN-VIVO; SIGNALING PATHWAY; PLASTICITY; OLIGOMERS; CA1; PHOSPHORYLATION; TRAFFICKING	Alzheimer disease is characterized by a gradual decrease of synaptic function and, ultimately, by neuronal loss. There is considerable evidence supporting the involvement of oligomeric amyloid-beta (A beta) in the etiology of Alzheimer's disease. Historically, AD research has mainly focused on the long-term changes caused by A beta rather than analyzing its immediate effects. Here we show that acute perfusion of hippocampal slice cultures with oligomeric A beta depresses synaptic transmission within 20 minutes. This depression is dependent on synaptic stimulation and the activation of NMDA-receptors, but not on NMDA-receptor mediated ion flux. It, therefore, appears that A beta dependent synaptic depression is mediated through a use-dependent metabotropic-like mechanism of the NMDA-receptor, but does not involve NMDA-receptor mediated synaptic transmission, i.e. it is independent of calcium flux through the NMDA-receptor.	[Tamburri, Albert; Dudilot, Anthony; Licea, Sara; Bourgeois, Catherine; Boehm, Jannic] Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Boehm, J (corresponding author), Univ Montreal, Dept Physiol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada.	jannic.boehm@umontreal.ca	Boehm, Jannic/AAK-8882-2020	Tamburri, Albert/0000-0001-8274-5089	CIHR; Alzheimer Society Canada	CIHR(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Canada	This work was funded by grants from the CIHR and the Alzheimer Society Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Cheng L, 2009, SYNAPSE, V63, P206, DOI 10.1002/syn.20599; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harney SC, 2006, J NEUROSCI, V26, P1128, DOI 10.1523/JNEUROSCI.2753-05.2006; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu NW, 2009, P NATL ACAD SCI USA, V106, P20504, DOI 10.1073/pnas.0908083106; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; Kessels HW, 2013, P NATL ACAD SCI USA, V110, P4033, DOI 10.1073/pnas.1219605110; Kim JH, 2001, J NEUROSCI, V21, P1327; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Mondragon-Rodriguez S, 2012, J BIOL CHEM, V287, P32040, DOI 10.1074/jbc.M112.401240; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; SAMUEL W, 1994, ARCH NEUROL-CHICAGO, V51, P772, DOI 10.1001/archneur.1994.00540200048015; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004	33	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65350	10.1371/journal.pone.0065350	http://dx.doi.org/10.1371/journal.pone.0065350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750255	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900057
J	Furst, T; Ouattara, M; Silue, KD; N'Goran, DN; Adiossan, LG; Bogoch, II; N'Guessan, Y; Kone, S; Utzinger, J; N'Goran, EK				Fuerst, Thomas; Ouattara, Mamadou; Silue, Kigbafori D.; N'Goran, Dje N.; Adiossan, Lukas G.; Bogoch, Isaac I.; N'Guessan, Yao; Kone, Siaka; Utzinger, Juerg; N'Goran, Eliezer K.			Scope and Limits of an Anamnestic Questionnaire in a Control-Induced Low-Endemicity Helminthiasis Setting in South-Central Cote d'Ivoire	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SOIL-TRANSMITTED HELMINTHIASIS; SELF-REPORTED MORBIDITY; CONTROL PROGRAMS; STRONGYLOIDES-STERCORALIS; SCHISTOSOMA-MANSONI; INTEGRATED CONTROL; PARASITIC INFECTIONS; RISK-FACTORS; AFRICA	Background: Schistosomiasis and soil-transmitted helminthiasis are two high-burden neglected tropical diseases. In highly endemic areas, control efforts emphasize preventive chemotherapy. However, as morbidity, infection, and transmission begin to decrease, more targeted treatment is likely to become more cost-effective, provided that comparatively cheap diagnostic methods with reasonable accuracy are available. Methodology: Adults were administered an anamnestic questionnaire in mid-2010 during a cross-sectional epidemiological survey in the Taabo health demographic surveillance system in south-central Cote d'Ivoire. Questions pertaining to risk factors and signs and symptoms for schistosomiasis and soil-transmitted helminthiasis were included. The individuals' helminth infection status and their belonging to three different anthelmintic treatment groups were compared with the questionnaire results (i) to inform the local health authorities about the epidemiological and clinical footprint of locally prevailing helminthiases, and (ii) to explore the scope and limits of an anamnestic questionnaire as monitoring tool, which eventually could help guiding the control of neglected tropical diseases in control-induced low-endemicity settings. Principal Findings: Our study sample consisted of 195 adults (101 males, 94 females). We found prevalences of hookworm, Trichuris trichiura, Schistosoma haematobium, and Schistosoma mansoni of 39.0%, 2.7%, 2.1%, and 2.1%, respectively. No Ascaris lumbricoides infection was found. Helminth infection intensities were generally very low. Seven, 74 and 79 participants belonged to three different treatment groups. Multivariable logistic regression models revealed statistically significant (p<0.05) associations between some risk factors, signs, and symptoms, and the different helminth infections and treatment groups. However, the risk factors, signs, and symptoms showed weak diagnostic properties. Conclusions/Significance: The generally low prevalence and intensity of helminth infection in this part of south-central Cote d'Ivoire indicates that recent control efforts have turned our study area into a low endemicity setting. Our anamnestic questionnaire had low sensitivity and specificity to identify infected individuals or treatment groups.	[Fuerst, Thomas; Utzinger, Juerg] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Fuerst, Thomas; Utzinger, Juerg] Univ Basel, Basel, Switzerland; [Ouattara, Mamadou; Silue, Kigbafori D.; N'Goran, Eliezer K.] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire; [Silue, Kigbafori D.; N'Guessan, Yao; Kone, Siaka; N'Goran, Eliezer K.] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [N'Goran, Dje N.] Programme Natl Lutte Schistosomiase Geohelminthia, Abidjan, Cote Ivoire; [Adiossan, Lukas G.] Hop Gen Taabo, Taabo Cite, Cote Ivoire; [Bogoch, Isaac I.] Toronto Gen Hosp, Div Internal Med, Toronto, ON, Canada; [Bogoch, Isaac I.] Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Utzinger, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	juerg.utzinger@unibas.ch	Bogoch, Isaac/AAS-9631-2020	Kigbafori Dieudonne, Silue/0000-0003-1003-9294; Ouattara, Mamadou/0000-0002-4650-9676	Pro*Doc Research Module from the Swiss National Science Foundation (SNSF) [PDFMP3-123185]; SNSF [IZ70Z-123900]	Pro*Doc Research Module from the Swiss National Science Foundation (SNSF); SNSF(Swiss National Science Foundation (SNSF))	The authors thank Fairmed for sustained funding that allowed us to establish and run the Taabo health demographic surveillance system in south-central Cote d'Ivoire, and the accompanying health interventions with the aim to reduce the mortality and morbidity due to malaria and neglected tropical diseases. TF is associated to the National Centre of Competence in Research North-South and received financial support through a Pro*Doc Research Module from the Swiss National Science Foundation (SNSF; project no. PDFMP3-123185). Furthermore, he is thankful for a personal stipend from the Freiwillige Akademische Gesellschaft Basel. JU and EKN are grateful to the SNSF (project no. IZ70Z-123900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acka CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000910; [Anonymous], 2006, PREV CHEM HUM HELM C; [Anonymous], 2010, 1 WHO; Becker SL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001292; Bergquist R, 2009, TRENDS PARASITOL, V25, P151, DOI 10.1016/j.pt.2009.01.004; Booth M, 1998, T ROY SOC TROP MED H, V92, P484, DOI 10.1016/S0035-9203(98)90884-7; Brooker S, 2004, TRENDS PARASITOL, V20, P537, DOI 10.1016/j.pt.2004.08.012; Brooker S, 2009, PARASITOLOGY, V136, P1707, DOI 10.1017/S0031182009005940; Brooker S, 2009, MANSONS TROPICAL DIS, P1515; Brooker S, 2007, GEOSPATIAL HEALTH, V1, P141, DOI 10.4081/gh.2007.262; Cairncross S, 2012, TRENDS PARASITOL, V28, P225, DOI 10.1016/j.pt.2012.03.003; Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Ehrenberg JP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-119; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Furst T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001855; Furst T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000513; Gabrielli AF, 2011, T ROY SOC TROP MED H, V105, P683, DOI 10.1016/j.trstmh.2011.08.013; Glinz D, 2010, J PARASITOL, V96, P431, DOI 10.1645/GE-2294.1; Gray DJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2651; Group, 1990, STAND INSTR US MEAS; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guyatt HL, 1996, AM J TROP MED HYG, V55, P159, DOI 10.4269/ajtmh.1996.55.159; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Kabatereine NB, 2006, TRENDS PARASITOL, V22, P332, DOI 10.1016/j.pt.2006.05.001; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Knopp S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000681; Kolaczinski JH, 2007, TRENDS PARASITOL, V23, P485, DOI 10.1016/j.pt.2007.08.007; Lammie PJ, 2006, TRENDS PARASITOL, V22, P313, DOI 10.1016/j.pt.2006.05.009; Lengeler C, 2002, TRENDS PARASITOL, V18, P375, DOI 10.1016/S1471-4922(02)02318-8; Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; N'Goran EK, 1997, B WORLD HEALTH ORGAN, V75, P541; N'Goran EK, 2003, AM J TROP MED HYG, V68, P24, DOI 10.4269/ajtmh.2003.68.24; N'Goran EK, 2001, TROP MED INT HEALTH, V6, P817, DOI 10.1046/j.1365-3156.2001.00785.x; Olsen A, 2007, T ROY SOC TROP MED H, V101, P747, DOI 10.1016/j.trstmh.2007.03.006; QualityMetric, 2012, SF36 ORG COMM MEAS H; Raso G, 2005, TROP MED INT HEALTH, V10, P42, DOI 10.1111/j.1365-3156.2004.01352.x; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Raso G, 2007, GEOSPATIAL HEALTH, V2, P85, DOI 10.4081/gh.2007.257; Righetti AA, 2013, J INFECT DIS, V207, P1604, DOI 10.1093/infdis/jit066; Rollinson D, 2012, ACTA TROP IN PRESS, DOI DOI 10.1016/J.ACTATR0PICA.2012.1004.1013); Silue K D, 2006, Med Trop (Mars), V66, P149; Steinmann P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000322; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Tan HZ, 2004, ACTA TROP, V90, P1, DOI 10.1016/j.actatropica.2003.09.008; Utzinger J, 2000, B WORLD HEALTH ORGAN, V78, P389; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; WHO, 2008, ACTION WORMS; World Health Organization, 1991, BAS LAB METH MED PAR; World Health Organization, 2002, WHO TECHN REP SER, V912, P1; World Health Organization (WHO), 1998, WHOQOL US MAN	58	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64380	10.1371/journal.pone.0064380	http://dx.doi.org/10.1371/journal.pone.0064380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755120	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000319872300017
J	Hogan, CS; Mole, BM; Grant, SR; Willis, DK; Charkowski, AO				Hogan, Clifford S.; Mole, Beth M.; Grant, Sarah R.; Willis, David K.; Charkowski, Amy O.			The Type III Secreted Effector DspE Is Required Early in Solanum tuberosum Leaf Infection by Pectobacterium carotovorum to Cause Cell Death, and Requires Wx((3-6))D/E Motifs	PLOS ONE			English	Article							STEWARTII SUBSP STEWARTII; ROT ERWINIA BACTERIA; SIGMA-FACTOR; PECTATE LYASE; NUCLEOTIDE-SEQUENCE; GENES; HRP; EXPRESSION; FAMILY; AMYLOVORA	Pectobacterium species are enterobacterial plant-pathogens that cause soft rot disease in diverse plant species. Unlike hemi-biotrophic plant pathogenic bacteria, the type III secretion system (T3SS) of Pectobacterium carotovorum subsp. carotovorum (P. carotovorum) appears to secrete only one effector protein, DspE. Previously, we found that the T3SS regulator HrpL and the effector DspE are required for P. carotovorum pathogenesis on leaves. Here, we identified genes up-regulated by HrpL, visualized expression of dspE in leaves, and established that DspE causes host cell death. DspE required its full length and WxxxE-like motifs, which are characteristic of the AvrE-family effectors, for host cell death. We also examined expression in plant leaves and showed that hrpL is required for the expression of dspE and hrpN, and that the loss of a functional T3SS had unexpected effects on expression of other genes during leaf infection. These data support a model where P. carotovorum uses the T3SS early in leaf infection to initiate pathogenesis through elicitation of DspE-mediated host cell death.	[Hogan, Clifford S.; Willis, David K.; Charkowski, Amy O.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Mole, Beth M.; Grant, Sarah R.] Univ N Carolina, Dept Biol & Curriculum Mol Biol & Genet, Chapel Hill, NC USA; [Willis, David K.] USDA ARS, Vegetable Crops Res Unit, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Agriculture (USDA)	Charkowski, AO (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	acharkowski@wisc.edu		Charkowski, Amy/0000-0002-8913-2071	National Science Foundation Environmental Genomics Program [0412599]; USDA-Hatch project the Wisconsin Potato and Vegetable Growers Association [WISO1637]	National Science Foundation Environmental Genomics Program(National Science Foundation (NSF)); USDA-Hatch project the Wisconsin Potato and Vegetable Growers Association	This work was funded by National Science Foundation Environmental Genomics Program through award number 0412599, USDA-Hatch project award WISO1637 the Wisconsin Potato and Vegetable Growers Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2003, FEBS LETT, V546, P173, DOI 10.1016/S0014-5793(03)00646-X; Ahn IP, 2007, MOL PLANT PATHOL, V8, P747, DOI 10.1111/J.1364-3703.2007.00428.X; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Boureau T, 2006, MOL PLANT MICROBE IN, V19, P16, DOI 10.1094/MPMI-19-0016; Cesbron S, 2006, FEMS MICROBIOL LETT, V257, P221, DOI 10.1111/j.1574-6968.2006.00172.x; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Chatterjee A, 2002, MOL PLANT PATHOL, V3, P359, DOI 10.1046/j.1364-3703.2002.00128.x; Chatterjee A, 2002, MOL PLANT MICROBE IN, V15, P971, DOI 10.1094/MPMI.2002.15.9.971; CHATTERJEE A, 1991, J BACTERIOL, V173, P1765, DOI 10.1128/jb.173.5.1765-1769.1991; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Glasner JD, 2008, MOL PLANT MICROBE IN, V21, P1549, DOI 10.1094/MPMI-21-12-1549; Ham JH, 2008, MOL PLANT PATHOL, V9, P633, DOI 10.1111/J.1364-3703.2008.00489.X; Ham JH, 2006, MOL PLANT MICROBE IN, V19, P1092, DOI 10.1094/MPMI-19-1092; Ham JH, 2009, MOL PLANT MICROBE IN, V22, P703, DOI 10.1094/MPMI-22-6-0703; HARRISON MD, 1987, J APPL BACTERIOL, V62, P565, DOI 10.1111/j.1365-2672.1987.tb02690.x; HINTON JCD, 1989, MOL MICROBIOL, V3, P1785, DOI 10.1111/j.1365-2958.1989.tb00164.x; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kim HS, 2011, MOL PLANT MICROBE IN, V24, P773, DOI 10.1094/MPMI-06-10-0143; Kim HS, 2009, APPL ENVIRON MICROB, V75, P4539, DOI 10.1128/AEM.01336-08; LIU Y, 1994, APPL ENVIRON MICROB, V60, P2545, DOI 10.1128/AEM.60.7.2545-2552.1994; MAE A, 1995, MOL GEN GENET, V247, P17, DOI 10.1007/BF00425817; MCCARTERZORNER NJ, 1985, J APPL BACTERIOL, V59, P357, DOI 10.1111/j.1365-2672.1985.tb03331.x; MCCARTERZORNER NJ, 1984, J APPL BACTERIOL, V57, P95, DOI 10.1111/j.1365-2672.1984.tb02361.x; Meng XD, 2006, MOL PLANT MICROBE IN, V19, P53, DOI 10.1094/MPMI-19-0053; MOLINA JJ, 1974, AM POTATO J, V51, P245, DOI 10.1007/BF02851435; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nissan G, 2005, MOL PLANT MICROBE IN, V18, P634, DOI 10.1094/MPMI-18-0634; Ohlson MB, 2008, CELL HOST MICROBE, V4, P434, DOI 10.1016/j.chom.2008.08.012; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; SAARILAHTI HT, 1990, MOL MICROBIOL, V4, P1037, DOI 10.1111/j.1365-2958.1990.tb00676.x; Sambrook J, 2001, MOL CLONING LAB MANU; Takle GW, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-50; Wang K, 2010, MOL PLANT PATHOL, V11, P597, DOI [10.1111/J.1364-3703.2010.00631.X, 10.1111/j.1364-3703.2010.00631.x]; WEI ZM, 1995, J BACTERIOL, V177, P6201, DOI 10.1128/jb.177.21.6201-6210.1995; XIAO YX, 1994, J BACTERIOL, V176, P1025, DOI 10.1128/JB.176.4.1025-1036.1994; Yap MN, 2008, MOL PLANT MICROBE IN, V21, P304, DOI 10.1094/MPMI-21-3-0304; Yap MN, 2005, J BACTERIOL, V187, P639, DOI 10.1128/JB.187.2.639-648.2005; YOSHIDA A, 1992, BIOSCI BIOTECH BIOCH, V56, P1596, DOI 10.1271/bbb.56.1596	45	18	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65534	10.1371/journal.pone.0065534	http://dx.doi.org/10.1371/journal.pone.0065534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755246	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300086
J	Li, LL; Wang, Z; Zuo, ZY				Li, Liaoliao; Wang, Zhi; Zuo, Zhiyi			Chronic Intermittent Fasting Improves Cognitive Functions and Brain Structures in Mice	PLOS ONE			English	Article							DIETARY RESTRICTION; OXIDATIVE STRESS; GLUCOSE-METABOLISM; DISEASE; PREVALENCE; RESISTANCE; OBESITY; RATS	Obesity is a major health issue. Obesity started from teenagers has become a major health concern in recent years. Intermittent fasting increases the life span. However, it is not known whether obesity and intermittent fasting affect brain functions and structures before brain aging. Here, we subjected 7-week old CD-1 wild type male mice to intermittent (alternate-day) fasting or high fat diet (45% caloric supplied by fat) for 11 months. Mice on intermittent fasting had better learning and memory assessed by the Barnes maze and fear conditioning, thicker CA1 pyramidal cell layer, higher expression of drebrin, a dendritic protein, and lower oxidative stress than mice that had free access to regular diet (control mice). Mice fed with high fat diet was obese and with hyperlipidemia. They also had poorer exercise tolerance. However, these obese mice did not present significant learning and memory impairment or changes in brain structures or oxidative stress compared with control mice. These results suggest that intermittent fasting improves brain functions and structures and that high fat diet feeding started early in life does not cause significant changes in brain functions and structures in obese middle-aged animals.	[Li, Liaoliao; Wang, Zhi; Zuo, Zhiyi] Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22903 USA; [Wang, Zhi] Sun Yat Sen Univ, Sun Yat Sen Memory Hosp, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China	University of Virginia; Sun Yat Sen University	Zuo, ZY (corresponding author), Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22903 USA.	zz3c@virginia.edu	Zuo, Zhiyi/F-3950-2010	Zuo, Zhiyi/0000-0002-3542-5047	National Institutes of Health, Bethesda, MD [R01 GM065211, R01 GM098308]; International Anesthesia Research Society, Cleveland,OH; American Heart Association Mid-Atlantic Affiliate, Baltimore, MD [10GRNT3900019]; Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065211, R01GM098308] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Anesthesia Research Society, Cleveland,OH; American Heart Association Mid-Atlantic Affiliate, Baltimore, MD(American Heart Association); Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants (R01 GM065211 and R01 GM098308 to ZZ) from the National Institutes of Health, Bethesda, MD, by a grant from the International Anesthesia Research Society (2007 Frontiers in Anesthesia Research Award to ZZ), Cleveland,OH, by a Grant-in-Aid from the American Heart Association Mid-Atlantic Affiliate (10GRNT3900019 to ZZ), Baltimore, MD, and the Robert M. Epstein Professorship endowment, University of Virginia, Charlottesville, VA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Bhatnagar D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a993; Butterfield DA, 2002, FREE RADICAL RES, V36, P1307, DOI 10.1080/1071576021000049890; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Djordjevic AM, 2010, NEUROCHEM INT, V56, P250, DOI 10.1016/j.neuint.2009.10.008; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; GOODRICK CL, 1983, EXP AGING RES, V9, P203, DOI 10.1080/03610738308258453; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li LL, 2011, J CEREBR BLOOD F MET, V31, P1283, DOI 10.1038/jcbfm.2010.222; Lin DW, 2012, BEHAV BRAIN RES, V228, P319, DOI 10.1016/j.bbr.2011.12.010; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Studzinski CM, 2009, J NEUROCHEM, V108, P860, DOI 10.1111/j.1471-4159.2008.05798.x; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407; Witte AV, 2009, P NATL ACAD SCI USA, V106, P1255, DOI 10.1073/pnas.0808587106	21	74	75	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66069	10.1371/journal.pone.0066069	http://dx.doi.org/10.1371/journal.pone.0066069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755298	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300101
J	Visser, MB; Sun, CX; Koh, A; Ellen, RP; Glogauer, M				Visser, Michelle B.; Sun, Chun-Xiang; Koh, Adeline; Ellen, Richard P.; Glogauer, Michael			Treponema denticola Major Outer Sheath Protein Impairs the Cellular Phosphoinositide Balance That Regulates Neutrophil Chemotaxis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; SURFACE PROTEIN; PTEN; PHOSPHATASE; RAC1; ACTIVATION; MOTILITY; POLARITY; LOCALIZATION; PTDINSP(3)	The major outer sheath protein (Msp) of Treponema denticola inhibits neutrophil polarization and directed chemotaxis together with actin dynamics in vitro in response to the chemoattractant N-formyl-methionine-leucine-phenylanine (fMLP). Msp disorients chemotaxis through inhibition of a Rac1-dependent signaling pathway, but the upstream mechanisms are unknown. We challenged murine bone marrow neutrophils with enriched native Msp to determine the role of phospholipid modifying enzymes in chemotaxis and actin assembly downstream of fMLP-stimulation. Msp modulated cellular phosphoinositide levels through inhibition of phosphatidylinositol 3-kinase (PI3-kinase) together with activation of the lipid phosphatase, phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Impaired phosphatidylinositol[(3,4,5)]triphosphate (PIP3) levels prevented recruitment and activation of the downstream mediator Akt. Release of the actin capping proteins gelsolin and CapZ in response to fMLP was also inhibited by Msp exposure. Chemical inhibition of PTEN restored PIP3 signaling, as measured by Akt activation, Rac1 activation, actin uncapping, neutrophil polarization and chemotaxis in response to fMLP-stimulation, even in the presence of Msp. Transduction with active Rac1 also restored fMLP-mediated actin uncapping, suggesting that Msp acts at the level of PIP3 in the hierarchical feedback loop of PIP3 and Rac1 activation. Taken together, Msp alters the phosphoinositide balance in neutrophils, impairing the cell "compass", which leads to inhibition of downstream chemotactic events.	[Visser, Michelle B.; Sun, Chun-Xiang; Koh, Adeline; Ellen, Richard P.; Glogauer, Michael] Univ Toronto, Dent Res Inst, Matrix Dynam Grp, Toronto, ON, Canada	University of Toronto	Visser, MB (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.	michelle.visser@utoronto.ca	Visser, Michelle/L-1262-2019; Glogauer, Michael/D-2504-2011	Visser, Michelle/0000-0002-6467-3314; Glogauer, Michael/0000-0002-6248-5977	Canadian Institutes of Health Research (CIHR) [MOP-86550, MOP-53136]; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by operating grants MOP-86550 (R.P.E) and MOP-53136 (M.G) from the Canadian Institutes of Health Research (CIHR) and a CIHR Postdoctoral fellowship (M.B.V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin M, 2004, INFECT IMMUN, V72, P3650, DOI 10.1128/IAI.72.6.3650-3654.2004; Caimano MJ, 1999, INFECT IMMUN, V67, P4072, DOI 10.1128/IAI.67.8.4072-4083.1999; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Capone R, 2008, ORAL MICROBIOL IMMUN, V23, P165, DOI 10.1111/j.1399-302X.2007.00404.x; Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302; da Silva APB, 2004, CELL MICROBIOL, V6, P485, DOI 10.1111/j.1462-5822.2004.00377.x; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; EGLI C, 1993, INFECT IMMUN, V61, P1694, DOI 10.1128/IAI.61.5.1694-1699.1993; Ellen RP, 2005, PERIODONTOL 2000, V38, P13, DOI 10.1111/j.1600-0757.2005.00108.x; Fenno JC, 1998, INFECT IMMUN, V66, P1869, DOI 10.1128/IAI.66.5.1869-1877.1998; Fenno JC, 2012, J ORAL MICROBIOL, V4; Fenteany G, 2004, CURR OPIN HEMATOL, V11, P15, DOI 10.1097/00062752-200401000-00004; Geny B, 2006, BIOL CELL, V98, P633, DOI 10.1042/BC20060038; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Godovikova V, 2011, INFECT IMMUN, V79, P4868, DOI 10.1128/IAI.05701-11; HAAPASALO M, 1992, INFECT IMMUN, V60, P2058, DOI 10.1128/IAI.60.5.2058-2065.1992; Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699; Hawkins PT, 2010, CURR TOP MICROBIOL, V346, P183, DOI 10.1007/82_2010_40; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Heit B, 2008, J CELL SCI, V121, P205, DOI 10.1242/jcs.020412; Kuiper JWP, 2011, BLOOD, V118, P6164, DOI 10.1182/blood-2010-09-310383; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Li YT, 2011, BLOOD, V117, P6702, DOI 10.1182/blood-2010-09-309864; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Magalhaes MAO, 2008, CELL MICROBIOL, V10, P344, DOI 10.1111/j.1462-5822.2007.01045.x; Magalhaes MAO, 2010, J LEUKOCYTE BIOL, V87, P545, DOI 10.1189/jlb.0609390; Mathers DA, 1996, INFECT IMMUN, V64, P2904, DOI 10.1128/IAI.64.8.2904-2910.1996; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Mondal S, 2012, MOL BIOL CELL, V23, P1219, DOI 10.1091/mbc.E11-10-0889; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sela MN, 2001, CRIT REV ORAL BIOL M, V12, P399, DOI 10.1177/10454411010120050301; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; Stephens L, 2002, CURR OPIN CELL BIOL, V14, P203, DOI 10.1016/S0955-0674(02)00311-3; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Sun CX, 2004, BLOOD, V104, P3758, DOI 10.1182/blood-2004-03-0781; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Thomas BP, 2006, INFECT IMMUN, V74, P1954, DOI 10.1128/IAI.74.3.1954-1957.2006; Visser MB, 2011, CLIN MICROBIOL INFEC, V17, P502, DOI 10.1111/j.1469-0691.2011.03460.x; Visser MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023736; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Wang Q, 2001, J BIOL CHEM, V276, P23056, DOI 10.1074/jbc.M011735200; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 1999, NAT CELL BIOL, V1, P75, DOI 10.1038/10042	50	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66209	10.1371/journal.pone.0066209	http://dx.doi.org/10.1371/journal.pone.0066209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755300	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300103
J	Zhang, LL; Li, ZJ; Li, JF; Wang, AX				Zhang, Lili; Li, Zhenjun; Li, Jingfu; Wang, Aoxue			Ectopic Overexpression of SsCBF1, a CRT/DRE-Binding Factor from the Nightshade Plant Solanum lycopersicoides, Confers Freezing and Salt Tolerance in Transgenic Arabidopsis	PLOS ONE			English	Article							STRESS TRANSCRIPTION FACTORS; COLD-RESPONSE PATHWAY; CIS-ACTING ELEMENT; CBF GENE FAMILY; LOW-TEMPERATURE; DNA-BINDING; EXPRESSION PATTERN; DROUGHT; ACTIVATOR; REGULATOR	The C-repeat (CRT)/dehydration-responsive element (DRE) binding factor (CBF/ DREB1) transcription factors play a key role in cold response. However, the detailed roles of many plant CBFs are far from fully understood. A CBF gene (SsCBF1) was isolated from the cold-hardy plant Solanum lycopersicoides. A subcellular localization study using GFP fusion protein indicated that SsCBF1 is localized in the nucleus. We delimited the SsCBF1 transcriptional activation domain to the C-terminal segment comprising amino acid residues 193-228 (SsCBF1(193-228)). The expression of SsCBF1 could be dramatically induced by cold, drought and high salinity. Transactivation assays in tobacco leaves revealed that SsCBF1 could specifically bind to the CRT cis-elements in vivo to activate the expression of downstream reporter genes. The ectopic overexpression of SsCBF1 conferred increased freezing and high-salinity tolerance and late flowering phenotype to transgenic Arabidopsis. RNA-sequencing data exhibited that a set of cold and salt stress responsive genes were up-regulated in transgenic Arabidopsis. Our results suggest that SsCBF1 behaves as a typical CBF to contribute to plant freezing tolerance. Increased resistance to high-salinity and late flowering phenotype derived from SsCBF1 OE lines lend more credence to the hypothesis that plant CBFs participate in diverse physiological and biochemical processes related to adverse conditions.	[Zhang, Lili; Wang, Aoxue] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China; [Li, Zhenjun] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing, Peoples R China; [Zhang, Lili; Li, Jingfu; Wang, Aoxue] Northeast Agr Univ, Coll Hort, Harbin, Peoples R China; [Wang, Aoxue] Northeast Agr Univ, Heilongjiang Prov Key Univ Lab Agr Biol Funct Gen, Harbin, Peoples R China	Northeast Agricultural University - China; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Northeast Agricultural University - China; Northeast Agricultural University - China	Li, JF (corresponding author), Northeast Agr Univ, Coll Hort, Harbin, Peoples R China.	jfli_neau@yahoo.com.cn; aoxuewang@yahoo.com.cn			National Key Technology R D Program [2012BAD02B02-07]; Key Project of Chinese Ministry of Education [211043]; Research Fund for the Doctoral Program of Higher Education of China [20092325110001]; Trans-Century Training Programme Foundation for the Talents by Heilongjiang Provincial Education Department [1251-NCET-004]	National Key Technology R D Program(National Key Technology R&D Program); Key Project of Chinese Ministry of Education(Ministry of Education, China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Trans-Century Training Programme Foundation for the Talents by Heilongjiang Provincial Education Department	This work was supported by National Key Technology R & D Program (No. 2012BAD02B02-07) from Jingfu Li, the Key Project of Chinese Ministry of Education (211043), the Research Fund for the Doctoral Program of Higher Education of China (20092325110001) and the Trans-Century Training Programme Foundation for the Talents by Heilongjiang Provincial Education Department (1251-NCET-004) from Aoxue Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Canella D, 2010, BBA-GENE REGUL MECH, V1799, P454, DOI 10.1016/j.bbagrm.2009.11.017; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Chetelat RT, 1997, EUPHYTICA, V95, P99, DOI 10.1023/A:1002958030799; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Choi DW, 2002, PLANT PHYSIOL, V129, P1781, DOI 10.1104/pp.003046; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doring P, 2000, PLANT CELL, V12, P265, DOI 10.1105/tpc.12.2.265; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; El Oirdi M, 2011, PLANT CELL, V23, P2405, DOI 10.1105/tpc.111.083394; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jiang C, 1996, PLANT MOL BIOL, V30, P679, DOI 10.1007/BF00049344; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; KURKELA S, 1992, PLANT MOL BIOL, V19, P689, DOI 10.1007/BF00026794; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lin CH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-85; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Owens CL, 2002, J AM SOC HORTIC SCI, V127, P489, DOI 10.21273/JASHS.127.4.489; Pino MT, 2008, PLANT CELL ENVIRON, V31, P393, DOI 10.1111/j.1365-3040.2008.01776.x; RAIKHEL N, 1992, PLANT PHYSIOL, V100, P1627, DOI 10.1104/pp.100.4.1627; RICK CM, 1988, THEOR APPL GENET, V76, P647, DOI 10.1007/BF00303508; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Song SJ, 2011, J MECH SCI TECHNOL, V25, P3; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Sun JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002594; Tahtiharju S, 1997, PLANTA, V203, P442, DOI 10.1007/s004250050212; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; TREUTER E, 1993, MOL GEN GENET, V240, P113, DOI 10.1007/BF00276890; Vagujfalvi A, 2003, MOL GENET GENOMICS, V269, P60, DOI 10.1007/s00438-003-0806-6; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang ZB, 2005, PLANT MOL BIOL, V58, P543, DOI 10.1007/s11103-005-6760-4; WOLF S, 1986, J AM SOC HORTIC SCI, V111, P960; Xiao H, 2006, PLANT CELL ENVIRON, V29, P1410, DOI 10.1111/j.1365-3040.2006.01524.x; Xue GP, 2003, PLANT J, V33, P373, DOI 10.1046/j.1365-313X.2003.01630.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yang LA, 2010, J EXP BOT, V61, P2519, DOI 10.1093/jxb/erq084; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhou Y, 2012, PLANT CELL, V24, P1034, DOI 10.1105/tpc.111.094383	69	13	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e61810	10.1371/journal.pone.0061810	http://dx.doi.org/10.1371/journal.pone.0061810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755095	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300003
J	Doherty, JE; Woodard, LE; Bear, AS; Foster, AE; Wilson, MH				Doherty, Joseph E.; Woodard, Lauren E.; Bear, Adham S.; Foster, Aaron E.; Wilson, Matthew H.			An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression	FASEB JOURNAL			English	Article						piggyBac; inducible expression; gene transfer	IMMUNE-RESPONSE; MAMMALIAN-CELLS; FIREFLY LUCIFERASE; LIVER; DELIVERY; THERAPY; TETRACYCLINE; ACTIVATION; HEMOPHILIA; STRATEGIES	Transposons permit permanent cellular genome engineering in vivo. However, transgene expression falls rapidly postdelivery due to a variety of mechanisms, including immune responses. We hypothesized that delaying initial transgene expression would improve long-term transgene expression by using an engineered piggyBac transposon system that can regulate expression. We found that a 2-part nonviral Tet-KRAB inducible expression system repressed expression of a luciferase reporter in vitro. However, we also observed nonspecific promoter-independent repression. Thus, to achieve temporary transgene repression after gene delivery in vivo, we utilized a nonintegrating version of the repressor plasmid while the gene of interest was delivered in an integrating piggyBac transposon vector. When we delivered the luciferase transposon and repressor to immunocompetent mice by hydrodynamic injection, initial luciferase expression was repressed by 2 orders of magnitude. When luciferase expression was followed long term in vivo, we found that expression was increased >200-fold compared to mice that received only the luciferase transposon and piggyBac transposase. We found that repression of early transgene expression could prevent the priming of luciferase-specific T cells in vivo. Therefore, transient transgene repression postgene delivery is an effective strategy for inhibiting the antitransgene immune response and improving long-term expression in vivo without using immunosuppression.Doherty, J. E., Woodard, L. E., Bear, A. S., Foster, A. E., Wilson, M. H. An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression.	[Doherty, Joseph E.; Bear, Adham S.; Foster, Aaron E.; Wilson, Matthew H.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Doherty, Joseph E.; Wilson, Matthew H.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Doherty, Joseph E.; Woodard, Lauren E.; Wilson, Matthew H.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Bear, Adham S.; Foster, Aaron E.; Wilson, Matthew H.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Bear, Adham S.; Foster, Aaron E.; Wilson, Matthew H.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Wilson, Matthew H.] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center	Wilson, MH (corresponding author), Baylor Coll Med, 1 Baylor Plaza,MS BCM395,ABBR R704, Houston, TX 77030 USA.	mhwilson@bcm.edu	Wilson, Matthew H/K-3193-2013		U.S. National Institutes of Health (NIH) [T32GM007330]; NIH [T32DK064717, T32DK062706, T32DK060445, R01 DK093660]; U.S. Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL092332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445, R01DK093660, T32DK062706, T32DK064717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007330] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J.E.D. was supported by U.S. National Institutes of Health (NIH) Medical Scientist Training Program grant T32GM007330, and subsequently by NIH Cell and Gene Therapy Training grant T32DK064717 and the generous support of Bill and Mary Jo Robbins. L. E. W. was supported by NIH grant T32DK062706 and subsequently by NIH grant T32DK060445. M. H. W. was supported in part by a career development award from the U.S. Department of Veterans Affairs and NIH grant R01 DK093660. This work was also made possible by the generous support of Dr. and Mrs. Harold M. Selzman.	Abina MA, 1996, GENE THER, V3, P212; Arruda VR, 2009, MOL THER, V17, P1492, DOI 10.1038/mt.2009.150; BEALE EG, 1992, FASEB J, V6, P3330, DOI 10.1096/fasebj.6.15.1281456; Bell JB, 2007, NAT PROTOC, V2, P3153, DOI 10.1038/nprot.2007.471; Cerullo V, 2007, MOL THER, V15, P2080, DOI 10.1038/sj.mt.6300308; Chu QM, 2005, MOL THER, V12, P264, DOI 10.1016/j.ymthe.2005.04.007; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907; Doherty JE, 2012, HUM GENE THER, V23, P311, DOI 10.1089/hum.2011.138; Frka K, 2009, J BIOTECHNOL, V141, P8, DOI 10.1016/j.jbiotec.2009.02.013; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Ginhoux F, 2004, MOL THER, V10, P279, DOI 10.1016/j.ymthe.2004.05.012; Gomez-Rodriguez J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn523; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022; Herweijer H, 2007, GENE THER, V14, P99, DOI 10.1038/sj.gt.3302891; Isenmann S, 2001, BRAIN RES, V892, P229, DOI 10.1016/S0006-8993(00)02957-7; Jeon YH, 2007, CANCER BIOL THER, V6, P781, DOI 10.4161/cbt.6.5.4005; Khanna A, 2000, J IMMUNOL, V164, P1346, DOI 10.4049/jimmunol.164.3.1346; Le Guiner C, 2007, CURR GENE THER, V7, P334; Limberis MP, 2009, GENE THER, V16, P441, DOI 10.1038/gt.2008.177; Limberis MP, 2010, MOL THER, V18, P143, DOI 10.1038/mt.2009.190; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; LoDuca PA, 2009, CURR GENE THER, V9, P104, DOI 10.2174/156652309787909490; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marshall E, 1999, SCIENCE, V286, P2244, DOI 10.1126/science.286.5448.2244; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Morris JC, 2004, BLOOD, V103, P492, DOI 10.1182/blood-2003-07-2324; Nakazawa Y, 2013, J IMMUNOTHER, V36, P3, DOI 10.1097/CJI.0b013e3182791234; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; No D, 1996, P NATL ACAD SCI USA, V93, P3346, DOI 10.1073/pnas.93.8.3346; Pastore L, 1999, HUM GENE THER, V10, P1773, DOI 10.1089/10430349950017455; Racz Z, 2011, NUCLEIC ACID THER, V21, P215, DOI 10.1089/nat.2010.0248; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Saridey SK, 2009, MOL THER, V17, P2115, DOI 10.1038/mt.2009.234; Sebestyen MG, 2006, J GENE MED, V8, P852, DOI 10.1002/jgm.921; Seiler MP, 2007, CURR GENE THER, V7, P297, DOI 10.2174/156652307782151452; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Suda T, 2007, GENE THER, V14, P129, DOI 10.1038/sj.gt.3302865; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Vilaboa N, 2006, CURR GENE THER, V6, P421, DOI 10.2174/156652306777934829; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; Woodard LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042666; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zaldumbide A, 2008, GENE THER, V15, P239, DOI 10.1038/sj.gt.3303082	53	7	7	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3753	3762		10.1096/fj.13-232090	http://dx.doi.org/10.1096/fj.13-232090			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23752206	Green Published			2022-12-25	WOS:000328840500033
J	Mulepati, S; Bailey, S				Mulepati, Sabin; Bailey, Scott			In Vitro Reconstitution of an Escherichia coli RNA-guided Immune System Reveals Unidirectional, ATP-dependent Degradation of DNA Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRISPR IMMUNITY; CAS3; CASCADE; BINDING; NUCLEASE; PROTEIN; INTERFERENCE; PROKARYOTES; MECHANISM; SEQUENCES	Many prokaryotes utilize small RNA transcribed from clustered, regularly interspaced, short palindromic repeats (CRISPRs) to protect themselves from foreign genetic elements, such as phage and plasmids. In Escherichia coli, this small RNA is packaged into a surveillance complex (Cascade) that uses the RNA sequence to direct binding to invasive DNA. Once bound, Cascade recruits the Cas3 nuclease-helicase, which then proceeds to progressively degrade the invading DNA. Here, using individually purified Cascade and Cas3 from E. coli, we reconstitute CRISPR-mediated plasmid degradation in vitro. Analysis of this reconstituted assay suggests that Cascade recruits Cas3 to a single-stranded region of the DNA target exposed by Cascade binding. Cas3 then nicks the exposed DNA. Recruitment and nicking is stimulated by the presence, but not hydrolysis, of ATP. Following nicking and powered by ATP hydrolysis, the concerted actions of the helicase and nuclease domains of Cas3 proceed to unwind and degrade the entire DNA target in a unidirectional manner.	[Mulepati, Sabin; Bailey, Scott] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bailey, S (corresponding author), Dept Biochem & Mol Biol, 615 N Wolfe St,W8704, Baltimore, MD 21205 USA.	scbailey@jhsph.edu	Bailey, Scott/N-7248-2019		National Institutes of Health [GM097330]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM097330 (to S.B.).	Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cai LP, 2001, NUCLEIC ACIDS RES, V29, P1389, DOI 10.1093/nar/29.6.1389; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Graham AI, 2009, J BIOL CHEM, V284, P18377, DOI 10.1074/jbc.M109.001503; Howard JAL, 2011, BIOCHEM J, V439, P85, DOI 10.1042/BJ20110901; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Macomber L, 2011, MOL MICROBIOL, V82, P1291, DOI 10.1111/j.1365-2958.2011.07891.x; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2012, J BIOL CHEM, V287, P22445, DOI 10.1074/jbc.C112.379503; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Westra ER, 2012, RNA BIOL, V9, P1134, DOI 10.4161/rna.21410; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Yosef I, 2011, P NATL ACAD SCI USA, V108, P20136, DOI 10.1073/pnas.1113519108	27	130	132	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22184	22192		10.1074/jbc.M113.472233	http://dx.doi.org/10.1074/jbc.M113.472233			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23760266	Green Published, hybrid			2022-12-25	WOS:000330596300001
J	Iguchi, M; Kujuro, Y; Okatsu, K; Koyano, F; Kosako, H; Kimura, M; Suzuki, N; Uchiyama, S; Tanaka, K; Matsuda, N				Iguchi, Masahiro; Kujuro, Yuki; Okatsu, Kei; Koyano, Fumika; Kosako, Hidetaka; Kimura, Mayumi; Suzuki, Norihiro; Uchiyama, Shinichiro; Tanaka, Keiji; Matsuda, Noriyuki			Parkin-catalyzed Ubiquitin-Ester Transfer Is Triggered by PINK1-dependent Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Parkin; Pink1; Ubiquitin; Ubiquitin Ligase; RING Finger	MITOCHONDRIAL TRANSLOCATION; PROTEIN LIGASE; OXIDATIVE STRESS; RING DOMAIN; CELL-DEATH; PINK1; DEGRADATION; MUTATIONS; DYSFUNCTION; MECHANISMS	PINK1 and PARKIN are causal genes for autosomal recessive familial Parkinsonism. PINK1 is a mitochondrial Ser/Thr kinase, whereas Parkin functions as an E3 ubiquitin ligase. Under steady-state conditions, Parkin localizes to the cytoplasm where its E3 activity is repressed. A decrease in mitochondrial membrane potential triggers Parkin E3 activity and recruits it to depolarized mitochondria for ubiquitylation of mitochondrial substrates. The molecular basis for how the E3 activity of Parkin is re-established by mitochondrial damage has yet to be determined. Here we provide in vitro biochemical evidence for ubiquitin-thioester formation on Cys-431 of recombinant Parkin. We also report that Parkin forms a ubiquitin-ester following a decrease in mitochondrial membrane potential in cells, and that this event is essential for substrate ubiquitylation. Importantly, the Parkin RING2 domain acts as a transthiolation or acyl-transferring domain rather than an E2-recruiting domain. Furthermore, formation of the ubiquitin-ester depends on PINK1 phosphorylation of Parkin Ser-65. A phosphorylation-deficient mutation completely inhibited formation of the Parkin ubiquitin-ester intermediate, whereas phosphorylation mimics, such as Ser to Glu substitution, enabled partial formation of the intermediate irrespective of Ser-65 phosphorylation. We propose that PINK1-dependent phosphorylation of Parkin leads to the ubiquitin-ester transfer reaction of the RING2 domain, and that this is an essential step in Parkin activation.	[Iguchi, Masahiro; Kujuro, Yuki; Okatsu, Kei; Koyano, Fumika; Kimura, Mayumi; Tanaka, Keiji; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Iguchi, Masahiro; Uchiyama, Shinichiro] Tokyo Womens Med Univ, Dept Neurol, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan; [Kujuro, Yuki; Suzuki, Norihiro] Keio Univ, Dept Neurol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Okatsu, Kei; Koyano, Fumika] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Kosako, Hidetaka] Univ Tokushima, Div Dis Prote, Inst Enzyme Res, Tokushima 7708503, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Women's Medical University; Keio University; University of Tokyo; Tokushima University	Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan.	tanaka-kj@igakuken.or.jp	Suzuki, Norihiro/J-5125-2013; Matsuda, Noriyuki/AAI-3156-2020	Suzuki, Norihiro/0000-0002-0399-6590; Matsuda, Noriyuki/0000-0001-8199-952X; Iguchi, Masahiro/0000-0001-6989-0687; Okatsu, Kei/0000-0001-8949-3750	Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [23-6061, 23791001, 21000012, 23687018, 24111557, 25112522]; Tomizawa Jun-ichi and Keiko Fund for Young Scientist; Takeda Science Foundation; Tomizawa Jun-ichi and Keiko Fund of Molecular Biology Society of Japan for Young Scientist	Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI; Tomizawa Jun-ichi and Keiko Fund for Young Scientist; Takeda Science Foundation(Takeda Science Foundation (TSF)); Tomizawa Jun-ichi and Keiko Fund of Molecular Biology Society of Japan for Young Scientist	This work was supported in part by Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grants 23-6061 (to K. O.), 23791001 (to Y. K.), 21000012 (to K. T.), and 23687018, 24111557, and 25112522 (to N. M.); the Tomizawa Jun-ichi and Keiko Fund for Young Scientist (to N. M.); and the Takeda Science Foundation (to H. K., N. M., and K. T.). Supported by Tomizawa Jun-ichi and Keiko Fund of Molecular Biology Society of Japan for Young Scientist.	Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chew KCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019720; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Koh H, 2010, ANAT CELL BIOL, V43, P179, DOI 10.5115/acb.2010.43.3.179; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Love KR, 2009, ACS CHEM BIOL, V4, P275, DOI 10.1021/cb9000348; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Narendra D, 2012, COLD SPRING HARB PER, V4; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2012, BIOCHEM BIOPH RES CO, V428, P197, DOI 10.1016/j.bbrc.2012.10.041; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pawlyk AC, 2003, J BIOL CHEM, V278, P48120, DOI 10.1074/jbc.M306889200; Pogson JH, 2011, CURR NEUROL NEUROSCI, V11, P283, DOI 10.1007/s11910-011-0187-x; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Rankin Carolyn A, 2011, Open Biochem J, V5, P9, DOI 10.2174/1874091X01105010009; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Rubio de la Torre E, 2009, HUM MOL GENET, V18, P809, DOI 10.1093/hmg/ddn407; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wauer T, 2013, EMBO J; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yacobi-Sharon K, 2013, DEV CELL, V25, P29, DOI 10.1016/j.devcel.2013.02.002; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	75	150	156	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							22019	10.1074/jbc.M113.467530	http://dx.doi.org/10.1074/jbc.M113.467530			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23754282	Green Published, hybrid			2022-12-25	WOS:000328841900048
J	Li, XY; Zhang, JY; Jia, R; Cheng, V; Xu, X; Qiao, WT; Guo, F; Liang, C; Cen, S				Li, Xiaoyu; Zhang, Jianyong; Jia, Rui; Cheng, Vicky; Xu, Xin; Qiao, Wentao; Guo, Fei; Liang, Chen; Cen, Shan			The MOV10 Helicase Inhibits LINE-1 Mobility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOBEC3 CYTIDINE DEAMINASES; L1 RETROTRANSPOSITION; LTR RETROTRANSPOSONS; RNA; METHYLATION; PROTEINS; IDENTIFICATION; EXPRESSION; FAMILY; RETROVIRUSES	LINE-1 (long interspersed element 1) is an autonomous non-long terminal repeat retrotransposon. Its replication often causes mutation and rearrangement of host genomic DNA. Accordingly, host cells have evolved mechanisms to control LINE-1 mobility. Here, we report that a helicase named MOV10 effectively suppresses LINE-1 transposition. Mutating the helicase motifs impairs this function of MOV10, suggesting that MOV10 requires its helicase activity to suppress LINE-1 replication. Further studies show that MOV10 post-transcriptionally diminishes the level of LINE-1 RNA. The association of MOV10 with both LINE-1 RNA and ORF1 suggests that MOV10 interacts with LINE-1 RNP and consequently causes its RNA degradation. These data demonstrate collectively that MOV10 contributes to the cellular control of LINE-1 replication.	[Li, Xiaoyu; Liang, Chen; Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Xu, Xin; Guo, Fei] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100050, Peoples R China; [Zhang, Jianyong; Cheng, Vicky] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Zhang, Jianyong; Liang, Chen] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Cheng, Vicky; Liang, Chen] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Jia, Rui; Xu, Xin; Qiao, Wentao] Nankai Univ, Tianjin 300071, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Lady Davis Institute; McGill University; McGill University; McGill University; Nankai University	Liang, C (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China.	chen.liang@mcgill.ca; shancen@imb.pumc.edu.cn	ZHANG, Jianyong/L-5934-2015	Jia, Rui/0000-0002-1797-4069; Guo, Fei/0000-0003-3500-1006	Canadian Institutes of Health Research 973 Program [2012CB911102]; National Natural Science Foundation of China [31270210]	Canadian Institutes of Health Research 973 Program(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Canadian Institutes of Health Research 973 Program Grant 2012CB911102 and National Natural Science Foundation of China Grant 31270210.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Arjan-Odedra S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-53; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Esnault C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-75; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Frost RJA, 2010, P NATL ACAD SCI USA, V107, P11847, DOI 10.1073/pnas.1007158107; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Goodier JL, 2010, HUM MOL GENET, V19, P1712, DOI 10.1093/hmg/ddq048; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lu CY, 2012, J VIROL, V86, P10517, DOI 10.1128/JVI.00868-12; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886, DOI 10.1128/MCB.11.2.886; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Renard M, 2010, J MOL BIOL, V400, P323, DOI 10.1016/j.jmb.2010.05.029; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Wissing S, 2011, J BIOL CHEM, V286, P36427, DOI 10.1074/jbc.M111.251058; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zamudio N, 2010, HEREDITY, V105, P92, DOI 10.1038/hdy.2010.53; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107; Zhou YD, 2008, VIROLOGY, V372, P97, DOI 10.1016/j.virol.2007.10.027	58	68	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21148	21160		10.1074/jbc.M113.465856	http://dx.doi.org/10.1074/jbc.M113.465856			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754279	Green Published, hybrid			2022-12-25	WOS:000322014400035
J	He, H; Liu, XL				He, Hua; Liu, Xiaolin			Characterization of Transcriptional Complexity during Longissimus Muscle Development in Bovines Using High-Throughput Sequencing	PLOS ONE			English	Article							GENE-EXPRESSION; RNA-SEQ; GLOBAL VIEW; TOOL	Background: Beef cattle are among the most economically important animals in the world because they are farmed for their meat and leather. However, a lack of genetic information remains an obstacle to understanding the mechanisms behind the development of this animal. Analysis of the beef cattle transcriptome and its expression profile data are essential to extending the genetic information resources for this species and would support studies on this animal. Results: RNA sequencing of beef cattle was performed using the Illumina High-Seq2000 platform. A total of 25,605,140 and 26,214,800 reads were sequenced for embryonic and adult pooled samples, respectively. We identified 24,464-29,994 novel transcript units in two pooled samples. In addition, 8,533-10,144 genes showed evidence of alternative splicing, in agreement with the finding that alternative 3' splicing is the most common type of alternative splicing event in cattle. We detected the expression levels of 16,174 genes, and 6,800 genes exhibited differential expression between the two pooled samples with a false discovery rate <= 0.001. Using GO enrichment and KEGG pathway analysis, multiple GO term and biological pathways were found to be significantly enriched for differentially expressed genes. In addition, we discovered that 30,618-31,334 putative single nucleotide polymorphisms were located in coding regions. Conclusions: We obtained a high-quality beef cattle reference transcriptome using a high throughput sequencing approach, thereby providing a valuable resource for better understanding the beef cattle genome. The transcriptome data will facilitate future functional studies on the beef cattle genome and can be applied to breeding programs for cattle and closely related mammals.	[He, Hua; Liu, Xiaolin] Northwest A& F Univ, Shaanxi Key Lab Mol Biol Agr, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Liu, XL (corresponding author), Northwest A& F Univ, Shaanxi Key Lab Mol Biol Agr, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	liuxiaolin@nwsuaf.edu.cn			National Science and Technology Major Project of the Ministry of Science and Technology of China [2011AA100307, 2008AA101010]; "13115" Sci-Tech Innovation Program of Shaanxi Province [2008ZDKG-11]	National Science and Technology Major Project of the Ministry of Science and Technology of China; "13115" Sci-Tech Innovation Program of Shaanxi Province	This study was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China during the "12th Five-Year Plan" (2011AA100307), the National Science and Technology Major Project of the Ministry of Science and Technology of China during the "11th Five-Year Plan" (No. 2008AA101010), and the "13115" Sci-Tech Innovation Program of Shaanxi Province (2008ZDKG-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Lehnert SA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-95; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Maxfield EK, 1998, BIOL REPROD, V59, P321, DOI 10.1095/biolreprod59.2.321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Werner T, 2010, BRIEF BIOINFORM, V11, P499, DOI 10.1093/bib/bbq018; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	27	56	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64356	10.1371/journal.pone.0064356	http://dx.doi.org/10.1371/journal.pone.0064356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762238	gold, Green Submitted, Green Published			2022-12-25	WOS:000321094800006
J	Cheng, X; Xiang, Y; Xie, H; Xu, CL; Xie, TF; Zhang, C; Li, Y				Cheng, Xi; Xiang, Yu; Xie, Hui; Xu, Chun-Ling; Xie, Teng-Fei; Zhang, Chao; Li, Yu			Molecular Characterization and Functions of Fatty Acid and Retinoid Binding Protein Gene (Ab-far-1) in Aphelenchoides besseyi	PLOS ONE			English	Article							STRUCTURAL-CHARACTERIZATION; CAENORHABDITIS-ELEGANS; ONCHOCERCA-VOLVULUS; PARASITIC NEMATODE; FILARIAL NEMATODES; TRANSPORT PROTEINS; FAR PROTEINS; ASCARIS-SUUM; FAMILY; PHOSPHORYLATION	Rice white tip nematode, Aphelenchoides besseyi, is a kind of plant parasitic nematodes that cause serious losses in rice and many other crops. Fatty acid and retinoid binding protein (FAR) is a specific protein in nematodes and is related to development, reproduction, infection to the host, and disruption of plant defense reactions, so the inhibition of FAR function is the potential approach to control A. besseyi. The full-length of Ab-far-1 cDNA is 805 bp, including 546 bp of ORF that encodes 181 amino acids. Software analysis revealed that the Ab-FAR-1 was rich in a-helix structure, contained a predicted consensus casein kinase II phosphorylation site and a hydrophobic secretory signal peptide, but did not have glycosylation sites. The Ab-FAR-1 had 52% homology to Gp-FAR-1 protein. The Ab-FAR-1 and Gp-FAR-1 were grouped in the same branch according to the phylogenetic tree. Fluorescence-based ligand binding analysis confirmed that the recombinant Ab-FAR-1 (rAb-FAR-1) bound with the fluorescent analogues 11-((5-dimethylaminonaphthalene-1-sulfonyl)amino) undecannoic acid (DAUDA), cis-parinaric acid and retinol, but the oleic acid would compete with the binding site. Quantitative PCR (qPCR) was used to assess the expression level of Ab-far-1 at different development stages of A. besseyi, the highest expression was found in the females, followed by eggs, juveniles and males. Using in situ hybridization technique, Ab-far-1 mRNA was present in the hypodermis of juveniles and adults, the ovaries of females and the testes of males. When A. besseyi was treated with Ab-far-1 dsRNA for 48 h, the silencing efficiency of Ab-far-1 was the best and the number of nematodes on the carrot was the least. Thus FAR plays important roles in the development and reproduction of nematodes. This study is useful and helpful to figure out a new way to control the plant parasitic nematodes.	[Xie, Hui] South China Agr Univ, Coll Nat Resources & Environm, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China; South China Agr Univ, Coll Nat Resources & Environm, Res Ctr Nematodes Plant Quarantine, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Xie, H (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China.	xiehui@scau.edu.cn			National Natural Science Foundation of China [30871629, 31071665]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (Nos. 30871629 and 31071665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANASZAK L, 1994, ADV PROTEIN CHEM, V45, P89; Basavaraju S, 2003, MOL BIOCHEM PARASIT, V126, P63, DOI 10.1016/S0166-6851(02)00253-0; Bath JL, 2009, J NEMATOL, V41, P228; Bradley JE, 2001, TRENDS PARASITOL, V17, P471, DOI 10.1016/S1471-4922(01)02036-0; Bridge J., 1990, P69; Brownlie P, 1997, STRUCTURE, V5, P509, DOI 10.1016/S0969-2126(97)00207-4; BUELT MK, 1992, BIOCHEMISTRY-US, V31, P3493, DOI 10.1021/bi00128a025; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; de Boer JM, 1998, J NEMATOL, V30, P309; Fairfax KC, 2009, INT J PARASITOL, V39, P1561, DOI 10.1016/j.ijpara.2009.06.005; Flower DR, 1996, BIOCHEM J, V318, P1; Franklin M.T., 1972, CIH DESCRIPTIONS PLA, VVolume 1; GANJEIZADEH M, 1995, J BIOL CHEM, V270, P15707, DOI 10.1074/jbc.270.26.15707; Garofalo A, 2003, MED MICROBIOL IMMUN, V192, P47, DOI 10.1007/s00430-002-0158-6; Garofalo A, 2003, J BIOL CHEM, V278, P8065, DOI 10.1074/jbc.M206278200; Garofalo A, 2002, MOL BIOCHEM PARASIT, V122, P161, DOI 10.1016/S0166-6851(02)00097-X; Gasymov OK, 1999, BBA-PROTEIN STRUCT M, V1433, P307, DOI 10.1016/S0167-4838(99)00133-8; Kennedy MW, 2000, BBA-PROTEIN STRUCT M, V1476, P149, DOI 10.1016/S0167-4838(99)00249-6; Kennedy MW, 1997, J BIOL CHEM, V272, P29442, DOI 10.1074/jbc.272.47.29442; KENNEDY MW, 1995, BIOCHEMISTRY-US, V34, P6700, DOI 10.1021/bi00020a015; Kuang L, 2009, MOL BIOCHEM PARASIT, V168, P84, DOI 10.1016/j.molbiopara.2009.07.001; MACGREGOR RB, 1986, NATURE, V319, P70, DOI 10.1038/319070a0; MATTHEWS BW, 1987, BIOCHEMISTRY-US, V26, P6885, DOI 10.1021/bi00396a001; McDermott L, 1999, MOL CELL BIOCHEM, V192, P69, DOI 10.1023/A:1006822321081; Mei BS, 1997, J BIOL CHEM, V272, P9933, DOI 10.1074/jbc.272.15.9933; Nirmalan N, 1999, INFECT IMMUN, V67, P6329; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Olson JK, 1997, J VIROL, V71, P110, DOI 10.1128/JVI.71.1.110-119.1997; Pei Yan-yan, 2012, Zhongguo Shuidao Kexue, V26, P218, DOI 10.3969/j.issn.1001-7216.2012.02.012; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; REISE RW, 1987, J NEMATOL, V19, P387; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Singh R, 2010, WORLD ACAD SCI ENG T, V72, P980; Suire S, 2001, BIOCHEM J, V356, P369, DOI 10.1042/0264-6021:3560369; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; Szilak L, 1997, NAT STRUCT BIOL, V4, P112, DOI 10.1038/nsb0297-112; TREE TIM, 1995, MOL BIOCHEM PARASIT, V69, P185, DOI 10.1016/0166-6851(94)00204-Z; Urwin PE, 2002, MOL PLANT MICROBE IN, V15, P747, DOI 10.1094/MPMI.2002.15.8.747; WILKINSON TCI, 1986, BIOCHEM J, V238, P419, DOI 10.1042/bj2380419; Zhang C, 2012, EUR J PLANT PATHOL, V133, P899, DOI 10.1007/s10658-012-0015-4	40	41	45	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e66011	10.1371/journal.pone.0066011	http://dx.doi.org/10.1371/journal.pone.0066011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755297	Green Published, Green Submitted, gold			2022-12-25	WOS:000320579400082
J	Isoe, J; Scaraffia, PY				Isoe, Jun; Scaraffia, Patricia Y.			Urea Synthesis and Excretion in Aedes aegypti Mosquitoes Are Regulated by a Unique Cross-Talk Mechanism	PLOS ONE			English	Article							YELLOW-FEVER; GLOBAL DISTRIBUTION; PROTEIN CATABOLISM; AMMONIA METABOLISM; NITRIC-OXIDE; AMINO-ACIDS; GENE	Aedes aegypti mosquitoes do not have a typical functional urea cycle for ammonia disposal such as the one present in most terrestrial vertebrates. However, they can synthesize urea by two different pathways, argininolysis and uricolysis. We investigated how formation of urea by these two pathways is regulated in females of A. aegypti. The expression of arginase (AR) and urate oxidase (UO), either separately or simultaneously (ARUO) was silenced by RNAi. The amounts of several nitrogen compounds were quantified in excreta using mass spectrometry. Injection of mosquitoes with either dsRNA-AR or dsRNA-UO significantly decreased the expressions of AR or UO in the fat body (FB) and Malpighian tubules (MT). Surprisingly, the expression level of AR was increased when UO was silenced and vice versa, suggesting a cross-talk regulation between pathways. In agreement with these data, the amount of urea measured 48 h after blood feeding remained unchanged in those mosquitoes injected with dsRNA-AR or dsRNA-UO. However, allantoin significantly increased in the excreta of dsRNA-AR-injected females. The knockdown of ARUO mainly led to a decrease in urea and allantoin excretion, and an increase in arginine excretion. In addition, dsRNA-AR-injected mosquitoes treated with a specific nitric oxide synthase inhibitor showed an increase of UO expression in FB and MT and a significant increase in the excretion of nitrogen compounds. Interestingly, both a temporary delay in the digestion of a blood meal and a significant reduction in the expression of several genes involved in ammonia metabolism were observed in dsRNA-AR, UO or ARUO-injected females. These results reveal that urea synthesis and excretion in A. aegypti are tightly regulated by a unique cross-talk signaling mechanism. This process allows blood-fed mosquitoes to regulate the synthesis and/or excretion of nitrogen waste products, and avoid toxic effects that could result from a lethal concentration of ammonia in their tissues.	[Isoe, Jun; Scaraffia, Patricia Y.] Univ Arizona, Ctr Insect Sci, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Arizona	Scaraffia, PY (corresponding author), Univ Arizona, Ctr Insect Sci, Dept Chem & Biochem, Tucson, AZ 85721 USA.	scaraffi@email.arizona.edu		Scaraffia, Patricia/0000-0003-2985-933X	NIH/NIAID [R01AI088092]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088092] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by NIH/NIAID Grant R01AI088092 (to PYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003; Bush DR, 2012, J MASS SPECTROM, V47, P1364, DOI 10.1002/jms.3063; Gaines PJ, 2004, INSECT BIOCHEM MOLEC, V34, P203, DOI 10.1016/j.ibmb.2003.10.002; Griffith OW, 1996, METHOD ENZYMOL, V268, P375; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Rogers DJ, 2006, ADV PARASIT, V62, P181, DOI 10.1016/S0065-308X(05)62006-4; Samson ML, 2000, J BIOL CHEM, V275, P31107, DOI 10.1074/jbc.M001346200; Scaraffia PY, 2008, P NATL ACAD SCI USA, V105, P518, DOI 10.1073/pnas.0708098105; Scaraffia PY, 2006, INSECT BIOCHEM MOLEC, V36, P614, DOI 10.1016/j.ibmb.2006.05.003; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Scaraffia PY, 2005, INSECT BIOCHEM MOLEC, V35, P491, DOI 10.1016/j.ibmb.2005.01.012; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; von Dungern P, 2001, J INSECT PHYSIOL, V47, P73, DOI 10.1016/S0022-1910(00)00095-0; von Dungern P, 2001, J INSECT PHYSIOL, V47, P131, DOI 10.1016/S0022-1910(00)00096-2; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wink DA, 1996, METHOD ENZYMOL, V268, P12; World Health Organization Special Programme for Research and Training in Tropical Diseases Department of Control of Neglected Tropical Diseases, 2009, EP PAND AL DENG GUID; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003	24	31	31	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65393	10.1371/journal.pone.0065393	http://dx.doi.org/10.1371/journal.pone.0065393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755226	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400057
J	Jensen, B; van den Berg, G; van den Doel, R; Oostra, RJ; Wang, T; Moorman, AFM				Jensen, Bjarke; van den Berg, Gert; van den Doel, Rick; Oostra, Roelof-Jan; Wang, Tobias; Moorman, Antoon F. M.			Development of the Hearts of Lizards and Snakes and Perspectives to Cardiac Evolution	PLOS ONE			English	Article							OUTFLOW TRACT; BULBUS-CORDIS; CONDUCTION SYSTEM; VERTEBRATE HEART; ARTERIAL POLE; HISTOLOGICAL SECTIONS; VENTRICULAR SEPTUM; PRIMARY MYOCARDIUM; MOLECULAR ANALYSIS; CHAMBER FORMATION	Birds and mammals both developed high performance hearts from a heart that must have been reptile-like and the hearts of extant reptiles have an unmatched variability in design. Yet, studies on cardiac development in reptiles are largely old and further studies are much needed as reptiles are starting to become used in molecular studies. We studied the growth of cardiac compartments and changes in morphology principally in the model organism corn snake (Pantherophis guttatus), but also in the genotyped anole (Anolis carolinenis and A. sagrei) and the Philippine sailfin lizard (Hydrosaurus pustulatus). Structures and chambers of the formed heart were traced back in development and annotated in interactive 3D pdfs. In the corn snake, we found that the ventricle and atria grow exponentially, whereas the myocardial volumes of the atrioventricular canal and the muscular outflow tract are stable. Ventricular development occurs, as in other amniotes, by an early growth at the outer curvature and later, and in parallel, by incorporation of the muscular outflow tract. With the exception of the late completion of the atrial septum, the adult design of the squamate heart is essentially reached halfway through development. This design strongly resembles the developing hearts of human, mouse and chicken around the time of initial ventricular septation. Subsequent to this stage, and in contrast to the squamates, hearts of endothermic vertebrates completely septate their ventricles, develop an insulating atrioventricular plane, shift and expand their atrioventricular canal toward the right and incorporate the systemic and pulmonary venous myocardium into the atria.	[Jensen, Bjarke; Wang, Tobias] Aarhus Univ, Dept Biosci Zoophysiol, Aarhus, Denmark; [Jensen, Bjarke; van den Berg, Gert; van den Doel, Rick; Oostra, Roelof-Jan; Moorman, Antoon F. M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands	Aarhus University; University of Amsterdam; Academic Medical Center Amsterdam	Jensen, B (corresponding author), Aarhus Univ, Dept Biosci Zoophysiol, Aarhus, Denmark.	bjarke.jensen@biology.au.dk	Jensen, Bjarke/I-7490-2019; Wang, Tobias/I-7946-2013; Jensen, Bjarke/GQI-3989-2022	Jensen, Bjarke/0000-0002-7750-8035; Wang, Tobias/0000-0002-4350-3682; Oostra, Roelof-Jan/0000-0002-2452-8307	Danish Council for Independent Research \ Natural Sciences	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF))	Bjarke Jensen and Tobias Wang were supported by The Danish Council for Independent Research vertical bar Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanhaanen WTJ, 2011, J CLIN INVEST, V121, P534, DOI 10.1172/JCI44350; Aanhaanen WTJ, 2009, CIRC RES, V104, P1267, DOI 10.1161/CIRCRESAHA.108.192450; Acolat LM, 1943, THESIS FS NANCY; Agassiz L., 1857, CONTRIBUTIONS NATURA, VII, P451; Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; ARBEL ER, 1977, AM J PHYSIOL, V232, pH24, DOI 10.1152/ajpheart.1977.232.1.H24; Benninghoff A., 1933, HDB VERGLEICHENDEN A, V6, P467; Benninghoff A, 1921, MORPH JB, V51, P355; Bertens LMF, 2010, ANAT REC, V293, P1101, DOI 10.1002/ar.21162; Bezuidenhout AJ, 1981, ANATOMY HEART OSTRIC; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Boas JEV., 1882, MORPH JB, V7, P488; Boixel C, 2003, J AM COLL CARDIOL, V42, P336, DOI 10.1016/S0735-1097(03)00578-3; Boukens BJ, 2012, PEDIATR CARDIOL, V33, P900, DOI 10.1007/s00246-012-0237-4; Brucke E., 1852, DENKSCHR AKAD WISS W, V3, P335; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; BUCHANAN J. G., 1956, TRANS ROY SOC NEW ZEALAND, V84, P103; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; BUGGE JORGEN, 1961, VIDENSK MEDDEL DANSK FORENING I KOBENHAVN, V123, P193; BURGGREN W, 1998, COMPREHENSIVE PHYSL, P215; Butcher JT, 2007, DEV DYNAM, V236, P802, DOI 10.1002/dvdy.20962; Castoe TA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-406; Christoffels VM, 2009, CIRC-ARRHYTHMIA ELEC, V2, P195, DOI 10.1161/CIRCEP.108.829341; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Cousins KL, 1997, J EXP BIOL, V200, P1351; Crossley DA, 2009, J MORPHOL, V270, P1400, DOI 10.1002/jmor.10764; DAVIES F, 1946, BIOL REV, V21, P173, DOI 10.1111/j.1469-185X.1946.tb00323.x; Davies F, 1931, J ANAT, V65, P339; DAVIES F, 1952, J ANAT, V86, P152; de Boer BA, 2012, DEV BIOL, V368, P203, DOI 10.1016/j.ydbio.2012.05.001; De Boer BA, 2010, IMAGE ANAL STEREOL, V29, P53, DOI 10.5566/ias.v29.p53-60; de Boer BA, 2011, DEVELOPMENT, V138, P159, DOI 10.1242/dev.051086; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; DOWD DA, 1969, ACTA ANAT, V74, P547; Farrell A. P., 1998, V19, P375; Farrell AP, 2007, FISH PHYSIOL, V26, P53, DOI 10.1016/S1546-5098(07)26002-9; Ferguson MWJ, 1985, BIOL REPTILIA, P331; Fuchs F., 1924, Zs ges Anat Miinchen Abt 1, V75, P1, DOI 10.1007/BF02117102; Gallego A, 1997, ANAT REC, V248, P224; Gasch FR, 1888, ARCH NATURGESCH, V54, P119; Gegenbaur C., 1878, ELEMENTS COMP ANATOM; Goodrich ES, 1930, STUDIES STRUCTURE DE, P536; GOOR DA, 1972, CIRCULATION, V46, P375, DOI 10.1161/01.CIR.46.2.375; Gregory JA, 2004, COMP BIOCHEM PHYS A, V138, P203, DOI 10.1016/j.cbpb.2004.03.014; Greil A., 1903, Morphologisches Jahrbuch, Vxxxi, P123; Grimes AC, 2009, J FISH BIOL, V74, P983, DOI 10.1111/j.1095-8649.2008.02125.x; Grimes AC, 2006, DEV BIOL, V290, P265, DOI 10.1016/j.ydbio.2005.11.042; Grimes AC, 2010, EVOL DEV, V12, P552, DOI 10.1111/j.1525-142X.2010.00441.x; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hami D, 2011, DEVELOPMENT, V138, P2389, DOI 10.1242/dev.061473; HART NH, 1968, J MORPHOL, V125, P1, DOI 10.1002/jmor.1051250102; HAYES JA, 1966, CIRCULATION, V33, P450, DOI 10.1161/01.CIR.33.3.450; Heine H, 1972, ANAT EMBRYOL, V137, P86; Hicks James W., 2012, P207; Hicks James W., 1998, V19, P425; Ho SY, 2000, HEART, V83, P444, DOI 10.1136/heart.83.4.444; HOLMES EB, 1975, J MORPHOL, V147, P209, DOI 10.1002/jmor.1051470207; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Icardo JM, 2005, J MORPHOL, V265, P43, DOI 10.1002/jmor.10340; ICARDO JM, 1993, J ANAT, V182, P87; Icardo JM, 2006, ANAT REC PART A, V288A, P900, DOI 10.1002/ar.a.20361; Icardo JM, 2011, ANAT REC, V294, P236, DOI 10.1002/ar.21320; Jahr M, 2011, DEV DYNAM, V240, P1518, DOI 10.1002/dvdy.22611; Jensen B, 2012, BIOCH BIOPHYS ACTA M, P783; Jensen B, 2011, COMP BIOCHEM PHYS A, V160, P35, DOI 10.1016/j.cbpa.2011.04.018; Jensen B, 2010, J MORPHOL, V271, P1066, DOI 10.1002/jmor.10854; Jensen B, 2010, J EXP BIOL, V213, P1611, DOI 10.1242/jeb.030999; JOHANSEN K, 1987, J EXP BIOL, V130, P1; JOHANSEN K, 1968, Z VERGL PHYSIOL, V59, P157; JOHANSEN KJELL, 1965, ANN N Y ACAD SCI, V127, P414, DOI 10.1111/j.1749-6632.1965.tb49417.x; Keith A, 1924, LANCET, V2, P1267; Keith A, 1907, J ANAT PHYSIOL, V41, P172; KLITGAARD T, 1978, ACTA ZOOL-STOCKHOLM, V59, P187, DOI 10.1111/j.1463-6395.1978.tb01033.x; KNAAPEN MWM, 1995, ANAT REC, V243, P93, DOI 10.1002/ar.1092430111; Koshiba-Takeuchi K, 2009, NATURE, V461, P95, DOI 10.1038/nature08324; Kulbs F, 1910, Z EXPER PATHOL THERA, V8, P313; Lai NC, 2004, COMP BIOCHEM PHYS A, V137, P505, DOI 10.1016/j.cbpb.2003.11.011; LAMERS WH, 1995, CIRCULATION, V91, P111, DOI 10.1161/01.CIR.91.1.111; Lamers WH, 2002, CIRC RES, V91, P93, DOI 10.1161/01.RES.0000027135.63141.89; LANGER A, 1894, MORPHOL JB, V21, P40; Lankester E.R., 1882, P ZOOL SOC LOND, V50, P549; LAWSON R, 1966, J ZOOL, V149, P320; Lyson TR, 2010, BIOL LETTERS, V6, P830, DOI 10.1098/rsbl.2010.0371; MACKINNON MR, 1981, J MORPHOL, V170, P1, DOI 10.1002/jmor.1051700102; MARCH HW, 1961, AM J PHYSIOL, V201, P1109, DOI 10.1152/ajplegacy.1961.201.6.1109; Meinertz T., 1966, MORPHOL JB, V108, P568; Mommersteeg MTM, 2007, CIRC RES, V101, P902, DOI 10.1161/CIRCRESAHA.107.161182; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Moorman AFM, 2012, HEART DEV REGENERATI, P219; MULLEN RK, 1967, PHYSIOL ZOOL, V40, P114, DOI 10.1086/physzool.40.2.30152446; MULLEN RK, 1973, COPEIA, P802; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Netter FH, 2003, NETTER PRESENTER HUM; O'Donoghue CH, 1912, P ZOOL SOC LOND, V1912, P612; Parsons CW, 1929, Q J MICROSC SCI, V73, P145; Pek M, 1997, J EXP BIOL, V200, P1913; Pernkopf E., 1933, ANAT ENTWICKLUNGSGES, V100, P563; Pettigrew JB., 1864, PHILOS T R SOC LOND, V154, P445, DOI DOI 10.1098/RSTL.1864.0014; PUTNAM JL, 1977, COPEIA, P476; Ramaswami LS, 1944, P ZOOL SOC LOND, V114, P117; Rana MS, 2007, CIRC RES, V100, P1000, DOI 10.1161/01.RES.0000262688.14288.b8; Rathke H, 1839, ENTWICKELUNGSGESCHIC; Robertson JI, 1913, Q J MICROSC SCI, V59, P53; Romanoff A.L., 1960, AVIAN EMBRYO STRUCTU; ROWLATT U, 1990, ZOOL J LINN SOC-LOND, V98, P73, DOI 10.1111/j.1096-3642.1990.tb01220.x; ROWLATT U, 1975, J MORPHOL, V146, P479, DOI 10.1002/jmor.1051460405; SANCHEZQUINTANA D, 1987, ANAT REC, V217, P263, DOI 10.1002/ar.1092170307; Sandblom E, 2007, COMP BIOCHEM PHYS A, V148, P785, DOI 10.1016/j.cbpa.2007.08.036; Sanger TJ, 2008, J MORPHOL, V269, P129, DOI 10.1002/jmor.10563; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; SHANER RF, 1962, ANAT RECORD, V142, P519, DOI 10.1002/ar.1091420409; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; SIMONS J. R., 1965, J ZOOL PROC ZOOL SOC LONDON, V146, P451; Sissman N J, 1970, Am J Cardiol, V25, P141, DOI 10.1016/0002-9149(70)90575-8; Sizarov A, 2012, J ANAT, V220, P336, DOI 10.1111/j.1469-7580.2012.01474.x; Sizarov A, 2011, CIRC-ARRHYTHMIA ELEC, V4, P532, DOI 10.1161/CIRCEP.111.963421; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Soufan AT, 2003, PHYSIOL GENOMICS, V13, P187, DOI 10.1152/physiolgenomics.00182.2002; Syme DA, 2002, J EXP BIOL, V205, P1843; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Tessadori F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047644; Valentinuzzi M E, 1969, J Electrocardiol, V2, P39, DOI 10.1016/S0022-0736(69)80048-8; van den Berg G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022055; van den Berg G, 2009, CIRC RES, V104, P179, DOI 10.1161/CIRCRESAHA.108.185843; van den Hoff MJB, 2004, BIOESSAYS, V26, P248, DOI 10.1002/bies.20006; Van Mierop L H, 1985, Heart Vessels, V1, P114; Van Mierop L.H.S., 1981, VENTRICULAR SEPTUM H, P35; van Mierop L. H. S., 1985, A BENZON S, P38; Van Mierop LHS, 1984, CONGENITAL HEART DIS, P459; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; VIRAGH S, 1977, DEV BIOL, V56, P382, DOI 10.1016/0012-1606(77)90278-0; VISCOR G, 1985, COMP BIOCHEM PHYS A, V82, P597, DOI 10.1016/0300-9629(85)90439-6; WEATHERS WW, 1974, J COMP PHYSIOL, V93, P127, DOI 10.1007/BF00696267; WEBB GJW, 1979, J MORPHOL, V161, P221, DOI 10.1002/jmor.1051610209; WEBB GJW, 1974, J MORPHOL, V142, P1, DOI 10.1002/jmor.1051420102; WHITE FC, 1981, BASIC RES CARDIOL, V76, P189, DOI 10.1007/BF01907957; WHITE FN, 1959, ANAT REC, V135, P129, DOI 10.1002/ar.1091350208; Wilkinson M, 1996, ZOOL J LINN SOC-LOND, V118, P135, DOI 10.1111/j.1096-3642.1996.tb00223.x; Wyneken Jeanette, 2009, Veterinary Clinics of North America Exotic Animal Practice, V12, P51, DOI 10.1016/j.cvex.2008.08.001; Yelbuz TM, 2003, DEV DYNAM, V228, P152, DOI 10.1002/dvdy.10364; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE	143	47	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e63651	10.1371/journal.pone.0063651	http://dx.doi.org/10.1371/journal.pone.0063651			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755108	Green Published, Green Submitted, gold			2022-12-25	WOS:000320579400005
J	Sidik, F; Lovelock, CE				Sidik, Frida; Lovelock, Catherine E.			CO2 Efflux from Shrimp Ponds in Indonesia	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSIONS; SOIL RESPIRATION; TROPICAL PEATLANDS; VEGETATION; FORESTS; ISLAND; FLUX	The conversion of mangrove forest to aquaculture ponds has been increasing in recent decades. One of major concerns of this habitat loss is the release of stored 'blue' carbon from mangrove soils to the atmosphere. In this study, we assessed carbon dioxide (CO2) efflux from soil in intensive shrimp ponds in Bali, Indonesia. We measured CO2 efflux from the floors and walls of shrimp ponds. Rates of CO2 efflux within shrimp ponds were 4.37 kg CO2 m(-2) y(-1) from the walls and 1.60 kg CO2 m(-2) y(-1) from the floors. Combining our findings with published data of aquaculture land use in Indonesia, we estimated that shrimp ponds in this region result in CO2 emissions to the atmosphere between 5.76 and 13.95 Tg y(-1). The results indicate that conversion of mangrove forests to aquaculture ponds contributes to greenhouse gas emissions that are comparable to peat forest conversion to other land uses in Indonesia. Higher magnitudes of CO2 emission may be released to atmosphere where ponds are constructed in newly cleared mangrove forests. This study indicates the need for incentives that can meet the target of aquaculture industry without expanding the converted mangrove areas, which will lead to increased CO2 released to atmosphere.	[Sidik, Frida; Lovelock, Catherine E.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland	Sidik, F (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	f.sidik@uq.edu.au	Lovelock, Catherine E/G-7370-2012; Lovelock, Catherine E./AAF-7294-2020	Lovelock, Catherine E/0000-0002-2219-6855; Lovelock, Catherine E./0000-0002-2219-6855; Sidik, Frida/0000-0001-7329-9937	Graduate School International Travel Award (GSITA), University of Queensland, Australia	Graduate School International Travel Award (GSITA), University of Queensland, Australia	The funding of the travel of the first author to Indonesia was supported by Graduate School International Travel Award (GSITA), University of Queensland, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; [Anonymous], 2003, GLOBAL BIOGEOCHEM CY, DOI DOI 10.1029/2002GB001917; Burford MA, 2003, MAR POLLUT BULL, V46, P1456, DOI 10.1016/S0025-326X(03)00282-0; Burford MA, 2001, MAR ECOL PROG SER, V224, P187, DOI 10.3354/meps224187; Chimner RA, 2004, WETLANDS, V24, P51, DOI 10.1672/0277-5212(2004)024[0051:SRROTP]2.0.CO;2; Crooks S., 2011, 121 WORLD BANK ENV D; Donato DC, 2012, J ENVIRON MANAGE, V97, P89, DOI 10.1016/j.jenvman.2011.12.004; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Friess DA, 2011, ENVIRON CONSERV, V38, P1, DOI 10.1017/S0376892911000026; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Hadi A, 2005, NUTR CYCL AGROECOSYS, V71, P73, DOI 10.1007/s10705-004-0380-2; Inubushi K, 2003, CHEMOSPHERE, V52, P603, DOI 10.1016/S0045-6535(03)00242-X; Lovelock CE, 2008, ECOSYSTEMS, V11, P342, DOI 10.1007/s10021-008-9125-4; Lovelock CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021279; MCTAGGART WD, 1988, SINGAPORE J TROP GEO, V9, P96, DOI 10.1111/j.1467-9493.1988.tb00199.x; Melling L, 2005, TELLUS B, V57, P1, DOI 10.1111/j.1600-0889.2005.00129.x; Ministry of Forestry, 2002, LINGK UD BAL MANGR; Ministry of Marine Affairs, 2012, REV TAMB KKP PAC PRO; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Puspita L, 2005, LAHAN BASAH BUATAN I; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reijnders L, 2008, J CLEAN PROD, V16, P477, DOI 10.1016/j.jclepro.2006.07.054; Siikamaki J, 2012, P NATL ACAD SCI USA, V109, P14369, DOI 10.1073/pnas.1200519109; TANAKA T, 1994, ENVIRON GEOL, V23, P182, DOI 10.1007/BF00771787; Wetlands International, 2012, REPL MANG AB SHRIMP	28	54	55	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e66329	10.1371/journal.pone.0066329	http://dx.doi.org/10.1371/journal.pone.0066329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755306	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400086
J	Lamontagne, A; Long, RE; Comunale, MA; Hafner, J; Rodemich-Betesh, L; Wang, MJ; Marrero, J; Di Bisceglie, AM; Block, T; Mehta, A				Lamontagne, Anne; Long, Ronald E.; Comunale, Mary Ann; Hafner, Julie; Rodemich-Betesh, Lucy; Wang, Mengjun; Marrero, Jorge; Di Bisceglie, Adrian M.; Block, Timothy; Mehta, Anand			Altered Functionality of Anti-Bacterial Antibodies in Patients with Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							IMMUNOGLOBULIN-G; FUCOSYLATED GLYCOPROTEINS; IGG ANTIBODIES; LIVER FIBROSIS; COMPLEMENT; BINDING; ACTIVATION; ENDOTOXIN; MODULATE	Background: Using comparative glycoproteomics, we have previously identified a glycoprotein that is altered in both amount and glycosylation as a function of liver cirrhosis. The altered glycoprotein is an agalactosylated (G0) immunoglobulin G molecule (IgG) that recognizes the heterophilic alpha-gal epitope. Since the alpha gal epitope is found on gut enterobacteria, it has been hypothesized that anti-gal antibodies are generated as a result of increased bacterial exposure in patients with liver disease. Methods: The N-linked glycosylation of anti-gal IgG molecules from patients with fibrosis and cirrhosis was determined and the effector function of anti-bacterial antibodies from over 100 patients examined. In addition, markers of microbial exposure were determined. Results: Surprisingly, the subset of agalactosylated anti-gal antibodies described here, was impaired in their ability to mediate complement mediated lysis and inhibited the complement-mediated destruction of common gut bacteria. In an analysis of serum from more than 100 patients with liver disease, we have shown that those with increased levels of this modified anti-gal antibody had increased levels of markers of bacterial exposure. Conclusions: Anti-gal antibodies in patients with liver cirrhosis were reduced in their ability to mediate complement mediated lysis of target cells. As bacterial infection is a major complication in patients with cirrhosis and bacterial products such as LPS are thought to play a major role in the development and progression of liver fibrosis, this finding has many clinical implications in the etiology, prognosis and treatment of liver disease.	[Lamontagne, Anne; Long, Ronald E.; Comunale, Mary Ann; Rodemich-Betesh, Lucy; Wang, Mengjun; Block, Timothy; Mehta, Anand] Drexel Univ, Coll Med, Doylestown, PA USA; [Lamontagne, Anne; Long, Ronald E.; Comunale, Mary Ann; Rodemich-Betesh, Lucy; Wang, Mengjun; Block, Timothy; Mehta, Anand] Dept Microbiol & Immunol, Doylestown, PA USA; [Lamontagne, Anne; Long, Ronald E.; Comunale, Mary Ann; Rodemich-Betesh, Lucy; Wang, Mengjun; Block, Timothy; Mehta, Anand] Drexel Inst Biotechnol & Virol, Doylestown, PA USA; [Hafner, Julie] Immunotope Inc, Doylestown, PA USA; [Marrero, Jorge] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO USA; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, Ctr Liver, St Louis, MO USA	Drexel University; Drexel University; University of Michigan System; University of Michigan; Saint Louis University; Saint Louis University	Lamontagne, A (corresponding author), Drexel Univ, Coll Med, Doylestown, PA USA.	anne.lamontagne@drexelmed.edu; asm54@me.com			National Cancer Institute (NCI) [R01 CA120206-01, R42 CA121506-02]; NCI's Early Research Detection Network (EDRN) [UO1 CA084951-06]; Hepatitis B Foundation; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA120206, U01CA168856, R42CA121506, U01CA084951] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI's Early Research Detection Network (EDRN); Hepatitis B Foundation; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01 CA120206-01 and R42 CA121506-02 from the National Cancer Institute (NCI), and grant UO1 CA084951-06 from the NCI's Early Research Detection Network (EDRN), the Hepatitis B Foundation, and an appropriation from The Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Comunale MA, 2006, J PROTEOME RES, V5, P308, DOI 10.1021/pr050328x; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Friedman SL, 2007, GASTROEN CLIN BIOL, V31, P812, DOI 10.1016/S0399-8320(07)73970-2; Friedman SL, 2007, NAT MED, V13, P1281, DOI 10.1038/nm1107-1281; Friedman SL, 2007, HEPATOLOGY, V45, P242, DOI 10.1002/hep.21459; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Galili U, 1999, Subcell Biochem, V32, P79; GALILI U, 1993, BLOOD, V82, P2485, DOI 10.1182/blood.V82.8.2485.bloodjournal8282485; Galili U, 1998, TRANSPLANTATION, V65, P1129, DOI 10.1097/00007890-199804270-00020; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; GALILI U, 1993, SPRINGER SEMIN IMMUN, V15, P155; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; HAMADEH RM, 1992, J CLIN INVEST, V89, P1223, DOI 10.1172/JCI115706; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hoofnagle JH, 1997, HEPATOLOGY, V26, pS15, DOI 10.1002/hep.510260703; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Jirillo E, 2002, J ENDOTOXIN RES, V8, P319, DOI 10.1179/096805102125000641; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; LaTemple DC, 1996, CANCER RES, V56, P3069; Mehal WZ, 2011, NAT MED, V17, P552, DOI 10.1038/nm0511-552; Mehta A, 2008, DIS MARKERS, V25, P259, DOI 10.1155/2008/264594; Mehta AS, 2008, J VIROL, V82, P1259, DOI 10.1128/JVI.01600-07; Nimmerjahn F, 2007, P NATL ACAD SCI USA, V104, P8433, DOI 10.1073/pnas.0702936104; NOLAN JP, 1989, HEPATOLOGY, V10, P887, DOI 10.1002/hep.1840100523; NOLAN JP, 1981, HEPATOLOGY, V1, P458, DOI 10.1002/hep.1840010516; Papp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012957; Parker W, 1999, GLYCOBIOLOGY, V9, P865, DOI 10.1093/glycob/9.9.865; Parker W, 2001, TRANSPLANTATION, V71, P440, DOI 10.1097/00007890-200102150-00018; Posekany KJ, 2002, INFECT IMMUN, V70, P6215, DOI 10.1128/IAI.70.11.6215-6222.2002; POTTER BJ, 1973, GUT, V14, P451, DOI 10.1136/gut.14.6.451; Rudd PM, 1997, NATURE, V388, P205, DOI 10.1038/40677; Rudd PM, 1999, BIOTECHNOL GENET ENG, V16, P1; Rudd PM, 1997, CURR OPIN BIOTECH, V8, P488, DOI 10.1016/S0958-1669(97)80073-0; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Shao BM, 2007, J BIOL CHEM, V282, P13726, DOI 10.1074/jbc.M609462200; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472; Yu PB, 1996, J IMMUNOL, V157, P5163	43	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64992	10.1371/journal.pone.0064992	http://dx.doi.org/10.1371/journal.pone.0064992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750224	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900026
J	Liu, C; Ma, N; Wang, PY; Fu, N; Shen, HL				Liu, Chen; Ma, Ning; Wang, Ping-Yong; Fu, Nan; Shen, Huo-Lin			Transcriptome Sequencing and De Novo Analysis of a Cytoplasmic Male Sterile Line and Its Near-Isogenic Restorer Line in Chili Pepper (Capsicum annuum L.)	PLOS ONE			English	Article							HONGLIAN CMS LINE; GENE-EXPRESSION; OF-FERTILITY; PARTIAL RESTORATION; OXIDATIVE STRESS; NUCLEAR GENES; MITOCHONDRIAL; MARKERS; WHEAT; RICE	Background: The use of cytoplasmic male sterility (CMS) in F-1 hybrid seed production of chili pepper is increasingly popular. However, the molecular mechanisms of cytoplasmic male sterility and fertility restoration remain poorly understood due to limited transcriptomic and genomic data. Therefore, we analyzed the difference between a CMS line 121A and its near-isogenic restorer line 121C in transcriptome level using next generation sequencing technology (NGS), aiming to find out critical genes and pathways associated with the male sterility. Results: We generated approximately 53 million sequencing reads and assembled de novo, yielding 85,144 high quality unigenes with an average length of 643 bp. Among these unigenes, 27,191 were identified as putative homologs of annotated sequences in the public protein databases, 4,326 and 7,061 unigenes were found to be highly abundant in lines 121A and 121C, respectively. Many of the differentially expressed unigenes represent a set of potential candidate genes associated with the formation or abortion of pollen. Conclusions: Our study profiled anther transcriptomes of a chili pepper CMS line and its restorer line. The results shed the lights on the occurrence and recovery of the disturbances in nuclear-mitochondrial interaction and provide clues for further investigations.	[Liu, Chen; Ma, Ning; Wang, Ping-Yong; Fu, Nan; Shen, Huo-Lin] China Agr Univ, Beijing 100094, Peoples R China	China Agricultural University	Shen, HL (corresponding author), China Agr Univ, Beijing 100094, Peoples R China.	shl1606@cau.edu.cn	Shen, Huolin/AAI-1644-2019		National Natural Science Foundation of China [31171972]; National "Twelfth Five-Year" Plan for Science & Technology Support [2012BA02B02]; Beijing key laboratory of growth and developmental regulation for protected vegetable crops	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National "Twelfth Five-Year" Plan for Science & Technology Support; Beijing key laboratory of growth and developmental regulation for protected vegetable crops	This project was supported by the National Natural Science Foundation of China(31171972); the National "Twelfth Five-Year" Plan for Science & Technology Support(2012BA02B02); the Beijing key laboratory of growth and developmental regulation for protected vegetable crops. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi H, 2004, THEOR APPL GENET, V108, P1449, DOI 10.1007/s00122-004-1591-2; Alfonso AA, 2003, PHILIPP AGRIC SCI, V86, P303; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; BEGU D, 1990, PLANT CELL, V2, P1283, DOI 10.1105/tpc.2.12.1283; Bennett MD, 2005, ANN BOT-LONDON, V95, P45, DOI 10.1093/aob/mci003; Bentolila S, 2012, PLANT PHYSIOL, V158, P996, DOI 10.1104/pp.111.190231; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Bosland P. W., 1992, HortTechnology, V2, P6; Bosland PW, 2012, CROP PROD SCI HORTIC, V22, P1, DOI 10.1079/9781845938253.0000; Brown GG, 2003, PLANT J, V35, P262, DOI 10.1046/j.1365-313X.2003.01799.x; Budar F, 2001, CR ACAD SCI III-VIE, V324, P543, DOI 10.1016/S0764-4469(01)01324-5; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Chen CM, 2012, MOL BIOL REP, V39, P737, DOI 10.1007/s11033-011-0793-3; Chen CM, 2012, PLANT MOL BIOL REP, V30, P403, DOI 10.1007/s11105-011-0358-6; Chen Xian-Feng, 1992, Acta Botanica Sinica, V34, P416; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; De AK., 2003, CAPSICUM GENUS CAPSI; Deng MH, 2012, SCI HORTIC-AMSTERDAM, V134, P232, DOI 10.1016/j.scienta.2011.10.027; Duan Jun, 1996, Plant Physiology Communications, V32, P331; Ekman DR, 2003, PLANT PHYSIOL, V133, P1397, DOI 10.1104/pp.103.028019; Gongora-Castillo E, 2012, BIOINFORMATION, V8, P43; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan JX, 1981, CHINA VEGETABLES, V1, P9; Gulyas G, 2006, BREEDING SCI, V56, P331, DOI 10.1270/jsbbs.56.331; Guo S, 2011, AGR SCI CHINA, V10, P1010, DOI 10.1016/S1671-2927(11)60088-6; Guo ShuAng, 2009, Acta Horticulturae Sinica, V36, P1443; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hong Sung-Tae, 1998, Journal of Plant Biology, V41, P116; Huang JinLing, 2004, Cotton Science, V16, P229; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P567, DOI 10.1016/j.tplants.2006.10.008; IWABUCHI M, 1993, EMBO J, V12, P1437, DOI 10.1002/j.1460-2075.1993.tb05787.x; Jin JK, 1984, RUPR ACTA HORTICULTU, V11, P182; Jo YD, 2010, MOL BREEDING, V25, P187, DOI 10.1007/s11032-009-9318-3; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim BS, 2012, KOREAN J HORTIC SCI, V30, P73, DOI 10.7235/hort.2012.11104; Kim DH, 2006, CURR GENET, V49, P59, DOI 10.1007/s00294-005-0032-3; Kim DH, 2005, MOL CELLS, V20, P416; Kim DH, 2007, PLANT MOL BIOL, V63, P519, DOI 10.1007/s11103-006-9106-y; Kim DS, 2006, MOL CELLS, V21, P135; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Lee J, 2008, THEOR APPL GENET, V117, P383, DOI 10.1007/s00122-008-0782-7; Lee JD, 2008, MOL BREEDING, V21, P95, DOI 10.1007/s11032-007-9111-0; Li Li, 2010, Agricultural Science & Technology - Hunan, V11, P9; Li SQ, 2004, FUNCT PLANT BIOL, V31, P369, DOI 10.1071/FP03224; [李莹莹 Li Yingying], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P134; Linke B, 2005, MITOCHONDRION, V5, P389, DOI 10.1016/j.mito.2005.10.001; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Liu SQ, 2012, PLANT CELL TISS ORG, V110, P111, DOI 10.1007/s11240-012-0135-8; LIU Y, 1988, Acta Genetica Sinica, V15, P348; Liu Z. S., 1990, Oil Crops of China, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu FH, 2012, MOL BIOL REP, V39, P3327, DOI 10.1007/s11033-011-1102-x; Lu FH, 2011, SCI HORTIC-AMSTERDAM, V129, P38, DOI 10.1016/j.scienta.2011.03.003; Ma JH, 1984, CHINA VEGETABLES, V3, P1; Min WK, 2008, MOL CELLS, V25, P20; MONEGER F, 1994, EMBO J, V13, P8, DOI 10.1002/j.1460-2075.1994.tb06230.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUEHLBAUER GJ, 1988, CROP SCI, V28, P729, DOI 10.2135/cropsci1988.0011183X002800050002x; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Palloix A, 2012, GENET MOL RES, V11, P43; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; PETERSON PA, 1958, AM NAT, V92, P111, DOI 10.1086/282017; Qiu WM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-397; RICARD B, 1986, PLANT SCI, V43, P141, DOI 10.1016/0168-9452(86)90155-X; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Scott RJ, 2004, PLANT CELL, V16, pS46, DOI 10.1105/tpc.017012; Shen H. L., 1994, Acta Agriculturae Universitatis Pekinensis, V20, P25; SINGH M, 1991, PLANT CELL, V3, P1349, DOI 10.1105/tpc.3.12.1349; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Teixeira RT, 2005, J EXP BOT, V56, P1245, DOI 10.1093/jxb/eri120; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Wan CX, 2007, PLANT CELL REP, V26, P373, DOI 10.1007/s00299-006-0234-2; Wang G, 2012, ACTA PHYSIOL PLANT, V34, P107, DOI 10.1007/s11738-011-0809-6; Wang LH, 2004, THEOR APPL GENET, V109, P1058, DOI 10.1007/s00122-004-1715-8; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; [王述彬 WANG Shubin], 2007, [华北农学报, Acta Agriculturae Boreali-Sinica], V22, P86; Wang Wen, 2011, China Cucurbits and Vegetables, V24, P1, DOI 10.1080/17544750.2011.544079; Wang X. Z., 1986, Acta Agronomica Sinica, V12, P177; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; YOUNG EG, 1987, CELL, V50, P41, DOI 10.1016/0092-8674(87)90660-X; YOUNG ND, 1988, GENETICS, V120, P579; Zhang BX, 2000, EUPHYTICA, V113, P155, DOI 10.1023/A:1003945723196; Zhang JianKui, 2001, Journal of Triticeae Crops, V21, P26; Zhang JuPing, 2007, Journal of Northwest A & F University - Natural Science Edition, V35, P153; Zhang MingYong, 1997, Acta Agronomica Sinica, V23, P603; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhang ZiXue, 2005, Acta Botanica Boreali-Occidentalia Sinica, V25, P799; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758; Zhou RH, 2005, THEOR APPL GENET, V110, P640, DOI 10.1007/s00122-004-1889-0	92	53	64	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65209	10.1371/journal.pone.0065209	http://dx.doi.org/10.1371/journal.pone.0065209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750245	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900047
J	Yoshida, W; Saito, T; Yokoyama, T; Ferri, S; Ikebukuro, K				Yoshida, Wataru; Saito, Taiki; Yokoyama, Tomomi; Ferri, Stefano; Ikebukuro, Kazunori			Aptamer Selection Based on G4-Forming Promoter Region	PLOS ONE			English	Article							QUADRUPLEX-FORMING REGION; DNA APTAMERS; VEGF; EVOLUTION; INSULIN; BIND; RECOGNITION; INHIBITION; ALGORITHM; MOLECULES	We developed a method for aptamer identification without in vitro selection. We have previously obtained several aptamers, which may fold into the G-quadruplex (G4) structure, against target proteins; therefore, we hypothesized that the G4 structure would be an excellent scaffold for aptamers to recognize the target protein. Moreover, the G4-forming sequence contained in the promoter region of insulin can reportedly bind to insulin. We thus expected that G4 DNAs, which are contained in promoter regions, could act as DNA aptamers against their gene products. We designated this aptamer identification method as "G4 promoter-derived aptamer selection (G4PAS).'' Using G4PAS, we identified vascular endothelial growth factor (VEGF) 165, platelet-derived growth factor-AA (PDGF)-AA, and RB1 DNA aptamers. Surface plasmon resonance (SPR) analysis revealed that the dissociation constant (K-d) values of VEGF165, PDGF-AA, and RB1 DNA aptamers were 1.76 x 10(-7) M, 6.3 x 10(-9) M, and 4.4 x 10(-7) M, respectively. G4PAS is a simple and rapid method of aptamer identification because it involves only binding analysis of G4 DNAs to the target protein. In the human genome, over 40% of promoters contain one or more potential G4 DNAs. G4PAS could therefore be applied to identify aptamers against target proteins that contain G4 DNAs on their promoters.	[Yoshida, Wataru; Saito, Taiki; Yokoyama, Tomomi; Ferri, Stefano; Ikebukuro, Kazunori] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Ferri, Stefano; Ikebukuro, Kazunori] Japan Sci & Technol Agcy, CREST, Koganei, Tokyo, Japan	Tokyo University of Agriculture & Technology; Japan Science & Technology Agency (JST)	Ikebukuro, K (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan.	ikebu@cc.tuat.ac.jp	Yoshida, Wataru/AAI-9404-2020; Ferri, Stefano/G-1166-2013; Ikebukuro, Kazunori/B-9957-2013	Yoshida, Wataru/0000-0001-9828-0896; Ikebukuro, Kazunori/0000-0003-2838-0562	JSPS KAKENHI [24760647]; TUAT Next Gen.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); TUAT Next Gen.	This work was supported by JSPS KAKENHI (Grant Number 24760647) to WY; and TUAT Next Gen. Grant 2012 to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chushak Y, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp408; Citartan M, 2012, BIOSENS BIOELECTRON, V34, P1, DOI 10.1016/j.bios.2012.01.002; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Connor AC, 2006, J AM CHEM SOC, V128, P4986, DOI 10.1021/ja056097c; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gatto B, 2009, CURR MED CHEM, V16, P1248, DOI 10.2174/092986709787846640; Hasegawa H, 2008, BIOTECHNOL LETT, V30, P829, DOI 10.1007/s10529-007-9629-6; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Ikebukuro K, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni108; Ikebukuro K, 2006, BIOTECHNOL LETT, V28, P1933, DOI 10.1007/s10529-006-9174-8; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; KLUG SJ, 1994, MOL BIOL REP, V20, P97, DOI 10.1007/BF00996358; Li WL, 2000, J CELL SCI, V113, P1525; Matylla-Kulinska K, 2012, WIRES RNA, V3, P73, DOI 10.1002/wrna.105; Morita Y, 2011, BIOSENS BIOELECTRON, V26, P4837, DOI 10.1016/j.bios.2011.05.050; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Noma T, 2006, BIOCHEM BIOPH RES CO, V347, P226, DOI 10.1016/j.bbrc.2006.06.083; Noma T, 2006, BIOTECHNOL LETT, V28, P1939, DOI 10.1007/s10529-006-9178-4; Nonaka Y, 2010, MOLECULES, V15, P215, DOI 10.3390/molecules15010215; Osawa Y, 2009, ELECTROANAL, V21, P1303, DOI 10.1002/elan.200804559; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Qin Y, 2010, BIOCHEMISTRY-US, V49, P4208, DOI 10.1021/bi100330w; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Savory N, 2010, BIOSENS BIOELECTRON, V26, P1386, DOI 10.1016/j.bios.2010.07.057; Seenisamy J, 2004, J AM CHEM SOC, V126, P8702, DOI 10.1021/ja040022b; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tsukakoshi K, 2012, ANAL CHEM, V84, P5542, DOI 10.1021/ac300330g; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vinkenborg JL, 2011, NAT CHEM BIOL, V7, P519, DOI [10.1038/NCHEMBIO.609, 10.1038/nchembio.609]; Xiao JF, 2009, J AM SOC MASS SPECTR, V20, P1974, DOI 10.1016/j.jasms.2009.08.002; Xiao JF, 2009, J SEP SCI, V32, P1654, DOI 10.1002/jssc.200900060; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485; Yoshida W, 2009, BIOSENS BIOELECTRON, V24, P1116, DOI 10.1016/j.bios.2008.06.016; Zhang R, 2008, NUCLEIC ACIDS RES, V36, pD372, DOI 10.1093/nar/gkm787	49	23	25	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65497	10.1371/journal.pone.0065497	http://dx.doi.org/10.1371/journal.pone.0065497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750264	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900066
J	Baniwal, SK; Chimge, NO; Jordan, VC; Tripathy, D; Frenkel, B				Baniwal, Sanjeev K.; Chimge, Nyam-Osor; Jordan, V. Craig; Tripathy, Debu; Frenkel, Baruch			Prolactin-Induced Protein (PIP) Regulates Proliferation of Luminal A Type Breast Cancer Cells in an Estrogen-Independent Manner	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR PORTRAITS; TUMORS; DNA; PHOSPHORYLATION; TAMOXIFEN; SUBTYPES; CULTURE; LINES	Prolactin-induced Protein (PIP), an aspartyl protease unessential for normal mammalian cell function, is required for the proliferation and invasion of some breast cancer (BCa) cell types. Because PIP expression is particularly high in the Luminal A BCa subtype, we investigated the roles of PIP in the related T47D BCa cell line. Nucleic acid and antibody arrays were employed to screen effects of PIP silencing on global gene expression and activation of receptor tyrosine kinases (RTKs), respectively. Expression of PIP-stimulated genes, as defined in the T47D cell culture model, was well correlated with the expression of PIP itself across a cohort of 557 mRNA profiles of diverse BCa tumors, and bioinformatics analysis revealed cJUN and cMYC as major nodes in the PIP-dependent gene network. Among 71 RTKs tested, PIP silencing resulted in decreased phosphorylation of focal adhesion kinase (FAK), ephrin B3 (EphB3), FYN, and hemopoietic cell kinase (HCK). Ablation of PIP also abrogated serum-induced activation of the downstream serine/threonine kinases AKT, ERK1/2, and JNK1. Consistent with these results, PIP-depleted cells exhibited defects in adhesion to fibronectin, cytoskeletal stress fiber assembly and protein secretion. In addition, PIP silencing abrogated the mitogenic response of T47D BCa cells to estradiol (E2). The dependence of BCa cell proliferation was unrelated, however, to estrogen signaling because: 1) PIP silencing did not affect the transcriptional response of estrogen target genes to hormone treatment, and 2) PIP was required for the proliferation of tamoxifen-resistant BCa cells. Pharmacological inhibition of PIP may therefore serve the bases for both augmentation of existing therapies for hormone-dependent tumors and the development of novel therapeutic approaches for hormone-resistant BCa.	[Baniwal, Sanjeev K.; Frenkel, Baruch] Univ So Calif, Keck Sch Med, Dept Orthoped Surg, Los Angeles, CA 90033 USA; [Baniwal, Sanjeev K.; Chimge, Nyam-Osor; Frenkel, Baruch] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; [Chimge, Nyam-Osor; Frenkel, Baruch] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Jordan, V. Craig] Georgetown Univ, Med Ctr, Georgetown Lombardi Comprehens Canc Ctr, Dept Oncol,Breast Canc Program, Washington, DC 20007 USA; [Tripathy, Debu] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; Georgetown University; University of Southern California	Baniwal, SK (corresponding author), Univ So Calif, Keck Sch Med, Dept Orthoped Surg, Los Angeles, CA 90033 USA.	Baniwal@usc.edu	Jordan, V. Craig/H-4491-2011; JORDAN, V.Craig/AAX-3562-2020		National Institutes of Health [DK071122, DK071122S1, SC CTSI UL1 RR03986]; Zumberge Fund Individual Grant; NIH [30CA051008]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031986, S10RR003986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071122, R56DK071122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zumberge Fund Individual Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK071122, DK071122S1, and SC CTSI UL1 RR03986 from the National Institutes of Health (NIH) to BF, Zumberge Fund Individual Grant to SKB, and NIH grant 30CA051008 to the Lombardi Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Baniwal SK, 2009, MOL ENDOCRINOL, V23, P1203, DOI 10.1210/me.2008-0470; Baniwal SK, J CELL PHYSL, V227, P2276; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Boudot A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020898; Boureux A, 2005, J CELL SCI, V118, P3717, DOI 10.1242/jcs.02491; Caputo E, 2000, J BIOL CHEM, V275, P7935, DOI 10.1074/jbc.275.11.7935; CASSONI P, 1995, INT J CANCER, V60, P216; CHALBOS D, 1987, CANCER RES, V47, P2787; Clark JW, 1999, BRIT J CANCER, V81, P1002, DOI 10.1038/sj.bjc.6690799; DEJARDIN L, 1991, J MOL ENDOCRINOL, V7, P105, DOI 10.1677/jme.0.0070105; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; Ghosh MG, 2000, CANCER RES, V60, P6367; Graf T, 1992, CURR OPIN GENET DEV, V2, P249, DOI 10.1016/S0959-437X(05)80281-3; HAAGENSEN DE, 1990, ANN NY ACAD SCI, V586, P161, DOI 10.1111/j.1749-6632.1990.tb17804.x; HAAGENSEN DE, 1992, BREAST CANCER RES TR, V23, P77, DOI 10.1007/BF01831479; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Kim J, 2000, J STEROID BIOCHEM, V74, P157, DOI 10.1016/S0960-0760(00)00119-9; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lee Dong Min, 2005, Korean J Gastroenterol, V46, P388; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; MURPHY CS, 1989, EUR J CANCER CLIN ON, V25, P1777, DOI 10.1016/0277-5379(89)90348-9; MURPHY LC, 1987, J BIOL CHEM, V262, P15236; Naderi A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3232; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Park WC, 2005, INT J ONCOL, V27, P1459; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; SHIU RPC, 1985, J BIOL CHEM, V260, P1307; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; TREISMAN JE, 1995, GENE DEV, V9, P1709, DOI 10.1101/gad.9.14.1709; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593	36	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e62361	10.1371/journal.pone.0062361	http://dx.doi.org/10.1371/journal.pone.0062361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755096	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300004
J	Goldstien, SJ; Inglis, GJ; Schiel, DR; Gemmell, NJ				Goldstien, Sharyn J.; Inglis, Graeme J.; Schiel, David R.; Gemmell, Neil J.			Using Temporal Sampling to Improve Attribution of Source Populations for Invasive Species	PLOS ONE			English	Article							GENETIC DIVERSITY; STYELA-CLAVA; MICROSATELLITE MARKERS; COMPUTER-PROGRAM; NORTH-AMERICA; PHYLOGEOGRAPHY; INTRODUCTIONS; COLONIZATION; CONNECTIVITY; SIMILARITY	Numerous studies have applied genetic tools to the identification of source populations and transport pathways for invasive species. However, there are many gaps in the knowledge obtained from such studies because comprehensive and meaningful spatial sampling to meet these goals is difficult to achieve. Sampling populations as they arrive at the border should fill the gaps in source population identification, but such an advance has not yet been achieved with genetic data. Here we use previously acquired genetic data to assign new incursions as they invade populations within New Zealand ports and marinas. We also investigated allelelic frequency change in these recently established populations over a two-year period, and assessed the effect of temporal genetic sampling on our ability to assign new incursions to their population of source. We observed shifts in the allele frequencies among populations, as well as the complete loss of some alleles and the addition of alleles novel to New Zealand, within these recently established populations. There was no significant level of genetic differentiation observed in our samples between years, and the use of these temporal data did alter the assignment probability of new incursions. Our study further suggests that new incursions can add genetic variation to the population in a single introduction event as the founders themselves are often more genetically diverse than theory initially predicted.	[Goldstien, Sharyn J.; Schiel, David R.; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand; [Inglis, Graeme J.] Natl Inst Water & Atmospher Res, Christchurch, New Zealand; [Gemmell, Neil J.] Univ Otago, Ctr Reprod & Genom, Dept Anat, Dunedin, New Zealand; [Gemmell, Neil J.] Univ Otago, Allan Wilson Ctr Mol Ecol & Evolut, Dunedin, New Zealand	University of Canterbury; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Otago; University of Otago	Goldstien, SJ (corresponding author), Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand.	sharyn.goldstien@canterbury.ac.nz	Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637	University of Canterbury Postdoctoral Fellowship; Ministry of Agriculture and Forestry, Biosecurity New Zealand [B0202]; National Institute of Water and Atmospheric Research; Biodiversity and Biosecurity OBI [C01X0502]	University of Canterbury Postdoctoral Fellowship; Ministry of Agriculture and Forestry, Biosecurity New Zealand; National Institute of Water and Atmospheric Research; Biodiversity and Biosecurity OBI	A University of Canterbury Postdoctoral Fellowship supported this study, with additional funding from the Ministry of Agriculture and Forestry, Biosecurity New Zealand (contract B0202), the National Institute of Water and Atmospheric Research, and a subcontract to NJG from the Biodiversity and Biosecurity OBI (C01X0502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew J, 1997, MAR ECOL PROG SER, V152, P131, DOI 10.3354/meps152131; Ashton GV, 2008, MOL ECOL, V17, P1293, DOI 10.1111/j.1365-294X.2007.03668.x; Audzijonyte A, 2008, DIVERS DISTRIB, V14, P179, DOI 10.1111/j.1472-4642.2007.00434.x; Bucciarelli G, 2002, J EXP MAR BIOL ECOL, V273, P143, DOI 10.1016/S0022-0981(02)00138-7; Cabaco S, 2011, MARINE ECOLOGY, V33, P280; Calderon I, 2009, MOL ECOL, V18, P3036, DOI 10.1111/j.1365-294X.2009.04239.x; Chandler EA, 2008, MOL ECOL, V17, P4079, DOI 10.1111/j.1365-294X.2008.03897.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chen YH, 2010, GENETICA, V138, P1059, DOI 10.1007/s10709-010-9491-7; Clark GF, 2009, OIKOS, V118, P1679, DOI 10.1111/j.1600-0706.2009.17564.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Dlugosch KM, 2008, MOL ECOL, V17, P4583, DOI 10.1111/j.1365-294X.2008.03932.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Dupont L, 2006, MOL ECOL NOTES, V6, P101, DOI 10.1111/j.1471-8286.2005.01153.x; Dupont L, 2009, MOL ECOL, V18, P442, DOI 10.1111/j.1365-294X.2008.04045.x; DYER C, 1992, S AFR J BOT, V58, P117, DOI 10.1016/S0254-6299(16)30881-X; Elderkin CL, 2004, FRESHWATER BIOL, V49, P1487, DOI 10.1111/j.1365-2427.2004.01285.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Folino-Rorem NC, 2009, BIOL INVASIONS, V11, P1869, DOI 10.1007/s10530-008-9365-4; Geller J, 2008, MAR ECOL PROG SER, V358, P211, DOI 10.3354/meps07466; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Goldstien SJ, 2010, MOL ECOL, V19, P874, DOI 10.1111/j.1365-294X.2010.04527.x; Goldstien SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016755; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grant PR, 2001, GENETICA, V112, P359, DOI 10.1023/A:1013363032724; Gust N, 2009, ASSESSMENT POPULATIO; Holland BS, 2004, MAR BIOL, V145, P1119, DOI 10.1007/s00227-004-1409-4; Holland BS, 2000, HYDROBIOLOGIA, V420, P63, DOI 10.1023/A:1003929519809; Hoos PM, 2010, DIVERS DISTRIB, V16, P582, DOI 10.1111/j.1472-4642.2010.00672.x; JOHNSON MS, 1984, MAR BIOL, V79, P295, DOI 10.1007/BF00393261; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Muller J, 2001, ZOOL-ANAL COMPLEX SY, V104, P346, DOI 10.1078/0944-2006-00040; Ng WC, 2010, MAR BIOL, V157, P325, DOI 10.1007/s00227-009-1320-0; Patti FP, 2001, MAR ECOL PROG SER, V215, P169, DOI 10.3354/meps215169; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez-Portela R, 2012, MAR ECOL PROG SER, V451, P93, DOI 10.3354/meps09560; Pineda MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025495; Pringle JM, 2011, P NATL ACAD SCI USA, V108, P15288, DOI 10.1073/pnas.1100473108; Provan J, 2005, MOL ECOL, V14, P189, DOI 10.1111/j.1365-294X.2004.02384.x; REYNOLDS J, 1983, GENETICS, V105, P767; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ryland JS, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2093.1.3; Shefer S, 2004, MOL ECOL, V13, P2333, DOI 10.1111/j.1365-294X.2004.02227.x; Siegel DA, 2008, P NATL ACAD SCI USA, V105, P8974, DOI 10.1073/pnas.0802544105; SINNOCK P, 1975, AM NAT, V109, P565, DOI 10.1086/283027; SLATKIN M, 1995, GENETICS, V139, P457; Uwai SY, 2006, PHYCOLOGIA, V45, P687, DOI 10.2216/05-66.1; Wong NA, 2011, MAR BIOL, V158, P2775, DOI 10.1007/s00227-011-1776-6	58	11	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65656	10.1371/journal.pone.0065656	http://dx.doi.org/10.1371/journal.pone.0065656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755264	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300089
J	Billet, A; Luo, YS; Balghi, H; Hanrahan, JW				Billet, Arnaud; Luo, Yishan; Balghi, Haouaria; Hanrahan, John W.			Role of Tyrosine Phosphorylation in the Muscarinic Activation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CFTR; G Protein-coupled Receptors (GPCR); PP2A; Src; Tyrosine Protein Kinase (Tyrosine Kinase); Muscarinic 3 Receptor	PROTEIN-KINASE-A; TRACHEAL SUBMUCOSAL GLANDS; CHLORIDE CHANNEL; CL-CHANNEL; CELLS; FLUID; SECRETION; CALCIUM; GENE; IDENTIFICATION	Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride (Cl-) channel, which plays an important role in physiological anion and fluid secretion, and is defective in several diseases. Although its activation by PKA and PKC has been studied extensively, its regulation by receptors is less well understood. To study signaling involved in CFTR activation, we measured whole-cell Cl- currents in BHK cells cotransfected with GPCRs and CFTR. In cells expressing the M3 muscarinic acetylcholine receptor, the agonist carbachol (Cch) caused strong activation of CFTR through two pathways; the canonical PKA-dependent mechanism and a second mechanism that involves tyrosine phosphorylation. The role of PKA was suggested by partial inhibition of cholinergic stimulation by the specific PKA inhibitor Rp-cAMPS. The role of tyrosine kinases was suggested by Cch stimulation of 15SA-CFTR and 9CA-CFTR, mutants that lack 15 PKA or 9 PKC consensus sequences and are unresponsive to PKA or PKC stimulation, respectively. Moreover the residual Cch response was sensitive to inhibitors of the Pyk2 and Src tyrosine kinase family. Our results suggest that tyrosine phosphorylation acts on CFTR directly and through inhibition of the phosphatase PP2A. Results suggest that PKA and tyrosine kinases contribute to CFTR regulation by GPCRs that are expressed at the apical membrane of intestinal and airway epithelia.	McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Res Inst, Ctr Hosp, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Billet, A (corresponding author), McIntyre Med Sci, Dept Physiol, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	arnaud.billet@mcgill.ca	billet, arnaud/P-9503-2016; Hanrahan, John/AGG-1926-2022; Billet, Arnaud/AAZ-3834-2020	Hanrahan, John/0000-0001-9080-2039; 	Canada Foundation for Innovation; Canadian Institutes for Health Research; Groupe d'Etude des Proteines Membranaire (GEPROM); Groupe de Recherche Axe sur la Structure des Proteines (GRASP); CIHR Program in Chemical Biology at McGill; Cystic Fibrosis Canada	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Groupe d'Etude des Proteines Membranaire (GEPROM); Groupe de Recherche Axe sur la Structure des Proteines (GRASP); CIHR Program in Chemical Biology at McGill(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada	This research was supported by the Canada Foundation for Innovation and Canadian Institutes for Health Research.; Supported by fellowships from the Groupe d'Etude des Proteines Membranaire (GEPROM), the Groupe de Recherche Axe sur la Structure des Proteines (GRASP), and the CIHR Program in Chemical Biology at McGill.; Supported by the CIHR Program in Chemical Biology at McGill and by Cystic Fibrosis Canada.	ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BERGER HA, 1993, J BIOL CHEM, V268, P2037; BERGER HA, 1991, J CLIN INVEST, V88, P1422, DOI 10.1172/JCI115450; Brinson AE, 1998, J BIOL CHEM, V273, P1711, DOI 10.1074/jbc.273.3.1711; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; CORRALES RJ, 1984, J APPL PHYSIOL, V56, P1076, DOI 10.1152/jappl.1984.56.4.1076; FIELD M, 1972, J CLIN INVEST, V51, P796, DOI 10.1172/JCI106874; Fischer H, 1996, BIOPHYS J, V71, P3073, DOI 10.1016/S0006-3495(96)79501-2; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Halls ML, 2011, COLD SPRING HARB PER, V3; Hirst R. A., 1993, BIOCHEM SOC T, V21, p431S; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Kerem E, 2006, PAEDIATR RESPIR REV, V7, pS144, DOI 10.1016/j.prrv.2006.04.219; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li HY, 2012, AM J PHYSIOL-RENAL, V303, pF1176, DOI 10.1152/ajprenal.00130.2012; Li X, 1998, J BIOL CHEM, V273, P9361, DOI 10.1074/jbc.273.16.9361; Liang LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021991; Liang L, 2009, AM J PHYSIOL-CELL PH, V296, pC131, DOI 10.1152/ajpcell.00346.2008; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397, DOI 10.1152/ajpcell.1998.274.5.C1397; Luo Y, 2009, BIOCHEM J, V419, P211, DOI 10.1042/BJ20081869; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luz S, 2011, MOL CELL BIOL, V31, P4392, DOI 10.1128/MCB.05517-11; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Park S., 2013, GASTROENTEROLOGY, V13; Park S, 2012, PHYSIOLOGY, V27, P291, DOI 10.1152/physiol.00028.2012; Reddy MM, 2001, AM J PHYSIOL-CELL PH, V280, pC604, DOI 10.1152/ajpcell.2001.280.3.C604; RIORDAN JR, 1989, SCIENCE, V245, P1066; Salinas D, 2004, FASEB J, V18, P431, DOI 10.1096/fj.04-2879fje; Schultheiss G, 2005, J MEMBRANE BIOL, V204, P117, DOI 10.1007/s00232-005-0757-4; Seibert FS, 1999, BBA-BIOMEMBRANES, V1461, P275, DOI 10.1016/S0005-2736(99)00163-7; SUIDAN HS, 1991, CELL REGUL, V2, P13, DOI 10.1091/mbc.2.1.13; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Thelin WR, 2005, J BIOL CHEM, V280, P41512, DOI 10.1074/jbc.M507308200; Watcharasit P, 2001, NEUROCHEM RES, V26, P809, DOI 10.1023/A:1011612118779; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40	44	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21815	10.1074/jbc.M113.479360	http://dx.doi.org/10.1074/jbc.M113.479360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760269	hybrid, Green Published			2022-12-25	WOS:000328841900031
J	Zirkin, S; Davidovich, A; Don, J				Zirkin, Shahar; Davidovich, Ateret; Don, Jeremy			The PIM-2 Kinase Is an Essential Component of the Ultraviolet Damage Response That Acts Upstream to E2F-1 and ATM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Base Excision Repair; Cancer Biology; Cell Signaling; DNA Damage Response; ATM; E2F-1; PIM-2	NUCLEOTIDE EXCISION-REPAIR; HISTONE H2AX PHOSPHORYLATION; INDUCED DNA-DAMAGE; DOUBLE-STRAND BREAKS; CELL-CYCLE PHASE; DEPENDENT PHOSPHORYLATION; INDUCED APOPTOSIS; LYMPHOID TUMORS; UV-IRRADIATION; ACTIVATES ATM	The oncogenic nature ascribed to the PIM-2 kinase relies mostly on phosphorylation of substrates that act as pro-survival/anti-apoptotic factors. Nevertheless, pro-survival effects can also result from activating DNA repair mechanisms following damage. In this study, we addressed the possibility that PIM-2 plays a role in the cellular response to UV damage, an issue that has never been addressed before. We found that in U2OS cells, PIM-2 expression and activity increased upon exposure to UVC radiation (2-50 mJ/cm(2)), and Pim-2-silenced cells were significantly more sensitive to UV radiation. Overexpression of PIM-2 accelerated removal of UV-induced DNA lesions over time, reduced gamma H2AX accumulation in damaged cells, and rendered these cells significantly more viable following UV radiation. The protective effect of PIM-2 was mediated by increased E2F-1 and activated ATM levels. Silencing E2F-1 reduced the protective effect of PIM-2, whereas inhibiting ATM activity abrogated this protective effect, irrespective of E2F-1 levels. The results obtained in this study place PIM-2 upstream to E2F-1 and ATM in the UV-induced DNA damage response.	[Zirkin, Shahar; Davidovich, Ateret; Don, Jeremy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel	Bar Ilan University	Don, J (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel.	jeremy.don@biu.ac.il	Don, Jeremy/AAS-1240-2021		Weinkselbaum family medical research fund [3-00000-5049]	Weinkselbaum family medical research fund	This study was supported by Grant 3-00000-5049 from the Weinkselbaum family medical research fund administered by the Israeli Ministry of Health Chief Scientist Research Fund.	Alarcon-Vargas D, 2002, ONCOGENE, V21, P4384, DOI 10.1038/sj.onc.1205543; Allen JD, 1996, SEMIN CANCER BIOL, V7, P299, DOI 10.1006/scbi.1996.0038; Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; AMSON R, 1989, P NATL ACAD SCI USA, V86, P8857, DOI 10.1073/pnas.86.22.8857; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; Claudio JO, 2002, BLOOD, V100, P2175, DOI 10.1182/blood-2002-01-0008; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; Dai H, 2005, PROSTATE, V65, P276, DOI 10.1002/pros.20294; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Downs JA, 2005, CELL CYCLE, V4, P1373, DOI 10.4161/cc.4.10.2108; Dunkern TR, 2002, MOL BIOL CELL, V13, P348, DOI 10.1091/mbc.01-05-0225; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Guo RF, 2010, J BIOL CHEM, V285, P19308, DOI 10.1074/jbc.M110.121939; Halicka HD, 2005, CELL CYCLE, V4, P339; Hammerman PS, 2004, CANCER RES, V64, P8341, DOI 10.1158/0008-5472.CAN-04-2284; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hsu JL, 2012, CANCER LETT, V319, P214, DOI 10.1016/j.canlet.2012.01.004; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Levy D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034736; Lin WC, 2001, GENE DEV, V15, P1833; Luo L. Z., 2012, PLOS ONE, V7; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; MOROY T, 1991, ONCOGENE, V6, P1941; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Oh KS, 2011, DNA REPAIR, V10, P5, DOI 10.1016/j.dnarep.2010.09.004; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Potter AJ, 2002, CARCINOGENESIS, V23, P389, DOI 10.1093/carcin/23.3.389; Powers JT, 2004, MOL CANCER RES, V2, P203; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Ren K, 2010, PATHOL ONCOL RES, V16, P229, DOI 10.1007/s12253-009-9215-4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; SMITH ML, 1995, ONCOGENE, V10, P1053; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Thyagarajan B, 2007, MUTAGENESIS, V22, P147, DOI 10.1093/mutage/gel071; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wang Z, 2001, J Vet Sci, V2, P167; Wang ZP, 2010, INT J BIOCHEM CELL B, V42, P1030, DOI 10.1016/j.biocel.2010.03.012; Xiaofei E., 2011, PLOS PATHOG, V7; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Yoshida S, 1999, ONCOGENE, V18, P7994, DOI 10.1038/sj.onc.1203293; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhao H, 2010, CYTOM PART A, V77A, P285, DOI 10.1002/cyto.a.20839; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	57	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21770	10.1074/jbc.M113.458851	http://dx.doi.org/10.1074/jbc.M113.458851			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760264	Green Published, hybrid			2022-12-25	WOS:000328841900027
J	Lim, EK; Mitchell, PJ; Brown, N; Drummond, RA; Brown, GD; Kaye, PM; Bowles, DJ				Lim, Eng-Kiat; Mitchell, Paul J.; Brown, Najmeeyah; Drummond, Rebecca A.; Brown, Gordon D.; Kaye, Paul M.; Bowles, Dianna J.			Regiospecific Methylation of a Dietary Flavonoid Scaffold Selectively Enhances IL-1 beta Production following Toll-like Receptor 2 Stimulation in THP-1 Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTOZOAN NEGLECTED DISEASES; ACTIVATED PROTEIN-KINASES; RAW 264.7 CELLS; SECONDARY METABOLITES; INFLAMMATORY RESPONSE; INNATE IMMUNITY; QUERCETIN; PLANTS; POLYMORPHISM	It is now recognized that innate immunity to intestinal microflora plays a significant role in mediating immune health, and modulation of microbial sensing may underpin the impact of plant natural products in the diet or when used as nutraceuticals. In this context, we have examined five classes of plant-derived flavonoids (flavonols, flavones, flavanones, catechins, and cyanidin) for their ability to regulate cytokine release induced by the Toll-like receptor 2 (TLR2) agonist Pam3CSK4. We found that the flavonols selectively co-stimulated IL-1 beta secretion but had no impact on the secretion of IL-6. Importantly, this costimulation of TLR2-induced cytokine secretion was dependent on regiospecific methylation of the flavonol scaffold with a rank order of quercetin-3,4'-dimethylether > quercetin-3-methylether > casticin. The mechanism underpinning this costimulation did not involve enhanced inflammasome activation. In contrast, the methylated flavonols enhanced IL-1 beta gene expression through transcriptional regulation, involving mechanisms that operate downstream of the initial NF-kappa B and STAT1 activation events. These studies demonstrate an exquisite level of control of scaffold bioactivity by regiospecific methylation, with important implications for understanding how natural products affect innate immunity and for their development as novel immunomodulators for clinical use.	[Lim, Eng-Kiat; Mitchell, Paul J.; Brown, Najmeeyah; Kaye, Paul M.] Univ York, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Lim, Eng-Kiat; Mitchell, Paul J.; Brown, Najmeeyah; Kaye, Paul M.; Bowles, Dianna J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Drummond, Rebecca A.; Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	University of Hull; University of York - UK; University of York - UK; University of Aberdeen	Kaye, PM (corresponding author), Univ York, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England.	paul.kaye@york.ac.uk; dianna.bowles@york.ac.uk	Drummond, Rebecca/I-3155-2019	Drummond, Rebecca/0000-0001-5424-7074; brown, gordon/0000-0002-0287-5383; Kaye, Paul/0000-0002-8796-4755	Wellcome Trust; Leverhulme Trust; Medical Research Council [G1000230] Funding Source: researchfish; MRC [G1000230] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Wellcome Trust project grant (to P. M. K., D. J. B., and E.-K. L.) and a Leverhulme Trust Senior Research Fellowship (to D. J. B.).	Albert EJ, 2008, J LEUKOCYTE BIOL, V83, P833, DOI 10.1189/jlb.0807557; Bhaskar S, 2011, IMMUNOBIOLOGY, V216, P367, DOI 10.1016/j.imbio.2010.07.011; Boesch-Saadatmandi C, 2010, J PHYSIOL PHARMACOL, V61, P99; Byun EH, 2011, FEBS LETT, V585, P814, DOI 10.1016/j.febslet.2011.02.010; Choi HJ, 2008, EUR J PHARMACOL, V601, P171, DOI 10.1016/j.ejphar.2008.09.032; Chu X, 2012, J AGR FOOD CHEM, V60, P3947, DOI 10.1021/jf2051587; Cohen-Poradosu R, 2011, J INFECT DIS, V204, P363, DOI 10.1093/infdis/jir277; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; de Oliveira JG, 2012, WORLD J GASTROENTERO, V18, P1235, DOI 10.3748/wjg.v18.i11.1235; De Santi C, 2002, INT J CLIN PHARM TH, V40, P207; Del Rio D, 2010, BRIT J NUTR, V104, pS67, DOI 10.1017/S0007114510003958; Dong L, 2012, J GASTROEN HEPATOL, V27, P110, DOI 10.1111/j.1440-1746.2011.06839.x; FENTON MJ, 1987, J IMMUNOL, V138, P3972; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Han JM, 2010, BIOL PHARM BULL, V33, P1019, DOI 10.1248/bpb.33.1019; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008; Huo MX, 2012, INT IMMUNOPHARMACOL, V12, P241, DOI 10.1016/j.intimp.2011.11.017; Jelavic TB, 2006, CLIN GENET, V70, P156, DOI 10.1111/j.1399-0004.2006.00651.x; Jones DJL, 2004, BRIT J CANCER, V91, P1213, DOI 10.1038/sj.bjc.6602091; Kim DH, 2012, BIOORG MED CHEM LETT, V22, P700, DOI 10.1016/j.bmcl.2011.10.067; Kim YJ, 2010, INT IMMUNOPHARMACOL, V10, P1127, DOI 10.1016/j.intimp.2010.06.017; Krenn L, 2009, FITOTERAPIA, V80, P267, DOI 10.1016/j.fitote.2009.03.001; Lee JK, 2009, BIOCHEM PHARMACOL, V77, P1391, DOI 10.1016/j.bcp.2009.01.009; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Marques R, 2011, CELL MOL LIFE SCI, V68, P3661, DOI 10.1007/s00018-011-0829-9; Martin C, 2011, PLANT CELL, V23, P1685, DOI 10.1105/tpc.111.083279; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Messlik A, 2009, J PROTEOME RES, V8, P4406, DOI 10.1021/pr9000465; Modolo LV, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P143, DOI 10.1007/978-0-387-85498-4_6; Morimoto M, 2009, J GASTROEN HEPATOL, V24, P1123, DOI 10.1111/j.1440-1746.2008.05714.x; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Park HY, 2012, INT J MOL MED, V29, P1146, DOI 10.3892/ijmm.2012.935; Park SE, 2011, BRIT J PHARMACOL, V164, P1008, DOI 10.1111/j.1476-5381.2011.01389.x; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Rhee SH, 2003, J BIOL CHEM, V278, P22506, DOI 10.1074/jbc.M208633200; Rios JL, 2009, CURR PHARM DESIGN, V15, P1212, DOI 10.2174/138161209787846874; Rubio S, 2006, EUR J PHARMACOL, V548, P9, DOI 10.1016/j.ejphar.2006.07.020; Schmidt TJ, 2012, CURR MED CHEM, V19, P2128; Schmidt TJ, 2012, CURR MED CHEM, V19, P2176; Shen JK, 2009, ANN HEMATOL, V88, P743, DOI 10.1007/s00277-008-0677-3; Soromou LW, 2012, MOLECULES, V17, P3574, DOI 10.3390/molecules17033574; Soromou LW, 2012, BIOCHEM BIOPH RES CO, V419, P256, DOI 10.1016/j.bbrc.2012.02.005; Tahara T, 2008, DIGEST DIS SCI, V53, P919, DOI 10.1007/s10620-007-9950-x; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Torres F, 2011, MOL CARCINOGEN, V50, P113, DOI 10.1002/mc.20693; Torres F, 2010, MOL CARCINOGEN, V49, P464, DOI 10.1002/mc.20619; Zhang Y, 2008, J IMMUNOL, V181, P503, DOI 10.4049/jimmunol.181.1.503; Zheng LT, 2008, INT IMMUNOPHARMACOL, V8, P484, DOI 10.1016/j.intimp.2007.12.012	51	12	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21126	21135		10.1074/jbc.M113.453514	http://dx.doi.org/10.1074/jbc.M113.453514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760261	hybrid, Green Published			2022-12-25	WOS:000322014400033
J	Shin, BH; Lim, Y; Oh, HJ; Park, SM; Lee, SK; Ahnn, J; Kim, DH; Song, WK; Kwak, TH; Park, WJ				Shin, Bae Hyun; Lim, Yunki; Oh, Hye Jin; Park, Sang Min; Lee, Sun-Kyung; Ahnn, Joohong; Kim, Do Han; Song, Woo Keun; Kwak, Tae Hwan; Park, Woo Jin			Pharmacological Activation of Sirt1 Ameliorates Polyglutamine-Induced Toxicity through the Regulation of Autophagy	PLOS ONE			English	Article							BREAST-CANCER CELLS; BETA-LAPACHONE; HUNTINGTONS-DISEASE; CAENORHABDITIS-ELEGANS; MUTANT HUNTINGTIN; INTRANUCLEAR INCLUSIONS; MOUSE MODELS; APOPTOSIS; AGGREGATION; INDUCTION	Intracellular accumulation of polyglutamine (polyQ)-expanded Huntingtin (Htt) protein is a hallmark of Huntington's disease (HD). This study evaluated whether activation of Sirt1 by the anti-cancer agent, beta-lapachone (beta-lap), induces autophagy in human neuroblastoma SH-SY5Y cells, thereby reducing intracellular levels of polyQ aggregates and their concomitant cytotoxicity. Treatment of cells with beta-lap markedly diminished the cytotoxicity induced by forced expression of Htt exon 1 containing a pathogenic polyQ stretch fused to green fluorescent protein (HttEx1(97Q)-GFP). beta-lap increased autophagy in SH-SY5Y cells, as evidenced by the increased formation of LC3-II and autolysosomes. Furthermore, beta-lap reduced HttEx1(97Q)-GFP aggregation, which was significantly prevented by co-incubation with 3-methyladenine, an inhibitor of autophagy. beta-lap increased Sirt1 activity, as shown by the increased deacetylation of the Sirt1 substrates, PARP-1 and Atg5, and the nuclear translocation of FOXO1. Both the induction of autophagy and attenuation of HttEx1(97Q)-GFP aggregation by beta-lap were significantly prevented by co-incubation with sirtinol, a general sirtuin inhibitor or by co-transfection with shRNA against Sirt1. The pro-autophagic actions of beta-lap were further investigated in a transgenic Caenorhabditis elegans (C. elegans) line that expressed Q67 fused to cyanine fluorescent protein (Q67). Notably, beta-lap reduced the number of Q67 puncta and restored Q67-induced defects in motility, which were largely prevented by pre-treatment with RNAi against sir-2.1, the C. elegans orthologue of Sirt1. Collectively, these data suggest that beta-lap induces autophagy through activation of Sirt1, which in turn leads to a reduction in polyQ aggregation and cellular toxicity. Thus, beta-lap provides a novel therapeutic opportunity for the treatment of HD.	[Shin, Bae Hyun; Park, Sang Min; Park, Woo Jin] GIST, Global Res Lab, Kwangju, South Korea; [Lim, Yunki; Oh, Hye Jin; Kim, Do Han; Song, Woo Keun] GIST, Coll Life Sci, Kwangju, South Korea; [Lee, Sun-Kyung; Ahnn, Joohong] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Lee, Sun-Kyung] Hanyang Univ, Res Inst Nat Sci, Seoul 133791, South Korea; [Kwak, Tae Hwan] Mazence Inc, R&D Inst, Suwon, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Hanyang University; Hanyang University	Park, WJ (corresponding author), GIST, Global Res Lab, Kwangju, South Korea.	woojinpark@me.com		Im, Yunki/0000-0002-6440-2194	National Research Foundation of Korea [2009-0085747]; Global Research Laboratory Program [M6-0605-00-0001]; Korean government (MEST); Gwangju Institute of Science and Technology (GIST)	National Research Foundation of Korea(National Research Foundation of Korea); Global Research Laboratory Program; Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Gwangju Institute of Science and Technology (GIST)	This work was supported by a grant from the National Research Foundation of Korea (2009-0085747), a grant from the Global Research Laboratory Program (M6-0605-00-0001) funded by the Korean government (MEST), and a grant from the "Systems biology infrastructure establishment grant" provided by Gwangju Institute of Science and Technology (GIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Beal MF, 2004, NAT REV NEUROSCI, V5, P373, DOI 10.1038/nrn1386; BRENNER S, 1974, GENETICS, V77, P71; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Chiang MC, 2007, MOL CELL PROTEOMICS, V6, P781, DOI 10.1074/mcp.M600356-MCP200; Choi YH, 2003, J BIOCHEM MOL BIOL, V36, P223; CRUZ FS, 1978, ANTIMICROB AGENTS CH, V14, P630, DOI 10.1128/AAC.14.4.630; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; GUIRAUD P, 1994, PLANTA MED, V60, P373, DOI 10.1055/s-2006-959504; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kim SY, 2009, CIRC RES, V104, P842, DOI 10.1161/CIRCRESAHA.108.189837; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047122; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Parker JA, 2012, J NEUROSCI, V32, P12630, DOI 10.1523/JNEUROSCI.0277-12.2012; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Salminen A, 2009, CELL SIGNAL, V21, P1356, DOI 10.1016/j.cellsig.2009.02.014; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SCHAFFNERSABBA K, 1984, J MED CHEM, V27, P990, DOI 10.1021/jm00374a010; Sellamuthu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022554; Wang H, 2006, HUM MOL GENET, V15, P1025, DOI 10.1093/hmg/ddl017; Woo HJ, 2006, J MED FOOD, V9, P161, DOI 10.1089/jmf.2006.9.161; Wuerzberger SM, 1998, CANCER RES, V58, P1876; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	45	32	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64953	10.1371/journal.pone.0064953	http://dx.doi.org/10.1371/journal.pone.0064953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762270	Green Published, Green Submitted, gold			2022-12-25	WOS:000320440500013
J	Kough, AS; Paris, CB; Butler, MJ				Kough, Andrew S.; Paris, Claire B.; Butler, Mark J.			Larval Connectivity and the International Management of Fisheries	PLOS ONE			English	Article							LOBSTER PANULIRUS-ARGUS; CARIBBEAN SPINY LOBSTER; WESTERN ROCK LOBSTER; REEF FISH; SPATIALLY-EXPLICIT; RECRUITMENT; POPULATIONS; DISPERSAL; ATLANTIC; CIRCULATION	Predicting the oceanic dispersal of planktonic larvae that connect scattered marine animal populations is difficult, yet crucial for management of species whose movements transcend international boundaries. Using multi-scale biophysical modeling techniques coupled with empirical estimates of larval behavior and gamete production, we predict and empirically verify spatio-temporal patterns of larval supply and describe the Caribbean-wide pattern of larval connectivity for the Caribbean spiny lobster (Panulirus argus), an iconic coral reef species whose commercial value approaches $1 billion USD annually. Our results provide long sought information needed for international cooperation in the management of marine resources by identifying lobster larval connectivity and dispersal pathways throughout the Caribbean. Moreover, we outline how large-scale fishery management could explicitly recognize metapopulation structure by considering larval transport dynamics and pelagic larval sanctuaries.	[Kough, Andrew S.; Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Butler, Mark J.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA	University of Miami; Old Dominion University	Kough, AS (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	akough@rsmas.miami.edu		Kough, Andrew/0000-0001-8732-6588; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334	NSF [OCE-0928930]; Coral Reef Targeted Research Program, a part of the World Bank Global Environment Fund; NSF-RAPID program [OCE-1048697]	NSF(National Science Foundation (NSF)); Coral Reef Targeted Research Program, a part of the World Bank Global Environment Fund; NSF-RAPID program	The authors are grateful for funding to MJB and CBP from the NSF (OCE-0928930) and from the Coral Reef Targeted Research Program, a part of the World Bank Global Environment Fund. Code development was funded through the NSF-RAPID program (OCE-1048697) to CBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Andrefouet S, 2004, P 10 INT COR REEF S, P1732; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; Bertelsen RD, 2001, MAR FRESHWATER RES, V52, P1559, DOI 10.1071/MF01214; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Briones-Fourzan P, 2008, LIMNOL OCEANOGR, V53, P970, DOI 10.4319/lo.2008.53.3.0970; Butler MJ, 2011, MAR ECOL PROG SER, V422, P223, DOI 10.3354/meps08878; Butler MJ, 2005, ECOL APPL, V15, P902, DOI 10.1890/04-1081; Butler MJ, 2003, FISH RES, V65, P63, DOI 10.1016/j.fishres.2003.09.007; Butler MJ, 1997, CAN J FISH AQUAT SCI, V54, P452; CAPUTI N, 1995, CRUSTACEANA, V68, P245, DOI 10.1163/156854095X01402; Chavez EA, 2013, P 12 INT CO IN PRESS; Chavez EA, 2009, CRUSTACEANA, V82, P1393, DOI 10.1163/001121609X12481627024373; Cherubin LM, 2013, PROGR OCEAN IN PRESS; Chiswell SM, 2008, MAR ECOL PROG SER, V354, P201, DOI 10.3354/meps07217; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cruz R, 2008, P 61 GULF CAR FISH I, V61, P433; Dataset from HYCOM Consortium, HYCOM NCODA GLOB 1 1; Dataset from HYCOM Consortium, HYCOM NCODA GULF MEX; Diniz FM, 2005, MAR BIOTECHNOL, V7, P462, DOI 10.1007/s10126-004-4062-5; Ehrhardt N.M., 2010, MARINE ECOSYSTEM BAS, P157; Ehrhardt NM, 2010, FISH OCEANOGR, V19, P434, DOI 10.1111/j.1365-2419.2010.00555.x; Ehrhardt NM, 2005, B MAR SCI, V76, P501; *FAO, 2006, 5 REG WORKSH ASS MAN; Feng M, 2011, CAN J FISH AQUAT SCI, V68, P1182, DOI 10.1139/F2011-065; Fratantoni DM, 2001, J GEOPHYS RES-OCEANS, V106, P22067, DOI 10.1029/2000JC000730; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Goldstein JS, 2008, J CRUSTACEAN BIOL, V28, P306, DOI 10.1651/0278-0372(2008)028[0306:TCDOLC]2.0.CO;2; Goldstein JS, 2009, LIMNOL OCEANOGR, V54, P1669, DOI 10.4319/lo.2009.54.5.1669; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Griffin DA, 2001, MAR FRESHWATER RES, V52, P1187, DOI 10.1071/MF01181; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Hidalgo M, 2012, P ROY SOC B-BIOL SCI, V279, P275, DOI 10.1098/rspb.2011.0750; Houde E, 2008, ICES COOPERATIVE RES, V295, P27; Incze L, 2010, FISH OCEANOGR, V19, P1, DOI 10.1111/j.1365-2419.2009.00522.x; Jeffs AG, 2005, NEW ZEAL J MAR FRESH, V39, P605, DOI 10.1080/00288330.2005.9517339; Kourafalou VH, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007383; Kritzer JP, 2004, FISH FISH, V5, P131, DOI 10.1111/j.1467-2979.2004.00131.x; Largier JL, 2003, ECOL APPL, V13, pS71; Lipcius R.N., 1994, P1; Lipcius RN, 1997, MAR FRESHWATER RES, V48, P807, DOI 10.1071/MF97194; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Muller R, 2005, FWC COLLECTOR DATA 2; Naro-Maciel E, 2011, MAR BIOL, V158, P2027, DOI 10.1007/s00227-011-1710-y; National Oceanographic Atmospheric Administration, 2002, FISH COS HAB; North E. W., 2009, 295 ICES; Paris CB, 2005, MAR ECOL PROG SER, V296, P93, DOI 10.3354/meps296093; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Paris CB, 2002, DEEP-SEA RES PT I, V49, P1363, DOI 10.1016/S0967-0637(02)00033-X; Paris CB, 2009, P 2009 ANN SCI C SEP; Paris CB, 2013, ENVIRON MODELL SOFTW, V42, P47, DOI 10.1016/j.envsoft.2012.12.006; Pauly D, 2009, SCI MAR, V73, P215, DOI 10.3989/scimar.2009.73n2215; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Petitgas P, 2009, ICES COOPERATIVE RES, P9; PHILLIPS BF, 1986, CAN J FISH AQUAT SCI, V43, P2126, DOI 10.1139/f86-261; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Puebla O, 2012, MOL ECOL, V21, P5675, DOI 10.1111/j.1365-294X.2012.05734.x; Rimmer DW, 1979, PANULIRUS CYGNUS, DOI [10.1007/BF00386590, DOI 10.1007/BF00386590]; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rudorff CAG, 2009, FISH RES, V96, P206, DOI 10.1016/j.fishres.2008.11.005; Saenz-Agudelo P, 2011, P ROY SOC B-BIOL SCI, V278, P2954, DOI 10.1098/rspb.2010.2780; SILBERMAN JD, 1994, MAR BIOL, V120, P601, DOI 10.1007/BF00350081; Smith MD, 2010, P NATL ACAD SCI USA, V107, P18300, DOI 10.1073/pnas.0907365107; Sponaugle S, 2012, MAR ECOL PROG SER, V453, P201, DOI 10.3354/meps09641; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3; Stockhausen WT, 2001, MAR FRESHWATER RES, V52, P1605, DOI 10.1071/MF01179; Tourinho JL, 2012, MAR BIOL, V159, P1897, DOI 10.1007/s00227-012-1977-7; *UN, 1998, KYOT PROT UN FRAM CO, DOI [10.51663/pnz.58.2.07, DOI 10.51663/PNZ.58.2.07]; Vikebo FB, 2011, PLOS ONE, DOI [10.1371/journal.pone.0027367, DOI 10.1371/J0URNAL.P0NE.0027367]; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Wikramanayake E, 2011, CONSERV LETT, V00, P1	75	127	128	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64970	10.1371/journal.pone.0064970	http://dx.doi.org/10.1371/journal.pone.0064970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762273	Green Published, gold			2022-12-25	WOS:000321094800011
J	Ebina, K; Shi, K; Hirao, M; Hashimoto, J; Kawato, Y; Kaneshiro, S; Morimoto, T; Koizumi, K; Yoshikawa, H				Ebina, Kosuke; Shi, Kenrin; Hirao, Makoto; Hashimoto, Jun; Kawato, Yoshitaka; Kaneshiro, Shoichi; Morimoto, Tokimitsu; Koizumi, Kota; Yoshikawa, Hideki			Oxygen and Air Nanobubble Water Solution Promote the Growth of Plants, Fishes, and Mice	PLOS ONE			English	Article							GAS BUBBLE; MICROBUBBLES; THERAPY	Nanobubbles (<200 nm in diameter) have several unique properties such as long lifetime in liquid owing to its negatively charged surface, and its high gas solubility into the liquid owing to its high internal pressure. They are used in variety of fields including diagnostic aids and drug delivery, while there are no reports assessing their effects on the growth of lives. Nanobubbles of air or oxygen gas were generated using a nanobubble aerator (BUVITAS; Ligaric Company Limited, Osaka, Japan). Brassica campestris were cultured hydroponically for 4 weeks within air-nanobubble water or within normal water. Sweetfish (for 3 weeks) and rainbow trout (for 6 weeks) were kept either within air-nanobubble water or within normal water. Finally, 5 week-old male DBA1/J mice were bred with normal free-chaw and free-drinking either of oxygen-nanobubble water or of normal water for 12 weeks. Oxygen-nanobubble significantly increased the dissolved oxygen concentration of water as well as concentration/size of nanobubbles which were relatively stable for 70 days. Air-nanobubble water significantly promoted the height (19.1 vs. 16.7 cm; P<0.05), length of leaves (24.4 vs. 22.4 cm; P<0.01), and aerial fresh weight (27.3 vs. 20.3 g; P<0.01) of Brassica campestris compared to normal water. Total weight of sweetfish increased from 3.0 to 6.4 kg in normal water, whereas it increased from 3.0 to 10.2 kg in air-nanobubble water. In addition, total weight of rainbow trout increased from 50.0 to 129.5 kg in normal water, whereas it increased from 50.0 to 148.0 kg in air-nanobubble water. Free oral intake of oxygen-nanobubble water significantly promoted the weight (23.5 vs. 21.8 g; P<0.01) and the length (17.0 vs. 16.1 cm; P<0.001) of mice compared to that of normal water. We have demonstrated for the first time that oxygen and air-nanobubble water may be potentially effective tools for the growth of lives.	[Ebina, Kosuke; Shi, Kenrin; Kawato, Yoshitaka; Kaneshiro, Shoichi; Morimoto, Tokimitsu; Koizumi, Kota; Yoshikawa, Hideki] Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan; [Hirao, Makoto] Natl Hosp Org, Osaka Minami Med Ctr, Dept Orthopaed Surg, Kawachi Nagano, Osaka, Japan; [Hashimoto, Jun] Natl Hosp Org, Osaka Minami Med Ctr, Dept Immunol, Kawachi Nagano, Osaka, Japan		Ebina, K (corresponding author), Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan.	k-ebina@umin.ac.jp	Ebina, Kosuke/AAH-6171-2019		Ligaric Company Limited; West Nippon Expressway Company; Grants-in-Aid for Scientific Research [24791542] Funding Source: KAKEN	Ligaric Company Limited; West Nippon Expressway Company; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by Ligaric Company Limited and West Nippon Expressway Company. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Abdelsalam M, 2010, RESP CARE, V55, P1483; Agarwal A, 2011, CHEMOSPHERE, V84, P1175, DOI 10.1016/j.chemosphere.2011.05.054; Barak M, 2005, CHEST, V128, P2918, DOI 10.1378/chest.128.4.2918; Barbosa FT, 2009, SAO PAULO MED J, V127, P97, DOI 10.1590/S1516-31802009000200008; Betit P, 2009, RESP CARE, V54, P1244; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Cavalli R, 2009, INT J PHARMACEUT, V381, P160, DOI 10.1016/j.ijpharm.2009.07.010; Eriksson JC, 1999, COLLOID SURFACE A, V159, P159, DOI 10.1016/S0927-7757(99)00171-5; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Kulikovsky M, 2009, ISR MED ASSOC J, V11, P480; Li P, 2009, CHEMOSPHERE, V77, P1157, DOI 10.1016/j.chemosphere.2009.07.062; Ljunggren S, 1997, COLLOID SURFACE A, V129, P151, DOI 10.1016/S0927-7757(97)00033-2; Matsuki N, 2012, EUR BIOPHYS J BIOPHY, V41, P571, DOI 10.1007/s00249-012-0811-y; NUMAKO C, 1995, PHYSICA B, V208, P387, DOI 10.1016/0921-4526(94)00706-2; Owerkowicz T, 2009, J EXP BIOL, V212, P1237, DOI 10.1242/jeb.023945; Park JS, 2009, HORTTECHNOLOGY, V19, P212, DOI 10.21273/HORTSCI.19.1.212; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Yoshida S, 1996, Acta Hortic, V440, P199; Zhao G, 2004, BIOPHYS CHEM, V107, P189, DOI 10.1016/S0301-4622(03)00211-4	19	192	200	15	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65339	10.1371/journal.pone.0065339	http://dx.doi.org/10.1371/journal.pone.0065339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755221	gold, Green Submitted, Green Published			2022-12-25	WOS:000320579400053
J	Wu, LX; Dai, YR; Jiang, XL; Petchprayoon, C; Lee, JE; Jiang, T; Yan, YL; Marriott, G				Wu, Liangxing; Dai, Yingrui; Jiang, Xiaoli; Petchprayoon, Chutima; Lee, Jessie E.; Jiang, Tao; Yan, Yuling; Marriott, Gerard			High-Contrast Fluorescence Imaging in Fixed and Living Cells Using Optimized Optical Switches	PLOS ONE			English	Article							LOCK-IN DETECTION; MICROSCOPY; SPIROPYRAN	We present the design, synthesis and characterization of new functionalized fluorescent optical switches for rapid, all-visible light-mediated manipulation of fluorescence signals from labelled structures within living cells, and as probes for high-contrast optical lock-in detection (OLID) imaging microscopy. A triazole-substituted BIPS (TzBIPS) is identified from a rational synthetic design strategy that undergoes robust, rapid and reversible, visible light-driven transitions between a colorless spiro-(SP) and a far-red absorbing merocyanine (MC) state within living cells. The excited MC-state of TzBIPS may also decay to the MC-ground state emitting near infra-red fluorescence, which is used as a sensitive and quantitative read-out of the state of the optical switch in living cells. The SP to MC transition for a membrane-targeted TzBIPS probe (C-12-TzBIPS) is triggered at 405 nm at an energy level compatible with studies in living cells, while the action spectrum of the reverse transition (MC to SP) has a maximum at 650 nm. The SP to MC transition is complete within the 790 ns pixel dwell time of the confocal microscope, while a single cycle of optical switching between the SP and MC states in a region of interest is complete within 8 ms (125 Hz) within living cells, the fastest rate attained for any optical switch probe in a biological sample. This property can be exploited for real-time correction of background signals in living cells. A reactive form of TzBIPS is linked to secondary antibodies and used, in conjunction with an enhanced scope-based analysis of the modulated MC-fluorescence in immuno-stained cells, for high-contrast immunofluorescence microscopic analysis of the actin cytoskeleton.	[Wu, Liangxing; Dai, Yingrui; Jiang, Xiaoli; Petchprayoon, Chutima; Lee, Jessie E.; Marriott, Gerard] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Jiang, Tao; Yan, Yuling] Santa Clara Univ, Dept Bioengn, Santa Clara, CA 95053 USA	University of California System; University of California Berkeley; Santa Clara University	Marriott, G (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	marriott1@berkeley.edu		Marriott, Gerard/0000-0003-3197-4839	National Institutes of Health (Nanomedicine Development Center for the optical control of biological function) [PN2 EY018241, R01 GM086233-01, GM086233-01]; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086233] Funding Source: NIH RePORTER	National Institutes of Health (Nanomedicine Development Center for the optical control of biological function)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by grants from the National Institutes of Health (PN2 EY018241 Nanomedicine Development Center for the optical control of biological function and R01 GM086233-01 to GM and GM086233-01 to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Berkovic G, 2000, CHEM REV, V100, P1741, DOI 10.1021/cr9800715; Bossi M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/11/275; Crano JC, 1999, T APPL CHEM, V1, P1; Du G., 2010, BIOINF BIOM ENG ICBB, P1; Jones WE, 1995, PHOTOCHROMISM MOL SY, V76; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Mao S, 2008, BIOPHYS J, V94, P4515, DOI 10.1529/biophysj.107.124859; MARRIOTT G, 1992, BIOCHEM INT, V26, P943; Marriott G, 2008, P NATL ACAD SCI USA, V105, P17789, DOI 10.1073/pnas.0808882105; Minkin VI, 2004, CHEM REV, V104, P2751, DOI 10.1021/cr020088u; MOAN J, 1989, J PHOTOCH PHOTOBIO B, V4, P21, DOI 10.1016/1011-1344(89)80099-5; Petchprayoon C, 2011, BIOORGAN MED CHEM, V19, P1030, DOI 10.1016/j.bmc.2010.07.015; Petchprayoon C, 2010, TETRAHEDRON LETT, V51, P6753, DOI 10.1016/j.tetlet.2010.10.084; Raymo FM, 2012, ISRN PHYS CHEM, DOI [10.5402/2012/619251, DOI 10.5402/2012/619251]; Richards CI, 2009, J AM CHEM SOC, V131, P4619, DOI 10.1021/ja809785s; Sakata T, 2008, J ORG CHEM, V73, P227, DOI 10.1021/jo7019898; Samanta S, 2012, ANGEW CHEM INT EDIT, V51, P6452, DOI 10.1002/anie.201202383; Seefeldt B, 2010, PHOTOCH PHOTOBIO SCI, V9, P213, DOI 10.1039/b9pp00118b; Song L, 2002, J PHOTOCH PHOTOBIO A, V150, P177, DOI 10.1016/S1010-6030(02)00129-6; Tian ZY, 2009, CHEMPHYSCHEM, V10, P2577, DOI 10.1002/cphc.200900492; Tomasulo M, 2007, J ORG CHEM, V72, P595, DOI 10.1021/jo062004d; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wohl CJ, 2005, J PHYS CHEM B, V109, P22186, DOI 10.1021/jp053782x; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yan YL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0031; Yan YL, 2011, BIOCHEM J, V433, P411, DOI 10.1042/BJ20100992	27	8	8	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64738	10.1371/journal.pone.0064738	http://dx.doi.org/10.1371/journal.pone.0064738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755140	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400023
J	Demeyer, I; De Raedt, R				Demeyer, Ineke; De Raedt, Rudi			Attentional Bias for Emotional Information in Older Adults: The Role of Emotion and Future Time Perspective	PLOS ONE			English	Article							SOCIAL PREFERENCES; AGE-DIFFERENCES; NEGATIVE AFFECT; ANXIETY; VALIDATION; MEMORY; REAPPRAISAL; COGNITION; THREAT; FACES	Objectives: Research suggests that older adults display a positivity bias at the level of information processing. However, because studies investigating attentional bias for emotional information in older adults have produced mixed findings, research identifying inter-individual differences that may explain these inconsistent results is necessary. Therefore, we investigated whether mood, symptoms of depression, symptoms of anxiety and future time perspective are related to attentional bias in older adults. Method: Thirty-seven healthy older adults and 25 healthy middle-aged adults completed questionnaires to assess mood, symptoms of depression, symptoms of anxiety and future time perspective. Attentional bias towards happy, sad and neutral information was measured using a modified exogenous cueing paradigm with long cue presentations, to measure maintained attention versus avoidance of emotional stimuli. Results: Older adults showed attentional avoidance for all emotional faces, whereas no attentional biases were found in the middle-aged group. Moreover, in the older adult group, avoidance for negative information was related to anxiety. Future time perspective was unrelated to attentional bias. Discussion: These findings suggest that anxiety may lead to inter-individual differences in attentional bias in older adults, and that avoidance from negative information may be an emotion regulation strategy.	[Demeyer, Ineke; De Raedt, Rudi] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University	Demeyer, I (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	Ineke.Demeyer@UGent.be	De Raedt, Rudi/AAL-4093-2021; De Raedt, Rudi/A-3269-2012	De Raedt, Rudi/0000-0001-6781-4808; De Raedt, Rudi/0000-0001-6781-4808	Special Research Fund (BOF) of Ghent University [B/09916/02]	Special Research Fund (BOF) of Ghent University(Ghent University)	This work was supported by a Grant of the Special Research Fund (BOF) of Ghent University (B/09916/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Beck A.T., 1996, MANUAL BECK DEPRESSI; Brown LA, 2011, EXP AGING RES, V37, P330, DOI 10.1080/0361073X.2011.568833; Bryant C, 2008, J AFFECT DISORDERS, V109, P233, DOI 10.1016/j.jad.2007.11.008; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; Cisler JM, 2010, CLIN PSYCHOL REV, V30, P203, DOI 10.1016/j.cpr.2009.11.003; De Raedt R, 2013, J GERONTOL B-PSYCHOL, V68, P41, DOI 10.1093/geronb/gbs047; De Raedt R, 2010, COGN AFFECT BEHAV NE, V10, P50, DOI 10.3758/CABN.10.1.50; Faust ME, 1999, PSYCHOL BULL, V125, P777, DOI 10.1037/0033-2909.125.6.777; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Fox LS, 2005, AGING MENT HEALTH, V9, P585, DOI 10.1080/13607860500294282; Fung HH, 2010, PSYCHOL AGING, V25, P321, DOI 10.1037/a0019079; Fung HH, 1999, PSYCHOL AGING, V14, P595, DOI 10.1037/0882-7974.14.4.595; Fung HH, 2001, PSYCHOL AGING, V16, P351, DOI 10.1037//0882-7974.16.2.351; Goeleven E, 2008, COGNITION EMOTION, V22, P1094, DOI 10.1080/02699930701626582; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; Isaacowitz DM, 2008, PSYCHOL SCI, V19, P848, DOI 10.1111/j.1467-9280.2008.02167.x; Isaacowitz DM, 2006, EMOTION, V6, P511, DOI 10.1037/1528-3542.6.3.511; Isaacowitz DM, 2009, J GERONTOL B-PSYCHOL, V64, P188, DOI 10.1093/geronb/gbn036; Kessler EM, 2009, PSYCHOL AGING, V24, P349, DOI 10.1037/a0015352; Lee LO, 2009, PSYCHOL AGING, V24, P741, DOI 10.1037/a0016409; Leyman L, 2007, PSYCHOL MED, V37, P393, DOI 10.1017/S003329170600910X; Li TY, 2011, J GERONTOL B-PSYCHOL, V66, P56, DOI 10.1093/geronb/gbq074; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Mather M, 2006, J GERONTOL B-PSYCHOL, V61, pP54, DOI 10.1093/geronb/61.1.P54; Murphy NA, 2008, PSYCHOL AGING, V23, P263, DOI 10.1037/0882-7974.23.2.263; Nolen-Hoeksema S, 2011, PERS INDIV DIFFER, V51, P704, DOI 10.1016/j.paid.2011.06.012; Olatunji BO, 2010, BEHAV RES THER, V48, P435, DOI 10.1016/j.brat.2009.11.014; Orgeta V, 2011, J ANXIETY DISORD, V25, P1019, DOI 10.1016/j.janxdis.2011.06.010; Peeters F.P.M.L., 1996, TIJDSCHR PSYCHIAT, V38, P240; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Price RB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.46; Price RB, 2012, AM J GERIAT PSYCHIAT, V20, P798, DOI 10.1097/JGP.0b013e318230340d; Scheibe S, 2010, J GERONTOL B-PSYCHOL, V65, P135, DOI 10.1093/geronb/gbp132; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Steinmetz KRM, 2010, PSYCHOL AGING, V25, P239, DOI 10.1037/a0018297; Van der Does A, 2002, NEDERLANDSE VERSIE B; Van der Ploeg HM, 2000, HANDLEIDING BIJ ZELF; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	45	21	21	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65429	10.1371/journal.pone.0065429	http://dx.doi.org/10.1371/journal.pone.0065429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158IE	23750261	Green Submitted, Green Published, gold			2022-12-25	WOS:000319961900063
J	Kennaway, DJ; Varcoe, TJ; Voultsios, A; Boden, MJ				Kennaway, David John; Varcoe, Tamara Jayne; Voultsios, Athena; Boden, Michael James			Global Loss of Bmal1 Expression Alters Adipose Tissue Hormones, Gene Expression and Glucose Metabolism	PLOS ONE			English	Article							CLOCK MUTANT MICE; REV-ERB-ALPHA; HIGH-FAT DIET; CIRCADIAN CLOCK; ADIPOCYTE DIFFERENTIATION; LIVER; RHYTHMICITY; HOMEOSTASIS; MUTATION; OBESITY	The close relationship between circadian rhythm disruption and poor metabolic status is becoming increasingly evident, but role of adipokines is poorly understood. Here we investigated adipocyte function and the metabolic status of mice with a global loss of the core clock gene Bmal1 fed either a normal or a high fat diet (22% by weight). Bmal1 null mice aged 2 months were killed across 24 hours and plasma adiponectin and leptin, and adipose tissue expression of Adipoq, Lep, Retn and Nampt mRNA measured. Glucose, insulin and pyruvate tolerance tests were conducted and the expression of liver glycolytic and gluconeogenic enzyme mRNA determined. Bmal1 null mice displayed a pattern of increased plasma adiponectin and plasma leptin concentrations on both control and high fat diets. Bmal1 null male and female mice displayed increased adiposity (1.8 fold and 2.3 fold respectively) on the normal diet, but the high fat diet did not exaggerate these differences. Despite normal glucose and insulin tolerance, Bmal1 null mice had increased production of glucose from pyruvate, implying increased liver gluconeogenesis. The Bmal1 null mice had arrhythmic clock gene expression in epigonadal fat and liver, and loss of rhythmic transcription of a range of metabolic genes. Furthermore, the expression of epigonadal fat Adipoq, Retn, Nampt, AdipoR1 and AdipoR2 and liver Pfkfb3 mRNA were down-regulated. These results show for the first time that global loss of Bmal1, and the consequent arrhythmicity, results in compensatory changes in adipokines involved in the cellular control of glucose metabolism.	[Kennaway, David John; Varcoe, Tamara Jayne; Voultsios, Athena; Boden, Michael James] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Kennaway, DJ (corresponding author), Univ Adelaide, Robinson Inst, Adelaide, SA, Australia.	david.kennaway@adelaide.edu.au	Varcoe, Tamara/H-2785-2014; Boden, Michael/L-9884-2013; Kennaway, David J/B-8955-2009	Kennaway, David J/0000-0002-5864-3514; Varcoe, Tamara/0000-0002-9462-1830	National Health and Medical Research Council of Australia [399131]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from the National Health and Medical Research Council of Australia, Grant #399131 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden MJ, 2010, REPRODUCTION, V139, P1077, DOI 10.1530/REP-09-0523; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; CHAWLA A, 1993, J BIOL CHEM, V268, P16265; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Guo BY, 2012, FASEB J, V26, P3453, DOI 10.1096/fj.12-205781; Hemmeryckx B, 2011, OBESITY, V19, P659, DOI 10.1038/oby.2010.266; Kennaway DJ, 2007, AM J PHYSIOL-REG I, V293, pR1528, DOI 10.1152/ajpregu.00018.2007; Kennaway DJ, 2006, AM J PHYSIOL-REG I, V291, pR1172, DOI 10.1152/ajpregu.00223.2006; Kennaway DJ, 2012, OBESITY, V20, P295, DOI 10.1038/oby.2011.276; Kennaway DJ, 2003, AM J PHYSIOL-REG I, V284, pR1231, DOI 10.1152/ajpregu.00697.2002; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kudo T, 2008, AM J PHYSIOL-ENDOC M, V294, pE120, DOI 10.1152/ajpendo.00061.2007; Kudo T, 2007, J BIOL RHYTHM, V22, P312, DOI 10.1177/0748730407302625; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; LEE JHW, 2011, J HYDRO-ENVIRON RES, V5, P1, DOI DOI 10.1016/J.JHER.2011.02.001; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Ratajczak CK, 2009, ENDOCRINOLOGY, V150, P1879, DOI 10.1210/en.2008-1021; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Shi SQ, 2010, CURR BIOL, V20, P316, DOI 10.1016/j.cub.2009.12.034; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; VANCAUTER E, 1989, J CLIN ENDOCR METAB, V69, P604; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07	37	55	62	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65255	10.1371/journal.pone.0065255	http://dx.doi.org/10.1371/journal.pone.0065255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750248	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900050
J	Nagaoka, K; Zhang, HL; Watanabe, G; Taya, K				Nagaoka, Kentaro; Zhang, Haolin; Watanabe, Gen; Taya, Kazuyoshi			Epithelial Cell Differentiation Regulated by MicroRNA-200a in Mammary Glands	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; MIR-200 FAMILY; E-CADHERIN; REPRESSORS ZEB1; MORPHOGENESIS; CANCER; POLARITY; EXPRESSION; MOUSE; MAINTENANCE	Mammary gland epithelial cells undergo periodic cycles of proliferation, differentiation, and involution. Many studies have reported that miRNAs, which are small, non-coding RNAs, influence a variety of biological processes during posttranscriptional regulation. Here, we found that one miRNA, miR-200a, was relatively highly expressed in epithelial cell-rich organs such as mammary glands, lung, and kidney in mice. In mammary glands, miR-200a expression increased during mid-pregnancy through lactation; its expression was stimulated by lactogenic hormone treatment of mammary epithelial cells. Lactogenic hormone also induced the expression of milk protein beta-casein mRNA (a marker of cell differentiation) and E-cadherin mRNA (a marker of epithelial cells). However, knockdown of miR-200a prevented increases in beta-casein and E-cadherin mRNA expression. Protein analysis revealed that E-cadherin signal was decreased and ZEB1 (a marker of EMT) was increased following miR-200a knockdown. Finally, in a three-dimensional culture system modeling lumen-containing mammary ducts, miR-200a knockdown decreased the cavity formation rate and suppressed claudin-3 and par-6b expression, indicating reduced epithelial cell polarity. These observations suggest that miR-200a is important for maintaining the epithelial cell phenotype, which contributes to lactogenic hormone induction of cellular differentiation in mammary glands.	[Nagaoka, Kentaro; Zhang, Haolin; Watanabe, Gen; Taya, Kazuyoshi] Tokyo Univ Agr & Technol, Dept Vet Med, Vet Physiol Lab, Tokyo, Japan	Tokyo University of Agriculture & Technology	Nagaoka, K (corresponding author), Tokyo Univ Agr & Technol, Dept Vet Med, Vet Physiol Lab, Tokyo, Japan.	nagaokak@cc.tuat.ac.jp	张(Zhang), 浩林 (Haolin)/AGP-9653-2022; Watanabe/G-1134-2013; Nagaoka, Kentaro/C-2019-2013	张(Zhang), 浩林 (Haolin)/0000-0001-6178-7431; Watanabe/0000-0001-7611-4678; Nagaoka, Kentaro/0000-0003-1038-1380	Japan Society for the Promotion of Science [24780268]; Grants-in-Aid for Scientific Research [24780268] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to K.N., 24780268) http://kaken.nii.ac.jp/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon VB, 2010, BIOL REPROD, V83, P347, DOI 10.1095/biolreprod.110.084400; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai JX, 2013, ENDOCRINOLOGY, V154, P635, DOI 10.1210/en.2012-1607; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchard AAA, 2006, DNA CELL BIOL, V25, P79, DOI 10.1089/dna.2006.25.79; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Chilton BS, 2005, CURR TOP DEV BIOL, V68, P1, DOI 10.1016/S0070-2153(05)68001-5; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Eades G, J BIOL CHEM, V286, P40725; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Galio L, PHYSL GENOM IN PRESS; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kobayashi K, 2011, HISTOCHEM CELL BIOL, V136, P587, DOI 10.1007/s00418-011-0863-6; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lelievre SA, 2010, J MAMMARY GLAND BIOL, V15, P49, DOI 10.1007/s10911-010-9168-y; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Nagaoka K, 2007, EXP CELL RES, V313, P2937, DOI 10.1016/j.yexcr.2007.04.017; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Piao HL, 2012, J MAMMARY GLAND BIOL, V17, P33, DOI 10.1007/s10911-012-9245-5; Reginato MJ, 2006, J MAMMARY GLAND BIOL, V11, P205, DOI 10.1007/s10911-006-9030-4; Sana J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-103; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Xu R, 2010, CELL CYCLE, V9, P4315, DOI 10.4161/cc.9.21.13578; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021	37	31	34	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65127	10.1371/journal.pone.0065127	http://dx.doi.org/10.1371/journal.pone.0065127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750238	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900040
J	Smit, AJ; Smit, JM; Botterblom, GJ; Mulder, DJ				Smit, Andries J.; Smit, Jitske M.; Botterblom, Gijs J.; Mulder, Douwe J.			Skin Autofluorescence Based Decision Tree in Detection of Impaired Glucose Tolerance and Diabetes	PLOS ONE			English	Article							LIFE-STYLE; FOLLOW-UP; TYPE-2; RISK; PREVENTION; MELLITUS; MARKER	Aim: Diabetes (DM) and impaired glucose tolerance (IGT) detection are conventionally based on glycemic criteria. Skin autofluorescence (SAF) is a noninvasive proxy of tissue accumulation of advanced glycation endproducts (AGE) which are considered to be a carrier of glycometabolic memory. We compared SAF and a SAF-based decision tree (SAF-DM) with fasting plasma glucose (FPG) and HbA1c, and additionally with the Finnish Diabetes Risk Score (FINDRISC) questionnaire +/- FPG for detection of oral glucose tolerance test (OGTT)- or HbA1c-defined IGT and diabetes in intermediate risk persons. Methods: Participants had >= 1 metabolic syndrome criteria. They underwent an OGTT, HbA1c, SAF and FINDRISC, in adition to SAF-DM which includes SAF, age, BMI, and conditional questions on DM family history, antihypertensives, renal or cardiovascular disease events (CVE). Results: 218 persons, age 56 yr, 128M/90F, 97 with previous CVE, participated. With OGTT 28 had DM, 46 IGT, 41 impaired fasting glucose, 103 normal glucose tolerance. SAF alone revealed 23 false positives (FP), 34 false negatives (FN) (sensitivity (S) 68%; specificity (SP) 86%). With SAF-DM, FP were reduced to 18, FN to 16 (5 with DM) (S 82%; SP 89%). HbA1c scored 48 FP, 18 FN (S 80%; SP 75%). Using HbA1c-defined DM-IGT/suspicion >= 6%/42 mmol/mol, SAF-DM scored 33 FP, 24 FN (4 DM) (S76%; SP72%), FPG 29 FP, 41 FN (S71%; SP80%). FINDRISC >= 10 points as detection of HbA1c-based diabetes/suspicion scored 79 FP, 23 FN (S 69%; SP 45%). Conclusion: SAF-DM is superior to FPG and non-inferior to HbA1c to detect diabetes/IGT in intermediate-risk persons. SAF-DM's value for diabetes/IGT screening is further supported by its established performance in predicting diabetic complications.	[Smit, Andries J.; Botterblom, Gijs J.; Mulder, Douwe J.] Univ Med Ctr Groningen, Dept Med, NL-9713 AV Groningen, Netherlands; [Smit, Andries J.; Botterblom, Gijs J.; Mulder, Douwe J.] Univ Groningen, Groningen, Netherlands; [Smit, Jitske M.] Gelre Ziekenhuis, Dept Med, Apeldoorn, Netherlands	University of Groningen; University of Groningen; Gelre Hospitals	Smit, AJ (corresponding author), Univ Med Ctr Groningen, Dept Med, NL-9713 AV Groningen, Netherlands.	a.j.smit@umcg.nl			Diagnoptics Technologies, Groningen, the Netherlands; University Medical Center Groningen; Diagnoptics Technologies	Diagnoptics Technologies, Groningen, the Netherlands(Netherlands Government); University Medical Center Groningen; Diagnoptics Technologies	The study was partly funded by Diagnoptics Technologies, Groningen, the Netherlands. The study was also partly funded by the University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by Diagnoptics Technologies. AJS is founder and shareholder, and JMS is also shareholder of Diagnoptics Technologies B.V., the Netherlands. Diagnoptics Technologies is the company that developed the AGE Reader, which is used in the present article. AJS was also the first inventor in the patent used for the AGE reader technology. He was inventor as employee of the University Medical Center Groningen (UMCG), which was co-owner of it. Later the patent was sold to Diagnoptics Technologies, so the UMCG has no financial interests anymore. AJS now works 80% of his time as as employee of the University Medical Center Groningen, but is also the scientific director of Diagnoptics technologies. As such, he has an interest in development and validation of possible further future applications of the AGE reader, such as described in the present paper. The other authors have declared that no competing interests exist; the personnel involved in the two participating hospitals in the study also had no competing interests. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	*AM ASS CLIN END, ENDOCR PRACT, V16, P155; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Christensen J, 2004, DIABETOLOGIA, V47, P1566, DOI 10.1007/s00125-004-1496-2; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Hische M, 2010, EUR J ENDOCRINOL, V163, P565, DOI 10.1530/EJE-10-0649; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; *INT EXP COMM REP, DIABETES CARE, V32, P1327; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113; Koetsier M, 2010, OPT EXPRESS, V18, P14416, DOI 10.1364/OE.18.014416; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414; Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173; Maynard JD, 2007, DIABETES CARE, V30, P1120, DOI 10.2337/dc06-2377; Meerwaldt R, 2005, ANN NY ACAD SCI, V1043, P290, DOI 10.1196/annals.1333.036; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Mulder DJ, 2009, NETH HEART J, V17, P162, DOI 10.1007/BF03086239; Nienhuis HLA, 2009, AUTOIMMUNITY, V42, P302, DOI 10.1080/08916930902831746; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337/dc10-0433; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Schwarz PEH, 2009, HORM METAB RES, V41, P86, DOI 10.1055/s-0028-1087203; Sliventoinen K, 2005, EUR J CARDIOV PREV R, V12, P451, DOI 10.1097/01.hjr.0000174793.31812.21; Smit AJ, 2010, CURR OPIN NEPHROL HY, V19, P527, DOI 10.1097/MNH.0b013e32833e9259; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; von Eckardstein A, 2000, J CLIN ENDOCR METAB, V85, P3101, DOI 10.1210/jc.85.9.3101	27	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65592	10.1371/journal.pone.0065592	http://dx.doi.org/10.1371/journal.pone.0065592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750268	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900070
J	Maciel-de-Freitas, R; Sylvestre, G; Gandini, M; Koella, JC				Maciel-de-Freitas, Rafael; Sylvestre, Gabriel; Gandini, Mariana; Koella, Jacob C.			The Influence of Dengue Virus Serotype-2 Infection on Aedes aegypti (Diptera: Culicidae) Motivation and Avidity to Blood Feed	PLOS ONE			English	Article							MALARIA PARASITE; TRADE-OFFS; MOSQUITO; BEHAVIOR; MANIPULATION; VECTOR; TRANSMISSION; FEMALES; SUCCESS; IMPACT	Background: Dengue virus (DENV) is transmitted by Aedes aegypti, a species that lives in close association with human dwellings. The behavior of DENV-infected mosquitoes needs further investigation, especially regarding the potential influence of DENV on mosquito biting motivation and avidity. Methodology/Principal findings: We orally challenged 4-5 day-old Ae. aegypti females with a low passage DENV serotype 2 (DENV-2) to test whether the virus influences motivation to feed (the likelihood that a mosquito obtains a blood-meal and the size of its blood meal) and avidity (the likelihood to re-feed after an interrupted first blood-meal). To assay motivation, we offered mosquitoes an anesthetized mouse for 2, 3, 4 or 5 minutes 7 or 14 days after the initial blood meals and measured the time they started feeding. 60.5% of the unexposed mosquitoes fed on the mouse, but only 40.5% of the positive ones did. Exposed but negative mosquitoes behaved similarly to unexposed ones (55.0% feeding). Thus DENV-2 infection decreased the mosquitoes' motivation to feed. To assay avidity, we offered the same mosquitoes a mouse two hours after the first round of feeding, and we measured the time at which they started probing. The exposed (positive or negative) mosquitoes were more likely to re-feed than the unexposed ones and, in particular, the size of the previous blood-meal that kept mosquitoes from re-feeding was larger in the exposed than in the unexposed mosquitoes. Thus, DENV-2 infection increased mosquito avidity. Conclusions/Significance: DENV-2 significantly decreased the mosquitoes' motivation to feed, but increased their avidity (even after taking account the amount of blood previously imbibed). As these are important components of transmission, we expect that the changes of the blood-feeding behaviour impact the vectorial capacity Ae. aegypti for dengue.	[Maciel-de-Freitas, Rafael; Sylvestre, Gabriel] Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, Fiocruz, Brazil; [Gandini, Mariana] Inst Oswaldo Cruz, Lab Imunol Viral, Fiocruz, Brazil; [Koella, Jacob C.] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of Neuchatel	Maciel-de-Freitas, R (corresponding author), Inst Oswaldo Cruz, Lab Transmissores Hematozoarios, Fiocruz, Brazil.	freitas@ioc.fiocruz.br	Kubelka, Claire F/C-5558-2009; Maciel-de-Freitas, Rafael/J-1997-2012; Gandini, Mariana/AAZ-6964-2021	Maciel-de-Freitas, Rafael/0000-0002-2198-6492; Gandini, Mariana/0000-0003-3603-6921				Anderson RA, 1996, J VECTOR ECOL, V21, P94; Anderson RA, 1999, ECOL LETT, V2, P98, DOI 10.1046/j.1461-0248.1999.22055.x; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; BRIEGEL H, 1979, J MED ENTOMOL, V15, P235, DOI 10.1093/jmedent/15.3.235; Clements A.N., 1999, BIOL MOSQUITOES SENS; Colisson R, 2010, BLOOD, V115, P2177, DOI 10.1182/blood-2009-06-224741; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; Halstead SB, 2003, AM J TROP MED HYG, V69, P5; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Koella JC, 2005, BEHAV PROCESS, V68, P271, DOI 10.1016/j.beproc.2004.10.004; Koella JC, 2002, BEHAV ECOL, V13, P816, DOI 10.1093/beheco/13.6.816; Koella JC, 1996, PARASITOLOGY, V113, P105, DOI 10.1017/S0031182000066348; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; Lambrechts L, 2012, MEM I OSWALDO CRUZ, V107, P1080, DOI 10.1590/S0074-02762012000800022; Lambrechts L, 2009, P R SOC B, V276, P1369, DOI 10.1098/rspb.2008.1709; Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690; Luz PM, 2011, MEM I OSWALDO CRUZ, V106, P755, DOI 10.1590/S0074-02762011000600017; Maciel-de-Freitas R, 2011, T ROY SOC TROP MED H, V105, P452, DOI 10.1016/j.trstmh.2011.05.006; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Miagostovich Mariz P., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P149, DOI 10.1590/S0036-46651993000200006; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; ROSSIGNOL PA, 1986, AM J TROP MED HYG, V35, P277, DOI 10.4269/ajtmh.1986.35.277; RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407; Schwartz A, 2001, TRENDS PARASITOL, V17, P189, DOI 10.1016/S1471-4922(00)01945-0; Sylvestre GR, 2013, PLOS ONE, V8; Torrentes-Carvalho A, 2009, MEM I OSWALDO CRUZ, V104, P1091, DOI 10.1590/S0074-02762009000800005; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292	33	22	23	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65252	10.1371/journal.pone.0065252	http://dx.doi.org/10.1371/journal.pone.0065252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755202	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300065
J	Nakagawa, T; Touhara, K				Nakagawa, Tatsuro; Touhara, Kazushige			Extracellular Modulation of the Silkmoth Sex Pheromone Receptor Activity by Cyclic Nucleotides	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; OLFACTORY RECEPTORS; BOMBYX-MORI; ANOPHELES-GAMBIAE; ION CHANNELS; GENE FAMILY; G-PROTEINS; GMP; MELANOGASTER; EXPRESSION	Odorants and pheromones are essential to insects as chemical cues for finding food or an appropriate mating partner. These volatile compounds bind to olfactory receptors (Ors) expressed by olfactory sensory neurons. Each insect Or functions as a ligand-gated ion channel and is a heteromeric complex that comprises one type of canonical Or and a highly conserved Orco subunit. Because there are many Or types, insect Ors can recognize with high specificity a myriad of chemical cues. Cyclic nucleotides can modulate the activity of insect Or-Orco complexes; however, the mechanism of action of these nucleotides is under debate. Here, we show that cyclic nucleotides, including cAMP and cGMP, interact with the silkmoth sex pheromone receptor complex, BmOr-1-BmOrco, from the outside of the cell and that these nucleotides act as antagonists at low concentrations and weak agonists at high concentrations. These cyclic nucleotides do not compete with the sex pheromone, bombykol, for binding to the BmOr-1 subunit. ATP and GTP also weakly inhibited BmOr-1-BmOrco activity, but D-ribose had no effect; these findings indicated that the purine moiety was crucial for the inhibition. Only the bombykol receptors have been so far shown to be subject to modulation by nucleotide-related compounds, indicating that this responsiveness to these compounds is not common for all insect Or-Orco complexes.	[Nakagawa, Tatsuro; Touhara, Kazushige] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Touhara, Kazushige] Univ Tokyo, JST ERATO Touhara Chemosensory Signal Project, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo; University of Tokyo	Touhara, K (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan.	ktouhara@mail.ecc.u-tokyo.ac.jp			MEXT Japan; Japan-USA Cooperative Science Program from JSPS; ERATO Touhara Chemosensory Signal Project from JST	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-USA Cooperative Science Program from JSPS; ERATO Touhara Chemosensory Signal Project from JST	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from MEXT Japan, Japan-USA Cooperative Science Program funding from JSPS, and ERATO Touhara Chemosensory Signal Project from JST. TN was supported by a Grant-in-Aid for JSPS Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Cervetto C, 2010, J PHARMACOL EXP THER, V332, P210, DOI 10.1124/jpet.109.154955; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Fox AN, 2001, P NATL ACAD SCI USA, V98, P14693, DOI 10.1073/pnas.261432998; GNATZY W, 1978, CELL TISSUE RES, V189, P549, DOI 10.1007/BF00209140; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hofer AM, 2007, PHYSIOLOGY, V22, P320, DOI 10.1152/physiol.00019.2007; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Miura N, 2009, INT J BIOL SCI, V5, P319; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Nascimento NRF, 2011, HYPERTENSION, V58, P107, DOI 10.1161/HYPERTENSIONAHA.110.168708; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; PARK CS, 1995, BIOCHEMISTRY-US, V34, P13328, DOI 10.1021/bi00041a008; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Redkozubov A, 2000, CHEM SENSES, V25, P381, DOI 10.1093/chemse/25.4.381; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Stengl M, 2001, CELL TISSUE RES, V304, P409, DOI 10.1007/s004410000336; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; ZIEGELBERGER G, 1990, J NEUROSCI, V10, P1217; ZUFALL F, 1991, P NATL ACAD SCI USA, V88, P8520, DOI 10.1073/pnas.88.19.8520	41	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63774	10.1371/journal.pone.0063774	http://dx.doi.org/10.1371/journal.pone.0063774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755109	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300013
J	Tachibana, Y; Aida, N; Niwa, T; Nozawa, K; Kusagiri, K; Mori, K; Endo, K; Obata, T; Inoue, T				Tachibana, Yasuhiko; Aida, Noriko; Niwa, Tetsu; Nozawa, Kumiko; Kusagiri, Kouki; Mori, Kana; Endo, Kazuo; Obata, Takayuki; Inoue, Tomio			Analysis of Multiple B-Value Diffusion-Weighted Imaging in Pediatric Acute Encephalopathy	PLOS ONE			English	Article							ACUTE NECROTIZING ENCEPHALOPATHY; HUMAN BRAIN; REDUCED DIFFUSION; BIPHASIC SEIZURES; SIGNAL DECAY; MRI; COMPARTMENTATION; COEFFICIENTS; CHILDHOOD; INFLUENZA	Acute encephalopathy is a disease group more commonly seen in children. It is often severe and has neurological sequelae. Imaging is important for early diagnosis and prompt treatment to ameliorate an unfavorable outcome, but insufficient sensitivity/specificity is a problem. To overcome this, a new value (fraction of high b-pair (F-H)) that could be processed from clinically acceptable MR diffusion-weighted imaging (DWI) with three different b-values was designed on the basis of a two-compartment model of water diffusion signal attenuation. The purpose of this study is to compare F-H with the apparent diffusion coefficient (ADC) regarding the detectability of pediatric acute encephalopathy. We retrospectively compared the clinical DWI of 15 children (1-10 years old, mean 2.34, 8 boys, 7 girls) of acute encephalopathy with another 16 children (1-11 years old, mean 4.89, 9 boys, 7 girls) as control. A comparison was first made visually by mapping F-H on the brain images, and then a second comparison was made on the basis of 10 regions of interest (ROIs) set on cortical and subcortical areas of each child. F-H map visually revealed diffusely elevated F-H in cortical and subcortical areas of the patients with acute encephalopathy; the changes seemed more diffuse in F-H compared to DWI. The comparison based on ROI revealed elevated mean F-H in the cortical and subcortical areas of the acute encephalopathy patients compared to control with significant difference (P<0.05). Similar findings were observed even in regions where the findings of DWI were slight. The reduction of mean ADC was significant in regions with severe findings in DWI, but it was not constant in the areas with slighter DWI findings. The detectability of slight changes of cortical and subcortical lesions in acute encephalopathy may be superior in F-H compared to ADC.	[Tachibana, Yasuhiko; Obata, Takayuki] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 260, Japan; [Tachibana, Yasuhiko; Aida, Noriko; Obata, Takayuki; Inoue, Tomio] Yokohama City Univ, Dept Radiol, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Tachibana, Yasuhiko; Aida, Noriko; Niwa, Tetsu; Nozawa, Kumiko; Kusagiri, Kouki; Mori, Kana; Endo, Kazuo] Kanagawa Childrens Med Ctr, Dept Radiol, Minami Ku, Yokohama, Kanagawa, Japan; [Niwa, Tetsu] Tokai Univ, Sch Med, Dept Radiol, Isehara, Kanagawa 25911, Japan	National Institutes for Quantum Science & Technology; Yokohama City University; Tokai University	Obata, T (corresponding author), Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 260, Japan.	t_obata@nirs.go.jp	Obata, Takayuki/AAR-9820-2020	Obata, Takayuki/0000-0001-7678-5033	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Benga O, 2012, MOL ASPECTS MED, V33, P562, DOI 10.1016/j.mam.2012.03.008; Brugieres P, 2004, AM J NEURORADIOL, V25, P692; Chen CI, 2011, PEDIATR NEUROL, V44, P389, DOI 10.1016/j.pediatrneurol.2010.12.007; Clark CA, 2000, MAGN RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; Hayashi N, 2012, BRAIN DEV-JPN, V34, P632, DOI 10.1016/j.braindev.2011.11.007; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Ichiyama T, 2009, BRAIN DEV-JPN, V31, P731, DOI 10.1016/j.braindev.2008.11.005; Ichlyama T, 2008, BRAIN DEV-JPN, V30, P47, DOI 10.1016/j.braindev.2007.05.008; Kobayashi K, 2010, EPILEPSY RES, V91, P143, DOI 10.1016/j.eplepsyres.2010.07.005; Kozak LR, 2010, ACTA PAEDIATR, V99, P237, DOI 10.1111/j.1651-2227.2009.01528.x; Kuwata S, 2012, BRAIN DEV-JPN, V34, P529, DOI 10.1016/j.braindev.2011.08.010; Lee JH, 2003, MAGNET RESON MED, V49, P450, DOI 10.1002/mrm.10402; Maier SE, 2001, RADIOLOGY, V219, P842, DOI 10.1148/radiology.219.3.r01jn02842; Maier SE, 2008, MAGN RESON IMAGING, V26, P897, DOI 10.1016/j.mri.2008.01.042; Mardor Y, 2003, J CLIN ONCOL, V21, P1094, DOI 10.1200/JCO.2003.05.069; Matsushita T, 2009, MULT SCLER J, V15, P1113, DOI 10.1177/1352458509106613; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Mizuguchi M, 1997, BRAIN DEV-JPN, V19, P81, DOI 10.1016/S0387-7604(96)00063-0; Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Mulkern RV, 1999, NMR BIOMED, V12, P51, DOI 10.1002/(SICI)1099-1492(199902)12:1<51::AID-NBM546>3.0.CO;2-E; Obata T, 2012, 20 ANN M INT SOC MAG, P1830; Okumura A, 2009, AM J NEURORADIOL, V30, P825, DOI 10.3174/ajnr.A1431; Okumura A, 2012, EPILEPSIA, V53, P79, DOI 10.1111/j.1528-1167.2011.03311.x; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Saitoh M, 2012, EPILEPSIA, V53, P558, DOI 10.1111/j.1528-1167.2011.03402.x; Sakai K, 2012, NMR BIOMED, V25, P340, DOI 10.1002/nbm.1755; Sakai K, 2011, NMR BIOMED, V24, P1063, DOI 10.1002/nbm.1656; Schwarcz A, 2004, MAGNET RESON MED, V51, P278, DOI 10.1002/mrm.10702; Shiihara T, 2012, PEDIATR INT, V54, P52, DOI 10.1111/j.1442-200X.2011.03454.x; ShinMoto H, 2009, MAGN RESON IMAGING, V27, P355, DOI 10.1016/j.mri.2008.07.008; Shinohara M, 2011, BRAIN DEV-JPN, V33, P512, DOI 10.1016/j.braindev.2010.09.002; Tadokoro R, 2010, BRAIN DEV-JPN, V32, P477, DOI 10.1016/j.braindev.2009.05.007; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5; Takanashi J, 2009, AM J NEURORADIOL, V30, P132, DOI 10.3174/ajnr.A1247; Takanashi J, 2009, BRAIN DEV-JPN, V31, P521, DOI 10.1016/j.braindev.2009.02.012; Tamura T, 2012, MAGN RESON MED, V68, P890, DOI 10.1002/mrm.23277; Tamura T, 2010, MAGN RESON MED SCI, V9, P195, DOI 10.2463/mrms.9.195; Traul DE, 2008, DEV MED CHILD NEUROL, V50, P717, DOI 10.1111/j.1469-8749.2008.03080.x; Wong AM, 2006, AM J NEURORADIOL, V27, P1919	40	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63869	10.1371/journal.pone.0063869	http://dx.doi.org/10.1371/journal.pone.0063869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755112	Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300015
J	Velghe, AI; Van Cauwenberghe, S; Polyansky, AA; Chand, D; Montano-Almendras, CP; Charni, S; Hallberg, B; Essaghir, A; Demoulin, JB				Velghe, A. I.; Van Cauwenberghe, S.; Polyansky, A. A.; Chand, D.; Montano-Almendras, C. P.; Charni, S.; Hallberg, B.; Essaghir, A.; Demoulin, J-B			PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations	ONCOGENE			English	Article						PDGF receptor; tyrosine kinase inhibitors; glioblastoma; leukemia; GIST	RECEPTOR TYROSINE KINASE; HYPEREOSINOPHILIC SYNDROME; CELL PROLIFERATION; EGF RECEPTOR; IMATINIB; ACTIVATION; MEMBRANE; DOMAIN; BETA; GENE	Activating mutations in the platelet-derived growth factor (PDGF) receptor alpha (PDGFRA) have been described in patients with gastrointestinal stromal tumors or myeloid malignancies associated with hypereosinophilia. These patients respond well to imatinib mesylate, raising the question as to whether patients with a PDGF receptor mutation in other tumor types should receive a tyrosine kinase inhibitor treatment. We characterized 10 novel somatic point mutations in PDGFRA that have been reported in isolated cases of glioblastoma, melanoma, acute myeloid leukemia, peripheral nerve sheath tumors and neuroendocrine carcinoma. The PDGFRA transmembrane domain mutation V536E stimulated Ba/F3 cell growth and signaling via ERK and STAT5 in the absence of ligand. This mutant, identified in glioblastoma, was strongly inhibited by imatinib. Modeling suggested that the mutation modulates the packing of the transmembrane domain helices in the receptor dimer. By contrast, two mutations in highly conserved residues affected the receptor traffic to the cell surface or kinase activity, thereby preventing the response to PDGF. The other mutations had no significant impact on the receptor activity. This functional analysis matched the predictions of SIFT and PolyPhen for only five mutations and these algorithms do not discriminate gain from loss of function. Finally, an E996K variant that had been identified in a melanoma cell line was not expressed in these cells. Altogether, several newly identified PDGFRA mutations do not activate the receptor and may therefore represent passenger mutations. Our results also underline the importance of characterizing novel kinase alterations in cancer patients.	[Velghe, A. I.; Van Cauwenberghe, S.; Montano-Almendras, C. P.; Charni, S.; Essaghir, A.; Demoulin, J-B] Catholic Univ Louvain, de Duve Inst, BE-1200 Brussels, Belgium; [Polyansky, A. A.] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, Vienna, Austria; [Polyansky, A. A.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow, Russia; [Chand, D.; Hallberg, B.] Umea Univ, Dept Mol Biol, Umea, Sweden	Universite Catholique Louvain; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Umea University	Demoulin, JB (corresponding author), Catholic Univ Louvain, de Duve Inst, MEXP B1-74-05,Ave Hippocrate 75, BE-1200 Brussels, Belgium.	jb.demoulin@uclouvain.be	Polyansky, Anton A/J-2145-2018	Polyansky, Anton A/0000-0002-1011-2706; Demoulin, Jean-Baptiste/0000-0002-8016-6689	Salus Sanguinis Foundation; 'Action de Recherches Concertees' (Communaute Francaise de Belgique, Belgium)	Salus Sanguinis Foundation; 'Action de Recherches Concertees' (Communaute Francaise de Belgique, Belgium)	We thank Francis Brasseur (Ludwig Institute for Cancer Research, Brussels, Belgium) for the LB373-MEL cell line and Stefan Constantinescu (de Duve Institute) for advices. This work was supported by the Salus Sanguinis Foundation and a grant from 'Action de Recherches Concertees' (Communaute Francaise de Belgique, Belgium).	Alentorn A, 2012, NEURO-ONCOLOGY, V14, P1393, DOI 10.1093/neuonc/nos217; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Burke CL, 1997, ONCOGENE, V14, P687, DOI 10.1038/sj.onc.1200873; Chiara F, 2004, J BIOL CHEM, V279, P19732, DOI 10.1074/jbc.M314070200; Clarke ID, 2003, ONCOGENE, V22, P722, DOI 10.1038/sj.onc.1206160; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; David M, 2007, BLOOD, V109, P61, DOI 10.1182/blood-2006-05-024828; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Demoulin JB, 2003, BIOCHEM J, V376, P505, DOI 10.1042/BJ20030385; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Demoulin JB, 2012, AM J BLOOD RES, V2, P44; Dresemann G, 2010, J NEURO-ONCOL, V96, P393, DOI 10.1007/s11060-009-9976-3; Elling C, 2011, BLOOD, V117, P2935, DOI 10.1182/blood-2010-05-286757; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hiwatari M, 2005, LEUKEMIA, V19, P476, DOI 10.1038/sj.leu.2403638; Holtkamp N, 2006, CARCINOGENESIS, V27, P664, DOI 10.1093/carcin/bgi273; Huss S, 2012, HISTOPATHOLOGY, V61, P59, DOI 10.1111/j.1365-2559.2012.04203.x; KEATING MT, 1989, J BIOL CHEM, V264, P9129; Medves S, 2012, J CELL MOL MED, V16, P237, DOI 10.1111/j.1582-4934.2011.01415.x; Medves S, 2011, HAEMATOL-HEMATOL J, V96, P1406, DOI 10.3324/haematol.2011.040147; Metzgeroth G, 2008, BRIT J HAEMATOL, V143, P707, DOI 10.1111/j.1365-2141.2008.07294.x; Montano-Almendras CR, 2012, HAEMATOL-HEMATOL J, V97, P1064, DOI 10.3324/haematol.2011.047530; Muhle-Goll C, 2012, J BIOL CHEM, V287, P26178, DOI 10.1074/jbc.M111.325555; Omura T, 1997, J BIOL CHEM, V272, P12676, DOI 10.1074/jbc.272.19.12676; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Paulsson J, 2011, INT J CANCER, V128, P1981, DOI 10.1002/ijc.25528; Polyansky AA, 2012, J AM CHEM SOC, V134, P14390, DOI 10.1021/ja303483k; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rand V, 2005, P NATL ACAD SCI USA, V102, P14344, DOI 10.1073/pnas.0507200102; Schonerr C, 2012, ONCOGENE, V31, P5193, DOI 10.1038/onc.2012.12; Schonherr C, 2011, TRANSL ONCOL, V4, P248, DOI 10.1593/tlo.11139; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Toffalini F, 2010, BLOOD, V116, P2429, DOI 10.1182/blood-2010-04-279752; Toffalini F, 2010, J BIOL CHEM, V285, P12268, DOI 10.1074/jbc.M109.076638; Toffalini F, 2009, HAEMATOL-HEMATOL J, V94, P1085, DOI 10.3324/haematol.2008.001149; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110	44	41	43	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2568	2576		10.1038/onc.2013.218	http://dx.doi.org/10.1038/onc.2013.218			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23752188				2022-12-25	WOS:000336502700003
J	Mamidi, R; Michael, JJ; Muthuchamy, M; Chandra, M				Mamidi, Ranganath; Michael, John Jeshurun; Muthuchamy, Mariappan; Chandra, Murali			Interplay between the overlapping ends of tropomyosin and the N terminus of cardiac troponin T affects tropomyosin states on actin	FASEB JOURNAL			English	Article						myofilament Ca2+ sensitivity; thin-filament activation; calcium-activated tension; molecular swivel; myofilament cooperativity	ACTOMYOSIN ATPASE ACTIVITY; THIN FILAMENT REGULATION; ALPHA-TROPOMYOSIN; MUSCLE CONTRACTILITY; DETACHMENT KINETICS; ISOFORMS MODULATE; CARBOXY-TERMINUS; STRIATED-MUSCLE; TRANSGENIC MICE; TAIL DOMAIN	The functional significance of the molecular swivel at the head-to-tail overlapping ends of contiguous tropomyosin (Tm) dimers in striated muscle is unknown. Contractile measurements were made in muscle fibers from transgenic (TG) mouse hearts that expressed a mutant -Tm (Tm-H276N). We also reconstituted mouse cardiac troponin T (McTnT) N-terminal deletion mutants, McTnT(1-44) and McTnT(45-74), into muscle fibers from Tm-H276N. For controls, we used the wild-type (WT) McTnT because altered effects could be correlated with the mutant forms of McTnT. Tm-H276N slowed crossbridge (XB) detachment rate (g) by 19%. McTnT(1-44) attenuated Ca2+-activated maximal tension against Tm-WT (36%) and Tm-H276N (38%), but sped g only against Tm-H276N by 35%. The rate of tension redevelopment decreased (17%) only in McTnT(1-44) + Tm-H276N fibers. McTnT(45-74) attenuated tension (19%) and myofilament Ca2+ sensitivity (pCa(50)=5.93 vs. 6.00 in the control fibers) against Tm-H276N, but not against Tm-WT background. Thus, altered XB cycling kinetics decreased the fraction of strongly bound XBs in McTnT(1-44) + Tm-H276N fibers, whereas diminished thin-filament cooperativity attenuated tension in McTnT(45-74) + Tm-H276N fibers. In summary, our study is the first to show that the interplay between the N terminus of cTnT and the overlapping ends of contiguous Tm effectuates different states of Tm on the actin filament. Mamidi, R., Michael, J. J., Muthuchamy, M., Chandra, M. Interplay between the overlapping ends of tropomyosin and the N terminus of cardiac troponin T affects tropomyosin states on actin.	[Mamidi, Ranganath; Michael, John Jeshurun; Chandra, Murali] Washington State Univ, Dept Integrat Physiol & Neurosci, Coll Vet Med, Pullman, WA 99164 USA; [Muthuchamy, Mariappan] Texas A&M Hlth Sci Ctr Coll Med, Dept Syst Biol Translat Med, Cardiovasc Res Inst, Div Lymphat Biol, College Stn, TX USA	Washington State University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Chandra, M (corresponding author), Washington State Univ, Dept Integrat Physiol & Neurosci, 251 Vet Biomed Res Bldg, Pullman, WA 99164 USA.	murali@vetmed.wsu.edu	Michael, John Jeshurun/AAP-5970-2020		U.S. National Heart, Lung, and Blood Institute [R01-HL-075643, R01-HL-80526]; Poncin fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080526, R01HL075643] Funding Source: NIH RePORTER	U.S. National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Poncin fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Sri Lakshmi Mallampalli for excellent technical assistance. This work was funded by U.S. National Heart, Lung, and Blood Institute grants R01-HL-075643 (M. C.) and R01-HL-80526 (M. M.) and by a Poncin fellowship (R. M.). The authors declare no conflicts of interest.	Bach CTT, 2010, CELL ADHES MIGR, V4, P226, DOI 10.4161/cam.4.2.10888; Borovikov YS, 2011, BIOCHEM BIOPH RES CO, V411, P496, DOI 10.1016/j.bbrc.2011.06.138; Borovikov YS, 2009, ARCH BIOCHEM BIOPHYS, V489, P20, DOI 10.1016/j.abb.2009.07.018; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9; BUTTERS CA, 1993, J BIOL CHEM, V268, P15565; Chandra M, 2006, BIOPHYS J, V90, P2867, DOI 10.1529/biophysj.105.076950; Chandra M, 1999, J MOL CELL CARDIOL, V31, P867, DOI 10.1006/jmcc.1999.0928; Chandra M, 2007, AM J PHYSIOL-REG I, V293, pR1595, DOI 10.1152/ajpregu.00157.2007; Chandra M, 2009, J BIOL CHEM, V284, P30889, DOI 10.1074/jbc.M109.049718; DETOMBE PP, 1995, CIRC RES, V76, P734, DOI 10.1161/01.RES.76.5.734; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Gaffin RD, 2004, J PHYSIOL-LONDON, V561, P777, DOI 10.1113/jphysiol.2004.070631; Gaffin RD, 2004, J PHYSIOL-LONDON, V556, P531, DOI 10.1113/jphysiol.2003.058487; Gollapudi SK, 2013, J MOL BIOL, V425, P1565, DOI 10.1016/j.jmb.2013.01.028; Gollapudi SK, 2012, BIOPHYS J, V103, P940, DOI 10.1016/j.bpj.2012.07.035; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gunning P, 2008, ADV EXP MED BIOL, V644, P293; Hammell RL, 1996, J BIOL CHEM, V271, P4236; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; Holmes KC, 2008, J MUSCLE RES CELL M, V29, P213, DOI 10.1007/s10974-008-9157-6; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Mamidi R, 2013, J PHYSIOL-LONDON, V591, P1217, DOI 10.1113/jphysiol.2012.243394; Mamidi R, 2012, ARCH BIOCHEM BIOPHYS, V525, P1, DOI 10.1016/j.abb.2012.05.024; Maytum R, 2002, J BIOL CHEM, V277, P29774, DOI 10.1074/jbc.M201761200; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; Michael JJ, 2013, AM J PHYSIOL-HEART C, V304, pH253, DOI 10.1152/ajpheart.00572.2012; Montgomery DE, 2001, J PHYSIOL-LONDON, V536, P583, DOI 10.1111/j.1469-7793.2001.0583c.xd; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Murakami K, 2008, P NATL ACAD SCI USA, V105, P7200, DOI 10.1073/pnas.0801950105; Oliveira DM, 2000, J BIOL CHEM, V275, P27513; PAN BS, 1991, J BIOL CHEM, V266, P12432; PATO MD, 1981, J BIOL CHEM, V256, P602; PEARLSTONE JR, 1977, CAN J BIOCHEM CELL B, V55, P1032, DOI 10.1139/o77-154; Perry SV, 2001, J MUSCLE RES CELL M, V22, P5, DOI 10.1023/A:1010303732441; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Smith DA, 2003, BIOPHYS J, V84, P3168, DOI 10.1016/S0006-3495(03)70041-1; Tardiff JC, 1998, J CLIN INVEST, V101, P2800, DOI 10.1172/JCI2389; Tobacman LS, 2002, J BIOL CHEM, V277, P27636, DOI 10.1074/jbc.M201768200; UENO H, 1976, J BIOCHEM, V80, P283, DOI 10.1093/oxfordjournals.jbchem.a131275	47	13	13	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3848	3859		10.1096/fj.13-232363	http://dx.doi.org/10.1096/fj.13-232363			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23748972	Green Published			2022-12-25	WOS:000328840500042
J	Creager-Allen, RL; Silversmith, RE; Bourret, RB				Creager-Allen, Rachel L.; Silversmith, Ruth E.; Bourret, Robert B.			A Link between Dimerization and Autophosphorylation of the Response Regulator PhoB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Signal Transduction; Cooperativity; Enzyme Kinetics; Protein Phosphorylation; Protein-Protein Interactions; Dimerization; PhoB; Phosphoramidate; Response Regulator; Two-component System	2-COMPONENT SIGNAL-TRANSDUCTION; SMALL-MOLECULE PHOSPHODONORS; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; KINETIC CHARACTERIZATION; CHEY PHOSPHORYLATION; CRYSTAL-STRUCTURE; ACETYL PHOSPHATE; RECEIVER DOMAIN; IN-VITRO	Response regulator proteins within two-component signal transduction systems are activated by phosphorylation and can catalyze their own covalent phosphorylation using small molecule phosphodonors. To date, comprehensive kinetic characterization of response regulator autophosphorylation is limited to CheY, which follows a simple model of phosphodonor binding followed by phosphorylation. We characterized autophosphorylation of the response regulator PhoB, known to dimerize upon phosphorylation. In contrast to CheY, PhoB time traces exhibited an initial lag phase and gave apparent pseudo-first order rate constants that increased with protein concentration. Furthermore, plots of the apparent autophosphorylation rate constant versus phosphodonor concentration were sigmoidal, as were PhoB binding isotherms for the phosphoryl group analog BeF3-. Successful mathematical modeling of the kinetic data necessitated inclusion of the formation of a PhoB heterodimer (one phosphorylated and one unphosphorylated monomer) with an enhanced rate of phosphorylation. Specifically, dimerization constants for the PhoB heterodimer and homodimer ( two phosphorylated monomers) were similar, but the rate constant for heterodimer phosphorylation was similar to 10-fold higher than for the monomer. In a test of the model, disruption of the known PhoB(N) dimerization interface by mutation led to markedly slower and noncooperative autophosphorylation kinetics. Furthermore, phosphotransfer from the sensor kinase PhoR was enhanced by dimer formation. Phosphorylation-mediated dimerization allows many response regulators to bind to tandem DNA-binding sites and regulate transcription. Our data challenge the notion that response regulator dimers primarily form between two phosphorylated monomers and raise the possibility that response regulator heterodimers containing one phosphoryl group may participate in gene regulation.	[Creager-Allen, Rachel L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Silversmith, Ruth E.; Bourret, Robert B.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bourret, RB (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	bourret@med.unc.edu	Bourret, Robert/X-3606-2019	Bourret, Robert/0000-0002-6666-9220	National Institutes of Health from NIGMS [R01GM050860]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050860] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM050860 from NIGMS.	Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Barbieri CM, 2010, J BIOL CHEM, V285, P32325, DOI 10.1074/jbc.M110.157164; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Bourret RB, 2010, METHOD ENZYMOL, V471, P89, DOI 10.1016/S0076-6879(10)71006-5; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Da Re SS, 1999, FEBS LETT, V457, P323, DOI 10.1016/S0014-5793(99)01057-1; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; FIEDLER U, 1995, EMBO J, V14, P3696, DOI 10.1002/j.1460-2075.1995.tb00039.x; Fisher SL, 1996, BIOCHEMISTRY-US, V35, P4732, DOI 10.1021/bi9525435; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gao R, 2008, MOL MICROBIOL, V69, P1358, DOI 10.1111/j.1365-2958.2008.06355.x; Gao R, 2013, P NATL ACAD SCI USA, V110, P672, DOI 10.1073/pnas.1214587110; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; GILLESGONZALEZ MA, 1993, J BIOL CHEM, V268, P16293; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; HESS JF, 1988, COLD SPRING HARB SYM, V53, P41, DOI 10.1101/SQB.1988.053.01.008; HIRATSU K, 1995, GENE, V161, P7, DOI 10.1016/0378-1119(95)00259-9; Hung DCI, 2012, J BACTERIOL, V194, P1127, DOI 10.1128/JB.06565-11; JANIN J, 1990, J BIOL CHEM, V265, P16027; Kierzek AM, 2010, MOL BIOSYST, V6, P531, DOI 10.1039/b906951h; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; LUKAT GS, 1990, BIOCHEMISTRY-US, V29, P5436, DOI 10.1021/bi00475a004; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Magasanik B., 1996, ESCHERICHIA COLI SAL, P1344; MAKINO K, 1988, J MOL BIOL, V203, P85, DOI 10.1016/0022-2836(88)90093-9; MARTIN RB, 1988, BIOCHEM BIOPH RES CO, V155, P1194; Mayover TL, 1999, BIOCHEMISTRY-US, V38, P2259, DOI 10.1021/bi981707p; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; MCCLEARY WR, 1990, J BACTERIOL, V172, P6661, DOI 10.1128/jb.172.12.6661-6668.1990; Psakis G, 2011, BIOCHEMISTRY-US, V50, P6178, DOI 10.1021/bi200612d; Schuster M, 2001, P NATL ACAD SCI USA, V98, P6003, DOI 10.1073/pnas.101571298; Sheridan R. C., 2007, INORG SYN, P23; SHINAGAWA H, 1983, J MOL BIOL, V168, P477, DOI 10.1016/S0022-2836(83)80297-6; Silversmith RE, 1997, BIOCHEMISTRY-US, V36, P14965, DOI 10.1021/bi9715573; Silversmith RE, 2005, BIOCHEMISTRY-US, V44, P7768, DOI 10.1021/bi0501636; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Sola M, 1999, J MOL BIOL, V285, P675, DOI 10.1006/jmbi.1998.2326; Sola M, 2006, ACTA CRYSTALLOGR D, V62, P1046, DOI 10.1107/S0907444906024541; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; Thomas SA, 2013, BIOCHEMISTRY-US, V52, P2262, DOI 10.1021/bi301654m; Huynh TN, 2011, MOL MICROBIOL, V82, P275, DOI 10.1111/j.1365-2958.2011.07829.x; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; Zapf JW, 1996, BIOCHEMISTRY-US, V35, P2926, DOI 10.1021/bi9519361; Zhou L., 2005, J INTEGR BIOINFORM, V2, P11; Zundel CJ, 1998, FEBS LETT, V441, P242, DOI 10.1016/S0014-5793(98)01556-7	60	31	31	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21755	10.1074/jbc.M113.471763	http://dx.doi.org/10.1074/jbc.M113.471763			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760278	Green Published, hybrid			2022-12-25	WOS:000328841900026
J	Huang, SH; Zhao, LX; Hong, C; Duo, CC; Guo, BN; Zhang, LJ; Gong, Z; Xiong, SD; Gong, FY; Gao, XM				Huang, Shang-Hui; Zhao, Li-Xiang; Hong, Chao; Duo, Cui-Cui; Guo, Bing-Nan; Zhang, Li-Juan; Gong, Zheng; Xiong, Si-Dong; Gong, Fang-Yuan; Gao, Xiao-Ming			Self-Oligomerization Is Essential for Enhanced Immunological Activities of Soluble Recombinant Calreticulin	PLOS ONE			English	Article							HUMAN PLACENTAL CALRETICULIN; CELL-SURFACE CALRETICULIN; HEAT-SHOCK PROTEINS; BINDING CHARACTERISTICS; MOLECULAR CHAPERONE; T-LYMPHOCYTES; ACTIVATION; LECTIN; PURIFICATION; ASSOCIATION	We have recently reported that calreticulin (CRT), a luminal resident protein, can be found in the sera of patients with rheumatoid arthritis and also that recombinant CRT (rCRT) exhibits extraordinarily strong immunological activities. We herein further demonstrate that rCRT fragments 18-412 (rCRT/18-412), rCRT/39-272, rCRT/120-308 and rCRT/120-250 can self-oligomerize in solution and are 50-100 fold more potent than native CRT (nCRT, isolated from mouse livers) in activating macrophages in vitro. We narrowed down the active site of CRT to residues 150-230, the activity of which also depends on dimerization. By contrast, rCRT/18-197 is almost completely inactive. When rCRT/18-412 is fractionated into oligomers and monomers by gel filtration, the oligomers maintain most of their immunological activities in terms of activating macrophages in vitro and inducing specific antibodies in vivo, while the monomers were much less active by comparison. Additionally, rCRT/18-412 oligomers are much better than monomers in binding to, and uptake by, macrophages. Inhibition of macrophage endocytosis partially blocks the stimulatory effect of rCRT/18-412. We conclude that the immunologically active site of CRT maps between residues 198-230 and that soluble CRT could acquire potent immuno-pathological activities in microenvironments favoring its oligomerization.	[Huang, Shang-Hui; Zhao, Li-Xiang; Hong, Chao; Duo, Cui-Cui; Guo, Bing-Nan; Zhang, Li-Juan; Gong, Zheng; Xiong, Si-Dong; Gong, Fang-Yuan; Gao, Xiao-Ming] Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Gong, FY (corresponding author), Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China.	gongfangyuan@suda.edu.cn; xmgao@suda.edu.cn	Zhang, Li/GWM-7501-2022		Program for Changjiang Scholars and Innovative Research Team PCSIRT [IRT1075]; National Foundation of Nature Science of China [30890142/31070781/31200649]; Priority Academic Program Development of Jiangsu Province Higher Education Institutions; National Key Basic Research Programs [2010CB529102]	Program for Changjiang Scholars and Innovative Research Team PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Foundation of Nature Science of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Province Higher Education Institutions; National Key Basic Research Programs(National Basic Research Program of China)	This study was supported by grants from the Program for Changjiang Scholars and Innovative Research Team PCSIRT (IRT1075), National Foundation of Nature Science of China (30890142/31070781/31200649), Priority Academic Program Development of Jiangsu Province Higher Education Institutions, and National Key Basic Research Programs (2010CB529102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; BURNS K, 1992, J BIOL CHEM, V267, P19039; Cho JH, 2001, CELL STRESS CHAPERON, V6, P148, DOI 10.1379/1466-1268(2001)006<0148:AOHMCL>2.0.CO;2; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; Ellgaard L, 2002, J MOL BIOL, V322, P773, DOI 10.1016/S0022-2836(02)00812-4; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Goeb V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2644; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Hojrup P, 2001, EUR J BIOCHEM, V268, P2558, DOI 10.1046/j.1432-1327.2001.02138.x; Hong C, 2010, J IMMUNOL, V185, P4561, DOI 10.4049/jimmunol.1000536; HOUEN G, 1994, ACTA CHEM SCAND, V48, P905, DOI 10.3891/acta.chem.scand.48-0905; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P792, DOI 10.1016/j.biocel.2010.01.008; LI WJ, 2013, CLIN VACCINE IMMUNOL; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Ling S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011703; Mancino L, 2002, P NATL ACAD SCI USA, V99, P5931, DOI 10.1073/pnas.092031799; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Nemoto TK, 2001, BIOCHEM J, V354, P663, DOI 10.1042/0264-6021:3540663; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Porcellini S, 2006, J EXP MED, V203, P461, DOI 10.1084/jem.20051519; Qiu X, 2012, MICROBIOL IMMUNOL, V56, P554, DOI 10.1111/j.1348-0421.2012.00467.x; ROWLING PJE, 1994, PROTEIN EXPRES PURIF, V5, P331, DOI 10.1006/prep.1994.1049; SCHLEGEL R, 1982, P NATL ACAD SCI-BIOL, V79, P2291, DOI 10.1073/pnas.79.7.2291; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wearsch PA, 1996, BIOCHEMISTRY-US, V35, P16760, DOI 10.1021/bi962068q; WHITE TK, 1995, J BIOL CHEM, V270, P15926, DOI 10.1074/jbc.270.27.15926; Wijeyesakere SJ, 2011, J BIOL CHEM, V286, P8771, DOI 10.1074/jbc.M110.169193; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641	41	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64951	10.1371/journal.pone.0064951	http://dx.doi.org/10.1371/journal.pone.0064951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762269	Green Submitted, gold, Green Published			2022-12-25	WOS:000320440500012
J	Zhang, X; He, LM; Zhang, FL; Sun, W; Li, ZY				Zhang, Xia; He, Liming; Zhang, Fengli; Sun, Wei; Li, Zhiyong			The Different Potential of Sponge Bacterial Symbionts in N-2 Release Indicated by the Phylogenetic Diversity and Abundance Analyses of Denitrification Genes, nirK and nosZ	PLOS ONE			English	Article							NITRITE REDUCTASE GENES; AMMONIA-OXIDIZING ARCHAEA; COMPLETE GENOME SEQUENCE; OIL-DEGRADING BACTERIUM; MARINE SPONGE; DENITRIFYING BACTERIA; SPATIAL-DISTRIBUTION; NITROGEN-FIXATION; COMMUNITIES; NITRIFICATION	Nitrogen cycle is a critical biogeochemical process of the oceans. The nitrogen fixation by sponge cyanobacteria was early observed. Until recently, sponges were found to be able to release nitrogen gas. However the gene-level evidence for the role of bacterial symbionts from different species sponges in nitrogen gas release is limited. And meanwhile, the quanitative analysis of nitrogen cycle-related genes of sponge microbial symbionts is relatively lacking. The nirK gene encoding nitrite reductase which catalyzes soluble nitrite into gas NO and nosZ gene encoding nitrous oxide reductase which catalyzes N2O into N-2 are two key functional genes in the complete denitrification pathway. In this study, using nirK and nosZ genes as markers, the potential of bacterial symbionts in six species of sponges in the release of N-2 was investigated by phylogenetic analysis and real-time qPCR. As a result, totally, 2 OTUs of nirK and 5 OTUs of nosZ genes were detected by gene library-based saturated sequencing. Difference phylogenetic diversity of nirK and nosZ genes were observed at OTU level in sponges. Meanwhile, real-time qPCR analysis showed that Xestospongia testudinaria had the highest abundance of nosZ gene, while Cinachyrella sp. had the greatest abundance of nirK gene. Phylogenetic analysis showed that the nirK and nosZ genes were probably of Alpha-, Beta-, and Gammaproteobacteria origin. The results from this study suggest that the denitrification potential of bacteria varies among sponges because of the different phylogenetic diversity and relative abundance of nosZ and nirK genes in sponges. Totally, both the qualitative and quantitative analyses of nirK and nosZ genes indicated the different potential of sponge bacterial symbionts in the release of nitrogen gas.	[Zhang, Xia; He, Liming; Zhang, Fengli; Sun, Wei; Li, Zhiyong] Shanghai Jiao Tong Univ, Marine Biotechnol Lab, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhang, Xia; He, Liming; Zhang, Fengli; Sun, Wei; Li, Zhiyong] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, ZY (corresponding author), Shanghai Jiao Tong Univ, Marine Biotechnol Lab, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	zyli@sjtu.edu.cn			National Natural Science Foundation of China (NSFC) [41076077]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Financial support from National Natural Science Foundation of China (NSFC) (41076077) is greatly acknowledged [http://www.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anceno AJ, 2009, BIORESOURCE TECHNOL, V100, P3678, DOI 10.1016/j.biortech.2009.02.045; Auclair J, 2012, MICROB ECOL, V63, P726, DOI 10.1007/s00248-011-9960-2; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Braker G, 2000, APPL ENVIRON MICROB, V66, P2096, DOI 10.1128/AEM.66.5.2096-2104.2000; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Cao BY, 2011, J BACTERIOL, V193, P4021, DOI 10.1128/JB.05242-11; Cassler M, 2008, MICROB ECOL, V55, P384, DOI 10.1007/s00248-007-9283-5; Chen Z, 2012, J SCI FOOD AGR, V92, P1064, DOI 10.1002/jsfa.4533; Chen Z, 2010, MICROB ECOL, V60, P850, DOI 10.1007/s00248-010-9700-z; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Diaz MC, 1997, MAR ECOL PROG SER, V156, P97, DOI 10.3354/meps156097; Donaldson KA, 2002, WATER RES, V36, P2505, DOI 10.1016/S0043-1354(01)00479-1; Fan L, 2012, P NATL ACAD SCI USA, V109, pE1878, DOI 10.1073/pnas.1203287109; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gruber N, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/B978-0-12-372522-6.00001-3; Han MQ, 2013, MICROB ECOL, V66, P427, DOI 10.1007/s00248-013-0197-0; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Heylen K, 2006, ENVIRON MICROBIOL, V8, P2012, DOI 10.1111/j.1462-2920.2006.01081.x; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Holmes B, 2007, MAR BIOL, V150, P759, DOI 10.1007/s00227-006-0361-x; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Kloos K, 2001, AUST J PLANT PHYSIOL, V28, P991; Lee OO, 2012, INT J SYST EVOL MICR, V62, P1980, DOI 10.1099/ijs.0.028811-0; Levy-Booth DJ, 2010, APPL ENVIRON MICROB, V76, P7116, DOI 10.1128/AEM.02188-09; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; Li SG, 2011, J BACTERIOL, V193, P2894, DOI 10.1128/JB.00333-11; Liu F, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI DOI 10.2174/157015911795017155; Liu XQ, 2008, FEMS MICROBIOL LETT, V289, P46, DOI 10.1111/j.1574-6968.2008.01362.x; Lopez-Legentil S, 2010, MICROB ECOL, V60, P561, DOI 10.1007/s00248-010-9662-1; Lund MB, 2012, ISME J, V6, P1966, DOI 10.1038/ismej.2012.40; Meyer B, 2008, MICROB ECOL, V56, P306, DOI 10.1007/s00248-007-9348-5; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Muller WEG, 1999, TRANSPLANTATION, V68, P1215; Palmer K, 2012, ISME J, V6, P1058, DOI 10.1038/ismej.2011.172; Palmer K, 2009, APPL ENVIRON MICROB, V75, P5170, DOI 10.1128/AEM.00254-09; Philippot L, 2009, ENVIRON MICROBIOL, V11, P1518, DOI 10.1111/j.1462-2920.2009.01879.x; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Skovhus TL, 2004, APPL ENVIRON MICROB, V70, P2373, DOI 10.1128/AEM.70.4.2373-2382.2004; Southwell MW, 2008, MAR CHEM, V108, P96, DOI 10.1016/j.marchem.2007.10.005; Spain AM, 2007, APPL ENVIRON MICROB, V73, P4892, DOI 10.1128/AEM.00331-07; Steger D, 2008, ENVIRON MICROBIOL, V10, P1087, DOI 10.1111/j.1462-2920.2007.01515.x; Stres B, 2004, APPL ENVIRON MICROB, V70, P301, DOI 10.1128/AEM.70.1.301-309.2004; Taylor MW, 2007, ISME J, V1, P187, DOI 10.1038/ismej.2007.32; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2013, ISME J, V7, P438, DOI 10.1038/ismej.2012.111; Turque AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015774; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Wilkinson C, 1999, AMBIO, V28, P188; Wilkinson C.R., 1979, Colloques Internationaux du Centre National de la Recherche Scientifique, P373; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Wu L, 2012, ENVIRON MANAGE, V50, P861, DOI 10.1007/s00267-012-9929-z; Yang ZY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00528; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zhou K, 2011, MICROB ECOL, V62, P644, DOI 10.1007/s00248-011-9859-y; Zhou ZF, 2011, ENVIRON SCI POLLUT R, V18, P1644, DOI 10.1007/s11356-011-0482-8	63	10	11	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65142	10.1371/journal.pone.0065142	http://dx.doi.org/10.1371/journal.pone.0065142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762300	gold, Green Submitted, Green Published			2022-12-25	WOS:000320440500028
J	Chen, YB; Lv, LZ; Jiang, ZL; Yang, HJ; Li, S; Jiang, Y				Chen, Yongbiao; Lv, Lizhi; Jiang, Zhelong; Yang, Hejun; Li, Song; Jiang, Yi			Mitofusin 2 Protects Hepatocyte Mitochondrial Function from Damage Induced by GCDCA	PLOS ONE			English	Article							EXTRAHEPATIC CHOLESTASIS; OXIDATIVE STRESS; RAT HEPATOCYTES; LIVER-INJURY; IN-VITRO; FUSION; APOPTOSIS; BIOGENESIS; MORPHOLOGY; PROTEINS	Mitochondrial impairment is hypothesized to contribute to the pathogenesis of chronic cholestatic liver diseases. Mitofusin 2 (Mfn2) regulates mitochondrial morphology and signaling and is involved in the development of numerous mitochondrial-related diseases; however, a functional role for Mfn2 in chronic liver cholestasis which is characterized by increased levels of toxic bile acids remain unknown. Therefore, the aims of this study were to evaluate the expression levels of Mfn2 in liver samples from patients with extrahepatic cholestasis and to investigate the role Mfn2 during bile acid induced injury in vitro. Endogenous Mfn2 expression decreased in patients with extrahepatic cholestasis. Glycochenodeoxycholic acid (GCDCA) is the main toxic component of bile acid in patients with extrahepatic cholestasis. In human normal hepatocyte cells (L02), Mfn2 plays an important role in GCDCA-induced mitochondrial damage and changes in mitochondrial morphology. In line with the mitochondrial dysfunction, the expression of Mfn2 decreased significantly under GCDCA treatment conditions. Moreover, the overexpression of Mfn2 effectively attenuated mitochondrial fragmentation and reversed the mitochondrial damage observed in GCDCA-treated L02 cells. Notably, a truncated Mfn2 mutant that lacked the normal C-terminal domain lost the capacity to induce mitochondrial fusion. Increasing the expression of truncated Mfn2 also had a protective effect against the hepatotoxicity of GCDCA. Taken together, these findings indicate that the loss of Mfn2 may play a crucial role the pathogenesis of the liver damage that is observed in patients with extrahepatic cholestasis. The findings also indicate that Mfn2 may directly regulate mitochondrial metabolism independently of its primary fusion function. Therapeutic approaches that target Mfn2 may have protective effects against hepatotoxic of bile acids during cholestasis.	[Chen, Yongbiao; Lv, Lizhi; Jiang, Zhelong; Yang, Hejun; Li, Song; Jiang, Yi] Fuzhou Gen Hosp, Dept Hepatobiliary Surg, Fuzhou, Peoples R China		Chen, YB (corresponding author), Fuzhou Gen Hosp, Dept Hepatobiliary Surg, Fuzhou, Peoples R China.	cybiao717@sina.com.cn; chenyongbiaosci@163.com			Nanjing military region medicine and health research fund of China [09MA97]	Nanjing military region medicine and health research fund of China	Grant support was from Nanjing military region medicine and health research fund of China (No. 09MA97). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681; Arduini A, 2011, AM J PHYSIOL-GASTR L, V301, pG119, DOI 10.1152/ajpgi.00253.2010; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Eschenbacher WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044296; Esquivel Lopez A, 1982, Rev Gastroenterol Mex, V47, P9; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Hernandez-Alvarez MI, 2012, ANTIOXID REDOX SIGNA; Hofmann AF, 2002, LIVER, V22, P14, DOI 10.1034/j.1600-0676.2002.00002.x; Huang PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020655; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029393; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Palmeira CM, 2004, TOXICOLOGY, V203, P1, DOI 10.1016/j.tox.2004.06.001; Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677; Pesce V, 2012, REJUV RES, V15, P136, DOI 10.1089/rej.2011.1255; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Rolo AP, 2000, TOXICOL SCI, V57, P177, DOI 10.1093/toxsci/57.1.177; Schoemaker MH, 2003, J HEPATOL, V39, P153, DOI 10.1016/S0168-8278(03)00214-9; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; SOKOL RJ, 1995, GASTROENTEROLOGY, V109, P1249, DOI 10.1016/0016-5085(95)90585-5; Sorensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001; Tiao MM, 2009, APOPTOSIS, V14, P890, DOI 10.1007/s10495-009-0357-3; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Trottier J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022094; Vendemiale G, 2002, J HEPATOL, V37, P601, DOI 10.1016/S0168-8278(02)00234-9; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Xu S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.7; Xu SC, 2012, FREE RADICAL BIO MED, V52, P1543, DOI 10.1016/j.freeradbiomed.2012.01.007; Xu SC, 2010, J PINEAL RES, V49, P86, DOI 10.1111/j.1600-079X.2010.00770.x; Yamaura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030250; Yerushalmi B, 2001, HEPATOLOGY, V33, P616, DOI 10.1053/jhep.2001.22702; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhang Y, 2011, METABOLISM, V60, P767, DOI 10.1016/j.metabol.2010.07.026; Zorzano A, 2010, SEMIN CELL DEV BIOL, V21, P566, DOI 10.1016/j.semcdb.2010.01.002	42	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65455	10.1371/journal.pone.0065455	http://dx.doi.org/10.1371/journal.pone.0065455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755235	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000070
J	Godnic, I; Zorc, M; Skok, DJ; Calin, GA; Horvat, S; Dovc, P; Kovac, M; Kunej, T				Godnic, Irena; Zorc, Minja; Skok, Dasa Jevsinek; Calin, George Adrian; Horvat, Simon; Dovc, Peter; Kovac, Milena; Kunej, Tanja			Genome-Wide and Species-Wide In Silico Screening for Intragenic MicroRNAs in Human, Mouse and Chicken	PLOS ONE			English	Article							MEDIATED GENE-REGULATION; HOST GENES; DNA HYPERMETHYLATION; INTRONIC MICRORNAS; CELL-PROLIFERATION; DOWN-REGULATION; CANCER-CELLS; CHOLESTEROL HOMEOSTASIS; EXPRESSION PROFILES; COLORECTAL-CANCER	MicroRNAs (miRNAs) are non-coding RNAs (ncRNAs) involved in regulation of gene expression. Intragenic miRNAs, especially those exhibiting a high degree of evolutionary conservation, have been shown to be coordinately regulated and/or expressed with their host genes, either with synergistic or antagonistic correlation patterns. However, the degree of cross-species conservation of miRNA/host gene co-location is not known and co-expression information is incomplete and fragmented among several studies. Using the genomic resources (miRBase and Ensembl) we performed a genome-wide in silico screening (GWISS) for miRNA/host gene pairs in three well-annotated vertebrate species: human, mouse, and chicken. Approximately half of currently annotated miRNA genes resided within host genes: 53.0% (849/1,600) in human, 48.8% (418/855) in mouse, and 42.0% (210/499) in chicken, which we present in a central publicly available Catalog of intragenic miRNAs (http://www.integratomics-time.com/miR-host/catalog). The miRNA genes resided within either protein-coding or ncRNA genes, which include long intergenic ncRNAs (lincRNAs) and small nucleolar RNAs (snoRNAs). Twenty-seven miRNA genes were found to be located within the same host genes in all three species and the data integration from literature and databases showed that most (26/27) have been found to be co-expressed. Particularly interesting are miRNA genes located within genes encoding for miRNA silencing machinery (DGCR8, DICER1, and SND1 in human and Cnot3, Gdcr8, Eif4e, Tnrc6b, and Xpo5 in mouse). We furthermore discuss a potential for phenotype misattribution of miRNA host gene polymorphism or gene modification studies due to possible collateral effects on miRNAs hosted within them. In conclusion, the catalog of intragenic miRNAs and identified 27 miRNA/host gene pairs with cross-species conserved co-location, co-expression, and potential co-regulation, provide excellent candidates for further functional annotation of intragenic miRNAs in health and disease.	[Godnic, Irena; Zorc, Minja; Skok, Dasa Jevsinek; Horvat, Simon; Dovc, Peter; Kovac, Milena; Kunej, Tanja] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Calin, George Adrian] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Horvat, Simon] Natl Inst Chem, Ljubljana, Slovenia	University of Ljubljana; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institute of Chemistry - Slovenia	Kunej, T (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia.	tanja.kunej@bf.uni-lj.si	Calin, George/E-9390-2011; Zorc, Minja/AGD-6914-2022; Kunej, Tanja/G-5957-2017	Zorc, Minja/0000-0003-3330-7909; Kunej, Tanja/0000-0002-0465-1762; Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615	Slovenian Research Agency (ARRS) through the Research programme Comparative genomics and genome biodiversity [P4-0220]; University of Texas M. D.; Anderson Research Trust; University of Texas System Regents Research Scholar; CLL Global Research Foundation; National Institutes of Health; Department of Defense; Developmental Research Awards in Breast Cancer, Ovarian Cancer and Leukemia SPOREs; Seena Magowitz - Pancreatic Cancer Action Network - AACR Pilot Grant	Slovenian Research Agency (ARRS) through the Research programme Comparative genomics and genome biodiversity; University of Texas M. D.; Anderson Research Trust; University of Texas System Regents Research Scholar; CLL Global Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Developmental Research Awards in Breast Cancer, Ovarian Cancer and Leukemia SPOREs; Seena Magowitz - Pancreatic Cancer Action Network - AACR Pilot Grant	This work was supported by the Slovenian Research Agency (ARRS) through the Research programme Comparative genomics and genome biodiversity [grant number P4-0220]. GAC is supported as a Fellow at The University of Texas M. D. Anderson Research Trust, as a Fellow of The University of Texas System Regents Research Scholar, and by the CLL Global Research Foundation. Work in Dr. Calin's laboratory is supported in part by National Institutes of Health, by Department of Defense, by Developmental Research Awards in Breast Cancer, Ovarian Cancer and Leukemia SPOREs, and by 2009 Seena Magowitz - Pancreatic Cancer Action Network - AACR Pilot Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderton JA, 2008, NEURO-ONCOLOGY, V10, P981, DOI 10.1215/15228517-2008-048; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bandyopadhyay S, 2012, MOL CELL BIOL, V32, P1202, DOI 10.1128/MCB.05977-11; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Beezhold K, 2011, TOXICOL SCI, V123, P411, DOI 10.1093/toxsci/kfr188; Bennett LB, 2009, GENE CHROMOSOME CANC, V48, P828, DOI 10.1002/gcc.20687; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Careccia S, 2009, ONCOGENE, V28, P4034, DOI 10.1038/onc.2009.255; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Dejeux E, 2009, ENDOCR-RELAT CANCER, V16, P939, DOI 10.1677/ERC-08-0331; Donzelli S, 2011, CELL DEATH DIFFER; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fellig Y, 2005, J CLIN PATHOL, V58, P1064, DOI 10.1136/jcp.2004.023648; Ferdin J, 2010, TECHNOL CANCER RES T, V9, P123, DOI 10.1177/153303461000900202; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Georges M, 2007, CURR OPIN GENET DEV, V17, P166, DOI 10.1016/j.gde.2007.04.005; Golan D, 2010, BIOINFORMATICS, V26, P992, DOI 10.1093/bioinformatics/btq077; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He C., 2012, NUCL ACIDS RES; He YH, 2011, NEOPLASIA, V13, P841, DOI 10.1593/neo.11698; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hibi K, 1996, CANCER RES, V56, P480; Hicks JA, 2010, PHYSIOL GENOMICS, V41, P185, DOI 10.1152/physiolgenomics.00156.2009; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Huang Y, 2011, CELL DEATH DIFFER, V18, P1220, DOI 10.1038/cdd.2010.188; Hwang SH, 2011, CLIN CHEM LAB MED, V49, P699, DOI 10.1515/CCLM.2011.108; Issa J-P, 2009, DNA METHYLATION EPIG; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kozaki K, 2012, CANCER SCI, V103, P837, DOI 10.1111/j.1349-7006.2012.02236.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kron KJ, 2010, LAB INVEST, V90, P1060, DOI 10.1038/labinvest.2010.57; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kunej T, 2012, CANCER J, V18, P223, DOI 10.1097/PPO.0b013e318258b771; Kunej T, 2011, MUTAT RES-FUND MOL M, V717, P77, DOI 10.1016/j.mrfmmm.2011.03.008; Kunej T, 2010, INT J BIOL SCI, V6, P769; Lages E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020600; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Matkovich SJ, 2012, CIRC RES, V111, P521, DOI 10.1161/CIRCRESAHA.112.265736; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Polster BJ, 2010, MOL GENET METAB, V101, P292, DOI 10.1016/j.ymgme.2010.07.016; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rearick D, 2011, NUCLEIC ACIDS RES, V39, P2357, DOI 10.1093/nar/gkq1080; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Sand M, 2011, MOL CARCINOG; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shen J, 2012, EPIGENETICS, V7; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Sikand K, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-21; Sun GH, 2009, RNA, V15, P1640, DOI 10.1261/rna.1560209; Tao J, 2012, MOL MED REP, V5, P167, DOI 10.3892/mmr.2011.591; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Tsuruta T, 2011, CANCER RES, V71, P6450, DOI 10.1158/0008-5472.CAN-11-0364; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013798; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Watanabe K, 2012, INT J CANCER, V130, P2580, DOI 10.1002/ijc.26254; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yan M, 2011, PATHOL ONCOL RES; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Ying SY, 2005, BIOCHEM BIOPH RES CO, V326, P515, DOI 10.1016/j.bbrc.2004.10.215; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang YF, 2009, SCI CHINA SER C, V52, P261, DOI 10.1007/s11427-009-0032-5; Zheng Cui-Ling, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P674; Zhou B, 2010, CLIN CHIM ACTA, V411, P1287, DOI 10.1016/j.cca.2010.05.010; Zorc M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030737	98	57	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65165	10.1371/journal.pone.0065165	http://dx.doi.org/10.1371/journal.pone.0065165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762306	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000038
J	Shipton, C; Clarkson, C; Bernal, MA; Boivin, N; Finlayson, C; Finlayson, G; Fa, D; Pacheco, FG; Petraglia, M				Shipton, Ceri; Clarkson, Christopher; Antonio Bernal, Marco; Boivin, Nicole; Finlayson, Clive; Finlayson, Geraldine; Fa, Darren; Giles Pacheco, Francisco; Petraglia, Michael			Variation in Lithic Technological Strategies among the Neanderthals of Gibraltar	PLOS ONE			English	Article							GORHAMS CAVE; MIDDLE; EXPLOITATION; PLEISTOCENE; EVOLUTION; GAME	The evidence for Neanderthal lithic technology is reviewed and summarized for four caves on The Rock of Gibraltar: Vanguard, Beefsteak, Ibex and Gorham's. Some of the observed patterns in technology are statistically tested including raw material selection, platform preparation, and the use of formal and expedient technological schemas. The main parameters of technological variation are examined through detailed analysis of the Gibraltar cores and comparison with samples from the classic Mousterian sites of Le Moustier and Tabun C. The Gibraltar Mousterian, including the youngest assemblage from Layer IV of Gorham's Cave, spans the typical Middle Palaeolithic range of variation from radial Levallois to unidirectional and multi-platform flaking schemas, with characteristic emphasis on the former. A diachronic pattern of change in the Gorham's Cave sequence is documented, with the younger assemblages utilising more localized raw material and less formal flaking procedures. We attribute this change to a reduction in residential mobility as the climate deteriorated during Marine Isotope Stage 3 and the Neanderthal population contracted into a refugium.	[Shipton, Ceri; Clarkson, Christopher] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Antonio Bernal, Marco; Boivin, Nicole; Petraglia, Michael] Univ Oxford, Sch Archaeol, Oxford, England; [Finlayson, Clive] Univ Toronto Scarborough, Dept Social Sci, Toronto, ON, Canada	University of Queensland; University of Oxford; University of Toronto; University Toronto Scarborough	Shipton, C (corresponding author), Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia.	c.shipton@uq.edu.au	Fa, Darren A./F-1863-2015; Petraglia, Michael/ABA-9748-2021; Fa, Darren/Z-4376-2019	Fa, Darren A./0000-0002-5900-9814; Fa, Darren/0000-0002-5900-9814; BOIVIN, NICOLE/0000-0002-7783-4199; Clarkson, Chris/0000-0002-8938-8974; Petraglia, Michael/0000-0003-2522-5727	McDonald Institute for Archaeological Research; H.M. Government of Gibraltar; University of Queensland	McDonald Institute for Archaeological Research; H.M. Government of Gibraltar; University of Queensland(University of Queensland)	The data collection for this study was funded by the McDonald Institute for Archaeological Research. The wider project of which this study is a part, is funded by H.M. Government of Gibraltar who are also funding the publication costs. Shipton is supported by a University of Queensland Post-doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DS, 2006, CURR ANTHROPOL, V47, P89, DOI 10.1086/432455; BAMFORTH DB, 1986, AM ANTIQUITY, V51, P38, DOI 10.2307/280392; Barton Nick, 2000, P211; Barton R.N.E., 2012, NEANDERTHALS CONTEXT, P243; Barton RNE, 1998, CULTURAS PLEISTOCENO, P13; Barton RNE., 2012, NEANDERTHALS CONTEXT, P151; Barton RNE, 2000, GIBRALTAR QUATERNARY; BINFORD LR, 1979, J ANTHROPOL RES, V35, P255, DOI 10.1086/jar.35.3.3629902; Binford LR., 1977, STONE TOOLS CULTURAL, P24; Blain H.-A., 2013, J HUMAN EVOLUTION; Brown K, 2011, INTERD CONTRIB ARCH, P247, DOI 10.1007/978-1-4419-8219-3_10; Busk G., 1864, READER, V4, P109; Caceres I., 2012, P253; Carrion JS, 2008, QUATERNARY SCI REV, V27, P2118, DOI 10.1016/j.quascirev.2008.08.016; Clarkson C, 2006, J ARCHAEOL SCI, V33, P132, DOI 10.1016/j.jas.2005.07.007; Clarkson C, 2012, QUATERN INT, V258, P165, DOI 10.1016/j.quaint.2011.11.007; Colcutt SN, 2012, NEANDERTHALS CONTEXT, P15; Currant A.P., 2012, P141; Currant A.P., 2012, P236; Fernandez-Jalvo Yolanda, 2000, P171; Finlayson C, 2005, TRENDS ECOL EVOL, V20, P457, DOI 10.1016/j.tree.2005.05.019; Finlayson C, 2008, QUATERN INT, V181, P64, DOI 10.1016/j.quaint.2007.11.016; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Finlayson G, 2008, QUATERN INT, V181, P55, DOI 10.1016/j.quaint.2007.01.009; FISH P R, 1981, Journal of Anthropological Research, V37, P374; Gale R., 2000, NEANDERTHALS EDGE, P207; GARROD DAE, 1928, J ROYAL ANTHR I, V58, P91; Geneste J.M., 1989, LHOMME NEANDERTAL, V6, P75; Giles F., 2007, GEOGACETA, V43, P131; Pacheco FG, 2012, QUATERN INT, V247, P151, DOI 10.1016/j.quaint.2011.02.026; Gleed-Owen C., 2012, P224; Gleed-Owen C.P., 2012, P102; Goldberg P., 2012, NEANDERTHALS CONTEXT, P50; Goodyear A.C., 1979, HYPOTHESIS USE CRYPT; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Higham T.F.G., 2012, P62; Jennings R., 2006, THESIS U OXFORD; Jennings R.P., 2012, P281; Jennings R, 2011, J BIOGEOGR, V38, P1873, DOI 10.1111/j.1365-2699.2011.02536.x; Kuhn SL., 1995, MOUSTERIAN LITHIC TE, DOI [10.1515/9781400864034, DOI 10.1515/9781400864034]; LIEBERMAN DE, 1994, AM ANTHROPOL, V96, P300, DOI 10.1525/aa.1994.96.2.02a00030; Macphail R. I., 2012, NEANDERTHALS CONTEXT, P193; Macphail RI., 2000, NEANDERTHALS EDGE, P183; Marks A.E., 1977, PREHISTORY PALEOEN 2, P191; MEIGNEN L, 2005, TRANSITIONS TRANSITI, P149; Mellars Paul A., 1996, NEANDERTHAL LEGACY A; Nelson MC, 1991, ARCHAEOLOGICAL METHO, V3, P57, DOI DOI 10.2307/20170213; Oakley KP, 1964, B I ARCHAEOLOGY, V4, P219; Pacheco FG, 2010, MINERALES ROCAS SOC, P139; Parry WJ., 1987, ORG CORE TECHNOLOGY, P285; Petraglia M, 2007, SCIENCE, V317, P114, DOI 10.1126/science.1141564; Pettitt P.B., 2000, NEANDERTHALS EDGE, P155; Price C., 2012, P128; Rhodes E.J., 2012, MONOGRAPH, V75, P211; Rhodes E. J. C. B., 2000, GIBRALTAR QUATERNARY, P109; Rhodes EJ., 2012, NEANDERTHALS CONTEXT, P77; Rink W.J., 2000, P165; Rodriguez-Vidal J, 2004, QUATERNARY SCI REV, V23, P2017, DOI 10.1016/j.quascirev.2004.02.008; Rodriguez-Vidal J, 2013, GEOMORPHOLOGY, DOI [10.1016/j.geomorph.2013.02.015, DOI 10.1016/J.GE0M0RPH.2013.02.015]; SHOTT MJ, 1989, AM ANTIQUITY, V54, P9, DOI 10.2307/281329; STINER MC, 1992, AM ANTHROPOL, V94, P306, DOI 10.1525/aa.1992.94.2.02a00030; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Stringer Chris, 2000, P133; Tarasov PE, 2000, J BIOGEOGR, V27, P609, DOI 10.1046/j.1365-2699.2000.00429.x; Torrence R, 1989, RETOOLING BEHAV THEO, P52; Volterra V., 2000, P163; Volterra V, 2000, NEANDERTHALS EDGE, P221; Waechter J.D.A., 1964, B INST ARCHAEOL, V4, P189; Wallace IJ, 2006, J ARCHAEOL SCI, V33, P1293, DOI 10.1016/j.jas.2006.01.005; Ward S., 2012, NEANDERTHALS CONTEXT, P89; Zilhao J., 2006, FARMING, V2006, P95	72	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65185	10.1371/journal.pone.0065185	http://dx.doi.org/10.1371/journal.pone.0065185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762312	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000041
J	Swift, SL; Rivera, GC; Dussupt, V; Leadley, RM; Hudson, LC; de Ridder, CMA; Kraaij, R; Burns, JE; Maitland, NJ; Georgopoulos, LJ				Swift, Stephanie L.; Rivera, Guillermo C.; Dussupt, Vincent; Leadley, Regina M.; Hudson, Lucy C.; de Ridder, Corrina M. A.; Kraaij, Robert; Burns, Julie E.; Maitland, Norman J.; Georgopoulos, Lindsay J.			Evaluating Baculovirus as a Vector for Human Prostate Cancer Gene Therapy	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; IN-VITRO; TRICHOPLUSIA-NI; RECOMBINANT BACULOVIRUSES; CELLULAR-DIFFERENTIATION; TRANSGENE EXPRESSION; MAMMALIAN-CELLS; STEM-CELLS; GROWTH; NITROREDUCTASE	Gene therapy represents an attractive strategy for the non-invasive treatment of prostate cancer, where current clinical interventions show limited efficacy. Here, we evaluate the use of the insect virus, baculovirus (BV), as a novel vector for human prostate cancer gene therapy. Since prostate tumours represent a heterogeneous environment, a therapeutic approach that achieves long-term regression must be capable of targeting multiple transformed cell populations. Furthermore, discrimination in the targeting of malignant compared to non-malignant cells would have value in minimising side effects. We employed a number of prostate cancer models to analyse the potential for BV to achieve these goals. In vitro, both traditional prostate cell lines as well as primary epithelial or stromal cells derived from patient prostate biopsies, in two-or three-dimensional cultures, were used. We also evaluated BV in vivo in murine prostate cancer xenograft models. BV was capable of preferentially transducing invasive malignant prostate cancer cell lines compared to early stage cancers and non-malignant samples, a restriction that was not a function of nuclear import. Of more clinical relevance, primary patient-derived prostate cancer cells were also efficiently transduced by BV, with robust rates observed in epithelial cells of basal phenotype, which expressed BV-encoded transgenes faster than epithelial cells of a more differentiated, luminal phenotype. Maximum transduction capacity was observed in stromal cells. BV was able to penetrate through three-dimensional structures, including in vitro spheroids and in vivo orthotopic xenografts. BV vectors containing a nitroreductase transgene in a gene-directed enzyme pro-drug therapy approach were capable of efficiently killing malignant prostate targets following administration of the pro-drug, CB1954. Thus, BV is capable of transducing a large proportion of prostate cell types within a heterogeneous 3-D prostate tumour, can facilitate cell death using a pro-drug approach, and shows promise as a vector for the treatment of prostate cancer.	[Swift, Stephanie L.; Rivera, Guillermo C.; Dussupt, Vincent; Leadley, Regina M.; Hudson, Lucy C.; Burns, Julie E.; Maitland, Norman J.; Georgopoulos, Lindsay J.] Univ York, Dept Biol, Yorkshire Canc Res Unit, York YO10 5DD, N Yorkshire, England; [de Ridder, Corrina M. A.; Kraaij, Robert] Erasmus MC, Dept Urol, Rotterdam, Netherlands	University of York - UK; Erasmus University Rotterdam; Erasmus MC	Maitland, NJ (corresponding author), Univ York, Dept Biol, Yorkshire Canc Res Unit, York YO10 5DD, N Yorkshire, England.	n.j.maitland@york.ac.uk		Burns, Julie/0000-0003-1238-8826; Dussupt, Vincent/0000-0002-8579-6356; Rivera Gonzalez, Guillermo Cipactl/0000-0003-4645-0069; Maitland, Norman/0000-0003-1607-9035	EU; Yorkshire Cancer Research; MRC [G0900871] Funding Source: UKRI; Medical Research Council [G0900871] Funding Source: researchfish	EU(European Commission); Yorkshire Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was carried out under EU-funded collaborative projects: Prostate Initiative for Gene Therapy 'PIG' (FP5), Baculogenes (FP6) and Gene Therapy: An Integrated Approach to Neoplastic Treatment 'GIANT' (FP6), with additional support from Yorkshire Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Airenne KJ, 2010, CURR GENE THER, V10, P187; Batra RK, 1998, AM J RESP CELL MOL, V18, P402, DOI 10.1165/ajrcmb.18.3.2784; BERTHON P, 1995, INT J ONCOL, V6, P333; Blackwood L, 2001, VET J, V161, P269, DOI 10.1053/tvjl.2000.0557; Bridgewater JA, 1997, HUM GENE THER, V8, P709, DOI 10.1089/hum.1997.8.6-709; BURGES HD, 1980, ENTOMOPHAGA, V25, P329, DOI 10.1007/BF02374693; CARSON DD, 1991, J VIROL, V65, P945, DOI 10.1128/JVI.65.2.945-951.1991; Collins AT, 2001, J CELL SCI, V114, P3865; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Cunha GR, 2001, REPROD FERT DEVELOP, V13, P285, DOI 10.1071/RD01010; Datta MW, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-9; DEKLERK DP, 1983, PROSTATE, V4, P73, DOI 10.1002/pros.2990040107; DEKLERK DP, 1984, J UROLOGY, V131, P1008, DOI 10.1016/S0022-5347(17)50750-8; Djeha AH, 2000, CANCER GENE THER, V7, P721, DOI 10.1038/sj.cgt.7700171; Duisit G, 1999, J GENE MED, V1, P93; El-Alfy M, 2000, MICROSC RES TECHNIQ, V51, P436, DOI 10.1002/1097-0029(20001201)51:5<436::AID-JEMT6>3.0.CO;2-T; Gao R, 2002, LIVER, V22, P15, DOI 10.1046/j.0106-9543.2001.01555.x; Georgopoulos LJ, 2009, MOL IMMUNOL, V46, P2911, DOI 10.1016/j.molimm.2009.07.008; Hanna NN, 1997, CANCER RES, V57, P4205; Ho YC, 2006, GENE THER, V13, P1471, DOI 10.1038/sj.gt.3302796; Hofmann C, 1998, GENE THER, V5, P531, DOI 10.1038/sj.gt.3300607; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Huang W, 2008, WORLD J GASTROENTERO, V14, P5810, DOI 10.3748/wjg.14.5810; Huser A, 2001, NAT BIOTECHNOL, V19, P451, DOI 10.1038/88122; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kaikkonen MU, 2010, MOL THER, V18, P987, DOI 10.1038/mt.2010.25; Kaname Y, 2010, J VIROL, V84, P3210, DOI 10.1128/JVI.02519-09; Kinnunen K, 2009, J GENE MED, V11, P382, DOI 10.1002/jgm.1311; KNUDSON DL, 1974, J VIROL, V14, P934, DOI 10.1128/JVI.14.4.934-944.1974; Kraaij R, 2002, LAB ANIM-UK, V36, P165, DOI 10.1258/0023677021912451; Lang SH, 2000, BRIT J CANCER, V82, P990, DOI 10.1054/bjoc.1999.1029; Lehtolainen P, 2002, GENE THER, V9, P1693, DOI 10.1038/sj.gt.3301854; Li Y, 2004, MOL THER, V10, P1121, DOI 10.1016/j.ymthe.2004.08.018; Maitland NJ, 2004, CURR PHARM DESIGN, V10, P531, DOI 10.2174/1381612043453252; Maitland NJ, 2001, RADIAT RES, V155, P133, DOI 10.1667/0033-7587(2001)155[0133:IVMTSC]2.0.CO;2; Maitland N, 2010, HUM GENE THER, V21, P815, DOI 10.1089/hum.2009.210; Marques RB, 2006, EUR UROL, V49, P245, DOI 10.1016/j.eururo.2005.12.035; Olumi AF, 1999, CANCER RES, V59, P5002; Rembrink K, 1997, PROSTATE, V31, P168; RUSSELL DW, 1994, P NATL ACAD SCI USA, V91, P8915, DOI 10.1073/pnas.91.19.8915; Sandig V, 1996, HUM GENE THER, V7, P1937, DOI 10.1089/hum.1996.7.16-1937; Sarkis C, 2000, P NATL ACAD SCI USA, V97, P14638, DOI 10.1073/pnas.260472897; Searle PF, 2004, CLIN EXP PHARMACOL P, V31, P811, DOI 10.1111/j.1440-1681.2004.04085.x; Shariat SF, 2008, BJU INT, V101, P232, DOI 10.1111/j.1464-410X.2007.07181.x; Swift SL, 2010, CANCER RES, V70, P347, DOI 10.1158/0008-5472.CAN-09-1252; Tani H, 2003, J VIROL, V77, P9799, DOI 10.1128/JVI.77.18.9799-9808.2003; van Leenders G, 2000, LAB INVEST, V80, P1251, DOI 10.1038/labinvest.3780133; van Loo ND, 2001, J VIROL, V75, P961, DOI 10.1128/JVI.75.2.961-970.2001; Vicente T, 2009, GENE THER, V16, P766, DOI 10.1038/gt.2009.33; VOLKMAN LE, 1976, J VIROL, V19, P820, DOI 10.1128/JVI.19.3.820-832.1976; VOLKMAN LE, 1983, APPL ENVIRON MICROB, V45, P1085, DOI 10.1128/AEM.45.3.1085-1093.1983; WANG X, 1985, J GEN VIROL, V66, P541, DOI 10.1099/0022-1317-66-3-541; Washburn JO, 2003, J VIROL, V77, P280, DOI 10.1128/JVI.77.1.280-290.2003; Washburn JO, 1999, J VIROL, V73, P411, DOI 10.1128/JVI.73.1.411-416.1999; WHITT MA, 1988, VIROLOGY, V163, P33, DOI 10.1016/0042-6822(88)90231-0; Wilson WR, 2002, CANCER RES, V62, P1425; ZACK JA, 1995, ADV EXP MED BIOL, V374, P27; Zeng JM, 2007, STEM CELLS, V25, P1055, DOI 10.1634/stemcells.2006-0616	60	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65557	10.1371/journal.pone.0065557	http://dx.doi.org/10.1371/journal.pone.0065557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755250	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000078
J	Tsyrlin, VA; Galagudza, MM; Kuzmenko, NV; Pliss, MG; Rubanova, NS; Shcherbin, YI				Tsyrlin, Vitaly A.; Galagudza, Michael M.; Kuzmenko, Nataly V.; Pliss, Michael G.; Rubanova, Nataly S.; Shcherbin, Yury I.			Arterial Baroreceptor Reflex Counteracts Long-Term Blood Pressure Increase in the Rat Model of Renovascular Hypertension	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; CHRONIC RENAL-HYPERTENSION; ANGIOTENSIN-II; BAROREFLEX SENSITIVITY; CONSCIOUS DOGS; SYSTEM; DENERVATION; RECEPTORS; RABBITS; KIDNEY	Introduction: The present study tested the hypothesis that long-term effects of baroreceptor activation might contribute to the prevention of persistent arterial blood pressure (BP) increase in the rat model of renovascular hypertension (HTN). Methods: Repetitive arterial baroreflex (BR) testing was performed in normo- and hypertensive rats. The relationship between initial arterial BR sensitivity and severity of subsequently induced two-kidney one-clip (2K1C) renovascular HTN was studied in Wistar rats. Additionally, the time course of changes in systolic BP (SBP) and cardiac beat-to-beat (RR) interval was studied for 8 weeks after the induction of 2K1C renovascular HTN in the rats with and without sinoaortic denervation (SAD). In a separate experimental series, cervical sympathetic nerve activity (cSNA) was assessed in controls, 2K1C rats, WKY rats, and SHR. Results: The inverse correlation between arterial BR sensitivity and BP was observed in the hypertensive rats during repetitive arterial BR testing. The animals with greater initial arterial BR sensitivity developed lower BP values after renal artery clipping than those with lower initial arterial BR sensitivity. BP elevation during the first 8 weeks of renal artery clipping in 2K1C rats was associated with decreased sensitivity of arterial BR. Although SAD itself resulted only in greater BP variability but not in persistent BP rise, the subsequent renal artery clipping invariably resulted in the development of sustained HTN. The time to onset of HTN was found to be shorter in the rats with SAD than in those with intact baroreceptors. cSNA was significantly greater in the 2K1C rats than in controls. Conclusions: Arterial BR appears to be an important mechanism of long-term regulation of BP, and is believed to be involved in the prevention of BP rise in the rat model of renovascular HTN.	[Tsyrlin, Vitaly A.; Galagudza, Michael M.; Kuzmenko, Nataly V.; Pliss, Michael G.; Rubanova, Nataly S.; Shcherbin, Yury I.] VA Almazov Fed Heart Blood & Endocrinol Ctr, Inst Expt Med, St Petersburg, Russia; [Tsyrlin, Vitaly A.; Kuzmenko, Nataly V.; Pliss, Michael G.; Rubanova, Nataly S.; Shcherbin, Yury I.] IP Pavlov Fed Med Univ, Inst Cardiovasc Dis, St Petersburg, Russia	Almazov National Medical Research Centre; Institute of Experimental Medicine; Pavlov First Saint Petersburg State Medical University	Tsyrlin, VA (corresponding author), VA Almazov Fed Heart Blood & Endocrinol Ctr, Inst Expt Med, St Petersburg, Russia.	tsyrlin@almazovcentre.ru	pliss, mikhail/AAI-8745-2021	Galagudza, Michael/0000-0001-5129-9944				ANGELLJAMES JE, 1973, CIRC RES, V32, P149, DOI 10.1161/01.RES.32.2.149; BARRES C, 1992, AM J PHYSIOL, V263, pR639, DOI 10.1152/ajpregu.1992.263.3.R639; Barrett CJ, 2003, CIRC RES, V92, P1330, DOI 10.1161/01.RES.0000078346.60663.A0; BROWN AM, 1980, CIRC RES, V46, P1, DOI 10.1161/01.RES.46.1.1; Cooper VL, 2007, CLIN AUTON RES, V17, P26, DOI 10.1007/s10286-006-0390-z; COWLEY AW, 1973, CIRC RES, V32, P564, DOI 10.1161/01.RES.32.5.564; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; Franchini K.G., 1994, AM J PHYSIOL PT 2, V266, pH1056 ; Grassi G, 2012, CAN J CARDIOL, V28, P311, DOI 10.1016/j.cjca.2011.11.005; Guild SJ, 2010, EXP PHYSIOL, V95, P41, DOI 10.1113/expphysiol.2008.046300; GUYTON AC, 1972, ANN BIOMED ENG, V1, P254, DOI 10.1007/BF02584211; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hall JE, 1996, KIDNEY INT S, V55, pS35; HEYMANS C., 1960, PERSPECTIVES IN BIOL AND MED, V3, P409; Heymans C., 1958, REFLEXOGENIC AREAS C; HOSSMANN V, 1980, CARDIOVASC RES, V14, P125, DOI 10.1093/cvr/14.3.125; Lohmeier TE, 2001, AM J HYPERTENS, V14, p147S, DOI 10.1016/S0895-7061(01)02082-9; LUNDGREN Y, 1974, ACTA PHYSIOL SCAND, V91, P103, DOI 10.1111/j.1748-1716.1974.tb05662.x; Malpas SC, 2004, AM J PHYSIOL-REG I, V286, pR1, DOI 10.1152/ajpregu.00496.2003; MCCUBBIN JW, 1956, CIRC RES, V4, P205, DOI 10.1161/01.RES.4.2.205; McMullan S, 2007, J PHYSIOL-LONDON, V582, P711, DOI 10.1113/jphysiol.2007.128983; OPARIL S, 1987, CAN J PHYSIOL PHARM, V65, P1548, DOI 10.1139/y87-244; OPARIL S, 1986, KIDNEY INT, V30, P437, DOI 10.1038/ki.1986.204; OSBORN JW, 1990, AM J PHYSIOL, V259, pR1172, DOI 10.1152/ajpregu.1990.259.6.R1172; Osborn JW, 2005, CLIN EXP PHARMACOL P, V32, P384, DOI 10.1111/j.1440-1681.2005.04200.x; Osborn JW, 2005, AM J PHYSIOL-REG I, V288, pR846, DOI 10.1152/ajpregu.00474.2004; PERSSON P, 1987, ACTA PHYSIOL SCAND, V130, P553, DOI 10.1111/j.1748-1716.1987.tb08176.x; PERSSON P, 1988, PFLUG ARCH EUR J PHY, V411, P160, DOI 10.1007/BF00582309; PLISS M G, 1983, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V69, P1510; SCHREIHOFER AM, 1992, AM J PHYSIOL, V263, pR258, DOI 10.1152/ajpregu.1992.263.2.R258; SLEIGHT P, 1977, CIRC RES, V41, P750, DOI 10.1161/01.RES.41.6.750; Sleight P, 1991, HYPERTENSION S3, V18, P31; SMYTH HS, 1969, CIRC RES, V24, P109, DOI 10.1161/01.RES.24.1.109; TAKESHITA A, 1980, CARDIOVASC RES, V14, P303, DOI 10.1093/cvr/14.5.303; TRIMARCO B, 1981, CARDIOVASC RES, V15, P436, DOI 10.1093/cvr/15.8.436; TSYRLIN VA, 1980, EUR J PHARMACOL, V67, P75, DOI 10.1016/0014-2999(80)90010-2; WEINSTOCK M, 1993, AM J PHYSIOL, V264, pH505, DOI 10.1152/ajpheart.1993.264.2.H505; Weinstock M, 1996, CLIN SCI, V90, P287, DOI 10.1042/cs0900287; WYSS JM, 1984, BRAIN RES, V298, P130, DOI 10.1016/0006-8993(84)91154-5; Yoshimoto M, 2010, HYPERTENSION, V55, P644, DOI 10.1161/HYPERTENSIONAHA.109.145110	40	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64788	10.1371/journal.pone.0064788	http://dx.doi.org/10.1371/journal.pone.0064788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762254	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000021
J	Kannan, R; Santhoshkumar, P; Mooney, BP; Sharma, KK				Kannan, Rama; Santhoshkumar, Puttur; Mooney, Brian P.; Sharma, K. Krishna			Identification of Subunit-Subunit Interaction Sites in alpha A-WT Crystallin and Mutant alpha A-G98R Crystallin Using Isotope-Labeled Cross-Linker and Mass Spectrometry	PLOS ONE			English	Article							CHAPERONE ACTIVITY; CONGENITAL CATARACT; STRUCTURAL-ANALYSIS; PROTEIN STRUCTURES; LENS CRYSTALLINS; DOMAIN DIMERS; EYE LENS; LINKING; MUTATION; CRYAA	Cataract is characterized by progressive protein aggregation and loss of vision. alpha-Crystallins are the major proteins in the lens responsible for maintaining transparency. They exist in the lens as highly polydisperse oligomers with variable numbers of subunits, and mutations in alpha-crystallin are associated with some forms of cataract in humans. Because the stability of proteins is dependent on optimal subunit interactions, the structural transformations and aggregation of mutant proteins that underlie cataract formation can be understood best by identifying the residue-specific inter-and intra-subunit interactions. Chemical crosslinking combined with mass spectrometry is increasingly used to provide structural insights into intra-and inter-protein interactions. We used isotope-labeled cross-linker in combination with LC-MS/MS to determine the subunit-subunit interaction sites in cataract-causing mutant alpha A-G98R crystallin. Peptides cross-linked by isotope-labeled (heavy and light forms) cross-linkers appear as doublets in mass spectra, thus facilitating the identification of cross-linker-containing peptides. In this study, we cross-linked wild-type (alpha A-WT) and mutant (alpha A-G98R) crystallins using the homobifunctional amine-reactive, isotope-labeled (d(0) and d(4)) cross-linker-BS(2)G (bis[sulfosuccinimidyl]glutarate). Tryptic in-solution digest of cross-linked complexes generates a wide array of peptide mixtures. Cross-linked peptides were enriched using strong cation exchange (SCX) chromatography followed by both MS and MS/MS to identify the cross-linked sites. We identified a distinct intermolecular interaction site between K88 - K99 in the beta 5 strand of the mutant alpha A-G98R crystallin that is not found in wild-type alpha A-crystallin. This interaction could explain the conformational instability and aggregation nature of the mutant protein that results from incorrect folding and assembly.	[Kannan, Rama; Mooney, Brian P.; Sharma, K. Krishna] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Santhoshkumar, Puttur; Sharma, K. Krishna] Univ Missouri, Dept Ophthalmol, Columbia, MO USA; [Mooney, Brian P.] Univ Missouri, Charles W Gehrke Prote Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sharma, KK (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	Sharmak@health.missouri.edu	Santhoshkumar, Puttur/G-1798-2010	Santhoshkumar, Puttur/0000-0002-6897-7278; Kannan, Rama/0000-0002-1631-830X	National Institutes of Health [EY019878]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY019878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY019878 (http://www.nih.gov/) and an unrestricted grant-in-aid from Research to Prevent Blindness to the Department of Ophthalmology (http://www.rpbusa.org/rpb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Baranova EV, 2011, J MOL BIOL, V411, P110, DOI 10.1016/j.jmb.2011.05.024; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Chu FX, 2006, PROTEIN SCI, V15, P1260, DOI 10.1110/ps.052065106; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Clark AR, 2012, INT J BIOCHEM CELL B, V44, P1687, DOI 10.1016/j.biocel.2012.02.015; Du JL, 2010, BIOCHEMISTRY-US, V49, P8276, DOI 10.1021/bi101280t; Fritzsche R, 2012, RAPID COMMUN MASS SP, V26, P653, DOI 10.1002/rcm.6150; Graw J, 2006, GRAEF ARCH CLIN EXP, V244, P912, DOI 10.1007/s00417-005-0234-x; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2009, EXP EYE RES, V88, P190, DOI 10.1016/j.exer.2008.07.007; Ihling C, 2006, J AM SOC MASS SPECTR, V17, P1100, DOI 10.1016/j.jasms.2006.04.020; Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kang S, 2006, J PROTEOME RES, V5, P370, DOI 10.1021/pr050356f; Kore R, 2012, MOL CELL BIOCHEM, V362, P93, DOI 10.1007/s11010-011-1131-8; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lambert W, 2013, CELL STRESS CHAPERON, V18, P75, DOI 10.1007/s12192-012-0360-4; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Mornon JP, 1998, INT J BIOL MACROMOL, V22, P219, DOI 10.1016/S0141-8130(98)00019-1; Muller DR, 2001, ANAL CHEM, V73, P1927, DOI 10.1021/ac001379a; Murugesan R, 2007, MOL VIS, V13, P2301; Peterson JJ, 2004, MOL VIS, V10, P857; Raju M, 2011, MOL VIS, V17, P7; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/NMETH.1192, 10.1038/nmeth.1192]; Santhiya S, 2006, MOL VIS, V12, P768; Singh D, 2007, J MOL BIOL, V373, P1293, DOI 10.1016/j.jmb.2007.08.062; Singh D, 2006, MOL VIS, V12, P1372; Sinz A, 2007, ANGEW CHEM INT EDIT, V46, P660, DOI 10.1002/anie.200602549; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Swaim CL, 2004, PROTEIN SCI, V13, P2832, DOI 10.1110/ps.04910004; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; WANG KY, 1994, J BIOL CHEM, V269, P13601; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097; Zhao A, 2013, J PHARMACEUT BIOMED, V73, P99, DOI 10.1016/j.jpba.2012.05.006	42	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65610	10.1371/journal.pone.0065610	http://dx.doi.org/10.1371/journal.pone.0065610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755258	Green Published, Green Submitted, gold			2022-12-25	WOS:000320579400071
J	Simon, UK; Polanschutz, LM; Koffler, BE; Zechmann, B				Simon, Uwe K.; Polanschuetz, Lisa M.; Koffler, Barbara E.; Zechmann, Bernd			High Resolution Imaging of Temporal and Spatial Changes of Subcellular Ascorbate, Glutathione and H2O2 Distribution during Botrytis cinerea Infection in Arabidopsis	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; FUNGAL PATHOGENS; LEAVES; CHLOROPLASTS; PLASTOGLOBULES; ACCUMULATION; MITOCHONDRIA; PLASTIDS; SPINACH; DEFENSE	In order to study the mechanisms behind the infection process of the necrotrophic fungus Botrytis cinerea, the subcellular distribution of hydrogen peroxide (H2O2) was monitored over a time frame of 96 h post inoculation (hpi) in Arabidopsis thaliana Col-0 leaves at the inoculation site (IS) and the area around the IS which was defined as area adjacent to the inoculation site (AIS). H2O2 accumulation was correlated with changes in the compartment-specific distribution of ascorbate and glutathione and chloroplast fine structure. This study revealed that the severe breakdown of the antioxidative system, indicated by a drop in ascorbate and glutathione contents at the IS at later stages of infection correlated with an accumulation of H2O2 in chloroplasts, mitochondria, cell walls, nuclei and the cytosol which resulted in the development of chlorosis and cell death, eventually visible as tissue necrosis. A steady increase of glutathione contents in most cell compartments within infected tissues (up to 600% in chloroplasts at 96 hpi) correlated with an accumulation of H2O2 in chloroplasts, mitochondria and cell walls at the AIS indicating that high glutathione levels could not prevent the accumulation of reactive oxygen species (ROS) which resulted in chlorosis. Summing up, this study reveals the intracellular sequence of events during Botrytis cinerea infection and shows that the breakdown of the antioxidative system correlated with the accumulation of H2O2 in the host cells. This resulted in the degeneration of the leaf indicated by severe changes in the number and ultrastructure of chloroplasts (e.g. decrease of chloroplast number, decrease of starch and thylakoid contents, increase of plastoglobuli size), chlorosis and necrosis of the leaves.	[Simon, Uwe K.; Polanschuetz, Lisa M.; Koffler, Barbara E.; Zechmann, Bernd] Graz Univ, Inst Plant Sci, Graz, Austria	University of Graz	Zechmann, B (corresponding author), Graz Univ, Inst Plant Sci, Graz, Austria.	bernd.zechmann@uni-graz.at	Simon, Uwe K./D-4555-2015	Simon, Uwe K./0000-0003-4164-8287; Zechmann, Bernd/0000-0002-7702-2588	Austrian Science Fund [FWF P22988-B16]; Austrian Science Fund (FWF) [P 22988] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF P22988-B16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergh B, 2007, PLANT PHYSIOL, V144, P1863, DOI 10.1104/pp.107.099226; Austin JR, 2006, PLANT CELL, V18, P1693, DOI 10.1105/tpc.105.039859; Blokhina OB, 2001, J EXP BOT, V52, P1179, DOI 10.1093/jexbot/52.359.1179; Cheeseman J.M., 2007, PLANT STRESS, V1, P4, DOI DOI 10.1371/J0URNAL.P0NE.0023776; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Deller S, 2011, J PLANT PHYSIOL, V168, P63, DOI 10.1016/j.jplph.2010.05.024; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gabara B, 2012, ENVIRON EXP BOT, V77, P33, DOI 10.1016/j.envexpbot.2011.10.010; Ghosh S, 2001, PLANT PHYSIOL BIOCH, V39, P777, DOI 10.1016/S0981-9428(01)01296-7; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Grosskinsky DK, 2012, PHYTOPATHOLOGY, V102, P662, DOI 10.1094/PHYTO-02-12-0022-R; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hernandez JA, 2004, PHYSIOL PLANTARUM, V122, P486, DOI 10.1111/j.1399-3054.2004.00431.x; Kulye MS, 2012, J INTEGR AGR, V11, P1305; Kuzniak E, 2005, PLANTA, V222, P192, DOI 10.1007/s00425-005-1514-8; Kuzniak E, 2005, J EXP BOT, V56, P921, DOI 10.1093/jxb/eri086; Kuzniak E, 2001, PLANT SCI, V160, P723, DOI 10.1016/S0168-9452(00)00457-X; Kuzniak E, 1999, PLANT SCI, V148, P69, DOI 10.1016/S0168-9452(99)00121-1; Lichtenthaler HK, 2007, PHOTOSYNTH RES, V92, P163, DOI 10.1007/s11120-007-9204-y; LICHTENTHALER HK, 1969, PROTOPLASMA, V68, P315, DOI 10.1007/BF01251616; Muckenschnabel I, 2002, J EXP BOT, V53, P207, DOI 10.1093/jexbot/53.367.207; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Schouten A, 2002, MOL PLANT PATHOL, V3, P227, DOI 10.1046/j.1364-3703.2002.00114.x; Schumacher J, 2012, MORPHOGENESIS PATHOG, V22, P225, DOI DOI 10.1007/978-3-642-22916-9_11; Solymosi K, 2012, AGRON SUSTAIN DEV, V32, P245, DOI 10.1007/s13593-011-0019-z; Tenberge KB, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P67; Tenberge KB, 2002, MICROSC MICROANAL, V8, P250, DOI DOI 10.1091/MBC.E09-06-0501; van Baarlen P, 2007, MOL PLANT PATHOL, V8, P41, DOI 10.1111/j.1364-3703.2006.00367.x; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI 10.1111/J.1364-3703.2007.00417.X; Windram O, 2012, PLANT CELL, V24, P3530, DOI 10.1105/tpc.112.102046; WRISCHER M, 1975, J CELL SCI, V18, P509; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zechmann B, 2008, J EXP BOT, V59, P4017, DOI 10.1093/jxb/ern243; Zechmann B, 2003, ARCH VIROL, V148, P1119, DOI 10.1007/s00705-003-0005-0; Zechmann B, 2011, PLANTA, V233, P1, DOI 10.1007/s00425-010-1275-x; Zechmann B, 2010, PROTOPLASMA, V246, P15, DOI 10.1007/s00709-010-0111-2; Zellnig G, 2004, PROTOPLASMA, V223, P221, DOI 10.1007/s00709-003-0034-2; Zellnig G, 2010, PROTOPLASMA, V243, P129, DOI 10.1007/s00709-009-0058-3	42	34	35	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65811	10.1371/journal.pone.0065811	http://dx.doi.org/10.1371/journal.pone.0065811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755284	Green Submitted, gold, Green Published			2022-12-25	WOS:000320579400079
J	Stoilova, B; Kowenz-Leutz, E; Scheller, M; Leutz, A				Stoilova, Bilyana; Kowenz-Leutz, Elisabeth; Scheller, Marina; Leutz, Achim			Lymphoid to Myeloid Cell Trans-Differentiation Is Determined by C/EBP beta Structure and Post-Translational Modifications	PLOS ONE			English	Article							BINDING PROTEIN-BETA; NF-M; DNA-BINDING; B-CELLS; MACROPHAGES; TRANSCRIPTION; LINEAGE; COMPLEX; GENES; TRANSDIFFERENTIATION	The transcription factor C/EBP beta controls differentiation, proliferation, and functionality of many cell types, including innate immune cells. A detailed molecular understanding of how C/EBP beta directs alternative cell fates remains largely elusive. A multitude of signal-dependent post-translational modifications (PTMs) differentially affect the protean C/EBP beta functions. In this study we apply an assay that converts primary mouse B lymphoid progenitors into myeloid cells in order to answer the question how C/EBP beta regulates (trans-)differentiation and determines myeloid cell fate. We found that structural alterations and various C/EBP beta PTMs determine the outcome of trans-differentiation of lymphoid into myeloid cells, including different types of monocytes/macrophages, dendritic cells, and granulocytes. The ability of C/EBP beta to recruit chromatin remodeling complexes is required for the granulocytic trans-differentiation outcome. These novel findings reveal that PTMs and structural plasticity of C/EBP beta are adaptable modular properties that integrate and rewire epigenetic functions to direct differentiation to diverse innate immune system cells, which are crucial for the organism survival.	[Stoilova, Bilyana; Kowenz-Leutz, Elisabeth; Scheller, Marina; Leutz, Achim] Max Delbruck Ctr Mol Med, Berlin, Germany; [Stoilova, Bilyana; Scheller, Marina; Leutz, Achim] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Leutz, Achim] Humboldt Univ, D-10099 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Leutz, A (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	aleutz@mdc-berlin.de	Leutz, Achim/K-9643-2013	Leutz, Achim/0000-0001-8259-927X; Stoilova, Bilyana/0000-0001-6192-9145; Scheller, Marina/0000-0001-6108-0831				Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Calkhoven CF, 2000, GENE DEV, V14, P1920; COLLINS LS, 1987, J IMMUNOL, V138, P1082; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Feldman AL, 2008, BLOOD, V111, P5433, DOI 10.1182/blood-2007-11-124792; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fortina P, 2008, NAT BIOTECHNOL, V26, P293, DOI 10.1038/nbt0308-293; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Graf T, 2011, CELL STEM CELL, V9, P504, DOI 10.1016/j.stem.2011.11.012; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hirai H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054862; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jundt F, 2005, BLOOD, V106, P1801, DOI 10.1182/blood-2004-11-4513; Katoh S, 1990, Dev Immunol, V1, P113, DOI 10.1155/1990/28760; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Krysinska H, 2007, MOL CELL BIOL, V27, P878, DOI 10.1128/MCB.01915-06; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lee S, 2010, J BIOL CHEM, V285, P21399, DOI 10.1074/jbc.M110.128413; Lee S, 2010, MOL CELL BIOL, V30, P2621, DOI 10.1128/MCB.00782-09; Leutz A, 2011, TRANSCR-AUSTIN, V2, P3, DOI 10.4161/trns.2.1.13510; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Muller C, 1995, EMBO J, V14, P6127, DOI 10.1002/j.1460-2075.1995.tb00303.x; MUROI K, 1995, INTERNAL MED, V34, P36, DOI 10.2169/internalmedicine.34.36; NERLOV C, 1995, EMBO J, V14, P4318, DOI 10.1002/j.1460-2075.1995.tb00106.x; Nerlov C, 1998, GENE DEV, V12, P2413, DOI 10.1101/gad.12.15.2413; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; Piva R, 2006, J CLIN INVEST, V116, P3171, DOI 10.1172/JCI29401; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Steinberg XP, 2012, BIOCHEMISTRY-US, V51, P952, DOI 10.1021/bi201593q; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Takahashi K, 1998, AM J PATHOL, V152, P445; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Vradii D, 2006, J CELL PHYSIOL, V206, P112, DOI 10.1002/jcp.20432; Wada T, 2009, J BIOL CHEM, V284, P30673, DOI 10.1074/jbc.M109.042242; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033	50	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65169	10.1371/journal.pone.0065169	http://dx.doi.org/10.1371/journal.pone.0065169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755188	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000320579400043
J	Cui, LL; Murikinati, SR; Wang, DL; Zhang, XJ; Duan, WM; Zhao, LR				Cui, Lili; Murikinati, Sasidhar R.; Wang, Dongliang; Zhang, Xiangjian; Duan, Wei-Ming; Zhao, Li-Ru			Reestablishing Neuronal Networks in the Aged Brain by Stem Cell Factor and Granulocyte-Colony Stimulating Factor in a Mouse Model of Chronic Stroke	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; LONG-TERM POTENTIATION; IN-VIVO; MATURE RAT; PERIINFARCT CORTEX; CA1 DENDRITES; PLASTICITY; MICE; DISEASE; SYNAPSE	Stroke has a high incidence in the elderly. Stroke enters the chronic phase 3 months after initial stroke onset. Currently, there is no pharmaceutical treatment available for chronic stroke. We have demonstrated the therapeutic effects of the combination of stem cell factor (SCF) and granulocyte-colony stimulating factor (G-CSF) (SCF+G-CSF) on chronic stroke. However, it remains unclear how SCF+G-CSF repairs the brain in chronic stroke. In this study, we determined the effects of SCF+G-CSF on neuronal network remodeling in the aged brain of chronic stroke. Cortical brain ischemia was produced in 16-18 month-old transgenic mice expressing yellow fluorescent protein in layer V pyramidal neurons. SCF+G-CSF was subcutaneously injected for 7 days beginning at 3.5 months post-ischemia. Using both live brain imaging and immunohistochemistry, we observed that SCF+G-CSF increased the mushroom-type spines on the apical dendrites of layer V pyramidal neurons adjacent to the infarct cavities 2 and 6 weeks after treatment. SCF+G-CSF also augmented dendritic branches and post-synaptic density protein 95 puncta in the peri-infarct cortex 6 weeks after treatment. These data suggest that SCF+G-CSF treatment in chronic stroke remodels neural circuits in the aged brain. This study provides evidence to support the development of a new therapeutic strategy for chronic stroke.	[Cui, Lili; Zhao, Li-Ru] SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA; [Murikinati, Sasidhar R.; Zhao, Li-Ru] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA; [Duan, Wei-Ming; Zhao, Li-Ru] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA; [Wang, Dongliang] SUNY Upstate Med Univ, Dept Publ Hlth & Prevent Med, Syracuse, NY 13210 USA; [Cui, Lili; Zhang, Xiangjian] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei, Peoples R China; [Duan, Wei-Ming] Capital Med Univ, Dept Anat, Beijing, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Hebei Medical University; Capital Medical University	Zhao, LR (corresponding author), SUNY Upstate Med Univ, Dept Neurosurg, Syracuse, NY 13210 USA.	ZHAOL@upstate.edu	Wang, Dongliang/A-1395-2014	Wang, Dongliang/0000-0003-4713-3516; Zhang, Xiangjian/0000-0003-0114-1668	National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS) in the USA [R01 NS060911]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060911] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS) in the USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke (NINDS) in the USA, R01 NS060911 to L.R.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2007, HIPPOCAMPUS, V17, P1, DOI 10.1002/hipo.20238; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Brown CE, 2010, J CEREBR BLOOD F MET, V30, P783, DOI 10.1038/jcbfm.2009.241; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Greenbaum AM, 2011, LEUKEMIA, V25, P211, DOI 10.1038/leu.2010.248; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARA H, 1993, BRAIN RES, V618, P251, DOI 10.1016/0006-8993(93)91273-U; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HIRATA T, 1993, DEVELOPMENT, V119, P49; Katafuchi T, 2000, LEARN MEMORY, V7, P383, DOI 10.1101/lm.33900; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MCNIECE IK, 1995, J LEUKOCYTE BIOL, V58, P14, DOI 10.1002/jlb.58.1.14; Mostany R, 2011, J NEUROSCI, V31, P1734, DOI 10.1523/JNEUROSCI.4386-10.2011; Mostany R, 2010, J NEUROSCI, V30, P14116, DOI 10.1523/JNEUROSCI.3908-10.2010; Motro B, 1996, P NATL ACAD SCI USA, V93, P1808, DOI 10.1073/pnas.93.5.1808; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Noguchi J, 2011, J PHYSIOL-LONDON, V589, P2447, DOI 10.1113/jphysiol.2011.207100; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Parsons MW, 2000, NEUROLOGY, V55, P498, DOI 10.1212/WNL.55.4.498; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Sigler A, 2010, STROKE, V41, pS117, DOI 10.1161/STROKEAHA.110.594648; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Tackenberg C, 2009, J NEUROSCI, V29, P14439, DOI 10.1523/JNEUROSCI.3590-09.2009; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Xu WF, 2011, CURR OPIN NEUROBIOL, V21, P306, DOI 10.1016/j.conb.2011.03.001; Zhao LR, 2007, STROKE, V38, P2804, DOI 10.1161/STROKEAHA.107.486217; Zhao LR, 2007, EXP NEUROL, V204, P569, DOI 10.1016/j.expneurol.2006.12.001	40	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64684	10.1371/journal.pone.0064684	http://dx.doi.org/10.1371/journal.pone.0064684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750212	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900014
J	Li, P; Grgurevic, S; Liu, ZM; Harris, D; Rozovski, U; Calin, GA; Keating, MJ; Estrov, Z				Li, Ping; Grgurevic, Srdana; Liu, Zhiming; Harris, David; Rozovski, Uri; Calin, George A.; Keating, Michael J.; Estrov, Zeev			Signal Transducer and Activator of Transcription-3 Induces MicroRNA-155 Expression in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							B-CELL LYMPHOMAS; STAT3; MIR-155; RESISTANCE; RESIDUES; SURVIVAL; REVEALS; PATHWAY; HODGKIN; CANCER	MicroRNA (miR) abnormalities play a key role in the pathogenesis of chronic lymphocytic leukemia (CLL). High levels of miR-155 have been detected in human neoplasms, and overexpression of miR-155 has been found to induce lymphoma in mice. High levels of miR-155 were detected in CLL cells and STAT3, which is known to induce miR-21 and miR-181b-1 expression, is constitutively activated in CLL. Given these findings, we hypothesized that STAT3 induces miR-155. Sequence analysis revealed that the miR-155 promoter harbors two putative STAT3 binding sites. Therefore, truncated miR-155 promoter constructs and STAT3 small interfering RNA (siRNA) were co-transfected into MM1 cells. Of the two putative binding sites, STAT3-siRNA reduced the luciferase activity of the construct containing the 700-709 bp STAT3 binding site, suggesting that this site is involved in STAT3-induced transcription. Electrophoretic mobility shift assay confirmed that STAT3 bound to the miR-155 promoter in CLL cells, and chromatin immunoprecipitation and luciferase assay confirmed that STAT3 bound to the 700-709 bp but not the 615-624 bp putative STAT3 binding site in CLL cells. Finally, STAT3-small hairpin RNA downregulated miR-155 gene expression, suggesting that constitutively activated STAT3 binds to the miR-155 gene promoter. Together, these results suggest that STAT3 activates miR-155 in CLL cells.	[Li, Ping; Grgurevic, Srdana; Liu, Zhiming; Harris, David; Rozovski, Uri; Keating, Michael J.; Estrov, Zeev] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Estrov, Z (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	zestrov@mdanderson.org	Calin, George/E-9390-2011	Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615	CLL Global Research Foundation; National Institutes of Health through MD Anderson's Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	CLL Global Research Foundation; National Institutes of Health through MD Anderson's Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the CLL Global Research Foundation and the National Institutes of Health through MD Anderson's Cancer Center Support Grant CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazargan A, 2012, EXPERT REV ANTICANC, V12, P393, DOI [10.1586/era.12.2, 10.1586/ERA.12.2]; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Calin GA, 2009, BLOOD, V114, P4761, DOI 10.1182/blood-2009-07-192740; Calin GA, 2009, BLOOD, V113, P3652, DOI 10.1182/blood-2008-11-189795; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Frank DA, 1997, J CLIN INVEST, V100, P3140, DOI 10.1172/JCI119869; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Huang X, 2012, AM J PATHOL, V181, P26, DOI 10.1016/j.ajpath.2012.03.013; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kutty RK, 2010, BIOCHEM BIOPH RES CO, V402, P390, DOI 10.1016/j.bbrc.2010.10.042; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Leng RX, 2011, RHEUMATOL INT, V31, P699, DOI 10.1007/s00296-010-1466-6; Li P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011859; Li SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016956; Liu ZM, 2011, MOL CANCER RES, V9, P507, DOI 10.1158/1541-7786.MCR-10-0559; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tam CS, 2010, NAT REV CLIN ONCOL, V7, P521, DOI 10.1038/nrclinonc.2010.101; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Wickremasinghe RG, 2001, BRIT J HAEMATOL, V114, P608, DOI 10.1046/j.1365-2141.2001.02978.x	34	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64678	10.1371/journal.pone.0064678	http://dx.doi.org/10.1371/journal.pone.0064678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750211	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900013
J	Panagopoulos, DJ; Johansson, O; Carlo, GL				Panagopoulos, Dimitris J.; Johansson, Olle; Carlo, George L.			Evaluation of Specific Absorption Rate as a Dosimetric Quantity for Electromagnetic Fields Bioeffects	PLOS ONE			English	Article							DIELECTRIC-PROPERTIES; IN-VITRO; CELL-PROLIFERATION; MICROWAVE EXPOSURE; BIOLOGICAL TISSUES; ELECTRIC-FIELDS; CEREBRAL TISSUE; STRAND BREAKS; BRAIN-TUMORS; RADIATION	Purpose: To evaluate SAR as a dosimetric quantity for EMF bioeffects, and identify ways for increasing the precision in EMF dosimetry and bioactivity assessment. Methods: We discuss the interaction of man-made electromagnetic waves with biological matter and calculate the energy transferred to a single free ion within a cell. We analyze the physics and biology of SAR and evaluate the methods of its estimation. We discuss the experimentally observed non-linearity between electromagnetic exposure and biological effect. Results: We find that: a) The energy absorbed by living matter during exposure to environmentally accounted EMFs is normally well below the thermal level. b) All existing methods for SAR estimation, especially those based upon tissue conductivity and internal electric field, have serious deficiencies. c) The only method to estimate SAR without large error is by measuring temperature increases within biological tissue, which normally are negligible for environmental EMF intensities, and thus cannot be measured. Conclusions: SAR actually refers to thermal effects, while the vast majority of the recorded biological effects from man-made non-ionizing environmental radiation are non-thermal. Even if SAR could be accurately estimated for a whole tissue, organ, or body, the biological/health effect is determined by tiny amounts of energy/power absorbed by specific biomolecules, which cannot be calculated. Moreover, it depends upon field parameters not taken into account in SAR calculation. Thus, SAR should not be used as the primary dosimetric quantity, but used only as a complementary measure, always reporting the estimating method and the corresponding error. Radiation/field intensity along with additional physical parameters (such as frequency, modulation etc) which can be directly and in any case more accurately measured on the surface of biological tissues, should constitute the primary measure for EMF exposures, in spite of similar uncertainty to predict the biological effect due to non-linearity.	[Panagopoulos, Dimitris J.] Univ Athens, Dept Biol, GR-15701 Athens, Greece; [Panagopoulos, Dimitris J.] Radiat & Environm Biophys Res Ctr, Athens, Greece; [Johansson, Olle] Karolinska Inst, Dept Neurosci, Expt Dermatol Unit, Stockholm, Sweden; [Carlo, George L.] Inst Healthful Adaptat, Sci & Publ Policy Inst, Washington, DC USA	National & Kapodistrian University of Athens; Karolinska Institutet	Panagopoulos, DJ (corresponding author), Univ Athens, Dept Biol, GR-15701 Athens, Greece.	dpanagop@biol.uoa.gr			University of Athens, Greece; Swedish Allergy, Cancer and Diabetes Foundation; Karolinska Institute, Stockholm, Sweden	University of Athens, Greece; Swedish Allergy, Cancer and Diabetes Foundation; Karolinska Institute, Stockholm, Sweden(Karolinska Institutet)	This study was supported by the University of Athens, Greece, the Swedish Allergy, Cancer and Diabetes Foundation, and the Karolinska Institute, Stockholm, Sweden. The contribution of Prof. A. R. Liboff with remarks and suggestions on the manuscript is gratefully acknowledged. The Irish Doctors Environmental Association, the Alliance for Irish Radiation Protection, Daryl Vernon, and Brian Stein, are gratefully acknowledged for their general support.	ADAIR RK, 1991, HLTH PHYS, V61; Agarwal A, 2008, FERTIL STERIL, V89, P124, DOI 10.1016/j.fertnstert.2007.01.166; Agarwal A, 2009, FERTIL STERIL, V92, P1318, DOI 10.1016/j.fertnstert.2008.08.022; Ahlbom A, 1998, HEALTH PHYS, V74, P494; Alberts B., 1994, MOL BIOL CELL; AVERBECK D, 2010, MUTAT RES, P7; BAWIN SM, 1975, ANN NY ACAD SCI, V247, P74, DOI 10.1111/j.1749-6632.1975.tb35984.x; BAWIN SM, 1976, P NATL ACAD SCI USA, V73, P1999, DOI 10.1073/pnas.73.6.1999; BAWIN SM, 1978, P NATL ACAD SCI USA, V75, P6314, DOI 10.1073/pnas.75.12.6314; BLACKMAN C F, 1980, Bioelectromagnetics, V1, P35, DOI 10.1002/bem.2250010104; BLACKMAN CF, 1989, BIOELECTROMAGNETICS, V10, P115, DOI 10.1002/bem.2250100202; BOLSHAKOV MA, 1992, BIOELECTROMAGNETICS, V13, P119, DOI 10.1002/bem.2250130206; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; Campisi A, 2010, NEUROSCI LETT, V473, P52, DOI 10.1016/j.neulet.2010.02.018; Carlo G L, 2000, MedGenMed, V2, pE40; CARLO GL, 1998, WIRELESS PHONES HLTH, V13; CARLO GL, 2001, WIRELESS PHONES HLTH, V12; CARPENTER RL, 1971, IEEE T MICROW THEORY, VMT19, P173, DOI 10.1109/TMTT.1968.1127480; Christ A, 2010, PHYS MED BIOL, V55, P1767, DOI 10.1088/0031-9155/55/7/001; Coggle JE., 1983, BIOL EFFECTS RAD, V2; Dawe AS, 2006, BIOELECTROMAGNETICS, V27, P88, DOI 10.1002/bem.20192; De Iuliis GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006446; Dertinger H, 1970, MOL RAD BIOL; Detlavs I, 1996, SCI TOTAL ENVIRON, V180, P35, DOI 10.1016/0048-9697(95)04917-7; Eberhardt JL, 2008, ELECTROMAGN BIOL MED, V27, P215, DOI 10.1080/15368370802344037; Elder JA, 2003, BIOELECTROMAGNETICS, pS162, DOI 10.1002/bem.10163; Fear EC, 1998, PHYS MED BIOL, V43, P1439, DOI 10.1088/0031-9155/43/6/005; Flyckt VMM, 2007, PHYS MED BIOL, V52, P2691, DOI 10.1088/0031-9155/52/10/004; FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25; Franzellitti S, 2010, MUTAT RES-FUND MOL M, V683, P35, DOI 10.1016/j.mrfmmm.2009.10.004; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; GOODMAN EM, 1995, INT REV CYTOL, V158, P279; Haemmerich D, 2005, PHYSIOL MEAS, V26, P59, DOI 10.1088/0967-3334/26/1/006; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hardell L, 2007, OCCUP ENVIRON MED, V64, P626, DOI 10.1136/oem.2006.029751; Hardell Lennart, 2009, Pathophysiology, V16, P113, DOI 10.1016/j.pathophys.2009.01.003; Hinrikus H, 2008, INT J RADIAT BIOL, V84, P69, DOI 10.1080/09553000701691679; Hoyto A, 2008, RADIAT RES, V170, P235, DOI 10.1667/RR1322.1; *IEEE, 2002, C953TM2002R2008 IEEE, P22002; Johansson O, 2006, ELECTROMAGN BIOL MED, V25, P245, DOI 10.1080/15368370601044150; Johansson Olle, 2009, Pathophysiology, V16, P157, DOI 10.1016/j.pathophys.2009.03.004; Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019; KRUGLIKOV IL, 1994, BIOELECTROMAGNETICS, V15, P539, DOI 10.1002/bem.2250150607; Kundrat P, 2012, INT J RADIAT BIOL, V88, P743, DOI 10.3109/09553002.2012.698029; Kwee S, 1998, BIOELECTROCH BIOENER, V44, P251, DOI 10.1016/S0302-4598(97)00095-0; La Vignera S, 2012, J ANDROL, V33, P350, DOI 10.2164/jandrol.111.014373; Lai H, 1996, INT J RADIAT BIOL, V69, P513, DOI 10.1080/095530096145814; LAI H, 1995, BIOELECTROMAGNETICS, V16, P207, DOI 10.1002/bem.2250160309; Lai H, 1997, BIOELECTROMAGNETICS, V18, P446, DOI 10.1002/(SICI)1521-186X(1997)18:6<446::AID-BEM7>3.0.CO;2-2; LEDNEV VV, 1991, BIOELECTROMAGNETICS, V12, P71, DOI 10.1002/bem.2250120202; Lenie S, 2008, MUTAT RES-GEN TOX EN, V651, P71, DOI 10.1016/j.mrgentox.2007.10.017; LEONARD JB, 1984, IEEE T BIO-MED ENG, V31, P533, DOI 10.1109/TBME.1984.325296; Levitt BB, 2010, ENVIRON REV, V18, P369, DOI 10.1139/A10-018; Liboff A.R., 1985, INTERACTIONS ELECTRO; LIBOFF AR, 1988, BIOELECTROMAGNETICS, V9, P39, DOI 10.1002/bem.2250090104; Liboff AR., 2003, BIOL EFFECTS ELECTRO, P76; LINLIU S, 1982, BIOELECTROMAGNETICS, V3, P309, DOI 10.1002/bem.2250030303; MANDL F, 1988, STAT PHYS, P2; Markova E, 2005, ENVIRON HEALTH PERSP, V113, P1172, DOI 10.1289/ehp.7561; Mitchel R. E. J., 2006, Dose-Response, V4, P75, DOI 10.2203/dose-response.04-002.Mitchel; Moulder JE, 1999, RADIAT RES, V151, P513, DOI 10.2307/3580028; Navarro EA, 2003, ELECTROMAGN BIOL MED, V22, P161, DOI 10.1081/JBC-120024625; *NCRP, 1981, 67 NCRP MEAS; Neher E., 1992, SCI AM, V266, P28; OM PG, 2012, ELECTROMAGN BIOL MED, V31, P34; Panagopoulos D. J., 2011, MOBILE PHONES TECHNO; Panagopoulos DJ, 2007, MUTAT RES-GEN TOX EN, V626, P69, DOI 10.1016/j.mrgentox.2006.08.008; Panagopoulos DJ, 2012, CELL BIOCHEM BIOPHYS, V63, P121, DOI 10.1007/s12013-012-9347-0; Panagopoulos DJ, 2010, INT J RADIAT BIOL, V86, P358, DOI 10.3109/09553000903567979; Panagopoulos DJ, 2010, INT J RADIAT BIOL, V86, P345, DOI 10.3109/09553000903567961; Panagopoulos DJ, 2000, BIOCHEM BIOPH RES CO, V272, P634, DOI 10.1006/bbrc.2000.2746; Panagopoulos DJ, 2002, BIOCHEM BIOPH RES CO, V298, P95, DOI 10.1016/S0006-291X(02)02393-8; Panagopoulos DJ., 2003, BIOL EFFECTS ELECTRO, P5; Panagopoulos DJ, 2011, ADV MED BIOL, V17; Panagopoulos DJ., 2018, MOBILE TELEPHONES, P107; Penafiel LM, 1997, BIOELECTROMAGNETICS, V18, P132, DOI 10.1002/(SICI)1521-186X(1997)18:2<132::AID-BEM6>3.0.CO;2-3; Peyman A, 2001, PHYS MED BIOL, V46, P1617, DOI 10.1088/0031-9155/46/6/303; Phillips J L, 2009, Pathophysiology, V16, P79, DOI 10.1016/j.pathophys.2008.11.005; Samoilov M O, 2003, Neurosci Behav Physiol, V33, P1, DOI 10.1023/A:1021119112927; SOMOSY Z, 1991, SCANNING MICROSCOPY, V5, P1145; Spottorno J, 2012, BIOELECTROMAGNETICS, V33, P612, DOI 10.1002/bem.21718; Stam R, 2010, BRAIN RES REV, V65, P80, DOI 10.1016/j.brainresrev.2010.06.001; Stryer L, 1996, BIOCHEMISTRY; Thuroczy G., 1994, Reviews on Environmental Health, V10, P135; Velizarov S, 1999, BIOELECTROCH BIOENER, V48, P177, DOI 10.1016/S0302-4598(98)00238-4; Verschaeve L, 2010, MUTAT RES-REV MUTAT, V705, P252, DOI 10.1016/j.mrrev.2010.10.001; VEYRET B, 1991, BIOELECTROMAGNETICS, V12, P47, DOI 10.1002/bem.2250120107; Wang JQ, 2006, PHYS MED BIOL, V51, P4119, DOI 10.1088/0031-9155/51/17/001	89	45	47	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e62663	10.1371/journal.pone.0062663	http://dx.doi.org/10.1371/journal.pone.0062663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750202	Green Submitted, Green Published, gold			2022-12-25	WOS:000319961900004
J	Sharon, D; Schumann, M; MacLeod, S; McPherson, R; Chaurasiya, S; Shaw, A; Hitt, MM				Sharon, David; Schuemann, Michael; MacLeod, Sheena; McPherson, Robyn; Chaurasiya, Shyambabu; Shaw, Andrew; Hitt, Mary M.			2-Aminopurine Enhances the Oncolytic Activity of an E1b-Deleted Adenovirus in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; TUMOR-SUPPRESSOR P53; IMMEDIATE-EARLY PROMOTER; HERPES-SIMPLEX VIRUS-1; E1B 55-KILODALTON; MRE11 COMPLEX; GAMMA(1)34.5 PROTEIN; DELETED ADENOVIRUS; VIRAL-INFECTION	Adenoviruses with deletions of viral genes have been extensively studied as potential cancer therapeutics. Although a high degree of cancer selectivity has been demonstrated with these conditionally replicating adenoviruses, low levels of virus replication can be detected in normal cells. Furthermore, these mutations were also found to reduce the activity of the replicating viruses in certain cancer cells. Recent studies have shown that co-administration of chemotherapeutic drugs may increase the activity of these viruses without affecting their specificity. We constructed an adenovirus with deletions of both the E1b and the VA-RNA genes and found that replication of this virus was selective for human hepatocellular carcinoma (HCC) cell lines when compared to normal cell lines. Furthermore, we show that 2-aminopurine (2'AP) treatment selectively enhanced virus replication and virus-mediated death of HCC cells. 2'AP did not compensate for the loss of VA-RNA activities, but rather the loss of an E1b-55K activity, such as the DNA damage response, suggesting that co-administration of 2'AP derivatives that block host DNA damage response, may increase the oncolytic activity of Ad Delta E1b Delta VA without reducing its selectivity for HCC cells.	[Sharon, David; MacLeod, Sheena; McPherson, Robyn; Chaurasiya, Shyambabu; Shaw, Andrew; Hitt, Mary M.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Schuemann, Michael] Klinikum Philipps Univ Marburg, Inst Virol, Marburg, Germany	University of Alberta; Philipps University Marburg	Hitt, MM (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB, Canada.	mary.hitt@albertahealthservices.ca	Chaurasiya, Shyambabu/AAM-3822-2020	Chaurasiya, Shyambabu/0000-0002-9543-5458	Canadian Institutes of Health Research [MOP-81203]; Canadian Breast Cancer Foundation/Prairies Chapter [24956]; Queen Elizabeth II Graduate Scholarship through the University of Alberta	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation/Prairies Chapter; Queen Elizabeth II Graduate Scholarship through the University of Alberta	This work was supported by the Canadian Institutes of Health Research (grant #MOP-81203, www.cihr-irsc.gc.ca) and the Canadian Breast Cancer Foundation/Prairies Chapter (grant #24956, www.cbcf.org/prairies). DS was supported by a Queen Elizabeth II Graduate Scholarship through the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 1997, J GEN VIROL, V78, P1653, DOI 10.1099/0022-1317-78-7-1653; Araujo FD, 2005, J VIROL, V79, P11382, DOI 10.1128/JVI.79.17.11382-11391.2005; ARMBRUST KE, 1946, J PHARMACOL EXP THER, V88, P382; BABISS LE, 1984, J VIROL, V50, P202, DOI 10.1128/JVI.50.1.202-212.1984; BARBER GN, 1993, P NATL ACAD SCI USA, V90, P4621, DOI 10.1073/pnas.90.10.4621; BARKER DD, 1987, VIROLOGY, V156, P107, DOI 10.1016/0042-6822(87)90441-7; BETT AJ, 1995, VIRUS RES, V39, P75; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Cascallo M, 2003, CANCER RES, V63, P5544; Cascallo M, 2006, HUM GENE THER, V17, P929, DOI 10.1089/hum.2006.17.929; Celis JE, 2006, CELL BIOL LAB HDB, P435; Cheng GF, 2003, J VIROL, V77, P10154, DOI 10.1128/JVI.77.18.10154-10161.2003; Cheng GF, 2001, VIROLOGY, V290, P115, DOI 10.1006/viro.2001.1148; CHOU J, 1994, P NATL ACAD SCI USA, V91, P5247, DOI 10.1073/pnas.91.12.5247; COGAN JD, 1992, J VIROL, V66, P3833, DOI 10.1128/JVI.66.6.3833-3845.1992; Connell CM, 2011, J CLIN INVEST, V121, P1283, DOI 10.1172/JCI43976; Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Geoerger B, 2002, CANCER RES, V62, P764; Gil J, 2000, APOPTOSIS, V5, P107, DOI 10.1023/A:1009664109241; Gonzalez R, 2006, J VIROL, V80, P964, DOI 10.1128/JVI.80.2.964-974.2006; Goodrum FD, 1999, J VIROL, V73, P7474, DOI 10.1128/JVI.73.9.7474-7488.1999; Goodrum FD, 1998, J VIROL, V72, P9479, DOI 10.1128/JVI.72.12.9479-9490.1998; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRAND RJA, 1994, VIROLOGY, V203, P229, DOI 10.1006/viro.1994.1480; Hartl B, 2008, ONCOGENE, V27, P3673, DOI 10.1038/sj.onc.1211039; Hasegawa T, 2000, BIOCHEM J, V352, P795, DOI 10.1042/0264-6021:3520795; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heise C, 1997, NAT MED, V3, P639, DOI 10.1038/nm0697-639; HU YH, 1993, J INTERFERON RES, V13, P323, DOI 10.1089/jir.1993.13.323; Huang S, 2003, ONCOGENE, V22, P3721, DOI 10.1038/sj.onc.1206490; JIMENEZGARCIA LF, 1993, J CELL SCI, V106, P11; KALVAKOLANU DVR, 1991, J BIOL CHEM, V266, P873; KAUFMAN RJ, 1987, MOL CELL BIOL, V7, P1568, DOI 10.1128/MCB.7.4.1568; Kim J, 2002, CANCER GENE THER, V9, P725, DOI 10.1038/sj.cgt.7700494; Kim J, 2009, GENE THER, V16, P1111, DOI 10.1038/gt.2009.72; KITAJEWSKI J, 1986, CELL, V45, P195, DOI 10.1016/0092-8674(86)90383-1; Lavin MF, 2004, DNA REPAIR, V3, P1515, DOI 10.1016/j.dnarep.2004.07.001; Leitner S, 2009, CLIN CANCER RES, V15, P1730, DOI 10.1158/1078-0432.CCR-08-2008; Li Z, 2004, CANCER RES, V64, P9080, DOI 10.1158/0008-5472.CAN-04-2419; Liu BL, 2003, GENE THER, V10, P292, DOI 10.1038/sj.gt.3301885; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; MARAN A, 1988, VIROLOGY, V164, P106, DOI 10.1016/0042-6822(88)90625-3; Matskevich AA, 2009, J INNATE IMMUN, V1, P389, DOI 10.1159/000191408; McCormick F, 2000, ONCOGENE, V19, P6670, DOI 10.1038/sj.onc.1204096; McCormick F, 2000, SEMIN CANCER BIOL, V10, P453, DOI 10.1006/scbi.2000.0336; METCALF JP, 1994, AM J RESP CELL MOL, V10, P448, DOI 10.1165/ajrcmb.10.4.8136160; Miller DL, 2009, J VIROL, V83, P3591, DOI 10.1128/JVI.02269-08; Mohammadi ES, 2004, NUCLEIC ACIDS RES, V32, P2652, DOI 10.1093/nar/gkh593; MUNDSCHAU LJ, 1992, J BIOL CHEM, V267, P23092; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nakajima T, 1998, J BIOL CHEM, V273, P20036, DOI 10.1074/jbc.273.32.20036; O'Shea CC, 2005, CANCER CELL, V8, P61, DOI 10.1016/j.ccr.2005.06.009; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; OLIVE DM, 1990, ARCH VIROL, V112, P67, DOI 10.1007/BF01348986; OMALLEY RP, 1986, CELL, V44, P391, DOI 10.1016/0092-8674(86)90460-5; RICE AP, 1989, J BIOL CHEM, V264, P20632; Ries SJ, 2000, NAT MED, V6, P1128, DOI 10.1038/80466; Sanchez TA, 2000, AM J RESP CELL MOL, V23, P670, DOI 10.1165/ajrcmb.23.5.3675; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; Schumann M, 2006, CELL CYCLE, V5, P315, DOI 10.4161/cc.5.3.2411; Schwartz RA, 2008, J VIROL, V82, P9043, DOI 10.1128/JVI.00925-08; Shen YQ, 2001, J VIROL, V75, P4297, DOI 10.1128/JVI.75.9.4297-4307.2001; Spurgeon ME, 2009, J VIROL, V83, P9970, DOI 10.1128/JVI.01113-09; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Steegenga WT, 1998, ONCOGENE, V16, P349, DOI 10.1038/sj.onc.1201540; Stracker TH, 2005, J VIROL, V79, P6664, DOI 10.1128/JVI.79.11.6664-6673.2005; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; TIWARI RK, 1988, MOL CELL BIOL, V8, P4289, DOI 10.1128/MCB.8.10.4289; Vollmer CM, 1999, CANCER RES, V59, P4369; Wang YH, 2005, CANCER RES, V65, P1523, DOI 10.1158/0008-5472.CAN-04-3113; WEIDEN MD, 1994, P NATL ACAD SCI USA, V91, P153, DOI 10.1073/pnas.91.1.153; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Yoon AR, 2006, HUM GENE THER, V17, P379, DOI 10.1089/hum.2006.17.379; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; ZHANG Y, 1994, J VIROL, V68, P2544, DOI 10.1128/JVI.68.4.2544-2555.1994; ZHANG Y, 1994, J VIROL, V68, P7040, DOI 10.1128/JVI.68.11.7040-7050.1994; Zheng XY, 2005, CANCER BIOL THER, V4, P1255, DOI 10.4161/cbt.4.11.2137; ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258	81	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65222	10.1371/journal.pone.0065222	http://dx.doi.org/10.1371/journal.pone.0065222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750246	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900048
J	Waithman, J; Zanker, D; Xiao, K; Oveissi, S; Wylie, B; Ng, R; Togel, L; Chen, WS				Waithman, Jason; Zanker, Damien; Xiao, Kun; Oveissi, Sara; Wylie, Ben; Ng, Royce; Toegel, Lars; Chen, Weisan			Resident CD8(+) and Migratory CD103(+) Dendritic Cells Control CD8 T Cell Immunity during Acute Influenza Infection	PLOS ONE			English	Article							MHC CLASS-I; ANTIGEN PRESENTATION; LYMPH-NODE; VIRUS; MOUSE; POPULATION; INDUCTION; SUBSETS; REVEALS; SURFACE	The identification of the specific DC subsets providing a critical role in presenting influenza antigens to naive T cell precursors remains contentious and under considerable debate. Here we show that CD8(+) T lymphocyte (TCD8+) responses are severely hampered in C57BL/6 mice deficient in the transcription factor Batf3 after intranasal challenge with influenza A virus (IAV). This transcription factor is required for the development of lymph node resident CD8(+) and migratory CD103(+) CD11b(-) DCs and we found both of these subtypes could efficiently stimulate anti-IAV TCD8+. Using a similar ex vivo approach, many publications on this subject matter excluded a role for resident, non-migratory CD8(+) DC. We postulate the differences reported can partially be explained by how DC are phenotyped, namely the use of MHC class II to segregate subtypes. Our results show that resident CD8(+) DC upregulate this marker during IAV infection and we advise against its use when isolating DC subtypes.	[Waithman, Jason; Wylie, Ben; Ng, Royce] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Waithman, Jason; Wylie, Ben; Ng, Royce] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Waithman, Jason; Zanker, Damien; Xiao, Kun; Oveissi, Sara; Toegel, Lars; Chen, Weisan] Ludwig Inst Canc Res, Melbourne Austin Branch, Melbourne, Vic 3050, Australia; [Zanker, Damien; Xiao, Kun; Oveissi, Sara; Chen, Weisan] La Trobe Univ, Sch Mol Sci, Melbourne, Vic, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; Ludwig Institute for Cancer Research; La Trobe University	Waithman, J (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	jwaithman@ichr.uwa.edu.au	Chen, Weisan/E-7828-2012; Oveissi, Sara/W-9426-2019; Wylie, Ben/GXM-4602-2022; Wylie, Ben/AAR-6292-2021	Chen, Weisan/0000-0002-5221-9771; Oveissi, Sara/0000-0002-7353-5108; Zanker, Damien/0000-0003-1163-9902; Wylie, Ben/0000-0001-8781-8611; Waithman, Jason/0000-0003-4940-0155	National Health and Medical Research Council Australia: Biomedical Training Fellowship [603100, 567122, 603104]	National Health and Medical Research Council Australia: Biomedical Training Fellowship	This work was partly supported by the National Health and Medical Research Council Australia: Biomedical Training Fellowship (603100) to JW; Senior Research Fellowship to WC (603104); and program grant to WC (567122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Edelson BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025660; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Hashimoto D, 2012, J CLIN INVEST; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Ho AWS, 2011, J IMMUNOL, V187, P6011, DOI 10.4049/jimmunol.1100987; Ingulli E, 2009, J IMMUNOL, V182, P29, DOI 10.4049/jimmunol.182.1.29; Kim TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004204; Langlois RA, 2012, P NATL ACAD SCI USA, V109, P12117, DOI 10.1073/pnas.1206039109; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; NUSSENZWEIG MC, 1981, J EXP MED, V154, P168, DOI 10.1084/jem.154.1.168; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Steinman RM, 2007, NAT MED, V13, P1155, DOI 10.1038/nm1643; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Tussiwand R., 2012, NATURE; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Waithman J, 2012, VIRULENCE, V3, P603, DOI 10.4161/viru.21864; Zanker D, 2012, J IMMUNOL METHODS	27	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66136	10.1371/journal.pone.0066136	http://dx.doi.org/10.1371/journal.pone.0066136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750278	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900080
J	Huang, CJ; Teng, HW; Chien, CC; Lin, JK; Yang, SH				Huang, Chi-Jung; Teng, Hao-Wei; Chien, Chih-Cheng; Lin, Jen-Kou; Yang, Shung-Haur			Prognostic Significance of C-Reactive Protein Polymorphism and KRAS/BRAF in Synchronous Liver Metastasis from Colorectal Cancer	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CLINICOPATHOLOGICAL FEATURES; INFLAMMATORY RESPONSE; RISK; BRAF; TUMORIGENESIS; ACTIVATION; INVASION; CELLS	Background: The liver is the most common target organ in the metastasis of colorectal cancer (CRC). Synchronous liver metastases may confer a poorer prognosis than metachronous metastases, and genetic alterations and an inflammatory response have also been associated with a poor prognosis in cases of a liver metastasis arising from CRC. However, few studies have examined the relationship between KRAS mutations and inflammatory status in CRC, especially with respect to liver metastases. Methods: The effect of the activated mitogen-activated protein kinase pathway and another protein involved in inflammation, C-reactive protein, in liver metastases were examined. We aimed to determine the impact of the CRP-specific single nucleotide polymorphism (SNP) rs7553007 in liver metastasis on the CRC-specific survival (CSS) of patients after colorectal liver metastasectomy. Results: We found no significant differences in genotype distributions and allele frequencies at the CRP SNP rs7553007 between CRC patients with liver metastasis and the control group. CSS rates were low in the subgroup of patients with synchronous metastasis with the A-allele (A/A and A/G) at rs7553007 or mutated KRAS/BRAF in liver metastatic specimens. Furthermore, the CRP SNP rs7553007 (hazard ratio [HR] = 1.101; 95% confidence interval [CI] = 1.011-1.200; P = 0.027) and KRAS/BRAF mutations (HR = 2.377; 95% CI = 1.293-4.368; P = 0.005) remained predictive for the CSS of CRC patients with synchronous liver metastasis in multivariate analysis. Conclusions: Both the CRP SNP rs7553007 and KRAS/BRAF mutations were independent prognostic factors for CRC patients with synchronous liver metastasis.	[Huang, Chi-Jung; Chien, Chih-Cheng] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan; [Huang, Chi-Jung; Chien, Chih-Cheng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Huang, Chi-Jung] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Teng, Hao-Wei] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Teng, Hao-Wei] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Teng, Hao-Wei; Lin, Jen-Kou; Yang, Shung-Haur] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chien, Chih-Cheng] Sijhih Cathay Gen Hosp, Dept Anesthesiol, New Taipei, Taiwan; [Lin, Jen-Kou; Yang, Shung-Haur] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan	Cathay General Hospital; Fu Jen Catholic University; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Cathay General Hospital; Taipei Veterans General Hospital	Yang, SH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.	yangsh@vghtpe.gov.tw		Chien, Chih-Cheng/0000-0002-8368-2005	Taipei Veterans General Hospital [V98C1-152, V99C1-109, V100C-170]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported by the grants (V98C1-152, V99C1-109, and V100C-170) from Taipei Veterans General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2007, BRIT J SURG, V94, P129, DOI 10.1002/bjs.5764; Ariake K, 2012, CANCER LETT, V325, P99, DOI 10.1016/j.canlet.2012.06.012; Barderas R, 2012, CANCER RES, V72, P2780, DOI 10.1158/0008-5472.CAN-11-4090; Bouchahda M, 2010, CANCER CHEMOTH PHARM, V66, P605, DOI 10.1007/s00280-010-1298-9; Braet F, 2007, WORLD J GASTROENTERO, V13, P821, DOI 10.3748/wjg.v13.i6.821; Chang KH, 2013, PLOS ONE, V8; Charpin C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3165; Chiu HM, 2008, AM J GASTROENTEROL, V103, P2317, DOI 10.1111/j.1572-0241.2008.01952.x; Ding QQ, 2011, J CLIN INVEST, V121, P4526, DOI 10.1172/JCI45008; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Ferrone C, 2010, J CLIN ONCOL, V28, P4045, DOI 10.1200/JCO.2010.27.9992; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Fujita S, 2000, JPN J CLIN ONCOL, V30, P7, DOI 10.1093/jjco/hyd002; Granville CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005061; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Ishizuka M, 2009, J SURG ONCOL, V100, P38, DOI 10.1002/jso.21294; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Khatri VP, 2005, J CLIN ONCOL, V23, P8490, DOI 10.1200/JCO.2004.00.6155; Lawlor DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003011; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; Mekenkamp LJM, 2010, BRIT J CANCER, V103, P159, DOI 10.1038/sj.bjc.6605737; Nikoloudis N, 2004, Tech Coloproctol, V8 Suppl 1, ps177, DOI 10.1007/s10151-004-0149-2; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Okumura T, 2010, CANCER RES, V70, P8435, DOI 10.1158/0008-5472.CAN-10-1506; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Poole EM, 2009, PHARMACOGENET GENOM, V19, P113, DOI 10.1097/FPC.0b013e32831bd976; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Shiu YC, 2008, DIS COLON RECTUM, V51, P443, DOI 10.1007/s10350-007-9133-z; Tan EK, 2010, ANN ACAD MED SINGAP, V39, P719; Teng HW, 2012, J SURG ONCOL, V106, P123, DOI 10.1002/jso.23063; Tsai MS, 2007, ANN SURG ONCOL, V14, P786, DOI 10.1245/s10434-006-9215-5; Tsilidis KK, 2009, CANCER CAUSE CONTROL, V20, P1739, DOI 10.1007/s10552-009-9427-7; Vermeire S, 2005, NAT CLIN PRACT GASTR, V2, P580, DOI 10.1038/ncpgasthep0359; Yang SH, 2011, ANN SURG ONCOL, V18, P1907, DOI 10.1245/s10434-011-1575-9; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042	36	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65117	10.1371/journal.pone.0065117	http://dx.doi.org/10.1371/journal.pone.0065117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755178	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300048
J	Kondo, Y; Hasegawa, G; Okada, H; Senmaru, T; Fukui, M; Nakamura, N; Sawada, M; Kitawaki, J; Okanoue, T; Kishimoto, Y; Amano, A; Maruyama, N; Obayashi, H; Ishigami, A				Kondo, Yoshitaka; Hasegawa, Goji; Okada, Hiroshi; Senmaru, Takafumi; Fukui, Michiaki; Nakamura, Naoto; Sawada, Morio; Kitawaki, Jo; Okanoue, Takeshi; Kishimoto, Yuki; Amano, Akiko; Maruyama, Naoki; Obayashi, Hiroshi; Ishigami, Akihito			Leprdb/db Mice with Senescence Marker Protein-30 Knockout (Leprdb/db Smp30Y/-) Exhibit Increases in Small Dense-LDL and Severe Fatty Liver Despite Being Fed a Standard Diet	PLOS ONE			English	Article							HEPATIC STEATOSIS; GENE-EXPRESSION; ACID; PLASMA; STEATOHEPATITIS; LIPOPROTEINS; ACCUMULATION; CHOLESTEROL; VALIDATION; DISEASE	Background/Aims: The senescence marker protein-30 (SMP30) is a 34 kDa protein originally identified in rat liver that shows decreased levels with age. Several functional studies using SMP30 knockout (Smp30(Y/-)) mice established that SMP30 functions as an antioxidant and protects against apoptosis. To address the potential role of SMP30 in nonalcoholic fatty liver disease (NAFLD) pathogenesis, we established Smp30(Y/-) mice on a Lepr(db/db) background (Lepr(db/db) Smp30(Y/-) mice). Research Design/Principal Findings: Male Lepr(db/db) Smp30(Y/-) mice were fed a standard diet (340 kcal/100 g, fat 5.6%) for 16 weeks whereupon the lipid/lipoprotein profiles, hepatic expression of genes related to lipid metabolism and endoplasmic reticulum stress markers were analyzed by HPLC, quantitative RT-PCR and western blotting, respectively. Changes in the liver at a histological level were also investigated. The amount of SMP30 mRNA and protein in livers was decreased in Lepr(db/db) Smp30(Y/+) mice compared with Lepr(db/+) Smp30(Y/+) mice. Compared with Lepr(db/db) Smp30(Y/+) mice, 24 week old Lepr(db/db) Smp30(Y/-) mice showed: i) increased small dense LDL-cho and decreased HDL-cho levels; ii) fatty liver accompanied by numerous inflammatory cells and increased oxidative stress; iii) decreased mRNA expression of genes involved in fatty acid oxidation (PPAR alpha) and lipoprotein uptake (LDLR and VLDLR) but increased CD36 levels; and iv) increased endoplasmic reticulum stress. Conclusion: Our data strongly suggest that SMP30 is closely associated with NAFLD pathogenesis, and might be a possible therapeutic target for NAFLD.	[Kondo, Yoshitaka; Kishimoto, Yuki; Amano, Akiko; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan; [Hasegawa, Goji; Okada, Hiroshi; Senmaru, Takafumi; Fukui, Michiaki; Nakamura, Naoto; Obayashi, Hiroshi] Kyoto Prefectural Univ Med, Dept Endocrinol & Metab, Kyoto, Japan; [Sawada, Morio; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kyoto, Japan; [Okanoue, Takeshi] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; [Obayashi, Hiroshi] Inst Bioresponse Informat, Kyoto, Japan	Tokyo Metropolitan Institute of Gerontology; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan.	ishigami@tmig.or.jp	Okada, Hiroshi/AAG-1588-2020; Yoshitaka, Kondo/AFK-7721-2022	Okada, Hiroshi/0000-0002-1707-970X; Yoshitaka, Kondo/0000-0002-0046-9429; Ishigami, Akihito/0000-0001-7875-7482; Amano, Akiko/0000-0003-4324-2758; Fukui, Michiaki/0000-0003-0903-1797	Japan Society for the Promotion of Science [24380073, 23590441, 23790122, 23591317]; Grants-in-Aid for Scientific Research [23790122] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html) KAKENHI Grant Number 24380073 (A. Ishigami), 23590441 (N. Maruyama), 23790122 (Y. Kondo) and 23591317 (G. Hasegawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Cali AMG, 2007, DIABETES CARE, V30, P3093, DOI 10.2337/dc07-1088; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327; Fukui M, 2011, BIOCHEM BIOPH RES CO, V415, P252, DOI 10.1016/j.bbrc.2011.10.025; Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x; Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163; Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x; Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010; Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005; Kim JC, 1997, LAB ANIM, V11, P113; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv S, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-17; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Park H, 2010, J GASTROENTEROL, V45, P426, DOI 10.1007/s00535-009-0154-3; Qiu SQ, 1998, J LIPID RES, V39, P1661; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364; Senmaru T, 2013, METABOLISM; Sugino I, 2011, J ATHEROSCLER THROMB, V18, P1, DOI 10.5551/jat.5447; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Toledo FGS, 2006, DIABETES CARE, V29, P1845, DOI 10.2337/dc06-0455; Usui S, 2002, J LIPID RES, V43, P805	34	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65698	10.1371/journal.pone.0065698	http://dx.doi.org/10.1371/journal.pone.0065698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755269	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300090
J	Mohring, MB; Kendrick, GA; Wernberg, T; Rule, MJ; Vanderklift, MA				Mohring, Margaret B.; Kendrick, Gary A.; Wernberg, Thomas; Rule, Michael J.; Vanderklift, Mathew A.			Environmental Influences on Kelp Performance across the Reproductive Period: An Ecological Trade-Off between Gametophyte Survival and Growth?	PLOS ONE			English	Article							ECKLONIA-RADIATA LAMINARIALES; MACROCYSTIS-PYRIFERA; UNDARIA-PINNATIFIDA; POPULATION BIOLOGY; SETTLEMENT DENSITY; MAXIMA ALARIACEAE; CLIMATE-CHANGE; LIFE-HISTORY; SEA-URCHINS; J-AGARDH	Most kelps (order Laminariales) exhibit distinct temporal patterns in zoospore production, gametogenesis and gametophyte reproduction. Natural fluctuations in ambient environmental conditions influence the intrinsic characteristics of gametes, which define their ability to tolerate varied conditions. The aim of this work was to document seasonal patterns in reproduction and gametophyte growth and survival of Ecklonia radiata (C. Agardh) J. Agardh in south-western Australia. These results were related to patterns in local environmental conditions in an attempt to ascertain which factors explain variation throughout the season. E. radiata was fertile (produced zoospores) for three and a half months over summer and autumn. Every two weeks during this time, gametophytes were grown in a range of temperatures (16-22 degrees C) in the laboratory. Zoospore densities were highly variable among sample periods; however, zoospores released early in the season produced gametophytes which had greater rates of growth and survival, and these rates declined towards the end of the reproductive season. Growth rates of gametophytes were positively related to day length, with the fastest growing recruits released when the days were longest. Gametophytes consistently survived best in the lowest temperature (16 degrees C), yet exhibited optimum growth in higher culture temperatures (20-22 degrees C). These results suggest that E. radiata releases gametes when conditions are favourable for growth, and E. radiata gametophytes are tolerant of the range of temperatures observed at this location. E. radiata releases the healthiest gametophytes when day length and temperature conditions are optimal for better germination, growth, and sporophyte production, perhaps as a mechanism to help compete against other species for space and other resources.	[Mohring, Margaret B.; Kendrick, Gary A.; Wernberg, Thomas; Rule, Michael J.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Mohring, Margaret B.; Kendrick, Gary A.; Wernberg, Thomas; Rule, Michael J.] Univ Western Australia, UWA Oceans Inst M096, Crawley, WA, Australia; [Wernberg, Thomas] Univ Western Australia, Australian Inst Marine Sci, Crawley, WA, Australia; [Rule, Michael J.] Dept Environm & Conservat, Kensington, NSW, Australia; [Vanderklift, Mathew A.] CSIRO Wealth Oceans Flagship, Floreat, WA, Australia	University of Western Australia; University of Western Australia; Australian Institute of Marine Science; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Mohring, MB (corresponding author), Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia.	margie.mohring@gmail.com	Wernberg, Thomas/B-4172-2010; Vanderklift, Mathew A/B-1003-2008; Kendrick, Gary Andrew/B-3460-2011	Wernberg, Thomas/0000-0003-1185-9745; Vanderklift, Mathew A/0000-0002-5170-7546; Kendrick, Gary Andrew/0000-0002-0276-6064; Rule, Michael/0000-0001-7278-8317	University of Western Australia; Australian Geographic Society; Australian Research Council	University of Western Australia; Australian Geographic Society; Australian Research Council(Australian Research Council)	This study was supported by the University of Western Australia (Australian Postgraduate Award to MM), the Australian Geographic Society (Seed Grant to MM) and the Australian Research Council (Future Fellowship to TW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSLER CD, 1989, J EXP MAR BIOL ECOL, V134, P117, DOI 10.1016/0022-0981(90)90104-K; Bidwell JR, 1998, MAR ECOL PROG SER, V163, P259, DOI 10.3354/meps163259; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; BOLTON JJ, 1985, MAR BIOL, V87, P131, DOI 10.1007/BF00539420; Buchholz C, 1999, J APPL PHYCOL, V11, P579, DOI 10.1023/A:1008116828263; Buschmann AH, 2006, J APPL PHYCOL, V18, P575, DOI 10.1007/s10811-006-9063-5; Choi HG, 2005, J APPL PHYCOL, V17, P423, DOI 10.1007/s10811-005-0432-2; Coelho Susana M., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P317, DOI 10.1023/A:1009916129009; Crawley KR, 2007, MAR BIOL, V151, P1433, DOI 10.1007/s00227-006-0581-0; DIECK IT, 1993, MAR ECOL PROG SER, V100, P253; FLETCHER WJ, 1987, ECOL MONOGR, V57, P89, DOI 10.2307/1942640; Fredersdorf J, 2009, OECOLOGIA, V160, P483, DOI 10.1007/s00442-009-1326-9; Fritsch FE, 1942, ANN BOT-LONDON, V6, P533, DOI 10.1093/oxfordjournals.aob.a088420; Fritsch FE, 1952, STRUCTURE REPROD ALG; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; JENNINGS R, 1967, Journal of the Royal Society of Western Australia, V50, P93; JOSKA MAP, 1987, BRIT PHYCOL J, V22, P209, DOI 10.1080/00071618700650251; KENNELLY SJ, 1983, AQUAT BOT, V17, P275, DOI 10.1016/0304-3770(83)90062-1; KIRKMAN H, 1981, J EXP MAR BIOL ECOL, V55, P243, DOI 10.1016/0022-0981(81)90115-5; Ladah LB, 2007, MAR BIOL, V152, P677, DOI 10.1007/s00227-007-0723-z; LARKUM AWD, 1986, J EXP MAR BIOL ECOL, V96, P177, DOI 10.1016/0022-0981(86)90241-8; LEE JA, 1988, J PHYCOL, V24, P181, DOI 10.1111/j.1529-8817.1988.tb04232.x; LUNING K, 1980, J PHYCOL, V16, P1; McConnico LA, 2005, J EXP MAR BIOL ECOL, V324, P61, DOI 10.1016/j.jembe.2005.04.006; Minitab Inc, 2000, MINITAB 13 1; Mohring MB, 2013, MAR BIOL, V160, P119, DOI 10.1007/s00227-012-2068-5; Nelson WA, 2005, J APPL PHYCOL, V17, P23, DOI 10.1007/s10811-005-5521-8; NOVACZEK I, 1984, MAR BIOL, V82, P241, DOI 10.1007/BF00392405; Provasoli L., 1968, CULTURES COLLECTIONS, P63; Rasband W. S., 2009, IMAGEJ 1 42Q; Reed DC, 1996, ECOLOGY, V77, P300, DOI 10.2307/2265679; REED DC, 1987, J EXP MAR BIOL ECOL, V113, P61, DOI 10.1016/0022-0981(87)90082-7; REED DC, 1991, J PHYCOL, V27, P361, DOI 10.1111/j.0022-3646.1991.00361.x; Reed DC, 1997, ECOLOGY, V78, P2443; Reed DC, 1999, MAR BIOL, V133, P737, DOI 10.1007/s002270050515; Russell BD, 2012, BIOL LETTERS, V8, P164, DOI 10.1098/rsbl.2011.0779; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; SCHIEL DR, 1986, OCEANOGR MAR BIOL, V24, P265; Smale DA, 2010, J EXP MAR BIOL ECOL, V384, P76, DOI 10.1016/j.jembe.2009.11.013; Smale DA, 2009, MAR ECOL PROG SER, V387, P27, DOI 10.3354/meps08132; Smith SDA, 1996, AUST J ECOL, V21, P81, DOI 10.1111/j.1442-9993.1996.tb00587.x; Steen H, 2003, BOT MAR, V46, P36, DOI 10.1515/BOT.2003.006; Steinberg P, 1999, SO SEAS ECOLOGY AUST, P60; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Tala F, 2004, NEW ZEAL J MAR FRESH, V38, P255, DOI 10.1080/00288330.2004.9517235; Thornber CS, 2004, MAR ECOL PROG SER, V268, P69, DOI 10.3354/meps268069; Tuya F, 2008, ESTUAR COAST SHELF S, V78, P774, DOI 10.1016/j.ecss.2008.02.017; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Underwood AJ, 1998, GMAV5 WINDOWS; Vanderklift MA, 2009, MAR ECOL PROG SER, V376, P203, DOI 10.3354/meps07811; Wernberg T, 2006, OECOLOGIA, V147, P692, DOI 10.1007/s00442-005-0318-7; Wernberg T, 2005, AQUAT ECOL, V39, P419, DOI 10.1007/s10452-005-9009-z; Wernberg T, 2003, DIVERS DISTRIB, V9, P427, DOI 10.1046/j.1472-4642.2003.00048.x; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021	55	28	28	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65310	10.1371/journal.pone.0065310	http://dx.doi.org/10.1371/journal.pone.0065310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755217	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300074
J	Pironet, A; Dauby, PC; Paeme, S; Kosta, S; Chase, JG; Desaive, T				Pironet, Antoine; Dauby, Pierre C.; Paeme, Sabine; Kosta, Sarah; Chase, J. Geoffrey; Desaive, Thomas			Simulation of Left Atrial Function Using a Multi-Scale Model of the Cardiovascular System	PLOS ONE			English	Article							PRESSURE-VOLUME RELATIONS; LEFT-VENTRICLE; LOAD-DEPENDENCE; HEART-RATE; IN-VIVO; CONTRACTION; CURVILINEARITY; ELASTANCE; DIAGNOSIS; DYNAMICS	During a full cardiac cycle, the left atrium successively behaves as a reservoir, a conduit and a pump. This complex behavior makes it unrealistic to apply the time-varying elastance theory to characterize the left atrium, first, because this theory has known limitations, and second, because it is still uncertain whether the load independence hypothesis holds. In this study, we aim to bypass this uncertainty by relying on another kind of mathematical model of the cardiac chambers. In the present work, we describe both the left atrium and the left ventricle with a multi-scale model. The multi-scale property of this model comes from the fact that pressure inside a cardiac chamber is derived from a model of the sarcomere behavior. Macroscopic model parameters are identified from reference dog hemodynamic data. The multi-scale model of the cardiovascular system including the left atrium is then simulated to show that the physiological roles of the left atrium are correctly reproduced. This include a biphasic pressure wave and an eight-shaped pressure-volume loop. We also test the validity of our model in non basal conditions by reproducing a preload reduction experiment by inferior vena cava occlusion with the model. We compute the variation of eight indices before and after this experiment and obtain the same variation as experimentally observed for seven out of the eight indices. In summary, the multi-scale mathematical model presented in this work is able to correctly account for the three roles of the left atrium and also exhibits a realistic left atrial pressure-volume loop. Furthermore, the model has been previously presented and validated for the left ventricle. This makes it a proper alternative to the time-varying elastance theory if the focus is set on precisely representing the left atrial and left ventricular behaviors.	[Pironet, Antoine; Dauby, Pierre C.; Paeme, Sabine; Kosta, Sarah; Desaive, Thomas] Univ Liege ULg, GIGA Cardiovasc Sci, Liege, Belgium; [Chase, J. Geoffrey] Univ Canterbury, Dept Mech Engn, Christchurch 1, New Zealand	University of Liege; University of Canterbury	Pironet, A (corresponding author), Univ Liege ULg, GIGA Cardiovasc Sci, Liege, Belgium.	a.pironet@ulg.ac.be	Chase, James G/B-1584-2012; Stefanadis, Christodoulos/ABH-2232-2020	Chase, James G/0000-0001-9989-4849; Stefanadis, Christodoulos/0000-0001-5974-6454	Federation Wallonie-Bruxelles (Actions de Recherches Concertees - Academie Wallonie-Europe); F.R.I.A. (Belgium); FNRS (Belgium)	Federation Wallonie-Bruxelles (Actions de Recherches Concertees - Academie Wallonie-Europe); F.R.I.A. (Belgium)(Fonds de la Recherche Scientifique - FNRS); FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Federation Wallonie-Bruxelles (Actions de Recherches Concertees - Academie Wallonie-Europe, http://www.federation-wallonie-bruxelles.be), the F.R.I.A. (Belgium, http://www.frs-fnrs.be/) and the FNRS (Belgium, http://www.frs-fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J, 1987, CIRC RES, V61, P209, DOI 10.1161/01.RES.61.2.209; BURKHOFF D, 1991, AM J PHYSIOL, V260, pH569, DOI 10.1152/ajpheart.1991.260.2.H569; BURKHOFF D, 1994, J MOL CELL CARDIOL, V26, P959, DOI 10.1006/jmcc.1994.1117; BURKHOFF D, 1993, AM J PHYSIOL, V265, pH1819, DOI 10.1152/ajpheart.1993.265.5.H1819; BURKHOFF D, 1987, AM J PHYSIOL, V252, pH1218, DOI 10.1152/ajpheart.1987.252.6.H1218; CHUNG DC, 1996, THESIS RICE U HOUSTO; COURTOIS M, 1988, CIRCULATION, V78, P661, DOI 10.1161/01.CIR.78.3.661; Dernellis JM, 1998, AM J CARDIOL, V81, P1138, DOI 10.1016/S0002-9149(98)00134-9; Ferasin L, 2010, J SMALL ANIM PRACT, V51, P412, DOI 10.1111/j.1748-5827.2010.00954.x; FINSTERER U, 1973, PFLUG ARCH EUR J PHY, V341, P63, DOI 10.1007/BF00587330; Gare M, 2001, ANESTHESIOLOGY, V95, P689, DOI 10.1097/00000542-200109000-00023; Guyton A.C., 2006, TXB MED PHYSL; HOIT BD, 1994, CIRCULATION, V89, P1829, DOI 10.1161/01.CIR.89.4.1829; KASS DA, 1989, CIRCULATION, V79, P167, DOI 10.1161/01.CIR.79.1.167; Kehl F, 2002, ANESTH ANALG, V94, P1421, DOI 10.1097/00000539-200206000-00008; Klabunde R., 2011, CARDIOVASCULAR PHYSL; Koon KTV, 2009, COMPUT CARDIOL, V36, P393; Korakianitis T, 2006, MED ENG PHYS, V28, P613, DOI 10.1016/j.medengphy.2005.10.004; Lamb Allison P, 2010, J Vet Cardiol, V12, P107, DOI 10.1016/j.jvc.2010.04.001; LAU VK, 1979, ANN BIOMED ENG, V7, P167, DOI 10.1007/BF02363133; Lu K, 2001, AM J PHYSIOL-HEART C, V281, pH2661, DOI 10.1152/ajpheart.2001.281.6.H2661; Luo C, 2008, CARDIOVASC ENG, V8, P174, DOI 10.1007/s10558-008-9054-z; MAUGHAN WL, 1979, CIRC RES, V44, P309, DOI 10.1161/01.RES.44.3.309; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Negroni JA, 1999, J MOL CELL CARDIOL, V31, P1509, DOI 10.1006/jmcc.1999.0984; Negroni JA, 1996, J MOL CELL CARDIOL, V28, P915, DOI 10.1006/jmcc.1996.0086; Nygren A, 1998, CIRC RES, V82, P63; Oh J.K., 2006, ECHO MANUAL; Olansen JB, 2000, COMPUT BIOMED RES, V33, P260, DOI 10.1006/cbmr.2000.1543; Paeme S, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-86; Pagel PS, 2003, ANESTHESIOLOGY, V98, P975, DOI 10.1097/00000542-200304000-00027; Pironet A, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-8; Revie JA, 2011, COMPUTER METHODS PRO; Revie JA, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-33; Rosca M, 2011, HEART, V97, P1982, DOI 10.1136/heartjnl-2011-300069; Saito S, 2006, EUR J CARDIO-THORAC, V30, P584, DOI 10.1016/j.ejcts.2006.07.021; Shim EB, 2006, PHILOS T R SOC A, V364, P1483, DOI 10.1098/rsta.2006.1782; SHROFF SG, 1985, AM J PHYSIOL, V249, pH358, DOI 10.1152/ajpheart.1985.249.2.H358; Smith BW, 2005, CONTROL ENG PRACT, V13, P1183, DOI 10.1016/j.conengprac.2004.10.014; Smith BW, 2004, MED ENG PHYS, V26, P131, DOI 10.1016/j.medengphy.2003.10.001; Starfinger C, 2007, COMPUT METH PROG BIO, V87, P46, DOI 10.1016/j.cmpb.2007.03.010; Starfinger C, 2008, MATH BIOSCI, V216, P132, DOI 10.1016/j.mbs.2008.08.014; Stefanadis C, 2001, EUR HEART J, V22, P22, DOI 10.1053/euhj.1999.2581; Stevenson D, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-73; Stevenson D, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-28; Stpeanek J, 1975, Bull Physiopathol Respir (Nancy), V11, P295; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; VAARTJES SR, 1987, CIRC RES, V60, P727, DOI 10.1161/01.RES.60.5.727; van Meurs W., 2011, MODELING SIMULATION; Wong KKL, 2012, COMPUT MED IMAG GRAP, V36, P527, DOI 10.1016/j.compmedimag.2012.04.003; YUE DT, 1987, AM J PHYSIOL, V252, pH760, DOI 10.1152/ajpheart.1987.252.4.H760	51	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65146	10.1371/journal.pone.0065146	http://dx.doi.org/10.1371/journal.pone.0065146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755183	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300051
J	Yen, FY; Chong, KMB; Ha, LM				Yen, Fang Yen; Chong, Khoo Michael Boon; Ha, Lee Ming			Synthetic-Type Control Charts for Time-Between-Events Monitoring	PLOS ONE			English	Article							HIGH-YIELD PROCESSES; CUSUM CHARTS; HEALTH-CARE; RUN-LENGTH; DESIGN; INSPECTION; INTERVALS; CCC	This paper proposes three synthetic-type control charts to monitor the mean time-between-events of a homogenous Poisson process. The first proposed chart combines an Erlang (cumulative time between events, T-r) chart and a conforming run length (CRL) chart, denoted as Synth-T-r chart. The second proposed chart combines an exponential (or T) chart and a group conforming run length (GCRL) chart, denoted as GR-T chart. The third proposed chart combines an Erlang chart and a GCRL chart, denoted as GR-T-r chart. By using a Markov chain approach, the zero- and steady-state average number of observations to signal (ANOS) of the proposed charts are obtained, in order to evaluate the performance of the three charts. The optimal design of the proposed charts is shown in this paper. The proposed charts are superior to the existing T chart, T-r chart, and Synth-T chart. As compared to the EWMA-T chart, the GR-T chart performs better in detecting large shifts, in terms of the zero- and steady-state performances. The zero-state Synth-T-4 and GR-T-r (r = 3 or 4) charts outperform the EWMA-T chart for all shifts, whereas the Synth-T-r (r = 2 or 3) and GR-T-2 charts perform better for moderate to large shifts. For the steady-state process, the Synth-T-r and GR-T-r charts are more efficient than the EWMA-T chart in detecting small to moderate shifts.	[Yen, Fang Yen; Chong, Khoo Michael Boon] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Ha, Lee Ming] Swinburne Univ Technol, Sch Engn Comp & Sci, Kuching, Sarawak, Malaysia	Universiti Sains Malaysia; Swinburne University of Technology; Swinburne University of Technology Sarawak	Yen, FY (corresponding author), Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia.	fangyenyen@hotmail.com	Khoo, Michael B.C./D-9033-2012; Lee, Ming Ha/I-9617-2014	Khoo, Michael B.C./0000-0002-3245-1127; Lee, Ming Ha/0000-0003-2096-5865; Fang, Yen Yen/0000-0003-2510-4116	MyBrain15 (MyPhD) Scholarship Program under the Ministry of Higher Education Malaysia; Fundamental Research Grant Scheme (FRGS) [203/PMATHS/6711232]	MyBrain15 (MyPhD) Scholarship Program under the Ministry of Higher Education Malaysia; Fundamental Research Grant Scheme (FRGS)	This research is supported by the MyBrain15 (MyPhD) Scholarship Program under the Ministry of Higher Education Malaysia and the Fundamental Research Grant Scheme (FRGS), no. 203/PMATHS/6711232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers W, 2010, J STAT PLAN INFER, V140, P214, DOI 10.1016/j.jspi.2009.07.005; Alemi Farrokh, 2004, Jt Comm J Qual Saf, V30, P95; Borror CM, 2003, INT J PROD RES, V41, P3435, DOI 10.1080/0020754031000138321; BOURKE PD, 1991, J QUAL TECHNOL, V23, P225, DOI 10.1080/00224065.1991.11979328; Bourke PD, 2001, J APPL STAT, V28, P951, DOI 10.1080/02664760120076643; BROOK D, 1972, BIOMETRIKA, V59, P539; CALVIN TW, 1983, IEEE T COMPON HYBR, V6, P323, DOI 10.1109/TCHMT.1983.1136174; Chan LY, 2000, INT J PROD RES, V38, P397, DOI 10.1080/002075400189482; Davis RB, 2002, J QUAL TECHNOL, V34, P200; Dogu E, 2012, INT J QUAL RES, V6, P151; Gadre M. P., 2004, EC QUAL CONTROL, V19, P29, DOI DOI 10.1515/EQC.2004.29; GAN FF, 1994, J QUAL TECHNOL, V26, P109, DOI 10.1080/00224065.1994.11979511; Gan FF, 1998, J QUAL TECHNOL, V30, P55; Ghute VB, 2008, COMMUN STAT-THEOR M, V37, P2136, DOI 10.1080/03610920701824265; Goh T. N., 1987, Quality Assurance, V13, P18; JARRETT RG, 1979, BIOMETRIKA, V66, P191, DOI 10.1093/biomet/66.1.191; Jones LA, 2002, QUAL RELIAB ENG INT, V18, P479, DOI 10.1002/qre.496; Khilare SK, 2012, QUAL RELIAB ENG INT, V28, P193, DOI 10.1002/qre.1233; Khoo MBC, 2013, COMPUT IND ENG, V64, P179, DOI 10.1016/j.cie.2012.08.017; Khoo MBC, 2011, QUAL RELIAB ENG INT, V27, P981, DOI 10.1002/qre.1189; Khoo MBC, 2009, QUAL RELIAB ENG INT, V25, P805, DOI 10.1002/qre.977; Liu J. Y., 2006, QUALITY TECHNOLOGY Q, V3, P347, DOI DOI 10.1080/16843703.2006.11673120; Liu JY, 2006, ADV RELIABILITY MODE, P739; Liu JY, 2004, INT ENG MAN C, P1061; Luo P, 2012, HEALTH PHYS, V102, P637, DOI 10.1097/HP.0b013e3182430106; Montgomery, 2009, STAT QUALITY CONTROL; Ohta H, 2001, QUAL RELIAB ENG INT, V17, P439, DOI 10.1002/qre.428; Ozsan G, 2010, QUAL RELIAB ENG INT, V26, P555, DOI 10.1002/qre.1079; Pehlivan C, 2010, QUAL RELIAB ENG INT, V26, P177, DOI 10.1002/qre.1033; Prasad SR, 2011, INT J COMPUTER APPL, V18, P1; Qu L, 2011, QUAL RELIAB ENG INT, V27, P529, DOI 10.1002/qre.1153; Radaelli G, 1998, TOTAL QUAL MANAGE, V9, P133, DOI 10.1080/0954412989324; REYNOLDS MR, 1990, TECHNOMETRICS, V32, P371, DOI 10.2307/1270114; Scariano S. M., 2003, Quality Engineering, V15, P677, DOI 10.1081/QEN-120018399; Scariano S. M., 2009, SEQUENTIAL ANAL, V28, P54, DOI DOI 10.1080/07474940802619261; Sharma P. R., 2006, SERIES QUALITY RELIA, V9, P43, DOI [10.1142/9789812707147_0003, DOI 10.1142/9789812707147_0003]; Sun J, 2000, TOTAL QUAL MANAGE, V11, P235, DOI 10.1080/0954412006973; Thor J, 2007, QUAL SAF HEALTH CARE, V16, P387, DOI 10.1136/qshc.2006.022194; VARDEMAN S, 1985, TECHNOMETRICS, V27, P145, DOI 10.2307/1268762; Woodall WH, 2006, J QUAL TECHNOL, V38, P89, DOI 10.1080/00224065.2006.11918593; Wu Z, 2000, J QUAL TECHNOL, V32, P32; Wu Z, 2001, J QUAL TECHNOL, V33, P104; Xie M, 2002, RELIAB ENG SYST SAFE, V77, P143, DOI 10.1016/S0951-8320(02)00041-8; Xie M, 1998, QUAL RELIAB ENG INT, V14, P339, DOI 10.1002/(SICI)1099-1638(199809/10)14:5<339::AID-QRE185>3.0.CO;2-S; Xie M., 2002, STAT MODELS CONTROL; Xie M., 1997, INT J QUALITY RELIAB, V14, P64, DOI DOI 10.1108/02656719710156789; XIE W, 1995, QUAL RELIAB ENG INT, V11, P189, DOI 10.1002/qre.4680110309; Xie YJ, 2010, MONITORING TIME BETW, P1; Yeong WC, 2012, QUAL RELIAB ENG INT, V28, P725, DOI 10.1002/qre.1264; Zhang CW, 2007, INT J PROD RES, V45, P5649, DOI 10.1080/00207540701325082; Zhang CW, 2005, INT J PROD RES, V43, P5019, DOI 10.1080/00207540500219387; Zhang HY, 2007, IN C IND ENG ENG MAN, P1408, DOI 10.1109/IEEM.2007.4419424; Zhang HY, 2011, COMPUT IND ENG, V60, P485, DOI 10.1016/j.cie.2010.11.008; Zhang LY, 2009, QUAL RELIAB ENG INT, V25, P933, DOI 10.1002/qre.1012	54	29	29	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65440	10.1371/journal.pone.0065440	http://dx.doi.org/10.1371/journal.pone.0065440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755231	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300081
J	Tran, T; Teoh, CM; Tam, JKC; Qiao, YK; Chin, CY; Chong, OK; Stewart, AG; Harris, T; Wong, WSF; Guan, SP; Leung, BP; Gerthoffer, WT; Unruh, H; Halayko, AJ				Thai Tran; Teoh, Chun Ming; Tam, John Kit Chung; Qiao, Yongkang; Chin, Chin Yein; Chong, Oi Khuan; Stewart, Alastair G.; Harris, Trudi; Wong, Wai Shiu Fred; Guan, Shou Ping; Leung, Bernard P.; Gerthoffer, William T.; Unruh, Helmut; Halayko, Andrew J.			Laminin drives survival signals to promote a contractile smooth muscle phenotype and airway hyperreactivity	FASEB JOURNAL			English	Article						apoptosis; phenotype plasticity; integrin	EXTRACELLULAR-MATRIX; ASTHMA; EXPRESSION; CELLS; PROLIFERATION; MATURATION; KINASE; MODEL; YIGSR; WALL	Increased airway smooth muscle (ASM) mass is believed to underlie the relatively fixed airway hyperresponsiveness (AHR) in asthma. Developments of therapeutic approaches to reverse airway remodeling are impeded by our lack of insight on the mechanisms behind the increase in mass of contractile ASM cells. Increased expression of laminin, an extracellular matrix protein, is associated with asthma. Our studies investigate the role of laminin-induced ASM survival signals in the development of increased ASM and AHR. Antagonizing laminin integrin binding using the laminin-selective competing peptide, YIGSR, and mimicking laminin with exogenous 2-chain laminin, we show that laminin is both necessary and sufficient to induce ASM cell survival, concomitant with the induction of ASM contractile phenotype. Using siRNA, we show that the laminin-binding integrin 71 mediates this process. Moreover, in laminin-211-deficient mice, allergen-induced AHR was not observed. Notably, ASM cells from asthmatic airways express a higher abundance of intracellular cell survival proteins, consistent with a role for reduced rates of cell apoptosis in development of ASM hyperplasia. Targeting the laminin-integrin 71 signaling pathway may offer new avenues for the development of therapies to reduce the increase in mass of contractile phenotype ASM cells that underlie AHR in asthma.Tran, T., Teoh, C. M., Tam, J. K. C., Qiao, Y., Chin, C. Y., Chong, O. K., Stewart, A. G., Harris, T., Wong, W. S. F., Guan, S. P., Leung, B. P., Gerthoffer, W. T., Unruh, H., and Halayko, A. J. Laminin drives survival signals to promote a contractile smooth muscle phenotype and airway hyperreactivity.	[Thai Tran; Teoh, Chun Ming; Qiao, Yongkang; Chin, Chin Yein; Chong, Oi Khuan; Leung, Bernard P.] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; [Thai Tran; Wong, Wai Shiu Fred; Guan, Shou Ping; Leung, Bernard P.] Natl Univ Singapore, Program Immunol, Inst Life Sci, Singapore 117597, Singapore; [Tam, John Kit Chung] Natl Univ Singapore, Dept Surg, Singapore 117597, Singapore; [Wong, Wai Shiu Fred; Guan, Shou Ping] Natl Univ Singapore, Dept Pharmacol, Singapore 117597, Singapore; [Stewart, Alastair G.; Harris, Trudi] Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia; [Gerthoffer, William T.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL USA; [Halayko, Andrew J.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Unruh, Helmut; Halayko, Andrew J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Unruh, Helmut; Halayko, Andrew J.] Univ Manitoba, Sect Resp Dis, Winnipeg, MB, Canada; [Halayko, Andrew J.] Manitoba Inst Child Hlth, Biol Breathing Grp, Winnipeg, MB, Canada	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; University of Melbourne; University of South Alabama; University of Manitoba; University of Manitoba; University of Manitoba	Tran, T (corresponding author), Natl Univ Singapore, Dept Physiol, Block MD9,2 Med Dr, Singapore 117597, Singapore.	tran_thai@nuhs.edu.sg	Tam, John/B-6048-2012; Leung, Bernard PuiLam/O-2409-2013	Halayko, Andrew/0000-0002-7865-4552; Wong, Wai Shiu Fred/0000-0001-7010-3759; TRAN, Thai/0000-0002-8662-3676; Leung, Bernard PuiLam/0000-0002-1119-4934; Gerthoffer, William/0000-0001-5154-4962; stewart, alastair/0000-0002-2271-5942	Singapore Ministry of Education's Academic Research Fund [T13-0702-P26]; Singapore Deputy President (Research and Technology) startup grant; Canada Research Chairs Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000] Funding Source: NIH RePORTER	Singapore Ministry of Education's Academic Research Fund; Singapore Deputy President (Research and Technology) startup grant; Canada Research Chairs Program(Canada Research Chairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Ms. Karol McNeill and Ms. Tie Khee Chan (TUNEL assay) for excellent technical assistance. This study received financial support from the Singapore Ministry of Education's Academic Research Fund (T13-0702-P26), as well as support from a Singapore Deputy President (Research and Technology) startup grant to T.T. A.J.H. is supported through the Canada Research Chairs Program.	Altraja A, 1996, AM J RESP CELL MOL, V15, P482, DOI 10.1165/ajrcmb.15.4.8879182; Bao Z, 2009, AM J RESP CRIT CARE, V179, P657, DOI 10.1164/rccm.200809-1516OC; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bentley JK, 2009, AM J PHYSIOL-LUNG C, V296, pL176, DOI 10.1152/ajplung.90376.2008; Dekkers BGJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1405, DOI 10.1152/ajplung.00331.2006; Dekkers BGJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-170; Deng H, 2010, AM J RESP CELL MOL, V42, P744, DOI 10.1165/rcmb.2009-0037OC; Freyer AM, 2001, AM J RESP CELL MOL, V25, P569, DOI 10.1165/ajrcmb.25.5.4605; Halayko AJ, 2004, AM J RESP CELL MOL, V31, P266, DOI 10.1165/rcmb.2003-0272OC; Herszberg B, 2006, J ALLERGY CLIN IMMUN, V118, P382, DOI 10.1016/j.jaci.2006.03.044; IWAMOTO Y, 1987, SCIENCE, V238, P1132, DOI 10.1126/science.2961059; Kaur D, 2010, CLIN EXP ALLERGY, V40, P279, DOI 10.1111/j.1365-2222.2009.03423.x; LAMBERT RK, 1993, J APPL PHYSIOL, V74, P2771, DOI 10.1152/jappl.1993.74.6.2771; Pullan S, 1996, J CELL SCI, V109, P631; Ramos-Barbon D, 2005, J CLIN INVEST, V115, P1580, DOI 10.1172/JCI19711; Robinson PJ, 1996, PEDIATR PULM, V22, P248, DOI 10.1002/(SICI)1099-0496(199610)22:4<248::AID-PPUL4>3.0.CO;2-I; Sharma P, 2008, AM J PHYSIOL-LUNG C, V294, pL57, DOI 10.1152/ajplung.00378.2007; Stewart AG, 2004, EUR RESPIR J, V24, P515, DOI 10.1183/09031936.04.00067404; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tran T, 2007, AM J RESP CELL MOL, V37, P668, DOI 10.1165/rcmb.2007-0165OC; Tran T, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-117; Ward JE, 2008, EUR RESPIR J, V32, P362, DOI 10.1183/09031936.00119307	22	16	18	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					3991	4003		10.1096/fj.12-221341	http://dx.doi.org/10.1096/fj.12-221341			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23756649	Green Published			2022-12-25	WOS:000329747100014
J	Itoh, S; Yokoyama, R; Kamoshida, G; Fujiwara, T; Okada, H; Takii, T; Tsuji, T; Fujii, S; Hashizume, H; Onozaki, K				Itoh, Saotomo; Yokoyama, Ryosuke; Kamoshida, Go; Fujiwara, Toshinobu; Okada, Hiromi; Takii, Takemasa; Tsuji, Tsutomu; Fujii, Satoshi; Hashizume, Hideki; Onozaki, Kikuo			Staphylococcal Superantigen-like Protein 10 (SSL10) Inhibits Blood Coagulation by Binding to Prothrombin and Factor Xa via Their gamma-Carboxyglutamic Acid (Gla) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxins; Blood Coagulation Factors; Coagulation Factors; Prothrombin; Staphylococcus aureus; Staphylococcal Superantigen-like Protein	AUREUS; RECEPTOR; ACTIVATION; EVASION; GENOME; ALPHA; GENE	The staphylococcal superantigen-like protein (SSL) family is composed of 14 exoproteins sharing structural similarity with superantigens but no superantigenic activity. Target proteins of four SSLs have been identified to be involved in host immune responses. However, the counterparts of other SSLs have been functionally uncharacterized. In this study, we have identified porcine plasma prothrombin as SSL10-binding protein by affinity purification using SSL10-conjugated Sepharose. The resin recovered the prodomain of prothrombin (fragment 1 + 2) as well as factor Xa in pull-down analysis. The equilibrium dissociation constant between SSL10 and prothrombin was 1.36 x 10(-7) m in surface plasmon resonance analysis. On the other hand, the resin failed to recover -carboxyglutamic acid (Gla) domain-less coagulation factors and prothrombin from warfarin-treated mice, suggesting that the Gla domain of the coagulation factors is essential for the interaction. SSL10 prolonged plasma clotting induced by the addition of Ca2+ and factor Xa. SSL10 did not affect the protease activity of thrombin but inhibited the generation of thrombin activity in recalcified plasma. S. aureus produces coagulase that non-enzymatically activates prothrombin. SSL10 attenuated clotting induced by coagulase, but the inhibitory effect was weaker than that on physiological clotting, and SSL10 did not inhibit protease activity of staphylothrombin, the complex of prothrombin with coagulase. These results indicate that SSL10 inhibits blood coagulation by interfering with activation of coagulation cascade via binding to the Gla domain of coagulation factor but not by directly inhibiting thrombin activity. This is the first finding that the bacterial protein inhibits blood coagulation via targeting the Gla domain of coagulation factors.	[Itoh, Saotomo; Yokoyama, Ryosuke; Fujiwara, Toshinobu; Takii, Takemasa; Onozaki, Kikuo] Nagoya City Univ, Dept Mol Hlth Sci, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Itoh, Saotomo; Kamoshida, Go; Tsuji, Tsutomu] Hoshi Univ, Dept Microbiol, Sch Pharm & Pharmaceut Sci, Shinagawa Ku, Tokyo 1428501, Japan; [Okada, Hiromi; Fujii, Satoshi] Nagoya City Univ, Dept Mol & Cellular Pathobiol & Therapeut, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Hashizume, Hideki] Inst Microbial Chem, Lab Dis Biol, Shinagawa Ku, Tokyo 1410021, Japan	Nagoya City University; Hoshi University; Nagoya City University	Itoh, S (corresponding author), Nagoya City Univ, Dept Mol Hlth Sci, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	s-itoh@phar.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ohyama Health Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ohyama Health Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Ohyama Health Foundation; and the Takeda Science Foundation.	Al-Shangiti AM, 2004, INFECT IMMUN, V72, P4261, DOI 10.1128/IAI.72.7.4261-4270.2004; Arcus VL, 2002, J BIOL CHEM, V277, P32274, DOI 10.1074/jbc.M203914200; Bardoel BW, 2012, J MOL MED, V90, P1109, DOI 10.1007/s00109-012-0926-8; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; Bestebroer J, 2010, CELL MICROBIOL, V12, P1506, DOI 10.1111/j.1462-5822.2010.01486.x; Bestebroer J, 2009, BLOOD, V113, P328, DOI 10.1182/blood-2008-04-153882; De Haas CJC, 2009, J THROMB HAEMOST, V7, P1867, DOI 10.1111/j.1538-7836.2009.03564.x; DODE C, 1980, BIOCHEM BIOPH RES CO, V94, P660, DOI 10.1016/0006-291X(80)91283-8; Fitzgerald JR, 2003, INFECT IMMUN, V71, P2827, DOI 10.1128/IAI.71.5.2827-2838.2003; Itoh S, 2012, MICROBIOL IMMUNOL, V56, P363, DOI 10.1111/j.1348-0421.2012.00452.x; Itoh S, 2010, INFECT IMMUN, V78, P3298, DOI 10.1128/IAI.00178-10; Itoh S, 2010, MOL IMMUNOL, V47, P932, DOI 10.1016/j.molimm.2009.09.027; KAWABATA S, 1985, J BIOCHEM, V98, P1603, DOI 10.1093/oxfordjournals.jbchem.a135430; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; LIJNEN HR, 1991, J BIOL CHEM, V266, P11826; McAdow M, 2012, J INNATE IMMUN, V4, P141, DOI 10.1159/000333447; Patel D, 2010, J IMMUNOL, V184, P6283, DOI 10.4049/jimmunol.0903311; Postma B, 2004, J IMMUNOL, V172, P6994, DOI 10.4049/jimmunol.172.11.6994; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Walenkamp AME, 2009, NEOPLASIA, V11, P333, DOI 10.1593/neo.81508; Williams RJ, 2000, INFECT IMMUN, V68, P4407, DOI 10.1128/IAI.68.8.4407-4415.2000; Yokoyama R, 2012, INFECT IMMUN, V80, P2816, DOI 10.1128/IAI.00399-12	24	30	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21569	21580		10.1074/jbc.M113.451419	http://dx.doi.org/10.1074/jbc.M113.451419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23754290	Green Published, hybrid			2022-12-25	WOS:000328841900010
J	Dhanasiri, AKS; Fernandes, JMO; Kiron, V				Dhanasiri, Anusha K. S.; Fernandes, Jorge M. O.; Kiron, Viswanath			Liver Transcriptome Changes in Zebrafish during Acclimation to Transport-Associated Stress	PLOS ONE			English	Article							HIGH STOCKING DENSITY; SOLE SOLEA-SENEGALENSIS; GILTHEAD SEA BREAM; RAINBOW-TROUT; PHYSIOLOGICAL-RESPONSES; GLUTAMINE-SYNTHETASE; OXIDATIVE STRESS; ORNAMENTAL FISH; GENE-EXPRESSION; P38 MAPK	Liver plays a key role during the stress acclimation, and liver transcriptome analysis of shipped zebrafish could reveal the molecular adjustments that occur in the organ. Transcriptional changes in liver were analyzed with a 44 K oligo array using total RNA from fish prior to transport and during a mock transport process - immediately after packing (0 h), at 48 and 72 h. Large numbers of genes related to a variety of biological processes and pathways were regulated, mainly during transport (at 48/72 h). Immediately after packing, transcripts of genes related to both gluconeogenesis and glycolysis were induced. During transport, induction of gluconeogenesis-linked genes and reduction of glycolysis-related genes may be supporting the increase in blood glucose levels. Inhibition of genes involved in fatty acid beta-oxidation may be pointing to the poor ability of fish to utilize energy from fatty acids, under transport conditions. Genes involved in some of the mechanisms that regulate body ammonia were also affected. Even though genes associated with certain transaminases were inhibited in liver, sustained glutamate deamination may have led to high ammonia accumulation in liver/body. Enhanced levels of gene transcripts in ubiquitination and MAPK signalling cascade and reduced levels of gene transcripts related to ROS generation via peroxisomal enzymes as well as xenobiotic metabolism may be signifying the importance of such cellular and tissue responses to maintain homeostasis. Furthermore, transcripts connected with stress and thyroid hormones were also regulated. Moreover, suppression of genes related to specific immune components may be denoting the deleterious impact of transport on fish health. Thus, this study has revealed the complex molecular -adjustments that occur in zebrafish when they are transported.	[Dhanasiri, Anusha K. S.; Fernandes, Jorge M. O.; Kiron, Viswanath] Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway	Nord University	Kiron, V (corresponding author), Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway.	kiron.viswanath@uin.no	Fernandes, Jorge MO/A-3526-2013; Fernandes, Jorge/AAC-4632-2022	Fernandes, Jorge MO/0000-0002-2550-1640; Fernandes, Jorge/0000-0002-2550-1640; Viswanath, Kiron/0000-0003-4640-1910	Norwegian Center for International Cooperation in Higher Education (SIU) [NUFUPRO-2007/10102]	Norwegian Center for International Cooperation in Higher Education (SIU)	The project "Developing an entrepreneurial university based on local opportunities and knowledge" (NUFUPRO-2007/10102) was funded by the Norwegian Center for International Cooperation in Higher Education (SIU)(http://siu.no/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru N, 2007, PHYSIOL GENOMICS, V31, P483, DOI 10.1152/physiolgenomics.00118.2007; Alves RN, 2010, AQUACULTURE, V299, P57, DOI 10.1016/j.aquaculture.2009.11.014; BALLANTYNE JS, 2001, NITROGEN EXCRETION, P77; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Bendhack F, 2009, J APPL ICHTHYOL, V25, P201, DOI 10.1111/j.1439-0426.2008.01208.x; Bernier NJ, 2008, J ENDOCRINOL, V196, P637, DOI 10.1677/JOE-07-0568; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Cairns MT, 2008, COMP BIOCHEM PHYS D, V3, P51, DOI 10.1016/j.cbd.2007.04.009; Calduch-Giner JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-193; Carneiro PCF, 2001, AQUAC RES, V32, P297, DOI 10.1046/j.1365-2109.2001.00558.x; Ching BY, 2009, AQUAT TOXICOL, V95, P203, DOI 10.1016/j.aquatox.2009.09.004; Cordeiro OD, 2012, MAR BIOTECHNOL, V14, P714, DOI 10.1007/s10126-012-9437-4; Costas B, 2011, AQUACULTURE, V316, P68, DOI 10.1016/j.aquaculture.2011.03.011; Davey GM, 2006, TISSUE ANTIGENS, V67, P1, DOI 10.1111/j.1399-0039.2005.00532.x; Dhanasiri AKS, 2011, J APPL MICROBIOL, V111, P278, DOI 10.1111/j.1365-2672.2011.05050.x; Dhanasiri AKS, 2013, ZEBRAFISH, V10, P87, DOI 10.1089/zeb.2012.0843; Dhanasiri AKS, 2012, COMP BIOCHEM PHYS B, V163, P274, DOI 10.1016/j.cbpb.2012.06.003; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Drew RE, 2008, PHYSIOL GENOMICS, V35, P283, DOI 10.1152/physiolgenomics.90213.2008; Encinas P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-518; Carneiro PCF, 2009, NEOTROP ICHTHYOL, V7, P283, DOI 10.1590/S1679-62252009000200021; Feidantsis K, 2012, J EXP ZOOL PART A, V317A, P303, DOI 10.1002/jez.1725; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Fernandes JMO, 2007, GENE, V391, P178, DOI 10.1016/j.gene.2006.12.015; Fernandes JMO, 2006, COMP BIOCHEM PHYS D, V1, P35, DOI 10.1016/j.cbd.2005.09.003; Fuzzen MLM, 2010, ZEBRAFISH, V7, P349, DOI 10.1089/zeb.2010.0662; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goncalves AF, 2012, DEV COMP IMMUNOL, V36, P279, DOI 10.1016/j.dci.2011.04.008; Hegazi MM, 2010, AQUAT TOXICOL, V99, P118, DOI 10.1016/j.aquatox.2010.04.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hur JW, 2007, ICHTHYOL RES, V54, P32, DOI 10.1007/s10228-006-0370-2; Ings JS, 2012, COMP BIOCHEM PHYS C, V156, P67, DOI 10.1016/j.cbpc.2012.04.002; Ip Y.K., 2001, Fish Physiology, V20, P109; Ip YK, 2004, PHYSIOL BIOCHEM ZOOL, V77, P390, DOI 10.1086/383510; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; Iversen M, 1998, AQUACULTURE, V168, P387, DOI 10.1016/S0044-8486(98)00364-0; JENEY Z, 1992, AQUACULTURE, V104, P139, DOI 10.1016/0044-8486(92)90144-A; Jin HJ, 2008, MOL IMMUNOL, V45, P1258, DOI 10.1016/j.molimm.2007.09.015; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kiron V, 2011, CONDITIONS ENTREPREN, P315; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Lim LC, 2003, AQUAC RES, V34, P923, DOI 10.1046/j.1365-2109.2003.00946.x; LONG Y, 2012, PLOS ONE, V7; Lushchak VI, 2005, INT J BIOCHEM CELL B, V37, P1670, DOI 10.1016/j.biocel.2005.02.024; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Lygren B, 2000, AQUAC RES, V31, P401, DOI 10.1046/j.1365-2109.2000.00459.x; Marshall WS, 2005, J EXP BIOL, V208, P1063, DOI 10.1242/jeb.01491; Martin SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-418; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Momoda TS, 2007, COMP BIOCHEM PHYS D, V2, P303, DOI 10.1016/j.cbd.2007.06.002; Montero D, 1999, FISH PHYSIOL BIOCHEM, V20, P53, DOI 10.1023/A:1007719928905; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; *ORN AQ TRAD ASS, 2008, WAT QUAL CRIT; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Paterson BD, 2003, AQUACULTURE, V218, P717, DOI 10.1016/S0044-8486(02)00564-1; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Person-Le Ruyet J, 2002, AQUACULTURE, V205, P373, DOI 10.1016/S0044-8486(01)00689-5; Peter MCS, 2011, GEN COMP ENDOCR, V172, P198, DOI 10.1016/j.ygcen.2011.02.023; Peterson BC, 2004, DOMEST ANIM ENDOCRIN, V26, P231, DOI 10.1016/j.domaniend.2003.10.005; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Puntarulo S, 1998, FREE RADICAL BIO MED, V24, P1324, DOI 10.1016/S0891-5849(97)00463-2; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salem M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-328; Sanderson LA, 2010, J EXP BIOL, V213, P2343, DOI 10.1242/jeb.039156; Sangiao-Alvarellos S, 2005, J EXP ZOOL PART A, V303A, P761, DOI 10.1002/jez.a.203; Schrader M, 2004, HISTOCHEM CELL BIOL, V122, P383, DOI 10.1007/s00418-004-0673-1; Urbinati EC, 2004, AQUACULTURE, V229, P389, DOI 10.1016/S0044-8486(03)00350-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VIJAYAN MM, 1990, AQUACULTURE, V88, P371, DOI 10.1016/0044-8486(90)90162-G; Walpita CN, 2007, GEN COMP ENDOCR, V150, P18, DOI 10.1016/j.ygcen.2006.07.002; Walsh Patrick J., 2001, Fish Physiology, V20, P1; Wicks BJ, 2002, AQUAT TOXICOL, V59, P71, DOI 10.1016/S0166-445X(01)00237-5; Wilkinson KD, 1999, J NUTR, V129, P1933, DOI 10.1093/jn/129.11.1933; Wiseman S, 2007, COMP BIOCHEM PHYS D, V2, P234, DOI 10.1016/j.cbd.2007.04.005; Wohr AC, 2005, BERL MUNCH TIERARZTL, V118, P177; Wright PA, 2007, J EXP BIOL, V210, P2905, DOI 10.1242/jeb.003905; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	83	22	25	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65028	10.1371/journal.pone.0065028	http://dx.doi.org/10.1371/journal.pone.0065028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762281	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000320440500019
J	Newman, S; Howarth, KD; Greenman, CD; Bignell, GR; Tavare, S; Edwards, PAW				Newman, Scott; Howarth, Karen D.; Greenman, Chris D.; Bignell, Graham R.; Tavare, Simon; Edwards, Paul A. W.			The Relative Timing of Mutations in a Breast Cancer Genome	PLOS ONE			English	Article							CELL-LINES; GERMLINE MUTATIONS; HETEROZYGOSITY; TRANSLOCATIONS; REARRANGEMENT; INSTABILITY; EVOLUTION; FUSION; BAP1; LANDSCAPES	Many tumors have highly rearranged genomes, but a major unknown is the relative importance and timing of genome rearrangements compared to sequence-level mutation. Chromosome instability might arise early, be a late event contributing little to cancer development, or happen as a single catastrophic event. Another unknown is which of the point mutations and rearrangements are selected. To address these questions we show, using the breast cancer cell line HCC1187 as a model, that we can reconstruct the likely history of a breast cancer genome. We assembled probably the most complete map to date of a cancer genome, by combining molecular cytogenetic analysis with sequence data. In particular, we assigned most sequence-level mutations to individual chromosomes by sequencing of flow sorted chromosomes. The parent of origin of each chromosome was assigned from SNP arrays. We were then able to classify most of the mutations as earlier or later according to whether they occurred before or after a landmark event in the evolution of the genome, endoreduplication (duplication of its entire genome). Genome rearrangements and sequence-level mutations were fairly evenly divided earlier and later, suggesting that genetic instability was relatively constant throughout the life of this tumor, and chromosome instability was not a late event. Mutations that caused chromosome instability would be in the earlier set. Strikingly, the great majority of inactivating mutations and in-frame gene fusions happened earlier. The non-random timing of some of the mutations may be evidence that they were selected.	[Newman, Scott; Howarth, Karen D.; Edwards, Paul A. W.] Univ Cambridge, Hutchison MRC Res Ctr, Cambridge, England; [Newman, Scott; Howarth, Karen D.; Edwards, Paul A. W.] Univ Cambridge, Dept Pathol, Cambridge, England; [Greenman, Chris D.; Bignell, Graham R.] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England; [Tavare, Simon] Univ Cambridge, CRUK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; CRUK Cambridge Institute; University of Cambridge	Edwards, PAW (corresponding author), Univ Cambridge, Hutchison MRC Res Ctr, Cambridge, England.	pawe1@cam.ac.uk	Edwards, Paul A/M-8291-2014	Edwards, Paul A/0000-0002-4789-3374	MRC; Cancer Research UK [C14303/A10825]; Breast Cancer Campaign; Wellcome Trust [077012/Z/05/Z]; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; Cancer Research UK [14545, 19556] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	SN was supported by an MRC studentship and the work was principally funded by Cancer Research UK and Breast Cancer Campaign. CDG and GB were supported by Wellcome Trust grant No.077012/Z/05/Z. ST was supported by Cancer Research UK grant C14303/A10825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Davidson JM, 2000, BRIT J CANCER, V83, P1309, DOI 10.1054/bjoc.2000.1458; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; DUTRILLAUX B, 1991, BREAST CANCER RES TR, V19, P245, DOI 10.1007/BF01961161; Edwards PAW, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3122; Edwards PAW, 2010, J PATHOL, V220, P244, DOI 10.1002/path.2632; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Howarth KD, 2008, ONCOGENE, V27, P3345, DOI 10.1038/sj.onc.1210993; Howarth KD, 2011, GENOME RES, V21, P525, DOI 10.1101/gr.114116.110; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Johansson B, 1996, GENE CHROMOSOME CANC, V16, P155, DOI 10.1002/(SICI)1098-2264(199607)16:3<155::AID-GCC1>3.0.CO;2-Y; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Liu XJ, 2010, CANCER GENET CYTOGEN, V197, P152, DOI 10.1016/j.cancergencyto.2009.11.005; MULERIS M, 1988, CANCER GENET CYTOGEN, V32, P43, DOI 10.1016/0165-4608(88)90310-X; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Ogiwara H, 2008, ONCOGENE, V27, P4788, DOI 10.1038/onc.2008.113; Osborne J, 2005, INT J CANCER, V116, P646, DOI 10.1002/ijc.21036; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Thiagalingam S, 2001, P NATL ACAD SCI USA, V98, P2698, DOI 10.1073/pnas.051625398; TINGLEY M, 1993, AM STAT, V47, P20, DOI 10.2307/2684776; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wistuba II, 1998, CLIN CANCER RES, V4, P2931; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Woods NT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002255	45	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64991	10.1371/journal.pone.0064991	http://dx.doi.org/10.1371/journal.pone.0064991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762276	Green Submitted, Green Published, gold			2022-12-25	WOS:000320440500017
J	Ford, KR; Ettinger, AK; Lundquist, JD; Raleigh, MS; Lambers, JHR				Ford, Kevin R.; Ettinger, Ailene K.; Lundquist, Jessica D.; Raleigh, Mark S.; Lambers, Janneke Hille Ris			Spatial Heterogeneity in Ecologically Important Climate Variables at Coarse and Fine Scales in a High-Snow Mountain Landscape	PLOS ONE			English	Article							SUB-ALPINE MEADOWS; PLANT DIVERSITY; RANGE SHIFTS; IMPACTS; MODELS; TERRAIN; PRECIPITATION; BIODIVERSITY; TEMPERATURE; COLORADO	Climate plays an important role in determining the geographic ranges of species. With rapid climate change expected in the coming decades, ecologists have predicted that species ranges will shift large distances in elevation and latitude. However, most range shift assessments are based on coarse-scale climate models that ignore fine-scale heterogeneity and could fail to capture important range shift dynamics. Moreover, if climate varies dramatically over short distances, some populations of certain species may only need to migrate tens of meters between microhabitats to track their climate as opposed to hundreds of meters upward or hundreds of kilometers poleward. To address these issues, we measured climate variables that are likely important determinants of plant species distributions and abundances (snow disappearance date and soil temperature) at coarse and fine scales at Mount Rainier National Park in Washington State, USA. Coarse-scale differences across the landscape such as large changes in elevation had expected effects on climatic variables, with later snow disappearance dates and lower temperatures at higher elevations. However, locations separated by small distances (similar to 20 m), but differing by vegetation structure or topographic position, often experienced differences in snow disappearance date and soil temperature as great as locations separated by large distances (>1 km). Tree canopy gaps and topographic depressions experienced later snow disappearance dates than corresponding locations under intact canopy and on ridges. Additionally, locations under vegetation and on topographic ridges experienced lower maximum and higher minimum soil temperatures. The large differences in climate we observed over small distances will likely lead to complex range shift dynamics and could buffer species from the negative effects of climate change.	[Ford, Kevin R.; Ettinger, Ailene K.; Lambers, Janneke Hille Ris] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Lundquist, Jessica D.; Raleigh, Mark S.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ford, KR (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	kford10@gmail.com	Raleigh, Mark S/M-7687-2015	Raleigh, Mark S/0000-0002-1303-3472; Ettinger, Ailene/0000-0002-6228-6732	University of Washington Department of Biology; American Alpine Club; Seattle chapter of the ARCS Foundation; NSF Doctoral Dissertation Improvement Grant [DEB-1010787]; University of Washington Royalty Research Foundation; US Department of Energy (DOE) [DE-FC02 06ER64159]; NSF Graduate Research Fellowship Program [DGE-0718124]; NSF [CBET-0931780]; NASA Headquarters under the NASA Earth and Space Science Fellowship Program [NNX09AO22H]; Direct For Biological Sciences [1209661] Funding Source: National Science Foundation; Division Of Environmental Biology [1054012] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [0931780] Funding Source: National Science Foundation	University of Washington Department of Biology(University of Washington); American Alpine Club; Seattle chapter of the ARCS Foundation; NSF Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); University of Washington Royalty Research Foundation(University of Washington); US Department of Energy (DOE)(United States Department of Energy (DOE)); NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NASA Headquarters under the NASA Earth and Space Science Fellowship Program(National Aeronautics & Space Administration (NASA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Research was supported by the University of Washington Department of Biology (KF, AE), the American Alpine Club (KF), the Seattle chapter of the ARCS Foundation (KF), an NSF Doctoral Dissertation Improvement Grant (DEB-1010787) (AE), the University of Washington Royalty Research Foundation (JH) and the US Department of Energy (DOE#DE-FC02 06ER64159) (JH). This material is based on work supported by the NSF Graduate Research Fellowship Program (DGE-0718124- KF, AE), NSF grant no. CBET-0931780 (JL) and by NASA Headquarters under the NASA Earth and Space Science Fellowship Program (NNX09AO22H) (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, CLIMATE CHANGE 2007; [Anonymous], 1975, COMMUNITIES ECOSYSTE; [Anonymous], CLIMATE CHANGE 2007; Austin MP, 2011, J BIOGEOGR, V38, P9, DOI 10.1111/j.1365-2699.2010.02415.x; Barrows CW, 2012, BIOL CONSERV, V152, P29, DOI 10.1016/j.biocon.2012.03.028; Bates D., 2011, PACKAGE LME4 LINEAR; Bennie JJ, 2010, AGR FOREST METEOROL, V150, P12, DOI 10.1016/j.agrformet.2009.07.014; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark MP, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010745; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Deems JS, 2008, J HYDROMETEOROL, V9, P977, DOI 10.1175/2008JHM901.1; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Egli L, 2012, HYDROL PROCESS, V26, P1574, DOI 10.1002/hyp.8244; Elsner M.M., 2009, WASHINGTON CLIMATE C, P69; Erickson TA, 2005, WATER RESOUR RES, V41, DOI 10.1029/2003WR002973; Franklin JF, 1988, SCI MONOGRAPH SERIES, V19; Fridley JD, 2009, J APPL METEOROL CLIM, V48, P1033, DOI 10.1175/2008JAMC2084.1; Geiger R., 2009, CLIMATE NEAR GROUND; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Humboldt A., 1807, ESSAY GEOGRAPHY PLAN; Huntley Brian, 2005, P109; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Larcher W, 2003, PHYSL PLANT ECOLOGY; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lundquist JD, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007561; Lundquist JD, 2010, J HYDROMETEOROL, V11, P1141, DOI 10.1175/2010JHM1264.1; Lundquist JD, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR007035; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; Merriam C.H., 1890, 3 USDA DIV ORN MAMM; Millar CI, 2010, ARCT ANTARCT ALP RES, V42, P76, DOI 10.1657/1938-4246-42.1.76; Mote P., 2009, WASHINGTON CLIMATE C; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Raleigh MS, 2013, REMOTE SENS ENVIRON, V128, P44, DOI 10.1016/j.rse.2012.09.016; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Rochefort RM, 1996, ARCTIC ALPINE RES, V28, P52, DOI 10.2307/1552085; Rochefort RM, 2006, RESTORING PACIFIC NW, P241; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Scherrer D, 2010, GLOBAL CHANGE BIOL, V16, P2602, DOI 10.1111/j.1365-2486.2009.02122.x; Sicart JE, 2004, J HYDROMETEOROL, V5, P774, DOI 10.1175/1525-7541(2004)005<0774:ASSODN>2.0.CO;2; Sturm M, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009434; Tamme R, 2010, J VEG SCI, V21, P796, DOI 10.1111/j.1654-1103.2010.01185.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Varhola A, 2010, J HYDROL, V392, P219, DOI 10.1016/j.jhydrol.2010.08.009; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838; Wipf S, 2010, POLAR RES-SWEDEN, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x; Wundram D, 2010, ARCT ANTARCT ALP RES, V42, P117, DOI 10.1657/1938-4246-42.1.117; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zald HSJ, 2012, LANDSCAPE ECOL, V27, P1197, DOI 10.1007/s10980-012-9774-8; Zuur Alain F., 2009, P1	60	47	48	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65008	10.1371/journal.pone.0065008	http://dx.doi.org/10.1371/journal.pone.0065008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762277	gold, Green Submitted, Green Published			2022-12-25	WOS:000321094800013
J	Teto, G; Kanmogne, GD; Torimiro, JN; Alemnji, G; Nguemaim, FN; Takou, D; Nanfack, A; Tazoacha, A				Teto, Georges; Kanmogne, Georgette D.; Torimiro, Judith N.; Alemnji, George; Nguemaim, Flore N.; Takou, Desire; Nanfack, Aubin; Tazoacha, Asonganyi			Lipid Peroxidation and Total Cholesterol in HAART-Naive Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; FREE-RADICALS; HIV DISEASE; PLASMA	Background: HIV infection has commonly been found to affect lipid profile and antioxidant defense. Objectives: To determine the effects of Human Immunodeficiency Virus (HIV) infection and viral subtype on patient's cholesterol and oxidative stress markers, and determine whether in the absence of Highly Active Antiretroviral Therapy (HAART), these biochemical parameters could be useful in patient's management and monitoring disease progression in Cameroon. For this purpose, we measured total cholesterol (TC), LDL cholesterol (LDLC), HDL cholesterol (HDLC), total antioxidant ability (TAA), lipid peroxidation indices (LPI), and malondialdehyde (MDA) in HIV negative persons and HIV positive HAART-naive patients infected with HIV-1 group M subtypes. Methods: We measured serum TC, LDLC, HDLC, plasma MDA, and TAA concentrations, and calculated LPI indices in 151 HIV-positive HAART-naive patients and 134 seronegative controls. We also performed gene sequence analysis on samples from 30 patients to determine the effect of viral genotypes on these biochemical parameters. We also determined the correlation between CD4 cell count and the above biochemical parameters. Results: We obtained the following controls/patients values for TC (1.96+/-0.54/1.12+/-0.48 g/l), LDLC (0.67+/-0.46/0.43+/-0.36 g/l), HDLC (105.51+/-28.10/46.54+/-23.36 mg/dl) TAA (0.63+/-0.17/0.16+/-0.16 mM), MDA (0.20+/-0.07/0.41+/-0.10 mM) and LPI (0.34+/-0.14/26.02+/-74.40). In each case, the difference between the controls and patients was statistically significant (p<0.05). There was a positive and statistically significant Pearson correlation between CD4 cell count and HDLC (r = +0.272; p<0.01), TAA (r = +0.199; p<0.05) and a negative and statistically significant Pearson correlation between CD4 cell count and LPI (r = 20.166; p<0.05). Pearson correlation between CD4 cell count and TC, CD4cell count and LDLC was positive but not statistically significant while it was negative but not statistically significant with MDA. The different subtypes obtained after sequencing were CRF02_AG (43.3%), CRF01_AE (20%), A1 (23.3%), H (6.7%), and G (6.7%). None of the HIV-1 subtypes significantly influenced the levels of the biochemical parameters, but by grouping them as pure subtypes and circulating recombinant forms (CRFs), the CRF significantly influenced TC levels. TC was significantly lower in patients infected with CRF (0.87+/-0.27 g/l) compared to patients infected with pure HIV-1 subtypes (1.32+/-0.68 g/l) (p<0.017). MDA levels were also significantly higher in patients infected with HIV-1CRF01_AE (0.50+/-0.10 mM), compared to ;patients infected with CRF02_AG (0.38+/-0.08 mM) (p<0.018). Conclusion: These results show that HIV infection in Cameroon is associated with significant decrease in TAA, LDLC, HDLC and TC, and increased MDA concentration and LPI indices which seem to be linked to the severity of HIV infection as assessed by CD4 cell count. The data suggests increased oxidative stress and lipid peroxidation in HIV-infected patients in Cameroon, and an influence of CRFs on TC and MDA levels.	[Teto, Georges; Alemnji, George; Nguemaim, Flore N.; Tazoacha, Asonganyi] Univ Yaounde I, Lab Immunol Biochem & Biotechnol, Yaounde, Cameroon; [Torimiro, Judith N.; Takou, Desire; Nanfack, Aubin] CIRCB Chantal Biya Int Res Ctr, Yaounde, Cameroon; [Teto, Georges; Torimiro, Judith N.; Alemnji, George; Nguemaim, Flore N.; Tazoacha, Asonganyi] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Kanmogne, Georgette D.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	University of Yaounde I; University of Yaounde I; University of Nebraska System; University of Nebraska Medical Center	Teto, G (corresponding author), Univ Yaounde I, Lab Immunol Biochem & Biotechnol, Yaounde, Cameroon.	ggteto@yahoo.fr			United States National Institute of Health [R01 MH094160]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094160] Funding Source: NIH RePORTER	United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	CIRCB for the facilities put at our disposal for this project. Dr. Georgette Kanmogne is partially supported by the United States National Institute of Health grant R01 MH094160. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adje C, 2001, J ACQ IMMUN DEF SYND, V26, P501, DOI 10.1097/00126334-200104150-00018; Agwale SM, 2001, J CLIN MICROBIOL, V39, P2110, DOI 10.1128/JCM.39.6.2110-2114.2001; Ariel C, 1997, CARDIOLOGIE PATHOLOG; Belec L, 1993, MEDECINE, P9; Belec L, 2007, TRANSMISSION SEXUELL, P301; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Chaix M, 2007, LETT INFECT, V22, P56; Djinhi J, 2008, BIOL CLIN, P11; Ducobu J, 2000, Rev Med Brux, V21, P11; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FULBERT JC, 1992, PATHOL BIOL, V40, P66; HALLIWELL B, 1991, ARCH INTERN MED, V151, P29, DOI 10.1001/archinte.151.1.29; HAMSTEN A, 1990, BAILLIERE CLIN ENDOC, V4, P895, DOI 10.1016/S0950-351X(05)80084-9; Heyndrickx L, 2000, AIDS, V14, P1862, DOI 10.1097/00002030-200008180-00028; Heyndrickx L, 2002, HETERODUPLEX MOBILIT; I-Favier Hinninger, 2011, LIPIDES DERIVES COUR; Jerri L, 1997, AM J CLIN PATHOL, V109, P268; Julian Falutz, 2010, J ACQUIR IMMUNE DEFI; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kohn HI, 1944, J PHARMACOL EXP THER, V82, P292; L'Henaff M, 2006, J SIDA; Lefevre G, 1998, ANN BIOL CLIN-PARIS, V56, P305; Levy JA, 2007, AM SOC MICROBIOLOGY, V3, P87; Lopez O, 1996, CLIN CHIM ACTA, V247, P181, DOI 10.1016/0009-8981(95)06249-1; Marston B, 2004, NEW ENGL J MED, V351, P78, DOI 10.1056/NEJMe048134; Montagnier L, 2003, APPORTS RECHERCHE LU; National AIDS Control Committee/National Statistique Institute, 2006, PREL REP CAM DEM HLT; Ndembi N, 2004, JAIDS-J ACQ IMM DEF, V37, P1641, DOI 10.1097/00126334-200412150-00019; Ndongmo CB, 2006, AIDS RES HUM RETROV, V22, P812, DOI 10.1089/aid.2006.22.812; Nguemaim N. F., 2012, Journal of Medical Sciences (Pakistan), V12, P131, DOI 10.3923/jms.2012.131.140; Nguemaim N, 2010, HIV MED, V11, P353, DOI 10.1111/j.1468-1293.2009.00784.x; Plantier JC, 2009, NAT MED, P1; Rabaud C, 1997, ANN BIOL CLIN-PARIS, V55, P565; Raisonnier A, 1988, ANN U SC SANTE, V5, P755; Rasheed Suraiya, 2008, OPEN ACCESS, V3, P1; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Suresh DR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-61; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UNAIDS, 2011, JOURN MOND SID 2011; UNAIDS, 2010, RAPP ONUSIDA EP MOND; Zabell Martin, 2011, NORMAL CHOLESTEROL L	45	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65126	10.1371/journal.pone.0065126	http://dx.doi.org/10.1371/journal.pone.0065126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762297	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800020
J	Simbolo, M; Gottardi, M; Corbo, V; Fassan, M; Mafficini, A; Malpeli, G; Lawlor, RT; Scarpa, A				Simbolo, Michele; Gottardi, Marisa; Corbo, Vincenzo; Fassan, Matteo; Mafficini, Andrea; Malpeli, Giorgio; Lawlor, Rita T.; Scarpa, Aldo			DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples	PLOS ONE			English	Article							EXTRACTION METHODS; GENOMIC DNA; CANCER; ABSORBENCY; MUTATIONS; EVOLUTION; QUALITY; TISSUE; RATIOS	Histopathological samples are a treasure-trove of DNA for clinical research. However, the quality of DNA can vary depending on the source or extraction method applied. Thus a standardized and cost-effective workflow for the qualification of DNA preparations is essential to guarantee interlaboratory reproducible results. The qualification process consists of the quantification of double strand DNA (dsDNA) and the assessment of its suitability for downstream applications, such as high-throughput next-generation sequencing. We tested the two most frequently used instrumentations to define their role in this process: NanoDrop, based on UV spectroscopy, and Qubit 2.0, which uses fluorochromes specifically binding dsDNA. Quantitative PCR (qPCR) was used as the reference technique as it simultaneously assesses DNA concentration and suitability for PCR amplification. We used 17 genomic DNAs from 6 fresh-frozen (FF) tissues, 6 formalin-fixed paraffin-embedded (FFPE) tissues, 3 cell lines, and 2 commercial preparations. Intra-and inter-operator variability was negligible, and intra-methodology variability was minimal, while consistent inter-methodology divergences were observed. In fact, NanoDrop measured DNA concentrations higher than Qubit and its consistency with dsDNA quantification by qPCR was limited to high molecular weight DNA from FF samples and cell lines, where total DNA and dsDNA quantity virtually coincide. In partially degraded DNA from FFPE samples, only Qubit proved highly reproducible and consistent with qPCR measurements. Multiplex PCR amplifying 191 regions of 46 cancer-related genes was designated the downstream application, using 40 ng dsDNA from FFPE samples calculated by Qubit. All but one sample produced amplicon libraries suitable for next-generation sequencing. NanoDrop UV-spectrum verified contamination of the unsuccessful sample. In conclusion, as qPCR has high costs and is labor intensive, an alternative effective standard workflow for qualification of DNA preparations should include the sequential combination of NanoDrop and Qubit to assess the purity and quantity of dsDNA, respectively.	[Simbolo, Michele; Gottardi, Marisa; Corbo, Vincenzo; Fassan, Matteo; Mafficini, Andrea; Lawlor, Rita T.; Scarpa, Aldo] Univ Verona, ARC NET Res Ctr, I-37100 Verona, Italy; [Simbolo, Michele; Scarpa, Aldo] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Malpeli, Giorgio; Scarpa, Aldo] Univ Integrata Verona, Azienda Osped, Dept Surg & Oncol, Verona, Italy	University of Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Scarpa, A (corresponding author), Univ Verona, ARC NET Res Ctr, I-37100 Verona, Italy.	aldo.scarpa@univr.it	Simbolo, Michele/AAB-1851-2019; Mafficini, Andrea/AAK-8158-2020; Fassan, Matteo/F-5152-2012; scarpa, aldo/K-6832-2016; Corbo, Vincenzo/J-7754-2016	Simbolo, Michele/0000-0002-0866-4499; Mafficini, Andrea/0000-0002-7471-3121; Fassan, Matteo/0000-0001-6515-5482; scarpa, aldo/0000-0003-1678-739X; Corbo, Vincenzo/0000-0002-6340-8009; Malpeli, Giorgio/0000-0002-2996-2903; lawlor, Rita/0000-0003-3160-0634	Associazione Italiana Ricerca sul Cancro 5xmille [12182]; Italian Cancer Genome Project grant from the Italian Ministry of Research [FIRB - RBAP10AHJB]	Associazione Italiana Ricerca sul Cancro 5xmille(Fondazione AIRC per la ricerca sul cancro); Italian Cancer Genome Project grant from the Italian Ministry of Research	This research has been supported financially by Associazione Italiana Ricerca sul Cancro 5xmille grant n. 12182; and an Italian Cancer Genome Project grant from the Italian Ministry of Research (FIRB - RBAP10AHJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Brosnan JA, 2012, SEMIN CELL DEV BIOL, V23, P237, DOI 10.1016/j.semcdb.2011.12.008; Corless CL, 2012, CANCER DISCOV, V2, P23, DOI 10.1158/2159-8290.CD-11-0319; Desjardins P, 2010, J VIS EXP; Dong Hui, 2012, Front Med, V6, P48, DOI 10.1007/s11684-012-0182-x; Foley C, 2011, J DAIRY SCI, V94, P3159, DOI 10.3168/jds.2010-3987; Gallagher S.R., 2006, CURR PROTOC MOL BIOL; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; Guo F, 2012, APPL MICROBIOL BIOTE; Haque KA, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-20; HUBERMAN JA, 1995, BIOTECHNIQUES, V18, P636; Lee JH, 2010, YONSEI MED J, V51, P104, DOI 10.3349/ymj.2010.51.1.104; Ma QLC, 2012, CURR OPIN GENET DEV, V22, P3, DOI 10.1016/j.gde.2012.01.008; Manchester KL, 1996, BIOTECHNIQUES, V20, P968; MANCHESTER KL, 1995, BIOTECHNIQUES, V19, P208; Mee BC, 2011, BIOPRESERV BIOBANK, V9, P389, DOI 10.1089/bio.2011.0034; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Moch H, 2012, VIRCHOWS ARCH, V460, P3, DOI 10.1007/s00428-011-1179-6; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; O'Neill M, 2011, J PHYS C SERIES, V307; Robertson C, 2003, SPECTROPHOTOMETRYS N; Ross JS, 2011, AM J CLIN PATHOL, V136, P527, DOI 10.1309/AJCPR1SVT1VHUGXW; Sironen A, 2011, AGR FOOD SCI, V20, P143, DOI 10.2137/145960611797215709; Su ZQ, 2011, EXPERT REV MOL DIAGN, V11, P333, DOI [10.1586/ERM.11.3, 10.1586/erm.11.3]; Tsongalis GJ, 2006, CLIN CHIM ACTA, V363, P127, DOI 10.1016/j.cccn.2005.05.043	25	169	173	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e62692	10.1371/journal.pone.0062692	http://dx.doi.org/10.1371/journal.pone.0062692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762227	Green Published, gold			2022-12-25	WOS:000321099000003
J	Singer, E; Linehan, J; Babilonia, G; Imam, SA; Smith, D; Loera, S; Wilson, T; Smith, S				Singer, Elizabeth; Linehan, Jennifer; Babilonia, Gail; Imam, S. Ashraf; Smith, David; Loera, Sofia; Wilson, Timothy; Smith, Steven			Stromal Response to Prostate Cancer: Nanotechnology-Based Detection of Thioredoxin-Interacting Protein Partners Distinguishes Prostate Cancer Associated Stroma from That of Benign Prostatic Hyperplasia	PLOS ONE			English	Article							NUCLEOPROTEIN ASSEMBLIES; MITOCHONDRIA	Histological staining of reactive stroma has been shown to be a predictor of biochemical recurrence in prostate cancer, however, molecular markers of the stromal response to prostate cancer have not yet been fully delineated. The objective of this study was to determine whether or not the stromal biomarkers detected with a thioredoxin-targeted nanodevice could be used to distinguish the stroma associated with benign prostatic hyperplasia from that associated with PCA. In this regard, we recently demonstrated that a thioredoxin-targeted nanodevice selectively binds to reactive stroma in frozen prostate tumor tissue sections. To accomplish this, random frozen prostate tissue sections from each of 35 patients who underwent resection were incubated with the nanodevice and graded for fluorescent intensity. An adjacent section from each case was stained with Hematoxylin & Eosin to confirm the diagnosis. Select cases were stained with Masson's Trichrome or immunohistochemically using antibodies to thioredoxin reductase 1, thioredoxin reductase 2 or peroxiredoxin 1. Our results demonstrate that the graded intensity of nanodevice binding to the stroma associated with PCA was significantly higher (p = 0.0127) than that of benign prostatic hyperplasia using the t-test. Immunohistochemical staining of adjacent sections in representative cases showed that none of the two commonly studied thioredoxin interacting protein partners mirrored the fluorescence pattern seen with the nanodevice. However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer. We conclude that the signal detected by the nanodevice, in contrast to individual targets detected with antibodies used in this study, originates from multiple thioredoxin interacting protein partners that distinguish the M2 neutrophil and macrophage associated inflammatory response in prostate cancer-associated stroma from the CD4+ T-Lymphocyte linked inflammation in benign prostatic hyperplasia.	[Singer, Elizabeth; Linehan, Jennifer; Babilonia, Gail; Smith, David; Loera, Sofia; Wilson, Timothy; Smith, Steven] City Hope Natl Med Ctr, Duarte, CA USA; [Imam, S. Ashraf] Huntington Med Res Inst, Pasadena, CA USA	City of Hope; Huntington Medical Research Institutes	Smith, S (corresponding author), City Hope Natl Med Ctr, Duarte, CA USA.	ssmith@coh.org	Smith, David/A-4115-2017	Smith, David/0000-0001-9644-2353	United States National Cancer Institute of the National Institutes of Health (NIH) [CA136055]; NIH National Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA033572, R03CA136055] Funding Source: NIH RePORTER	United States National Cancer Institute of the National Institutes of Health (NIH); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grant CA136055 from the United States National Cancer Institute of the National Institutes of Health (NIH). This grant entitled: Thioredoxin Targeted Nanoparticles for Cancer Research, was peer reviewed and then funded based on merit by the NIH National Cancer Institute. The funders (the NIH itself) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala G, 2003, CLIN CANCER RES, V9, P2003; Ayala GE, 2011, AM J PATHOL, V178, P79, DOI 10.1016/j.ajpath.2010.09.042; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Clark J, 2003, BIOTECHNIQUES, V35, P548, DOI 10.2144/03353rr01; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Klimp AH, 2001, CANCER RES, V61, P7305; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Orsted DD, 2011, EUR UROL, V60, P691, DOI 10.1016/j.eururo.2011.06.016; Porta C, 2009, IMMUNOBIOLOGY, V214, P761, DOI 10.1016/j.imbio.2009.06.014; Schenk JM, 2011, AM J EPIDEMIOL, V173, P1419, DOI 10.1093/aje/kwq493; Singer EM, 2006, NANO LETT, V6, P1184, DOI 10.1021/nl060549h; Singer EM, 2011, NANOMEDICINE-UK, V6, P659, DOI [10.2217/nnm.11.22, 10.2217/NNM.11.22]; Smith SS, 1997, P NATL ACAD SCI USA, V94, P2162, DOI 10.1073/pnas.94.6.2162; Stanley BA, 2011, J BIOL CHEM, V286, P33669, DOI 10.1074/jbc.M111.284612; Wendel JA, 1998, NANOTECHNOLOGY, V9, P297, DOI 10.1088/0957-4484/9/3/021; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615	19	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e60562	10.1371/journal.pone.0060562	http://dx.doi.org/10.1371/journal.pone.0060562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762225	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000002
J	Stephenson, JD; Hallis, LJ; Nagashima, K; Freeland, SJ				Stephenson, James D.; Hallis, Lydia J.; Nagashima, Kazuhide; Freeland, Stephen J.			Boron Enrichment in Martian Clay	PLOS ONE			English	Article							AQUEOUS ALTERATION; ADSORPTION; ISOTOPES; RIBOSE; SUGARS; SEA	We have detected a concentration of boron in martian clay far in excess of that in any previously reported extra-terrestrial object. This enrichment indicates that the chemistry necessary for the formation of ribose, a key component of RNA, could have existed on Mars since the formation of early clay deposits, contemporary to the emergence of life on Earth. Given the greater similarity of Earth and Mars early in their geological history, and the extensive disruption of Earth's earliest mineralogy by plate tectonics, we suggest that the conditions for prebiotic ribose synthesis may be better understood by further Mars exploration.	[Stephenson, James D.; Hallis, Lydia J.; Freeland, Stephen J.] Univ Hawaii, NASA Astrobiol Inst, Honolulu, HI 96822 USA; [Hallis, Lydia J.; Nagashima, Kazuhide] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	National Aeronautics & Space Administration (NASA); University of Hawaii System; University of Hawaii System	Stephenson, JD (corresponding author), Univ Hawaii, NASA Astrobiol Inst, Honolulu, HI 96822 USA.	jds@ifa.hawaii.edu		Nagashima, Kazuhide/0000-0002-9322-3187; Stephenson, James/0000-0002-6427-5703; hallis, lydia/0000-0001-6455-8415	National Aeronautics and Space Administration through the NASA Astrobiology Institute through the Office of Space Science [NNA09DA77A]	National Aeronautics and Space Administration through the NASA Astrobiology Institute through the Office of Space Science	This material is based upon work supported by the National Aeronautics and Space Administration through the NASA Astrobiology Institute under Cooperative Agreement No. NNA09DA77A issued through the Office of Space Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; APPEL PWU, 1995, PRECAMBRIAN RES, V72, P227, DOI 10.1016/0301-9268(94)00089-A; Boutlerow M.A., 1861, CR HEBD ACAD SCI, V53, P145; BRUMSACK HJ, 1992, EARTH PLANET SC LETT, V113, P427, DOI 10.1016/0012-821X(92)90143-J; Cairns-Smith AG, 1985, 7 CLUES ORIGIN LIFE; Changela HG, 2010, METEORIT PLANET SCI, V45, P1847, DOI 10.1111/j.1945-5100.2010.01123.x; Chaussidon M, 1997, CHEM GEOL, V136, P171, DOI 10.1016/S0009-2541(96)00140-4; Chitnis SR, 1997, REACT FUNCT POLYM, V32, P93, DOI 10.1016/S1381-5148(96)00074-0; COUCH EL, 1968, CLAY CLAY MINER, V16, P249, DOI 10.1346/CCMN.1968.0160307; Deamer D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004929; DECKER P, 1982, J CHROMATOGR, V244, P281, DOI 10.1016/S0021-9673(00)85692-7; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; FRIPIAT JJ, 1974, ANNU REV EARTH PL SC, V2, P239, DOI 10.1146/annurev.ea.02.050174.001323; GOODING JL, 1991, METEORITICS, V26, P135, DOI 10.1111/j.1945-5100.1991.tb01029.x; Grew ES, 2011, ORIGINS LIFE EVOL B, V41, P307, DOI 10.1007/s11084-010-9233-y; Hallis LJ, 2011, METEORIT PLANET SCI, V46, P1787, DOI 10.1111/j.1945-5100.2011.01293.x; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Hervig RL, 1996, REV MINERAL, V33, P789; HINGSTON F. J., 1964, AUSTRALIAN J SOIL RES, V2, P83, DOI 10.1071/SR9640083; Jenniskens P, 2012, SCIENCE, V338, P1583, DOI 10.1126/science.1227163; Jochum KP, 2005, GEOSTAND GEOANAL RES, V29, P285, DOI 10.1111/j.1751-908X.2005.tb00901.x; Joshi PC, 2009, J AM CHEM SOC, V131, P13369, DOI 10.1021/ja9036516; KEREN R, 1981, CLAY CLAY MINER, V29, P198, DOI 10.1346/CCMN.1981.0290305; Kim HJ, 2010, SCIENCE, V20, P5994; Kim HJ, 2011, J AM CHEM SOC, V133, P9457, DOI 10.1021/ja201769f; LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158; Murchie S, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003343; Okazaki R, 2003, ANTARCTIC METEORITE, V16, P58; Pucci A., 2010, J COSMOLOGY, V10, P3398; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; SCHWARCZ HP, 1969, EARTH PLANET SC LETT, V6, P1, DOI 10.1016/0012-821X(69)90084-3; SHAPIRO R, 1988, ORIGINS LIFE EVOL B, V18, P71, DOI 10.1007/BF01808782; Spivak-Birndorf LJ, 2008, GOLDSCHM C; STAUFFER H, 1962, J GEOPHYS RES, V67, P2023, DOI 10.1029/JZ067i005p02023; Sugiura N, 2001, METEORIT PLANET SCI, V36, P1397, DOI 10.1111/j.1945-5100.2001.tb01832.x; Szostak J. W., 2012, J SYST CHEM, V3, P2, DOI [10.1186/1759-2208-3-2, DOI 10.1186/1759-2208-3-2]; Thomson BJ, 2011, ICARUS, V214, P413, DOI 10.1016/j.icarus.2011.05.002; TREIMAN AH, 1993, METEORITICS, V28, P86, DOI 10.1111/j.1945-5100.1993.tb00251.x; Wielandt D, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/2/L25; Williams LB, 2001, GEOCHIM COSMOCHIM AC, V65, P1783, DOI 10.1016/S0016-7037(01)00558-0; Wray JJ, 2013, INT J ASTROBIOL, V12, P25, DOI 10.1017/S1473550412000328	42	23	23	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64624	10.1371/journal.pone.0064624	http://dx.doi.org/10.1371/journal.pone.0064624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762242	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000321099000009
J	Cany, J; van der Waart, AB; Tordoir, M; Franssen, GM; Hangalapura, BN; de Vries, J; Boerman, O; Schaap, N; van der Voort, R; Spanholtz, J; Dolstra, H				Cany, Jeannette; van der Waart, Anniek B.; Tordoir, Marleen; Franssen, Gerben M.; Hangalapura, Basav N.; de Vries, Jolanda; Boerman, Otto; Schaap, Nicolaas; van der Voort, Robbert; Spanholtz, Jan; Dolstra, Harry			Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rg(null) Mice	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; NK CELLS; T-CELLS; EXPANSION; TRANSPLANTATION; INFUSION	Natural killer (NK) cell-based adoptive immunotherapy is an attractive adjuvant treatment option for patients with acute myeloid leukemia. Recently, we reported a clinical-grade, cytokine-based culture method for the generation of NK cells from umbilical cord blood (UCB) CD34(+) hematopoietic progenitor cells with high yield, purity and in vitro functionality. The present study was designed to evaluate the in vivo anti-leukemic potential of UCB-NK cells generated with our GMP-compliant culture system in terms of biodistribution, survival and cytolytic activity following adoptive transfer in immunodeficient NOD/SCID/IL2Rg(null) mice. Using single photon emission computed tomography, we first demonstrated active migration of UCB-NK cells to bone marrow, spleen and liver within 24 h after infusion. Analysis of the chemokine receptor expression profile of UCB-NK cells matched in vivo findings. Particularly, a firm proportion of UCB-NK cells functionally expressed CXCR4, what could trigger BM homing in response to its ligand CXCL12. In addition, high expression of CXCR3 and CCR6 supported the capacity of UCB-NK cells to migrate to inflamed tissues via the CXCR3/CXCL10-11 and CCR6/CCL20 axis. Thereafter, we showed that low dose IL-15 mediates efficient survival, expansion and maturation of UCB-NK cells in vivo. Most importantly, we demonstrate that a single UCB-NK cell infusion combined with supportive IL-15 administration efficiently inhibited growth of human leukemia cells implanted in the femur of mice, resulting in significant prolongation of mice survival. These preclinical studies strongly support the therapeutic potential of ex vivo-generated UCB-NK cells in the treatment of myeloid leukemia after immunosuppressive chemotherapy.	[Cany, Jeannette; van der Waart, Anniek B.; Tordoir, Marleen; Hangalapura, Basav N.; van der Voort, Robbert; Spanholtz, Jan; Dolstra, Harry] RUNMC, Hematol Lab, Dept Lab Med, Nijmegen, Netherlands; [Tordoir, Marleen; Spanholtz, Jan] Glycostem Therapeut, Nijmegen, Netherlands; [Franssen, Gerben M.; Boerman, Otto] RUNMC, Dept Nucl Med, Nijmegen, Netherlands; [de Vries, Jolanda] Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands; [Schaap, Nicolaas] RUNMC, Dept Hematol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Dolstra, H (corresponding author), RUNMC, Hematol Lab, Dept Lab Med, Nijmegen, Netherlands.	H.Dolstra@labgk.umcn.nl	Cany, J.S./L-4244-2015; Schaap, Nicolaas/L-4625-2015; Dolstra, H./L-4276-2015; van der Waart, Anniek B/O-4185-2015; van der Waart, Anniek/AAD-9606-2020; Boerman, Otto C/A-8112-2014	Schaap, Nicolaas/0000-0001-7696-4752; Dolstra, H./0000-0002-3998-687X; van der Waart, Anniek B/0000-0001-5986-3060; van der Waart, Anniek/0000-0001-5986-3060; Boerman, Otto C/0000-0001-6832-101X; Spanholtz, Jan/0000-0001-7152-6956	ZonMW [40-41400-98-9018]; Radboud University Nijmegen Medical Centre	ZonMW(Netherlands Organization for Health Research and Development); Radboud University Nijmegen Medical Centre	This work was supported by ZonMW (40-41400-98-9018) and the Radboud University Nijmegen Medical Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayello J, 2006, BIOL BLOOD MARROW TR, V12, P608, DOI 10.1016/j.bbmt.2006.01.009; Beider K, 2003, BLOOD, V102, P1951, DOI 10.1182/blood-2002-10-3293; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; BOGGS DR, 1984, AM J HEMATOL, V16, P277, DOI 10.1002/ajh.2830160309; Brand JM, 2004, STEM CELLS DEV, V13, P307, DOI 10.1089/154732804323099235; Buchner T, 2005, CRIT REV ONCOL HEMAT, V56, P247, DOI 10.1016/j.critrevonc.2004.09.010; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Curti A, 2011, BLOOD, V118, P3273, DOI 10.1182/blood-2011-01-329508; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fujisaki H, 2009, CANCER RES, V69, P4010, DOI 10.1158/0008-5472.CAN-08-3712; Guimaraes F, 2006, LEUKEMIA, V20, P833, DOI 10.1038/sj.leu.2404147; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lehmann D, 2012, STEM CELLS DEV, V21, P2926, DOI 10.1089/scd.2011.0659; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Matera L, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-49; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Nguyen S, 2011, TRANSFUSION, V51, P1769, DOI 10.1111/j.1537-2995.2010.03058.x; Pinthus JH, 2004, J CLIN INVEST, V114, P1774, DOI 10.1172/JCI200422284; Rowe JM, 2009, BLOOD, V113, P4129, DOI 10.1182/blood-2008-12-192856; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Tanaka J, 2012, LEUKEMIA, V26, P1149, DOI 10.1038/leu.2011.345; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Woll PS, 2009, BLOOD, V113, P6094, DOI 10.1182/blood-2008-06-165225; Yoon SR, 2010, BONE MARROW TRANSPL, V45, P1038, DOI 10.1038/bmt.2009.304; Zhao ED, 2012, ONCOIMMUNOLOGY, V1, P152, DOI 10.4161/onci.1.2.18480	31	61	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64384	10.1371/journal.pone.0064384	http://dx.doi.org/10.1371/journal.pone.0064384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755121	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400013
J	Compte, N; Boudjeltia, KZ; Vanhaeverbeek, M; De Breucker, S; Tassignon, J; Trelcat, A; Pepersack, T; Goriely, S				Compte, Nathalie; Boudjeltia, Karim Zouaoui; Vanhaeverbeek, Michel; De Breucker, Sandra; Tassignon, Joel; Trelcat, Anne; Pepersack, Thierry; Goriely, Stanislas			Frailty in Old Age Is Associated with Decreased Interleukin-12/23 Production in Response to Toll-Like Receptor Ligation	PLOS ONE			English	Article							ILLNESS RATING-SCALE; PLASMACYTOID DENDRITIC CELLS; LIPOPOLYSACCHARIDE LPS; INFLUENZA VACCINE; ELDERLY HUMANS; VALIDATION; PREDICTORS; CHALLENGES; SENIORS; ADULTS	Aging is associated with progressive alterations of immune functions, leading to higher susceptibility to bacterial and viral infections and reduced vaccine responses. Data concerning cytokine production in response to Toll-like receptor (TLR) ligands are highly variable in old people, reflecting the heterogeneity of the geriatric population. The aim of our study was to define the relative contribution of age and clinical status on TLR-induced interleukin (IL)-12p70 and IL-23 production as these cytokines play an important role in the protection against intracellular and extracellular pathogens, respectively. For this purpose, we recruited 100 subjects (aged 23-96 years) in the general population or hospitalized for chronic diseases. We collected information on clinical status (medical history, ongoing comorbidities, treatments and geriatric scales), biological parameters (biochemical and hematological tests, telomere length determination, cytomegalovirus serology). Whole blood samples were stimulated with a combination of TLR4 and TLR7/8 ligands. We performed univariate and stepwise backward multivariate analyses regression to define which set of clinical variables could be predictive for IL-12p70 and IL-23 production in these conditions. Our results indicated that age was not correlated with TLR-mediated IL-12p70 and IL-23 production. In contrast, poor nutritional status and frailty in subjects >75 years were associated with decreased IL12p70 and IL-23 production. By intracytoplasmic staining, we confirmed that production of IL-12/23p40 by conventional dendritic cells (DCs) upon TLR ligation was decreased in frail patients. However, proportion of DCs and monocytes subsets, phenotypic maturation and proximal signaling events were found to be comparable in frail and healthy old subjects. These results suggest the importance of age-associated clinical parameters and not age by itself in the alteration of innate immune responses in old individuals and emphasis the importance of innate immune responses in the susceptibility of frail geriatric patients to infections.	[Compte, Nathalie; Goriely, Stanislas] Univ Libre Brussels, Inst Med Immunol, Charleroi, Belgium; [Boudjeltia, Karim Zouaoui; Vanhaeverbeek, Michel] Univ Libre Brussels, Expt Med Lab, Unit 222, Hop A Vesale, Montignies le Tilleul, Belgium; [De Breucker, Sandra; Pepersack, Thierry] Hop Erasme, Serv Geriatrie, Brussels, Belgium; [Tassignon, Joel; Trelcat, Anne] ImmuneHlth, Charleroi, Belgium	Universite Libre de Bruxelles	Goriely, S (corresponding author), Univ Libre Brussels, Inst Med Immunol, Charleroi, Belgium.	stgoriel@ulb.ac.be	De Breucker, Sandra/AAZ-1759-2020	De Breucker, Sandra/0000-0003-4598-0295; Goriely, Stanislas/0000-0002-7005-6195; Pepersack, Thierry/0000-0001-6197-582X; compte, nathalie/0000-0002-1175-4153	government of the Walloon Region; GlaxoSmithKline Biologicals; Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium); Interuniversity Attraction Pole of the Belgian Federal Science Policy; FRS-FNRS; Fonds Erasme	government of the Walloon Region; GlaxoSmithKline Biologicals(GlaxoSmithKline); Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole of the Belgian Federal Science Policy(Belgian Federal Science Policy Office); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme	The Institute for Medical Immunology is sponsored by the government of the Walloon Region and GlaxoSmithKline Biologicals. This study was supported by the Fonds National de la Recherche Scientifique (FRS-FNRS, Belgium) and an Interuniversity Attraction Pole of the Belgian Federal Science Policy. NC was supported by the FRS-FNRS and Fonds Erasme. SG is a research associate of the FRS-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Anpalahan M, 2008, INTERN MED J, V38, P16, DOI 10.1111/j.1445-5994.2007.01398.x; Beasley JM, 2010, J AM GERIATR SOC, V58, P1063, DOI 10.1111/j.1532-5415.2010.02866.x; Bruunsgaard H, 1999, CLIN EXP IMMUNOL, V118, P235; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Corsini E, 2006, J LEUKOCYTE BIOL, V80, P376, DOI 10.1189/jlb.0306190; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; Fock RA, 2007, CYTOKINE, V40, P105, DOI 10.1016/j.cyto.2007.08.007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman SL, 2010, ANN NY ACAD SCI, V1190, P97, DOI 10.1111/j.1749-6632.2009.05264.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; GRAVENSTEIN S, 1994, J AM GERIATR SOC, V42, P245, DOI 10.1111/j.1532-5415.1994.tb01746.x; Grolleau-Julius A, 2010, CLIN REV ALLERG IMMU, V39, P42, DOI 10.1007/s12016-009-8169-3; Guigoz Y, 1996, NUTR REV, V54, pS59; Jing Y, 2009, HUM IMMUNOL, V70, P777, DOI 10.1016/j.humimm.2009.07.005; Kagansky N, 2005, AM J CLIN NUTR, V82, P784, DOI 10.1093/ajcn/82.4.784; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Langkamp-Henken B, 2004, J AM GERIATR SOC, V52, P3, DOI 10.1111/j.1532-5415.2004.52003.x; Langkamp-Henken B, 2006, J AM GERIATR SOC, V54, P1861, DOI 10.1111/j.1532-5415.2006.00982.x; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; McCusker J, 1998, ACAD EMERG MED, V5, P883, DOI 10.1111/j.1553-2712.1998.tb02818.x; Nagaratnam N, 2007, ARCH GERONTOL GERIAT, V44, P29, DOI 10.1016/j.archger.2006.02.002; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nyugen J, 2010, J CLIN IMMUNOL, V30, P806, DOI 10.1007/s10875-010-9448-8; Ongradi Joseph, 2010, Immun Ageing, V7, P7, DOI 10.1186/1742-4933-7-7; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Perez-Cabezas B, 2007, EXP GERONTOL, V42, P1033, DOI 10.1016/j.exger.2007.05.010; Pietschmann P, 2000, EXP GERONTOL, V35, P213, DOI 10.1016/S0531-5565(99)00089-3; Qian F, 2012, AGING CELL, V11, P104, DOI 10.1111/j.1474-9726.2011.00759.x; Sagawa M, 2011, GERIATR GERONTOL INT, V11, P63, DOI 10.1111/j.1447-0594.2010.00641.x; Shodell M, 2002, SCAND J IMMUNOL, V56, P518, DOI 10.1046/j.1365-3083.2002.01148.x; van den Biggelaar AHJ, 2004, EXP GERONTOL, V39, P1407, DOI 10.1016/j.exger.2004.06.009; van Duin D, 2007, J AM GERIATR SOC, V55, P1438, DOI 10.1111/j.1532-5415.2007.01300.x; Vellas B, 2006, J NUTR HEALTH AGING, V10, P456; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	44	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65325	10.1371/journal.pone.0065325	http://dx.doi.org/10.1371/journal.pone.0065325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755218	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400052
J	Guo, JJ; Li, JZ; Zhang, Y; Jin, XJ; Liu, HX; Yao, XJ				Guo, Jingjing; Li, Jiazhong; Zhang, Yan; Jin, Xiaojie; Liu, Huanxiang; Yao, Xiaojun			Exploring the Influence of Carbon Nanoparticles on the Formation of beta-Sheet-Rich Oligomers of IAPP(22-28) Peptide by Molecular Dynamics Simulation	PLOS ONE			English	Article							AMYLOIDOGENIC HEXAPEPTIDE NFGAIL; PROTEIN AGGREGATION; ORDERED OLIGOMERS; BINDING-AFFINITY; EXPLICIT SOLVENT; AROMATIC CONTENT; DISEASE; SURFACE; TOXICITY; GRAPHENE	Recent advances in nanotechnologies have led to wide use of nanomaterials in biomedical field. However, nanoparticles are found to interfere with protein misfolding and aggregation associated with many human diseases. It is still a controversial issue whether nanoparticles inhibit or promote protein aggregation. In this study, we used molecular dynamics simulations to explore the effects of three kinds of carbon nanomaterials including graphene, carbon nanotube and C-60 on the aggregation behavior of islet amyloid polypeptide fragment 22-28 (IAPP(22-28)). The diverse behaviors of IAPP(22-28) peptides on the surfaces of carbon nanomaterials were studied. The results suggest these nanomaterials can prevent beta-sheet formation in differing degrees and further affect the aggregation of IAPP(22-28). The pi-pi stacking and hydrophobic interactions are different in the interactions between peptides and different nanoparticles. The subtle differences in the interaction are due to the difference in surface curvature and area. The results demonstrate the adsorption interaction has competitive advantages over the interactions between peptides. Therefore, the fibrillation of IAPP(22-28) may be inhibited at its early stage by graphene or SWCNT. Our study can not only enhance the understanding about potential effects of nanomaterials to amyloid formation, but also provide valuable information to develop potential beta-sheet formation inhibitors against type II diabetes.	[Guo, Jingjing; Li, Jiazhong; Zhang, Yan; Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Guo, Jingjing; Jin, Xiaojie; Liu, Huanxiang; Yao, Xiaojun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Guo, Jingjing; Jin, Xiaojie; Liu, Huanxiang; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University	Liu, HX (corresponding author), Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China.	hxliu@lzu.edu.cn; xjyao@lzu.edu.cn	Guo, Jingjing/GZL-0645-2022	Guo, Jingjing/0000-0002-4632-4364; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21103075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No: 21103075, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Cabaleiro-Lago C, 2012, LANGMUIR, V28, P1852, DOI 10.1021/la203078w; Chan HM, 2012, BIOMATERIALS, V33, P4443, DOI 10.1016/j.biomaterials.2012.03.024; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Elsaesser A, 2012, ADV DRUG DELIVER REV, V64, P129, DOI 10.1016/j.addr.2011.09.001; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fan WJ, 2009, J CHEM THEORY COMPUT, V5, P2879, DOI 10.1021/ct9002493; Frishman D, 2004, PROTEIN-STRUCT FUNCT, V23, P566; Ge CC, 2011, P NATL ACAD SCI USA, V108, P16968, DOI 10.1073/pnas.1105270108; Gilbert N, 2009, NATURE, V460, P937, DOI 10.1038/460937a; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hein K.L., 2009, ANGEW CHEM, V121, P2152; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang P, 2011, BIOPHYS J, V100, P1550, DOI 10.1016/j.bpj.2011.02.010; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim JE, 2003, BIOCHEM BIOPH RES CO, V303, P576, DOI 10.1016/S0006-291X(03)00393-0; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Lee CM, 2011, NANOMED-NANOTECHNOL, V7, P107, DOI 10.1016/j.nano.2010.06.009; Li HY, 2011, BIOPHYS J, V101, P2267, DOI 10.1016/j.bpj.2011.09.046; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Liu G, 2005, BBA-MOL BASIS DIS, V1741, P246, DOI 10.1016/j.bbadis.2005.06.006; Mahmoudi M, 2012, NANOSCALE, V4, P7322, DOI 10.1039/c2nr31657a; Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g; Marsagishvili L.G., 2010, BIOPHYSICS, V55, P699, DOI [10.1134/S0006350910050027, DOI 10.1134/S0006350910050027]; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Melquiond A, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2435358; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Ou LC, 2011, J PHYS CHEM B, V115, P9813, DOI 10.1021/jp201474m; Podlubnaya Z. A., 2006, Biophysics, V51, P701, DOI 10.1134/S0006350906050046; Ritzel RA, 2007, DIABETES, V56, P65, DOI 10.2337/db06-0734; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sahni JK, 2011, J CONTROL RELEASE, V152, P208, DOI 10.1016/j.jconrel.2010.11.033; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sharifi S, 2012, CHEM SOC REV, V41, P2323, DOI 10.1039/c1cs15188f; Shemetov AA, 2012, ACS NANO, V6, P4585, DOI 10.1021/nn300415x; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2007, NEUROSCIENTIST, V13, P519, DOI 10.1177/1073858407303428; Stefani M, 2010, METHODS MOL BIOL, V648, P25, DOI 10.1007/978-1-60761-756-3_2; Tomasio SM, 2009, J PHYS CHEM C, V113, P8778, DOI 10.1021/jp8087594; Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833; Wang X, 2008, CA-CANCER J CLIN, V58, P97, DOI 10.3322/CA.2007.0003; Wei L, 2011, J BIOL CHEM, V286, P6291, DOI 10.1074/jbc.M110.166678; Wu C, 2005, J AM CHEM SOC, V127, P13530, DOI 10.1021/ja050767x; Wu C, 2005, BIOPHYS J, V88, P2897, DOI 10.1529/biophysj.104.055574; Wu C, 2004, BIOPHYS J, V87, P3000, DOI 10.1529/biophysj.104.047076; Wu C, 2006, BIOPHYS J, V91, P3664, DOI 10.1529/biophysj.106.081877; Wu C, 2008, J MOL BIOL, V384, P718, DOI 10.1016/j.jmb.2008.09.062; Xiao LH, 2010, BIOMATERIALS, V31, P91, DOI 10.1016/j.biomaterials.2009.09.014; Yu X, 2012, LANGMUIR, V28, P6595, DOI 10.1021/la3002306; Zanuy D, 2003, BIOPHYS J, V84, P1884, DOI 10.1016/S0006-3495(03)74996-0; Zorbas V, 2005, J AM CHEM SOC, V127, P12323, DOI 10.1021/ja050747v; Zuo G, 2011, J PHYS CHEM C, V115, P23323, DOI 10.1021/jp208967t; Zuo GH, 2010, ACS NANO, V4, P7508, DOI 10.1021/nn101762b	63	39	39	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65579	10.1371/journal.pone.0065579	http://dx.doi.org/10.1371/journal.pone.0065579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755253	Green Published, gold			2022-12-25	WOS:000320579400067
J	Yang, CQ; Liu, YZ; An, JC; Li, S; Jin, LF; Zhou, GF; Wei, QJ; Yan, HQ; Wang, NN; Fu, LN; Liu, X; Hu, XM; Yan, TS; Peng, SA				Yang, Cheng-Quan; Liu, Yong-Zhong; An, Ji-Cui; Li, Shuang; Jin, Long-Fei; Zhou, Gao-Feng; Wei, Qing-Jiang; Yan, Hui-Qing; Wang, Nan-Nan; Fu, Li-Na; Liu, Xiao; Hu, Xiao-Mei; Yan, Ting-Shuai; Peng, Shu-Ang			Digital Gene Expression Analysis of Corky Split Vein Caused by Boron Deficiency in 'Newhall' Navel Orange (Citrus sinensis Osbeck) for Selecting Differentially Expressed Genes Related to Vascular Hypertrophy	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE; RHAMNOGALACTURONAN II; CELL-CYCLE; MEMBRANE-PERMEABILITY; ARABIDOPSIS-THALIANA; RESPONSE REGULATORS; SIGNAL-TRANSDUCTION; BORIC-ACID; LEAVES; TRANSPORT	Corky split vein caused by boron (B) deficiency in 'Newhall' Navel Orange was studied in the present research. The borondeficient citrus exhibited a symptom of corky split vein in mature leaves. Morphologic and anatomical surveys at four representative phases of corky split veins showed that the symptom was the result of vascular hypertrophy. Digital gene expression (DGE) analysis was performed based on the Illumina HiSeq (TM) 2000 platform, which was applied to analyze the gene expression profilings of corky split veins at four morphologic phases. Over 5.3 million clean reads per library were successfully mapped to the reference database and more than 22897 mapped genes per library were simultaneously obtained. Analysis of the differentially expressed genes (DEGs) revealed that the expressions of genes associated with cytokinin signal transduction, cell division, vascular development, lignin biosynthesis and photosynthesis in corky split veins were all affected. The expressions of WOL and ARR12 involved in the cytokinin signal transduction pathway were upregulated at 1st phase of corky split vein development. Furthermore, the expressions of some cell cycle genes, CYCs and CDKB, and vascular development genes, WOX4 and VND7, were up-regulated at the following 2nd and 3rd phases. These findings indicated that the cytokinin signal transduction pathway may play a role in initiating symptom observed in our study.	[Yang, Cheng-Quan; Liu, Yong-Zhong; An, Ji-Cui; Li, Shuang; Jin, Long-Fei; Zhou, Gao-Feng; Wei, Qing-Jiang; Yan, Hui-Qing; Wang, Nan-Nan; Fu, Li-Na; Liu, Xiao; Hu, Xiao-Mei; Yan, Ting-Shuai; Peng, Shu-Ang] Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University	Yang, CQ (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	chqyang@webmail.hzau.edu.cn; shuangpeng428@126.com	Wang, Nan/GRY-3150-2022; Peng, shuang/GPX-0999-2022		National Natural Science Foundation of China [31071761]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China (NO. 31071761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONI R, 1987, ANNU REV PLANT PHYS, V38, P179, DOI 10.1146/annurev.pp.38.060187.001143; Alves M, 2011, PHYSIOL PLANTARUM, V142, P224, DOI 10.1111/j.1399-3054.2011.01462.x; An JC, 2012, SCI HORTIC-AMSTERDAM, V142, P149, DOI 10.1016/j.scienta.2012.05.013; Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BLASERGRILL J, 1989, PLANT PHYSIOL, V90, P280, DOI 10.1104/pp.90.1.280; Bolanos L, 1996, PLANT PHYSIOL, V110, P1249, DOI 10.1104/pp.110.4.1249; Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740; CAKMAK I, 1995, PHYSIOL PLANTARUM, V95, P11, DOI 10.1111/j.1399-3054.1995.tb00801.x; Cara FA, 2002, PLANT PHYSIOL BIOCH, V40, P853, DOI 10.1016/S0981-9428(02)01447-X; da Silva DH, 2008, SCI AGR, V65, P659, DOI 10.1590/S0103-90162008000600014; Dai R, 2011, AGR SCI CHINA, V10, P1861, DOI 10.1016/S1671-2927(11)60186-7; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; Fukuda H, 1997, PLANT CELL, V9, P1147, DOI 10.1105/tpc.9.7.1147; GARG OK, 1979, PLANT SOIL, V52, P591, DOI 10.1007/BF02277956; Gmitter FG, 2012, PLANT ANIMAL GENOME; Han S, 2008, J PLANT PHYSIOL, V165, P1331, DOI 10.1016/j.jplph.2007.11.002; Heyl A, 2003, CURR OPIN PLANT BIOL, V6, P480, DOI 10.1016/S1369-5266(03)00087-6; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Hoagland DR, 1950, 347 CAL AGR EXP STAT, V347; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Ishida K, 2008, PLANT CELL PHYSIOL, V49, P47, DOI 10.1093/pcp/pcm165; Ji JB, 2010, PLANT PHYSIOL, V152, P1346, DOI 10.1104/pp.109.149641; Jiang CunCang, 2009, Plant Nutrition and Fertilizer Science, V15, P656; Kakimoto T, 2003, ANNU REV PLANT BIOL, V54, P605, DOI 10.1146/annurev.arplant.54.031902.134802; Kasajima I, 2010, PHYSIOL PLANTARUM, V139, P80, DOI 10.1111/j.1399-3054.2010.01349.x; KASTORI R, 1995, J PLANT NUTR, V18, P1751, DOI 10.1080/01904169509365021; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Komaki S, 2012, PLANT CELL PHYSIOL, V53, P953, DOI 10.1093/pcp/pcs070; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Kubo M, 2004, J PLANT RES, V117, P121; Li HP, 2009, PLANT MICROSCOPY TEC; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu Z., 1980, Acta Pedologica Sinica, V17, P228; Liu Z, 1989, ACTA PEDOLOGICA SINI, V4, P006; Magyar Z, 1997, PLANT CELL, V9, P223, DOI 10.1105/tpc.9.2.223; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Main D, 2012, PLANT ANIMAL GENOME; Matsumoto-Kitano M, 2008, P NATL ACAD SCI USA, V105, P20027, DOI 10.1073/pnas.0805619105; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Miwa K, 2010, ADV EXP MED BIOL, V679, P83; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Nakagawa Y, 2007, PLANT CELL, V19, P2624, DOI 10.1105/tpc.106.049015; Nieminen K, 2008, P NATL ACAD SCI USA, V105, P20032, DOI 10.1073/pnas.0805617106; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; OBREZA T.A, 2008, NUTR FLORIDA CITRUS; Papadakis IE, 2004, ENVIRON EXP BOT, V51, P247, DOI 10.1016/j.envexpbot.2003.11.004; Papadakis IE, 2004, PLANT SCI, V166, P539, DOI 10.1016/j.plantsci.2003.10.027; Porceddu A, 2001, J BIOL CHEM, V276, P36354, DOI 10.1074/jbc.M011060200; Reguera M, 2010, J PLANT PHYSIOL, V167, P625, DOI 10.1016/j.jplph.2009.11.017; Rerkasem B, 2004, FIELD CROP RES, V89, P173, DOI 10.1016/j.fcr.2004.01.022; Ruiz JM, 1998, PHYTOCHEMISTRY, V48, P269, DOI 10.1016/S0031-9422(97)01132-1; Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; SCHERES B, 1995, DEVELOPMENT, V121, P53; Sheng O, 2009, SCI HORTIC-AMSTERDAM, V121, P278, DOI 10.1016/j.scienta.2009.02.009; Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2001, SOIL SCI PLANT NUTR, V47, P345, DOI 10.1080/00380768.2001.10408398; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; Tanaka M, 2008, PFLUG ARCH EUR J PHY, V456, P671, DOI 10.1007/s00424-007-0370-8; Tanaka M, 2011, PLANT CELL, V23, P3547, DOI 10.1105/tpc.111.088351; Tewari RK, 2010, TREE PHYSIOL, V30, P68, DOI 10.1093/treephys/tpp093; Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098; Warington K, 1923, ANN BOT-LONDON, V37, P629, DOI 10.1093/oxfordjournals.aob.a089871; Xiao JX, 2007, J PLANT NUTR, V30, P671, DOI 10.1080/01904160701289347; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Yokoyama A, 2007, PLANT CELL PHYSIOL, V48, P84, DOI 10.1093/pcp/pcl040; Zhao ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045215	72	30	32	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65737	10.1371/journal.pone.0065737	http://dx.doi.org/10.1371/journal.pone.0065737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755275	Green Submitted, Green Published, gold			2022-12-25	WOS:000320579400075
J	Brown, SAN; Cheng, E; Williams, MS; Winkles, JA				Brown, Sharron A. N.; Cheng, Emily; Williams, Mark S.; Winkles, Jeffrey A.			TWEAK-Independent Fn14 Self-Association and NF-kappa B Activation Is Mediated by the C-Terminal Region of the Fn14 Cytoplasmic Domain	PLOS ONE			English	Article							NECROSIS-FACTOR-RECEPTOR; CYSTEINE-RICH DOMAIN; WEAK INDUCER; TUMOR-GROWTH; THERAPEUTIC TARGET; APOPTOSIS TWEAK; BREAST-CANCER; TNF; CELLS; PATHWAY	The tumor necrosis factor (TNF) superfamily member TNF-like weak inducer of apoptosis (TWEAK) is a pro-inflammatory and pro-angiogenic cytokine implicated in physiological tissue regeneration and wound repair. TWEAK binds to a 102-amino acid type I transmembrane cell surface receptor named fibroblast growth factor-inducible 14 (Fn14). TWEAK:Fn14 engagement activates several intracellular signaling cascades, including the NF-kappa B pathway, and sustained Fn14 signaling has been implicated in the pathogenesis of chronic inflammatory diseases and cancer. Although several groups are developing TWEAK- or Fn14-targeted agents for therapeutic use, much more basic science research is required before we fully understand the TWEAK/Fn14 signaling axis. For example, we and others have proposed that TWEAK-independent Fn14 signaling may occur in cells when Fn14 levels are highly elevated, but this idea has never been tested directly. In this report, we first demonstrate TWEAK-independent Fn14 signaling by showing that an Fn14 deletion mutant that is unable to bind TWEAK can activate the NF-kappa B pathway in transfected cells. We then show that ectopically-expressed, cell surface-localized Fn14 can self-associate into Fn14 dimers, and we show that Fn14 self-association is mediated by an 18-aa region within the Fn14 cytoplasmic domain. Endogenously-expressed Fn14 as well as ectopically-overexpressed Fn14 could also be detected in dimeric form when cell lysates were subjected to SDS-PAGE under non-reducing conditions. Additional experiments revealed that Fn14 dimerization occurs during cell lysis via formation of an intermolecular disulfide bond at cysteine residue 122. These findings provide insight into the Fn14 signaling mechanism and may aid current studies to develop therapeutic agents targeting this small cell surface receptor.	[Brown, Sharron A. N.; Cheng, Emily; Winkles, Jeffrey A.] Univ Maryland, Sch Med, Dept Surg, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Williams, Mark S.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Winkles, JA (corresponding author), Univ Maryland, Sch Med, Dept Surg, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	jwinkles@som.umaryland.edu			NIH [R01 AI070823, R01 NS055126, R01 CA130967]; NATIONAL CANCER INSTITUTE [P30CA134274, R01CA130967] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055126] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants R01 AI070823 (MSW), R01 NS055126 (JAW) and R01 CA130967 (JAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Brown SAN, 2010, J BIOL CHEM, V285, P17432, DOI 10.1074/jbc.M110.131979; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chan FKM, 2007, CYTOKINE, V37, P101, DOI 10.1016/j.cyto.2007.03.005; Chao DT, 2013, J CANCER RES CLIN, V139, P315, DOI 10.1007/s00432-012-1332-x; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Foley SF, 2008, ANAL BIOCHEM, V377, P95, DOI 10.1016/j.ab.2008.02.025; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Fortin SP, 2009, MOL CANCER RES, V7, P1871, DOI 10.1158/1541-7786.MCR-09-0194; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; He F, 2009, PROTEIN SCI, V18, P650, DOI 10.1002/pro.49; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Horie R, 2002, ONCOGENE, V21, P2493, DOI 10.1038/sj.onc.1205337; Huang MG, 2011, CARCINOGENESIS, V32, P1589, DOI 10.1093/carcin/bgr182; Jain M, 2009, CIRCULATION, V119, P2058, DOI 10.1161/CIRCULATIONAHA.108.837286; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Mehl AM, 2001, J IMMUNOL, V167, P6388, DOI 10.4049/jimmunol.167.11.6388; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Michaelson JS, 2012, CANCER BIOL THER, V13, P812, DOI 10.4161/cbt.20564; Michaelson JS, 2011, MABS-AUSTIN, V3, P362, DOI 10.4161/mabs.3.4.16090; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sanz AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008955; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Valley CC, 2012, J BIOL CHEM, V287, P21265, DOI 10.1074/jbc.M111.306480; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; Whitsett TG, 2012, AM J PATHOL, V181, P111, DOI 10.1016/j.ajpath.2012.03.026; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2006, CANCER LETT, V235, P11, DOI 10.1016/j.canlet.2005.03.048; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Winkles JA, 2007, FRONT BIOSCI-LANDMRK, V12, P2761, DOI 10.2741/2270; Yousaf N, 2005, ARTHRITIS RHEUM-US, V52, P2906, DOI 10.1002/art.21268; Zhou H, 2013, J INVEST DERMATOL, V133, P1052, DOI 10.1038/jid.2012.402; Zhou H, 2011, MOL CANCER THER, V10, P1276, DOI 10.1158/1535-7163.MCT-11-0161	54	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65248	10.1371/journal.pone.0065248	http://dx.doi.org/10.1371/journal.pone.0065248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750247	gold, Green Published, Green Submitted			2022-12-25	WOS:000319961900049
J	Li, QY; Zhang, ZY; Li, ZM; Zhou, M; Liu, B; Pan, L; Ma, ZX; Zheng, YF				Li, Qingyu; Zhang, Zhengyu; Li, Zengmin; Zhou, Mei; Liu, Bin; Pan, Le; Ma, Zhixing; Zheng, Yufang			ADAM17 Is Critical for Multipolar Exit and Radial Migration of Neuronal Intermediate Progenitor Cells in Mice Cerebral Cortex	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; POSTTRANSCRIPTIONAL UP-REGULATION; CONVERTING-ENZYME; NEURITE OUTGROWTH; CORTICAL-NEURONS; GENE-TRANSFER; EGFR LIGANDS; STEM-CELLS; RECEPTOR; BRAIN	The radial migration of neuronal progenitor cells is critical for the development of cerebral cortex layers. They go through a critical step transforming from multipolar to bipolar before outward migration. A Disintegrin and Metalloprotease 17 (ADAM17) is a transmembrane protease which can process many substrates involved in cell-cell interaction, including Notch, ligands of EGFR, and some cell adhesion molecules. In this study, we used in utero electroporation to knock down or overexpress ADAM17 at embryonic day 14.5 (E14.5) in neuronal progenitor cells to examine the role of ADAM17 in cortical embryonic neurogenesis. Our results showed that the radial migration of ADAM17-knocked down cells were normal till E16.5 and reached the intermediate zone (IZ). Then most transfected cells stopped migration and stayed at the IZ to inner cortical plate (CP) layer at E18.5, and there was higher percentage of multipolar cells at IZ layer in the ADAM17-knocked down group compared to the cells in control group. Marker staining revealed that those ADAM17-knocked down cells differentiated normally from neural stem cells (NSCs) to neuronal intermediate progenitor cells (nIPCs) but did not differentiate into mature neurons. The migration and multipolar exit defects caused by ADAM17 knockdown could be partially rescued by over-expressing an shRNA resistant ADAM17, while overexpressing ADAM17 alone did not affect the radial migration. Taken together, our results showed for the first time that, ADAM17 is critical in regulating the multipolar-stage exit and radial migration of the nIPCs during telencephalon cortex development in mice.	[Li, Qingyu; Zhang, Zhengyu; Li, Zengmin; Zhou, Mei; Liu, Bin; Pan, Le; Ma, Zhixing; Zheng, Yufang] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University	Zheng, YF (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.	zhengyf@fudan.edu.cn	Zheng, Yufang/F-1091-2011	Zheng, Yufang/0000-0002-0488-2624; Li, Zengmin/0000-0001-5870-6557	National Nature Science Foundation of China [30800322]; National Basic Research Program of China (973 Program) [2011CB503703, 2013CB945404]; Shanghai Leading Academic Discipline Project [B111]; Shanghai Pujiang Program [08PJ1401300]; Ministry of Education start fund; Ministry of Education Research Fund for New Teachers in Doctoral Program of Higher Educational Institutes [200802461050]; Zuoxue project of Fudan University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Pujiang Program(Shanghai Pujiang Program); Ministry of Education start fund; Ministry of Education Research Fund for New Teachers in Doctoral Program of Higher Educational Institutes; Zuoxue project of Fudan University	This work was supported by National Nature Science Foundation of China (grant number 30800322); National Basic Research Program of China (973 Program, grant number 2011CB503703 and 2013CB945404); the Shanghai Leading Academic Discipline Project (grant number B111); Shanghai Pujiang Program (grant number 08PJ1401300); Ministry of Education start fund to returned overseas scholars; Ministry of Education Research Fund for New Teachers in Doctoral Program of Higher Educational Institutes (grant number 200802461050); and Zuoxue project of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 1997, DEVELOPMENT, V124, P3501; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; BAUMRIND NL, 1992, DEV DYNAM, V194, P311, DOI 10.1002/aja.1001940407; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Bzowska M, 2004, EUR J BIOCHEM, V271, P2808, DOI 10.1111/j.1432-1033.2004.04215.x; Caric D, 2001, DEVELOPMENT, V128, P4203; Charbonneau M, 2007, J BIOL CHEM, V282, P33714, DOI 10.1074/jbc.M704041200; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Gordon WR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006613; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Ip JPK, 2012, NAT NEUROSCI, V15, P39, DOI 10.1038/nn.2972; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Li L, 2012, J NEUROSCI, V32, P12673, DOI 10.1523/JNEUROSCI.0016-12.2012; Liu WH, 2010, J CELL BIOCHEM, V111, P148, DOI 10.1002/jcb.22681; Liu XX, 2012, P NATL ACAD SCI USA, V109, P8280, DOI 10.1073/pnas.1205880109; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nikolaidis NM, 2010, SHOCK, V33, P197, DOI 10.1097/SHK.0b013e3181ae8155; Okamura Y, 2011, NEUROSCI RES, V71, P63, DOI 10.1016/j.neures.2011.05.012; Oyagi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007461; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Poluch S, 2007, GLIA, V55, P822, DOI 10.1002/glia.20488; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Rakic P, 1998, J AM ACAD CHILD PSY, V37, P116, DOI 10.1097/00004583-199801000-00026; Ramasamy SK, 2010, MOL CELL BIOL, V30, P1946, DOI 10.1128/MCB.01419-09; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Saftig P, 2010, EUR J CELL BIOL; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Santiago-Josefat B, 2007, J BIOL CHEM, V282, P8325, DOI 10.1074/jbc.M608826200; Shi W, 2003, DEV BIOL, V261, P371, DOI 10.1016/S0012-1606(03)00315-4; Shimogori T, 2010, NAT NEUROSCI, V13, P767, DOI 10.1038/nn.2545; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Szalad A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-129; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi M, 2002, DIFFERENTIATION, V70, P155, DOI 10.1046/j.1432-0436.2002.700405.x; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Zhao JS, 2001, DEV BIOL, V232, P204, DOI 10.1006/dbio.2001.0176	57	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65703	10.1371/journal.pone.0065703	http://dx.doi.org/10.1371/journal.pone.0065703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755270	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300091
J	Ronsholt, FF; Ullum, H; Katzenstein, TL; Gerstoft, J; Ostrowski, SR				Ronsholt, Frederikke F.; Ullum, Henrik; Katzenstein, Terese L.; Gerstoft, Jan; Ostrowski, Sisse R.			Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; PLASMA-LEVELS; MARKERS	Objective: The study investigated markers of inflammation and endothelial activation in HIV infected patients after 12 years of successful combination antiretroviral treatment (cART). Methods: Inflammation and endothelial activation were assessed by measuring levels of immunoglobulins, beta 2-microglobulin, interleukin (IL) 8, tumor necrosis factor alpha (TNF alpha), vascular cell adhesion molecule-1 (sVCAM-1), intercellular adhesion molecule-1 (sICAM-1), sE-Selectin, and sP-Selectin. Results: HIV infected patients had higher levels of beta 2-microglobulin, IL-8, TNF alpha, and sICAM-1 than uninfected controls, and HIV infected patients lacked correlation between platelet counts and sP-Selectin levels found in uninfected controls. Conclusion: Discrete signs of systemic and vascular inflammation persist even after very long term cART.	[Ronsholt, Frederikke F.; Katzenstein, Terese L.; Gerstoft, Jan] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Ullum, Henrik; Ostrowski, Sisse R.] Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Ronsholt, FF (corresponding author), Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	frederikkefr@gmail.com	Ostrowski, Sisse R/E-7423-2011	Ostrowski, Sisse R/0000-0001-5288-3851; Ullum, Henrik/0000-0001-7306-9058; Katzenstein, Terese L/0000-0002-2233-500X; Ronsholt, Frederikke/0000-0002-1170-5896	Danish Medical Research Council; The Danish AIDS Foundation; A.P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Fonden til Laegevidenskabens Fremme); Augustinus Foundation; Rigshospitalets Forskningspulje	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); The Danish AIDS Foundation; A.P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Fonden til Laegevidenskabens Fremme); Augustinus Foundation; Rigshospitalets Forskningspulje	This work was supported by the Danish Medical Research Council, The Danish AIDS Foundation, A.P. Moller and wife Chastine Mc-Kinney Mollers Foundation (Fonden til Laegevidenskabens Fremme) and the Augustinus Foundation and Rigshospitalets Forskningspulje. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Calza L, 2009, JAIDS-J ACQ IMM DEF, V50, P430, DOI 10.1097/QAI.0b013e31819a292c; Corrales-Medina VF, 2010, JAIDS-J ACQ IMM DEF, V54, P217, DOI 10.1097/QAI.0b013e3181c8f4c9; DEGAETANO DK, 2004, LANCET INFECT DIS, V4, P213, DOI DOI 10.1016/S1473-3099(04)00971-5; Fichtenbaum Carl J, 2011, Curr Infect Dis Rep, V13, P94, DOI 10.1007/s11908-010-0153-9; Franco JM, 1999, EUR J CLIN MICROBIOL, V18, P733, DOI 10.1007/s100960050388; Haissman JM, 2009, JAIDS-J ACQ IMM DEF, V52, P493, DOI 10.1097/QAI.0b013e3181b627dc; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Landro L, 2011, J THROMB HAEMOST, V9, P1075, DOI 10.1111/j.1538-7836.2011.04242.x; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; Ronsholt FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039356; Sachdeva RK, 2010, J INTERF CYTOK RES, V30, P299, DOI 10.1089/jir.2009.0056; Sundd P, 2011, BIORHEOLOGY, V48, P1, DOI 10.3233/BIR-2011-0579; Wolf K, 2002, J INFECT DIS, V185, P456, DOI 10.1086/338572	16	59	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65182	10.1371/journal.pone.0065182	http://dx.doi.org/10.1371/journal.pone.0065182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755191	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300055
J	Zetterqvist, AV; Berglund, LM; Blanco, F; Garcia-Vaz, E; Wigren, M; Duner, P; Andersson, AMD; To, F; Spegel, P; Nilsson, J; Bengtsson, E; Gomez, MF				Zetterqvist, Anna V.; Berglund, Lisa M.; Blanco, Fabiana; Garcia-Vaz, Eliana; Wigren, Maria; Duner, Pontus; Andersson, Anna-Maria Dutius; To, Fong; Spegel, Peter; Nilsson, Jan; Bengtsson, Eva; Gomez, Maria F.			Inhibition of Nuclear Factor of Activated T-Cells (NFAT) Suppresses Accelerated Atherosclerosis in Diabetic Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE; MYOCARDIAL-INFARCTION; RECEPTOR; EXPRESSION; GLUCOSE; RISK; GENE; INTERLEUKIN-6; PATHWAYS; LESIONS	Objective of the Study: Diabetic patients have a much more widespread and aggressive form of atherosclerosis and therefore, higher risk for myocardial infarction, peripheral vascular disease and stroke, but the molecular mechanisms leading to accelerated damage are still unclear. Recently, we showed that hyperglycemia activates the transcription factor NFAT in the arterial wall, inducing the expression of the pro-atherosclerotic protein osteopontin. Here we investigate whether NFAT activation may be a link between diabetes and atherogenesis. Methodology and Principal Findings: Streptozotocin (STZ)-induced diabetes in apolipoprotein E-/- mice resulted in 2.2 fold increased aortic atherosclerosis and enhanced pro-inflammatory burden, as evidenced by elevated blood monocytes, endothelial activation- and inflammatory markers in aorta, and pro-inflammatory cytokines in plasma. In vivo treatment with the NFAT blocker A-285222 for 4 weeks completely inhibited the diabetes-induced aggravation of atherosclerosis, having no effect in non-diabetic mice. STZ-treated mice exhibited hyperglycemia and higher plasma cholesterol and triglycerides, but these were unaffected by A-285222. NFAT-dependent transcriptional activity was examined in aorta, spleen, thymus, brain, heart, liver and kidney, but only augmented in the aorta of diabetic mice. A-285222 completely blocked this diabetes-driven NFAT activation, but had no impact on the other organs or on splenocyte proliferation or cytokine secretion, ruling out systemic immunosuppression as the mechanism behind reduced atherosclerosis. Instead, NFAT inhibition effectively reduced IL-6, osteopontin, monocyte chemotactic protein 1, intercellular adhesion molecule 1, CD68 and tissue factor expression in the arterial wall and lowered plasma IL-6 in diabetic mice. Conclusions: Targeting NFAT signaling may be a novel and attractive approach for the treatment of diabetic macrovascular complications.	[Zetterqvist, Anna V.; Berglund, Lisa M.; Blanco, Fabiana; Garcia-Vaz, Eliana; Wigren, Maria; Duner, Pontus; Andersson, Anna-Maria Dutius; To, Fong; Spegel, Peter; Nilsson, Jan; Bengtsson, Eva; Gomez, Maria F.] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden	Lund University	Gomez, MF (corresponding author), Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden.	maria.gomez@med.lu.se	Gomez, Maria F/D-3696-2014; Spégel, Peter/G-9947-2018; Bengtsson, Eva/AAA-1968-2019; Bengtsson, Eva/AGH-2754-2022	Gomez, Maria F/0000-0001-6210-3142; Spégel, Peter/0000-0002-6092-2387; Bengtsson, Eva/0000-0001-7075-1772; Duner, Pontus/0000-0003-4171-5646; Blanco Camera, Fabiana/0000-0003-0027-8371; Berglund, Lisa/0000-0001-6440-116X	Swedish Heart and Lung Foundation [HLF20080843, HLF20100532]; Swedish Research Council [2009-4120, 2011-3900, 2009-1039]; Lund University Diabetes Centre; Swedish Medical Society; Swedish Society for Medical Research; Royal Physiographic Society in Lund; Skane Hospital Research Funds; Crafoord foundation; Albert Pahlsson foundation; Lars Hierta Memorial foundation; Knut & Alice Wallenberg foundation; Innovative Medicines Initiative Joint Undertaking [115006]; European Union's Seventh Framework Programme [FP7]; EFPIA	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University Diabetes Centre; Swedish Medical Society; Swedish Society for Medical Research; Royal Physiographic Society in Lund; Skane Hospital Research Funds; Crafoord foundation; Albert Pahlsson foundation; Lars Hierta Memorial foundation; Knut & Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme [FP7]; EFPIA	This work was supported by the Swedish Heart and Lung Foundation [HLF20080843; HLF20100532]; the Swedish Research Council [#2009-4120; #2011-3900; #2009-1039], Lund University Diabetes Centre, the Swedish Medical Society; the Swedish Society for Medical Research, the Royal Physiographic Society in Lund, Skane Hospital Research Funds, and Crafoord; Albert Pahlsson; Lars Hierta Memorial; and the Knut & Alice Wallenberg foundations. This work was also supported by Innovative Medicines Initiative Joint Undertaking [#115006], comprising funds from the European Union's Seventh Framework Programme [FP7/2007-2013] and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2000, MOL PHARMACOL, V58, P946, DOI 10.1124/mol.58.5.946; Amberg GC, 2004, J BIOL CHEM, V279, P47326, DOI 10.1074/jbc.M408789200; Awla D, 2012, GASTROENTEROLOGY; Berglund LM, 2012, CARDIOVASC RES, V93, P414, DOI 10.1093/cvr/cvr309; Birsan T, 2004, TRANSPL INT, V17, P145, DOI 10.1007/s00147-003-0676-1; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; Breitenstein A, 2010, CLIN SCI, V118, P159, DOI 10.1042/CS20080622; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Donners MMPC, 2005, AM J TRANSPLANT, V5, P1204, DOI 10.1111/j.1600-6143.2005.00821.x; Engelbertsen D, 2013, ARTERIOSCL THROM VAS, V33, P637, DOI 10.1161/ATVBAHA.112.300871; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P879, DOI 10.1161/01.ATV.0000067937.93716.DB; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; Kockx M, 2010, PHARMACOL THERAPEUT, V128, P106, DOI 10.1016/j.pharmthera.2010.06.001; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Lee MY, 2010, HUM MOL GENET, V19, P468, DOI 10.1093/hmg/ddp511; Lipskaia L, 2005, CIRC RES, V97, P488, DOI 10.1161/01.RES.0000180663.42594.aa; Lipskaia L, 2003, CIRC RES, V92, P1115, DOI 10.1161/01.RES.0000074880.25540.D0; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Lohmann C, 2009, ATHEROSCLEROSIS, V207, P360, DOI 10.1016/j.atherosclerosis.2009.05.004; Maziere C, 2005, FREE RADICAL BIO MED, V38, P472, DOI 10.1016/j.freeradbiomed.2004.10.028; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Nilsson J, 2006, ARTERIOSCL THROM VAS, V26, P794, DOI 10.1161/01.ATV.0000209513.00765.13; Nilsson LM, 2008, CURR OPIN LIPIDOL, V19, P483, DOI 10.1097/MOL.0b013e32830dd545; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Nilsson-Berglund LM, 2010, ARTERIOSCL THROM VAS, V30, P218, DOI 10.1161/ATVBAHA.109.199299; Norata GD, 2007, ATHEROSCLEROSIS, V193, P321, DOI 10.1016/j.atherosclerosis.2006.09.015; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Prevost G, 2011, DIABETES METAB, V37, P106, DOI 10.1016/j.diabet.2010.08.005; Rahman S, 2007, DIABETES OBES METAB, V9, P767, DOI 10.1111/j.1463-1326.2006.00655.x; Rasmussen-Torvik LJ, 2011, DIABETES, V60, P331, DOI 10.2337/db10-0839; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Shi WB, 2003, ARTERIOSCL THROM VAS, V23, P1901, DOI 10.1161/01.ATV.0000091249.34404.B7; Takeda N, 2006, ARTERIOSCL THROM VAS, V26, P1177, DOI 10.1161/01.ATV.0000214296.94849.1c; Trevillyan JM, 2001, J BIOL CHEM, V276, P48118, DOI 10.1074/jbc.M107919200; Wigren M, 2012, ARTERIOSCL THROM VAS, V32, P2000, DOI 10.1161/ATVBAHA.112.251579; Wigren M, 2009, CIRC RES, V104, pE62, DOI 10.1161/CIRCRESAHA.109.196667; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18	43	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65020	10.1371/journal.pone.0065020	http://dx.doi.org/10.1371/journal.pone.0065020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755169	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300042
J	Cruz-Gallardo, I; Diaz-Moreno, I; Diaz-Quintana, A; Donaire, A; Velazquez-Campoy, A; Curd, RD; Rangachari, K; Birdsall, B; Ramos, A; Holder, AA; De la Rosa, MA				Cruz-Gallardo, Isabel; Diaz-Moreno, Irene; Diaz-Quintana, Antonio; Donaire, Antonio; Velazquez-Campoy, Adrian; Curd, Rachel D.; Rangachari, Kaveri; Birdsall, Berry; Ramos, Andres; Holder, Anthony A.; De la Rosa, Miguel A.			Antimalarial Activity of Cupredoxins THE INTERACTION OF PLASMODIUM MEROZOITE SURFACE PROTEIN 1(19) (MSP1(19)) AND RUSTICYANIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE-INHIBITORY ANTIBODIES; CYTOCHROME-F; THIOBACILLUS-FERROOXIDANS; HYDROPHOBIC INTERACTIONS; TRANSIENT COMPLEX; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; MALARIA; FALCIPARUM; PLASTOCYANIN	The discovery of effective new antimalarial agents is urgently needed. One of the most frequently studied molecules anchored to the parasite surface is the merozoite surface protein-1 (MSP1). At red blood cell invasion MSP1 is proteolytically processed, and the 19-kDa C-terminal fragment (MSP1(19)) remains on the surface and is taken into the red blood cell, where it is transferred to the food vacuole and persists until the end of the intracellular cycle. Because a number of specific antibodies inhibit erythrocyte invasion and parasite growth, MSP1(19) is therefore a promising target against malaria. Given the structural homology of cupredoxins with the Fab domain of monoclonal antibodies, an approach combining NMR and isothermal titration calorimetry (ITC) measurements with docking calculations based on BiGGER is employed on MSP1(19)-cupredoxin complexes. Among the cupredoxins tested, rusticyanin forms a well defined complex with MSP1(19) at a site that overlaps with the surface recognized by the inhibitory antibodies. The addition of holo-rusticyanin to infected cells results in parasitemia inhibition, but negligible effects on parasite growth can be observed for apo-rusticyanin and other proteins of the cupredoxin family. These findings point to rusticyanin as an excellent therapeutic tool for malaria treatment and provide valuable information for drug design.	[Cruz-Gallardo, Isabel; Diaz-Moreno, Irene; Diaz-Quintana, Antonio; De la Rosa, Miguel A.] Univ Seville, CSIC, CicCartuja, IBVF, Seville 41092, Spain; [Donaire, Antonio] Univ Murcia, Dept Quim Inorgan, Fac Quim, Murcia 30100, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza 50018, Spain; [Curd, Rachel D.; Rangachari, Kaveri; Holder, Anthony A.] Natl Inst Med Res, MRC, Div Parasitol, London W7 1AA, England; [Birdsall, Berry; Ramos, Andres] Natl Inst Med Res, MRC, Mol Struct Div, London W7 1AA, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-JA-USE - Centro de Investigaciones Cientificas Isla de La Cartuja (CICIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); University of Murcia; University of Zaragoza; MRC National Institute for Medical Research; MRC National Institute for Medical Research	De la Rosa, MA (corresponding author), Univ Seville, CSIC, CicCartuja, IBVF, Ave Americo Vespucio 49, Seville 41092, Spain.	marosa@us.es	Cruz-Gallardo, Isabel/J-7042-2014; Díaz-Moreno, Irene/E-7181-2010; Donaire, Antonio/K-7782-2014; Díaz-Quintana, Antonio/A-1946-2011; De la Rosa, Miguel/B-2545-2014; Velazquez-Campoy, Adrian/E-7946-2012; Holder, Anthony A/A-7554-2013	Cruz-Gallardo, Isabel/0000-0002-5936-2749; Díaz-Moreno, Irene/0000-0002-5318-7644; Donaire, Antonio/0000-0002-1456-2085; Díaz-Quintana, Antonio/0000-0001-8973-8009; De la Rosa, Miguel/0000-0003-1187-5737; Velazquez-Campoy, Adrian/0000-0001-5702-4538; Holder, Anthony A/0000-0002-8490-6058	Junta de Andalucia (Spain) [P08-CVI-3876, BIO198]; European Social Fund-ERDF; Junta de Andalucia [P08-CVI-3876]; Ministerio de Economia y Competitividad [SAF2011-26611]; Fundacion Seneca de la Region de Murcia (Spain) [15354/PI/10]; Ministerio de Ciencia e Innovacion (Spain) [BFU2010-19451]; Medical Research Council [U117574558, U117532067]; European Union FP7 Network of Excellence EviMalar; MRC [MC_U117532067, MC_U117533887, MC_U117574558, MC_PC_13051] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117574558, MC_U117532067, MC_PC_13051] Funding Source: researchfish	Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); European Social Fund-ERDF; Junta de Andalucia(Junta de Andalucia); Ministerio de Economia y Competitividad(Spanish Government); Fundacion Seneca de la Region de Murcia (Spain)(Fundacion Seneca); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union FP7 Network of Excellence EviMalar; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Junta de Andalucia Grants P08-CVI-3876 and BIO198 (Spain) and European Social Fund-ERDF 2007-2013.; Supported by Junta de Andalucia Ph.D. Grant P08-CVI-3876 and GERMN bursaries for short term stays (Spain).; Supported by Ministerio de Economia y Competitividad Grant SAF2011-26611 and Fundacion Seneca de la Region de Murcia Grant 15354/PI/10 (Spain).; Supported by Ministerio de Ciencia e Innovacion Grant BFU2010-19451 (Spain).; Supported by Medical Research Council Grant U117574558.; Laboratory work supported by Medical Research Council Grant U117532067 and the European Union FP7 Network of Excellence EviMalar.	Alcaraz LA, 2005, FEBS LETT, V579, P5223, DOI 10.1016/j.febslet.2005.08.048; Autore F, 2007, PROTEINS, V66, P513, DOI 10.1002/prot.21212; Babon JJ, 2007, MOL BIOCHEM PARASIT, V153, P31, DOI 10.1016/j.molbiopara.2007.01.015; Badsberg U, 1996, BIOCHEMISTRY-US, V35, P7021, DOI 10.1021/bi960621y; Benjamin PA, 1999, MOL BIOCHEM PARASIT, V104, P147, DOI 10.1016/S0166-6851(99)00142-5; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLAKE RC, 1987, J BIOL CHEM, V262, P14983; Chakrabarty A. M., 2006, U.S. Patent, Patent No. [WO 2006/127477 A3, 2006127477]; Chaudhari A, 2006, CELL CYCLE, V5, P1642, DOI 10.4161/cc.5.15.2992; Chitarra V, 1999, MOL CELL, V3, P457, DOI 10.1016/S1097-2765(00)80473-6; Crane BR, 2001, J AM CHEM SOC, V123, P11623, DOI 10.1021/ja0115870; Crowley PB, 2001, J AM CHEM SOC, V123, P10444, DOI 10.1021/ja0112700; Cruz-Gallardo I, 2012, FEBS LETT, V586, P646, DOI 10.1016/j.febslet.2011.08.035; Diaz-Moreno I, 2005, J BIOL CHEM, V280, P18908, DOI 10.1074/jbc.M413298200; Fleck SL, 2003, J BIOL CHEM, V278, P47670, DOI 10.1074/jbc.M306603200; Garman SC, 2003, J BIOL CHEM, V278, P7264, DOI 10.1074/jbc.M210716200; Goddard T. D., 2006, SPARKY 3; Hall JF, 1996, FEMS MICROBIOL LETT, V137, P85, DOI 10.1111/j.1574-6968.1996.tb08087.x; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Hobbs Charlotte, 2011, F1000 Biol Rep, V3, P24, DOI 10.3410/B3-24; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; HOLDER AA, 1994, PARASITOL TODAY, V10, P182, DOI 10.1016/0169-4758(94)90025-6; Holder AA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000638; Jimenez B, 2003, BIOCHEMISTRY-US, V42, P10396, DOI 10.1021/bi034692q; Lange C, 2005, BBA-BIOENERGETICS, V1707, P179, DOI 10.1016/j.bbabio.2004.12.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazarou M, 2009, INFECT IMMUN, V77, P5659, DOI 10.1128/IAI.00167-09; LING IT, 1994, PARASITE IMMUNOL, V16, P63, DOI 10.1111/j.1365-3024.1994.tb00324.x; Morgan WD, 2000, J BIOMOL NMR, V17, P337, DOI 10.1023/A:1008313530207; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Morgan WD, 2005, BIOCHEMISTRY-US, V44, P518, DOI 10.1021/bi0482957; Moss DK, 2012, INFECT IMMUN, V80, P1280, DOI 10.1128/IAI.05887-11; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; Opar A, 2011, NAT REV DRUG DISCOV, V10, P887, DOI 10.1038/nrd3611; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Pizarro JC, 2003, J MOL BIOL, V328, P1091, DOI 10.1016/S0022-2836(03)00376-0; Valero LMS, 1998, INFECT IMMUN, V66, P3925, DOI 10.1128/IAI.66.8.3925-3930.1998; VANDEKAMP M, 1990, BIOCHIM BIOPHYS ACTA, V1019, P283, DOI 10.1016/0005-2728(90)90206-J; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; Yamada T, 2004, CELL CYCLE, V3, P1182; Yamada T, 2002, INFECT IMMUN, V70, P7054, DOI 10.1128/IAI.70.12.7054-7062.2002; Zaballa ME, 2012, P NATL ACAD SCI USA, V109, P9254, DOI 10.1073/pnas.1119460109; Zhao D, 1998, BIOPHYS J, V74, pA233	46	9	9	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20896	20907		10.1074/jbc.M113.460162	http://dx.doi.org/10.1074/jbc.M113.460162			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23749994	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000322014400013
J	Fan, C; Li, Z; Yin, HY; Xiang, S				Fan, Chen; Li, Zi; Yin, Huiyong; Xiang, Song			Structure and Function of Allophanate Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS CATALYTIC TRIAD; UREA CARBOXYLASE; ADENOSINE-TRIPHOSPHATE; PROVIDES INSIGHTS; CRYSTAL-STRUCTURE; IDENTIFICATION; AMIDOLYASE; ENZYME; CYCLOTRANSFERASE; PURIFICATION	Allophanate hydrolase converts allophanate to ammonium and carbon dioxide. It is conserved in many organisms and is essential for their utilization of urea as a nitrogen source. It also has important functions in a newly discovered eukaryotic pyrimidine nucleic acid precursor degradation pathway, the yeast-hypha transition that several pathogens utilize to escape the host defense, and an s-triazine herbicide degradation pathway recently emerged in many soil bacteria. We have determined the crystal structure of the Kluyveromyces lactis allophanate hydrolase. Together with structure-directed functional studies, we demonstrate that its N and C domains catalyze a two-step reaction and contribute to maintaining a dimeric form of the enzyme required for their optimal activities. Our studies also provide molecular insights into their catalytic mechanism. Interestingly, we found that the C domain probably catalyzes a novel form of decarboxylation reaction that might expand the knowledge of this common reaction in biological systems.	[Fan, Chen; Li, Zi; Yin, Huiyong; Xiang, Song] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xiang, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China.	sxiang@sibs.ac.cn	Xiang, Song/AAF-6422-2019	Xiang, Song/0000-0001-9314-4684; yin, hui yong/0000-0001-7049-1560	Ministry of Science and Technology of China (973 Program) [2011CB910500, 2010CB912502]; One Hundred Talents Program of the Chinese Academy of Sciences	Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the Ministry of Science and Technology of China (973 Program Grants 2011CB910500 and 2010CB912502) and the One Hundred Talents Program of the Chinese Academy of Sciences.	Andersen G, 2008, J MOL BIOL, V380, P656, DOI 10.1016/j.jmb.2008.05.029; ARTHUR H, 1976, J BACTERIOL, V128, P56, DOI 10.1128/JB.128.1.56-68.1976; Blaise M, 2010, EMBO J, V29, P3118, DOI 10.1038/emboj.2010.192; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan C, 2012, J BIOL CHEM, V287, P9389, DOI 10.1074/jbc.M111.319475; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito T, 2010, NATURE, V467, P612, DOI 10.1038/nature09411; Jacques DA, 2011, ACTA CRYSTALLOGR D, V67, P105, DOI 10.1107/S0907444910051127; Jacques DA, 2011, J MOL BIOL, V405, P214, DOI 10.1016/j.jmb.2010.10.047; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanamori T, 2005, FEMS MICROBIOL LETT, V245, P61, DOI 10.1016/j.femsle.2005.02.023; Kanamori T, 2004, J BACTERIOL, V186, P2532, DOI 10.1128/JB.186.9.2532-2539.2004; Labahn J, 2002, J MOL BIOL, V322, P1053, DOI 10.1016/S0022-2836(02)00886-0; LEFTLEY JW, 1973, J GEN MICROBIOL, V77, P109, DOI 10.1099/00221287-77-1-109; Li TF, 2012, BIOORG CHEM, V43, P2, DOI 10.1016/j.bioorg.2012.03.001; Lin Y, 2013, BIOCHEMISTRY-US, V52, P690, DOI 10.1021/bi301242m; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Navarathna DHMLP, 2010, FEMS YEAST RES, V10, P209, DOI 10.1111/j.1567-1364.2010.00602.x; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; Oakley AJ, 2010, J BIOL CHEM, V285, P9642, DOI 10.1074/jbc.M109.082099; Ohtaki A, 2010, BBA-PROTEINS PROTEOM, V1804, P184, DOI 10.1016/j.bbapap.2009.10.001; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; ROON RJ, 1968, J BIOL CHEM, V243, P5213; Shapir N, 2006, APPL ENVIRON MICROB, V72, P2491, DOI 10.1128/AEM.72.4.2491-2495.2006; Shapir N, 2005, J BACTERIOL, V187, P3731, DOI 10.1128/JB.187.11.3731-3738.2005; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Shin S, 2003, J BIOL CHEM, V278, P24937, DOI 10.1074/jbc.M302156200; Sirko A, 2000, ACTA BIOCHIM POL, V47, P1189, DOI 10.18388/abp.2000_3972; Sterner R. W., 2002, ECOLOGICAL STOICHIOM, P44; Strope PK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-80; Takahashi S., 1959, NIPPON KAGAKU ZASSHI, V80, P92; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; WHITNEY PA, 1972, J BIOL CHEM, V247, P1349; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu J, 2009, J MOL BIOL, V391, P703, DOI 10.1016/j.jmb.2009.06.014; Yasuhira K, 2010, J BIOL CHEM, V285, P1239, DOI 10.1074/jbc.M109.041285	43	19	19	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21422	21432		10.1074/jbc.M113.453837	http://dx.doi.org/10.1074/jbc.M113.453837			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754281	hybrid, Green Published			2022-12-25	WOS:000322014400060
J	Perrett, RM; Fowkes, RC; Caunt, CJ; Tsaneva-Atanasova, K; Bowsher, CG; McArdle, CA				Perrett, Rebecca M.; Fowkes, Robert C.; Caunt, Christopher J.; Tsaneva-Atanasova, Krasimira; Bowsher, Clive G.; McArdle, Craig A.			Signaling to Extracellular Signal-regulated Kinase from ErbB1 Kinase and Protein Kinase C FEEDBACK, HETEROGENEITY, AND GATING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ERK MAP KINASE; NEGATIVE FEEDBACK; SPATIOTEMPORAL REGULATION; NUCLEAR TRANSLOCATION; RECEPTOR; PHOSPHORYLATION; LOCALIZATION; SPECIFICITY; ACTIVATION	Many extracellular signals act via the Raf/MEK/ERK cascade in which kinetics, cell-cell variability, and sensitivity of the ERK response can all influence cell fate. Here we used automated microscopy to explore the effects of ERK-mediated negative feedback on these attributes in cells expressing endogenous ERK or ERK2-GFP reporters. We studied acute rather than chronic stimulation with either epidermal growth factor (ErbB1 activation) or phorbol 12,13-dibutyrate (PKC activation). In unstimulated cells, ERK-mediated negative feedback reduced the population-average and cell-cell variability of the level of activated ppERK and increased its robustness to changes in ERK expression. In stimulated cells, negative feedback (evident between 5 min and 4 h) also reduced average levels and variability of phosphorylated ERK (ppERK) without altering the "gradedness" or sensitivity of the response. Binning cells according to total ERK expression revealed, strikingly, that maximal ppERK responses initially occur at submaximal ERK levels and that this non-monotonic relationship changes to an increasing, monotonic one within 15 min. These phenomena occur in HeLa cells and MCF7 breast cancer cells and in the presence and absence of ERK-mediated negative feedback. They were best modeled assuming distributive (rather than processive) activation. Thus, we have uncovered a novel, time-dependent change in the relationship between total ERK and ppERK levels that persists without negative feedback. This change makes acute response kinetics dependent on ERK level and provides a "gating" or control mechanism in which the interplay between stimulus duration and the distribution of ERK expression across cells could modulate the proportion of cells that respond to stimulation.	[McArdle, Craig A.] Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England; [Fowkes, Robert C.] Univ London Royal Vet Coll, Endocrine Signaling Grp, London NW1 0TU, England; [Caunt, Christopher J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Tsaneva-Atanasova, Krasimira] Univ Bristol, Dept Engn Math, Bristol Ctr Appl Nonlinear Math, Bristol BS8 1TR, Avon, England; [Bowsher, Clive G.] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England	University of Bristol; University of London; University of London Royal Veterinary College; University of Bath; University of Bristol; University of Bristol	McArdle, CA (corresponding author), Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Whitson St, Bristol BS1 3NY, Avon, England.	craig.mcardle@bristol.ac.uk	Fowkes, Robert/HHT-0664-2022; McArdle, Craig/AAQ-5660-2021; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; Fowkes, Robert/AAI-4756-2020	McArdle, Craig/0000-0003-4836-5351; Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Fowkes, Robert/0000-0002-2222-2056	Medical Research Council [MRC G0901763]; Medical Research Council Biomedical Informatics Fellowship; EPSRC [EP/D063485/1] Funding Source: UKRI; MRC [G0701772, G0901763] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D063485/1] Funding Source: researchfish; Medical Research Council [G0901763, G0701772] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Biomedical Informatics Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council Project Grant MRC G0901763 (to C. A. M. and R. C. F).; Supported by a Medical Research Council Biomedical Informatics Fellowship.	AHARONOV A, 1978, J BIOL CHEM, V253, P3970; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Armstrong SP, 2010, J BIOL CHEM, V285, P24360, DOI 10.1074/jbc.M110.115964; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Birtwistle MR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-109; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Caunt CJ, 2010, J CELL SCI, V123, P4310, DOI 10.1242/jcs.076349; Caunt CJ, 2010, METHODS MOL BIOL, V661, P507, DOI 10.1007/978-1-60761-795-2_32; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Cohen DM, 1996, J BIOL CHEM, V271, P12903, DOI 10.1074/jbc.271.22.12903; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Finch AR, 2012, CELL SIGNAL, V24, P1002, DOI 10.1016/j.cellsig.2011.12.021; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kupzig S, 2005, P NATL ACAD SCI USA, V102, P7577, DOI 10.1073/pnas.0409611102; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ruf F, 2007, BIOPHYS J, V93, P4474, DOI 10.1529/biophysj.107.115170; Ruf F, 2006, J BIOL CHEM, V281, P30967, DOI 10.1074/jbc.M606486200; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Shankaran H, 2010, CURR OPIN GENET DEV, V20, P650, DOI 10.1016/j.gde.2010.08.002; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P2473, DOI 10.1073/pnas.0906885107; Takahashi S, 2008, CURR BIOL, V18, P1184, DOI 10.1016/j.cub.2008.07.050; Walker SA, 2003, FEBS LETT, V546, P6, DOI 10.1016/S0014-5793(03)00412-5; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	49	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21001	21014		10.1074/jbc.M113.455345	http://dx.doi.org/10.1074/jbc.M113.455345			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754287	Green Published, hybrid			2022-12-25	WOS:000322014400022
J	Pawela, L; Gawron, P; Puchala, Z; Sladkowski, J				Pawela, Lukasz; Gawron, Piotr; Puchala, Zbigniew; Sladkowski, Jan			Enhancing Pseudo-Telepathy in the Magic Square Game	PLOS ONE			English	Article							QUANTUM; ALGORITHM	We study the possibility of reversing an action of a quantum channel. Our principal objective is to find a specific channel that reverses as accurately as possible an action of a given quantum channel. To achieve this goal we use semidefinite programming. We show the benefits of our method using the quantum pseudo-telepathy Magic Square game with noise. Our strategy is to move the pseudo-telepathy region to higher noise values. We show that it is possible to reverse the action of a noise channel using semidefinite programming.	[Pawela, Lukasz; Gawron, Piotr; Puchala, Zbigniew] Polish Acad Sci, Inst Theoret & Appl Informat, Gliwice, Poland; [Puchala, Zbigniew] Jagiellonian Univ, Inst Phys, Krakow, Poland; [Sladkowski, Jan] Univ Silesia, Inst Phys, Katowice, Poland	Polish Academy of Sciences; Institute of Theoretical & Applied Informatics of the Polish Academy of Sciences; Jagiellonian University; University of Silesia in Katowice	Pawela, L (corresponding author), Polish Acad Sci, Inst Theoret & Appl Informat, Gliwice, Poland.	lpawela@iitis.pl	Sladkowski, Jan/AAF-3401-2019; Puchała, Zbigniew/F-2189-2011; Pawela, Łukasz/B-4629-2013; Sładkowski, Jan Antoni/I-2782-2019; Gawron, Piotr/F-2255-2011	Puchała, Zbigniew/0000-0002-4739-0400; Pawela, Łukasz/0000-0002-0476-7132; Sładkowski, Jan Antoni/0000-0002-1898-4824; Gawron, Piotr/0000-0001-7476-9160	Polish National Science Centre [N N516 481840, DEC-2011/01/B/ST6/07197]; Polish Ministry of Science and Higher Education [IP2011 014071, IP2011 044271]	Polish National Science Centre; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish National Science Centre: L. Pawela by the grant number N N516 481840, J. Sladkowski by the grant number DEC-2011/01/B/ST6/07197. Work was also supported by the Polish Ministry of Science and Higher Education: P. Gawron under the project number IP2011 014071, Z. Puchala under the project number IP2011 044271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, QUANTUM COMPUTATION; Aravind PK, 2004, AM J PHYS, V72, P1303, DOI 10.1119/1.1773173; Bengtsson I., 2006, GEOMETRY QUANTUM STA; Brassard G, 2005, FOUND PHYS, V35, P1877, DOI 10.1007/s10701-005-7353-4; Burer S, 2005, MATH PROGRAM, V103, P427, DOI 10.1007/s10107-004-0564-1; Burer S, 2003, MATH PROGRAM, V95, P329, DOI 10.1007/s10107-002-0352-8; Eisert J, 1999, PHYS REV LETT, V83, P3077, DOI 10.1103/PhysRevLett.83.3077; Flitney AP, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.062318; Frackiewicz P, 2012, INT J QUANTUM INF, V10, DOI 10.1142/S0219749912500487; Gawron P, 2008, INT J QUANTUM INF, V6, P667, DOI 10.1142/S0219749908003931; Gawron P, 2012, INT J AP MAT COM-POL, V22, P493, DOI 10.2478/v10006-012-0037-2; Gawron P, 2010, FLUCT NOISE LETT, V9, P9, DOI 10.1142/S0219477510000034; MERMIN ND, 1990, PHYS REV LETT, V65, P3373, DOI 10.1103/PhysRevLett.65.3373; Miszczak JA, 2012, QUANTUM INF PROCESS, V11, P1571, DOI 10.1007/s11128-011-0322-2; Piotrowski EW, 2008, PHYSICA A, V387, P3949, DOI 10.1016/j.physa.2008.02.071; Piotrowski EW, 2003, INT J THEOR PHYS, V42, P1089, DOI 10.1023/A:1025443111388; Puchala Z, 2011, QUANTUM INF PROCESS, V10, P1, DOI 10.1007/s11128-010-0166-1; Schmidt AGM, 2012, PHYSICA A; Watrous J., 2011, LECT NOTES	20	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64694	10.1371/journal.pone.0064694	http://dx.doi.org/10.1371/journal.pone.0064694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762246	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000014
J	Yaguchi, S; Ogawa, Y; Shimmura, S; Kawakita, T; Hatou, S; Satofuka, S; Nakamura, S; Imada, T; Miyashita, H; Yoshida, S; Yaguchi, T; Ozawa, Y; Mori, T; Okamoto, S; Kawakami, Y; Ishida, S; Tsubota, K				Yaguchi, Saori; Ogawa, Yoko; Shimmura, Shigeto; Kawakita, Tetsuya; Hatou, Shin; Satofuka, Shingo; Nakamura, Shigeru; Imada, Toshihiro; Miyashita, Hideyuki; Yoshida, Satoru; Yaguchi, Tomonori; Ozawa, Yoko; Mori, Takehiko; Okamoto, Shinichiro; Kawakami, Yutaka; Ishida, Susumu; Tsubota, Kazuo			Angiotensin II Type 1 Receptor Antagonist Attenuates Lacrimal Gland, Lung, and Liver Fibrosis in a Murine Model of Chronic Graft-Versus-Host Disease	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; SHOCK-PROTEIN 47; DRY EYE; SYSTEM; MECHANISMS; EXPRESSION; INFLAMMATION; FIBROBLASTS; INDUCTION; CHAPERONE	Chronic graft-versus-host disease (cGVHD), a serious complication following allogeneic HSCT (hematopoietic stem cell transplantation), is characterized by systemic fibrosis. The tissue renin-angiotensin system (RAS) is involved in the fibrotic pathogenesis, and an angiotensin II type 1 receptor (AT1R) antagonist can attenuate fibrosis. Tissue RAS is present in the lacrimal gland, lung, and liver, and is known to be involved in the fibrotic pathogenesis of the lung and liver. This study aimed to determine whether RAS is involved in fibrotic pathogenesis in the lacrimal gland and to assess the effect of an AT1R antagonist on preventing lacrimal gland, lung, and liver fibrosis in cGVHD model mice. We used the B10.D2-->BALB/c (H-2(d)) MHC-compatible, multiple minor histocompatibility antigen-mismatched model, which reflects clinical and pathological symptoms of human cGVHD. First, we examined the localization and expression of RAS components in the lacrimal glands using immunohistochemistry and quantitative real-time polymerase chain reaction (PCR). Next, we administered an AT1R antagonist (valsartan; 10 mg/kg) or angiotensin II type 2 receptor (AT2R) antagonist (PD123319; 10 mg/kg) intraperitoneally into cGVHD model mice and assessed the fibrotic change in the lacrimal gland, lung, and liver. We demonstrated that fibroblasts expressed angiotensin II, AT1R, and AT2R, and that the mRNA expression of angiotensinogen was greater in the lacrimal glands of cGVHD model mice than in controls generated by syngeneic-HSCT. The inhibition experiment revealed that fibrosis of the lacrimal gland, lung, and liver was suppressed in mice treated with the AT1R antagonist, but not the AT2R antagonist. We conclude that RAS is involved in fibrotic pathogenesis in the lacrimal gland and that AT1R antagonist has a therapeutic effect on lacrimal gland, lung, and liver fibrosis in cGVHD model mice. Our findings point to AT1R antagonist as a possible target for therapeutic intervention in cGVHD.	[Yaguchi, Saori; Ogawa, Yoko; Shimmura, Shigeto; Kawakita, Tetsuya; Hatou, Shin; Satofuka, Shingo; Nakamura, Shigeru; Imada, Toshihiro; Miyashita, Hideyuki; Yoshida, Satoru; Ozawa, Yoko; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Yaguchi, Tomonori; Kawakami, Yutaka] Keio Univ, Sch Med, Inst Adv Med Res, Div Cellular Signaling, Tokyo, Japan; [Mori, Takehiko; Okamoto, Shinichiro] Keio Univ, Sch Med, Div Hematol, Dept Internal Med, Tokyo, Japan; [Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan	Keio University; Keio University; Keio University; Hokkaido University	Ogawa, Y (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	yoko@z7.keio.jp	Ogawa, Yoko/AAV-1932-2021; Ozawa, Yoko/AAH-9888-2020; Shimmura, Shigeto/J-4678-2013; Kawakami, Yutaka/E-7429-2013; Mori, Takehiko/AAD-7389-2019	Ogawa, Yoko/0000-0002-2906-9621; Kawakami, Yutaka/0000-0003-4836-2855; Mori, Takehiko/0000-0002-8176-4760; Hatou, Shin/0000-0001-9273-5909	Japanese Ministry of Education, Science, Sports, and Culture [23592590]; Grants-in-Aid for Scientific Research [25830122] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japanese Ministry of Education, Science, Sports, and Culture (#23592590) and Japan Medical Association 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BE, 2004, BLOOD, V104, P1565, DOI 10.1182/blood-2004-01-0328; Anderson G, 1996, CHURCHILL LIVING STO, P47; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Bullock GR, 2001, HISTOCHEM CELL BIOL, V115, P117, DOI 10.1007/s004180000235; Chan YC, 2011, ANTIOXID REDOX SIGN, V15, P2743, DOI 10.1089/ars.2011.4071; Chou HC, 2012, J PHARMACOL EXP THER, V340, P169, DOI 10.1124/jpet.111.186288; Cole BK, 2010, HYPERTENSION, V55, P715, DOI 10.1161/HYPERTENSIONAHA.109.148049; Cooke KR, 2009, LUNG INJURY FOLLOWIN, P1456; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Hopwood J, 1996, FIXATION FIXTATIVE T, P23; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Kawano H, 2000, CIRCULATION, V101, P1130, DOI 10.1161/01.CIR.101.10.1130; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Lang YD, 2010, FREE RADICAL BIO MED, V49, P88, DOI 10.1016/j.freeradbiomed.2010.03.022; Lee SJ, 2005, BLOOD, V105, P4200, DOI 10.1182/blood-2004-10-4023; Li JA, 1996, TRANSPLANTATION, V62, P1621, DOI 10.1097/00007890-199612150-00016; Luft FC, 2012, ANN MED, V44, pS49, DOI 10.3109/07853890.2011.653396; Marshall RP, 2004, AM J PHYSIOL-LUNG C, V286, pL156, DOI 10.1152/ajplung.00313.2002; Marshall RP, 2000, AM J RESP CRIT CARE, V161, P1999, DOI 10.1164/ajrccm.161.6.9907004; McCormick LL, 1999, J IMMUNOL, V163, P5693; Munshi MK, 2011, EXP BIOL MED, V236, P557, DOI 10.1258/ebm.2011.010375; Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P4342, DOI 10.1167/iovs.06-1473; Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe; Nagata K, 1998, MATRIX BIOL, V16, P379, DOI 10.1016/S0945-053X(98)90011-7; Nonomura A, 1998, PATHOL INT, V48, P421, DOI 10.1111/j.1440-1827.1998.tb03927.x; Ogawa Y, 1999, BRIT J OPHTHALMOL, V83, P1125, DOI 10.1136/bjo.83.10.1125; Ogawa Y, 2001, INVEST OPHTH VIS SCI, V42, P111; Ogawa Y, 2007, INVEST OPHTH VIS SCI, V48, P1079, DOI 10.1167/iovs.06-0601; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Paizis G, 2002, GASTROENTEROLOGY, V123, P1667, DOI 10.1053/gast.2002.36561; Papp M, 2002, AM J PHYSIOL-LUNG C, V282, pL713, DOI 10.1152/ajplung.00103.2001; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; Rasini E, 2006, REGUL PEPTIDES, V134, P69, DOI 10.1016/j.regpep.2006.01.007; REID IA, 1978, ANNU REV PHYSIOL, V40, P377, DOI 10.1146/annurev.ph.40.030178.002113; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ruster C, 2011, J AM SOC NEPHROL, V22, P1189, DOI 10.1681/ASN.2010040384; Sabattini E, 1998, J CLIN PATHOL, V51, P506, DOI 10.1136/jcp.51.7.506; Sata M, 2011, INFLAMM REGEN, V31, P245; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; Strasser SI, 2009, GASTROINTESTINAL HEP, P1434; Taguchi T, 2011, ACTA HISTOCHEM CYTOC, V44, P35, DOI 10.1267/ahc.11001; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yaguchi S, 2012, INVEST OPHTH VIS SCI, V53, P5416, DOI 10.1167/iovs.12-9891; Yahata Y, 2006, J BIOL CHEM, V281, P13209, DOI 10.1074/jbc.M509771200; Yoshiji H, 2001, HEPATOLOGY, V34, P745, DOI 10.1053/jhep.2001.28231; Zhang Y, 2002, J IMMUNOL, V168, P3088, DOI 10.4049/jimmunol.168.6.3088	51	40	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64724	10.1371/journal.pone.0064724	http://dx.doi.org/10.1371/journal.pone.0064724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762250	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000017
J	Arnold, K; Zuberbuhler, K				Arnold, Kate; Zuberbuehler, Klaus			Female Putty-Nosed Monkeys Use Experimentally Altered Contextual Information to Disambiguate the Cause of Male Alarm Calls	PLOS ONE			English	Article							NONHUMAN PRIMATE; DIANA MONKEYS; BABOONS; COMBINATIONS; BEHAVIOR; SYSTEM; COMMUNICATION; VOCALIZATIONS; SIGNALS	Many animal vocal signals are given in a wide range of contexts which can sometimes have little in common. Yet, to respond adaptively, listeners must find ways to identify the cause of a signal, or at least rule out alternatives. Here, we investigate the nature of this process in putty-nosed monkeys, a forest primate. In this species, adult males have a very restricted repertoire of vocalizations which are given in response to a wide variety of events occurring under conditions of limited visibility. We carried out a series of field playback experiments on females (N = 6) in a habituated group in Gashaka Gumti National Park, Nigeria, in which male alarm/loud calls were presented either alone, or following acoustic information that simulated the occurrence of natural disturbances. We demonstrate that listeners appear to integrate contextual information in order to distinguish among possible causes of calls. We conclude that, in many cases, pragmatic aspects of communication play a crucial role in call interpretation and place a premium on listeners' abilities to integrate information from different sources.	[Arnold, Kate; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Zuberbuehler, Klaus] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland	University of St Andrews; University of Neuchatel	Arnold, K (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	ka11@st-andrews.ac.uk	Zuberbühler, Klaus/A-9053-2011; Arnold, Kate/C-1129-2009; Arnold, Kate/B-2021-2014	Zuberbühler, Klaus/0000-0001-8378-088X; Arnold, Kate/0000-0002-5598-2174; Arnold, Kate/0000-0002-5598-2174	Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	Funding was provided by The Leverhulme Trust (http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, NATURE, V441, P303, DOI 10.1038/441303a; Arnold K, 2008, BEHAV ECOL SOCIOBIOL, V62, P549, DOI 10.1007/s00265-007-0479-y; Arnold K, 2008, CURR BIOL, V18, pR202, DOI 10.1016/j.cub.2008.01.040; Arnold K, 2006, ANIM BEHAV, V72, P643, DOI 10.1016/j.anbehav.2005.11.017; Arnold K, 2012, BRAIN LANG, V120, P303, DOI 10.1016/j.bandl.2011.10.001; Arnold K, 2011, DEV PRIMATOL-PROG PR, P385, DOI 10.1007/978-1-4419-7403-7_11; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Clay Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018786; Crockford C, 2007, ANIM BEHAV, V73, P885, DOI 10.1016/j.anbehav.2006.10.016; Digweed SM, 2005, BEHAVIOUR, V142, P997, DOI 10.1163/156853905774405344; Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009; EVANS CS, 1993, ANIM BEHAV, V46, P23, DOI 10.1006/anbe.1993.1158; Fichtel C, 2002, BEHAV ECOL SOCIOBIOL, V51, P262, DOI 10.1007/S00265-001-0436-0; FISCHER J, 1995, ETHOLOGY, V101, P51, DOI 10.1111/j.1439-0310.1995.tb00345.x; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fischer J, 2013, ANIMAL COMMUNICATION THEORY: INFORMATION AND INFLUENCE, P297; Gautier J.-P., 1977, ANIMALS COMMUNICATE, P890; MACEDONIA JM, 1993, ETHOLOGY, V93, P177, DOI 10.1111/j.1439-0310.1993.tb00988.x; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; Marler P., 1977, P85; Price T, 2009, BEHAVIOUR, V146, P871, DOI 10.1163/156853908X396610; Rendall D, 1999, ANIM BEHAV, V57, P583, DOI 10.1006/anbe.1998.1031; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Ruxton GD, 2011, J EVOLUTION BIOL, V24, P2574, DOI 10.1111/j.1420-9101.2011.02386.x; Scarantino A, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2010.03.005; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Shannon C., 1964, MATH THEORY COMMUNIC; Shultz S, 2001, FOLIA PRIMATOL, V72, P248, DOI 10.1159/000049945; Slocombe KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011473; Smith W.J., 1977, BEHAV COMMUNICATING; Wheeler BC, 2012, EVOL ANTHROPOL, V21, P195, DOI 10.1002/evan.21319; Wheeler Brandon C., 2011, P187; Zuberbuhler K, 1999, ETHOLOGY, V105, P477, DOI 10.1046/j.1439-0310.1999.00396.x; Zuberbuhler K, 2003, ADV STUD BEHAV, V33, P265, DOI 10.1016/S0065-3454(03)33006-2; Zuberbuhler K, 2000, COGNITION, V76, P195, DOI 10.1016/S0010-0277(00)00079-2; Zuberbuhler K, 1997, ANIM BEHAV, V53, P589, DOI 10.1006/anbe.1996.0334; Zuberbuhler K, 2000, ANIM BEHAV, V59, P917, DOI 10.1006/anbe.1999.1317	38	41	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65660	10.1371/journal.pone.0065660	http://dx.doi.org/10.1371/journal.pone.0065660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755265	Green Published, gold			2022-12-25	WOS:000320579400072
J	Palermo, L; Nori, R; Piccardi, L; Zeri, F; Babino, A; Giusberti, F; Guariglia, C				Palermo, Liana; Nori, Raffaella; Piccardi, Laura; Zeri, Fabrizio; Babino, Antonio; Giusberti, Fiorella; Guariglia, Cecilia			Refractive Errors Affect the Vividness of Visual Mental Images	PLOS ONE			English	Article							CONGENITALLY BLIND; PERCEPTION; REPRESENTATIONS; INFORMATION; VISION; MEMORY; ADULTS; EYE	The hypothesis that visual perception and mental imagery are equivalent has never been explored in individuals with vision defects not preventing the visual perception of the world, such as refractive errors. Refractive error (i.e., myopia, hyperopia or astigmatism) is a condition where the refracting system of the eye fails to focus objects sharply on the retina. As a consequence refractive errors cause blurred vision. We subdivided 84 individuals according to their spherical equivalent refraction into Emmetropes (control individuals without refractive errors) and Ametropes (individuals with refractive errors). Participants performed a vividness task and completed a questionnaire that explored their cognitive style of thinking before their vision was checked by an ophthalmologist. Although results showed that Ametropes had less vivid mental images than Emmetropes this did not affect the development of their cognitive style of thinking; in fact, Ametropes were able to use both verbal and visual strategies to acquire and retrieve information. Present data are consistent with the hypothesis of equivalence between imagery and perception.	[Palermo, Liana; Guariglia, Cecilia] Sapienza Univ Roma, Dipartimento Psicol, Rome, Italy; [Palermo, Liana; Piccardi, Laura; Guariglia, Cecilia] Ist Ricovero, Sezione Neuropsicol, Rome, Italy; [Palermo, Liana; Piccardi, Laura; Guariglia, Cecilia] Carattere Scientifico Fdn Santa Lucia, Rome, Italy; [Nori, Raffaella; Giusberti, Fiorella] Univ Bologna, Dipartimento Psicol, Bologna, Italy; [Piccardi, Laura] Univ Aquila, Dipartimento Sci Salute, Coppito, Italy; [Zeri, Fabrizio] Fis & Sci Natur Univ Roma TRE, CdL Ott & Optometria, Fac Matemat, Rome, Italy; [Babino, Antonio] Casa Cura Tortorella, Salerno, Italy	Sapienza University Rome; IRCCS Santa Lucia; University of Bologna; University of L'Aquila	Palermo, L (corresponding author), Sapienza Univ Roma, Dipartimento Psicol, Rome, Italy.	liana.palermo@uniroma1.it	guariglia, cecilia/J-9898-2018; Palermo, Liana/ABG-2726-2021; Piccardi, laura/AAC-7587-2022	Palermo, Liana/0000-0001-8047-7201; guariglia, cecilia/0000-0001-7474-6030; Piccardi, Laura/0000-0002-1322-5538; Zeri, Fabrizio/0000-0003-0529-555X	Ministero della Salute (RC)	Ministero della Salute (RC)	This study was partially supported by funding from Ministero della Salute (RC 2010-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding were received for this study.	Amedi A, 2005, NEURON, V48, P859, DOI 10.1016/j.neuron.2005.10.032; ARDITI A, 1988, NEUROPSYCHOLOGIA, V26, P1, DOI 10.1016/0028-3932(88)90026-7; AUSBURN LJ, 1978, ECTJ-EDUC COMMUN TEC, V26, P337; Bailey IL, 1998, BORISHS CLIN REFRACT, P217; Bartolomeo P, 2002, CORTEX, V38, P357, DOI 10.1016/S0010-9452(08)70665-8; Bartolomeo P, 1998, NEUROPSYCHOLOGIA, V36, P239, DOI 10.1016/S0028-3932(97)00103-6; Blazhenkova O, 2009, APPL COGNITIVE PSYCH, V23, P638, DOI 10.1002/acp.1473; Cattaneo Z, 2008, NEUROSCI BIOBEHAV R, V32, P1346, DOI 10.1016/j.neubiorev.2008.05.002; Cornoldi C, 2000, DEBATES PSYCHOL, P143; Cornoldi C., 1989, RESEARCHGATE, V1, P321; Cornoldi C., 1992, J MENT IMAGERY, V16, P89; Cornoldi C, 2009, ACTA PSYCHOL, V130, P11, DOI 10.1016/j.actpsy.2008.09.012; CRAVERLEMLEY C, 1992, PSYCHOL REV, V99, P633, DOI 10.1037/0033-295X.99.4.633; Cui X, 2007, VISION RES, V47, P474, DOI 10.1016/j.visres.2006.11.013; D'Angiulli A, 2007, AM J PSYCHOL, V120, P521, DOI 10.2307/20445424; Denis M, 1999, CAH PSYCHOL COGN, V18, P409; Dulin D, 2008, NEUROSCI BIOBEHAV R, V32, P1396, DOI 10.1016/j.neubiorev.2008.04.007; FARAH MJ, 1988, BRAIN COGNITION, V8, P147, DOI 10.1016/0278-2626(88)90046-2; FARAH MJ, 1992, J EXP PSYCHOL HUMAN, V18, P241, DOI 10.1037/0096-1523.18.1.241; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Gentaz, 2003, TOUCHING KNOWING COG, P173, DOI [DOI 10.1075/AICR.53.14COR, 10.1075/aicr.53]; GOLDENBERG G, 1992, NEUROPSYCHOLOGIA, V30, P1081, DOI 10.1016/0028-3932(92)90100-Z; GREEN KE, 1990, PSYCHOL REP, V66, P939, DOI 10.2466/PR0.66.3.939-945; HABER RN, 1993, PERCEPT PSYCHOPHYS, V54, P1, DOI 10.3758/BF03206932; Hatakeyama T, 1997, PERCEPT MOTOR SKILL, V84, P1315, DOI 10.2466/pms.1997.84.3c.1315; Jonassen D.H., 1993, HDB INDIVIDUAL DIFFE; KERR NH, 1983, J EXP PSYCHOL GEN, V112, P265, DOI 10.1037/0096-3445.112.2.265; KIRBY JR, 1988, CONTEMP EDUC PSYCHOL, V13, P169, DOI 10.1016/0361-476X(88)90017-3; Knauff M, 2000, NEUROREPORT, V11, P3957, DOI 10.1097/00001756-200012180-00011; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI; Kosslyn SM, 2003, PSYCHOL BULL, V129, P723, DOI 10.1037/0033-2909.129.5.723; KOSSLYN SM, 1995, NATURE, V378, P496, DOI 10.1038/378496a0; Kosslyn SM, 2005, COGN NEUROPSYCHOL, V22, P333, DOI 10.1080/02643290442000130; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; KOSSLYN SM, 1987, PSYCHOL REV, V94, P148, DOI 10.1037/0033-295X.94.2.148; KOSSLYN SM, 1978, J EXP PSYCHOL HUMAN, V4, P47, DOI 10.1037/0096-1523.4.1.47; KOSSLYN SM, 1973, PERCEPT PSYCHOPHYS, V14, P90, DOI 10.3758/BF03198621; Kozhevnikov M, 2005, MEM COGNITION, V33, P710, DOI 10.3758/BF03195337; Kozhevnikov M, 2002, COGNITION INSTRUCT, V20, P47, DOI 10.1207/S1532690XCI2001_3; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; Lean G., 1981, EDUC STUD MATH, V12, P267, DOI [10.1007/BF00311060, DOI 10.1007/BF00311060]; LEVINE DN, 1978, BRAIN LANG, V5, P341, DOI 10.1016/0093-934X(78)90031-7; Marks D., 1972, FUNCTION NATURE IMAG, P83; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; MCKELVIE SJ, 1979, BRIT J PSYCHOL, V70, P51, DOI 10.1111/j.2044-8295.1979.tb02142.x; MCKELVIE SJ, 1994, BRIT J PSYCHOL, V85, P93, DOI 10.1111/j.2044-8295.1994.tb02510.x; Mellet E, 1996, J NEUROSCI, V16, P6504; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Messick S., 1976, INDIVIDUALITY LEARNI; Paivio A, 1971, IMAGERY VERBAL PROCE; Palermo L, 2010, COGN NEUROPSYCHOL, V27, P115, DOI 10.1080/02643294.2010.503478; Perky CW, 1910, AM J PSYCHOL, V21, P422, DOI 10.2307/1413350; Richardson A., 1977, J MENT IMAG, V1, P109; Roder B, 2003, INT J PSYCHOPHYSIOL, V50, P27, DOI 10.1016/S0167-8760(03)00122-3; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Shepard R, 1988, MENTAL IMAGES THEIR; Thyagarajan S, 2007, OPHTHAL PHYSL OPT, V27, P315, DOI 10.1111/j.1475-1313.2007.00469.x; TROJANO L, 1994, BRAIN COGNITION, V24, P213, DOI 10.1006/brcg.1994.1012; Vanlierde A, 2004, ACTA PSYCHOL, V116, P205, DOI 10.1016/j.actpsy.2004.03.001; Vincenzi G, 2000, THESIS U BOLOGNA ITA; WITKIN HA, 1977, REV EDUC RES, V47, P1	62	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65161	10.1371/journal.pone.0065161	http://dx.doi.org/10.1371/journal.pone.0065161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755186	Green Submitted, gold, Green Published			2022-12-25	WOS:000320579400042
J	Santiago-Rodriguez, TM; Narganes-Storde, YM; Chanlatte, L; Crespo-Torres, E; Toranzos, GA; Jimenez-Flores, R; Hamrick, A; Cano, RJ				Santiago-Rodriguez, Tasha M.; Narganes-Storde, Yvonne M.; Chanlatte, Luis; Crespo-Torres, Edwin; Toranzos, Gary A.; Jimenez-Flores, Rafael; Hamrick, Alice; Cano, Raul J.			Microbial Communities in Pre-Columbian Coprolites	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FECES; POPULATIONS; DELIVERY; PATTERN; GENES; TOOLS; AGE	The study of coprolites from earlier cultures represents a great opportunity to study an "unaltered'' composition of the intestinal microbiota. To test this, pre-Columbian coprolites from two cultures, the Huecoid and Saladoid, were evaluated for the presence of DNA, proteins and lipids by cytochemical staining, human and/or dog-specific Bacteroides spp. by PCR, as well as bacteria, fungi and archaea using Terminal Restriction Fragment analyses. DNA, proteins and lipids, and human-specific Bacteroides DNA were detected in all coprolites. Multidimensional scaling analyses resulted in spatial arrangements of microbial profiles by culture, further supported by cluster analysis and ANOSIM. Differences between the microbial communities were positively correlated with culture, and SIMPER analysis indicated 68.8% dissimilarity between the Huecoid and Saladoid. Proteobacteria, Bacteroidetes and methanogens were found in all coprolite samples. Propionebacteria, Shewanella and lactic acid bacteria dominated in the Huecoid samples, while Acidobacteria, and peptococci were dominant in Saladoid samples. Yeasts, including Candida albicans and Crypotococcus spp. were found in all samples. Basidiomycetes were the most notable fungi in Huecoid samples while Ascomycetes predominated in Saladoid samples, suggesting differences in dietary habits. Our study provides an approach for the study of the microbial communities of coprolite samples from various cultures.	[Santiago-Rodriguez, Tasha M.; Toranzos, Gary A.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Narganes-Storde, Yvonne M.; Chanlatte, Luis; Crespo-Torres, Edwin] Univ Puerto Rico, Ctr Archaeol Res, San Juan, PR 00936 USA; [Jimenez-Flores, Rafael] Calif Polytech State Univ San Luis Obispo, Dairy Prod Technol Ctr, San Luis Obispo, CA 93407 USA; [Hamrick, Alice; Cano, Raul J.] Calif Polytech State Univ San Luis Obispo, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; California State University System; California Polytechnic State University San Luis Obispo; California State University System; California Polytechnic State University San Luis Obispo	Cano, RJ (corresponding author), Calif Polytech State Univ San Luis Obispo, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA.	rcano@calpoly.edu	Jimenez-Flores, Rafael/B-6830-2017; Jimenez-Flores, Rafael/I-5229-2013	Jimenez-Flores, Rafael/0000-0003-4905-5021; 	Center for Applied Biotechnology at the California Polytechnic State University	Center for Applied Biotechnology at the California Polytechnic State University	Funding for the project was provided by the Center for Applied Biotechnology at the California Polytechnic State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne S, 2005, MICROBES INFECT, V7, P1256, DOI 10.1016/j.micinf.2005.04.011; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; BRUNS TD, 1993, MOL ECOL, V2, P233, DOI 10.1111/j.1365-294X.1993.tb00013.x; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; Chanlatte L, 1980, P 8 INT C CAR ARCH B, P501; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; CLARKE KR, 1994, MAR BIOL, V118, P167, DOI 10.1007/BF00699231; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Coleman D.C., 1991, CARBON ISOTOPE TECHN; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DERMOUN Z, 1985, BIOTECHNOL BIOENG, V27, P1005, DOI 10.1002/bit.260270711; Frey JC, 2010, J APPL MICROBIOL, V108, P1982, DOI 10.1111/j.1365-2672.2009.04602.x; Hamada M, 2009, INT J SYST EVOL MICR, V59, P2809, DOI 10.1099/ijs.0.011106-0; HOLDEMAN LV, 1976, APPL ENVIRON MICROB, V31, P359, DOI 10.1128/AEM.31.3.359-375.1976; Kaplan CW, 2004, APPL ENVIRON MICROB, V70, P1777, DOI 10.1128/AEM.70.3.1777-1786.2004; Kaplan CW, 2001, APPL ENVIRON MICROB, V67, P1935, DOI 10.1128/AEM.67.4.1935-1939.2001; Kendall AI, 1924, J INFECT DIS, V35, P67, DOI 10.1093/infdis/35.1.67; Kildare BJ, 2007, WATER RES, V41, P3701, DOI 10.1016/j.watres.2007.06.037; Kitts C L, 2001, Curr Issues Intest Microbiol, V2, P17; Kutschera U, 2007, PLANT SIGNAL BEHAV, V2, P74, DOI 10.4161/psb.2.2.4073; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Narganes-Storde Y, 1982, VERTEBRATE FAUNAL RE; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Pagan-Jimenez JR, 2009, MUNDO VIVIDO ANTIGUO; Pagan-Jimenez JR, 2007, ANTIGUOS PUEBLOS CUL; Reinhard KJ, 1992, PAPERS NATURAL RESOU; Reyes-Becerril M, 2008, FISH SHELLFISH IMMUN, V25, P731, DOI 10.1016/j.fsi.2008.02.010; Scott TM, 2002, APPL ENVIRON MICROB, V68, P5796, DOI 10.1128/AEM.68.12.5796-5803.2002; Sobolik KD, 1990, TEXAS J SCI, V42; Sorensen T, 1948, BIOL SKRIFTER, V5, P1; Tito RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051146; Wasser MP, 1999, INT J MED MUSHROOMS, V1, P31; Wood JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040025; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	38	31	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65191	10.1371/journal.pone.0065191	http://dx.doi.org/10.1371/journal.pone.0065191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755194	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400045
J	Brouwers, J; Noviyanti, R; Fijnheer, R; de Groot, PG; Trianty, L; Mudaliana, S; Roest, M; Syafruddin, D; van der Ven, A; de Mast, Q				Brouwers, Judith; Noviyanti, Rintis; Fijnheer, Rob; de Groot, Philip G.; Trianty, Leily; Mudaliana, Siti; Roest, Mark; Syafruddin, Din; van der Ven, Andre; de Mast, Quirijn			Platelet Activation Determines Angiopoietin-1 and VEGF Levels in Malaria: Implications for Their Use as Biomarkers	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CEREBRAL MALARIA; UNCOMPLICATED MALARIA; FALCIPARUM-MALARIA; AFRICAN CHILDREN; WHOLE-BLOOD; PLASMA; RELEASE; CELLS; THROMBOCYTOPENIA	Introduction: The angiogenic proteins angiopoietin (Ang)-1, Ang-2 and vascular endothelial growth factor (VEGF) are regulators of endothelial inflammation and integrity. Since platelets store large amounts of Ang-1 and VEGF, measurement of circulation levels of these proteins is sensitive to platelet number, in vivo platelet activation and inadvertent platelet activation during blood processing. We studied plasma Ang-1, Ang-2 and VEGF levels in malaria patients, taking the necessary precautions to avoid ex vivo platelet activation, and related plasma levels to platelet count and the soluble platelet activation markers P-selectin and CXCL7. Methods: Plasma levels of Ang-1, Ang-2, VEGF, P-selectin and CXCL7 were measured in CTAD plasma, minimizing ex vivo platelet activation, in 27 patients with febrile Plasmodium falciparum malaria at presentation and day 2 and 5 of treatment and in 25 healthy controls. Results: Levels of Ang-1, Ang-2 and VEGF were higher at day 0 in malaria patients compared to healthy controls. Ang-2 levels, which is a marker of endothelial activation, decreased after start of antimalarial treatment. In contrast, Ang-1 and VEGF plasma levels increased and this corresponded with the increase in platelet number. Soluble P-selectin and CXCL7 levels followed the same trend as Ang-1 and VEGF levels. Plasma levels of these four proteins correlated strongly in malaria patients, but only moderately in controls. Conclusion: In contrast to previous studies, we found elevated plasma levels of Ang-1 and VEGF in patients with malaria resulting from in vivo platelet activation. Ang-1 release from platelets may be important to dampen the disturbing effects of Ang-2 on the endothelium. Evaluation of plasma levels of these angiogenic proteins requires close adherence to a stringent protocol to minimize ex vivo platelet activation.	[Brouwers, Judith; Fijnheer, Rob; de Groot, Philip G.; Roest, Mark; de Mast, Quirijn] Univ Med Ctr, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Noviyanti, Rintis; Trianty, Leily; Mudaliana, Siti; Syafruddin, Din] Eijkman Inst Mol Biol, Jakarta, Indonesia; [van der Ven, Andre; de Mast, Quirijn] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Eijkman Institute; Radboud University Nijmegen	de Mast, Q (corresponding author), Univ Med Ctr, Dept Clin Chem & Haematol, Utrecht, Netherlands.	q.demast@aig.umcn.nl	van der Ven, A.J.A.M./H-8102-2014; de Mast, Quirijn/H-3427-2015	van der Ven, A.J.A.M./0000-0003-1833-3391; Trianty, Leily/0000-0002-4368-476X; Syafruddin, din/0000-0001-7141-2545; Noviyanti, Rintis/0000-0003-1383-3274; de Mast, Quirijn/0000-0001-6056-157X	KNAW (Royal Academy of Sciences) through the SPIN Postdoc Research Programme; Noaber foundation; Augeo foundation	KNAW (Royal Academy of Sciences) through the SPIN Postdoc Research Programme; Noaber foundation; Augeo foundation	Research support from the KNAW (Royal Academy of Sciences) through the SPIN Postdoc Research Programme (RN) and the Noaber foundation and Augeo foundation (JB, QM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158; Casals-Pascual C, 2008, P NATL ACAD SCI USA, V105, P2634, DOI 10.1073/pnas.0709715105; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; de Mast Q, 2007, J INFECT DIS, V196, P622, DOI 10.1086/519844; de Mast Q, 2010, BRIT J HAEMATOL, V151, P495, DOI 10.1111/j.1365-2141.2010.08399.x; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fijnheer R, 1997, THROMB HAEMOSTASIS, V77, P1081; Golanski J, 1996, THROMB RES, V83, P199, DOI 10.1016/0049-3848(96)00129-6; Ho-Tin-Noe B, 2011, J THROMB HAEMOST, V9, P56, DOI 10.1111/j.1538-7836.2011.04317.x; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Jain V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-383; Kim I, 2001, J BIOL CHEM, V276, P7614, DOI 10.1074/jbc.M009705200; KUHNE T, 1995, AM J HEMATOL, V50, P40, DOI 10.1002/ajh.2830500108; Lei H, 2009, CLIN BIOCHEM, V42, P1452, DOI 10.1016/j.clinbiochem.2009.06.012; Li JJ, 2001, THROMB HAEMOSTASIS, V85, P204, DOI 10.1055/s-0037-1615677; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Ranieri G, 2004, ONCOL REP, V11, P435; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Starlinger P, 2011, DIS MARKERS, V31, P55, DOI [10.1155/2011/535109, 10.3233/DMA-2011-0798]; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 2005, EXP SUPPL, V94, P233; van Bladel ER, 2011, HAEMATOL-HEMATOL J, V96, P888, DOI 10.3324/haematol.2011.042663; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Zimmermann R, 2005, CLIN CHEM, V51, P2365, DOI 10.1373/clinchem.2005.055558; Zimmermann R, 2003, VOX SANG, V85, P283, DOI 10.1111/j.0042-9007.2003.00361.x; Zimmermann R, 2009, J IMMUNOL METHODS, V347, P91, DOI 10.1016/j.jim.2009.04.010	31	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64850	10.1371/journal.pone.0064850	http://dx.doi.org/10.1371/journal.pone.0064850			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755151	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300031
J	Gast, CM; Skalski, JR; Isabelle, JL; Clawson, MV				Gast, Christopher M.; Skalski, John R.; Isabelle, Jason L.; Clawson, Michael V.			Random Effects Models and Multistage Estimation Procedures for Statistical Population Reconstruction of Small Game Populations	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; CATCH-EFFORT; INFERENCE; TRENDS; TESTS; RATIO	Recently, statistical population models using age-at-harvest data have seen increasing use for monitoring of harvested wildlife populations. Even more recently, detailed evaluation of model performance for long-lived, large game animals indicated that the use of random effects to incorporate unmeasured environmental variation, as well as second-stage Horvitz-Thompson-type estimators of abundance, provided more reliable estimates of total abundance than previous models. We adapt this new modeling framework to small game, age-at-harvest models with only young-of-the-year and adult age classes. Our Monte Carlo simulation results indicate superior model performance for the new modeling framework, evidenced by lower bias and proper confidence interval coverage. We apply this method to male wild turkey harvest in the East Ozarks turkey productivity region, Missouri, USA, where statistical population reconstruction indicates a relatively stationary population for 1996-2010.	[Gast, Christopher M.] Univ Washington, Seattle, WA 98195 USA; [Skalski, John R.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Isabelle, Jason L.] Missouri Dept Conservat, Columbia, MO USA; [Clawson, Michael V.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Missouri System; University of Missouri Columbia; University of Washington; University of Washington Seattle	Skalski, JR (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	skalski@uw.edu		Skalski, John/0000-0002-7070-2505; Clawson, Michael/0000-0002-8413-7009				Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 1982, ESTIMATION ANIMAL AB; Broms K, 2010, J WILDLIFE MANAGE, V74, P310, DOI 10.2193/2008-469; Buckland ST, 2010, BIOMETRICS, V66, P169, DOI 10.1111/j.1541-0420.2009.01239.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Conn PB, 2008, BIOMETRICS, V64, P1170, DOI 10.1111/j.1541-0420.2008.00987.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Diefenbach DR, 2010, TECHNICAL REPORT; DUPONT WD, 1983, BIOMETRICS, V39, P1021, DOI 10.2307/2531336; Fieberg JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012114; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Gast CM, 2013, J WILDLIFE IN PRESS; Gove NE, 2002, J WILDLIFE MANAGE, V66, P310, DOI 10.2307/3803163; Laake J. L., 2004, METHODS INCOMPLETE D; Leslie P. H., 1945, BIOMETRIKA, V33, P183, DOI [10.1093/biomet/33.3.183, DOI 10.1093/BIOMET/33.3.1832-S2.0-77956980711]; Molenberghs G, 2007, AM STAT, V61, P22, DOI 10.1198/000313007X171322; Nigh T.A., 2002, ATLAS MISSOURI ECORE; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Skalski JR, 2007, J WILDLIFE MANAGE, V71, P1309, DOI 10.2193/2005-707; Skalski JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033910; Skalski JR, 2011, J WILDLIFE MANAGE, V75, P1767, DOI 10.1002/jwmg.227; WARE S, 1992, AM MIDL NAT, V128, P40, DOI 10.2307/2426411; [No title captured]	23	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65244	10.1371/journal.pone.0065244	http://dx.doi.org/10.1371/journal.pone.0065244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755199	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300062
J	Granado, M; Fernandez, N; Monge, L; Carreno-Tarragona, G; Figueras, JC; Amor, S; Garcia-Villalon, AL				Granado, Miriam; Fernandez, Nuria; Monge, Luis; Carreno-Tarragona, Gonzalo; Carlos Figueras, Juan; Amor, Sara; Luis Garcia-Villalon, Angel			Long-Term Effects of Early Overnutrition in the Heart of Male Adult Rats: Role of the Renin-Angiotensin System	PLOS ONE			English	Article							OBESE ZUCKER RATS; DEPENDENT APOPTOTIC PATHWAY; CARDIOVASCULAR-DISEASE; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; ISCHEMIA-REPERFUSION; RENIN/PRORENIN RECEPTOR; VASCULAR INFLAMMATION; CORONARY-ARTERIES; OXIDATIVE STRESS	To analyze the long-term effects of early overfeeding on the heart and coronary circulation, the effect of ischemia-reperfusion (I/R) and the role of the renin-angiotensin system (RAS) was studied in isolated hearts from control and overfed rats during lactation. On the day of birth litters were adjusted to twelve pups per mother (controls) or to three pups per mother (overfed). At 5 months of age, the rats from reduced litters showed higher body weight and body fat than the controls. The hearts from these rats were perfused in a Langendorff system and subjected to 30 min of ischemia followed by 15 min of reperfusion (I/R). The myocardial contractility (dP/dt) and the coronary vasoconstriction to angiotensin II were lower, and the expression of the apoptotic marker was higher, in the hearts from overfed rats compared to controls. I/R reduced the myocardial contractily, the coronary vasoconstriction to angiotensin II and the vasodilatation to bradykinin, and increased the expression of (pro)renin receptor and of apoptotic and antiapoptotic markers, in both experimental groups. I/R also increased the expression of angiotensinogen in control but not in overfed rats. In summary, the results of this study suggest that early overnutrition induces reduced activity of the RAS and impairment of myocardial and coronary function in adult life, due to increased apoptosis. Ischemia-reperfusion produced myocardial and coronary impairment and apoptosis, which may be related to activation of RAS in control but not in overfed rats, and there may be protective mechanisms in both experimental groups.	[Granado, Miriam; Fernandez, Nuria; Monge, Luis; Carreno-Tarragona, Gonzalo; Carlos Figueras, Juan; Amor, Sara; Luis Garcia-Villalon, Angel] Univ Autonoma Madrid, Fac Med, Dept Physiol, E-28049 Madrid, Spain; [Granado, Miriam] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Granado, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Physiol, E-28049 Madrid, Spain.	miriam.granado@uam.es	Granado, Miriam/B-8978-2017; Fernández, Nuria/AAM-7639-2021; Monge, Luis/M-3515-2014; Monge, Luis/O-6840-2019; Monsalve, Nuria Fernández/E-6235-2013; Garcia-Villalon, Angel/AAA-3067-2019	Granado, Miriam/0000-0001-9178-8822; Fernández, Nuria/0000-0002-9268-3333; Monge, Luis/0000-0001-7688-7531; Monge, Luis/0000-0001-7688-7531; Monsalve, Nuria Fernández/0000-0002-9268-3333; Carreno-Tarragona, Gonzalo/0000-0002-9570-5542	Fundacion Mapfre; Fondo de Investigaciones Sanitarias [PS09/00394]	Fundacion Mapfre; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was financed by Fundacion Mapfre (2011) and Fondo de Investigaciones Sanitarias (PS09/00394). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarche-Xifro W, 2009, STEM CELLS, V27, P2488, DOI 10.1002/stem.171; Barouch LA, 2006, CIRC RES, V98, P119, DOI 10.1161/01.RES.0000199348.10580.1d; Batenburg WW, 2012, CLIN SCI, V123, P121, DOI 10.1042/CS20120042; Black MJ, 2012, AM J PHYSIOL-REG I, V302, pR1101, DOI 10.1152/ajpregu.00030.2012; Bohlen HG, 2002, AM J PHYSIOL-HEART C, V283, pH391, DOI 10.1152/ajpheart.00019.2002; Busche S, 2000, AM J PATHOL, V157, P605, DOI 10.1016/S0002-9440(10)64571-3; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Danser AHJ, 2002, J MOL CELL CARDIOL, V34, P1463, DOI 10.1006/jmcc.2002.2078; Davidowa H, 2000, NEUROSCI LETT, V293, P21, DOI 10.1016/S0304-3940(00)01475-0; Davidowa H, 2007, NEUROREPORT, V18, P521, DOI 10.1097/WNR.0b013e32805dfb93; de Chantemele EJB, 2012, J MOL CELL CARDIOL, V52, P840, DOI 10.1016/j.yjmcc.2011.08.018; De Mello W, 2003, REGUL PEPTIDES, V114, P87, DOI 10.1016/S0167-0115(03)00121-6; De Mello WC, 2011, PEPTIDES, V32, P1774, DOI 10.1016/j.peptides.2011.06.018; Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; du Toit EF, 2005, BASIC RES CARDIOL, V100, P346, DOI 10.1007/s00395-005-0528-5; Dyntar D, 2001, DIABETES, V50, P2105, DOI 10.2337/diabetes.50.9.2105; Eisenmann JC, 2005, AM HEART J, V149, P46, DOI 10.1016/j.ahj.2004.07.016; Erdos B, 2004, DIABETES, V53, P1352, DOI 10.2337/diabetes.53.5.1352; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Fowler JD, 2009, AM J PHYSIOL-ENDOC M, V296, pE343, DOI 10.1152/ajpendo.90693.2008; Frisbee JC, 2001, AM J PHYSIOL-HEART C, V281, pH1304, DOI 10.1152/ajpheart.2001.281.3.H1304; Fujiwara K, 1999, HYPERTENSION, V33, P1470, DOI 10.1161/01.HYP.33.6.1470; Galili O, 2007, AM J PHYSIOL-HEART C, V292, pH904, DOI 10.1152/ajpheart.00628.2006; Garcia-Villalon AL, 2005, EUR J PHARMACOL, V509, P165, DOI 10.1016/j.ejphar.2004.11.065; Garcia-Villalon AL, 2004, EXP BIOL MED, V229, P118, DOI 10.1177/153537020422900114; Garcia-Villalon AL, 2009, CARDIOVASC RES, V81, P336, DOI 10.1093/cvr/cvn321; GAVRAS H, 1971, LANCET, V2, P19; GAVRAS H, 1975, AM HEART J, V89, P321, DOI 10.1016/0002-8703(75)90082-4; GIACOMELLI F, 1976, AM J PATHOL, V84, P111; Goossens G H, 2003, Obes Rev, V4, P43; Granado M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054984; Hirose T, 2009, PEPTIDES, V30, P2316, DOI 10.1016/j.peptides.2009.09.015; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Knudson JD, 2005, AM J PHYSIOL-HEART C, V289, pH1038, DOI 10.1152/ajpheart.00244.2005; KREMER D, 1981, CARDIOVASC RES, V15, P43, DOI 10.1093/cvr/15.1.43; Lamarche B, 1998, GROWTH HORM IGF RES, V8, P1, DOI 10.1016/S1096-6374(98)80018-X; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lee SD, 2007, OBESITY, V15, P2407, DOI 10.1038/oby.2007.286; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li ZL, 2012, ARTERIOSCL THROM VAS, V32, P1132, DOI 10.1161/ATVBAHA.111.244061; LINDPAINTNER K, 1990, CIRC RES, V67, P564, DOI 10.1161/01.RES.67.3.564; Listenberger LL, 2002, TRENDS CARDIOVAS MED, V12, P134, DOI 10.1016/S1050-1738(02)00152-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logue J, 2011, CLIN PHARMACOL THER, V90, P174, DOI 10.1038/clpt.2011.88; Lu MC, 2007, OBESITY, V15, P2634, DOI 10.1038/oby.2007.315; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Miller AW, 1999, J VASC RES, V36, P385, DOI 10.1159/000025678; Muller DN, 1998, CIRC RES, V82, P13; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; NIO Y, 1995, J CLIN INVEST, V95, P46, DOI 10.1172/JCI117675; Oltman CL, 2006, AM J PHYSIOL-HEART C, V291, pH1780, DOI 10.1152/ajpheart.01297.2005; Pascual M, 2003, HEART, V89, P1152, DOI 10.1136/heart.89.10.1152; Prakash R, 2006, MICROCIRCULATION, V13, P389, DOI 10.1080/10739680600745919; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Schunkert H, 2002, INT J OBESITY, V26, pS15, DOI 10.1038/sj.ijo.0802214; Shimizu M, 1999, J CARDIOVASC PHARM, V34, P512, DOI 10.1097/00005344-199910000-00006; Sishi B, 2011, EXP PHYSIOL, V96, P179, DOI 10.1113/expphysiol.2010.054189; Stepp DW, 1999, CIRCULATION, V100, P1555, DOI 10.1161/01.CIR.100.14.1555; Trask AJ, 2008, AM J PHYSIOL-HEART C, V294, pH2242, DOI 10.1152/ajpheart.00175.2008; Trivedi PS, 2008, CURR HYPERTENS REP, V10, P454, DOI 10.1007/s11906-008-0085-z; Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183; Wang QD, 1999, EUR J PHARMACOL, V380, P13, DOI 10.1016/S0014-2999(99)00499-9; Werrmann JG, 1996, J CARDIOVASC PHARM, V27, P177, DOI 10.1097/00005344-199602000-00001; Yim HE, 2011, J NUTR BIOCH; Zhang CH, 2008, BASIC RES CARDIOL, V103, P407, DOI 10.1007/s00395-008-0725-0; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	70	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65172	10.1371/journal.pone.0065172	http://dx.doi.org/10.1371/journal.pone.0065172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755190	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300054
J	Jung, SB; Kim, CS; Kim, YR; Naqvi, A; Yamamori, T; Kumar, S; Kumar, A; Irani, K				Jung, Saet-Byel; Kim, Cuk-Seong; Kim, Young-Rae; Naqvi, Asma; Yamamori, Tohru; Kumar, Santosh; Kumar, Ajay; Irani, Kaikobad			Redox Factor-1 Activates Endothelial SIRTUIN1 through Reduction of Conserved Cysteine Sulfhydryls in Its Deacetylase Domain	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVITY; SIRT1; IDENTIFICATION; APE1/REF-1; REF-1; PROMOTES; HYPOXIA; PROTEIN	Apurinic/Apyrmidinic Endonuclease 1/Redox Factor-1 (APE1/Ref-1) is a reductant which is important for vascular homeostasis. SIRTUIN1 (SIRT1) is a lysine deacetylase that also promotes endothelium-dependent vasorelaxation. We asked if APE1/Ref-1 governs the redox state and activity of SIRT1, and whether SIRT1 mediates the effect of APE1/Ref-1 on endothelium-dependent vascular function. APE1/Ref-1 maintains sulfhydryl (thiol) groups of cysteine residues in SIRT1 in the reduced form and promotes endothelial SIRT1 activity. APE1/Ref-1 stimulates SIRT1 activity by targeting highly conserved vicinal thiols 371 and 374 which form a zinc tetra-thiolate motif in the deacetylase domain of SIRT1. Cysteine residues in the N-terminal redox domain of APE1/Ref-1 are essential for reducing SIRT1 and stimulating its activity. APE1/Ref-1 protects endothelial SIRT1 from hydrogen peroxide-induced oxidation of sulfhydryls and from inactivation. APE1/Ref-1 also promotes lysine deacetylation of the SIRT1 target endothelial nitric oxide synthase (eNOS). SIRT1 mutated at cysteines 371 and 374, which renders it non-reducible by APE1/Ref-1, prevents lysine deacetylation of eNOS by APE1/Ref-1. SIRT1 free thiol (reduced sulfhydryl) content and deacetylase activity are diminished in all examined tissues of APE1/Ref-1(+/-) mice, including the vasculature. Overexpression of SIRT1 in aortas of APE1/Ref-1(+/-) mice restores endothelium-dependent vasorelaxation and bioavailable nitric oxide (NO) to levels similar to those observed in wild-type mice. Thus, APE1/Ref-1, by maintaining functionally important cysteine sulfhydryls in SIRT1 in the reduced form, promotes endothelial SIRT1 activity. This reductive activation of endothelial SIRT1 by APE1/Ref-1 mediates the effect of APE1/Ref-1 on eNOS acetylation, promoting endothelium-derived NO and endothelium-dependent vasorelaxation.	[Jung, Saet-Byel; Kim, Cuk-Seong; Kim, Young-Rae; Naqvi, Asma; Yamamori, Tohru; Kumar, Santosh; Kumar, Ajay; Irani, Kaikobad] Univ Pittsburgh, Dept Med, Div Cardiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Irani, K (corresponding author), Univ Iowa, Dept Internal Med, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA.	iranik@upmc.edu	Yamamori, Tohru/A-7285-2012; Kumar, Santosh/N-9922-2014	Kumar, Santosh/0000-0003-1418-2020; Kim, Cuk-Seong/0000-0001-7647-6089; Irani, Kaikobad/0000-0001-9194-7387	Grants-in-Aid for Scientific Research [24654112] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Angkeow P, 2002, CELL DEATH DIFFER, V9, P717, DOI 10.1038/sj.cdd.4401025; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Chen L, 2010, J INORG BIOCHEM, V104, P180, DOI 10.1016/j.jinorgbio.2009.10.021; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jeon BH, 2004, CIRC RES, V95, P902, DOI 10.1161/01.RES.0000146947.84294.4c; Jiang AH, 2011, VISION RES, V51, P93, DOI 10.1016/j.visres.2010.10.008; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Sherman JM, 1999, MOL BIOL CELL, V10, P3045, DOI 10.1091/mbc.10.9.3045; Stein S, 2010, AGING-US, V2, P353, DOI 10.18632/aging.100162; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Yamamori T, 2010, NUCLEIC ACIDS RES, V38, P832, DOI 10.1093/nar/gkp1039; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	30	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65415	10.1371/journal.pone.0065415	http://dx.doi.org/10.1371/journal.pone.0065415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755229	Green Published, gold, Green Accepted			2022-12-25	WOS:000319872300079
J	Palla, AR; Piazzolla, D; Abad, M; Li, H; Dominguez, O; Schonthaler, HB; Wagner, EF; Serrano, M				Palla, A. R.; Piazzolla, D.; Abad, M.; Li, H.; Dominguez, O.; Schonthaler, H. B.; Wagner, E. F.; Serrano, M.			Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer	ONCOGENE			English	Article						NANOG; NANOGP8; cancer; reprogramming; pluripotency	PLURIPOTENT STEM-CELLS; DIFFERENTIATION; GENE; PROMOTES; ES	NANOG is a key transcription factor for pluripotency in embryonic stem cells. The analysis of NANOG in human cells is confounded by the presence of multiple and highly similar paralogs. In particular, there are three paralogs encoding full-length proteins, namely, NANOG1, NANOG2 and NANOGP8, and at least eight additional paralogs that do not encode full-length NANOG proteins. Here, we have examined NANOG family expression in human embryonic stem cells (hESCs) and in human cancer cell lines using a multi-NANOG PCR that amplifies the three functional paralogs and most of the non-functional ones. As anticipated, we found that hESCs express large amounts of NANOG1 and, interestingly, they also express NANOG2. In contrast, most human cancer cells tested express NANOGP8 and the non-coding paralogs NANOGP4 and NANOGP5. Notably, in some cancer cell lines, the NANOG protein levels produced by NANOGP8 are comparable to those produced by NANOG1 in pluripotent cells. Finally, we show that NANOGP8 is as active as NANOG1 in the reprogramming of human and murine fibroblasts into induced pluripotent stem cells. These results show that cancer-associated NANOGP8 can contribute to promote de-differentiation and/or cellular plasticity.	[Palla, A. R.; Piazzolla, D.; Abad, M.; Li, H.; Serrano, M.] Spanish Natl Canc Res Ctr CNIO, Tumour Suppress Grp, Mol Oncol Programme, E-28029 Madrid, Spain; [Dominguez, O.] Spanish Natl Canc Res Ctr CNIO, Genom Core Unit, Biotechnol Programme, E-28029 Madrid, Spain; [Schonthaler, H. B.; Wagner, E. F.] Spanish Natl Canc Res Ctr CNIO, F BBVA CNIO Canc Cell Biol Programme, Genes Dev & Dis Grp, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, 3 Melchor Fernandez Almagro St, E-28029 Madrid, Spain.	mserrano@cnio.es	Schönthaler, Helia/AAG-4767-2021; Abad, Maria/I-3911-2015; Serrano, Manuel/H-2634-2015; Abad, Maria/AAI-2366-2019; Dominguez, Orlando/M-7515-2018; Vivancos, Ana/AAG-8331-2019	Abad, Maria/0000-0002-1462-2498; Serrano, Manuel/0000-0001-7177-9312; Abad, Maria/0000-0002-1462-2498; Wagner, Erwin F/0000-0001-7872-0196; Vivancos, Ana/0000-0003-2888-6512; Palla, Adelaida/0000-0003-2695-9335	FPI Program of the Spanish Department of Science (MINECO); EMBO Long-Term Fellowship; 'Ramon y Cajal' Program (MINECO); CNIO; MINECO (SAF); European Union (ERC); Regional Government of Madrid; Botin Foundation; Ramon Areces Foundation; AXA Foundation; F-BBVA	FPI Program of the Spanish Department of Science (MINECO); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); 'Ramon y Cajal' Program (MINECO); CNIO; MINECO (SAF); European Union (ERC)(European Research Council (ERC)European Commission); Regional Government of Madrid; Botin Foundation; Ramon Areces Foundation; AXA Foundation; F-BBVA(BBVA Foundation)	We are grateful to Dr Maria S Soengas (CNIO) for providing us with human primary fibroblasts and to Dr Miguel A Piris (CNIO) for providing us with all the human cancer cell lines. ARP is supported by the FPI Program of the Spanish Department of Science (MINECO). DP was funded by an EMBO Long-Term Fellowship. HL is supported by the 'Ramon y Cajal' Program (MINECO). Work in the laboratory of MS is funded by the CNIO and by grants from the MINECO (SAF), the European Union (ERC Advanced Grant), the Regional Government of Madrid, the Botin Foundation, the Ramon Areces Foundation and the AXA Foundation. Work in the laboratory of EFW is supported by grants from F-BBVA and the European Union (ERC Advanced Grant).	Ambady S, 2010, INT J DEV BIOL, V54, P1743, DOI 10.1387/ijdb.103192sa; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chang DF, 2009, STEM CELLS, V27, P812, DOI 10.1634/stemcells.2008-0657; Do HJ, 2009, J CELL BIOCHEM, V106, P1079, DOI 10.1002/jcb.22089; Eberle I, 2010, NUCLEIC ACIDS RES, V38, P5384, DOI 10.1093/nar/gkq307; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Ishiguro T, 2012, BIOCHEM BIOPH RES CO, V418, P199, DOI 10.1016/j.bbrc.2011.10.123; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kim JS, 2005, EXP MOL MED, V37, P601, DOI 10.1038/emm.2005.73; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretto-Zita M, 2010, P NATL ACAD SCI USA, V107, P13312, DOI 10.1073/pnas.1005847107; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Ramakrishna S, 2011, STEM CELLS DEV, V20, P1512, DOI 10.1089/scd.2010.0410; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theunissen TW, 2011, DEVELOPMENT, V138, P4853, DOI 10.1242/dev.068775; Uchino K, 2012, EXP CELL RES, V318, P1799, DOI 10.1016/j.yexcr.2012.04.011; Wang SH, 2003, GENE EXPR PATTERNS, V3, P99, DOI 10.1016/S1567-133X(03)00005-X; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461; Zhang JY, 2010, ONCOL LETT, V1, P457, DOI 10.3892/ol_00000081; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x	35	31	34	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2513	2519		10.1038/onc.2013.196	http://dx.doi.org/10.1038/onc.2013.196			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23752184				2022-12-25	WOS:000336033600011
J	Kurasawa, JH; Shestopal, SA; Karnaukhova, E; Struble, EB; Lee, TK; Sarafanov, AG				Kurasawa, James H.; Shestopal, Svetlana A.; Karnaukhova, Elena; Struble, Evi B.; Lee, Timothy K.; Sarafanov, Andrey G.			Mapping the Binding Region on the Low Density Lipoprotein Receptor for Blood Coagulation Factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood Coagulation Factors; Factor VIII; Lipoprotein Receptor; Receptor Structure-Function; Recombinant Protein Expression; Hemophilia A	CONSERVED ACIDIC RESIDUE; CORONARY-ARTERY-DISEASE; NMR SOLUTION STRUCTURE; CYSTEINE-RICH REPEATS; VON-WILLEBRAND-FACTOR; LIGAND-BINDING; LDL RECEPTOR; ALPHA-2-MACROGLOBULIN RECEPTOR; FACTOR IXA; STRUCTURAL REQUIREMENTS	Low density lipoprotein receptor (LDLR) was shown to mediate clearance of blood coagulation factor VIII (FVIII) from the circulation. To elucidate the mechanism of interaction of LDLR and FVIII, our objective was to identify the region of the receptor necessary for binding FVIII. Using surface plasmon resonance, we found that LDLR exodomain and its cluster of complement-type repeats (CRs) bind FVIII in the same mode. This indicated that the LDLR site for FVIII is located within the LDLR cluster. Similar results were obtained for another ligand of LDLR, -2-macroglobulin receptor-associated protein (RAP), a common ligand of receptors from the LDLR family. We further generated a set of recombinant fragments of the LDLR cluster and assessed their structural integrity by binding to RAP and by circular dichroism. A number of fragments overlapping CR.2-5 of the cluster were positive for binding RAP and FVIII. The specificity of these interactions was tested by site-directed mutagenesis of conserved tryptophans within the LDLR fragments. For FVIII, the specificity was also tested using a single-chain variable antibody fragment directed against the FVIII light chain as a competitor. Both cases resulted in decreased binding, thus confirming its specificity. The mutagenic study also showed an importance of the conserved tryptophans in LDLR for both ligands, and the competitive binding results showed an involvement of the light chain of FVIII in its interaction with LDLR. In conclusion, the region of CR.2-5 of LDLR was defined as the binding site for FVIII and RAP.	[Kurasawa, James H.; Shestopal, Svetlana A.; Karnaukhova, Elena; Struble, Evi B.; Lee, Timothy K.; Sarafanov, Andrey G.] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA	US Food & Drug Administration (FDA)	Sarafanov, AG (corresponding author), US FDA, Div Hematol, Off Blood Res & Review, Ctr Biol Evaluat & Res, 1401 Rockville Pike HFM-340, Rockville, MD 20852 USA.	andrey.sarafanov@fda.hhs.gov		Shestopal, Svetlana/0000-0003-0725-5885; Sarafanov, Andrey/0000-0001-6124-9713	Center for Biologics Evaluation and Research (CBER) of the United States Food and Drug Administration (FDA); Research Participation Program at the CBER	Center for Biologics Evaluation and Research (CBER) of the United States Food and Drug Administration (FDA); Research Participation Program at the CBER	This work was supported by funds from the Center for Biologics Evaluation and Research (CBER) of the United States Food and Drug Administration (FDA) and also by the Research Participation Program at the CBER administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the United States Department of Energy and the United States Food and Drug Administration. This work was initially presented at the 54th American Society of Hematology Annual Meeting, December 8-11,2012, in Atlanta, GA.	Ananyeva NM, 2008, BLOOD COAGUL FIBRIN, V19, P543, DOI 10.1097/MBC.0b013e3283068859; Ananyeva NM, 2008, BLOOD COAGUL FIBRIN, V19, P166, DOI 10.1097/MBC.0b013e3282f5457b; Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Andersen OM, 2001, BIOCHEM J, V357, P289, DOI 10.1042/0264-6021:3570289; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Bieri S, 1998, BIOCHEMISTRY-US, V37, P10994, DOI 10.1021/bi980452c; Bovenschen N, 2006, J THROMB HAEMOST, V4, P1487, DOI 10.1111/j.1538-7836.2006.01965.x; Bovenschen N, 2005, BLOOD, V106, P906, DOI 10.1182/blood-2004-11-4230; Bovenschen N, 2004, BRIT J HAEMATOL, V126, P722, DOI 10.1111/j.1365-2141.2004.05093.x; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; Bovenschen N, 2003, BLOOD, V101, P3933, DOI 10.1182/blood-2002-07-2081; Butenas S, 2009, HAEMOPHILIA, V15, P63, DOI 10.1111/j.1365-2516.2008.01826.x; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; Christiansen MLS, 2010, HAEMOPHILIA, V16, P878, DOI 10.1111/j.1365-2516.2010.02333.x; Croy JE, 2004, BIOCHEMISTRY-US, V43, P7328, DOI 10.1021/bi036208p; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Dolmer K, 2000, J BIOL CHEM, V275, P3264, DOI 10.1074/jbc.275.5.3264; Dolmer K, 2006, J BIOL CHEM, V281, P34189, DOI 10.1074/jbc.M604389200; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Guo Y, 2004, J BIOL CHEM, V279, P16629, DOI 10.1074/jbc.M400157200; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; Kurasawa JH, 2013, PROTEIN EXPRES PURIF, V88, P201, DOI 10.1016/j.pep.2012.12.008; Lazic A, 2003, BIOCHEMISTRY-US, V42, P14913, DOI 10.1021/bi035779e; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Lin Y, 2004, HAEMOPHILIA, V10, P459, DOI 10.1111/j.1365-2516.2004.00957.x; Martinelli N, 2010, BLOOD, V116, P5688, DOI 10.1182/blood-2010-03-277079; MEDH JD, 1995, J BIOL CHEM, V270, P536, DOI 10.1074/jbc.270.2.536; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; Meijer A., 2007, J THROMB HAEMOST S2, V5; Meijer A., 2005, J THROMB HAEMOST S1, V3, pOR162; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; Mello TBT, 2008, THROMB RES, V121, P625, DOI 10.1016/j.thromres.2007.08.002; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Ofosu FA, 2012, HAEMOPHILIA, V18, P917, DOI 10.1111/j.1365-2516.2012.02861.x; Orlando RA, 1997, P NATL ACAD SCI USA, V94, P2368, DOI 10.1073/pnas.94.6.2368; Pahl S, 2013, HAEMOPHILIA, V19, P392, DOI 10.1111/hae.12076; Pocathikorn A, 2003, ATHEROSCLEROSIS, V168, P115, DOI 10.1016/S0021-9150(03)00087-X; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Saenko EL, 1999, J BIOL CHEM, V274, P37685, DOI 10.1074/jbc.274.53.37685; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; Sarafanov A, 2004, ANAL BIOCHEM, V328, P98, DOI 10.1016/j.ab.2003.11.028; Sarafanov AG, 2001, J BIOL CHEM, V276, P11970, DOI 10.1074/jbc.M008046200; Sarafanov AG, 2007, THROMB HAEMOSTASIS, V98, P1170, DOI 10.1160/TH07-05-0353; Sato A, 1999, BIOCHEM J, V341, P377, DOI 10.1042/0264-6021:3410377; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; van den Biggelaar M, 2011, J THROMB HAEMOST, V9, P821; van den Brink EN, 2001, BLOOD, V97, P966, DOI 10.1182/blood.V97.4.966; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; Vormittag R, 2007, J THROMB HAEMOST, V5, P497, DOI 10.1111/j.1538-7836.2007.02337.x; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	69	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							22033	10.1074/jbc.M113.468108	http://dx.doi.org/10.1074/jbc.M113.468108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23754288	Green Published, hybrid			2022-12-25	WOS:000328841900049
J	Owens, CP; Chim, N; Graves, AB; Harmston, CA; Iniguez, A; Contreras, H; Liptak, MD; Goulding, CW				Owens, Cedric P.; Chim, Nicholas; Graves, Amanda B.; Harmston, Christine A.; Iniguez, Angelina; Contreras, Heidi; Liptak, Matthew D.; Goulding, Celia W.			The Mycobacterium tuberculosis Secreted Protein Rv0203 Transfers Heme to Membrane Proteins MmpL3 and MmpL11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heme; Iron; Kinetics; Mycobacterium tuberculosis; Protein Domains; Transport; Heme Uptake Pathway; Iron Acquisition	MAGNETIC CIRCULAR-DICHROISM; METAL EFFLUX COMPLEX; STAPHYLOCOCCUS-AUREUS; BINDING PROTEIN; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; SULFOLIPID-1 BIOSYNTHESIS; SECONDARY STRUCTURE; ACQUISITION-SYSTEM; CELL-WALL	Mycobacterium tuberculosis is the causative agent of tuberculosis, which is becoming an increasingly global public health problem due to the rise of drug-resistant strains. While residing in the human host, M. tuberculosis needs to acquire iron for its survival. M. tuberculosis has two iron uptake mechanisms, one that utilizes non-heme iron and another that taps into the vast host heme-iron pool. To date, proteins known to be involved in mycobacterial heme uptake are Rv0203, MmpL3, and MmpL11. Whereas Rv0203 transports heme across the bacterial periplasm or scavenges heme from host heme proteins, MmpL3 and MmpL11 are thought to transport heme across the membrane. In this work, we characterize the heme-binding properties of the predicted extracellular soluble E1 domains of both MmpL3 and MmpL11 utilizing absorption, electron paramagnetic resonance, and magnetic circular dichroism spectroscopic methods. Furthermore, we demonstrate that Rv0203 transfers heme to both MmpL3-E1 and MmpL11-E1 domains at a rate faster than passive heme dissociation from Rv0203. This work elucidates a key step in the mycobacterial uptake of heme, and it may be useful in the development of anti-tuberculosis drugs targeting this pathway.	[Owens, Cedric P.; Chim, Nicholas; Harmston, Christine A.; Iniguez, Angelina; Contreras, Heidi; Goulding, Celia W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Goulding, Celia W.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Graves, Amanda B.; Liptak, Matthew D.] Univ Vermont, Dept Chem, Burlington, VT 05405 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Vermont	Goulding, CW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	celia.goulding@uci.edu	Liptak, Matthew/AAJ-2533-2021	Liptak, Matthew/0000-0002-4951-6636; Owens, Cedric/0000-0002-8102-8181	National Institutes of Health [AI081161, GM101945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM101945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI081161 (to C. W. G.) and GM101945 (to H. C.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; BARTSCH RG, 1971, J BIOL CHEM, V246, P4489; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Block DR, 2007, BIOCHEMISTRY-US, V46, P14391, DOI 10.1021/bi701509n; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Chan ACK, 2006, J MOL BIOL, V362, P1108, DOI 10.1016/j.jmb.2006.08.001; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Critchton R. R., 2009, IRON METABOLISM MOL, P170; Dawson R. M. C., 1986, DATA BIOCH RES, P230; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Du J, 2011, COORDIN CHEM REV, V255, P700, DOI 10.1016/j.ccr.2011.01.029; Ekworomadu MT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002559; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2010, J BIOL CHEM, V285, P34579, DOI 10.1074/jbc.M110.172924; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11310, DOI 10.1021/bi9603736; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Hawkins BK, 1996, BBA-PROTEIN STRUCT M, V1295, P165, DOI 10.1016/0167-4838(96)00031-3; Hopkinson BM, 2008, APPL ENVIRON MICROB, V74, P6263, DOI 10.1128/AEM.00964-08; Izadi N, 1997, BIOCHEMISTRY-US, V36, P7050, DOI 10.1021/bi962577s; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Jones CM, 2011, J BACTERIOL, V193, P1767, DOI 10.1128/JB.01312-10; KAWAMURAKONISHI Y, 1988, EUR J BIOCHEM, V170, P589, DOI 10.1111/j.1432-1033.1988.tb13738.x; Kim EH, 2011, J BACTERIOL, V193, P2381, DOI 10.1128/JB.01323-10; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Lei BF, 2003, INFECT IMMUN, V71, P5962, DOI 10.1128/IAI.71.10.5962-5969.2003; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; Long F, 2012, PHILOS T R SOC B, V367, P1047, DOI 10.1098/rstb.2011.0203; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Masuda T, 1999, J BIOL CHEM, V274, P33594, DOI 10.1074/jbc.274.47.33594; Mattle D, 2010, J MOL BIOL, V404, P220, DOI 10.1016/j.jmb.2010.09.005; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Moller JKS, 2007, MEAT SCI, V75, P203, DOI 10.1016/j.meatsci.2006.07.005; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Perera R, 2011, ARCH BIOCHEM BIOPHYS, V507, P119, DOI 10.1016/j.abb.2010.12.010; Pond AE, 1999, BIOCHEMISTRY-US, V38, P7601, DOI 10.1021/bi9825448; Scherman MS, 2012, BIOORGAN MED CHEM, V20, P3255, DOI 10.1016/j.bmc.2012.03.058; Seeliger JC, 2012, J BIOL CHEM, V287, P7990, DOI 10.1074/jbc.M111.315473; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; VICKERY L, 1976, J AM CHEM SOC, V98, P343, DOI 10.1021/ja00418a005; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; White GF, 2011, FEBS J, V278, P2011, DOI 10.1111/j.1742-4658.2011.08117.x; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	76	66	70	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21714	21728		10.1074/jbc.M113.453076	http://dx.doi.org/10.1074/jbc.M113.453076			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760277	Green Published, hybrid			2022-12-25	WOS:000328841900023
J	Hubbi, ME; Hu, HX; Kshitiz; Gilkes, DM; Semenza, GL				Hubbi, Maimon E.; Hu, Hongxia; Kshitiz; Gilkes, Daniele M.; Semenza, Gregg L.			Sirtuin-7 Inhibits the Activity of Hypoxia-inducible Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-1-ALPHA HIF-1-ALPHA; TRANSCRIPTIONAL ACTIVITY; FACTOR 1-ALPHA; HIF-ALPHA; DEGRADATION; BINDING; TRANSACTIVATION; RESPONSES; SIRT7; VHL	Hypoxia-inducible factor (HIF) 1 and HIF-2 are heterodimeric proteins composed of an oxygen-regulated HIF-1 alpha or HIF-2 alpha subunit, respectively, and a constitutively expressed HIF-1 beta subunit, which mediate adaptive transcriptional responses to hypoxia. Here, we report that Sirt7 (sirtuin-7) negatively regulates HIF-1 alpha and HIF-2 alpha protein levels by a mechanism that is independent of prolyl hydroxylation and that does not involve proteasomal or lysosomal degradation. The effect of Sirt7 was maintained in the presence of the sirtuin inhibitor nicotinamide and upon deletion or mutation of its deacetylase domain, indicating a non-catalytic function. Knockdown of Sirt7 led to an increase in HIF-1 alpha and HIF-2 alpha protein levels and an increase in HIF-1 and HIF-2 transcriptional activity. Thus, we identify a novel molecular function of Sirt7 as a negative regulator of HIF signaling.	[Hubbi, Maimon E.; Hu, Hongxia; Kshitiz; Gilkes, Daniele M.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA; [Hubbi, Maimon E.; Hu, Hongxia; Gilkes, Daniele M.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Hu, Hongxia] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD 21205 USA; [Kshitiz] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Miller Res Bldg,Suite 671,733 N Broadway, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Kz, Kshitiz/B-9143-2013; Kz, Kshitiz/I-3657-2013; Gilkes, Daniele M/AAI-8133-2020; Hu, Hongxia/Q-7765-2016	Kz, Kshitiz/0000-0003-4241-9427; Kz, Kshitiz/0000-0003-4241-9427; Gilkes, Daniele M/0000-0003-3984-9338; Hubbi, Maimon/0000-0001-9763-287X	United States Public Health Service [N01-HV28180, HHS-N268201000032c]; Johns Hopkins Institute for Cell Engineering; American Heart Association [10PRE4160120]; Komen Foundation [KG111254];  [T32-HL007525]; NATIONAL CANCER INSTITUTE [K99CA181352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Johns Hopkins Institute for Cell Engineering; American Heart Association(American Heart Association); Komen Foundation(Susan G. Komen Breast Cancer Foundation); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Contracts N01-HV28180 and HHS-N268201000032c from the United States Public Health Service and Postdoctoral Training Grant T32-HL007525 (to M. E. H.). This work was also supported by the Johns Hopkins Institute for Cell Engineering, American Heart Association Predoctoral Fellowship 10PRE4160120 (to K.), and Komen Foundation Postdoctoral Fellowship KG111254 (to D. M. G.).	Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Chiang WC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002948; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Foxler DE, 2012, NAT CELL BIOL, V14, P201, DOI 10.1038/ncb2424; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Grob A, 2009, J CELL SCI, V122, P489, DOI 10.1242/jcs.042382; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Hubbi ME, 2012, J BIOL CHEM, V287, P6139, DOI 10.1074/jbc.M111.278630; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin J, 2012, IUBMB LIFE, V64, P921, DOI 10.1002/iub.1089; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	39	101	108	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20768	20775		10.1074/jbc.M113.476903	http://dx.doi.org/10.1074/jbc.M113.476903			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23750001	Green Published, hybrid			2022-12-25	WOS:000322014400001
J	Sengupta, S; Powell, E; Kong, L; Blackard, JT				Sengupta, Satarupa; Powell, Eleanor; Kong, Ling; Blackard, Jason T.			Effects of HCV on Basal and Tat-Induced HIV LTR Activation	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; LONG TERMINAL REPEAT; BLOOD MONONUCLEAR-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN HEPATOMA-CELLS; CORE PROTEIN; FACTOR-ALPHA	Hepatitis C virus (HCV) co-infection occurs in similar to 30-40% of the HIV-infected population in the US. While a significant body of research suggests an adverse effect of HIV on HCV replication and disease progression, the impact of HCV on HIV infection has not been well studied. Increasing data suggest that hepatocytes and other liver cell populations can serve as reservoirs for HIV replication. Therefore, to gain insight into the impact of HCV on HIV, the effects of the HCV Core protein and infectious hepatitis C virions were evaluated on basal and Tat-induced activation of the HIV long terminal repeat (LTR) in hepatocytes. The HIV LTR was highly induced by the HIV transactivator protein Tat in hepatocytes. Activation varied according to the number of NF-kB binding sites present in the LTRs from different HIV subtypes. Involvement of the NF-kB binding pathway in LTR activation was demonstrated using an NF-kB inhibitor and deletion of the NF-kB binding sites. TNF alpha, a pro-inflammatory cytokine that plays an important role in HIV pathogenesis, also induced LTR activity in hepatocytes. However, HIV LTR activity was suppressed in hepatocytes in the presence of HCV Core protein, and the suppressive effect persisted in the presence of TNF alpha. In contrast, infectious hepatitis C virions upregulated HIV LTR activation and gene transcription. Core-mediated suppression remained unaltered in the presence of HCV NS3/4A protein, suggesting the involvement of other viral/cellular factors. These findings have significant clinical implications as they imply that HCV could accelerate HIV disease progression in HIV/HCV co-infected patients. Such analyses are important to elucidate the mechanisms by which these viruses interact and could facilitate the development of more effective therapies to treat HIV/HCV co-infection.	[Sengupta, Satarupa; Powell, Eleanor; Kong, Ling; Blackard, Jason T.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Digest Dis, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Blackard, JT (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Digest Dis, Cincinnati, OH 45221 USA.	jason.blackard@uc.edu			University Research Council Postdoctoral Fellow Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	University Research Council Postdoctoral Fellow Research Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was partly supported by the University Research Council Postdoctoral Fellow Research Grant (to SS). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Anderson KB, 2004, CLIN INFECT DIS, V39, P1507, DOI 10.1086/425360; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Backus LI, 2005, JAIDS-J ACQ IMM DEF, V39, P613; Balasubramanian A, 2005, CLIN INFECT DIS, V41, pS32, DOI 10.1086/429493; Balasubramanian A, 2003, J BIOL CHEM, V278, P35755, DOI 10.1074/jbc.M302889200; Balasubramanian A, 2006, J INFECT DIS, V194, P670, DOI 10.1086/505708; BESSHO R, 1994, BIOCHEM PHARMACOL, V48, P1883, DOI 10.1016/0006-2952(94)90586-X; Blackard JT, 2005, J INFECT DIS, V192, P258, DOI 10.1086/430949; Braitstein P, 2006, AIDS, V20, P323, DOI 10.1097/01.aids.0000198091.70325.f4; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crotti Andrea, 2007, Open Virol J, V1, P26, DOI 10.2174/1874357900701010026; Daar ES, 2001, J INFECT DIS, V183, P589, DOI 10.1086/318539; De Baar MP, 2000, AIDS RES HUM RETROV, V16, P499; De Luca A, 2002, ARCH INTERN MED, V162, P2125, DOI 10.1001/archinte.162.18.2125; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; FRANKEL A, 1988, CELL DEATH DIFFER, V55, P118; Fromentin R, 2010, VIROLOGY, V398, P168, DOI 10.1016/j.virol.2009.12.008; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Guitart A, 2005, J GEN VIROL, V86, P3065, DOI 10.1099/vir.0.81273-0; Gupta N, 2007, AIDS, V21, P1491, DOI 10.1097/QAD.0b013e3281c616bb; Hassan M, 2007, CELL SIGNAL, V19, P301, DOI 10.1016/j.cellsig.2006.07.002; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Iser DM, 2010, J VIROL, V84, P5860, DOI 10.1128/JVI.02594-09; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Kang L, 2012, VIRUS RES, V163, P74, DOI 10.1016/j.virusres.2011.08.011; Kato N, 1997, J VIROL, V71, P8856, DOI 10.1128/JVI.71.11.8856-8859.1997; Khabar KSA, 1997, J EXP MED, V186, P1077, DOI 10.1084/jem.186.7.1077; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Kondo Y, 2007, VIROLOGY, V361, P161, DOI 10.1016/j.virol.2006.11.009; Kong L, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-157; Laskus T, 1997, J GEN VIROL, V78, P2747, DOI 10.1099/0022-1317-78-11-2747; Laskus T, 1998, J INFECT DIS, V178, P1189, DOI 10.1086/515682; Laskus T, 2000, J INFECT DIS, V181, P442, DOI 10.1086/315283; Laskus T, 2004, BLOOD, V103, P3854, DOI 10.1182/blood-2003-08-2923; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lerat H, 1996, J CLIN INVEST, V97, P845, DOI 10.1172/JCI118485; Lerat H, 1998, BLOOD, V91, P3841, DOI 10.1182/blood.V91.10.3841.3841_3841_3849; Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24; Macias J, 2003, EUR J CLIN MICROBIOL, V22, P675, DOI 10.1007/s10096-003-1015-2; Mann EA, 2006, VIRUS RES, V121, P51, DOI 10.1016/j.virusres.2006.04.001; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; Murakami K, 2008, J GEN VIROL, V89, P1587, DOI 10.1099/vir.0.83618-0; Nelson DR, 1997, DIGEST DIS SCI, V42, P2487, DOI 10.1023/A:1018804426724; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Pham TNQ, 2005, J GEN VIROL, V86, P657, DOI 10.1099/vir.0.80624-0; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Piroth L, 2000, J VIRAL HEPATITIS, V7, P302; PIZZELLA T, 1994, DNA CELL BIOL, V13, P67, DOI 10.1089/dna.1994.13.67; Polyak SJ, 2001, J VIROL, V75, P6095, DOI 10.1128/JVI.75.13.6095-6106.2001; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Raboud J, 2012, HIV CLIN TRIALS, V13, P90, DOI 10.1310/hct1302-90; Radkowski M, 2004, J GEN VIROL, V85, P47, DOI 10.1099/vir.0.19491-0; Radkowski M, 1998, TRANSPLANTATION, V66, P664, DOI 10.1097/00007890-199809150-00022; Ray RB, 2002, VIRUS RES, V87, P21, DOI 10.1016/S0168-1702(02)00046-1; RAY RB, 1995, VIRUS RES, V37, P209, DOI 10.1016/0168-1702(95)00034-N; Revie D, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-37; Sato Y, 2006, GUT, V55, P1801, DOI 10.1136/gut.2005.070417; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; SHIH CM, 1993, J VIROL, V67, P5823, DOI 10.1128/JVI.67.10.5823-5832.1993; Shivraj SO, 2006, J TROP PEDIATRICS, V52, P206, DOI 10.1093/tropej/fmi103; Shrivastava A, 1998, J VIROL, V72, P9722, DOI 10.1128/JVI.72.12.9722-9728.1998; Srinivas RV, 1996, VIRUS RES, V45, P87, DOI 10.1016/S0168-1702(96)01361-5; Suzuki R, 2001, VIROLOGY, V280, P301, DOI 10.1006/viro.2000.0785; Tawadrous GA, 2012, J INVEST MED, V60, P878, DOI 10.2310/JIM.0b013e318254519e; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Verhoef K, 1999, J VIROL, V73, P1331, DOI 10.1128/JVI.73.2.1331-1340.1999; Reiche EMV, 2008, INT J MOL MED, V21, P387; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200; Wu XY, 2008, VIRUS RES, V135, P155, DOI 10.1016/j.virusres.2008.03.006; Xiao P, 2008, AIDS, V22, P1749, DOI 10.1097/QAD.0b013e328308937c; Yan FM, 2000, WORLD J GASTROENTERO, V6, P805, DOI 10.3748/wjg.v6.i6.805; You LR, 1999, J VIROL, V73, P1672, DOI 10.1128/JVI.73.2.1672-1681.1999; Zhu MH, 1996, AIDS RES HUM RETROV, V12, P1093, DOI 10.1089/aid.1996.12.1093; Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008	84	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e64956	10.1371/journal.pone.0064956	http://dx.doi.org/10.1371/journal.pone.0064956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762271	Green Published, gold, Green Submitted			2022-12-25	WOS:000320440500014
J	Li, HS; Usas, A; Poddar, M; Chen, CW; Thompson, S; Ahani, B; Cummins, J; Lavasani, M; Huard, J				Li, Hongshuai; Usas, Arvydas; Poddar, Minakshi; Chen, Chien-Wen; Thompson, Seth; Ahani, Bahar; Cummins, James; Lavasani, Mitra; Huard, Johnny			Platelet-Rich Plasma Promotes the Proliferation of Human Muscle Derived Progenitor Cells and Maintains Their Stemness	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; HUMAN SKELETAL-MUSCLE; IN-VITRO EXPANSION; VIVO GENE-THERAPY; GROWTH-FACTOR; OSTEOGENIC DIFFERENTIATION; BONE-FORMATION; ANIMAL SERUM; RAT MODEL; PDGF-BB	Human muscle-derived progenitor cells (hMDPCs) offer great promise for muscle cell-based regenerative medicine; however, prolonged ex-vivo expansion using animal sera is necessary to acquire sufficient cells for transplantation. Due to the risks associated with the use of animal sera, the development of a strategy for the ex vivo expansion of hMDPCs is required. The purpose of this study was to investigate the efficacy of using platelet-rich plasma (PRP) for the ex-vivo expansion of hMDPCs. Pre-plated MDPCs, myoendothelial cells, and pericytes are three populations of hMDPCs that we isolated by the modified pre-plate technique and Fluorescence Activated Cell Sorting (FACS), respectively. Pooled allogeneic human PRP was obtained from a local blood bank, and the effect that thrombin-activated PRP-releasate supplemented media had on the ex-vivo expansion of the hMDPCs was tested against FBS supplemented media, both in vitro and in vivo. PRP significantly enhanced short and long-term cell proliferation, with or without FBS supplementation. Antibody-neutralization of PDGF significantly blocked the mitogenic/proliferative effects that PRP had on the hMDPCs. A more stable and sustained expression of markers associated with stemness, and a decreased expression of lineage specific markers was observed in the PRP-expanded cells when compared with the FBS-expanded cells. The in vitro osteogenic, chondrogenic, and myogenic differentiation capacities of the hMDPCs were not altered when expanded in media supplemented with PRP. All populations of hMDPCs that were expanded in PRP supplemented media retained their ability to regenerate myofibers in vivo. Our data demonstrated that PRP promoted the proliferation and maintained the multi-differentiation capacities of the hMDPCs during ex-vivo expansion by maintaining the cells in an undifferentiated state. Moreover, PDGF appears to be a key contributing factor to the beneficial effect that PRP has on the proliferation of hMDPCs.	[Li, Hongshuai; Usas, Arvydas; Poddar, Minakshi; Chen, Chien-Wen; Thompson, Seth; Ahani, Bahar; Cummins, James; Lavasani, Mitra; Huard, Johnny] Univ Pittsburgh, Stem Cell Res Ctr, Dept Orthoped Surg, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Huard, J (corresponding author), Univ Pittsburgh, Stem Cell Res Ctr, Dept Orthoped Surg, Pittsburgh, PA 15260 USA.	jhuard@pitt.edu		Chen, William CW/0000-0002-6891-3557; Li, hongshuai/0000-0002-9793-0540	Department of Defense [W81XWH-06-1-0406, W81XWH-08-2-0032]; William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh; Henry J. Mankin Endowed Chair at the University of Pittsburgh; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh; Henry J. Mankin Endowed Chair at the University of Pittsburgh; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding support was provided in part by the Department of Defense (awarded to Dr. Johnny Huard, W81XWH-06-1-0406 and W81XWH-08-2-0032 (AFIRM)), the William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh, and the Henry J. Mankin Endowed Chair at the University of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsousou J, 2009, J BONE JOINT SURG BR, V91B, P987, DOI 10.1302/0301-620X.91B8.22546; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Borrione P, 2010, AM J PHYS MED REHAB, V89, P854, DOI 10.1097/PHM.0b013e3181f1c1c7; Cao BH, 2004, CELL CYCLE, V3, P104; Cassiede P, 1996, J BONE MINER RES, V11, P1264; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Galing VLW, 2009, ORAL SURG ORAL MED O, V108, P48, DOI 10.1016/j.tripleo.2009.02.007; Garbayo E, 2011, J NEUROCHEM, V119, P972, DOI 10.1111/j.1471-4159.2011.07272.x; Gates CB, 2008, J AM ACAD ORTHOP SUR, V16, P68, DOI 10.5435/00124635-200802000-00004; Gruber R, 2004, PLATELETS, V15, P29, DOI 10.1080/09537100310001643999; Guo J, 2008, J BIOMED SCI, V15, P89, DOI 10.1007/s11373-007-9207-x; Huang Z, 2010, CYTOKINE, V51, P305, DOI 10.1016/j.cyto.2010.06.002; Kalen A, 2008, BIOCHEM BIOPH RES CO, V375, P261, DOI 10.1016/j.bbrc.2008.08.014; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kasten P, 2006, CELLS TISSUES ORGANS, V183, P68, DOI 10.1159/000095511; KIEVITS F, 1988, J IMMUNOL, V140, P4253; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Lange C, 2007, J CELL PHYSIOL, V213, P18, DOI 10.1002/jcp.21081; Lee JY, 2002, HUM GENE THER, V13, P1201, DOI 10.1089/104303402320138989; Lee KS, 2011, AM J ROENTGENOL, V196, P628, DOI 10.2214/AJR.10.5975; Lei H, 2009, CLIN BIOCHEM, V42, P1452, DOI 10.1016/j.clinbiochem.2009.06.012; Levy MM, 2001, BONE, V29, P317, DOI 10.1016/S8756-3282(01)00585-3; Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X; Lubowitz JH, 2011, ARTHROSCOPY, V27, P1453, DOI 10.1016/j.arthro.2011.08.291; Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5; MacDermott R P, 1983, Behring Inst Mitt, P122; MARTIN JF, 1983, BRIT MED J, V287, P456, DOI 10.1136/bmj.287.6390.456; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Mastrogiacomo M, 2005, J CELL PHYSIOL, V204, P594, DOI 10.1002/jcp.20325; Mathur A, 2001, THROMB HAEMOSTASIS, V85, P989, DOI 10.1055/s-0037-1615952; Matsumoto T, 2009, ARTHRITIS RHEUM-US, V60, P1390, DOI 10.1002/art.24443; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mazzucco L, 2009, VOX SANG, V97, P110, DOI 10.1111/j.1423-0410.2009.01188.x; Mishra A, 2011, CURR PHARM BIOTECHNO; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Musgrave DS, 2002, J BONE JOINT SURG BR, V84B, P120, DOI 10.1302/0301-620X.84B1.11708; Nguyen RT, 2011, PM&R, V3, P226, DOI 10.1016/j.pmrj.2010.11.007; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Olson E N, 1992, Semin Cell Biol, V3, P127; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Parsons P, 2008, J ORTHOP TRAUMA, V22, P595, DOI 10.1097/BOT.0b013e318188dbb7; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0; Pierantozzi E, 2011, STEM CELLS DEV, V20, P915, DOI 10.1089/scd.2010.0353; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Refaai MA, 2011, THROMB RES, V127, P287, DOI 10.1016/j.thromres.2010.10.012; Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9; Risau W, 1992, GROWTH FACTORS, V7, P261, DOI 10.3109/08977199209046408; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Scharf RE, 2011, HAMOSTASEOLOGIE, V31, P28, DOI 10.5482/ha-1145; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Soomekh DJ, 2011, CLIN PODIATR MED SUR, V28, P155, DOI 10.1016/j.cpm.2010.09.001; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385; TSCHOEPE D, 1991, SEMIN THROMB HEMOST, V17, P433, DOI 10.1055/s-2007-1002650; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; Vogel JP, 2006, PLATELETS, V17, P462, DOI 10.1080/09537100600758867; Weibrich G, 2002, J CRANIO MAXILL SURG, V30, P97, DOI 10.1054/jcms.2002.0285; Zaky SH, 2008, J TISSUE ENG REGEN M, V2, P472, DOI 10.1002/term.119; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334; Zhou SH, 2011, J CELL BIOCHEM, V112, P1651, DOI 10.1002/jcb.23079; Zong M, 2011, NAT REV RHEUMATOL, V7, P297, DOI 10.1038/nrrheum.2011.39	79	60	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64923	10.1371/journal.pone.0064923	http://dx.doi.org/10.1371/journal.pone.0064923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762264	Green Published, Green Accepted, gold			2022-12-25	WOS:000321094800009
J	Matsumoto, Y; Buemio, A; Chu, R; Vafaee, M; Crews, D				Matsumoto, Yuiko; Buemio, Alvin; Chu, Randy; Vafaee, Mozhgon; Crews, David			Epigenetic Control of Gonadal Aromatase (cyp19a1) in Temperature-Dependent Sex Determination of Red-Eared Slider Turtles	PLOS ONE			English	Article							HEAT-SHOCK FACTORS; P450 AROMATASE; TRACHEMYS-SCRIPTA; GENE-EXPRESSION; DNA METHYLATION; OREOCHROMIS-NILOTICUS; TRANSPOSON TAM3; GERM-CELLS; PROMOTER; DIFFERENTIATION	In the red-eared slider turtle (Trachemys scripta), a species with temperature-dependent sex determination (TSD), the expression of the aromatase gene during gonad development is strictly limited to the female-producing temperature. The underlying mechanism remains unknown. In this study, we identified the upstream 5'-flanking region of the aromatase gene, gonad-specific promoter, and the temperature-dependent DNA methylation signatures during gonad development in the red-eared slider turtle. The 5'-flanking region of the slider aromatase exhibited sequence similarities to the aromatase genes of the American alligator, chicken, quail, and zebra finch. A putative TATA box was located 31 bp upstream of the gonad-specific transcription start site. DNA methylation at the CpG sites between the putative binding sites of the fork head domain factor (FOX) and vertebrate steroidogenic factor 1 (SF1) and adjacent TATA box in the promoter region were significantly lower in embryonic gonads at the female-producing temperature compared the male-producing temperature. A shift from male-to female-, but not from female-to male-, producing temperature changed the level of DNA methylation in gonads. Taken together these results indicate that the temperature, particularly female-producing temperature, allows demethylation at the specific CpG sites of the promoter region which leads the temperature-specific expression of aromatase during gonad development.	[Matsumoto, Yuiko; Buemio, Alvin; Chu, Randy; Vafaee, Mozhgon; Crews, David] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Crews, D (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	crews@austin.utexas.edu			National Science Foundation [IOS-1051623]; Direct For Biological Sciences [1051623] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (grant number IOS-1051623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abane R, 2010, FEBS J, V277, P4150, DOI 10.1111/j.1742-4658.2010.07830.x; Akatsuka N, 2005, J STEROID BIOCHEM, V96, P45, DOI 10.1016/j.jsbmb.2005.01.027; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blazquez M, 2004, MOL CELL ENDOCRINOL, V219, P83, DOI 10.1016/j.mce.2004.01.006; Bohm RA, 2000, J EXP BIOL, V203, P693; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Caron KM, 1997, STEROIDS, V62, P53, DOI 10.1016/S0039-128X(96)00159-6; Chiang EFL, 2001, J EXP ZOOL, V290, P709, DOI 10.1002/jez.1121; CREWS D, 1994, J ENDOCRINOL, V143, P279, DOI 10.1677/joe.0.1430279; Crews D, 1996, ZOOL SCI, V13, P1, DOI 10.2108/zsj.13.1; D'Cotta H, 2001, MOL REPROD DEV, V59, P265, DOI 10.1002/mrd.1031; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Fan WQ, 2007, ENVIRON HEALTH PERSP, V115, P720, DOI 10.1289/ehp.9758; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Gardner L, 2005, J STEROID BIOCHEM, V94, P395, DOI 10.1016/j.jsbmb.2004.12.045; Gilbert S. F., 2008, ECOLOGICAL DEV BIOL; Greenbaum E, 2002, CAN J ZOOL, V80, P1350, DOI 10.1139/Z02-111; Guillette LJ, 2000, AM ZOOL, V40, P438, DOI 10.1668/0003-1569(2000)040[0438:AAEDCA]2.0.CO;2; Hashida S, 2003, PLANT PHYSIOL, V132, P1207, DOI 10.1104/pp.102.017533; Hashida SN, 2006, PLANT CELL, V18, P104, DOI 10.1105/tpc.105.037655; Iwabuchi J, 2007, J STEROID BIOCHEM, V107, P149, DOI 10.1016/j.jsbmb.2007.01.007; Kitano T, 1999, J MOL ENDOCRINOL, V23, P167, DOI 10.1677/jme.0.0230167; Kitano T, 2000, AID MRDI 3 0 CO, P2; Kojima Y, 2008, GEN COMP ENDOCR, V156, P628, DOI 10.1016/j.ygcen.2008.02.003; Kudo Toshiyuki, 1996, Journal of Reproduction and Development, V42, P101, DOI 10.1262/jrd.42.101; Kuntz S, 2004, J MOL ENDOCRINOL, V33, P717, DOI 10.1677/jme.1.01588; Lei N, 2009, BIOL REPROD, V81, P118, DOI 10.1095/biolreprod.108.072314; Loffler KA, 2003, ENDOCRINOLOGY, V144, P3237, DOI 10.1210/en.2002-0095; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; MATSUMINE H, 1991, J BIOL CHEM, V266, P19900; Matsumoto Y, 2012, MOL CELL ENDOCRINOL, V354, P103, DOI 10.1016/j.mce.2011.10.012; MEANS GD, 1991, MOL ENDOCRINOL, V5, P2005, DOI 10.1210/mend-5-12-2005; MICHAEL MD, 1995, J BIOL CHEM, V270, P13561, DOI 10.1074/jbc.270.22.13561; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morohashi KI, 1996, FASEB J, V10, P1569, DOI 10.1096/fasebj.10.14.9002548; Murdock C, 2003, GEN COMP ENDOCR, V130, P109, DOI 10.1016/S0016-6480(02)00573-7; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Oshima Y, 2006, ZOOL SCI, V23, P79, DOI 10.2108/zsj.23.79; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Ramachandran B, 1999, GENE, V240, P209, DOI 10.1016/S0378-1119(99)00399-6; Ramsey M, 2007, SEX DEV, V1, P181, DOI 10.1159/000102107; Ramsey M, 2007, DIFFERENTIATION, V75, P978, DOI 10.1111/j.1432-0436.2007.00182.x; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sakata N, 2005, INT J DEV BIOL, V49, P417, DOI 10.1387/ijdb.041916ns; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Shoemaker C, 2007, DEV DYNAM, V236, P1055, DOI 10.1002/dvdy.21096; Shoemaker-Daly CM, 2010, DEV DYNAM, V239, P1061, DOI 10.1002/dvdy.22266; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Smith CA, 1997, J STEROID BIOCHEM, V60, P295, DOI 10.1016/S0960-0760(96)00196-3; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Tchoudakova A, 2001, J STEROID BIOCHEM, V78, P427, DOI 10.1016/S0960-0760(01)00120-0; Tong SK, 2003, J STEROID BIOCHEM, V86, P381, DOI 10.1016/S0960-0760(03)00347-9; Wallace H, 1999, CELL MOL LIFE SCI, V55, P901, DOI 10.1007/s000180050343; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Watson JD, 2007, MOL BIOL GENE; WIBBELS T, 1991, J EXP ZOOL, V260, P371, DOI 10.1002/jez.1402600311; Wu GC, 2005, ANN NY ACAD SCI, V1040, P206, DOI 10.1196/annals.1327.026; Yao HHC, 2005, MOL CELL ENDOCRINOL, V230, P87, DOI 10.1016/j.mce.2004.11.003; Yoshiura Y, 2003, BIOL REPROD, V68, P1545, DOI 10.1095/biolreprod.102.010843	69	109	113	5	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e63599	10.1371/journal.pone.0063599	http://dx.doi.org/10.1371/journal.pone.0063599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762231	Green Submitted, gold, Green Published			2022-12-25	WOS:000321094800002
J	Camerlink, I; Turner, SP; Bijma, P; Bolhuis, JE				Camerlink, Irene; Turner, Simon P.; Bijma, Piter; Bolhuis, J. Elizabeth			Indirect Genetic Effects and Housing Conditions in Relation to Aggressive Behaviour in Pigs	PLOS ONE			English	Article							INDIVIDUAL COPING CHARACTERISTICS; ENVIRONMENTAL ENRICHMENT; VARIANCE-COMPONENTS; HERITABLE VARIATION; COGNITIVE BIAS; ANIMAL-WELFARE; SOCIAL STRESS; GROWING PIGS; LAYING HENS; COMPETITION	Indirect Genetic Effects (IGEs), also known as associative effects, are the heritable effects that an individual has on the phenotype of its social partners. Selection for IGEs has been proposed as a method to reduce harmful behaviours, in particular aggression, in livestock and aquaculture. The mechanisms behind IGEs, however, have rarely been studied. The objective was therefore to assess aggression in pigs which were divergently selected for IGEs on growth (IGEg). In a one generation selection experiment, we studied 480 offspring of pigs (Sus scrofa) that were selected for relatively high or low IGEg and housed in homogeneous IGEg groups in either barren or enriched environments. Skin lesion scores, a proxy measure of aggression, and aggressive behaviours were recorded. The two distinct IGEg groups did not differ in number of skin lesions, or in amount of reciprocal fighting, both under stable social conditions and in confrontation with unfamiliar pigs in a 24 h regrouping test. Pigs selected for a positive effect on the growth of their group members, however, performed less non-reciprocal biting and showed considerably less aggression at reunion with familiar group members after they had been separated during a 24 h regrouping test. The enriched environment was associated with more skin lesions but less non-reciprocal biting under stable social conditions. Changes in aggression between pigs selected for IGEg were not influenced by GxE interactions with regard to the level of environmental enrichment. It is likely that selection on IGEg targets a behavioural strategy, rather than a single behavioural trait such as aggressiveness.	[Camerlink, Irene; Bolhuis, J. Elizabeth] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands; [Camerlink, Irene; Bijma, Piter] Wageningen Univ, Dept Anim Sci, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Turner, Simon P.] SRUC, Edinburgh, Midlothian, Scotland	Wageningen University & Research; Wageningen University & Research	Camerlink, I (corresponding author), Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands.	Irene.Camerlink@wur.nl	Bolhuis, J. Elizabeth/P-7978-2015; Baines, Andrew D/B-3491-2014; Camerlink, Irene/AAO-9931-2020	Bolhuis, J. Elizabeth/0000-0002-5172-7635; Turner, Simon/0000-0001-9198-9448; Camerlink, Irene/0000-0002-3427-2210	Netherlands Organisation for Scientific Research (NWO); Dutch Ministry of Economic Affairs; program 'The Value of Animal Welfare' of the Netherlands Organization for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); program 'The Value of Animal Welfare' of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was financially supported by the Netherlands Organisation for Scientific Research (NWO) and the Dutch Ministry of Economic Affairs. This study is part of the project 'Seeking sociable swine? Incorporating social genetic effects into pig breeding programs to achieve balanced improvement in productivity and welfare' which is financially supported by the program 'The Value of Animal Welfare' of the Netherlands Organization for Scientific Research (NWO) and the Dutch Ministry of Economic Affairs. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andersen IL, 2000, APPL ANIM BEHAV SCI, V68, P107, DOI 10.1016/S0168-1591(00)00092-7; Arango J, 2005, J ANIM SCI, V83, P1241; AREY DS, 1995, APPL ANIM BEHAV SCI, V45, P23, DOI 10.1016/0168-1591(95)00600-W; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Bergsma R, 2008, GENETICS, V178, P1559, DOI 10.1534/genetics.107.084236; Bergsma R., 2011, THESIS; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; Bijma P, 2007, GENETICS, V175, P289, DOI 10.1534/genetics.106.062729; Bijma P, 2011, GENETICS, V189, P1347, DOI 10.1534/genetics.111.130617; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Brotherstone S, 2011, SILVAE GENET, V60, P149, DOI 10.1515/sg-2011-0020; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Canario L, 2012, J ANIM SCI; Cappa EP, 2008, SILVAE GENET, V57, P45, DOI 10.1515/sg-2008-0008; Chen CY, 2007, GENET MOL RES, V6, P594; Silva JCE, 2013, NEW PHYTOL, V197, P631, DOI 10.1111/nph.12035; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; CRUMP RE, 2004, AGBU PIG GEN WORKSH, P107; Cutts CJ, 1998, J FISH BIOL, V52, P1026, DOI 10.1111/j.1095-8649.1998.tb00601.x; D'Eath RB, 2009, ANIMAL, V3, P1544, DOI 10.1017/S1751731109990528; de Groot J, 2001, PHYSIOL BEHAV, V73, P145, DOI 10.1016/S0031-9384(01)00472-3; DEWAAL FBM, 1986, Q REV BIOL, V61, P459, DOI 10.1086/415144; DICKERSON G. E., 1947, Composition of hog carcasses as influenced by heritable differences in rate and economy of gain., P492; Dudink S, 2006, APPL ANIM BEHAV SCI, V101, P86, DOI 10.1016/j.applanim.2005.12.008; Ellen ED, 2008, POULTRY SCI, V87, P233, DOI 10.3382/ps.2007-00374; Elwood RW, 1998, NATURE, V393, P66, DOI 10.1038/29980; Falconer D. S, 1996, INTRO QUANTITATIVE G; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; GONYOU HW, 1994, J ANIM SCI, V72, P2171, DOI 10.2527/1994.7282171x; GRIFFING B, 1967, AUST J BIOL SCI, V20, P127, DOI 10.1071/BI9670127; Guy JH, 2002, LIVEST PROD SCI, V75, P233, DOI 10.1016/S0301-6226(01)00327-X; HAEMISCH A, 1994, PHYSIOL BEHAV, V56, P1041, DOI 10.1016/0031-9384(94)90341-7; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; Hyun Y, 1998, J ANIM SCI, V76, P721; Kadry VO, 2010, NEOTROP ICHTHYOL, V8, P329, DOI 10.1590/S1679-62252010000200011; KIRKPATRICK M, 1989, EVOLUTION, V43, P485, DOI 10.1111/j.1558-5646.1989.tb04247.x; LYONS CAP, 1995, LIVEST PROD SCI, V43, P265, DOI 10.1016/0301-6226(95)00050-U; Marchant-Forde J. N., 2005, Pig News and Information, V26, p63N; MARLER P, 1976, AM PSYCHOL, V31, P239, DOI 10.1037/0003-066X.31.3.239; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Meyers RA., 2011, ENCY SUSTAINABILITY; Miles DR, 1997, J PERS SOC PSYCHOL, V72, P207, DOI 10.1037/0022-3514.72.1.207; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Morgan CA, 1998, APPL ANIM BEHAV SCI, V58, P23, DOI 10.1016/S0168-1591(97)00141-X; Muir WM, 2005, GENETICS, V170, P1247, DOI 10.1534/genetics.104.035956; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Peeters K, 2012, GENETICS, V192, P705, DOI 10.1534/genetics.112.142554; PETHERICK JC, 1987, AUST J EXP AGR, V27, P605, DOI 10.1071/EA9870605; Rodenburg TB, 2010, ANIM WELFARE, V19, P77; Rodenburg TB, 2008, APPL ANIM BEHAV SCI, V110, P217, DOI 10.1016/j.applanim.2007.09.009; Ruis MAW, 2002, APPL ANIM BEHAV SCI, V75, P207, DOI 10.1016/S0168-1591(01)00191-5; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Scott JP, 1984, PHYSIOL ZOOL, V21, P31; Scott K, 2006, LIVEST SCI, V103, P104, DOI 10.1016/j.livsci.2006.01.008; Souza AS, 2008, APPL ANIM BEHAV SCI, V110, P182, DOI 10.1016/j.applanim.2007.03.023; Spoolder HAM, 2000, LIVEST PROD SCI, V64, P167, DOI 10.1016/S0301-6226(99)00152-9; STOOKEY JM, 1994, J ANIM SCI, V72, P2804, DOI 10.2527/1994.72112804x; Takahashi T, 2004, NEUROSCI LETT, V363, P125, DOI 10.1016/j.neulet.2004.03.062; Tanaka T, 1998, PHARMACOL BIOCHEM BE, V59, P27, DOI 10.1016/S0091-3057(97)00312-2; Turner SP, 2009, J ANIM SCI, V87, P3076, DOI 10.2527/jas.2008-1558; Turner SP, 2011, APPL ANIM BEHAV SCI, V134, P1, DOI 10.1016/j.applanim.2011.06.001; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; Tuyttens FAM, 2005, APPL ANIM BEHAV SCI, V92, P261, DOI 10.1016/j.applanim.2005.05.007; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; Van Loo PLP, 2002, APPL ANIM BEHAV SCI, V76, P65, DOI 10.1016/S0168-1591(01)00200-3; Van Vleck LD, 2005, J ANIM SCI, V83, P68; Whittaker X, 1999, APPL ANIM BEHAV SCI, V63, P25, DOI 10.1016/S0168-1591(98)00243-3; WILLHAM RL, 1972, J ANIM SCI, V35, P1288; Wilson AJ, 2011, J EVOLUTION BIOL, V24, P772, DOI 10.1111/j.1420-9101.2010.02212.x; Wilson AJ, 2009, P ROY SOC B-BIOL SCI, V276, P533, DOI 10.1098/rspb.2008.1193; Wolf JB, 2011, PHILOS T R SOC B, V366, P1358, DOI 10.1098/rstb.2010.0239; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; ZAYAN R, 1990, CURR T VET, V53, P157	76	47	48	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65136	10.1371/journal.pone.0065136	http://dx.doi.org/10.1371/journal.pone.0065136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762299	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000034
J	Schirm, S; Engel, C; Loeffler, M; Scholz, M				Schirm, Sibylle; Engel, Christoph; Loeffler, Markus; Scholz, Markus			A Biomathematical Model of Human Erythropoiesis under Erythropoietin and Chemotherapy Administration	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; 3-WEEKLY CHOP CHEMOTHERAPY; NON-HODGKINS-LYMPHOMA; MATHEMATICAL-MODEL; EPOETIN-ALPHA; PHARMACODYNAMIC ANALYSIS; AGGRESSIVE LYMPHOMAS; HUMAN GRANULOPOIESIS; ELDERLY-PATIENTS; YOUNG-PATIENTS	Anaemia is a common haematologic side effect of dose-dense multi-cycle cytotoxic polychemotherapy requiring erythrocyte transfusions or erythropoietin (EPO) administration. To simulate the effectiveness of different EPO application schedules, we performed both modelling of erythropoiesis under chemotherapy and pharmacokinetic and dynamic modelling of EPO applications in the framework of a single comprehensive biomathematical model. For this purpose, a cell kinetic model of bone marrow erythropoiesis was developed that is based on a set of differential compartment equations describing proliferation and maturation of erythropoietic cell stages. The system is regulated by several feedback loops comprising those mediated by EPO. We added a model of EPO absorption after injection at different sites and a pharmacokinetic model of EPO derivatives to account for the effects of external EPO applications. Chemotherapy is modelled by a transient depletion of bone marrow cell stages. Unknown model parameters were determined by fitting the predictions of the model to data sets of circulating erythrocytes, haemoglobin, haematocrit, percentage of reticulocytes or EPO serum concentrations derived from the literature or cooperating clinical study groups. Parameter fittings resulted in a good agreement of model and data. Depending on site of injection and derivative (Alfa, Beta, Delta, Darbepoetin), nine groups of EPO applications were distinguished differing in either absorption kinetics or pharmacokinetics. Finally, eight different chemotherapy protocols were modelled. The model was validated on the basis of scenarios not used for parameter fitting. Simulations were performed to analyze the impact of EPO applications on the risk of anaemia during chemotherapy. We conclude that we established a model of erythropoiesis under chemotherapy that explains a large set of time series data under EPO and chemotherapy applications. It allows predictions regarding yet untested EPO schedules. Prospective clinical studies are needed to validate model predictions and to explore the feasibility and effectiveness of the proposed schedules.	[Schirm, Sibylle; Engel, Christoph; Loeffler, Markus; Scholz, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany; [Schirm, Sibylle; Scholz, Markus] Univ Leipzig, LIFE Res Ctr Civilizat Dis, D-04109 Leipzig, Germany	Leipzig University; Leipzig University	Schirm, S (corresponding author), Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04109 Leipzig, Germany.	sibylle.schirm@imise.uni-leipzig.de		Engel, Christoph/0000-0002-7247-282X	Federal Ministry of Education and Research of the Federal Republic of Germany ("Haematosys'') [BMBF/PTJ0315452A]; LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony within the framework of the excellence initiative; LIFE	Federal Ministry of Education and Research of the Federal Republic of Germany ("Haematosys''); LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony within the framework of the excellence initiative; LIFE	S. S. was partially funded by a grant of the Federal Ministry of Education and Research of the Federal Republic of Germany ("Haematosys'', BMBF/PTJ0315452A) and by LIFE - Leipzig Research Center for Civilization Diseases, University of Leipzig. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by means of the Free State of Saxony within the framework of the excellence initiative. M.S. was also funded by LIFE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoram B, 2007, BRIT J CLIN PHARMACO, V63, P41, DOI 10.1111/j.1365-2125.2006.02752.x; Ait-Oudhia S, 2010, J PHARMACOL EXP THER, V334, P897, DOI 10.1124/jpet.110.167304; Banks HT, 2004, MATH BIOSCI ENG, V1, P15, DOI 10.3934/mbe.2004.1.15; BELAIR J, 1995, MATH BIOSCI, V128, P317, DOI 10.1016/0025-5564(94)00078-E; Chapel SH, 2000, J PHARMACOL EXP THER, V295, P346; Cheung W, 1998, CLIN PHARMACOL THER, V8, P309; Crauste F, 2008, J THEOR BIOL, V250, P322, DOI 10.1016/j.jtbi.2007.09.041; Diehl V, 2003, NEW ENGL J MED, P348; Egrie JC, 2001, BRIT J CANCER, V84, P3, DOI 10.1054/bjoc.2001.1746; Elliott S, 2004, EXP HEMATOL, V32, P1146, DOI 10.1016/j.exphem.2004.08.004; Engel C, 2004, BLOOD, V104, P2323, DOI 10.1182/blood-2004-01-0306; Faris PM, 1998, CLIN ORTHOP RELAT R, P60; FLAHARTY KK, 1990, CLIN PHARMACOL THER, V47, P557, DOI 10.1038/clpt.1990.76; Fuertinger DH, 2013, J MATH BIOL, V66, P1209, DOI 10.1007/s00285-012-0530-0; Goldberg MA, 1995, AM J SURG, V170, pS37, DOI 10.1016/S0002-9610(99)80057-9; Guminski AD, 2001, CANCER CHEMOTH PHARM, V48, P229, DOI 10.1007/s002800100279; Hayashi N, 1998, BRIT J CLIN PHARMACO, V46, P11, DOI 10.1046/j.1365-2125.1998.00043.x; Jelkmann W, 2006, RECOMBINANT ERYTHROP; JENSEN JD, 1994, J AM SOC NEPHROL, V5, P177; Kota J, 2007, DRUG METAB DISPOS, V35, P2211, DOI 10.1124/dmd.107.015669; Krzyzanski W, 2005, EUR J PHARM SCI, V26, P295, DOI 10.1016/j.ejps.2005.06.010; Krzyzanski W, 2008, N-S ARCH PHARMACOL, V377, P637, DOI 10.1007/s00210-007-0225-z; LOEFFLER M, 1989, CELL TISSUE KINET, V22, P13, DOI 10.1111/j.1365-2184.1989.tb00198.x; Lohrmann H, 1982, CYOTOXIC DRUGS GRANU; Lundby C, 2007, J PHYSIOL-LONDON, V578, P309, DOI 10.1113/jphysiol.2006.122689; Macdougall IC, 2007, NEPHROL DIAL TRANSPL, V22, P2, DOI 10.1093/ndt/gfm160; Macdougall IC, 2002, NEPHROL DIAL TRANSPL, V17, P66, DOI 10.1093/ndt/17.suppl_5.66; MACDOUGALL IC, 1991, CONTRIB NEPHROL, V88, P152; Mahaffy JM, 1998, J THEOR BIOL, V190, P135, DOI 10.1006/jtbi.1997.0537; MARKHAM A, 1995, DRUGS, V49, P232, DOI 10.2165/00003495-199549020-00008; MCMAHON FG, 1990, BLOOD, V76, P1718; Meyer G, 2004, THESIS U LEIPZIG; PANTEL K, 1990, CELL TISSUE KINET, V23, P283, DOI 10.1111/j.1365-2184.1990.tb01125.x; Pantel K, 1987, THESIS U KOLN; Pfreundschuh M, 2008, ANN ONCOL, V19, P545, DOI 10.1093/annonc/mdm514; Pfreundschuh M, 2004, BLOOD, V104, P626, DOI 10.1182/blood-2003-06-2094; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pirker R, 2008, J CLIN ONCOLOGY, P26; Rechenberg I., 1994, EVOLUTIONSSTRATEGIE; Savill NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000416; SAWADA K, 1990, J CELL PHYSIOL, V142, P219, DOI 10.1002/jcp.1041420202; SAWADA K, 1987, J CLIN INVEST, V80, P357, DOI 10.1172/JCI113080; Scholz M, 2006, BRIT J HAEMATOL, V132, P723, DOI 10.1111/j.1365-2141.2005.05957.x; Scholz M, 2005, J MATH BIOL, V50, P397, DOI 10.1007/s00285-004-0295-1; Scholz M, 2009, CELL PROLIFERAT, V42, P823, DOI 10.1111/j.1365-2184.2009.00641.x; Scholz M, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-32; Scholz M, 2010, J THEOR BIOL, V264, P287, DOI 10.1016/j.jtbi.2009.12.032; SCHWEFEL H, 1984, ANN OPER RES, V1, P65, DOI DOI 10.1007/BF01876146; Sieber M, 2003, J CLIN ONCOL, V21, P1734, DOI 10.1200/JCO.2003.06.028; Smith WB, 2007, CLIN THER, V29, P1368, DOI 10.1016/j.clinthera.2007.07.014; Sorgel F, 2009, PHARMACOLOGY, V83, P122, DOI 10.1159/000189027; Souillard A, 1996, BRIT J CLIN PHARMACO, V42, P355, DOI 10.1046/j.1365-2125.1996.41911.x; Togawa A, 2004, BRIT J CLIN PHARMACO, V58, P269, DOI 10.1111/j.1365-2125.2004.02151.x; Veng-Pedersen P, 2002, PHARM RES-DORDR, V19, P1630, DOI 10.1023/A:1020797110836; Wichmann H, 1985, MATH MODELING CELL P, V1, P2; Wichmann H, 1983, CURRENT CONCEPTS ERY; WICHMANN HE, 1989, CELL TISSUE KINET, V22, P31, DOI 10.1111/j.1365-2184.1989.tb00199.x; Woo S, 2008, CANCER CHEMOTH PHARM, V62, P123, DOI 10.1007/s00280-007-0582-9; Wunderlich A, 2003, ANN ONCOL, V14, P881, DOI 10.1093/annonc/mdg249; Zelenetz AD, 2003, ANN ONCOL, V14, P5, DOI 10.1093/annonc/mdg702; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	62	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65630	10.1371/journal.pone.0065630	http://dx.doi.org/10.1371/journal.pone.0065630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755260	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000083
J	Yuan, MQ; Lu, T; Li, CH; Lu, L				Yuan, Manqiong; Lu, Teng; Li, Chunhua; Lu, Ling			The Evolutionary Rates of HCV Estimated with Subtype 1a and 1b Sequences over the ORF Length and in Different Genomic Regions	PLOS ONE			English	Article							HEPATITIS-C VIRUS; MOLECULAR EPIDEMIOLOGY; GENETIC HISTORY; GENOTYPE 2; INFECTION; INFERENCE; TRANSMISSION; GLYCOPROTEIN	Background: Considerable progress has been made in the HCV evolutionary analysis, since the software BEAST was released. However, prior information, especially the prior evolutionary rate, which plays a critical role in BEAST analysis, is always difficult to ascertain due to various uncertainties. Providing a proper prior HCV evolutionary rate is thus of great importance. Methods/Results: 176 full-length sequences of HCV subtype 1a and 144 of 1b were assembled by taking into consideration the balance of the sampling dates and the even dispersion in phylogenetic trees. According to the HCV genomic organization and biological functions, each dataset was partitioned into nine genomic regions and two routinely amplified regions. A uniform prior rate was applied to the BEAST analysis for each region and also the entire ORF. All the obtained posterior rates for 1a are of a magnitude of 10 23 substitutions/site/year and in a bell-shaped distribution. Significantly lower rates were estimated for 1b and some of the rate distribution curves resulted in a one-sided truncation, particularly under the exponential model. This indicates that some of the rates for subtype 1b are less accurate, so they were adjusted by including more sequences to improve the temporal structure. Conclusion: Among the various HCV subtypes and genomic regions, the evolutionary patterns are dissimilar. Therefore, an applied estimation of the HCV epidemic history requires the proper selection of the rate priors, which should match the actual dataset so that they can fit for the subtype, the genomic region and even the length. By referencing the findings here, future evolutionary analysis of the HCV subtype 1a and 1b datasets may become more accurate and hence prove useful for tracing their patterns.	[Yuan, Manqiong; Li, Chunhua; Lu, Ling] Univ Kansas, Med Ctr, Ctr Viral Oncol, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Lu, Teng] Univ So Calif, Los Angeles, CA USA	University of Kansas; University of Kansas Medical Center; University of Southern California	Lu, L (corresponding author), Univ Kansas, Med Ctr, Ctr Viral Oncol, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	llu@kumc.edu			National Institute of Allergy and Infectious Diseases [5 R01 AI080734-03A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080734] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a grant from The National Institute of Allergy and Infectious Diseases (5 R01 AI080734-03A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edo-Matas D, 2011, MOL BIOL EVOL, V28, P1605, DOI 10.1093/molbev/msq326; Ferraro D, 2008, J MED VIROL, V80, P1723, DOI 10.1002/jmv.21276; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P10015, DOI 10.1073/pnas.87.24.10015; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; HIJIKATA M, 1991, BIOCHEM BIOPH RES CO, V175, P220, DOI 10.1016/S0006-291X(05)81223-9; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; KUROSAKI M, 1993, HEPATOLOGY, V18, P1293, DOI 10.1002/hep.1840180602; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lim PJ, 2012, J BIOL CHEM, V287, P30861, DOI 10.1074/jbc.M112.376822; Markov PV, 2009, J GEN VIROL, V90, P2086, DOI 10.1099/vir.0.011569-0; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Njouom R, 2009, J GEN VIROL, V90, P2452, DOI 10.1099/vir.0.011981-0; Pouillot R, 2008, INFECT GENET EVOL, V8, P676, DOI 10.1016/j.meegid.2008.06.001; POWER JP, 1995, LANCET, V345, P1211, DOI 10.1016/S0140-6736(95)91993-7; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010; Veillon P, 2004, PATHOL BIOL, V52, P505, DOI 10.1016/j.patbio.2004.07.011; WEINER AJ, 1992, P NATL ACAD SCI USA, V89, P3468, DOI 10.1073/pnas.89.8.3468; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zhou XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024889	33	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64698	10.1371/journal.pone.0064698	http://dx.doi.org/10.1371/journal.pone.0064698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762247	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000015
J	de Juan, S; Thrush, SF; Hewitt, JE				de Juan, Silvia; Thrush, Simon F.; Hewitt, Judi E.			Counting on beta-Diversity to Safeguard the Resilience of Estuaries	PLOS ONE			English	Article							SPECIES-DIVERSITY; REGIME SHIFTS; DISPERSAL; HABITAT; SCALE; PATTERNS; COASTAL; HOMOGENIZATION; VARIABILITY; DISTURBANCE	Coastal ecosystems are often stressed by non-point source and cumulative effects that can lead to local-scale community homogenisation and a concomitant loss of large-scale ecological connectivity. Here we investigate the use of beta-diversity as a measure of both community heterogeneity and ecological connectivity. To understand the consequences of different environmental scenarios on heterogeneity and connectivity, it is necessary to understand the scale at which different environmental factors affect beta-diversity. We sampled macrofauna from intertidal sites in nine estuaries from New Zealand's North Island that represented different degrees of stress derived from land-use. We used multiple regression models to identify relationships between beta-diversity and local sediment variables, factors related to the estuarine and catchment hydrodynamics and morphology and land-based stressors. At local scales, we found higher beta-diversity at sites with a relatively high total richness. At larger scales, beta-diversity was positively related to gamma-diversity, suggesting that a large regional species pool was linked with large-scale heterogeneity in these systems. Local environmental heterogeneity influenced beta-diversity at both local and regional scales, although variables at the estuarine and catchment scales were both needed to explain large scale connectivity. The estuaries expected a priori to be the most stressed exhibited higher variance in community dissimilarity between sites and connectivity to the estuary species pool. This suggests that connectivity and heterogeneity metrics could be used to generate early warning signals of cumulative stress.	[de Juan, Silvia; Thrush, Simon F.; Hewitt, Judi E.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	de Juan, S (corresponding author), Natl Inst Water & Atmospher Res, Hamilton, New Zealand.	Silvia.dejuan@niwa.co.nz	de Juan Mohan, Silvia/P-2899-2019	de Juan Mohan, Silvia/0000-0002-8891-8371; Thrush, Simon/0000-0002-4005-3882	Spanish Ministry of Education (Programa nacional de movilidad de recursos humanos del Plan Nacional I+D+i); MBIE [NIWA COMS1302, COER1201, C01X0501]	Spanish Ministry of Education (Programa nacional de movilidad de recursos humanos del Plan Nacional I+D+i); MBIE(New Zealand Ministry of Business, Innovation and Employment (MBIE))	SdJ was funded by a postdoctoral mobility grant from The Spanish Ministry of Education (Programa nacional de movilidad de recursos humanos del Plan Nacional I+D+i 2008-2011). This work was supported by funding from MBIE (NIWA COMS1302, COER1201 & C01X0501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Bevilacqua S, 2012, ECOL INDIC, V18, P140, DOI 10.1016/j.ecolind.2011.11.006; Bierschenk AM, 2012, ECOSYSTEMS, V15, P637, DOI 10.1007/s10021-012-9536-0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brock WA, 2010, ECOL MONOGR, V80, P353, DOI 10.1890/09-1824.1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Clarke K. R., 2001, CHANGES MARINE COMMU; Colwell R K, 2006, ESTIMATES BIODIVERSI; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cottenie K, 2004, ECOLOGY, V85, P114, DOI 10.1890/03-3004; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; de Juan S, 2011, MAR ECOL PROG SER, V423, P117, DOI 10.3354/meps08935; Edgar GJ, 2000, ESTUAR COAST SHELF S, V50, P639, DOI 10.1006/ecss.2000.0591; Ellingsen KE, 2002, MAR ECOL PROG SER, V232, P15, DOI 10.3354/meps232015; Freestone AL, 2006, ECOLOGY, V87, P2425, DOI 10.1890/0012-9658(2006)87[2425:DLAEHS]2.0.CO;2; Fujita R, 2013, MAR POLICY, V38, P538, DOI 10.1016/j.marpol.2012.05.025; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hastie T.J., 2017, STAT SCI; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hewitt J, 2010, BIODIVERS CONSERV, V19, P1315, DOI 10.1007/s10531-009-9763-7; Hewitt JE, 2010, MAR ECOL PROG SER, V413, P267, DOI 10.3354/meps08626; Hume TM, 2007, OCEAN COAST MANAGE, V50, P905, DOI 10.1016/j.ocecoaman.2007.05.009; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Keil P, 2012, J BIOGEOGR, V39, P1473, DOI 10.1111/j.1365-2699.2012.02701.x; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038410; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Lundquist CJ, 2010, MAR ECOL PROG SER, V413, P217, DOI 10.3354/meps08578; Ricotta C, 2008, THEOR POPUL BIOL, V73, P244, DOI 10.1016/j.tpb.2007.10.005; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Shackell NL, 2012, ECOL APPL, V22, P336, DOI 10.1890/10-2093.1; Shurin JB, 2001, AM NAT, V158, P624, DOI 10.1086/323589; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Thrush SF, 2012, ECOL APPL, V22, P1213, DOI 10.1890/11-1403.1; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Thrush SF, 2008, ECOL APPL, V18, P12, DOI 10.1890/07-0436.1; Thrush SF, 2006, ECOL APPL, V16, P1636, DOI 10.1890/1051-0761(2006)016[1636:PTEOHH]2.0.CO;2; Thrush SF, 2013, ECOL APPL, V23, P226, DOI 10.1890/12-0793.1; Thrush SF, 2011, MAR ECOL PROG SER, V424, P119, DOI 10.3354/meps08960; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; Thrush SF, 2009, P ROY SOC B-BIOL SCI, V276, P3209, DOI 10.1098/rspb.2009.0661; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X	53	34	34	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65575	10.1371/journal.pone.0065575	http://dx.doi.org/10.1371/journal.pone.0065575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755252	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400066
J	Lee, SI; Hwang, S; Joe, YE; Cha, HK; Joo, GH; Lee, HJ; Kim, JW; Jablonski, PG				Lee, Sang-im; Hwang, Soyun; Joe, Young-eun; Cha, Hyun-kyung; Joo, Gun-ho; Lee, Hyeon-jeong; Kim, Ji-won; Jablonski, Piotr G.			Direct Look from a Predator Shortens the Risk-Assessment Time by Prey	PLOS ONE			English	Article							FLIGHT-INITIATION DISTANCE; ANCIENT ESCAPE CIRCUIT; DECISION-MAKING; AVIAN PREDATOR; MOTOR-ACTIVITY; VISUAL-FIELDS; ANIMALS; BIRDS; CUES; EXPLOITATION	Decision making process is an important component of information use by animals and has already been studied in natural situations. Decision making takes time, which is expressed as a cost in evolutionary explanations of decision making abilities of animals. However, the duration of information assessment and decision making process has not been measured in a natural situation. Here, we use responses of wild magpies (Pica pica) to predictably approaching humans to demonstrate that, regardless of whether the bird perceived high (decided to fly away) or low (resumed foraging) threat level, the bird assessed the situation faster when approaching humans looked directly at it than when the humans were not directly looking at it. This indicates that prey is able to extract more information about the predator's intentions and to respond sooner when the predator is continuously ("intently'') looking at the prey. The results generally illustrate how an increase of information available to an individual leads to a shorter assessment and decision making process, confirming one of central tenets of psychology of information use in a wild bird species in its natural habitat.	[Lee, Sang-im] Seoul Natl Univ, Inst Adv Machinery & Design, Seoul, South Korea; [Lee, Sang-im; Hwang, Soyun; Joe, Young-eun; Cha, Hyun-kyung; Joo, Gun-ho; Lee, Hyeon-jeong; Kim, Ji-won; Jablonski, Piotr G.] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Jablonski, Piotr G.] Polish Acad Sci, Ctr Ecol Studies, Dziekanow Lesny, Lomianki, Poland	Seoul National University (SNU); Seoul National University (SNU); Polish Academy of Sciences	Lee, SI (corresponding author), Seoul Natl Univ, Inst Adv Machinery & Design, Seoul, South Korea.	snulbee@behecolpiotrsangim.org; snulbee@behecolpiotrsangim.org	Jablonski, Piotr G/A-2753-2015	Cha, Hyunkyung/0000-0002-3462-3789; /0000-0002-8333-0106; Hwang, Soyun/0000-0002-4290-0213	National Research Foundation of Korea [313-2007-2-C00747, 2010-0025546, 2010-0009006, 2011-0030744]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was funded by the following grants of the National Research Foundation of Korea (www.nrf.re.kr); 313-2007-2-C00747, 2010-0025546, 2010-0009006 and 2011-0030744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barret HC, 2005, HDB EVOLUTIONARY PSY, P210; Bateman PW, 2011, J ZOOL, V285, P316, DOI 10.1111/j.1469-7998.2011.00846.x; BERGSTROM BJ, 1985, J FIELD ORNITHOL, V56, P415; Blanchard DC, 2011, NEUROSCI BIOBEHAV R, V35, P991, DOI 10.1016/j.neubiorev.2010.10.016; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Blumstein DT, 1996, OIKOS, V77, P569, DOI 10.2307/3545948; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; Bradbury Jack W., 1998, pi; Broom M, 2005, BEHAV ECOL, V16, P534, DOI 10.1093/beheco/ari024; Burrows M, 2006, J EXP BIOL, V209, P4607, DOI 10.1242/jeb.02539; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Carter J, 2008, P ROY SOC B-BIOL SCI, V275, P1709, DOI 10.1098/rspb.2008.0095; Castellano S, 2011, J THEOR BIOL, V274, P161, DOI 10.1016/j.jtbi.2011.01.001; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Cooper WE, 1998, BEHAVIOUR, V135, P55; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; Cooper WE, 2012, BEHAV ECOL, V23, P790, DOI 10.1093/beheco/ars032; Cooper WE, 2011, ETHOLOGY, V117, P620, DOI 10.1111/j.1439-0310.2011.01911.x; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Doshi A, 2009, IEEE T INTELL TRANSP, V10, P453, DOI 10.1109/TITS.2009.2026675; Dukas R, 1998, COGNITIVE ECOLOGY EV; Eason PK, 2006, J WILDLIFE MANAGE, V70, P1796, DOI 10.2193/0022-541X(2006)70[1796:FAFIDI]2.0.CO;2; Eaton R. L., 1970, Z TIERPSYCHOL, V27, P492, DOI DOI 10.1111/J.1439-0310.1970.TB01883X; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fernandez-Juricic E, 2002, CAN J ZOOL, V80, P1212, DOI 10.1139/Z02-104; Fernandez-Juricic E, 2008, IBIS, V150, P779, DOI 10.1111/j.1474-919X.2008.00860.x; Fotowat H, 2007, J NEUROSCI, V27, P10047, DOI 10.1523/JNEUROSCI.1515-07.2007; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; HAMPTON RR, 1994, BEHAVIOUR, V130, P41, DOI 10.1163/156853994X00136; Heylen D, 2010, HUMAN-CENTRIC INTERFACES FOR AMBIENT INTELLIGENCE, P49, DOI 10.1016/B978-0-12-374708-2.00003-6; Jablonski PG, 2001, BRAIN BEHAV EVOLUT, V58, P218, DOI 10.1159/000057565; Jablonski PG, 2000, BRAIN BEHAV EVOLUT, V56, P94, DOI 10.1159/000006680; Javurkova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032522; Ji Q, 2002, REAL-TIME IMAGING, V8, P357, DOI 10.1006/rtim.2002.0279; Kavaliers M, 2001, NEUROSCI BIOBEHAV R, V25, P577, DOI 10.1016/S0149-7634(01)00042-2; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Lee SI, 2011, J ETHOL, V29, P401, DOI 10.1007/s10164-011-0275-z; Lee WY, 2011, ANIM COGN, V14, P817, DOI 10.1007/s10071-011-0415-4; Luttbeg B, 1996, BEHAV ECOL, V7, P451, DOI 10.1093/beheco/7.4.451; MAININI B, 1993, BIOL CONSERV, V64, P161, DOI 10.1016/0006-3207(93)90653-I; Martin GR, 1999, P 22 INT ORN C DURB, P2711; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; Miller SG, 2001, WILDLIFE SOC B, V29, P124; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Railsback SF, 2002, ECOLOGY, V83, P1817, DOI 10.1890/0012-9658(2002)083[1817:AOHSRU]2.0.CO;2; Ristau CA, 1991, COGNITIVE ETHOLOGY M; Ristau CA, 1991, NATURAL THEORIES MIN, P209; Rodriguez-Prieto I, 2008, BEHAVIOUR, V145, P1125, DOI 10.1163/156853908784474489; Runyan AM, 2004, J WILDLIFE MANAGE, V68, P1124, DOI 10.2193/0022-541X(2004)068[1124:DIDIFI]2.0.CO;2; Santer RD, 2005, J COMP PHYSIOL A, V191, P965, DOI 10.1007/s00359-005-0023-3; Schmidt KA, 2010, OIKOS, V119, P304, DOI 10.1111/j.1600-0706.2009.17573.x; SEIDENSTICKER J, 1993, SYM ZOOL S, P105; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Sutton GP, 2008, J COMP PHYSIOL A, V194, P557, DOI 10.1007/s00359-008-0329-z; Swaisgood RR, 1999, ANIM BEHAV, V57, P1301, DOI 10.1006/anbe.1999.1095; Tijerina L, 2005, TRANSPORT RES REC, P37; Trimmer PC, 2011, ANIM COGN, V14, P465, DOI 10.1007/s10071-011-0387-4; von Bayern AMP, 2009, CURR BIOL, V19, P1; Watve M, 2002, ANIM COGN, V5, P253, DOI 10.1007/s10071-002-0155-6; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	68	15	15	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64977	10.1371/journal.pone.0064977	http://dx.doi.org/10.1371/journal.pone.0064977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755164	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400033
J	Tempalski, B; Pouget, ER; Cleland, CM; Brady, JE; Cooper, HLF; Hall, HI; Lansky, A; West, BS; Friedman, SR				Tempalski, Barbara; Pouget, Enrique R.; Cleland, Charles M.; Brady, Joanne E.; Cooper, Hannah L. F.; Hall, H. Irene; Lansky, Amy; West, Brooke S.; Friedman, Samuel R.			Trends in the Population Prevalence of People Who Inject Drugs in US Metropolitan Areas 1992-2007	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; UNITED-STATES; HEROIN USERS; RISK-FACTORS; ESTIMATING NUMBERS; SUBSTANCE-ABUSE; HIV PREVALENCE; PUBLIC-HEALTH; YOUNG-ADULTS	Background: People who inject drugs (PWID) have increased risk of morbidity and mortality. We update and present estimates and trends of the prevalence of current PWID and PWID subpopulations in 96 US metropolitan statistical areas (MSAs) for 1992-2007. Current estimates of PWID and PWID subpopulations will help target services and help to understand long-term health trends among PWID populations. Methodology: We calculated the number of PWID in the US annually from 1992-2007 and apportioned estimates to MSAs using multiplier methods. We used four types of data indicating drug injection to allocate national annual totals to MSAs, creating four distinct series of component estimates of PWID in each MSA and year. The four component estimates are averaged to create the best estimate of PWID for each MSA and year. We estimated PWID prevalence rates for three subpopulations defined by gender, age, and race/ethnicity. We evaluated trends using multi-level polynomial models. Results: PWID per 10,000 persons aged 15-64 years varied across MSAs from 31 to 345 in 1992 (median 104.4) to 34 to 324 in 2007 (median 91.5). Trend analysis indicates that this rate declined during the early period and then was relatively stable in 2002-2007. Overall prevalence rates for non-Hispanic black PWID increased in 2005 as compared to other racial/ethnic groups. Hispanic prevalence, in contrast, declined across time. Importantly, results show a worrisome trend in young PWID prevalence since HAART was initiated - the mean prevalence was 90 to 100 per 10,000 youth in 1992-1996, but increased to >120 PWID per 10,000 youth in 2006-2007. Conclusions: Overall, PWID rates remained constant since 2002, but increased for two subpopulations: non-Hispanic black PWID and young PWID. Estimates of PWID are important for planning and evaluating public health programs to reduce harm among PWID and for understanding related trends in social and health outcomes.	[Tempalski, Barbara; Pouget, Enrique R.; Cleland, Charles M.; West, Brooke S.; Friedman, Samuel R.] Natl Dev & Res Inst Inc NDRI, Inst AIDS Res, New York, NY 10010 USA; [Cleland, Charles M.] NYU, Coll Nursing, New York, NY USA; [Brady, Joanne E.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Cooper, Hannah L. F.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Hall, H. Irene] Ctr Dis Control, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Lansky, Amy] Ctr Dis Control, Div HIV AIDS Prevent Surveillance Epidemiol & Lab, Atlanta, GA 30333 USA; [Friedman, Samuel R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	National Development & Research Institutes, Inc; New York University; Columbia University; Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tempalski, B (corresponding author), Natl Dev & Res Inst Inc NDRI, Inst AIDS Res, New York, NY 10010 USA.	tempalski@ndri.org	Pouget, Enrique Rodriguez/AAJ-5786-2020	Pouget, Enrique Rodriguez/0000-0002-5907-1909; West, Brooke S./0000-0003-0496-5769; Brady, Joanne/0000-0002-1730-2676; Tempalski, Barbara/0000-0002-6128-2510; Cleland, Charles/0000-0002-6931-9904; Friedman, Sam/0000-0003-2083-1226	National Institute of Drug Abuse [R01 DA13336]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013336] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research described in this paper is supported by the National Institute of Drug Abuse grant # R01 DA13336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro H, 2001, PUBLIC HEALTH REP, V116, P434, DOI 10.1016/S0033-3549(04)50072-9; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P681; [Anonymous], NAT SURV DRUG US HLT; [Anonymous], 2010, HIV COUNS TEST PUBL; Arfken CL, 2010, J SUBST ABUSE TREAT, V39, P96, DOI 10.1016/j.jsat.2010.05.004; Balding DJ, 2004, APPL LONGITUDINAL AN; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bargagli AM, 2006, EUR J PUBLIC HEALTH, V16, P198, DOI 10.1093/eurpub/cki168; Bjerg O, 2008, BODY SOC, V14, P1, DOI 10.1177/1357034X08090695; Bluthenthal R N, 1997, Med Anthropol, V18, P61, DOI 10.1080/01459740.1997.9966150; Bluthenthal RN, 1999, J DRUG ISSUES, V29, P1; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Broz D, 2008, DRUG ALCOHOL DEPEN, V94, P221, DOI 10.1016/j.drugalcdep.2007.11.020; Cai R., 2010, Morbidity and Mortality Weekly Report, V59, P705; Centers for Disease Control and Prevention, 2010, AIDS SURV DAT; Centers for Disease Control and Prevention, MON SEL NAT HIV PR A, P17; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P636; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P358; Chatterjee S, 2011, AIDS BEHAV, V15, P1570, DOI 10.1007/s10461-011-9992-0; Chen CM, 2007, ALCOHOL CLIN EXP RES, V31, P285, DOI 10.1111/j.1530-0277.2006.00304.x; Church D., 2011, Morbidity and Mortality Weekly Report, V60, P1457; Ciccarone D, 2003, SUBST USE MISUSE, V38, P2049, DOI 10.1081/JA-120025125; Cooper H, 2005, SOC SCI MED, V61, P673, DOI 10.1016/j.socscimed.2004.12.030; Cooper HLF, 2008, CLIN INFECT DIS, V46, P955, DOI 10.1086/528870; Cooper HLF, 2012, HEALTH PLACE, V18, P218, DOI 10.1016/j.healthplace.2011.09.005; Cooper HLF, 2008, J URBAN HEALTH, V85, P826, DOI 10.1007/s11524-008-9304-9; Cox S, 1997, SOC PSYCH PSYCH EPID, V32, P19, DOI 10.1007/BF00800663; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Department of Justice, 2010, UN CRIM REP RPGR DAT; Des Jarlais DC, 2003, AM J EPIDEMIOL, V157, P467, DOI 10.1093/aje/kwf222; EMCDDA and Centre for Drug Misuse Research, 1999, METH GUID EST PREV P; European Monitoring Centre for Drugs and Drug Addiction, EMCDDA STAT B 2005; Fischer B, 2007, J URBAN HEALTH, V84, P552, DOI 10.1007/s11524-007-9198-y; Friedman S.R., 1988, CALIF SOCIOL, V11, P55; Friedman SR, 2007, INT J DRUG POLICY, V18, P475, DOI 10.1016/j.drugpo.2006.10.004; Friedman SR, 2011, AM J PUBLIC HEALTH, V101, P344, DOI 10.2105/AJPH.2010.191759; Friedman SR, 2009, AM J PUBLIC HEALTH, V99, P1002, DOI 10.2105/AJPH.2008.140327; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; FRIEDMAN SR, 1987, MILBANK Q, V65, P455, DOI 10.2307/3349999; Friedman SR, 2001, AM J PUBLIC HEALTH, V91, P791, DOI 10.2105/AJPH.91.5.791; Frischer M, 2001, ADDICTION, V96, P1465, DOI 10.1046/j.1360-0443.2001.9610146510.x; Greenfield SF, 2010, PSYCHIAT CLIN N AM, V33, P339, DOI 10.1016/j.psc.2010.01.004; Grigoryan A., 2009, Morbidity and Mortality Weekly Report, V58, P1291; Habarta NM, 2010, COMMUNICATION; Hall HI, 2006, ANN EPIDEMIOL, V16, P824, DOI 10.1016/j.annepidem.2006.01.009; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Hickman M, 2003, J URBAN HEALTH, V80, P274, DOI 10.1093/jurban/jtg030; Hickman M, 1999, ADDICTION, V94, P1653, DOI 10.1046/j.1360-0443.1999.941116534.x; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; Joint United Nations Program on HIV/AIDS, 2007, RED HIV STIGM DISCR; Jones CM, DRUG ALCOHO IN PRESS; Kaplan GA, 1996, BRIT MED J, V312, P999; Kelly JF, 2010, INT J DRUG POLICY, V21, P202, DOI 10.1016/j.drugpo.2009.10.010; Khan MR, 2008, ANN EPIDEMIOL, V18, P403, DOI 10.1016/j.annepidem.2007.12.003; Kimber J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3172; Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Kraus L, 2003, ADDICTION, V98, P471, DOI 10.1046/j.1360-0443.2003.00326.x; Kresina TF, 2011, INT J ENV RES PUB HE, V8, P4102, DOI 10.3390/ijerph8104102; Krusi A, 2010, INT J DRUG POLICY, V21, P4, DOI 10.1016/j.drugpo.2009.08.003; Lanehart R E, 1994, J Subst Abuse, V6, P441, DOI 10.1016/S0899-3289(94)90390-5; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Larson A, 1996, AUST NZ J PUBL HEAL, V20, P493, DOI 10.1111/j.1467-842X.1996.tb01628.x; LARSON A, 1994, SOC SCI MED, V39, P823, DOI 10.1016/0277-9536(94)90044-2; Latkin CA, 2001, J SUBST ABUSE, V13, P89, DOI 10.1016/S0899-3289(01)00070-0; Lert F, 2007, INT J DRUG POLICY, V18, P255, DOI 10.1016/j.drugpo.2007.05.002; LURIE P, 1993, PUBLIC HLTH IMPACT N, V1; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Lynch JW, 1998, AM J PUBLIC HEALTH, V88, P1074, DOI 10.2105/AJPH.88.7.1074; MacKellar DA, 2011, AIDS BEHAV, V15, P788, DOI 10.1007/s10461-010-9813-x; Mallory C, 1999, J Assoc Nurses AIDS Care, V10, P51, DOI 10.1016/S1055-3290(06)60232-X; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Metzger DS, 2010, JAIDS-J ACQ IMM DEF, V55, pS32, DOI 10.1097/QAI.0b013e3181f9c10b; Miller Cari L, 2007, Harm Reduct J, V4, P1, DOI 10.1186/1477-7517-4-1; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Milloy MJ, 2009, AM J PUBLIC HLTH; Montaner JSG, 2010, JAIDS-J ACQ IMM DEF, V55, pS5, DOI 10.1097/QAI.0b013e3181f9c1f0; Morgan O, 2006, INT J EPIDEMIOL, V35, P1579, DOI 10.1093/ije/dyl207; [National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention], 2012, CDC FACT SHEET HIV A; National Institutes of Health HCV Virus Concensus Development Panel, 2002, MAN HCV 2002; NOVICK DM, 1997, SUBSTANCE ABUSE COMP, P534; Nurutdinova Diana, 2011, BMC Res Notes, V4, P126, DOI 10.1186/1756-0500-4-126; Office of Management and Budget, 2000, FED REG, V65, P8228; Ogden J., 2005, COMMON ITS CORE HIV; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Paulozzi LJ, 2007, INJURY PREV, V13, P130, DOI 10.1136/ip.2006.014357; Pezzotti P, 1999, J ACQ IMMUN DEF SYND, V20, P275, DOI 10.1097/00042560-199903010-00010; Pierce TG, 1999, SUBST USE MISUSE, V34, P2095, DOI 10.3109/10826089909039440; Pinkham S., 2007, WOMEN HARM REDUCTION; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Pouget ER, 2012, J URBAN HEALTH, V89, P527, DOI 10.1007/s11524-012-9670-1; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Ritter A, 2006, INT J DRUG POLICY, V17, P453, DOI 10.1016/j.drugpo.2006.09.004; Roberts SCM, 2010, WOMEN HEALTH ISS, V20, P193, DOI 10.1016/j.whi.2010.02.003; SAS, 2002, SAS 9 2; SELIK RM, 1988, AM J PUBLIC HEALTH, V78, P1539, DOI 10.2105/AJPH.78.12.1539; SELIK RM, 1989, AM J PUBLIC HEALTH, V79, P836, DOI 10.2105/AJPH.79.7.836; Sherman SG, 2007, DRUG ALCOHOL DEPEN, V88, P182, DOI 10.1016/j.drugalcdep.2006.10.006; Shoptaw S, 2007, ADDICTION, V102, P130, DOI 10.1111/j.1360-0443.2006.01775.x; Spijkerman IJB, 1996, J CLIN EPIDEMIOL, V49, P1149, DOI 10.1016/0895-4356(96)00180-1; Spire B, 2007, INT J DRUG POLICY, V18, P262, DOI 10.1016/j.drugpo.2006.12.014; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Syed N, 2005, EUR J GASTROEN HEPAT, V15, P901; Tempalski B, 2009, J URBAN HEALTH, V86, P132, DOI 10.1007/s11524-008-9328-1; Tempalski B, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-23; U.S. Census Bureau Population Division Population Distribution Branch, 2005, HIST METR AR DEF; [U.S. Department of Health and Human Services National Center for Health Statistics], 2010, US DEP HLTH HUM SERV, V20; [U.S. Department of Health and Human Services Division of HIV/AIDS Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention], 2006, CDC FACT SHEET NEW E; [U.S. Department of Health and Human Services National Center for Health Statistics], 2009, US DEP HLTH HUM SERV, V20; [U.S. Department of Health and Human Services Division of HIV/AIDS Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention (CDC) Atlanta Georgia], 2009, TECHN NOT HIV SURV R, P22; [U.S. Department of Health and Human Services Division of HIV/AIDS Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention], 2010, POIS US FACT SHEET; [U.S. Department of Health and Human Services National Center for Health Statistics], 2007, US DEP HLTH HUM SERV, V20; [U.S. Department of Health and Human Services Division of HIV/AIDS Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention], 2011, HIV COUNS TEST CDC F; U.S. Department of Health and Human Services National Center for Health Statistics, 2004, MULT CAUS DEATH FIL; UN Office on Drugs and Crime (UNODC), 2006, HIV AIDS PREVENTION; [US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies], 2010, NAT SURV SUBST AB TR; [US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies], 2010, TREATM EP DAT SET 19; [US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies], 2004, UN FAC DAT SET UFDS; [US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Office of Applied Studies], UN FAC DAT SET UFDS; Vanhandel M, 2011, COMMUNICATION; Vlahov D, 2004, J URBAN HEALTH, V81, P14, DOI 10.1093/jurban/jth083; Vong S, 2004, HEPATOLOGY, V39, P476, DOI 10.1002/hep.20049; Wallace R, 1997, BRIT MED J, V314, P1341, DOI 10.1136/bmj.314.7090.1341; Wilton R, 2000, URBAN GEOGR, V21, P586, DOI 10.2747/0272-3638.21.7.586; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165	126	99	99	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64789	10.1371/journal.pone.0064789	http://dx.doi.org/10.1371/journal.pone.0064789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755143	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400025
J	Wang, M; Yang, JX; Chen, XY				Wang, Mo; Yang, Jun-Xing; Chen, Xiao-Yong			Molecular Phylogeny and Biogeography of Percocypris (Cyprinidae, Teleostei)	PLOS ONE			English	Article							TERMINALIA-FRANCHETII COMBRETACEAE; SCHIZOTHORACINE FISHES TELEOSTEI; MULTIPLE SEQUENCE ALIGNMENT; RIBOSOMAL-RNA GENE; STREAM STICKLEBACK; MORPHOLOGICAL DIVERGENCE; CYTOCHROME-B; THREESPINE STICKLEBACK; ADAPTIVE DIVERGENCE; YUNNAN PROVINCE	Fierce predatory freshwater fishes, the species of Percocypris (Cyprinidae, Teleostei) inhabit large rivers or lakes, and have a specific distribution pattern. Only a single species or subspecies occurs in each large-scale drainage basin of the Southeastern Tibetan Plateau. In this study, the molecular phylogenetic relationships for all but one of the described subspecies/species of Percocypris were investigated based on three mitochondrial genes (16S; COI; Cyt b) and one nuclear marker (Rag2). The results of Maximum Likelihood and Bayesian Inference analyses show that Percocypris is a strongly supported monophyletic group and that it is the sister group of Schizothorax. Combined with analyses of morphological characters, our results suggest that Percocypris needs to be reclassified, and we propose that six species be recognized, with corresponding distributions in five main drainages (including one lake). In addition, based on the results of the estimation of divergence times and ancestral drainages, we hypothesize that Percocypris likely originated in the early Miocene from a paleo-connected drainage system containing the contemporary main drainages of the Southeastern Tibetan Plateau. This study suggests that vicariance (due to the uplift of the Tibetan Plateau modifying the large-scale morphologies of drainage basins in the Southeastern Tibetan Plateau) has played an important role in the speciation of the genus. Furthermore, external morphological characters (such as the length of the fins) and an internal trait (the position of pterygiophore) appear to be correlated with different habitats in rivers and the lake.	[Wang, Mo; Yang, Jun-Xing; Chen, Xiao-Yong] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Wang, Mo] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, JX (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	yangjx@mail.kiz.ac.cn; chenxy@mail.kiz.ac.cn			National Natural Science Foundation of China [30870288, 30730017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (No. 30870288, No. 30730017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2005, MOL BIOL EVOL, V22, P691, DOI 10.1093/molbev/msi050; Aguirre WE, 2009, BIOL J LINN SOC, V98, P139, DOI 10.1111/j.1095-8312.2009.01267.x; AMATO G, 1998, PHYLOGENY TIBETAN ST, P245; [Anonymous], 2002, GEOL CHINA; Bart HL, 2010, INT J MOL SCI, V11, P1090, DOI 10.3390/ijms11031090; BEACHAM TD, 1989, T AM FISH SOC, V118, P46, DOI 10.1577/1548-8659(1989)118<0046:AMABGV>2.3.CO;2; Berner D, 2008, J EVOLUTION BIOL, V21, P1653, DOI 10.1111/j.1420-9101.2008.01583.x; Berner D, 2011, J EVOLUTION BIOL, V24, P1975, DOI 10.1111/j.1420-9101.2011.02330.x; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Bohme M., 2003, FOSFARBASE; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; BROOKS DR, 1985, ANN MO BOT GARD, V72, P660, DOI 10.2307/2399219; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Chen PF, 2010, J VERTEBR PALEONTOL, V30, P333, DOI 10.1080/02724631003620930; CHU XL, 1989, FISHES YUNNAN 1, P177; Chu Y.T., 1935, BIOL BULL+, V2, P1, DOI DOI 10.2307/1436747; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Collin H, 2011, MOL ECOL, V20, P4490, DOI 10.1111/j.1365-294X.2011.05284.x; CUI GH, 1990, DONG WU FEN LEI XUE, V15, P118; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drinan TJ, 2012, ECOL FRESHW FISH, V21, P420, DOI 10.1111/j.1600-0633.2012.00561.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang XM, 2002, SCI CHINA SER D, V45, P289, DOI 10.1360/02yd9031; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Franssen NR, 2011, EVOL APPL, V4, P791, DOI 10.1111/j.1752-4571.2011.00200.x; Guo XG, 2005, MOL PHYLOGENET EVOL, V35, P344, DOI 10.1016/j.ympev.2004.12.015; Haas TC, 2010, BIOL LETTERS, V6, P803, DOI 10.1098/rsbl.2010.0401; Harris PM, 2001, MOL PHYLOGENET EVOL, V20, P225, DOI 10.1006/mpev.2001.0980; He DK, 2007, CHINESE SCI BULL, V52, P777, DOI 10.1007/s11434-007-0123-2; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; He DK, 2004, CHINESE SCI BULL, V49, P39, DOI 10.1360/03wc0212; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Hendry AP, 2011, J EVOLUTION BIOL, V24, P23, DOI 10.1111/j.1420-9101.2010.02155.x; Hendry AP, 2002, EVOLUTION, V56, P1199; Hendry AP, 2004, EVOLUTION, V58, P2319; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kaeuffer R, 2012, EVOLUTION, V66, P402, DOI 10.1111/j.1558-5646.2011.01440.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kottelat Maurice, 2001, pi; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langerhans RB, 2003, BIOL J LINN SOC, V80, P689, DOI 10.1111/j.1095-8312.2003.00266.x; LAVIN PA, 1993, CAN J ZOOL, V71, P11, DOI 10.1139/z93-003; Levin BA, 2012, MOL PHYLOGENET EVOL, V62, P542, DOI 10.1016/j.ympev.2011.09.004; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li JB, 2008, MOL PHYLOGENET EVOL, V47, P472, DOI 10.1016/j.ympev.2007.09.012; Liu J, 2009, SCI CHINA SER D, V52, P189, DOI 10.1007/s11430-009-0022-2; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031453; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; McGuigan K, 2003, EVOLUTION, V57, P104; Ming Q.Z., 2006, YUNNAN GEOG ENV RES, V18, P1, DOI [10.3969/j.issn.1001-7852.2006.04.001, DOI 10.3969/J.ISSN.1001-7852.2006.04.001]; Nanjing Institute of Geography and Limnology CAS Lanzhou Institute of Geology CAS Institute of Geochemistry CAS Nanjing Institute of Geology and Paleontology CAS, 1989, ENV SED FAULT LAK YU; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pavey SA, 2010, T AM FISH SOC, V139, P1584, DOI 10.1577/T09-182.1; Pellegrin J., 1936, B SOC ZOOLOGIQUE FRA, V61, P375; Peng ZG, 2006, MOL PHYLOGENET EVOL, V39, P568, DOI 10.1016/j.ympev.2005.10.016; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Rambaut A., 2007, TRACER V1 5; REIMCHEN TE, 1985, CAN J ZOOL, V63, P2944, DOI 10.1139/z85-441; Ripplinger J, 2008, SYST BIOL, V57, P76, DOI 10.1080/10635150801898920; Roesma Dewi Imelda, 2011, Biodiversitas, V12, P141; Ruber L, 2004, MOL PHYLOGENET EVOL, V32, P1010, DOI 10.1016/j.ympev.2004.04.020; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schonhuth S, 2012, ZOOTAXA, P281, DOI 10.11646/zootaxa.3586.1.27; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAN XH, 2000, FAUNA SINICA OSTEICH, P47; Sharpe DMT, 2008, EVOL ECOL RES, V10, P849; Shi Y.F., 1999, ACTA GEOGRAPH SIN, V54, P10, DOI DOI 10.1007/S11295-016-0968-0; SUN HL, 1996, SCI MONOGRAPHIC SERI, P104; SWAIN DP, 1989, CAN J FISH AQUAT SCI, V46, P1406, DOI 10.1139/f89-180; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Tao WJ, 2013, MOL PHYLOGENET EVOL, V66, P603, DOI 10.1016/j.ympev.2012.09.024; Taylor EB, 2011, EVOL APPL, V4, P100, DOI 10.1111/j.1752-4571.2010.00136.x; Tchang T. L., 1935, Bulletin of the Fan Memorial Institute of Biology Zool Ser, V6, P60; TCHANG TCHUNG-LIN, 1930, BULL MUS NATION HIST NAT [PARIS], V2, P84; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsigenopoulos CS, 2003, BIOL J LINN SOC, V80, P207, DOI 10.1046/j.1095-8312.2003.00237.x; VOGLER AP, 1994, CONSERV BIOL, V8, P354, DOI 10.1046/j.1523-1739.1994.08020354.x; Wang XZ, 2007, MOL PHYLOGENET EVOL, V42, P157, DOI 10.1016/j.ympev.2006.06.014; WU XW, 1977, ZHONGGUO YULEI ZHI, P265; XiangHui K, 2007, SCI CHINA SER C, V50, P780, DOI 10.1007/s11427-007-0076-3; Yang J, 2012, J ZOOL SYST EVOL RES, V50, P184, DOI 10.1111/j.1439-0469.2012.00661.x; Yang ZH, 1996, J MOL EVOL, V42, P587, DOI 10.1007/BF02352289; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zhang TC, 2011, J PLANT RES, V124, P63, DOI 10.1007/s10265-010-0360-3; Zhao Xitao, 2011, Dizhi Xuebao, V85, P1963; ZHAO Y, 2009, ENDEMIC FISHES SINOC, P255; Zwickl D., 2006, GARLI GENETIC ALGORI	98	15	17	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e61827	10.1371/journal.pone.0061827	http://dx.doi.org/10.1371/journal.pone.0061827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750199	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900001
J	Gvozdik, L; Cernicka, E; Van Damme, R				Gvozdik, Lumir; Cernicka, Eva; Van Damme, Raoul			Predator-Prey Interactions Shape Thermal Patch Use in a Newt Larvae-Dragonfly Nymph Model	PLOS ONE			English	Article							COST-BENEFIT MODEL; HABITAT SELECTION; VERTICAL MIGRATION; TEMPERATURE; THERMOREGULATION; PLASTICITY; BEHAVIOR; GAMES; HEAT; RISK	Thermal quality and predation risk are considered important factors influencing habitat patch use in ectothermic prey. However, how the predator's food requirement and the prey's necessity to avoid predation interact with their respective thermoregulatory strategies remains poorly understood. The recently developed 'thermal game model' predicts that in the face of imminent predation, prey should divide their time equally among a range of thermal patches. In contrast, predators should concentrate their hunting activities towards warmer patches. In this study, we test these predictions in a laboratory setup and an artificial environment that mimics more natural conditions. In both cases, we scored thermal patch use of newt larvae (prey) and free-ranging dragonfly nymphs (predators). Similar effects were seen in both settings. The newt larvae spent less time in the warm patch if dragonfly nymphs were present. The patch use of the dragonfly nymphs did not change as a function of prey availability, even when the nymphs were starved prior to the experiment. Our behavioral observations partially corroborate predictions of the thermal game model. In line with asymmetric fitness pay-offs in predator-prey interactions (the 'life-dinner' principle), the prey's thermal strategy is more sensitive to the presence of predators than vice versa.	[Gvozdik, Lumir; Cernicka, Eva] Inst Vertebrate Biol AS CR, Brno, Czech Republic; [Van Damme, Raoul] Univ Antwerp, Dept Biol, Antwerp, Belgium	Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; University of Antwerp	Gvozdik, L (corresponding author), Inst Vertebrate Biol AS CR, Brno, Czech Republic.	gvozdik@brno.cas.cz	Gvoždík, Lumír/G-1178-2014	Gvoždík, Lumír/0000-0002-6495-2233; Van Damme, Raoul/0000-0002-4585-6940	Czech Science Foundation [P506/10/2170];  [RVO:68081766]	Czech Science Foundation(Grant Agency of the Czech Republic); 	This study was funded by a grant from the Czech Science Foundation (P506/10/2170) and institutional support (RVO:68081766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Bates D, 2012, LINEAR MIXED EFFECTS; BEITINGER TL, 1975, J FISH RES BOARD CAN, V32, P2133, DOI 10.1139/f75-251; BEUCHAT CA, 1987, ECOL MONOGR, V57, P45, DOI 10.2307/1942638; Bouskila A, 1998, EVOL ECOL, V12, P701, DOI 10.1023/A:1006585516023; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Crawley M.J., 2007, R BOOK; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Downes S, 1998, ANIM BEHAV, V55, P1387, DOI 10.1006/anbe.1997.0705; Downes S, 2001, ECOLOGY, V82, P2870, DOI 10.2307/2679967; Dvorak J, 2010, EVOL ECOL, V24, P1115, DOI 10.1007/s10682-010-9355-8; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; GLIWICZ MZ, 1986, NATURE, V320, P746, DOI 10.1038/320746a0; Gvozdik L, 2002, CAN J ZOOL, V80, P479, DOI 10.1139/SZ02-015; Herczeg G, 2008, OECOLOGIA, V155, P1, DOI 10.1007/s00442-007-0886-9; Hirvonen H, 1999, OIKOS, V86, P443, DOI 10.2307/3546649; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; HUGIE DM, 1994, J FISH BIOL, V45, P151, DOI 10.1111/j.1095-8649.1994.tb01090.x; Johnston I, 2006, COMP DEV PHYSL, P124; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; KRAMER DL, 1988, CAN J ZOOL, V66, P89, DOI 10.1139/z88-012; Kurdikova V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023842; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Luttbeg B, 2004, ISR J ZOOL, V50, P233, DOI 10.1560/L6QV-UA5T-RDR7-L7QG; Marek V, 2012, J ETHOL, V30, P35, DOI 10.1007/s10164-011-0287-8; Melville J, 2002, ECOL LETT, V5, P386, DOI 10.1046/j.1461-0248.2002.00328.x; Merakova E, 2009, FUNCT ECOL, V23, P989, DOI 10.1111/j.1365-2435.2009.01588.x; Mitchell WA, 2009, FUNCT ECOL, V23, P510, DOI 10.1111/j.1365-2435.2009.01542.x; Nonacs P, 2001, BEHAV ECOL, V12, P71, DOI 10.1093/oxfordjournals.beheco.a000381; Orizaola G, 2005, FRESHWATER BIOL, V50, P438, DOI 10.1111/j.1365-2427.2005.01332.x; Polo V, 2005, EVOL ECOL RES, V7, P23; R Core Team, 2021, R LANG ENV STAT COMP; Schmidt BR, 2005, J EVOLUTION BIOL, V18, P415, DOI 10.1111/j.1420-9101.2004.00822.x; Sih Andrew, 2005, P240; Sih Andrew, 1998, P221; Smolinsky R, 2009, J ZOOL, V279, P180, DOI 10.1111/j.1469-7998.2009.00603.x; Smolinsky R, 2013, BIOL J LINN SOC, V108, P109, DOI 10.1111/j.1095-8312.2012.02004.x; Smolinsky R, 2012, OECOLOGIA, V170, P47, DOI 10.1007/s00442-012-2283-2; STICH HB, 1981, NATURE, V293, P396, DOI 10.1038/293396a0; Tattersall GJ, 2012, J EXP BIOL, V215, P1892, DOI 10.1242/jeb.065946; Turcotte MM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001332; Van Buskirk J, 2000, ECOLOGY, V81, P3009, DOI 10.1890/0012-9658(2000)081[3009:PIPPIL]2.0.CO;2; Venables W.N., 2002, MODERN APPL STAT S; Vickers M, 2011, AM NAT, V177, P452, DOI 10.1086/658150	48	7	7	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65079	10.1371/journal.pone.0065079	http://dx.doi.org/10.1371/journal.pone.0065079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755175	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300046
J	Zhao, HL; Yoshida, A; Xiao, W; Ologunde, R; O'Dea, KP; Takata, M; Tralau-Stewart, C; George, AJT; Ma, DQ				Zhao, Hailin; Yoshida, Akira; Xiao, Wei; Ologunde, Rele; O'Dea, Kieran P.; Takata, Masao; Tralau-Stewart, Catherine; George, Andrew J. T.; Ma, Daqing			Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats	FASEB JOURNAL			English	Article						acute rejection; renoprotection	ISCHEMIA-REPERFUSION INJURY; DELAYED GRAFT FUNCTION; KIDNEY-TRANSPLANTATION; HEME OXYGENASE-1; ACUTE REJECTION; ISCHEMIA/REPERFUSION INJURY; NEONATAL ASPHYXIA; ANESTHESIA; SURVIVAL; MECHANISMS	Prolonged hypothermic storage elicits severe ischemia-reperfusion injury (IRI) to renal grafts, contributing to delayed graft function (DGF) and episodes of acute immune rejection and shortened graft survival. Organoprotective strategies are therefore needed for improving long-term transplant outcome. The aim of this study is to investigate the renoprotective effect of xenon on early allograft injury associated with prolonged hypothermic storage. Xenon exposure enhanced the expression of heat-shock protein 70 (HSP-70) and heme oxygenase 1 (HO-1) and promoted cell survival after hypothermia-hypoxia insult in human proximal tubular (HK-2) cells, which was abolished by HSP-70 or HO-1 siRNA. In the brown Norway to Lewis rat renal transplantation, xenon administered to donor or recipient decreased the renal tubular cell death, inflammation, and MHC II expression, while delayed graft function (DGF) was therefore reduced. Pathological changes associated with acute rejection, including T-cell, macrophage, and fibroblast infiltration, were also decreased with xenon treatment. Donors or recipients treated with xenon in combination with cyclosporin A had prolonged renal allograft survival. Xenon protects allografts against delayed graft function, attenuates acute immune rejection, and enhances graft survival after prolonged hypothermic storage. Furthermore, xenon works additively with cyclosporin A to preserve post-transplant renal function.Zhao, H., Yoshida, A., Xiao, W., Ologunde, R., O'Dea, K. P., Takata, M., Tralau-Stewart, C., George, A. J. T., Ma, D. Xenon treatment attenuates early renal allograft injury associated with prolonged hypothermic storage in rats.	[Zhao, Hailin; Yoshida, Akira; Xiao, Wei; Ologunde, Rele; O'Dea, Kieran P.; Takata, Masao; Ma, Daqing] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Sect Anaesthet Pain Med & Intens Care, Fac Med,Chelsea & Westminster Hosp, London, England; [Xiao, Wei] Capital Med Univ, Dept Anaesthesiol, Xuanwu Hosp, Beijing, Peoples R China; [Tralau-Stewart, Catherine] Univ London Imperial Coll Sci Technol & Med, Ctr Drug Discovery, Dept Med, London, England; [George, Andrew J. T.] Univ London Imperial Coll Sci Technol & Med, Sect Mol Immunol, Dept Med, Hammersmith Hosp, London, England	Imperial College London; Capital Medical University; Imperial College London; Imperial College London	Ma, DQ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Sect Anaesthet Pain Med & Intens Care, Fac Med,Chelsea & Westminster Hosp, London, England.	d.ma@imperial.ac.uk	Ma, Daqing/GLT-2735-2022	Ma, Daqing/0000-0003-1235-0537; Yoshida, Akira/0000-0003-3590-1637; George, Andrew/0000-0002-2866-0241; Ma, Daqing/0000-0002-0688-2097; Ologunde, Rele/0000-0002-1203-8327	British Medical Research Council (MRC) Developmental Pathway Funding Scheme (DPFS) program [G802392]; MRC [G0802392] Funding Source: UKRI; Medical Research Council [G0802392] Funding Source: researchfish	British Medical Research Council (MRC) Developmental Pathway Funding Scheme (DPFS) program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the British Medical Research Council (MRC) Developmental Pathway Funding Scheme (DPFS) program (project grant G802392). The authors declare no conflicts of interest.	Abraini JH, 2005, ANN NY ACAD SCI, V1053, P289, DOI 10.1196/annals.1344.025; Asderakis A, 2001, TRANSPLANTATION, V72, P674, DOI 10.1097/00007890-200108270-00020; Bilolo KK, 2003, TRANSPLANTATION, V75, P1881, DOI 10.1097/01.TP.0000064710.78335.D3; Blydt-Hansen TD, 2003, J AM SOC NEPHROL, V14, P745, DOI 10.1097/01.ASN.0000050760.87113.25; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Giffard RG, 2004, J NEUROSURG ANESTH, V16, P53, DOI 10.1097/00008506-200401000-00010; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Jevnikar AM, 2008, CLIN J AM SOC NEPHRO, V3, pS56, DOI 10.2215/CJN.03040707; Jurewicz M, 2010, J IMMUNOL, V184, P2939, DOI 10.4049/jimmunol.0901889; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Kuboki S, 2007, AM J PHYSIOL-GASTR L, V292, pG1141, DOI 10.1152/ajpgi.00491.2006; Kumar S, 2009, J AM SOC NEPHROL, V20, P2412, DOI 10.1681/ASN.2008080868; LACHMANN B, 1990, LANCET, V335, P1413; Lepore DA, 2001, CELL STRESS CHAPERON, V6, P93, DOI 10.1379/1466-1268(2001)006<0093:ROPSAH>2.0.CO;2; Li C, 2009, NAT REV NEPHROL, V5, P513, DOI 10.1038/nrneph.2009.113; Lockwood GG, 2006, ANESTHESIOLOGY, V104, P458, DOI 10.1097/00000542-200603000-00012; Lu CY, 1999, KIDNEY INT, V55, P2157, DOI 10.1046/j.1523-1755.1999.00491.x; Lynch C, 2000, ANESTHESIOLOGY, V92, P865, DOI 10.1097/00000542-200003000-00031; Ma D, 2002, BRIT J ANAESTH, V89, P739, DOI 10.1093/bja/aef258; Ma DQ, 2009, J AM SOC NEPHROL, V20, P713, DOI 10.1681/ASN.2008070712; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Mikhalski D, 2008, TRANSPLANTATION, V85, pS3, DOI 10.1097/TP.0b013e318169c29e; Moeller S, 2002, NEPHROL DIAL TRANSPL, V17, P2071, DOI 10.1093/ndt/17.12.2071; Pagel PS, 2010, J CARDIOTHOR VASC AN, V24, P143, DOI 10.1053/j.jvca.2009.03.016; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rawat S, 2010, ANESTH ANALG, V110, P101, DOI 10.1213/ANE.0b013e3181be0e17; Sanders RD, 2004, BRIT MED BULL, V71, P115, DOI 10.1093/bmb/ldh034; Sheikh SZ, 2011, J IMMUNOL, V186, P5506, DOI 10.4049/jimmunol.1002433; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; Tantravahi J, 2007, ANNU REV MED, V58, P369, DOI 10.1146/annurev.med.58.061705.145143; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048	40	26	28	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4076	4088		10.1096/fj.13-232173	http://dx.doi.org/10.1096/fj.13-232173			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23759444	Bronze			2022-12-25	WOS:000329747100020
J	Fujieda, N; Yabuta, S; Ikeda, T; Oyama, T; Muraki, N; Kurisu, G; Itoh, S				Fujieda, Nobutaka; Yabuta, Shintaro; Ikeda, Takuya; Oyama, Takuji; Muraki, Norifumi; Kurisu, Genji; Itoh, Shinobu			Crystal Structures of Copper-depleted and Copper-bound Fungal Pro-tyrosinase INSIGHTS INTO ENDOGENOUS CYSTEINE-DEPENDENT COPPER INCORPORATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Copper; Copper Transport; Post-translational Modification; Protein Cross-linking; Tyrosinase; Copper Chaperone; Protein-derived Cofactor; Zymogen	MECHANISM; RECOGNITION; PROTEIN; CLONING; OXIDASE; GENE	Tyrosinase, a dinuclear copper monooxygenase/oxidase, plays a crucial role in the melanin pigment biosynthesis. The structure and functions of tyrosinase have so far been studied extensively, but the post-translational maturation process from the pro-form to the active form has been less explored. In this study, we provide the crystal structures of Aspergillus oryzae full-length pro-tyrosinase in the holo- and the apo-forms at 1.39 and 2.05 resolution, respectively, revealing that Phe(513) on the C-terminal domain is accommodated in the substrate-binding site as a substrate analog to protect the dicopper active site from substrate access (proteolytic cleavage of the C-terminal domain or deformation of the C-terminal domain by acid treatment transforms the pro-tyrosinase to the active enzyme (Fujieda, N., Murata, M., Yabuta, S., Ikeda, T., Shimokawa, C., Nakamura, Y., Hata, Y., and Itoh, S. (2012) ChemBioChem. 13, 193-201 and Fujieda, N., Murata, M., Yabuta, S., Ikeda, T., Shimokawa, C., Nakamura, Y., Hata, Yl, and Itoh, S. (2013) J. Biol. Inorg. Chem. 18, 19-26). Detailed crystallographic analysis and structure-based mutational studies have shown that the copper incorporation into the active site is governed by three cysteines as follows: Cys(92), which is covalently bound to His(94) via an unusual thioether linkage in the holo-form, and Cys(522) and Cys(525) of the CXXC motif located on the C-terminal domain. Molecular mechanisms of the maturation processes of fungal tyrosinase involving the accommodation of the dinuclear copper unit, the post-translational His-Cys thioether cross-linkage formation, and the proteolytic C-terminal cleavage to produce the active tyrosinase have been discussed on the basis of the detailed structural information.	[Fujieda, Nobutaka; Yabuta, Shintaro; Ikeda, Takuya; Itoh, Shinobu] Osaka Univ, Grad Sch Engn, Div Adv Sci & Biotechnol, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan; [Oyama, Takuji; Muraki, Norifumi; Kurisu, Genji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kurisu, G (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamada Oka, Suita, Osaka 5650871, Japan.	gkurisu@protein.osaka-u.ac.jp; shinobu@mls.eng.osaka-u.ac.jp	Fujieda, Nobutaka/AED-3193-2022; Itoh, Shinobu/AAF-4038-2020; KURISU, GENJI/ABA-5960-2020; Muraki, Norifumi/AAW-2540-2020; KURISU, GENJI/AAD-7109-2022	Fujieda, Nobutaka/0000-0003-1045-6063; KURISU, GENJI/0000-0002-5354-0807; Muraki, Norifumi/0000-0003-4112-2955; KURISU, GENJI/0000-0002-5354-0807; Oyama, Takuji/0000-0002-3411-7608	Ministry of Education, Culture, Sports, Science and Technology. Japan [22105007, 20038784]; Grants-in-Aid for Scientific Research [22105007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology. Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research on Innovative Areas (Molecular Activation Directed toward Straightforward Synthesis) 22105007 (to S. I.) and Grant-in-aid for Challenging Exploratory Research 20038784 from the Ministry of Education, Culture, Sports, Science and Technology. Japan (to N. F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Davis AV, 2008, NAT CHEM BIOL, V4, P148, DOI 10.1038/nchembio0308-148; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flurkey WH, 2008, J INORG BIOCHEM, V102, P2160, DOI 10.1016/j.jinorgbio.2008.08.007; Fujieda N, 2012, CHEMBIOCHEM, V13, P193, DOI 10.1002/cbic.201100609; Fujieda N, 2011, J AM CHEM SOC, V133, P1180, DOI 10.1021/ja108280w; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Halaouli S, 2006, APPL MICROBIOL BIOT, V70, P580, DOI 10.1007/s00253-005-0109-4; HAZES B, 1993, PROTEIN SCI, V2, P597; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; ITOH S, 2004, COMPREHENSIVE COORDI, V8, P369; Itoh S, 2007, ACCOUNTS CHEM RES, V40, P592, DOI 10.1021/ar6000395; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARLIN KD, 1993, SCIENCE, V261, P701, DOI 10.1126/science.7688141; Kawamura-Konishi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1752, DOI 10.1271/bbb.70171; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; KUPPER U, 1989, J BIOL CHEM, V264, P17250; Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Matoba Y, 2011, J BIOL CHEM, V286, P30219, DOI 10.1074/jbc.M111.256818; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Sendovski M, 2011, J MOL BIOL, V405, P227, DOI 10.1016/j.jmb.2010.10.048; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yike I, 2011, MYCOPATHOLOGIA, V171, P299, DOI 10.1007/s11046-010-9386-2	32	54	54	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22128	22140		10.1074/jbc.M113.477612	http://dx.doi.org/10.1074/jbc.M113.477612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23749993	hybrid, Green Published			2022-12-25	WOS:000328841900056
J	Lloyd, SJA; Raychaudhuri, S; Espenshade, PJ				Lloyd, S. Julie-Ann; Raychaudhuri, Sumana; Espenshade, Peter J.			Subunit Architecture of the Golgi Dsc E3 Ligase Required for Sterol Regulatory Element-binding Protein (SREBP) Cleavage in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSATURATED FATTY-ACIDS; UBIQUITIN; DISLOCATION; CDC48; UBXD8; DEGRADATION; MACHINERY; DERLIN-1; REVEALS; DOMAINS	The membrane-bound sterol regulatory element-binding protein (SREBP) transcription factors regulate lipogenesis in mammalian cells and are activated through sequential cleavage by the Golgi-localized Site-1 and Site-2 proteases. The mechanism of fission yeast SREBP cleavage is less well defined and, in contrast, requires the Golgi-localized Dsc E3 ligase complex. The Dsc E3 ligase consists of five integral membrane subunits, Dsc1 through Dsc5, and resembles membrane E3 ligases that function in endoplasmic reticulum-associated degradation. Using immunoprecipitation assays and blue native electrophoresis, we determined the subunit architecture for the complex of Dsc1 through Dsc5, showing that the Dsc proteins form sub-complexes and display defined connectivity. Dsc2 is a rhomboid pseudoprotease family member homologous to mammalian UBAC2 and a central component of the Dsc E3 ligase. We identified conservation in the architecture of the Dsc E3 ligase and the multisubunit E3 ligase gp78 in mammals. Specifically, Dsc1-Dsc2-Dsc5 forms a complex resembling gp78-UBAC2-UBXD8. Further characterization of Dsc2 revealed that its C-terminal UBA domain can bind to ubiquitin chains but that the Dsc2 UBA domain is not essential for yeast SREBP cleavage. Based on the ability of rhomboid superfamily members to bind transmembrane proteins, we speculate that Dsc2 functions in SREBP recognition and binding. Homologs of Dsc1 through Dsc4 are required for SREBP cleavage and virulence in the human opportunistic pathogen Aspergillus fumigatus. Thus, these studies advance our organizational understanding of multisubunit E3 ligases involved in endoplasmic reticulum-associated degradation and fungal pathogenesis.	[Lloyd, S. Julie-Ann; Raychaudhuri, Sumana; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu		Raychaudhuri, Sumana/0000-0002-3164-0057	National Institutes of Health [R01 HL077588, F31 HL097668]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588, F31HL097668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL077588 (to P. J. E.) and F31 HL097668 (S. J. L.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lee JN, 2010, P NATL ACAD SCI USA, V107, P21424, DOI 10.1073/pnas.1011859107; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Lemberg MK, 2013, TRENDS CELL BIOL, V23, P210, DOI 10.1016/j.tcb.2013.01.002; Matta-Camacho E, 2009, J MOL BIOL, V386, P569, DOI 10.1016/j.jmb.2008.09.086; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Olzmann JA, 2012, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A013185; Olzmann JA, 2013, P NATL ACAD SCI USA, V110, P1345, DOI 10.1073/pnas.1213738110; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Porter JR, 2010, J BIOL CHEM, V285, P41051, DOI 10.1074/jbc.M110.144337; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Suzuki M, 2012, MOL BIOL CELL, V23, P800, DOI 10.1091/mbc.E11-11-0950; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Tse MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028511; Willger SD, 2012, EUKARYOT CELL, V11, P1557, DOI 10.1128/EC.00252-12; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047; Ziegler FD, 1999, GLYCOBIOLOGY, V9, P497, DOI 10.1093/glycob/9.5.497; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	42	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21043	21054		10.1074/jbc.M113.468215	http://dx.doi.org/10.1074/jbc.M113.468215			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760507	hybrid, Green Published			2022-12-25	WOS:000322014400025
J	Tsutsui, T; Fukasawa, R; Shinmyouzu, K; Nakagawa, R; Tobe, K; Tanaka, A; Ohkuma, Y				Tsutsui, Taiki; Fukasawa, Rikiya; Shinmyouzu, Kaori; Nakagawa, Reiko; Tobe, Kazuyuki; Tanaka, Aki; Ohkuma, Yoshiaki			Mediator Complex Recruits Epigenetic Regulators via Its Two Cyclin-dependent Kinase Subunits to Repress Transcription of Immune Response Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; BINDING PROTEIN-BETA; REPEAT DOMAIN; CDK8; C/EBP; EXPRESSION; METHYLATION; ACTIVATION; RECEPTOR; PRMT5	The Mediator complex (Mediator) plays pivotal roles in activating transcription by RNA polymerase II, but relatively little is known about its roles in repression. Here, we identified the histone arginine methyltransferase PRMT5 and WD repeat protein 77/methylosome protein 50 (WDR77/MEP50) as Mediator cyclin-dependent kinase (CDK)-interacting proteins and studied the roles of PRMT5 in the transcriptional regulation of CCAAT enhancer-binding protein (C/EBP) beta target genes. First, we purified CDK8- and CDK19-containing complexes from HeLa nuclear extracts and subjected these purified complexes to mass spectrometric analyses. These experiments revealed that two Mediator CDKs, CDK8 and CDK19, individually interact with PRMT5 and WDR77, and their interactions with PRMT5 cause transcriptional repression of C/EBP beta target genes by regulating symmetric dimethylation of histone H4 arginine 3 (H4R3me2s) in the promoter regions of those genes. Furthermore, the recruitment of the DNA methyltransferase DNMT3A correlated with H4R3 dimethylation potentially leading to DNA methylation at the promoter proximal region and tight inhibition of preinitiation complex formation. In vertebrates, C/EBP beta regulates many genes involved in immune responses and cell differentiation. These findings shed light on the molecular mechanisms of the repressive roles of Mediator CDKs in transcription of C/EBP beta target genes and might provide clues that enable future studies of the functional associations between Mediators and epigenetic regulation.	[Tsutsui, Taiki; Fukasawa, Rikiya; Tanaka, Aki; Ohkuma, Yoshiaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, Toyama 9300194, Japan; [Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 9300194, Japan; [Shinmyouzu, Kaori; Nakagawa, Reiko] RIKEN Ctr Dev Biol, Mass Spectrometry Anal Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of Toyama; University of Toyama; RIKEN	Ohkuma, Y (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, 2630 Sugitani, Toyama 9300194, Japan.	ohkumay@pha.u-toyama.ac.jp	Nakagawa, Reiko/C-4214-2017	Nakagawa, Reiko/0000-0002-6178-2945; Tsutsui, Taiki/0000-0002-9793-4402	National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science	National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants from the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology (to Y.O.) and from the Japan Society for the Promotion of Science through "Research Fellowships for Young Scientists" (to T.T.).	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Furumoto T, 2007, GENES CELLS, V12, P119, DOI 10.1111/j.1365-2443.2007.01036.x; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2008, J BIOL CHEM, V283, P13077, DOI 10.1074/jbc.M800604200; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Meyer KD, 2008, EMBO J, V27, P1447, DOI 10.1038/emboj.2008.78; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; NONET ML, 1989, GENETICS, V123, P715; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tsutsui T, 2008, GENES CELLS, V13, P817, DOI 10.1111/j.1365-2443.2008.01208.x; Tsutsui T, 2011, GENES CELLS, V16, P1208, DOI 10.1111/j.1365-2443.2011.01565.x; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; Xu XJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-396; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033	59	54	66	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20955	20965		10.1074/jbc.M113.486746	http://dx.doi.org/10.1074/jbc.M113.486746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23749998	hybrid, Green Published			2022-12-25	WOS:000322014400018
J	Alvarez-Gallardo, H; Kjelland, ME; Moreno, JF; Welsh, TH; Randel, RD; Lammoglia, MA; Perez-Martinez, M; Lara-Sagahon, AV; Esperon-Sumano, E; Romo, S				Alvarez-Gallardo, Horacio; Kjelland, Michael E.; Moreno, Juan F.; Welsh, Thomas H., Jr.; Randel, Ronald D.; Lammoglia, Miguel A.; Perez-Martinez, Mario; Lara-Sagahon, Alma V.; Esperon-Sumano, Enrique; Romo, Salvador			Gamete Therapeutics: Recombinant Protein Adsorption by Sperm for Increasing Fertility via Artificial Insemination	PLOS ONE			English	Article							HEPARIN-BINDING PROTEINS; SEMINAL PLASMA-PROTEINS; SPERMATOZOA; BULLS	A decrease in fertility can have a negative economic impact, both locally and over a broader geographical scope, and this is especially the case with regard to the cattle industry. Therefore, much interest exists in evaluating proteins that might be able to increase the fertility of sperm. Heparin binding proteins (HBPs), specifically the fertility associated antigen (FAA) and the Type-2 tissue inhibitor of metalloproteinase (TIMP-2), act to favor the capacitation and acrosome reaction and perhaps even modulate the immune system's response toward the sperm. The objective of this research was to determine the effect on fertility of adding recombinant FAA (rFAA) and recombinant TIMP-2 (rTIMP-2) to bovine semen before cryopreservation for use in an artificial insemination (AI) program in a tropical environment. For this experiment, 100 crossbred (Bos taurus x Bos indicus) heifers were selected based on their estrus cycle, body condition score (BCS), of 4 to 6 on a scale of 1 to 9, and adequate anatomical conformation evaluated by pelvic and genital (normal) measurements. Heifers were synchronized using estradiol benzoate (EB), Celosil (R) (PGF2 alpha) (Shering-Plough) and a controlled internal drug release (CIDR) device was inserted that contained progesterone. Inseminations were performed in two groups at random, 50 animals per group. The control group was inseminated with conventional semen. The treatment group was inseminated with semen containing rFAA (25 mu g/mL) and rTIMP-2 (25 mu g/mL). In the control group a 16% pregnancy rate was obtained versus a 40% pregnancy rate for the HBP treatment group, resulting in a significant difference (P = 0.0037). Given the results herein, one may conclude that the HBPs can increase fertility and could be an option for cattle in tropical conditions; however, one needs to consider the environment, nutrition, and the genetic interaction affecting the final result in whatever reproductive program that is implemented.	[Alvarez-Gallardo, Horacio] Ctr Nacl Recursos Genet, Inst Nacl Invest Forestales Agr & Pecuarias, Tepatitlan De Morelos, Jalisco, Mexico; [Kjelland, Michael E.] Wayne State Coll, Wayne, NE USA; [Moreno, Juan F.] Sexing Technol, Navasota, TX USA; [Welsh, Thomas H., Jr.] Texas A&M Univ, College Stn, TX USA; [Randel, Ronald D.] Texas A&M AgriLife Res Overton, Overton, TX USA; [Lammoglia, Miguel A.] Univ Veracruzana, Fac Ciencias Biol & Agr, Tuxpan, Veracruz, Mexico; [Perez-Martinez, Mario] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Mexico City 04510, DF, Mexico; [Lara-Sagahon, Alma V.; Esperon-Sumano, Enrique; Romo, Salvador] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Cuautitlan, Estado De Mexic, Mexico	Nebraska State College System; Wayne State College; Texas A&M University System; Texas A&M University College Station; Universidad Veracruzana; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Kjelland, ME (corresponding author), Wayne State Coll, Wayne, NE USA.	mkjelland@hotmail.com	Moreira, Nei/AAK-1357-2020; Randel, Ronald/W-2108-2019	Moreira, Nei/0000-0002-9236-667X; 	Texas A&M University-Conacyt Collaborative Research Grant Program [2009-004]	Texas A&M University-Conacyt Collaborative Research Grant Program	Funding for this research came from the Texas A&M University-Conacyt Collaborative Research Grant Program, Project Nr. 2009-004: Adaptation of Biotechnologies for Reproduction of Cattle in the Tropics (2009-2010), http://vpr.tamu.edu/funding/conacyt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Further, no individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agado BJ, 2011, J ANIM SCI S1, V89, P498; Agresti A, 2007, INTRO CATEGORICAL DA; Alghamdi AS, 2005, BIOL REPROD, V73, P1174, DOI 10.1095/biolreprod.105.045666; Alghamdi AS, 2004, REPRODUCTION, V127, P593, DOI 10.1530/rep.1.00096; Amann RP, 1999, J ANDROL, V20, P42; [Anonymous], 2010, GUID CAR US AGR AN R; Ax RL, 2002, FACTORS AFFECTING CALF CROP: BIOTECHNOLOGY OF REPRODUCTION, P287; Barrios B, 2000, BIOL REPROD, V63, P1531, DOI 10.1095/biolreprod63.5.1531; BELLIN ME, 1994, J ANIM SCI, V72, P2441, DOI 10.2527/1994.7292441x; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; Bo GA, 2003, ANIM REPROD SCI, V78, P307, DOI 10.1016/S0378-4320(03)00097-6; Cutaia LE, 2010, PROGRAMAS SINCRONIZA; Dawson GR, 2005, THESIS ARIZONA U US; Enciclopedia de los Municipios de Mexico, 2010, ENC MUN MEX; Galina CS, 2007, HORM BEHAV, V52, P32, DOI 10.1016/j.yhbeh.2007.03.025; Gene HD, 1992, BEEF CATTLE HDB; Harshan HM, 2006, ANIM REPROD SCI, V93, P124, DOI 10.1016/j.anireprosci.2005.07.010; HERD DB, 1986, EXTENSION B TEXAS A, V1526; KILLIAN GJ, 1993, BIOL REPROD, V49, P1202, DOI 10.1095/biolreprod49.6.1202; Lenz RW, 2011, J ANIM SCI, V89, P383, DOI 10.2527/jas.2010-3056; Lenz RW, 2000, BOVINE FERTILITY ASS; MARKS JL, 1985, J DAIRY SCI, V68, P2078, DOI 10.3168/jds.S0022-0302(85)81070-5; McCauley TC, 1999, MOL REPROD DEV, V54, P145, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;145::AID-MRD6&gt;3.0.CO;2-6; McCauley TC, 1996, J ANIM SCI, V74, P429; McCauley TC, 2001, MOL REPROD DEV, V58, P336, DOI 10.1002/1098-2795(200103)58:3&lt;336::AID-MRD12&gt;3.0.CO;2-Z; MILLER DJ, 1990, BIOL REPROD, V42, P899, DOI 10.1095/biolreprod42.6.899; Mogielnicka-Brzozowska M, 2011, POL J VET SCI, V14, P489, DOI 10.2478/v10181-011-0074-z; Mogielnicka-Brzozowska M, 2011, ACTA BIOCHIM POL, V58, P171; NASS SJ, 1990, MOL REPROD DEV, V25, P237, DOI 10.1002/mrd.1080250305; Nauc V, 2000, BIOL REPROD, V63, P1058, DOI 10.1095/biolreprod63.4.1058; Nikon, 2008, NIS EL BR 3 00; Ordonez-Leon EA, 2012, REPROD FERT DEVELOP, V24, P197, DOI 10.1071/RDv24n1Ab171; R Development Core Team, 2012, R LANG ENV STAT COMP; Rae DO, 2002, FACTORS AFFECTING CALF CROP: BIOTECHNOLOGY OF REPRODUCTION, P7; Rekawiecki R, 2008, J PHYSIOL PHARMACOL, V59, P75; Sprott LR, 2000, J ANIM SCI, V78, P795; TARONE RE, 1985, BIOMETRIKA, V72, P91, DOI 10.1093/biomet/72.1.91; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Waterman R. C., 2010, P GRAZ LIV NUTR C, P93; Zhang H, 2001, PLANT AN GEN 9 C SAN	40	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65083	10.1371/journal.pone.0065083	http://dx.doi.org/10.1371/journal.pone.0065083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762288	gold, Green Published, Green Submitted			2022-12-25	WOS:000320440500023
J	Ryazantsev, S; Tischenko, V; Nguyen, C; Abramov, V; Zav'yalov, V				Ryazantsev, Sergey; Tischenko, Vladimir; Christopher Nguyen; Abramov, Vyacheslav; Zav'yalov, Vladimir			Three-Dimensional Structure of the Human Myeloma IgG2	PLOS ONE			English	Article							HUMAN-IMMUNOGLOBULIN; ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; MONOCLONAL-ANTIBODIES; DISULFIDE ISOMERS; CORE HINGE; RESOLUTION; SUBCLASS; THERAPEUTICS; FLEXIBILITY	Human immunoglobulin G, subclass 2 (hIgG2), plays an important role in immunity to bacterial pathogens and in numerous pathological conditions. However, there is a lack of information regarding the three-dimensional (3D) structure of the hIgG2 molecule. We used electron microscopy (EM), differential scanning microcalorimetry (DSC) and fluorescence for structural analysis of the hIgG2. DSC and fluorescence indicated two types of interaction between C(H)1 domain of Fab (antigen-binding fragment/subunit) and C(H)2 domain of Fc (complement fixation fragment/subunit) simultaneously present in the sample: close interaction, which increases the thermostability of both, C(H)1 and C(H)2 domains, and weak (or no) interaction, which is typical for most IgGs but not hIgG2. Thermodynamics could not determine if both types of interactions are present within a single molecule. To address this question, EM was used. We employed a single-particle reconstruction and negative staining approach to reveal the three-dimensional structure of the hIgG2. A three-dimensional model of hIgG2 was created at 1.78 nm resolution. The hIgG2 is asymmetrical: one Fab subunit is in close proximity to the upper portion of the Fc subunit (C(H)2 domain) and the other Fab is distant from Fc. The plane of Fab subunits is nearly perpendicular to Fc. EM structure of the hIgG2 is in good agreement with thermodynamic data: a Fab distant from Fc should exhibit a lower melting temperature while a Fab interacting with Fc should exhibit a higher melting temperature. Both types of Fab subunits exist within one molecule resembling an A/B hIgG2 isoform introduced earlier on physicochemical level by Dillon et al. (2008). In such an arrangement, the access to the upper portion of Fc subunit is partially blocked by a Fab subunit. That might explain for instance why hIgG2 mildly activates complement and binds poorly to Fc receptors. Understanding of the three-dimensional structure of the hIgG2 should lead to better design of antibody-based therapeutics.	[Ryazantsev, Sergey; Christopher Nguyen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Tischenko, Vladimir] Russian Acad Sci, Inst Theoret & Expt Biophys, Pushchino 142292, Russia; [Abramov, Vyacheslav] Inst Immunol Engn, Lyubuchany, Russia; [Zav'yalov, Vladimir] Univ Turku, Dept Chem, Math & Nat Sci Fac, Joint Biotechnol Lab, Turku, Finland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Theoretical & Experimental Biophysics; University of Turku	Ryazantsev, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	sryazant@ucla.edu	Abramov, Vyacheslav M./AAB-9462-2020	Zav'Yalov, Vladimir/0000-0001-5351-8741; Abramov, Vyacheslav M/0000-0001-6650-3936	European Commission/Research Executive Agency under a Marie Curie International Incoming Fellowship [235538]; Academy of Finland [112900]; Institute of Digital Research and Education, University of California Los Angeles; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	European Commission/Research Executive Agency under a Marie Curie International Incoming Fellowship; Academy of Finland(Academy of Finland); Institute of Digital Research and Education, University of California Los Angeles; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the European Commission/Research Executive Agency under a Marie Curie International Incoming Fellowship (235538) and a grant from the Academy of Finland (112900) to V.Z. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California San Francisco [supported by National Institutes of Health (NIH) P41 RR001081]. This research was supported in part by Institute of Digital Research and Education, University of California Los Angeles through Hoffman2 computing resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Burton DR, 1992, ADV IMMUNOL, V55, P1; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; DAVIES DR, 1975, ANNU REV BIOCHEM, V44, P639, DOI 10.1146/annurev.bi.44.070175.003231; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Frank J, 1996, 3 DIMENSIONAL ELECT, P208; Grassucci RA, 2007, NAT PROTOC, V2, P3239, DOI 10.1038/nprot.2007.452; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Jonsson G, 2006, J IMMUNOL, V177, P722, DOI 10.4049/jimmunol.177.1.722; KLEIN M, 1981, P NATL ACAD SCI-BIOL, V78, P524, DOI 10.1073/pnas.78.1.524; KRATZIN HD, 1989, BIOL CHEM H-S, V370, P263, DOI 10.1515/bchm3.1989.370.1.263; Lai ZZ, 2005, VACCINE, V23, P3264, DOI 10.1016/j.vaccine.2005.01.088; Lightle S, 2010, PROTEIN SCI, V19, P753, DOI 10.1002/pro.352; Liu XY, 2008, IMMUNOL REV, V222, P9, DOI 10.1111/j.1600-065X.2008.00601.x; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; LOSEVA OI, 1986, MOL IMMUNOL, V23, P743, DOI 10.1016/0161-5890(86)90085-4; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Nezlin R, 1990, Adv Immunol, V48, P1, DOI 10.1016/S0065-2776(08)60750-6; Pan Q, 2000, IMMUNOL REV, V178, P99, DOI 10.1034/j.1600-065X.2000.17815.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS ML, 1994, MOL IMMUNOL, V31, P1201, DOI 10.1016/0161-5890(94)90034-5; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Privalov P L, 1986, Methods Enzymol, V131, P4; Rodriguez ME, 1999, J INFECT DIS, V179, P423, DOI 10.1086/314603; Roux KH, 1997, J IMMUNOL, V159, P3372; RYAZANTSEV S, 1990, EUR J BIOCHEM, V190, P393, DOI 10.1111/j.1432-1033.1990.tb15588.x; Ryazantsev S, 2007, FEBS LETT, V581, P1898, DOI 10.1016/j.febslet.2007.03.088; RYAZANTSEV SN, 1989, FEBS LETT, V244, P291, DOI 10.1016/0014-5793(89)80548-4; RYAZANTSEV SN, 1990, FEBS LETT, V275, P221, DOI 10.1016/0014-5793(90)81476-5; Saltz Leonard, 2006, Nat Rev Drug Discov, V5, P987, DOI 10.1038/nrd2204; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SARVAS H, 1990, INT IMMUNOL, V2, P317, DOI 10.1093/intimm/2.4.317; Smith CA, 1984, J ULTRASTRUCT RES, V89, P119; Tischenko VM, 2003, IMMUNOL LETT, V86, P281, DOI 10.1016/S0165-2478(03)00045-2; Tischenko VM, 2003, IMMUNOL LETT, V90, P43, DOI 10.1016/S0165-2478(03)00161-5; Tischenko VM, 1998, BIOCHEMISTRY-US, V37, P5576, DOI 10.1021/bi972647a; Tishchenko VM, 1982, EUR J BIOCHEM, V126, P517; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; van Dijk MA, 2001, CURR OPIN CHEM BIOL, V5, P368, DOI 10.1016/S1367-5931(00)00216-7; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Vasiliev V D, 1979, Methods Enzymol, V59, P612; Wang QA, 2010, J SEP SCI, V33, P2671, DOI 10.1002/jssc.201000230; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200; ZAVYALOV VP, 1991, SCAND J IMMUNOL, V33, P755, DOI 10.1111/j.1365-3083.1991.tb02550.x; Zhou ZH, 2008, CURR OPIN STRUC BIOL, V18, P218, DOI 10.1016/j.sbi.2008.03.004	52	24	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64076	10.1371/journal.pone.0064076	http://dx.doi.org/10.1371/journal.pone.0064076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762236	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800005
J	Chen, J; Ding, JL; Dai, YM; Xing, W; Sun, J; Zhang, ZS; Xuan, Y; Pilli, V; Haacke, EM; Hu, JN				Chen, Jie; Ding, Jiule; Dai, Yongming; Xing, Wei; Sun, Jun; Zhang, Zishu; Xuan, Yang; Pilli, Vasuki; Haacke, E. Mark; Hu, Jiani			Assessment of Intratumoral Micromorphology for Patients with Clear Cell Renal Cell Carcinoma Using Susceptibility-Weighted Imaging	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; HISTOLOGIC SUBTYPES; TUMOR ANGIOGENESIS; SIZE; CALCIFICATION; HEMORRHAGE; EXPERIENCE; MANAGEMENT; GLIOMAS; GRADE	Background: Multiple treatment options exist for the management of renal cell carcinomas. Preoperative evaluation of clear cell renal cell carcinoma (CRCC) grades is important for deciding upon the appropriate method of therapy. We hypothesize that susceptibility weighted imaging (SWI) is sensitive enough to detect intratumoral microvessles and microbleeding in renal cell carcinoma, which can be used to grade CRCC. Material and Methods: Retrospective reviews of 37 patients with pathologically proven CRCCs were evaluated. All patients underwent SWI examinations. The characteristics of intratumoral susceptibility signal intensity (ITSS) includes the likelihood of the presence of ITSS, morphology of ITSS, dominant structure of ITSS and ratio of ITSS area to tumor area, which were all assessed on SWI. The results were compared using the nonparametric Mann-Whitney test. Results: ITSS was seen in all patients except 4 patients with low-grade CRCCs. There was no significant difference between low and high-grade CRCCs when looking at the likelihood of the presence of ITSS. There was a significant difference in the mean score of dominant structures between low and high-grade CRCCs. Specifically, more dominant vascular structures and less hemorrhage were seen in low-grade tumors (2.15 +/- 1.05) compared to high-grade tumors (1.27 +/- 0.47) (P<0.005). The ratio of ITSS area to tumor area was also significantly higher for the high-grade group (1.55 +/- 0.52) than that for the low-grade group (0.88 +/- 0.43) on SWI (P<0.005). Conclusion: SWI is useful for grading CRCCs.	[Chen, Jie; Ding, Jiule; Xing, Wei; Sun, Jun] Suzhou Univ, Affiliated Hosp 3, Dept Radiol, Changzhou, Jiangsu, Peoples R China; [Chen, Jie; Xuan, Yang; Pilli, Vasuki; Haacke, E. Mark; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Dai, Yongming] Siemens Healthcare China, MR Collaborat NE Asia, Shanghai, Peoples R China; [Zhang, Zishu] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA	Wayne State University; Siemens AG; University of Michigan System; University of Michigan	Xing, W (corresponding author), Suzhou Univ, Affiliated Hosp 3, Dept Radiol, Changzhou, Jiangsu, Peoples R China.	suzhxingwei@sina.cn; jhu@med.wayne.edu		Chen, Jie/0000-0002-0110-1706				ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Breen DJ, 2007, CARDIOVASC INTER RAD, V30, P936, DOI 10.1007/s00270-007-9090-x; Chen DYT, 2009, J NATL COMPR CANC NE, V7, P635, DOI 10.6004/jnccn.2009.0044; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036454; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Ficarra V, 2005, CANCER, V103, P68, DOI 10.1002/cncr.20749; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gudbjartsson T, 2005, EUR UROL, V48, P593, DOI 10.1016/j.eururo.2005.04.016; Hori M, 2010, MAGN RESON IMAGING, V28, P594, DOI 10.1016/j.mri.2010.01.002; Kinouchi T, 2003, UROLOGY, V62, P765, DOI 10.1016/S0090-4295(03)00512-0; Kitagawa Y, 2011, JPN J CLIN ONCOL, V41, P637, DOI 10.1093/jjco/hyr007; Lam JS, 2009, INDIAN J UROL, V25, P446, DOI 10.4103/0970-1591.57906; Li XS, 2012, J CANCER RES CLIN, V138, P269, DOI 10.1007/s00432-011-1083-0; Nativ O, 1998, UROLOGY, V51, P693, DOI 10.1016/S0090-4295(98)00019-3; Pahernik S, 2007, J UROLOGY, V178, P414, DOI 10.1016/j.juro.2007.03.129; Park MJ, 2009, AM J NEURORADIOL, V30, P1402, DOI 10.3174/ajnr.A1593; Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055; RECHT L, 1990, J NEUROSURG, V72, P941, DOI 10.3171/jns.1990.72.6.0941; Schachter LR, 2007, J ENDOUROL, V21, P819, DOI 10.1089/end.2006.9937; Song TR, 2012, UROL ANNALS, V4, P24, DOI 10.4103/0974-7796.91617; Sung HH, 2012, INT J HYPERTHER, V28, P227, DOI 10.3109/02656736.2012.666319; Thompson RH, 2009, J UROLOGY, V181, P2033, DOI 10.1016/j.juro.2009.01.027; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Xing W, 2012, PLOS ONE, V8; Zhang C, 2012, BJU INT; Zhu WZ, 2008, CHINESE MED J-PEKING, V121, P2021, DOI 10.1097/00029330-200810020-00014	27	2	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65866	10.1371/journal.pone.0065866	http://dx.doi.org/10.1371/journal.pone.0065866			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755287	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000114
J	Hou, L; Kongsted, AH; Ghoreishi, SM; Takhtsabzy, TK; Friedrichsen, M; Hellgren, LI; Kadarmideen, HN; Vaag, A; Nielsen, MO				Hou, Lei; Kongsted, Anna H.; Ghoreishi, Seyed M.; Takhtsabzy, Tasnim K.; Friedrichsen, Martin; Hellgren, Lars I.; Kadarmideen, Haja N.; Vaag, Allan; Nielsen, Mette O.			Pre- and Early-Postnatal Nutrition Modify Gene and Protein Expressions of Muscle Energy Metabolism Markers and Phospholipid Fatty Acid Composition in a Muscle Type Specific Manner in Sheep	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; SKELETAL-MUSCLE; INSULIN-RESISTANCE; LATE-GESTATION; NUTRIENT RESTRICTION; GROWTH VELOCITY; ADIPOSE-TISSUE; OBESE SUBJECTS; PGC-1-ALPHA; HUMANS	We previously reported that undernutrition in late fetal life reduced whole-body insulin sensitivity in adult sheep, irrespective of dietary exposure in early postnatal life. Skeletal muscle may play an important role in control of insulin action. We therefore studied a range of putative key muscle determinants of insulin signalling in two types of skeletal muscles (longissimus dorsi (LD) and biceps femoris (BF)) and in the cardiac muscle (ventriculus sinister cordis (VSC)) of sheep from the same experiment. Twin-bearing ewes were fed either 100% (NORM) or 50% (LOW) of their energy and protein requirements during the last trimester of gestation. From day-3 postpartum to 6-months of age (around puberty), twin offspring received a high-carbohydrate-high-fat (HCHF) or a moderate-conventional (CONV) diet, whereafter all males were slaughtered. Females were subsequently raised on a moderate diet and slaughtered at 2-years of age (young adults). The only long-term consequences of fetal undernutrition observed in adult offspring were lower expressions of the insulin responsive glucose transporter 4 (GLUT4) protein and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC1 alpha) mRNA in BF, but increased PGC1a expression in VSC. Interestingly, the HCHF diet in early postnatal life was associated with somewhat paradoxically increased expressions in LD of a range of genes (but not proteins) related to glucose uptake, insulin signalling and fatty acid oxidation. Except for fatty acid oxidation genes, these changes persisted into adulthood. No persistent expression changes were observed in BF and VSC. The HCHF diet increased phospholipid ratios of n-6/n-3 polyunsaturated fatty acids in all muscles, even in adults fed identical diets for 11/2 years. In conclusion, early postnatal, but not late gestation, nutrition had long-term consequences for a number of determinants of insulin action and metabolism in LD. Tissues other than muscle may account for reduced whole body insulin sensitivity in adult LOW sheep.	[Hou, Lei; Kongsted, Anna H.; Kadarmideen, Haja N.; Nielsen, Mette O.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark; [Takhtsabzy, Tasnim K.; Hellgren, Lars I.] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Friedrichsen, Martin; Vaag, Allan] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Friedrichsen, Martin] Univ Copenhagen, August Krogh Ctr, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Ghoreishi, Seyed M.] Univ Jiroft, Dept Anim Sci, Jiroft, Iran; [Hou, Lei; Kongsted, Anna H.; Hellgren, Lars I.; Vaag, Allan; Nielsen, Mette O.] Ctr Fetal Programming, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark; Rigshospitalet; University of Copenhagen; University of Copenhagen	Nielsen, MO (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark.	mette.olaf.nielsen@sund.ku.dk	Friedrichsen, Martin/A-3638-2015; Hellgren, Lars/B-5137-2010; Nielsen, Mette O/I-5822-2012; Biguzzi, Felipe A/E-4724-2015	Friedrichsen, Martin/0000-0003-3383-9593; Hellgren, Lars/0000-0001-9215-4880; hou, lei/0000-0002-3030-5329; Kadarmideen, Haja/0000-0001-6294-382X; Ghoreishi, SeyedMehdi/0000-0002-6417-0848; Vaag, Allan Arthur/0000-0002-3690-2191; Kongsted, Anna/0000-0003-1959-8308	Danish Strategic Research Council [09-059921, 09-067124]; Steno Diabetes Center through Research School of Animal Nutrition, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Steno Diabetes Center through Research School of Animal Nutrition, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark	This study is supported by Danish Strategic Research Council Grant no. 09-059921 and 09-067124, and Steno Diabetes Center through Research School of Animal Nutrition, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/476279; Andersson A, 2002, AM J CLIN NUTR, V76, P1222, DOI 10.1093/ajcn/76.6.1222; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bispham J, 2005, ENDOCRINOLOGY, V146, P3943, DOI 10.1210/en.2005-0246; Blachnio-Zabielska A, 2010, J CELL PHYSIOL, V225, P786, DOI 10.1002/jcp.22283; Borsting CF, 2003, KVAEGETS ERNAERING F; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Buhl ES, 2010, AM J PHYSIOL-ENDOC M, V298, pE920, DOI 10.1152/ajpendo.00606.2009; Burrage DM, 2009, J PHYSIOL-LONDON, V587, P611, DOI 10.1113/jphysiol.2008.165944; Chan LLY, 2009, AM J PHYSIOL-REG I, V296, pR1455, DOI 10.1152/ajpregu.91019.2008; Costello PM, 2008, J PHYSIOL-LONDON, V586, P2371, DOI 10.1113/jphysiol.2008.150987; Drachmann T, 2007, EUR J LIPID SCI TECH, V109, P1003, DOI 10.1002/ejlt.200600240; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedrichsen M, 2010, J CLIN ENDOCR METAB, V95, P414, DOI 10.1210/jc.2009-1147; GORSKI J, 1986, AM J PHYSIOL, V250, pE441, DOI 10.1152/ajpendo.1986.250.4.E441; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Haugaard SB, 2008, EUR J CLIN INVEST, V38, P494, DOI 10.1111/j.1365-2362.2008.01969.x; Haugaard SB, 2010, INT J OBESITY, V34, P500, DOI 10.1038/ijo.2009.264; Haugaard SB, 2006, CLIN ENDOCRINOL, V64, P169, DOI 10.1111/j.1365-2265.2006.02444.x; Huber K, 2009, ENDOCRINOLOGY, V150, P4135, DOI 10.1210/en.2009-0125; Hulbert AJ, 2005, BIOL REV, V80, P155, DOI 10.1017/S1464793104006578; Husted SM, 2007, AM J PHYSIOL-ENDOC M, V293, pE548, DOI 10.1152/ajpendo.00441.2006; Jaquet D, 2001, J CLIN ENDOCR METAB, V86, P3266, DOI 10.1210/jc.86.7.3266; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jorgensen W, 2009, AM J PHYSIOL-ENDOC M, V297, pE1349, DOI 10.1152/ajpendo.00505.2009; Kadarmideen HN, 2008, IET SYST BIOL, V2, P423, DOI 10.1049/iet-syb:20070072; Kadarmideen HN, 2007, PHYSIOL GENOMICS, V29, P57, DOI 10.1152/physiolgenomics.00144.2006; Kongsted AH, 2014, ACTA PHYSIOL, V210, P84, DOI 10.1111/apha.12080; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; LUCAS A, 1991, CIBA F SYMP, V156, P38; Marotta M, 2004, METABOLISM, V53, P1032, DOI 10.1016/j.metabol.2004.03.011; McLennan PL, 2007, J CARDIOVASC MED, V8, pS15, DOI 10.2459/01.JCM.0000289272.87803.ce; McMillen IC, 2009, ADV EXP MED BIOL, V646, P71, DOI 10.1007/978-1-4020-9173-5_8; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Muhlhausler BS, 2009, ENDOCRINOLOGY, V150, P4287, DOI 10.1210/en.2009-0462; Nielsen MO, 2013, BRIT J NUTR, V109, P2098, DOI 10.1017/S0007114512004199; Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Pilgaard K, 2011, J CLIN ENDOCR METAB, V96, P2835, DOI 10.1210/jc.2011-0577; Price ER, 2009, AM J PHYSIOL-REG I, V297, pR775, DOI 10.1152/ajpregu.00150.2009; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; ROSS JJ, 1987, DEVELOPMENT, V100, P383; Rozen S, 2000, Methods Mol Biol, V132, P365; Safayi S, 2010, J DAIRY SCI, V93, P203, DOI 10.3168/jds.2009-2507; Sebert SP, 2010, REPRODUCTION, V139, P265, DOI 10.1530/REP-09-0173; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; TOMANEK RJ, 1977, AM J ANAT, V149, P227, DOI 10.1002/aja.1001490207; Tygesen MP, 2008, ARCH ANIM NUTR, V62, P44, DOI 10.1080/17450390701780276; Valencak TG, 2011, J COMP PHYSIOL B, V181, P289, DOI 10.1007/s00360-010-0520-8; Vielwerth SE, 2008, DIABETOLOGIA, V51, P1483, DOI 10.1007/s00125-008-1037-5; WILSON SJ, 1992, J MUSCLE RES CELL M, V13, P534, DOI 10.1007/BF01737996	56	9	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65452	10.1371/journal.pone.0065452	http://dx.doi.org/10.1371/journal.pone.0065452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755234	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000069
J	Lecocq, T; Vereecken, NJ; Michez, D; Dellicour, S; Lhomme, P; Valterova, I; Rasplus, JY; Rasmont, P				Lecocq, Thomas; Vereecken, Nicolas J.; Michez, Denis; Dellicour, Simon; Lhomme, Patrick; Valterova, Irena; Rasplus, Jean-Yves; Rasmont, Pierre			Patterns of Genetic and Reproductive Traits Differentiation in Mainland vs. Corsican Populations of Bumblebees	PLOS ONE			English	Article							SEX-PHEROMONE COMPONENTS; LABIAL GLAND SECRETIONS; BOMBUS-TERRESTRIS; ISLAND POPULATIONS; PHYLOGENETIC-RELATIONSHIPS; INTRASPECIFIC VARIATION; MATING PREFERENCES; JUVENILE-HORMONE; MATE RECOGNITION; TRUE ARMYWORM	Populations on islands often exhibit lower levels of genetic variation and ecomorphological divergence compared to their mainland relatives. While phenotypic differentiation in characters, such as size or shape among insular organisms, has been well studied, insular differentiation in quantitative reproductive traits involved in chemical communication has received very little attention to date. Here, we investigated the impact of insularity on two syntopic bumblebee species pairs: one including species that are phylogenetically related (Bombus terrestris and B. lucorum), and the other including species that interact ecologically (B. terrestris and its specific nest inquiline B. vestalis). For each bumblebee species, we characterized the patterns of variation and differentiation of insular (Corsican) vs. mainland (European) populations (i) with four genes (nuclear and mitochondrial, 3781 bp) and (ii) in the chemical composition of male marking secretions (MMS), a key trait for mate attraction in bumblebees, by gas chromatography-mass spectrometry (GC-MS). Our results provide evidence for genetic differentiation in Corsican bumblebees and show that, contrary to theoretical expectations, island populations of bumblebees exhibit levels of genetic variation similar to the mainland populations. Likewise, our comparative chemical analyses of MMS indicate that Corsican populations of bumblebees are significantly differentiated from the mainland yet they hold comparative levels of within-population MMS variability compared to the mainland. Therefore, insularity has led Corsican populations to diverge both genetically and chemically from their mainland relatives, presumably through genetic drift, but without a decrease of genetic diversity in island populations. We hypothesize that MMS divergence in Corsican bumblebees was driven by a persistent lack of gene flow with mainland populations and reinforced by the preference of Corsican females for sympatric (Corsican) MMS. The impoverished Corsican bumblebee fauna has not led to relaxation of stabilizing selection on MMS but to consistent differentiation chemical reproductive traits on the island.	[Lecocq, Thomas; Michez, Denis; Lhomme, Patrick; Rasmont, Pierre] Univ Mons, Zool Lab, B-7000 Mons, Belgium; [Vereecken, Nicolas J.; Dellicour, Simon] Univ Libre Bruxelles, Brussels, Belgium; [Valterova, Irena] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Rasplus, Jean-Yves] INRA, UMR Ctr Biol Gest Populat, Montferrier Sur Lez, France	University of Mons; Universite Libre de Bruxelles; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; INRAE; Institut de Recherche pour le Developpement (IRD)	Lecocq, T (corresponding author), Univ Mons, Zool Lab, B-7000 Mons, Belgium.	thomas.lecocq@umons.ac.be	Lhomme, Patrick/M-6395-2014; Lhomme, Patrick/AFN-5332-2022; Rasplus, Jean-Yves/O-2873-2017; Michez, Denis/L-1370-2019; Dellicour, Simon/AAE-9054-2020	Lhomme, Patrick/0000-0001-6735-9104; Lhomme, Patrick/0000-0001-6735-9104; Rasplus, Jean-Yves/0000-0001-8614-6665; Michez, Denis/0000-0001-8880-1838; Dellicour, Simon/0000-0001-9558-1052; Lecocq, Thomas/0000-0002-4947-0332; Vereecken, Nicolas/0000-0002-8858-4623; Valterova, Irena/0000-0001-5723-6143	Fonds pour la recherche dans l'industrie et l'agriculture (FRIA); Fonds national pour la recherche scientifique (FRS-FNRS); Fonds pour la Formation a la Recherche Fondamentale et Collective (FNRS) [FRFC 2.4613.10]; Office de l'Environnement de la Corse; Direction Regionale de l'Environnement de Corse; Academy of Sciences of the Czech Republic [RVO: 61388963]; network Bibliotheque du Vivant; CNRS; Museum National d'Histoire Naturelle; Institut National de la recherche en Agronomie; FRIA; FRS-FNRS (Belgium)	Fonds pour la recherche dans l'industrie et l'agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Fonds national pour la recherche scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Formation a la Recherche Fondamentale et Collective (FNRS)(Fonds de la Recherche Scientifique - FNRS); Office de l'Environnement de la Corse(Region Corse); Direction Regionale de l'Environnement de Corse; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); network Bibliotheque du Vivant; CNRS(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle; Institut National de la recherche en Agronomie; FRIA(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Fonds pour la recherche dans l'industrie et l'agriculture (FRIA), the Fonds national pour la recherche scientifique (FRS-FNRS), the Fonds pour la Formation a la Recherche Fondamentale et Collective (FNRS, FRFC 2.4613.10), the Office de l'Environnement de la Corse, the Direction Regionale de l'Environnement de Corse, the Academy of Sciences of the Czech Republic (subvention for development of research organization RVO: 61388963), the network Bibliotheque du Vivant funded by the CNRS, the Museum National d'Histoire Naturelle and the Institut National de la recherche en Agronomie, and technically supported by the Genoscope. TL, PL and SD are FRIA grant holders. NJV received financial support from the FRS-FNRS (Belgium) through a post-doctoral grant (2008-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER GH, 1994, Q REV BIOL, V69, P473, DOI 10.1086/418744; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Andersson Malte, 1994; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; Baer B, 2003, BEHAV ECOL SOCIOBIOL, V54, P521, DOI 10.1007/s00265-003-0673-5; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beheregaray LB, 2003, CONSERV GENET, V4, P31, DOI 10.1023/A:1021864214375; Bergman P, 1997, CHEM COMMUNICATION B, P26; Bergstrom G., 1981, Biosystematics of social insects, P175; Bisconti R, 2011, BIOL J LINN SOC, V103, P159, DOI 10.1111/j.1095-8312.2011.01643.x; Blondel J, 2000, VIE MILIEU, V50, P205; Blondel J, 2010, MEDITERRANEAN REGION; Blondel J., 1995, BIOGEOGRAPHIE APPROC; Blyth JE, 2008, ETHOLOGY, V114, P728, DOI 10.1111/j.1439-0310.2008.01519.x; Boake CRB, 2002, GENETICA, V116, P205, DOI 10.1023/A:1021224207727; Bossio A, 2000, ATTIVITA SCI U PISA, P87; BOURSOT P, 1986, GENET SEL EVOL, V18, P73, DOI 10.1186/1297-9686-18-1-73; Burger R, 2006, EVOLUTION, V60, P2185; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; CARLQUIST S, 1974, P660; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; CARSON HL, 1984, ANNU REV ECOL SYST, V15, P97, DOI 10.1146/annurev.es.15.110184.000525; CLEARWATER JR, 1991, J CHEM ECOL, V17, P413, DOI 10.1007/BF00994342; Clegg SM, 2002, P ROY SOC B-BIOL SCI, V269, P1359, DOI 10.1098/rspb.2002.2024; Cody ML, 2006, PLANTS ON ISLANDS: DIVERSITY AND DYNAMICS ON A CONTINENTAL ARCHIPELAGO, P1, DOI 10.1525/california/9780520247291.001.0001; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Coppee A, 2010, BOMBUS TERRESTRIS L; Coppee A, 2008, CHEM BIODIVERS, V5, P2654, DOI 10.1002/cbdv.200890219; Covas R, 2012, P ROY SOC B-BIOL SCI, V279, P1531, DOI 10.1098/rspb.2011.1785; Coyne JA, 2004, SPECIATION, V37; Damgaard J, 2005, INSECT SYST EVOL, V36, P395, DOI 10.1163/187631205788838537; Danforth BN, 1999, SYST ENTOMOL, V24, P377, DOI 10.1046/j.1365-3113.1999.00087.x; Dapporto L, 2010, BIOL J LINN SOC, V100, P195, DOI 10.1111/j.1095-8312.2010.01434.x; de Bellocq JG, 2003, PARASITOL RES, V90, P64, DOI 10.1007/s00436-002-0806-1; De Meulemeester T, 2011, INSECT SOC, V58, P227, DOI 10.1007/s00040-011-0146-1; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferton C, 1901, COMPTES RENDUS IAFAS; Forchler MI, 2007, J BIOGEOGR, V34, P1591, DOI 10.1111/j.1365-2699.2007.01722.x; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Frankham R., 2002, INTRO CONSERVATION G; Friese H, 1904, ZOOL JB            S, V7, P551; Gee JM, 2005, INTEGR COMP BIOL, V45, P1000; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Goulson D, 2011, CONSERV GENET, V12, P867, DOI 10.1007/s10592-011-0190-4; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; GRANT P. R., 1965, SYST ZOOL, V14, P47, DOI 10.2307/2411902; Grant P.R., 1998, EVOLUTION ISLANDS; Grill A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P273, DOI 10.1007/1-4020-4904-8_10; Groot AT, 2006, P NATL ACAD SCI USA, V103, P5858, DOI 10.1073/pnas.0508609103; HALKKA O, 1974, HEREDITAS, V78, P73; HANSSON BS, 1990, J CHEM ECOL, V16, P1611, DOI 10.1007/BF01014094; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hille SM, 2003, MOL ECOL, V12, P2145, DOI 10.1046/j.1365-294X.2003.01891.x; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hines HM, 2006, INVERTEBR SYST, V20, P289, DOI 10.1071/IS05028; Hinten G, 2003, CONSERV GENET, V4, P759, DOI 10.1023/B:COGE.0000006113.58749.ac; Hochberg ME, 2001, J EVOLUTION BIOL, V14, P539, DOI 10.1046/j.1420-9101.2001.00312.x; Hsieh HY, 2012, ECOL EVOL, V2, P2181, DOI 10.1002/ece3.322; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Hulva P, 2007, FOLIA ZOOL, V56, P378; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Ings TC, 2005, ENTOMOL GEN, V28, P233; JAMES FC, 1983, SCIENCE, V221, P184, DOI 10.1126/science.221.4606.184; Jeanmonod D., 2007, FLORA CORSICA; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Jonghe de R, 1986, PHEGEA, V14, P19; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawakita A, 2004, MOL PHYLOGENET EVOL, V31, P799, DOI 10.1016/j.ympev.2003.12.003; Kawazu K, 2005, APPL ENTOMOL ZOOL, V40, P483, DOI 10.1303/aez.2005.483; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Knopp T, 2007, CONSERV GENET, V8, P45, DOI 10.1007/s10592-006-9147-4; Kodric-Brown A, 2001, BEHAV ECOL SOCIOBIOL, V50, P346, DOI 10.1007/s002650100374; Kraus FB, 2009, J ANIM ECOL, V78, P247, DOI 10.1111/j.1365-2656.2008.01479.x; Kreuter K, 2012, BEHAV ECOL SOCIOBIOL, V66, P475, DOI 10.1007/s00265-011-1294-z; Krieger GM, 2006, J CHEM ECOL, V32, P453, DOI 10.1007/s10886-005-9013-8; KULLENBERG B, 1973, ZOON Supplement, P23; Laenen B, 2011, J BIOGEOGR, V38, P631, DOI 10.1111/j.1365-2699.2010.02440.x; Lecocq T, 2011, SYST ENTOMOL, V36, P453, DOI 10.1111/j.1365-3113.2011.00576.x; Lepais O, 2010, MOL ECOL, V19, P819, DOI 10.1111/j.1365-294X.2009.04500.x; Lhomme P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043053; LOFSTEDT C, 1993, PHILOS T R SOC B, V340, P167, DOI 10.1098/rstb.1993.0055; LOFSTEDT C, 1986, OIKOS, V46, P250, DOI 10.2307/3565474; LOFSTEDT C, 1990, ENTOMOL EXP APPL, V54, P199, DOI 10.1007/BF00186789; LOFTUSHILLS JJ, 1992, EVOLUTION, V46, P896, DOI 10.1111/j.1558-5646.1992.tb00607.x; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Maddison, 2019, MESQUITE MODULAR SYS; Mardulyn P, 2009, EVOLUTION, V63, P2717, DOI 10.1111/j.1558-5646.2009.00755.x; Martens Jochen, 1996, P221; Mayr E., 1942, P1; McFrederick QS, 2009, OECOLOGIA, V160, P411, DOI 10.1007/s00442-009-1318-9; McNeil JN, 1996, ARCH INSECT BIOCHEM, V32, P575, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;575::AID-ARCH29&gt;3.0.CO;2-8; McNeil JN, 2000, PHYSIOL ENTOMOL, V25, P103, DOI 10.1046/j.1365-3032.2000.00171.x; Medail F, 1997, ANN MO BOT GARD, V84, P112, DOI 10.2307/2399957; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Mutun S, 2011, TURK J ZOOL, V35, P559, DOI 10.3906/zoo-1003-150; NEI M, 1983, GENETICS, V105, P207; Nei M, 1987, MOL EVOLUTIONARY GEN; Nieberding C, 2006, J BIOGEOGR, V33, P1212, DOI 10.1111/j.1365-2699.2006.01503.x; NILSON G, 1981, ZOOL J LINN SOC-LOND, V72, P355, DOI 10.1111/j.1096-3642.1981.tb01576.x; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pasquet E, 1997, IBIS, V139, P679, DOI 10.1111/j.1474-919X.1997.tb04691.x; Paterson H.E.H., 1993, EVOLUTION RECOGNITIO; Patricelli GL, 2003, P ROY SOC B-BIOL SCI, V270, P2389, DOI 10.1098/rspb.2003.2530; Pedersen BV, 2002, INSECT SYST EVOL, V33, P361, DOI 10.1163/187631202X00208; Phillimore AB, 2008, MOL ECOL, V17, P2839, DOI 10.1111/j.1365-294X.2008.03794.x; POPOV V. B., 1931, EOS, V7, P131; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quammen David, 1996, P1; R Core Team, 2021, R LANG ENV STAT COMP; Radoszkowski O., 1884, B MOSKOVSKOGO OBSHCH, V59, P51; Raia P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-289; Rambaut A., 2007, TRACER V1 4; Rasmont P, 2005, APIDOLOGIE, V36, P571, DOI 10.1051/apido:2005047; RASMONT P, 1996, NOTES FAUNIQUES GEMB, V31, P1; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; ROELOFS WL, 1982, ANNU REV ECOL SYST, V13, P395, DOI 10.1146/annurev.es.13.110182.002143; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 1997, COMPUT APPL BIOSCI, V13, P307; Salvi D, 2010, MOL PHYLOGENET EVOL, V56, P690, DOI 10.1016/j.ympev.2010.03.017; Segraves Kari A., 2010, Evolution Education and Outreach, V3, P62; Shao ZY, 2004, J HERED, V95, P46, DOI 10.1093/jhered/esh008; Shaw KL, 2002, AM NAT, V159, pS61, DOI 10.1086/338373; SIMMONS LW, 1989, ANIM BEHAV, V38, P68, DOI 10.1016/S0003-3472(89)80066-1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith CI, 2008, P ROY SOC B-BIOL SCI, V275, P249, DOI 10.1098/rspb.2007.1405; STOWE MK, 1995, P NATL ACAD SCI USA, V92, P23, DOI 10.1073/pnas.92.1.23; Suzuki R, 2011, PVCLUST HIERARCHICAL; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Symonds MRE, 2009, BIOL J LINN SOC, V97, P594, DOI 10.1111/j.1095-8312.2009.01245.x; Symonds MRE, 2004, P ROY SOC B-BIOL SCI, V271, P839, DOI 10.1098/rspb.2003.2647; Takanashi T, 2005, BIOL J LINN SOC, V84, P143, DOI 10.1111/j.1095-8312.2005.00421.x; TEMPLETON AR, 1980, GENETICS, V94, P1011; Terzo M, 2005, APIDOLOGIE, V36, P85, DOI 10.1051/apido:2004072; Terzo M, 2007, CHEM BIODIVERS, V4, P1466, DOI 10.1002/cbdv.200790124; Thompson J.D., 2005, PLANT EVOLUTION MEDI; Thompson JN, 1994, COEVOLUTIONARY PROCE; TOTH M, 1992, J CHEM ECOL, V18, P1337, DOI 10.1007/BF00994360; Urbanova K, 2004, BIOCHEM SYST ECOL, V32, P1025, DOI 10.1016/j.bse.2004.02.010; Urbanova K, 2001, EUR J ENTOMOL, V98, P111, DOI 10.14411/eje.2001.017; van den Eijnde J., 2000, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V11, P159; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Velthuis HHW, 2002, POLLINATING BEES CON; Vereecken NJ, 2007, BEHAV ECOL SOCIOBIOL, V61, P811, DOI 10.1007/s00265-006-0312-z; Vogt O., 1909, SITZUNGSBERICHTE GES, V1909, P28; Whittaker R. J., 1998, ISLAND BIOGEOGRAPHY; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wickler W, 1986, DIALEKTE TIERREICH I; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; Williams Paul H., 1998, Bulletin of the Natural History Museum Entomology Series, V67, P79; WILLIAMS PH, 1985, SYST ENTOMOL, V10, P239, DOI 10.1111/j.1365-3113.1985.tb00529.x; Wilson EO, 1967, THEORY ISLAND BIOGEO; Wong BBM, 2004, J EVOLUTION BIOL, V17, P701, DOI 10.1046/j.1420-9101.2003.00651.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, DOI 10.1017/CBO9780511615061; Zacek P, 2013, CHEMBIOCHEM, V14, P361, DOI 10.1002/cbic.201200684; Zacek P, 2009, J CHEM ECOL, V35, P698, DOI 10.1007/s10886-009-9650-4; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhu JW, 1997, J INSECT BEHAV, V10, P805, DOI 10.1023/B:JOIR.0000010414.28494.9a; Zimma BO, 2003, J COMP PHYSIOL A, V189, P769, DOI 10.1007/s00359-003-0451-x; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	175	64	66	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65642	10.1371/journal.pone.0065642	http://dx.doi.org/10.1371/journal.pone.0065642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755263	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000085
J	Weiss, RM; Lund, DD; Chu, Y; Brooks, RM; Zimmerman, KA; El Accaoui, R; Davis, MK; Hajj, GP; Zimmerman, MB; Heistad, DD				Weiss, Robert M.; Lund, Donald D.; Chu, Yi; Brooks, Robert M.; Zimmerman, Kathy A.; El Accaoui, Ramzi; Davis, Melissa K.; Hajj, Georges P.; Zimmerman, M. Bridget; Heistad, Donald D.			Osteoprotegerin Inhibits Aortic Valve Calcification and Preserves Valve Function in Hypercholesterolemic Mice	PLOS ONE			English	Article							VASCULAR CALCIFICATION; STENOSIS; PROGRESSION; ROSUVASTATIN; ARTERIAL	Background: There are no rigorously confirmed effective medical therapies for calcific aortic stenosis. Hypercholesterolemic Ldlr(-/-) Apob(100/100) mice develop calcific aortic stenosis and valvular cardiomyopathy in old age. Osteoprotegerin (OPG) modulates calcification in bone and blood vessels, but its effect on valve calcification and valve function is not known. Objectives: To determine the impact of pharmacologic treatment with OPG upon aortic valve calcification and valve function in aortic stenosis-prone hypercholesterolemic Ldlr(-/-) Apob(100/100) mice. Methods: Young Ldlr(-/-) Apob(100/100) mice (age 2 months) were fed a Western diet and received exogenous OPG or vehicle (N = 12 each) 3 times per week, until age 8 months. After echocardiographic evaluation of valve function, the aortic valve was evaluated histologically. Older Ldlr(-/-) Apob(100/100) mice were fed a Western diet beginning at age 2 months. OPG or vehicle (N = 12 each) was administered from 6 to 12 months of age, followed by echocardiographic evaluation of valve function, followed by histologic evaluation. Results: In Young Ldlr(-/-) Apob(100/100) mice, OPG significantly attenuated osteogenic transformation in the aortic valve, but did not affect lipid accumulation. In Older Ldlr(-/-) Apob(100/100) mice, OPG attenuated accumulation of the osteoblast-specific matrix protein osteocalcin by similar to 80%, and attenuated aortic valve calcification by similar to 70%. OPG also attenuated impairment of aortic valve function. Conclusions: OPG attenuates pro-calcific processes in the aortic valve, and protects against impairment of aortic valve function in hypercholesterolemic aortic stenosis-prone Ldlr(-/-) Apob(100/100) mice.	[Weiss, Robert M.; Lund, Donald D.; Chu, Yi; Brooks, Robert M.; Zimmerman, Kathy A.; El Accaoui, Ramzi; Davis, Melissa K.; Hajj, Georges P.; Heistad, Donald D.] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [Zimmerman, M. Bridget] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Heistad, Donald D.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Weiss, RM (corresponding author), Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Iowa City, IA 52242 USA.	robert-weiss@uiowa.edu		Weiss, Robert/0000-0003-1307-2647; El Accaoui, Ramzi/0000-0002-5515-5427	National Institutes of Health [HL62984, NS24621, RR026293]; Amgen Corp (Thousand Oaks, CA); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026293] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL062984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen Corp (Thousand Oaks, CA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (HL62984, NS24621, RR026293; research grant from Amgen Corp (Thousand Oaks, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Hjortnaes J, 2010, EUR HEART J, V31, P1975, DOI 10.1093/eurheartj/ehq237; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Miller JD, 2011, CIRC RES, V108, P1392, DOI 10.1161/CIRCRESAHA.110.234138; Miller JD, 2010, ARTERIOSCL THROM VAS, V30, P2482, DOI 10.1161/ATVBAHA.110.211029; Miller JD, 2009, CIRCULATION, V119, P2693, DOI 10.1161/CIRCULATIONAHA.108.834614; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Moura LM, 2007, J AM COLL CARDIOL, V49, P554, DOI 10.1016/j.jacc.2006.07.072; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Otto CM, 2008, NEW ENGL J MED, V359, P1395, DOI 10.1056/NEJMe0807001; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Panizo S, 2009, CIRC RES, V104, P1041, DOI 10.1161/CIRCRESAHA.108.189001; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Tintut Y, 2006, J INVEST MED, V54, P395, DOI 10.2310/6650.2006.06019; Wallby L, 2002, HEART, V88, P348, DOI 10.1136/heart.88.4.348; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139	24	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65201	10.1371/journal.pone.0065201	http://dx.doi.org/10.1371/journal.pone.0065201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762316	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000043
J	Tovar-Sanchez, A; Sanchez-Quiles, D; Basterretxea, G; Benede, JL; Chisvert, A; Salvador, A; Moreno-Garrido, I; Blasco, J				Tovar-Sanchez, Antonio; Sanchez-Quiles, David; Basterretxea, Gotzon; Benede, Juan L.; Chisvert, Alberto; Salvador, Amparo; Moreno-Garrido, Ignacio; Blasco, Julian			Sunscreen Products as Emerging Pollutants to Coastal Waters	PLOS ONE			English	Article							UV FILTERS; GROWTH; TOXICITY; TESTS; CYCLE; CELL	A growing awareness of the risks associated with skin exposure to ultraviolet (UV) radiation over the past decades has led to increased use of sunscreen cosmetic products leading the introduction of new chemical compounds in the marine environment. Although coastal tourism and recreation are the largest and most rapidly growing activities in the world, the evaluation of sunscreen as source of chemicals to the coastal marine system has not been addressed. Concentrations of chemical UV filters included in the formulation of sunscreens, such as benzophehone 3 (BZ-3), 4-methylbenzylidene camphor (4-MBC), TiO2 and ZnO, are detected in nearshore waters with variable concentrations along the day and mainly concentrated in the surface microlayer (i.e. 53.6-577.5 ng L-1 BZ-3; 51.4-113.4 ng L-1 4-MBC; 6.9-37.6 mu g L-1 Ti; 1.0-3.3 mu g L-1 Zn). The presence of these compounds in seawater suggests relevant effects on phytoplankton. Indeed, we provide evidences of the negative effect of sunblocks on the growth of the commonly found marine diatom Chaetoceros gracilis (mean EC50 = 125 +/- 71 mg L-1). Dissolution of sunscreens in seawater also releases inorganic nutrients (N, P and Si forms) that can fuel algal growth. In particular, PO43- is released by these products in notable amounts (up to 17 mu mol PO43- g(-1)). We conservatively estimate an increase of up to 100% background PO43- concentrations (0.12 mu mol L-1 over a background level of 0.06 mu mol L-1) in nearshore waters during low water renewal conditions in a populated beach in Majorca island. Our results show that sunscreen products are a significant source of organic and inorganic chemicals that reach the sea with potential ecological consequences on the coastal marine ecosystem.	[Tovar-Sanchez, Antonio; Sanchez-Quiles, David] Mediterranean Inst Adv Studies UIB CSIC, Dept Global Change Res, Esporles, Balearic Island, Spain; [Basterretxea, Gotzon] Mediterranean Inst Adv Studies UIB CSIC, Dept Ecol & Marine Resources, Esporles, Balearic Island, Spain; [Benede, Juan L.; Chisvert, Alberto; Salvador, Amparo] Univ Valencia, Dept Analyt Chem, Fac Quim, Valencia, Spain; [Moreno-Garrido, Ignacio; Blasco, Julian] CSIC, ICMAN Inst Ciencias Marinas Andalucia, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN)	Tovar-Sanchez, A (corresponding author), Mediterranean Inst Adv Studies UIB CSIC, Dept Global Change Res, Esporles, Balearic Island, Spain.	atovar@imedea.uib-csic.es	Tovar-Sánchez, Antonio/B-8003-2010; Salvador, Amparo/M-2383-2014; Sánchez-Quiles, David/H-8031-2015; Benedé, Juan Luis/C-8324-2018; Sánchez-Quiles, D./K-1283-2019; Blasco, Julian/A-5319-2008; Chisvert, Alberto/M-2026-2014; Basterretxea, Gotzon/D-2314-2011	Tovar-Sánchez, Antonio/0000-0003-4375-1982; Salvador, Amparo/0000-0003-1248-4076; Sánchez-Quiles, David/0000-0003-4109-6136; Benedé, Juan Luis/0000-0002-1888-7223; Sánchez-Quiles, D./0000-0003-4109-6136; Blasco, Julian/0000-0002-9750-383X; Chisvert, Alberto/0000-0003-1349-0478; Basterretxea, Gotzon/0000-0001-7466-1360; Moreno-Garrido, Ignacio/0000-0003-2664-8713	Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment [CTM2011-22645, 384/2011]	Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment	This work was funded by the ISUMAR project (CTM2011-22645) and CONCORDA project (384/2011) of the Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACNielsen Global Services, 2007, WHATS HOT GLOB INS P; [Anonymous], 1976, OFFICIAL J L, VL 262, P0169; ASTM, 2008, PRACT PREP SUBS OC W; Basterretxea G, 2007, MAR ECOL PROG SER, V352, P53, DOI 10.3354/meps07168; Bonnet S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003213; Botta C, 2011, ENVIRON POLLUT, V159, P1543, DOI 10.1016/j.envpol.2011.03.003; Chen JY, 2011, AQUAT TOXICOL, V101, P493, DOI 10.1016/j.aquatox.2010.12.004; Coronado M, 2008, AQUAT TOXICOL, V90, P182, DOI 10.1016/j.aquatox.2008.08.018; Diffey B, 2001, J PHOTOCH PHOTOBIO B, V64, P105, DOI 10.1016/S1011-1344(01)00195-6; Division on Earth & Life Studies, 2012, OC REP AC FIND DIV E; Executive News Report from Nielsen Global Services, 2007, WHATS HOT GLOB INS P; Garin-Munoz T, 2007, TOURISM MANAGE, V28, P1224, DOI 10.1016/j.tourman.2005.07.020; Giokas DL, 2007, TRAC-TREND ANAL CHEM, V26, P360, DOI 10.1016/j.trac.2007.02.012; Grasshon K, 1976, METHODS SEAWATER ANA; Hampel M, 2001, ECOTOX ENVIRON SAFE, V48, P287, DOI 10.1006/eesa.2000.2028; Hernandez-Almeida I, 2011, MAR MICROPALEONTOL, V78, P14, DOI 10.1016/j.marmicro.2010.09.005; Kaiser D, 2012, ENVIRON POLLUT, V163, P84, DOI 10.1016/j.envpol.2011.12.014; Kunz PY, 2006, TOXICOL SCI, V93, P311, DOI 10.1093/toxsci/kfl070; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Moreno-Garrido I, 2000, ECOTOX ENVIRON SAFE, V47, P112, DOI 10.1006/eesa.2000.1953; NYHOLM N, 1990, ARCH ENVIRON CON TOX, V19, P518, DOI 10.1007/BF01059070; Pascoa RNMJ, 2011, SENSOR ACTUAT B-CHEM, V157, P51, DOI 10.1016/j.snb.2011.03.025; Peck AM, 2006, ANAL BIOANAL CHEM, V386, P907, DOI 10.1007/s00216-006-0728-3; Poiger T, 2004, CHEMOSPHERE, V55, P951, DOI 10.1016/j.chemosphere.2004.01.012; Quartier S, 2006, CONTACT DERMATITIS, V55, P257, DOI 10.1111/j.1600-0536.2006.00960.x; Salvador A, 2007, ANALYSIS OF COSMETIC PRODUCTS, P1; Santos AJM, 2012, WATER RES, V46, P3167, DOI 10.1016/j.watres.2012.03.057; Sieratowicz A, 2011, J ENVIRON SCI HEAL A, V46, P1311, DOI 10.1080/10934529.2011.602936; Diaz-Cruz MS, 2009, TRAC-TREND ANAL CHEM, V28, P708, DOI 10.1016/j.trac.2009.03.010; Stortini A. M, 2012, COMPREHENSIVE SAMPLI, P223; Sundseth K., 2009, NATURA 2000 MEDITERR; Tonning K, 2009, SURVEY HLTH ASSESSME; Tovar- Sa 'nchezA, 2012, COMPREHENSIVE SAMPLI, P317; UNEP, 2009, SUST COAST TOUR INT; Vaulot D, 1996, APPL ENVIRON MICROB, V62, P2527, DOI 10.1128/AEM.62.7.2527-2533.1996; Weisz A, 2007, 4 2 COL AG COSM PROD, P153	36	132	134	10	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65451	10.1371/journal.pone.0065451	http://dx.doi.org/10.1371/journal.pone.0065451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755233	gold, Green Published			2022-12-25	WOS:000320579400059
J	Zhang, C; Wu, XH; Zhang, MF; Zhu, LC; Zhao, R; Xu, DQ; Lin, ZH; Liang, CG; Chen, TP; Chen, L; Ren, Y; Zhang, J; Qin, N; Zhang, XW				Zhang, Chao; Wu, Xihan; Zhang, Meifang; Zhu, Liangcheng; Zhao, Rong; Xu, Danqing; Lin, Zhaohu; Liang, Chungen; Chen, Taiping; Chen, Li; Ren, Yi; Zhang, Joe; Qin, Ning; Zhang, Xiongwen			Small Molecule R1498 as a Well-Tolerated and Orally Active Kinase Inhibitor for Hepatocellular Carcinoma and Gastric Cancer Treatment via Targeting Angiogenesis and Mitosis Pathways	PLOS ONE			English	Article							SUPPRESSES TUMOR-GROWTH; FREQUENT OVEREXPRESSION; PHASE-II; SORAFENIB; POTENT; ACTIVATION; RECEPTOR; THERAPY	Protein kinases play important roles in tumor development and progression. Lots of kinase inhibitors have entered into market and show promising clinical benefits. Here we report the discovery of a novel small molecule, well-tolerated, orally active kinase inhibitor, R1498, majorly targeting both angiogenic and mitotic pathways for the treatment of hepatocellular carcinoma (HCC) and gastric cancer (GC). A series of biochemical and cell-based assays indicated that the target kinase cluster of R1498 included Aurora kinases and VEGFR2 et al. R1498 showed moderate in vitro growth inhibition on a panel of tumor cells with IC50 of micromole range. The in vivo anti-tumor efficacy of R1498 was evaluated on a panel of GC and HCC xenografts in a parallel comparison with another multikinase inhibitor sorafenib. R1498 demonstrated superior efficacy and toxicity profile over sorafenib in all test models with >80% tumor growth inhibition and tumor regression in some xenogratfts. The therapeutic potential of R1498 was also highlighted by its efficacy on three human GC primary tumor derived xenograft models with 10-30% tumor regression rate. R1498 was shown to actively inhibit the Aurora A activity in vivo, and decrease the vascularization in tumors. Furthermore, R1498 presented good in vivo exposure and therapeutic window in the pharmacokinetic and dose range finding studies. Theses evidences indicate that R1498 is a potent, well-tolerated, orally active multitarget kinase inhibitor with a unique antiangiogenic and antiproliferative profile, and provide strong confidence for further development for HCC and GC therapy.	[Zhang, Chao; Wu, Xihan; Zhang, Meifang; Zhu, Liangcheng; Zhao, Rong; Xu, Danqing; Lin, Zhaohu; Liang, Chungen; Chen, Li; Ren, Yi; Zhang, Joe; Qin, Ning; Zhang, Xiongwen] Roche Res & Early Dev China, Shanghai, Peoples R China; [Chen, Taiping] Crown Biosci Inc, Beijing, Peoples R China		Zhang, XW (corresponding author), Roche Res & Early Dev China, Shanghai, Peoples R China.	xwzhang@sat.ecnu.edu.cn						Arbab AS, 2012, HISTOL HISTOPATHOL, V27, P549, DOI 10.14670/HH-27.549; Bang YJ, 2010, LANCET, V376, P1302; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; Dar AA, 2008, CANCER-AM CANCER SOC, V112, P1688, DOI 10.1002/cncr.23371; Donate F, 2008, CLIN CANCER RES, V14, P2137, DOI 10.1158/1078-0432.CCR-07-4530; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Ferrara Napoleone, 2011, Int J Dev Biol, V55, P383, DOI 10.1387/ijdb.103216dr; Fletcher GC, 2011, MOL CANCER THER, V10, P126, DOI 10.1158/1535-7163.MCT-10-0574; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hata T, 2005, CANCER RES, V65, P2899, DOI 10.1158/0008-5472.CAN-04-3981; Herbst RS, 2005, BRIT J CANCER, V92, pS21, DOI 10.1038/sj.bjc.6602605; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Liu JJ, 2010, BIOORG MED CHEM LETT, V20, P5984, DOI 10.1016/j.bmcl.2010.08.079; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Minor DR, 2012, CLIN CANC RES; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Sun WJ, 2010, J CLIN ONCOL, V28, P2947, DOI 10.1200/JCO.2009.27.7988; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xie BR, 2012, DIGEST DIS SCI, V57, P1122, DOI 10.1007/s10620-012-2136-1; Zhang C, 2006, BRIT J PHARMACOL, V148, P741, DOI 10.1038/sj.bjp.0706741; Zhang C, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004881, 10.1371/journal.pone.0005429]	31	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65264	10.1371/journal.pone.0065264	http://dx.doi.org/10.1371/journal.pone.0065264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755206	Green Published, Green Submitted, gold			2022-12-25	WOS:000320579400048
J	Hennings, JM; Kohli, MA; Czamara, D; Giese, M; Eckert, A; Wolf, C; Heck, A; Domschke, K; Arolt, V; Baune, BT; Horstmann, S; Bruckl, T; Klengel, T; Menke, A; Muller-Myhsok, B; Ising, M; Uhr, M; Lucae, S				Hennings, Johannes M.; Kohli, Martin A.; Czamara, Darina; Giese, Maria; Eckert, Anne; Wolf, Christiane; Heck, Angela; Domschke, Katharina; Arolt, Volker; Baune, Bernhard T.; Horstmann, Sonja; Brueckl, Tanja; Klengel, Torsten; Menke, Andreas; Mueller-Myhsok, Bertram; Ising, Marcus; Uhr, Manfred; Lucae, Susanne			Possible Associations of NTRK2 Polymorphisms with Antidepressant Treatment Outcome: Findings from an Extended Tag SNP Approach	PLOS ONE			English	Article							NEUROTROPHIC FACTOR GENE; MAJOR DEPRESSIVE DISORDER; GENOME-WIDE ASSOCIATION; TREATMENT RESPONSE; MOOD DISORDERS; BIPOLAR DISORDER; VAL66MET POLYMORPHISM; SEQUENCE VARIATIONS; MESSENGER-RNA; BRAIN	Background: Data from clinical studies and results from animal models suggest an involvement of the neurotrophin system in the pathology of depression and antidepressant treatment response. Genetic variations within the genes coding for the brain-derived neurotrophic factor (BDNF) and its key receptor Trkb (NTRK2) may therefore influence the response to antidepressant treatment. Methods: We performed a single and multi-marker association study with antidepressant treatment outcome in 398 depressed Caucasian inpatients participating in the Munich Antidepressant Response Signature (MARS) project. Two Caucasian replication samples (N = 249 and N = 247) were investigated, resulting in a total number of 894 patients. 18 tagging SNPs in the BDNF gene region and 64 tagging SNPs in the NTRK2 gene region were genotyped in the discovery sample; 16 nominally associated SNPs were tested in two replication samples. Results: In the discovery analysis, 7 BDNF SNPs and 9 NTRK2 SNPs were nominally associated with treatment response. Three NTRK2 SNPs (rs10868223, rs1659412 and rs11140778) also showed associations in at least one replication sample and in the combined sample with the same direction of effects (P-corr = .018, P-corr = .015 and P-corr = .004, respectively). We observed an across-gene BDNF-NTRK2 SNP interaction for rs4923468 and rs1387926. No robust interaction of associated SNPs was found in an analysis of BDNF serum protein levels as a predictor for treatment outcome in a subset of 93 patients. Conclusions/Limitations: Although not all associations in the discovery analysis could be unambiguously replicated, the findings of the present study identified single nucleotide variations in the BDNF and NTRK2 genes that might be involved in antidepressant treatment outcome and that have not been previously reported in this context. These new variants need further validation in future association studies.	[Hennings, Johannes M.; Kohli, Martin A.; Czamara, Darina; Wolf, Christiane; Heck, Angela; Horstmann, Sonja; Brueckl, Tanja; Klengel, Torsten; Menke, Andreas; Mueller-Myhsok, Bertram; Ising, Marcus; Uhr, Manfred; Lucae, Susanne] Max Planck Inst Psychiat, Munich, Germany; [Czamara, Darina; Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Giese, Maria; Eckert, Anne] Psychiat Univ Clin Basel, Neurobiol Lab Brain Aging & Mental Hlth, Basel, Switzerland; [Domschke, Katharina] Univ Wurzburg, Dept Psychiat, Wurzburg, Germany; [Arolt, Volker] Univ Munster, Dept Psychiat, D-48149 Munster, Germany; [Baune, Bernhard T.] Univ Adelaide, Royal Adelaide Hosp, Dept Psychiat, Adelaide, SA, Australia	Max Planck Society; University of Munich; University of Basel; University of Wurzburg; University of Munster; Royal Adelaide Hospital; University of Adelaide	Hennings, JM (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	hennings@mpipsykl.mpg.de	Menke, Andreas/D-5939-2014; Klengel, Torsten/E-5629-2010; Domschke, Katharina/I-7921-2013	Menke, Andreas/0000-0002-1498-1992; Klengel, Torsten/0000-0001-7045-9229; Hennings, Johannes/0000-0003-3259-7991; Heck, Angela/0000-0002-1543-3197	German Federal Ministry for Education and Research (BMBF); NGFN-Plus and within the Molecular Diagnostics Program [FKZ 01GS0481, 01ES0811]; Astra-Zeneca; Lundbeck; Wyeth; Deutsche Forschungsgemeinschaft (German Research Foundation); Pfizer; Lilly; Bristol-Myers Squibb; Astra Zeneca	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NGFN-Plus and within the Molecular Diagnostics Program; Astra-Zeneca(AstraZeneca); Lundbeck(Lundbeck Corporation); Wyeth(Wyeth); Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Pfizer(Pfizer); Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Astra Zeneca(AstraZeneca)	The study was supported in part by a research grant from the German Federal Ministry for Education and Research (BMBF) in the framework of the National Genome Research Network (NGFN2 and NGFN-Plus, FKZ 01GS0481) and within the Molecular Diagnostics Program (01ES0811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Arolt is member of advisory boards and/or gave presentations for the following companies: Astra-Zeneca, Janssen-Organon, Eli Lilly, Lundbeck, Pfizer, Servier, and Wyeth. He also received grants from Astra-Zeneca, Lundbeck, and Wyeth. He chaired the committee for the "Wyeth Research Award Depression and Anxiety''. Czamara was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy). Domschke has received speaker fees from Pfizer, Lilly and Bristol-Myers Squibb; she is a consultant for Johnson & Johnson and has received funding by Astra Zeneca. Hennings has received travel support to scientific congresses from Eli Lilly, Bayer Vital and Novartis. Menke, Holsboer inventors: Means and methods for diagnosing predisposition for treatment emergent suicidal ideation (TESI). European application number: 08016477.5. International application number: PCT/EP2009/061575. Uhr is patent holder of WO2005/108605A2 and WO2008/151803A2. Katharina Domschke is a PLOS ONE Editorial Board member. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adams JH, 2005, AM J MED GENET B, V132B, P90, DOI 10.1002/ajmg.b.30084; Alonso P, 2008, BIOL PSYCHIAT, V63, P619, DOI 10.1016/j.biopsych.2007.06.020; Angst J, 2005, J AFFECT DISORDERS, V84, P149, DOI 10.1016/S0165-0327(03)00195-2; [Anonymous], 1932, STAT METHODS RES WOR; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Baghai TC, 2006, MOL PSYCHIATR, V11, P1003, DOI 10.1038/sj.mp.4001884; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baune BT, 2008, NEUROPSYCHOPHARMACOL, V33, P924, DOI 10.1038/sj.npp.1301462; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Cozza A, 2008, J ALZHEIMERS DIS, V15, P61; Dong C, 2009, MOL PSYCHIATR, V14, P1105, DOI 10.1038/mp.2009.92; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dwivedi Y, 2006, NEUROSCIENCE, V139, P1017, DOI 10.1016/j.neuroscience.2005.12.058; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghaemi S N, 2001, J Psychiatr Pract, V7, P287, DOI 10.1097/00131746-200109000-00002; Gratacos M, 2008, PHARMACOGENOMICS J, V8, P101, DOI 10.1038/sj.tpj.6500460; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hennings JM, 2008, J PSYCHIATR RES, V43, P215, DOI 10.1016/j.jpsychires.2008.05.002; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Horstmann S, 2009, PSYCHONEUROENDOCRINO, V34, P238, DOI 10.1016/j.psyneuen.2008.09.004; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Ising M, 2009, ARCH GEN PSYCHIAT, V66, P966, DOI 10.1001/archgenpsychiatry.2009.95; KATO M, 2008, MOL PSYCHIAT; Knapman A, 2010, J PSYCHIATR RES, V44, P566, DOI 10.1016/j.jpsychires.2009.11.014; Kocabas NA, 2011, INT CLIN PSYCHOPHARM, V26, P1, DOI 10.1097/YIC.0b013e32833d18f8; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Kozisek ME, 2008, PHARMACOL THERAPEUT, V117, P30, DOI 10.1016/j.pharmthera.2007.07.001; Kunugi H, 2004, BIOL PSYCHIAT, V56, P376, DOI 10.1016/j.biopsych.2004.06.017; Licinio J, 2009, ARCH GEN PSYCHIAT, V66, P488, DOI 10.1001/archgenpsychiatry.2009.38; Lin E, 2009, REJUV RES, V12, P387, DOI 10.1089/rej.2009.0871; McMahon FJ, 2006, AM J HUM GENET, V78, P804, DOI 10.1086/503820; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; Mitchell PB, 2008, BIPOLAR DISORD, V10, P144, DOI 10.1111/j.1399-5618.2007.00559.x; Nakata K, 2003, NEUROSCI LETT, V337, P17, DOI 10.1016/S0304-3940(02)01292-2; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; NIBUYA M, 1995, J NEUROSCI, V15, P7539; North BV, 2002, AM J HUM GENET, V71, P439, DOI 10.1086/341527; PERROUD N., 2009, NEUROPSYCHOPHARMACOL; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rantamaki T, 2006, NEUROPHARMACOLOGY, V50, P421, DOI 10.1016/j.neuropharm.2005.10.001; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Saarelainen T, 2003, J NEUROSCI, V23, P349; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Schumacher J, 2005, BIOL PSYCHIAT, V58, P307, DOI 10.1016/j.biopsych.2005.04.006; Sillaber I, 2008, PSYCHOPHARMACOLOGY, V200, P557, DOI 10.1007/s00213-008-1232-6; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Tadic A, 2011, PROG NEURO-PSYCHOPH, V35, P415, DOI 10.1016/j.pnpbp.2010.08.011; Taylor WD, 2010, PHARMACOGENOMICS J; Tsai SJ, 2008, PHARMACOGENOMICS, V9, P1353, DOI 10.2217/14622416.9.9.1353; Uher R, 2009, PHARMACOGENOMICS J, V9, P225, DOI 10.1038/tpj.2009.12; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wilkie MJV, 2007, PHARMACOGENET GENOM, V17, P207, DOI 10.1097/FPC.0b013e32801a3be6; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Wong M, 2009, J PSYCHOPHARMACOL OX; Yoshida K, 2007, J PSYCHOPHARMACOL, V21, P650, DOI 10.1177/0269881106072192; Young R, 2009, INT J NEUROPSYCHOPH, P1; Zou YF, 2010, NEUROPSYCHOBIOLOGY, V61, P71, DOI 10.1159/000265132	67	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64947	10.1371/journal.pone.0064947	http://dx.doi.org/10.1371/journal.pone.0064947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750220	Green Published, gold			2022-12-25	WOS:000319961900022
J	Larimore, J; Ryder, PV; Kim, KY; Ambrose, LA; Chapleau, C; Calfa, G; Gross, C; Bassell, GJ; Pozzo-Miller, L; Smith, Y; Talbot, K; Park, IH; Faundez, V				Larimore, Jennifer; Ryder, Pearl V.; Kim, Kun-Yong; Ambrose, L. Alex; Chapleau, Christopher; Calfa, Gaston; Gross, Christina; Bassell, Gary J.; Pozzo-Miller, Lucas; Smith, Yoland; Talbot, Konrad; Park, In-Hyun; Faundez, Victor			MeCP2 Regulates the Synaptic Expression of a Dysbindin-BLOC-1 Network Component in Mouse Brain and Human Induced Pluripotent Stem Cell-Derived Neurons	PLOS ONE			English	Article							SCHIZOPHRENIA SUSCEPTIBILITY GENE; RETT-SYNDROME; ORGANELLES COMPLEX-1; NEUROTROPHIC FACTOR; HIPPOCAMPAL-FORMATION; MESSENGER-RNA; MUTANT MICE; II-ALPHA; PROTEIN; BLOC-1	Clinical, epidemiological, and genetic evidence suggest overlapping pathogenic mechanisms between autism spectrum disorder (ASD) and schizophrenia. We tested this hypothesis by asking if mutations in the ASD gene MECP2 which cause Rett syndrome affect the expression of genes encoding the schizophrenia risk factor dysbindin, a subunit of the biogenesis of lysosome-related organelles complex-1 (BLOC-1), and associated interacting proteins. We measured mRNA and protein levels of key components of a dysbindin interaction network by, quantitative real time PCR and quantitative immunohistochemistry in hippocampal samples of wild-type and Mecp2 mutant mice. In addition, we confirmed results by performing immunohistochemistry of normal human hippocampus and quantitative qRT-PCR of human inducible pluripotent stem cells (iPSCs)-derived human neurons from Rett syndrome patients. We defined the distribution of the BLOC-1 subunit pallidin in human and mouse hippocampus and contrasted this distribution with that of symptomatic Mecp2 mutant mice. Neurons from mutant mice and Rett syndrome patients displayed selectively reduced levels of pallidin transcript. Pallidin immunoreactivity decreased in the hippocampus of symptomatic Mecp2 mutant mice, a feature most prominent at asymmetric synapses as determined by immunoelectron microcopy. Pallidin immunoreactivity decreased concomitantly with reduced BDNF content in the hippocampus of Mecp2 mice. Similarly, BDNF content was reduced in the hippocampus of BLOC-1 deficient mice suggesting that genetic defects in BLOC-1 are upstream of the BDNF phenotype in Mecp2 deficient mice. Our results demonstrate that the ASD-related gene Mecp2 regulates the expression of components belonging to the dysbindin interactome and these molecular differences may contribute to synaptic phenotypes that characterize Mecp2 deficiencies and ASD.	[Larimore, Jennifer; Ambrose, L. Alex] Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA; [Ryder, Pearl V.; Gross, Christina; Bassell, Gary J.; Faundez, Victor] Emory Univ, Atlanta, GA 30322 USA; [Kim, Kun-Yong; Park, In-Hyun] Yale Univ, Sch Med, Dept Genet, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Chapleau, Christopher; Calfa, Gaston; Pozzo-Miller, Lucas] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Smith, Yoland] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Smith, Yoland] Emory Univ, Yerkes Natl Primate Ctr, Atlanta, GA 30322 USA; [Talbot, Konrad] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA	Emory University; Yale University; University of Alabama System; University of Alabama Birmingham; Emory University; Emory University; University of Pennsylvania; Pennsylvania Medicine	Faundez, V (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	vfaunde@emory.edu		Faundez, Victor/0000-0002-2114-5271; Pozzo-Miller, Lucas/0000-0001-6085-5527; Talbot, Konrad/0000-0003-4549-0835	National Institutes of Health (NIH) [GM077569, K12 GM000680, NS-065027, NS-40593, GM0099130-01]; Emory University Research Committee; IRSF award [2823]; NRSA [F31NS0765]; Neuronal Imaging Core of the Emory Neuroscience NINDS Core Facilities Grant [P30NS055077]; National Center for Research Resources [P51RR000165]; Office of Research Infrastructure Programs/OD [P51OD011132]; International Rett Syndrome Foundation [IRSF-0804]; CSCRF [12-SCB-YALE-11]; CTSA Grant from the National Center for Advancing Translational Science (NCATS), a component of the NIH [UL1 RR025750]; NIH roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169, R01GM077569, K12GM000680, P01GM099130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, R01NS065027, R01NS040593] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Research Committee; IRSF award; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuronal Imaging Core of the Emory Neuroscience NINDS Core Facilities Grant; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; International Rett Syndrome Foundation; CSCRF; CTSA Grant from the National Center for Advancing Translational Science (NCATS), a component of the NIH; NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH) to VF. (GM077569), Emory University Research Committee to VF. JL was supported by NIH FIRST program Fellowship K12 GM000680 and IRSF award number 2823. PVR was supported by an NRSA fellowship F31NS0765 and supported in part by the Neuronal Imaging Core of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077 as well as by the National Center for Research Resources P51RR000165 and the Office of Research Infrastructure Programs/OD P51OD011132 to the Yerkes Primate Center. LP-M and GC acknowledge support from NIH grants NS-065027, NS-40593, and by Postdoctoral Fellowships IRSF-0804 from the International Rett Syndrome Foundation. IHP was partly supported by NIH (GM0099130-01), CSCRF (12-SCB-YALE-11), and by CTSA Grant UL1 RR025750 from the National Center for Advancing Translational Science (NCATS), a component of the NIH, and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. Thanks to Dr. Wei Li (UAB) for information on Mecp2 primer sequences for qRT-PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Ayalew M, 2012, MOL PSYCHIAT; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; Buizer-Voskamp JE, 2011, SCHIZOPHR RES, V129, P128, DOI 10.1016/j.schres.2011.03.021; Calfa G, 2011, J NEUROPHYSIOL, V105, P1768, DOI 10.1152/jn.00800.2010; Calfa G, 2011, EXP BIOL MED, V236, P3, DOI 10.1258/ebm.2010.010261; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chapleau CA, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/976164; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Cohen D, 2002, AM J PSYCHIAT, V159, P148, DOI 10.1176/appi.ajp.159.1.148-a; Consortium C-DGotPG, 2013, LANCET; Cristino A.S., 2013, MOL PSYCHIAT; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dean C, 2012, J NEUROSCI, V32, P5398, DOI 10.1523/JNEUROSCI.4515-11.2012; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Dickman DK, 2012, J NEUROSCI, V32, P8716, DOI 10.1523/JNEUROSCI.5465-11.2012; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038; Doherty JL, 2012, CLIN GENET, V81, P103, DOI 10.1111/j.1399-0004.2011.01773.x; Gauthier J, 2011, HUM GENET, V130, P563, DOI 10.1007/s00439-011-0975-z; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Ghiani CA, 2011, ASN NEURO, V3, DOI 10.1042/AN20110010; Gokhale A, 2012, J NEUROSCI, V32, P3697, DOI 10.1523/JNEUROSCI.5640-11.2012; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hamlyn J, 2012, NEUROBIOL DIS; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Iqbal Z., 2013, HUM MOL GENET; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Jokiranta E, 2013, PSYCHIAT RES; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; King BH, 2011, BRAIN RES, V1380, P34, DOI 10.1016/j.brainres.2010.11.031; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Korkmaz B, 2011, PEDIATR RES, V69, p101R, DOI 10.1203/PDR.0b013e318212c177; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; Larimore J, 2011, MOL BIOL CELL, V22, P4854, DOI 10.1091/mbc.E11-07-0592; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Li W, 2012, P NATL ACAD SCI USA, V109, P17087, DOI 10.1073/pnas.1205271109; Li XJ, 2006, METH MOL B, V331, P169; Lugnegard T, 2013, SCHIZOPHR RES, V143, P277, DOI 10.1016/j.schres.2012.12.001; Ma X, 2011, MOL PSYCHIATR, V16, P1105, DOI 10.1038/mp.2011.43; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; Mitchell EB, 2013, HUM MOL GENET; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Na ES, 2012, NEUROPSYCHOPHARMACOL; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Newell-Litwa K, 2010, J NEUROSCI, V30, P820, DOI 10.1523/JNEUROSCI.3400-09.2010; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Peters A., 1991, FINE STRUCTURE NERVO; Qiu ZL, 2012, J NEUROSCI, V32, P989, DOI 10.1523/JNEUROSCI.0175-11.2012; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Rodriguez-Fernandez IA, 2009, J INHERIT METAB DIS, V32, P190, DOI 10.1007/s10545-008-1014-7; Ryder PV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293pe66; Salazar G, 2006, MOL BIOL CELL, V17, P4014, DOI 10.1091/mbc.E06-02-0103; Salazar G, 2005, MOL BIOL CELL, V16, P3692, DOI 10.1091/mbc.E05-01-0020; Schaaf CP, 2012, EUR J HUM GENET; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; Sullivan P, 2012, ARCH GEN PSYCHIAT, V2, P1; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Talbot K, 2009, HANDBOOK OF NEUROCHEMISTRY AND MOLECULAR NEUROBIOLOGY: SCHIZOPHRENIA, THIRD EDITION, P107, DOI 10.1007/978-0-387-30410-6_2.2; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Talbot K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016886; Tang JX, 2009, HUM MOL GENET, V18, P3851, DOI 10.1093/hmg/ddp329; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Wang H, 2006, J NEUROSCI, V26, P10911, DOI 10.1523/JNEUROSCI.1810-06.2006; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Zoghbi HY, 2012, COLD SPRING HARB PER, V4	88	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65069	10.1371/journal.pone.0065069	http://dx.doi.org/10.1371/journal.pone.0065069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750231	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900033
J	Lynch, SJ; Zavadil, J; Pellicer, A				Lynch, Stephen J.; Zavadil, Jiri; Pellicer, Angel			In TCR-Stimulated T-cells, N-ras Regulates Specific Genes and Signal Transduction Pathways	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; H-RAS; K-RAS; MENTAL-RETARDATION; SILENT CHROMATIN; EXPRESSION; MOUSE; CHST1; MUTATIONS; ONCOGENES	It has been recently shown that N-ras plays a preferential role in immune cell development and function; specifically: N-ras, but not H-ras or K-ras, could be activated at and signal from the Golgi membrane of immune cells following a low level Tcell receptor stimulus. The goal of our studies was to test the hypothesis that N-ras and H-ras played distinct roles in immune cells at the level of the transcriptome. First, we showed via mRNA expression profiling that there were over four hundred genes that were uniquely differentially regulated either by N-ras or H-ras, which provided strong evidence in favor of the hypothesis that N-ras and H-ras have distinct functions in immune cells. We next characterized the genes that were differentially regulated by N-ras in T cells following a low-level T-cell receptor stimulus. Of the large pool of candidate genes that were differentially regulated by N-ras downstream of TCR ligation, four genes were verified in qRT-PCR-based validation experiments (Dntt, Slc9a6, Chst1, and Lars2). Finally, although there was little overlap between individual genes that were regulated by N-ras in unstimulated thymocytes and stimulated CD4(+) T-cells, there was a nearly complete correspondence between the signaling pathways that were regulated by N-ras in these two immune cell types.	[Lynch, Stephen J.; Pellicer, Angel] NYU, Dept Pathol, Langone Sch Med, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Dept Pathol, Langone Med Ctr, NYU Canc Inst, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Ctr Hlth Informat & Bioinformat, Langone Med Ctr, New York, NY 10016 USA; [Pellicer, Angel] NYU, Langone Sch Med, Inst Canc, New York, NY USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Pellicer, A (corresponding author), NYU, Dept Pathol, Langone Sch Med, 550 1St Ave, New York, NY 10016 USA.	Angel.Pellicer@nyumc.org	MARTINEZ, ANTONIO PELLICER/C-4832-2015; Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Pellicer, Angel/0000-0002-5062-0692	National Institutes of Health [CA36327]; NIH/NCI [P30 CA016087-30, 5 P30CA16087-33]; NYU Genome Technology; NYU Flow Cytometry facility; NATIONAL CANCER INSTITUTE [P30CA016087, R37CA036327, R01CA036327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NYU Genome Technology; NYU Flow Cytometry facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health award CA36327 to AP. NIH/NCI P30 CA016087-30 supporting the NYU Genome Technology and JZ. NIH/NCI 5 P30CA16087-33 supporting the NYU Flow Cytometry facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOS JL, 1989, CANCER RES, V49, P4682; Castellano E, 2007, ONCOGENE, V26, P917, DOI 10.1038/sj.onc.1209845; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dustin ML, 2010, COLD SPRING HARB PER; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; Fruman DA, 2004, CURR OPIN IMMUNOL, V16, P314, DOI 10.1016/j.coi.2004.03.014; Garbern JY, 2010, BRAIN, V133, P1391, DOI 10.1093/brain/awq071; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Iida A, 2002, J HUM GENET, V47, P14, DOI 10.1007/s10038-002-8650-9; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Jutila MA, 1996, J IMMUNOL, V156, P289; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Li X, 2001, J LEUKOCYTE BIOL, V69, P565; Li XA, 1999, GENOMICS, V55, P345, DOI 10.1006/geno.1998.5653; Malumbres M, 1998, FRONT BIOSCI-LANDMRK, V3, P887; Mangues R, 1996, ONCOGENE, V13, P1053; Munakata K, 2005, BIOL PSYCHIAT, V57, P525, DOI 10.1016/j.biopsych.2004.11.041; Ohgaki R, 2011, BIOCHEMISTRY-US, V50, P443, DOI 10.1021/bi101082e; Ohgaki R, 2010, MOL BIOL CELL, V21, P1293, DOI 10.1091/mbc.E09-09-0767; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Perez de Castro I, 2003, CANCER RES, V63, P1615; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Su RC, 2005, SEMIN IMMUNOL, V17, P129, DOI 10.1016/j.smim.2005.01.003; Su RC, 2004, NAT GENET, V36, P502, DOI 10.1038/ng1351; Tu LL, 1999, J IMMUNOL, V163, P5070; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Wang XD, 2001, GENE DEV, V15, P2922; Wiegers GJ, 2011, IMMUNOL CELL BIOL, V89, P33, DOI 10.1038/icb.2010.127; Wolfman JC, 2002, MOL CELL BIOL, V22, P1589, DOI 10.1128/MCB.22.5.1589-1606.2002; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Zhou W, 2009, ACTA BIOCH BIOPH SIN, V41, P54, DOI 10.1093/abbs/gmn006; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	43	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63193	10.1371/journal.pone.0063193	http://dx.doi.org/10.1371/journal.pone.0063193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755101	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300007
J	Kibret, KT; Yalew, AW; Belaineh, BG; Asres, MM				Kibret, Kelemu Tilahun; Yalew, Alemayehu Worku; Belaineh, Belaineh Girma; Asres, Muluken Melese			Determinant Factors Associated with Occurrence of Tuberculosis among Adult People Living with HIV after Antiretroviral Treatment Initiation in Addis Ababa, Ethiopia: A Case Control Study	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; RISK-FACTORS; INFECTED PATIENTS; COUNTRIES; MORTALITY; AFRICA; UGANDA; HAART	Introdugtion: Tuberculosis (TB) is a leading morbidity and mortality, and the first presenting sign in majority of people living with Human Immune deficiency Virus (PLWH). Determinants of active TB among HIV patients on anti retroviral treatment (ART) are not well described in resource limited settings. The aim of this study was to assess determinant factors for the occurrence of TB among people living with HIV after ART initiation in public hospitals and health centers in Addis Ababa, Ethiopia. Methods and Findings: A case control study was conducted from December 2011 to February 2012 in 2 public hospitals and 13 health centers in Addis Ababa. The study population consisted of 204 cases and 409 controls. Cases were adult people living with HIV who developed TB after ART initiation and controls were adult people living with HIV who did not develop TB after ART initiation. An interviewer administered structured questionnaire was used to collect information. After adjustment for potential confounders, presence of isoniazid prophylaxis (adjusted odd ratio [AOR] 0.35, 95% confidence interval [CI] 0.125, 0.69) and cotrimoxazole prophylaxis (AOR = 0.19; 95% CI: 0.06, 0.62) had protective benefit against risk of TB. In contrary, bedridden (AOR = 9.36; 95% CI: 3.39, 25.85), having World Health Organization (WHO) clinical stage III/IV (AOR = 3.40; 95% CI: 1.69, 6.87) and hemoglobin level < 10 mg/dl (AOR = 7.43; 95% CI; 3.04, 18.31) at enrollment to ART care were predictors for increased risk of tuberculosis in PLWH after ART initiation. Conclusion: Increasing coverage of isoniazid preventive therapy and cotrimoxazole preventive therapy reduced risk of TB among HIV patients who started treatment. All PLWH should be screened for TB, but for patients who have advanced disease condition (WHO clinical stage III/IV, being bedridden and having hemoglobin level < 10 mg/dl) intensified screening is highly recommended during treatment follow up.	[Kibret, Kelemu Tilahun] Wollega Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia; [Yalew, Alemayehu Worku] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Belaineh, Belaineh Girma; Asres, Muluken Melese] MSH USAID Management Sci Hlth MSH, Help Ethiopia Address Low TB HEAL TB Project, Addis Ababa, Ethiopia	Addis Ababa University	Kibret, KT (corresponding author), Wollega Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia.	ktwu27@gmail.com	Kibret, Kelemu T/AAT-4813-2020; Belaineh, Belaineh Girma/HGD-1377-2022	Kibret, Kelemu T/0000-0002-4357-4122; 	Help Ethiopia Address Low TB Performance (HEAL TB) Project; USAID/Management Sciences for Health(MSH), Addis Ababa, Ethiopia	Help Ethiopia Address Low TB Performance (HEAL TB) Project; USAID/Management Sciences for Health(MSH), Addis Ababa, Ethiopia(United States Agency for International Development (USAID))	Help Ethiopia Address Low TB Performance (HEAL TB) Project, USAID/Management Sciences for Health(MSH), Addis Ababa, Ethiopia funded this article. The views expressed in this publication are the responsibility of authors and do not necessarily reflect the views of USAID. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2004, INT HIV AIDS TB EFF; [Anonymous], 2011, GUID INT TUB CAS FIN; Baalwa J, 2008, AFR HEALTH SCI, V8, P190; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Bonnet MMB, 2006, AIDS, V20, P1275, DOI 10.1097/01.aids.0000232235.26630.ee; Churchyard GJ, 2003, AIDS, V17, P2063, DOI 10.1097/00002030-200309260-00007; Duchateau L, 2001, ETHIOP J HLTH SCI, V21, P131; Federal Ministry of Health Ethiopia, 2008, TUB LEPR TB HIV PREV; Federal Ministry of Health of Ethiopia, 2007, IMPL GUID TB HIV COL; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Habib AG, 2009, ANN AFR MED, V8, P147, DOI 10.4103/1596-3519.57236; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Huruy K, 2008, JPN J INFECT DIS, V61, P205; Komati S, 2010, AIDS, V24, P1849, DOI 10.1097/QAD.0b013e32833a2507; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Mayanja-Kizza H, 2008, AFR HEALTH SCI, V8, P190; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Perez A, 2006, AM J TROP MED HYG, V74, P604, DOI 10.4269/ajtmh.2006.74.604; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Rodwell TC, 2010, AM J PUBLIC HEALTH, V100, pS178, DOI 10.2105/AJPH.2009.170142; Westerich D, 2007, RISK FACTORS INCIDEN; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, WHOHTMTB20107; WHO, 2011, GLOB TUB CONTR REP; *WHO, 2009, WHO GLOB TB REP; Wolday H, 2003, INT J TUBERC LUNG D, V7, P110; Worku A, 2011, EFFECT HAART I UNPUB; World Health Organization, 2010, WHOHTMTB20107	33	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2013	8	5							e64488	10.1371/journal.pone.0064488	http://dx.doi.org/10.1371/journal.pone.0064488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149OK	23762214	Green Submitted, Green Published, gold			2022-12-25	WOS:000319330200142
J	Zhang, Y; Zhao, HF; Wang, J; Ge, JP; Li, Y; Gu, JK; Li, P; Feng, Y; Yang, MJ				Zhang, Yi; Zhao, Haifeng; Wang, Jia; Ge, Jingpeng; Li, Yang; Gu, Jinke; Li, Peng; Feng, Yue; Yang, Maojun			Structural Insight into Caenorhabditis elegans Sex-determining Protein FEM-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; Protein Phosphatase; Protein Structure; Structural Biology; X-ray Crystallography; FEM-2; Novel Fold; Sex Determination; Substrate	C-ELEGANS; PHOSPHATASES; SPECIFICITY; MECHANISM; SOFTWARE; DOMAIN; MODEL; PP2C	In the nematode Caenorhabditis elegans, fem-1, fem-2, and fem-3 play crucial roles in male sexual development. Among these three genes, fem-2 encodes a PP2C (serine/threonine phosphatase type 2C)-like protein, whose activity promotes the development of masculinity. Different from the canonical PP2Cs, FEM-2 consists of an additional N-terminal domain (NTD) apart from its C-terminal catalytic domain. Interestingly, genetic studies have indicated indispensable roles for both of these two domains of FEM-2 in promoting male development, but the underlying mechanism remains unknown. In the present study, we solved the crystal structure of full-length FEM-2, which revealed a novel structural fold formed by its NTD. Structural and functional analyses demonstrated that the NTD did not directly regulate the in vitro dephosphorylation activity of FEM-2, but instead functioned as a scaffold domain in the assembly of the FEM-1/2/3 complex, the executioner in the final step of the sex determination pathway. Biochemical studies further identified the regions in the NTD involved in FEM-1 and FEM-3 interactions. Our results not only identified a novel fold formed by the extra domain of a noncanonical PP2C enzyme, but also provided important insights into the molecular mechanism of how the NTD works in mediating the sex-determining role of FEM-1/2/3 complex.	[Zhang, Yi; Zhao, Haifeng; Wang, Jia; Ge, Jingpeng; Li, Yang; Gu, Jinke; Li, Peng; Feng, Yue; Yang, Maojun] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Minist Educ MOE,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Feng, Yue] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China	Tsinghua University; Beijing University of Chemical Technology	Yang, MJ (corresponding author), Tsinghua Univ, Med Bldg C232, Beijing 100084, Peoples R China.	maojunyang@tsinghua.edu.cn	Gai, Jingpeng/AAT-9369-2021; Feng, Yue/HGE-4589-2022; Ge, Jingpeng/AGG-3471-2022	Gai, Jingpeng/0000-0001-6164-1221; Feng, Yue/0000-0002-1576-1385; Gu, Jinke/0000-0001-5942-480X; Yang, Maojun/0000-0002-6798-3094	Ministry of Science and Technology [31030020, 2012CB911101, 2011CB910502, 31170679]; National Natural Science Foundation of China	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 31030020, 2012CB911101, and 2011CB910502 and Grant 31170679 from the Ministry of Science and Technology and the National Natural Science Foundation of China.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen D, 1998, GENETICS, V149, P1353; HODGKIN J, 1986, GENETICS, V114, P15; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lum DH, 2000, GENE DEV, V14, P3153; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehra A, 1999, GENE DEV, V13, P1453, DOI 10.1101/gad.13.11.1453; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PILGRIM D, 1995, MOL BIOL CELL, V6, P1159, DOI 10.1091/mbc.6.9.1159; Reiner DJ, 1999, NATURE, V402, P199, DOI 10.1038/46072; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; SERGIENKO EA, 1994, ANAL BIOCHEM, V221, P348, DOI 10.1006/abio.1994.1424; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Starostina NG, 2007, DEV CELL, V13, P127, DOI 10.1016/j.devcel.2007.05.008; Tan KML, 2001, J BIOL CHEM, V276, P44193, DOI 10.1074/jbc.M105880200; Wang Q, 2002, J NEUROSCI, V22, P2274, DOI 10.1523/JNEUROSCI.22-06-02274.2002; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zarkower D, 2006, WORMBOOK, V1, P1, DOI DOI 10.1895/WORMBOOK.1.84.1; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	27	10	18	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22058	22066		10.1074/jbc.M113.464339	http://dx.doi.org/10.1074/jbc.M113.464339			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760267	Green Published, hybrid			2022-12-25	WOS:000328841900051
J	Tesorero, RA; Yu, N; Wright, JO; Svencionis, JP; Cheng, Q; Kim, JH; Cho, KH				Tesorero, Rafael A.; Yu, Ning; Wright, Jordan O.; Svencionis, Juan P.; Cheng, Qiang; Kim, Jeong-Ho; Cho, Kyu Hong			Novel Regulatory Small RNAs in Streptococcus pyogenes	PLOS ONE			English	Article							SMALL NONCODING RNAS; GROUP-A STREPTOCOCCUS; VIRULENCE FACTOR REGULATION; ESCHERICHIA-COLI; SOLUBLE-RNAS; OUTER-MEMBRANE; PREDICTION; IDENTIFICATION; SEQUENCE; GENES	Streptococcus pyogenes (Group A Streptococcus or GAS) is a Gram-positive bacterial pathogen that has shown complex modes of regulation of its virulence factors to cause diverse diseases. Bacterial small RNAs are regarded as novel widespread regulators of gene expression in response to environmental signals. Recent studies have revealed that several small RNAs (sRNAs) have an important role in S. pyogenes physiology and pathogenesis by regulating gene expression at the translational level. To search for new sRNAs in S. pyogenes, we performed a genomewide analysis through computational prediction followed by experimental verification. To overcome the limitation of low accuracy in computational prediction, we employed a combination of three different computational algorithms (sRNAPredict, eQRNA and RNAz). A total of 45 candidates were chosen based on the computational analysis, and their transcription was analyzed by reverse-transcriptase PCR and Northern blot. Through this process, we discovered 7 putative novel trans-acting sRNAs. Their abundance varied between different growth phases, suggesting that their expression is influenced by environmental or internal signals. Further, to screen target mRNAs of an sRNA, we employed differential RNA sequencing analysis. This study provides a significant resource for future study of small RNAs and their roles in physiology and pathogenesis of S. pyogenes.	[Tesorero, Rafael A.; Wright, Jordan O.; Svencionis, Juan P.; Cho, Kyu Hong] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA; [Yu, Ning; Cheng, Qiang] So Illinois Univ, Dept Comp Sci, Carbondale, IL 62901 USA; [Kim, Jeong-Ho] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; George Washington University	Cho, KH (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	kyuhongcho@gmail.com		Tesorero, Rafael/0000-0002-1636-0954	American Heart Association [11SDG7440083]; NIH [GM087470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087470] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Scientist Development Grant 11SDG7440083 from the American Heart Association to KHC and NIH grant GM087470 to JHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2011, NUCLEIC ACIDS RES, V39, P1843, DOI 10.1093/nar/gkq1065; Altuvia S, 2007, CURR OPIN MICROBIOL, V10, P257, DOI 10.1016/j.mib.2007.05.003; Backofen R, 2010, RNA BIOL, V7, P33, DOI 10.4161/rna.7.1.10655; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Biswas I, 2001, INFECT IMMUN, V69, P7029, DOI 10.1128/IAI.69.11.7029-7038.2001; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; BYEON WH, 1984, J BACTERIOL, V158, P543, DOI 10.1128/JB.158.2.543-550.1984; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Coventry A, 2004, P NATL ACAD SCI USA, V101, P12102, DOI 10.1073/pnas.0404193101; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Eggenhofer F, 2011, NUCLEIC ACIDS RES, V39, pW149, DOI 10.1093/nar/gkr467; Federle MJ, 2002, MOL MICROBIOL, V43, P1161, DOI 10.1046/j.1365-2958.2002.02810.x; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; Gripenland J, 2010, NAT REV MICROBIOL, V8, P857, DOI 10.1038/nrmicro2457; GRUNDY FJ, 1994, J MOL BIOL, V235, P798, DOI 10.1006/jmbi.1994.1038; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Li ZQ, 1999, J BACTERIOL, V181, P6019, DOI 10.1128/JB.181.19.6019-6027.1999; Livny J, 2005, NUCLEIC ACIDS RES, V33, P4096, DOI 10.1093/nar/gki715; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Mraheil MA, 2010, MICROB BIOTECHNOL, V3, P658, DOI 10.1111/j.1751-7915.2010.00171.x; Nelson N, 2000, J EXP BIOL, V203, P89; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Patenge N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-550; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Pichon C, 2003, BIOINFORMATICS, V19, P1707, DOI 10.1093/bioinformatics/btg235; Raasch P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-491; Ramirez-Pena E, 2010, MOL MICROBIOL, V78, P1332, DOI 10.1111/j.1365-2958.2010.07427.x; Repoila F, 2003, MOL MICROBIOL, V48, P855, DOI 10.1046/j.1365-2958.2003.03454.x; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; SOLIOZ M, 1994, J BIOL CHEM, V269, P9453; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trevino J, 2010, MICROBIOL-SGM, V156, P1342, DOI 10.1099/mic.0.036558-0; Udekwu KI, 2007, NUCLEIC ACIDS RES, V35, P1279, DOI 10.1093/nar/gkl1154; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Yachie N, 2006, GENE, V372, P171, DOI 10.1016/j.gene.2005.12.034; Zhou YX, 2011, J CELL PHYSIOL, V226, P968, DOI 10.1002/jcp.22483	65	30	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64021	10.1371/journal.pone.0064021	http://dx.doi.org/10.1371/journal.pone.0064021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762235	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000005
J	Shende, VR; Neuendorff, N; Earnest, DJ				Shende, Vikram R.; Neuendorff, Nichole; Earnest, David J.			Role of miR-142-3p in the Post-Transcriptional Regulation of the Clock Gene Bmal1 in the Mouse SCN	PLOS ONE			English	Article							CIRCADIAN-CLOCK; SUPRACHIASMATIC NUCLEUS; RHYTHMS; EXPRESSION; COMPONENT; PERIOD; TRANSCRIPTION; OSCILLATION; SPECIFICITY; MICRORNAS	MicroRNAs (miRNAs) are small non-coding RNAs that function as post-transcriptional modulators by regulating stability or translation of target mRNAs. Recent studies have implicated miRNAs in the regulation of mammalian circadian rhythms. To explore the role of miRNAs in the post-transcriptional modulation of core clock genes in the master circadian pacemaker, we examined miR-142-3p for evidence of circadian expression in the suprachiasmatic nuclei (SCN), regulation of its putative clock gene target Bmal1 via specific binding sites in the 3' UTR and overexpression-induced changes in the circadian rhythm of BMAL1 protein levels in SCN cells. In mice exposed to constant darkness (DD), miR-142-3p levels in the SCN were characterized by circadian rhythmicity with peak expression during early subjective day at CT 3. Mutagenesis studies indicate that two independent miRNA recognition elements located at nucleotides 1-7 and 335-357 contribute equally to miR-142-3p-induced repression of luciferase-reported Bmal1 3' UTR activity. Importantly, overexpression of miR-142-3p in immortalized SCN cells abolished circadian variation in endogenous BMAL1 protein levels in vitro. Collectively, our results suggest that miR-142-3p may play a role in the post-transcriptional modulation of Bmal1 and its oscillatory regulation in molecular feedback loops mediating SCN circadian function.	[Shende, Vikram R.; Earnest, David J.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Shende, Vikram R.; Earnest, David J.] Texas A&M Univ, Ctr Biol Clocks Res, College Stn, TX USA; [Neuendorff, Nichole; Earnest, David J.] Coll Med, Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Bryan, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Earnest, DJ (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	dearnest@medicine.tamhsc.edu	Shende, Vikram/M-2816-2017	Earnest, David/0000-0003-4433-6481	Texas A&M Health Science Center bridging funds	Texas A&M Health Science Center bridging funds	This work was supported by Texas A&M Health Science Center bridging funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GC, 2004, NEUROSCIENCE, V127, P989, DOI 10.1016/j.neuroscience.2004.06.003; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BOS NPA, 1990, BRAIN RES, V511, P158, DOI 10.1016/0006-8993(90)90235-4; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; EARNEST DJ, 1986, BRAIN RES, V382, P129, DOI 10.1016/0006-8993(86)90119-8; Farnell YF, 2011, EUR J NEUROSCI, V33, P1533, DOI 10.1111/j.1460-9568.2011.07629.x; Farnell YZ, 2008, ALCOHOL CLIN EXP RES, V32, P544, DOI 10.1111/j.1530-0277.2007.00598.x; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; GROOS G, 1982, NEUROSCI LETT, V34, P283, DOI 10.1016/0304-3940(82)90189-6; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang FQ, 1998, NEUROSCI LETT, V242, P89, DOI 10.1016/S0304-3940(98)00062-7; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Nagel R, 2009, FEBS J, V276, P5447, DOI 10.1111/j.1742-4658.2009.07229.x; Nahm SS, 2005, J NEUROSCI, V25, P9304, DOI 10.1523/jneurosci.2733-05.2005; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; PROSSER RA, 1989, J NEUROSCI, V9, P1073; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SCHWARTZ WJ, 1980, J COMP NEUROL, V189, P157, DOI 10.1002/cne.901890109; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; SHIBATA S, 1982, BRAIN RES, V247, P154, DOI 10.1016/0006-8993(82)91041-1; Staiger D, 2011, CELL MOL LIFE SCI, V68, P71, DOI 10.1007/s00018-010-0513-5; TUREK FW, 1985, ANNU REV PHYSIOL, V47, P49, DOI 10.1146/annurev.ph.47.030185.000405; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	46	36	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65300	10.1371/journal.pone.0065300	http://dx.doi.org/10.1371/journal.pone.0065300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755214	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400051
J	Yang, Y; Shiao, C; Hemingway, JF; Jorstad, NL; Shalloway, BR; Chang, R; Keene, CD				Yang, Yue; Shiao, Christine; Hemingway, Jake Frederick; Jorstad, Nikolas L.; Shalloway, Bryan Richard; Chang, Rubens; Keene, C. Dirk			Suppressed Retinal Degeneration in Aged Wild Type and APP swe/PS1 Delta E9 Mice by Bone Marrow Transplantation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BETA-AMYLOID DEPOSITION; RADIATION-INDUCED APOPTOSIS; ALZHEIMERS-DISEASE; TAU-HYPERPHOSPHORYLATION; COGNITIVE IMPAIRMENT; HEMATOPOIETIC-CELLS; PRECURSOR-PROTEIN; GANGLION-CELLS; MOUSE MODEL	Alzheimer's disease (AD) is an age-related condition characterized by accumulation of neurotoxic amyloid beta peptides (A beta) in brain and retina. Because bone marrow transplantation (BMT) results in decreased cerebral A beta in experimental AD, we hypothesized that BMT would mitigate retinal neurotoxicity through decreased retinal A beta. To test this, we performed BMT in APPswe/PS1 Delta E9 double transgenic mice using green fluorescent protein expressing wild type (wt) mice as marrow donors. We first examined retinas from control, non-transplanted, aged AD mice and found a two-fold increase in microglia compared with wt mice, prominent inner retinal A beta and paired helical filament-tau, and decreased retinal ganglion cell layer neurons. BMT resulted in near complete replacement of host retinal microglia with BMT-derived cells and normalized total AD retinal microglia to non-transplanted wt levels. A beta and paired helical filament-tau were reduced (61.0% and 44.1% respectively) in BMT-recipient AD mice, which had 20.8% more retinal ganglion cell layer neurons than non-transplanted AD controls. Interestingly, aged wt BMT recipients also had significantly more neurons (25.4%) compared with non-transplanted aged wt controls. Quantitation of retinal ganglion cell layer neurons in young mice confirmed age-related retinal degeneration was mitigated by BMT. We found increased MHC class II expression in BMT-derived microglia and decreased oxidative damage in retinal ganglion cell layer neurons. Thus, BMT is neuroprotective in age-related as well as AD-related retinal degeneration, and may be a result of alterations in innate immune function and oxidative stress in BMT recipient mice.	[Yang, Yue; Shiao, Christine; Hemingway, Jake Frederick; Jorstad, Nikolas L.; Shalloway, Bryan Richard; Chang, Rubens; Keene, C. Dirk] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Keene, CD (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	cdkeene@uw.edu	Keene, Christopher D/N-1806-2015	Jorstad, Nikolas/0000-0001-7906-9470; Keene, Christopher/0000-0002-5291-1469	National Institutes of Health [P50AG05136, T32AG000258, R01AG024011]; Nancy and Buster Alvord Endowed Chair in Neuropathology; NATIONAL INSTITUTE ON AGING [T32AG000258, P50AG005136, R01AG024011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy and Buster Alvord Endowed Chair in Neuropathology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health grants P50AG05136, T32AG000258, R01AG024011 and the Nancy and Buster Alvord Endowed Chair in Neuropathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Anderson MG, 2005, P NATL ACAD SCI USA, V102, P4566, DOI 10.1073/pnas.0407357102; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; BLANKS JC, 1989, BRAIN RES, V501, P364, DOI 10.1016/0006-8993(89)90653-7; Blanks JC, 1996, NEUROBIOL AGING, V17, P385, DOI 10.1016/0197-4580(96)00009-7; Boettcher C, 2008, BRIT J OPHTHALMOL, V92, P272, DOI 10.1136/bjo.2007.126318; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borges HL, 2004, CELL DEATH DIFFER, V11, P494, DOI 10.1038/sj.cdd.4401366; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; CURCIO CA, 1993, ANN NEUROL, V33, P248, DOI 10.1002/ana.410330305; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Danesh-Meyer HV, 2006, NEUROLOGY, V67, P1852, DOI 10.1212/01.wnl.0000244490.07925.8b; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Frautschy SA, 1998, AM J PATHOL, V152, P307; Golde TE, 2003, J CLIN INVEST, V111, P11, DOI 10.1172/JCI200317527; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Gomez-Isla Teresa, 2008, Handb Clin Neurol, V89, P233, DOI 10.1016/S0072-9752(07)01222-5; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Guo L, 2010, CURR ALZHEIMER RES, V7, P3, DOI 10.2174/156720510790274491; Gupta N, 2008, CAN J OPHTHALMOL, V43, P53, DOI 10.3129/i07-185; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harwerth RS, 2008, INVEST OPHTH VIS SCI, V49, P4437, DOI 10.1167/iovs.08-1753; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Herzog KH, 2007, EUR J NEUROSCI, V25, P1349, DOI 10.1111/j.1460-9568.2007.05381.x; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Igarashi T, 2007, CURR EYE RES, V32, P543, DOI 10.1080/02713680701389333; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Jackson GR, 2003, NEUROL CLIN, V21, P709, DOI 10.1016/S0733-8619(02)00107-X; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Keene CD, 2010, AM J PATHOL, V177, P346, DOI 10.2353/ajpath.2010.090840; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Keri S, 1999, VISION RES, V39, P2261, DOI 10.1016/S0042-6989(98)00310-1; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lei Y, 2011, BRIT J OPHTHALMOL, V95, P727, DOI 10.1136/bjo.2010.180869; Leinonen V, 2010, ANN NEUROL, V68, P446, DOI 10.1002/ana.22100; Liu BQ, 2009, AM J PATHOL, V175, P2099, DOI 10.2353/ajpath.2009.090159; LOFFLER KU, 1995, INVEST OPHTH VIS SCI, V36, P24; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; MILLER NR, 1990, OPHTHALMOLOGY, V97, P7; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Otani A, 2012, AM J PATHOL, V180, P328, DOI 10.1016/j.ajpath.2011.09.025; Otth C, 2002, J ALZHEIMERS DIS, V4, P417, DOI 10.3233/JAD-2002-4508; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Quinn JF, 2007, NEUROBIOL AGING, V28, P213, DOI 10.1016/j.neurobiolaging.2005.12.014; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Schmidt SL, 2001, INT J DEV NEUROSCI, V19, P469, DOI 10.1016/S0736-5748(00)00068-X; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Tetewsky SJ, 1999, NEUROLOGY, V52, P958, DOI 10.1212/WNL.52.5.958; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Walsh DT, 2005, NEUROPATH APPL NEURO, V31, P491, DOI 10.1111/j.1365-2990.2005.00666.x; Wang AL, 2010, NEUROBIOL AGING, V31, P2002, DOI 10.1016/j.neurobiolaging.2008.10.019; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Yin YQ, 2003, J NEUROSCI, V23, P2284	80	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64246	10.1371/journal.pone.0064246	http://dx.doi.org/10.1371/journal.pone.0064246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750207	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900009
J	Abranches, J; Tijerina, P; Aviles-Reyes, A; Gaca, AO; Kajfasz, JK; Lemos, JA				Abranches, Jacqueline; Tijerina, Pamella; Aviles-Reyes, Alejandro; Gaca, Anthony O.; Kajfasz, Jessica K.; Lemos, Jose A.			The Cell Wall-Targeting Antibiotic Stimulon of Enterococcus faecalis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; LISTERIA-MONOCYTOGENES; VANCOMYCIN RESISTANCE; LIPOTEICHOIC ACID; HISTIDINE KINASE; STRESS-RESPONSE; EXPRESSION; BIOSYNTHESIS; PHOSPHATASE; REVEALS	Enterococcus faecalis is an opportunistic nosocomial pathogen that is highly resistant to a variety of environmental insults, including an intrinsic tolerance to antimicrobials that target the cell wall (CW). With the goal of determining the CW-stress stimulon of E. faecalis, the global transcriptional profile of E. faecalis OG1RF exposed to ampicillin, bacitracin, cephalotin or vancomycin was obtained via microarrays. Exposure to the beta-lactams ampicillin and cephalotin resulted in the fewest transcriptional changes with 50 and 192 genes differentially expressed 60 min after treatment, respectively. On the other hand, treatment with bacitracin or vancomycin for 60 min affected the expression of, respectively, 377 and 297 genes. Despite the differences in the total number of genes affected, all antibiotics induced a very similar gene expression pattern with an overrepresentation of genes encoding hypothetical proteins, followed by genes encoding proteins associated with cell envelope metabolism as well as transport and binding proteins. In particular, all drug treatments, most notably bacitracin and vancomycin, resulted in an apparent metabolic downshift based on the repression of genes involved in translation, energy metabolism, transport and binding. Only 19 genes were up-regulated by all conditions at both the 30 and 60 min time points. Among those 19 genes, 4 genes encoding hypothetical proteins (EF0026, EF0797, EF1533 and EF3245) were inactivated and the respective mutant strains characterized in relation to antibiotic tolerance and virulence in the Galleria mellonella model. The phenotypes obtained for two of these mutants, DEF1533 and DEF3245, support further characterization of these genes as potential candidates for the development of novel preventive or therapeutic approaches.	[Abranches, Jacqueline; Tijerina, Pamella; Aviles-Reyes, Alejandro; Gaca, Anthony O.; Kajfasz, Jessica K.; Lemos, Jose A.] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Abranches, Jacqueline; Tijerina, Pamella; Aviles-Reyes, Alejandro; Gaca, Anthony O.; Lemos, Jose A.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Lemos, JA (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	jose_lemos@urmc.rochester.edu		Gaca, Anthony/0000-0003-3476-7034; Lemos, Jose/0000-0003-0791-5863	National Institutes of Health-National Institute of General Medical Sciences [R25 GM064133]; National Institutes of Health-National Institute of Dental and Craniofacial Research grant [T90 DE021985]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064133] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health-National Institute of Dental and Craniofacial Research grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PT was supported by National Institutes of Health-National Institute of General Medical Sciences grant R25 GM064133. AOG and AAR were supported by National Institutes of Health-National Institute of Dental and Craniofacial Research grant T90 DE021985. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; Aakra A, 2010, INT J MICROBIOL, V2010; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Bearman GML, 2005, ARCH MED RES, V36, P646, DOI 10.1016/j.arcmed.2005.02.005; Bernard R, 2005, J BIOL CHEM, V280, P28852, DOI 10.1074/jbc.M413750200; Bitoun JP, 2012, APPL ENVIRON MICROB, V78, P2914, DOI 10.1128/AEM.07823-11; Bizzini A, 2009, J ANTIMICROB CHEMOTH, V64, P1196, DOI 10.1093/jac/dkp369; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Breidenstein EBM, 2012, ANTIMICROB AGENTS CH, V56, P2879, DOI 10.1128/AAC.06014-11; Brunskill EW, 1996, J BACTERIOL, V178, P5810, DOI 10.1128/jb.178.19.5810-5812.1996; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Chatfield CH, 2005, MICROBIOL-SGM, V151, P625, DOI 10.1099/mic.0.27604-0; Collins B, 2012, APPL ENVIRON MICROB, V78, P2923, DOI 10.1128/AEM.07402-11; Doun SS, 2005, PROTEIN SCI, V14, P1134, DOI 10.1110/ps.041210405; Fontana R, 1996, MICROB DRUG RESIST, V2, P209, DOI 10.1089/mdr.1996.2.209; Fritsch F, 2011, MICROBIOL-SGM, V157, P373, DOI 10.1099/mic.0.044776-0; Gaca AO, 2012, MICROBIOL-SGM, V158, P1994, DOI 10.1099/mic.0.060236-0; Gutmann L, 1996, ANTIMICROB AGENTS CH, V40, P257, DOI 10.1128/AAC.40.1.257; Haas W, 2005, J BACTERIOL, V187, P8205, DOI 10.1128/JB.187.23.8205-8210.2005; Heuston S, 2012, MICROBIOL-SGM, V158, P1389, DOI 10.1099/mic.0.051599-0; Hollenbeck BL, 2012, VIRULENCE, V3, P421, DOI 10.4161/viru.21282; Hubscher J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-617; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kristich CJ, 2007, PLASMID, V57, P131, DOI 10.1016/j.plasmid.2006.08.003; Lebreton F, 2009, INFECT IMMUN, V77, P2832, DOI 10.1128/IAI.01218-08; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Lopez G, 2012, BIOMETALS, V25, P737, DOI 10.1007/s10534-012-9539-5; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; McCormick NE, 2011, MICROBIOL-SGM, V157, P2248, DOI 10.1099/mic.0.048140-0; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; PALLARES R, 1993, ARCH INTERN MED, V153, P1581, DOI 10.1001/archinte.153.13.1581; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Ramarao N, 2012, JOVE-J VIS EXP, DOI 10.3791/4392; Reynolds PE, 2005, ANTIMICROB AGENTS CH, V49, P21, DOI 10.1128/AAC.49.1.21-25.2005; Rigottier-Gois L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029023; Rogers PD, 2007, J ANTIMICROB CHEMOTH, V59, P616, DOI 10.1093/jac/dkl560; Rossi J, 2003, ANTIMICROB AGENTS CH, V47, P2558, DOI 10.1128/AAC.47.8.2558-2564.2003; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Solheim M, 2007, APPL ENVIRON MICROB, V73, P5767, DOI 10.1128/AEM.00651-07; Song Y, 2012, ANTIMICROB AGENTS CH, V56, P3157, DOI 10.1128/AAC.05403-11; STONE KJ, 1972, P NATL ACAD SCI USA, V69, P1287, DOI 10.1073/pnas.69.5.1287; TERLECKYJ B, 1975, INFECT IMMUN, V11, P649, DOI 10.1128/IAI.11.4.649-655.1975; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Vebo HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012489; Vebo HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007660; Waggoner DW, 1996, J BIOL CHEM, V271, P16506, DOI 10.1074/jbc.271.28.16506; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wen ZZT, 2006, J BACTERIOL, V188, P2983, DOI 10.1128/JB.188.8.2983-2992.2006; Zhang XL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002804; Zhang Y, 2008, BIOSCI BIOTECH BIOCH, V72, P3134, DOI 10.1271/bbb.80305	56	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64875	10.1371/journal.pone.0064875	http://dx.doi.org/10.1371/journal.pone.0064875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755154	Green Submitted, Green Published, gold			2022-12-25	WOS:000319872300034
J	Claudio, ERG; Endlich, PW; Santos, RL; Moyses, MR; Bissoli, NS; Gouvea, SA; Silva, JF; Lemos, VS; Abreu, GR				Claudio, Erick R. G.; Endlich, Patrick W.; Santos, Roger L.; Moyses, Margareth R.; Bissoli, Nazare S.; Gouvea, Sonia A.; Silva, Josiane F.; Lemos, Virginia S.; Abreu, Glaucia R.			Effects of Chronic Swimming Training and Oestrogen Therapy on Coronary Vascular Reactivity and Expression of Antioxidant Enzymes in Ovariectomized Rats	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; CU/ZN-SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; NITRIC-OXIDE; ANGIOTENSIN-II; ENDOTHELIAL DYSFUNCTION; BODY-COMPOSITION; BLOOD-PRESSURE; HEART-DISEASE	The aim of this study was to evaluate the effects of swimming training (SW) and oestrogen replacement therapy (ERT) on coronary vascular reactivity and the expression of antioxidant enzymes in ovariectomized rats. Animals were randomly assigned to one of five groups: sham (SH), ovariectomized (OVX), ovariectomized with E2 (OE2), ovariectomized with exercise (OSW), and ovariectomized with E2 plus exercise (OE2+SW). The SW protocol (5x/week, 60 min/day) and/or ERT were conducted for 8 weeks; the vasodilator response to bradykinin was analysed (Langendorff Method), and the expression of antioxidant enzymes (SOD-1 and 2, catalase) and eNOS and iNOS were evaluated by Western blotting. SW and ERT improved the vasodilator response to the highest dose of bradykinin (1000 ng). However, in the OSW group, this response was improved at 100, 300 and 1000 ng when compared to OVX (p<0,05). The SOD-1 expression was increased in all treated/trained groups compared to the OVX group (p<0,05), and catalase expression increased in the OSW group only. In the trained group, eNOS increased vs. OE2, and iNOS decreased vs. SHAM (p<0,05). SW may represent an alternative to ERT by improving coronary vasodilation, most likely by increasing antioxidant enzyme and eNOS expression and augmenting NO bioavailability.	[Claudio, Erick R. G.; Endlich, Patrick W.; Santos, Roger L.; Moyses, Margareth R.; Bissoli, Nazare S.; Gouvea, Sonia A.; Abreu, Glaucia R.] Univ Fed Espirito Santo, Hlth Sci Ctr, Dept Physiol Sci, Vitoria, ES, Brazil; [Silva, Josiane F.; Lemos, Virginia S.] Univ Fed Minas Gerais, Dept Physiol & Biophys, Inst Biol Sci, Belo Horizonte, MG, Brazil	Universidade Federal do Espirito Santo; Universidade Federal de Minas Gerais	Claudio, ERG (corresponding author), Univ Fed Espirito Santo, Hlth Sci Ctr, Dept Physiol Sci, Vitoria, ES, Brazil.	erick_edf@yahoo.com.br	dos Santos, Roger Lyrio/AAH-7100-2020; Bissoli, Nazare/ABA-2679-2021; Lemos, Virginia/B-7305-2018; Abreu, Glaucia/F-8610-2012; Silva, Josiane/AAC-8361-2019	dos Santos, Roger Lyrio/0000-0003-4316-7196; Lemos, Virginia/0000-0003-1234-9325; Silva, Josiane/0000-0002-6623-7946; Goncalves Claudio, Erick Roberto/0000-0001-7030-3558	Conselho Nacional de Pesquisa [139522/2010-7]	Conselho Nacional de Pesquisa	ERGC was supported by a fellowship from Conselho Nacional de Pesquisa - 139522/2010-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas IA, 2006, HYPERTENSION, V48, P497, DOI 10.1161/01.HYP.0000235865.03528.f1; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Borgo MV, 2011, BRAZ J MED BIOL RES, V44, P786, DOI 10.1590/S0100-879X2011000800008; Bourassa PAK, 1996, P NATL ACAD SCI USA, V93, P10022, DOI 10.1073/pnas.93.19.10022; Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cai H, 2001, ARTERIOSCL THROM VAS, V21, P1571, DOI 10.1161/hq1001.097028; Ceravolo GS, 2013, STEROIDS, V78, P341, DOI 10.1016/j.steroids.2012.11.018; Colditz GA, 1998, JNCI-J NATL CANCER I, V90, P814, DOI 10.1093/jnci/90.11.814; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; de Moraes C, 2008, BMC PHYSL, V29, P8; Douchi T, 2000, MATURITAS, V35, P25, DOI 10.1016/S0378-5122(00)00094-3; Elhage R, 1997, ARTERIOSCL THROM VAS, V17, P2679, DOI 10.1161/01.ATV.17.11.2679; Endlich PW, 2011, PEPTIDES, V32, P1706, DOI 10.1016/j.peptides.2011.06.027; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; Ferrara CM, 2002, J CLIN ENDOCR METAB, V87, P4166, DOI 10.1210/jc.2001-012034; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Genazzani AR, 2006, GYNECOL ENDOCRINOL, V22, P145, DOI 10.1080/09513590600629092; Goldhammer E, 2005, INT J CARDIOL, V100, P93, DOI 10.1016/j.ijcard.2004.08.073; Hernandez I, 2000, AM J PHYSIOL-REG I, V279, pR1599, DOI 10.1152/ajpregu.2000.279.5.R1599; Hsia J, 2006, ARCH INTERN MED; Inoue N, 1996, CIRC RES, V79, P32, DOI 10.1161/01.RES.79.1.32; Kang LS, 2011, AM J PHYSIOL-HEART C, V300, pH2105, DOI 10.1152/ajpheart.00349.2010; Karolkiewicz J, 2009, ARCH GERONTOL GERIAT, V49, pE67, DOI 10.1016/j.archger.2008.09.001; Kohno H, 2002, JPN HEART J, V43, P25, DOI 10.1536/jhj.43.25; Kuru O, 2009, J APPL PHYSIOL, V107, P896, DOI 10.1152/japplphysiol.91180.2008; Lauer N, 2005, CARDIOVASC RES, V65, P254, DOI 10.1016/j.cardiores.2004.09.010; Laughlin MH, 2003, J APPL PHYSIOL, V94, P234, DOI 10.1152/japplphysiol.00246.2002; LeBlanc AJ, 2009, AM J PHYSIOL-REG I, V297, pR1713, DOI 10.1152/ajpregu.00178.2009; Lee S, 2011, AM J PHYSIOL-HEART C, V301, pH306, DOI 10.1152/ajpheart.01306.2010; Liu JK, 2000, J APPL PHYSIOL, V89, P21; Liu YP, 2002, CIRC RES, V91, P1070, DOI 10.1161/01.RES.0000046003.14031.98; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; McAllister RM, 2010, EUR J APPL PHYSIOL, V110, P1019, DOI 10.1007/s00421-010-1584-6; Moraes AN, 2011, BASIC CLIN PHARMACOL, V109, P334, DOI 10.1111/j.1742-7843.2011.00734.x; Okabe T, 2007, CARDIOVASC RES, V74, P537, DOI 10.1016/j.cardiores.2007.02.019; Otake A, 2010, INT HEART J, V51, P125, DOI 10.1536/ihj.51.125; Park JH, 2008, ACTA PHYSIOL, V193, P47, DOI 10.1111/j.1748-1716.2007.01799.x; Ray P, 1997, FEBS LETT, V409, P79, DOI 10.1016/S0014-5793(97)00487-0; Roque FR, 2011, CLINICS, V66, P2105, DOI 10.1590/S1807-59322011001200017; Rush JWE, 2000, AM J PHYSIOL-HEART C, V279, pH2068, DOI 10.1152/ajpheart.2000.279.5.H2068; Saengsirisuwan V, 2009, METABOLISM, V58, P38, DOI 10.1016/j.metabol.2008.08.004; Santos RL, 2004, BRAZ J MED BIOL RES, V37, P569, DOI 10.1590/S0100-879X2004000400014; Senechal M, 2011, CLIN INTERV AGING, V6, P221, DOI 10.2147/CIA.S23574; Shimada K, 2007, CIRC J, V71, P1147, DOI 10.1253/circj.71.1147; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P915, DOI 10.1007/s00424-010-0790-8; Shinoda M, 2002, INT J OBESITY, V26, P335, DOI 10.1038/sj.ijo.0801900; Silva-Antonialli MM, 2004, CARDIOVASC RES, V62, P587, DOI 10.1016/j.cardiores.2004.01.020; Stice JP, 2011, ENDOCRINOLOGY, V152, P1589, DOI 10.1210/en.2010-0627; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; Suvorava T, 2010, FREE RADICAL RES, V44, P199, DOI 10.3109/10715760903402898; Suvorava T, 2009, BBA-BIOENERGETICS, V1787, P802, DOI 10.1016/j.bbabio.2009.04.005; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006; Velthuis MJ, 2009, MENOPAUSE, V16, P777, DOI [10.1097/GME.0b013e318197122a, 10.1097/gme.0b013e318197122a]; Weigt C, 2012, MOL CELL ENDOCRINOL, V351, P227, DOI 10.1016/j.mce.2011.12.013; Wenger NK, 1997, BMJ-BRIT MED J, V315, P1085, DOI 10.1136/bmj.315.7115.1085; White RE, 2002, VASC PHARMACOL, V38, P73, DOI 10.1016/S0306-3623(02)00129-5; Witte MM, 2010, GEN COMP ENDOCR, V166, P520, DOI 10.1016/j.ygcen.2010.01.006; Xu XH, 2010, EXP PHYSIOL, V95, P1008, DOI 10.1113/expphysiol.2010.054221; Xu Y, 2004, AM J PHYSIOL-HEART C, V287, pH165, DOI 10.1152/ajpheart.00037.2004; Yang H, 2004, CIRC RES, V95, P1075, DOI 10.1161/01.RES.0000149564.49410.0d; Yang H, 2009, ATHEROSCLEROSIS, V207, P51, DOI 10.1016/j.atherosclerosis.2009.03.052; Yuksel H, 2007, GYNECOL ENDOCRINOL, V23, P99, DOI 10.1080/09513590601152177; Zoth N, 2010, J STEROID BIOCHEM, V122, P100, DOI 10.1016/j.jsbmb.2010.03.029; Zou MH, 1996, FEBS LETT, V382, P101, DOI 10.1016/0014-5793(96)00160-3	67	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64806	10.1371/journal.pone.0064806	http://dx.doi.org/10.1371/journal.pone.0064806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755145	gold, Green Submitted, Green Published			2022-12-25	WOS:000319872300028
J	Zhou, LR; Hosohata, K; Gao, S; Gu, ZP; Wang, ZX				Zhou, Liran; Hosohata, Keiko; Gao, Shen; Gu, Zhongping; Wang, Zhengxin			cGMP-Dependent Protein Kinase I beta Interacts with p44/WDR77 to Regulate Androgen Receptor- Driven Gene Expression	PLOS ONE			English	Article							PROSTATIC INTRAEPITHELIAL NEOPLASIA; SMOOTH-MUSCLE; CANCER CELLS; MEDIATED TRANSCRIPTION; SIGNAL-TRANSDUCTION; MOLECULAR-BIOLOGY; INDUCE APOPTOSIS; MICE LACKING; COFACTOR P44; G ACTIVATION	The androgen receptor (AR) pathway plays critical roles in controlling differentiation and proliferation of prostate epithelial cells. We previously identified a novel AR cofactor, p44/WDR77, which specifically enhances AR transcriptional activity in the prostate gland and prostate cancer. To further elucidate p44/WDR77's role in the AR signaling pathway, we conducted a yeast two-hybrid screening and identified cGMP-dependent protein kinase (PKG) as a p44/WDR77-interacting protein. Further investigation by lusiferase assay and kinase assay demonstrated that PKG-I beta physically interacted with and phosphorylated both p44 and AR and enhanced AR transactivity in synergy with p44 in an androgen-and cGMP-dependent manner. Furthermore, PKG1 beta expression promoted p44/WDR77 nuclear translocation and inhibited prostate cancer cell growth via G1 cell cycle arrest. Our findings characterize PKG as a novel regulator of AR-mediated transcription by enhancing AR cofactor p44/WDR77's function, which provide a novel mechanism for the growth regulation of prostate cancer cells by the androgen signaling.	[Zhou, Liran; Hosohata, Keiko; Gao, Shen; Gu, Zhongping; Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Wang, ZX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	zhenwang@mdanderson.org			National Institute of Diabetes and Digestive and Kidney Diseases [1R01 DK065156 01]; National Institutes of Health; Cancer Center Support Core grant [CA16672]; National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065156] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Core grant; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant (1R01 DK065156 01) to Z. W. from the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institutes of Health and by a Cancer Center Support Core grant (CA16672) to The University of Texas M. D. Anderson Cancer Center from the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz A, 2001, PROSTATE, V47, P29; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Birschmann I, 2004, ACTA BIOCHIM POL, V51, P397; Brinkmann A, 1999, J STEROID BIOCH MOL, V69; Busch JL, 2002, J BIOL CHEM, V277, P34048, DOI 10.1074/jbc.M202761200; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; Casteel DE, 2005, J BIOL CHEM, V280, P38211, DOI 10.1074/jbc.M507021200; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chatterjee B, 2003, MOL CELL BIOCHEM, V253, P89, DOI 10.1023/A:1026057402945; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Deguchi A, 2004, CANCER RES, V64, P3966, DOI 10.1158/0008-5472.CAN-03-3740; Deguchi A, 2002, MOL CANCER THER, V1, P803; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Foster CS, 2000, SCAND J UROL NEPHROL, V34, P19, DOI 10.1080/003655900750169284; Francis SH, 2002, FRONT BIOSCI-LANDMRK, V7, pD580, DOI 10.2741/francis; Fukumoto S, 1999, CIRC RES, V85, P985; Gao S, 2004, PROSTATE, V59, P214, DOI 10.1002/pros.10375; Gao S, 2010, ENDOCRINOLOGY, V151, P3941, DOI 10.1210/en.2009-1080; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gertzberg N, 2000, AM J RESP CELL MOL, V22, P105, DOI 10.1165/ajrcmb.22.1.3801; GLYNN RJ, 1985, AM J EPIDEMIOL, V121, P78; Goluboff ET, 2001, EXPERT OPIN INV DRUG, V10, P1875, DOI 10.1517/13543784.10.10.1875; Goluboff ET, 1999, UROLOGY, V53, P440, DOI 10.1016/S0090-4295(98)00513-5; Gu Z., 2012, ONCOGENE; Gu ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022395; Gudi T, 1996, J BIOL CHEM, V271, P4597; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; Haanen C, 2001, Curr Opin Investig Drugs, V2, P677; Hayward SW, 1996, ACTA ANAT, V155, P81; He B, 2003, EUR J BIOCHEM, V270, P2174, DOI 10.1046/j.1432-1033.2003.03574.x; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hou YL, 2006, CANCER LETT, V240, P60, DOI 10.1016/j.canlet.2005.08.035; Huang Y, 2001, CANCER RES, V61, P6918; Jenster G, 1999, SEMIN ONCOL, V26, P407; KELLOKUMPULEHTINEN P, 1985, BIOL NEONATE, V48, P157; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Kish J A, 2001, Cancer Control, V8, P487; Lim JTE, 1999, BIOCHEM PHARMACOL, V58, P1097, DOI 10.1016/S0006-2952(99)00200-2; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Liu GZ, 2003, J BIOL CHEM, V278, P14956, DOI 10.1074/jbc.M212229200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MCNEAL JE, 1988, AM J SURG PATHOL, V12, P619, DOI 10.1097/00000478-198808000-00003; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Ryan CW, 2005, BJU INT, V95, P963, DOI 10.1111/j.1464-410X.2005.05448.x; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Sakr WA, 2001, UROLOGY, V57, P115, DOI 10.1016/S0090-4295(00)00953-5; SAKR WA, 1995, PATHOL RES PRACT, V191, P838, DOI 10.1016/S0344-0338(11)80965-9; Smolenski A, 1998, N-S ARCH PHARMACOL, V358, P134, DOI 10.1007/PL00005234; Soh JW, 2001, J BIOL CHEM, V276, P16406, DOI 10.1074/jbc.C100079200; Swerdloff RS, 2004, BEST PRACT RES CL EN, V18, P349, DOI 10.1016/j.beem.2004.03.011; Taylor MK, 2002, J BIOL CHEM, V277, P37242, DOI 10.1074/jbc.M202060200; Thompson HJ, 1997, CANCER RES, V57, P267; Thompson WJ, 2000, CANCER RES, V60, P3338; TIMMS BG, 1994, J UROLOGY, V151, P1427, DOI 10.1016/S0022-5347(17)35273-4; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Wang G, 2006, ONCOGENE; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Zhou LR, 2006, J MOL ENDOCRINOL, V37, P283, DOI 10.1677/jme.1.02062; Zhu B, 2005, J CELL BIOCHEM, V94, P336, DOI 10.1002/jcb.20286	69	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63119	10.1371/journal.pone.0063119	http://dx.doi.org/10.1371/journal.pone.0063119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755100	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300006
J	Bergeron, D; Lapointe, C; Bissonnette, C; Tremblay, G; Motard, J; Roucou, X				Bergeron, Danny; Lapointe, Catherine; Bissonnette, Cyntia; Tremblay, Guillaume; Motard, Julie; Roucou, Xavier			An Out-of-frame Overlapping Reading Frame in the Ataxin-1 Coding Sequence Encodes a Novel Ataxin-1 Interacting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ataxia; Gene Expression; Nucleus; RNA-Binding Protein; Translation; Alternative Translation Initiation; Spinocerebellar Ataxia Type 1; Dual Coding Gene; Overlapping Reading Frame	POLYGLUTAMINE-INDUCED DISEASE; NUCLEAR-LOCALIZATION; SHUTTLING SEQUENCE; MESSENGER-RNA; CAG REPEAT; GENE; TRANSCRIPTION; IMPORT; STRESS; IDENTIFICATION	Spinocerebellar ataxia type 1 is an autosomal dominant cerebellar ataxia associated with the expansion of a polyglutamine tract within the ataxin-1 (ATXN1) protein. Recent studies suggest that understanding the normal function of ATXN1 in cellular processes is essential to decipher the pathogenesis mechanisms in spinocerebellar ataxia type 1. We found an alternative translation initiation ATG codon in the +3 reading frame of human ATXN1 starting 30 nucleotides downstream of the initiation codon for ATXN1 and ending at nucleotide 587. This novel overlapping open reading frame (ORF) encodes a 21-kDa polypeptide termed Alt-ATXN1 (Alternative ATXN1) with a completely different amino acid sequence from ATXN1. We introduced a hemagglutinin tag in-frame with Alt-ATXN1 in ATXN1 cDNA and showed in cell culture the co-expression of both ATXN1 and Alt-ATXN1. Remarkably, Alt-ATXN1 colocalized and interacted with ATXN1 in nuclear inclusions. In contrast, in the absence of ATXN1 expression, Alt-ATXN1 displays a homogenous nucleoplasmic distribution. Alt-ATXN1 interacts with poly(A)(+) RNA, and its nuclear localization is dependent on RNA transcription. Polyclonal antibodies raised against Alt-ATXN1 confirmed the expression of Alt-ATXN1 in human cerebellum expressing ATXN1. These results demonstrate that human ATXN1 gene is a dual coding sequence and that ATXN1 interacts with and controls the subcellular distribution of Alt-ATXN1.	[Bergeron, Danny; Lapointe, Catherine; Bissonnette, Cyntia; Tremblay, Guillaume; Motard, Julie; Roucou, Xavier] Univ Sherbrooke, Dept Biochem, Fac Med & Sci Sante, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Roucou, X (corresponding author), Univ Sherbrooke, Dept Biochim Z8 2001, Fac Med & Sci Sante, 3201 Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada.	xavier.roucou@usherbrooke.ca			Canadian Institutes for Health Research [MOP-89881]; Natural Sciences and Engineering Research Council of Canada; Fonds de la Recherche en sante du Quebec	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la Recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes for Health Research (MOP-89881; to X. R.).; Recipient of a postgraduate scholarship from the Natural Sciences and Engineering Research Council of Canada and from the Fonds de la Recherche en sante du Quebec.	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Beaudoin S, 2009, BBA-MOL CELL RES, V1793, P335, DOI 10.1016/j.bbamcr.2008.10.009; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Cvetanovic M, 2007, EMBO REP, V8, P671, DOI 10.1038/sj.embor.7400983; Cvetanovic M, 2012, NEUROBIOL DIS, V48, P526, DOI 10.1016/j.nbd.2012.07.024; DUNCAN RF, 1987, ARCH BIOCHEM BIOPHYS, V256, P651, DOI 10.1016/0003-9861(87)90622-9; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Goggin K, 2008, BBA-MOL CELL RES, V1783, P479, DOI 10.1016/j.bbamcr.2007.10.008; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Ito T, 2010, BIOCHEM BIOPH RES CO, V403, P161, DOI 10.1016/j.bbrc.2010.10.036; Kang S, 2009, MOL CELLS, V27, P621, DOI 10.1007/s10059-009-0095-y; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee S, 1999, MOL CELL BIOL, V19, P1486; Lee Y, 2011, DEV CELL, V21, P746, DOI 10.1016/j.devcel.2011.08.017; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Michael WM, 1995, COLD SPRING HARB SYM, V60, P663, DOI 10.1101/SQB.1995.060.01.071; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; QUELLE DE, 1995, CELL, V83, P993; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Rosenberg SA, 2002, J IMMUNOL, V168, P2402, DOI 10.4049/jimmunol.168.5.2402; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Smith D.B., 2001, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.MB1607S28, DOI 10.1002/0471142727.MB1607S28]; Tong X, 2011, EMBO REP, V12, P428, DOI 10.1038/embor.2011.49; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Vanderperre B, 2011, FASEB J, V25, P2373, DOI 10.1096/fj.10-173815; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang C, 2010, J BIOL CHEM, V285, P8515, DOI 10.1074/jbc.M109.079079; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	49	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21824	10.1074/jbc.M113.472654	http://dx.doi.org/10.1074/jbc.M113.472654			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760502	hybrid, Green Published			2022-12-25	WOS:000328841900032
J	Liu, J; Dyer, D; Wang, JP; Wang, SQ; Du, XF; Xu, B; Zhang, HB; Wang, XN; Hu, W				Liu, Jian; Dyer, Dave; Wang, Jipeng; Wang, Shuqi; Du, Xiaofeng; Xu, Bin; Zhang, Haobing; Wang, Xiaoning; Hu, Wei			3-Oxoacyl-ACP Reductase from Schistosoma japonicum: Integrated In Silico-In Vitro Strategy for Discovering Antischistosomal Lead Compounds	PLOS ONE			English	Article							FATTY-ACID BIOSYNTHESIS; KETOACYL-ACP REDUCTASE; CARRIER PROTEIN REDUCTASE; MYCOBACTERIUM-TUBERCULOSIS; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; REDUCED SUSCEPTIBILITY; CHEMICAL MECHANISMS; CRYSTAL-STRUCTURE; DRUG DISCOVERY	Background: Schistosomiasis is a disease caused by parasitic worms and more than 200 million people are infected worldwide. The emergence of resistance to the most commonly used drug, praziquantel (PZQ), makes the development of novel drugs an urgent task. 3-oxoacyl-ACP reductase (OAR), a key enzyme involved in the fatty acid synthesis pathway, has been identified as a potential drug target against many pathogenic organisms. However, no research on Schistosoma japonicum OAR (SjOAR) has been reported. The characterization of the SjOAR protein will provide new strategies for screening antischistosomal drugs that target SjOAR. Methodology/Principal Findings: After cloning the SjOAR gene, recombinant SjOAR protein was purified and assayed for enzymatic activity. The tertiary structure of SjOAR was obtained by homology modeling and 27 inhibitor candidates were identified from 14,400 compounds through molecular docking based on the structure. All of these compounds were confirmed to be able to bind to the SjOAR protein by BIAcore analysis. Two compounds exhibited strong antischistosomal activity and inhibitory effects on the enzymatic activity of SjOAR. In contrast, these two compounds showed relatively low toxicity towards host cells. Conclusions/Significance: The work presented here shows the feasibility of isolation of new antischistosomal compounds using a combination of virtual screening and experimental validation. Based on this strategy, we successfully identified 2 compounds that target SjOAR with strong antischistosomal activity but relatively low cytotoxicity to host cells.	[Liu, Jian; Wang, Jipeng; Wang, Shuqi; Du, Xiaofeng; Wang, Xiaoning; Hu, Wei] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Liu, Jian; Xu, Bin; Zhang, Haobing; Hu, Wei] Chinese Ctr Dis Control & Prevent, Inst Parasit Dis, Minist Publ Hlth, Key Lab Parasite & Vector Biol, Shanghai, Peoples R China; [Dyer, Dave] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	Fudan University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; University of Wisconsin System; University of Wisconsin Madison	Hu, W (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	huwwyz@163.com	Wang, Jipeng/AAF-2575-2020; HU, Wei/F-1004-2012	Wang, Jipeng/0000-0003-0107-424X; Wang, Shuqi/0000-0002-4460-7221	National Natural Science Foundation of China [30400562]; National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment" [2009ZX10004-302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment"	This work was supported by grants from The National Natural Science Foundation of China (grant no. 30400562, http://www.nsfc.gov.cn/) and The National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment" (grant no. 2009ZX10004-302, http://www.nmp.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN D, 1987, MOL BIOCHEM PARASIT, V23, P123, DOI 10.1016/0166-6851(87)90147-2; Alonso D, 2006, AM J TROP MED HYG, V74, P342, DOI 10.4269/ajtmh.2006.74.342; Brouwers JFHM, 1998, BIOCHEM J, V334, P315, DOI 10.1042/bj3340315; Chebotareva M A, 2011, Zh Evol Biokhim Fiziol, V47, P383; Chen Hong-Chen, 2011, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V23, P5; Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Cohen-Gonsaud M, 2002, J MOL BIOL, V320, P249, DOI 10.1016/S0022-2836(02)00463-1; Fawcett T, 2000, FEBS LETT, V484, P65, DOI 10.1016/S0014-5793(00)02128-1; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Kanzok SM, 2000, J BIOL CHEM, V275, P40180, DOI 10.1074/jbc.M007633200; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kumar NS, 2012, BIOORGAN MED CHEM, V20, P7069, DOI 10.1016/j.bmc.2012.10.002; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Lee WG, 2012, J MED CHEM, V55, P3687, DOI 10.1021/jm2012326; Lepore R, 2011, J CHEM INF MODEL, V51, P3005, DOI 10.1021/ci2001764; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lykidis A, 2008, BIOENERGY, P407; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Patel MP, 2005, BIOCHEMISTRY-US, V44, P16753, DOI 10.1021/bi050947j; Payne DJ, 2001, DRUG DISCOV TODAY, V6, P537, DOI 10.1016/S1359-6446(01)01774-3; Pillai S, 2003, BIOCHEM BIOPH RES CO, V303, P387, DOI 10.1016/S0006-291X(03)00321-8; Poncet-Montange G, 2007, ACTA CRYSTALLOGR D, V63, P923, DOI 10.1107/S0907444907024158; Postigo MP, 2010, J CHEM INF MODEL, V50, P1693, DOI 10.1021/ci100128k; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Salas JJ, 2011, J AGR FOOD CHEM, V59, P12486, DOI 10.1021/jf203366z; SCHULZ H, 1971, J BIOL CHEM, V246, P1895; Shimokawa T, 2002, P NATL ACAD SCI USA, V99, P66, DOI 10.1073/pnas.012606199; Silva RG, 2008, ARCH BIOCHEM BIOPHYS, V471, P1, DOI 10.1016/j.abb.2007.12.002; Silva RG, 2006, BIOCHEMISTRY-US, V45, P13064, DOI 10.1021/bi0611210; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; Sogabe S, 2003, J BIOL CHEM, V278, P19387, DOI 10.1074/jbc.M208146200; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; Vo MT, 2008, J BIOSCI BIOENG, V106, P95, DOI 10.1263/jbb.106.95; Wang W, 2010, PARASITOLOGY, V137, P1905, DOI 10.1017/S0031182010001204; Wickramasinghe SR, 2006, BIOCHEM J, V393, P447, DOI 10.1042/BJ20050832; Witkowski A, 2004, CHEM BIOL, V11, P1667, DOI 10.1016/j.chembiol.2004.09.016; Xiao SH, 2009, PARASITOL RES, V106, P237, DOI 10.1007/s00436-009-1656-x	42	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e64984	10.1371/journal.pone.0064984	http://dx.doi.org/10.1371/journal.pone.0064984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762275	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800012
J	Cai, CY; Shi, WT; Zeng, Z; Zhang, MY; Ling, C; Chen, L; Cai, CQ; Zhang, BS; Li, WD				Cai, Chunyou; Shi, Wentao; Zeng, Zheng; Zhang, Meiyun; Ling, Chao; Chen, Lei; Cai, Chunquan; Zhang, Benshu; Li, Wei-Dong			GTP Cyclohydrolase I and Tyrosine Hydroxylase Gene Mutations in Familial and Sporadic Dopa-Responsive Dystonia Patients	PLOS ONE			English	Article							DELETION; GCH1; DEFICIENCY; PENETRANCE; PHENOTYPE; FREQUENCY; PROMOTER; DYT14; FORM	Dopa-responsive dystonia (DRD) is a rare inherited dystonia that responds very well to levodopa treatment. Genetic mutations of GTP cyclohydrolase I (GCH1) or tyrosine hydroxylase (TH) are disease-causing mutations in DRD. To evaluate the genotype-phenotype correlations and diagnostic values of GCH1 and TH mutation screening in DRD patients, we carried out a combined study of familial and sporadic cases in Chinese Han subjects. We collected 23 subjects, 8 patients with DRD, 5 unaffected family members, and 10 sporadic cases. We used PCR to sequence all exons and splicing sites of the GCH1 and TH genes. Three novel heterozygous GCH1 mutations (Tyr75Cys, Ala98Val, and Ile135Thr) were identified in three DRD pedigrees. We failed to identify any GCH1 or TH mutation in two affected sisters. Three symptom-free male GCH1 mutation carriers were found in two DRD pedigrees. For those DRD siblings that shared the same GCH1 mutation, symptoms and age of onset varied. In 10 sporadic cases, only two heterozygous TH mutations (Ser19Cys and Gly397Arg) were found in two subjects with unknown pathogenicity. No GCH1 and TH mutation was found in 40 unrelated normal Han Chinese controls. GCH1 mutation is the main etiology of familial DRD. Three novel GCH1 mutations were identified in this study. Genetic heterogeneity and incomplete penetrance were quite common in DRD patients, especially in sporadic cases. Genetic screening may help establish the diagnosis of DRD; however, a negative GCH1 and TH mutation test would not exclude the diagnosis.	[Cai, Chunyou; Shi, Wentao; Ling, Chao; Li, Wei-Dong] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China; [Zeng, Zheng] Tianjin Med Univ, Tianjin Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Zhang, Meiyun; Chen, Lei] Tianjin Peoples Hosp, Dept Neurol, Tianjin, Peoples R China; [Cai, Chunquan] Tianjin Childrens Hosp, Dept Surg, Tianjin, Peoples R China; [Zhang, Benshu] Tianjin Med Univ, Tianjin Gen Hosp, Dept Neurol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Zhang, BS (corresponding author), Tianjin Med Univ, Tianjin Gen Hosp, Dept Neurol, Tianjin, Peoples R China.	zxdgmcp@sina.com; liweidong98@tijmu.edu.cn	LING, CHAO/W-3528-2019; SHI, wen/GPW-9531-2022	Li, Wei-Dong/0000-0003-0521-7412; LING, CHAO/0000-0001-5328-4906	National Natural Science Foundation of China (NSFC) [81070576]; Tianjin Municipal Science and Technology Commission [12JCZDJC24700]; Scientific Research Foundation of Tianjin Bureau of Public Health [09KY14, 2011KZ87]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission; Scientific Research Foundation of Tianjin Bureau of Public Health	This work was supported in part by grants (81070576) from the National Natural Science Foundation of China (NSFC) and (12JCZDJC24700) from Tianjin Municipal Science and Technology Commission to WDL, and a grant from the Scientific Research Foundation of Tianjin Bureau of Public Health (09KY14 and 2011KZ87) (both to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodzioch M, 2011, MOVEMENT DISORD, V26, P337, DOI 10.1002/mds.23364; Brautigam C, 1999, CLIN CHEM, V45, P2073; Brique S, 1999, NEUROREPORT, V10, P487, DOI 10.1097/00001756-199902250-00008; CALNE DB, 1994, ANN NEUROL, V35, P381, DOI 10.1002/ana.410350402; Chaila EC, 2006, ARCH NEUROL-CHICAGO, V63, P1185, DOI 10.1001/archneur.63.8.1185; Dionisi-Vici C, 2000, J PEDIATR-US, V136, P560, DOI 10.1016/S0022-3476(00)90027-1; Furukawa Y, 1998, NEUROLOGY, V50, P1015, DOI 10.1212/WNL.50.4.1015; Furukawa Y, 1999, MOVEMENT DISORD, V14, P709, DOI 10.1002/1531-8257(199909)14:5<709::AID-MDS1001>3.0.CO;2-T; Furukawa Y, 2000, ANN NEUROL, V47, P517; Grotzsch H, 2002, NEUROLOGY, V58, P1839, DOI 10.1212/WNL.58.12.1839; Hahn H, 2001, ARCH NEUROL-CHICAGO, V58, P749, DOI 10.1001/archneur.58.5.749; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; LUDECKE B, 1995, HUM GENET, V95, P123; NAR H, 1995, STRUCTURE, V3, P459, DOI 10.1016/S0969-2126(01)00179-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Segawa M, 1976, Adv Neurol, V14, P215; Segawa Masaya, 2011, Handb Clin Neurol, V100, P539, DOI 10.1016/B978-0-444-52014-2.00039-2; Steinberger D, 1998, ANN NEUROL, V43, P634, DOI 10.1002/ana.410430512; Steinberger D, 2007, NEUROGENETICS, V8, P51, DOI 10.1007/s10048-006-0069-6; TAKAHASHI H, 1994, ANN NEUROL, V35, P354, DOI 10.1002/ana.410350317; Theuns J, 2012, MOVEMENT DISORD, V27, P1451, DOI 10.1002/mds.25147; Trender-Gerhard I, 2009, J NEUROL NEUROSUR PS, V80, P839, DOI 10.1136/jnnp.2008.155861; Van Hove JLK, 2006, J NEUROL NEUROSUR PS, V77, P18, DOI 10.1136/jnnp.2004.051664; Wevers RA, 1999, J INHERIT METAB DIS, V22, P364, DOI 10.1023/A:1005539803576; Wider C, 2008, NEUROLOGY, V70, P1377, DOI 10.1212/01.wnl.0000275527.35752.c5; Wu-Chou YH, 2010, AM J MED GENET B, V153B, P903, DOI 10.1002/ajmg.b.31058; Yu L, 2012, EUR J HUM GENET; Zirn B, 2008, J NEUROL NEUROSUR PS, V79, P183, DOI 10.1136/jnnp.2007.128413	28	8	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65215	10.1371/journal.pone.0065215	http://dx.doi.org/10.1371/journal.pone.0065215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762320	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000045
J	Chang, DH; Rutledge, JR; Patel, AA; Heerdt, BG; Augenlicht, LH; Korst, RJ				Chang, David H.; Rutledge, John R.; Patel, Ankur A.; Heerdt, Barbara G.; Augenlicht, Leonard H.; Korst, Robert J.			The Effect of Lung Cancer on Cytokine Expression in Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							INTERLEUKIN-8; IMMUNOTHERAPY; TRANSFUSION; CHEMOKINES; PROGNOSIS; SURVIVAL; PROTEIN; TUMORS; RISK	The purpose of this study is to evaluate cytokine expression by peripheral blood mononuclear cells (PBMC) from stage I lung cancer patients and to confirm these expression patterns by exposing PBMCs to lung cancer cells in vitro. Five altered cytokines in stage I lung cancer patients (CCL3, IL8, IL1 beta, CXCL10, sIL2R alpha) were identified in plasma from subjects (n = 15) before and after resection using a 30-plex panel protein assay. Gene expression studies using quantitative RT-qPCR were performed on PBMCs from stage I lung cancer patients (n = 62) before and after resection, and compared to non-cancer patients (n = 32) before and after surgery for benign disease. Co-culture experiments that exposed healthy donor PBMCs to lung cancer cells in vitro were performed to evaluate the effect on PBMC cytokine expression. PBMC gene expression of CCL3, IL8 and IL1 beta was higher in lung cancer patients compared to the same patients at each of four sequential timepoints after removal of their tumors, while CXCL10 and IL2R alpha were essentially unchanged. This pattern was also detected when lung cancer patients were compared to non-cancer patients. When non-cancer patients underwent surgery for benign diseases, these cytokine expression changes were not demonstrable. Lung cancer cell lines, but not benign bronchial epithelial cells, induced similar changes in cytokine gene and protein expression by healthy donor PBMCs in an in vitro coculture system. We conclude that PBMCs from stage I lung cancer patients possess distinct cytokine expression patterns compared to both non-cancer patients, and lung cancer patients following tumor removal. These expression patterns are replicated by healthy donor PBMCs exposed to lung cancer cell lines, but not benign bronchial epithelial cells in vitro. These findings have implications for understanding the immune response to lung cancer.	[Chang, David H.; Rutledge, John R.; Patel, Ankur A.; Heerdt, Barbara G.; Korst, Robert J.] Daniel & Gloria Blumenthal Canc Ctr, Ctr Canc Res & Genom Med, Paramus, NJ USA; [Korst, Robert J.] Valley Hosp, Dept Surg, Div Thorac Surg, Ridgewood, NJ USA; [Augenlicht, Leonard H.] Montefiore Med Ctr, Albert Einstein Canc Ctr, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Korst, RJ (corresponding author), Daniel & Gloria Blumenthal Canc Ctr, Ctr Canc Res & Genom Med, Paramus, NJ USA.	korsro@valleyhealth.com			Valley Hospital Foundation	Valley Hospital Foundation	This work was supported by the Valley Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Chen JJW, 2003, CLIN CANCER RES, V9, P729; DAVATELIS G, 1988, J EXP MED, V167, P1939, DOI 10.1084/jem.167.6.1939; Ganepola GAP, 2010, CLIN EXP METASTAS, V27, P1, DOI 10.1007/s10585-009-9295-2; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Homey B, 2002, NAT REV IMMUNOL, V2, P175, DOI 10.1038/nri748; Kaminska J, 2006, ONCOLOGY-BASEL, V70, P115, DOI 10.1159/000093002; Kolesar L, 2012, IMMUNOL RES, V52, P269, DOI 10.1007/s12026-012-8338-y; Landvik NE, 2009, CARCINOGENESIS, V30, P1186, DOI 10.1093/carcin/bgp122; Lechner MG, 2011, IMMUNOTHERAPY-UK, V3, P1317, DOI [10.2217/imt.11.115, 10.2217/IMT.11.115]; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Millar HJ, 2008, CANCER EPIDEM BIOMAR, V17, P2180, DOI 10.1158/1055-9965.EPI-07-2915; Mocellin S, 2001, J IMMUNOTHER, V24, P392, DOI 10.1097/00002371-200109000-00002; MODI WS, 1990, HUM GENET, V84, P185; MOORES DWO, 1989, ANN THORAC SURG, V47, P346, DOI 10.1016/0003-4975(89)90371-8; NETER J, 1996, APPL LINEAR STAT MOD, P1164; Pakkala Suchita, 2010, J Thorac Oncol, V5, P1864, DOI 10.1097/JTO.0b013e3181f387fd; Penna F, 2010, EXPERT OPIN BIOL TH, V10, P1241, DOI 10.1517/14712598.2010.503773; Pine SR, 2011, JNCI-J NATL CANCER I, V103, P1112, DOI 10.1093/jnci/djr216; RUCKDESCHEL JC, 1972, NEW ENGL J MED, V287, P1013, DOI 10.1056/NEJM197211162872004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; TARTTER PI, 1984, J THORAC CARDIOV SUR, V88, P659; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Whitson BA, 2008, ANN THORAC SURG, V86, P2008, DOI 10.1016/j.athoracsur.2008.07.009	26	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64456	10.1371/journal.pone.0064456	http://dx.doi.org/10.1371/journal.pone.0064456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762239	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000007
J	Mulla, MJ; Salmon, JE; Chamley, LW; Brosens, JJ; Boeras, CM; Kavathas, PB; Abrahams, VM				Mulla, Melissa J.; Salmon, Jane E.; Chamley, Larry W.; Brosens, Jan J.; Boeras, Crina M.; Kavathas, Paula B.; Abrahams, Vikki M.			A Role for Uric Acid and the Nalp3 Inflammasome in Antiphospholipid Antibody-Induced IL-1 beta Production by Human First Trimester Trophoblast	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; XANTHINE-OXIDASE; PATHOGENIC ROLE; PREGNANCY; FETAL; ACTIVATION; INTERLEUKIN-1-BETA; SECRETION; INFECTION; INVASION	Women with antiphospholipid syndrome (APS) are at risk of recurrent pregnancy loss and obstetrical disorders, such as preeclampsia and intrauterine growth restriction (IUGR). Antiphospholipid antibodies (aPL) directly target the placenta by binding beta(2)-glycoprotein I (beta(2)GPI) expressed on the trophoblast. We recently demonstrated in human first trimester trophoblast cells that anti-beta(2)GPI antibodies (Abs) induce the secretion of IL-1 beta in a Toll-like receptor 4 (TLR4)-dependent manner. IL-1 beta secretion requires processing of pro-IL-1 beta and this is mediated by the inflammasome, a complex of Nalp3, apoptosis-associated speck-like protein containing a CARD (ASC) and caspase-1. The objective of this study was to determine if aPL induce IL-1 beta production in trophoblast via the inflammasome. Using a human first trimester trophoblast cell line, we demonstrated that a mouse anti-beta(2)GPI mAb and human polyclonal aPL-IgG induce IL-1 beta processing and secretion, which was partially blocked upon caspase-1 inhibition. Nalp3 and ASC knockdown also attenuated anti-beta(2)GPI Ab-induced IL-1 beta secretion. Furthermore, aPL stimulated the production of uric acid in a TLR4-dependent manner; and inhibition of uric acid prevented aPL-induced IL-1 beta production by the trophoblast. These findings demonstrate that aPL, via TLR4 activation, induce a uric acid response in human trophoblast, which in turn activates the Nalp3/ASC inflammasome leading to IL-1 beta processing and secretion. This novel mechanism may account for the inflammation at the maternal-fetal interface, which causes placental dysfunction and increases the risk of adverse pregnancy outcome in patients with APS.	[Mulla, Melissa J.; Abrahams, Vikki M.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, New Haven, CT 06520 USA; [Salmon, Jane E.] Hosp Special Surg, New York, NY 10021 USA; [Salmon, Jane E.] Weill Cornell Med Coll, New York, NY USA; [Chamley, Larry W.] Univ Auckland, Dept Obstet & Gynecol, Auckland 1, New Zealand; [Brosens, Jan J.] Univ Warwick, Clin Sci Res Inst, Div Reprod Hlth, Coventry CV4 7AL, W Midlands, England; [Boeras, Crina M.; Kavathas, Paula B.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Boeras, Crina M.; Kavathas, Paula B.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA	Yale University; Cornell University; University of Auckland; University of Warwick; Yale University; Yale University	Abrahams, VM (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, New Haven, CT 06520 USA.	vikki.abrahams@yale.edu		Brosens, Jan/0000-0003-0116-9329; Chamley, Lawrence/0000-0002-7501-1340	American Heart Association; March of Dimes; NIH [RO1AR49772, RO1CA048511]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049772] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); March of Dimes(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the American Heart Association and the March of Dimes (to VMA), grant RO1AR49772 from the NIH (to JES), and grant RO1CA048511 from the NIH (to PKB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2009, THROMB RES, V124, P521, DOI 10.1016/j.thromres.2009.07.011; Berman J, 2005, J IMMUNOL, V174, P485, DOI 10.4049/jimmunol.174.1.485; Bose P, 2006, PLACENTA, V27, P869, DOI 10.1016/j.placenta.2005.09.007; BUTTERWORTH BH, 1991, BRIT J OBSTET GYNAEC, V98, P929, DOI 10.1111/j.1471-0528.1991.tb13516.x; Carroll TY, 2011, AM J REPROD IMMUNOL, V66, P286, DOI 10.1111/j.1600-0897.2011.01007.x; Chamley LW, 1999, CLIN EXP IMMUNOL, V115, P571; Chamley LW, 2001, FERTIL STERIL, V76, P700, DOI 10.1016/S0015-0282(01)01984-7; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Correa-Costa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029004; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Hirsch E, 1999, AM J OBSTET GYNECOL, V180, P429, DOI 10.1016/S0002-9378(99)70227-9; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kavathas PB, 2013, MUCOSAL IMMUNOL, V6, P235, DOI 10.1038/mi.2012.63; Keelan JA, 2004, BIOL REPROD, V70, P253, DOI 10.1095/biolreprod.103.016204; Lane T, 2011, CURR ALLERGY ASTHM R, V11, P361, DOI 10.1007/s11882-011-0207-6; Lockshin MD, 2012, ARTHRITIS RHEUM-US, V64, P2311, DOI 10.1002/art.34402; Many A, 1996, AM J OBSTET GYNECOL, V174, P288, DOI 10.1016/S0002-9378(96)70410-6; Martin AC, 2010, NAT REV NEPHROL, V6, P744, DOI 10.1038/nrneph.2010.125; Matsuura E, 2012, AUTOIMMUN REV, V12, P241, DOI 10.1016/j.autrev.2012.04.003; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Mulla MJ, 2011, AM J REPROD IMMUNOL, V65, P542, DOI 10.1111/j.1600-0897.2010.00960.x; Mulla MJ, 2010, AM J REPROD IMMUNOL, V63, P339, DOI 10.1111/j.1600-0897.2009.00805.x; Mulla MJ, 2009, AM J REPROD IMMUNOL, V62, P96, DOI 10.1111/j.1600-0897.2009.00717.x; Munno I, 1999, AM J REPROD IMMUNOL, V42, P369; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Netea MG, 2008, EXPERT OPIN BIOL TH, V8, P1867, DOI [10.1517/14712590802494212, 10.1517/14712590802494212 ]; Nicholas SA, 2011, CELL MOL LIFE SCI, V68, P151, DOI 10.1007/s00018-010-0450-3; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Reister F, 2001, LAB INVEST, V81, P1143, DOI 10.1038/labinvest.3780326; Rinehart BK, 1999, AM J OBSTET GYNECOL, V181, P915, DOI 10.1016/S0002-9378(99)70325-X; Salmon JE, 2008, LUPUS, V17, P405, DOI 10.1177/0961203308090025; Salmon JE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001013; Sebire NJ, 2002, HUM REPROD, V17, P1067, DOI 10.1093/humrep/17.4.1067; Stallmach T, 1999, VIRCHOWS ARCH, V434, P207, DOI 10.1007/s004280050329; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Tincani A, 2008, SEMIN THROMB HEMOST, V34, P267, DOI 10.1055/s-0028-1082270; Wilczynski JR, 2003, EUR J OBSTET GYN R B, V109, P8, DOI 10.1016/S0301-2115(02)00350-0	41	73	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65237	10.1371/journal.pone.0065237	http://dx.doi.org/10.1371/journal.pone.0065237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762324	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000047
J	Todaro, M; Orlando, V; Cicero, G; Caccamo, N; Meraviglia, S; Stassi, G; Dieli, F				Todaro, Matilde; Orlando, Valentina; Cicero, Giuseppe; Caccamo, Nadia; Meraviglia, Serena; Stassi, Giorgio; Dieli, Francesco			Chemotherapy Sensitizes Colon Cancer Initiating Cells to V gamma 9V delta 2 T Cell- Mediated Cytotoxicity	PLOS ONE			English	Article							GAMMA-DELTA CELLS; TRAIL-INDUCED APOPTOSIS; STEM-CELLS; TUMOR-CELLS; MONOCLONAL-ANTIBODY; HUMAN GLIOBLASTOMA; RECEPTOR; LINES; IMMUNOTHERAPY; ACTIVATION	Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is responsible for tumor maintenance and resistance to anti-cancer therapies, possibly allowing for tumor recapitulation once treatment stops. Combinations of immune-based therapies with chemotherapy and other anti-tumor agents may be of significant clinical benefit in the treatment of colon cancer. However, cellular immune-based therapies have not been experimented yet in the population of colon CICs. Here, we demonstrate that treatment with low concentrations of commonly used chemotherapeutic agents, 5-fluorouracyl and doxorubicin, sensitize colon CICs to V gamma 9V delta 2 T cell cytotoxicity. V gamma 9V delta 2 T cell cytotoxicity was largely mediated by TRAIL interaction with DR5, following NKG2D-dependent recognition of colon CIC targets. We conclude that in vivo activation of V gamma 9V delta 2 T cells or adoptive administration of ex-vivo expanded V gamma 9V delta 2 T cells at suitable intervals after chemotherapy may substantially increase anti-tumor activities and represent a novel strategy for colon cancer immunotherapy.	[Todaro, Matilde; Cicero, Giuseppe; Stassi, Giorgio] Univ Palermo, Dipartimento Discipline Chirurg & Anat, Palermo, Italy; [Todaro, Matilde; Orlando, Valentina; Caccamo, Nadia; Dieli, Francesco] Univ Palermo, Biomed Res Ctr, Palermo, Italy; [Orlando, Valentina; Caccamo, Nadia; Meraviglia, Serena; Dieli, Francesco] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy	University of Palermo; University of Palermo; University of Palermo	Dieli, F (corresponding author), Univ Palermo, Biomed Res Ctr, Palermo, Italy.	francesco.dieli@unipa.it	Caccamo, Nadia/J-6808-2018; Stassi, Giorgio/AAC-1175-2022; todaro, matilde/AAC-1003-2022; Meraviglia, Serena/K-5164-2016	todaro, matilde/0000-0001-8686-8043; Cicero, Giuseppe/0000-0002-4717-437X; CACCAMO, Nadia Rosalia/0000-0002-1018-5710; Dieli, Francesco/0000-0002-6685-352X	Italian Ministry for Instruction, University and Research [2008L57JXW]; Italian Ministry of Health; Istituto Superiore di Sanita Oncoproteomic Project [2007-527/B/3A/3]; University of Palermo	Italian Ministry for Instruction, University and Research; Italian Ministry of Health(Ministry of Health, Italy); Istituto Superiore di Sanita Oncoproteomic Project; University of Palermo	This work has been supported by grants from the Italian Ministry for Instruction, University and Research (contract no. 2008L57JXW to FD), the Italian Ministry of Health (Progetto Ricerca Finalizzata 2007 "Stem cells in different pathological conditions: innovative therapeutical approches'' to FD), Istituto Superiore di Sanita Oncoproteomic Project 2007-527/B/3A/3 (to GS and FD) and the University of Palermo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal RR, 2012, EUR J IMMUNOL, V42, P110, DOI 10.1002/eji.201142017; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Caccamo N, 2006, J IMMUNOL, V177, P5290, DOI 10.4049/jimmunol.177.8.5290; Caccamo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041940; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Corvaisier M, 2005, J IMMUNOL, V175, P5481, DOI 10.4049/jimmunol.175.8.5481; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deniger DC, 2013, MOL THER, V21, P638, DOI 10.1038/mt.2012.267; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; Eberl M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000308; Evdokiou A, 2002, INT J CANCER, V99, P491, DOI 10.1002/ijc.10376; Feldman EJ, 2005, J CLIN ONCOL, V23, P4110, DOI 10.1200/JCO.2005.09.133; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Hannani D, 2012, TRENDS IMMUNOL, V33, P199, DOI 10.1016/j.it.2012.01.006; Kang J, 2005, PROSTATE CANCER P D, V8, P274, DOI 10.1038/sj.pcan.4500798; Keane MM, 1999, CANCER RES, V59, P734; Kirkwood JM, 2012, CA-CANCER J CLIN, V62, P309, DOI 10.3322/caac.20132; Kistowska M, 2008, EUR J IMMUNOL, V38, P2200, DOI 10.1002/eji.200838366; Koch U, 2010, SEMIN CANCER BIOL, V20, P116, DOI 10.1016/j.semcancer.2010.02.003; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Linck D, 2005, LEUKEMIA LYMPHOMA, V46, P285, DOI 10.1080/10428190400015535; Ma YT, 2011, J EXP MED, V208, P491, DOI 10.1084/jem.20100269; Mattarollo SR, 2007, CANCER IMMUNOL IMMUN, V56, P1285, DOI 10.1007/s00262-007-0279-2; Mattarollo SR, 2006, INT J CANCER, V119, P1630, DOI 10.1002/ijc.22019; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Meraviglia S, 2010, J IMMUNOL, V185, P1770, DOI 10.4049/jimmunol.1000966; Sireci G, 2001, EUR J IMMUNOL, V31, P1628, DOI 10.1002/1521-4141(200105)31:5<1628::AID-IMMU1628>3.0.CO;2-T; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2009, J IMMUNOL, V182, P7287, DOI 10.4049/jimmunol.0804288; Tong HX, 2011, EUR J PEDIATR SURG, V21, P304, DOI 10.1055/s-0031-1279762; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Vermijlen D, 2007, J IMMUNOL, V178, P4304, DOI 10.4049/jimmunol.178.7.4304; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wen JH, 2000, BLOOD, V96, P3900, DOI 10.1182/blood.V96.12.3900.h8003900_3900_3906; Wesch D, 2001, CELL IMMUNOL, V212, P110, DOI 10.1006/cimm.2001.1850; Wrobel P, 2007, SCAND J IMMUNOL, V66, P320, DOI 10.1111/j.1365-3083.2007.01963.x; Wu XX, 2007, CANCER SCI, V98, P1969, DOI 10.1111/j.1349-7006.2007.00632.x; Yoshida S, 2003, PEDIATR RES, V54, P709, DOI 10.1203/01.PDR.0000085038.53151.D0	47	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							0065145	10.1371/journal.pone.0065145	http://dx.doi.org/10.1371/journal.pone.0065145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762301	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000035
J	Wallner, S; Lutz-Nicoladoni, C; Tripp, CH; Gastl, G; Baier, G; Penninger, JM; Stoitzner, P; Wolf, D				Wallner, Stephanie; Lutz-Nicoladoni, Christina; Tripp, Christoph H.; Gastl, Guenther; Baier, Gottfried; Penninger, Josef M.; Stoitzner, Patrizia; Wolf, Dominik			The Role of the E3 Ligase Cbl-B in Murine Dendritic Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; IN-VIVO; ANTIGEN PRESENTATION; NEGATIVE REGULATION; TGF-BETA; TOLERANCE; LIPOPOLYSACCHARIDE; UNRESPONSIVENESS	Dendritic cells (DCs) are potent antigen-presenting cells with a promising potential in cancer immunotherapy. Cbl proteins are E3 ubiquitin ligases and have been implicated in regulating the functional activity of various immune cells. As an example, c-Cbl negatively affects DC activation. We here describe that another member of the Cbl-protein family (i.e. Cbl-b) is highly expressed in murine bone-marrow-derived DCs (BMDCs). Differentiation of cblb-/- bone marrow mononuclear cells into classical BMDCs is unaltered, except enhanced induction of DEC-205 (CD205) expression. When tested in mixed-lymphocyte reaction (MLR), cblb-/- BMDCs exhibit increased allo-stimulatory capacity in vitro. BMDCs were next in vitro stimulated by various toll like receptor (TLR)-agonists (LPS, Poly(I: C), CpG) and exposed to FITC-labeled dextran. Upon TLR-stimulation, cblb-/- BMDCs produce higher levels of proinflammatory cytokines (IL-1 alpha, IL-6 and TNF-alpha) and exhibit a slightly higher level of FITC-dextran uptake. To further characterize the functional significance of cblb-/- BMDCs we tested them in antigen-specific T cell responses against ovalbumin (OVA) protein and peptides, activating either CD8(+) OT-I or CD4(+) OT-II transgenic T cells. However, cblb-/- BMDCs are equally effective in inducing antigen-specific T cell responses when compared to wildtype BMDCs both in vitro and in vivo. The migratory capacity into lymph nodes during inflammation was similarly not affected by the absence of Cbl-b. In line with these observations, cblb-/- peptide-pulsed BMDCs are equally effective vaccines against OVA-expressing B16 tumors in vivo when compared to wildtype BMDCs. We conclude that in contrast to c-Cbl, Cbl-b plays only a limited role in the induction of Ag-specific T cell responses by murine BMDCs in vitro and in vivo.	[Wallner, Stephanie; Lutz-Nicoladoni, Christina; Gastl, Guenther; Wolf, Dominik] Tyrolean Canc Res Inst, Lab Tumor Immunol, Innsbruck, Austria; [Tripp, Christoph H.; Stoitzner, Patrizia] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria; [Baier, Gottfried] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1010 Vienna, Austria; [Wolf, Dominik] Univ Hosp Bonn, Dept Hematol & Oncol, Bonn, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Bonn	Wolf, D (corresponding author), Tyrolean Canc Res Inst, Lab Tumor Immunol, Innsbruck, Austria.	dominik.wolf@ukb.uni-bonn.de	; Penninger, Josef/I-6860-2013	Tripp, Christoph/0000-0001-5502-7241; Penninger, Josef/0000-0002-8194-3777; stoitzner, patrizia/0000-0002-8488-6704; Baier, Gottfried/0000-0002-2085-8325	FWF Austrian Sience Fund [T550-B19]; MFF Tirol; Tiroler Landeskrankenanstalten GmbH; DFG German Research Foundation [WO1877/1-1]; Austrian Science Fund (FWF) [P 25044] Funding Source: researchfish	FWF Austrian Sience Fund; MFF Tirol; Tiroler Landeskrankenanstalten GmbH; DFG German Research Foundation(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported from the FWF Austrian Sience Fund (T550-B19), the MFF Tirol, the Tiroler Landeskrankenanstalten GmbH and the DFG German Research Foundation (WO1877/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Bauer B, 2000, EUR J IMMUNOL, V30, P3645, DOI 10.1002/1521-4141(200012)30:12<3645::AID-IMMU3645>3.0.CO;2-#; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Burgdorf S, 2012, J IMMUNOL, V176, P6770; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Chiou S-H, 2011, EMBO REPORTS, P1; Curtsinger JM, 2003, J EXP MED, V197, P1141, DOI 10.1084/jem.20021910; Delamarre L, 2011, SEMIN IMMUNOL, V23, P2, DOI 10.1016/j.smim.2011.02.001; den Brok MHMGM, 2005, EXPERT REV VACCINES, V4, P699, DOI 10.1586/14760584.4.5.699; Engell-Noerregaard L, 2009, CANCER IMMUNOL IMMUN, V58, P1, DOI 10.1007/s00262-008-0568-4; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kamala T, 2007, J IMMUNOL METHODS, V328, P204, DOI 10.1016/j.jim.2007.08.004; Karwacz K, 2011, EMBO MOL MED, V3, P581, DOI 10.1002/emmm.201100165; Kojo S, 2009, P NATL ACAD SCI USA, V106, P17847, DOI 10.1073/pnas.0904078106; Krawczyk CM, 2005, J IMMUNOL, V174, P1472, DOI 10.4049/jimmunol.174.3.1472; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Liechtenstein T, 2013, IMMUNOLOGY ENDOCRINE, V12, P1; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; Lugade AA, 2012, J IMMUNOL, P7516; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz- Nicoladoni C, 2011, IMMUNOL CELL BIOL, V2011, P1; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Mahnke K, 2003, BLOOD, V101, P4862, DOI 10.1182/blood-2002-10-3229; McLellan AD, 2002, BLOOD, V99, P2084, DOI 10.1182/blood.V99.6.2084; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Mukhopadhaya A, 2008, P NATL ACAD SCI USA, V105, P6374, DOI 10.1073/pnas.0802644105; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Nurieva R, 2006, EMBO J, V25, P2623, DOI 10.1038/sj.emboj.7601146; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Paolino M, 2011, J IMMUNOL, V186, P2138, DOI 10.4049/jimmunol.1003390; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schuler G, 2010, EUR J IMMUNOL, V40, P2123, DOI 10.1002/eji.201040630; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeda Kiyoshi, 2005, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V4, P3, DOI 10.2174/1568014053005336; Tjoa BA, 1998, PROSTATE, V36, P39; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wallner S, 2012, DEV CLIN IMMUNOLOGY, V2012, P1; Wanping J, 1995, NATURE, V375, P151; Wohlfert EA, 2006, J IMMUNOL, V176, P1316, DOI 10.4049/jimmunol.176.3.1316; Wohlfert EA, 2004, J IMMUNOL, V173, P1059, DOI 10.4049/jimmunol.173.2.1059	57	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65178	10.1371/journal.pone.0065178	http://dx.doi.org/10.1371/journal.pone.0065178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762309	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000040
J	Andersen, MLM; Rasmussen, MA; Porksen, S; Svensson, J; Vikre-Jorgensen, J; Thomsen, J; Hertel, NT; Johannesen, J; Pociot, F; Petersen, JS; Hansen, L; Mortensen, HB; Nielsen, LB				Andersen, Marie Louise Max; Rasmussen, Morten Arendt; Porksen, Sven; Svensson, Jannet; Vikre-Jorgensen, Jennifer; Thomsen, Jane; Hertel, Niels Thomas; Johannesen, Jesper; Pociot, Flemming; Petersen, Jacob Sten; Hansen, Lars; Mortensen, Henrik Bindesbol; Nielsen, Lotte Brondum			Complex Multi-Block Analysis Identifies New Immunologic and Genetic Disease Progression Patterns Associated with the Residual beta-Cell Function 1 Year after Diagnosis of Type 1 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PARTIAL REMISSION; GLYCEMIC CONTROL; CHILDREN; ADOLESCENTS; GLUCAGON; AUTOANTIBODIES; GLUCOSE; ZINC; SUSCEPTIBILITY	The purpose of the present study is to explore the progression of type 1 diabetes (T1D) in Danish children 12 months after diagnosis using Latent Factor Modelling. We include three data blocks of dynamic paraclinical biomarkers, baseline clinical characteristics and genetic profiles of diabetes related SNPs in the analyses. This method identified a model explaining 21.6% of the total variation in the data set. The model consists of two components: (1) A pattern of declining residual beta-cell function positively associated with young age, presence of diabetic ketoacidosis and long duration of disease symptoms (P = 0.0004), and with risk alleles of WFS1, CDKN2A/2B and RNLS (P = 0.006). (2) A second pattern of high ZnT8 autoantibody levels and low postprandial glucagon levels associated with risk alleles of IFIH1, TCF2, TAF5L, IL2RA and PTPN2 and protective alleles of ERBB3 gene (P = 0.0005). These results demonstrate that Latent Factor Modelling can identify associating patterns in clinical prospective data - future functional studies will be needed to clarify the relevance of these patterns.	[Andersen, Marie Louise Max; Porksen, Sven; Svensson, Jannet; Johannesen, Jesper; Hansen, Lars; Mortensen, Henrik Bindesbol; Nielsen, Lotte Brondum] Univ Copenhagen, Herlev Hosp, Dept Pediat, Fac Hlth Sci, Copenhagen, Denmark; [Rasmussen, Morten Arendt] Dept Food Sci Qual & Technol, Copenhagen, Denmark; [Vikre-Jorgensen, Jennifer] Skejby Univ Hosp, Dept Pediat, Aarhus, Denmark; [Thomsen, Jane] Kolding Cty Hosp, Dept Pediat, Kolding, Denmark; [Hertel, Niels Thomas] Odense Univ Hosp, HC Andersen Childrens Hosp, DK-5000 Odense, Denmark; [Pociot, Flemming] Glostrup Univ Hosp, Diagnost Unit, Dept Biochem, Glostrup, Denmark; [Petersen, Jacob Sten] Novo Nordisk AS, Diabet Pharmacol & Bioanal, Malov, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; Kolding Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Novo Nordisk	Andersen, MLM (corresponding author), Univ Copenhagen, Herlev Hosp, Dept Pediat, Fac Hlth Sci, Copenhagen, Denmark.	ml.max.andersen@dadlnet.dk	Svensson, Jannet/AAI-9913-2021; Rasmussen, Morten/AAE-9517-2020; Arendt, Morten/S-8843-2017	Svensson, Jannet/0000-0002-9365-0728; Rasmussen, Morten/0000-0001-7431-5206; Arendt, Morten/0000-0001-7431-5206; Johannesen, Jesper/0000-0003-2772-2567; Pociot, Flemming/0000-0003-3274-5448; Mortensen, Henrik Bindesbol/0000-0001-9231-8363; Thomsen, Jane Valentin/0000-0003-2143-8274; Porksen, Sven/0000-0003-1868-356X	Novo Nordisk A/S; Danish Agency for Science, Technology and Innovation	Novo Nordisk A/S(Novo Nordisk); Danish Agency for Science, Technology and Innovation	The present study is a part of an industrial PhD project funded by Novo Nordisk A/S and the Danish Agency for Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar E, 2011, ARXIV11053422; Acar E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032227; Andersen MLM, 2012, PEDIAT DIABETES; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bergholdt R, 2012, DIABETES, P1; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Cooper JD, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-71; COUPER JJ, 1991, DIABETES RES CLIN PR, V11, P9, DOI 10.1016/0168-8227(91)90135-Z; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dien J, 2005, CLIN NEUROPHYSIOL, V116, P1808, DOI 10.1016/j.clinph.2004.11.025; Egefjord L, 2010, CURR DIABETES REV, V6, P52, DOI 10.2174/157339910790442655; GREENBAUM CJ, 1992, DIABETES, V41, P1570, DOI 10.2337/diabetes.41.12.1570; GREENBAUM CJ, 1991, J CLIN INVEST, V88, P767, DOI 10.1172/JCI115375; Hanley AJG, 2002, DIABETES, V51, P2642, DOI 10.2337/diabetes.51.8.2642; HOLST JJ, 1982, BIOCHEM J, V207, P381, DOI 10.1042/bj2070381; Howson JMM, 2012, DIABETOLOGIA, V55, P1978, DOI 10.1007/s00125-012-2540-2; Howson JMM, 2012, DIABETES; Kaas A, 2012, PEDIATR DIABETES, V13, P51, DOI 10.1111/j.1399-5448.2011.00812.x; Kahn R, 2003, DIABETES CARE, V26, P3168, DOI 10.2337/diacare.26.11.3168; Keene KL, 2012, GENES IMMUN, V13, P66, DOI 10.1038/gene.2011.56; Komulainen J, 1999, DIABETES CARE, V22, P1950, DOI 10.2337/diacare.22.12.1950; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Mortensen HB, 2010, PEDIATR DIABETES, V11, P218, DOI 10.1111/j.1399-5448.2009.00566.x; Mortensen HB, 2009, DIABETES CARE, V32, P1384, DOI 10.2337/dc08-1987; Nielsen LB, 2006, DIABETOLOGIA, V49, P71, DOI 10.1007/s00125-005-0042-1; Nielsen LB, 2011, AUTOIMMUNITY, V44, P616, DOI 10.3109/08916934.2011.576724; Petrone A, 2008, DIABETES CARE, V31, P1214, DOI 10.2337/dc07-1158; Pociot F, 2004, AM J HUM GENET, V74, P647, DOI 10.1086/383095; Porksen S, 2007, J CLIN ENDOCR METAB, V92, P2910, DOI 10.1210/jc.2007-0244; Rasmussen MA, 2010, BRIT J CLIN PHARMACO, V69, P379, DOI 10.1111/j.1365-2125.2009.03600.x; Savola K, 1998, DIABETOLOGIA, V41, P1293, DOI 10.1007/s001250051067; Scholin A, 2011, DIABETIC MED, V28, P156, DOI 10.1111/j.1464-5491.2010.03191.x; SJOROOS M, 1995, BIOTECHNIQUES, V18, P870; Smilde AK, 2012, J CHEMOMETR, V17, P323; Thomson G, 2007, TISSUE ANTIGENS, V70, P110, DOI 10.1111/j.1399-0039.2007.00867.x; Torn C, 2000, J CLIN ENDOCR METAB, V85, P4619, DOI 10.1210/jc.85.12.4619; Wang LM, 2012, DIABETES CARE, V35, P465, DOI 10.2337/dc11-1236; Wei FY, 2011, ENDOCR J, V58, P819, DOI 10.1507/endocrj.EJ11-0099; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	41	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64632	10.1371/journal.pone.0064632	http://dx.doi.org/10.1371/journal.pone.0064632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755131	Green Published, Green Submitted, gold			2022-12-25	WOS:000320579400020
J	Keville, MP; Reed, SC; Cleveland, CC				Keville, Megan P.; Reed, Sasha C.; Cleveland, Cory C.			Nitrogen Cycling Responses to Mountain Pine Beetle Disturbance in a High Elevation Whitebark Pine Ecosystem	PLOS ONE			English	Article							GREATER YELLOWSTONE ECOSYSTEM; INSECT DEFOLIATION; FOREST ECOSYSTEMS; EXTRACTION METHOD; SOIL PROPERTIES; TREE MORTALITY; FIR FOREST; LOSSES; CARBON; EXPORT	Ecological disturbances can significantly affect biogeochemical cycles in terrestrial ecosystems, but the biogeochemical consequences of the extensive mountain pine beetle outbreak in high elevation whitebark pine (WbP) (Pinus albicaulis) ecosystems of western North America have not been previously investigated. Mountain pine beetle attack has driven widespread WbP mortality, which could drive shifts in both the pools and fluxes of nitrogen (N) within these ecosystems. Because N availability can limit forest regrowth, understanding how beetle-induced mortality affects N cycling in WbP stands may be critical to understanding the trajectory of ecosystem recovery. Thus, we measured above-and belowground N pools and fluxes for trees representing three different times since beetle attack, including unattacked trees. Litterfall N inputs were more than ten times higher under recently attacked trees compared to unattacked trees. Soil inorganic N concentrations also increased following beetle attack, potentially driven by a more than two-fold increase in ammonium (NH4+) concentrations in the surface soil organic horizon. However, there were no significant differences in mineral soil inorganic N or soil microbial biomass N concentrations between attacked and unattacked trees, implying that short-term changes in N cycling in response to the initial stages of WbP attack were restricted to the organic horizon. Our results suggest that while mountain pine beetle attack drives a pulse of N from the canopy to the forest floor, changes in litterfall quality and quantity do not have profound effects on soil biogeochemical cycling, at least in the short-term. However, continuous observation of these important ecosystems will be crucial to determining the long-term biogeochemical effects of mountain pine beetle outbreaks.	[Keville, Megan P.; Cleveland, Cory C.] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Reed, Sasha C.] US Geol Survey, Southwest Biol Sci Ctr, Moab, UT USA	University of Montana System; University of Montana; United States Department of the Interior; United States Geological Survey	Cleveland, CC (corresponding author), Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA.	Cory.Cleveland@umontana.edu	Reed, Sasha C/ABE-9476-2020	Reed, Sasha C/0000-0002-8597-8619; Cleveland, Cory/0000-0002-8804-4248	United States Department of Agriculture National Needs Fellowship [USDA-CSREES 2008-38420-19524]; McIntire-Stennis Cooperative Forestry Research Program	United States Department of Agriculture National Needs Fellowship; McIntire-Stennis Cooperative Forestry Research Program	Funding sources include a United States Department of Agriculture National Needs Fellowship (USDA-CSREES 2008-38420-19524)(http://www.csrees.usda.gov/fo/nationalneedsgraduatefellowships.cfm) and a grant from the McIntire-Stennis Cooperative Forestry Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 2002, ECOSYSTEMS, V5, P648, DOI 10.1007/s10021-002-0203-8; Aber JD, 1982, ENV BIOGEOCHEM, V35, P179; Arno S.F., 2001, WHITEBARK PINE COMMU, P74; BORMANN FH, 1969, BIOSCIENCE, V19, P600, DOI 10.2307/1294934; Bormann FH., 1994, PATTERN PROCESS FORE; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Clow DW, 2011, APPL GEOCHEM, V26, pS174, DOI 10.1016/j.apgeochem.2011.03.096; Concilio A, 2005, CAN J FOREST RES, V35, P1581, DOI 10.1139/X05-091; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DAVIDSON EA, 1986, APPL ENVIRON MICROB, V52, P1287, DOI 10.1128/AEM.52.6.1287-1292.1986; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; Eshleman KN, 1998, WATER RESOUR RES, V34, P2005, DOI 10.1029/98WR01198; FARNES PE, 1990, USDA INTERM, V270, P302; Frost CJ, 2004, ECOLOGY, V85, P3335, DOI 10.1890/04-0003; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Griffin JM, 2011, FOREST ECOL MANAG, V261, P1077, DOI 10.1016/j.foreco.2010.12.031; Griffiths RP, 2010, NORTHWEST SCI, V84, P33, DOI 10.3955/046.084.0104; GUTSCHICK VP, 1981, AM NAT, V118, P607, DOI 10.1086/283858; Houle D, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009057; Huber C, 2005, J ENVIRON QUAL, V34, P1772, DOI 10.2134/jeq2004.0210; Jenkins JC, 1999, CAN J FOREST RES, V29, P630, DOI 10.1139/cjfr-29-5-630; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; LANNER RM, 1980, P 6 N AM FOR BIOL WO, P15; le Mellec A, 2008, CAN J FOREST RES, V38, P1829, DOI 10.1139/X08-045; Logan JA, 2009, IFOREST, V2, P19, DOI 10.3832/ifor0477-002; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Lovett GM, 2010, ECOSYSTEMS, V13, P1188, DOI 10.1007/s10021-010-9381-y; Lovett GM, 2002, BIOSCIENCE, V52, P335, DOI 10.1641/0006-3568(2002)052[0335:IDANCI]2.0.CO;2; McCambridge WF, 1982, RM416 USDA FOR SERV; Metzger KL, 2006, FOREST ECOL MANAG, V227, P22, DOI 10.1016/j.foreco.2006.02.005; Morehouse K, 2008, FOREST ECOL MANAG, V255, P2698, DOI 10.1016/j.foreco.2008.01.050; Nave LE, 2011, J GEOPHYS RES-BIOGEO, V116, DOI [10.1029/2011JG001758, 10.1029/20113G001758]; Orwig DA, 2008, CAN J FOREST RES, V38, P834, DOI 10.1139/X07-196; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Reynolds Barbara C., 2000, Selbyana, V21, P74; Riscassi AL, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000860; SAFRANYIK L, 1999, BCX386 PAC FOR CTR C, P35; Stone JE, 1999, RESTOR ECOL, V7, P172, DOI 10.1046/j.1526-100X.1999.72009.x; Stone WE, 1996, VEGETATIO, V122, P1, DOI 10.1007/BF00052811; SWANK WT, 1981, OECOLOGIA, V51, P297, DOI 10.1007/BF00540897; Tomback DF, 2001, WHITEBARK PINE COMMU, P88; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1982, ECOL MONOGR, V52, P155, DOI 10.2307/1942609; VITOUSEK PM, 1979, SCIENCE, V204, P469, DOI 10.1126/science.204.4392.469; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Webb JR, 1995, WATER AIR SOIL POLL, V85, P535, DOI 10.1007/BF00476884; ZINKE PJ, 1962, ECOLOGY, V43, P130, DOI 10.2307/1932049	49	12	12	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65004	10.1371/journal.pone.0065004	http://dx.doi.org/10.1371/journal.pone.0065004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755166	gold, Green Submitted, Green Published			2022-12-25	WOS:000320579400034
J	Pedroso, SS; Barber, I; Svensson, O; Fonseca, PJ; Amorim, MCP				Pedroso, Silvia S.; Barber, Iain; Svensson, Ola; Fonseca, Paulo J.; Amorim, Maria Clara P.			Courtship Sounds Advertise Species Identity and Male Quality in Sympatric Pomatoschistus spp. Gobies	PLOS ONE			English	Article							SAND GOBY; ACOUSTIC-SIGNALS; SEXUAL SELECTION; INTERSPECIFIC VARIATION; REPRODUCTIVE SUCCESS; LUSITANIAN TOADFISH; PAINTED GOBY; MATE CHOICE; MALE SIZE; RECOGNITION	Acoustic signals can encode crucial information about species identity and individual quality. We recorded and compared male courtship drum sounds of the sand goby Pomatoschistus minutus and the painted goby P. pictus and examined if they can function in species recognition within sympatric populations. We also examined which acoustic features are related to male quality and the factors that affect female courtship in the sand goby, to determine whether vocalisations potentially play a role in mate assessment. Drums produced by the painted goby showed significantly higher dominant frequencies, higher sound pulse repetition rates and longer intervals between sounds than those of the sand goby. In the sand goby, male quality was predicted by visual and acoustic courtship signals. Regression analyses showed that sound amplitude was a good predictor of male length, whereas the duration of nest behaviour and active calling rate (i.e. excluding silent periods) were good predictors of male condition factor and fat reserves respectively. In addition, the level of female courtship was predicted by male nest behaviour. The results suggest that the frequency and temporal patterns of sounds can encode species identity, whereas sound amplitude and calling activity reflects male size and fat reserves. Visual courtship duration (nest-related behaviour) also seems relevant to mate choice, since it reflects male condition and is related to female courtship. Our work suggests that acoustic communication can contribute to mate choice in the sand goby group, and invites further study.	[Pedroso, Silvia S.; Amorim, Maria Clara P.] Inst Univ, Inst Super Psicol Aplicada, Unidade Invest Ecoetol, Lisbon, Portugal; [Barber, Iain] Univ Leicester, Dept Biol, Coll Med Biol Sci & Psychol, Leicester, Leics, England; [Svensson, Ola] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Fonseca, Paulo J.] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal; [Fonseca, Paulo J.] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Instituto Universitario de Lisboa; University of Leicester; University of Gothenburg; Universidade de Lisboa; Universidade de Lisboa	Amorim, MCP (corresponding author), Inst Univ, Inst Super Psicol Aplicada, Unidade Invest Ecoetol, Lisbon, Portugal.	amorim@ispa.pt	Amorim, M. Clara P./K-1889-2012; Fonseca, Paulo J/K-1537-2012; Svensson, Ola/F-5232-2013; Barber, Iain/B-8872-2008	Amorim, M. Clara P./0000-0002-2453-6999; Fonseca, Paulo J/0000-0002-2663-9385; Svensson, Ola/0000-0003-3752-3131; Barber, Iain/0000-0003-3955-6674	Portuguese Science and Technology Foundation [PTDC/MAR/68868/2006, UID 331/94, UID 329, SFRH/BPD/41489/2007]; ASSEMBLE grant [227799]; Fisheries Society of the British Isles; Banco Santander; Centre for Marine Evolutionary Biology, University of Gothenburg, Sweden	Portuguese Science and Technology Foundation(Portuguese Foundation for Science and Technology); ASSEMBLE grant; Fisheries Society of the British Isles; Banco Santander; Centre for Marine Evolutionary Biology, University of Gothenburg, Sweden	SSP, PJF and MCPA acknowledge the financial support of the Portuguese Science and Technology Foundation (project PTDC/MAR/68868/2006, pluriannual programs UI&D 331/94 and UI&D 329, grants SFRH/BPD/41489/2007) and of an ASSEMBLE grant (no. 227799). IB received financial support from the Fisheries Society of the British Isles (a research grant) and from Banco Santander (a travel grant). OS was funded by the Centre for Marine Evolutionary Biology, University of Gothenburg, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MCP, 2008, J MAR BIOL ASSOC UK, V88, P1069, DOI 10.1017/S0025315408001677; Amorim MCP, 2008, J FISH BIOL, V72, P1355, DOI 10.1111/j.1095-8649.2008.01802.x; Amorim MCP, 2007, J MAR BIOL ASSOC UK, V87, P1017, DOI 10.1017/S0025315407056822; Amorim MCP, 2010, J EXP BIOL, V213, P2997, DOI 10.1242/jeb.044586; Amorim MCP, 2013, FUNCT ECOL, V27, P289, DOI 10.1111/1365-2435.12032; Amorim MCP, 2004, J FISH BIOL, V65, P1358, DOI 10.1111/j.0022-1112.2004.00535.x; Amundsen T, 2003, BEHAV ECOL SOCIOBIOL, V54, P55, DOI 10.1007/s00265-003-0593-4; Barber I, 2002, J FISH BIOL, V61, P185, DOI 10.1006/jfbi.2002.2031; Bertram SM, 2012, ETHOLOGY, V118, P360, DOI 10.1111/j.1439-0310.2011.02019.x; Bolgan M, 2012, ADV EXP MED BIOL, V730, P109, DOI 10.1007/978-1-4419-7311-5_24; Boul KE, 2007, P ROY SOC B-BIOL SCI, V274, P399, DOI 10.1098/rspb.2006.3736; Bradbury Jack W., 1998, pi; CHELLAPPA S, 1995, J FISH BIOL, V47, P775, DOI 10.1111/j.1095-8649.1995.tb06002.x; Colleye O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-365; Connaughton MA, 2002, J EXP BIOL, V205, P2183; Crawford JD, 1997, J ACOUST SOC AM, V102, P1200, DOI 10.1121/1.419923; Cure C, 2012, ANIM BEHAV, V84, DOI 10.1016/j.anbehav.2012.04.039; De Jong K, 2007, ANIM BEHAV, V74, P1285, DOI 10.1016/j.anbehav.2007.02.023; EDLUND AM, 1980, SARSIA, V65, P239; FONSECA PJ, 2011, Patent No. 105933; Forsgren E, 1997, P ROY SOC B-BIOL SCI, V264, P1283, DOI 10.1098/rspb.1997.0177; Forsgren E, 1999, BEHAV CONSERVATION L, P249; Gentner TQ, 2000, ANIM BEHAV, V59, P443, DOI 10.1006/anbe.1999.1313; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; Hochkirch A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1637, DOI 10.1007/s00265-011-1174-6; Johnston CE, 2007, ENVIRON BIOL FISH, V78, P183, DOI 10.1007/s10641-006-9087-3; Jones AG, 2001, P NATL ACAD SCI USA, V98, P9151, DOI 10.1073/pnas.171310198; Judge KA, 2001, ANIM BEHAV, V62, P849, DOI 10.1006/anbe.2001.1801; Kihslinger RL, 2002, J COMP PSYCHOL, V116, P210, DOI 10.1037//0735-7036.116.2.210; Kotiaho JS, 1998, P ROY SOC B-BIOL SCI, V265, P2203, DOI 10.1098/rspb.1998.0560; Kvarnemo C, 2000, BEHAV ECOL SOCIOBIOL, V48, P378, DOI 10.1007/s002650000246; Lehtonen TK, 2008, ANIM BEHAV, V75, P55, DOI 10.1016/j.anbehav.2007.04.011; Lehtonen TK, 2012, ANIM BEHAV, V83, P1153, DOI 10.1016/j.anbehav.2012.01.040; Lindstrom K, 2000, ENVIRON BIOL FISH, V58, P411, DOI 10.1023/A:1007695526177; LINDSTROM K, 1993, ETHOL ECOL EVOL, V5, P97, DOI 10.1080/08927014.1993.9523117; LONGRIE N, 2008, J ZOOL, V276, P266; Luttbeg B, 2001, ETHOLOGY, V107, P545, DOI 10.1046/j.1439-0310.2001.00694.x; MAGNHAGEN C, 1989, J FISH BIOL, V35, P755, DOI 10.1111/j.1095-8649.1989.tb03027.x; Malavasi S, 2008, BIOL J LINN SOC, V93, P763, DOI 10.1111/j.1095-8312.2008.00947.x; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Miller P.J., 1986, P1019; Myrberg A.A. Jr, 1978, P137; MYRBERG AA, 1986, ANIM BEHAV, V34, P913, DOI 10.1016/S0003-3472(86)80077-X; Nemeth E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043259; Olsson KH, 2009, ANIM BEHAV, V77, P541, DOI 10.1016/j.anbehav.2008.10.021; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Parmentier E, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-12; RAND AS, 1992, AM ZOOL, V32, P81; Rice AN, 2011, P ROY SOC B-BIOL SCI, V278, P3762, DOI 10.1098/rspb.2011.0656; Rice AN, 2009, J EXP BIOL, V212, P1377, DOI 10.1242/jeb.028506; Ritschard M, 2010, ANIM BEHAV, V79, P877, DOI 10.1016/j.anbehav.2009.12.038; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; Saarikettu M, 2005, BEHAV GENET, V35, P257, DOI 10.1007/s10519-005-3218-z; SEARCY WA, 1981, ANIM BEHAV, V29, P997, DOI 10.1016/S0003-3472(81)80053-X; Searcy WA, 1996, ETHOLOGY, V102, P187; SPANIER E, 1979, Z TIERPSYCHOL, V51, P301; Svensson O, 2004, J FISH BIOL, V64, P1425, DOI 10.1111/j.0022-1112.2004.00381.x; Svensson O, 2007, BEHAV ECOL, V18, P410, DOI 10.1093/beheco/arl098; Vasconcelos RO, 2012, BEHAV ECOL, V23, P375, DOI 10.1093/beheco/arr199; Verzijden MN, 2010, BEHAV ECOL, V21, P548, DOI 10.1093/beheco/arq018; WALLIS GP, 1980, MAR ECOL PROG SER, V3, P309, DOI 10.3354/meps003309; Welling PP, 1997, BEHAVIOUR, V134, P891, DOI 10.1163/156853997X00214; Zar JH, 1999, BIOSTATISTICAL ANAL; Zelick R., 1999, COMP HEARING FISH AM	65	30	30	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64620	10.1371/journal.pone.0064620	http://dx.doi.org/10.1371/journal.pone.0064620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755129	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400019
J	Platte, P; Herbert, C; Pauli, P; Breslin, PAS				Platte, Petra; Herbert, Cornelia; Pauli, Paul; Breslin, Paul A. S.			Oral Perceptions of Fat and Taste Stimuli Are Modulated by Affect and Mood Induction	PLOS ONE			English	Article							FOOD-INTAKE; DEPRESSIVE SYMPTOMS; HEALTHY-SUBJECTS; NEGATIVE AFFECT; SWEET TASTE; SENSITIVITY; RESPONSES; OBESE; MAGNITUDE; SUCROSE	This study examined the impact of three clinical psychological variables (non-pathological levels of depression and anxiety, as well as experimentally manipulated mood) on fat and taste perception in healthy subjects. After a baseline orosensory evaluation, 'sad', 'happy' and 'neutral' video clips were presented to induce corresponding moods in eighty participants. Following mood manipulation, subjects rated five different oral stimuli, appearing sweet, umami, sour, bitter, fatty, which were delivered at five different concentrations each. Depression levels were assessed with Beck's Depression Inventory (BDI) and anxiety levels were assessed via the Spielberger's STAI-trait and state questionnaire. Overall, subjects were able to track the concentrations of the stimuli correctly, yet depression level affected taste ratings. First, depression scores were positively correlated with sucrose ratings. Second, subjects with depression scores above the sample median rated sucrose and quinine as more intense after mood induction (positive, negative and neutral). Third and most important, the group with enhanced depression scores did not rate low and high fat stimuli differently after positive or negative mood induction, whereas, during baseline or during the non-emotional neutral condition they rated the fat intensity as increasing with concentration. Consistent with others' prior observations we also found that sweet and bitter stimuli at baseline were rated as more intense by participants with higher anxiety scores and that after positive and negative mood induction, citric acid was rated as stronger tasting compared to baseline. The observation that subjects with mild subclinical depression rated low and high fat stimuli similarly when in positive or negative mood is novel and likely has potential implications for unhealthy eating patterns. This deficit may foster unconscious eating of fatty foods in sub-clinical mildly depressed populations.	[Platte, Petra; Herbert, Cornelia; Pauli, Paul] Univ Wurzburg, Dept Physiol, Wurzburg, Germany; [Herbert, Cornelia] German Sport Univ Cologne, Inst Psychol, Cologne, Germany; [Breslin, Paul A. S.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Breslin, Paul A. S.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	University of Wurzburg; German Sport University Cologne; Rutgers State University New Brunswick; Monell Chemical Senses Center	Platte, P (corresponding author), Univ Wurzburg, Dept Physiol, Wurzburg, Germany.	platte@psychologie.uni-wuerzburg.de		Breslin, Paul/0000-0001-5988-8401; Pauli, Paul/0000-0003-0692-6720	National Institutes of Health (NIH) [DC 02995, DC 011393]; German Reserarch Foundation (DFG) [HE 5880/3-1]; University of Wuerzburg; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002995, R21DC011393, R01DC002995] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Reserarch Foundation (DFG); University of Wuerzburg; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health (NIH) grants DC 02995, DC 011393 (PASB) and DFG grant HE 5880/3-1. This publication was funded by the German Reserarch Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al'absi M, 2012, PSYCHOPHYSIOLOGY, V49, P96, DOI 10.1111/j.1469-8986.2011.01289.x; AMSTERDAM JD, 1987, BIOL PSYCHIAT, V22, P1481, DOI 10.1016/0006-3223(87)90108-9; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Bartoshuk LM, 2004, PHYSIOL BEHAV, V82, P109, DOI 10.1016/j.physbeh.2004.02.033; Beauchamp GK, 2009, AM J CLIN NUTR, V90, p723S, DOI 10.3945/ajcn.2009.27462E; Beck AT, 1971, BECK DEPRESSION INVE; Berlin I, 1998, EUR PSYCHIAT, V13, P303, DOI 10.1016/S0924-9338(98)80048-5; BRAUCHLI P, 1995, CHEM SENSES, V20, P505, DOI 10.1093/chemse/20.5.505; Chen D, 2005, CHEM SENSES, V30, P345, DOI 10.1093/chemse/bji029; DESS NK, 1990, BRAIN RES BULL, V24, P669, DOI 10.1016/0361-9230(90)90006-L; Dess NK, 1998, BIOL PSYCHOL, V48, P103, DOI 10.1016/S0301-0511(98)00014-3; Dichter GS, 2010, DEPRESS ANXIETY, V27, P859, DOI 10.1002/da.20690; Donaldson LF, 2009, AM J CLIN NUTR, V90, p800S, DOI 10.3945/ajcn.2009.27462Q; FUJIMURA A, 1990, AM J PHYSIOL, V259, pR931, DOI 10.1152/ajpregu.1990.259.5.R931; Galindo MM, 2012, CHEM SENSES, V37, P123, DOI 10.1093/chemse/bjr069; Goldschmidt AB, 2011, EAT BEHAV, V12, P37, DOI 10.1016/j.eatbeh.2010.11.001; Goris AHC, 2000, AM J CLIN NUTR, V71, P130; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; GREEN BG, 1993, CHEM SENSES, V18, P683, DOI 10.1093/chemse/18.6.683; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Heath TP, 2006, J NEUROSCI, V26, P12664, DOI 10.1523/JNEUROSCI.3459-06.2006; Hewig J, 2005, COGNITION EMOTION, V19, P1095, DOI 10.1080/02699930541000084; Hoefling A, 2010, APPETITE, V54, P603, DOI 10.1016/j.appet.2010.02.016; Ileri-Gurel E, 2012, CHEM SENSES; Jansen A, 2008, APPETITE, V51, P556, DOI 10.1016/j.appet.2008.04.009; Keller KL, 2012, J FOOD SCI, V77, pS143, DOI 10.1111/j.1750-3841.2011.02585.x; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; Kobayashi C, 2006, CHEM SENSES, V31, P301, DOI 10.1093/chemse/bjj033; Kuga M, 1999, PHYSIOL BEHAV, V66, P317, DOI 10.1016/S0031-9384(98)00307-2; Kuga M, 2002, ACTA OTO-LARYNGOL, V122, P146, DOI 10.1080/00016480260046544; Laeger I, 2012, BEHAV BRAIN RES, V233, P508, DOI 10.1016/j.bbr.2012.05.036; Mata-Garcia M, 2007, J SENS STUD, V22, P187, DOI 10.1111/j.1745-459X.2007.00101.x; Mathes CM, 2013, CHEM SENSES, V38, P211, DOI 10.1093/chemse/bjs096; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; MOGG K, 1990, BRIT J CLIN PSYCHOL, V29, P227, DOI 10.1111/j.2044-8260.1990.tb00874.x; Mojet J, 2001, CHEM SENSES, V26, P845, DOI 10.1093/chemse/26.7.845; Moser JS, 2008, BIOL PSYCHOL, V78, P93, DOI 10.1016/j.biopsycho.2008.01.005; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; PLATTE P, 1995, INT J EAT DISORDER, V17, P51, DOI 10.1002/1098-108X(199501)17:1&lt;51::AID-EAT2260170107&gt;3.0.CO;2-Q; Potts AJ, 1997, CAN J EXP PSYCHOL, V51, P57, DOI 10.1037/1196-1961.51.1.57; Scinska A, 2004, PHYSIOL BEHAV, V82, P899, DOI 10.1016/j.physbeh.2004.07.012; Spielberger C. D., 1973, MANUAL STATE TRAIT I; STEINER JE, 1969, ISR J PSYCHIAT REL D, V7, P223; Stewart JE, 2010, BRIT J NUTR, V104, P145, DOI 10.1017/S0007114510000267; Szalay C, 2010, PSYCHIAT CLIN NEUROS, V64, P403, DOI 10.1111/j.1440-1819.2010.02106.x; Thompson T, 2008, PAIN, V134, P187, DOI 10.1016/j.pain.2007.04.018; TOMARKEN AJ, 1990, J PERS SOC PSYCHOL, V59, P791, DOI 10.1037/0022-3514.59.4.791; Tucker RM, 2013, CHEM SENSES; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WesterterpPlantenga MS, 1996, EUR J CLIN NUTR, V50, P401; Wilson GD, 2000, PERS INDIV DIFFER, V29, P1077, DOI 10.1016/S0191-8869(99)00255-X	51	43	44	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65006	10.1371/journal.pone.0065006	http://dx.doi.org/10.1371/journal.pone.0065006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755167	Green Published, gold			2022-12-25	WOS:000320579400035
J	Anwar, N; Sem, XH; Rhen, M				Anwar, Naeem; Sem, Xiao Hui; Rhen, Mikael			Oxidoreductases that Act as Conditional Virulence Suppressors in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; NF-KAPPA-B; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; BACTERIAL; SECRETION; DSBA; THIOREDOXIN; EXPRESSION; GENE	In Salmonella enterica serovar Typhimurium, oxidoreductases of the thioredoxin superfamily contribute to bacterial invasiveness, intracellular replication and to the virulence in BALB/c mice as well as in the soil nematode Caenorhabditis elegans. The scsABCD gene cluster, present in many but not all enteric bacteria, codes for four putative oxidoreductases of the thioredoxin superfamily. Here we have analyzed the potential role of the scs genes in oxidative stress tolerance and virulence in S. Typhimurium. An scsABCD deletion mutant showed moderate sensitization to the redox-active transition metal ion copper and increased protein carbonylation upon exposure to hydrogen peroxide. Still, the scsABCD mutant was not significantly affected for invasiveness or intracellular replication in respectively cultured epithelial or macrophage-like cells. However, we noted a significant copper chloride sensitivity of SPI1 T3SS mediated invasiveness that strongly depended on the presence of the scs genes. The scsABCD deletion mutant was not attenuated in animal infection models. In contrast, the mutant showed a moderate increase in its competitive index upon intraperitoneal challenge and enhanced invasiveness in small intestinal ileal loops of BALB/c mice. Moreover, deletion of the scsABCD genes restored the invasiveness of a trxA mutant in epithelial cells and its virulence in C. elegans. Our findings thus demonstrate that the scs gene cluster conditionally affects virulence and underscore the complex interactions between oxidoreductases of the thioredoxin superfamily in maintaining host adaptation of S. Typhimurium.	[Anwar, Naeem; Rhen, Mikael] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Sem, Xiao Hui] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore	Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Rhen, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	mikael.rhen@ki.se	Anwar, Naeem/A-6945-2011	Anwar, Naeem/0000-0001-8638-2158	Vetenskapsradet (Swedish Research Council) [VR-2011-3379]	Vetenskapsradet (Swedish Research Council)(Swedish Research Council)	This study was supported by grants from Vetenskapsradet (Swedish Research Council) to Mikael Rhen with grant number VR-2011-3379. Naeem Anwar is a Ph.D. fellow of Higher Education Commission of Pakistan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard MES, 2012, BIOCHEM J, V444, P51, DOI 10.1042/BJ20112180; Agbor TA, 2011, CELL MICROBIOL, V13, P1858, DOI 10.1111/j.1462-5822.2011.01701.x; AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Aussel L, 2011, MOL MICROBIOL, V80, P628, DOI 10.1111/j.1365-2958.2011.07611.x; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bjorkman J, 1996, FEMS MICROBIOL LETT, V139, P121, DOI 10.1016/0378-1097(96)00129-2; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; BRENNER S, 1974, GENETICS, V77, P71; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Chung J, 2000, MOL MICROBIOL, V35, P1099, DOI 10.1046/j.1365-2958.2000.01778.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Donnenberg MS, 1997, GENE, V192, P33, DOI 10.1016/S0378-1119(96)00826-8; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eriksson S, 2000, CELL MICROBIOL, V2, P239, DOI 10.1046/j.1462-5822.2000.00051.x; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Gao YL, 2012, TOXICOL IN VITRO, V26, P1, DOI 10.1016/j.tiv.2011.09.019; Gupta SD, 1997, J BACTERIOL, V179, P4977, DOI 10.1128/jb.179.16.4977-4984.1997; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Harrison JJ, 2009, ENVIRON MICROBIOL, V11, P2491, DOI 10.1111/j.1462-2920.2009.01973.x; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; Hobbie S, 1997, J IMMUNOL, V159, P5550; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Horst SA, 2010, J BACTERIOL, V192, P2929, DOI 10.1128/JB.01652-09; HURME R, 1994, J BIOL CHEM, V269, P10675; JACOBDUBUISSON F, 1994, P NATL ACAD SCI USA, V91, P11552, DOI 10.1073/pnas.91.24.11552; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Lee Y, 2009, FEMS MICROBIOL LETT, V297, P38, DOI 10.1111/j.1574-6968.2009.01650.x; LEHRER SS, 1975, P NATL ACAD SCI USA, V72, P3377, DOI 10.1073/pnas.72.9.3377; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; Lyons S, 2004, J CELL SCI, V117, P5771, DOI 10.1242/jcs.01500; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Mastroeni P, 2004, MICROBES INFECT, V6, P398, DOI 10.1016/j.micinf.2003.12.009; Mastroeni P, 2003, REV MED MICROBIOL, V14, P53; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; Negrea A, 2007, ANTIMICROB AGENTS CH, V51, P2867, DOI 10.1128/AAC.00223-07; Negrea A, 2009, J BACTERIOL, V191, P6918, DOI 10.1128/JB.00532-09; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; PALVA ET, 1978, J BACTERIOL, V136, P286, DOI 10.1128/JB.136.1.286-294.1978; Peters SE, 2010, INFECT IMMUN, V78, P326, DOI 10.1128/IAI.00768-09; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; RHEN M, 1988, MICROB PATHOGENESIS, V5, P275, DOI 10.1016/0882-4010(88)90100-3; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Sem X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045417; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Takemoto T, 1998, FREE RADICAL BIO MED, V24, P556, DOI 10.1016/S0891-5849(97)00287-6; WATARAI M, 1995, P NATL ACAD SCI USA, V92, P4927, DOI 10.1073/pnas.92.11.4927; XIE QW, 1994, J BIOL CHEM, V269, P4705; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7	70	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64948	10.1371/journal.pone.0064948	http://dx.doi.org/10.1371/journal.pone.0064948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750221	gold, Green Published, Green Submitted			2022-12-25	WOS:000319961900023
J	Chen, VL; Surana, NK; Duan, JY; Kasper, DL				Chen, Vincent L.; Surana, Neeraj K.; Duan, Jinyou; Kasper, Dennis L.			Role of Murine Intestinal Interleukin-1 Receptor 1-Expressing Lymphoid Tissue Inducer-Like Cells in Salmonella Infection	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; ROR-GAMMA-T; INDUCED IL-1-BETA; DENDRITIC CELLS; INNATE IMMUNITY; CRUCIAL ROLE; IL-22; IL-17; INFLAMMATION; DIFFERENTIATION	Interleukin (IL)-1 signaling plays a critical role in intestinal immunology. Here, we report that the major population of intestinal lamina propria lymphocytes expressing IL-1 receptor 1 (IL-1R1) is the lymphoid tissue inducer (LTi)-like cell, a type of innate lymphoid cell. These cells are significant producers of IL-22, and this IL-22 production depends on IL-1R1 signaling. LTi-like cells are required for defense against Salmonella enterica serovar Typhimurium. Moreover, colonic LTi-like cell numbers depend on the presence of the intestinal microbiota. LTi-like cells require IL-1R1 for production of protective cytokines and confer protection in infectious colitis, and their cell numbers in the colon depend upon having a microbiome.	[Chen, Vincent L.; Surana, Neeraj K.; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Surana, Neeraj K.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Duan, Jinyou] Northwest A&F Univ, Coll Sci, Yangling, Peoples R China	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Northwest A&F University - China	Duan, JY (corresponding author), Northwest A&F Univ, Coll Sci, Yangling, Peoples R China.	jduan@nwsuaf.cn; dennis_kasper@hms.harvard.edu	duan, jinyou/I-9156-2012	Chen, Vincent/0000-0002-0157-6066	Crohn's and Colitis Foundation; NIH [F32 AI091104, K12 HD052896]; Faculty Career Development Award from Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052896, T32HD055148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI091104] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty Career Development Award from Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Crohn's and Colitis Foundation (http://www.ccfa.org/) Senior Research Award to DLK. NKS was supported by NIH (www.nih.gov) grants F32 AI091104 and K12 HD052896 and a Faculty Career Development Award from Boston Children's Hospital (www.childrenshospital.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baptista AP, 2012, MUCOSAL IMMUNOL; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Briercheck E, 2010, IMMUNITY, V32, P803; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Chung HC, 2010, CURR OPIN IMMUNOL, V22, P455, DOI 10.1016/j.coi.2010.06.008; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Duan JY, 2011, CURR OPIN RHEUMATOL, V23, P372, DOI 10.1097/BOR.0b013e3283476d3e; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson C, 2005, SEMIN IMMUNOL, V17, P284, DOI 10.1016/j.smim.2005.05.010; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Lane P, 2008, SEMIN IMMUNOL, V20, P159, DOI 10.1016/j.smim.2008.02.002; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Prakash T, 2011, CELL HOST MICROBE, V10, P273, DOI 10.1016/j.chom.2011.08.007; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Siegemund S, 2009, INT IMMUNOL, V21, P555, DOI 10.1093/intimm/dxp025; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wick MJ, 2002, CURR OPIN IMMUNOL, V14, P437, DOI 10.1016/S0952-7915(02)00364-3; Withers DR, 2012, J IMMUNOL, V189, P2094, DOI 10.4049/jimmunol.1201639; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003	62	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65405	10.1371/journal.pone.0065405	http://dx.doi.org/10.1371/journal.pone.0065405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750260	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900062
J	Huang, J; Xiao, D; Li, G; Ma, J; Chen, P; Yuan, W; Hou, F; Ge, J; Zhong, M; Tang, Y; Xia, X; Chen, Z				Huang, J.; Xiao, D.; Li, G.; Ma, J.; Chen, P.; Yuan, W.; Hou, F.; Ge, J.; Zhong, M.; Tang, Y.; Xia, X.; Chen, Z.			EphA2 promotes epithelial-mesenchymal transition through the Wnt/beta-catenin pathway in gastric cancer cells	ONCOGENE			English	Article						EphA2; gastric cancer; epithelial-mensenchymal transition; Wnt/beta-catenin	DEPENDENT TRANSCRIPTION; COLORECTAL-CANCER; RECEPTOR; ACTIVATION; EXPRESSION	This study aims to investigate the significance of erythropoietin-producing hepatocellular (Eph)A2 expression and the mechanism by which EphA2 is involved in the epithelial-mensenchymal transition (EMT) of gastric cancer cells. EphA2 expression levels were upregulated and positively correlated with metastasis and EMT markers in human gastric cancer specimens. Modulation of EphA2 expression levels had distinct effects on cell proliferation, cell cycle, migration, invasion and morphology in the gastric cancer cell lines SGC7901 and AGS in vitro and in vivo. Overexpression of EphA2 resulted in the upregulation of the EMT molecular markers N-cadherin and Snail, as well as the Wnt/beta-catenin targets TCF4, Cyclin-D1 and c-Myc, while silencing EphA2 using short hairpin RNA had the opposite effect. Furthermore, inhibition of the Wnt/beta-catenin pathway by XAV939 negated the effect of EphA2 overexpression, whereas activation of the Wnt/beta-catenin pathway by LiCl impaired the effect of the EphA2 knockdown on EMT. These observations demonstrate that EphA2 upregulation is a common event in gastric cancer specimens that is closely correlated with cancer metastasis and that EphA2 promotes EMT of gastric cancer cells through activation of Wnt/beta-catenin signaling.	[Huang, J.; Zhong, M.; Tang, Y.] Cent S Univ, Xiangya Hosp, Dept Oncol, Changsha 410008, Hunan, Peoples R China; [Xiao, D.] Cent S Univ, Xiangya Hosp, Dept Pathol, Changsha 410008, Hunan, Peoples R China; [Li, G.; Ma, J.; Chen, P.] Cent S Univ, Hunan Key Lab Nonresolving Inflammat & Canc, Canc Res Inst, Changsha 410008, Hunan, Peoples R China; [Yuan, W.; Hou, F.; Ge, J.; Chen, Z.] Cent S Univ, Xiangya Hosp, Dept Gen Surg, Changsha 410008, Hunan, Peoples R China; [Xia, X.] Weill Cornell Sch Med, Methodist Hosp Res Inst, Ctr Genom Med, Houston, TX USA	Central South University; Central South University; Central South University; Central South University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute	Chen, Z (corresponding author), Cent S Univ, Xiangya Hosp, Dept Gen Surg, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	zihuachenxy@126.com			Nature Scientific Foundation of China [81172297]; Ministry of Education (SRF for ROCS) [NCET-11-0520]; Hunan Province Natural Sciences Foundation of China [B2010-010]	Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education (SRF for ROCS)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Hunan Province Natural Sciences Foundation of China(Natural Science Foundation of Hunan Province)	This work was supported by Nature Scientific Foundation of China (81172297), Ministry of Education (NCET-11-0520, SRF for ROCS) and Hunan Province Natural Sciences Foundation of China (B2010-010). We thank Yangchun Xie and Liyang Zhang for their technical help.	Amit I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100195; Baeten CIM, 2009, DIS COLON RECTUM, V52, P2028, DOI 10.1007/DCR.0b013e3181beb4ff; Brannan JM, 2009, CLIN CANCER RES, V15, P4423, DOI 10.1158/1078-0432.CCR-09-0473; Cui XD, 2010, INT J CANCER, V126, P940, DOI 10.1002/ijc.24798; Fukuyama R, 2008, ONCOGENE, V27, P6044, DOI 10.1038/onc.2008.204; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Li X, 2010, TUMOR BIOL, V31, P477, DOI 10.1007/s13277-010-0060-6; Lovatt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012794; Lu C, 2008, CANCER BIOL THER, V7, P1098, DOI 10.4161/cbt.7.7.6168; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Merritt WM, 2010, CANCER BIOL THER, V10, P1306, DOI 10.4161/cbt.10.12.13582; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Pratt RL, 2002, ONCOGENE, V21, P7690, DOI 10.1038/sj.onc.1205758; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Sulman EP, 1997, GENOMICS, V40, P371, DOI 10.1006/geno.1996.4569; Sundaram Meera V, 2006, WormBook, P1; Taddei ML, 2011, MOL CANCER RES, V9, P149, DOI 10.1158/1541-7786.MCR-10-0298; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Udayakumar D, 2011, ONCOGENE, V30, P4921, DOI 10.1038/onc.2011.210; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Yuan W, 2012, NEOPLASMA, V59, P105, DOI 10.4149/neo_2012_014; Yuan WJ, 2009, DIGEST DIS SCI, V54, P2410, DOI 10.1007/s10620-008-0649-4; Yuan WJ, 2009, PATHOL ONCOL RES, V15, P473, DOI 10.1007/s12253-008-9132-y; Zhang GQ, 2008, CANCER RES, V68, P1691, DOI 10.1158/0008-5472.CAN-07-2372	31	159	180	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2737	2747		10.1038/onc.2013.238	http://dx.doi.org/10.1038/onc.2013.238			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23752181				2022-12-25	WOS:000337231700007
J	Li, ZJ; Mack, SC; Mak, TH; Angers, S; Taylor, MD; Hui, CC				Li, Z. J.; Mack, S. C.; Mak, T. H.; Angers, S.; Taylor, M. D.; Hui, C-C			Evasion of p53 and G(2)/M checkpoints are characteristic of Hh-driven basal cell carcinoma	ONCOGENE			English	Article						Sufu; Ptc1; Hedgehog; basal cell carcinoma; cell cycle; p53	CYCLE PROGRESSION; SIGNALING PATHWAY; SMAD PROTEINS; HEDGEHOG; SKIN; MICE; EXPRESSION; TUMORIGENESIS; SUPPRESSOR; PROLIFERATION	Basal cell carcinoma (BCC), the most common type of cancer, is characterized by aberrant Hedgehog (Hh) pathway activity. Mutations in pathway components, such as PATCHED1 (PTCH1), are commonly found in BCC. While the tumor suppressor role of PTCH1 in BCC is well established, how Hh pathway activation disrupts normal skin homeostasis to promote BCC formation remains poorly understood. Like Ptc1, Sufu is a major negative regulator of the Hh pathway. Previously, we showed that inactivation of Sufu in the skin does not result in BCC formation. Why loss of Ptc1, but not Sufu, in the epidermis induces BCC formation is unclear. In this report, we utilized gene expression profiling to identify biological pathways and processes that distinguish Sufu from Ptc1 mutants, and discovered a novel role for Sufu in cell cycle regulation. We demonstrated that the Hh pathway activation in Sufu and Ptc1 mutant skin is associated with abnormal cell cycle entry, ectopic expression of D-type cyclins and increased DNA damage. However, despite the presence of DNA damage, p53 stabilization was impaired in the mutant skin. Alternative mechanism to halt genomic instability is the activation of G2/M cell cycle checkpoint, which can occur independent of p53. We found that while Ptc1 mutant cells continue to cycle, which would favor genomic instability, loss of Sufu results in G2/M cell cycle arrest. This finding may explain why inactivation of Sufu is not sufficient to drive BCC formation. Taken together, these studies revealed a unique role for Sufu in G2/M phase progression, and uncovered the molecular and cellular features associated with Hh-driven BCC.	[Li, Z. J.; Mack, S. C.; Mak, T. H.; Taylor, M. D.; Hui, C-C] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Li, Z. J.; Hui, C-C] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Mack, S. C.; Taylor, M. D.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Div Neurosurg, Toronto, ON M5G 1X8, Canada; [Mack, S. C.; Taylor, M. D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Angers, S.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Angers, S.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Hui, CC (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 101 Coll St,TMDT East Tower,Room 13-314, Toronto, ON M5G 1L7, Canada.	cchui@sickkids.ca	Angers, Stephane/E-1432-2014	Angers, Stephane/0000-0001-7241-9044; Mack, Stephen C./0000-0001-9620-4742; Taylor, Michael/0000-0001-7009-3466	Canadian Cancer Society Research Institute [2011-700774]	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	We thank E Nieuwenhuis and W Nien for initial characterization of the Sufu and Ptc1 mutants, and T Satkunendran for technical help. This research is funded by the Canadian Cancer Society Research Institute (2011-700774) to CCH.	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Cwinn MA, 2011, J NEUROSCI, V31, P5169, DOI 10.1523/JNEUROSCI.5495-10.2011; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Fan HR, 1999, J CELL BIOL, V147, P71, DOI 10.1083/jcb.147.1.71; Gambichler T, 2007, EUR J MED RES, V12, P509; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Grachtchouk V, 2003, EMBO J, V22, P2741, DOI 10.1093/emboj/cdg271; Howell BG, 2005, J DERMATOL SCI, V39, P39, DOI 10.1016/j.jdermsci.2005.02.004; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Lange D, 1999, INT J ONCOL, V14, P1049; Li ZJ, 2012, DEVELOPMENT, V139, P4152, DOI 10.1242/dev.081190; Mancuso M, 2004, CANCER RES, V64, P934, DOI 10.1158/0008-5472.CAN-03-2460; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mill P, 2005, DEV CELL, V9, P293, DOI 10.1016/j.devcel.2005.05.009; Ng D, 2005, AM J MED GENET A, V134A, P399, DOI 10.1002/ajmg.a.30653; Nieuwenhuis E, 2006, MOL CELL BIOL, V26, P6609, DOI 10.1128/MCB.00295-06; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; O'Driscoll L, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-74; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Ribeiro GRH, 2004, J DERMATOL SCI, V36, P79, DOI 10.1016/j.jdermsci.2004.08.003; Sardi I, 2000, ONCOL REP, V7, P1119; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Van Haren R, 2009, BRIT J DERMATOL, V161, P1278, DOI 10.1111/j.1365-2133.2009.09338.x; Villani RM, 2010, CANCER PREV RES, V3, P1222, DOI 10.1158/1940-6207.CAPR-10-0082; Welss T, 2003, INT J CANCER, V104, P66, DOI 10.1002/ijc.10912	41	16	17	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2674	2680		10.1038/onc.2013.212	http://dx.doi.org/10.1038/onc.2013.212			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23752195				2022-12-25	WOS:000336502700013
J	Li, JH; Zhuo, M; Pei, L; Yu, ASL				Li, Jiahua; Zhuo, Min; Pei, Lei; Yu, Alan S. L.			Conserved Aromatic Residue Confers Cation Selectivity in Claudin-2 and Claudin-10b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION; PARACELLULAR PORES; POTASSIUM CHANNEL; AQUEOUS-SOLUTIONS; MOLECULAR-BASIS; FORMS; LOCALIZATION; BINDING; KIDNEY; SITE	In tight junctions, both claudin-2 and claudin-10b form paracellular cation-selective pores by the interaction of the first ECL 1 with permeating ions. We hypothesized that a highly conserved aromatic residue near the pore selectivity filter of claudins contributes to cation selectivity by cation-pi interaction with the permeating cation. To test this, we generated MDCK I Tet-off cells stably transfected with claudin-2 Tyr(67) mutants. The Y67L mutant showed reduced cation selectivity compared with wild-type claudin-2 due to a decrease in Na+ permeability, without affecting the Cl- permeability. The Y67A mutant enlarged the pore size and further decreased the charge selectivity due to an increase in Cl- permeability. The Y67F mutant restored the Na+ permeability, Cl- permeability, and pore size back to wild-type. The accessibility of Y67C to methanethiosulfonate modification indicated that its side chain faces the lumen of the pore. In claudin-10b, the F66L mutant reduced cation selectivity, and the F66A mutant lost pore conductance. We conclude that the conserved aromatic residue near the cation pore domain of claudins contributes to cation selectivity by a dual role of cation-pi interaction and a luminal steric effect. Our findings provide new insight into how ion selectivity is achieved in the paracellular pore.	[Li, Jiahua; Zhuo, Min; Pei, Lei; Yu, Alan S. L.] Univ Kansas, Med Ctr, Div Nephrol & Hypertens, Kansas City, KS 66160 USA; [Li, Jiahua; Zhuo, Min; Pei, Lei; Yu, Alan S. L.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA; [Pei, Lei; Yu, Alan S. L.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Yu, ASL (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, 3901 Rainbow Blvd,Mail Stop 3018, Kansas City, KS 66160 USA.	ayu@kumc.edu	Yu, Alan/AID-7467-2022	Yu, Alan/0000-0002-1776-2533	National Institutes of Health [9P20GM104936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, U01GM094627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Confocal Imaging Core at the University of Kansas Medical Center was supported by National Institutes of Health Grant 9P20GM104936 (to Dale Abrahamson).	Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Guidoni L, 2002, J RECEPT SIGNAL TR R, V22, P315, DOI 10.1081/RRS-120014604; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107; Kielland J, 1937, J AM CHEM SOC, V59, P1675, DOI 10.1021/ja01288a032; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Koneshan S, 1998, J PHYS CHEM B, V102, P4193, DOI 10.1021/jp980642x; Krug SM, 2012, CELL MOL LIFE SCI, V69, P2765, DOI 10.1007/s00018-012-0949-x; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Tamura A, 2011, GASTROENTEROLOGY, V140, P913, DOI 10.1053/j.gastro.2010.08.006; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2006, AM J PHYSIOL-RENAL, V291, pF1288, DOI 10.1152/ajprenal.00138.2006; Wulfsberg G, 2000, INORG CHEM, P57; Yu ASL, 2011, METHODS MOL BIOL, V762, P27, DOI 10.1007/978-1-61779-185-7_3; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	22	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22790	22797		10.1074/jbc.M113.484238	http://dx.doi.org/10.1074/jbc.M113.484238			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23760508	Green Published, hybrid			2022-12-25	WOS:000330596300056
J	Lund, J; Olsen, OH; Sorensen, ES; Stennicke, HR; Petersen, HH; Overgaard, MT				Lund, Jacob; Olsen, Ole H.; Sorensen, Esben S.; Stennicke, Henning R.; Petersen, Helle H.; Overgaard, Michael T.			ADAMDEC1 Is a Metzincin Metalloprotease with Dampened Proteolytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-BINDING SITE; STREPTOMYCES-CAESPITOSUS; INTRACELLULAR MATURATION; CANDIDATE GENES; FAMILY; DISINTEGRIN; ALPHA; EXPRESSION; DECYSIN; PROPROTEIN	ADAMDEC1 (Decysin-1) is a putative ADAM (a disintegrin and metalloprotease)-like metalloprotease with an unknown physiological role, selectively expressed in mature dendritic cells and macrophages. When compared with other members of the ADAM family, ADAMDEC1 displays some unusual features. It lacks the auxiliary cysteine-rich, EGF, and transmembrane domains, as well as the cytoplasmic tail. The active site of ADAMDEC1 is unique by being the only mammalian ADAM protease with a non-histidine zinc ligand, having an aspartic acid residue instead. Here we demonstrate that ADAMDEC1, despite these unique features, functions as an active metalloprotease. Thus, ADAMDEC1 is secreted as a mature, glycosylated, and proteolytically active metalloprotease, capable of cleaving macromolecular substrates. In the recombinant form, three of the four potential N-linked glycosylation sites are modified by carbohydrate attachment. Substitution of basic residues at the predicted proprotein convertase cleavage site blocks proprotein processing, revealing both specific ADAMDEC1-dependent and specific ADAMDEC1-independent cleavage of the prodomain. The pro-form of ADAMDEC1 does not have proteolytic activity, demonstrating that the prodomain of ADAMDEC1, like in other members of the ADAM family, confers catalytic latency. Interestingly, the proteolytic activity of mature ADAMDEC1 can be significantly enhanced when a canonical ADAM active site with three zinc-coordinating histidine residues is introduced.	[Lund, Jacob; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biotechnol, DK-9000 Aalborg, Denmark; [Lund, Jacob; Olsen, Ole H.; Stennicke, Henning R.; Petersen, Helle H.] Novo Nordisk AS, Dept Haemophilia Biochem, DK-2760 Malov, Denmark; [Sorensen, Esben S.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	Aalborg University; Novo Nordisk; Aarhus University	Overgaard, MT (corresponding author), Aalborg Univ, Dept Chem & Biotechnol, Sohngaardsholmsvej 49, DK-9000 Aalborg, Denmark.	mto@bio.aau.dk	Lund, Jacob/G-9885-2013; Overgaard, Michael Toft/E-1354-2011	Lund, Jacob/0000-0001-8627-7382; Overgaard, Michael Toft/0000-0002-1423-2481; Sorensen, Esben Skipper/0000-0002-7050-3354				Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Baran N, 2003, BIOL REPROD, V68, P1787, DOI 10.1095/biolreprod.102.009761; Bates EEM, 2002, IMMUNOGENETICS, V54, P96, DOI 10.1007/s00251-002-0430-3; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Dommels YEM, 2007, GENES NUTR, V2, P209, DOI 10.1007/s12263-007-0051-4; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Fritsche J, 2003, IMMUNOLOGY, V110, P450, DOI 10.1111/j.1365-2567.2003.01754.x; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; HARPEL PC, 1973, J EXP MED, V138, P508, DOI 10.1084/jem.138.3.508; HARPEL PC, 1979, J BIOL CHEM, V254, P8669; Howard L, 2000, BIOCHEM J, V348, P21, DOI 10.1042/0264-6021:3480021; IPPOLITO JA, 1994, BIOCHEMISTRY-US, V33, P15241, DOI 10.1021/bi00255a004; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kang TB, 2002, J BIOL CHEM, V277, P25583, DOI 10.1074/jbc.M203532200; KESTER WR, 1977, BIOCHEMISTRY-US, V16, P2506, DOI 10.1021/bi00630a030; KIEFER LL, 1993, J AM CHEM SOC, V115, P12581, DOI 10.1021/ja00079a046; Klein T, 2011, J PROTEOME RES, V10, P17, DOI 10.1021/pr100556z; Kurisu G, 1997, J FERMENT BIOENG, V83, P590, DOI 10.1016/S0922-338X(97)81142-7; Kurisu G, 2000, J INORG BIOCHEM, V82, P225, DOI 10.1016/S0162-0134(00)00136-7; LAMPEL JS, 1992, J BACTERIOL, V174, P2797, DOI 10.1128/JB.174.9.2797-2808.1992; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Long JY, 2012, GENE, V507, P36, DOI 10.1016/j.gene.2012.07.016; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Macartney-Coxson DP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-187; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mueller CGF, 1997, J EXP MED, V186, P655, DOI 10.1084/jem.186.5.655; Mueller CGF, 2001, J IMMUNOL, V167, P5052, DOI 10.4049/jimmunol.167.9.5052; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SHAKINESHLEMAN SH, 1993, BIOCHEMISTRY-US, V32, P9465, DOI 10.1021/bi00087a026; SOTTRUPJENSEN L, 1990, J BIOL CHEM, V265, P17727; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Tortorella MD, 2004, J BIOL CHEM, V279, P17554, DOI 10.1074/jbc.M313041200; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xu JG, 2012, NEUROL RES, V34, P701, DOI 10.1179/1743132812Y.0000000067; Zhou WH, 2009, BLOOD, V113, P929, DOI 10.1182/blood-2008-07-167775	45	18	21	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21367	21375		10.1074/jbc.M113.474536	http://dx.doi.org/10.1074/jbc.M113.474536			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754285	hybrid, Green Published			2022-12-25	WOS:000322014400055
J	Heneidi, S; Simerman, AA; Keller, E; Singh, P; Li, XM; Dumesic, DA; Chazenbalk, G				Heneidi, Saleh; Simerman, Ariel A.; Keller, Erica; Singh, Prapti; Li, Xinmin; Dumesic, Daniel A.; Chazenbalk, Gregorio			Awakened by Cellular Stress: Isolation and Characterization of a Novel Population of Pluripotent Stem Cells Derived from Human Adipose Tissue	PLOS ONE			English	Article							PROGENITOR CELLS; ENDOTHELIAL-CELLS; NEURAL PRECURSORS; DIFFERENTIATION; EXPRESSION; PURIFICATION; ENGRAFTMENT; GENERATION; RECEPTOR; MARKERS	Advances in stem cell therapy face major clinical limitations, particularly challenged by low rates of post-transplant cell survival. Hostile host factors of the engraftment microenvironment such as hypoxia, nutrition deprivation, pro-inflammatory cytokines, and reactive oxygen species can each contribute to unwanted differentiation or apoptosis. In this report, we describe the isolation and characterization of a new population of adipose tissue (AT) derived pluripotent stem cells, termed Multilineage Differentiating Stress-Enduring (Muse) Cells, which are isolated using severe cellular stress conditions, including long-term exposure to the proteolytic enzyme collagenase, serum deprivation, low temperatures and hypoxia. Under these conditions, a highly purified population of Muse-AT cells is isolated without the utilization of cell sorting methods. Muse-AT cells grow in suspension as cell spheres reminiscent of embryonic stem cell clusters. Muse-AT cells are positive for the pluripotency markers SSEA3, TR-1-60, Oct3/4, Nanog and Sox2, and can spontaneously differentiate into mesenchymal, endodermal and ectodermal cell lineages with an efficiency of 23%, 20% and 22%, respectively. When using specific differentiation media, differentiation efficiency is greatly enhanced in Muse-AT cells (82% for mesenchymal, 75% for endodermal and 78% for ectodermal). When compared to adipose stem cells (ASCs), microarray data indicate a substantial up-regulation of Sox2, Oct3/4, and Rex1. Muse-ATs also exhibit gene expression patterns associated with the down-regulation of genes involved in cell death and survival, embryonic development, DNA replication and repair, cell cycle and potential factors related to oncogenecity. Gene expression analysis indicates that Muse-ATs and ASCs are mesenchymal in origin; however, Muse-ATs also express numerous lymphocytic and hematopoietic genes, such as CCR1 and CXCL2, encoding chemokine receptors and ligands involved in stem cell homing. Being highly resistant to severe cellular stress, Muse-AT cells have the potential to make a critical impact on the field of regenerative medicine and cell-based therapy.	[Heneidi, Saleh] Georgetown Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20007 USA; [Simerman, Ariel A.; Keller, Erica; Singh, Prapti; Dumesic, Daniel A.; Chazenbalk, Gregorio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Li, Xinmin] Univ Calif Los Angeles, David Geffen Sch Med, Clin Microarray Core, Los Angeles, CA 90095 USA	Georgetown University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chazenbalk, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.	gchazenbalk@mednet.ucla.edu		Dumesic, Daniel/0000-0003-0387-1277	Department of Obstetrics/Gynecology at University of California Los Angeles; Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health [U54 HD071836]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071836, P50HD071836] Funding Source: NIH RePORTER	Department of Obstetrics/Gynecology at University of California Los Angeles; Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Part of these studies were supported by the Department of Obstetrics/Gynecology at University of California Los Angeles and by the Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health through cooperative agreement U54 HD071836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi H, 2011, J SURG RES, V165, P112, DOI 10.1016/j.jss.2009.09.057; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; Beier JP, 2011, CELL BIOL INT, V35, P397, DOI 10.1042/CBI20100417; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Carlini P, 2007, BIOMETALS, V20, P869, DOI 10.1007/s10534-006-9080-5; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chazenbalk G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017834; Couture JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004743; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; Dayem Ahmed Abdal, 2010, Cancers (Basel), V2, P859, DOI 10.3390/cancers2020859; del Castillo FJ, 2010, HUM MOL GENET, V19, P262, DOI 10.1093/hmg/ddp490; Di Rocco G, 2006, J CELL SCI, V119, P2945, DOI 10.1242/jcs.03029; Eliasson P, 2010, EXP HEMATOL, V38, P301, DOI 10.1016/j.exphem.2010.01.005; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Fulda S, 2009, INT J CELL BIOL, V2010; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gottlieb DI, 1999, CELLS TISSUES ORGANS, V165, P165, DOI 10.1159/000016696; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hodgetts SI, 2000, CELL TRANSPLANT, V9, P489, DOI 10.1177/096368970000900406; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hollenbeck ST, 2012, WOUND REPAIR REGEN, V20, P872, DOI 10.1111/j.1524-475X.2012.00854.x; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Hu AB, 2004, LIVER INT, V24, P237, DOI 10.1111/j.1478-3231.2004.00910.x; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Kang KS, 2011, TOXICOL SCI, V120, pS269, DOI 10.1093/toxsci/kfq370; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Kuhlmann WD, 2006, INT J EXP PATHOL, V87, P343, DOI 10.1111/j.1365-2613.2006.00485.x; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; KUZNETSOV SA, 1981, FEBS LETT, V135, P237, DOI 10.1016/0014-5793(81)80790-9; Levy YS, 2003, J MOL NEUROSCI, V21, P121, DOI 10.1385/JMN:21:2:121; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; MacPherson PA, 1997, NEUROSCIENCE, V80, P487, DOI 10.1016/S0306-4522(97)00102-4; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mingliang R, 2011, STEM CELLS INT, V2011; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; MOLNAR E, 1993, NEUROSCIENCE, V53, P307, DOI 10.1016/0306-4522(93)90198-O; Oh JS, 2011, CELL TRANSPLANT, V20, P837, DOI 10.3727/096368910X539083; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Teramoto K, 2005, J HEPATO-BILIARY-PAN, V12, P196, DOI 10.1007/s00534-005-0980-5; Thompson SA, 2011, CIRCULATION, V123, P2083, DOI 10.1161/CIRCULATIONAHA.110.015057; Trosko JE, 2000, METHODS, V20, P245, DOI 10.1006/meth.1999.0941; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Xiao N, 2012, BLOOD, V119, P4898, DOI 10.1182/blood-2012-01-403089; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zamule SM, 2011, CHEM-BIOL INTERACT, V190, P62, DOI 10.1016/j.cbi.2011.01.009; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	67	90	95	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64752	10.1371/journal.pone.0064752	http://dx.doi.org/10.1371/journal.pone.0064752			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755141	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400024
J	Kim, HJ; Son, YK; An, WS				Kim, Hyun Jeong; Son, Young Ki; An, Won Suk			Effect of Sodium Bicarbonate Administration on Mortality in Patients with Lactic Acidosis: A Retrospective Analysis	PLOS ONE			English	Article							HEMODYNAMICS; ARTERIAL; THERAPY; FAILURE; LACTATE; DISEASE; BLOOD	Background: Lactic acidosis is a common cause of high anion gap metabolic acidosis. Sodium bicarbonate may be considered for an arterial pH <7.15 but paradoxically depresses cardiac performance and exacerbates acidosis by enhancing lactate production. This study aimed to evaluate the cause and mortality rate of lactic acidosis and to investigate the effect of factors, including sodium bicarbonate use, on death. Methods: We conducted a single center analysis from May 2011 through April 2012. We retrospectively analyzed 103 patients with lactic acidosis among 207 patients with metabolic acidosis. We used SOFA and APACHE II as severity scores to estimate illness severity. Multivariate logistic regression analysis and Cox regression analysis models were used to identify factors that affect mortality. Results: Of the 103 patients with a mean age of 66.1 +/- 11.4 years, eighty-three patients (80.6%) died from sepsis (61.4%), hepatic failure, cardiogenic shock and other causes. The percentage of sodium bicarbonate administration (p = 0.006), catecholamine use, ventilator care and male gender were higher in the non-survival group than the survival group. The non-survival group had significantly higher initial and follow-up lactic acid levels, lower initial albumin, higher SOFA scores and APACHE II scores than the survival group. The mortality rate was significantly higher in patients who received sodium bicarbonate. Sodium bicarbonate administration (p = 0.016) was associated with higher mortality. Independent factors that affected mortality were SOFA score (Exp (B) = 1.72, 95% CI = 1.12-2.63, p = 0.013) and sodium bicarbonate administration (Exp (B) = 6.27, 95% CI = 1.10-35.78, p = 0.039). Conclusions: Lactic acidosis, which has a high mortality rate, should be evaluated in patients with metabolic acidosis. In addition, sodium bicarbonate should be prescribed with caution in the case of lactic acidosis because sodium bicarbonate administration may affect mortality.	[Kim, Hyun Jeong; Son, Young Ki; An, Won Suk] Dong A Univ, Dept Internal Med, Coll Med, Pusan, South Korea; [An, Won Suk] Dong A Univ, Inst Med Sci, Coll Med, Pusan, South Korea	Dong A University; Dong A University	An, WS (corresponding author), Dong A Univ, Dept Internal Med, Coll Med, Pusan, South Korea.	anws@dau.ac.kr			Dong-A University	Dong-A University	This study was supported by research funds from Dong-A University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADROGUE HJ, 1989, NEW ENGL J MED, V320, P1312, DOI 10.1056/NEJM198905183202004; COOPER DJ, 1990, ANN INTERN MED, V112, P492, DOI 10.7326/0003-4819-112-7-492; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; Jansen TC, 2009, CRIT CARE MED, V37, P2369, DOI 10.1097/CCM.0b013e3181a0f919; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kraut Jeffrey A, 2006, Clin Exp Nephrol, V10, P111, DOI 10.1007/s10157-006-0408-9; Luft FC, 2001, J AM SOC NEPHROL, V12, pS15; MADIAS NE, 1986, KIDNEY INT, V29, P752, DOI 10.1038/ki.1986.62; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; MITCHELL JH, 1972, KIDNEY INT, V1, P375, DOI 10.1038/ki.1972.48; Rachoin JS, 2011, J HOSP MED, V6, pE1, DOI 10.1002/jhm.703; STACPOOLE PW, 1994, AM J MED, V97, P47, DOI 10.1016/0002-9343(94)90047-7; Susantitaphong P, 2012, AM J NEPHROL, V35, P540, DOI 10.1159/000339329; Trzeciak S, 2007, INTENS CARE MED, V33, P970, DOI 10.1007/s00134-007-0563-9; Valenza F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046035; WEIL MH, 1986, NEW ENGL J MED, V315, P153, DOI 10.1056/NEJM198607173150303; WILDENTH.K, 1968, AM J PHYSIOL, V214, P1352, DOI 10.1152/ajplegacy.1968.214.6.1352	18	45	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65283	10.1371/journal.pone.0065283	http://dx.doi.org/10.1371/journal.pone.0065283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755210	Green Published, gold, Green Submitted			2022-12-25	WOS:000320579400050
J	Gao, J; Li, LS; Wu, MQ; Liu, M; Xie, XH; Guo, JL; Tang, HL; Xie, XM				Gao, Jie; Li, Laisheng; Wu, Minqing; Liu, Min; Xie, Xinhua; Guo, Jiaoli; Tang, Hailin; Xie, Xiaoming			MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1	PLOS ONE			English	Article							PACLITAXEL-RESISTANCE; MICRORNA EXPRESSION; LUNG-CANCER; CELL-DEATH; IN-VIVO; METASTASIS; APOPTOSIS; TARGETS; CARCINOGENESIS; CHALLENGES	Breast cancer is the most commonly malignancies in women. MicroRNAs are a family of small non-coding RNAs 18-25 nucleotides in length that post-transcriptionally modulate gene expression. MiR-26a has been reported as a tumor suppressor microRNA in breast cancer, which is attributed mainly to targeting of MTDH and EZH2, however, the expression profile and therapeutic potential of miR-26a is still unclear. Here we demonstrate that miR-26a is down-regulated in breast cancer cells and clinical specimens and its modulation in breast cancer cells regulates cell proliferation, colony formation, migration and apoptosis. MCL-1, an anti-apoptotic member of the Bcl-2 family, as novel targets of miR-26a was found to be in reverse correlation with ectopic expression of miR-26a and knockdown of MCL-1 phenocopied the effect of miR-26a in breast cancer cell lines. It was further explored that miR-26a increased sensitivity of breast cancer cells to paclitaxel in which MCL-1 was involved. Thus, miR-26a impacts on cell proliferation and migration of breast cancer by regulating several carcinogenesis-related processes, including a novel mechanism involving the targeting of MCL-1.	[Gao, Jie; Wu, Minqing; Xie, Xinhua; Guo, Jiaoli; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Laisheng; Liu, Min] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Jie; Li, Laisheng; Wu, Minqing; Xie, Xinhua; Guo, Jiaoli; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Xie, XM (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China.	xiexm@sysucc.org.cn	Li, Laisheng/G-6674-2015		National Natural Science Foundation of China [81272514, 31030061, 31100935]; China Postdoctoral Science Foundation [2012M520075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by funds from Key Program of National Natural Science Foundation of China number 31030061, National Natural Science Foundation of China number 81272514, National Natural Science Foundation of China (31100935), and the China Postdoctoral Science Foundation (2012M520075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2007, EXPERT REV MOL DIAGN, V7, P569, DOI 10.1586/14737159.7.5.569; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Entschladen F, 2004, LANCET ONCOL, V5, P254, DOI 10.1016/S1470-2045(04)01431-7; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gong J., 2012, ONCOGENE; Holleman A, 2011, ONCOGENE, V30, P4386, DOI 10.1038/onc.2011.148; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kasinski AL, 2011, NAT REV CANCER, V11, P849; Kim SJ, 2011, J CONTROL RELEASE, V155, P427, DOI 10.1016/j.jconrel.2011.06.026; Kojima K, 2010, PROSTATE, V70, P1501, DOI 10.1002/pros.21185; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li L, 2012, CLIN EXP MED; Li L, 2012, MOL THER; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Rivera E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2573; Saito Y, 2012, INT J CANC; Sander S, 2009, CELL CYCLE, V8, P556, DOI 10.4161/cc.8.4.7599; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032115, 10.1371/journal.pone.0047003]; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046173; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang JX, 2012, CANC LETT; Zhang YK, 2011, BIOCHEM BIOPH RES CO, V414, P233, DOI 10.1016/j.bbrc.2011.09.063	48	49	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65138	10.1371/journal.pone.0065138	http://dx.doi.org/10.1371/journal.pone.0065138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750239	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900041
J	Ngai, KLK; Chan, MCW; Chan, PKS				Ngai, Karry L. K.; Chan, Martin C. W.; Chan, Paul K. S.			Replication and Transcription Activities of Ribonucleoprotein Complexes Reconstituted from Avian H5N1, H1N1pdm09 and H3N2 Influenza A Viruses	PLOS ONE			English	Article							N-TERMINAL REGION; RNA-POLYMERASE; PA SUBUNIT; CAP-BINDING; HOST RESTRICTION; VIRAL POLYMERASE; PROMOTER-BINDING; CONSERVED MOTIFS; PANDEMIC H1N1; PB2	Avian influenza viruses pose a serious pandemic threat to humans. Better knowledge on cross-species adaptation is important. This study examined the replication and transcription efficiency of ribonucleoprotein complexes reconstituted by plasmid co-transfection between H5N1, H1N1pdm09 and H3N2 influenza A viruses, and to identify mutations in the RNA polymerase subunit that affect human adaptation. Viral RNA polymerase subunits PB1, PB2, PA and NP derived from influenza viruses were co-expressed with pPoll-vNP-Luc in human cells, and with its function evaluated by luciferase reporter assay. A quantitative RT-PCR was used to measure vRNA, cRNA, and mRNA levels for assessing the replication and transcription efficiency. Mutations in polymerase subunit were created to identify signature of increased human adaptability. H5N1 ribonucleoprotein complexes incorporated with PB2 derived from H1N1pdm09 and H3N2 viruses increased the polymerase activity in human cells. Furthermore, single amino acid substitutions at PB2 of H5N1 could affect polymerase activity in a temperature-dependent manner. By using a highly sensitive quantitative reverse transcription-polymerase chain reaction, an obvious enhancement in replication and transcription activities of ribonucleoproteins was observed by the introduction of lysine at residue 627 in the H5N1 PB2 subunit. Although less strongly in polymerase activity, E158G mutation appeared to alter the accumulation of H5N1 RNA levels in a temperature-dependent manner, suggesting a temperature-dependent mechanism in regulating transcription and replication exists. H5N1 viruses can adapt to humans either by acquisition of PB2 from circulating human-adapted viruses through reassortment, or by mutations at critical sites in PB2. This information may help to predict the pandemic potential of newly emerged influenza strains, and provide a scientific basis for stepping up surveillance measures and vaccine production.	[Ngai, Karry L. K.; Chan, Martin C. W.; Chan, Paul K. S.] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Paul K. S.] Chinese Univ Hong Kong, Fac Med, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, PKS (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk	Chan, Martin/B-3588-2009; Chan, Paul KS/J-9360-2013	Chan, Martin/0000-0002-1568-1596; Chan, Paul KS/0000-0002-6360-4608	Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region	Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region	This research was supported by the Research Fund for the Control of Infectious Diseases, Food and Health Bureau, Hong Kong Special Administrative Region. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; BRAAM J, 1983, CELL, V34, P609; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Dalton RM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-58; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Honda A, 2007, GENES CELLS, V12, P133, DOI 10.1111/j.1365-2443.2007.01047.x; Kashiwagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015140; Kashiwagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005473; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Lam WY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-528; Leung BW, 2010, VIROLOGY, V401, P96, DOI 10.1016/j.virol.2010.01.036; Li OTW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005658; Liu D, 2009, SCI CHINA SER C, V52, P428, DOI 10.1007/s11427-009-0062-z; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Nakazono Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032634; Ng SSF, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-2; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Wang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040752; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10	38	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65038	10.1371/journal.pone.0065038	http://dx.doi.org/10.1371/journal.pone.0065038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750226	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900028
J	Han, HY; Zhang, JP; Ji, SQ; Liang, QM; Kang, HC; Tang, RH; Zhu, SQ; Xue, Z				Han, Hai-Yan; Zhang, Jin-Ping; Ji, Su-Qiong; Liang, Qi-Ming; Kang, Hui-Cong; Tang, Rong-Hua; Zhu, Sui-Qiang; Xue, Zheng			alpha nu and beta 1 Integrins Mediate A beta-Induced Neurotoxicity in Hippocampal Neurons via the FAK Signaling Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ALZHEIMERS-DISEASE; TYROSINE PHOSPHORYLATION; SYNAPTIC PLASTICITY; TERMINAL DOMAIN; CELL-SURVIVAL; INTEGRIN; PEPTIDE; INHIBITION; PROTEIN	alpha nu and beta 1 integrins mediate A beta-induced neurotoxicity in primary hippocampal neurons. We treated hippocampal neurons with 2.5 mu g/mL 17E6 and 5 mu g/mL ab58524, which are specific alpha nu and beta 1 integrin antagonists, respectively, for 42 h prior to 10 mu M A beta treatment. Next, we employed small interfering RNA (siRNA) to silence focal adhesion kinase (FAK), a downstream target gene of integrins. The siRNAs were designed with a target sequence, an MOI of 10 and the addition of 5 mu g/mL polybrene. Under these conditions, the neurons were transfected and the apoptosis of different cell types was detected. Moreover, we used real-time PCR and Western blotting analyses to detect the expression of FAK and rho FAK genes in different cell types and investigated the underlying mechanism and signal pathway by which alpha nu and beta 1 integrins mediate A beta-induced neurotoxicity in hippocampal neurons. An MTT assay showed that both 17E6 and ab58524 significantly increased cell viability compared with the A beta-treated neurons (P<0.01 and P<0.05, respectively). However, this protective effect was markedly attenuated after transfection with silencing FAK (siFAK). Moreover, TUNEL immunostaining and flow cytometry indicated that both 17E6 and ab58524 significantly protected hippocampal neurons against apoptosis induced by A beta (P<0.05) compared with the A beta-treated cells. However, this protective effect was reversed with siFAK treatment. Both the gene and protein expression of FAK increased after A beta treatment. Interestingly, as the gene and protein levels of FAK decreased, the rho FAK protein expression markedly increased. Furthermore, both the gene and protein expression of FAK and rho FAK were significantly diminished. Thus, we concluded that both alpha nu and beta 1 integrins interfered with A beta-induced neurotoxicity in hippocampal neurons and that this mechanism partially contributes to the activation of the Integrin-FAK signaling pathway.	[Han, Hai-Yan; Ji, Su-Qiong; Liang, Qi-Ming; Kang, Hui-Cong; Tang, Rong-Hua; Zhu, Sui-Qiang; Xue, Zheng] Huazhong Univ Sci & Technol, Dept Neurol, Tongji Hosp, Wuhan 430074, Hubei Province, Peoples R China; [Zhang, Jin-Ping] Shan Dong Univ, Qianfoshan Hosp, Dept Neurol, Jinan, Shandong, Peoples R China	Huazhong University of Science & Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Xue, Z (corresponding author), Huazhong Univ Sci & Technol, Dept Neurol, Tongji Hosp, Wuhan 430074, Hubei Province, Peoples R China.	xuezheng@hotmail.com	Kang, Huicong/AAA-8606-2019; zhang, jin/GXV-9154-2022		National Natural Science Fundation [30700244]	National Natural Science Fundation(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Fundation (No. 30700244). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul HM, 2006, J NEUROSCI RES, V84, P398, DOI 10.1002/jnr.20877; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Aplin AE, 2003, FEBS LETT, V534, P11, DOI 10.1016/S0014-5793(02)03840-1; Azizi Z, 2010, ALZ DIS ASSOC DIS, V24, P204, DOI 10.1097/WAD.0b013e3181a7c8fd; Choi YA, 2009, BIOCHIMIE, V91, P624, DOI 10.1016/j.biochi.2009.03.006; Cordes N, 2004, J MOL HISTOL, V35, P327; Creed MC, 2010, AGE, V32, P365, DOI 10.1007/s11357-010-9142-z; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Grace EA, 2003, J NEUROSCI, V23, P493, DOI 10.1523/JNEUROSCI.23-02-00493.2003; Gupta A, 2009, MOL CELL ENDOCRINOL, V309, P55, DOI 10.1016/j.mce.2009.05.018; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Juhasz G, 2008, BRAIN RES, V1233, P20, DOI 10.1016/j.brainres.2008.05.032; Kasahara T, 2002, ANTIOXID REDOX SIGN, V4, P491, DOI 10.1089/15230860260196290; Kelly BL, 2007, NEUROSCIENCE, V147, P60, DOI 10.1016/j.neuroscience.2007.03.047; Lee FT, 2005, CLIN CANCER RES, V11, p7080S, DOI 10.1158/1078-0432.CCR-1004-0019; Leu ST, 2004, DEV BIOL, V276, P416, DOI 10.1016/j.ydbio.2004.09.003; Lim M, 2005, HUM PATHOL, V36, P665, DOI 10.1016/j.humpath.2005.03.014; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; Monferran S, 2008, INT J CANCER, V123, P357, DOI 10.1002/ijc.23498; Ramjaun AR, 2009, INT J BIOCHEM CELL B, V41, P521, DOI 10.1016/j.biocel.2008.05.030; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Rowan MJ, 2005, BIOCHEM SOC T, V33, P563, DOI 10.1042/BST0330563; Schwartz MA, 2001, J CELL SCI, V114, P2553; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Takahashi RH, 2010, NEUROBIOL AGING, V31, P1145, DOI 10.1016/j.neurobiolaging.2008.07.021; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Wang PY, 2010, J NUTR BIOCHEM, V21, P345, DOI 10.1016/j.jnutbio.2009.01.012; Wang QW, 2008, NEUROBIOL AGING, V29, P1485, DOI 10.1016/j.neurobiolaging.2007.03.018; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Yu QS, 2013, ANTIINFLAMM ANTIALLE; Yu YX, 2009, HIPPOCAMPUS, V19, P1247, DOI 10.1002/hipo.20587; ZHANG C, 1994, J BIOL CHEM, V269, P25247; Zhao-Yang Z, 2008, CANCER LETT, V266, P209, DOI 10.1016/j.canlet.2008.02.054; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034	42	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64839	10.1371/journal.pone.0064839	http://dx.doi.org/10.1371/journal.pone.0064839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755149	Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300029
J	Ortega-Recalde, O; Vergara, JI; Fonseca, DJ; Rios, X; Mosquera, H; Bermudez, OM; Medina, CL; Vargas, CI; Pallares, AE; Restrepo, CM; Laissue, P				Ortega-Recalde, Oscar; Ines Vergara, Jessica; Janeth Fonseca, Dora; Rios, Xiomara; Mosquera, Hernando; Maria Bermudez, Olga; Liliana Medina, Claudia; Ines Vargas, Clara; Enrique Pallares, Argemiro; Martin Restrepo, Carlos; Laissue, Paul			Whole-Exome Sequencing Enables Rapid Determination of Xeroderma Pigmentosum Molecular Etiology	PLOS ONE			English	Article							DNA-POLYMERASE-ETA; NUCLEOTIDE EXCISION-REPAIR; Y-FAMILY; MUTATIONS; GENE; LOCALIZATION; DISORDERS; CAPTURE; EUROPE	Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder characterized by extreme sensitivity to actinic pigmentation changes in the skin and increased incidence of skin cancer. In some cases, patients are affected by neurological alterations. XP is caused by mutations in 8 distinct genes (XPA through XPG and XPV). The XP-V (variant) subtype of the disease results from mutations in a gene (XPV, also named POLH) which encodes for Pol eta, a member of the Y-DNA polymerase family. Although the presence and severity of skin and neurological dysfunctions differ between XP subtypes, there are overlapping clinical features among subtypes such that the sub-type cannot be deduced from the clinical features. In this study, in order to overcome this drawback, we undertook whole-exome sequencing in two XP sibs and their father. We identified a novel homozygous nonsense mutation (c.897T>G, p.Y299X) in POLH which causes the disease. Our results demonstrate that next generation sequencing is a powerful approach to rapid determination of XP genetic etiology.	[Ortega-Recalde, Oscar; Janeth Fonseca, Dora; Maria Bermudez, Olga; Martin Restrepo, Carlos; Laissue, Paul] Univ Rosario, Unidad Genet, Escuela Med & Ciencias Salud, Bogota, Colombia; [Ines Vergara, Jessica; Rios, Xiomara; Mosquera, Hernando; Liliana Medina, Claudia; Enrique Pallares, Argemiro] Univ Autonoma Bucaramanga, Dept Dermatol, Bucaramanga, Colombia; [Ines Vergara, Jessica; Rios, Xiomara; Mosquera, Hernando; Liliana Medina, Claudia; Enrique Pallares, Argemiro] Clin Carlos Ardila Lulle, Unidad Dermatol, Bucaramanga, Colombia; [Janeth Fonseca, Dora; Martin Restrepo, Carlos; Laissue, Paul] Dept Biol Mol Genet Mol Colombia, Bogota, Colombia; [Ines Vargas, Clara] Univ Ind Santander, Bucaramanga, Colombia	Universidad del Rosario; Universidad Industrial de Santander	Laissue, P (corresponding author), Univ Rosario, Unidad Genet, Escuela Med & Ciencias Salud, Bogota, Colombia.	paul.laissue@urosario.edu.co	Laissue, Paul/C-6787-2012; Restrepo, Carlos M./K-2830-2016; Fonseca-Mendoza, Dora Janeth/K-3286-2016	Laissue, Paul/0000-0003-4180-4796; Restrepo, Carlos M./0000-0001-6410-0084; Ortega-Recalde, Oscar/0000-0002-8076-0346; Fonseca-Mendoza, Dora Janeth/0000-0002-7323-6570	Universidad del Rosario	Universidad del Rosario	This study was supported by the Universidad del Rosario, grant CS/Genetics 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Ben Rekaya M, 2011, J GENET, V90, P483; Boudsocq F, 2002, DNA REPAIR, V1, P343, DOI 10.1016/S1568-7864(02)00019-8; Bradford PT, 2011, J MED GENET, V48, P168, DOI 10.1136/jmg.2010.083022; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Chin ELH, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-6; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cordonnier AM, 1999, MOL CELL BIOL, V19, P2206; Diggle CP, 2012, HUM MUTAT, V33, P1175, DOI 10.1002/humu.22111; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Gratchev A, 2003, EXP DERMATOL, V12, P529, DOI 10.1034/j.1600-0625.2003.00124.x; Hirai Y, 2006, MUTAT RES-FUND MOL M, V601, P171, DOI 10.1016/j.mrfmmm.2006.06.010; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Khan SG, 2009, DNA REPAIR, V8, P114, DOI 10.1016/j.dnarep.2008.09.007; Kleijer WJ, 2008, DNA REPAIR, V7, P744, DOI 10.1016/j.dnarep.2008.01.014; Lehmann AR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-70; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; Leibeling D, 2006, J MOL HISTOL, V37, P225, DOI 10.1007/s10735-006-9041-x; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lower M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002714; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nakazawa Y, 2012, NAT GENET, V44, P586, DOI 10.1038/ng.2229; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Niedernhofer Laura J, 2011, Mech Ageing Dev, V132, P340, DOI 10.1016/j.mad.2011.06.004; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Schafer A, 2013, EXP DERMATOL, V22, P24, DOI 10.1111/exd.12052; Shyr D, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-4; Tanioka M, 2007, J INVEST DERMATOL, V127, P1745, DOI 10.1038/sj.jid.5700759; Ware JS, 2013, J CARDIOVASC TRANSL, V6, P94, DOI 10.1007/s12265-012-9401-8; Yuasa M, 2000, ONCOGENE, V19, P4721, DOI 10.1038/sj.onc.1203842	35	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64692	10.1371/journal.pone.0064692	http://dx.doi.org/10.1371/journal.pone.0064692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755135	Green Published, gold			2022-12-25	WOS:000319872300023
J	Shishido, SN; Faulkner, EB; Beck, A; Nguyen, TA				Shishido, Stephanie N.; Faulkner, Emma B.; Beck, Amanda; Nguyen, Thu A.			The Effect of Antineoplastic Drugs in a Male Spontaneous Mammary Tumor Model	PLOS ONE			English	Article							MALE BREAST-CANCER; ESTROGEN-RECEPTOR-BETA; ANTI-APOPTOSIS GENE; CYCLIN D1; EXPRESSION; SURVIVIN; CELLS; CARCINOMA; DISEASE; BCL-2	Male breast cancer is a rare disease. The limited number of clinical cases has led to the primary treatments for men being derived from female breast cancer studies. Here the transgenic strain FVB/N-Tg(MMTV-PyVT)634Mul/J ( also known as PyVT) was used as a model system for measuring tumor burden and drug sensitivity of the antineoplastic drugs tamoxifen, cisplatin, and paclitaxel on tumorigenesis at an early stage of mammary carcinoma development in a male mouse model. Cisplatin treatment significantly reduced tumor volume, while paclitaxel and tamoxifen did not attenuate tumor growth. Cisplatin treatment was shown to induce apoptosis, grossly observed by reduced tumor formation, through reduced Bcl-2 and survivin protein expression levels with an increase in caspase 3 expression compared to control tumors. Tamoxifen treatment significantly altered the hormone receptor expression levels of the tumor, while additionally upregulating Bcl-2 and Cyclin D1. This suggests an importance in hormonal signaling in male breast cancer pathogenesis. The results of this study provide valuable information toward the better understanding of male breast cancer and may help guide treatment decisions.	[Shishido, Stephanie N.; Faulkner, Emma B.; Beck, Amanda; Nguyen, Thu A.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	Kansas State University	Nguyen, TA (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.	tnguyen@vet.k-state.edu	Beck, Amanda P/H-9573-2017	Beck, Amanda P/0000-0003-1867-4110	Johnson Center for Basic Cancer Research;  [NIH-1R15CA152922]; NATIONAL CANCER INSTITUTE [R15CA152922] Funding Source: NIH RePORTER	Johnson Center for Basic Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge financial support from NIH-1R15CA152922 (Nguyen) and The Johnson Center for Basic Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Anderson WF, 2004, BREAST CANCER RES TR, V83, P77, DOI 10.1023/B:BREA.0000010701.08825.2d; Appelbaum AH, 1999, RADIOGRAPHICS, V19, P559, DOI 10.1148/radiographics.19.3.g99ma01559; Bloom KJ, 2001, AM J SURG, V182, P389, DOI 10.1016/S0002-9610(01)00733-4; Callagy GM, 2006, CLIN CANCER RES, V12, P2468, DOI 10.1158/1078-0432.CCR-05-2719; Covaleda AMS, 2008, TOXICOL SCI, V105, P303, DOI 10.1093/toxsci/kfn141; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Esslimani-Sahla M, 2004, CLIN CANCER RES, V10, P5769, DOI 10.1158/1078-0432.CCR-04-0389; Foerster R, 2009, CANCER RES, V69, p628S; Formby B, 1999, MOL CELL BIOCHEM, V202, P53, DOI 10.1023/A:1007081021483; FUCHS DA, 1978, CANCER TREAT REP, V62, P1219; Giordano SH, 2004, CANCER, V101, P51, DOI 10.1002/cncr.20312; Giordano SH, 2002, ANN INTERN MED, V137, P678, DOI 10.7326/0003-4819-137-8-200210150-00013; Goss PE, 1999, CANCER-AM CANCER SOC, V85, P629, DOI 10.1002/(SICI)1097-0142(19990201)85:3<629::AID-CNCR13>3.0.CO;2-V; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Howlader N, 2012, SEER CANC STAT REV 1; JIANG W, 1993, ONCOGENE, V8, P3447; Kandouz M, 1996, INT J CANCER, V68, P120, DOI 10.1002/(SICI)1097-0215(19960927)68:1<120::AID-IJC21>3.0.CO;2-E; Kari B, DIS BREAST; Korde LA, 2010, J CLIN ONCOL, V28, P2114, DOI 10.1200/JCO.2009.25.5729; Kornegoor R, 2012, HISTOPATHOLOGY; Kornegoor R, 2012, MODERN PATHOL, V25, P398, DOI 10.1038/modpathol.2011.174; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Lu CD, 1998, CANCER RES, V58, P1808; Maglione JE, 2001, CANCER RES, V61, P8298; Mann S, 2001, HUM PATHOL, V32, P113, DOI 10.1053/hupa.2001.21506; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Muir D, 2003, ARCH PATHOL LAB MED, V127, P36; Nahleh ZA, 2006, CANCER TREAT REV, V32, P101, DOI 10.1016/j.ctrv.2005.12.007; Nilsson C, 2012, MOD PATHOL; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Rayson D, 1998, CANCER, V83, P1947, DOI 10.1002/(SICI)1097-0142(19981101)83:9<1947::AID-CNCR10>3.0.CO;2-J; RIBEIRO G, 1992, BRIT J CANCER, V65, P252, DOI 10.1038/bjc.1992.50; Saibara T, 1998, LANCET, V352, P404, DOI 10.1016/S0140-6736(05)60502-8; Sanchez-Munoz A, 2012, ONCOLOGY-BASEL, V83, P228, DOI 10.1159/000341537; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Secreto FJ, 2007, J CELL BIOCHEM, V101, P1125, DOI 10.1002/jcb.21205; Shaaban AM, 2012, BREAST CANCER RES TR, V133, P949, DOI 10.1007/s10549-011-1856-9; Skliris GP, 2006, BRIT J CANCER, V95, P616, DOI 10.1038/sj.bjc.6603295; Speirs V, 1999, CANCER RES, V59, P525; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Sugiura H, 2007, JPN J CLIN ONCOL, V37, P820, DOI 10.1093/jjco/hym114; Taber KAJ, 2010, ONCOL REP, V24, P1115, DOI 10.3892/or_00000962; Tischkowitz MD, 2002, INT J CLIN PRACT, V56, P750; vanDiest PJ, 1997, AM J PATHOL, V150, P705; Volm Matthew D, 2003, Curr Treat Options Oncol, V4, P159, DOI 10.1007/s11864-003-0017-8; Wang-Rodriguez J, 2002, MODERN PATHOL, V15, P853, DOI 10.1097/01.MP.0000022251.61944.1D; Waters KM, 2001, J CELL BIOCHEM, V83, P448, DOI 10.1002/jcb.1242; WeberChappuis K, 1996, EUR J CANCER, V32A, P1686, DOI 10.1016/0959-8049(96)00154-2; Weiss JR, 2005, CANCER EPIDEM BIOMAR, V14, P20, DOI 10.1158/1055-9965.EPI-05-0414; Young IE, 1999, BRIT J CANCER, V81, P141, DOI 10.1038/sj.bjc.6690663; ZAMBLE DB, 1995, TRENDS BIOCHEM SCI, V20, P435, DOI 10.1016/S0968-0004(00)89095-7; ZHANG SY, 1994, AM J CLIN PATHOL, V102, P695, DOI 10.1093/ajcp/102.5.695	57	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64866	10.1371/journal.pone.0064866	http://dx.doi.org/10.1371/journal.pone.0064866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755153	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300033
J	Wu, JB; Guan, DX; Yuan, FH; Wang, AZ; Jin, CJ				Wu, Jiabing; Guan, Dexin; Yuan, Fenhui; Wang, Anzhi; Jin, Changjie			Soil Temperature Triggers the Onset of Photosynthesis in Korean Pine	PLOS ONE			English	Article							CARBON-DIOXIDE; WATER-VAPOR; SCOTS PINE; NORWAY SPRUCE; SEASONAL AIR; BOREAL; RECOVERY; ECOSYSTEM; FOREST; PRODUCTIVITY	In forest ecosystems, the onset of spring photosynthesis may have an important influence on the annual carbon balance. However, triggers for the onset of photosynthesis have yet to be clearly identified, especially for temperate evergreen conifers. The effects of climatic factors on recovery of photosynthetic capacity in a Korean pine forest were investigated in the field. No photosynthesis was detectable when the soil temperature was below 0 degrees C even if the air temperature was far beyond 15 degrees C. The onset of photosynthesis and sap flow was coincident with the time of soil thawing. The rates of recovery of photosynthetic capacity highly fluctuated with air temperature after onset of photosynthesis, and intermittent frost events remarkably inhibited the photosynthetic capacity of the needles. The results suggest that earlier soil thawing is more important than air temperature increases in triggering the onset of photosynthesis in Korean pine in temperate zones under global warming scenarios.	[Wu, Jiabing; Guan, Dexin; Yuan, Fenhui; Wang, Anzhi; Jin, Changjie] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Guan, DX (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	bjfu_1999@hotmail.com	Yuan, Fenghui/W-3609-2019; Guan, Dexin/I-4184-2018; Yuan, Fenghui/M-7424-2013	Yuan, Fenghui/0000-0003-1004-873X; Guan, Dexin/0000-0002-2183-3779; Yuan, Fenghui/0000-0003-1004-873X	State Key Development Program of Basic Research (SKDPBR) [2009CB421101]; Youth Fund for Creative Research Groups, Institute of Applied Ecology, Chinese Academy of Sciences	State Key Development Program of Basic Research (SKDPBR); Youth Fund for Creative Research Groups, Institute of Applied Ecology, Chinese Academy of Sciences	This study was jointly financed by State Key Development Program of Basic Research (SKDPBR) (2009CB421101), and the Youth Fund for Creative Research Groups, Institute of Applied Ecology, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADGER MR, 1982, PLANT CELL ENVIRON, V5, P85; Bergh J, 1998, FOREST ECOL MANAG, V110, P127, DOI 10.1016/S0378-1127(98)00280-1; Bergh J, 1999, GLOB CHANGE BIOL, V5, P245, DOI 10.1046/j.1365-2486.1999.00205.x; Davidson NJ, 2004, TREES-STRUCT FUNCT, V18, P245, DOI 10.1007/s00468-003-0298-3; DELUCIA EH, 1987, CAN J FOREST RES, V17, P527, DOI 10.1139/x87-088; Ellsworth DS, 2000, TREE PHYSIOL, V20, P435; Ensminger I, 2004, GLOBAL CHANGE BIOL, V10, P995, DOI 10.1111/j.1365-2486.2004.00781.x; Ensminger I, 2006, PHYSIOL PLANTARUM, V126, P28, DOI 10.1111/j.1399-3054.2006.00627.x; Ensminger I, 2008, NEW PHYTOL, V177, P428, DOI 10.1111/j.1469-8137.2007.02273.x; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Foken T, 1996, AGR FOREST METEOROL, V78, P83, DOI 10.1016/0168-1923(95)02248-1; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Ham JM, 1998, AGR FOREST METEOROL, V89, P1, DOI 10.1016/S0168-1923(97)00062-2; Hannerz M, 1999, CAN J FOREST RES, V29, P9, DOI 10.1139/cjfr-29-1-9; Havranek W., 1995, ECOPHYSIOLOGY CONIFE, P95, DOI DOI 10.1016/B978-0-08-092593-6.50010-4; Hollinger DY, 1999, GLOB CHANGE BIOL, V5, P891, DOI 10.1046/j.1365-2486.1999.00281.x; HUNTER AF, 1992, J APPL ECOL, V29, P597, DOI 10.2307/2404467; Idso CD, 2000, ENVIRON EXP BOT, V43, P91, DOI 10.1016/S0098-8472(99)00054-4; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jarvis P, 2000, NATURE, V405, P904, DOI 10.1038/35016154; Linkosalo T, 2000, CAN J FOREST RES, V30, P667, DOI 10.1139/x99-243; Lundmark T, 1988, TREES-STRUCT FUNCT, V2, P110, DOI 10.1007/BF00196757; Monson RK, 2005, OECOLOGIA, V146, P130, DOI 10.1007/s00442-005-0169-2; MOORE CJ, 1986, BOUND-LAY METEOROL, V37, P17, DOI 10.1007/BF00122754; Moore TR, 2006, GLOBAL CHANGE BIOL, V12, P2323, DOI 10.1111/j.1365-2486.2006.01247.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Oksanen E, 2005, CAN J FOREST RES, V35, P703, DOI 10.1139/X05-007; OTTANDER C, 1991, PLANT CELL ENVIRON, V14, P345, DOI 10.1111/j.1365-3040.1991.tb01511.x; OTTANDER C, 1995, PLANTA, V197, P176, DOI 10.1007/BF00239954; Saitoh TM, 2010, J PLANT RES, V123, P473, DOI 10.1007/s10265-009-0308-7; Saxe H, 2001, NEW PHYTOL, V149, P369, DOI 10.1046/j.1469-8137.2001.00057.x; SCHULTZ PA, 1993, ADV SPACE RES-SERIES, V13, P277, DOI 10.1016/0273-1177(93)90559-T; Schwarz PA, 1997, TREE PHYSIOL, V17, P187; Sevanto S, 2006, TREE PHYSIOL, V26, P749, DOI 10.1093/treephys/26.6.749; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Strand M, 2002, TREE PHYSIOL, V22, P839, DOI 10.1093/treephys/22.12.839; Tanja S, 2003, GLOBAL CHANGE BIOL, V9, P1410, DOI 10.1046/j.1365-2486.2003.00597.x; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Wu JB, 2012, ATMOS ENVIRON, V61, P9, DOI 10.1016/j.atmosenv.2012.07.013; Yuan FM, 2008, GLOBAL CHANGE BIOL, V14, P1765, DOI 10.1111/j.1365-2486.2008.01612.x; Zheng YP, 2012, SCAND J FOREST RES, V27, P520, DOI 10.1080/02827581.2012.683532; Zhou Yong-bin, 2007, Shengtaixue Zazhi, V26, P793	44	16	16	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65401	10.1371/journal.pone.0065401	http://dx.doi.org/10.1371/journal.pone.0065401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755227	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300078
J	Zhen, Y; Ye, YF; Yu, XL; Mai, CP; Zhou, Y; Chen, Y; Yang, HL; Lyu, XM; Song, Y; Wu, QY; Fu, QF; Zhao, MY; Hua, SN; Wang, H; Liu, Z; Zhang, YJ; Fang, WY				Zhen, Yan; Ye, Yanfen; Yu, Xiaoli; Mai, Chunping; Zhou, Ying; Chen, Yan; Yang, Huiling; Lyu, Xiaoming; Song, Ye; Wu, Qiangyun; Fu, Qiaofen; Zhao, Mengyang; Hua, Shengni; Wang, Hao; Liu, Zhen; Zhang, Yajie; Fang, Weiyi			Reduced CTGF Expression Promotes Cell Growth, Migration, and Invasion in Nasopharyngeal Carcinoma (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							FACTOR CTGF/CCN2; DOWN-REGULATION; CANCER CELLS; SURVIVAL; CYR61; PROLIFERATION; INVASIVENESS; INHIBITION; DECREASES; PROGNOSIS	Background: The role of CTGF varies in different types of cancer. The purpose of this study is to investigate the involvement of CTGF in tumor progression and prognosis of human nasopharyngeal carcinoma (NPC). Experimental design: CTGF expression levels were examined in NPC tissues and cells, nasopharynx (NP) tissues, and NP69 cells. The effects and molecular mechanisms of CTGF expression on cell proliferation, migration, invasion, and cell cycle were also explored. Results: NPC cells exhibited decreased mRNA expression of CTGF compared to immortalized human nasopharyngeal epithelial cell line NP69. Similarly, CTGF was observed to be downregulated in NPC compared to normal tissues at mRNA and protein levels. Furthermore, reduced CTGF was negatively associated with the progression of NPC. Knocking down CTGF expression enhanced the colony formation, cell migration, invasion, and G1/S cell cycle transition. Mechanistic analysis revealed that CTGF suppression activated FAK/PI3K/AKT and its downstream signals regulating the cell cycle, epithelialmesenchymal transition (EMT) and MMPs. Finally, DNA methylation microarray revealed a lack of hypermethylation at the CTGF promoter, suggesting other mechanisms are associated with suppression of CTGF in NPC. Conclusion: Our study demonstrates that reduced expression of CTGF promoted cell proliferation, migration, invasion and cell cycle progression through FAK/PI3K/AKT, EMT and MMP pathways in NPC.	[Zhen, Yan; Ye, Yanfen; Yu, Xiaoli; Mai, Chunping; Zhou, Ying; Chen, Yan; Lyu, Xiaoming; Wu, Qiangyun; Fu, Qiaofen; Zhao, Mengyang; Hua, Shengni; Wang, Hao; Liu, Zhen; Zhang, Yajie; Fang, Weiyi] Southern Med Univ, Basic Med Sch, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Liu, Zhen; Zhang, Yajie] Med Univ Guangzhou, Basic Sch, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Yang, Huiling] Guangdong Med Coll, Sch Pharm, Dongguan, Peoples R China; [Song, Ye] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangdong Medical University; Southern Medical University - China	Liu, Z (corresponding author), Southern Med Univ, Basic Med Sch, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	narcissus_jane@163.com; yajie.zhang@163.com; fangweiyi1975@yahoo.com.cn	Lyu, Xiaoming/AAC-8564-2020; hua, shengni/HDN-5084-2022	Lyu, Xiaoming/0000-0002-6243-3536; 	National Nature Science Fund of China [81272268]; Yangcheng scholar research projects from Universities of Guangzhou [12A011D]; Natural science fund of Guangdong Province [S2012010009583]; New star plan of Pearl River Science and Technology from Guangzhou City [2011J2200009]; Guangdong Province Breeding Project Plan [LYM11102]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Yangcheng scholar research projects from Universities of Guangzhou; Natural science fund of Guangdong Province(National Natural Science Foundation of Guangdong Province); New star plan of Pearl River Science and Technology from Guangzhou City; Guangdong Province Breeding Project Plan	This study was supported by National Nature Science Fund of China (No. 81272268), Yangcheng scholar research projects from Universities of Guangzhou(No. 12A011D), Natural science fund of Guangdong Province (No. S2012010009583), New star plan of Pearl River Science and Technology from Guangzhou City (No. 2011J2200009), and Guangdong Province Breeding Project Plan (LYM11102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.64; Barbolina MV, 2009, INT J CANCER, V125, P816, DOI 10.1002/ijc.24347; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Chang CC, 2004, JNCI-J NATL CANCER I, V96, P364, DOI 10.1093/jnci/djh059; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034071; Chien WW, 2011, INT J ONCOL, V38, P1741, DOI 10.3892/ijo.2011.985; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Chuang JY, 2011, INT IMMUNOPHARMACOL, V11, P948, DOI 10.1016/j.intimp.2011.02.008; Croci S, 2004, CANCER RES, V64, P1730, DOI 10.1158/0008-5472.CAN-3502-02; Cui L, 2011, TUMOR BIOL, V32, P721, DOI 10.1007/s13277-011-0173-6; Fang WY, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-32; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Jang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-391; Jia XQ, 2011, CHINESE MED J-PEKING, V124, P3794, DOI 10.3760/cma.j.issn.0366-6999.2011.22.034; Jiang CG, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-122; Kikuchi R, 2007, CANCER RES, V67, P7095, DOI 10.1158/0008-5472.CAN-06-4567; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Liu LY, 2007, PATHOL INT, V57, P712, DOI 10.1111/j.1440-1827.2007.02162.x; Liu Z, 2012, ACTA BIOCH BIOPH SIN, V44, P503, DOI 10.1093/abbs/gms030; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Ma B, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.100; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055298; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang SA, 2011, HISTOPATHOLOGY, V58, P217, DOI 10.1111/j.1365-2559.2010.03739.x; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660; Xie JJ, 2010, AM J PATHOL, V176, P939, DOI 10.2353/ajpath.2010.090118; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yang MH, 2012, ONCOGENE, V31, P2401, DOI 10.1038/onc.2011.423; Zhou ZQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-291	31	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e64976	10.1371/journal.pone.0064976	http://dx.doi.org/10.1371/journal.pone.0064976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755163	Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300040
J	Sangar, F; Schreurs, AS; Umana-Diaz, C; Claperon, A; Desbois-Mouthon, C; Calmel, C; Mauger, O; Zaanan, A; Miquel, C; Flejou, JF; Praz, F				Sangar, F.; Schreurs, A-S; Umana-Diaz, C.; Claperon, A.; Desbois-Mouthon, C.; Calmel, C.; Mauger, O.; Zaanan, A.; Miquel, C.; Flejou, J-F; Praz, F.			Involvement of small ArfGAP1 (SMAP1), a novel Arf6-specific GTPase-activating protein, in microsatellite instability oncogenesis	ONCOGENE			English	Article						colorectal cancer; microsatellite instability; small ArfGAP1 (SMAP1); cell invasion; cell cycle; epithelial-to-mesenchymal transition	COLORECTAL CANCERS; MESSENGER-RNA; ARF6; INTERACTS; CLATHRIN; CELLS; REQUIREMENT; ENDOCYTOSIS; MUTATIONS; MIGRATION	Small ArfGAP1 (stromal membrane-associated protein 1, SMAP1), a GTPase-activating protein specific for ADP-ribosylation factor 6 (Arf6), which is a small GTPase acting on membrane trafficking and actin remodeling, is frequently mutated in various tumors displaying microsatellite instability (MSI), notably in MSI colorectal cancers (CRC). Genotyping of 93 MSI CRCs (40 stage II, 32 stage III and 21 stage IV) allowed us to underscore that SMAP1 mutation frequency was inversely correlated with disease stage (P = 0.01). Analysis of 46 cancer cell lines showed that SMAP1 mutations occurred only in MSI tumors, and consisted exclusively in short insertion or deletion in the coding 10-adenine repeat, generating a premature termination codon located downstream the ArfGAP domain. SMAP1 transcript levels were significant decreased (P = 0.006), and truncated SMAP1 protein could not be detected in cells displaying biallelic SMAP1 mutations, owing to its sensitivity to proteasome degradation. To investigate the role of SMAP1 mutations, we used the SMAP1-null HCT116 cell line and we established three isogenic SMAP1-complemented clones. Cell proliferation was first assessed in vivo using subcutaneous xenografts into immunodeficient mice. Tumors developed in all animals regardless of the cell line injected, but tumor volumes were significantly smaller for both SMAP1-complemented clones compared with HCT116 (P < 0.0001, at the time of killing). In vitro, SMAP1 mutations also increased cell clonogenicity (P = 0.02-0.04), cell proliferation (P = 0.008) by shortening the G2/M phase and decreased cell invasiveness (P = 0.03-0.003). In keeping, SMAP1-complemented HCT116 gained several mesenchymal markers (Snail, Slug and vimentin) considered as a hallmark of epithelial-to-mesenchymal transition. These observations are reminiscent of some clinical characteristics of MSI CRCs, notably their larger size and lower rate of metastasis. Our observations suggest that SMAP1 loss-of-function mutations in MSI CRC may contribute to the emerging oncogenic pathway involving abnormal Arf6 regulation.	[Sangar, F.; Schreurs, A-S; Umana-Diaz, C.; Claperon, A.; Desbois-Mouthon, C.; Calmel, C.; Mauger, O.; Zaanan, A.; Flejou, J-F; Praz, F.] INSERM, UMR S 938, St Antoine Res Ctr, Paris, France; [Sangar, F.; Schreurs, A-S; Umana-Diaz, C.; Claperon, A.; Desbois-Mouthon, C.; Calmel, C.; Mauger, O.; Zaanan, A.; Flejou, J-F; Praz, F.] Univ Paris 06, UMR S 938, St Antoine Res Ctr, Paris, France; [Miquel, C.] Univ Paris 05, St Anne Hosp, Dept Pathol, Paris, France; [Flejou, J-F] St Antoine Hosp, AP HP, Dept Pathol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Praz, F (corresponding author), INSERM UPMC UMR S 938, Ctr Rech St Antoine, Batiment Kourilsky,184 Rue Faubourg St Antoine, F-75571 Paris 12, France.	francoise.praz@upmc.fr	Desbois-Mouthon, Christele/M-7076-2017; PRAZ, Françoise/A-7291-2008; PRAZ, Françoise/AAF-7761-2020	Desbois-Mouthon, Christele/0000-0002-0772-1711; PRAZ, Françoise/0000-0002-5353-8889; PRAZ, Françoise/0000-0002-5353-8889	'Ministe re de l'Enseignement Superieur et de la Recherche; 'Fondation ARC pour la Recherche sur le Cancer; Association pour la Recherche sur le Cancer [5091]; Ligue Nationale Contre le Cancer [RS10/75-72, RS11/75-89]	'Ministe re de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); 'Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	We thank Drs Mathieu Boissan, Philippe Chavrier, Marie-Lise Lacombe and Guillaume Montagnac for their constant support and helpful discussions, as well as Dr Peggy Cuilliere-Dartigues for sharing some data. We are grateful to Martine Mergey, Anne-Marie Faussat and Philippe Fontanges for their invaluable help in RT-PCRq analyses, cytometry and confocal microscopy, respectively. We further acknowledge the expert technical assistance of Fatiha Merabtene in performing immunohistochemical analyses of mouse and human tumor samples. We are indebted to the members of INSERM UMR_S 903 for sharing the ImageJ plugin. Fatiha Sangar received a 3-year fellowship from 'Ministe re de l'Enseignement Superieur et de la Recherche' followed by a 6-month funding from 'Fondation ARC pour la Recherche sur le Cancer'. This work has been supported by grants from the Association pour la Recherche sur le Cancer (# 5091) and from the Ligue Nationale Contre le Cancer (RS10/75-72 and RS11/75-89).	Claperon A, 2012, ONCOGENE, V31, P1376, DOI 10.1038/onc.2011.334; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Duval A, 2002, CANCER RES, V62, P2447; El-Bchiri J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002583; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hempen PM, 2003, CANCER RES, V63, P994; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kon S, 2008, EXP CELL RES, V314, P1415, DOI 10.1016/j.yexcr.2007.11.006; Loire E, 2009, MOL BIOL EVOL, V26, P111, DOI 10.1093/molbev/msn230; Marcos I, 2002, GENE, V292, P167, DOI 10.1016/S0378-1119(02)00645-5; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Muralidharan-Chari V, 2009, CANCER RES, V69, P2201, DOI 10.1158/0008-5472.CAN-08-1301; Natsume W, 2006, MOL BIOL CELL, V17, P2592, DOI 10.1091/mbc.E05-10-0909; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Tanabe K, 2005, MOL BIOL CELL, V16, P1617, DOI 10.1091/mbc.E04-08-0683; Tanabe K, 2006, CANCER SCI, V97, P801, DOI 10.1111/j.1349-7006.2006.00251.x; WANG J, 1995, J BIOL CHEM, V270, P22044, DOI 10.1074/jbc.270.37.22044; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; Zaanan A, 2011, CELL ONCOL, V34, P155, DOI 10.1007/s13402-011-0024-x	23	10	10	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2758	2767		10.1038/onc.2013.211	http://dx.doi.org/10.1038/onc.2013.211			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23752192				2022-12-25	WOS:000337231700009
J	Brown, L; Waseem, A; Cruz, IN; Szary, J; Gunic, E; Mannan, T; Unadkat, M; Yang, M; Valderrama, F; O'Toole, EA; Wan, H				Brown, L.; Waseem, A.; Cruz, I. N.; Szary, J.; Gunic, E.; Mannan, T.; Unadkat, M.; Yang, M.; Valderrama, F.; O'Toole, E. A.; Wan, H.			Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation	ONCOGENE			English	Article						desmoglein; ERM proteins; AP-1 transcription factor; cell migration and invasion; keratinocytes	PEMPHIGUS-VULGARIS-IGG; EZRIN/RADIXIN/MOESIN ERM PROTEINS; CARCINOMA-CELLS; RHO-KINASE; HEPATOCELLULAR-CARCINOMA; ACTIN REORGANIZATION; UPSTREAM REGULATOR; ENDOTHELIAL-CELLS; INHIBITS INVASION; EPIDERMAL-GROWTH	Desmoglein 3 (Dsg3), the pemphigus vulgaris antigen, has recently been shown to be upregulated in squamous cell carcinoma (SCC) and has been identified as a good tumor-specific marker for clinical staging of cervical sentinel lymph nodes in head and neck SCC. However, little is known about its biological function in cancer. The actin-binding protein Ezrin and the activator protein 1 (AP-1) transcription factor are implicated in cancer progression and metastasis. Here, we report that Dsg3 regulates the activity of c-Jun/AP-1 as well as protein kinase C (PKC)-mediated phosphorylation of Ezrin-Thr567, which contributes to the accelerated motility of cancer cells. Ectopic expression of Dsg3 in cancer cell lines caused enhanced phosphorylation at Ezrin-Thr567 with concomitant augmented membrane protrusions, cell spreading and invasive phenotype. We showed that Dsg3 formed a complex with Ezrin at the plasma membrane that was required for its proper function of interacting with F-actin and CD44 as Dsg3 knockdown impaired these associations. The increased Ezrin phosphorylation in Dsg3-overexpressing cells could be abrogated substantially by various pharmacological inhibitors for Ser/Thr kinases, including PKC and Rho kinase that are known to activate Ezrin. Furthermore, a marked increase in c-Jun S63 phosphorylation, among others, was found in Dsg3-overexpressing cells and the activation of c-Jun/AP-1 was further supported by a luciferase reporter assay. Taken together, our study identifies a novel Dsg3mediated c-Jun/AP-1 regulatory mechanism and PKC-dependent Ezrin phosphorylation that could be responsible for Dsg3-associated cancer metastasis.	[Brown, L.; Waseem, A.; Szary, J.; Gunic, E.; Mannan, T.; Unadkat, M.; Wan, H.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Clin & Diagnost Oral Sci, Inst Dent, London E1 2AT, England; [Cruz, I. N.; Yang, M.] UCL Sch Pharm, Dept Pharmaceut & Biol Chem, London, England; [Valderrama, F.] Univ London, Div Biomed Sci, London, England; [O'Toole, E. A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Cutaneous Res, Blizard Inst, London E1 2AT, England	University of London; Queen Mary University London; University of London; University College London; University of London; University of London; Queen Mary University London	Wan, H (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Clin & Diagnost Oral Sci, Inst Dent, Blizard Bldg, London E1 2AT, England.	h.wan@qmul.ac.uk		O'Toole, Edel/0000-0002-4084-4836	British Skin Foundation; Institute of Dentistry; Facial Surgery Research Foundation-Saving Faces; Engineering and Physical Sciences Research Council [EP/K023071/1] Funding Source: researchfish; EPSRC [EP/K023071/1] Funding Source: UKRI	British Skin Foundation; Institute of Dentistry; Facial Surgery Research Foundation-Saving Faces; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank Dr MT Teh, Professor K Parkinson, Dr SM Tsang, Dr MS Ikram and members of CDOS for helpful discussion and technical assistance. This work was supported by a British Skin Foundation-funded studentship awarded to HW and in part by the Institute of Dentistry as well as The Facial Surgery Research Foundation-Saving Faces.	AMAGAI, 1994, J INVEST DERMATOL, V103, P608, DOI 10.1111/1523-1747.ep12397292; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO;2-4; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Bogatcheva NV, 2011, AM J RESP CELL MOL, V45, P1185, DOI 10.1165/rcmb.2011-0092OC; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Chen YJ, 2007, ONCOGENE, V26, P467, DOI 10.1038/sj.onc.1209802; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Chuan YC, 2006, J BIOL CHEM, V281, P29938, DOI 10.1074/jbc.M602237200; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Cui YZ, 2010, CANCER INVEST, V28, P242, DOI 10.3109/07357900903124498; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Elliott BE, 2004, J CELL BIOCHEM, V92, P16, DOI 10.1002/jcb.20033; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Fan LL, 2011, CANCER BIOL THER, V11, P746, DOI 10.4161/cbt.11.8.14691; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Ferris RL, 2005, CANCER RES, V65, P2147, DOI 10.1158/0008-5472.CAN-04-3717; Ferris RL, 2011, CLIN CANCER RES, V17, P1858, DOI 10.1158/1078-0432.CCR-10-3110; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; GARY R, 1993, P NATL ACAD SCI USA, V90, P10846, DOI 10.1073/pnas.90.22.10846; Gliem M, 2010, AM J PHYSIOL-CELL PH, V299, pC606, DOI 10.1152/ajpcell.00075.2010; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Hong SH, 2011, VET COMP ONCOL, V9, P207, DOI 10.1111/j.1476-5829.2010.00249.x; Huang CC, 2010, LARYNGOSCOPE, V120, P26, DOI 10.1002/lary.20151; Hunter KW, 2004, TRENDS MOL MED, V10, P201, DOI 10.1016/j.molmed.2004.03.001; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; Jensen PV, 2004, HISTOCHEM CELL BIOL, V121, P361, DOI 10.1007/s00418-004-0648-2; Jeong HJ, 2011, KOREAN J PHYSIOL PHA, V15, P245, DOI 10.4196/kjpp.2011.15.4.245; Johnston IMP, 2000, ONCOGENE, V19, P5348, DOI 10.1038/sj.onc.1203927; Kanno M, 2008, EXP CELL RES, V314, P1683, DOI 10.1016/j.yexcr.2008.01.031; KARPATI S, 1994, DERMATOLOGY, V189, P24, DOI 10.1159/000246923; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kobel M, 2006, INT J GYNECOL PATHOL, V25, P121, DOI 10.1097/01.pgp.0000185410.39050.ac; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Legg JW, 1998, CURR BIOL, V8, P705, DOI 10.1016/S0960-9822(98)70277-5; Ling ZQ, 2010, CANCER SCI, V101, P624, DOI 10.1111/j.1349-7006.2009.01470.x; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Meng YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-61; Morgan MR, 2011, ONCOGENE, V30, P1422, DOI 10.1038/onc.2010.535; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Nystrom ML, 2005, J PATHOL, V205, P468, DOI 10.1002/path.1716; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Patel V, 2013, ORAL ONCOL, V49, P93, DOI 10.1016/j.oraloncology.2012.08.001; Payne AS, 2004, CURR OPIN CELL BIOL, V16, P536, DOI 10.1016/j.ceb.2004.07.006; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Savci-Heijink CD, 2009, AM J PATHOL, V174, P1629, DOI 10.2353/ajpath.2009.080778; Shinohara M, 1998, J PATHOL, V184, P369, DOI 10.1002/(SICI)1096-9896(199804)184:4<369::AID-PATH1236>3.0.CO;2-L; Solassol J, 2010, BRIT J CANCER, V102, P181, DOI 10.1038/sj.bjc.6605470; Stapleton G, 2002, J CELL SCI, V115, P2713; Tamma G, 2007, AM J PHYSIOL-CELL PH, V292, pC1476, DOI 10.1152/ajpcell.00375.2006; Tang FQ, 2011, J BIOL CHEM, V286, P36956, DOI 10.1074/jbc.M111.259234; Teh MT, 2011, J ORAL PATHOL MED, V40, P67, DOI 10.1111/j.1600-0714.2010.00951.x; Tsang SM, 2012, EXP CELL RES, V318, P2269, DOI 10.1016/j.yexcr.2012.07.002; Tsang SM, 2012, J PATHOL, V227, P81, DOI 10.1002/path.3982; Tsang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014211; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; van Baal J, 2005, J BIOL CHEM, V280, P9870, DOI 10.1074/jbc.M409301200; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wald FA, 2008, J CELL SCI, V121, P644, DOI 10.1242/jcs.016246; Wang HJ, 2009, J DIGEST DIS, V10, P258, DOI 10.1111/j.1751-2980.2009.00394.x; Wang Longyun, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P969, DOI 10.3969/j.issn.1672-7347.2010.09.012; Wang YY, 2011, ORAL SURG ORAL MED O, V112, P96, DOI 10.1016/j.tripleo.2011.02.018; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Xie JJ, 2009, INT J CANCER, V124, P2549, DOI 10.1002/ijc.24216; Yeh CN, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-233; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 2002, J CELL SCI, V115, P2569; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007; Zhu LX, 2010, AM J PHYSIOL-CELL PH, V299, pC431, DOI 10.1152/ajpcell.00090.2010	80	42	44	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2363	2374		10.1038/onc.2013.186	http://dx.doi.org/10.1038/onc.2013.186			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23752190				2022-12-25	WOS:000335451800009
J	Zhang, L; He, ZG				Zhang, Lei; He, Zheng-Guo			Radiation-sensitive Gene A (RadA) Targets DisA, DNA Integrity Scanning Protein A, to Negatively Affect Cyclic Di-AMP Synthesis Activity in Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; REGULATES EXPRESSION; CHECKPOINT PROTEIN; BIOFILM FORMATION; ESCHERICHIA-COLI; CYTOSOLIC DNA; GMP-AMP; RECOMBINATION; TRANSFORMATION; 2ND-MESSENGER	Cyclic di-AMP has been recognized as a ubiquitous second messenger involved in the regulation of bacterial signal transduction. However, little is known about the control of its synthesis and its physiological role in bacteria. In this study, we report a novel mechanism of control of c-di-AMP synthesis and its effects on bacterial growth in Mycobacterium smegmatis. We identified a DisA homolog in M. smegmatis, MsDisA, as an enzyme involved in c-di-AMP synthesis. Furthermore, MsRadA, a RadA homolog in M. smegmatis was found to act as an antagonist of the MsDisA protein. MsRadA can physically interact with MsDisA and inhibit the c-di-AMP synthesis activity of MsDisA. Overexpression of MsdisA in M. smegmatis led to cell expansion and bacterial aggregation as well as loss of motility. However, co-expression of MsradA and MsdisA rescued these abnormal phenotypes. Furthermore, we show that the interaction between RadA and DisA and its role in inhibiting c-di-AMP synthesis may be conserved in bacteria. Our findings enhance our understanding of the control of c-di-AMP synthesis and its physiological roles in bacteria.	[Zhang, Lei; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014; Zhang, Lei/M-6146-2013	Zhang, Lei/0000-0002-8566-6068	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Creative Research Groups of Hubei; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Creative Research Groups of Hubei; Hubei Chutian Scholar Program	This work was supported by the National Natural Science Foundation of China Grants 31025002 and 30930003, Fundamental Research Funds for the Central Universities Grant 2011PY140, the Creative Research Groups of Hubei, and the Hubei Chutian Scholar Program (to Z.-G. H.).	Bai Y., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE; Beam CE, 2002, J BACTERIOL, V184, P6836, DOI 10.1128/JB.184.24.6836-6844.2002; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Burghout P, 2007, J BACTERIOL, V189, P6540, DOI 10.1128/JB.00573-07; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gopalaswamy R, 2008, FEMS MICROBIOL LETT, V278, P121, DOI 10.1111/j.1574-6968.2007.00989.x; Huang F, 2010, NUCLEIC ACIDS RES, V38, P8219, DOI 10.1093/nar/gkq737; Jani C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-327; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Rao MD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383604; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Song YH, 1996, J BACTERIOL, V178, P5045, DOI 10.1128/jb.178.16.5045-5048.1996; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zhang L, 2009, P NATL ACAD SCI USA, V106, P7792, DOI 10.1073/pnas.0813056106	35	42	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22426	22436		10.1074/jbc.M113.464883	http://dx.doi.org/10.1074/jbc.M113.464883			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23760274	Green Published, hybrid			2022-12-25	WOS:000330596300024
J	Gadd, MS; Jacques, DA; Nisevic, I; Craig, VJ; Kwan, AH; Guss, JM; Matthews, JM				Gadd, Morgan S.; Jacques, David A.; Nisevic, Ivan; Craig, Vanessa J.; Kwan, Ann H.; Guss, J. Mitchell; Matthews, Jacqueline M.			A Structural Basis for the Regulation of the LIM-Homeodomain Protein Islet 1 (Isl1) by Intra- and Intermolecular Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein-Nucleic Acid Interaction; Protein-Protein Interactions; Structural Biology; Tissue-specific Transcription Factors; Transcription Regulation; Competitive Binding; LIM-Homeodomain Transcription Factors	THERMAL SHIFT ASSAYS; MOTOR-NEURON; TRANSCRIPTION FACTORS; LMO4-LDB1 COMPLEX; NMR-SPECTROSCOPY; DRUG DISCOVERY; BINDING; DOMAINS; CRYSTALLIZATION; DIFFERENTIATION	Islet 1 (Isl1) is a transcription factor of the LIM-homeodomain (LIM-HD) protein family and is essential for many developmental processes. LIM-HD proteins all contain two protein-interacting LIM domains, a DNA-binding homeodomain (HD), and a C-terminal region. In Isl1, the C-terminal region also contains the LIM homeobox 3 (Lhx3)-binding domain (LBD), which interacts with the LIM domains of Lhx3. The LIM domains of Isl1 have been implicated in inhibition of DNA binding potentially through an intramolecular interaction with or close to the HD. Here we investigate the LBD as a candidate intramolecular interaction domain. Competitive yeast-two hybrid experiments indicate that the LIM domains and LBD from Isl1 can interact with apparently low affinity, consistent with no detection of an intermolecular interaction in the same system. Nuclear magnetic resonance studies show that the interaction is specific, whereas substitution of the LBD with peptides of the same amino acid composition but different sequence is not specific. We solved the crystal structure of a similar but higher affinity complex between the LIM domains of Isl1 and the LIM interaction domain from the LIM-HD cofactor protein LIM domain-binding protein 1 (Ldb1) and used these coordinates to generate a homology model of the intramolecular interaction that indicates poorer complementarity for the weak intramolecular interaction. The intramolecular interaction in Isl1 may provide protection against aggregation, minimize unproductive DNA binding, and facilitate cofactor exchange within the cell.	[Gadd, Morgan S.; Jacques, David A.; Nisevic, Ivan; Craig, Vanessa J.; Kwan, Ann H.; Guss, J. Mitchell; Matthews, Jacqueline M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Matthews, JM (corresponding author), Univ Sydney, Sch Mol Biosci, Bldg G08, Sydney, NSW 2006, Australia.	jacqui.matthews@sydney.edu.au	Guss, Jules Mitchell/N-1387-2019	Guss, Jules Mitchell/0000-0003-4259-6079; Gadd, Morgan/0000-0001-6124-0858; Matthews, Jacqueline/0000-0001-8518-3472; Jacques, David/0000-0002-6426-4510; Kwan, Ann/0000-0002-1506-2226	Australian Research Council; Australian Postgraduate Awards; Senior Research Fellowship from the National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); Australian Postgraduate Awards(Australian Government); Senior Research Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a grant from the Australian Research Council.; Supported by Australian Postgraduate Awards.; Supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bachy I, 2002, NEUROREPORT, V13, pA23, DOI 10.1097/00001756-200202110-00002; Bachy I, 2001, J NEUROSCI, V21, P7620, DOI 10.1523/JNEUROSCI.21-19-07620.2001; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Bhati M, 2008, ACTA CRYSTALLOGR F, V64, P297, DOI 10.1107/S174430910800691X; Bhati M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040719; Bridwell JL, 2001, GENE, V277, P239, DOI 10.1016/S0378-1119(01)00704-1; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cross AJ, 2010, J MOL BIOL, V399, P133, DOI 10.1016/j.jmb.2010.04.006; Dawid IB, 1998, TRENDS GENET, V14, P480, DOI 10.1016/S0168-9525(98)01615-1; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; Deane JE, 2003, ACTA CRYSTALLOGR D, V59, P1484, DOI 10.1107/S0907444903011843; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Deane JE, 2001, PROTEIN ENG, V14, P493, DOI 10.1093/protein/14.7.493; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gadd MS, 2012, ACTA CRYSTALLOGR F, V68, P1398, DOI 10.1107/S1744309112040031; Gadd MS, 2011, J BIOL CHEM, V286, P42971, DOI 10.1074/jbc.M111.248559; Gadd MS, 2009, ACTA CRYSTALLOGR F, V65, P151, DOI 10.1107/S1744309108043431; Jeffries CM, 2006, PROTEIN SCI, V15, P2612, DOI 10.1110/ps.062377006; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwan AH, 2011, FEBS J, V278, P687, DOI 10.1111/j.1742-4658.2011.08004.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee C, 2005, J BIOMOL NMR, V33, P198, DOI 10.1007/s10858-005-3209-7; Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Liew CK, 2008, PROTEIN SCI, V17, P1630, DOI 10.1110/ps.034983.108; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUMSDEN A, 1995, CURR BIOL, V5, P491, DOI 10.1016/S0960-9822(95)00100-X; Matthews JM, 2013, FEBS LETT, V587, P1164, DOI 10.1016/j.febslet.2013.01.002; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Radde-Gallwitz K, 2004, J COMP NEUROL, V477, P412, DOI 10.1002/cne.20257; Ryan DP, 2006, J MOL BIOL, V359, P66, DOI 10.1016/j.jmb.2006.02.074; SANCHEZGARCIA I, 1993, EMBO J, V12, P4243, DOI 10.1002/j.1460-2075.1993.tb06108.x; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; Takuma N, 1998, DEVELOPMENT, V125, P4835; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wissmueller S, 2011, PROTEINS, V79, P2365, DOI 10.1002/prot.23068; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239	64	18	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21924	10.1074/jbc.M113.478586	http://dx.doi.org/10.1074/jbc.M113.478586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23750000	Green Published, hybrid			2022-12-25	WOS:000328841900040
J	Nakajima, C; Kulik, A; Frotscher, M; Herz, J; Schafer, M; Bock, HH; May, P				Nakajima, Chikako; Kulik, Akos; Frotscher, Michael; Herz, Joachim; Schaefer, Michael; Bock, Hans H.; May, Petra			Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Modulates N-Methyl-D-aspartate (NMDA) Receptor-dependent Intracellular Signaling and NMDA-induced Regulation of Postsynaptic Protein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamate Receptors; Lipoprotein Receptor; Secretases; Signaling; Synapses	GAMMA-SECRETASE; NERVOUS-SYSTEM; HUMAN BRAIN; RAT-BRAIN; GENE; NEURONS; MICE; LOCALIZATION; DISRUPTION; ACTIVATION	The lipoprotein receptor LRP1 is essential in neurons of the central nervous system, as was revealed by the analysis of conditional Lrp1-deficient mouse models. The molecular basis of its neuronal functions, however, is still incompletely understood. Here we show by immunocytochemistry, electron microscopy, and postsynaptic density preparation that LRP1 is located postsynaptically. Basal and NMDA-induced phosphorylation of the transcription factor cAMP-response element-binding protein (CREB) as well as NMDA target gene transcription are reduced in LRP1-deficient neurons. In control neurons, NMDA promotes -secretase-dependent release of the LRP1 intracellular domain (LRP1-ICD). However, pull-down and chromatin immunoprecipitation (ChIP) assays showed no direct interaction between the LRP1-ICD and either CREB or target gene promoters. On the other hand, NMDA-induced degradation of the postsynaptic scaffold protein PSD-95 was impaired in the absence of LRP1, whereas its ubiquitination was increased, indicating that LRP1 influences the composition of postsynaptic protein complexes. Accordingly, NMDA-induced internalization of the AMPA receptor subunit GluA1 was impaired in LRP1-deficient neurons. These results show a role of LRP1 in the regulation and turnover of synaptic proteins, which may contribute to the reduced dendritic branching and to the neurological phenotype observed in the absence of LRP1.	[Nakajima, Chikako; Bock, Hans H.; May, Petra] Univ Hosp, Dept Med 2, D-79104 Freiburg, Germany; [Nakajima, Chikako; Frotscher, Michael; Herz, Joachim; Schaefer, Michael; Bock, Hans H.; May, Petra] Univ Hosp, Ctr Neurosci, D-79104 Freiburg, Germany; [Nakajima, Chikako; Frotscher, Michael; Herz, Joachim; Schaefer, Michael; Bock, Hans H.; May, Petra] Univ Freiburg, D-79104 Freiburg, Germany; [Kulik, Akos] Univ Freiburg, Inst Physiol 2, D-79104 Freiburg, Germany; [Nakajima, Chikako; May, Petra] Univ Hosp, Dept Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany; [Nakajima, Chikako; May, Petra] Univ Dusseldorf, D-40225 Dusseldorf, Germany; [Frotscher, Michael] Univ Hamburg, Inst Struct Neurobiol, Ctr Mol Neurobiol Hamburg ZMNH, D-20251 Hamburg, Germany; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurotherapeut, Dallas, TX 75390 USA; [Kulik, Akos] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Schaefer, Michael] Univ Med Ctr, Dept Anesthesiol, D-55131 Mainz, Germany; [Schaefer, Michael] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, D-55131 Mainz, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Heinrich Heine University Dusseldorf; University of Hamburg; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Freiburg; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	May, P (corresponding author), Univ Hosp Dusseldorf, Dept Gastroenterol Hepatol & Infectiol, Bldg 13-54-00-81,Moorenstr 5, D-40225 Dusseldorf, Germany.	Petra.May@med.uni-duesseldorf.de	Bock, Hans/AAF-2635-2021; Schaefer, Michael K.E./S-1715-2019	Schaefer, Michael K.E./0000-0001-6055-6244; Nakajima, Chikako/0000-0003-3071-8585	Deutsche Forschungsgemeinschaft [MA 2410/1-3, MA 2410/1-4, SFB 780/TP5, BO1806/3-1]; Wolfgang Paul Award by the Humboldt Foundation; National Institutes of Health; Ted Nash Longlife Foundation; BrightFocus Foundation; Consortium for Frontotemporal Dementia Research;  [BIOSS-2 (TP6)]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wolfgang Paul Award by the Humboldt Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ted Nash Longlife Foundation; BrightFocus Foundation(BrightFocus Foundation); Consortium for Frontotemporal Dementia Research; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Deutsche Forschungsgemeinschaft Grants MA 2410/1-3 and 1-4 (to P. M.), SFB 780/TP5 (to J. H., H. B., and M. F.) and BO1806/3-1 (to H. B.).; Recipient of a grant in BIOSS-2 (TP6).; The recipient of a Wolfgang Paul Award by the Humboldt Foundation. Supported by grants from the National Institutes of Health, the Ted Nash Longlife Foundation, the BrightFocus Foundation, and the Consortium for Frontotemporal Dementia Research.	Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Bianchetta MJ, 2011, J NEUROSCI, V31, P12029, DOI 10.1523/JNEUROSCI.2388-11.2011; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; BU GJ, 1994, J BIOL CHEM, V269, P18521; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; KALB RG, 1994, DEVELOPMENT, V120, P3063; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Qiu ZH, 2002, J BIOL CHEM, V277, P14458, DOI 10.1074/jbc.M112066200; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; TOOYAMA I, 1995, BRAIN RES, V691, P235, DOI 10.1016/0006-8993(95)00735-9; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; WOLF BB, 1992, AM J PATHOL, V141, P37; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	32	52	52	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21909	10.1074/jbc.M112.444364	http://dx.doi.org/10.1074/jbc.M112.444364			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760271	Green Published, hybrid			2022-12-25	WOS:000328841900039
J	Youngchim, S; Nosanchuk, JD; Pornsuwan, S; Kajiwara, S; Vanittanakom, N				Youngchim, Sirida; Nosanchuk, Joshua D.; Pornsuwan, Soraya; Kajiwara, Susumu; Vanittanakom, Nongnuch			The Role of L-DOPA on Melanization and Mycelial Production in Malassezia Furfur	PLOS ONE			English	Article							CONIDIAL PIGMENT BIOSYNTHESIS; MELANIN-LIKE PIGMENTS; SPECIES IN-VITRO; ASPERGILLUS-FUMIGATUS; CRYPTOCOCCUS-NEOFORMANS; PITYROSPORUM-ORBICULARE; MAMMALIAN INFECTION; CYTOKINE PRODUCTION; TINEA VERSICOLOR; STRATUM-CORNEUM	Melanins are synthesized by organisms of all biological kingdoms and comprise a heterogeneous class of natural pigments. Certain of these polymers have been implicated in the pathogenesis of several important human fungal pathogens. This study investigated whether the fungal skin pathogen Malassezia furfur produces melanin or melanin-like compounds. A melanin-binding monoclonal antibody (MAb) labelled in vitro cultivated yeast cells of M. furfur. In addition, melanization of Malassezia yeasts and hyphae was detected by anti-melanin MAb in scrapings from patients with pityriasis versicolor. Treatment of Malassezia yeasts with proteolytic enzymes, denaturant and concentrated hot acid yielded dark particles and electron spin resonance spectroscopy revealed that these particles contained a stable free radical compound, consistent with their identification as melanins. Malassezia yeasts required phenolic compounds, such as L-DOPA, in order to synthesize melanin. L-DOPA also triggered hyphal formation in vitro when combined with kojic acid, a tyrosinase inhibitor, in a dose-dependent manner. In this respect, L-DOPA is thought to be an essential substance that is linked to both melanization and yeast-mycelial transformation in M. furfur. In summary, M. furfur can produce melanin or melanin-like compounds in vitro and in vivo, and the DOPA melanin pathway is involved in cell wall melanization.	[Youngchim, Sirida; Vanittanakom, Nongnuch] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Med Infect Dis, Bronx, NY 10467 USA; [Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Microbiol Immunol, Bronx, NY 10467 USA; [Pornsuwan, Soraya] Mahidol Univ, Fac Sci, Dept Phys Chem, Bangkok 10400, Thailand; [Kajiwara, Susumu] Tokyo Inst Technol, Dept Life Sci, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Chiang Mai University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Mahidol University; Tokyo Institute of Technology	Youngchim, S (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand.	syoungchim@gmail.com	KAJIWARA, SUSUMU/D-3405-2014; Nosanchuk, Joshua/AAS-7801-2021	KAJIWARA, SUSUMU/0000-0001-6732-5043; 	Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; NIH [AI52733]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733] Funding Source: NIH RePORTER	Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand. JDN is partially supported by NIH AI52733. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affes M, 2009, MYCOSES, V52, P251, DOI 10.1111/j.1439-0507.2008.01589.x; Brunke S, 2006, MICROBIOL-SGM, V152, P547, DOI 10.1099/mic.0.28501-0; Casadevall A, 2000, CURR OPIN MICROBIOL, V3, P354, DOI 10.1016/S1369-5274(00)00103-X; Chee Hee Youn, 2003, Mycobiology, V31, P248; Crespo-Erchiga V, 2006, CURR OPIN INFECT DIS, V19, P139, DOI 10.1097/01.qco.0000216624.21069.61; Crowe JD, 2001, APPL ENVIRON MICROB, V67, P2088, DOI 10.1128/AEM.67.5.2088-2094.2001; Dadachova E, 2008, PIGM CELL MELANOMA R, V21, P192, DOI 10.1111/j.1755-148X.2007.00430.x; DeAngelis YM, 2007, J INVEST DERMATOL, V127, P2138, DOI 10.1038/sj.jid.5700844; DORN M, 1977, J INVEST DERMATOL, V69, P244, DOI 10.1111/1523-1747.ep12506384; Eisenhofer G, 2003, FASEB J, V17, P1248, DOI 10.1096/fj.02-0736com; EL-KHADEM M, 1976, Zentralblatt fuer Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene Zweite Naturwissenschaftliche Abteilung Allgemeine Landwirtschaftliche und Technische Mikrobiologie, V131, P497; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; FAERGEMANN J, 1989, J INVEST DERMATOL, V92, P117, DOI 10.1111/1523-1747.ep13071328; FAERGEMANN J, 1981, J INVEST DERMATOL, V77, P314, DOI 10.1111/1523-1747.ep12482488; Faergemann J, 1981, SABOURAUDIA, V19, P171; Falck B, 2003, EXP DERMATOL, V12, P602, DOI 10.1034/j.1600-0625.2003.00019.x; Gaitanis G, 2005, J CLIN MICROBIOL, V43, P4147, DOI 10.1128/JCM.43.8.4147-4151.2005; Gueho E, 1996, ANTON LEEUW INT J G, V69, P337, DOI 10.1007/BF00399623; Guillot J, 1998, J VET DIAGN INVEST, V10, P384, DOI 10.1177/104063879801000418; Gupta AK, 2000, J CLIN MICROBIOL, V38, P1869, DOI 10.1128/JCM.38.5.1869-1875.2000; Gupta AK, 2003, CLIN DERMATOL, V21, P417, DOI 10.1016/j.clindermatol.2003.08.003; Hamilton AJ, 2002, J MED MICROBIOL, V51, P189, DOI 10.1099/0022-1317-51-3-189; Jahn B, 1997, INFECT IMMUN, V65, P5110, DOI 10.1128/IAI.65.12.5110-5117.1997; Kahn V, 1995, PIGM CELL RES, V8, P234, DOI 10.1111/j.1600-0749.1995.tb00669.x; Kesavan S, 1998, MED MYCOL, V36, P97, DOI 10.1080/02681219880000161; Kesavan S, 2000, MED MYCOL, V38, P239, DOI 10.1080/714030945; KWONCHUNG KJ, 1981, J CLIN MICROBIOL, V13, P383, DOI 10.1128/JCM.13.2.383-387.1981; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; LEEMING JP, 1989, J APPL BACTERIOL, V67, P47, DOI 10.1111/j.1365-2672.1989.tb04953.x; MARINARO RE, 1978, J CUTAN PATHOL, V5, P15, DOI 10.1111/j.1600-0560.1978.tb00932.x; Mayser P, 2004, MYCOSES, V47, P34, DOI 10.1046/j.1439-0507.2003.00957.x; Mayser P, 1998, ANTON LEEUW INT J G, V73, P315, DOI 10.1023/A:1001500310537; Mayser P, 1998, MYCOSES, V41, P265, DOI 10.1111/j.1439-0507.1998.tb00336.x; MONTES LF, 1970, J AMER MED ASSOC, V213, P1469, DOI 10.1001/jama.213.9.1469; Morris-Jones R, 2003, INFECT IMMUN, V71, P4026, DOI 10.1128/IAI.71.7.4026-4033.2003; NAZZAROPORRO M, 1978, J INVEST DERMATOL, V71, P205, DOI 10.1111/1523-1747.ep12547184; Nosanchuk JD, 2000, LANCET, V355, P2049, DOI 10.1016/S0140-6736(00)02356-4; Nosanchuk JD, 1998, J IMMUNOL, V160, P6026; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Nosanchuk JD, 2002, INFECT IMMUN, V70, P5124, DOI 10.1128/IAI.70.9.5124-5131.2002; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; Rosas AL, 2000, INFECT IMMUN, V68, P2845, DOI 10.1128/IAI.68.5.2845-2853.2000; Shibata N, 2006, FEMS MICROBIOL LETT, V256, P137, DOI 10.1111/j.1574-6968.2006.00106.x; SRINIVASAN C, 1995, APPL ENVIRON MICROB, V61, P4274, DOI 10.1128/AEM.61.12.4274-4277.1995; Tarazooie B., 2004, BMC DERMATOL, V1, P4; Thomas DS, 2008, FEMS IMMUNOL MED MIC, V54, P203, DOI 10.1111/j.1574-695X.2008.00468.x; TOSTI A, 1972, J INVEST DERMATOL, V59, P233, DOI 10.1111/1523-1747.ep12627257; Tsai HF, 1999, J BACTERIOL, V181, P6469, DOI 10.1128/JB.181.20.6469-6477.1999; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Wang Y, 1996, J BACTERIOL, V176, P656; Wheeler M H, 1988, Curr Top Med Mycol, V2, P338; Youngchim S, 2005, MICROBIOL-SGM, V151, P291, DOI 10.1099/mic.0.27433-0; Youngchim S, 2004, J MED MICROBIOL, V53, P175, DOI 10.1099/jmm.0.05421-0; Youngchim S, 2011, MICROBIOL-SGM, V157, P2348, DOI 10.1099/mic.0.047928-0	54	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e63764	10.1371/journal.pone.0063764	http://dx.doi.org/10.1371/journal.pone.0063764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762233	Green Submitted, Green Published, gold			2022-12-25	WOS:000321094800003
J	Yue, GF; Wei, J; Qian, XP; Yu, LX; Zou, ZY; Guan, WX; Wang, H; Shen, J; Liu, BR				Yue, Guofeng; Wei, Jia; Qian, Xiaoping; Yu, Lixia; Zou, Zhengyun; Guan, Wenxian; Wang, Hao; Shen, Jie; Liu, Baorui			Synergistic Anticancer Effects of Polyphyllin I and Evodiamine on Freshly-Removed Human Gastric Tumors	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE GENE; MESSENGER-RNA EXPRESSION; DRUG RESPONSE ASSAY; PROTEIN EXPRESSION; GROWTH-INHIBITION; CANCER PATIENTS; MITOTIC ARREST; LUNG-CANCER; APOPTOSIS; CELLS	Objective: The present study was designed to examine the anticancer effect of Traditional Chinese Medicine of polyphyllin I (PPI) and evodiamine (EVO) on freshly-removed gastric tumor tissues. Methods: Sixty freshly-removed gastric tumor tissues were collected. Their sensitivity to PPI, EVO, platinum (Pt), 5-FU, irinotecan (CPT-11) were determined by histoculture drug response assay (HDRA). Those samples were also formalin-fixed and paraffin-embedded, which were used to examine the mRNA expression levels of aprataxin(APTX), excision repair cross-complementing 1(ERCC1), thymidylate synthase(TS) and topoisomerase I(TOPO1) by quantitative RT-PCR. The association of the gene expression levels and in vitro sensitivity were analyzed. Results: PPI, EVO, Pt, 5-FU and CPT-11 had anticancer effects on the freshly-removed gastric tumor tissues with average inhibition rates of 20.64%+/-14.25% for PPI, 21.14%+/-13.43% for EVO, 50.57%+/-22.37% for Pt, 53.54%+/-22.03% for 5-FU, and 39.33%+/-24.79% for CPT-11, respectively. Combination of PPI and Pt, EVO and Pt, EVO and 5-FU had higher inhibition rates than any single drug of them (P<0.001, P = 0.028, P = 0.017, respectively). The mRNA expression levels of ERCC1 were correlated with Pt sensitivity (rho = -0.645, P<0.001); the mRNA expression levels of TS were correlated with 5-FU sensitivity (rho = -0.803, P<0.001). There were also weak but significant correlations between APTX mRNA expression levels and CPT-11 sensitivity (rho = -0.376, P = 0.017) or EVO sensitivity (rho = -0.322, P = 0.036). ERCC1 mRNA expression levels was markedly suppressed by the presentation of PPI (P = 0.001) and slightly suppressed by the presentation of EVO (P = 0.04); whereas, TS mRNA expression levels was markedly decreased by the presentation of EVO (P = 0.017) and slightly decreased by the presentation of PPI (P = 0.047). Conclusion: PPI and EVO both could inhibit the activity of freshly-removed gastric tumor, and they could enhance the anticancer effect of Pt and 5-FU by reducing the mRNA expression levels of ERCC1 and TS.	[Yue, Guofeng; Wei, Jia; Qian, Xiaoping; Yu, Lixia; Zou, Zhengyun; Shen, Jie; Liu, Baorui] Nanjing Univ Chinese Med, Drum Tower Clin Med Coll, Ctr Comprehens Canc, Nanjing, Jiangsu, Peoples R China; [Wei, Jia; Qian, Xiaoping; Yu, Lixia; Zou, Zhengyun; Shen, Jie; Liu, Baorui] Nanjing Univ, Clin Canc Inst, Sch Med, Drum Tower Hosp,Comprehens Canc Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Guan, Wenxian; Wang, Hao] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University; Nanjing University	Shen, J (corresponding author), Nanjing Univ Chinese Med, Drum Tower Clin Med Coll, Ctr Comprehens Canc, Nanjing, Jiangsu, Peoples R China.	shenjie2008nju@163.com; baoruiliu@nju.edu.cn	Wei, Jia/AAE-9973-2020		National Natural Science Foundation of China [81172094]; Top Six Talents Project of Jiangsu Province [2011ws005]; Medical Science and Technology Development Projects of Nanjing [ZKX10011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Six Talents Project of Jiangsu Province; Medical Science and Technology Development Projects of Nanjing	Supported by grants from the National Natural Science Foundation of China (Grant No. 81172094), Top Six Talents Project of Jiangsu Province (Grant No. 2011ws005), and Medical Science and Technology Development Projects of Nanjing (Grant No. ZKX10011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2007, PLANTA MED, V73, P1554, DOI 10.1055/s-2007-993743; Ariyoshi Y, 2003, ORAL ONCOL, V39, P701, DOI 10.1016/S1368-8375(03)00082-4; Bathe OF, 1999, CANCER J SCI AM, V5, P34; Cascinu S, 1999, CLIN CANCER RES, V5, P1996; Cecere F, 2006, NEW ENGL J MED, V355, P2590; Chan ALF, 2009, MOLECULES, V14, P1342, DOI 10.3390/molecules14041342; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Dopeso H, 2010, CLIN CANCER RES, V16, P2375, DOI 10.1158/1078-0432.CCR-09-3275; Fujita Y, 2009, ONCOL REP, V21, P499, DOI 10.3892/or_00000250; FURUKAWA T, 1995, CLIN CANCER RES, V1, P305; Hasegawa Y, 2007, ORAL ONCOL, V43, P749, DOI 10.1016/j.oraloncology.2006.09.003; Huang DM, 2005, J UROLOGY, V173, P256, DOI 10.1097/01.ju.0000141587.72429.e3; Huang YC, 2004, LIFE SCI, V75, P35, DOI 10.1016/j.lfs.2003.11.025; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kong MJ, 2010, ACTA BIOCH BIOPH SIN, V42, P827, DOI 10.1093/abbs/gmq091; Lee MS, 2005, CANCER BIOL THER, V4, P1248, DOI 10.4161/cbt.4.11.2136; Lenz HJ, 1996, J CLIN ONCOL, V14, P176, DOI 10.1200/JCO.1996.14.1.176; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margeli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009499; MILLER BE, 1984, J CELL PHYSIOL, P105; Ong RCY, 2008, CANCER LETT, V261, P158, DOI 10.1016/j.canlet.2007.11.005; Pan XB, 2012, PHYTOMEDICINE, V19, P618, DOI 10.1016/j.phymed.2012.02.003; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Shen J, 2012, INT J CANCER, V131, pE938, DOI 10.1002/ijc.27530; Sun J, 2007, PHYTOTHER RES, V21, P1102, DOI 10.1002/ptr.2196; Tanino H, 2001, ANTICANCER RES, V21, P4083; Wagner AD, 2006, J CLIN ONCOL, V24, P2903, DOI 10.1200/JCO.2005.05.0245; Wei J, 2008, BRIT J CANCER, V98, P1398, DOI 10.1038/sj.bjc.6604317; Wei J, 2011, J NATL CANCER I, V103, P1552, DOI 10.1093/jnci/djr326; Zhang Y, 2004, J ASIAN NAT PROD RES, V6, P19, DOI 10.1080/1028602031000119772; Zhang Y, 2003, BIOL PHARM BULL, V26, P1543, DOI 10.1248/bpb.26.1543	33	40	46	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65164	10.1371/journal.pone.0065164	http://dx.doi.org/10.1371/journal.pone.0065164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762305	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800021
J	Juvet, SC; Thomson, CW; Kim, EY; Han, M; Zhang, L				Juvet, Stephen C.; Thomson, Christopher W.; Kim, Edward Y.; Han, Mei; Zhang, Li			FcR gamma Controls the Fas-Dependent Regulatory Function of Lymphoproliferative Double Negative T Cells	PLOS ONE			English	Article							CARDIAC ALLOGRAFT SURVIVAL; NATURAL-KILLER-CELLS; CD95 CO-STIMULATION; VERSUS-HOST-DISEASE; EPSILON-RI-GAMMA; LPR LPR MICE; ZETA-CHAIN; SURFACE EXPRESSION; LUPUS NEPHRITIS; NK CELLS	Patients with autoimmune lymphoproliferative syndrome (ALPS) and lymphoproliferation (LPR) mice are deficient in Fas, and accumulate large numbers of alpha beta-TCR+, CD4(-), CD8(-) double negative (DN) T cells. The function of these DN T cells remains largely unknown. The common gamma subunit of the activating Fc receptors, FcR gamma, plays an important role in mediating innate immune responses. We have shown previously that a significant proportion of DN T cells express FcR gamma, and that this molecule is required for TCR transgenic DN T cells to suppress allogeneic immune responses. Whether FcR gamma plays a critical role in LPR DN T cell-mediated suppression of immune responses to auto and allo-antigens is not known. Here, we demonstrated that FcR gamma(+), but not FcR gamma(-) LPR DN T cells could suppress Fas(+) CD4(+) and CD8(+) T cell proliferation in vitro and attenuated CD4(+) T cell-mediated graft-versus host disease. Although FcR gamma expression did not allow LPR DN T cells to inhibit the expansion of Fas-deficient cells within the LPR context, adoptive transfer of FcR gamma(+), but not FcR gamma(-), DN T cells inhibited lymphoproliferation in generalized lymphoproliferative disease (GLD) mice. Furthermore, FcR gamma acted in a cell-intrinsic fashion to limit DN T cell accumulation by increasing the rate of apoptosis in proliferated cells. These results indicate that FcR gamma can confer Fas-dependent regulatory properties on LPR DN T cells, and suggest that FcR gamma may be a novel marker for functional DN Tregs.	[Juvet, Stephen C.; Zhang, Li] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Juvet, Stephen C.] Univ Toronto, Dept Med, Univ Hlth Network, Div Respirol, Toronto, ON, Canada; [Juvet, Stephen C.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON, Canada; [Juvet, Stephen C.] Univ Toronto, Dept Med, Clinician Scientist Training Program, Toronto, ON, Canada; [Thomson, Christopher W.; Kim, Edward Y.; Han, Mei; Zhang, Li] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Zhang, Li] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Juvet, Stephen C.; Thomson, Christopher W.; Kim, Edward Y.; Han, Mei; Zhang, Li] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Zhang, L (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	lzhang@uhnres.utoronto.ca		Juvet, Stephen/0000-0002-7243-556X	Canadian Institutes of Health Research [MOP-14431]; Canadian Cancer Society [020516]; Clinician-Scientist Training Program, Department of Medicine, University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Clinician-Scientist Training Program, Department of Medicine, University of Toronto	This work was funded by the Canadian Institutes of Health Research (grant number MOP-14431) and Canadian Cancer Society ( grant number 020516). S.C.J. received salary support from the Clinician-Scientist Training Program, Department of Medicine, University of Toronto. L.Z. is the Maria H. Bacardi Chair in Transplantation at the University Health Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZZONI L, 1995, J IMMUNOL, V154, P491; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; Chen W, 2003, TRANSPL P, V35, P2479, DOI 10.1016/j.transproceed.2003.08.030; CHU JL, 1995, J EXP MED, V181, P393, DOI 10.1084/jem.181.1.393; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; DAVIDSON WF, 1986, J IMMUNOL, V136, P4075; Eischen CM, 1996, J IMMUNOL, V156, P2693; Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Ford MS, 2002, J EXP MED, V196, P261, DOI 10.1084/jem.20020029; Gao JF, 2011, EUR J IMMUNOL; Gonzalez-Quintial R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027528; Gupta S, 2012, J CLIN INVEST, V122, P2395, DOI 10.1172/JCI45138; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; HILLHOUSE EE, 2012, J AUTOIMMUN, P45237; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; Juvet SC, 2013, J AUTOIMMUN IN PRESS; Juvet SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047732; Juvet SC, 2012, J MOL CELL BIOL, V4, P48, DOI 10.1093/jmcb/mjr043; KAKKANAIAH VN, 1990, CELL IMMUNOL, V127, P442, DOI 10.1016/0008-8749(90)90145-H; KLINMAN DM, 1990, J IMMUNOL, V144, P506; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Kyttaris VC, 2010, J IMMUNOL, V184, P4605, DOI 10.4049/jimmunol.0903595; Lee BPL, 2005, J IMMUNOL, V174, P4535, DOI 10.4049/jimmunol.174.8.4535; LETTAU M, 2004, SIGNAL TRANSDUCT, V4, P206, DOI DOI 10.1002/SITA.200400037; MERINO R, 1995, J AUTOIMMUN, V8, P33, DOI 10.1006/jaut.1995.0003; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nambiar MP, 2003, J IMMUNOL, V170, P2871, DOI 10.4049/jimmunol.170.6.2871; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; OHNO H, 1993, INT IMMUNOL, V5, P1403, DOI 10.1093/intimm/5.11.1403; OHNO H, 1994, J EXP MED, V179, P365, DOI 10.1084/jem.179.1.365; Okoye FI, 2007, CLIN IMMUNOL, V125, P5, DOI 10.1016/j.clim.2007.07.002; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; ORTALDO JR, 1995, J EXP MED, V181, P339, DOI 10.1084/jem.181.1.339; PARK SY, 1995, EUR J IMMUNOL, V25, P2107, DOI 10.1002/eji.1830250746; Paulsen M, 2011, CELL DEATH DIFFER, V18, P619, DOI 10.1038/cdd.2010.134; RODEWALD HR, 1991, J BIOL CHEM, V266, P15974; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Shores E, 1997, J IMMUNOL, V159, P222; Strauss G, 2009, J EXP MED, V206, P1379, DOI 10.1084/jem.20082363; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Thomson CW, 2006, J IMMUNOL, V177, P2250, DOI 10.4049/jimmunol.177.4.2250; Voelkl S, 2011, EUR J IMMUNOL, V41, P739, DOI 10.1002/eji.201040982; WATANABE D, 1995, EMBO J, V14, P12, DOI 10.1002/j.1460-2075.1995.tb06970.x; Young KJ, 2003, J IMMUNOL, V171, P134, DOI 10.4049/jimmunol.171.1.134; Young KJ, 2002, BLOOD, V100, P3408, DOI 10.1182/blood-2002-01-0235; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	50	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65253	10.1371/journal.pone.0065253	http://dx.doi.org/10.1371/journal.pone.0065253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762329	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000050
J	Li, YG; Ji, DF; Zhong, S; Lv, ZQ; Lin, TB				Li, You-Gui; Ji, Dong-Feng; Zhong, Shi; Lv, Zhi-Qiang; Lin, Tian-Bao			Cooperative Anti-Diabetic Effects of Deoxynojirimycin-Polysaccharide by Inhibiting Glucose Absorption and Modulating Glucose Metabolism in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							CARBOHYDRATE-METABOLISM; KEY ENZYMES; NA+/GLUCOSE COTRANSPORTER; MECHANISMS; EXPRESSION; TISSUES; CORTEX; RATS	We had previously shown that deoxynojirimycin-polysaccharide mixture (DPM) not only decreased blood glucose but also reversed the damage to pancreatic beta-cells in diabetic mice, and that the anti-hyperglycemic efficacy of this combination was better than that of 1-deoxynojirimycin (DNJ) or polysachharide alone. However, the mechanisms behind these effects were not fully understood. The present study aimed to evaluate the therapeutic effects of DPM on streptozotocin (STZ)-induced diabetic symptoms and their potential mechanisms. Diabetic mice were treated with DPM (150 mg/kg body weight) for 90 days and continued to be fed without DPM for an additional 30 days. Strikingly, decrease of blood glucose levels was observed in all DPM treated diabetic mice, which persisted 30 days after cessation of DPM administration. Significant decrease of glycosylated hemoglobin and hepatic pyruvate concentrations, along with marked increase of serum insulin and hepatic glycogen levels were detected in DPM treated diabetic mice. Results of a labeled C-13(6)-glucose uptake assay indicated that DPM can restrain glucose absorption. Additionally, DPM down-regulated the mRNA and protein expression of jejunal Na+/glucose cotransporter, Na+/K+-ATPase and glucose transporter 2, and enhanced the activities as well as mRNA and protein levels of hepatic glycolysis enzymes (glucokinase, phosphofructokinase, private kinase and pyruvate decarboxylas E1). Activity and expression of hepatic gluconeogenesis enzymes (phosphoenolpyruvate carboxykinase and glucose-6-phosphatase) were also found to be attenuated in diabetic mice treated with DPM. Purified enzyme activity assays verified that the increased activities of glucose glycolysis enzymes resulted not from their direct activation, but from the relative increase in protein expression. Importantly, our histopathological observations support the results of our biochemical analyses and validate the protective effects of DPM on STZ-induced damage to the pancreas. Thus, DPM has significant potential as a therapeutic agent against diabetes.	[Li, You-Gui; Ji, Dong-Feng; Zhong, Shi; Lv, Zhi-Qiang; Lin, Tian-Bao] Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Ji, DF (corresponding author), Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China.	dongfeng_ji@126.com			earmarked fund for Modern Agro-industry Technology Research System of China; Science and Technology Department of Zhejiang Province [2011C220621/4CE2012C12910]; Natural Science Foundation of Zhejiang Province [LQ12H31002]; Zhejiang Sericultural Sci-Tech Innovation Team [2011R50028]	earmarked fund for Modern Agro-industry Technology Research System of China; Science and Technology Department of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Zhejiang Sericultural Sci-Tech Innovation Team	This study was supported by the earmarked fund for Modern Agro-industry Technology Research System of China, by Science and Technology Department of Zhejiang Province (2011C220621/4CE2012C12910), by the Natural Science Foundation of Zhejiang Province (LQ12H31002) and by the Zhejiang Sericultural Sci-Tech Innovation Team (2011R50028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Andallu B, 2001, CLIN CHIM ACTA, V314, P47, DOI 10.1016/S0009-8981(01)00632-5; Asano T, 2004, CURR MED CHEM, V11, P2717, DOI 10.2174/0929867043364360; Asgary S, 1999, Pharm Acta Helv, V73, P223, DOI 10.1016/S0031-6865(98)00025-9; Baldea LAN, 2010, J ETHNOPHARMACOL, V132, P473, DOI 10.1016/j.jep.2010.07.055; Berendzen K, 2006, MITOCHONDRION, V6, P126, DOI 10.1016/j.mito.2006.04.001; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Boyer S, 1996, FEBS LETT, V396, P218, DOI 10.1016/0014-5793(96)01102-7; Burns N, 2007, TOXICOL SCI, V95, P391, DOI 10.1093/toxsci/kfl164; Drozdowski LA, 2006, WORLD J GASTROENTERO, V12, P1657, DOI 10.3748/wjg.v12.i11.1657; Ducroc R, 2007, DIABETES, V56, P2494, DOI 10.2337/db07-0614; Feksa LR, 2005, INT J DEV NEUROSCI, V23, P509, DOI 10.1016/j.ijdevneu.2005.06.002; Fu JF, 2012, CARBOHYD POLYM, V87, P2327, DOI 10.1016/j.carbpol.2011.10.068; Giaccari A, 2009, NUTR METAB CARDIOVAS, V19, P365, DOI 10.1016/j.numecd.2009.03.018; Ito M, 2001, ENVIRON TOXICOL PHAR, V9, P71, DOI 10.1016/S1382-6689(00)00064-8; Klover PJ, 2004, INT J BIOCHEM CELL B, V36, P753, DOI 10.1016/j.biocel.2003.10.002; KOIDE H, 1959, CLIN CHIM ACTA, V4, P554; Kuriyama C, 2008, BIOORGAN MED CHEM, V16, P7330, DOI 10.1016/j.bmc.2008.06.026; Lei H, 2013, CARBOHYD POLYM, V92, P1211, DOI 10.1016/j.carbpol.2012.10.037; Li JM, 2006, INT J BIOCHEM CELL B, V38, P985, DOI 10.1016/j.biocel.2005.10.002; Li YG, 2011, J ETHNOPHARMACOL, V134, P961, DOI 10.1016/j.jep.2011.02.009; [李有贵 Li Yougui], 2010, [蚕业科学, Acta Sericologica Sinica], V36, P885; Mohammad S, 2004, CLIN CHIM ACTA, V342, P105, DOI 10.1016/j.cccn.2003.12.005; Naowaboot J., 2006, NUTR RES, V29, P602; Ozeki T, 1999, COMP BIOCHEM PHYS B, V124, P327, DOI 10.1016/S0305-0491(99)00127-3; Palsamy P, 2009, CHEM-BIOL INTERACT, V179, P356, DOI 10.1016/j.cbi.2008.11.008; Pari L, 2010, BIOMED PHARMACOTHER, V64, P477, DOI 10.1016/j.biopha.2010.02.001; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Prasath GS, 2011, EUR J PHARMACOL, V668, P492, DOI 10.1016/j.ejphar.2011.07.021; Robinson B.H., 1995, METABOLIC MOL BASES, P1479; Sundaram R, 2012, EUR J PHARMACOL, V674, P460, DOI 10.1016/j.ejphar.2011.10.039; Ugochukwu NH, 2006, PHARMACOL RES, V54, P172, DOI 10.1016/j.phrs.2006.04.004; Vats V, 2003, J ETHNOPHARMACOL, V85, P237, DOI 10.1016/S0378-8741(03)00022-9; Wild GE, 1997, J NUTR BIOCHEM, V8, P673, DOI 10.1016/S0955-2863(97)00118-6; Winchester BG, 2009, TETRAHEDRON ASYMMETR; Xue SX, 2009, CARBOHYD POLYM, V75, P415, DOI 10.1016/j.carbpol.2008.08.003; Zhang XM, 2009, BIOMED PHARMACOTHER, V63, P180, DOI 10.1016/j.biopha.2007.07.006; Zheng Y, 2012, SURGERY, V151, P13, DOI 10.1016/j.surg.2011.07.010; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	39	18	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65892	10.1371/journal.pone.0065892	http://dx.doi.org/10.1371/journal.pone.0065892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755289	gold, Green Submitted, Green Published			2022-12-25	WOS:000321099000117
J	Matsuda, YT; Okanoya, K; Myowa-Yamakoshi, M				Matsuda, Yoshi-Taka; Okanoya, Kazuo; Myowa-Yamakoshi, Masako			Shyness in Early Infancy: Approach-Avoidance Conflicts in Temperament and Hypersensitivity to Eyes during Initial Gazes to Faces	PLOS ONE			English	Article							BEHAVIORAL-INHIBITION; EARLY-CHILDHOOD; SOCIAL WITHDRAWAL; FEAR; SOCIABILITY; STRANGERS; FAMILIARITY; PREFERENCE; ATTENTION; PATTERNS	A growing awareness of the risks associated with skin exposure to ultraviolet (UV) radiation over the past decades has led to increased use of sunscreen cosmetic products leading the introduction of new chemical compounds in the marine environment. Although coastal tourism and recreation are the largest and most rapidly growing activities in the world, the evaluation of sunscreen as source of chemicals to the coastal marine system has not been addressed. Concentrations of chemical UV filters included in the formulation of sunscreens, such as benzophehone 3 (BZ-3), 4-methylbenzylidene camphor (4-MBC), TiO2 and ZnO, are detected in nearshore waters with variable concentrations along the day and mainly concentrated in the surface microlayer (i.e. 53.6-577.5 ng L-1 BZ-3; 51.4-113.4 ng L-1 4-MBC; 6.9-37.6 mu g L-1 Ti; 1.0-3.3 mu g L-1 Zn). The presence of these compounds in seawater suggests relevant effects on phytoplankton. Indeed, we provide evidences of the negative effect of sunblocks on the growth of the commonly found marine diatom Chaetoceros gracilis (mean EC50 = 125 +/- 71 mu g L-1). Dissolution of sunscreens in seawater also releases inorganic nutrients (N, P and Si forms) that can fuel algal growth. In particular, PO43- is released by these products in notable amounts (up to 17 mu mol PO43- g(-1)). We conservatively estimate an increase of up to 100% background PO43- concentrations (0.12 mu mol L-1 over a background level of 0.06 mu mol L-1) in nearshore waters during low water renewal conditions in a populated beach in Majorca island. Our results show that sunscreen products are a significant source of organic and inorganic chemicals that reach the sea with potential ecological consequences on the coastal marine ecosystem.	[Matsuda, Yoshi-Taka; Okanoya, Kazuo; Myowa-Yamakoshi, Masako] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Okanoya Emot Informat Project, Saitama, Japan; [Matsuda, Yoshi-Taka; Okanoya, Kazuo] RIKEN, Brain Sci Inst, Emot Informat Joint Res Lab, Saitama, Japan; [Matsuda, Yoshi-Taka] Doshisha Univ, Ctr Baby Sci, Kyoto 602, Japan; [Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Myowa-Yamakoshi, Masako] Kyoto Univ, Grad Sch Educ, Kyoto, Japan	Japan Science & Technology Agency (JST); RIKEN; Doshisha University; University of Tokyo; Kyoto University	Matsuda, YT (corresponding author), Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Okanoya Emot Informat Project, Saitama, Japan.	matsuda@brain.riken.jp; myowa@educ.kyoto-u.ac.jp	Myowa, Masako/E-8965-2010		Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment	Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment	This work was funded by the ISUMAR project (CTM2011-22645) and CONCORDA project (384/2011) of the Spanish Ministries of Economy and Competitiveness and of Agriculture, Food and Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; [Anonymous], 2003, PSYCHOLOGY; Asendorpf J. B., 2010, DEV SHYNESS SOCIAL W, P157; ASENDORPF JB, 1993, J CHILD PSYCHOL PSYC, V34, P1069, DOI 10.1111/j.1469-7610.1993.tb01774.x; ASENDORPF JB, 1990, HUM DEV, V33, P250, DOI 10.1159/000276522; ASENDORPF JB, 1990, DEV PSYCHOL, V26, P721, DOI 10.1037/0012-1649.26.5.721; Bridges KMB, 1932, CHILD DEV, V3, P324, DOI 10.2307/1125359; Brunet PM, 2009, J ANXIETY DISORD, V23, P909, DOI 10.1016/j.janxdis.2009.05.009; Buehler C, 1930, 1 YEAR LIFE; Buss A., 1984, TEMPERAMENT EARLY DE; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; CHEEK JM, 1981, J PERS SOC PSYCHOL, V41, P330, DOI 10.1037/0022-3514.41.2.330; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; Colonnesi C, 2013, INFANCY, V18, P202, DOI 10.1111/j.1532-7078.2012.00117.x; Coplan RJ, 2004, DEV PSYCHOL, V40, P244, DOI 10.1037/0012-1649.40.2.244; Coplan RJ, 2007, CHILD DEV PERSPECT, V1, P26, DOI 10.1111/j.1750-8606.2007.00006.x; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; DEPUE RA, 1989, ANNU REV PSYCHOL, V40, P457, DOI 10.1146/annurev.ps.40.020189.002325; Eggum ND, 2009, INFANCY, V14, P325, DOI 10.1080/15250000902839971; Fox NA, 2001, CHILD DEV, V72, P1, DOI 10.1111/1467-8624.00262; FREEDMAN DG, 1961, J CHILD PSYCHOL PSYC, V2, P242, DOI 10.1111/j.1469-7610.1961.tb02028.x; GARCIA S, 1991, J PERS SOC PSYCHOL, V61, P35, DOI 10.1037/0022-3514.61.1.35; Garcia-Coll C, 1984, CHILD DEV, V55; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; GRAY JA, 1982, BEHAV BRAIN SCI, V5, P469, DOI 10.1017/S0140525X00013066; Gredeback G, 2010, DEV NEUROPSYCHOL, V35, P1, DOI 10.1080/87565640903325758; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Hunnius S, 2004, INFANCY, V6, P231, DOI 10.1207/s15327078in0602_5; KAGAN J, 1984, CHILD DEV, V55, P2212, DOI 10.1111/j.1467-8624.1984.tb03916.x; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kagan J, 1999, SER AFFECTIVE SCI, P3; Kagan J., 1994, GALENS PROPHECY TEMP, DOI DOI 10.4324/9780429500282; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; Kinsbourne M., 1978, ASYMMETRICAL FUNCTIO, P3; Lewis M, 2008, HDB EMOTIONS, pxvi; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Marshall P. J., 2001, INT HDB SOCIAL ANXIE, P53; Matsuda YT, 2012, BIOL LETTERS, V8, P725, DOI 10.1098/rsbl.2012.0346; Merin N, 2007, J AUTISM DEV DISORD, V37, P108, DOI 10.1007/s10803-006-0342-4; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; PANKSEPP J, 1982, BEHAV BRAIN SCI, V5, P407, DOI 10.1017/S0140525X00012759; PILKONIS PA, 1977, J PERS, V45, P596, DOI 10.1111/j.1467-6494.1977.tb00174.x; Preyer WT, 1888, MIND CHILD; Putnam SP, 2005, CHILD DEV, V76, P212, DOI 10.1111/j.1467-8624.2005.00840.x; Putnam SP, 2002, DEVELOPMENTAL SCI, V5, P441, DOI 10.1111/1467-7687.00239; Reddy V, 2005, EMOTIONAL DEV, P183; ROTHBART MK, 1988, CHILD DEV, V59, P1241, DOI 10.1111/j.1467-8624.1988.tb01493.x; ROWE DC, 1977, J PERS ASSESS, V41, P150, DOI 10.1207/s15327752jpa4102_5; Sato W, 2004, COGNITION EMOTION, V18, P701, DOI 10.1080/02699930341000176; SCHAFFER HR, 1966, J CHILD PSYCHOL PSYC, V7, P95, DOI 10.1111/j.1469-7610.1966.tb02167.x; SCHAFFER HR, 1972, CHILD DEV, V43, P165, DOI 10.1111/j.1467-8624.1972.tb01088.x; Schmidt L.A., 1999, EXTREME FEAR SHYNESS, DOI [10.1093/acprof:oso/9780195118872.001.0001, DOI 10.1093/ACPROF:OSO/9780195118872.001.0001]; Schmidt LA, 1999, PSYCHOL SCI, V10, P316, DOI 10.1111/1467-9280.00161; SCHMIDT LA, 1994, BIOL PSYCHOL, V38, P183, DOI 10.1016/0301-0511(94)90038-8; Spitz RA, 1950, INT J PSYCHOANAL, V31, P138; TENNES KH, 1964, J NERV MENT DIS, V139, P247, DOI 10.1097/00005053-196409000-00005; von Hofsten C, 2005, INFANCY, V8, P217, DOI 10.1207/s15327078in0803_2; WILCOX BM, 1968, J EXP CHILD PSYCHOL, V6, P22, DOI 10.1016/0022-0965(68)90068-4	61	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e65476	10.1371/journal.pone.0065476	http://dx.doi.org/10.1371/journal.pone.0065476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755238	gold, Green Submitted, Green Published			2022-12-25	WOS:000320579400060
J	Monge, J; Kricun, M; Radovcic, J; Radovcic, D; Mann, A; Frayer, DW				Monge, Janet; Kricun, Morrie; Radovcic, Jakov; Radovcic, Davorka; Mann, Alan; Frayer, David W.			Fibrous Dysplasia in a 120,000+Year Old Neandertal from Krapina, Croatia	PLOS ONE			English	Article							ENAMEL HYPOPLASIA; CANCER; RIBS; BONE	We describe the first definitive case of a fibrous dysplastic neoplasm in a Neandertal rib (120.71) from the site of Krapina in present-day Croatia. The tumor predates other evidence for these kinds of tumor by well over 100,000 years. Tumors of any sort are a rare occurrence in recent archaeological periods or in living primates, but especially in the human fossil record. Several studies have surveyed bone diseases in past human populations and living primates and fibrous dysplasias occur in a low incidence. Within the class of bone tumors of the rib, fibrous dysplasia is present in living humans at a higher frequency than other bone tumors. The bony features leading to our diagnosis are described in detail. In living humans effects of the neoplasm present a broad spectrum of symptoms, from asymptomatic to debilitating. Given the incomplete nature of this rib and the lack of associated skeletal elements, we resist commenting on the health effects the tumor had on the individual. Yet, the occurrence of this neoplasm shows that at least one Neandertal suffered a common bone tumor found in modern humans.	[Monge, Janet] Univ Penn, Univ Penn Museum, Philadelphia, PA 19104 USA; [Kricun, Morrie] Univ Penn, Dept Radiol, Univ Penn Museum, Philadelphia, PA 19104 USA; [Radovcic, Jakov; Radovcic, Davorka] Croatian Nat Hist Museum, Zagreb, Croatia; [Mann, Alan] Princeton Univ, Dept Anthropol, Princeton, NJ 08544 USA; [Frayer, David W.] Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA	University of Pennsylvania; University of Pennsylvania; Princeton University; University of Kansas	Frayer, DW (corresponding author), Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA.	frayer@ku.edu						American Cancer Society, 2012, BON CANC OV; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; BAXTER AD, 1995, NUCL MED COMMUN, V16, P834, DOI 10.1097/00006231-199510000-00006; Capasso LL, 2005, INT J CANCER, V113, P2, DOI 10.1002/ijc.20610; Caspari R, 2004, P NATL ACAD SCI USA, V101, P10895, DOI 10.1073/pnas.0402857101; Gardner JC, 2008, NEW INSIGHTS KRAPINA, P237; GIBSON MJ, 1971, BRIT J RADIOL, V44, P1; Gorjanovic-Kramberger D, 1908, KORR DTSCH GES ANTHR, V38, P108; Gorjanovic-Kramberger D, 1908, UMSCHAU, V12, P623; Gorjanovic-Kramberger G, 1906, STUDIEN ENTWICKLUNGS, VII, P59; Guatelli-Steinberg D, 2004, J HUM EVOL, V47, P65, DOI 10.1016/j.jhevol.2004.05.004; Halperin EC, 2004, PERSPECT BIOL MED, V47, P1, DOI 10.1353/pbm.2004.0010; HARRIS WH, 1962, J BONE JOINT SURG AM, V44, P207, DOI 10.2106/00004623-196244020-00001; Hauber EJ, 2009, BONE CANC PROGR THER, P3; HOCHBERG LA, 1953, AMA ARCH SURG, V67, P566, DOI 10.1001/archsurg.1953.01260040575011; Hutchinson DL, 1997, CURR ANTHROPOL, V38, P904, DOI 10.1086/204681; Hutton Estabrook V, 2013, BIOARCHAEOLOGY HUMAN; Kricun M, 1999, KRAPINA HOMINIDS RAD; Kricun ME, 1993, IMAGE BONE TUMORS, P6; Kricun ME, 1993, IMAGE BONE TUMORS, P311; Mann A, 2008, NEW INSIGHTS KRAPINA, P261; Miracle P.T, 2007, KRAPINA PALEOLITHIC; Mirra JM, 1980, BONE TUMORS DIAGNOSI, P125; MOLNAR S, 1985, AM ANTHROPOL, V87, P536, DOI 10.1525/aa.1985.87.3.02a00020; Monge Janet, 2007, P673, DOI 10.1007/978-3-540-33761-4_22; Ortner DJ, 1981, IDENTIFICATION PATHO, V28, P365; PASCUZZI CA, 1957, SURG GYNECOL OBSTET, V104, P390; Radovcic J, 1988, DRAGUTIN GORJANOVIC; Radovcic J, 2008, KRAPINA HOMINIDS ILL; RINK WJ, 1995, NATURE, V378, P24, DOI 10.1038/378024a0; Rodenberg J, 1996, SKELETAL RADIOL, V25, P682, DOI 10.1007/s002560050159; RUSSELL MD, 1987, AM J PHYS ANTHROPOL, V72, P381, DOI 10.1002/ajpa.1330720311; Schajowicz F, 1994, TUMORS TUMORLIKE LES, P567; Simek JF, 1997, J HUM EVOL, V32, P561, DOI 10.1006/jhev.1996.0129; The Netherlands Committee on Bone Tumors, 1973, RAD ATL BON TUM, V2, p[X, XII]	35	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64539	10.1371/journal.pone.0064539	http://dx.doi.org/10.1371/journal.pone.0064539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755126	Green Published, Green Submitted, gold			2022-12-25	WOS:000320579400017
J	Shroufi, A; Mafara, E; Saint-Sauveur, JF; Taziwa, F; Vinoles, MC				Shroufi, Amir; Mafara, Emma; Saint-Sauveur, Jean Francis; Taziwa, Fabian; Vinoles, Mari Carmen			Mother to Mother (M2M) Peer Support for Women in Prevention of Mother to Child Transmission (PMTCT) Programmes: A Qualitative Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; HIV TRANSMISSION; BEHAVIORAL INTERVENTION; RANDOMIZED-TRIAL; RURAL ZIMBABWE; PREGNANT-WOMEN; SOUTH-AFRICA; ADHERENCE; BOTSWANA	Introduction: Mother-to-Mother (M2M) or "Mentor Mother" programmes utilise HIV positive mothers to provide support and advice to HIV positive pregnant women and mothers of HIV exposed babies. Medecins Sans Frontieres (MSF) supported a Mentor Mother programme in Bulawayo, Zimbabwe from 2009 to 2012; with programme beneficiaries observed to have far higher retention at 6-8 weeks (99% vs 50%, p<0.0005) and to have higher adherence to Prevention of Mother to Child Transmission (PMTCT) guidelines, compared to those not opting in. In this study we explore how the M2M progamme may have contributed to these findings. Methods: In this qualitative study we used thematic analysis of in-depth interviews (n = 79). This study was conducted in 2 urban districts of Bulawayo, Zimbabwe's second largest city. Results: Interviews were completed by 14 mentor mothers, 10 mentor mother family members, 30 beneficiaries (women enrolled both in PMTCT and M2M), 10 beneficiary family members, 5 women enrolled in PMTCT but who had declined to take part in the M2M programme and 10 health care staff members. All beneficiaries and health care staff reported that the programme had improved retention and provided rich information on how this was achieved. Additionally respondents described how the programme had helped bring about beneficial behaviour change. Conclusions: M2M programmes offer great potential to empower communities affected by HIV to catalyse positive behaviour change. Our results illustrate how M2M involvement may increase retention in PMTCT programmes. Nondisclosure to one's partner, as well as some cultural practices prevalent in Zimbabwe appear to be major barriers to participation in M2M programmes.	[Shroufi, Amir; Mafara, Emma; Saint-Sauveur, Jean Francis; Taziwa, Fabian; Vinoles, Mari Carmen] Medecins Sans Frontieres, Operat Ctr Barcelona Athens, Harare, Zimbabwe		Shroufi, A (corresponding author), Medecins Sans Frontieres, Operat Ctr Barcelona Athens, Harare, Zimbabwe.	amir.shroufi@doctors.org.uk						Aizire J, 2013, CURR HIV RES, V11, P144, DOI 10.2174/1570162X11311020007; Albrecht S, 2006, JAIDS-J ACQ IMM DEF, V41, P114, DOI 10.1097/01.qai.0000179425.27036.d7; [Anonymous], 2002, UN PROGR HIV AIDS UN; Bajunirwe Francis, 2005, AIDS Res Ther, V2, P10, DOI 10.1186/1742-6405-2-10; Busza J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17373; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; COX AD, 1991, J ROY SOC MED, V84, P217, DOI 10.1177/014107689108400411; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; Decroo T, 2010, J ACQ IMMUN DEF SYND; Decroo T, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/749718; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; Dryden-Peterson S, 2011, JAIDS-J ACQ IMM DEF, V58, P353, DOI 10.1097/QAI.0b013e31822d4063; Dube S, 2008, JAIDS-J ACQ IMM DEF, V48, P72, DOI 10.1097/QAI.0b013e31816bcdbb; Futterman D, 2010, AIDS CARE, V22, P1093, DOI 10.1080/09540121003600352; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2011, GLOB PLAN EL NEW HIV; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Meldrum A, 2008, LANCET, V371, P1059, DOI 10.1016/S0140-6736(08)60468-7; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Ministry of Health and Child Welfare Zimbabwe, 2011, MOHCW 2011 NAT STRAT; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Orne-Gliemann J, 2006, TROP MED INT HEALTH, V11, P341, DOI 10.1111/j.1365-3156.2006.01563.x; Peltzer K, 2010, ACTA PAEDIATR, V99, P699, DOI 10.1111/j.1651-2227.2010.01699.x; Perez F, 2004, BRIT MED J, V329, P1147, DOI 10.1136/bmj.329.7475.1147; Perez F, 2004, IMPLEMENTING RURAL P; Raine P, 2003, HEALTH SOC CARE COMM, V11, P463, DOI 10.1046/j.1365-2524.2003.00449.x; Roura M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-427; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Shapiro RL, 2003, AIDS EDUC PREV, V15, P221, DOI 10.1521/aeap.15.4.221.23830; Shetty AK, 2010, J PERINATOL, V30, P763, DOI 10.1038/jp.2010.104; Shetty AK, 2005, INT J STD AIDS, V16, P755, DOI 10.1258/095646205774763090; Skovdal M, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-29; Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13; Tchendjou PT, 2011, JAIDS-J ACQ IMM DEF, V57, pS9, DOI 10.1097/QAI.0b013e31821ec6e2; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Wanyama J, 2007, AIDS, V21, P1486, DOI 10.1097/QAD.0b013e32823ecf7f; Wools-Kaloustian KK, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-22; World Health Organization, 2021, ANT DRUGS TREAT PREG; Wringe A, 2012, TROP MED INT HEALTH, V17, pe38, DOI 10.1111/j.1365-3156.2011.02925.x; Zimbabwe National AIDS Council, 2010, 2010 ZIMBABWE AN HIV	45	53	54	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64717	10.1371/journal.pone.0064717	http://dx.doi.org/10.1371/journal.pone.0064717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166TB	23755137	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400022
J	Descamps, S				Descamps, Sebastien			Winter Temperature Affects the Prevalence of Ticks in an Arctic Seabird	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; IXODES-URIAE ACARI; MORTALITY; PENGUINS; IXODIDAE; ECOLOGY; COLONY; MODEL	The Arctic is rapidly warming and host-parasite relationships may be modified by such environmental changes. Here, I showed that the average winter temperature in Svalbard, Arctic Norway, explained almost 90% of the average prevalence of ticks in an Arctic seabird, the Brunnich's guillemot Uria lomvia. An increase of 1 degrees C in the average winter temperature at the nesting colony site was associated with a 5% increase in the number of birds infected by these ectoparasites in the subsequent breeding season. Guillemots were generally infested by only a few ticks (<5) and I found no direct effect of tick presence on their body condition and breeding success. However, the strong effect of average winter temperature described here clearly indicates that tick-seabird relationships in the Arctic may be strongly affected by ongoing climate warming.	Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway	Norwegian Polar Institute	Descamps, S (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	descamps@npolar.no		Chiaradia, Andre/0000-0002-6178-4211	MOSJ; SEAPOP	MOSJ; SEAPOP	This study was funded by programs MOSJ (http://mosj.npolar.no/) and SEAPOP (http://seapop.no/). There is no grant number for these funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov OA, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P653; [Anonymous], 2010, R LANG ENV STAT COMP; Barton TR, 1996, PARASITOLOGY, V112, P571, DOI 10.1017/S0031182000066154; Benoit JB, 2009, ANTARCT SCI, V21, P151, DOI 10.1017/S0954102008001685; Bergstrom S, 1999, INT J PARASITOL, V29, P1359, DOI 10.1016/S0020-7519(99)00088-0; Boulinier T, 1996, IBIS, V138, P326, DOI 10.1111/j.1474-919X.1996.tb04345.x; Coulson SJ, 2009, POLAR RES, V28, P399, DOI 10.1111/j.1751-8369.2009.00117.x; CROLL DA, 1991, CONDOR, V93, P496, DOI 10.2307/1368181; Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2; Davidson R, 2011, TRENDS PARASITOL, V27, P238, DOI 10.1016/j.pt.2011.02.001; Dietrich M, 2011, VECTOR-BORNE ZOONOT, V11, P453, DOI 10.1089/vbz.2010.0009; DUFFY DC, 1983, ECOLOGY, V64, P110, DOI 10.2307/1937334; Epstein PR, 2001, MICROBES INFECT, V3, P747, DOI 10.1016/S1286-4579(01)01429-0; Eveleigh E. S., 1974, Acarologia, V16, P621; FEARE CJ, 1976, IBIS, V118, P112, DOI 10.1111/j.1474-919X.1976.tb02015.x; Gaston A.J., 1998, THE AUKS; Gaston AJ, 2002, IBIS, V144, P185, DOI 10.1046/j.1474-919X.2002.00038.x; Gauthier-Clerc M, 1998, COLON WATERBIRD, V21, P229, DOI 10.2307/1521910; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285; Kutz SJ, 2009, VET PARASITOL, V163, P217, DOI 10.1016/j.vetpar.2009.06.008; LEE RE, 1987, PHYSIOL ZOOL, V60, P499, DOI 10.1086/physzool.60.4.30157912; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Mangin S, 2003, J AVIAN BIOL, V34, P30, DOI 10.1034/j.1600-048X.2003.02916.x; McCoy K, 1999, J PARASITOL, V85, P196, DOI 10.2307/3285619; McCoy KD, 2005, P ROY SOC B-BIOL SCI, V272, P2389, DOI 10.1098/rspb.2005.3230; McCoy KD, 2002, EVOL ECOL RES, V4, P441; Moller AP, 2009, BIOL REV, V84, P567, DOI 10.1111/j.1469-185X.2009.00087.x; Morbey YE, 1996, CAN J ZOOL, V74, P1585, DOI 10.1139/z96-172; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Potti J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001276; Wanless S, 1997, COLON WATERBIRD, V20, P540, DOI 10.2307/1521606	33	31	31	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65374	10.1371/journal.pone.0065374	http://dx.doi.org/10.1371/journal.pone.0065374			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750259	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900061
J	Herget, M; Scheibinger, M; Guo, ZH; Jan, TA; Adams, CM; Cheng, AG; Heller, S				Herget, Meike; Scheibinger, Mirko; Guo, Zhaohua; Jan, Taha A.; Adams, Christopher M.; Cheng, Alan G.; Heller, Stefan			A Simple Method for Purification of Vestibular Hair Cells and Non-Sensory Cells, and Application for Proteomic Analysis	PLOS ONE			English	Article							EAR STEM-CELLS; INNER-EAR; MASS-SPECTROMETRY; RIBBON SYNAPSE; COCHLEA; OTOFERLIN; DEAFNESS; HEARING; PROTEIN; FORM	Mechanosensitive hair cells and supporting cells comprise the sensory epithelia of the inner ear. The paucity of both cell types has hampered molecular and cell biological studies, which often require large quantities of purified cells. Here, we report a strategy allowing the enrichment of relatively pure populations of vestibular hair cells and non-sensory cells including supporting cells. We utilized specific uptake of fluorescent styryl dyes for labeling of hair cells. Enzymatic isolation and flow cytometry was used to generate pure populations of sensory hair cells and non-sensory cells. We applied mass spectrometry to perform a qualitative high-resolution analysis of the proteomic makeup of both the hair cell and non-sensory cell populations. Our conservative analysis identified more than 600 proteins with a false discovery rate of <3% at the protein level and <1% at the peptide level. Analysis of proteins exclusively detected in either population revealed 64 proteins that were specific to hair cells and 103 proteins that were only detectable in non-sensory cells. Statistical analyses extended these groups by 53 proteins that are strongly upregulated in hair cells versus non-sensory cells and vice versa by 68 proteins. Our results demonstrate that enzymatic dissociation of styryl dye-labeled sensory hair cells and non-sensory cells is a valid method to generate pure enough cell populations for flow cytometry and subsequent molecular analyses.	[Herget, Meike; Scheibinger, Mirko; Guo, Zhaohua; Jan, Taha A.; Cheng, Alan G.; Heller, Stefan] Stanford Univ, Dept Otolaryngol HNS, Stanford, CA 94305 USA; [Herget, Meike; Scheibinger, Mirko; Guo, Zhaohua; Heller, Stefan] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Adams, Christopher M.] Stanford Univ, Mass Spectrometry Core, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Heller, S (corresponding author), Stanford Univ, Dept Otolaryngol HNS, Stanford, CA 94305 USA.	hellers@stanford.edu		Cheng, Alan/0000-0002-4702-8401; Jan, Taha/0000-0001-8971-7769	Deutsche Forschungsgemeinschaft; Stanford Dean's fellowship; National Institutes of Health [DC004563, DC010363]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC011043, R01DC012250, R01DC004563, P30DC010363] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Stanford Dean's fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by postdoctoral grants from the Deutsche Forschungsgemeinschaft and a Stanford Dean's fellowship to MH, and National Institutes of Health grants DC004563 and DC010363 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashiri A, 2003, J Matern Fetal Neonatal Med, V14, P344, DOI 10.1080/713606702; BURRIDGE K, 1983, J CELL BIOL, V97, P359, DOI 10.1083/jcb.97.2.359; Chai RJ, 2012, P NATL ACAD SCI USA, V109, P8167, DOI 10.1073/pnas.1202774109; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; DECHESNE CJ, 1994, J COMP NEUROL, V346, P517, DOI 10.1002/cne.903460405; Doetzlhofer A, 2006, BRAIN RES, V1091, P282, DOI 10.1016/j.brainres.2006.02.071; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Gale JE, 2000, JARO-J ASSOC RES OTO, V1, P172, DOI 10.1007/s101620010037; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Goodyear RJ, 2010, JARO-J ASSOC RES OTO, V11, P573, DOI 10.1007/s10162-010-0231-6; Goodyear RJ, 1999, J NEUROCYTOL, V28, P851, DOI 10.1023/A:1007070121751; Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; Hertzano R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002309; Jan TA, 2011, JOVE-J VIS EXP, DOI 10.3791/3432; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kachar B, 1997, HEARING RES, V107, P102, DOI 10.1016/S0378-5955(97)00027-0; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Meyers JR, 2003, J NEUROSCI, V23, P4054; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Pangrsic T, 2010, NAT NEUROSCI, V13, P869, DOI 10.1038/nn.2578; Ronaghi M, 2012, STEM CELLS, V30, P69, DOI 10.1002/stem.785; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Safieddine S, 2012, ANNU REV NEUROSCI, V35, P509, DOI 10.1146/annurev-neuro-061010-113705; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Shi FX, 2012, J NEUROSCI, V32, P9639, DOI 10.1523/JNEUROSCI.1064-12.2012; Shin JB, 2013, NAT NEUROSCI, V16, P365, DOI 10.1038/nn.3312; Sinkkonen ST, 2011, SCI REP-UK, V1, DOI 10.1038/srep00026; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Spinelli KJ, 2012, P NATL ACAD SCI USA, V109, pE268, DOI 10.1073/pnas.1115866109; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Wang DX, 2012, PLANT BIOTECHNOL J, V10, P925, DOI 10.1111/j.1467-7652.2012.00721.x; Yang D, 2004, J NEUROBIOL, V58, P479, DOI 10.1002/neu.10289; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zheng JL, 1997, J NEUROSCI, V17, P8270	39	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66026	10.1371/journal.pone.0066026	http://dx.doi.org/10.1371/journal.pone.0066026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750277	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900079
J	Ozaki, A; Yoshida, K; Fuji, K; Kubota, S; Kai, W; Aoki, J; Kawabata, Y; Suzuki, J; Akita, K; Koyama, T; Nakagawa, M; Hotta, T; Tsuzaki, T; Okamoto, N; Araki, K; Sakamoto, T				Ozaki, Akiyuki; Yoshida, Kazunori; Fuji, Kanako; Kubota, Satoshi; Kai, Wataru; Aoki, Jun-ya; Kawabata, Yumi; Suzuki, Junpei; Akita, Kazuki; Koyama, Takashi; Nakagawa, Masahiro; Hotta, Takurou; Tsuzaki, Tatsuo; Okamoto, Nobuaki; Araki, Kazuo; Sakamoto, Takashi			Quantitative Trait Loci (QTL) Associated with Resistance to a Monogenean Parasite (Benedenia seriolae) in Yellowtail (Seriola quinqueradiata) through Genome Wide Analysis	PLOS ONE			English	Article							INFECTIOUS PANCREATIC NECROSIS; FLOUNDER PARALICHTHYS-OLIVACEUS; JAPANESE FLOUNDER; LEPEOPHTHEIRUS-SALMONIS; WHIRLING DISEASE; LINKAGE MAPS; SUSCEPTIBILITY; IDENTIFICATION; SOFTWARE; VIRUS	Benedenia infections caused by the monogenean fluke ectoparasite Benedenia seriolae seriously impact marine finfish aquaculture. Genetic variation has been inferred to play a significant role in determining the susceptibility to this parasitic disease. To evaluate the genetic basis of Benedenia disease resistance in yellowtail (Seriola quinqueradiata), a genome-wide and chromosome-wide linkage analyses were initiated using F-1 yellowtail families (n = 90 per family) based on a high-density linkage map with 860 microsatellite and 142 single nucleotide polymorphism (SNP) markers. Two major quantitative trait loci (QTL) regions on linkage groups Squ2 (BDR-1) and Squ20 (BDR-2) were identified. These QTL regions explained 32.9-35.5% of the phenotypic variance. On the other hand, we investigated the relationship between QTL for susceptibility to B. seriolae and QTL for fish body size. The QTL related to growth was found on another linkage group (Squ7). As a result, this is the first genetic evidence that contributes to detailing phenotypic resistance to Benedenia disease, and the results will help resolve the mechanism of resistance to this important parasitic infection of yellowtail.	[Ozaki, Akiyuki; Kai, Wataru; Aoki, Jun-ya; Kawabata, Yumi; Araki, Kazuo] Fisheries Res Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan; [Yoshida, Kazunori; Nakagawa, Masahiro; Hotta, Takurou; Tsuzaki, Tatsuo] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Nagasaki, Japan; [Fuji, Kanako; Kubota, Satoshi; Suzuki, Junpei; Akita, Kazuki; Koyama, Takashi; Okamoto, Nobuaki; Sakamoto, Takashi] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Minato Ku, Tokyo, Japan	Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Tokyo University of Marine Science & Technology	Ozaki, A (corresponding author), Fisheries Res Agcy, Natl Res Inst Aquaculture, Minamiise, Mie, Japan.	aozaki@affrc.go.jp	Kubota, Satoshi/N-1279-2018; SAKAMOTO, Takashi/O-1949-2014	SAKAMOTO, Takashi/0000-0002-8399-851X; Kubota, Satoshi/0000-0002-6143-4430; KOYAMA, Takashi/0000-0001-7140-7244	ministry of Fisheries Research Agency (FRA); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	ministry of Fisheries Research Agency (FRA); Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN)	The work was supported by ministry of Fisheries Research Agency (FRA) grants-in-aid for scientific research "New Technology of Fish Breeding''. And funded by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Baerwald MR, 2011, HEREDITY, V106, P920, DOI 10.1038/hdy.2010.137; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHURCHILL GA, 1994, GENETICS, V138, P963; Danzmann R.G., 2006, LINKAGE ANAL PACKAGE; FUJI K, 2012, BMC GENOMICS UNPUB; Fuji K, 2006, AQUACULTURE, V254, P203, DOI 10.1016/j.aquaculture.2005.11.024; Fuji K, 2010, AQUACULTURE, V308, pS51, DOI 10.1016/j.aquaculture.2010.06.035; Gharbi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-20; Glover KA, 2007, DIS AQUAT ORGAN, V76, P57, DOI 10.3354/dao076057; Glover KA, 2005, AQUACULTURE, V245, P19, DOI 10.1016/j.aquaculture.2004.11.047; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Houston RD, 2008, GENETICS, V178, P1109, DOI 10.1534/genetics.107.082974; Hutson KS, 2007, AQUACULTURE, V271, P85, DOI 10.1016/j.aquaculture.2007.03.020; Hwang SD, 2011, MAR BIOTECHNOL, V13, P1086, DOI 10.1007/s10126-011-9371-x; ISHIKAWA A, 2010, JAPANESE ASS LAB ANI, V51, P51; JANSEN RC, 1994, GENETICS, V136, P1447; JANSEN RC, 1995, THEOR APPL GENET, V91, P33, DOI 10.1007/BF00220855; KUBOTA S, 2009, 10 INT S GEN AQ BANG, P194; *MAFF, 2009, ANN STAT FISH AQ PRO; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Matsuyama T, 2007, DIS AQUAT ORGAN, V75, P79, DOI 10.3354/dao075079; Moen T, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-53; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; MUSHIAKE K, 1994, FISHERIES SCI, V60, P647, DOI 10.2331/fishsci.60.647; Mushiake K, 1998, FISHERIES SCI, V64, P727, DOI 10.2331/fishsci.64.727; Nagakura Y., 2010, J FISHERIES TECHNOLO, V3, P21; Nagakura Y., 2006, AQUAC SCI, V54, P335; Nakada M., 2008, FAO Fisheries Technical Paper, P199; Nichols KM, 2003, DIS AQUAT ORGAN, V56, P145, DOI 10.3354/dao056145; Ogawa K, 1996, VET PARASITOL, V64, P95, DOI 10.1016/0304-4017(96)00962-4; Ohara E, 2005, AQUACULTURE, V244, P41, DOI 10.1016/j.aquaculture.2004.10.022; Ohno Y, 2008, AQUACULTURE, V274, P30, DOI 10.1016/j.aquaculture.2007.11.013; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; Ozakil A, 2007, FISH PATHOL, V42, P131, DOI 10.3147/jsfp.42.131; Ryce EKN, 2005, DIS AQUAT ORGAN, V63, P69, DOI 10.3354/dao063069; Ryce EKN, 2004, DIS AQUAT ORGAN, V59, P225, DOI 10.3354/dao059225; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yoshinaga T, 2002, INT J PARASITOL, V32, P381, DOI 10.1016/S0020-7519(01)00339-3	42	28	32	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e64987	10.1371/journal.pone.0064987	http://dx.doi.org/10.1371/journal.pone.0064987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750223	Green Submitted, gold, Green Published			2022-12-25	WOS:000319961900025
J	Alter, DA; Franklin, B; Ko, DT; Austin, PC; Lee, DS; Oh, PI; Stukel, TA; Tu, JV				Alter, David A.; Franklin, Barry; Ko, Dennis T.; Austin, Peter C.; Lee, Douglas S.; Oh, Paul I.; Stukel, Therese A.; Tu, Jack V.			Socioeconomic Status, Functional Recovery, and Long-Term Mortality among Patients Surviving Acute Myocardial Infarction	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; CARDIAC REHABILITATION; SECONDARY PREVENTION; DEPRESSIVE SYMPTOMS; EXERCISE CAPACITY; ELDERLY-PATIENTS; HEALTH-SERVICES; YOUNG-ADULTS; FOLLOW-UP	Objectives: To examine the relationship between socio-economic status (SES), functional recovery and long-term mortality following acute myocardial infarction (AMI). Background: The extent to which SES mortality disparities are explained by differences in functional recovery following AMI is unclear. Methods: We prospectively examined 1368 patients who survived at least one-year following an index AMI between 1999 and 2003 in Ontario, Canada. Each patient was linked to administrative data and followed over 9.6 years to track mortality. All patients underwent medical chart abstraction and telephone interviews following AMI to identify individual-level SES, clinical factors, processes of care (i.e., use of, and adherence, to evidence-based medications, physician visits, invasive cardiac procedures, referrals to cardiac rehabilitation), as well as changes in psychosocial stressors, quality of life, and self-reported functional capacity. Results: As compared with their lower SES counterparts, higher SES patients experienced greater functional recovery (1.80 ml/kg/min average increase in peak V02, P<0.001) after adjusting for all baseline clinical factors. Post-AMI functional recovery was the strongest modifiable predictor of long-term mortality (Adjusted HR for each ml/kg/min increase in functional capacity: 0.91; 95% CI: 0.87-0.94, P<0.001) irrespective of SES (P = 0.51 for interaction between SES, functional recovery, and mortality). SES-mortality associations were attenuated by 27% after adjustments for functional recovery, rendering the residual SES-mortality association no longer statistically significant (Adjusted HR: 0.84; 95% CI: 0.70-1.00, P = 0.05). The effects of functional recovery on SES-mortality associations were not explained by access inequities to physician specialists or cardiac rehabilitation. Conclusions: Functional recovery may play an important role in explaining SES-mortality gradients following AMI.	[Alter, David A.; Ko, Dennis T.; Austin, Peter C.; Lee, Douglas S.; Stukel, Therese A.; Tu, Jack V.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Alter, David A.; Oh, Paul I.] Toronto Rehabil Inst, Cardiac Rehabil & Secondary Prevent Program, Toronto, ON, Canada; [Ko, Dennis T.; Tu, Jack V.] Schulich Heart Ctr, Toronto, ON, Canada; [Ko, Dennis T.; Tu, Jack V.] Sunnybrook Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON M4N 3M5, Canada; [Alter, David A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Alter, David A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Franklin, Barry] William Beaumont Hosp, Cardiac Rehabil & Exercise Labs, Royal Oak, MI 48072 USA; [Alter, David A.; Ko, Dennis T.; Austin, Peter C.; Lee, Douglas S.; Stukel, Therese A.; Tu, Jack V.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Beaumont Health; University of Toronto	Alter, DA (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	david.alter@ices.on.ca		Lee, Douglas/0000-0001-7078-745X; Ko, Dennis/0000-0001-6840-8051; Austin, Peter/0000-0003-3337-233X; Stukel, Therese/0000-0002-2951-1360	Canadian Institute for Health Research (MOP) [119956]	Canadian Institute for Health Research (MOP)(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institute for Health Research (MOP #119956). The Institute for Clinical Evaluative Sciences is supported in part by a grant from the Ontario Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 1999, CAN J PUBLIC HEALTH, V90, P85, DOI 10.1007/BF03404107; Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Alter DA, 2006, AM HEART J, V151, P323, DOI 10.1016/j.ahj.2005.07.013; Alter DA, 2006, ANN INTERN MED, V144, P82, DOI 10.7326/0003-4819-144-2-200601170-00005; Alter DA, 2004, CAN J CARDIOL, V20, P1219; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Alter DA, 2011, HEALTH AFFAIR, V30, P274, DOI 10.1377/hlthaff.2009.0669; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Bloch Katia Vergetti, 2003, Arq. Bras. Cardiol., V80, P179, DOI 10.1590/S0066-782X2003000200006; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Buurman BM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-296; Candido E, 2011, CAN J CARDIOL, V27, P200, DOI 10.1016/j.cjca.2011.01.008; Candido E, 2011, J CLIN EPIDEMIOL, V64, P213, DOI 10.1016/j.jclinepi.2010.03.010; Carter Rick, 2002, J Cardiopulm Rehabil, V22, P298, DOI 10.1097/00008483-200207000-00014; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Clark RA, 2012, CIRCULATION, V125, P2006, DOI 10.1161/CIRCULATIONAHA.111.083394; Cohen B, 2008, AM J CARDIOL, V101, P462, DOI 10.1016/j.amjcard.2007.09.093; Danenberg HD, 2009, ISR MED ASSOC J, V11, P529; Ganova-Iolovska M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-15; Gerber Y, 2010, CIRCULATION, V121, P375, DOI 10.1161/CIRCULATIONAHA.109.882555; Gerber Y, 2009, MED CARE, V47, P342, DOI 10.1097/MLR.0b013e3181894270; Ghosh R, 2009, CURR OPIN CRIT CARE, V15, P279, DOI 10.1097/MCC.0b013e32832faef2; Harkins C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-391; Hillier FC, 2012, PUBLIC HEALTH NUTR, V15, P1446, DOI 10.1017/S1368980011002862; HLATKY MA, 1989, AM J CARDIOL, V64, P651, DOI 10.1016/0002-9149(89)90496-7; Hunt J, 2008, HEALTH PROMOT J AUST, V19, P102, DOI 10.1071/HE08102; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Koenig HG, 1999, AM J GERIAT PSYCHIAT, V7, P124; Kokkinos P, 2010, CIRCULATION, V122, P790, DOI 10.1161/CIRCULATIONAHA.110.938852; Kurdyak PA, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-200; Lee DS, 2010, CIRCULATION, V122, P1806, DOI 10.1161/CIRCULATIONAHA.110.940262; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Melville MR, 2003, HEART, V89, P1445, DOI 10.1136/heart.89.12.1445; Menec VH, 2001, CAN J PUBLIC HEALTH, V92, P299, DOI 10.1007/BF03404965; Merz CNB, 2000, J WOMEN HEALTH GEN-B, V9, P769, DOI 10.1089/15246090050147745; Morey MC, 2002, J AM GERIATR SOC, V50, P1929, DOI 10.1046/j.1532-5415.2002.50602.x; Oberg EB, 2009, PREV CHRONIC DIS, V6; Pitsavos C, 2008, J AM COLL CARDIOL, V51, P2034, DOI 10.1016/j.jacc.2008.01.053; Raine R, 2003, HEALTH POLICY, V63, P63, DOI 10.1016/S0168-8510(02)00056-8; Rosvall M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-44; Sainio P, 2007, J EPIDEMIOL COMMUN H, V61, P401, DOI 10.1136/jech.2006.048306; Shishehbor MH, 2008, AM HEART J, V155, P699, DOI 10.1016/j.ahj.2007.07.055; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; SIHM I, 1991, EUR HEART J, V12, P203, DOI 10.1093/oxfordjournals.eurheartj.a059869; Statistics Canada, 1999, 1996 NAT POP HLTH SU; Suaya JA, 2007, CIRCULATION, V116, P1653, DOI 10.1161/CIRCULATIONAHA.107.701466; Sulander T, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-78; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009	50	65	65	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65130	10.1371/journal.pone.0065130	http://dx.doi.org/10.1371/journal.pone.0065130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	157CD	23755180	Green Published, gold, Green Submitted			2022-12-25	WOS:000319872300050
J	Price, JC; Pollock, LM; Rudd, ML; Fogoros, SK; Mohamed, H; Hanigan, CL; Le Gallo, M; Zhang, SY; Cruz, P; Cherukuri, PF; Hansen, NF; McManus, KJ; Godwin, AK; Sgroi, DC; Mullikin, JC; Merino, MJ; Hieter, P; Bell, DW				Price, Jessica C.; Pollock, Lana M.; Rudd, Meghan L.; Fogoros, Sarah K.; Mohamed, Hassan; Hanigan, Christin L.; Le Gallo, Matthieu; Zhang, Suiyuan; Cruz, Pedro; Cherukuri, Praveen F.; Hansen, Nancy F.; McManus, Kirk J.; Godwin, Andrew K.; Sgroi, Dennis C.; Mullikin, James C.; Merino, Maria J.; Hieter, Philip; Bell, Daphne W.		NIH Intramural Sequencing Ctr NISC	Sequencing of Candidate Chromosome Instability Genes in Endometrial Cancers Cancers Reveals Somatic Mutations in ESCO1, CHTF18, and MRE11A	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; CTF18-REPLICATION FACTOR-C; ANTIGEN LOADER COMPLEX; DNA MISMATCH REPAIR; MICROSATELLITE INSTABILITY; S-PHASE; SACCHAROMYCES-CEREVISIAE; COLORECTAL CANCERS; CONSERVED PROTEIN; HUMAN-CELLS	Most endometrial cancers can be classified histologically as endometrioid, serous, or clear cell. Non-endometrioid endometrial cancers (NEECs; serous and clear cell) are the most clinically aggressive of the three major histotypes and are characterized by aneuploidy, a feature of chromosome instability. The genetic alterations that underlie chromosome instability in endometrial cancer are poorly understood. In the present study, we used Sanger sequencing to search for nucleotide variants in the coding exons and splice junctions of 21 candidate chromosome instability genes, including 19 genes implicated in sister chromatid cohesion, from 24 primary, microsatellite-stable NEECs. Somatic mutations were verified by sequencing matched normal DNAs. We subsequently resequenced mutated genes from 41 additional NEECs as well as 42 endometrioid ECs (EECs). We uncovered nonsynonymous somatic mutations in ESCO1, CHTF18, and MRE11A in, respectively, 3.7% (4 of 107), 1.9% (2 of 107), and 1.9% (2 of 107) of endometrial tumors. Overall, 7.7% (5 of 65) of NEECs and 2.4% (1 of 42) of EECs had somatically mutated one or more of the three genes. A subset of mutations are predicted to impact protein function. The co-occurrence of somatic mutations in ESCO1 and CHTF18 was statistically significant (P = 0.0011, two-tailed Fisher's exact test). This is the first report of somatic mutations within ESCO1 and CHTF18 in endometrial tumors and of MRE11A mutations in microsatellite-stable endometrial tumors. Our findings warrant future studies to determine whether these mutations are driver events that contribute to the pathogenesis of endometrial cancer.	[Price, Jessica C.; Pollock, Lana M.; Rudd, Meghan L.; Fogoros, Sarah K.; Mohamed, Hassan; Hanigan, Christin L.; Le Gallo, Matthieu; Bell, Daphne W.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.; NIH Intramural Sequencing Ctr NISC] NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Zhang, Suiyuan; Cruz, Pedro; Cherukuri, Praveen F.; Hansen, Nancy F.; Mullikin, James C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [McManus, Kirk J.] Univ Manitoba, Manitoba Inst Cell Biol, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Godwin, Andrew K.] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Merino, Maria J.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hieter, Philip] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Manitoba; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of British Columbia	Bell, DW (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	belldaph@mail.nih.gov	Cherukuri, Praveen/AFU-2005-2022; Le Gallo, Matthieu/F-7188-2012; McManus, Kirk J./AAE-3521-2020; Sgroi, Dennis/AAV-2487-2021; Le Gallo, Matthieu/T-4181-2019	Cherukuri, Praveen/0000-0002-9509-1245; Le Gallo, Matthieu/0000-0001-9085-8155; McManus, Kirk J./0000-0003-0081-8737; 	National Human Genome Research Institute at NIH; NIH [CA016519, RO1-1CA112021-01]; Canadian Institutes of Health Research (CIHR) [MOP-38096]; Manitoba Health Research Council (MHRC); CIHR/MHRC RPP New Investigator award; NCI SPORE in breast cancer at Massachusetts General Hospital; Avon Foundation;  [U01 CA113916];  [R01 CA140323]; NATIONAL CANCER INSTITUTE [R01CA140323, P01CA016519, ZIESC000853, R01CA158162, R01CA112021, U01CA113916] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200338, ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER	National Human Genome Research Institute at NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council (MHRC); CIHR/MHRC RPP New Investigator award; NCI SPORE in breast cancer at Massachusetts General Hospital; Avon Foundation; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded, in part, by the Intramural Research Program of the National Human Genome Research Institute at NIH (DWB, JCM); NIH grant CA016519 (PH); Canadian Institutes of Health Research (CIHR) grant MOP-38096 (PH); Manitoba Health Research Council (MHRC) grant (KJM); CIHR/MHRC RPP New Investigator award (KJM); U01 CA113916 and R01 CA140323 (AKG); NIH RO1-1CA112021-01 (DCS); the NCI SPORE in breast cancer at Massachusetts General Hospital (DCS); and the Avon Foundation (DCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIG 2013, P1, DOI DOI 10.1017/CB09781107415324.004; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bell DW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002245; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Berkowitz KM, 2008, MOL HUM REPROD, V14, P143, DOI 10.1093/molehr/gan005; Bhangale TR, 2006, NAT GENET, V38, P1457, DOI 10.1038/ng1925; Bilbao C, 2010, EUR J CANCER, V46, P2821, DOI 10.1016/j.ejca.2010.06.116; BURKS RT, 1994, ONCOGENE, V9, P1163; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chines P, 2005, AM J HUM GENET, V77, P1257; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; DUGGAN BD, 1994, J NATL CANCER I, V86, P1216, DOI 10.1093/jnci/86.16.1216; Esteller M, 1999, AM J PATHOL, V155, P1767, DOI 10.1016/S0002-9440(10)65492-2; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farina A, 2008, J BIOL CHEM, V283, P20925, DOI 10.1074/jbc.M802696200; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; KOBAYASHI K, 1995, GENE CHROMOSOME CANC, V14, P128, DOI 10.1002/gcc.2870140207; Konski AA, 1996, AM J CLIN ONCOL-CANC, V19, P164, DOI 10.1097/00000421-199604000-00015; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Maradeo ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015381; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Micci F, 2004, GENE CHROMOSOME CANC, V40, P229, DOI 10.1002/gcc.20038; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moreau S, 1999, MOL CELL BIOL, V19, P556; Murakami T, 2010, J BIOL CHEM, V285, P34608, DOI 10.1074/jbc.M110.166710; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; NEWBURY R, 1990, OBSTET GYNECOL, V76, P251; O'Hara Andrea J, 2012, Adv Genomics Genet, V2012, P33; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Park YB, 2011, STRUCTURE, V19, P1591, DOI 10.1016/j.str.2011.09.010; Parnas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005497; Pere H, 1998, CANCER RES, V58, P892; Pradhan M, 2006, MODERN PATHOL, V19, P1227, DOI 10.1038/modpathol.3800641; PRAT J, 1994, CANCER, V74, P1778, DOI 10.1002/1097-0142(19940915)74:6<1778::AID-CNCR2820740621>3.0.CO;2-5; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Ries LAG, 2007, NIH PUB, V07-6215; Rocquain J, 2010, AM J HEMATOL, V85, P717, DOI 10.1002/ajh.21798; ROSENBERG P, 1989, GYNECOL ONCOL, V35, P50, DOI 10.1016/0090-8258(89)90010-3; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Sherman ME, 2000, MODERN PATHOL, V13, P295, DOI 10.1038/modpathol.3880051; Shiomi Y, 2007, J BIOL CHEM, V282, P20906, DOI 10.1074/jbc.M610102200; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Williams GJ, 2011, NAT STRUCT MOL BIOL, V18, P423, DOI 10.1038/nsmb.2038; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhong H, 2005, HUM MOL GENET, V14, P2685, DOI 10.1093/hmg/ddi302	67	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e63313	10.1371/journal.pone.0063313	http://dx.doi.org/10.1371/journal.pone.0063313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755103	Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300008
J	Tanaka, M; Suzuki, HI; Shibahara, J; Kunita, A; Isagawa, T; Yoshimi, A; Kurokawa, M; Miyazono, K; Aburatani, H; Ishikawa, S; Fukayama, M				Tanaka, M.; Suzuki, H. I.; Shibahara, J.; Kunita, A.; Isagawa, T.; Yoshimi, A.; Kurokawa, M.; Miyazono, K.; Aburatani, H.; Ishikawa, S.; Fukayama, M.			EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis	ONCOGENE			English	Article						pancreatic cancer; PanIN; EVI1; KRAS; microRNA	DUCTAL ADENOCARCINOMA; EXPRESSION PROFILES; DOWN-REGULATION; RAS ACTIVITY; BETA; MODULATION; CLAUDIN-18; MUTATIONS; PROGNOSIS; NEOPLASMS	Despite frequent KRAS mutation, the early molecular mechanisms of pancreatic ductal adenocarcinoma (PDAC) development have not been fully elucidated. By tracking a potential regulator of another feature of PDAC precursors, acquisition of foregut or gastric epithelial gene signature, we herein report that aberrant overexpression of ecotropic viral integration site 1 (EVI1) oncoprotein, which is usually absent in normal pancreatic duct, is a widespread marker across the full spectrum of human PDAC precursors and PDAC. In pancreatic cancer cells, EVI1 depletion caused remarkable inhibition of cell growth and migration, indicating its oncogenic roles. Importantly, we found that EVI1 upregulated KRAS expression through suppression of a potent KRAS suppressor, miR-96, in pancreatic cancer cells. Collectively, the present findings suggest that EVI1 overexpression and KRAS mutation converge on activation of the KRAS pathway in early phases of pancreatic carcinogenesis and propose EVI1 and/or miR-96 as early markers and therapeutic targets in this dismal disease.	[Tanaka, M.; Shibahara, J.; Kunita, A.; Ishikawa, S.; Fukayama, M.] Univ Tokyo, Dept Pathol, Tokyo 1130033, Japan; [Suzuki, H. I.; Miyazono, K.] Univ Tokyo, Dept Mol Pathol, Tokyo 1130033, Japan; [Isagawa, T.] Univ Tokyo, Dept Cardiovasc Med, Tokyo 1130033, Japan; [Yoshimi, A.; Kurokawa, M.] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1130033, Japan; [Aburatani, H.] Univ Tokyo, RCAST, Genome Sci Div, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Fukayama, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mfukayama-tky@umin.ac.jp	Yoshimi, Akihide/I-3792-2019	Yoshimi, Akihide/0000-0002-0664-7281; Suzuki, Hiroshi/0000-0003-4682-5086	Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Cell Science Research Foundation; Grants-in-Aid for Scientific Research [26860474] Funding Source: KAKEN	Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all members of the Department of Pathology, University of Tokyo. This work was supported by the Industrial Technology Research Grant Program (2008) from the New Energy and Industrial Technology Development Organization (NEDO) of Japan (SI), the Grant-in-Aid for Scientific Research on Innovative Areas (SI),<SUP>46</SUP> the Grant-in-Aid for Young Scientists (A),<SUP>46</SUP> the GCOE Program for 'Integrative Life Science Based on the Study of Biosignaling Mechanisms' (HIS, KM), and for 'Chemical Biology of the Diseases' (MF and MK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Cell Science Research Foundation (HIS, KM).	Bosman FT, 2010, WHO CLASSIFICATION T, P279; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; De Weer A, 2011, BRIT J HAEMATOL, V154, P337, DOI 10.1111/j.1365-2141.2011.08737.x; Dickstein J, 2010, P NATL ACAD SCI USA, V107, P9783, DOI 10.1073/pnas.1004297107; Gao JS, 2011, FEBS LETT, V585, P693, DOI 10.1016/j.febslet.2011.01.033; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Gomez-Benito M, 2010, BRIT J CANCER, V103, P1292, DOI 10.1038/sj.bjc.6605874; Goyama S, 2009, CANCER SCI, V100, P990, DOI 10.1111/j.1349-7006.2009.01152.x; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; HRUBAN RH, 2007, AFIP ATLAS TUMOR PAT, P51; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Jimenez RE, 1999, ANN SURG, V230, P501, DOI 10.1097/00000658-199910000-00006; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kim GE, 2002, GASTROENTEROLOGY, V123, P1052, DOI 10.1053/gast.2002.36018; Kitago M, 2004, INT J CANCER, V110, P177, DOI 10.1002/ijc.20084; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Kwei KA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000081; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Logsdon CD, 2009, CLIN GASTROENTEROL H, V7, pS40, DOI 10.1016/j.cgh.2009.07.040; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Sentani K, 2008, AM J SURG PATHOL, V32, P1182, DOI 10.1097/PAS.0b013e318163a8f8; Senyuk V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020793; Shin KH, 2011, BIOCHEM BIOPH RES CO, V404, P896, DOI 10.1016/j.bbrc.2010.12.055; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Suzuki HI, 2011, J BIOCHEM, V149, P15, DOI 10.1093/jb/mvq113; Suzuki HI, 2010, J MOL MED, V88, P1085, DOI 10.1007/s00109-010-0650-1; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tanaka M, 2011, J HISTOCHEM CYTOCHEM, V59, P942, DOI 10.1369/0022155411420569; Vazquez I, 2011, HAEMATOL-HEMATOL J, V96, P1448, DOI 10.3324/haematol.2011.040535; Yonezawa S, 2010, J HEPATO-BIL-PAN SCI, V17, P108, DOI 10.1007/s00534-009-0174-7; Yoshimi A, 2011, ONCOTARGET, V2, P575, DOI 10.18632/oncotarget.304; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531	46	46	46	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2454	2463		10.1038/onc.2013.204	http://dx.doi.org/10.1038/onc.2013.204			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23752186				2022-12-25	WOS:000336033600005
J	Zaffagnini, M; Morisse, S; Bedhomme, M; Marchand, CH; Festa, M; Rouhier, N; Lemaire, SD; Trost, P				Zaffagnini, Mirko; Morisse, Samuel; Bedhomme, Mariette; Marchand, Christophe H.; Festa, Margherita; Rouhier, Nicolas; Lemaire, Stephane D.; Trost, Paolo			Mechanisms of Nitrosylation and Denitrosylation of Cytoplasmic Glyceraldehyde-3-phosphate Dehydrogenase from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN S-NITROSYLATION; NITRIC-OXIDE; THIOREDOXIN REDUCTASE; PROTEOMIC ANALYSIS; GLUTAREDOXIN S12; CELL-DEATH; NITROSATION; GLUTATHIONYLATION; NITROSOTHIOLS; GAPDH	Nitrosylation is a reversible post-translational modification of protein cysteines playing a major role in cellular regulation and signaling in many organisms, including plants where it has been implicated in the regulation of immunity and cell death. The extent of nitrosylation of a given cysteine residue is governed by the equilibrium between nitrosylation and denitrosylation reactions. The mechanisms of these reactions remain poorly studied in plants. In this study, we have employed glycolytic GAPDH from Arabidopsis thaliana as a tool to investigate the molecular mechanisms of nitrosylation and denitrosylation using a combination of approaches, including activity assays, the biotin switch technique, site-directed mutagenesis, and mass spectrometry. Arabidopsis GAPDH activity was reversibly inhibited by nitrosylation of catalytic Cys-149 mediated either chemically with a strong NO donor or by trans-nitrosylation with GSNO. GSNO was found to trigger both GAPDH nitrosylation and glutathionylation, although nitrosylation was widely prominent. Arabidopsis GAPDH was found to be denitrosylated by GSH but not by plant cytoplasmic thioredoxins. GSH fully converted nitrosylated GAPDH to the reduced, active enzyme, without forming any glutathionylated GAPDH. Thus, we found that nitrosylation of GAPDH is not a step toward formation of the more stable glutathionylated enzyme. GSH-dependent denitrosylation of GAPC1 was found to be linked to the [GSH]/[GSNO] ratio and to be independent of the [GSH]/[GSSG] ratio. The possible importance of these biochemical properties for the regulation of Arabidopsis GAPDH functions in vivo is discussed.	[Zaffagnini, Mirko; Festa, Margherita; Trost, Paolo] Univ Bologna, Dept Pharm & Biotechnol, Lab Plant Redox Biol, I-40126 Bologna, Italy; [Zaffagnini, Mirko; Morisse, Samuel; Bedhomme, Mariette; Marchand, Christophe H.; Lemaire, Stephane D.] Univ Paris 06, Lab Biol Mol & Cellulaire Eucaryotes, CNRS FRE3354, Inst Biol Physicochim, F-75005 Paris, France; [Rouhier, Nicolas] Univ Lorraine, Inst Natl Rech Agronom, IFR 110, Interact Arbres Microorganismes UMR1136, F-54506 Vandoeuvre Les Nancy, France	University of Bologna; UDICE-French Research Universities; Sorbonne Universite; INRAE; Universite de Lorraine	Lemaire, SD (corresponding author), Univ Paris 06, Lab Biol Mol & Cellulaire Eucaryotes, CNRS FRE3354, Inst Biol Physicochim, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	stephane.lemaire@ibpc.fr; paolo.trost@unibo.it	Lemaire, Stéphane D/A-3530-2008; MARCHAND, Christophe H/B-5854-2008; Festa, Margherita/AAE-4539-2019	Lemaire, Stéphane D/0000-0001-6442-0547; MARCHAND, Christophe H/0000-0002-0729-3841; Festa, Margherita/0000-0003-4990-7554; Trost, Paolo/0000-0002-6347-8701; Zaffagnini, Mirko/0000-0001-5115-0859; Rouhier, Nicolas/0000-0002-2036-7884	PRIN; ANR [12-BSV5-0019 REDPRO2]; Ville de Paris; LABEX DYNAMO [ANR-11-0011]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); ANR(French National Research Agency (ANR)); Ville de Paris; LABEX DYNAMO	This work was supported in part by Grants PRIN 2008 (to P. T.) and PRIN 2009 (to M. Z.), ANR Grant 12-BSV5-0019 REDPRO2 (to C. H. M. and S. D. L.), a "Research in Paris" fellowship from Ville de Paris (to M. Z.), and by LABEX DYNAMO ANR-11-0011.	Abat JK, 2008, FEBS J, V275, P2862, DOI 10.1111/j.1742-4658.2008.06425.x; Airaki M, 2011, PLANT CELL PHYSIOL, V52, P2006, DOI 10.1093/pcp/pcr133; Akhtar Mohd Waseem, 2012, Int J Cell Biol, V2012, P463756, DOI 10.1155/2012/463756; Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Anderson LE, 2004, PROTOPLASMA, V223, P33, DOI 10.1007/s00709-003-0030-6; Astier J, 2012, BIOCHEM J, V447, P249, DOI 10.1042/BJ20120257; Astier J, 2011, PLANT SCI, V181, P527, DOI 10.1016/j.plantsci.2011.02.011; Bedhomme M, 2012, BIOCHEM J, V445, P337, DOI 10.1042/BJ20120505; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2010, BIOCHEMISTRY-US, V49, P6963, DOI 10.1021/bi100619k; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; BIESECKER G, 1977, NATURE, V266, P328, DOI 10.1038/266328a0; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; Castello PR, 2008, P NATL ACAD SCI USA, V105, P8203, DOI 10.1073/pnas.0709461105; Chakravarti R, 2012, J BIOL CHEM, V287, P16179, DOI 10.1074/jbc.M112.342758; Coles SJ, 2009, BIOCHEMISTRY-US, V48, P645, DOI 10.1021/bi801805h; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Dietz KJ, 2008, PHYSIOL PLANTARUM, V133, P459, DOI 10.1111/j.1399-3054.2008.01120.x; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Fermani S, 2007, P NATL ACAD SCI USA, V104, P11109, DOI 10.1073/pnas.0611636104; Fermani S, 2012, J BIOL CHEM, V287, P21372, DOI 10.1074/jbc.M112.350355; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gao XH, 2010, FEBS LETT, V584, P2242, DOI 10.1016/j.febslet.2010.04.034; Gelhaye E, 2003, FEBS LETT, V555, P443, DOI 10.1016/S0014-5793(03)01301-2; Gelhaye E, 2002, PHYSIOL PLANTARUM, V114, P165, DOI 10.1034/j.1399-3054.2002.1140202.x; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; Giustarini D, 2009, CRIT REV CL LAB SCI, V46, P241, DOI 10.3109/10408360903142326; Goyer A, 1999, FEBS LETT, V444, P165, DOI 10.1016/S0014-5793(99)00051-4; Hancock JT, 2009, MOL BIOTECHNOL, V43, P162, DOI 10.1007/s12033-009-9189-1; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hogg N, 2002, ANNU REV PHARMACOL, V42, P585, DOI 10.1146/annurev.pharmtox.42.092501.104328; Holtgrefe S, 2008, PHYSIOL PLANTARUM, V133, P211, DOI 10.1111/j.1399-3054.2008.01066.x; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kaneko R, 2003, J MASS SPECTROM, V38, P526, DOI 10.1002/jms.466; Konorev EA, 2000, FREE RADICAL BIO MED, V28, P1671, DOI 10.1016/S0891-5849(00)00281-1; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Lindermayr C, 2009, J PROTEOMICS, V73, P1, DOI 10.1016/j.jprot.2009.07.002; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Mazzola JL, 2003, J NEUROSCI RES, V71, P279, DOI 10.1002/jnr.10484; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Mitchell DA, 2007, P NATL ACAD SCI USA, V104, P11609, DOI 10.1073/pnas.0704898104; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Moreau M, 2010, PHYSIOL PLANTARUM, V138, P372, DOI 10.1111/j.1399-3054.2009.01308.x; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Qu J, 2011, P NATL ACAD SCI USA, V108, P14330, DOI 10.1073/pnas.1105172108; Romero JM, 2009, J NEUROSCI RES, V87, P701, DOI 10.1002/jnr.21897; Romero-Puertas MC, 2008, PROTEOMICS, V8, P1459, DOI 10.1002/pmic.200700536; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sengupta R, 2013, ANTIOXID REDOX SIGN, V18, P259, DOI 10.1089/ars.2012.4716; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; Sicard-Roselli C, 2004, EUR J BIOCHEM, V271, P3481, DOI 10.1111/j.1432-1033.2004.04279.x; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Sliskovic I, 2005, J BIOL CHEM, V280, P8733, DOI 10.1074/jbc.M408080200; Spadaro D, 2010, PHYSIOL PLANTARUM, V138, P360, DOI 10.1111/j.1399-3054.2009.01307.x; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; Starke DW, 1997, FREE RADICAL BIO MED, V23, P373, DOI 10.1016/S0891-5849(97)00009-9; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Talfournier F, 1998, EUR J BIOCHEM, V252, P447, DOI 10.1046/j.1432-1327.1998.2520447.x; Tanou G, 2012, PLANT J, V72, P585, DOI 10.1111/j.1365-313X.2012.05100.x; Tanou G, 2009, PLANT J, V60, P795, DOI 10.1111/j.1365-313X.2009.04000.x; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Vescovi M, 2013, PLANT PHYSIOL, V162, P333, DOI 10.1104/pp.113.215194; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang XW, 1999, ARCH BIOCHEM BIOPHYS, V367, P348, DOI 10.1006/abbi.1999.1261; Wang YQ, 2009, J BIOL CHEM, V284, P2131, DOI 10.1074/jbc.M806782200; Wawer I, 2010, BIOCHEM J, V429, P73, DOI 10.1042/BJ20100492; Wu CG, 2011, J PROTEOMICS, V74, P2498, DOI 10.1016/j.jprot.2011.06.001; Wu C, 2010, MOL CELL PROTEOMICS, V9, P2262, DOI 10.1074/mcp.M110.000034; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Yu MD, 2012, CURR OPIN PLANT BIOL, V15, P424, DOI 10.1016/j.pbi.2012.03.005; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x; Zaffagnini M, 2012, ANTIOXID REDOX SIGN, V16, P17, DOI 10.1089/ars.2011.3933	94	83	84	2	40	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22777	22789		10.1074/jbc.M113.475467	http://dx.doi.org/10.1074/jbc.M113.475467			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23749990	Green Published, hybrid			2022-12-25	WOS:000330596300055
J	Antinone, SE; Ghadge, GD; Lam, TT; Wang, LJ; Roos, RP; Green, WN				Antinone, Sarah E.; Ghadge, Ghanashyam D.; Lam, Tukiet T.; Wang, Lijun; Roos, Raymond P.; Green, William N.			Palmitoylation of Superoxide Dismutase 1 (SOD1) Is Increased for Familial Amyotrophic Lateral Sclerosis-linked SOD1 Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig Disease); Neurodegenerative Diseases; Post-translational Modification; Protein Palmitoylation; Superoxide Dismutase (SOD)	WILD-TYPE SOD1; UNFOLDED PROTEIN RESPONSE; MOTOR-NEURONS; SPINAL-CORD; ER STRESS; CU,ZN-SUPEROXIDE DISMUTASE; MAMMALIAN-CELLS; TRANSGENIC MICE; DISULFIDE BOND; FREE CYSTEINES	Mutations in Cu,Zn-superoxide dismutase (mtSOD1) cause familial amyotrophic lateral sclerosis (FALS), a neurodegenerative disease resulting from motor neuron degeneration. Here, we demonstrate that wild type SOD1 (wtSOD1) undergoes palmitoylation, a reversible post-translational modification that can regulate protein structure, function, and localization. SOD1 palmitoylation was confirmed by multiple techniques, including acyl-biotin exchange, click chemistry, cysteine mutagenesis, and mass spectrometry. Mass spectrometry and cysteine mutagenesis demonstrated that cysteine residue 6 was the primary site of palmitoylation. The palmitoylation of FALS-linked mtSOD1s (A4V and G93A) was significantly increased relative to that of wtSOD1 expressed in HEK cells and a motor neuron cell line. The palmitoylation of FALS-linked mtSOD1s (G93A and G85R) was also increased relative to that of wtSOD1 when assayed from transgenic mouse spinal cords. We found that the level of SOD1 palmitoylation correlated with the level of membrane-associated SOD1, suggesting a role for palmitoylation in targeting SOD1 to membranes. We further observed that palmitoylation occurred predominantly on disulfide-reduced as opposed to disulfide-bonded SOD1, suggesting that immature SOD1 is the primarily palmitoylated species. Increases in SOD1 disulfide bonding and maturation with increased copper chaperone for SOD1 expression caused a decrease in wtSOD1 palmitoylation. Copper chaperone for SOD1 overexpression decreased A4V palmitoylation less than wtSOD1 and had little effect on G93A mtSOD1 palmitoylation. These findings suggest that SOD1 palmitoylation occurs prior to disulfide bonding during SOD1 maturation and that palmitoylation is increased when disulfide bonding is delayed or decreased as observed for several mtSOD1s.	[Antinone, Sarah E.; Green, William N.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Ghadge, Ghanashyam D.; Wang, Lijun; Roos, Raymond P.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Lam, Tukiet T.] Yale Univ, WM Keck Biotechnol Resource Lab, New Haven, CT 06511 USA	University of Chicago; University of Chicago; Yale University	Roos, RP (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	rroos@neurology.bsd.uchicago.edu; wgreen@bsd.uchicago.edu			National Institutes of Health [NS043782, DA019695, MH081251, F32NS077609]; Yale University/NIDA Neuroproteomics Center [P30DA018343]; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH081251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077609, R56NS043782, R01NS043782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035430, P30DA018343, P01DA019695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University/NIDA Neuroproteomics Center; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS043782, DA019695, and MH081251 and by the Yale University/NIDA Neuroproteomics Center Grant P30DA018343 (to W. N. G.).; Supported by National Institutes of Health Grant F32NS077609 and by the Epilepsy Foundation.	ABERNETHY JL, 1974, J BIOL CHEM, V249, P7339; Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/NCHEMBIO.1202, 10.1038/nchembio.1202]; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Bianchetta MJ, 2011, J NEUROSCI, V31, P12029, DOI 10.1523/JNEUROSCI.2388-11.2011; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brotherton T, 2011, AMYOTROPH LATERAL SC, V12, P215, DOI 10.3109/17482968.2010.531279; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruns CK, 2007, EMBO J, V26, P855, DOI 10.1038/sj.emboj.7601528; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Cozzolino M, 2012, PROG NEUROBIOL, V97, P54, DOI 10.1016/j.pneurobio.2011.06.003; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Fujisawa T, 2012, ANN NEUROL, V72, P739, DOI 10.1002/ana.23668; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Ghadge GD, 2006, NEUROBIOL DIS, V21, P194, DOI 10.1016/j.nbd.2005.07.006; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kawamata H, 2008, HUM MOL GENET, V17, P3303, DOI 10.1093/hmg/ddn226; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; Li QA, 2010, P NATL ACAD SCI USA, V107, P21146, DOI 10.1073/pnas.1014862107; Magrane J, 2012, J NEUROSCI, V32, P229, DOI 10.1523/JNEUROSCI.1233-11.2012; Marin EP, 2012, CIRC RES, V110, P1336, DOI 10.1161/CIRCRESAHA.112.269514; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Morita M, 1996, NEUROSCI LETT, V205, P79, DOI 10.1016/0304-3940(96)12378-8; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Prudencio M, 2012, J NEUROCHEM, V121, P475, DOI 10.1111/j.1471-4159.2012.07690.x; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X; Urushitani M, 2008, FASEB J, V22, P2476, DOI 10.1096/fj.07-092783; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang LJ, 2011, HUM MOL GENET, V20, P1008, DOI 10.1093/hmg/ddq546; Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Watanabe S, 2007, FREE RADICAL BIO MED, V42, P1534, DOI 10.1016/j.freeradbiomed.2007.02.004; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	74	30	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21606	21617		10.1074/jbc.M113.487231	http://dx.doi.org/10.1074/jbc.M113.487231			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760509	hybrid, Green Published			2022-12-25	WOS:000328841900013
J	Wang, C; Chang, JYF; Yang, CF; Huang, YQ; Liu, JC; You, P; McKeehan, WL; Wang, F; Li, XK				Wang, Cong; Chang, Julia Yu Fong; Yang, Chaofeng; Huang, Yanqing; Liu, Junchen; You, Pan; McKeehan, Wallace L.; Wang, Fen; Li, Xiaokun			Type 1 Fibroblast Growth Factor Receptor in Cranial Neural Crest Cell-derived Mesenchyme Is Required for Palatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Craniofacial Development; Fibroblast Growth Factor (FGF); Fibroblast Growth Factor Receptor (FGFR); Transgenic Mice; Tyrosinase	ABNORMAL TONGUE DEVELOPMENT; CAUSES CLEFT-PALATE; CRANIOFACIAL DEVELOPMENT; HYPOGONADOTROPIC HYPOGONADISM; MOUSE EMBRYOS; MUTANT MICE; LIP; FGFR1; FUSION; TRANSFORMATION	Cleft palate is a common congenital birth defect. The fibroblast growth factor (FGF) family has been shown to be important for palatogenesis, which elicits the regulatory functions by activating the FGF receptor tyrosine kinase. Mutations in Fgf or Fgfr are associated with cleft palate. To date, most mechanistic studies on FGF signaling in palate development have focused on FGFR2 in the epithelium. Although Fgfr1 is expressed in the cranial neural crest (CNC)-derived palate mesenchyme and Fgfr1 mutations are associated with palate defects, how FGFR1 in palate mesenchyme regulates palatogenesis is not well understood. Here, we reported that by using Wnt1(Cre) to delete Fgfr1 in neural crest cells led to cleft palate, cleft lip, and other severe craniofacial defects. Detailed analyses revealed that loss-of-function mutations in Fgfr1 did not abrogate patterning of CNC cells in palate shelves. However, it upset cell signaling in the frontofacial areas, delayed cell proliferation in both epithelial and mesenchymal compartments, prevented palate shelf elevation, and compromised palate shelf fusion. This is the first report revealing how FGF signaling in CNC cells regulates palatogenesis.	[Wang, Cong; Li, Xiaokun] Wenzhou Med Coll, Coll Pharm, Wenzhou 325000, Zhejiang, Peoples R China; [Wang, Cong; Chang, Julia Yu Fong; Yang, Chaofeng; Huang, Yanqing; Liu, Junchen; You, Pan; McKeehan, Wallace L.; Wang, Fen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA	Wenzhou Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wang, F (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA.	fwang@ibt.tamhsc.edu; xiaokunli@163.net		CHANG, JULIA YU-FONG/0000-0002-3880-3787; Liu, Junchen/0000-0003-2765-9780	National Institutes of Health [K08DE020883]; USPHS [CA96824, CA140388]; Natural Science Foundation of Zhejiang Province of China [Y2110492]; J. S. Dunn Research Foundation; Cancer Prevention and Research Institution of Texas [CPRIT110555]; National Natural Science Foundation of China [81101712, 81270761]; NATIONAL CANCER INSTITUTE [R56CA096824, R01CA096824, P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE020883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); J. S. Dunn Research Foundation; Cancer Prevention and Research Institution of Texas; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant K08DE020883 (to J. Y. C.) and Grants CA96824 and CA140388 from USPHS (to F. W.). This work was also supported by the Natural Science Foundation of Zhejiang Province of China Grant Y2110492 (to C. W.), the J. S. Dunn Research Foundation (to W. L. M.), and Grant CPRIT110555 from the Cancer Prevention and Research Institution of Texas (to F. W. and W. L. M.), and the National Natural Science Foundation of China Grants 81101712 and 81270761 (to X. L.).	Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Barrow JR, 1999, DEVELOPMENT, V126, P5011; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; Chai Y, 1998, INT J DEV BIOL, V42, P87; Charoenchaikorn K, 2009, DEV BIOL, V326, P392, DOI 10.1016/j.ydbio.2008.10.018; Cobourne MT, 2009, DEV BIOL, V331, P38, DOI 10.1016/j.ydbio.2009.04.021; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; He FL, 2011, DEV BIOL, V350, P511, DOI 10.1016/j.ydbio.2010.12.021; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; Hosokawa R, 2009, J EXP ZOOL PART B, V312B, P343, DOI 10.1002/jez.b.21274; Huang X, 2008, DEV DYNAM, V237, P3079, DOI 10.1002/dvdy.21714; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; Jin YR, 2012, DEVELOPMENT, V139, P1821, DOI 10.1242/dev.075796; Kaartinen V, 1997, DEV DYNAM, V209, P255, DOI 10.1002/(SICI)1097-0177(199707)209:3<255::AID-AJA1>3.0.CO;2-H; Kanda T, 2003, ARCH ORAL BIOL, V48, P213, DOI 10.1016/S0003-9969(02)00204-2; KHRAPUNOV SM, 1975, UKR BIOKHIM ZH+, V47, P284; Kim HG, 2005, J MED GENET, V42, P666, DOI 10.1136/jmg.2004.026989; Lee JM, 2008, DEV BIOL, V314, P341, DOI 10.1016/j.ydbio.2007.11.033; Lee S, 2001, PLAST RECONSTR SURG, V107, P1776, DOI 10.1097/00006534-200106000-00021; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Martinez-Abadias N, 2013, DIS MODEL MECH, V6, P768, DOI 10.1242/dmm.010397; Matsumura K, 2011, BIOCHEM BIOPH RES CO, V404, P1076, DOI 10.1016/j.bbrc.2010.12.116; MCKEEHAN WL, 2009, HDB CELL SIGNALING, P253; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Minowada G, 1999, DEVELOPMENT, V126, P4465; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nie XG, 2006, ORAL DIS, V12, P102, DOI 10.1111/j.1601-0825.2005.01176.x; Pitteloud N, 2006, P NATL ACAD SCI USA, V103, P6281, DOI 10.1073/pnas.0600962103; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Ricks JE, 2002, TERATOLOGY, V65, P116, DOI 10.1002/tera.10022; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Sato N, 2004, J CLIN ENDOCR METAB, V89, P1079, DOI 10.1210/jc.2003-030476; Shimabukuro Y, 2008, MATRIX BIOL, V27, P232, DOI 10.1016/j.matbio.2007.10.005; SHIOTA K, 1990, ACTA ANAT, V137, P59; SHULER CF, 1995, CRIT REV ORAL BIOL M, V6, P202, DOI 10.1177/10454411950060030301; Snyder-Warwick AK, 2012, J CRANIOFAC SURG, V23, P397, DOI 10.1097/SCS.0b013e318240fed7; Snyder-Warwick AK, 2010, P NATL ACAD SCI USA, V107, P2515, DOI 10.1073/pnas.0913985107; Song ZC, 2013, J BIOL CHEM, V288, P10440, DOI 10.1074/jbc.M112.432286; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takamori K, 2008, J DENT RES, V87, P238, DOI 10.1177/154405910808700307; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397; Trokovic N, 2003, GENE DEV, V17, P141, DOI 10.1101/gad.250703; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; Welsh IC, 2007, MECH DEVELOP, V124, P746, DOI 10.1016/j.mod.2007.06.007; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	51	48	50	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22174	22183		10.1074/jbc.M113.463620	http://dx.doi.org/10.1074/jbc.M113.463620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23754280	Green Published, hybrid			2022-12-25	WOS:000328841900060
J	Chen, SQ; Huang, ZF; Dai, Y; Qin, SW; Gao, YY; Zhang, LL; Gao, Y; Chen, JM				Chen, Shiqiang; Huang, Zefeng; Dai, Yi; Qin, Shuwen; Gao, Yingying; Zhang, Lulu; Gao, Yong; Chen, Jianmin			The Development of 7E Chromosome-Specific Molecular Markers for Thinopyrum elongatum Based on SLAF-seq Technology	PLOS ONE			English	Article							FUSARIUM HEAD BLIGHT; CYTOGENETIC CHARACTERIZATION; LEAF RUST; RESISTANCE; WHEAT; ADDITIONS; LINES; LR19	Thinopyrum elongatum is an important relative of wheat, it is favored by many researchers for the disease resistant genes that exist in its E genome. Some studies have showed that the 7E chromosome of Th. elongatum contains resistance genes related to Fusarium head blight and wheat rust. Therefore, developing 7E chromosome-specific molecular markers linked to resistance genes will provide an important tool for exploring and using the resistant genes of Th. elongatum. In addition, it would greatly contribute in the effort to cultivate disease-resistant wheat varieties. Featured in high throughput, high-accuracy and low-cost, SLAF-seq technology has been widely used in molecular breeding, system evolution, and germplasm resource detection. Based on SLAF-seq, 518 specific fragments on the 7E chromosome of Th. elongatum were successfully amplified. A total of 135 primers were designed according to 135 randomly selected fragments, and 89 specific molecular markers of Th. elongatum were developed, with efficiencies up to 65.9%. These markers were all detected in a variety of materials, and they are all proved to be specific and stable. These markers can be used not only for detecting the 7E chromosome of Th. elongatum but also for providing an important theoretical and practical basis for wheat breeding by marker-assisted selection (MAS). This paper reports the first application of SLAF-seq technology with a high success rate in developing specific molecular markers for Th. elongatum, providing a strong case for the application of this new technology.	[Chen, Shiqiang; Huang, Zefeng; Dai, Yi; Qin, Shuwen; Gao, Yingying; Zhang, Lulu; Gao, Yong; Chen, Jianmin] Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Peoples R China	Yangzhou University	Chen, JM (corresponding author), Yangzhou Univ, Coll Biosci & Biotechnol, Yangzhou, Peoples R China.	jmchen@yzu.edu.cn			National Natural Science Foundation of China [31071406]; Specialized Research Fund for the Doctoral Program of Higher Education [20123250110010]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the National Natural Science Foundation of China (31071406), Specialized Research Fund for the Doctoral Program of Higher Education (20123250110010) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GuoYue, 2007, Acta Agronomica Sinica, V33, P1782; Chen ShiQiang, 2012, Journal of Triticeae Crops, V32, P839; Cuthbert PA, 2007, THEOR APPL GENET, V114, P429, DOI 10.1007/s00122-006-0439-3; Du JunKai, 2010, Journal of Triticeae Crops, V30, P829; DVORAK J, 1974, CAN J GENET CYTOL, V16, P627; DVORAK J, 1974, CAN J GENET CYTOL, V16, P399, DOI 10.1139/g74-043; Fu SL, 2012, J GENET GENOMICS, V39, P103, DOI 10.1016/j.jgg.2011.11.008; Garg M, 2009, J CEREAL SCI, V50, P358, DOI 10.1016/j.jcs.2009.06.012; Ge JiangYan, 2012, Acta Agronomica Sinica, V38, P1818; Gennaro A, 2009, FUNCT INTEGR GENOMIC, V9, P325, DOI 10.1007/s10142-009-0115-1; Jauhar PP, 2009, GENOME, V52, P467, DOI [10.1139/G09-014, 10.1139/g09-014]; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lammer D, 2004, J EXP BOT, V55, P1715, DOI 10.1093/jxb/erh209; Li Na, 2005, Acta Genetica Sinica, V32, P571; Li XM, 2007, GENOME, V50, P400, DOI 10.1139/G07-025; Li ZS, 1977, ACTA GENETIC SINICA, V4, P279; Liu Shu-Bing, 1999, Acta Genetica Sinica, V26, P37; Liu ShuBing, 1998, Acta Agronomica Sinica, V24, P687; Ma J.X., 1999, CHINESE SCI BULL, V44, P65, DOI [10.1007/BF02885488, DOI 10.1007/BF02885488]; Mao PS, 2010, AGR SCI CHINA, V9, P1553, DOI 10.1016/S1671-2927(09)60251-0; McDonald MP, 2001, ANN BOT-LONDON, V88, P215, DOI 10.1006/anbo.2001.1444; Oliver RE, 2006, THEOR APPL GENET, V112, P1473, DOI 10.1007/s00122-006-0250-1; Prabhu KV, 2004, PLANT BREEDING, V123, P417, DOI 10.1111/j.1439-0523.2004.00971.x; Prins R, 2001, THEOR APPL GENET, V103, P618, DOI 10.1007/PL00002918; Qi LL, 2008, THEOR APPL GENET, V117, P1155, DOI 10.1007/s00122-008-0853-9; SEARS ER, 1993, CROP SCI, V33, P897, DOI 10.2135/cropsci1993.0011183X003300050004x; Shen X, 2006, PLANT BREEDING, V125, P424, DOI 10.1111/j.1439-0523.2006.01274.x; Shen XR, 2007, MOL BREEDING, V20, P131, DOI 10.1007/s11032-007-9079-9; Wang JR, 2010, CAN J PLANT PATHOL, V32, P188, DOI 10.1080/07060661003740512; Wang Jing-xue, 2000, J SHANXI U, V23, P271; Yan HongFei, 2009, Acta Phytopathologica Sinica, V39, P76; [闫小丹 Yan Xiaodan], 2010, [生物技术通报, Biotechnology Bulletin], P18; You MingShan, 2003, Journal of Agricultural Biotechnology, V11, P577; You MingShan, 2002, Journal of China Agricultural University, V7, P1; Zhang Li, 2008, Journal of Agricultural Biotechnology, V16, P465; Zhang XL, 2011, THEOR APPL GENET, V122, P263, DOI 10.1007/s00122-010-1441-3	36	79	94	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65122	10.1371/journal.pone.0065122	http://dx.doi.org/10.1371/journal.pone.0065122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762296	Green Published, Green Submitted, gold			2022-12-25	WOS:000320440500027
J	Egan, CE; Daugherity, EK; Rogers, AB; Abdallah, DSA; Denkers, EY; Maurer, KJ				Egan, Charlotte E.; Daugherity, Erin K.; Rogers, Arlin B.; Abdallah, Delbert S. Abi; Denkers, Eric Y.; Maurer, Kirk J.			CCR2 and CD44 Promote Inflammatory Cell Recruitment during Fatty Liver Formation in a Lithogenic Diet Fed Mouse Model	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; TNF-ALPHA; CYTOKINE INDUCTION; HYALURONAN-BINDING; INSULIN-RESISTANCE; MONOCYTE CD44; MICE; EXPRESSION; DISEASE	Non-alcoholic fatty liver disease (NAFLD) is a common disease with a spectrum of presentations. The current study utilized a lithogenic diet model of NAFLD. The diet was fed to mice that are either resistant (AKR) or susceptible (BALB/c and C57BL/6) to hepatitis followed by molecular and flow cytometric analysis. Following this, a similar approach was taken in congenic mice with specific mutations in immunological genes. The initial study identified a significant and profound increase in multiple ligands for the chemokine receptor CCR2 and an increase in CD44 expression in susceptible C57BL/6 (B6) but not resistant AKR mice. Ccr2(-/-) mice were completely protected from hepatitis and Cd44(-/-) mice were partially protected. Despite protection from inflammation, both strains displayed similar histological steatosis scores and significant increases in serum liver enzymes. CD45(+)CD44(+) cells bound to hyaluronic acid (HA) in diet fed B6 mice but not Cd44(-/-) or Ccr2(-/-) mice. Ccr2(-/-) mice displayed a diminished HA binding phenotype most notably in monocytes, and CD8(+) T-cells. In conclusion, this study demonstrates that absence of CCR2 completely and CD44 partially reduces hepatic leukocyte recruitment. These data also provide evidence that there are multiple redundant CCR2 ligands produced during hepatic lipid accumulation and describes the induction of a strong HA binding phenotype in response to LD feeding in some subsets of leukocytes from susceptible strains.	[Egan, Charlotte E.; Abdallah, Delbert S. Abi; Denkers, Eric Y.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Daugherity, Erin K.; Maurer, Kirk J.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Daugherity, Erin K.; Maurer, Kirk J.] Cornell Univ, Coll Vet Med, Ctr Anim Resources & Educ, Ithaca, NY 14853 USA; [Rogers, Arlin B.] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA; [Rogers, Arlin B.] Univ N Carolina, Lab Med, Chapel Hill, NC USA	Cornell University; Cornell University; Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Maurer, KJ (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	Kirk.J.Maurer@Dartmouth.edu	denkers, eric/Q-3173-2019; Egan, Charlotte/F-4468-2012	Egan, Charlotte/0000-0003-3238-4574	National Institutes of Heath [DK077728, AI083526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK077728] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Heath grants DK077728 and AI083526. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarapurkar Deepak N, 2004, Trop Gastroenterol, V25, P130; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Charatcharoenwitthaya P, 2012, DIGEST DIS SCI, V57, P1925, DOI 10.1007/s10620-012-2098-3; Daugherity EK, 2012, CELL CYCLE, V11, P1918, DOI 10.4161/cc.20259; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Egan CE, 2011, MUCOSAL IMMUNOL, V4, P658, DOI 10.1038/mi.2011.31; Egan CE, 2009, MUCOSAL IMMUNOL, V2, P527, DOI 10.1038/mi.2009.105; Egan C.E., 2011, IMMUNOL CELL BIOL; Gee K, 2004, ARCH IMMUNOL THER EX, V52, P13; Gee K, 2002, J IMMUNOL, V169, P5660, DOI 10.4049/jimmunol.169.10.5660; Harmon RC, 2011, EXPERT REV GASTROENT, V5, P189, DOI [10.1586/egh.11.21, 10.1586/EGH.11.21]; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Ibrahim J, 2012, GASTROENTEROLOGY, V143, P1061, DOI 10.1053/j.gastro.2012.06.003; Kamada Y, 2011, AM J PHYSIOL-GASTR L, V301, pG1031, DOI 10.1152/ajpgi.00211.2011; Kang HH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058417, 10.1371/journal.pone.0084097]; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kassel KM, 2010, LAB INVEST, V90, P1794, DOI 10.1038/labinvest.2010.143; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Legras S, 1997, BLOOD, V89, P1905, DOI 10.1182/blood.V89.6.1905; Levesque MC, 1997, J IMMUNOL, V159, P6184; Levesque MC, 2001, J IMMUNOL, V166, P188, DOI 10.4049/jimmunol.166.1.188; LIAO HX, 1995, J IMMUNOL, V155, P3938; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Mbitikon-Kobo FM, 2009, J IMMUNOL, V182, P3846, DOI 10.4049/jimmunol.0802438; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Serbina NV, 2009, J IMMUNOL, V183, P1900, DOI 10.4049/jimmunol.0900612; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Syn WK, 2012, GUT, V61, P1323, DOI 10.1136/gutjnl-2011-301857; Syn WK, 2011, HEPATOLOGY, V53, P106, DOI 10.1002/hep.23998; Tamura Y, 2008, ARTERIOSCL THROM VAS, V28, P2195, DOI 10.1161/ATVBAHA.108.168633; Tamura Y, 2010, J ATHEROSCLER THROMB, V17, P219, DOI 10.5551/jat.3368; Termeer C, 2001, J LEUKOCYTE BIOL, V70, P715; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Uppal H, 2008, HEPATOLOGY, V47, P1331, DOI 10.1002/hep.22175; Vanbervliet A, 2002, EUR J IMMUNOL, V32, P231, DOI 10.1002/1521-4141(200201)32:1<231::AID-IMMU231>3.0.CO;2-8; Vicari Alain P, 2004, Novartis Found Symp, V256, P241; Wang DQH, 2005, BBA-MOL CELL BIOL L, V1733, P90, DOI 10.1016/j.bbalip.2004.12.005; Wang DQH, 2002, BBA-MOL CELL BIOL L, V1583, P141, DOI 10.1016/S1388-1981(02)00194-4; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wittenburg H, 2002, PHYSIOL GENOMICS, V8, P67, DOI 10.1152/physiolgenomics.00097.2001; WOLPE SD, 1988, J EXP MED, V167, P570, DOI 10.1084/jem.167.2.570; WOO J, 1994, TRANSPLANTATION, V58, P484, DOI 10.1097/00007890-199408270-00015; Yamawaki H, 2009, GLYCOBIOLOGY, V19, P83, DOI 10.1093/glycob/cwn109; Zaldivar MM, 2010, HEPATOLOGY, V51, P1345, DOI 10.1002/hep.23435	56	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65247	10.1371/journal.pone.0065247	http://dx.doi.org/10.1371/journal.pone.0065247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762326	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800030
J	Jia, XM; Han, B; Onengut-Gumuscu, S; Chen, WM; Concannon, PJ; Rich, SS; Raychaudhuri, S; de Bakker, PIW				Jia, Xiaoming; Han, Buhm; Onengut-Gumuscu, Suna; Chen, Wei-Min; Concannon, Patrick J.; Rich, Stephen S.; Raychaudhuri, Soumya; de Bakker, Paul I. W.			Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAJOR HISTOCOMPATIBILITY COMPLEX; CLASSICAL HLA ALLELES; EXTENDED HUMAN MHC; GENOTYPE IMPUTATION; DISEASE ASSOCIATION; COMMON DISEASES; HAPLOTYPE; SUSCEPTIBILITY; INFERENCE	DNA sequence variation within human leukocyte antigen (HLA) genes mediate susceptibility to a wide range of human diseases. The complex genetic structure of the major histocompatibility complex (MHC) makes it difficult, however, to collect genotyping data in large cohorts. Long-range linkage disequilibrium between HLA loci and SNP markers across the major histocompatibility complex (MHC) region offers an alternative approach through imputation to interrogate HLA variation in existing GWAS data sets. Here we describe a computational strategy, SNP2HLA, to impute classical alleles and amino acid polymorphisms at class I (HLA-A, -B, -C) and class II (-DPA1, -DPB1, -DQA1, -DQB1, and -DRB1) loci. To characterize performance of SNP2HLA, we constructed two European ancestry reference panels, one based on data collected in HapMap-CEPH pedigrees (90 individuals) and another based on data collected by the Type 1 Diabetes Genetics Consortium (T1DGC, 5,225 individuals). We imputed HLA alleles in an independent data set from the British 1958 Birth Cohort (N = 918) with gold standard four-digit HLA types and SNPs genotyped using the Affymetrix GeneChip 500 K and Illumina Immunochip microarrays. We demonstrate that the sample size of the reference panel, rather than SNP density of the genotyping platform, is critical to achieve high imputation accuracy. Using the larger T1DGC reference panel, the average accuracy at four-digit resolution is 94.7% using the low-density Affymetrix GeneChip 500 K, and 96.7% using the high-density Illumina Immunochip. For amino acid polymorphisms within HLA genes, we achieve 98.6% and 99.3% accuracy using the Affymetrix GeneChip 500 K and Illumina Immunochip, respectively. Finally, we demonstrate how imputation and association testing at amino acid resolution can facilitate fine-mapping of primary MHC association signals, giving a specific example from type 1 diabetes.	[Jia, Xiaoming] Harvard MIT Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA; [Han, Buhm; Raychaudhuri, Soumya; de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Han, Buhm; Raychaudhuri, Soumya; de Bakker, Paul I. W.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Han, Buhm; Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol, Boston, MA 02115 USA; [Onengut-Gumuscu, Suna; Chen, Wei-Min; Concannon, Patrick J.; Rich, Stephen S.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Raychaudhuri, Soumya] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Virginia; Partners Healthcare System; University of Manchester; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Raychaudhuri, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA.	soumya@broadinstitute.org; pdebakker@umcutrecht.nl	Han, Buhm/AAQ-9672-2020; de Bakker, Paul IW/B-8730-2009	de Bakker, Paul IW/0000-0001-7735-7858; Raychaudhuri, Soumya/0000-0002-1901-8265; Jia, Xiaoming/0000-0002-5104-5431; Rich, Stephen/0000-0003-3872-7793; Concannon, Patrick/0000-0002-5801-1859	Howard Hughes Medical Institute; Bill and Melinda Gates Foundation; National Institutes of Health [K08AR055688, 1R01AR062886-01]; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International (JDRF); Netherlands Organization for Scientific Research (NWO);  [U01 DK062418]; MRC [G1001799, G0000934] Funding Source: UKRI; Medical Research Council [G1001799] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062886, K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was made possible by the Howard Hughes Medical Institute (Research Fellowship for Medical Students to XJ), the Bill and Melinda Gates Foundation (Collaboration for AIDS Vaccine Discovery sub-award to PIWdB), and the National Institutes of Health (K08AR055688 to SR and 1R01AR062886-01 to PIWdB). The authors acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. This research uses resources provided by the Type 1 Diabetes Genetics Consortium (T1DGC); a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International (JDRF), supported by U01 DK062418. PIWdB is the recipient of a VIDI Award from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JP, 2012, GENES IMMUN, V13, P245, DOI 10.1038/gene.2011.79; Bharadwaj M, 2012, ANNU REV PHARMACOL, V52, P401, DOI 10.1146/annurev-pharmtox-010611-134701; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; Dilthey AT, 2011, BIOINFORMATICS, V27, P968, DOI 10.1093/bioinformatics/btr061; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Erlich RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-42; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Gregersen PK, 2012, ANN NEUROLOGY; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Invernizzi P, 2012, GENES IMMUNITY; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; McLaren PJ, 2012, HUMAN MOL GENETICS; Monsuur AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002270; Morishima S, 2010, BLOOD, V115, P4664, DOI 10.1182/blood-2009-10-251157; Moutsianas L, 2011, BLOOD, V118, P670, DOI 10.1182/blood-2011-03-339630; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Setty MN, 2011, J COMPUT BIOL, V18, P483, DOI 10.1089/cmb.2010.0258; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Strachan DP, 2007, INT J EPIDEMIOL, V36, P522, DOI 10.1093/ije/dyl309; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Traherne JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/journal.pgen.0020009; Xie MZ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S11-S10	40	179	186	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e64683	10.1371/journal.pone.0064683	http://dx.doi.org/10.1371/journal.pone.0064683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762245	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000013
J	Shen, FX; Yao, MS				Shen, Fangxia; Yao, Maosheng			Are We Biologically Safe with Snow Precipitation? A Case Study in Beijing	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; SACCHAROMYCES-CEREVISIAE; AIRBORNE MICROORGANISMS; SIZE DISTRIBUTION; FUNGAL SPORES; MOUTH-DISEASE; DESERT DUST; BACTERIA; AEROSOL; CULTURABILITY	In this study, the bacterial and fungal abundances, diversities, conductance levels as well as total organic carbon (TOC) were investigated in the snow samples collected from five different snow occurrences in Beijing between January and March, 2010. The collected snow samples were melted and cultured at three different temperatures (4, 26 and 37 degrees C). The culturable bacterial concentrations were manually counted and the resulting colony forming units (CFUs) at 26 degrees C were further studied using V3 region of 16 S rRNA gene-targeted polymerase chain reaction -denaturing gradient gel electrophoresis (PCR-DGGE). The clone library was constructed after the liquid culturing of snow samples at 26 degrees C. And microscopic method was employed to investigate the fungal diversity in the samples. In addition, outdoor air samples were also collected using mixed cellulose ester (MCE) filters and compared with snow samples with respect to described characteristics. The results revealed that snow samples had bacterial concentrations as much as 16000 CFU/ml for those cultured at 26 degrees C, and the conductance levels ranged from 5.6x10(-6) to 2.4x10(-5) S. PCR-DGGE, sequencing and microscopic analysis revealed remarkable bacterial and fungal diversity differences between the snow samples and the outdoor air samples. In addition, DGGE banding profiles for the snow samples collected were also shown distinctly different from one another. Absent from the outdoor air, certain human, plant, and insect fungal pathogens were found in the snow samples. By calculation, culturable bacteria accounted for an average of 3.38% (+/- 1.96%) of TOC for the snow samples, and 0.01% for that of outdoor air samples. The results here suggest that snow precipitations are important sources of fungal pathogens and ice nucleators, thus could affect local climate, human health and agriculture security.	[Shen, Fangxia; Yao, Maosheng] Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100871, Peoples R China	Peking University	Yao, MS (corresponding author), Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100871, Peoples R China.	yao@pku.edu.cn	Shen, Fangxia/I-5774-2016; Shen, Fangxia/F-3718-2018; shen, fangxia/HGA-6200-2022	Shen, Fangxia/0000-0003-4166-4615; shen, fangxia/0000-0003-4166-4615	National Science Foundation of China [21277007, 41121004]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (Grants 21277007 and 41121004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony R, 2012, ENVIRON MONIT ASSESS, V184, P5929, DOI 10.1007/s10661-011-2391-1; Ariya PA, 2009, INT REV PHYS CHEM, V28, P1, DOI 10.1080/01442350802597438; AUCOTT JN, 1990, REV INFECT DIS, V12, P406; Bauer H, 2002, ATMOS RES, V64, P109, DOI 10.1016/S0169-8095(02)00084-4; Bauer H, 2010, GEOPH RES ABSTR, V12, P15472; Bold HC, 1980, MORPHOLOGY PLANTS FU; Bouillon S, 2004, FEMS MICROBIOL ECOL, V49, P171, DOI 10.1016/j.femsec.2004.03.004; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Carpenter EJ, 2000, APPL ENVIRON MICROB, V66, P4514, DOI 10.1128/AEM.66.10.4514-4517.2000; Casareto BE, 1996, GEOPHYS RES LETT, V23, P173, DOI 10.1029/95GL03785; Christner BC, 2008, SCIENCE, V319, P1214, DOI 10.1126/science.1149757; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Elster J., 2007, BIOGEOSCIENCES DISCU, V4, P1779, DOI [10.5194/bgd-4-1779-2007, DOI 10.5194/BGD-4-1779-2007, DOI 10.5194/bgd-4-1779-2007]; Fuzzi S, 1997, ATMOS ENVIRON, V31, P287, DOI 10.1016/1352-2310(96)00160-4; Griffin D.W., 2001, AEROBIOLOGIA BOLOGNA, V17, P203, DOI [10.1023/A:1011868218901, DOI 10.1023/A:1011868218901]; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Griffin DW, 2006, AEROBIOLOGIA, V22, P211, DOI 10.1007/s10453-006-9033-z; Grollert C, 2000, WATER AIR SOIL POLL, V117, P157, DOI 10.1023/A:1005192901234; Heidelberg JF, 1997, APPL ENVIRON MICROB, V63, P3585, DOI 10.1128/AEM.63.9.3585-3588.1997; Hsueh PR, 1998, J CLIN MICROBIOL, V36, P2914, DOI 10.1128/JCM.36.10.2914-2917.1998; IMSHENETSKY AA, 1978, APPL ENVIRON MICROB, V35, P1; Jones AM, 2004, SCI TOTAL ENVIRON, V326, P151, DOI 10.1016/j.scitotenv.2003.11.021; Joo YS, 2002, CAN J VET RES, V66, P122; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; La Duc MT, 2003, ENVIRON MICROBIOL, V5, P977, DOI 10.1046/j.1462-2920.2003.00496.x; Larose C, 2010, EXTREMOPHILES, V14, P205, DOI 10.1007/s00792-009-0299-2; Lee T, 2006, ATMOS ENVIRON, V40, P2902, DOI 10.1016/j.atmosenv.2006.01.011; Li KJ, 2010, AEROBIOLOGIA, V26, P233, DOI 10.1007/s10453-010-9159-x; Liebers V, 2006, AM J IND MED, V49, P474, DOI 10.1002/ajim.20310; Liu YQ, 2007, CHINESE SCI BULL, V52, P2350, DOI 10.1007/s11434-007-0360-4; Liu YQ, 2006, CHINESE SCI BULL, V51, P1476, DOI 10.1007/s11434-006-1476-7; MAKI LR, 1978, J APPL METEOROL, V17, P1049, DOI 10.1175/1520-0450(1978)017<1049:BABSOF>2.0.CO;2; Matthias-Maser S, 2000, ATOMOS ENV, V34, P279; MatthiasMaser S, 1995, ATMOS RES, V39, P279, DOI 10.1016/0169-8095(95)00017-8; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Morris CE, 2004, J PHYS IV, V121, P87, DOI 10.1051/jp4:2004121004; Morris CE, 2007, INFECT GENET EVOL, V7, P84, DOI 10.1016/j.meegid.2006.05.002; Murphy A, 1999, ENZYME MICROB TECH, V25, P551, DOI 10.1016/S0141-0229(99)00086-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Ozawa H, 2003, REV GEOPHYS, V41, DOI 10.1029/2002RG000113; Polymenakou PN, 2008, ENVIRON HEALTH PERSP, V116, P292, DOI 10.1289/ehp.10684; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Prospero JM, 2005, AEROBIOLOGIA, V21, P1, DOI 10.1007/s10453-004-5872-7; Sakamoto K, 2002, REV SCI TECH OIE, V21, P459, DOI 10.20506/rst.21.3.1347; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Shen FX, 2013, CHINESE SCI BULL, V58, P440, DOI 10.1007/s11434-012-5621-1; Suehiro J, 2006, SENSOR ACTUAT B-CHEM, V119, P319, DOI 10.1016/j.snb.2005.12.027; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VALI G, 1976, J ATMOS SCI, V33, P1565, DOI 10.1175/1520-0469(1976)033<1565:BINPIB>2.0.CO;2; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Wu PC, 2004, ATMOS ENVIRON, V38, P4879, DOI 10.1016/j.atmosenv.2004.05.039; Xu ZQ, 2011, AEROSOL SCI TECH, V45, P1143, DOI 10.1080/02786826.2011.582195; YANKOFSKY SA, 1981, CURR MICROBIOL, V5, P213, DOI 10.1007/BF01571149	58	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65249	10.1371/journal.pone.0065249	http://dx.doi.org/10.1371/journal.pone.0065249			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762327	gold, Green Submitted, Green Published			2022-12-25	WOS:000321099000048
J	Seekatz, AM; Panda, A; Rasko, DA; Toapanta, FR; Eloe-Fadrosh, EA; Khan, AQ; Liu, ZQ; Shipley, ST; DeTolla, LJ; Sztein, MB; Fraser, CM				Seekatz, Anna M.; Panda, Aruna; Rasko, David A.; Toapanta, Franklin R.; Eloe-Fadrosh, Emiley A.; Khan, Abdul Q.; Liu, Zhenqiu; Shipley, Steven T.; DeTolla, Louis J.; Sztein, Marcelo B.; Fraser, Claire M.			Differential Response of the Cynomolgus Macaque Gut Microbiota to Shigella Infection	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FLEXNERI 2A; MAURITIAN CYNOMOLGUS; GENETIC-VARIATION; IMMUNE-RESPONSES; BREEDING COLONY; MHC HAPLOTYPES; VACCINE; POPULATIONS; HEALTH	Little is known about the role of gut microbiota in response to live oral vaccines against enteric pathogens. We examined the effect of immunization with an oral live-attenuated Shigella dysenteriae 1 vaccine and challenge with wild-type S. dysenteriae 1 on the fecal microbiota of cynomolgus macaques using 16 S rRNA analysis of fecal samples. Multi-dimensional cluster analysis identified different bacterial community types within macaques from geographically distinct locations. The fecal microbiota of Mauritian macaques, observed to be genetically distinct, harbored a high-diversity community and responded differently to Shigella immunization, as well as challenge compared to the microbiota in non-Mauritian macaques. While both macaque populations exhibited anti-Shigella antibody responses, clinical shigellosis was observed only among non-Mauritian macaques. These studies highlight the importance of further investigation into the possible protective role of the microbiota against enteric pathogens and consideration of host genetic backgrounds in conducting vaccine studies.	[Seekatz, Anna M.; Rasko, David A.; Eloe-Fadrosh, Emiley A.; Liu, Zhenqiu; Fraser, Claire M.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Panda, Aruna; Shipley, Steven T.; DeTolla, Louis J.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Toapanta, Franklin R.; Sztein, Marcelo B.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Rasko, David A.; Fraser, Claire M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Sztein, Marcelo B.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [DeTolla, Louis J.; Fraser, Claire M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Liu, Zhenqiu; DeTolla, Louis J.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Khan, Abdul Q.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Uniformed Services University of the Health Sciences - USA	Fraser, CM (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	cmfraser@som.umaryland.edu	Eloe-Fadrosh, Emiley/AAP-8019-2021; Toapanta, Franklin/Y-1774-2019	Eloe-Fadrosh, Emiley/0000-0002-8162-1276; Fraser, Claire/0000-0003-1462-2428; David, Rasko/0000-0002-7337-7154	National Institutes of Health (CCHI) [U19 AI082655]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082655] Funding Source: NIH RePORTER	National Institutes of Health (CCHI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health grant U19 AI082655 (CCHI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bailey MT, 2004, J PEDIATR GASTR NUTR, V38, P414, DOI 10.1097/00005176-200404000-00009; Bien J, 2011, BIOMETRIKA, V98, P807, DOI 10.1093/biomet/asr054; Bonhomme M, 2007, TISSUE ANTIGENS, V70, P398, DOI 10.1111/j.1399-0039.2007.00925.x; Bonhomme M, 2005, AM J PRIMATOL, V67, P385, DOI 10.1002/ajp.20193; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Coster TS, 1999, INFECT IMMUN, V67, P3437, DOI 10.1128/IAI.67.7.3437-3443.1999; Degnan PH, 2012, P NATL ACAD SCI USA, V109, P13034, DOI 10.1073/pnas.1110994109; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferreira RBR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001190; Florese RH, 2008, VACCINE, V26, P3312, DOI 10.1016/j.vaccine.2008.03.100; FORMAL SB, 1991, J INFECT DIS, V164, P533, DOI 10.1093/infdis/164.3.533; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Hallander HO, 2002, VACCINE, V21, P138, DOI 10.1016/S0264-410X(02)00348-1; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Huurre A, 2008, NEONATOLOGY, V93, P236, DOI 10.1159/000111102; Kanthaswamy S, 2008, INT J PRIMATOL, V29, P1295, DOI 10.1007/s10764-008-9295-0; Katz DE, 2004, INFECT IMMUN, V72, P923, DOI 10.1128/IAI.72.2.923-930.2004; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Krebs KC, 2005, J IMMUNOL, V175, P5230, DOI 10.4049/jimmunol.175.8.5230; Kweon MN, 2008, CURR OPIN INFECT DIS, V21, P313, DOI 10.1097/QCO.0b013e3282f88b92; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Mee ET, 2009, J MED PRIMATOL, V38, P1, DOI 10.1111/j.1600-0684.2008.00299.x; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Migot-Nabias F, 1999, EXP PARASITOL, V91, P30, DOI 10.1006/expr.1999.4342; Mitchell JL, 2012, IMMUNOGENETICS, V64, P123, DOI 10.1007/s00251-011-0567-z; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Penedo MCT, 2005, IMMUNOGENETICS, V57, P198, DOI 10.1007/s00251-005-0787-1; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rahman KM, 2011, VACCINE, V29, P1347, DOI 10.1016/j.vaccine.2010.10.035; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shipley ST, 2010, COMPARATIVE MED, V60, P54; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; SUHARYONO, 1992, LANCET, V340, P689, DOI 10.1016/0140-6736(92)92231-4; Suleyman Y, 2010, PLOS ONE, V5; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu T, 2011, INFECT IMMUN, V79, P4912, DOI 10.1128/IAI.05814-11; Xia LC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S15	48	41	41	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2013	8	6							e64212	10.1371/journal.pone.0064212	http://dx.doi.org/10.1371/journal.pone.0064212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166TB	23755118	gold, Green Published, Green Submitted			2022-12-25	WOS:000320579400011
J	He, Y; Luo, MJ; Yi, MH; Sheng, Y; Cheng, YB; Zhou, RJ; Cheng, HH				He, Yan; Luo, Majing; Yi, Minhan; Sheng, Yue; Cheng, Yibin; Zhou, Rongjia; Cheng, Hanhua			Identification of a Testis-Enriched Heat Shock Protein and Fourteen Members of Hsp70 Family in the Swamp Eel	PLOS ONE			English	Article							SEX-DETERMINING GENE; RICE FIELD EEL; HEAT-SHOCK-PROTEIN-70 FAMILY; CELL GROWTH; HSPA2; R-SPONDIN1; APOPTOSIS; MEDAKA; MOUSE; DUPLICATION	Background: Gonad differentiation is one of the most important developmental events in vertebrates. Some heat shock proteins are associated with gonad development. Heat shock protein 70 (Hsp70) in the teleost fish and its roles in sex differentiation are poorly understood. Methods and Findings: We have identified a testis-enriched heat shock protein Hspa8b2 in the swamp eel using Western blot analysis and Mass Spectrometry (MS). Fourteen Hsp70 family genes were further identified in this species based on transcriptome information. The phylogenetic tree of Hsp70 family was constructed using the Maximum Likelihood method and their expression patterns in the swamp eel gonads were analyzed by reverse transcription-polymerase chain reaction (RT-PCR). Conclusion: There are fourteen gene members in the Hsp70 family in the swamp eel genome. Hsp70 family, particularly Hspa8, has expanded in the species. One of the family members Hspa8b2 is predominantly expressed in testis of the swamp eel.	[He, Yan] Huazhong Agr Univ, Coll Fisheries, Wuhan, Peoples R China; [Luo, Majing; Yi, Minhan; Sheng, Yue; Cheng, Yibin; Zhou, Rongjia; Cheng, Hanhua] Wuhan Univ, Coll Life Sci, Dept Genet, Wuhan 430072, Peoples R China	Huazhong Agricultural University; Wuhan University	Zhou, RJ (corresponding author), Wuhan Univ, Coll Life Sci, Dept Genet, Wuhan 430072, Peoples R China.	rjzhou@whu.edu.cn; hhcheng@whu.edu.cn	Zhou, Rongjia/N-9739-2019; Zhou, Rongjia/G-4660-2013	Zhou, Rongjia/0000-0002-9701-8009; Zhou, Rongjia/0000-0002-9701-8009	National Natural Science Foundation of China; National Key Basic Research project, National Key Technologies RD Program; Chinese 111 project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research project, National Key Technologies RD Program(National Basic Research Program of China); Chinese 111 project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China, the National Key Basic Research project, National Key Technologies R&D Program and the Chinese 111 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrionuevo F, 2010, INT J BIOCHEM CELL B, V42, P433, DOI 10.1016/j.biocel.2009.07.015; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Cheng H, 2003, CYTOGENET GENOME RES, V101, P274, DOI 10.1159/000074348; Daugaard M, 2005, CELL CYCLE, V4, P877, DOI 10.4161/cc.4.7.1838; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Eddy EM, 1999, REV REPROD, V4, P23, DOI 10.1530/revreprod/4.1.23; Filipczak PT, 2012, BIOCHEM CELL BIOL, V90, P224, DOI [10.1139/O11-083, 10.1139/o11-083]; Georg I, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101907; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; He Y, 2010, J EXP ZOOL PART B, V314B, P257, DOI 10.1002/jez.b.21333; Ito Y, 1998, J BIOCHEM, V124, P347, DOI 10.1093/oxfordjournals.jbchem.a022118; Jolesch A, 2012, EUR J CELL BIOL, V91, P48, DOI 10.1016/j.ejcb.2011.02.001; Kamiya T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002798; Kaufer S, 2012, J VIROL, V86, P1079, DOI 10.1128/JVI.02662-10; Kikuchi K, 2013, DEV DYNAM, V242, P339, DOI 10.1002/dvdy.23927; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KRAWCZYK Z, 1987, MOL BIOL REP, V12, P27, DOI 10.1007/BF00580647; Lavery R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003170; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Motiei M, 2013, ANDROLOGIA, V45, P66, DOI 10.1111/j.1439-0272.2012.01315.x; Myosho T, 2012, GENETICS, V191, P163, DOI 10.1534/genetics.111.137497; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; NEI M, 1969, NATURE, V221, P40, DOI 10.1038/221040a0; Nei M., 1992, 11 HIST WORKSH C OXF 11 HIST WORKSH C OXF; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Pitetti JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003160; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Scieglinska D, 2008, J CELL BIOCHEM, V104, P2193, DOI 10.1002/jcb.21778; Son WY, 1999, MOL HUM REPROD, V5, P1122, DOI 10.1093/molehr/5.12.1122; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Wilhelm D, 2007, BIOESSAYS, V29, P314, DOI 10.1002/bies.20553; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; ZAKERI ZF, 1987, MOL CELL BIOL, V7, P1791, DOI 10.1128/MCB.7.5.1791; Zarkower D, 2013, CURR TOP DEV BIOL, V102, P327, DOI 10.1016/B978-0-12-416024-8.00012-X; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	48	18	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e65269	10.1371/journal.pone.0065269	http://dx.doi.org/10.1371/journal.pone.0065269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750249	Green Published, Green Submitted, gold			2022-12-25	WOS:000319961900051
J	Wall, JS; Williams, A; Richey, T; Stuckey, A; Huang, Y; Wooliver, C; Macy, S; Heidel, E; Gupta, N; Lee, A; Rader, B; Martin, EB; Kennel, SJ				Wall, Jonathan S.; Williams, Angela; Richey, Tina; Stuckey, Alan; Huang, Ying; Wooliver, Craig; Macy, Sallie; Heidel, Eric; Gupta, Neil; Lee, Angela; Rader, Brianna; Martin, Emily B.; Kennel, Stephen J.			A Binding-Site Barrier Affects Imaging Efficiency of High Affinity Amyloid-Reactive Peptide Radiotracers In Vivo	PLOS ONE			English	Article							P COMPONENT; TC-99M-DPD SCINTIGRAPHY; MODELING ANALYSIS; DIAGNOSIS; ANTIBODIES; TASSER; TUMORS	Amyloid is a complex pathology associated with a growing number of diseases including Alzheimer's disease, type 2 diabetes, rheumatoid arthritis, and myeloma. The distribution and extent of amyloid deposition in body organs establishes the prognosis and can define treatment options; therefore, determining the amyloid load by using non-invasive molecular imaging is clinically important. We have identified a heparin-binding peptide designated p5 that, when radioiodinated, was capable of selectively imaging systemic visceral AA amyloidosis in a murine model of the disease. The p5 peptide was posited to bind effectively to amyloid deposits, relative to similarly charged polybasic heparin-reactive peptides, because it adopted a polar a helix secondary structure. We have now synthesized a variant, p5R, in which the 8 lysine amino acids of p5 have been replaced with arginine residues predisposing the peptide toward the a helical conformation in an effort to enhance the reactivity of the peptide with the amyloid substrate. The p5R peptide had higher affinity for amyloid and visualized AA amyloid in mice by using SPECT/CT imaging; however, the microdistribution, as evidenced in micro-autoradiographs, was dramatically altered relative to the p5 peptide due to its increased affinity and a resultant "binding site barrier'' effect. These data suggest that radioiodinated peptide p5R may be optimal for the in vivo detection of discreet, perivascular amyloid, as found in the brain and pancreatic vasculature, by using molecular imaging techniques; however, peptide p5, due to its increased penetration, may yield more quantitative imaging of expansive tissue amyloid deposits.	[Wall, Jonathan S.; Williams, Angela; Richey, Tina; Huang, Ying; Wooliver, Craig; Macy, Sallie; Gupta, Neil; Lee, Angela; Rader, Brianna; Martin, Emily B.; Kennel, Stephen J.] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37996 USA; [Wall, Jonathan S.; Stuckey, Alan; Kennel, Stephen J.] Univ Tennessee, Dept Radiol, Grad Sch Med, Knoxville, TN 37996 USA; [Heidel, Eric] Univ Tennessee, Grad Sch Med, Dept Surg, Knoxville, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Wall, JS (corresponding author), Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37996 USA.	jwall@utmck.edu		Wall, Jonathan/0000-0002-5516-8578; Heidel, Robert/0000-0002-1518-8072	National Institute Of Diabetes And Digestive And Kidney Diseases [R01DK079984]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079984] Funding Source: NIH RePORTER	National Institute Of Diabetes And Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Award Number R01DK079984 from the National Institute Of Diabetes And Digestive And Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni G, 2013, J NUCL MED, V54, P213, DOI 10.2967/jnumed.111.102053; AXELRAD MA, 1982, LAB INVEST, V47, P139; Blancas-Mejia LM, 2013, ANN REV BIOCH; Crandall YM, 2008, BIOPOLYMERS, V89, P197, DOI 10.1002/bip.20891; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; FUJIMORI K, 1990, J NUCL MED, V31, P1191; FUJIMORI K, 1989, CANCER RES, V49, P5656; GEJYO F, 1995, CLIN NEPHROL, V44, pS14; Glaudemans AWJM, 2009, EUR J NUCL MED MOL I, V36, P702, DOI 10.1007/s00259-008-1037-1; Guan J, 2012, AM J PHYSIOL-HEART C, V302, pH544, DOI 10.1152/ajpheart.00815.2011; Hachulla E, 2002, JOINT BONE SPINE, V69, P538, DOI 10.1016/S1297-319X(02)00449-9; HAWKINS PN, 1995, EUR J NUCL MED, V22, P595, DOI 10.1007/BF01254559; Hawkins PN, 2002, CURR OPIN NEPHROL HY, V11, P649, DOI 10.1097/00041552-200211000-00013; Hazenberg BPC, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.043; Jayaraman G, 2000, FEBS LETT, V482, P154, DOI 10.1016/S0014-5793(00)01964-5; Johnson KA, 2013, ALZHEIMERS DEMENT; JUWEID M, 1992, CANCER RES, V52, P5144; Ketteler M, 2001, SEMIN DIALYSIS, V14, P90, DOI 10.1046/j.1525-139x.2001.00025.x; Loitfelder M, 2012, PANMINERVA MED, V54, P149; Magota K, 2011, EUR J NUCL MED MOL I, V38, P742, DOI 10.1007/s00259-010-1683-y; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Nitz M, 2008, CHEMBIOCHEM, V9, P1545, DOI 10.1002/cbic.200800056; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; PEPYS MB, 1992, J INTERN MED, V232, P519, DOI 10.1111/j.1365-2796.1992.tb00630.x; Puille M, 2002, EUR J NUCL MED MOL I, V29, P376, DOI 10.1007/s00259-001-0730-0; Rapezzi C, 2008, J AM COLL CARDIOL, V51, P1509, DOI 10.1016/j.jacc.2007.12.038; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Rullo A, 2010, BIOPOLYMERS, V93, P290, DOI 10.1002/bip.21339; Schaadt BK, 2003, J NUCL MED, V44, P177; SJOHOLM I, 1972, FEBS LETT, V22, P109, DOI 10.1016/0014-5793(72)80232-1; Skaper SD, 2012, INT REV NEUROBIOL, V102, P277, DOI 10.1016/B978-0-12-386986-9.00011-9; Smyth DR, 2005, NUCL MED BIOL, V32, P885, DOI 10.1016/j.nucmedbio.2005.06.006; Solomon A, 1999, AM J PATHOL, V154, P1267, DOI 10.1016/S0002-9440(10)65378-3; VANOSDOL W, 1991, CANCER RES, V51, P4776; Wall JS, 2006, METHOD ENZYMOL, V412, P161, DOI 10.1016/S0076-6879(06)12011-X; Wall JS, 2013, AMYLOID, V20, P21, DOI 10.3109/13506129.2012.757216; Wall JS, 2012, MOL IMAGING BIOL, V14, P402, DOI 10.1007/s11307-011-0524-0; Wall JS, 2011, P NATL ACAD SCI USA, V108, pE586, DOI 10.1073/pnas.1103247108; Wall JS, 2008, COMPARATIVE MED, V58, P542; Westermark P, 2011, UPSALA J MED SCI, V116, P81, DOI 10.3109/03009734.2011.573884; Yang LC, 2012, NEW ENGL J MED, V367, P885, DOI 10.1056/NEJMp1208061; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	44	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2013	8	6							e66181	10.1371/journal.pone.0066181	http://dx.doi.org/10.1371/journal.pone.0066181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IE	23750281	Green Published, gold, Green Submitted			2022-12-25	WOS:000319961900083
J	Cook, GW; Konkel, MK; Walker, JA; Bourgeois, MG; Fullerton, ML; Fussell, JT; Herbold, HD; Batzer, MA				Cook, George W.; Konkel, Miriam K.; Walker, Jerilyn A.; Bourgeois, Matthew G.; Fullerton, Mitchell L.; Fussell, John T.; Herbold, Heath D.; Batzer, Mark A.			A Comparison of 100 Human Genes Using an Alu Element-Based Instability Model	PLOS ONE			English	Article							HUMAN GENOME; RECOMBINATION; DELETIONS; CONVERSION; REPEATS; CANCER; RETROTRANSPOSONS; STABILITY; DISEASE	The human retrotransposon with the highest copy number is the Alu element. The human genome contains over one million Alu elements that collectively account for over ten percent of our DNA. Full-length Alu elements are randomly distributed throughout the genome in both forward and reverse orientations. However, full-length widely spaced Alu pairs having two Alus in the same (direct) orientation are statistically more prevalent than Alu pairs having two Alus in the opposite (inverted) orientation. The cause of this phenomenon is unknown. It has been hypothesized that this imbalance is the consequence of anomalous inverted Alu pair interactions. One proposed mechanism suggests that inverted Alu pairs can ectopically interact, exposing both ends of each Alu element making up the pair to a potential double-strand break, or "hit". This hypothesized "two-hit" (two double-strand breaks) potential per Alu element was used to develop a model for comparing the relative instabilities of human genes. The model incorporates both 1) the two-hit double-strand break potential of Alu elements and 2) the probability of exon-damaging deletions extending from these double-strand breaks. This model was used to compare the relative instabilities of 50 deletion-prone cancer genes and 50 randomly selected genes from the human genome. The output of the Alu element-based genomic instability model developed here is shown to coincide with the observed instability of deletion-prone cancer genes. The 50 cancer genes are collectively estimated to be 58% more unstable than the randomly chosen genes using this model. Seven of the deletion-prone cancer genes, ATM, BRCA1, FANCA, FANCD2, MSH2, NCOR1 and PBRM1, were among the most unstable 10% of the 100 genes analyzed. This algorithm may lay the foundation for comparing genetic risks posed by structural variations that are unique to specific individuals, families and people groups.	[Cook, George W.; Konkel, Miriam K.; Walker, Jerilyn A.; Bourgeois, Matthew G.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Fullerton, Mitchell L.] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Fussell, John T.] Louisiana Business & Technol Ctr, Baton Rouge, LA USA; [Herbold, Heath D.] Albemarle Corp, Pasadena, TX USA	Louisiana State University System; Louisiana State University; Clemson University; Albemarle Corporation	Batzer, MA (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu	Fullerton, Mitchell/HIK-2189-2022		National Institutes of Health [RO1 GM59290]; Louisiana Board of Regents Governor's Biotechnology Initiative GBI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents Governor's Biotechnology Initiative GBI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (http://www.nih.gov/)RO1 GM59290 (MAB), and the Louisiana Board of Regents Governor's Biotechnology Initiative GBI (http://web.laregents.org/programs/special-programs/) (2002-005) (MAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin A, 2010, MOL BIOL EVOL, V27, P2300, DOI 10.1093/molbev/msq116; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Cook GW, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-10; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; de Smith AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003104; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Fogedby HC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061915; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Franke G, 2009, HUM MUTAT, V30, P776, DOI 10.1002/humu.20948; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Hedges DJ, 2007, MUTAT RES-FUND MOL M, V616, P46, DOI 10.1016/j.mrfmmm.2006.11.021; Jeon JH, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2192774; Jurka J, 2004, P NATL ACAD SCI USA, V101, P1268, DOI 10.1073/pnas.0308084100; KASS DH, 1995, MOL CELL BIOL, V15, P19, DOI 10.1128/MCB.15.1.19; Kitada K, 2012, CYTOGENET GENOME RES; Konkel MK, 2010, SEMIN CANCER BIOL, V20, P211, DOI 10.1016/j.semcancer.2010.03.001; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004047; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lupski JR, 2010, CELL, V141, P1110, DOI 10.1016/j.cell.2010.06.014; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Roy AM, 2000, GENOME RES, V10, P1485, DOI 10.1101/gr.152300; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Serrano M, 2010, NATURE, V464, P363, DOI 10.1038/464363a; Smit A, 1996, REPEATMASKER OPEN 30; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Witherspoon DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-530; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002046; Zhi DG, 2007, GENE, V390, P117, DOI 10.1016/j.gene.2006.09.030	38	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65188	10.1371/journal.pone.0065188	http://dx.doi.org/10.1371/journal.pone.0065188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755193	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300057
J	Hosek, J; Novotna, R; Babula, P; Vanco, J; Travnicek, Z				Hosek, Jan; Novotna, Radka; Babula, Petr; Vanco, Jan; Travnicek, Zdenek			Zn(II)-Chlorido Complexes of Phytohormone Kinetin and Its Derivatives Modulate Expression of Inflammatory Mediators in THP-1 Cells	PLOS ONE			English	Article							X-RAY STRUCTURES; ZINC(II) COMPLEXES; IN-VITRO; KAPPA-B; MATRIX METALLOPROTEINASES; ACID; ACTIVATION; INHIBITION; LIPOPOLYSACCHARIDE; PROLIFERATION	Kinetin (N6-furfuryladenine) belongs to a group of plant growth hormones involved in cell division, differentiation and other physiological processes. One of the possible ways to obtain biologically active compounds is to complex biologically relevant natural compounds to suitable metal atoms. In this work, two structural groups of Zn(II) complexes [Zn(L-n)(2)Cl-2]center dot Solv (1-5) and [Zn(HLn)Cl-3]center dot xL(n) (6-7); n = 1-5, Solv = CH3OH for 1 and 2H(2)O for 2; x = 1 for 6 and 2 for 7; involving a phytohormone kinetin and its derivatives (L-n) were evaluated for their ability to modulate secretion of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1 beta and matrix metalloproteinase (MMP)-2 in a lipopolysaccharide (LPS)-activated macrophage-like THP-1 cell model. The penetration of the complexes to cells was also detected. The mechanism of interactions of the zinc(II) complexes with a fluorescent sensor N-(6-methoxy-8-quinolyl)-p-toluene sulphonamide (TSQ) and sulfur-containing biomolecules (l-cysteine and reduced glutathione) was studied by electrospray-ionization mass spectrometry and flow-injection analysis with fluorescence detection. The present study showed that the tested complexes exhibited a low cytotoxic effect on the THP-1 cell line (IC50>40 mu M), apart from complex 4, with an IC50 = 10.9 +/- 1.1 mu M. Regarding the inflammation-related processes, the Zn(II) complexes significantly decreased IL-1 beta production by a factor of 1.47-2.22 compared with the control (DMSO), but did not affect TNF-alpha and MMP-2 secretions. However, application of the Zn(II) complexes noticeably changed the pro-MMP-2/MMP-2 ratio towards a higher amount of maturated MMP-2, when they induced a 4-times higher production of maturated MMP-2 in comparison with the vehicle-treated cells under LPS stimulation. These results indicated that the complexes are able to modulate an inflammatory response by influencing secretion and activity of several inflammation-related cytokines and enzymes.	[Hosek, Jan; Novotna, Radka; Vanco, Jan; Travnicek, Zdenek] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, Dept Inorgan Chem, CR-77147 Olomouc, Czech Republic; [Babula, Petr] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Nat Drugs, Brno, Czech Republic	Palacky University Olomouc; University of Veterinary Sciences Brno	Travnicek, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, Dept Inorgan Chem, CR-77147 Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	KŘIKAVOVÁ, Radka/CAG-6109-2022; Vanco, Jan/H-2705-2013; Hosek, Jan/B-6274-2009; Babula, Petr/AAL-6510-2020	KŘIKAVOVÁ, Radka/0000-0002-8466-4829; Vanco, Jan/0000-0003-3351-1192; Hosek, Jan/0000-0003-0975-1671; Travnicek, Zdenek/0000-0002-5890-7874	Operational Program Research and Development for Innovations - European Regional Development Fund [CZ.1.05/2.1.00/03.0058]; Operational Program Education for Competitiveness - European Social Fund [CZ.1.07/2.3.00/20.0017]; Palacky University [IGA PrF_2013_015]	Operational Program Research and Development for Innovations - European Regional Development Fund; Operational Program Education for Competitiveness - European Social Fund(European Social Fund (ESF)); Palacky University	The authors would like to thank the Operational Program Research and Development for Innovations - European Regional Development Fund (CZ.1.05/2.1.00/03.0058), the Operational Program Education for Competitiveness - European Social Fund (CZ.1.07/2.3.00/20.0017) and Palacky University (IGA PrF_2013_015) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barciszewski J, 2007, INT J BIOL MACROMOL, V40, P182, DOI 10.1016/j.ijbiomac.2006.06.024; Berge U, 2006, ANN NY ACAD SCI, V1067, P332, DOI 10.1196/annals.1354.045; Bispo W, 2011, MOLECULES, V16, P6902, DOI 10.3390/molecules16086902; Buchtik R, 2012, J INORG BIOCHEM, V116, P163, DOI 10.1016/j.jinorgbio.2012.07.009; Casati S, 2011, ANTICANCER RES, V31, P3401; Celik I, 2006, PESTIC BIOCHEM PHYS, V86, P180, DOI 10.1016/j.pestbp.2006.03.007; de Souza AP, 2000, DENT MATER, V16, P103, DOI 10.1016/S0109-5641(99)00084-6; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; DRIESSEN C, 1995, IMMUNOLOGY, V84, P272; Dudzik P, 2011, J CELL BIOCHEM, V112, P2115, DOI 10.1002/jcb.23132; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fahrni CJ, 1999, J AM CHEM SOC, V121, P11448, DOI 10.1021/ja992709f; Campos PMBGM, 2012, PHOTOCHEM PHOTOBIOL, V88, P748, DOI 10.1111/j.1751-1097.2012.01086.x; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Jeon KI, 2000, J IMMUNOL, V164, P5981, DOI 10.4049/jimmunol.164.11.5981; Kim YM, 2007, CELL SIGNAL, V19, P538, DOI 10.1016/j.cellsig.2006.08.003; Knoell DL, 2010, INT J VITAM NUTR RES, V80, P271, DOI 10.1024/0300-9831/a000034; Li HH, 2011, BIOCHEM PHARMACOL, V82, P701, DOI 10.1016/j.bcp.2011.06.042; Lu KV, 2004, LAB INVEST, V84, P8, DOI 10.1038/labinvest.3700003; Meeusen JW, 2012, INORG CHEM, V51, P3625, DOI 10.1021/ic2025236; Meeusen JW, 2011, INORG CHEM, V50, P7563, DOI 10.1021/ic200478q; Mei XT, 2012, CHEM-BIOL INTERACT, V197, P31, DOI 10.1016/j.cbi.2012.03.006; Morad Y, 2005, INVEST OPHTH VIS SCI, V46, P1640, DOI 10.1167/iovs.04-1165; Moreira-Tabaka H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034184; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Nasir MS, 1999, J BIOL INORG CHEM, V4, P775, DOI 10.1007/s007750050350; Novotna R, 2011, INORG CHIM ACTA, V365, P113, DOI 10.1016/j.ica.2010.08.040; Novotna R, 2010, INORG CHIM ACTA, V363, P2071, DOI 10.1016/j.ica.2010.02.004; Okumura S, 2004, Japan Patent, Patent No. [JP 2004083435 A, 2004083435]; Pavlica S, 2010, NEUROCHEM INT, V56, P84, DOI 10.1016/j.neuint.2009.09.005; Pencikova K, 2012, PHYTOMEDICINE, V19, P890, DOI 10.1016/j.phymed.2012.04.001; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Prasad AS, 2011, NUTRITION, V27, P816, DOI 10.1016/j.nut.2010.08.010; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; RAINSFORD KD, 1992, J PHARM PHARMACOL, V44, P476, DOI 10.1111/j.2042-7158.1992.tb03650.x; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; RATTAN SIS, 1994, BIOCHEM BIOPH RES CO, V201, P665, DOI 10.1006/bbrc.1994.1752; Rattan SIS, 2002, J ANTI-AGING MED, V5, P113, DOI 10.1089/109454502317629336; REINHOLD JG, 1975, CLIN CHEM, V21, P476; Reyes Juan G., 1994, Biological Research, V27, P49; Salemi G, 2009, NEUROL SCI, V30, P361, DOI 10.1007/s10072-009-0090-2; SHARMA SP, 1995, BIOCHEM BIOPH RES CO, V216, P1067, DOI 10.1006/bbrc.1995.2729; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Takashima A, 2003, Japan Patent, Patent No. [JP 2003155238 A, 2003155238]; TOROPTSE.IV, 1972, TSITOLOGIYA+, V14, P805; Travnicek Z, 2006, J INORG BIOCHEM, V100, P214, DOI 10.1016/j.jinorgbio.2005.07.006; Travnicek Z, 2012, J MED CHEM, V55, P4568, DOI 10.1021/jm201416p; Valiante N, 2006, WIPO Patent, Patent No. [2006002422, WO 2006/002422 A2]; von Bulow V, 2005, J IMMUNOL, V175, P4697, DOI 10.4049/jimmunol.175.7.4697; Waddell FE, 1992, US Patent, Patent No. [US 5151425, 5151425]; Wong CP, 2012, MOL NUTR FOOD RES, V56, P77, DOI 10.1002/mnfr.201100511; Wu JJ, 2007, CLIN EXP DERMATOL, V32, P693, DOI 10.1111/j.1365-2230.2007.02513.x	55	10	11	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65214	10.1371/journal.pone.0065214	http://dx.doi.org/10.1371/journal.pone.0065214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755195	Green Submitted, gold, Green Published			2022-12-25	WOS:000319872300058
J	Jin, QY; Liu, GM; Domeier, PP; Ding, W; Mulder, KM				Jin, Qunyan; Liu, Guangming; Domeier, Phillip P.; Ding, Wei; Mulder, Kathleen M.			Decreased Tumor Progression and Invasion by a Novel Anti-Cell Motility Target for Human Colorectal Carcinoma Cells	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; TGF-BETA RECEPTOR; LIGHT-CHAIN; SIGNALING PATHWAY; CANCER CELLS; COLON-CANCER; KINASE-A; TERNARY COMPLEX; GROWTH; MIGRATION	We have previously described a novel modulator of the actin cytoskeleton that also regulates Ras and mitogen-activated protein kinase activities in TGF beta-sensitive epithelial cells. Here we examined the functional role of this signaling regulatory protein (km23-1) in mediating the migration, invasion, and tumor growth of human colorectal carcinoma (CRC) cells. We show that small interfering RNA (siRNA) depletion of km23-1 in human CRC cells inhibited constitutive extracellular signal-regulated kinase (ERK) activation, as well as pro-invasive ERK effector functions that include phosphorylation of Elk-1, constitutive regulation of c-Fos-DNA binding, TGF beta 1 promoter transactivation, and TGF beta 1 secretion. In addition, knockdown of km23-1 reduced the paracrine effects of CRC cell-secreted factors in conditioned medium and in fibroblast co-cultures. Moreover, km23-1 depletion in human CRC cells reduced cell migration and invasion, as well as expression of the ERK-regulated, metastasis-associated scaffold protein Ezrin. Finally, km23-1 inhibition significantly suppressed tumor formation in vivo. Thus, our results implicate km23-1 as a novel anti-metastasis target for human colon carcinoma cells, capable of decreasing tumor growth and invasion via a mechanism involving suppression of various pro-migratory features of CRC. These include a reduction in ERK signaling, diminished TGF beta 1 production, decreased expression of the plasma membrane-cytoskeletal linker Ezrin, as well as attenuation of the paracrine effects of colon carcinoma-secreted factors on fibroblast migration and mitogenesis. As such, km23-1 inhibitors may represent a viable therapeutic strategy for interfering with colon cancer progression and invasion.	[Jin, Qunyan; Liu, Guangming; Domeier, Phillip P.; Mulder, Kathleen M.] Penn State Hershey Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA; [Ding, Wei] Penn State Hershey Coll Med, Dept Pediat, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Mulder, KM (corresponding author), Penn State Hershey Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA.	kmm15@psu.edu		Domeier, Phillip/0000-0002-9937-8251	National Institutes of Health [CA090765, CA092889]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA092889, R01CA090765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA090765 and CA092889 to K.M.M. This work was also funded, in part, under a grant from the Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bahassi EM, 2004, CLIN EXP METASTAS, V21, P293, DOI 10.1023/B:CLIN.0000046132.46946.dd; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Biname F, 2008, MOL BIOL CELL, V19, P945, DOI 10.1091/mbc.E07-09-0967; Briggs JW, 2012, NEOPLASIA, V14, P297, DOI 10.1593/neo.11518; Buard A, 1996, INT J CANCER, V67, P539, DOI 10.1002/(SICI)1097-0215(19960807)67:4<539::AID-IJC13>3.0.CO;2-2; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gao SY, 2009, J BIOL CHEM, V284, P7995, DOI 10.1074/jbc.M809734200; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Hayashi Y, 2010, NEOPLASIA, V12, P1013, DOI 10.1593/neo.10780; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ilangovan U, 2005, J MOL BIOL, V352, P338, DOI 10.1016/j.jmb.2005.07.002; Jarnaess E, 2008, J BIOL CHEM, V283, P33708, DOI 10.1074/jbc.M804807200; Jin Q, 2007, J BIOL CHEM, V282, P19122, DOI 10.1074/jbc.M609915200; Jin QY, 2013, EXP CELL RES, V319, P897, DOI 10.1016/j.yexcr.2012.12.029; Jin QY, 2012, BIOCHEM BIOPH RES CO, V428, P333, DOI 10.1016/j.bbrc.2012.10.047; Jin QY, 2012, J BIOL CHEM, V287, P26453, DOI 10.1074/jbc.M112.344887; Jin QY, 2009, J CELL PHYSIOL, V221, P707, DOI 10.1002/jcp.21910; Jin QY, 2005, CELL SIGNAL, V17, P1363, DOI 10.1016/j.cellsig.2005.02.004; Kanthan, 2012, PATHOLOG RES INT, V2012, DOI [10.1155/2012/597497, DOI 10.1155/2012/597497]; Karydis A, 2009, MOL BIOL CELL, V20, P2327, DOI 10.1091/mbc.E08-08-0842; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Link A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008146; Liu GM, 2006, MOL CARCINOGEN, V45, P582, DOI 10.1002/mc.20189; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Meng YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-61; Miertzschke M, 2011, EMBO J, V30, P4185, DOI 10.1038/emboj.2011.291; Mulder K. M., 1989, CELL MOL BIOL COLON, P45; Naumovski L, 2006, MOL CANCER THER, V5, P2798, DOI 10.1158/1535-7163.MCT-06-0246; Nowak D, 2010, EUR J HISTOCHEM, V54, P59, DOI 10.4081/ejh.2010.e14; Odrowaz Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049892; Oliveira C, 2003, ONCOGENE, V22, P9192, DOI 10.1038/sj.onc.1207061; Ono H, 2012, ONCOGENE, V31, P4923, DOI 10.1038/onc.2011.646; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Pandey MK, 2012, INT J CANCER, V130, P213, DOI 10.1002/ijc.25997; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ren L, 2012, CANCER RES, V72, P1001, DOI 10.1158/0008-5472.CAN-11-0210; Roberts AB, 1990, PEPTIDE GROWTH FACTO, P419; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Simms NAK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-221; Singh N, 2013, INT J CANCER, V132, P1996, DOI 10.1002/ijc.27902; Sperka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027511; Takakura M, 2005, MOL CELL BIOL, V25, P8037, DOI 10.1128/MCB.25.18.8037-8043.2005; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang HJ, 2009, WORLD J GASTROENTERO, V15, P2016, DOI 10.3748/wjg.15.2016; Xie JJ, 2009, INT J CANCER, V124, P2549, DOI 10.1002/ijc.24216; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; YANG SH, 2006, BIOCHEM SOC SYMP, P121; Yu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030605; Yue JB, 2000, J BIOL CHEM, V275, P30765, DOI 10.1074/jbc.M000039200; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7	70	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e66439	10.1371/journal.pone.0066439	http://dx.doi.org/10.1371/journal.pone.0066439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755307	Green Published, Green Submitted, gold			2022-12-25	WOS:000319872300106
J	Wang, C; Deng, PY; Chen, LL; Wang, XT; Ma, H; Hu, W; Yao, NC; Feng, Y; Chai, RH; Yang, GX; He, GY				Wang, Chen; Deng, Pengyi; Chen, Liulin; Wang, Xiatian; Ma, Hui; Hu, Wei; Yao, Ningcong; Feng, Ying; Chai, Ruihong; Yang, Guangxiao; He, Guangyuan			A Wheat WRKY Transcription Factor TaWRKY10 Confers Tolerance to Multiple Abiotic Stresses in Transgenic Tobacco	PLOS ONE			English	Article							OXYGEN GENE NETWORK; PLANT-RESPONSES; SALT-STRESS; SEED-GERMINATION; ABSCISIC-ACID; EXPRESSION; ARABIDOPSIS; PROTEIN; OVEREXPRESSION; DROUGHT	WRKY transcription factors are reported to be involved in defense regulation, stress response and plant growth and development. However, the precise role of WRKY transcription factors in abiotic stress tolerance is not completely understood, especially in crops. In this study, we identified and cloned 10 WRKY genes from genome of wheat (Triticum aestivum L.). TaWRKY10, a gene induced by multiple stresses, was selected for further investigation. TaWRKY10 was upregulated by treatment with polyethylene glycol, NaCl, cold and H2O2. Result of Southern blot indicates that the wheat genome contains three copies of TaWRKY10. The TaWRKY10 protein is localized in the nucleus and functions as a transcriptional activator. Overexpression of TaWRKY10 in tobacco (Nicotiana tabacum L.) resulted in enhanced drought and salt stress tolerance, mainly demonstrated by the transgenic plants exhibiting of increased germination rate, root length, survival rate, and relative water content under these stress conditions. Further investigation showed that transgenic plants also retained higher proline and soluble sugar contents, and lower reactive oxygen species and malonaldehyde contents. Moreover, overexpression of the TaWRKY10 regulated the expression of a series of stress related genes. Taken together, our results indicate that TaWRKY10 functions as a positive factor under drought and salt stresses by regulating the osmotic balance, ROS scavenging and transcription of stress related genes.	[Wang, Chen; Deng, Pengyi; Chen, Liulin; Wang, Xiatian; Ma, Hui; Hu, Wei; Yao, Ningcong; Feng, Ying; Chai, Ruihong; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Chinese Minist Educ,Key Lab Mol Biophys,Chinese M, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Yang, GX (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Chinese Minist Educ,Key Lab Mol Biophys,Chinese M, Wuhan 430074, Peoples R China.	ygx@hust.edu.cn; hegy@hust.edu.cn			Ministry of Science and Technology of China [2009DFB30340]; National Genetically Modified New Varieties of Major Projects of China [2011ZX08002-004, 2011ZX08010-004]; Key Projects of Science and Technology Research of the Ministry of Education of China [109105]; Wuhan Municipal Science and Technology research project [201120922286]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Genetically Modified New Varieties of Major Projects of China; Key Projects of Science and Technology Research of the Ministry of Education of China(Ministry of Education, China); Wuhan Municipal Science and Technology research project	This work was supported by the International Science and Technology Cooperation Key Projects of the Ministry of Science and Technology of China (Grant No. 2009DFB30340), the National Genetically Modified New Varieties of Major Projects of China (2011ZX08002-004, 2011ZX08010-004), the Key Projects of Science and Technology Research of the Ministry of Education of China (Grant No. 109105) and the Wuhan Municipal Science and Technology research project (Grant No. 201120922286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoni R, 2011, CURR OPIN PLANT BIOL, V14, P547, DOI 10.1016/j.pbi.2011.06.004; Baxter CJ, 2001, ANN APPL BIOL, V138, P47, DOI 10.1111/j.1744-7348.2001.tb00084.x; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen L, 2010, MOL BIOL REP, V37, P737, DOI 10.1007/s11033-009-9582-7; Chen P, 2008, J CEREAL SCI, V48, P734, DOI 10.1016/j.jcs.2008.04.002; Chen S, 2005, PLANT PHYSIOL, V139, P1163, DOI 10.1104/pp.105.069468; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; DRAPER HH, 1993, FREE RADICAL BIO MED, V15, P353, DOI 10.1016/0891-5849(93)90035-S; Eshdat Y, 1997, PHYSIOL PLANTARUM, V100, P234, DOI 10.1034/j.1399-3054.1997.1000204.x; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; Garay-Arroyo A, 1999, YEAST, V15, P879, DOI 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.3.CO;2-H; Guillaumie S, 2010, PLANT MOL BIOL, V72, P215, DOI 10.1007/s11103-009-9563-1; Han QQ, 2012, MOL BIOL REP, V39, P1713, DOI 10.1007/s11033-011-0911-2; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hong JP, 2005, PLANTA, V220, P875, DOI 10.1007/s00425-004-1412-5; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hu W, 2012, PLANT CELL PHYSIOL, V53, P2127, DOI 10.1093/pcp/pcs154; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kong XP, 2011, PLANT CELL ENVIRON, V34, P1291, DOI 10.1111/j.1365-3040.2011.02329.x; Lagace M, 2004, PLANTA, V219, P185, DOI 10.1007/s00425-004-1253-2; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makandar R, 2010, MOL PLANT MICROBE IN, V23, P861, DOI 10.1094/MPMI-23-7-0861; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nevo E., 2002, EVOLUTION WILD EMMER; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Proietti S, 2011, J EXP BOT, V62, P1975, DOI 10.1093/jxb/erq396; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sathiyaraj G, 2011, MOL BIOL REP, V38, P2761, DOI 10.1007/s11033-010-0421-7; Shao HB, 2006, COLLOID SURFACE B, V53, P113, DOI 10.1016/j.colsurfb.2006.08.008; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; SHIEH MW, 1993, PLANT PHYSIOL, V101, P353, DOI 10.1104/pp.101.2.353; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; Song Y, 2009, CHINESE SCI BULL, V54, P4671, DOI 10.1007/s11434-009-0710-5; Takemoto D, 2003, PHYSIOL PLANTARUM, V118, P545, DOI 10.1034/j.1399-3054.2003.00145.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tseng MJ, 2007, PLANT PHYSIOL BIOCH, V45, P822, DOI 10.1016/j.plaphy.2007.07.011; Ueda M, 2011, DEV CELL, V20, P264, DOI 10.1016/j.devcel.2011.01.009; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Wang F, 2012, MOL BIOL REP, V39, P4553, DOI 10.1007/s11033-011-1245-9; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wilkinson MD, 2013, J CEREAL SCI, V57, P1, DOI 10.1016/j.jcs.2012.09.005; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Xie Z, 2007, PLANT MOL BIOL, V64, P293, DOI 10.1007/s11103-007-9152-0; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xiong X, 2010, MOL BREEDING, V25, P419, DOI 10.1007/s11032-009-9341-4; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zhou SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052439; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zou CS, 2010, J EXP BOT, V61, P3901, DOI 10.1093/jxb/erq204	71	334	360	17	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65120	10.1371/journal.pone.0065120	http://dx.doi.org/10.1371/journal.pone.0065120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762295	Green Published, gold, Green Submitted			2022-12-25	WOS:000320440500026
J	Wang, HLS; Yu, RJ; Wu, YT; Lee, WY; Lin, MF; Chen, CY; Shen, EY				Wang, Hsiao-Lan Sharon; Yu, Rongjun; Wu, Yu-Tzu; Lee, Wen-Yuan; Lin, Ming-Fan; Chen, Chia-Yuan; Shen, Ein-Yiao			The Changes of Cerebral Morphology Related to Aging in Taiwanese Population	PLOS ONE			English	Article							AGE-RELATED-CHANGES; WHITE-MATTER; PHYSICAL-ACTIVITY; CHILDREN-A; BRAIN; MR; VOLUME; ADULT; MECHANISMS; PATTERNS	A cross-sectional study with the 3-dimensional (3D) MRI reconstruction technique was conducted to investigate cerebral complexity changes related to age differences in native Taiwanese population. In our sample of 85 participants aged between 25 and 81, age was associated with gradual ventricular expansion. A nonlinear quadratic relationship between white matter volume and age was found overall in the brain. Widespread age-related reduction in white matter was detected from late adulthood onwards. However, no significant age-related changes in the cortex and whole brain volume were determined throughout adulthood. These findings provided information in describing brain structural complexity, which might in the future serve as an objective diagnostic index or as a predictive parameter for neurological diseases. Our method then may be used for cross-cultural longitudinal studies to evaluate the effect of disease, environment and aging on the brain.	[Wang, Hsiao-Lan Sharon] Natl Taiwan Normal Univ, Dept Special Educ, Taipei, Taiwan; [Yu, Rongjun] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Wu, Yu-Tzu] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Lee, Wen-Yuan; Shen, Ein-Yiao] China Med Univ Hosp, Taipei Branch, Taipei, Taiwan; [Lin, Ming-Fan; Chen, Chia-Yuan; Shen, Ein-Yiao] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan	National Taiwan Normal University; South China Normal University; South China Normal University; University of Cambridge; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Shen, EY (corresponding author), China Med Univ Hosp, Taipei Branch, Taipei, Taiwan.	acupmoxi123@gmail.com	Chen, Chia-Yuan/N-7780-2014; Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524; Chen, Chun-Hong/0000-0002-5166-9017; Wang, Hui-Min/0000-0002-4692-4917; Ho, Mei-Ling/0000-0001-8064-8488; Wu, Yu-Tzu/0000-0002-0874-4448	National Science Council in Taiwan, NSC [99-2320-B-039-018-MY2]	National Science Council in Taiwan, NSC	This study was supported the National Science Council in Taiwan, NSC 99-2320-B-039-018-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Blanton RE, 2001, PSYCHIAT RES-NEUROIM, V107, P29, DOI 10.1016/S0925-4927(01)00091-9; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Boss B J, 1991, SCI Nurs, V8, P42; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Free SL, 1996, CEREB CORTEX, V6, P830, DOI 10.1093/cercor/6.6.830; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Goh JO, 2007, COGN AFFECT BEHAV NE, V7, P44, DOI 10.3758/CABN.7.1.44; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; Gunning-Dixon FM, 1998, AM J NEURORADIOL, V19, P1501; Hillman CH, 2006, HEALTH PSYCHOL, V25, P678, DOI 10.1037/0278-6133.25.6.678; Hobbs F, 2000, CENSUS 2000 SPECIAL; Hof PR, 2004, TRENDS NEUROSCI, V27, P607, DOI 10.1016/j.tins.2004.07.013; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Luders E, 2004, NAT NEUROSCI, V7, P799, DOI 10.1038/nn1277; Maillet D, 2011, BRAIN RES, V1420, P68, DOI 10.1016/j.brainres.2011.08.071; MILLER AKH, 1980, NEUROPATH APPL NEURO, V6, P119, DOI 10.1111/j.1365-2990.1980.tb00283.x; Mrak RE, 1997, J NEUROPATH EXP NEUR, V56, P1269, DOI 10.1097/00005072-199712000-00001; Shen EY, 2010, CHILD NERV SYST, V26, P1619, DOI 10.1007/s00381-010-1280-1; SKULLERUD K, 1985, ACTA NEUROL SCAND, V71, P5; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wang X, 1985, Popul Res, V2, P24; Webb SJ, 2001, DEV NEUROPSYCHOL, V19, P147, DOI 10.1207/S15326942DN1902_2; Wu KH, 2011, PEDIATR RES, V69, P80, DOI 10.1203/PDR.0b013e3181ff2f6c; Xu J, 2000, AM J NEURORADIOL, V21, P112	35	81	85	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2013	8	1							e55241	10.1371/journal.pone.0055241	http://dx.doi.org/10.1371/journal.pone.0055241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077JK	23762223	gold, Green Submitted, Green Published			2022-12-25	WOS:000314023600161
J	Lee, JK; So, KA; Piyathilake, CJ; Kim, MK				Lee, Jae Kwan; So, Kyeong A.; Piyathilake, Chandrika J.; Kim, Mi Kyung			Mild Obesity, Physical Activity, Calorie Intake, and the Risks of Cervical Intraepithelial Neoplasia and Cervical Cancer	PLOS ONE			English	Article							BODY-MASS INDEX; POSTMENOPAUSAL BREAST-CANCER; NIH-AARP DIET; OVARIAN-CANCER; WOMEN; ASSOCIATION; PROSTATE; IMPACT; COHORT; EPIDEMIOLOGY	Objective: We investigated whether obesity, physical activity, and calorie intake are associated with the risks of cervical intraepithelial neoplasia (CIN) and cervical cancer. Methods: We enrolled 1125 women (age, 18-65 years) into a human papillomavirus cohort study established from 2006 to 2012. Multinomial logistic regression models were used to estimate crude and multivariate odds ratios (ORs) and the corresponding 95% confidence intervals (95% CIs), and to assess whether body mass index (BMI), height, weight, total calorie intake, and physical activity were associated with the risks of CIN and cervical cancer. Results: Cervical cancer risk was positively associated with BMI and inversely associated with physical activity. When compared with women with a normal BMI (18.5-23 kg/m(2)), the multivariate ORs (95% CIs) for those overweight (23-25 kg/m(2)) and mild obesity (>= 25 kg/m(2)) were 1.25 (0.79-2.00) and 1.70 (1.10-2.63), respectively. When compared with women with the lowest tertile of physical activity (<38.5 MET-hours/week), the ORs (95% CIs) for cervical cancer were 0.95 (0.61-1.48) and 0.61 (0.38-0.98) for women with medium physical activity (38.5-71.9 MET-hours/week) and those with high physical activity (72 MET-hours/week), respectively (p for linear trend = 0.03). The CIN2/3 risk was inversely associated with physical activity after adjustment for confounders. Compared with women with low physical activity (< 38.5 MET-hours/week), the ORs (95% CIs) for CIN2/3 were 0.64 (0.40-1.01) and 0.58 (0.36-0.93) for the medium and high physical activity groups, respectively (p for linear trend = 0.02). Total calorie intake was not statistically associated with the risks of CIN and cervical cancer after adjustment for confounders. Conclusion: Our results indicate that in addition to screening for and treatment of CIN, recommendations on the maintenance of an appropriate BMI with an emphasis on physical activity could be an important preventive strategy against the development of cervical cancer.	[Lee, Jae Kwan; So, Kyeong A.] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea; [Piyathilake, Chandrika J.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Kim, Mi Kyung] Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Alabama System; University of Alabama Birmingham; National Cancer Center - Korea (NCC)	Kim, MK (corresponding author), Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea.	alrud@ncc.re.kr	Auger, Cyril/N-4702-2016; Kang, Moonkyu/AAR-8974-2021; Oak, Min-Ho/AAE-7405-2020	LEE, Jae Kwan/0000-0003-3101-6403; Kang, Moonkyu/0000-0002-2039-4866	Korea National Cancer Center [NCC-1110320, NCC-1310361]	Korea National Cancer Center	This study was supported by a grant-in-aid from the Korea National Cancer Center (grant no. NCC-1110320, NCC-1310361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Aldrich T, 2010, J MIDWIFERY WOM HEAL, V55, P344, DOI 10.1016/j.jmwh.2009.10.001; [Anonymous], 2002, WEIGHT CONTR PHYS AC; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Brown Pamela, 2002, W V Med J, V98, P271; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castle Philip E, 2003, J Natl Cancer Inst Monogr, P29; Chang SC, 2006, CANCER EPIDEM BIOMAR, V15, P334, DOI 10.1158/1055-9965.EPI-05-0479; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; Deurenberg-Yap M, 2001, INT J OBESITY, V25, P1554, DOI 10.1038/sj.ijo.0801739; Gierach GL, 2009, INT J CANCER, V124, P2139, DOI 10.1002/ijc.24059; Hwang JH, 2010, INT J GYNECOL CANCER, V20, P398, DOI 10.1111/IGC.0b013e3181d02ff2; Hwang JH, 2010, CANCER CAUSE CONTROL, V21, P51, DOI 10.1007/s10552-009-9433-9; Inoue M, 2008, AM J EPIDEMIOL, V168, P391, DOI 10.1093/aje/kwn146; James PT, 2001, OBES RES, V9, p228S, DOI 10.1038/oby.2001.123; Kim YO, 2009, BRIT J NUTR, V101, P1218, DOI 10.1017/S0007114508061497; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Korea Health Industry Development Institute Ministry of Health and Welfare, 2000, DEV NUTR DAT REC PRO; Lacey JV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-84; Lacey JV, 2003, CANCER-AM CANCER SOC, V98, P814, DOI 10.1002/cncr.11567; Lane Geoffrey, 2008, Menopause Int, V14, P33, DOI 10.1258/mi.2007.007036; Lee GJ, 2005, J KOREAN MED SCI, V20, P267, DOI 10.3346/jkms.2005.20.2.267; Lundqvist E, 2007, INT J CANCER, V121, P810, DOI 10.1002/ijc.22746; Maruthur NM, 2009, OBESITY, V17, P375, DOI 10.1038/oby.2008.480; Mitchell RS, 2008, AM J PREV MED, V35, P127, DOI 10.1016/j.amepre.2008.03.031; Modesitt SC, 2005, OBSTET GYNECOL SURV, V60, P683, DOI 10.1097/01.ogx.0000180866.62409.01; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Patil V, 2006, Indian J Public Health, V50, P38; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Peters TM, 2009, CANCER EPIDEM BIOMAR, V18, P289, DOI 10.1158/1055-9965.EPI-08-0768; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Rajkumar T, 2003, BRIT J CANCER, V88, P1388, DOI 10.1038/sj.bjc.6600902; Regional Office for the Western Pacific/World Health Organization International Obesity TaskForce/International Association for the Study of Obesity, 2000, AS PAC PERSP RED OB; Rieck G, 2006, BEST PRACT RES CL OB, V20, P227, DOI 10.1016/j.bpobgyn.2005.10.010; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; SCHIFFMAN MH, 1995, CANCER-AM CANCER SOC, V76, P1888, DOI 10.1002/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H; SCHILL W, 1993, BIOMETRIKA, V80, P339, DOI 10.2307/2337204; Schouten LJ, 2008, CANCER EPIDEM BIOMAR, V17, P902, DOI 10.1158/1055-9965.EPI-07-2524; Schouten LJ, 2004, JNCI-J NATL CANCER I, V96, P1635, DOI 10.1093/jnci/djh291; SHEPHARD RJ, 1995, CAN J APPL PHYSIOL, V20, P1, DOI 10.1139/h95-001; Song SH, 2008, GYNECOL ONCOL, V108, P543, DOI 10.1016/j.ygyno.2007.11.006; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Stefanescu B I, 2007, Rev Med Chir Soc Med Nat Iasi, V111, P155; Stein CJ, 2004, BRIT J CANCER, V90, P299, DOI 10.1038/sj.bjc.6601509; Tong SY, 2010, CANCER CAUSE CONTROL, V21, P23, DOI 10.1007/s10552-009-9430-z; TORNBERG SA, 1994, BRIT J CANCER, V69, P358, DOI 10.1038/bjc.1994.65; Ulmer H, 2012, GYNECOL ONCOL, V125, P330, DOI 10.1016/j.ygyno.2012.01.052; van Gils CH, 2009, CANCER EPIDEM BIOMAR, V18, P377, DOI 10.1158/1055-9965.EPI-08-0823; Velthuis MJ, 2009, MENOPAUSE, V16, P777, DOI [10.1097/GME.0b013e318197122a, 10.1097/gme.0b013e318197122a]; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; WHO, 2004, LANCET, V363, P902; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2000, INT ASS STUD OB INT; Yajnik C S, 2002, Obes Rev, V3, P217, DOI 10.1046/j.1467-789X.2002.00072.x; Yoo K Y, 1997, J Epidemiol, V7, P117; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	60	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66555	10.1371/journal.pone.0066555	http://dx.doi.org/10.1371/journal.pone.0066555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23755196	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400111
J	Moreira, GF; Batista, ESD; Campos, HBN; Lemos, RE; Ferreira, MD				Moreira, Grazielle Furtado; de Paula Batista, Elder Simoes; Neves Campos, Henrique Borges; Lemos, Raphael Emilio; Ferreira, Marcelo da Costa			Spray Nozzles, Pressures, Additives and Stirring Time on Viability and Pathogenicity of Entomopathogenic Nematodes (Nematoda: Rhabditida) for Greenhouses	PLOS ONE			English	Article							STEINERNEMA-FELTIAE; HETERORHABDITIDAE; INFECTIVITY; LARVAE	The objective of this study was to evaluate different strategies for the application of entomopathogenic nematodes (EPN). Three different models of spray nozzles with air induction (AI 11003, TTI 11003 and AD-IA 11004), three spray pressures (207, 413 and 720 kPa), four different additives for tank mixtures (cane molasses, mineral oil, vegetable oil and glycerin) and the influence of tank mixture stirring time were all evaluated for their effect on EPN (Steinernema feltiae) viability and pathogenicity. The different nozzles, at pressures of up to 620 kPa, were found to be compatible with S. feltiae. Vegetable oil, mineral oil and molasses were found to be compatible adjuvants for S. feltiae, and stirring in a motorized backpack sprayer for 30 minutes did not impact the viability or pathogenicity of this nematode. Appropriate techniques for the application of nematodes with backpack sprayers are discussed.	[Moreira, Grazielle Furtado; de Paula Batista, Elder Simoes; Neves Campos, Henrique Borges; Lemos, Raphael Emilio; Ferreira, Marcelo da Costa] Univ Estadual Paulista UNESP, Dept Fitossanidade, Sao Paulo, Brazil	Universidade Estadual Paulista	Moreira, GF (corresponding author), Univ Estadual Paulista UNESP, Dept Fitossanidade, Jaboticabal Campus, Sao Paulo, Brazil.	grabiologia@yahoo.com.br	C, Ferreira M/C-6165-2012; Batista, Elder/D-3077-2014; McBride, Alan/D-4106-2012	C, Ferreira M/0000-0002-0159-7422; Batista, Elder/0000-0003-2794-0468; McBride, Alan/0000-0001-9682-540X				Adams Byron J., 2002, P1, DOI 10.1079/9780851995670.0001; Andalo V., 2009, Nematologia Mediterranea, V37, P11; Cunha J.P.A.R., 2003, Planta daninha, V21, P325, DOI 10.1590/S0100-83582003000200019; Cunha JPAR, 2010, PLANTA DANINHA, V28, P1153, DOI 10.1590/S0100-83582010000500023; Da Camara FT, 2008, ENG AGR-JABOTICABAL, V28, P740, DOI 10.1590/S0100-69162008000400014; DUTKY SR, 1964, J INSECT PATHOL, V6, P417; Fernandes Ana P., 2007, Eng. Agríc., V27, P728, DOI 10.1590/S0100-69162007000400016; Ferraz L.C.C.B, 2008, CONTROLE MICROBIANO, V14, P171; Ferraz LCCB, 1998, CONTROLE MICROBIANO, P541; Fife JP, 2007, APPL ENG AGRIC, V23, P405; Fife JP, 2005, T ASAE, V48, P45, DOI 10.13031/2013.17939; Fife JP, 2004, BIOTECHNOL BIOENG, V86, P96, DOI 10.1002/bit.10879; Fife JP, 2003, BIOL CONTROL, V27, P65, DOI 10.1016/S1049-9644(02)00183-4; Garcia Luiz C., 2005, Eng. Agríc., V25, P783; Garcia LC, 2008, NEOTROP ENTOMOL, V37, P305, DOI 10.1590/S1519-566X2008000300010; Gaugler R., 2002, Entomopathogenic nematology, P289, DOI 10.1079/9780851995670.0289; Grewal P. S., 2002, Entomopathogenic nematology, P265, DOI 10.1079/9780851995670.0265; Lara JC, 2008, SCI AGR, V65, P433, DOI 10.1590/S0103-90162008000400017; Mahmoud M. F., 2007, Nematologia Mediterranea, V35, P221; Matthews G. A., 2000, PESTICIDE APPL METHO, V3; Miller P.C.H., 2008, 22 ILASS EUROPE; Molina Acevedo Juan Pablo, 2001, Revista Colombiana de Entomologia, V27, P73; Nilsson U, 1999, CROP PROT, V18, P53, DOI 10.1016/S0261-2194(98)00095-7; Parra JRP, 1998, CONTROLE MICROBIANO, P1015; Queiroz AA, 2008, BIOSCI J, V24, P8; Scheepmaker JWA, 1998, BIOCONTROL, V43, P201, DOI 10.1023/A:1009954401065; Susurluk IA, 2011, TURK J AGRIC FOR, V35, P413, DOI 10.3906/tar-1002-715; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a	28	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65759	10.1371/journal.pone.0065759	http://dx.doi.org/10.1371/journal.pone.0065759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	24260572	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000103
J	Messe, A; Caplain, S; Pelegrini-Issac, M; Blancho, S; Levy, R; Aghakhani, N; Montreuil, M; Benali, H; Lehericy, S				Messe, Arnaud; Caplain, Sophie; Pelegrini-Issac, Melanie; Blancho, Sophie; Levy, Richard; Aghakhani, Nozar; Montreuil, Michele; Benali, Habib; Lehericy, Stephane			Specific and Evolving Resting-State Network Alterations in Post-Concussion Syndrome Following Mild Traumatic Brain Injury	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; HEAD-INJURY; SYMPTOMS; SUBJECT; LEVEL; PHASE	Post-concussion syndrome has been related to axonal damage in patients with mild traumatic brain injury, but little is known about the consequences of injury on brain networks. In the present study, our aim was to characterize changes in functional brain networks following mild traumatic brain injury in patients with post-concussion syndrome using resting-state functional magnetic resonance imaging data. We investigated 17 injured patients with persistent post-concussion syndrome (under the DSM-IV criteria) at 6 months post-injury compared with 38 mild traumatic brain injury patients with no post-concussion syndrome and 34 healthy controls. All patients underwent magnetic resonance imaging examinations at the subacute (1-3 weeks) and late (6 months) phases after injury. Group-wise differences in functional brain networks were analyzed using graph theory measures. Patterns of long-range functional networks alterations were found in all mild traumatic brain injury patients. Mild traumatic brain injury patients with post-concussion syndrome had greater alterations than patients without post-concussion syndrome. In patients with post-concussion syndrome, changes specifically affected temporal and thalamic regions predominantly at the subacute stage and frontal regions at the late phase. Our results suggest that the post-concussion syndrome is associated with specific abnormalities in functional brain network that may contribute to explain deficits typically observed in PCS patients.	[Messe, Arnaud; Pelegrini-Issac, Melanie; Benali, Habib] Univ Paris 06, INSERM, Lab Imagerie Fonct, UMRS 678, Paris, France; [Messe, Arnaud; Pelegrini-Issac, Melanie; Benali, Habib; Lehericy, Stephane] Univ Paris 11, IFR49, DSV NeuroSpin I2BM, Gif Sur Yvette, France; [Caplain, Sophie; Montreuil, Michele] Univ Paris 08, EA 2027, St Denis, France; [Blancho, Sophie] Inst Rech Moelle Epiniere & Encephale, Paris, France; [Levy, Richard; Lehericy, Stephane] Univ Paris 06, INSERM, Grp Hosp Pitie Salpetriere, UMRS 975,CNRS UMR 7225,CRICM, Paris, France; [Levy, Richard] Hop St Antoine, Assistance Publ Hop Paris, F-75571 Paris, France; [Aghakhani, Nozar] Hop Univ Bicetre, Assistance Publ Hop Paris, Neurosurg Dept, Le Kremlin Bicetre, France; [Benali, Habib] Univ Montreal, MIC UNF, Montreal, PQ, Canada; [Lehericy, Stephane] Univ Paris 06, CHU Pitie Salpetriere, CENIR, Ctr Neuroimaging Res, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Universite Paris-VIII; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Messe, A (corresponding author), Univ Paris 06, INSERM, Lab Imagerie Fonct, UMRS 678, Paris, France.	Arnaud.Messe@imed.jussieu.fr	aghakhani, nozar/ABF-7908-2021; Levy, Richard/D-8411-2011; Messé, Arnaud/I-1738-2019	Messé, Arnaud/0000-0001-9081-3088; aghakhani, nozar/0000-0001-8389-8167; Pelegrini-Issac, Melanie/0000-0003-3260-5795	IRME (Institut pour la Recherche sur la Moelle Epiniere et l'Encephale); GMF (Garantie Mutuelle des Fonctionnaires); program "Investissements d'avenir" [ANR-10-IAIHU-06]	IRME (Institut pour la Recherche sur la Moelle Epiniere et l'Encephale); GMF (Garantie Mutuelle des Fonctionnaires); program "Investissements d'avenir"(French National Research Agency (ANR))	This study was initiated by the IRME (Institut pour la Recherche sur la Moelle Epiniere et l'Encephale) and supported by a grant from the GMF (Garantie Mutuelle des Fonctionnaires). The research leading to these results has received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00010]; APA, 1994, DIAGN STAT MAN MENT; Azouvi P, 2001, REV NEUROPSYCHOL, V11, P383; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benjamini Y, 2001, ANN STAT, V29, P1165; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bressler SL, 2006, INT J PSYCHOPHYSIOL, V60, P139, DOI 10.1016/j.ijpsycho.2005.12.008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FitzGerald DB, 2011, INT J PSYCHOPHYSIOL, V82, P79, DOI 10.1016/j.ijpsycho.2011.02.011; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Ginestet CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021570; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hou R, 2011, J NEUROL NEUROSUR PS, V83, P217; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Irimia A, 2012, NEUROIMAGE, V60, P1340, DOI 10.1016/j.neuroimage.2012.01.107; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Legome E, 2006, POSTCONCUSSION SYNDR; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sandrone S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00261; Sandrone S, 2012, J NEUROSCI, V32, P1915, DOI 10.1523/JNEUROSCI.5637-11.2012; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O., 2016, NETWORKS BRAIN; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Wild KRH, 2008, ACT NEUR S, V101, P55; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Xia M, 2011, P 17 INT C FUNCT MAP; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068	69	90	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65470	10.1371/journal.pone.0065470	http://dx.doi.org/10.1371/journal.pone.0065470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23755237	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000072
J	Lee, JO; Auger, C; Park, DH; Kang, M; Oak, MH; Kim, KR; Schini-Kerth, VB				Lee, Jung-Ok; Auger, Cyril; Park, Dong Hyun; Kang, Moonkyu; Oak, Min-Ho; Kim, Kyoung Rak; Schini-Kerth, Valerie B.			An Ethanolic Extract of Lindera obtusiloba Stems, YJP-14, Improves Endothelial Dysfunction, Metabolic Parameters and Physical Performance in Diabetic db/db Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; II-INDUCED HYPERTENSION; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; VASCULAR REACTIVITY; PIOGLITAZONE; PREVALENCE; CELLS; RISK; RATS	Lindera obtusiloba is a medicinal herb traditionally used in Asia for improvement of blood circulation, treatment of inflammation, and prevention of liver damage. A previous study has shown that an ethanolic extract of Lindera obtusiloba stems (LOE) has vasoprotective and antihypertensive effects. The possibility that Lindera obtusiloba improves endothelial function and metabolic parameters in type 2 diabetes mellitus (T2DM) remains to be examined. Therefore, the aim of the present study was to determine the potential of LOE to prevent the development of an endothelial dysfunction, and improve metabolic parameters including hyperglycemia, albuminuria and physical exercise capacity in db/db mice, an experimental model of T2DM. The effect of LOE (100 mg/kg/day by gavage for 8 weeks) on these parameters was compared to that of an oral antidiabetic drug, pioglitazone (30 mg/kg/day by gavage). Reduced blood glucose level, body weight and albumin-creatinine ratio were observed in the group receiving LOE compared to the control db/db group. The LOE treatment improved endothelium-dependent relaxations, abolished endothelium-dependent contractions to acetylcholine in the aorta, and normalized the increased vascular oxidative stress and expression of NADPH oxidase, cyclooxygenases, angiotensin II, angiotensin type 1 receptors and peroxynitrite and the decreased expression of endothelial NO synthase in db/db mice. The angiotensin-converting enzyme (ACE) activity was reduced in the LOE group compared to that in the control db/db group. LOE also inhibited the activity of purified ACE, COX-1 and COX-2 in a dose-dependent manner. In addition, LOE improved physical exercise capacity. Thus, the present findings indicate that LOE has a beneficial effect on the vascular system in db/db mice by improving endothelium-dependent relaxations and vascular oxidative stress most likely by normalizing the angiotensin system, and also on metabolic parameters, and these effects are associated with an enhanced physical exercise capacity.	[Lee, Jung-Ok; Auger, Cyril; Schini-Kerth, Valerie B.] Univ Strasbourg, CNRS, Fac Pharm, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France; [Lee, Jung-Ok; Kang, Moonkyu; Kim, Kyoung Rak] Hanwha Pharma Co Ltd, Ctr Res & Dev, Chunchon, South Korea; [Park, Dong Hyun] YangJi Chem, Res Ctr, Suwon, South Korea; [Oak, Min-Ho] Mokpo Natl Univ, Coll Pharm, Muan, Jeonam, South Korea	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Mokpo National University	Schini-Kerth, VB (corresponding author), Univ Strasbourg, CNRS, Fac Pharm, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Auger, Cyril/N-4702-2016; Kang, Moonkyu/AAR-8974-2021; Oak, Min-Ho/AAE-7405-2020	LEE, Jae Kwan/0000-0003-3101-6403; Kang, Moonkyu/0000-0002-2039-4866	The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program [70007579]; Hanwha Pharma. Co., Ltd; Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea	The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Hanwha Pharma. Co., Ltd; Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea	The study was supported, in part, by The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program (number 70007579), and by Hanwha Pharma. Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jung-Ok Lee, Moonkyu Kang and Kyoung Rak Kim are all employees of Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea, whose company provided funding toward this study. Dong Hyun Park is an employee of YangJi Chemicals, Suwon, Republic of Korea, which is a daughter company of Hanwha. Hanwha has filed a European and US patent on YJP14 and endothelial dysfunction. The Korean FDA have approved further clinical studies regarding YJP-14 and endothelial dysfunction in diabetes. At present there are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.	Ajay M, 2006, VASC PHARMACOL, V45, P127, DOI 10.1016/j.vph.2006.05.001; Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Bakker W, 2009, CELL TISSUE RES, V335, P165, DOI 10.1007/s00441-008-0685-6; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; Capellini VK, 2010, CURR VASC PHARMACOL, V8, P526; CHANG KC, 1993, J PHARMACOL EXP THER, V266, P992; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; Cohen RA, 2010, J CARDIOVASC PHARM, V55, P308, DOI 10.1097/FJC.0b013e3181d89670; Ding H, 2010, PFLUG ARCH EUR J PHY, V459, P977, DOI 10.1007/s00424-010-0807-3; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Freise C, 2010, J NUTR BIOCHEM, V21, P1170, DOI 10.1016/j.jnutbio.2009.09.013; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Henry RMA, 2004, ATHEROSCLEROSIS, V174, P49, DOI 10.1016/j.atherosclerosis.2004.01.002; Idris-Khodja N, 2012, N-S ARCH PHARMACOL, V385, P749, DOI 10.1007/s00210-012-0749-8; Ihm SH, 2009, ATHEROSCLEROSIS, V206, P47, DOI 10.1016/j.atherosclerosis.2009.01.036; Jimenez R, 2007, FREE RADICAL BIO MED, V43, P462, DOI 10.1016/j.freeradbiomed.2007.05.007; Johnson DK, 2002, ENDOTHELIUM-J ENDOTH, V9, P191, DOI 10.1080/10623320213638; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kanda Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE278, DOI 10.1152/ajpendo.00388.2009; Kusunoki M, 2011, EUR J PHARMACOL, V668, P486, DOI 10.1016/j.ejphar.2011.07.030; Lee JO, 2011, N-S ARCH PHARMACOL, V383, P635, DOI 10.1007/s00210-011-0643-9; Lewis TV, 1999, J AM COLL CARDIOL, V33, P805, DOI 10.1016/S0735-1097(98)00667-6; Liang W, 2008, J PHYSIOL SCI, V58, P405, DOI 10.2170/physiolsci.RP012808; Lim YK, 2002, ATHEROSCLEROSIS, V160, P311, DOI 10.1016/S0021-9150(01)00576-7; Mohan S, 2008, LAB INVEST, V88, P515, DOI 10.1038/labinvest.2008.23; Musicki B, 2010, J SEX MED, V7, P3023, DOI 10.1111/j.1743-6109.2010.01880.x; Nichols GA, 2001, DIABETES CARE, V24, P1614, DOI 10.2337/diacare.24.9.1614; ODriscoll G, 1997, J CLIN INVEST, V100, P678, DOI 10.1172/JCI119580; Okudan N, 2011, J MED FOOD, V14, P1298, DOI 10.1089/jmf.2010.0030; Ota H, 2010, ARTERIOSCL THROM VAS, V30, P2205, DOI 10.1161/ATVBAHA.110.210500; Park JH, 2011, J BIOCHEM MOL TOXIC, V25, P238, DOI 10.1002/jbt.20381; Park Y, 2008, AM J PHYSIOL-HEART C, V295, pH1982, DOI 10.1152/ajpheart.01261.2007; Plutzky J, 2011, AM J CARDIOL, V108, p25B, DOI 10.1016/j.amjcard.2011.03.014; Regensteiner JG, 2003, VASC MED, V8, P169, DOI 10.1191/1358863x03vm489oa; Sallam N, 2011, N-S ARCH PHARMACOL, V383, P483, DOI 10.1007/s00210-011-0614-1; Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022; Savage S, 1996, DIABETES CARE, V19, P1243, DOI 10.2337/diacare.19.11.1243; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Sharma A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/750126; Smith SR, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2004.07.008; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Sridulyakul P, 2006, CLIN HEMORHEOL MICRO, V34, P315; Stapleton PA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-54; Thompson D, 2001, Obes Rev, V2, P189, DOI 10.1046/j.1467-789x.2001.00037.x; Ting HH, 1996, J CLIN INVEST, V97, P22, DOI 10.1172/JCI118394; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; Urso C, 2011, MINERVA MED, V102, P59; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wang XR, 2011, AM J PHYSIOL-ENDOC M, V300, pE1135, DOI 10.1152/ajpendo.00001.2011; Wong WT, 2010, ANTIOXID REDOX SIGN, V13, P757, DOI 10.1089/ars.2009.2831; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Yook C., 1997, COLORED MED PLANTS K, P588; Zanetti M, 2010, EXP GERONTOL, V45, P848, DOI 10.1016/j.exger.2010.07.002; Zhang HR, 2010, AM J PHYSIOL-HEART C, V299, pH985, DOI 10.1152/ajpheart.00489.2010; Zhang SL, 2007, PEDIATR NEPHROL, V22, P813, DOI 10.1007/s00467-007-0444-z; Zheng Z, 2011, DIABETES	64	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65227	10.1371/journal.pone.0065227	http://dx.doi.org/10.1371/journal.pone.0065227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755196	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300059
J	Zhang, HD; Song, J; Ren, H; Xu, ZR; Wang, XN; Shan, LF; Fang, J				Zhang, Huidan; Song, Jin; Ren, Hui; Xu, Zhangrun; Wang, Xiaonan; Shan, Lianfeng; Fang, Jin			Detection of Low-Abundance KRAS Mutations in Colorectal Cancer Using Microfluidic Capillary Electrophoresis-Based Restriction Fragment Length Polymorphism Method with Optimized Assay Conditions	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; K-RAS MUTATIONS; CONTEMPORARY SAMPLE STACKING; REAL-TIME PCR; MICROCHIP ELECTROPHORESIS; FLUORESCENCE DETECTION; 1ST-LINE TREATMENT; ANTIBODY THERAPY; ENERGY-TRANSFER; DNA	Constitutively active KRAS mutations have been found to be involved in various processes of cancer development, and render tumor cells resistant to EGFR-targeted therapies. Mutation detection methods with higher sensitivity will increase the possibility of choosing the correct individual therapy. Here, we established a highly sensitive and efficient microfluidic capillary electrophoresis-based restriction fragment length polymorphism (mu CE-based RFLP) platform for low-abundance KRAS genotyping with the combination of mu CE and RFLP techniques. By using our self-built sensitive laser induced fluorescence (LIF) detector and a new DNA intercalating dye YOYO-1, the separation conditions of mu CE for Phi 174 HaeIII DNA marker were first optimized. Then, a Mav I digested 107-bp KRAS gene fragment was directly introduced into the microfluidic device and analyzed by mu CE, in which field amplified sample stacking (FASS) technique was employed to obtain the enrichment of the RFLP digestion products and extremely improved the sensitivity. The accurate analysis of KRAS statuses in HT29, LS174T, CCL187, SW480, Clone A, and CX-1 colorectal cancer (CRC) cell lines by mu CE-based RFLP were achieved in 5 min with picoliter-scale sample consumption, and as low as 0.01% of mutant KRAS could be identified from a large excess of wild-type genomic DNA (gDNA). In 98 paraffin-embedded CRC tissues, KRAS codon 12 mutations were discovered in 28 (28.6%), significantly higher than that obtained by direct sequencing (13, 13.3%). Clone sequencing confirmed these results and showed this system could detect at least 0.4% of the mutant KRAS in CRC tissue slides. Compared with direct sequencing, the new finding of the mu CE-based RFLP platform was that KRAS mutations in codon 12 were correlated with the patient's age. In conclusion, we established a sensitive, fast, and cost-effective screening method for KRAS mutations, and successfully detected low-abundance KRAS mutations in clinical samples, which will allow provision of more precise individualized cancer therapy.	[Zhang, Huidan; Song, Jin; Wang, Xiaonan; Fang, Jin] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang, Peoples R China; [Zhang, Huidan; Song, Jin; Wang, Xiaonan; Fang, Jin] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Ren, Hui] Shenyang Anal Rectum Hosp, Dept Colon Surg, Shenyang, Peoples R China; [Xu, Zhangrun] Northeastern Univ, Res Ctr Analyt Sci, Shenyang, Peoples R China; [Shan, Lianfeng] China Med Univ, Coll Basic Med Sci, Dept Math, Shenyang, Peoples R China	China Medical University; China Medical University; Northeastern University - China; China Medical University	Fang, J (corresponding author), China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Dept Cell Biol, Shenyang, Peoples R China.	jfang61@gmail.com	Zhang, Huidan/K-8399-2015; Zhang, Hai-Lin/H-2715-2017	Chen, Guifen/0000-0002-5459-660X; Zhang, Hai-Lin/0000-0002-7426-2885	National Natural Science Foundation of China [30901727, 20975019, 20875103, 20375047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No. 30901727, 20975019, 20875103, 20375047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine R, 2009, J PHARMACEUT BIOMED, V50, P947, DOI 10.1016/j.jpba.2009.06.034; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Assenat E, 2011, ONCOLOGIST, V16, P1557, DOI 10.1634/theoncologist.2011-0141; Beard NR, 2003, ELECTROPHORESIS, V24, P732, DOI 10.1002/elps.200390088; BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5720, DOI 10.1093/nar/21.24.5720; BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5727, DOI 10.1093/nar/21.24.5727; Bornholdt J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-53; CAPELLA G, 1991, ENVIRON HEALTH PERSP, V93, P125, DOI 10.2307/3431180; Cavallini A, 2010, ANTICANCER RES, V30, P5251; Chowdhury J, 2007, J MOL DIAGN, V9, P521, DOI 10.2353/jmoldx.2007.070014; DELATTRE O, 1989, LANCET, V2, P353; Evenhuis CJ, 2009, ELECTROPHORESIS, V30, P897, DOI 10.1002/elps.200800643; Fang Q, 2002, ANAL CHEM, V74, P1223, DOI 10.1021/ac010925c; Gebauer P, 2009, ELECTROPHORESIS, V30, pS27, DOI 10.1002/elps.200900053; Gotz S, 2007, ANAL BIOANAL CHEM, V387, P183, DOI 10.1007/s00216-006-0820-8; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia ZJ, 2004, ANAL CHEM, V76, P5597, DOI 10.1021/ac0494477; Jiang GF, 2000, BIOSENS BIOELECTRON, V14, P861, DOI 10.1016/S0956-5663(99)00056-1; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kleparnik K, 2007, CHEM REV, V107, P5279, DOI 10.1021/cr0101860; Ko JMY, 1998, CANCER LETT, V134, P169, DOI 10.1016/S0304-3835(98)00257-2; Lanthaler AJ, 2011, DIAGN MOL PATHOL, V20, P90, DOI 10.1097/PDM.0b013e31820e5f9a; Li J, 2008, NAT MED, V14, P579, DOI 10.1038/nm1708; LODA M, 1994, HUM PATHOL, V25, P564, DOI 10.1016/0046-8177(94)90220-8; Loupakis F, 2012, CANCER-AM CANCER SOC, V118, P1523, DOI 10.1002/cncr.26460; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Lurje G, 2008, CLIN CANCER RES, V14, P7884, DOI 10.1158/1078-0432.CCR-07-5165; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mala Z, 2009, J CHROMATOGR A, V1051, P147; Mala Z, 2007, ELECTROPHORESIS, V28, P243, DOI 10.1002/elps.200600397; Mala Z, 2009, ELECTROPHORESIS, V30, P215, DOI 10.1002/elps.200800433; Mao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036653; Marchetti A, 2009, NEW ENGL J MED, V360, P833, DOI 10.1056/NEJMc082346; Mayo Skye C, 2009, Expert Rev Gastroenterol Hepatol, V3, P131, DOI 10.1586/egh.09.8; Milano G, 2008, ANN ONCOL, V19, P2033, DOI 10.1093/annonc/mdn416; Minucci A, 2008, J SEP SCI, V31, P2694, DOI 10.1002/jssc.200800216; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Nachamkin I, 2001, J CLIN MICROBIOL, V39, P754, DOI 10.1128/JCM.39.2.754-757.2001; Nishikawa T, 2002, CLIN CHIM ACTA, V318, P107, DOI 10.1016/S0009-8981(01)00806-3; Ohno K, 2008, ELECTROPHORESIS, V29, P4443, DOI 10.1002/elps.200800121; OUDEJANS JJ, 1991, INT J CANCER, V49, P875, DOI 10.1002/ijc.2910490613; Petersen NJ, 2004, ELECTROPHORESIS, V25, P253, DOI 10.1002/elps.200305747; Qin JH, 2005, ELECTROPHORESIS, V26, P219, DOI 10.1002/elps.200406158; Sarasqueta AF, 2011, J MOL DIAGN, V13, P199, DOI 10.1016/j.jmoldx.2010.10.006; Schimanski CC, 2010, INT J COLORECTAL DIS, V25, P181, DOI 10.1007/s00384-009-0843-7; Schimanski CC, 1999, CANCER RES, V59, P5169; Scholtka B, 2009, CANCER EPIDEMIOL, V33, P123, DOI 10.1016/j.canep.2009.05.001; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Sood A, 2012, CLIN COLORECTAL CANC, V11, P143, DOI 10.1016/j.clcc.2011.12.001; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Waldner MJ, 2010, MOL ASPECTS MED, V31, P171, DOI 10.1016/j.mam.2010.02.005; Weidlich S, 2011, BRIT J CANCER, V105, P246, DOI 10.1038/bjc.2011.197; Winder T, 2010, CANCER TREAT REV, V36, P550, DOI 10.1016/j.ctrv.2010.03.005; Wu CM, 2005, CANCER GENET CYTOGEN, V158, P55, DOI 10.1016/j.cancergencyto.2004.08.030; Xiao SX, 1997, PROG BIOCHEM BIOPHYS, V24, P375; Xu F, 2004, J CHROMATOGR A, V1051, P147, DOI 10.1016/j.chroma.2004.05.019; Yang YZ, 2006, ANAL CHEM, V78, P4752, DOI 10.1021/ac051735v; Zhang HD, 2011, LAB INVEST, V91, P788, DOI 10.1038/labinvest.2010.200; Zou HZ, 2009, GASTROENTEROLOGY, V136, P459, DOI 10.1053/j.gastro.2008.10.023	61	203	206	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54510	10.1371/journal.pone.0054510	http://dx.doi.org/10.1371/journal.pone.0054510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23750250	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500082
